Citrus Sinensis ID: 008729
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 556 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LUC3 | 598 | Mitogen-activated protein | yes | no | 0.946 | 0.879 | 0.804 | 0.0 | |
| Q9C5C0 | 615 | Mitogen-activated protein | no | no | 0.931 | 0.842 | 0.769 | 0.0 | |
| Q5ZCI1 | 611 | Mitogen-activated protein | yes | no | 0.915 | 0.833 | 0.773 | 0.0 | |
| Q9SJG9 | 606 | Mitogen-activated protein | no | no | 0.893 | 0.820 | 0.745 | 0.0 | |
| Q5SN53 | 569 | Mitogen-activated protein | no | no | 0.847 | 0.827 | 0.720 | 0.0 | |
| Q67C40 | 569 | Mitogen-activated protein | no | no | 0.825 | 0.806 | 0.735 | 0.0 | |
| Q75KK8 | 542 | Mitogen-activated protein | no | no | 0.897 | 0.920 | 0.675 | 0.0 | |
| Q6L5D4 | 700 | Mitogen-activated protein | no | no | 0.884 | 0.702 | 0.733 | 0.0 | |
| Q53N72 | 498 | Mitogen-activated protein | no | no | 0.883 | 0.985 | 0.692 | 0.0 | |
| Q8W4J2 | 567 | Mitogen-activated protein | no | no | 0.866 | 0.850 | 0.697 | 0.0 |
| >sp|Q9LUC3|MPK19_ARATH Mitogen-activated protein kinase 19 OS=Arabidopsis thaliana GN=MPK19 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 848 bits (2191), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/531 (80%), Positives = 467/531 (87%), Gaps = 5/531 (0%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+ Q KK +K+ +FFTEYGDANRY+ILEVIGKGSYGVVCAAIDT TGEKVAIKKI+DVF
Sbjct: 1 MQKTQEKKNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA+RILREVKLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV+F+DT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP ETIA VRNEKARKYL EMRKK VP QKFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA EALADPYFK LAK+EREPSCQPISK+EFEFERRR+TKDDIRELIYREILEYH
Sbjct: 301 PKDRPTAAEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRSTVHSG 420
PQLLKDY+N +EG++FLYPSAIG RKQFAYLEEN G+SGPVIPP+RKH SLPRS VHS
Sbjct: 361 PQLLKDYMN-SEGSSFLYPSAIGHLRKQFAYLEENSGKSGPVIPPDRKHASLPRSAVHSS 419
Query: 421 TTPPIVQHNAASSESQQMTEDTSRNFRVTDEISGNHSKFPRPPPRVPAAKPGRVVGSVMP 480
Q + +S+S++++ + SRN V S +K PPPRVP+ KPGRVV S +
Sbjct: 420 AVNSNAQPSLNASDSRRVSIEPSRN-GVVPSTSAYSTKPLGPPPRVPSGKPGRVVESSVT 478
Query: 481 YENGRNIKD-TYDARM-FYRNAVLPPQNVSPHCFFRTNTINQEK-SGLESG 528
YEN RN+K+ +YDAR +YR+ VLPPQ VSP+C+F NT+NQEK SG E+
Sbjct: 479 YENDRNLKESSYDARTSYYRSTVLPPQTVSPNCYFLPNTMNQEKRSGTEAA 529
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4 |
| >sp|Q9C5C0|MPK18_ARATH Mitogen-activated protein kinase 18 OS=Arabidopsis thaliana GN=MPK18 PE=1 SV=4 | Back alignment and function description |
|---|
Score = 812 bits (2097), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 410/533 (76%), Positives = 455/533 (85%), Gaps = 15/533 (2%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQ+Q KK K+ +FFTEYGDANRY+ILEVIGKGSYGVVCAAIDTHTGEKVAIKKI+DVF
Sbjct: 1 MQQNQVKKGTKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA+RILREVKLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALK+MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF+DT
Sbjct: 121 DDLTREHHQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
+LITDLLGTP ETI+ VRN+KARKYLTEMRKK PV QKF DPLALRLLQRL+AFD
Sbjct: 241 ELITDLLGTPKSETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPT EALADPYFKGL+KIEREPS Q ISK+EFEFERRR+TKDDIRELIYREILEYH
Sbjct: 301 PKDRPTPAEALADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRSTVHSG 420
PQLLKDY++G+EG+NF+YPSAIG R+QF YLEEN R+GPVIP ERKH SLPRSTVHS
Sbjct: 361 PQLLKDYMSGSEGSNFVYPSAIGHLRQQFTYLEENSSRNGPVIPLERKHASLPRSTVHST 420
Query: 421 TTPPIVQHNAASSESQQMTEDTSRNFRVTD---EISGNHSKFPRPPPRV-PAAKPGRVVG 476
Q N +++S++++ + S+N + S +K PPPRV P+ +PGRVV
Sbjct: 421 VVHSTSQPNLGATDSRRVSFEPSKNGASSAGHPSTSAYPTKSIGPPPRVPPSGRPGRVVE 480
Query: 477 SVMPYENGRNIKDTYDARMFYRNAVLPPQNVSPHCFFRTNTI-NQEKSGLESG 528
S + YENGRN+K+ Y +R+AV SPHC+FR NT+ N E +E+
Sbjct: 481 SSVSYENGRNLKEAY-----FRSAV-----SSPHCYFRPNTMTNPENRNIEAS 523
|
Mitogen-activated protein kinase (MAPK) that is specifically regulated by PHS1 and mediates signaling that regulates cortical microtubule functions, maybe through regulation of microtubule dynamic instability. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5ZCI1|MPK10_ORYSJ Mitogen-activated protein kinase 10 OS=Oryza sativa subsp. japonica GN=MPK10 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 798 bits (2061), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/513 (77%), Positives = 440/513 (85%), Gaps = 4/513 (0%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQDQ KK + DFFTEYGDA+RYKI EVIGKGSYGVVC+AID HTGEKVAIKKIHD+F
Sbjct: 1 MQQDQRKKSSTEADFFTEYGDASRYKIQEVIGKGSYGVVCSAIDVHTGEKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA RILRE+KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLT+EH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILAN+NCKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTKEHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANSNCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T+FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TDLLGTPS +TI+ VRN+KAR+YL+ MRKK P+ QKFP+ DPLAL LLQ+L+AFD
Sbjct: 241 DLMTDLLGTPSMDTISRVRNDKARRYLSSMRKKEPILFSQKFPSADPLALDLLQKLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALA PYFKGLAK+EREPSCQPI+K+EFEFERRRVTK+DIRELI+REILEYH
Sbjct: 301 PKDRPTAEEALAHPYFKGLAKVEREPSCQPITKMEFEFERRRVTKEDIRELIFREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRST-VHS 419
PQLLKDYINGTE T FLYPSA+ QFRKQFA+LEENGG +GPVIP +RKH SLPRST VHS
Sbjct: 361 PQLLKDYINGTERTTFLYPSAVDQFRKQFAHLEENGG-NGPVIPMDRKHTSLPRSTIVHS 419
Query: 420 GTTPPIVQHNAASSESQQMTEDTSRNFRVTDEISGNHSKFPRPPPRVPAAKPGRVVGSVM 479
P Q S + E S N R D SGN + + P RVP A+PGRVVG V+
Sbjct: 420 TPIPAKEQPRIGPSRDKPSDEPYS-NPREFDRFSGNAPRTSQAPQRVPTARPGRVVGPVL 478
Query: 480 PYENGRNIKDTYDARMFYRNAVLPPQNVSPHCF 512
PYENG KD+YDAR N+ PPQ P +
Sbjct: 479 PYENGAT-KDSYDARRLAMNSGYPPQQQIPQAY 510
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q9SJG9|MPK20_ARATH Mitogen-activated protein kinase 20 OS=Arabidopsis thaliana GN=MPK20 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 774 bits (1999), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/503 (74%), Positives = 426/503 (84%), Gaps = 6/503 (1%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQD KK + +FF++YGDANR+K+ EVIGKGSYGVVC+AIDT TGEKVAIKKIHD+F
Sbjct: 1 MQQDNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA RILRE+KLLRLLRHPDIVEIK IMLPPS+REFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T+FWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVL GKPLFPGK+VVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TDLLGTPS +TI+ VRNEKAR+YLT MRKKPP+P QKFPN DPL+L+LL+RL+AFD
Sbjct: 241 DLMTDLLGTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAK+EREPSCQPI+K+EFEFERR+VTK+DIRELI REILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRSTVHSG 420
PQLLKD++NG + +FLYPSA+ QFR+QFA+LEEN G++GPV P ERKH SLPRSTV
Sbjct: 361 PQLLKDHMNGADKASFLYPSAVDQFRRQFAHLEENSGKTGPVAPLERKHASLPRSTVIHS 420
Query: 421 TTPPIVQHNAASSESQQMTEDTSRNFRVTDEISGNHSKFPRPPPRVPAAKPGRVVGSVMP 480
T A + + M + N T I NH+ + AAKP +G V P
Sbjct: 421 TAV------ARGGQPKLMNNTNTLNPETTQNIPFNHATIQAQQRNLSAAKPSTFMGPVAP 474
Query: 481 YENGRNIKDTYDARMFYRNAVLP 503
++NGR +D YD R F R+ LP
Sbjct: 475 FDNGRISRDAYDPRSFIRSTNLP 497
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q5SN53|MPK8_ORYSJ Mitogen-activated protein kinase 8 OS=Oryza sativa subsp. japonica GN=MPK8 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 756 bits (1953), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/504 (72%), Positives = 419/504 (83%), Gaps = 33/504 (6%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
DFF+EYGDANRYKI EVIGKGSYGVVC+AID HTG+KVAIKKIH++FEH+SDA RILRE+
Sbjct: 2 DFFSEYGDANRYKIQEVIGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILREI 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELM++DLHQVIKANDDLT+EHHQFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
QMLRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DTP TVFWTDYVATR
Sbjct: 122 QMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFF+KY+PAIDIWSIGCIFAE+LTGKPLFPGK+VVHQLDL+TDLLGTPS +
Sbjct: 182 WYRAPELCGSFFTKYSPAIDIWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSMD 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
T+ +RNEKAR+YL+ MRKK PVP ++FP DP AL+LLQRL+AFDPKDRPTAEEALAD
Sbjct: 242 TVTRIRNEKARRYLSSMRKKQPVPFSERFPKADPAALKLLQRLLAFDPKDRPTAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEG 373
PYFKGLAK EREPSCQPI+K+EFEFERR+VTK+D++ELI+REILEYHPQLLKDY+NGTE
Sbjct: 302 PYFKGLAKAEREPSCQPITKMEFEFERRKVTKEDVKELIFREILEYHPQLLKDYMNGTEK 361
Query: 374 TNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR-STVHSGTTPPIVQHNAAS 432
TNFLYPSA+ FR+QFA LEENGG++G +P +RKHVSLPR +TVHS PP N
Sbjct: 362 TNFLYPSALDNFRRQFANLEENGGKNGDAVPSDRKHVSLPRTTTVHSAPIPPKDHQN--- 418
Query: 433 SESQQMTEDTSRNFRVTDEISGNHSKFPRPPPRVPAAKPGRVVGSVMPYENGRNIKDTYD 492
+T ++ P R+P + GR V+P+EN + Y+
Sbjct: 419 ---------------ITSQV----------PQRIP-GRTGRGACPVIPFENLSAM-GPYN 451
Query: 493 ARMFYRNAVLPPQ--NVSPHCFFR 514
R RN VLPP N+S + + R
Sbjct: 452 QRRVVRNPVLPPATTNLSAYAYHR 475
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q67C40|MPK7_ORYSJ Mitogen-activated protein kinase 7 OS=Oryza sativa subsp. japonica GN=MPK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 744 bits (1921), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 362/492 (73%), Positives = 420/492 (85%), Gaps = 33/492 (6%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
DFF+EYGD++RYKI E++GKGSYGVVC+AID HTG+KVAIKKIH++FEH+SDA RILRE+
Sbjct: 2 DFFSEYGDSSRYKIQEIVGKGSYGVVCSAIDQHTGDKVAIKKIHNIFEHLSDAARILREI 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELM++DLHQVIKANDDLT+EHHQFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMDTDLHQVIKANDDLTKEHHQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
QMLRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DTP TVFWTDYVATR
Sbjct: 122 QMLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDTPTTVFWTDYVATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFFSKY+PAID WSIGCIFAE+LTGKPLFPGK+VVHQLDL+TDLLGTPS +
Sbjct: 182 WYRAPELCGSFFSKYSPAIDTWSIGCIFAEILTGKPLFPGKNVVHQLDLMTDLLGTPSMD 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
I+ +RN+KAR+YL+ MR+K PVP +KFPNVDPLAL+LLQRL+AFDPKDRPTAEEALAD
Sbjct: 242 AISRIRNDKARRYLSSMRRKQPVPFSEKFPNVDPLALKLLQRLLAFDPKDRPTAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEG 373
PYFKGLAK+EREPSCQPISK+EFEFERR+VTKDDI+ELI+REILEYHPQLLKDY+NG+E
Sbjct: 302 PYFKGLAKVEREPSCQPISKMEFEFERRKVTKDDIKELIFREILEYHPQLLKDYMNGSEN 361
Query: 374 TNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPR-STVHSGTTPPIVQHNAAS 432
T+FLYPSA+ FR+QFA LEENGG+SG + +RKHVSLPR +TVHS + PP N
Sbjct: 362 TSFLYPSAVDNFRRQFAILEENGGKSGAL---DRKHVSLPRATTVHSTSIPP----NEGL 414
Query: 433 SESQQMTEDTSRNFRVTDEISGNHSKFPRPPPRVPAAKPGRVVGSVMPYENGRNIKDTYD 492
+ Q+T+ R+P A+PGR VG V+P+EN D +
Sbjct: 415 DATSQVTQ------------------------RIPTARPGRTVGPVLPFENP-GAADPHS 449
Query: 493 ARMFYRNAVLPP 504
AR RN ++PP
Sbjct: 450 ARRVVRNPMVPP 461
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q75KK8|MPK14_ORYSJ Mitogen-activated protein kinase 14 OS=Oryza sativa subsp. japonica GN=MPK14 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 735 bits (1898), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/521 (67%), Positives = 419/521 (80%), Gaps = 22/521 (4%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
DFFTEYG+ NRYKI EVIGKGSYGVVC+A+DTHTG+KVAIKKI+D+FEH+SDA RILRE+
Sbjct: 2 DFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGDKVAIKKINDIFEHVSDATRILREI 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIK I+LPPS+REFKDIYVVFELMESDLHQVIKANDDLT EH+QFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARVAFSDTP +FWTDY+ATR
Sbjct: 122 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYIATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQLD+ITDLLGTPSPE
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSPE 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
TI+ +RNEKAR+YL MR+K P+P QKFPN DPLA+RLL+R++AFDPKDRP+AEEALAD
Sbjct: 242 TISRIRNEKARRYLNSMRRKKPIPFTQKFPNADPLAMRLLERMLAFDPKDRPSAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEG 373
PYFK +A ++REPS QPI+KLEFEFERRR+TK+DIRELIYREILEYHP++L++++ GTE
Sbjct: 302 PYFKNIANVDREPSAQPITKLEFEFERRRITKEDIRELIYREILEYHPKMLREFLEGTES 361
Query: 374 TNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRSTVHSGTTPPIVQHNAASS 433
T F+YPSA+ F+KQFAYLEE+ + PPER+H SLPR P +V +
Sbjct: 362 TGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPR--------PCVVYSDNRPQ 413
Query: 434 ESQQMTEDTSR------NFRVTDEISGNHSKFPRPPPRVPAAKPGRVVGSVMPYENGRN- 486
+ +TED SR N + D S S+ P+ AA+PG+ VGSV+ Y N
Sbjct: 414 STASVTEDLSRCLIRDNNLKSQDSASVGASRIPQG----AAARPGKAVGSVLRYGNCSTS 469
Query: 487 -IKDTYDARMFYRNAVLPPQNVSP--HCFFRTNTINQEKSG 524
+ Y+ R RN + P + P + R N + ++G
Sbjct: 470 AAEQQYEQRRVVRNPAIAPNSSVPLGSSYPRRNQTCKSETG 510
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q6L5D4|MPK9_ORYSJ Mitogen-activated protein kinase 9 OS=Oryza sativa subsp. japonica GN=MPK9 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 726 bits (1874), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/496 (73%), Positives = 418/496 (84%), Gaps = 4/496 (0%)
Query: 13 KDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILRE 72
++FFTEYGDANRY+I EVIGKGSYGVVC+AID HT +KVAIKK+H++FEH+SDA RILRE
Sbjct: 95 EEFFTEYGDANRYRIQEVIGKGSYGVVCSAIDLHTRQKVAIKKVHNIFEHVSDAARILRE 154
Query: 73 VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL 132
+KLLRLLRHPDIVEIK IMLPPS+R+FKDIYVVFELMESDLHQVIKANDDLT+EH+QFFL
Sbjct: 155 IKLLRLLRHPDIVEIKHIMLPPSRRDFKDIYVVFELMESDLHQVIKANDDLTKEHYQFFL 214
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
YQ+LRALKY+HTA+VYHRDLKPKNILAN+NCKLK+CDFGLARVAF+DTP TVFWTDYVAT
Sbjct: 215 YQLLRALKYIHTASVYHRDLKPKNILANSNCKLKICDFGLARVAFNDTPTTVFWTDYVAT 274
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQLDL+TDLLGTPS
Sbjct: 275 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLMTDLLGTPSM 334
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+TI+ VRNEKAR+YL+ MRKK PVP QKFPN DPLAL+LLQRL+AFDPKDRPTAEEAL
Sbjct: 335 DTISRVRNEKARRYLSSMRKKDPVPFSQKFPNADPLALKLLQRLLAFDPKDRPTAEEALT 394
Query: 313 DPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTE 372
DPYFKGL+KI+REPSCQPI KLEFEFE+++++K+DIRELI++EILEYHPQL K+Y NG E
Sbjct: 395 DPYFKGLSKIDREPSCQPIRKLEFEFEQKKLSKEDIRELIFQEILEYHPQLQKNYRNGRE 454
Query: 373 GTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRS-TVHSGTTPPIVQHNAA 431
FLYPSA+ QF+KQF+ LEE+ G SG IP ERKH SLPRS TVHS PP Q AA
Sbjct: 455 RATFLYPSAVDQFKKQFSNLEESNG-SGSAIPMERKHASLPRSTTVHSTPIPPKEQPLAA 513
Query: 432 SSESQQ-MTEDTSRNFRVTDEISGNHSKFPRPPPRVPAAKPGRVVGSVMPYENGRNIKDT 490
S +S + ++++ +N V SGN + PGR VGSV PYE G + D
Sbjct: 514 SLKSSRPVSDEPCKNPWVMGGFSGNIPTSSQVSQVAKPVAPGRPVGSVFPYETG-STNDP 572
Query: 491 YDARMFYRNAVLPPQN 506
Y R ++ PPQ
Sbjct: 573 YGPRGPVMSSGYPPQQ 588
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q53N72|MPK15_ORYSJ Mitogen-activated protein kinase 15 OS=Oryza sativa subsp. japonica GN=MPK15 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 725 bits (1872), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 344/497 (69%), Positives = 406/497 (81%), Gaps = 6/497 (1%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
DFFTEYG+ NRYKI EVIGKGSYGVVC+A+DTHTGEKVAIKKI+D+FEH+SDA RILRE+
Sbjct: 2 DFFTEYGEGNRYKIEEVIGKGSYGVVCSALDTHTGEKVAIKKINDIFEHVSDATRILREI 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIK I+LPPS+REFKDIYVVFELMESDLHQVIKANDDLT EH+QFFLY
Sbjct: 62 KLLRLLRHPDIVEIKHILLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHYQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARVAFSDTP +FWTDYVATR
Sbjct: 122 QLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFSDTPTAIFWTDYVATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQLD+ITDLLGTPS E
Sbjct: 182 WYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQLDIITDLLGTPSTE 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
I+ +RNEKAR+YL+ MR+K P+P QKFPN DPLALRLL+R+++F+PKDRP AEEALAD
Sbjct: 242 AISRIRNEKARRYLSSMRRKKPIPFTQKFPNADPLALRLLERMLSFEPKDRPNAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEG 373
PYF+ +A ++REPS QP++KLEFEFERRR+TK+DIRELIYR+ILEYHP +L++Y+ GTE
Sbjct: 302 PYFRNIANVDREPSAQPVTKLEFEFERRRITKEDIRELIYRDILEYHPNMLREYLEGTES 361
Query: 374 TNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRSTVHSGTTPPIVQHNAASS 433
F+YPSA+ F+KQFAYLEE+ + PPER+H SLPR +V P N A
Sbjct: 362 AGFMYPSAVDHFKKQFAYLEEHYAKGSTAAPPERQHNSLPRPSVLYSDDRPQNTANIAED 421
Query: 434 ESQQMTEDTSRNFRVTDEISGNHSKFPRPPPRVPAAKPGRVVGSVMPYEN-GRNIKDTYD 492
S+ + D ++ G+ S P+ AA+PG+VVGS + Y N + + Y+
Sbjct: 422 LSKCVLGDNTQKMH-----QGSASVCANRVPQGGAARPGKVVGSALRYGNCSTSTAEQYE 476
Query: 493 ARMFYRNAVLPPQNVSP 509
R RN L VSP
Sbjct: 477 HRRTDRNPALATNTVSP 493
|
Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
| >sp|Q8W4J2|MPK16_ARATH Mitogen-activated protein kinase 16 OS=Arabidopsis thaliana GN=MPK16 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 716 bits (1847), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 343/492 (69%), Positives = 408/492 (82%), Gaps = 10/492 (2%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ D KK + DFFTEYG+ +RY+I EVIGKGSYGVVC+A DTHTGEKVAIKKI+D+F
Sbjct: 1 MQPDHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILRE+KLLRLLRHPDIVEIK I+LPPS+REF+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLT EH+QFFLYQ+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P +FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TD+LGTPS E I VRNEKAR+YL+ MRKK P+P KFP+ DPLALRLL+++++F+
Sbjct: 241 DLMTDMLGTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALAD YFKGLAK+EREPS QP++KLEFEFERRR+TK+D+RELIYRE LEYH
Sbjct: 301 PKDRPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPER-KHVSLPRSTV-H 418
P++LK+Y++G+E TNF+YPSA+ F+KQFAYLEE+ PPER +H SLPR+ V +
Sbjct: 361 PKMLKEYLDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQQHASLPRACVLY 420
Query: 419 SGTTPPIVQHNAASSESQQMTEDTSRNFRVTDEISGNHSKFPRPPPRVP-------AAKP 471
S P+ Q ++A + +++ + R+ R R P VP A+P
Sbjct: 421 SDNNHPVAQQSSAEV-TDGLSKCSIRDERPRGADRNAQMPMSRIPINVPQTIQGAAVARP 479
Query: 472 GRVVGSVMPYEN 483
G+VVGSV+ Y N
Sbjct: 480 GKVVGSVLRYNN 491
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 4 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 556 | ||||||
| 255575145 | 606 | big map kinase/bmk, putative [Ricinus co | 0.964 | 0.884 | 0.856 | 0.0 | |
| 224056591 | 610 | predicted protein [Populus trichocarpa] | 0.967 | 0.881 | 0.860 | 0.0 | |
| 224119110 | 596 | predicted protein [Populus trichocarpa] | 0.944 | 0.880 | 0.851 | 0.0 | |
| 356556856 | 607 | PREDICTED: mitogen-activated protein kin | 0.951 | 0.871 | 0.824 | 0.0 | |
| 225461820 | 598 | PREDICTED: mitogen-activated protein kin | 0.937 | 0.871 | 0.820 | 0.0 | |
| 356549594 | 588 | PREDICTED: LOW QUALITY PROTEIN: mitogen- | 0.955 | 0.903 | 0.793 | 0.0 | |
| 4732123 | 608 | mitogen-activated protein kinase homolog | 0.929 | 0.850 | 0.815 | 0.0 | |
| 358348772 | 608 | Mitogen-activated protein kinase [Medica | 0.929 | 0.850 | 0.815 | 0.0 | |
| 186510066 | 598 | mitogen-activated protein kinase 19 [Ara | 0.946 | 0.879 | 0.804 | 0.0 | |
| 297830018 | 586 | ATMPK19 [Arabidopsis lyrata subsp. lyrat | 0.915 | 0.868 | 0.822 | 0.0 |
| >gi|255575145|ref|XP_002528477.1| big map kinase/bmk, putative [Ricinus communis] gi|223532086|gb|EEF33894.1| big map kinase/bmk, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 946 bits (2445), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 459/536 (85%), Positives = 494/536 (92%)
Query: 8 KELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI 67
++LK+ DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI
Sbjct: 3 QDLKEIDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI 62
Query: 68 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREH 127
RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI+VVFELMESDLHQVIKANDDLTREH
Sbjct: 63 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIFVVFELMESDLHQVIKANDDLTREH 122
Query: 128 HQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
HQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP TVFWT
Sbjct: 123 HQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPTTVFWT 182
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247
DYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVL+GKPLFPGKSVVHQLDLITDLL
Sbjct: 183 DYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLSGKPLFPGKSVVHQLDLITDLL 242
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
GTPSPET++ VRN+KARKYLTEMRKK PV QKFPN DPLALRLLQRL+AFDPKDRPTA
Sbjct: 243 GTPSPETVSGVRNDKARKYLTEMRKKHPVSFTQKFPNADPLALRLLQRLLAFDPKDRPTA 302
Query: 308 EEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDY 367
EEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK+D+REL+YREILEYHPQLLKDY
Sbjct: 303 EEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKEDVRELLYREILEYHPQLLKDY 362
Query: 368 INGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRSTVHSGTTPPIVQ 427
+NG EGTNFLYPSAIG FRKQFAYLEENGGRSGPVIP ERKHVSLPRSTVHS T PP VQ
Sbjct: 363 LNGNEGTNFLYPSAIGHFRKQFAYLEENGGRSGPVIPLERKHVSLPRSTVHSSTIPPNVQ 422
Query: 428 HNAASSESQQMTEDTSRNFRVTDEISGNHSKFPRPPPRVPAAKPGRVVGSVMPYENGRNI 487
+ + +++Q+ E+ ++N+R TD ISGN SK RPPPRVPAAKPGRVVGSV+P ENGRN+
Sbjct: 423 PTSTAFDNRQVAEEAAKNYRATDSISGNASKVSRPPPRVPAAKPGRVVGSVVPCENGRNV 482
Query: 488 KDTYDARMFYRNAVLPPQNVSPHCFFRTNTINQEKSGLESGRGLLMLNQSPHNTTL 543
KD D+R+FYRNAVLPPQ VSPHCFFRTNT+ QEKS + S + + + P + +
Sbjct: 483 KDACDSRIFYRNAVLPPQTVSPHCFFRTNTMIQEKSMMASEKDTSQVKRQPLQSNI 538
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224056591|ref|XP_002298926.1| predicted protein [Populus trichocarpa] gi|222846184|gb|EEE83731.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 941 bits (2433), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/538 (86%), Positives = 493/538 (91%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQD KK+LK+ DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTG+KVAIKKI+DVF
Sbjct: 1 MQQDHPKKDLKEIDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGDKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI+VVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIFVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTPS ETI+ VRN+KARKYLTEMRKK PVP QKF NVDPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPSSETISGVRNDKARKYLTEMRKKQPVPFAQKFLNVDPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDR TAEEALADPYFKGLAK+EREPSCQPISKLEFEFERRRVTK+D+REL+YREILEYH
Sbjct: 301 PKDRLTAEEALADPYFKGLAKVEREPSCQPISKLEFEFERRRVTKEDVRELLYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRSTVHSG 420
PQLLKDY+NG E TNFLYPSAIGQFRKQFAYLEEN GRSGPVIPPERKHVSLPRSTVHS
Sbjct: 361 PQLLKDYMNGNENTNFLYPSAIGQFRKQFAYLEENSGRSGPVIPPERKHVSLPRSTVHSN 420
Query: 421 TTPPIVQHNAASSESQQMTEDTSRNFRVTDEISGNHSKFPRPPPRVPAAKPGRVVGSVMP 480
T PP +Q + S +++ +TEDTS+NFRV D GN +K RPPPRVP+AK GRVVGS +P
Sbjct: 421 TIPPNMQSTSTSFDNRLVTEDTSKNFRVPDASFGNPAKVARPPPRVPSAKQGRVVGSAVP 480
Query: 481 YENGRNIKDTYDARMFYRNAVLPPQNVSPHCFFRTNTINQEKSGLESGRGLLMLNQSP 538
Y+NGRN+KD YD+R+FYRN+VLPPQ VSPHCFFRTNT+ QEKS E + Q P
Sbjct: 481 YDNGRNVKDAYDSRIFYRNSVLPPQTVSPHCFFRTNTMVQEKSISEPEKDSQTKQQPP 538
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119110|ref|XP_002331327.1| predicted protein [Populus trichocarpa] gi|222873910|gb|EEF11041.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 936 bits (2418), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 447/525 (85%), Positives = 476/525 (90%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
+FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI++VFEHISDA RILREV
Sbjct: 2 EFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKINNVFEHISDAFRILREV 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIKRIMLPPSKREFKDI+VVFELMESDLHQVIKANDDLTREHHQFFLY
Sbjct: 62 KLLRLLRHPDIVEIKRIMLPPSKREFKDIFVVFELMESDLHQVIKANDDLTREHHQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
QMLRALKYMHTAN+YHRDLKPKNILANANCKLKVCDFGLARVAFSDTP TVFWTDYVATR
Sbjct: 122 QMLRALKYMHTANMYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPTTVFWTDYVATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSFFSKYT AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS E
Sbjct: 182 WYRAPELCGSFFSKYTRAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSLE 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
TI+ VRN+KARKYLTEMRKK PVP QKFPN DP A RLLQRL+AFDPKDRPTAEEALAD
Sbjct: 242 TISRVRNDKARKYLTEMRKKQPVPFAQKFPNADPSAHRLLQRLLAFDPKDRPTAEEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEG 373
PYFKGLAK+EREPSCQPI+KLEFEFERRRVTK+D+REL+YREILEYHPQLLKDY+NG E
Sbjct: 302 PYFKGLAKVEREPSCQPITKLEFEFERRRVTKEDVRELLYREILEYHPQLLKDYMNGNES 361
Query: 374 TNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRSTVHSGTTPPIVQHNAASS 433
TNFLYPSAIG FRKQFAYLEEN GRS PVIP ERKHVSLPRSTVHS T PP +Q N+ S
Sbjct: 362 TNFLYPSAIGHFRKQFAYLEENSGRSAPVIPLERKHVSLPRSTVHSNTMPPNMQSNSTSF 421
Query: 434 ESQQMTEDTSRNFRVTDEISGNHSKFPRPPPRVPAAKPGRVVGSVMPYENGRNIKDTYDA 493
+++Q+TED S+N RV D N +K RPPPR+P+AKPGRVVGSV+PYENGRN+KD YD
Sbjct: 422 DNRQVTEDASKNLRVQDTSFENPAKVARPPPRMPSAKPGRVVGSVVPYENGRNVKDLYDT 481
Query: 494 RMFYRNAVLPPQNVSPHCFFRTNTINQEKSGLESGRGLLMLNQSP 538
RMF RNAVLPPQ SPHCF RTNT+ QEKS E+G+ Q P
Sbjct: 482 RMFCRNAVLPPQTSSPHCFLRTNTLIQEKSISETGKDSQTKQQPP 526
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356556856|ref|XP_003546736.1| PREDICTED: mitogen-activated protein kinase 19-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 895 bits (2314), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/531 (82%), Positives = 474/531 (89%), Gaps = 2/531 (0%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQDQ KK++K+ +FFTEYGDANRYKILEV+GKGSYGVVC+AIDTHTG KVAIKKIHD+F
Sbjct: 1 MQQDQLKKDMKEVEFFTEYGDANRYKILEVVGKGSYGVVCSAIDTHTGGKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRA+KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD
Sbjct: 121 DDLTREHHQFFLYQMLRAMKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDA 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTTFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP PETIA VRN+KARKYL EMRKK PVP QKFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPPPETIAGVRNDKARKYLMEMRKKSPVPFEQKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA+EALADP+FKGLAK+EREPSCQPIS+LEFEFERRRVTKDD+RELIYREILEYH
Sbjct: 301 PKDRPTAQEALADPFFKGLAKVEREPSCQPISRLEFEFERRRVTKDDVRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRSTVHSG 420
PQLLKDY+NGTEGT+FLYPSAI QFRK FAYLEEN G+SGPVIPPERKHVSLPRSTVHS
Sbjct: 361 PQLLKDYMNGTEGTHFLYPSAIDQFRKHFAYLEENHGKSGPVIPPERKHVSLPRSTVHSS 420
Query: 421 TTPPIVQHNAASSESQQMTEDTSRNFRVTDEISGNHSKFPRPPPRVPAAKPGRVVGSVMP 480
T PP Q + S E++ M E+ S+ R + SG+ + RPPPRVPAAKPGR+VG V+
Sbjct: 421 TIPPSTQPSFTSYENKHMAEEASKVTRSVESNSGSQLRSSRPPPRVPAAKPGRIVGPVLH 480
Query: 481 YENGRNIKDTYDARMFYRNAVLPPQNVSPHCFFRTNTINQEKSGLESGRGL 531
Y+NGR +KDTYD R+FYRN + PQ VSPHCF R K+ E+ + +
Sbjct: 481 YDNGRTLKDTYDQRIFYRNTL--PQAVSPHCFHRVQQPTITKTTSETYKNI 529
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225461820|ref|XP_002285641.1| PREDICTED: mitogen-activated protein kinase 19 [Vitis vinifera] gi|302142803|emb|CBI20098.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 872 bits (2254), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 433/528 (82%), Positives = 471/528 (89%), Gaps = 7/528 (1%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+D KK LK+KDFFT YG+ANRYKILEV+GKGSYGVVC+AIDTHTGEKVAIKKI+D+F
Sbjct: 1 MQKDLPKKGLKEKDFFTGYGEANRYKILEVVGKGSYGVVCSAIDTHTGEKVAIKKINDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILRE+KLLRLLRHPDIVEIKRIMLPPS REFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREIKLLRLLRHPDIVEIKRIMLPPSSREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH QFFLYQ+LRALKYMHTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTREHQQFFLYQLLRALKYMHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T+FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TDLLGTPS + I+ VRN+KARKYLTEMRKK PVP QKFPN DPLALRLL+RL+AFD
Sbjct: 241 DLMTDLLGTPSLDAISKVRNDKARKYLTEMRKKHPVPFSQKFPNADPLALRLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
P DRPTAEEALADPYFKGLAK+EREPSCQ ISKLEF+FERRRVTK+D++ELI+REILEYH
Sbjct: 301 PMDRPTAEEALADPYFKGLAKVEREPSCQSISKLEFDFERRRVTKEDVKELIFREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRST-VHS 419
PQLLKDYIN TE TN LYPSAIGQFRK FA+ EENGGRSGPVIPPERKHVSLPRST VHS
Sbjct: 361 PQLLKDYINRTEETNVLYPSAIGQFRKHFAHFEENGGRSGPVIPPERKHVSLPRSTVVHS 420
Query: 420 GTTPPIVQHNAASSESQQMTEDTSRNFRVTDEISGNHSKFPRPPPRVPAAKPGRVVGSVM 479
T N S E+Q++ E+ +N+RVT ISGN K RPPPRVP AKPGRVVG V+
Sbjct: 421 STATLNAHPNLTSFENQKIAEEACKNYRVTGTISGNLMKASRPPPRVPTAKPGRVVGPVL 480
Query: 480 PYENGRNIKDTYDARMFYRNAVLPPQNVSPHCFFRTNTINQEKSGLES 527
PYENGRN+KDT + A L PQ+VSP+C FRTNTI+QEKS E+
Sbjct: 481 PYENGRNLKDTLTSI-----ATL-PQSVSPNCIFRTNTISQEKSTTEA 522
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356549594|ref|XP_003543177.1| PREDICTED: LOW QUALITY PROTEIN: mitogen-activated protein kinase 19-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 863 bits (2231), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/538 (79%), Positives = 465/538 (86%), Gaps = 7/538 (1%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQDQ KK++K+ +FFTEYGDANRYKILEV+GKGSYGVVC+AIDTHTG KVAIKKIHD+F
Sbjct: 1 MQQDQLKKDIKEVEFFTEYGDANRYKILEVVGKGSYGVVCSAIDTHTGGKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRI+LPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIVLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH+QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD
Sbjct: 121 DDLTREHYQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDA 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T FWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTTFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTPSPETIA VRN+KARKYL EMRKK PVP QKF N DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPSPETIAGVRNDKARKYLMEMRKKSPVPFEQKFQNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA+EALADP+FKGL+K+EREPSCQPISKLEFEFERRRVTKDD+RELIYREILEYH
Sbjct: 301 PKDRPTAQEALADPFFKGLSKVEREPSCQPISKLEFEFERRRVTKDDVRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRSTVHSG 420
PQLLKDY+NGTEGT+FLYPSA+ QFRK FAYLEEN G+SGPVIPPERKHVSLPRS VHS
Sbjct: 361 PQLLKDYMNGTEGTHFLYPSAVDQFRKHFAYLEENHGKSGPVIPPERKHVSLPRSIVHSS 420
Query: 421 TTPPIVQHNAASSESQQMTEDTSRNFRVTDEISGNHSKFPRPPPRVPAAKPGRVVGSVMP 480
T PP Q + S E++QM + S+ R + S + + PPPRVPAAK GR+ G V+
Sbjct: 421 TIPPSSQPSFTSYENKQMALEASKVSRSVESNSRSQLRSSXPPPRVPAAKAGRITGPVLH 480
Query: 481 YENGRNIKDTYDARMFYRNAVLPPQNVSPHCFFRTNTINQEKSGLESGRGLLMLNQSP 538
Y+NGR IKD YD PQ VSPHCF R K+ E+ +G+ ++ P
Sbjct: 481 YDNGRTIKDAYDQGSL-------PQFVSPHCFHRVQQPTNIKTTSETYKGISQQDKHP 531
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|4732123|gb|AAD28617.1|AF129087_1 mitogen-activated protein kinase homologue [Medicago sativa] | Back alignment and taxonomy information |
|---|
Score = 856 bits (2211), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/520 (81%), Positives = 463/520 (89%), Gaps = 3/520 (0%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+DQ KK++K+ FFT+YGDANRYKILEV+GKGSYGVVCAAIDTHTG KVAIKKIHDVF
Sbjct: 1 MQKDQLKKDVKEVKFFTDYGDANRYKILEVVGKGSYGVVCAAIDTHTGGKVAIKKIHDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH QFFLYQMLRALK+MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF+DT
Sbjct: 121 DDLTREHQQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T FWTDYVATRWYRAPELCGSFF+KYTPAIDIWSIGCIFAEVLTGKPLFPGKS+VHQL
Sbjct: 181 PTTTFWTDYVATRWYRAPELCGSFFAKYTPAIDIWSIGCIFAEVLTGKPLFPGKSIVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP PE I+ VRNEKARKYL EMRKK PVP +KFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPPPEIISGVRNEKARKYLMEMRKKLPVPFERKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA+EALADP+FKGLAKIEREPS QPIS++EF+FERRRV+KDDI+ELIYREILEYH
Sbjct: 301 PKDRPTAQEALADPFFKGLAKIEREPSSQPISRMEFDFERRRVSKDDIKELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRSTVHSG 420
PQLLKDYI+GTEGTNF+YPSAI QFRKQFAYLEEN G+ GPVIPPERKHVSLPRSTV S
Sbjct: 361 PQLLKDYISGTEGTNFMYPSAIDQFRKQFAYLEENNGKCGPVIPPERKHVSLPRSTVLSS 420
Query: 421 TTPPIVQHNAASSESQQMTEDTSRNFRVTDEISGNHSKFPRPPPRVPAAKPGRVVGSVMP 480
T PP Q + A ++Q+T++ R + S + SK RPPPR PAAK GRV G V+
Sbjct: 421 TIPPSTQPSFAPYANRQITQEAFSIPRAAESNSLSQSKGLRPPPRAPAAKSGRVTGPVL- 479
Query: 481 YENGRNIKDTYDARMFYRNAVLPPQNVSPHCFFRTNTINQ 520
Y+NGR+ KD YDAR+FY+NA+ PQ +SPHCF R +Q
Sbjct: 480 YDNGRSTKDNYDARIFYQNAI--PQAISPHCFQRVANAHQ 517
|
Source: Medicago sativa Species: Medicago sativa Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358348772|ref|XP_003638417.1| Mitogen-activated protein kinase [Medicago truncatula] gi|355504352|gb|AES85555.1| Mitogen-activated protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 855 bits (2210), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/520 (81%), Positives = 461/520 (88%), Gaps = 3/520 (0%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+DQ KK++K+ FFT+YGDANRYKILEV+GKGSYGVVCAAIDTHTG KVAIKKIHDVF
Sbjct: 1 MQKDQLKKDVKEVKFFTDYGDANRYKILEVVGKGSYGVVCAAIDTHTGGKVAIKKIHDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH QFFLYQMLRALK+MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF+DT
Sbjct: 121 DDLTREHQQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T FWTDYVATRWYRAPELCGSFF+KYTPAIDIWSIGCIFAEVLTGKPLFPGKS+VHQL
Sbjct: 181 PTTTFWTDYVATRWYRAPELCGSFFAKYTPAIDIWSIGCIFAEVLTGKPLFPGKSIVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP PE I+ VRNEKARKYL EMRKK PVP +KFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPPPEIISGVRNEKARKYLMEMRKKLPVPFERKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA+EALADP+FKGLAKIEREPS Q IS++EFEFERRRV+KDDI+ELIYREILEYH
Sbjct: 301 PKDRPTAQEALADPFFKGLAKIEREPSSQSISRMEFEFERRRVSKDDIKELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRSTVHSG 420
PQLLKDYINGTEGTNF+YPSAI QFRKQFAYLEEN G+ GPVIPPERKHVSLPRSTV S
Sbjct: 361 PQLLKDYINGTEGTNFMYPSAIDQFRKQFAYLEENNGKCGPVIPPERKHVSLPRSTVLSS 420
Query: 421 TTPPIVQHNAASSESQQMTEDTSRNFRVTDEISGNHSKFPRPPPRVPAAKPGRVVGSVMP 480
T PP Q + A ++Q+ ++ R + S + SK RPPPR PAAK GRV G V+
Sbjct: 421 TIPPSTQSSFAPYANRQIAQEAFSIPRAAESNSLSQSKGLRPPPRAPAAKSGRVTGPVL- 479
Query: 481 YENGRNIKDTYDARMFYRNAVLPPQNVSPHCFFRTNTINQ 520
Y+NGR+ KD YDAR+FY+NA+ PQ +SPHCF R +Q
Sbjct: 480 YDNGRSTKDNYDARIFYQNAI--PQAISPHCFQRVAHAHQ 517
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|186510066|ref|NP_188090.2| mitogen-activated protein kinase 19 [Arabidopsis thaliana] gi|209572650|sp|Q9LUC3.2|MPK19_ARATH RecName: Full=Mitogen-activated protein kinase 19; Short=AtMPK19; Short=MAP kinase 19 gi|332642038|gb|AEE75559.1| mitogen-activated protein kinase 19 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 848 bits (2191), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/531 (80%), Positives = 467/531 (87%), Gaps = 5/531 (0%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+ Q KK +K+ +FFTEYGDANRY+ILEVIGKGSYGVVCAAIDT TGEKVAIKKI+DVF
Sbjct: 1 MQKTQEKKNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA+RILREVKLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV+F+DT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP ETIA VRNEKARKYL EMRKK VP QKFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA EALADPYFK LAK+EREPSCQPISK+EFEFERRR+TKDDIRELIYREILEYH
Sbjct: 301 PKDRPTAAEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRSTVHSG 420
PQLLKDY+N +EG++FLYPSAIG RKQFAYLEEN G+SGPVIPP+RKH SLPRS VHS
Sbjct: 361 PQLLKDYMN-SEGSSFLYPSAIGHLRKQFAYLEENSGKSGPVIPPDRKHASLPRSAVHSS 419
Query: 421 TTPPIVQHNAASSESQQMTEDTSRNFRVTDEISGNHSKFPRPPPRVPAAKPGRVVGSVMP 480
Q + +S+S++++ + SRN V S +K PPPRVP+ KPGRVV S +
Sbjct: 420 AVNSNAQPSLNASDSRRVSIEPSRN-GVVPSTSAYSTKPLGPPPRVPSGKPGRVVESSVT 478
Query: 481 YENGRNIKD-TYDARM-FYRNAVLPPQNVSPHCFFRTNTINQEK-SGLESG 528
YEN RN+K+ +YDAR +YR+ VLPPQ VSP+C+F NT+NQEK SG E+
Sbjct: 479 YENDRNLKESSYDARTSYYRSTVLPPQTVSPNCYFLPNTMNQEKRSGTEAA 529
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297830018|ref|XP_002882891.1| ATMPK19 [Arabidopsis lyrata subsp. lyrata] gi|297328731|gb|EFH59150.1| ATMPK19 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 845 bits (2183), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/513 (82%), Positives = 458/513 (89%), Gaps = 4/513 (0%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREV 73
+FFTEYGDANRY+ILEVIGKGSYGVVCAAIDTHTGEKVAIKKI+DVFEH+SDA+RILREV
Sbjct: 2 EFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVFEHVSDALRILREV 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
KLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY
Sbjct: 62 KLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV+F+DTP TVFWTDYVATR
Sbjct: 122 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDTPTTVFWTDYVATR 181
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
WYRAPELCGSF SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP E
Sbjct: 182 WYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPKSE 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
TIA VRNEKARKYL EMRKK PVP QKFPN DPLALRLLQRL+AFDPKDRPTA EALAD
Sbjct: 242 TIAGVRNEKARKYLNEMRKKNPVPFSQKFPNADPLALRLLQRLLAFDPKDRPTAAEALAD 301
Query: 314 PYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEG 373
PYFK LAKIEREPSCQPISK+EFEFERRR+TKDDIRELIYREILEYHPQLLKDY+N +EG
Sbjct: 302 PYFKVLAKIEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYHPQLLKDYMN-SEG 360
Query: 374 TNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRSTVHSGTTPPIVQHNAASS 433
+NFLYPSAIG RKQFAYLEEN G+SGPVIPP+RKH SLPRSTVHS Q + +S
Sbjct: 361 SNFLYPSAIGHLRKQFAYLEENSGKSGPVIPPDRKHASLPRSTVHSSAVNSNAQPSLNAS 420
Query: 434 ESQQMTEDTSRNFRVTDEISGNHSKFPRPPPRVPAAKPGRVVGSVMPYENGRNIKD-TYD 492
+S++++ + SRN V S +K PPPRVP+ +PGR+V S + YEN RN+K+ +YD
Sbjct: 421 DSRRVSIEPSRN-GVVPSTSAYSTKPIGPPPRVPSGRPGRIVESSVTYENDRNLKESSYD 479
Query: 493 ARM-FYRNAVLPPQNVSPHCFFRTNTINQEKSG 524
AR +YR+ VLPPQ +SP+CFF NT+NQEK G
Sbjct: 480 ARTSYYRSTVLPPQTISPNCFFHPNTMNQEKRG 512
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 556 | ||||||
| TAIR|locus:2089576 | 598 | MPK19 "MAP kinase 19" [Arabido | 0.944 | 0.877 | 0.783 | 7.9e-220 | |
| TAIR|locus:2024887 | 615 | MPK18 "mitogen-activated prote | 0.924 | 0.835 | 0.747 | 1.9e-209 | |
| TAIR|locus:2052357 | 606 | MPK20 "MAP kinase 20" [Arabido | 0.893 | 0.820 | 0.737 | 1.6e-203 | |
| TAIR|locus:2179609 | 567 | MPK16 "mitogen-activated prote | 0.775 | 0.760 | 0.755 | 1.4e-183 | |
| TAIR|locus:2092717 | 510 | MPK9 "MAP kinase 9" [Arabidops | 0.744 | 0.811 | 0.765 | 2.4e-179 | |
| TAIR|locus:2027814 | 576 | MPK15 "MAP kinase 15" [Arabido | 0.739 | 0.713 | 0.754 | 1.4e-174 | |
| TAIR|locus:2194040 | 589 | ATMPK8 [Arabidopsis thaliana ( | 0.796 | 0.752 | 0.685 | 3e-172 | |
| TAIR|locus:2049552 | 486 | MPK17 "MAP kinase 17" [Arabido | 0.780 | 0.893 | 0.699 | 3.2e-168 | |
| DICTYBASE|DDB_G0286353 | 529 | erkA "mitogen-activated protei | 0.600 | 0.631 | 0.516 | 4.5e-91 | |
| TAIR|locus:2124943 | 376 | MPK4 "MAP kinase 4" [Arabidops | 0.589 | 0.872 | 0.504 | 1.9e-90 |
| TAIR|locus:2089576 MPK19 "MAP kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2123 (752.4 bits), Expect = 7.9e-220, P = 7.9e-220
Identities = 415/530 (78%), Positives = 454/530 (85%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ+ Q KK +K+ +FFTEYGDANRY+ILEVIGKGSYGVVCAAIDT TGEKVAIKKI+DVF
Sbjct: 1 MQKTQEKKNMKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTQTGEKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA+RILREVKLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV+F+DT
Sbjct: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVSFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSF SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFCSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DLITDLLGTP ETIA VRNEKARKYL EMRKK VP QKFPN DPLALRLLQRL+AFD
Sbjct: 241 DLITDLLGTPKSETIAGVRNEKARKYLNEMRKKNLVPFSQKFPNADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTA EALADPYFK LAK+EREPSCQPISK+EFEFERRR+TKDDIRELIYREILEYH
Sbjct: 301 PKDRPTAAEALADPYFKCLAKVEREPSCQPISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRSTVHSG 420
PQLLKDY+N +EG++FLYPSAIG RKQFAYLEEN G+SGPVIPP+RKH SLPRS VHS
Sbjct: 361 PQLLKDYMN-SEGSSFLYPSAIGHLRKQFAYLEENSGKSGPVIPPDRKHASLPRSAVHSS 419
Query: 421 TTPPIVQHNAASSESQQMTEDTSRNFRVTDEISGNHSKFXXXXXXXXXXXXXXXXGSVMP 480
Q + +S+S++++ + SRN V S +K S +
Sbjct: 420 AVNSNAQPSLNASDSRRVSIEPSRN-GVVPSTSAYSTKPLGPPPRVPSGKPGRVVESSVT 478
Query: 481 YENGRNIKDT-YDARM-FYRNAVLPPQNVSPHCFFRTNTINQEK-SGLES 527
YEN RN+K++ YDAR +YR+ VLPPQ VSP+C+F NT+NQEK SG E+
Sbjct: 479 YENDRNLKESSYDARTSYYRSTVLPPQTVSPNCYFLPNTMNQEKRSGTEA 528
|
|
| TAIR|locus:2024887 MPK18 "mitogen-activated protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2025 (717.9 bits), Expect = 1.9e-209, P = 1.9e-209
Identities = 400/535 (74%), Positives = 444/535 (82%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQ+Q KK K+ +FFTEYGDANRY+ILEVIGKGSYGVVCAAIDTHTGEKVAIKKI+DVF
Sbjct: 1 MQQNQVKKGTKEMEFFTEYGDANRYRILEVIGKGSYGVVCAAIDTHTGEKVAIKKINDVF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA+RILREVKLLRLLRHPDIVEIK IMLPPSKREFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDALRILREVKLLRLLRHPDIVEIKSIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREHHQFFLYQMLRALK+MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF+DT
Sbjct: 121 DDLTREHHQFFLYQMLRALKFMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P TVFWTDYVATRWYRAPELCGSFFSKYTPAID+WSIGCIFAEVLTGKPLFPGKSVVHQL
Sbjct: 181 PTTVFWTDYVATRWYRAPELCGSFFSKYTPAIDVWSIGCIFAEVLTGKPLFPGKSVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
+LITDLLGTP ETI+ VRN+KARKYLTEMRKK PV QKF DPLALRLLQRL+AFD
Sbjct: 241 ELITDLLGTPKSETISGVRNDKARKYLTEMRKKNPVTFSQKFSKADPLALRLLQRLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPT EALADPYFKGL+KIEREPS Q ISK+EFEFERRR+TKDDIRELIYREILEYH
Sbjct: 301 PKDRPTPAEALADPYFKGLSKIEREPSSQQISKMEFEFERRRLTKDDIRELIYREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRSTVHSG 420
PQLLKDY++G+EG+NF+YPSAIG R+QF YLEEN R+GPVIP ERKH SLPRSTVHS
Sbjct: 361 PQLLKDYMSGSEGSNFVYPSAIGHLRQQFTYLEENSSRNGPVIPLERKHASLPRSTVHST 420
Query: 421 TTPPIVQHNAASSESQQMTEDTSRNFRVTDEISGNHSKFXXXXXXXXXXXXXXXXG---- 476
Q N +++S++++ + S+N + +G+ S G
Sbjct: 421 VVHSTSQPNLGATDSRRVSFEPSKNGASS---AGHPSTSAYPTKSIGPPPRVPPSGRPGR 477
Query: 477 ---SVMPYENGRNIKDTYDARMFYRNAVLPPQNVSPHCFFRTNTI-NQEKSGLES 527
S + YENGRN+K+ Y +R+AV SPHC+FR NT+ N E +E+
Sbjct: 478 VVESSVSYENGRNLKEAY-----FRSAVS-----SPHCYFRPNTMTNPENRNIEA 522
|
|
| TAIR|locus:2052357 MPK20 "MAP kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1969 (698.2 bits), Expect = 1.6e-203, P = 1.6e-203
Identities = 371/503 (73%), Positives = 420/503 (83%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQQD KK + +FF++YGDANR+K+ EVIGKGSYGVVC+AIDT TGEKVAIKKIHD+F
Sbjct: 1 MQQDNRKKNNLEMEFFSDYGDANRFKVQEVIGKGSYGVVCSAIDTLTGEKVAIKKIHDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EHISDA RILRE+KLLRLLRHPDIVEIK IMLPPS+REFKDIYVVFELMESDLHQVIKAN
Sbjct: 61 EHISDAARILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLTREH+QFFLYQ+LRALKY+HTANVYHRDLKPKNILANANCKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTREHYQFFLYQLLRALKYIHTANVYHRDLKPKNILANANCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P T+FWTDYVATRWYRAPELCGSF+SKYTPAIDIWSIGCIFAEVL GKPLFPGK+VVHQL
Sbjct: 181 PTTIFWTDYVATRWYRAPELCGSFYSKYTPAIDIWSIGCIFAEVLMGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TDLLGTPS +TI+ VRNEKAR+YLT MRKKPP+P QKFPN DPL+L+LL+RL+AFD
Sbjct: 241 DLMTDLLGTPSLDTISRVRNEKARRYLTSMRKKPPIPFAQKFPNADPLSLKLLERLLAFD 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALADPYFKGLAK+EREPSCQPI+K+EFEFERR+VTK+DIRELI REILEYH
Sbjct: 301 PKDRPTAEEALADPYFKGLAKVEREPSCQPITKMEFEFERRKVTKEDIRELISREILEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRSTVHSG 420
PQLLKD++NG + +FLYPSA+ QFR+QFA+LEEN G++GPV P ERKH SLPRSTV
Sbjct: 361 PQLLKDHMNGADKASFLYPSAVDQFRRQFAHLEENSGKTGPVAPLERKHASLPRSTVIHS 420
Query: 421 TTPPIVQHNAASSESQQMTEDTSRNFRVTDEISGNHSKFXXXXXXXXXXXXXXXXGSVMP 480
T A + + M + N T I NH+ G V P
Sbjct: 421 TAV------ARGGQPKLMNNTNTLNPETTQNIPFNHATIQAQQRNLSAAKPSTFMGPVAP 474
Query: 481 YENGRNIKDTYDARMFYRNAVLP 503
++NGR +D YD R F R+ LP
Sbjct: 475 FDNGRISRDAYDPRSFIRSTNLP 497
|
|
| TAIR|locus:2179609 MPK16 "mitogen-activated protein kinase 16" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1781 (632.0 bits), Expect = 1.4e-183, P = 1.4e-183
Identities = 327/433 (75%), Positives = 383/433 (88%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
MQ D KK + DFFTEYG+ +RY+I EVIGKGSYGVVC+A DTHTGEKVAIKKI+D+F
Sbjct: 1 MQPDHRKKSSVEVDFFTEYGEGSRYRIEEVIGKGSYGVVCSAYDTHTGEKVAIKKINDIF 60
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILRE+KLLRLLRHPDIVEIK I+LPPS+REF+DIYVVFELMESDLHQVIKAN
Sbjct: 61 EHVSDATRILREIKLLRLLRHPDIVEIKHILLPPSRREFRDIYVVFELMESDLHQVIKAN 120
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLT EH+QFFLYQ+LR LKY+HTANV+HRDLKPKNILANA+CKLK+CDFGLARVAF+DT
Sbjct: 121 DDLTPEHYQFFLYQLLRGLKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 180
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P +FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQL
Sbjct: 181 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAELLTGKPLFPGKNVVHQL 240
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TD+LGTPS E I VRNEKAR+YL+ MRKK P+P KFP+ DPLALRLL+++++F+
Sbjct: 241 DLMTDMLGTPSAEAIGRVRNEKARRYLSSMRKKKPIPFSHKFPHTDPLALRLLEKMLSFE 300
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDRPTAEEALAD YFKGLAK+EREPS QP++KLEFEFERRR+TK+D+RELIYRE LEYH
Sbjct: 301 PKDRPTAEEALADVYFKGLAKVEREPSAQPVTKLEFEFERRRITKEDVRELIYRESLEYH 360
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERK-HVSLPRSTV-H 418
P++LK+Y++G+E TNF+YPSA+ F+KQFAYLEE+ PPER+ H SLPR+ V +
Sbjct: 361 PKMLKEYLDGSEPTNFMYPSAVEHFKKQFAYLEEHYKNGTSHNPPERQQHASLPRACVLY 420
Query: 419 SGTTPPIVQHNAA 431
S P+ Q ++A
Sbjct: 421 SDNNHPVAQQSSA 433
|
|
| TAIR|locus:2092717 MPK9 "MAP kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1741 (617.9 bits), Expect = 2.4e-179, P = 2.4e-179
Identities = 317/414 (76%), Positives = 371/414 (89%)
Query: 4 DQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI 63
D KK + +FFTEYG+A+RY+I EVIGKGSYGVV +AIDTH+GEKVAIKKI+DVFEH+
Sbjct: 2 DPHKKVALETEFFTEYGEASRYQIQEVIGKGSYGVVASAIDTHSGEKVAIKKINDVFEHV 61
Query: 64 SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDL 123
SDA RILRE+KLLRLLRHPDIVEIK +MLPPS+REF+DIYVVFELMESDLHQVIKANDDL
Sbjct: 62 SDATRILREIKLLRLLRHPDIVEIKHVMLPPSRREFRDIYVVFELMESDLHQVIKANDDL 121
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183
T EH+QFFLYQ+LR LK++HTANV+HRDLKPKNILAN++CKLK+CDFGLARV+F+D P
Sbjct: 122 TPEHYQFFLYQLLRGLKFIHTANVFHRDLKPKNILANSDCKLKICDFGLARVSFNDAPSA 181
Query: 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
+FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE+LTGKPLFPGK+VVHQLD++
Sbjct: 182 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEMLTGKPLFPGKNVVHQLDIM 241
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303
TDLLGTP PE IA +RNEKAR+YL MR+KPPVP KFP+VDPLALRLL RL+AFDPKD
Sbjct: 242 TDLLGTPPPEAIARIRNEKARRYLGNMRRKPPVPFTHKFPHVDPLALRLLHRLLAFDPKD 301
Query: 304 RPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQL 363
RP+AEEALADPYF GLA ++REPS QPI KLEFEFERR++TK+D+RELIYREILEYHPQ+
Sbjct: 302 RPSAEEALADPYFYGLANVDREPSTQPIPKLEFEFERRKITKEDVRELIYREILEYHPQM 361
Query: 364 LKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRSTV 417
L++Y+ G E T+F+YPS + +F++QFA+LEEN G+ P +R+H SLPR V
Sbjct: 362 LQEYLRGGEQTSFMYPSGVDRFKRQFAHLEENYGKGEKGSPLQRQHASLPRERV 415
|
|
| TAIR|locus:2027814 MPK15 "MAP kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1696 (602.1 bits), Expect = 1.4e-174, P = 1.4e-174
Identities = 310/411 (75%), Positives = 361/411 (87%)
Query: 7 KKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA 66
KK + + +FFTEYG+ANRY+I EV+GKGSYGVV +AIDTHTGE+VAIKKI+DVF+HISDA
Sbjct: 72 KKGIPNAEFFTEYGEANRYQIQEVVGKGSYGVVGSAIDTHTGERVAIKKINDVFDHISDA 131
Query: 67 IRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTRE 126
RILRE+KLLRLL HPD+VEIK IMLPPS+REF+D+YVVFELMESDLHQVIKANDDLT E
Sbjct: 132 TRILREIKLLRLLLHPDVVEIKHIMLPPSRREFRDVYVVFELMESDLHQVIKANDDLTPE 191
Query: 127 HHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186
HHQFFLYQ+LR LKY+H ANV+HRDLKPKNILANA+CKLK+CDFGLARV+F+D P +FW
Sbjct: 192 HHQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDAPTAIFW 251
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
TDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGK+VVHQLD++TD
Sbjct: 252 TDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQLDIMTDF 311
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
LGTP PE I+ +RN+KAR+YL MRKK PVP +KFP DP ALRLL+RLIAFDPKDRP+
Sbjct: 312 LGTPPPEAISKIRNDKARRYLGNMRKKQPVPFSKKFPKADPSALRLLERLIAFDPKDRPS 371
Query: 307 AEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKD 366
AEEALADPYF GL+ REPS QPISKLEFEFER+++TKDDIRELIYREILEYHPQ+L++
Sbjct: 372 AEEALADPYFNGLSSKVREPSTQPISKLEFEFERKKLTKDDIRELIYREILEYHPQMLEE 431
Query: 367 YINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPVIPPERKHVSLPRSTV 417
Y+ G +F+YPS + +FR+QFA+LEEN G G +R+H SLPR V
Sbjct: 432 YLRGGNQLSFMYPSGVDRFRRQFAHLEENQGPGGRSNALQRQHASLPRERV 482
|
|
| TAIR|locus:2194040 ATMPK8 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1674 (594.3 bits), Expect = 3.0e-172, P = 3.0e-172
Identities = 312/455 (68%), Positives = 378/455 (83%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
+ D KK + +FFTEYG+ANRY+I EV+GKGSYGVV +A+D+HTGE+VAIKKI+DVF
Sbjct: 82 LPMDPHKKG--ETEFFTEYGEANRYQIQEVVGKGSYGVVASAVDSHTGERVAIKKINDVF 139
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
EH+SDA RILRE+KLLRLLRHPD+VEIK IMLPPS+REF+DIYVVFELMESDLHQVIKAN
Sbjct: 140 EHVSDATRILREIKLLRLLRHPDVVEIKHIMLPPSRREFRDIYVVFELMESDLHQVIKAN 199
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDLT EH+QFFLYQ+LR LKY+H ANV+HRDLKPKNILANA+CKLK+CDFGLARV+F+D
Sbjct: 200 DDLTPEHYQFFLYQLLRGLKYVHAANVFHRDLKPKNILANADCKLKICDFGLARVSFNDA 259
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
P +FWTDYVATRWYRAPELCGSFFSKYTPAIDIWS+GCIFAE+L GKPLFPGK+VVHQL
Sbjct: 260 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSVGCIFAEMLLGKPLFPGKNVVHQL 319
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
DL+TD LGTP PE+I+ +RNEKAR+YL+ MRKK PVP KFP DPLALRLL+RL+AFD
Sbjct: 320 DLMTDFLGTPPPESISRIRNEKARRYLSSMRKKQPVPFSHKFPKADPLALRLLERLLAFD 379
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
PKDR +AE+ALADPYF GL+ EREP+ QPISKLEF+FER+++ KDD+RELIYREILEYH
Sbjct: 380 PKDRASAEDALADPYFSGLSNSEREPTTQPISKLEFDFERKKLVKDDVRELIYREILEYH 439
Query: 361 PQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGPV-----IPPERKHVSLPRS 415
PQ+L++Y+ G + +F+YPS + +F++QFA+LEEN G+ G R H SLPR
Sbjct: 440 PQMLEEYLRGGDQLSFMYPSGVDRFKRQFAHLEENQGKPGAAGGGRSTALHRHHASLPRE 499
Query: 416 TVHS--GTTPPI---VQHNAASSESQQMTEDTSRN 445
V + G T V+ AA++ + + + + N
Sbjct: 500 RVPAPNGETAEESSDVERRAAAAVASTLESEEADN 534
|
|
| TAIR|locus:2049552 MPK17 "MAP kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1636 (581.0 bits), Expect = 3.2e-168, P = 3.2e-168
Identities = 307/439 (69%), Positives = 369/439 (84%)
Query: 12 DKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR 71
+K+FFTEYG+A++Y+I EV+GKGSYGVV +A HTG KVAIKK+ +VFEH+SDAIRILR
Sbjct: 3 EKEFFTEYGEASQYQIQEVVGKGSYGVVASAECPHTGGKVAIKKMTNVFEHVSDAIRILR 62
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFF 131
E+KLLRLLRHPDIVEIK IMLPP ++EFKDIYVVFELMESDLH V+K NDDLT +HHQFF
Sbjct: 63 EIKLLRLLRHPDIVEIKHIMLPPCRKEFKDIYVVFELMESDLHHVLKVNDDLTPQHHQFF 122
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
LYQ+LR LK+MH+A+V+HRDLKPKNILANA+CK+K+CD GLARV+F+D+P VFWTDYVA
Sbjct: 123 LYQLLRGLKFMHSAHVFHRDLKPKNILANADCKIKICDLGLARVSFTDSPSAVFWTDYVA 182
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
TRWYRAPELCGSF+S YTPAID+WS+GCIFAE+LTGKPLFPGK+VVHQL+L+TDLLGTPS
Sbjct: 183 TRWYRAPELCGSFYSNYTPAIDMWSVGCIFAEMLTGKPLFPGKNVVHQLELVTDLLGTPS 242
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
P T++ +RNEKARKYL MR+K PVP KFPN+DP+AL+LLQRLIAFDPKDRP+AEEAL
Sbjct: 243 PITLSRIRNEKARKYLGNMRRKDPVPFTHKFPNIDPVALKLLQRLIAFDPKDRPSAEEAL 302
Query: 312 ADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGT 371
ADPYF+GLA ++ EPS QPISKLEFEFERR++T+DD+REL+YREILEYHPQ+L++Y+ G
Sbjct: 303 ADPYFQGLANVDYEPSRQPISKLEFEFERRKLTRDDVRELMYREILEYHPQMLQEYLQGE 362
Query: 372 EGTN--FLYPSAIGQFRKQFAYLEE-NGGRSGPVIPP-ERKHVSLPRSTVHSGTTPPIVQ 427
E N FLYPS + QF+++FA LEE N PP +RK+ SLPR V S
Sbjct: 363 ENINSHFLYPSGVDQFKQEFARLEEHNDDEEEHNSPPHQRKYTSLPRERVCSSEDEGSDS 422
Query: 428 -HNAASSESQQMTEDTSRN 445
H +SS S T + N
Sbjct: 423 VHAQSSSASVVFTPPQTPN 441
|
|
| DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 908 (324.7 bits), Expect = 4.5e-91, P = 4.5e-91
Identities = 175/339 (51%), Positives = 236/339 (69%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY I++ IG G+YGVVC+A D TGEKVAIKKI F+++ D R LRE+ LLR +H +
Sbjct: 148 RYSIVKCIGHGAYGVVCSAKDNLTGEKVAIKKISKAFDNLKDTKRTLREIHLLRHFKHEN 207
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
++ IK I+ P SK +F+D+Y+V ELM++DLHQ+I + L+ +H Q+F+YQMLR LK++H
Sbjct: 208 LISIKDILKPNSKEQFEDVYIVSELMDTDLHQIITSPQPLSDDHCQYFVYQMLRGLKHIH 267
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP N+L N +C LK+CD GLARV D F T+YVATRWYRAPE+ S
Sbjct: 268 SANVLHRDLKPSNLLINEDCLLKICDLGLARV--EDATHQGFMTEYVATRWYRAPEVILS 325
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
+ +KYT AIDIWS+GCIFAE+L KPLF GK +HQ+ LI + +G+PS E I + NE+A
Sbjct: 326 W-NKYTKAIDIWSVGCIFAELLGRKPLFQGKDYIHQITLIIETIGSPSEEDICNIANEQA 384
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R+++ M +P V FP +P A+ LL+R++ FDP R T EEALA PYF+ L
Sbjct: 385 RQFIRNMGNQPKVNFANMFPKANPDAIDLLERMLYFDPSKRLTVEEALAHPYFQSLHDPS 444
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362
EP C + K FE + +D ++ELIY E+L YHP+
Sbjct: 445 DEPIC--LHKFSLNFEAWDLNRDLLKELIYNEMLAYHPE 481
|
|
| TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 902 (322.6 bits), Expect = 1.9e-90, P = 1.9e-90
Identities = 169/335 (50%), Positives = 242/335 (72%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
L IG+G+YG+VCAA ++ TGE+VAIKKI + F++I DA R LRE+KLL+ + H +++ +
Sbjct: 46 LRPIGRGAYGIVCAATNSETGEEVAIKKIGNAFDNIIDAKRTLREIKLLKHMDHENVIAV 105
Query: 88 KRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV 147
K I+ PP + F D+Y+V+ELM++DLHQ+I++N LT +H +FFLYQ+LR LKY+H+ANV
Sbjct: 106 KDIIKPPQRENFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRGLKYVHSANV 165
Query: 148 YHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK 207
HRDLKP N+L NANC LK+ DFGLAR S+T F T+YV TRWYRAPEL + S+
Sbjct: 166 LHRDLKPSNLLLNANCDLKLGDFGLARTK-SETD---FMTEYVVTRWYRAPELLLNC-SE 220
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYL 267
YT AIDIWS+GCI E +T +PLFPGK VHQL LIT+L+G+P ++ +R++ AR+Y+
Sbjct: 221 YTAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNARRYV 280
Query: 268 TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327
++ + P +FPN+ A+ LL++++ FDP R T +EAL PY L I EP
Sbjct: 281 RQLPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDINEEPV 340
Query: 328 CQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362
C + F+FE+ +T+++I+ELIYRE ++++PQ
Sbjct: 341 C--VRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q5SN53 | MPK8_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7202 | 0.8471 | 0.8277 | no | no |
| Q9LUC3 | MPK19_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.8041 | 0.9460 | 0.8795 | yes | no |
| Q67C40 | MPK7_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7357 | 0.8255 | 0.8066 | no | no |
| P42525 | ERK1_DICDI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.5162 | 0.6007 | 0.6313 | yes | no |
| Q5ZCI1 | MPK10_ORYSJ | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7738 | 0.9154 | 0.8330 | yes | no |
| A2X0M1 | MPK13_ORYSI | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7475 | 0.7338 | 0.8063 | N/A | no |
| Q9C5C0 | MPK18_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7692 | 0.9316 | 0.8422 | no | no |
| Q9SJG9 | MPK20_ARATH | 2, ., 7, ., 1, 1, ., 2, 4 | 0.7455 | 0.8938 | 0.8201 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.24 | 0.979 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 556 | |||
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 0.0 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.0 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-158 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-144 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-137 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-126 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-117 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-115 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-105 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-104 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-102 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-96 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-89 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-88 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-88 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-88 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-87 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-87 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-87 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-85 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-83 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-82 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-80 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-79 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-76 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-76 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-74 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-72 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-70 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-68 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-68 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-66 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-66 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-66 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-63 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-62 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-62 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-62 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-61 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-61 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 7e-61 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-60 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-60 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-60 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-60 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-60 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-57 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 7e-55 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-54 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-53 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-51 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-48 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-48 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-47 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-46 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-46 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-44 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-41 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-41 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-40 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-39 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-39 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-39 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-37 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-36 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-36 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-35 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-34 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-31 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-31 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-30 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-29 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-29 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-27 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 6e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-27 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-24 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-24 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-23 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-23 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-23 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-22 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-21 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-21 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-20 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-20 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-20 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-20 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 8e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-19 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-18 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-17 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-16 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-15 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-15 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-15 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-14 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-14 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-14 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-13 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-13 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 6e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 7e-13 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-13 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-12 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-12 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-12 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-12 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 8e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-11 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-11 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-11 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-10 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-10 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-10 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-07 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-07 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 6e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.002 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 732 bits (1892), Expect = 0.0
Identities = 302/338 (89%), Positives = 325/338 (96%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RYKI EVIGKGSYGVVC+AIDTHTGEKVAIKKI+DVFEH+SDA RILRE+KLLRLLRHPD
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
IVEIK IMLPPS+REFKDIYVVFELMESDLHQVIKANDDLT EHHQFFLYQ+LRALKY+H
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
TANV+HRDLKPKNILANA+CKLK+CDFGLARVAF+DTP +FWTDYVATRWYRAPELCGS
Sbjct: 121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK+VVHQLDLITDLLGTPSPETI+ VRNEKA
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R+YL+ MRKK PVP QKFPN DPLALRLL+RL+AFDPKDRPTAEEALADPYFKGLAK+E
Sbjct: 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE 300
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
REPS QPI+KLEFEFERRR+TK+D+RELIYREILEYHP
Sbjct: 301 REPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 534 bits (1377), Expect = 0.0
Identities = 186/332 (56%), Positives = 242/332 (72%), Gaps = 2/332 (0%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY++L+ IG G+YGVVC+A+D TG KVAIKKI +VF+ + DA RILRE+KLLR LRH +
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
I+ + I+ PPS +F D+Y+V ELME+DLH+VIK+ LT +H Q+FLYQ+LR LKY+H
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP NIL N+NC LK+CDFGLAR D F T+YV TRWYRAPEL S
Sbjct: 121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS 180
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
S+YT AIDIWS+GCIFAE+LT KPLFPG+ + QL+LI ++LGTPS E + + +EKA
Sbjct: 181 -SSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R YL + KKP PL + FP P A+ LL++++ FDPK R TA+EALA PY L E
Sbjct: 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE 299
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYRE 355
EP +P +F F+ +T+++++ELIY E
Sbjct: 300 DEPVAKPPFDFDF-FDDDELTEEELKELIYEE 330
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 455 bits (1173), Expect = e-158
Identities = 182/338 (53%), Positives = 245/338 (72%), Gaps = 6/338 (1%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y ++ IG+G+YG+VC+A ++ T EKVAIKKI + F++ DA R LRE+KLLR L H +
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
++ IK IM PP + F D+Y+V+ELM++DLHQ+I+++ L+ +H Q+FLYQ+LR LKY+H
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP N+L NANC LK+CDFGLAR S+ F T+YV TRWYRAPEL +
Sbjct: 126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTT-SEKGD--FMTEYVVTRWYRAPELLLN 182
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
S+YT AID+WS+GCIFAE+L KPLFPGK VHQL LIT+LLG+PS E + +RNEKA
Sbjct: 183 -CSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R+Y+ + P + FP+ +PLA+ LL++++ FDP R T EEALA PY L
Sbjct: 242 RRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
EP CQ + F+FE +T++DI+ELIY E+L YHP
Sbjct: 302 DEPVCQ--TPFSFDFEEDALTEEDIKELIYNEMLAYHP 337
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 419 bits (1078), Expect = e-144
Identities = 168/334 (50%), Positives = 226/334 (67%), Gaps = 4/334 (1%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L IG+G+YG+VC+A TG KVAIKKI FEH + R LRE+K+LR +H +
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP-FEHQTFCQRTLREIKILRRFKHEN 64
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
I+ I I+ PPS F D+Y+V ELME+DL+++IK L+ +H Q+FLYQ+LR LKY+H
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQH-LSNDHIQYFLYQILRGLKYIH 123
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ANV HRDLKP N+L N NC LK+CDFGLAR+A + T F T+YVATRWYRAPE+ +
Sbjct: 124 SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN 183
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
YT AIDIWS+GCI AE+L+ +PLFPGK +HQL+LI +LGTPS E + + + +A
Sbjct: 184 S-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRA 242
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
R Y+ + KP VP + FPN DP AL LL +++ F+P R T EEALA PY +
Sbjct: 243 RNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPS 302
Query: 324 REPSCQPISKLEFEFERRRVTKDDIRELIYREIL 357
EP + +FE + K+ ++ELI+ EI+
Sbjct: 303 DEPVAEEPFPFDFEL-FDDLPKEKLKELIFEEIM 335
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 401 bits (1032), Expect = e-137
Identities = 166/333 (49%), Positives = 235/333 (70%), Gaps = 5/333 (1%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RYK +E IG G+YGVVC+AIDT +G+KVAIKKI F+ + A R LRE+K+LR +H +
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
I+ I+ I+ PP +FKD+YVV +LMESDLH +I ++ LT EH ++FLYQ+LR LKY+H
Sbjct: 66 IIAIRDILRPPGA-DFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLAR-VAFSDTPMTVFWTDYVATRWYRAPELCG 202
+ANV HRDLKP N+L N +C+L++ DFG+AR ++ S T F T+YVATRWYRAPEL
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
S +YT AID+WS+GCIFAE+L + LFPGK+ VHQL LI +LG+PS E + + +++
Sbjct: 185 SL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
RKY+ + +K PVP + FP P AL LL +++ FDP++R T E+AL P+
Sbjct: 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYRE 355
+ EP+C P +F+FE ++++ ++E I +E
Sbjct: 304 DDEPTCPP--PFDFDFEAIELSREQLKEAIVKE 334
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 373 bits (961), Expect = e-126
Identities = 149/337 (44%), Positives = 214/337 (63%), Gaps = 11/337 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HP 82
+Y+IL+ +GKG+YG+V AID T E VA+KKI D F + +DA R RE+ L+ L HP
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHP 67
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+IV++ ++ ++ + KDIY+VFE ME+DLH VI+AN L H ++ +YQ+L+ALKY+
Sbjct: 68 NIVKLLNVI--KAEND-KDIYLVFEYMETDLHAVIRANI-LEDVHKRYIMYQLLKALKYI 123
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVA--FSDTPMTVFWTDYVATRWYRAPE- 199
H+ NV HRDLKP NIL N++C++K+ DFGLAR + P TDYVATRWYRAPE
Sbjct: 124 HSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEI 183
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
L GS ++YT +D+WS+GCI E+L GKPLFPG S ++QL+ I +++G PS E I ++
Sbjct: 184 LLGS--TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
+ A L + +P PL + P AL LL++L+ F+P R TAEEAL PY
Sbjct: 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301
Query: 320 AKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREI 356
EP + + + +++ + R +Y EI
Sbjct: 302 HNPSDEPVLPYPITIPLD-DNVKLSVAEYRNKLYEEI 337
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 349 bits (896), Expect = e-117
Identities = 160/339 (47%), Positives = 220/339 (64%), Gaps = 13/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHT--GEKVAIKKIHDVFEHISDAIRILREVKLLRLLR- 80
RY++++ +G+G+YG+VC+A + T E VAIKKI +VF A R LRE+KLLR R
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 81 HPDIVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
H +I + + + P F ++Y+ ELME+DLHQ+I++ LT H Q F+YQ+L L
Sbjct: 61 HKNITCLYDMDIVFPGN--FNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGL 118
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV--FWTDYVATRWYRA 197
KY+H+ANV HRDLKP N+L NA+C+LK+CDFGLAR FS+ P F T+YVATRWYRA
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVATRWYRA 177
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE+ SF YT AID+WS+GCI AE+L KP+F GK V QL+ I +LGTP ET++
Sbjct: 178 PEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + KA+ Y+ + P P FPN +PLAL LL++L+AFDP R + EEAL PY
Sbjct: 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLA 296
Query: 318 GLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREI 356
+ EP CQ FE E + +++R++I E+
Sbjct: 297 IWHDPDDEPVCQKPFDFSFESED---SMEELRDMIIEEV 332
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 345 bits (887), Expect = e-115
Identities = 149/346 (43%), Positives = 213/346 (61%), Gaps = 12/346 (3%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
T + +RY+ L +G G+YG VC+A DT TG KVAIKK+ F+ A R RE++LL
Sbjct: 9 TVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLL 68
Query: 77 RLLRHPDIVEIKRIMLPPSKRE-FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ + H +++ + + P S E F+D+Y+V LM +DL+ ++K L+ +H QF +YQ+
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK-LSDDHIQFLVYQI 127
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
LR LKY+H+A + HRDLKP NI N +C+LK+ DFGLAR D MT YVATRWY
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT--DDEMT----GYVATRWY 181
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
RAPE+ ++ Y +DIWS+GCI AE+LTGK LFPG + QL I +L+GTP E +
Sbjct: 182 RAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL 240
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ +E AR Y+ + + P + F +PLA+ LL++++ DP R TA EALA PY
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
E EP P + FE R +T D+ +EL+Y+EI+ + P
Sbjct: 301 LAEYHDPEDEPVAPPYDQS---FESRDLTVDEWKELVYKEIMNFKP 343
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 317 bits (816), Expect = e-105
Identities = 128/296 (43%), Positives = 179/296 (60%), Gaps = 18/296 (6%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRHP 82
Y+ LE +G+G+YGVV A D TGE VA+KKI ++ + I LRE+ LL+ L+HP
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHP 58
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKY 141
+IV++ ++ K +Y+VFE + DL + + L+ + +YQ+LR L Y
Sbjct: 59 NIVKLLDVIHTERK-----LYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
H+ + HRDLKP+NIL N + LK+ DFGLAR AF P+ + T V T WYRAPE L
Sbjct: 114 CHSHRILHRDLKPQNILINRDGVLKLADFGLAR-AFG-IPLRTY-THEVVTLWYRAPEIL 170
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
GS Y+ A+DIWS+GCIFAE++TGKPLFPG S + QL I +LGTP+ E+ V
Sbjct: 171 LGS--KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGV-- 226
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
K Y K PP L + P +DP + LL +++ ++P R +A+EAL PYF
Sbjct: 227 TKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 313 bits (805), Expect = e-104
Identities = 135/294 (45%), Positives = 178/294 (60%), Gaps = 13/294 (4%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y+ L IG+G+YGVV A D TGE VAIKKI FE LRE+KLL+ L HP+I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKYMH 143
+++ + D+Y+VFE M++DL+++IK E + +LYQ+L+ L + H
Sbjct: 61 IKLLDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCG 202
+ + HRDLKP+N+L N LK+ DFGLAR S +T YV TRWYRAPE L G
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP---YTHYVVTRWYRAPELLLG 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y+ +DIWS+GCIFAE+L+ +PLFPGKS + QL I LGTP PE +
Sbjct: 173 DKG--YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS-L 229
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
AR Y KK +PL + FPN P AL LL +++ +DP R TAE+ALA PYF
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 310 bits (797), Expect = e-102
Identities = 154/343 (44%), Positives = 220/343 (64%), Gaps = 18/343 (5%)
Query: 15 FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK 74
F T + NRY L+ +G G++G+VC+A D TG+ VAIKKI F A R RE+K
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 75 LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQ 134
LL+ LRH +I+ + I + P +DIY V EL+ +DLH+++ + L ++ Q+FLYQ
Sbjct: 62 LLKHLRHENIISLSDIFISP----LEDIYFVTELLGTDLHRLLTSRP-LEKQFIQYFLYQ 116
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+LR LKY+H+A V HRDLKP NIL N NC LK+CDFGLAR+ D MT YV+TR+
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI--QDPQMT----GYVSTRY 170
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
YRAPE+ ++ KY +DIWS GCIFAE+L GKPLFPGK V+Q +ITDLLGTP +
Sbjct: 171 YRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
I + +E +++ + K+ PVP +KF N DP A+ LL++++ FDP+ R +A EALA P
Sbjct: 230 INTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP 289
Query: 315 YFKGLAKIEREPSCQPISKLEFE--FERRRVTKDDIRELIYRE 355
Y +P+ +P+++ +F+ F + D + ++Y E
Sbjct: 290 YLAPY----HDPTDEPVAEEKFDWSFNDADLPVDTWKVMMYSE 328
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 298 bits (765), Expect = 1e-96
Identities = 143/353 (40%), Positives = 208/353 (58%), Gaps = 30/353 (8%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG G++GVV + D G++VA+KK+ +VF+++ R+ RE+K+L +H +++ I
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
+ PP F++IYVV ELM+SDLH++I + L+ +H + FLYQ+LR LKY+H+A + HR
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHR 127
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYT 209
D+KP N+L N+NC LK+CDFGLARV D + T V T++YRAPE L GS YT
Sbjct: 128 DIKPGNLLVNSNCVLKICDFGLARVEEPDE--SKHMTQEVVTQYYRAPEILMGS--RHYT 183
Query: 210 PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTE 269
A+DIWS+GCIFAE+L + LF +S + QLDLITDLLGTPS E + E AR ++
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSAC-EGARAHILR 242
Query: 270 MRKKPPV--PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG--------- 318
KPP L+ A+ LL R++ FDP R +A +ALA PY
Sbjct: 243 GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRYHTCM 302
Query: 319 -----------LAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYH 360
+ + EPS P + E+E+ + ++E +++ ILE
Sbjct: 303 CKCCYTTSGGRVYTSDFEPSANP--PFDDEYEKNLTSVRQVKEELHQFILEQQ 353
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 277 bits (709), Expect = 7e-89
Identities = 142/339 (41%), Positives = 208/339 (61%), Gaps = 12/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L +G G+YG VCAA DT TG +VA+KK+ F+ I A R RE++LL+ ++H +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77
Query: 84 IVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+LR LKY+
Sbjct: 78 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYI 136
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+A++ HRDLKP N+ N +C+LK+ DFGLAR +D MT YVATRWYRAPE+
Sbjct: 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMT----GYVATRWYRAPEIML 190
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
++ Y +DIWS+GCI AE+LTG+ LFPG + QL LI L+GTP E + + +E
Sbjct: 191 NWM-HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
AR Y+ + + P + F +PLA+ LL++++ D R TA +ALA YF
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
+ EP P + FE R + D+ + L Y E++ + P
Sbjct: 310 DDEPVADPYDQ---SFESRDLLIDEWKSLTYDEVISFVP 345
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 276 bits (708), Expect = 1e-88
Identities = 134/339 (39%), Positives = 197/339 (58%), Gaps = 13/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY L+ +G G+YG VC+AID TGEKVAIKK+ F+ A R RE+ LL+ ++H +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 84 IVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
++ + + S EF+D Y+V M++DL +++ L+ + Q+ +YQML LKY+
Sbjct: 76 VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLCGLKYI 133
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+A + HRDLKP N+ N +C+LK+ DFGLAR A D MT YV TRWYRAPE+
Sbjct: 134 HSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA--DAEMT----GYVVTRWYRAPEVIL 187
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
++ Y +DIWS+GCI AE+LTGK LF GK + QL I + G P PE + + ++
Sbjct: 188 NWM-HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
A+ Y+ + K P FP P A+ LL++++ D R TA EAL PYF
Sbjct: 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
+ E QP E +++ D+ ++ IY+E+ + P
Sbjct: 307 DEETEQQPYDD---SLENEKLSVDEWKKHIYKEVKSFSP 342
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 272 bits (698), Expect = 3e-88
Identities = 108/293 (36%), Positives = 154/293 (52%), Gaps = 40/293 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y+ILE +G+GS+G V A D TG+ VAIK I D RILRE+K+L+ L+HP+I
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI-KKDRERILREIKILKKLKHPNI 59
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V + + +Y+V E E DL ++K L+ + +F+L Q+L AL+Y+H
Sbjct: 60 VRLYDVFEDE-----DKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH 114
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + HRDLKP+NIL + + +K+ DFGLAR + T +V T Y APE+
Sbjct: 115 SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL----TTFVGTPEYMAPEVLLG 170
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
Y A+DIWS+G I E+LTGKP FPG QL + +G
Sbjct: 171 --KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIG--------------- 210
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
KP P ++ P A L+++L+ DP+ R TAEEAL P+F
Sbjct: 211 ---------KPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 273 bits (700), Expect = 5e-88
Identities = 126/300 (42%), Positives = 167/300 (55%), Gaps = 20/300 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRI--LREVKLLRLLR 80
RY+ + +G+G+Y VV A D TG VAIKKI + D I LRE+KLL+ L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRAL 139
HP+I+ + + K +I +VFE ME+DL +VIK LT + ++ LR L
Sbjct: 61 HPNIIGLLDVF--GHK---SNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+Y+H+ + HRDLKP N+L ++ LK+ DFGLAR +F P T V TRWYRAPE
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR-SFGS-PNRKM-THQVVTRWYRAPE 172
Query: 200 LCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
L F Y +D+WS+GCIFAE+L P PG S + QL I + LGTP+ E
Sbjct: 173 L---LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
V + E + PP PL Q FP AL LLQRL+ +P R TA +AL PYF
Sbjct: 230 V---TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 271 bits (696), Expect = 2e-87
Identities = 121/302 (40%), Positives = 176/302 (58%), Gaps = 29/302 (9%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHPD 83
YK+++ +G G++G V A + TGE VAIKK+ F + + LREVK L +L HP+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNEHPN 59
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQMLRALKY 141
IV++K + RE ++Y VFE ME +L+Q++K + + +YQ+L+ L +
Sbjct: 60 IVKLKEVF-----RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL- 200
+H +HRDLKP+N+L + +K+ DFGLAR S P +TDYV+TRWYRAPE+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP----YTDYVSTRWYRAPEIL 170
Query: 201 --CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS----PET 254
S Y+ +DIW++GCI AE+ T +PLFPG S + QL I +LGTP+ PE
Sbjct: 171 LRSTS----YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEG 226
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ A K + P L Q PN P A+ L++ ++ +DPK RPTA +AL P
Sbjct: 227 YKL-----ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281
Query: 315 YF 316
YF
Sbjct: 282 YF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 273 bits (699), Expect = 2e-87
Identities = 135/339 (39%), Positives = 206/339 (60%), Gaps = 12/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L+ +G G+YG VC+A+D TG KVAIKK++ F+ A R RE++LL+ ++H +
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHEN 75
Query: 84 IVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
++ + + P S F D Y+V M +DL +++K ++ L+ + QF +YQML+ LKY+
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYI 134
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H A + HRDLKP N+ N +C+LK+ DFGLAR D+ MT YV TRWYRAPE+
Sbjct: 135 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT--DSEMT----GYVVTRWYRAPEVIL 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
++ YT +DIWS+GCI AE+LTGKPLF G + QL I + GTPS E + +++E
Sbjct: 189 NWM-HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
A+ Y+ ++ + PN +PLA+ +L++++ D + R TA EALA PYF+
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
E E P + F+ + ++ + L + EIL + P
Sbjct: 308 EDETEAPP---YDDSFDEVDQSLEEWKRLTFTEILSFQP 343
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 273 bits (699), Expect = 3e-87
Identities = 140/339 (41%), Positives = 208/339 (61%), Gaps = 12/339 (3%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L +G G+YG VC+A DT +KVA+KK+ F+ + A R RE++LL+ ++H +
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75
Query: 84 IVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
++ + + P S F ++Y+V LM +DL+ ++K L+ EH QF +YQ+LR LKY+
Sbjct: 76 VIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK-LSDEHVQFLIYQLLRGLKYI 134
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+A + HRDLKP N+ N +C+L++ DFGLAR A D MT YVATRWYRAPE+
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA--DDEMT----GYVATRWYRAPEIML 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
++ Y +DIWS+GCI AE+L GK LFPG + QL I +++GTPSPE + + +E
Sbjct: 189 NWM-HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
ARKY+ + P L + F +PLA+ LL++++ D R +A EALA PYF
Sbjct: 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307
Query: 323 EREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
E EP +P + E + T ++ +EL Y E+ + P
Sbjct: 308 EDEPEAEPYDE---SPENKERTIEEWKELTYEEVSSFKP 343
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 267 bits (684), Expect = 1e-85
Identities = 115/297 (38%), Positives = 171/297 (57%), Gaps = 15/297 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y+ + IG+G+YG V A + TGE VA+KKI E I +RE+KLL+ LRHP+I
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQVI-KANDDLTREHHQFFLYQMLRALKYMH 143
V +K I+ K IY+VFE M+ DL ++ T + ++ Q+L L+Y+H
Sbjct: 61 VRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH 117
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCG 202
+ + HRD+K NIL N + LK+ DFGLAR ++ + T+ V T WYR PE L G
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLAR-PYTKRNSADY-TNRVITLWYRPPELLLG 175
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+ ++Y P +D+WS+GCI AE+ GKP+F G + + QL+ I +L G+P+ E V
Sbjct: 176 A--TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK-- 231
Query: 263 ARKYLTEMRKKPPVP--LFQKFPNV-DPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ ++ K P L + F ++ DP AL LL +L+ DPK R +A++AL YF
Sbjct: 232 -LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 261 bits (670), Expect = 1e-83
Identities = 119/301 (39%), Positives = 176/301 (58%), Gaps = 24/301 (7%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLRH 81
RYKIL IG+G++G+V A D TGE VA+KK+ + I + LRE+K L+ +H
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQA--LREIKALQACQH 58
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRALK 140
P +V++ + S +V E M SDL +V++ + L + ++ +L+ +
Sbjct: 59 PYVVKLLDVFPHGS-----GFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVA 113
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
YMH + HRDLKP N+L +A+ LK+ DFGLAR+ + P ++ VATRWYRAPEL
Sbjct: 114 YMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL--YSHQVATRWYRAPEL 171
Query: 201 C-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
G+ KY P +D+W++GCIFAE+L G PLFPG++ + QL ++ LGTP+ ET +
Sbjct: 172 LYGA--RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229
Query: 260 N----EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ K + P+PL + FP+ P AL LL+ L+ +DP R +A EAL PY
Sbjct: 230 SLPDYNKIT-----FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284
Query: 316 F 316
F
Sbjct: 285 F 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 257 bits (658), Expect = 6e-82
Identities = 118/299 (39%), Positives = 176/299 (58%), Gaps = 16/299 (5%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
N+Y++L V+G+G+YGVV + TGE VAIKK + + + ++ LREVK+LR LR
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLR 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRAL 139
H +IV +K +R+ + +Y+VFE +E L ++++A+ L + + +++Q+L+A+
Sbjct: 59 HENIVNLKEAF----RRKGR-LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAI 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y H+ N+ HRD+KP+NIL + + LK+CDFG AR TDYVATRWYRAPE
Sbjct: 114 AYCHSHNIIHRDIKPENILVSESGVLKLCDFGFAR--ALRARPASPLTDYVATRWYRAPE 171
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L G + Y +D+W+IGCI AE+L G+PLFPG S + QL LI LG P +
Sbjct: 172 LLVGD--TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ + P L +++P V AL L+ + DPK+R T +E L PYF
Sbjct: 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 256 bits (655), Expect = 1e-80
Identities = 129/348 (37%), Positives = 195/348 (56%), Gaps = 24/348 (6%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
RY+ L+ IG G+ G+VCAA DT TG+ VAIKK+ F++++ A R RE+ L++L+ H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 83 DIVEIKRIMLPPSK-REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+I+ + + P EF+D+Y+V ELM+++L QVI DL E + LYQML +K+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLCGIKH 133
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+A + HRDLKP NI+ ++C LK+ DFGLAR A + M T YV TR+YRAPE+
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TPYVVTRYYRAPEVI 189
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y +DIWS+GCI E++ G LFPG + Q + I + LGTPS E ++ +
Sbjct: 190 LGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL-QP 246
Query: 262 KARKYLTEMRKKPPVPLFQKFPNV-------DPLALR------LLQRLIAFDPKDRPTAE 308
R Y+ K + FP+V L+ LL +++ DP+ R + +
Sbjct: 247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVD 306
Query: 309 EALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREI 356
+AL PY E P + + + R T ++ +ELIY+E+
Sbjct: 307 DALQHPYINVWYD-PSEVEAPPPAPYDHSIDEREHTVEEWKELIYKEV 353
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 248 bits (635), Expect = 9e-79
Identities = 94/294 (31%), Positives = 143/294 (48%), Gaps = 36/294 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y++L +G GS+G V A TG+ VA+K + E RE+++LR L HP+I
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V + + +Y+V E E DL + L+ + + Q+LR L+Y+H
Sbjct: 61 VRLIDAF-----EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH 115
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + HRDLKP+NIL + N +K+ DFGLA+ + T +V T WY APE+
Sbjct: 116 SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL---TTFVGTPWYMAPEVL-L 171
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
+ Y P +D+WS+G I E+LTGKP F G++++ QL
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQL----------------------- 208
Query: 264 RKYLTEMRKKPPVPL-FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
L PP+ K+ + A L+++ + DP RPTAEE L P+F
Sbjct: 209 --QLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 245 bits (626), Expect = 2e-76
Identities = 130/361 (36%), Positives = 194/361 (53%), Gaps = 44/361 (12%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---LREVKL 75
+ +RY L +G GS G+V +A+D+ ++VA+KKI ++D + LRE+K+
Sbjct: 1 FDLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIV-----LTDPQSVKHALREIKI 55
Query: 76 LRLLRHPDIVEIKRIMLPPSKR---------EFKDIYVVFELMESDLHQVIKANDDLTRE 126
+R L H +IV++ ++ P E +Y+V E ME+DL V++ L+ E
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-LSEE 114
Query: 127 HHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVF 185
H + F+YQ+LR LKY+H+ANV HRDLKP N+ N + LK+ DFGLAR+ +
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
++ + T+WYR+P L S + YT AID+W+ GCIFAE+LTGKPLF G + Q+ LI +
Sbjct: 175 LSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233
Query: 246 LLGTPSPETIAVVRNE-----------KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
++ VVR E R E R+ PL P V+P AL L+
Sbjct: 234 --------SVPVVREEDRNELLNVIPSFVRNDGGEPRR----PLRDLLPGVNPEALDFLE 281
Query: 295 RLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYR 354
+++ F+P DR TAEEAL PY + EP +E E + + +I +IY
Sbjct: 282 QILTFNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFHIEDELD-DILLMTEIHSIIYN 340
Query: 355 E 355
Sbjct: 341 W 341
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 5e-76
Identities = 120/298 (40%), Positives = 168/298 (56%), Gaps = 17/298 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRHP 82
Y+ L I +G+YGVV A D TGE VA+KK+ E + I LRE+ +L L+HP
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK--MEKEKEGFPITSLREINILLKLQHP 64
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKY 141
+IV +K +++ IY+V E +E DL +++ + + + Q+L + +
Sbjct: 65 NIVTVKEVVV---GSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
+H + HRDLK N+L N LK+CDFGLAR + P+ + T V T WYRAPE L
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGS-PLKPY-TQLVVTLWYRAPELL 178
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G+ +Y+ AID+WS+GCIFAE+LT KPLFPGKS + QL+ I LLGTP+ +
Sbjct: 179 LGA--KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236
Query: 261 EKARKYLTEMRKKPPVPLFQKFPN--VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
K T K P L +KFP + LL RL+ +DP R +AE+AL PYF
Sbjct: 237 LPGAKKKT-FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 237 bits (607), Expect = 5e-74
Identities = 134/321 (41%), Positives = 179/321 (55%), Gaps = 32/321 (9%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVK 74
TE+ NR IG+G+YG+V A DT +GE VA+KK+ ++ D I I LRE+
Sbjct: 7 TEFEKLNR------IGEGTYGIVYRARDTTSGEIVALKKVR--MDNERDGIPISSLREIT 58
Query: 75 LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLY 133
LL LRHP+IVE+K +++ + I++V E E DL ++ + + +
Sbjct: 59 LLLNLRHPNIVELKEVVV---GKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLML 115
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV-AFSDTPMTVFWTDYVAT 192
Q+LR L+Y+H + HRDLK N+L LK+ DFGLAR PMT V T
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT----PKVVT 171
Query: 193 RWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
WYRAPE L G + YT AID+W++GCI AE+L KPL PGKS + QLDLI LLGTP+
Sbjct: 172 LWYRAPELLLGC--TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPN 229
Query: 252 PETI--AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
E+I K+ + K+P L KFP + LRLL L+ +DPK R TAEE
Sbjct: 230 -ESIWPGFSDLPLVGKF--TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEE 286
Query: 310 ALADPYFKGLAKIEREPSCQP 330
AL YFK E+ C+P
Sbjct: 287 ALESSYFK-----EKPLPCEP 302
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 234 bits (598), Expect = 1e-72
Identities = 115/313 (36%), Positives = 166/313 (53%), Gaps = 28/313 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y+IL +G+G++G V A TG VA+KKI E I LRE+K+L+ L+HP
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHP 67
Query: 83 DIVEIKRIML---PPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQF--FLYQMLR 137
++V + + + SKR+ +Y+V M+ DL +++ N + Q ++ Q+L
Sbjct: 68 NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIKCYMLQLLE 126
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM--------TVFWTDY 189
+ Y+H ++ HRD+K NIL + LK+ DFGLAR P T +T+
Sbjct: 127 GINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 190 VATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
V TRWYR PEL G +YT A+DIW IGC+FAE+ T +P+ GKS + QL LI L G
Sbjct: 187 VVTRWYRPPELLLGE--RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244
Query: 249 TPSPETIAVVRNEKARKYL---TEMRKKPPVP--LFQKFPNVDPLALRLLQRLIAFDPKD 303
TP+ ET R L + P L ++F + P L LL +L++ DP
Sbjct: 245 TPTEETWPGWR------SLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYK 298
Query: 304 RPTAEEALADPYF 316
R TA +AL PYF
Sbjct: 299 RLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 226 bits (579), Expect = 3e-70
Identities = 119/297 (40%), Positives = 167/297 (56%), Gaps = 19/297 (6%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI--RILREVKLLRLLRHP 82
Y+ +E IG+G+YGVV A D TGE VA+KKI E + + +RE+ LL+ L HP
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIR--LETEDEGVPSTAIREISLLKELNHP 58
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVI--KANDDLTREHHQFFLYQMLRALK 140
+IV + ++ +K +Y+VFE ++ DL + + L + +LYQ+L+ +
Sbjct: 59 NIVRLLDVVHSENK-----LYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE- 199
Y H+ V HRDLKP+N+L + LK+ DFGLAR AF P+ + T V T WYRAPE
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEI 170
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
L GS Y+ +DIWSIGCIFAE++ +PLFPG S + QL I LGTP + V
Sbjct: 171 LLGSRQ--YSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV- 227
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
Y K L + PN+D L LL +++ +DP R +A+ AL PYF
Sbjct: 228 -TSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 221 bits (566), Expect = 3e-68
Identities = 108/306 (35%), Positives = 163/306 (53%), Gaps = 33/306 (10%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA---IRILREVKLLRLLR- 80
Y+ L IG+G+YG V A D +TG VA+KK+ +S+ + LRE+ LL+ L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLES 57
Query: 81 --HPDIVEIKRIML-PPSKREFKDIYVVFELMESDLHQVIK--ANDDLTREHHQFFLYQM 135
HP+IV + + P + RE + +VFE ++ DL + L E + + Q+
Sbjct: 58 FEHPNIVRLLDVCHGPRTDREL-KLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQL 116
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
LR + ++H+ + HRDLKP+NIL ++ ++K+ DFGLAR+ + +T V T WY
Sbjct: 117 LRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALT----SVVVTLWY 172
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS--- 251
RAPE L S Y +D+WS+GCIFAE+ +PLF G S QLD I D++G PS
Sbjct: 173 RAPEVLLQS---SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 252 -PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
P +++ R + P P + L LL++++ F+P R +A EA
Sbjct: 230 WPRNVSLPR--------SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA 281
Query: 311 LADPYF 316
L PYF
Sbjct: 282 LQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 221 bits (564), Expect = 5e-68
Identities = 117/299 (39%), Positives = 172/299 (57%), Gaps = 20/299 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI----LREVKLLRLL 79
+Y+ L IG+GSYGVV + TG+ VAIKK F D I LRE+++L+ L
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKK----FVESEDDPVIKKIALREIRMLKQL 57
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRA 138
+HP++V + + R + +++VFE + + L+++ K + + ++Q L+A
Sbjct: 58 KHPNLVNLIEVF-----RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQA 112
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ + H N HRD+KP+NIL ++K+CDFG AR+ T +TDYVATRWYRAP
Sbjct: 113 VNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYTDYVATRWYRAP 169
Query: 199 EL-CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
EL G ++Y P +D+W+IGC+FAE+LTG+PL+PGKS V QL LI LG P +
Sbjct: 170 ELLVGD--TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQI 227
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ K L+ + PL KFPN+ AL L+ + DP +R + EE L PYF
Sbjct: 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 1e-66
Identities = 111/302 (36%), Positives = 173/302 (57%), Gaps = 30/302 (9%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPD 83
YKIL IG+G++ V A TG+ AIK + F+ + LRE++ LR L HP+
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPHPN 59
Query: 84 IVEIKRIML-PPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH------QFFLYQML 136
I+ + ++ + R + +VFELM+ +L+++IK R+ + ++YQ+L
Sbjct: 60 ILRLIEVLFDRKTGR----LALVFELMDMNLYELIKG-----RKRPLPEKRVKSYMYQLL 110
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
++L +MH ++HRD+KP+NIL + LK+ DFG R +S P +T+Y++TRWYR
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPP----YTEYISTRWYR 165
Query: 197 APE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE L + Y P +DIW++GC+F E+L+ PLFPG + + Q+ I D+LGTP E
Sbjct: 166 APECLLTDGY---YGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEV 222
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ R + Y K L + PN L LL++L+A+DP +R TA++AL P
Sbjct: 223 LKKFRKSRHMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHP 280
Query: 315 YF 316
YF
Sbjct: 281 YF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 2e-66
Identities = 118/298 (39%), Positives = 173/298 (58%), Gaps = 21/298 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHI-SDAIRILREVKLLRLLRHP 82
+K LE +G+G+Y V + TGE VA+K+IH D E S AIR E+ L++ L+H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKHE 58
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD---LTREHHQFFLYQMLRAL 139
+IV + ++ +K + +VFE M+ DL + + + L + F YQ+L+ +
Sbjct: 59 NIVRLHDVIHTENK-----LMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGI 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+ H V HRDLKP+N+L N +LK+ DFGLAR AF P+ F + V T WYRAP+
Sbjct: 114 AFCHENRVLHRDLKPQNLLINKRGELKLADFGLAR-AFG-IPVNTFSNE-VVTLWYRAPD 170
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L GS Y+ +IDIWS+GCI AE++TG+PLFPG + QL I ++GTP+ T +
Sbjct: 171 VLLGS--RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGI 228
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+Y + PP L Q FP+ DPL + LL RL+ +P+ R +A +AL P+F
Sbjct: 229 SQ--LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 219 bits (558), Expect = 3e-66
Identities = 126/348 (36%), Positives = 195/348 (56%), Gaps = 23/348 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+ L+ IG G+ G+VCAA DT G VA+KK+ F++ + A R RE+ LL+ + H +
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKN 81
Query: 84 IVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
I+ + + P S EF+D+Y+V ELM+++L QVI +L E + LYQML +K++
Sbjct: 82 IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHL 139
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+A + HRDLKP NI+ ++C LK+ DFGLAR A ++ M T YV TR+YRAPE+
Sbjct: 140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM----TPYVVTRYYRAPEVIL 195
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y +DIWS+GCI E++ G +F G + Q + + + LGTPS E + ++
Sbjct: 196 GM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ-PT 252
Query: 263 ARKYLTEMRKKPPVPLFQKFPN--------VDPL----ALRLLQRLIAFDPKDRPTAEEA 310
R Y+ + P + + FP+ D L A LL +++ DP R + +EA
Sbjct: 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312
Query: 311 LADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILE 358
L PY + E P + + E R ++ +ELIY+E+++
Sbjct: 313 LRHPYIT-VWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELIYKEVMD 359
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 8e-63
Identities = 120/302 (39%), Positives = 174/302 (57%), Gaps = 16/302 (5%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++Y+ +E IG+G+YGVV A D T E +A+KKI E +RE+ LL+ ++H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH--QFFLYQMLRALK 140
+IV ++ ++ K +Y+VFE ++ DL + + ++ D + + +LYQ+LR +
Sbjct: 62 NIVRLQDVV-----HSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 141 YMHTANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y H+ V HRDLKP+N+L + LK+ DFGLAR AF P+ F T V T WYRAPE
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFG-IPVRTF-THEVVTLWYRAPE 173
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L GS Y+ +DIWS+GCIFAE++ KPLFPG S + +L I +LGTP+ ET V
Sbjct: 174 ILLGS--RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
+ Y + K PP L P ++P + LL +++ DP R TA AL YFK
Sbjct: 232 TS--LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289
Query: 319 LA 320
L
Sbjct: 290 LG 291
|
Length = 294 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 206 bits (527), Expect = 1e-62
Identities = 117/306 (38%), Positives = 173/306 (56%), Gaps = 35/306 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHI-SDAIRILREVKLLRLLR 80
+Y+ LE IG+G+YG V A + T E VA+K++ D E + S A LRE+ LL+ L+
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA---LREICLLKELK 57
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRAL 139
H +IV + ++ K + +VFE + DL + + N D+ E + F++Q+L+ L
Sbjct: 58 HKNIVRLYDVLHSDKK-----LTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+ H+ NV HRDLKP+N+L N N +LK+ DFGLAR AF P+ + + V T WYR P+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR-AFG-IPVRCYSAE-VVTLWYRPPD 169
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG V QL I LLGTP
Sbjct: 170 VLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP------- 220
Query: 258 VRNEKARKYLTEMRKKPPVPLF-------QKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
E++ ++++ P P++ P ++ LLQ L+ +P R +AEEA
Sbjct: 221 --TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA 278
Query: 311 LADPYF 316
L PYF
Sbjct: 279 LQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 209 bits (533), Expect = 2e-62
Identities = 133/369 (36%), Positives = 205/369 (55%), Gaps = 31/369 (8%)
Query: 11 KDKDFFT-EYGDAN-----RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS 64
+D +F++ E GD+ RY+ L+ IG G+ G+VCAA D VAIKK+ F++ +
Sbjct: 6 RDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 65
Query: 65 DAIRILREVKLLRLLRHPDIVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDL 123
A R RE+ L++ + H +I+ + + P S EF+D+Y+V ELM+++L QVI+ +L
Sbjct: 66 HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--EL 123
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183
E + LYQML +K++H+A + HRDLKP NI+ ++C LK+ DFGLAR A + M
Sbjct: 124 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM- 182
Query: 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
T YV TR+YRAPE+ Y +DIWS+GCI E++ G LFPG + Q + +
Sbjct: 183 ---TPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQK-FPNV------------DPLAL 290
+ LGTP PE + ++ R Y+ E R K F+K FP+V A
Sbjct: 238 IEQLGTPCPEFMKKLQ-PTVRTYV-ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQAR 295
Query: 291 RLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRE 350
LL +++ D R + +EAL PY + E P + + + R T ++ +E
Sbjct: 296 DLLSKMLVIDASKRISVDEALQHPYIN-VWYDPSEAEAPPPKIPDKQLDEREHTIEEWKE 354
Query: 351 LIYREILEY 359
LIY+E+++
Sbjct: 355 LIYKEVMDL 363
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 205 bits (523), Expect = 6e-62
Identities = 110/304 (36%), Positives = 174/304 (57%), Gaps = 28/304 (9%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
+Y+ L ++G+GSYG+V TG+ VAIKK + + ++ +RE+++L+ LR
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLR 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-------QFFLY 133
H ++V + + R K +Y+VFE ++ H V+ DDL + + + +L+
Sbjct: 59 HENLVNLIEVF-----RRKKRLYLVFEFVD---HTVL---DDLEKYPNGLDESRVRKYLF 107
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+LR +++ H+ N+ HRD+KP+NIL + + +K+CDFG AR P V+ TDYVATR
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVY-TDYVATR 164
Query: 194 WYRAPEL-CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
WYRAPEL G +KY A+DIW++GC+ E+LTG+PLFPG S + QL I LG P
Sbjct: 165 WYRAPELLVGD--TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP 222
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ + + K PL ++FP + L L L ++ + DP DRP++ + L
Sbjct: 223 RHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
Query: 313 DPYF 316
+F
Sbjct: 283 HEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 4e-61
Identities = 114/300 (38%), Positives = 167/300 (55%), Gaps = 16/300 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH-PD 83
Y+ LE IG+G+YG V A D +TG+ VA+KK + LRE+ LL++L
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN-----DDLTREHHQFFLYQMLRA 138
IV + + K +Y+VFE ++SDL + + +N L + + F+YQ+L+
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 139 LKYMHTANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ + H V HRDLKP+N+L + LK+ D GL R AFS P+ + T + T WYRA
Sbjct: 123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR-AFS-IPVKSY-THEIVTLWYRA 179
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE L GS + Y+ +DIWS+GCIFAE+ +PLFPG S + QL I LLGTP+ +
Sbjct: 180 PEVLLGS--THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWP 237
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
V + E + P L + P++ P L LLQ+++ +DP R +A+ AL PYF
Sbjct: 238 GVSKLRD---WHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 7e-61
Identities = 130/364 (35%), Positives = 200/364 (54%), Gaps = 34/364 (9%)
Query: 15 FFTEYGDAN-----RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI 69
+ E GD+ RY+ L+ IG G+ G+VCAA D VAIKK+ F++ + A R
Sbjct: 4 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA 63
Query: 70 LREVKLLRLLRHPDIVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHH 128
RE+ L++ + H +I+ + + P S EF+D+Y+V ELM+++L QVI+ +L E
Sbjct: 64 YRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERM 121
Query: 129 QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
+ LYQML +K++H+A + HRDLKP NI+ ++C LK+ DFGLAR A + M T
Sbjct: 122 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TP 177
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
YV TR+YRAPE+ Y +DIWS+GCI E++ K LFPG+ + Q + + + LG
Sbjct: 178 YVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235
Query: 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV------------DPLALRLLQRL 296
TP PE + ++ R Y+ K + + FP+ A LL ++
Sbjct: 236 TPCPEFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294
Query: 297 IAFDPKDRPTAEEALADPYFK---GLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIY 353
+ DP R + +EAL PY A++E P Q K + + R T ++ +ELIY
Sbjct: 295 LVIDPAKRISVDEALQHPYINVWYDPAEVEAPPP-QIYDK---QLDEREHTIEEWKELIY 350
Query: 354 REIL 357
+E++
Sbjct: 351 KEVM 354
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 7e-61
Identities = 116/299 (38%), Positives = 170/299 (56%), Gaps = 22/299 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH---ISDAIRILREVKLLRLLRH 81
Y +E IG+G+YGVV + TG+ VA+KKI E S AIR E+ LL+ L+H
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR---EISLLKELQH 58
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQ---VIKANDDLTREHHQFFLYQMLRA 138
P+IV ++ +++ S+ +Y++FE + DL + + + E + +LYQ+L+
Sbjct: 59 PNIVCLQDVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQG 113
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ + H+ V HRDLKP+N+L + +K+ DFGLAR AF P+ V+ T V T WYRAP
Sbjct: 114 ILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFG-IPVRVY-THEVVTLWYRAP 170
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
E L GS +Y+ +DIWSIG IFAE+ T KPLF G S + QL I +LGTP+ +
Sbjct: 171 EVLLGS--PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPG 228
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
V Y K L N+D L LL++++ +DP R +A++AL PYF
Sbjct: 229 V--TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 202 bits (515), Expect = 1e-60
Identities = 117/305 (38%), Positives = 169/305 (55%), Gaps = 21/305 (6%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLR 77
+G YK L+ +G+GSY V TG+ VA+K+I EH A +RE LL+
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR--LEHEEGAPFTAIREASLLK 58
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML 136
L+H +IV + I+ K + +VFE +++DL Q + H+ + FL+Q+L
Sbjct: 59 DLKHANIVTLHDII-----HTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL 113
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L Y H V HRDLKP+N+L + +LK+ DFGLAR A S T +++ V T WYR
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKT--YSNEVVTLWYR 170
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQLDLITDLLGTPSPET 254
P+ L GS ++Y+ ++D+W +GCIF E+ TG+PLFPG V QL I +LGTP+ ET
Sbjct: 171 PPDVLLGS--TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET 228
Query: 255 I-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVD--PLALRLLQRLIAFDPKDRPTAEEAL 311
V N + + Y PP PL P +D P L + + ++PK R +A EA+
Sbjct: 229 WPGVSSNPEFKPY--SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286
Query: 312 ADPYF 316
PYF
Sbjct: 287 KHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 200 bits (509), Expect = 5e-60
Identities = 112/292 (38%), Positives = 164/292 (56%), Gaps = 15/292 (5%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+E IG+G+YGVV A + TGE VA+KKI E +RE+ LL+ L HP+IV++
Sbjct: 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 64
Query: 88 KRIMLPPSKREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTA 145
++ +K +Y+VFE + DL + + A+ + + +L+Q+L+ L + H+
Sbjct: 65 LDVIHTENK-----LYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCGSF 204
V HRDLKP+N+L N +K+ DFGLAR AF P+ + T V T WYRAPE L G
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLAR-AFG-VPVRTY-THEVVTLWYRAPEILLGCK 176
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
+ Y+ A+DIWS+GCIFAE++T + LFPG S + QL I LGTP V +
Sbjct: 177 Y--YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP-- 232
Query: 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
Y K + P +D LL +++ +DP R +A+ ALA P+F
Sbjct: 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 5e-60
Identities = 117/315 (37%), Positives = 165/315 (52%), Gaps = 42/315 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-------------ILREVKLLR 77
+G+G+YG V A DT TG+ VAIKK+ + E +D + LRE+K++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKII-EISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLR 137
++H +I+ + + + + +F I +V ++M SDL +V+ LT + L Q+L
Sbjct: 76 EIKHENIMGLVDVYV---EGDF--INLVMDIMASDLKKVVDRKIRLTESQVKCILLQILN 130
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM-----------TVFW 186
L +H HRDL P NI N+ K+ DFGLAR
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 187 TDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
T V T WYRAPEL G+ KY A+D+WS+GCIFAE+LTGKPLFPG++ + QL I +
Sbjct: 191 TSKVVTLWYRAPELLMGA--EKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248
Query: 246 LLGTPSPETIAVVRNEKARKYL---TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPK 302
LLGTP+ + N K L TE + P L FPN A+ LLQ L+ +P
Sbjct: 249 LLGTPNED------NWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPL 302
Query: 303 DRPTAEEALADPYFK 317
+R +A+EAL YFK
Sbjct: 303 ERISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 7e-60
Identities = 115/300 (38%), Positives = 164/300 (54%), Gaps = 16/300 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+ I+ IG+G+YG V A D TGE VA+KK+ E I +RE+K+LR L H +I
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 85 VEIKRIMLPPS-----KREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRA 138
V +K I+ K++ Y+VFE M+ DL ++++ + +H + F+ Q+L
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEG 128
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L Y H N HRD+K NIL N ++K+ DFGLAR+ S+ +T+ V T WYR P
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP--YTNKVITLWYRPP 186
Query: 199 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
EL G +Y PAID+WS GCI E+ T KP+F + QL+LI+ L G+P P AV
Sbjct: 187 ELLLGE--ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP---AV 241
Query: 258 VRNEKARKYLTEMRKKPPV--PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ Y M+ K L ++F + AL LL ++ DP R TAEEAL P+
Sbjct: 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 200 bits (511), Expect = 9e-60
Identities = 114/332 (34%), Positives = 164/332 (49%), Gaps = 55/332 (16%)
Query: 24 RYKILEVIGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEH---ISDAIRILREVKLLRL 78
+Y+I IG+G+YG V A + G++ AIKK E IS + RE+ LLR
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSA--CREIALLRE 58
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH---------- 128
L+H ++V + + L + + +Y++F+ E DL Q+IK H
Sbjct: 59 LKHENVVSLVEVFLEHADKS---VYLLFDYAEHDLWQIIK--------FHRQAKRVSIPP 107
Query: 129 ---QFFLYQMLRALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTP 181
+ L+Q+L + Y+H+ V HRDLKP NIL +K+ D GLAR+ F+
Sbjct: 108 SMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL-FNAPL 166
Query: 182 MTVFWTD-YVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-----K 234
+ D V T WYRAPEL G+ YT AIDIW+IGCIFAE+LT +P+F G K
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIK 224
Query: 235 SVV----HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPP------VPLFQKFPN 284
QL+ I ++LGTP+ + ++ L + K +K
Sbjct: 225 KSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKK 284
Query: 285 VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
D LL++L+ +DP R TAEEAL PYF
Sbjct: 285 PDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 4e-57
Identities = 111/304 (36%), Positives = 155/304 (50%), Gaps = 11/304 (3%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ ++Y+ L IG+G++G V A T + VA+KK+ E I LRE+K+L+LL+
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK 69
Query: 81 HPDIV---EIKRIMLPPSKREFKDIYVVFELMESDLHQVIK-ANDDLTREHHQFFLYQML 136
H ++V EI R P R Y+VFE E DL ++ N T + + +L
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS--DTPMTVFWTDYVATRW 194
L Y+H + HRD+K NIL + LK+ DFGLAR AFS +T+ V T W
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR-AFSLSKNSKPNRYTNRVVTLW 188
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
YR PE L G Y P ID+W GCI AE+ T P+ G + HQL LI+ L G+ +PE
Sbjct: 189 YRPPELLLGE--RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246
Query: 254 TI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
V + E +K +K V K DP AL L+ +L+ DP R A+ AL
Sbjct: 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306
Query: 313 DPYF 316
+F
Sbjct: 307 HDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 7e-55
Identities = 117/306 (38%), Positives = 172/306 (56%), Gaps = 18/306 (5%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLR 77
+G Y LE +G+G+Y V T VA+K+I EH A +REV LL+
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLK 59
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML 136
L+H +IV + I+ K + +VFE ++ DL Q + ++ H+ + FLYQ+L
Sbjct: 60 DLKHANIVTLHDIV-----HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQIL 114
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L Y H V HRDLKP+N+L N +LK+ DFGLAR + + T +++ V T WYR
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYR 171
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
P+ L GS S+Y+ ID+W +GCIF E+ +G+PLFPG +V +L LI LLGTP+ ET
Sbjct: 172 PPDVLLGS--SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229
Query: 256 -AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ N++ + Y K P PL P +D + LL + + ++ K R +AEEA+
Sbjct: 230 PGISSNDEFKNY--NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287
Query: 315 YFKGLA 320
YF+ L
Sbjct: 288 YFRSLG 293
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 1e-54
Identities = 115/307 (37%), Positives = 169/307 (55%), Gaps = 18/307 (5%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLR 77
+G Y L+ +G+G+Y V T VA+K+I EH A +REV LL+
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIR--LEHEEGAPCTAIREVSLLK 59
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML 136
L+H +IV + I+ K + +VFE ++ DL Q + + H+ + FL+Q+L
Sbjct: 60 DLKHANIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLL 114
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L Y H V HRDLKP+N+L N +LK+ DFGLAR + + T +++ V T WYR
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYR 171
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
P+ L GS + Y+ ID+W +GCIF E+ TG+PLFPG +V QL I +LGTP+ ET
Sbjct: 172 PPDILLGS--TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW 229
Query: 256 -AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
++ NE+ + Y K L P +D LL +L+ F+ + R +AEEA+ P
Sbjct: 230 PGILSNEEFKSY--NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287
Query: 315 YFKGLAK 321
YF L +
Sbjct: 288 YFHCLGE 294
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 183 bits (465), Expect = 1e-53
Identities = 113/302 (37%), Positives = 169/302 (55%), Gaps = 18/302 (5%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLR 77
+G Y L+ +G+G+Y V T VA+K+I EH A +REV LL+
Sbjct: 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIR--LEHEEGAPCTAIREVSLLK 58
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML 136
L+H +IV + I+ + + +VFE ++SDL Q + +L H+ + F++Q+L
Sbjct: 59 NLKHANIVTLHDII-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLL 113
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L Y H + HRDLKP+N+L N +LK+ DFGLAR + + T +++ V T WYR
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYR 170
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
P+ L GS ++Y+ ID+W +GCI E+ TG+P+FPG +V +L LI LLGTP+ ET
Sbjct: 171 PPDVLLGS--TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228
Query: 256 -AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ NE+ R YL + PL P +D + LL L+ ++ K R +AE AL
Sbjct: 229 PGITSNEEFRSYLFPQYR--AQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286
Query: 315 YF 316
YF
Sbjct: 287 YF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 103/296 (34%), Positives = 168/296 (56%), Gaps = 11/296 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
N++++L V+G+G+YGVV T E VAIKK D E+ LRE+K+LR L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKY 141
+IVE+K R +Y+VFE +E ++ ++++ + + E + ++YQ+++A+ +
Sbjct: 61 NIVELKEAF-----RRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H ++ HRD+KP+N+L + N LK+CDFG AR + +T+YVATRWYR+PEL
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN--YTEYVATRWYRSPELL 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ Y A+D+WS+GCI E+ G+PLFPG+S + QL I +LG E + + +
Sbjct: 174 --LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231
Query: 262 KARKYLTEMRKKPPVPLFQKFPNV-DPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
L P L +++ + + L L++ L+ +P DR E+ L P F
Sbjct: 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 1e-48
Identities = 76/294 (25%), Positives = 131/294 (44%), Gaps = 35/294 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+ E++G+GS+G V A+D TGE +A+K + + + + RE+++L L+HP+
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV E + + E + L ++K L + + Q+L L Y+
Sbjct: 61 IVRYYGSER---DEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ + HRD+K NIL +++ +K+ DFG A+ D T ++ APE+
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFGCAKR-LGDIETGEGTGSVRGTPYWMAPEVIR 176
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+Y A DIWS+GC E+ TGKP + + + + + + P
Sbjct: 177 G--EEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSSGEP---------- 222
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
P +P ++ A L++ + DPK RPTA+E L P+
Sbjct: 223 -----------PEIP-----EHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 4e-48
Identities = 108/304 (35%), Positives = 157/304 (51%), Gaps = 19/304 (6%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL 78
+G A Y LE +G+GSY V I G+ VA+K I E +RE LL+
Sbjct: 1 FGAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKG 59
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLR 137
L+H +IV + I+ F VFE M +DL Q + + ++ + F++Q+LR
Sbjct: 60 LKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L Y+H ++ HRDLKP+N+L + +LK+ DFGLAR P + ++ V T WYR
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSE-VVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETI 255
P+ L G+ + Y+ A+DIW GCIF E+L G+P FPG S V QL+ I +LG P+ +T
Sbjct: 172 PDVLLGA--TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW 229
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPN---VDPLALRLLQRLIAFDPKDRPTAEEALA 312
V K Y E + P A L +++ PKDR +A++AL
Sbjct: 230 PGV--SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287
Query: 313 DPYF 316
PYF
Sbjct: 288 HPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 3e-47
Identities = 70/196 (35%), Positives = 107/196 (54%), Gaps = 13/196 (6%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
+G+G +G V A D TG+KVAIK I S +LRE+++L+ L HP+IV++ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS-SLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 91 MLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVY 148
+ +Y+V E E L ++K N+ L+ + L Q+L L+Y+H+ +
Sbjct: 60 FE-----DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114
Query: 149 HRDLKPKNIL-ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK 207
HRDLKP+NIL + N K+K+ DFGL+++ SD + V T Y APE+
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL---KTIVGTPAYMAPEVL-LGKGY 170
Query: 208 YTPAIDIWSIGCIFAE 223
Y+ DIWS+G I E
Sbjct: 171 YSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 167 bits (422), Expect = 2e-46
Identities = 89/355 (25%), Positives = 147/355 (41%), Gaps = 35/355 (9%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLRHPD 83
Y+IL +G+GS+G V A D + VA+K + E S + R LRE+++L L HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 84 -IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD---LTREHHQFFLYQMLRAL 139
IV++ V+ + L ++K L+ F L Q+L AL
Sbjct: 59 NIVKLYDFFQDEGS----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 140 KYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVA---FSDTPMTVFWTDYVATRWY 195
+Y+H+ + HRD+KP+NIL + + +K+ DFGLA++ S + + + V T Y
Sbjct: 115 EYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 196 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE+ G + + + DIWS+G E+LTG P F G+ +T
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATS-----------QT 223
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ ++ + + P + A LL++L+A DPK+R ++ L+
Sbjct: 224 LKIILELPTPSLASPLSPSNP-------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 315 YFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYIN 369
L E + S + + L D N
Sbjct: 277 LLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSN 331
|
Length = 384 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 4e-46
Identities = 104/304 (34%), Positives = 162/304 (53%), Gaps = 26/304 (8%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEK-VAIKKIHDVFEHISDAIRILREVKLLRLLR-- 80
+Y+ + IG+G+YG V A D G + VA+K++ + +REV +LR L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 81 -HPDIVEIKRI-MLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQML 136
HP++V + + + + RE K + +VFE ++ DL + + + E + ++Q+L
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETK-LTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR+ +T V T WYR
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV----VVTLWYR 176
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE--- 253
APE+ S Y +D+WS+GCIFAE+ KPLF G S V QL I D++G P E
Sbjct: 177 APEVL--LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234
Query: 254 -TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+A+ R K P+ + ++D L LL + + F+P R +A AL+
Sbjct: 235 RDVALPRQAFH--------SKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286
Query: 313 DPYF 316
PYF
Sbjct: 287 HPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 1e-45
Identities = 113/337 (33%), Positives = 179/337 (53%), Gaps = 29/337 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
YK+ +IG GS+GVV AI T EKVAIKK+ + D RE+ +++ L H +I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMKNLNHINI 121
Query: 85 VEIKRIMLPPS-KREFKDIY--VVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLR 137
+ +K K+ K+I+ VV E + +H+ +K N L + + YQ+ R
Sbjct: 122 IFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCR 181
Query: 138 ALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL Y+H+ + HRDLKP+N+L + N LK+CDFG A+ + Y+ +R+YR
Sbjct: 182 ALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV----SYICSRFYR 237
Query: 197 APEL-CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APEL G+ + YT ID+WS+GCI AE++ G P+F G+S V QL I +LGTP+ + +
Sbjct: 238 APELMLGA--TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP-LALRLLQRLIAFDPKDRPTAEEALADP 314
+ A +++ K L + FP P A+ + + + ++P R EALADP
Sbjct: 296 KEMNPNYADIKFPDVKPK---DLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352
Query: 315 YFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
+F L R+P + ++ + +I+E+
Sbjct: 353 FFDDL----RDPCIKLPKYIDKLPDLFNFCDAEIKEM 385
|
Length = 440 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 3e-44
Identities = 90/305 (29%), Positives = 146/305 (47%), Gaps = 59/305 (19%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRH 81
+Y+I++ IGKGS+G V G+ +K+I ++S+ R L EVK+L+ L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID--LSNMSEKEREDALNEVKILKKLNH 58
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFF--------L 132
P+I++ S E + +V E + DL Q IK ++ + F
Sbjct: 59 PNIIKYYE-----SFEEKGKLCIVMEYADGGDLSQKIKK----QKKEGKPFPEEQILDWF 109
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
Q+ ALKY+H+ + HRD+KP+NI +N +K+ DFG+++V S + V T
Sbjct: 110 VQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA---KTVVGT 166
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL-GTPS 251
+Y +PELC + Y DIWS+GC+ E+ T K F G++ L+L +L G
Sbjct: 167 PYYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQYP 221
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
P + + +Y +E+R L LLQ+ DP++RP+ + L
Sbjct: 222 P-----IPS----QYSSELRN---------------LVSSLLQK----DPEERPSIAQIL 253
Query: 312 ADPYF 316
P+
Sbjct: 254 QSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 3e-43
Identities = 103/303 (33%), Positives = 150/303 (49%), Gaps = 25/303 (8%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y+ + IG G+YG V A D H+G VA+K + + +REV LL+ L D
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 84 IVEIKRIM----LPPSKREFKDIYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLR 137
I R+M + RE K + +VFE ++ DL + L E + + Q LR
Sbjct: 61 HPNIVRLMDVCATSRTDRETK-VTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L ++H + HRDLKP+NIL + ++K+ DFGLAR+ +T V T WYRA
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT----PVVVTLWYRA 175
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS----PE 253
PE+ S Y +D+WS+GCIFAE+ KPLF G S QL I DL+G P P
Sbjct: 176 PEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+ + R + P P+ P ++ +LL ++ F+P R +A AL
Sbjct: 234 DVTLPRG--------AFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285
Query: 314 PYF 316
P+F
Sbjct: 286 PFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 5e-41
Identities = 81/302 (26%), Positives = 134/302 (44%), Gaps = 61/302 (20%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++ILE IGKG +G V A TG++VAIK I + + +I+ E+++L+ +HP+I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKE--KIINEIQILKKCKHPNI 59
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYM 142
V+ L + +++V E L ++K+ + LT + ++L+ L+Y+
Sbjct: 60 VKYYGSYLKKDE-----LWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ + HRD+K NIL ++ ++K+ DFGL+ SDT V T ++ APE+
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTM---VGTPYWMAPEVI- 169
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y DIWS+G E+ GKP +
Sbjct: 170 -NGKPYDYKADIWSLGITAIELAEGKPPY---------------------------SELP 201
Query: 263 ARKYLTEMRKKPPVPL---------FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
K L ++ P L F+ F + LQ +P+ RPTAE+ L
Sbjct: 202 PMKALFKIATNGPPGLRNPEKWSDEFKDFLK------KCLQ----KNPEKRPTAEQLLKH 251
Query: 314 PY 315
P+
Sbjct: 252 PF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 5e-41
Identities = 87/308 (28%), Positives = 140/308 (45%), Gaps = 62/308 (20%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHP 82
Y++LE IGKGS+G V G+ + K+I + ++++ + ++ EV +LR L+HP
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHP 59
Query: 83 DIVE-IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFF--------L 132
+IV RI+ ++ +Y+V E E DL Q+I+ ++ ++ L
Sbjct: 60 NIVRYYDRIIDRSNQT----LYIVMEYCEGGDLAQLIQK----CKKERKYIEEEFIWRIL 111
Query: 133 YQMLRALKYMHTAN-----VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
Q+L AL H + V HRDLKP NI +AN +K+ DFGLA++ D+
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA---K 168
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247
YV T +Y +PE Y DIWS+GC+ E+ P F ++ QL L + +
Sbjct: 169 TYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKI- 222
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
K K+ +P L +++ ++ DP RP+
Sbjct: 223 --------------KEGKF-------RRIPYRYS----SELN-EVIKSMLNVDPDKRPST 256
Query: 308 EEALADPY 315
EE L P
Sbjct: 257 EELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 86/294 (29%), Positives = 136/294 (46%), Gaps = 41/294 (13%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y++ ++IG+G++GVV ++ TG+ VAIK+I I++E+ LL+ L+HP+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV K I + Y++ E E+ L Q+IK ++YQ+L+ L Y+
Sbjct: 61 IV--KYIGSIETSDSL---YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H V HRD+K NIL + +K+ DFG+A + V T ++ APE+
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD---ASVVGTPYWMAPEVIE 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
S + A DIWS+GC E+LTG P + DL P +V+++
Sbjct: 173 --MSGASTASDIWSLGCTVIELLTGNPPY--------YDL------NPMAALFRIVQDD- 215
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
PP+P + P L + DP RPTA++ L P+
Sbjct: 216 ----------HPPLP-----EGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 114/330 (34%), Positives = 163/330 (49%), Gaps = 65/330 (19%)
Query: 31 IGKGSYGVVCAA--IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+G+G+YG V A D ++ A+K+I E ++ RE+ LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64
Query: 89 RIMLPPSKREFKDIYVVFELMESDL------HQVIKAND---DLTREHHQFFLYQMLRAL 139
++ L S R+ ++++F+ E DL H+ KAN L R + LYQ+L +
Sbjct: 65 KVFLSHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121
Query: 140 KYMHTANVYHRDLKPKNILANANC----KLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
Y+H V HRDLKP NIL ++K+ D G AR+ S V T WY
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 196 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------SVVH--QLDLITD 245
RAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + + H QLD I
Sbjct: 182 RAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239
Query: 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQK------FPNV-------------D 286
++G P A K ++RK P P QK + N D
Sbjct: 240 VMGFP------------ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPD 287
Query: 287 PLALRLLQRLIAFDPKDRPTAEEALADPYF 316
LLQ+L+ DP R T+E+AL DPYF
Sbjct: 288 SKVFLLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 5e-39
Identities = 107/306 (34%), Positives = 164/306 (53%), Gaps = 17/306 (5%)
Query: 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL 78
+G A+ Y+ LE +G+GSY V G+ VA+K I + E +RE LL+
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR-LQEEEGTPFTAIREASLLKG 59
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVI-KANDDLTREHHQFFLYQMLR 137
L+H +IV + I+ + + +VFE + +DL Q + K L E+ + FL+Q+LR
Sbjct: 60 LKHANIVLLHDII-----HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L Y+H + HRDLKP+N+L + +LK+ DFGLAR P + ++ V T WYR
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTY-SNEVVTLWYRP 171
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQLDLITDLLGTPSPETI 255
P+ L GS ++Y+ +D+W +GCIF E++ G FPG K + QL+ I +LGTP+ +T
Sbjct: 172 PDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229
Query: 256 AVVRNEKARK--YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
V + K T K + K V+ A L +L+ PK+R +A+ AL+
Sbjct: 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNH-AEDLASKLLQCFPKNRLSAQAALSH 288
Query: 314 PYFKGL 319
YF L
Sbjct: 289 EYFSDL 294
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 5e-39
Identities = 110/329 (33%), Positives = 166/329 (50%), Gaps = 63/329 (19%)
Query: 31 IGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+G+G+YG V A D A+K+I E ++ RE+ LLR L+HP+++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64
Query: 89 RIMLPPSKREFKDIYVVFELMESDL------HQVIKAND---DLTREHHQFFLYQMLRAL 139
++ L + R+ ++++F+ E DL H+ KAN L R + LYQ+L +
Sbjct: 65 KVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121
Query: 140 KYMHTANVYHRDLKPKNILANANC----KLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
Y+H V HRDLKP NIL ++K+ D G AR+ S V T WY
Sbjct: 122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 181
Query: 196 RAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------SVVH--QLDLITD 245
RAPEL G+ YT AIDIW+IGCIFAE+LT +P+F + + H QLD I +
Sbjct: 182 RAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239
Query: 246 LLGTPS----------PETIAVVRNEKAR--------KYLTEMRKKPPVPLFQKFPNVDP 287
++G P+ PE ++++ + KY+ + + KP D
Sbjct: 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP-----------DS 288
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPYF 316
A LLQ+L+ DP R T+E+A+ DPYF
Sbjct: 289 KAFHLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 2e-37
Identities = 91/323 (28%), Positives = 143/323 (44%), Gaps = 59/323 (18%)
Query: 4 DQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DV 59
++ K LKD GD YK LE IG+G+ G V A D TG++VAIKK+
Sbjct: 2 EELKAALKD---IVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN 58
Query: 60 FEHISDAIRILREVKLLRLLRHPDIVE-IKRIMLPPSKREFKDIYVVFELMES-DLHQVI 117
E I+ E+ +++ +HP+IV+ S +++VV E M+ L +I
Sbjct: 59 KE------LIINEILIMKDCKHPNIVDYYD------SYLVGDELWVVMEYMDGGSLTDII 106
Query: 118 KAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176
N + + ++L+ L+Y+H+ NV HRD+K NIL + + +K+ DFG A
Sbjct: 107 TQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166
Query: 177 FSDTPM--TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
+ +V V T ++ APE+ Y P +DIWS+G + E+ G+P + +
Sbjct: 167 TKEKSKRNSV-----VGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLRE 219
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
+ L LIT G P + P L
Sbjct: 220 PPLRALFLITT-KGIPPLKNPE---------------------------KWSPEFKDFLN 251
Query: 295 RLIAFDPKDRPTAEEALADPYFK 317
+ + DP+ RP+AEE L P+ K
Sbjct: 252 KCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 2e-36
Identities = 86/295 (29%), Positives = 135/295 (45%), Gaps = 35/295 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
R++ IG G++G V A++ TGE +A+K+I I E+K+L LL+HP+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFEL-MESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+V+ + + RE +Y+ E L ++++ L + + Q+L L Y+
Sbjct: 61 LVKYYGVEV---HRE--KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYL 115
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLA-RVAFSDTPMTVFWTDYVATRWYRAPEL- 200
H+ + HRD+KP NI + N +K+ DFG A ++ + T M T Y APE+
Sbjct: 116 HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G + A DIWS+GC+ E+ TGK + +LD N
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMATGKRPW------SELD------------------N 211
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
E + KPP+P + + P L R + DPK RPTA E L P+
Sbjct: 212 EFQIMFHVGAGHKPPIPDSLQ---LSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 5e-36
Identities = 84/297 (28%), Positives = 132/297 (44%), Gaps = 58/297 (19%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---LREVKLLRLLRHPDIVEI 87
+GKGS+G V TG+ A+K + + I + L E +L + HP IV++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKK--KKIIKRKEVEHTLTERNILSRINHPFIVKL 58
Query: 88 KRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
F+ +Y+V E +L + + E +F+ +++ AL+Y+H
Sbjct: 59 HY--------AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLH 110
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + +RDLKP+NIL +A+ +K+ DFGLA+ S+ T + T Y APE+
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT---NTFCGTPEYLAPEVLLG 167
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
Y A+D WS+G + E+LTGKP F +
Sbjct: 168 --KGYGKAVDWWSLGVLLYEMLTGKPPFYAED---------------------------- 197
Query: 264 RKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDRPT---AEEALADPYF 316
RK + E K P+ +FP + P A L+ L+ DP R AEE A P+F
Sbjct: 198 RKEIYEKILKDPL----RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 7e-35
Identities = 81/301 (26%), Positives = 128/301 (42%), Gaps = 67/301 (22%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLR 80
+ + +G+G++G V +VA+K + + + I LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKE--DASEQQIEEFLREARIMRKLD 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRA 138
HP++V++ + + +Y+V E ME DL ++ N L+ F Q+ R
Sbjct: 60 HPNVVKLLGVCTEE-----EPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
++Y+ + N HRDL +N L N +K+ DFGL+R + D DY
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD--------DYYRKRGGKLP 166
Query: 193 -RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGT 249
RW APE S K+T D+WS G + E+ T G+ +PG S
Sbjct: 167 IRWM-APE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-------------- 208
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPTAE 308
NE+ +YL + P P P L L+ + A DP+DRPT
Sbjct: 209 ----------NEEVLEYLKNGYRLPQ-------PPNCPPELYDLMLQCWAEDPEDRPTFS 251
Query: 309 E 309
E
Sbjct: 252 E 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 5e-34
Identities = 77/295 (26%), Positives = 125/295 (42%), Gaps = 54/295 (18%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLR 80
+ + +G+G++G V +VA+K + + + I LRE +++R L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE--DASEQQIEEFLREARIMRKLD 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLR 137
HP+IV++ + + +V E M DL ++ N L+ F Q+ R
Sbjct: 60 HPNIVKLLGVCTEEEP-----LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
++Y+ + N HRDL +N L N +K+ DFGL+R + D + RW A
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD-YYKVKGGKLPIRWM-A 172
Query: 198 PELCGSFF-SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255
PE S K+T D+WS G + E+ T G+ +PG S
Sbjct: 173 PE---SLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-------------------- 209
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPTAEE 309
N + +YL + + P P P L +L+ + A DP+DRPT E
Sbjct: 210 ----NAEVLEYLKKGYRLPK-------PPNCPPELYKLMLQCWAEDPEDRPTFSE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 93/330 (28%), Positives = 144/330 (43%), Gaps = 86/330 (26%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIK---KIHDVFEHISDAIRILREVKLLRLL 79
+ +K ++IG+GS+ V A + T ++ AIK K + E ++I +EV L RL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEV-LTRLN 59
Query: 80 RHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQM 135
HP I IK F+D +Y V E + +L Q I+ L + +F+ ++
Sbjct: 60 GHPGI--IKLYY------TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEI 111
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV-----------------AFS 178
L AL+Y+H+ + HRDLKP+NIL + + +K+ DFG A+V
Sbjct: 112 LLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH 238
+ +V T Y +PEL + D+W++GCI ++LTGKP F G +
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSN--- 226
Query: 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQK-------FP-NVDPLAL 290
+YLT FQK FP N P A
Sbjct: 227 --------------------------EYLT----------FQKILKLEYSFPPNFPPDAK 250
Query: 291 RLLQRLIAFDPKDRPTA----EEALADPYF 316
L+++L+ DP+DR +E A P+F
Sbjct: 251 DLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 3e-31
Identities = 83/296 (28%), Positives = 133/296 (44%), Gaps = 41/296 (13%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+ ++V+G+GS GVV TG+ A+KKIH V ++LRE+K LR P +V
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+ +I +V E M+ L ++K + + Q+L+ L Y+HT
Sbjct: 63 KCYGAFYKEG-----EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 145 -ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
++ HRD+KP N+L N+ ++K+ DFG+++V + + T +V T Y +PE
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNT-FVGTVTYMSPERIQG 174
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y+ A DIWS+G E GK P P +L+ + P P A + +
Sbjct: 175 --ESYSYAADIWSLGLTLLECALGKFPFLPPGQPS-FFELMQAICDGPPPSLPAEEFSPE 231
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
R +++ LQ+ DPK RP+A E L P+ K
Sbjct: 232 FRDFIS----------------------ACLQK----DPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 71/292 (24%), Positives = 121/292 (41%), Gaps = 48/292 (16%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
++ + +G+G++G V T KVA+K + + + L E +++ L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLSH 60
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF-FLYQMLRAL 139
P+IV + + +Y+V E M DL ++ + + Q+ + +
Sbjct: 61 PNIVRLLGVCTQGEP-----LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+Y+ + N HRDL +N L N +K+ DFGL+R + D + +W APE
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM-APE 174
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
K+T D+WS G + E+ T G+ +PG S
Sbjct: 175 SL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS----------------------- 209
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPTAEE 309
NE+ + L + + P P P L L+ + A+DP+DRPT E
Sbjct: 210 -NEEVLELLEDGYRLPR-------PENCPDELYELMLQCWAYDPEDRPTFSE 253
|
Length = 258 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 89/314 (28%), Positives = 137/314 (43%), Gaps = 76/314 (24%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKI---------HDVFEHISDAIRILR-EVKLLRL 78
E+IGKG+YG V A++ TGE +A+K++ HD D ++ LR E++ L+
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHD--SRQKDMVKALRSEIETLKD 64
Query: 79 LRHPDIV---------EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQ 129
L H +IV E I L YV + S L + + L R
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLE---------YVPGGSIGSCLRTYGRFEEQLVR---- 111
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA------FSDTPM- 182
FF Q+L L Y+H+ + HRDLK N+L +A+ K+ DFG+++ + + M
Sbjct: 112 FFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ 171
Query: 183 -TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241
+VFW APE+ S+ Y+ +DIWS+GC+ E+ G+ + + +
Sbjct: 172 GSVFWM---------APEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI---- 218
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDP 301
A L R PP+P N+ P+AL L +P
Sbjct: 219 --------------------AAMFKLGNKRSAPPIPP-DVSMNLSPVALDFLNACFTINP 257
Query: 302 KDRPTAEEALADPY 315
+RPTA E L P+
Sbjct: 258 DNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 1e-30
Identities = 92/305 (30%), Positives = 144/305 (47%), Gaps = 61/305 (20%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRIL-REVKLLRLLR 80
R++ E++G GS+G V ++ G+ A+K + D + +A++ L +E+ LL L+
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP+IV+ ++RE ++Y+ EL+ L +++K + + Q+L L
Sbjct: 61 HPNIVQYL-----GTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGL 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDYVATRWYRA 197
+Y+H N HRD+K NIL + N +K+ DFG+A+ V FS F + + ++ A
Sbjct: 116 EYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS------FAKSFKGSPYWMA 169
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE+ Y A DIWS+GC E+ TGKP + QL E +A
Sbjct: 170 PEVIAQ-QGGYGLAADIWSLGCTVLEMATGKPPW------SQL------------EGVAA 210
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLA-------LRLLQRLIAFDPKDRPTAEEA 310
V K L PP+P D L+ L+ LQR DP RPTA E
Sbjct: 211 VFKIGRSKEL------PPIP--------DHLSDEAKDFILKCLQR----DPSLRPTAAEL 252
Query: 311 LADPY 315
L P+
Sbjct: 253 LEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 85/301 (28%), Positives = 140/301 (46%), Gaps = 50/301 (16%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKI--HDV-FEHISDAIRILREVKLLRLLRHPDIVEI 87
I KG+YG V A TG+ AIK I D+ ++ D ++L E +L + P +V+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVD--QVLTERDILSQAQSPYVVK- 57
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L S + K++Y+V E + DL +++ L + + ++ +++ AL+Y+H+
Sbjct: 58 ----LYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG 113
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY-----VATRWYRAPELC 201
+ HRDLKP NIL ++N LK+ DFGL++V + + + V T Y APE+
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
++ +D WS+GCI E L G P F G++ E + N
Sbjct: 174 LG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETP---------------EEIFQNILNG 216
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA---EEALADPYFKG 318
K + + V A+ L+ +L+ DP+ R A EE P+FKG
Sbjct: 217 KIE--------------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
Query: 319 L 319
+
Sbjct: 263 I 263
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 8e-29
Identities = 89/316 (28%), Positives = 127/316 (40%), Gaps = 82/316 (25%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRH 81
+ +LE IGKGS+G V AID T + VAIK I E D I I +E++ L R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID--LEEAEDEIEDIQQEIQFLSQCRS 58
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLR 137
P I + L SK ++++ E DL + K L + F L ++L
Sbjct: 59 PYITKYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKPGK----LDETYIAFILREVLL 109
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA---------RVAFSDTPMTVFWTD 188
L+Y+H HRD+K NIL + +K+ DFG++ R F TP FW
Sbjct: 110 GLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTP---FWM- 165
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
APE+ S Y DIWS+G E+ G+P + L LI
Sbjct: 166 --------APEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP---- 211
Query: 249 TPSPETIAVVRNEKARKYLTEMRKKPPV-------PLFQKFPNVDPLALRLLQRLIAFDP 301
+ PP F+ F ++L L + DP
Sbjct: 212 ----------------------KNNPPSLEGNKFSKPFKDF-----VSLCLNK-----DP 239
Query: 302 KDRPTAEEALADPYFK 317
K+RP+A+E L + K
Sbjct: 240 KERPSAKELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 63/218 (28%), Positives = 112/218 (51%), Gaps = 23/218 (10%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS-DAIR-ILREVKLLRLLRHP 82
+++L VIGKG++G VC T + A+K ++ + + ++R +L E ++L+ L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQELNHP 60
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
+V + F+D +Y+V +L+ DL + + E +F++ +++ A
Sbjct: 61 FLVNLWY--------SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLA 112
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+Y+H+ + HRD+KP NIL + + + DF +A + +T T T Y AP
Sbjct: 113 LEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATK-VTPDTLT---TSTSGTPGYMAP 168
Query: 199 ELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKS 235
E+ + Y+ A+D WS+G E L GK + G S
Sbjct: 169 EV---LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 82/304 (26%), Positives = 131/304 (43%), Gaps = 63/304 (20%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRH 81
Y + V+GKG++G T V K+++ +S+ R L E+ +L LL+H
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVN--LTRLSEKERRDALNEIVILSLLQH 58
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQ--FFLYQM 135
P+I+ F D + ME L+ I E ++L+Q+
Sbjct: 59 PNIIAYYN--------HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQI 110
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM--TVFWTDYVATR 193
+ A+ Y+H A + HRD+K NI +K+ DFG++++ S+ M TV V T
Sbjct: 111 VSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-----VGTP 165
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG---TP 250
+Y +PELC KY DIW++GC+ E+LT K F + L+L+ ++ TP
Sbjct: 166 YYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGNYTP 220
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
Y +E+ L+ L+ DP+ RPTA+E
Sbjct: 221 VVS-----------VYSSELIS-------------------LVHSLLQQDPEKRPTADEV 250
Query: 311 LADP 314
L P
Sbjct: 251 LDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 67/208 (32%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
+KI + IGKG + VV AI G VA+KK+ +FE + R L+E+ LL+ L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQ-IFEMMDAKARQDCLKEIDLLKQLD 60
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK--ANDDLTREHHQF--FLYQM 135
HP++ I S E ++ +V EL ++ DL ++IK + Q+
Sbjct: 61 HPNV-----IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL 115
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
AL++MH+ + HRD+KP N+ A +K+ D GL R FS V T +Y
Sbjct: 116 CSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAH--SLVGTPYY 172
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAE 223
+PE + Y DIWS+GC+ E
Sbjct: 173 MSPERIHE--NGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 78/287 (27%), Positives = 127/287 (44%), Gaps = 40/287 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG+GS G+VC A D TG +VA+KK+ D+ + + + EV ++R +HP+IVE+
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRREL-LFNEVVIMRDYQHPNIVEMYSS 84
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
L +++VV E +E I + + E +L+AL ++H V HR
Sbjct: 85 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHR 139
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL ++ ++K+ DFG + P V T ++ APE+ Y
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPEVISR--LPYGT 194
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEM 270
+DIWS+G + E++ G+P + NE + + +
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPY---------------------------FNEPPLQAMKRI 227
Query: 271 RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
R P P + V P L R++ DP R TA E L P+
Sbjct: 228 RDNLP-PKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 74/286 (25%), Positives = 134/286 (46%), Gaps = 40/286 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG+GS G+VC A + H+G +VA+K + D+ + + + EV ++R +H ++VE+ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMM-DLRKQQRREL-LFNEVVIMRDYQHQNVVEMYKS 86
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
L ++++V+ E ++ I + L E +L+AL Y+H+ V HR
Sbjct: 87 YLVG-----EELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL + ++K+ DFG D P V T ++ APE+ + Y
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR---KSLVGTPYWMAPEVISR--TPYGT 196
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEM 270
+DIWS+G + E++ G+P + S V + +
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQA---------------------------MKRL 229
Query: 271 RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
R PP P + + P+ L+R++ +P++R TA+E L P+
Sbjct: 230 RDSPP-PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 80/303 (26%), Positives = 126/303 (41%), Gaps = 45/303 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y+++EVIG G+ VV AAI EKVAIK+I D+ + + + +EV+ + HP
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK---ANDDLTREHHQFFLYQMLRA 138
++V+ S ++++V + L ++K L L ++L+
Sbjct: 60 NVVKYY-----TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF-WTDYVATRWYRA 197
L+Y+H+ HRD+K NIL + +K+ DFG++ T +V T + A
Sbjct: 115 LEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP----LFPGKSVVHQLDLITDLLGTPSPE 253
PE+ Y DIWS G E+ TG P K ++ L P
Sbjct: 175 PEVMEQ-VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML-------TLQNDPP- 225
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
T K F+K ++L L + DP RPTAEE L
Sbjct: 226 -----------SLETGADYKKYSKSFRKM-----ISLCLQK-----DPSKRPTAEELLKH 264
Query: 314 PYF 316
+F
Sbjct: 265 KFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 70/298 (23%), Positives = 130/298 (43%), Gaps = 40/298 (13%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILR-EVKLLRLL 79
++ +++G+G++G V D TG ++A+K++ + L E++LL+ L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
+H IV+ + R+ + + + E M + +KA LT + + Q+L
Sbjct: 62 QHERIVQYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG 116
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
++Y+H+ + HRD+K NIL ++ +K+ DFG ++ + T ++ +P
Sbjct: 117 VEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ Y D+WS+GC E+LT KP + + E +A +
Sbjct: 177 EVISG--EGYGRKADVWSVGCTVVEMLTEKPPW------------AEF------EAMAAI 216
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ +P P Q +V P A L+R + K RP+AEE L +
Sbjct: 217 FK---------IATQPTNP--QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 33/213 (15%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKI--HDVF-----EHISDAIRILREVKLLRLLRHPD 83
+G G +G V A+K + + EHI E ++L HP
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHI------FSEKEILEECNHPF 54
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES----DLHQVIKANDDLTREHHQFFLYQMLRAL 139
IV ++ R FKD ++ LME +L +++ +F++ ++ A
Sbjct: 55 IV---KLY-----RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAF 106
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+Y+H + +RDLKP+N+L ++N +K+ DFG A+ S WT + T Y APE
Sbjct: 107 EYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT---WT-FCGTPEYVAPE 162
Query: 200 LCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLF 231
+ +K Y ++D WS+G + E+LTG+P F
Sbjct: 163 II---LNKGYDFSVDYWSLGILLYELLTGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 85/301 (28%), Positives = 136/301 (45%), Gaps = 58/301 (19%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+ ILE +G+GSYG V AI TG+ VAIK + V E + + I++E+ +L+ P I
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQE---IIKEISILKQCDSPYI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLRALK 140
V+ S + D+++V E SD+ ++ N LT E LYQ L+ L+
Sbjct: 61 VKYY-----GSYFKNTDLWIVMEYCGAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLE 113
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLA-----RVAFSDTPMTVFWTDYVATRWY 195
Y+H+ HRD+K NIL N + K+ DFG++ +A +T + T ++
Sbjct: 114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--------VIGTPFW 165
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ Y DIWS+G E+ GKP + S +H P
Sbjct: 166 MAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPY---SDIH-----------PM---- 205
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ + + KPP P P +++ + DP++RP+A + L P+
Sbjct: 206 ---------RAIFMIPNKPP-PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255
Query: 316 F 316
Sbjct: 256 I 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 65/218 (29%), Positives = 108/218 (49%), Gaps = 16/218 (7%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-R 80
++++EVIG+G+YG V A TG+ VAIK + + + + I E +LR
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE---IKEEYNILRKYSN 61
Query: 81 HPDIVEIKRIMLPPSKREFKD-IYVVFELME----SDLHQVIKANDDLTREHH-QFFLYQ 134
HP+I + + D +++V EL +DL + ++ +E + L +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
LR L Y+H V HRD+K +NIL N ++K+ DFG++ A D+ + T ++ T +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS--AQLDSTLGRRNT-FIGTPY 178
Query: 195 YRAPE--LCG-SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
+ APE C + Y D+WS+G E+ GKP
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 85/312 (27%), Positives = 132/312 (42%), Gaps = 60/312 (19%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRLLRH 81
Y+ LE+IG+G+YG V TG VA+K I+ + +SD I REV LL LR
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSD---IQREVALLSQLRQ 58
Query: 82 PDIVEIKR----IMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
I + + P ++++ E E + ++KA + ++ + ++L
Sbjct: 59 SQPPNITKYYGSYLKGPR------LWIIMEYAEGGSVRTLMKAGP-IAEKYISVIIREVL 111
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
ALKY+H V HRD+K NIL +K+CDFG VA + + +V T ++
Sbjct: 112 VALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFG---VAALLNQNSSKRSTFVGTPYWM 168
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
APE+ Y DIWS+G E+ TG P + + LI
Sbjct: 169 APEVITE-GKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP------------ 215
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF----DPKDRPTAEEALA 312
+ KPP + D +LL+ +A +PK+R +AEE L
Sbjct: 216 --------------KSKPP-----RLE--DNGYSKLLREFVAACLDEEPKERLSAEELLK 254
Query: 313 DPYFKGLAKIER 324
+ K +K
Sbjct: 255 SKWIKAHSKTPV 266
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 78/298 (26%), Positives = 132/298 (44%), Gaps = 44/298 (14%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG+GS G+VC A + HTG++VA+KK+ D+ + + + EV ++R H ++V++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM-DLRKQQRREL-LFNEVVIMRDYHHENVVDMYNS 87
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
L +++VV E +E I + + E +LRAL Y+H V HR
Sbjct: 88 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL ++ ++K+ DFG + P V T ++ APE+ Y
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR---KSLVGTPYWMAPEVISRL--PYGT 197
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEM 270
+DIWS+G + E++ G+P + NE + + +
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPY---------------------------FNEPPLQAMRRI 230
Query: 271 RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSC 328
R P P + V + L ++ +P R TA+E L P+ K+ PSC
Sbjct: 231 RDNLP-PRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFL----KLAGPPSC 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 85/296 (28%), Positives = 129/296 (43%), Gaps = 44/296 (14%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPDIV 85
L +G G+ GVV + TG+ +A+K I I++AI+ ILRE+ +L P IV
Sbjct: 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIR---LEINEAIQKQILRELDILHKCNSPYIV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHH-QFFLYQMLRALKYMH 143
DI + E M+ L +++K E +L+ L Y+H
Sbjct: 63 GFYGAFY----NN-GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 144 TA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
+ HRD+KP NIL N+ ++K+CDFG++ + T +V T Y APE
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-----FVGTSSYMAPERIQ 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+ Y+ DIWS+G E+ TG+ FP D I +LL +V NE
Sbjct: 173 G--NDYSVKSDIWSLGLSLIELATGR--FPYPPENDPPDGIFELLQ-------YIV-NEP 220
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
+ + FQ F N L + DP++RP+ +E L P+ K
Sbjct: 221 PPRLPSGKFSPD----FQDFVN------LCLIK----DPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 5e-23
Identities = 81/300 (27%), Positives = 137/300 (45%), Gaps = 55/300 (18%)
Query: 24 RYKILEVIGKGSYGVV--CAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLL 79
+Y+ + V+G+G++G+V C + V IK+I E ++ R E ++L+LL
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQ--KLVIIKQIP--VEQMTKDERLAAQNECQVLKLL 56
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI--KANDDLTREHHQFFLYQML 136
HP+I+E L E K + +V E L + I + N L + F Q+L
Sbjct: 57 SHPNIIEYYENFL-----EDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 137 RALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAFSDTPM-TVFWTDYVATRW 194
AL ++HT + HRDLK +NIL + + +K+ DFG++++ S + TV V T
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-----VGTPC 166
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
Y +PELC Y DIW++GC+ E+ + K F ++ + I GT +P
Sbjct: 167 YISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS--GTFAP-- 220
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ +Y ++R +L+ ++ DP RP + +A P
Sbjct: 221 -------ISDRYSPDLR-------------------QLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 5e-23
Identities = 84/295 (28%), Positives = 131/295 (44%), Gaps = 51/295 (17%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
V+GKG+YG+V AA D T ++AIK+I + + E+ L L+H +IV +
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLH--EEIALHSYLKHRNIV---Q 69
Query: 90 IMLPPSKREFKDIYVVFELMES----DLHQVIKANDDLTREHHQ---FFLYQMLRALKYM 142
+ S+ F I+ ME L ++++ +++ Q F+ Q+L LKY+
Sbjct: 70 YLGSDSENGFFKIF-----MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYL 124
Query: 143 HTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H + HRD+K N+L N + +K+ DFG ++ P T +T T Y APE+
Sbjct: 125 HDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPEVI 181
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y DIWS+GC E+ TGKP F + LG P
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPPF------IE-------LGEP----------- 217
Query: 262 KARKYLTEMRKK-PPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+A + M K P +P ++ A + R DP R +A + L DP+
Sbjct: 218 QAAMFKVGMFKIHPEIP-----ESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 9e-23
Identities = 69/296 (23%), Positives = 120/296 (40%), Gaps = 55/296 (18%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDI 84
+ +G+G++G V K VA+K + + + + + L+E ++++ L HP++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKE--DASEEERKDFLKEARVMKKLGHPNV 58
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN---------DDLTREHHQFFLYQ 134
V + + +Y+V E ME DL ++ + L+ + F Q
Sbjct: 59 VRLLGVCTEEEP-----LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ + ++Y+ + HRDL +N L + +K+ DFGL+R + D + RW
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRW 173
Query: 195 YRAPELCGSFFS-KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
APE S +T D+WS G + E+ T L TP P
Sbjct: 174 M-APE---SLKDGIFTSKSDVWSFGVLLWEIFT-------------------LGATPYPG 210
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ NE+ +YL + + P P L+ DP+DRPT E
Sbjct: 211 ----LSNEEVLEYLRK-GYRLPKP-----EYCPDELYELMLSCWQLDPEDRPTFSE 256
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-22
Identities = 71/293 (24%), Positives = 122/293 (41%), Gaps = 43/293 (14%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++IL IGKGS+GVV + A+K+I + + + E ++L L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRALKY 141
+ L K + +V E E+ DLH+++K L + F Q+L L +
Sbjct: 62 IRYYESFLDKGK-----LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ + HRD+K N+ +A +K+ D G+A++ + T F V T +Y +PELC
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC 173
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y D+W++G + E TGK F + A++
Sbjct: 174 ED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQG------------------ALILKI 213
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ PPV Q + +L+ + + D + RP + L +P
Sbjct: 214 IRGVF-------PPVS--QMY---SQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 85/304 (27%), Positives = 130/304 (42%), Gaps = 62/304 (20%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIH---------DVFEHISDAIRILREVKLLRLLR 80
+IG GS+G V ++ +GE +A+K++ D + DA+ RE+ LL+ L+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALA--REIALLKELQ 64
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
H +IV+ L YV + + L+ + L R F+ Q+L+ L
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN----FVRQILKGLN 120
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+H + HRD+K NIL + +K+ DFG+++ +++ T T R P L
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLST-------KTNGAR-PSL 172
Query: 201 CGSFF---------SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
GS F + YT DIWS+GC+ E+LTGK FP QL I + S
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD---CTQLQAIFKIGENAS 229
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
PE P N+ A+ L++ D RPTA E L
Sbjct: 230 PE--------------------IP-------SNISSEAIDFLEKTFEIDHNKRPTAAELL 262
Query: 312 ADPY 315
P+
Sbjct: 263 KHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 78/286 (27%), Positives = 124/286 (43%), Gaps = 40/286 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
IG+GS G+VC A +G+ VA+KK+ D+ + + + EV ++R +H ++VE+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM-DLRKQQRREL-LFNEVVIMRDYQHENVVEMYNS 85
Query: 91 MLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHR 150
L +++VV E +E I + + E +L+AL +H V HR
Sbjct: 86 YLVGD-----ELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
D+K +IL + ++K+ DFG + P V T ++ APEL Y P
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR---KSLVGTPYWMAPELISRL--PYGP 195
Query: 211 AIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEM 270
+DIWS+G + E++ G+P + NE K + +
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPY---------------------------FNEPPLKAMKMI 228
Query: 271 RKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
R P P + V P L RL+ DP R TA E L P+
Sbjct: 229 RDNLP-PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 84/318 (26%), Positives = 127/318 (39%), Gaps = 85/318 (26%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRLL 79
Y++++ IG G+YG V A D TGE VAIK I D FE I I +L+E
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC------ 57
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQM 135
RHP+IV R K +++V E D++QV L+ + +
Sbjct: 58 RHPNIVA----YFGSYLRRDK-LWIVMEYCGGGSLQDIYQVT--RGPLSELQIAYVCRET 110
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA---------RVAFSDTPMTVFW 186
L+ L Y+H HRD+K NIL + +K+ DFG++ R +F TP +W
Sbjct: 111 LKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTP---YW 167
Query: 187 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
APE Y DIW++G E+ +P P +H +
Sbjct: 168 M---------APEVAAVERKGGYDGKCDIWALGITAIELAELQP--P-MFDLHPM----- 210
Query: 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPV--------PLFQKFPNVDPLALRLLQRLI 297
+A +++ PP P+F F +++ +
Sbjct: 211 ----------------RALFLISKSNFPPPKLKDKEKWSPVFHDF----------IKKCL 244
Query: 298 AFDPKDRPTAEEALADPY 315
DPK RPTA + L P+
Sbjct: 245 TKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 60/216 (27%), Positives = 110/216 (50%), Gaps = 29/216 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVF-----EHISDAIRILREVKLLR 77
++ ++ +G GS+G V +G+ A+K + EH+ + RIL+ +
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI---- 58
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQML 136
RHP +V L S ++ ++Y+V E + +L ++ + +F+ Q++
Sbjct: 59 --RHPFLVN-----LYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVV 111
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL+Y+H+ ++ +RDLKP+N+L +++ +K+ DFG A+ T +T T Y
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT-----YT-LCGTPEYL 165
Query: 197 APELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLF 231
APE+ SK Y A+D W++G + E+L G P F
Sbjct: 166 APEI---ILSKGYGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 80/303 (26%), Positives = 129/303 (42%), Gaps = 61/303 (20%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRH 81
+K+L+ +GKGSYG V + A+K++ +S R + E+++L + H
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVD--LGSMSQKEREDAVNEIRILASVNH 58
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTR-----EHHQFFLYQM 135
P+I+ K L +K + +V E DL + I + E + F+ Q+
Sbjct: 59 PNIISYKEAFLDGNK-----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QL 112
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
LR L+ +H + HRDLK NIL AN +K+ D G+++V + T + T Y
Sbjct: 113 LRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-----IGTPHY 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ Y+ DIWS+GC+ E+ T P F +S
Sbjct: 168 MAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARS-------------------- 205
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF----DPKDRPTAEEAL 311
+ ++R K K+P + P+ + LQ I PK RP ++ L
Sbjct: 206 -----------MQDLRYK---VQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251
Query: 312 ADP 314
A P
Sbjct: 252 ASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 6e-22
Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 14/215 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y +L V+G+GS+G ++ +K A+K+I + + S +E LL ++HP+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIR-LPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRALK 140
IV K S +Y+V E + DL Q IK + + QM ++
Sbjct: 60 IVAFKE-----SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
++H V HRD+K KNI N K+K+ DFG AR+ S P + YV T +Y PE+
Sbjct: 115 HIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGA-YACTYVGTPYYVPPEI 171
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235
+ Y DIWS+GCI E+ T K F S
Sbjct: 172 WENM--PYNNKSDIWSLGCILYELCTLKHPFQANS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-21
Identities = 82/298 (27%), Positives = 132/298 (44%), Gaps = 46/298 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY+I++ IG+GS+G + A E IK+I + + +EV LL ++HP+
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLY--QMLRALK 140
IV S +E +++V E + DL + I + Q + Q+ LK
Sbjct: 61 IVTFFA-----SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 141 YMHTANVYHRDLKPKNILANANCKL-KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
++H + HRD+K +NI + N + K+ DFG+AR +D+ V T +Y +PE
Sbjct: 116 HIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDS--MELAYTCVGTPYYLSPE 172
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+C + Y DIWS+GC+ E+ T K F G + +HQL L
Sbjct: 173 ICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVL----------------- 212
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-LLQRLIAFDPKDRPTAEEALADPYF 316
+ + P P F + LR L+ +L P+DRP+ L P+
Sbjct: 213 ------KICQGYFAPISPNFSR-------DLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 70/227 (30%), Positives = 104/227 (45%), Gaps = 46/227 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRI--LREVKL 75
D + I +VIG G +G VC G+K VAIK + SD R+ L E +
Sbjct: 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEASI 58
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFF---- 131
+ HP+I+ ++ ++ +K + + ++ E ME+ + D RE+ F
Sbjct: 59 MGQFDHPNIIRLEGVV---TKS--RPVMIITEYMENG------SLDKFLRENDGKFTVGQ 107
Query: 132 LYQMLR----ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV--AFSDTPMT-- 183
L MLR +KY+ N HRDL +NIL N+N KV DFGL+R T T
Sbjct: 108 LVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG 167
Query: 184 ----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ WT APE + K+T A D+WS G + EV++
Sbjct: 168 GKIPIRWT---------APEAIA--YRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 79/304 (25%), Positives = 134/304 (44%), Gaps = 48/304 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRH 81
++IL +G+G YG V A TGE VA+K++ + +R +L E +L +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLR 137
+V++ F+D ++ ME D ++ L+ +H +F++ +M
Sbjct: 61 EWLVKLLY--------AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFE 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
A+ +H HRDLKP+N L +A+ +K+ DFGL++ + V DY+ A
Sbjct: 113 AVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYM------A 166
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE+ Y +D WS+GC+ E L G P F G + ET
Sbjct: 167 PEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---------------NETWEN 209
Query: 258 VRNEKARKYLTEMRKKPPVPLF-QKFPNVDPLALRLLQRLIAFDPKDR-PTAEEALADPY 315
++ K E ++ P++ N+ A L+ +LI DP R + E+ P+
Sbjct: 210 LKYWK------ETLQR---PVYDDPRFNLSDEAWDLITKLIN-DPSRRFGSLEDIKNHPF 259
Query: 316 FKGL 319
FK +
Sbjct: 260 FKEV 263
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 90/330 (27%), Positives = 142/330 (43%), Gaps = 72/330 (21%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ +++++VIG+G++G V D TG+ A+K + SD I+ ++ +R R
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRK-----SDMIK-RNQIAHVRAER-- 52
Query: 83 DI-VEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR 137
DI + + F+D +Y+V E M DL ++ D E +F++ +++
Sbjct: 53 DILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVL 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA----------------RVAFSDTP 181
AL +H HRD+KP NIL +A+ +K+ DFGL
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 182 MTVFWTDY----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
+ V D+ V T Y APE L G + Y D WS+G I E+L G P
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG---TPYGLECDWWSLGVILYEMLYGFPP 229
Query: 231 FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL 290
F ++ ET + N K + L F P V P A+
Sbjct: 230 FYSDTLQ---------------ETYNKIINWK--ESLR----------FPPDPPVSPEAI 262
Query: 291 RLLQRLIAFDPKDR-PTAEEALADPYFKGL 319
L+ RL+ DP+DR + EE + P+FKG+
Sbjct: 263 DLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 93/296 (31%), Positives = 130/296 (43%), Gaps = 56/296 (18%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI---SDAIRILREVKLLRLLRHPDIVEI 87
IGKGS+G V T A+K I HI S+ L E +L + P IV +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRK--AHIVSRSEVTHTLAERTVLAQVNCPFIVPL 58
Query: 88 KRIMLPPSKREFKDIYVVFELM---ESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
K P K +Y+V + E H + DL+R +F+ ++L AL+ +H
Sbjct: 59 KFSFQSPEK-----LYLVLAFINGGELFHHLQREGRFDLSRA--RFYTAELLCALENLHK 111
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF 204
NV +RDLKP+NIL + + +CDFGL ++ D T + T Y APEL
Sbjct: 112 FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT---NTFCGTPEYLAPELLLGH 168
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
YT A+D W++G + E+LTG P F ++V NE R
Sbjct: 169 --GYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----------------------NEMYR 203
Query: 265 KYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDR---PTAEEALADPYF 316
K L E PL +FP D A LL L++ DP R A+E P+F
Sbjct: 204 KILQE-------PL--RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 48/300 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR----ILREVKLLRLLRHPDI 84
+ +G G++ A D TG +A+K++ V S+ + +E++L+ L HP I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 85 VEIKRIMLPPSKREFKDIYVVFELM-----ESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
+ R++ + +++V E M L + + + + Q+LR L
Sbjct: 66 I---RMLGATCEDSHFNLFV--EWMAGGSVSHLLSKYGAFKEAVIIN----YTEQLLRGL 116
Query: 140 KYMHTANVYHRDLKPKNILANANCK-LKVCDFGLA-RVAFSDTPMTVFWTDYVATRWYRA 197
Y+H + HRD+K N+L ++ + L++ DFG A R+A T F + T + A
Sbjct: 117 SYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE+ +Y + D+WS+GC+ E+ T KP + + + L LI + +
Sbjct: 177 PEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA----- 229
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
P +P P + + LR L+ P+DRP + E L P F+
Sbjct: 230 ----------------PSIPEHLS-PGLRDVTLRCLEL----QPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 74/295 (25%), Positives = 130/295 (44%), Gaps = 43/295 (14%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y ++ IG+GS+G G++ IK+I+ + +EV +L ++HP+
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRALK 140
IV+ + S E ++Y+V + E DL++ I A + Q + Q+ ALK
Sbjct: 61 IVQYQE-----SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
++H + HRD+K +NI + +K+ DFG+ARV S + + T +Y +PE+
Sbjct: 116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA---RTCIGTPYYLSPEI 172
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
C + Y DIW++GC+ E+ T K F G + ++R
Sbjct: 173 CEN--RPYNNKSDIWALGCVLYEMCTLKHAFEA--------------GNMKNLVLKIIRG 216
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
PPV ++ L +L +R +P+DRP+ L +
Sbjct: 217 S-----------YPPVSS-HYSYDLRNLVSQLFKR----NPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 3e-20
Identities = 80/297 (26%), Positives = 129/297 (43%), Gaps = 48/297 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHP 82
Y + V+GKGSYG V G++ IKK++ + S R +E +LL L+HP
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN--LRNASRRERKAAEQEAQLLSQLKHP 59
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRAL 139
+IV + + E +Y+V E DL+ +K +Q + Q+ AL
Sbjct: 60 NIVAYRE----SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+Y+H ++ HRDLK +N+ +KV D G+ARV + M + + T +Y +PE
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA---STLIGTPYYMSPE 172
Query: 200 LCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L F +K Y D+W++GC E+ T K F K +
Sbjct: 173 L---FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM---------------------- 207
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ Y K PP+P + P L+ +++ P+ RP+ + L PY
Sbjct: 208 ---NSLVYRIIEGKLPPMP-----KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 3e-20
Identities = 69/250 (27%), Positives = 119/250 (47%), Gaps = 33/250 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEK-VAIKKIH--------DVFEHISDAIRILREVKL 75
Y +LE +G G++G V + G+ +A+K+I+ D E I+ EV +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 76 LR-LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQF--- 130
++ LRHP+IV + L E +Y+V +L+E + L + + L + +F
Sbjct: 62 IKEQLRHPNIVRYYKTFL-----ENDRLYIVMDLIEGAPLGEHFNS---LKEKKQRFTEE 113
Query: 131 ----FLYQMLRALKYMHTAN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185
QM+ AL+Y+H + HRDL P NI+ + K+ + DFGLA+ ++ +
Sbjct: 114 RIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL--- 170
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
T V T Y PE+ + Y D+W+ GCI ++ T +P F +++ I +
Sbjct: 171 -TSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE 227
Query: 246 LLGTPSPETI 255
+ P PE +
Sbjct: 228 AVYEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 7e-20
Identities = 72/221 (32%), Positives = 110/221 (49%), Gaps = 33/221 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIR--ILREVKL 75
DA+ KI +VIG G +G VC+ G++ VAIK + + ++ R L E +
Sbjct: 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASI 58
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQ 134
+ HP+I+ ++ ++ + K + +V E ME+ + D R+H QF + Q
Sbjct: 59 MGQFDHPNIIHLEGVV-----TKSKPVMIVTEYMENG------SLDAFLRKHDGQFTVIQ 107
Query: 135 ---MLRA----LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
MLR +KY+ HRDL +NIL N+N KV DFGL+RV D P + T
Sbjct: 108 LVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDPEAAYTT 166
Query: 188 D--YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW APE + K+T A D+WS G + EV++
Sbjct: 167 RGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 8e-20
Identities = 57/219 (26%), Positives = 107/219 (48%), Gaps = 27/219 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVF-----EHISDAIRILREVKLLR 77
+ ++ +G G++G V D + A+K I +V +H+ + R+L+EV
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV---- 58
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
HP I+ L ++ + + +Y++ E + +L ++ + + F+ +++
Sbjct: 59 --SHPFIIR-----LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIV 111
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL+Y+H+ + +RDLKP+NIL + +K+ DFG A+ T WT T Y
Sbjct: 112 CALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WT-LCGTPEYL 165
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235
APE+ S + A+D W++G + E+L G P F +
Sbjct: 166 APEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDN 202
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 83/302 (27%), Positives = 141/302 (46%), Gaps = 49/302 (16%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y E IG+G+ G V AID TG++VAIK+I+ + I+ E+ +++ L++P+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQIN--LQKQPKKELIINEILVMKELKNPN 77
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
IV L +++VV E + + + + L+AL+++H
Sbjct: 78 IVNFLDSFLVGD-----ELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLH 132
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
V HRD+K N+L + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP---SPETIAVVR 259
Y P +DIWS+G + E++ G+P + ++ + L LI GTP +PE ++
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLS--- 242
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
P+F+ F L R + D + R +A+E L P+ K L
Sbjct: 243 -----------------PIFRDF----------LNRCLEMDVEKRGSAKELLQHPFLK-L 274
Query: 320 AK 321
AK
Sbjct: 275 AK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 72/230 (31%), Positives = 107/230 (46%), Gaps = 32/230 (13%)
Query: 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI----HDVFEHISDAIRI 69
+ F++ + L IG GS+G V A D T E VAIKK+ E D I
Sbjct: 6 ELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD---I 62
Query: 70 LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME------SDLHQVIKANDDL 123
++EV+ L+ LRHP+ +E K L RE + + +ME SD+ +V K L
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYL----RE----HTAWLVMEYCLGSASDILEVHK--KPL 112
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183
+ L+ L Y+H+ HRD+K NIL +K+ DFG A + +P
Sbjct: 113 QEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV---SPAN 169
Query: 184 VFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGK-PLF 231
F V T ++ APE+ + +Y +D+WS+G E+ K PLF
Sbjct: 170 SF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 88/310 (28%), Positives = 146/310 (47%), Gaps = 56/310 (18%)
Query: 20 GDANR-YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL 78
GD + Y E IG+G+ G V AID TG++VAIK+++ + I+ E+ ++R
Sbjct: 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMN--LQQQPKKELIINEILVMRE 72
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFE-LMESDLHQVIKANDDLTREHHQF--FLYQM 135
+HP+IV L +++VV E L L V+ + + Q +
Sbjct: 73 NKHPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCREC 124
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRW 194
L+AL+++H+ V HRD+K NIL + +K+ DFG A++ TP + V T +
Sbjct: 125 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPY 180
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP---S 251
+ APE+ Y P +DIWS+G + E++ G+P + ++ + L LI GTP +
Sbjct: 181 WMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQN 237
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
PE ++ +F+ F L R + D + R +A+E L
Sbjct: 238 PEKLS--------------------AIFRDF----------LNRCLEMDVEKRGSAKELL 267
Query: 312 ADPYFKGLAK 321
P+ K +AK
Sbjct: 268 QHPFLK-IAK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 6e-19
Identities = 83/302 (27%), Positives = 138/302 (45%), Gaps = 49/302 (16%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y E IG+G+ G V AID TG++VAIK+++ + I+ E+ ++R ++P+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMN--LQQQPKKELIINEILVMRENKNPN 77
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
IV L +++VV E + + + + L+AL ++H
Sbjct: 78 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH 132
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 133 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP---SPETIAVVR 259
Y P +DIWS+G + E++ G+P + ++ + L LI GTP +PE ++ V
Sbjct: 189 R--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPELQNPERLSAV- 244
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
F+ F L R + D R +A+E L P+ K L
Sbjct: 245 -------------------FRDF----------LNRCLEMDVDRRGSAKELLQHPFLK-L 274
Query: 320 AK 321
AK
Sbjct: 275 AK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 6e-19
Identities = 80/306 (26%), Positives = 124/306 (40%), Gaps = 67/306 (21%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
L+ I KG++G V A TG+ AIK + SD I +V ++ R
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKK-----SDMIA-KNQVTNVKAER------- 47
Query: 88 KRIMLPPSKREF----------KD-IYVVFE-LMESDLHQVIKANDDLTREHHQFFLYQM 135
IM+ + + KD +Y+V E L D +IK L + + ++ ++
Sbjct: 48 -AIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEV 106
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
+ ++ +H + HRD+KP+N+L + LK+ DFGL+R + +V T Y
Sbjct: 107 VLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-------KKFVGTPDY 159
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE + G D WS+GC+ E L G P F TP
Sbjct: 160 LAPETILG---VGDDKMSDWWSLGCVIFEFLFGYPPFHA--------------ETPD--- 199
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA---EEAL 311
AV N +R+ P A+ L+ RL+ DP R A +E
Sbjct: 200 -AVFDNILSRRINWPEE---------VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249
Query: 312 ADPYFK 317
+ P+FK
Sbjct: 250 SHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 8e-19
Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 38/229 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKL 75
D + L+ +G G +GVV H G+ VAIK I + D I E K+
Sbjct: 2 DPSELTFLKELGSGQFGVV------HLGKWRGKIDVAIKMIREGAMSEDDFIE---EAKV 52
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ L HP++V++ + + + I++V E M + + + RE +
Sbjct: 53 MMKLSHPNLVQLYGVCT-----KQRPIFIVTEYMA---NGCLL---NYLRERKGKLGTEW 101
Query: 136 L--------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
L A++Y+ + HRDL +N L + +KV DFGLAR D + T
Sbjct: 102 LLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT 161
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235
+ +W PE+ +S+++ D+WS G + EV + GK + S
Sbjct: 162 KF-PVKW-APPEVFD--YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 66/239 (27%), Positives = 120/239 (50%), Gaps = 18/239 (7%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+Y E IG+G+ G V A+D TG++VAI++++ + I+ E+ ++R ++P+
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNPN 78
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
IV L +++VV E + + + + L+AL+++H
Sbjct: 79 IVNYLDSYLVGD-----ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
+ V HRD+K NIL + +K+ DFG A++ TP + V T ++ APE+
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTMVGTPYWMAPEVVT 189
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP---SPETIAVV 258
Y P +DIWS+G + E++ G+P + ++ + L LI GTP +PE ++ +
Sbjct: 190 R--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQNPEKLSAI 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 23/208 (11%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+VIG G +G V I G K VAIK + + L E ++ H +I+
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE-KQRQDFLSEASIMGQFSHHNII 69
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRA----LK 140
++ ++ +FK ++ E ME+ L + ++ +D E + L MLR +K
Sbjct: 70 RLEGVV-----TKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMK 121
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD--YVATRWYRAP 198
Y+ N HRDL +NIL N+N + KV DFGL+RV D P + T + RW AP
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-LEDDPEGTYTTSGGKIPIRW-TAP 179
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
E + K+T A D+WS G + EV++
Sbjct: 180 EAIA--YRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 86/307 (28%), Positives = 142/307 (46%), Gaps = 40/307 (13%)
Query: 8 KELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI 67
K+ + D F + + L IG GS+G V A ++HT E VA+KK+ + ++
Sbjct: 6 KDPEIADLFYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKW 65
Query: 68 R-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME------SDLHQVIKAN 120
+ I++EVK L+ L+HP+ +E K L K+ + + +ME SDL +V K
Sbjct: 66 QDIIKEVKFLQQLKHPNTIEYKGCYL-------KE-HTAWLVMEYCLGSASDLLEVHK-- 115
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L + L+ L Y+H+ N+ HRD+K NIL ++K+ DFG A + +
Sbjct: 116 KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---S 172
Query: 181 PMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKP-LFPGKSVVH 238
P F V T ++ APE+ + +Y +D+WS+G E+ KP LF
Sbjct: 173 PANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF------- 221
Query: 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIA 298
++ ++ L ++ + NE T+ + QK P P + LL+
Sbjct: 222 NMNAMSALYHIAQNDSPTLQSNE-----WTDSFRGFVDYCLQKIPQERPASAELLRH--D 274
Query: 299 FDPKDRP 305
F +DRP
Sbjct: 275 FVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 70/222 (31%), Positives = 107/222 (48%), Gaps = 33/222 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIR--ILREVKL 75
D + KI EVIG G +G VC G++ VAIK + + ++ R L E +
Sbjct: 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEASI 58
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQ 134
+ HP+I+ ++ ++ + + + ++ E ME+ L ++ ND QF + Q
Sbjct: 59 MGQFDHPNIIHLEGVV-----TKSRPVMIITEFMENGALDSFLRQNDG------QFTVIQ 107
Query: 135 ---MLRA----LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV---AFSDTPMTV 184
MLR +KY+ N HRDL +NIL N+N KV DFGL+R SD T
Sbjct: 108 LVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTS 167
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW APE + K+T A D+WS G + EV++
Sbjct: 168 SLGGKIPIRW-TAPEAIA--YRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 75/306 (24%), Positives = 123/306 (40%), Gaps = 45/306 (14%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
L +G+G+ G V +TG A+K I + +ILRE+++ + + P IV+
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTI-TTDPNPDLQKQILRELEINKSCKSPYIVKY 64
Query: 88 KRIMLPPSKREFKDIYVVFELMES----DLHQVIKANDDLTREHHQFFLYQ-MLRALKYM 142
L S I + E E +++ +K E + + +L+ L Y+
Sbjct: 65 YGAFLDESSSS---IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LC 201
H+ + HRD+KP NIL ++K+CDFG++ + T + T +Y APE +
Sbjct: 122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT-----FTGTSFYMAPERIQ 176
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
G Y+ D+WS+G EV + FP + G P I ++
Sbjct: 177 GK---PYSITSDVWSLGLTLLEVAQNRFPFPPE-------------GEPPLGPIELL--- 217
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF----DPKDRPTAEEALADPYFK 317
Y+ M P P + P + I DP RPT + L P+ K
Sbjct: 218 ---SYIVNM----PNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
Query: 318 GLAKIE 323
K +
Sbjct: 271 AQMKKK 276
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 6e-18
Identities = 78/305 (25%), Positives = 124/305 (40%), Gaps = 59/305 (19%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS-------DAIRILREVKLL 76
RY + + +GKGS+G V D + +K V + I + ++ +E +LL
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLK----VLKEIPVGELNPNETVQANQEAQLL 56
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLH---QVIKANDDLTREHHQF-F 131
L HP IV+ L E ++ E E DL + +K E+ +
Sbjct: 57 SKLDHPAIVKFHASFL-----ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
Q+L + YMH + HRDLK KNI N LK+ DFG++R+ + T +
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLA---TTFTG 167
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T +Y +PE Y DIWS+GCI E+ F G++ L ++ ++ P+
Sbjct: 168 TPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVVLRIVEGPT 222
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-LLQRLIAFDPKDRPTAEEA 310
P P L ++Q ++ DP RP+A E
Sbjct: 223 PS----------------------------LPETYSRQLNSIMQSMLNKDPSLRPSAAEI 254
Query: 311 LADPY 315
L +P+
Sbjct: 255 LRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 63/222 (28%), Positives = 105/222 (47%), Gaps = 26/222 (11%)
Query: 31 IGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+G G +GVV H G+ KVAIK I++ D I E K++ L HP +V
Sbjct: 12 LGSGQFGVV------HLGKWRAQIKVAIKAINEGAMSEEDFIE---EAKVMMKLSHPKLV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
++ + + K +Y+V E ME+ L+ + + L+++ + ++Y+
Sbjct: 63 QLYGVCT-----QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ HRDL +N L ++ +KV DFG+ R D + + +W PE+
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKW-SPPEVFN- 174
Query: 204 FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
FSKY+ D+WS G + EV T GK F KS +++I+
Sbjct: 175 -FSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 62/207 (29%), Positives = 104/207 (50%), Gaps = 18/207 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHP 82
++I + IG+G + V A + VA+KK+ +FE + R ++E+ LL+ L HP
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQ-IFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI---KANDDLTREHHQF-FLYQMLR 137
++++ + E ++ +V EL ++ DL Q+I K L E + + Q+
Sbjct: 63 NVIKYLDSFI-----EDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
A+++MH+ V HRD+KP N+ A +K+ D GL R S T V T +Y +
Sbjct: 118 AVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPYYMS 174
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEV 224
PE + Y DIWS+GC+ E+
Sbjct: 175 PERIHE--NGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 67/241 (27%), Positives = 114/241 (47%), Gaps = 18/241 (7%)
Query: 28 LEVIGKGSYG---VVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
L+V+G+GS+G +V G+ A+K + + D +R E +L + HP I
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V++ K +Y++ + + DL + T E +F+L ++ AL ++H
Sbjct: 61 VKLHYAFQTEGK-----LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + +RDLKP+NIL + +K+ DFGL++ + + T Y APE+
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNR 172
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL-LGTP---SPETIAVVR 259
+T + D WS G + E+LTG F GK + +I LG P SPE +++R
Sbjct: 173 --RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 230
Query: 260 N 260
Sbjct: 231 A 231
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-17
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 26/214 (12%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKI----HDVFEHISDAIRILREVKLLRLLRHPDI 84
EV+GKG+YG V + T+ G+ +A+K++ +V + ++ EV LL+ L+H +I
Sbjct: 6 EVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V+ L + I + E + + ++ L + Q+L + Y+H
Sbjct: 65 VQYLGTCL-----DDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH 119
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLAR--------VAFSDTPMTVFWTDYVATRWY 195
V HRD+K N++ N +K+ DFG AR S+ ++ T Y +
Sbjct: 120 NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY-----W 174
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
APE+ S Y DIWSIGC E+ TGKP
Sbjct: 175 MAPEVINE--SGYGRKSDIWSIGCTVFEMATGKP 206
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-17
Identities = 66/200 (33%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 47 TGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105
TG +VAIK + D E R RE L L HP+IV +L + ++ V
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVA----LLDSGEAPPGLLFAV 57
Query: 106 FELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANA 161
FE + L +V+ A+ L + Q+L AL H + HRDLKP+NI+
Sbjct: 58 FEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGV 117
Query: 162 NCKLKVCDFGLAR----VAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWS 216
KV DFG+ V +D T+ + T Y APE L G TP D+++
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG---EPVTPNSDLYA 174
Query: 217 IGCIFAEVLTGKPLFPGKSV 236
G IF E LTG+ + G SV
Sbjct: 175 WGLIFLECLTGQRVVQGASV 194
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 65/212 (30%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 26 KILEVIGKGSYGVVCAA----IDTHTGEKVAIKKI-HD-VFEHISDAIRILREVKLLRLL 79
K ++ +G+G +G V + +TGE+VA+K + H +H SD RE+++LR L
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSD---FEREIEILRTL 63
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMES----DLHQVIKANDDLTREHHQFFLYQM 135
H +IV+ K + P R + ++ E + S D Q + +L R F Q+
Sbjct: 64 DHENIVKYKGVCEKPGGRSLR---LIMEYLPSGSLRDYLQRHRDQINLKRL--LLFSSQI 118
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA-FSDTPMTVFWTDYVATRW 194
+ + Y+ + HRDL +NIL + +K+ DFGLA+V V W
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
Y APE C SK++ A D+WS G E+ T
Sbjct: 179 Y-APE-CLR-TSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 57/213 (26%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRLLRH 81
+++ +++G+G++G V D TG ++A+K++ + E + + E++LL+ L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
IV+ + P +R + E M + +K+ LT + + Q+L +
Sbjct: 64 ERIVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVS 120
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLAR----VAFSDTPMTVFWTDYVATRWYR 196
Y+H+ + HRD+K NIL ++ +K+ DFG ++ + S T M T ++
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM----KSVTGTPYWM 176
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
+PE+ Y DIWS+GC E+LT KP
Sbjct: 177 SPEVISG--EGYGRKADIWSVGCTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 5e-17
Identities = 88/328 (26%), Positives = 143/328 (43%), Gaps = 53/328 (16%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
R+KIL ++G+G++G V A D E A+K + +V ++ DA +I E++ + +R D
Sbjct: 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDA-KI--EIQFMEKVRQAD 186
Query: 84 IVEIKRIMLPPSKREFKD----IYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
+ R L +R F++ + +V L I + + H ++Q AL
Sbjct: 187 PAD--RFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVAL 244
Query: 140 KYMHTA-NVYHRDLKPKNILANAN----------------CKLKVCDFGLARVAFSDTPM 182
Y HT ++ H DLKP+NIL + C++++CD G D
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG----GCCDERH 300
Query: 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242
+ T V+TR YR+PE+ Y+ D+WS+GCI E+ TGK L+ + L L
Sbjct: 301 SR--TAIVSTRHYRSPEVVLGLGWMYS--TDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356
Query: 243 ITDLLGTPSPETIAVVRNEKAR---------------KYLTEMRKKPPVPLFQKFPNVDP 287
+ LG E E+AR K+L + + PV + D
Sbjct: 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIR----DD 412
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPY 315
L L+ L+ +D + R A + PY
Sbjct: 413 LLCDLIYGLLHYDRQKRLNARQMTTHPY 440
|
Length = 467 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 6e-17
Identities = 105/353 (29%), Positives = 161/353 (45%), Gaps = 69/353 (19%)
Query: 10 LKDKD----FFTEYGDANR-YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS 64
LKD + FF E D + + L IG GS+G V A D T E VAIKK+ + +
Sbjct: 9 LKDPEIAELFFKE--DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSN 66
Query: 65 DAIR-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM---ESDLHQVIKAN 120
+ + I++EVK L+ ++HP+ +E K L RE ++V E SDL +V K
Sbjct: 67 EKWQDIIKEVKFLQRIKHPNSIEYKGCYL----RE-HTAWLVMEYCLGSASDLLEVHK-- 119
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L + L+ L Y+H+ N+ HRD+K NIL ++K+ DFG A +A +
Sbjct: 120 KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA---S 176
Query: 181 PMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVH 238
P F V T ++ APE+ + +Y +D+WS+G E+ K PLF
Sbjct: 177 PANSF----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF------- 225
Query: 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIA 298
++ ++ L E+ + NE + F+ F VD LQ++
Sbjct: 226 NMNAMSALYHIAQNESPTLQSNEWS-------------DYFRNF--VD----SCLQKI-- 264
Query: 299 FDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
P+DRPT+EE L K + + P I ++ TKD +REL
Sbjct: 265 --PQDRPTSEELL-----KHMFVLRERPETVLIDLIQ-------RTKDAVREL 303
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 7e-17
Identities = 56/212 (26%), Positives = 109/212 (51%), Gaps = 15/212 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRLLRH 81
+++ +++G+G++G V D TG ++A+K++ D E + + E++LL+ LRH
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
IV+ + P +++ I+V + + + +KA LT + + Q+L+ + Y
Sbjct: 64 DRIVQYYGCLRDPEEKKLS-IFVEY-MPGGSIKDQLKAYGALTENVTRRYTRQILQGVSY 121
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLAR----VAFSDTPMTVFWTDYVATRWYRA 197
+H+ + HRD+K NIL ++ +K+ DFG ++ + S T + T ++ +
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI----KSVTGTPYWMS 177
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
PE+ Y D+WS+ C E+LT KP
Sbjct: 178 PEVISG--EGYGRKADVWSVACTVVEMLTEKP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 63/226 (27%), Positives = 105/226 (46%), Gaps = 20/226 (8%)
Query: 16 FTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIK---KIHDVFEHISDAIRILR 71
F + D ++ ++I+E IGKG+YG V ++ G K A+K IHD+ E I IL+
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILK 69
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQ-VIKANDDLTRE 126
L HP++V+ + + +++V EL +DL + +K + +
Sbjct: 70 A-----LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP 124
Query: 127 HHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186
+ L++ L L+++H HRD+K NIL +K+ DFG V+ T +
Sbjct: 125 IIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRR 181
Query: 187 TDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
V T ++ APE+ S Y D+WS+G E+ G P
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 18/216 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHP 82
++I + IG+G + V A G VA+KK+ +F+ + R ++E+ LL+ L HP
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQ-IFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI---KANDDLTREHHQF-FLYQMLR 137
++++ + E ++ +V EL ++ DL ++I K L E + + Q+
Sbjct: 63 NVIKYYASFI-----EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
AL++MH+ V HRD+KP N+ A +K+ D GL R S T V T +Y +
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVGTPYYMS 174
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
PE + Y DIWS+GC+ E+ + F G
Sbjct: 175 PERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 1e-16
Identities = 66/217 (30%), Positives = 111/217 (51%), Gaps = 33/217 (15%)
Query: 26 KILEVIGKGSYGVV--CA--AIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLR 80
K ++ +GKG++G V C + +TGE VA+KK+ H EH+ D RE+++L+ L+
Sbjct: 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRD---FEREIEILKSLQ 63
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFE-LMESDLHQVIKANDDLTREHHQFFLY--QMLR 137
H +IV+ K + +R + +V E L L ++ + + +H + LY Q+ +
Sbjct: 64 HDNIVKYKGVCYSAGRRNLR---LVMEYLPYGSLRDYLQKHRERL-DHRKLLLYASQICK 119
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR---- 193
++Y+ + HRDL +NIL + ++K+ DFGL +V D +Y R
Sbjct: 120 GMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-------KEYYKVREPGE 172
Query: 194 ----WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
WY APE SK++ A D+WS G + E+ T
Sbjct: 173 SPIFWY-APESLTE--SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 62/239 (25%), Positives = 99/239 (41%), Gaps = 31/239 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLRHPD 83
+ + +G G +G V + +VAIK + D D +EV+ L+ LRH
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQD---FQKEVQALKRLRHKH 63
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRALK 140
++ + + + +Y++ ELME L +++ + L Q+ +
Sbjct: 64 LISLFAVC-----SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARV------AFSDTPMTVFWTDYVATRW 194
Y+ N HRDL +NIL + KV DFGLAR+ SD + WT
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT------- 171
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252
APE ++ D+WS G + E+ T G+ +PG + D IT P P
Sbjct: 172 --APEAAS--HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCP 226
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 68/210 (32%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPDIV 85
L +G G+ GVV + +G +A K IH E I AIR I+RE+K+L P IV
Sbjct: 6 LGELGAGNGGVVTKVLHRPSGLIMARKLIH--LE-IKPAIRNQIIRELKVLHECNSPYIV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+I + E M+ L QV+K + +LR L Y+
Sbjct: 63 GFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 145 A-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCG 202
+ HRD+KP NIL N+ ++K+CDFG+ S + +V TR Y +PE L G
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDSMANSFVGTRSYMSPERLQG 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
+ YT DIWS+G E+ G+ +P
Sbjct: 173 ---THYTVQSDIWSLGLSLVEMAIGR--YP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 40/234 (17%)
Query: 26 KILEVIGKGSYGVVCAAI-DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
K+ +G G +G V + T KVA+K + L+E ++++ LRH +
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGTT--KVAVKTLK---PGTMSPEAFLQEAQIMKKLRHDKL 63
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLRALKY 141
V++ + S+ E IY+V E M L +K+ + L Q+ + Y
Sbjct: 64 VQLYAVC---SEEE--PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARV-------AFSDTPMTVFWTDYVATRW 194
+ + N HRDL +NIL N K+ DFGLAR+ A + WT
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT------- 171
Query: 195 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLDL 242
APE G F K D+WS G + E++T G+ +PG + V+ Q++
Sbjct: 172 --APEAANYGRFTIKS----DVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER 219
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 5e-16
Identities = 72/296 (24%), Positives = 127/296 (42%), Gaps = 49/296 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRLLRHPDIV 85
+++G+G++G V D TG ++A K++ + E + + E++LL+ L+H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+ + R K + + E M + +KA LT + + Q+L + Y+H+
Sbjct: 68 QYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS 124
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFG----LARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+ HRD+K NIL ++ +K+ DFG L + S T + T ++ +PE+
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI----RSVTGTPYWMSPEV 180
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQLDLITDLLGTPSPETIAVVR 259
Y D+WS+GC E+LT KP + +++ + T P I+
Sbjct: 181 ISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHIS--- 235
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
E AR +L I + + RP+AEE L P+
Sbjct: 236 -EHARDFL---------------------------GCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDIVE 86
L IG GS+G V A D E VAIKK+ + ++ + I++EV+ L+ LRHP+ ++
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 87 IKRIMLPPSKREFKDIYVVFELME------SDLHQVIKANDDLTREHHQFFLYQMLRALK 140
+ L RE + + +ME SDL +V K L + L+ L
Sbjct: 80 YRGCYL----RE----HTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLA 129
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+H+ N+ HRD+K NIL + +K+ DFG A + P F V T ++ APE+
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---APANXF----VGTPYWMAPEV 182
Query: 201 CGSF-FSKYTPAIDIWSIGCIFAEVLTGKP 229
+ +Y +D+WS+G E+ KP
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-16
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 25/213 (11%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKL 75
+ +++ IG G +G+V G KVAIK I + D I E ++
Sbjct: 2 HPSELTLVQEIGSGQFGLV------WLGYWLEKRKVAIKTIREGAMSEEDFIE---EAQV 52
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKAND-DLTREHHQFFLY 133
+ L HP +V++ + E I +VFE ME L ++A ++E
Sbjct: 53 MMKLSHPKLVQLYGVCT-----ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCL 107
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ + Y+ ++NV HRDL +N L N +KV DFG+ R D + T + +
Sbjct: 108 DVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF-PVK 166
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
W +PE+ FSKY+ D+WS G + EV +
Sbjct: 167 W-SSPEVFS--FSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 77/311 (24%), Positives = 134/311 (43%), Gaps = 55/311 (17%)
Query: 25 YKILEVIGKGSYG---VVCAAIDTHTG--------EKVAIKKIHDVFEHISDAIRILREV 73
+++L+V+G G+YG +V TG +K A+ + EH +L V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
+ + P +V + +K YV M + L+Q D+ + + +F+
Sbjct: 62 R-----QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSG 112
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+++ AL+++H + +RD+K +NIL ++ + + DFGL++ S+ + + T
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY--SFCGTI 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y APE+ + A+D WS+G + E+LTG SP
Sbjct: 171 EYMAPEIIRG-KGGHGKAVDWWSLGILIFELLTGA----------------------SPF 207
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAE 308
T+ RN ++ ++ PP P + P A LL +L+ DPK R A
Sbjct: 208 TLEGERNTQSEVSRRILKCDPPFP-----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGAS 262
Query: 309 EALADPYFKGL 319
E P+FKGL
Sbjct: 263 EIKEHPFFKGL 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 72/306 (23%), Positives = 136/306 (44%), Gaps = 44/306 (14%)
Query: 25 YKILEVIGKGSYGVV--CAAIDTH-TGEKVAIK--KIHDVFEHISDAIRILREVKLLRLL 79
+++L+V+G G+YG V + H +G+ A+K K + + E ++L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 80 RH-PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRA 138
R P +V + +K Y+ + + L Q + + Q + +++ A
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----FKEQEVQIYSGEIVLA 117
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+++H + +RD+K +NIL ++N + + DFGL++ D + + T Y AP
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAY--SFCGTIEYMAP 175
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
++ + A+D WS+G + E+LTG SP T+
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGA----------------------SPFTVDGE 213
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----PT-AEEALAD 313
+N +A ++ +PP P + LA ++QRL+ DPK R P+ A+E
Sbjct: 214 KNSQAEISRRILKSEPPYP-----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268
Query: 314 PYFKGL 319
P+F+ +
Sbjct: 269 PFFQKI 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 15/209 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHP 82
+++ E +G GS+G V A TGE AIK K ++ + + + +E +L L HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILK-MKQVQHVAQEKSILMELSHP 78
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV + ++ F +VV + + L + + +D+ + F+ +++ A +Y+
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAK----FYHAELVLAFEYL 134
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ ++ +RDLKP+N+L + +KV DFG A+ D T+ T Y APE+
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-KVPDRTFTL-----CGTPEYLAPEVIQ 188
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
S + A+D W++G + E + G P F
Sbjct: 189 S--KGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 82/285 (28%), Positives = 126/285 (44%), Gaps = 43/285 (15%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDIVE 86
LE IGKGS+G V ID T E VAIK I E D I I +E+ +L P I
Sbjct: 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYITR 66
Query: 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L +K ++++ E + + L + L ++L+ L Y+H+
Sbjct: 67 YYGSYLKGTK-----LWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSER 121
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
HRD+K N+L + +K+ DFG+A +DT + +V T ++ APE+ S
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKR--NTFVGTPFWMAPEVIKQ--S 176
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266
Y DIWS+G E+ G+P S +H + ++ L+ SP T
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPPN---SDLHPMRVLF-LIPKNSPPT------------ 220
Query: 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
L KP F++F ++ + DP+ RPTA+E L
Sbjct: 221 LEGQYSKP----FKEF----------VEACLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 74/309 (23%), Positives = 133/309 (43%), Gaps = 52/309 (16%)
Query: 25 YKILEVIGKGSYG---VVCAAIDTHTGEKVAIK---KIHDV-----FEHISDAIRILREV 73
+++L V+G G+YG +V G+ A+K K V EH R R+V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT----RTERQV 57
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
L + R P +V + +K YV + + L+Q + T + ++
Sbjct: 58 -LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIA 112
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+++ AL ++H + +RD+K +NIL ++ + + DFGL++ ++ + + T
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--SFCGTI 170
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y APE+ + A+D WS+G + E+LTG SP
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGA----------------------SPF 208
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEA 310
T+ +N ++ ++ KPP P + A +Q+L+ DPK R A+E
Sbjct: 209 TVDGEQNSQSEISRRILKSKPPFP-----KTMSAEARDFIQKLLEKDPKKRLGANGADEI 263
Query: 311 LADPYFKGL 319
P+F+G+
Sbjct: 264 KNHPFFQGI 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 83/312 (26%), Positives = 126/312 (40%), Gaps = 40/312 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+ ILE G+ G A ID T E V IK E +LR + HP I
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKA--------GQRGGTATEAHILRAINHPSI 145
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+++K ++ ++DL+ + A ++ +LRA++Y+H
Sbjct: 146 IQLKGTFTYNKF-----TCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE 200
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF-WTDYVATRWYRAPELCGS 203
+ HRD+K +NI N + + DFG A + W +AT APEL
Sbjct: 201 NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT---NAPELLAR 257
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSV------VHQLDLITDLLGT-PSPETI 255
Y PA+DIWS G + E+ T LF + Q+ LI GT P+ I
Sbjct: 258 --DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315
Query: 256 ---AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-LLQRLIAFDPKDRPTAE--- 308
A + RK PL+ + P+ L L+ +++AFD RP+AE
Sbjct: 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYEL-PIDLEYLICKMLAFDAHHRPSAEALL 374
Query: 309 -----EALADPY 315
+ + DPY
Sbjct: 375 DFAAFQDIPDPY 386
|
Length = 391 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 77/299 (25%), Positives = 137/299 (45%), Gaps = 46/299 (15%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKL-LRLLRHPDIV 85
++E +G+G+YGVV TG +A+K+I + R+L ++ + +R + P V
Sbjct: 5 VIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQKRLLMDLDISMRSVDCPYTV 63
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM----LRALKY 141
+ RE D+++ E+M++ L + K D + L ++ ++AL+Y
Sbjct: 64 TFYGALF----RE-GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 142 MHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+H+ +V HRD+KP N+L N N ++K+CDFG++ T+ + Y APE
Sbjct: 119 LHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTI----DAGCKPYMAPER 174
Query: 201 CGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
++ Y D+WS+G E+ TG+ FP S + ++ PSP
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVEEPSP------ 226
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
++ + P FQ F N + L++ + K+RP E L P+F+
Sbjct: 227 ----------QLPAEKFSPEFQDFVN------KCLKK----NYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 63/222 (28%), Positives = 108/222 (48%), Gaps = 16/222 (7%)
Query: 28 LEVIGKGSYGVVCAAIDTH---TGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHP 82
L+V+GKG YG V TG+ A+K K + + D E +L ++HP
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFE-LMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
IV++ K +Y++ E L +L ++ + F+L ++ AL++
Sbjct: 61 FIVDLIYAFQTGGK-----LYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEH 115
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H + +RDLKP+NIL +A +K+ DFGL + + + +T + T Y APE+
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT---HTFCGTIEYMAPEIL 172
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
S + A+D WS+G + ++LTG P F ++ +D I
Sbjct: 173 MR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI 212
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 19/216 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK---KIHDVFEHISDAIRILREVKLLRLLRH 81
++I+E IGKG+YG V + G A+K I DV E I IL+ L H
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQS-----LPNH 78
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESD-----LHQVIKANDDLTREHHQFFLYQML 136
P++V+ + K +++V EL + ++ L + LY L
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
L+++H + HRD+K NIL +K+ DFG V+ T + V T ++
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFG---VSAQLTSTRLRRNTSVGTPFWM 195
Query: 197 APELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
APE+ + Y D+WS+G E+ G P
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 7e-15
Identities = 76/297 (25%), Positives = 119/297 (40%), Gaps = 67/297 (22%)
Query: 29 EVIGKGSYGVVCAAIDT-HTGEK--VAIK--KIHDVFEHISDAIRILREVKLLRLLRHPD 83
IG+G +G V + EK VA+K K S + L+E ++R HP
Sbjct: 12 RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMRQFDHPH 68
Query: 84 IVE-IKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALK 140
IV+ I I P +++V EL +L ++ N L + YQ+ AL
Sbjct: 69 IVKLIGVITENP-------VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA 121
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR------W 194
Y+ + HRD+ +N+L ++ +K+ DFGL+R D + Y A++ W
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDE------SYYKASKGKLPIKW 174
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITDLLGTPSP 252
APE F ++T A D+W G E+L KP G +
Sbjct: 175 M-APESIN--FRRFTSASDVWMFGVCMWEILMLGVKPFQ----------------GVKNN 215
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ I + N ++ P+P PN P L+ + A+DP RP E
Sbjct: 216 DVIGRIENG----------ERLPMP-----PNCPPTLYSLMTKCWAYDPSKRPRFTE 257
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 63/220 (28%), Positives = 107/220 (48%), Gaps = 17/220 (7%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHD-VFEHISDAIRILREVK-LLRLLRHPDIVE 86
+VIGKGS+G V A G+ A+K + + + + I+ E LL+ ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
+ S + + +Y V + + +L ++ +F+ ++ AL Y+H+
Sbjct: 61 LHY-----SFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDYVATRWYRAPELCGS 203
N+ +RDLKP+NIL ++ + + DFGL + +A SDT T + T Y APE+
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT-----FCGTPEYLAPEVIRK 170
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
Y +D W +G + E+L G P F + V D I
Sbjct: 171 --QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 75/303 (24%), Positives = 122/303 (40%), Gaps = 53/303 (17%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+ + +G G+ G V TG +A K +H + S +ILRE++++ R P IV
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVH-IGAKSSVRKQILRELQIMHECRSPYIV 66
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
L + +I + E M+ L ++ K + E ++ L Y++
Sbjct: 67 SFYGAFLNEN-----NICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN 121
Query: 145 AN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ + HRD+KP NIL N+ ++K+CDFG++ + T +V T Y +PE
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT-----FVGTSTYMSPERIQG 176
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFP-------GKSVVHQ---LDLITDLLGTPSPE 253
KYT D+WS+G E+ GK FP LDL+ ++ P P
Sbjct: 177 --GKYTVKSDVWSLGISIIELALGK--FPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP- 231
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+ P FP + + DP +RPT ++ A
Sbjct: 232 ------------------RLPS----SDFP---EDLRDFVDACLLKDPTERPTPQQLCAM 266
Query: 314 PYF 316
P F
Sbjct: 267 PPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLR---LLRHPDIVE 86
IGKG++G V T A+K + + + E +L L P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
+K S D+Y+V + M +L ++ + + +F++ +++ AL+++H
Sbjct: 61 LKFSFQTDS-----DLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
++ +RDLKP+NIL +A + +CDFGL++ +D T + T Y APE+
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTT---NTFCGTTEYLAPEVLLD-E 171
Query: 206 SKYTPAIDIWSIGCIFAEVLTG 227
YT +D WS+G + E+ G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 72/299 (24%), Positives = 119/299 (39%), Gaps = 61/299 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D ++L +G G +G V + +T VA+K + D L E ++++ LR
Sbjct: 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLK---PGTMDPKDFLAEAQIMKKLR 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQF--FLYQMLR 137
HP ++++ + + E IY+V ELM+ L + ++ + Q Q+
Sbjct: 60 HPKLIQLYAVC---TLEE--PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVAS 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD-------TPMTVFWTDYV 190
+ Y+ N HRDL +N+L N KV DFGLARV D + WT
Sbjct: 115 GMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWT--- 171
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGT 249
APE + +++++ D+WS G + E++T G+ +PG + L +
Sbjct: 172 ------APE--AALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM 223
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
P P P L+ ++ DP DRPT E
Sbjct: 224 PCPPGC-------------------PKELYD-----------IMLDCWKEDPDDRPTFE 252
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 43/228 (18%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+ IGKG +G V + + G+KVA+K + D + A L E ++ LRHP++V
Sbjct: 9 KLGATIGKGEFGDV--MLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTLRHPNLV 63
Query: 86 EIKRIMLPPSKREFKDIYVVFELME---------SDLHQVIKANDDLTREHHQFFLYQML 136
++ ++L + +Y+V E M S VI T F +
Sbjct: 64 QLLGVVL-----QGNPLYIVTEYMAKGSLVDYLRSRGRAVI------TLAQQLGFALDVC 112
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD---TPMTVFWTDYVATR 193
++Y+ N HRDL +N+L + + KV DFGLA+ A + V WT
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT------ 166
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK---PLFPGKSVV 237
APE K++ D+WS G + E+ + G+ P P K VV
Sbjct: 167 ---APEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 75/307 (24%), Positives = 126/307 (41%), Gaps = 60/307 (19%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLL--- 79
++ L V+G+G +G V A TGE AIK K D+ D + L K +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIAR--DEVESLMCEKRIFETANS 58
Query: 80 -RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR 137
RHP +V + + V E DL I D + F+ ++
Sbjct: 59 ERHPFLVNLFACFQTEDH-----VCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVL 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDYVATRWY 195
L+Y+H + +RDLK N+L + +K+ DFGL + + F D T + T +
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-----FCGTPEF 167
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ + YT A+D W +G + E+L G+ FPG D
Sbjct: 168 LAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD-------------- 211
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEA 310
++V +E + +F + + A+ +++RL+ +P+ R AE+
Sbjct: 212 SIVNDE---------------VRYPRFLSRE--AISIMRRLLRRNPERRLGSGEKDAEDV 254
Query: 311 LADPYFK 317
P+F+
Sbjct: 255 KKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 13/203 (6%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDIVE 86
LE IGKGS+G V ID T + VAIK I E D I I +E+ +L P + +
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L +K ++++ E + + L L ++L+ L Y+H+
Sbjct: 67 YYGSYLKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
HRD+K N+L + + ++K+ DFG+A +DT + +V T ++ APE+ S
Sbjct: 122 KIHRDIKAANVLLSEHGEVKLADFGVAG-QLTDTQIKR--NTFVGTPFWMAPEVIKQ--S 176
Query: 207 KYTPAIDIWSIGCIFAEVLTGKP 229
Y DIWS+G E+ G+P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 68/287 (23%), Positives = 122/287 (42%), Gaps = 58/287 (20%)
Query: 27 ILEVIGKGSYGVV-----CAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLR 80
+ +G+G++G V + E VA+K + + +DA + RE +LL +
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQ 66
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND--------------DLTR 125
H +IV+ + E +VFE ME DL++ ++++ +LT
Sbjct: 67 HENIVKFYGVCT-----EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 126 EHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185
Q+ + Y+ + + HRDL +N L + +K+ DFG++R V+
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--------DVY 173
Query: 186 WTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236
TDY + RW PE + K+T D+WS G + E+ T GK + G S
Sbjct: 174 TTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230
Query: 237 VHQLDLITD--LLGTPS--PETIAVV------RNEKARKYLTEMRKK 273
++ IT LL P P + + R+ + R + ++ ++
Sbjct: 231 EEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHER 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 65/221 (29%), Positives = 106/221 (47%), Gaps = 42/221 (19%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
E+IG+G +G V +TG+KVA+K I DV A L E ++ L H ++V +
Sbjct: 12 EIIGEGEFGAVLQG--EYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRL 64
Query: 88 KRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQFFLYQMLR-------AL 139
++L +Y+V ELM + +L ++ TR + Q+L+ +
Sbjct: 65 LGVIL------HNGLYIVMELMSKGNLVNFLR-----TRGRALVSVIQLLQFSLDVAEGM 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV---AFSDTPMTVFWTDYVATRWYR 196
+Y+ + + HRDL +NIL + + KV DFGLARV ++ + V WT
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT--------- 164
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236
APE K++ D+WS G + EV + G+ +P S+
Sbjct: 165 APEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL 203
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 66/233 (28%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK--------LLRLLRH 81
VIGKGS+G V A G+ A+K + AI +E K LL+ ++H
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQ------KKAILKKKEQKHIMAERNVLLKNVKH 55
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELM---ESDLHQVIKANDDLTREHH------QFFL 132
P +V + K +Y V + + E H L RE +F+
Sbjct: 56 PFLVGLHYSFQTADK-----LYFVLDYVNGGELFFH--------LQRERSFPEPRARFYA 102
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDYV 190
++ AL Y+H+ N+ +RDLKP+NIL ++ + + DFGL + + S T T +
Sbjct: 103 AEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-----FC 157
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
T Y APE+ Y +D W +G + E+L G P F + D I
Sbjct: 158 GTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDIVE 86
LE IGKGS+G V ID T + VAIK I E D I I +E+ +L P + +
Sbjct: 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L +K ++++ E + + L ++L+ L Y+H+
Sbjct: 67 YYGSYLKGTK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
HRD+K N+L + +K+ DFG+A +DT + +V T ++ APE+ S
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAG-QLTDTQIKR--NTFVGTPFWMAPEVIQQ--S 176
Query: 207 KYTPAIDIWSIGCIFAEVLTGKP 229
Y DIWS+G E+ G+P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP 199
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 81/312 (25%), Positives = 140/312 (44%), Gaps = 59/312 (18%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-IRILREVKLLRLLRHPD 83
++I++VIG+G++G V A + E++ KI + +E + A RE + +L + D
Sbjct: 3 FEIIKVIGRGAFGEV-AVVKMKHTERIYAMKILNKWEMLKRAETACFREER--NVLVNGD 59
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVI-KANDDLTREHHQFFLYQMLRA 138
I + F+D ++ +M+ DL ++ K D L + +F++ +M+ A
Sbjct: 60 CQWITTL-----HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLA 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ +H + HRD+KP N+L + N +++ DFG D TV + V T Y +P
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVAVGTPDYISP 172
Query: 199 ELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
E+ + KY P D WS+G E+L G+ F +S+V ET
Sbjct: 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---------------ETY 217
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFP----NVDPLALRLLQRLIAFDPKDRPTAEEAL 311
+ N + R FQ FP +V A L+QRLI ++R + +
Sbjct: 218 GKIMNHEER--------------FQ-FPSHITDVSEEAKDLIQRLIC--SRERRLGQNGI 260
Query: 312 AD----PYFKGL 319
D +F+G+
Sbjct: 261 EDFKKHAFFEGI 272
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 12/228 (5%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI--SDAIRILREVKLLRLL 79
A Y +++VIG+G++G V + + +KV K+ FE I SD+ E ++
Sbjct: 42 AEDYDVVKVIGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
P +V+ L + ++ K +Y+V E M + +N D+ + +F+ +++ AL
Sbjct: 101 NSPWVVQ-----LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLAL 155
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+H+ + HRD+KP N+L + + LK+ DFG + +T M V V T Y +PE
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGM-VRCDTAVGTPDYISPE 213
Query: 200 LCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
+ S Y D WS+G E+L G F S+V I D
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMD 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 9e-14
Identities = 72/306 (23%), Positives = 118/306 (38%), Gaps = 63/306 (20%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---------LREVKLLRLLRH 81
+GKG +G VCA TG+ A KK+ D R+ L E K+L +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKL--------DKKRLKKRKGEQMALNEKKILEKVSS 52
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLRA 138
IV + D+ +V LM DL I + F+ Q++
Sbjct: 53 RFIVSLAYAFETKD-----DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG 107
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+++H + +RDLKP+N+L + + +++ D GLA V T Y AP
Sbjct: 108 LEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKI---KGRAGTPGYMAP 163
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ Y ++D +++GC E++ G+ F +
Sbjct: 164 EVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQR------------------------ 197
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALAD 313
+ + ++ L + V KF P A L + L+ DP+ R +A+E
Sbjct: 198 KEKVEKEELKRRTLEMAVEYPDKF---SPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254
Query: 314 PYFKGL 319
P FK L
Sbjct: 255 PLFKDL 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 9e-14
Identities = 78/301 (25%), Positives = 129/301 (42%), Gaps = 51/301 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
++I+ +G G++G V A TG A K I + E + D + E+ +L +HP+
Sbjct: 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED---FMVEIDILSECKHPN 63
Query: 84 IVEIKRIMLPPSKR----EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
IV + +K EF D + +M + LT ++ QML AL
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIML-------ELERGLTEPQIRYVCRQMLEAL 116
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGL-ARVAFSDTPMTVFWTDYVATRWYRAP 198
++H+ V HRDLK NIL + +K+ DFG+ A+ + F + T ++ AP
Sbjct: 117 NFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF----IGTPYWMAP 172
Query: 199 EL--CGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
E+ C +F Y DIWS+G E+ +P P ++ + ++ +L + P
Sbjct: 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEP--P-HHELNPMRVLLKILKSEPPTL- 228
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
++ K+ + F F L+ + DP DRPTA E L P+
Sbjct: 229 -----DQPSKWSSS---------FNDF----------LKSCLVKDPDDRPTAAELLKHPF 264
Query: 316 F 316
Sbjct: 265 V 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 16/234 (6%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHD---VFEHISDAIRILREVKLLRLLRHPDIV 85
+VIGKGS+G V A G A+K + + + + I R V LL+ L+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHPFLV 59
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+ K +Y V + + +L ++ +F+ ++ A+ Y+H+
Sbjct: 60 GLHYSFQTAEK-----LYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHS 114
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF 204
N+ +RDLKP+NIL ++ + + DFGL + T + + T Y APE+
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGTPEYLAPEVLRK- 170
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD-LITDLLGTPSPETIAV 257
Y +D W +G + E+L G P F + V D ++ L P +T+A
Sbjct: 171 -EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAA 223
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 57/291 (19%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86
E IGKG++G V + +VA+K + + + L+E ++L+ HP+IV+
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPD---LKRKFLQEAEILKQYDHPNIVK 56
Query: 87 IKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLR----ALK 140
+ + + + + IY+V EL+ S L + K + LT + L QM ++
Sbjct: 57 LIGVCV-----QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKK----LLQMSLDAAAGME 107
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+ + N HRDL +N L N LK+ DFG++R + +W APE
Sbjct: 108 YLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKW-TAPEA 166
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ +YT D+WS G + E + G +PG S
Sbjct: 167 LN--YGRYTSESDVWSYGILLWETFSLGDTPYPGMS------------------------ 200
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPTAEE 309
N++ R+ + + P P + P + RL+ + A+DP++RP+ E
Sbjct: 201 NQQTRERIESGYRMPA-------PQLCPEEIYRLMLQCWAYDPENRPSFSE 244
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 70/254 (27%), Positives = 108/254 (42%), Gaps = 49/254 (19%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRL 78
D N + L IG G+ G V TG +A+K++ E RIL ++ ++ L
Sbjct: 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENK---RILMDLDVV-L 68
Query: 79 LRH--PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFF----- 131
H P IV+ + S D+++ ELM + L D L +
Sbjct: 69 KSHDCPYIVKCYGYFITDS-----DVFICMELMSTCL-------DKLLKRIQGPIPEDIL 116
Query: 132 ---LYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
+++AL Y+ V HRD+KP NIL +A+ +K+CDFG++
Sbjct: 117 GKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG----------RLV 166
Query: 188 DYVA-TR-----WYRAPELCG--SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ 239
D A TR Y APE KY D+WS+G E+ TG+ FP K+ +
Sbjct: 167 DSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ--FPYKNCKTE 224
Query: 240 LDLITDLLGTPSPE 253
+++T +L P
Sbjct: 225 FEVLTKILQEEPPS 238
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 78/313 (24%), Positives = 122/313 (38%), Gaps = 41/313 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y +++ + GS G V A + V +K I L E LL+ + HP +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLK--------IGQKGTTLIEAMLLQNVNHPSV 119
Query: 85 VEIKRIMLPPSKREFKDIY-VVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRALKYM 142
+ +K ++ I +V SDL+ + L + Q+L L+Y+
Sbjct: 120 IRMKDTLV------SGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL 173
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRD+K +NI N ++ + D G A+ P + V T APE+
Sbjct: 174 HAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVET---NAPEVLA 229
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-------GKPLFPGKSVV----HQLDLITDLLGTP- 250
KY DIWS G + E+L P P + V H L +I+ L P
Sbjct: 230 R--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE 287
Query: 251 ----SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
P + + E + P FQ+ N+ L+ +++ FD RP+
Sbjct: 288 EFPRDPGS--RLVRGFIEYASLERQPYTRYPCFQRV-NLPIDGEFLVHKMLTFDAAMRPS 344
Query: 307 AEEALADPYFKGL 319
AEE L P F L
Sbjct: 345 AEEILNYPMFAQL 357
|
Length = 357 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-13
Identities = 86/324 (26%), Positives = 137/324 (42%), Gaps = 62/324 (19%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
RY I+ +IGKG G V A D +VA+KKI D+ E+ R LRE K+ L HP
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHP 62
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQ-----FFL---YQ 134
IV + I + Y+ ++S L V + + L++E + FL ++
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQK-ESLSKELAEKTSVGAFLSIFHK 121
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--------VAFSDTP----- 181
+ ++Y+H+ V HRDLKP NIL ++ + D+G A + D
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 182 ---MTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
MT+ V T Y APE L G S+ T DI+++G I ++LT FP
Sbjct: 182 YSSMTIP-GKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQMLTLS--FP----- 230
Query: 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLI 297
R +K RK P+ + + + P ++ + +
Sbjct: 231 --------------------YRRKKGRKISYRDVILSPIEV-APYREIPPFLSQIAMKAL 269
Query: 298 AFDPKDRPTAEEALAD---PYFKG 318
A DP +R ++ + L P+ +G
Sbjct: 270 AVDPAERYSSVQELKQDLEPHLQG 293
|
Length = 932 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 73/315 (23%), Positives = 124/315 (39%), Gaps = 61/315 (19%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86
+L+ +GKG+YG V + TG +A+K+I + S +I+ E+ +L P IV+
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDE-SKFNQIIMELDILHKAVSPYIVD 63
Query: 87 IKRIMLPPSKREFKDIYVVFELMES---------DLHQVIKANDDLTREHHQFFLYQMLR 137
+Y+ E M++ + D L R + + + L+
Sbjct: 64 FYGAFFIEGA-----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLK 116
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
LK H N+ HRD+KP N+L N N ++K+CDFG++ + T + + Y A
Sbjct: 117 FLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT-----NIGCQSYMA 169
Query: 198 PE----LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK---SVVHQLDLITDLLGTP 250
PE + YT D+WS+G E+ G+ +P + ++ QL I D G P
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDP 227
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
P +P A + + + P RPT +
Sbjct: 228 -----------------------PTLP-----SGYSDDAQDFVAKCLNKIPNRRPTYAQL 259
Query: 311 LADPYFKGLAKIERE 325
L P+ + +
Sbjct: 260 LEHPWLVKYKNADVD 274
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLR-HPDIVE 86
+V+GKGS+G V A T E AIK + DV D + E ++L L HP
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHP---- 56
Query: 87 IKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
L F+ +F +ME DL I+ + +F+ ++ AL ++
Sbjct: 57 ----FLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFL 112
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H V +RDLK NIL +A K+ DFG+ + + T T + T Y APE+
Sbjct: 113 HRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQ 169
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
+Y P++D W++G + E++ G+P F
Sbjct: 170 EL--EYGPSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 62/250 (24%), Positives = 101/250 (40%), Gaps = 62/250 (24%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFE-----HISDAIRILREVKLLRLLR 80
++VIG+G++G V TG A+KK+ ++ E H+ IL E
Sbjct: 6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD------ 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQML 136
+P +V++ F+D ++ +ME D+ ++ D T E +F++ + +
Sbjct: 60 NPWVVKLYY--------SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI 111
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL----------------------AR 174
A+ +H HRD+KP N+L +A +K+ DFGL
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNF 171
Query: 175 VAFSDTPMT-------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
+ F PM+ V T Y APE+ + Y D WS+G I
Sbjct: 172 LDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIM 229
Query: 222 AEVLTGKPLF 231
E+L G P F
Sbjct: 230 YEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 35/214 (16%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPDIVEIK 88
IG G+ G V I TG A+K I+ E D +R I RE+++LR + HP++V+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALKVIYGNHE---DTVRRQICREIEILRDVNHPNVVKCH 138
Query: 89 RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL----YQMLRALKYMHT 144
+ +I V+ E M+ + + T + FL Q+L + Y+H
Sbjct: 139 DMF-----DHNGEIQVLLEFMD-------GGSLEGTHIADEQFLADVARQILSGIAYLHR 186
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARV-AFSDTPMTVFWTDYVATRWYRAPE---- 199
++ HRD+KP N+L N+ +K+ DFG++R+ A + P V T Y +PE
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC----NSSVGTIAYMSPERINT 242
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
L + Y A DIWS+G E G+ FP
Sbjct: 243 DLNHGAYDGY--AGDIWSLGVSILEFYLGR--FP 272
|
Length = 353 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 84/273 (30%), Positives = 124/273 (45%), Gaps = 43/273 (15%)
Query: 9 ELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
ELKD DF +I E +G G+ GVV +G +A K IH I AIR
Sbjct: 1 ELKDDDF---------ERISE-LGAGNGGVVTKVQHKPSGLIMARKLIH---LEIKPAIR 47
Query: 69 --ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTR 125
I+RE+++L P IV +I + E M+ L QV+K +
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKEAKRIPE 102
Query: 126 EHHQFFLYQMLRALKYMHTAN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
E +LR L Y+ + + HRD+KP NIL N+ ++K+CDFG+ S +
Sbjct: 103 EILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDS 157
Query: 185 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDL 242
+V TR Y +PE L G+ +S + DIWS+G E+ G+ P+ P + +L+
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQS---DIWSMGLSLVELAIGRYPIPPPDA--KELEA 212
Query: 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPP 275
I G P VV E+ + R +PP
Sbjct: 213 I---FGRP------VVDGEEGEPHSISPRPRPP 236
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 17/221 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++IL+VIG+G++G V A + +KV KI + +E + A E R R +
Sbjct: 3 FEILKVIGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRA-----ETACFREERDV-L 55
Query: 85 VEIKRIMLPPSKREFKD---IYVVFEL-MESDLHQVI-KANDDLTREHHQFFLYQMLRAL 139
V + F+D +Y+V + + DL ++ K D L + +F+L +M+ A+
Sbjct: 56 VNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI 115
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+H + HRD+KP NIL + N +++ DFG D TV + V T Y +PE
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDYISPE 173
Query: 200 LCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
+ + KY P D WS+G E+L G+ F +S+V
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 79/279 (28%), Positives = 125/279 (44%), Gaps = 33/279 (11%)
Query: 9 ELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
ELKD DF KI E +G G+ GVV +G +A K IH I AIR
Sbjct: 1 ELKDDDF---------EKISE-LGAGNGGVVFKVSHKPSGLIMARKLIH---LEIKPAIR 47
Query: 69 --ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTR 125
I+RE+++L P IV +I + E M+ L QV+K +
Sbjct: 48 NQIIRELQVLHECNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKKAGRIPE 102
Query: 126 EHHQFFLYQMLRALKYMHTAN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
+ +++ L Y+ + + HRD+KP NIL N+ ++K+CDFG+ S +
Sbjct: 103 QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV-----SGQLIDS 157
Query: 185 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDL 242
+V TR Y +PE L G+ +S + DIWS+G E+ G+ P+ P + +L
Sbjct: 158 MANSFVGTRSYMSPERLQGTHYSVQS---DIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214
Query: 243 ITDLLGTPSPETIAVVRNEKARKYLTE-MRKKPPVPLFQ 280
+ G P+ + R + +PP+ +F+
Sbjct: 215 GCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFE 253
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 81/350 (23%), Positives = 146/350 (41%), Gaps = 67/350 (19%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLL-RHPDIVEI 87
V+GKGS+G V A T E A+K + DV D + E ++L L +HP + ++
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 88 KRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
+ +F +ME DL I+ + +F+ +++ L+++H
Sbjct: 62 HSCFQTKDR--------LFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ +RDLK N+L ++ +K+ DFG+ + T + + T Y APE+
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEILS- 169
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
+ Y PA+D W++G + E+L G+ F G E + ++
Sbjct: 170 -YQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---------------EDELFQSILEDEV 213
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----PTAEEALAD-PYFKG 318
R Y + K+ A +L+ + +P+ R PT E+ + P+F+
Sbjct: 214 R-YPRWLSKE---------------AKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257
Query: 319 L--AKIER---EPSCQP-------ISKLEFEFERRRVTKDDIRELIYREI 356
+ K+ER +P +P +S + EF + + E I R I
Sbjct: 258 IDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPVLTPPDEAIIRNI 307
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 6e-13
Identities = 53/217 (24%), Positives = 104/217 (47%), Gaps = 26/217 (11%)
Query: 29 EVIGKGSYGVVCAA--IDTHTGE-KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
VIGKG +G V ID+ + A+K ++ + + + + L+E +++ HP+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIK--ANDDLTREHHQFFLYQMLRALKYMH 143
+ I LP E + V+ + DL I+ ++ ++ F L Q+ + ++Y+
Sbjct: 60 SLLGICLPS---EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL-QVAKGMEYLA 115
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ HRDL +N + + + +KV DFGLAR ++ +Y + + +L
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLAR--------DIYDKEYYSVHNHTGAKLPVK 167
Query: 204 FFS-------KYTPAIDIWSIGCIFAEVLT-GKPLFP 232
+ + K+T D+WS G + E++T G P +P
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 23/224 (10%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHPDIVE 86
L IG+G++G V + +G +A+K+I + + R+L ++ ++R P IV+
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVK 67
Query: 87 IKRIMLPPSKREFK--DIYVVFELMESDLHQVIK-ANDDLTREHHQFFL----YQMLRAL 139
+ F+ D ++ ELM+ L + K + L + L ++AL
Sbjct: 68 FYGAL-------FREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120
Query: 140 KYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
Y+ + HRD+KP NIL + N +K+CDFG++ T D R Y AP
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTR---D-AGCRPYMAP 176
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQL 240
E + S Y D+WS+G EV TGK +P SV QL
Sbjct: 177 ERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 13/206 (6%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLR-HPDIVE 86
V+GKGS+G V A +G A+K + DV D + E ++L L R HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
+ P + ++ V E + DL I+ + +F+ ++ AL ++H
Sbjct: 61 LYCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
+ +RDLK N+L + K+ DFG+ + + T + + T Y APE+
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT---STFCGTPDYIAPEILQEML 172
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLF 231
Y P++D W++G + E+L G F
Sbjct: 173 --YGPSVDWWAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 80/333 (24%), Positives = 136/333 (40%), Gaps = 78/333 (23%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD--AIRILREVKLLRLLRH 81
+K ++++GKG G V TG+ A+K + D E I R+L E ++L L H
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVL-DKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFEL-MESDLHQVIKANDD--LTREHHQFFLYQMLRA 138
P + L S + + +V + +L ++++ L+ E +F+ ++L A
Sbjct: 61 PFLPT-----LYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA 115
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM---------------- 182
L+Y+H + +RDLKP+NIL + + + + DF L++ + + P
Sbjct: 116 LEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 183 ---------TVFWT-DYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
F + +V T Y APE+ G + A+D W++G + E+L G
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-----HGSAVDWWTLGILLYEMLYGTT 230
Query: 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLA 289
F G + R+E L KK F P V A
Sbjct: 231 PFKGSN-----------------------RDETFSNIL----KKE--VTFPGSPPVSSSA 261
Query: 290 LRLLQRLIAFDPKDR----PTAEEALADPYFKG 318
L+++L+ DP R A E P+F+G
Sbjct: 262 RDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 8e-13
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 15/218 (6%)
Query: 70 LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHH 128
L+E ++++ LRH +V++ ++ + IY+V E M + L +K
Sbjct: 49 LQEAQVMKKLRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLP 102
Query: 129 QF--FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186
Q Q+ + Y+ N HRDL+ NIL N KV DFGLAR+ D T
Sbjct: 103 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQ 161
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITD 245
+W APE + + ++T D+WS G + E+ T G+ +PG LD +
Sbjct: 162 GAKFPIKW-TAPE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 218
Query: 246 LLGTPSP-ETIAVVRNEKARKYLTEMRKKPPVPLFQKF 282
P P E + + + + E ++P Q F
Sbjct: 219 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 256
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 26 KILEVIGKGSYGVV-CAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
K+ + +G G +G V A + HT KVA+K + + L E +++ L+H +
Sbjct: 9 KLEKKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSMSVE---AFLAEANVMKTLQHDKL 63
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRALKY 141
V++ ++ +E IY++ E M L +K+++ + + F Q+ + +
Sbjct: 64 VKLHAVV----TKE--PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 117
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+ N HRDL+ NIL +A+ K+ DFGLARV D T +W APE
Sbjct: 118 IEQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKW-TAPEAI 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235
F +T D+WS G + E++T G+ +PG S
Sbjct: 176 N--FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 80/307 (26%), Positives = 128/307 (41%), Gaps = 53/307 (17%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD--VFEHISDAIRILREVKLLRLLRHP 82
++ V+GKG +G VCA TG+ A KK+ + + +A+ L E ++L +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA-LNEKQILEKVNSR 60
Query: 83 DIVEIKRIMLPPSKREFKD-IYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRA 138
+V + E KD + +V LM DL H N E F+ ++
Sbjct: 61 FVVSLAYAY------ETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+ +H + +RDLKP+NIL + +++ D GLA + P V T Y AP
Sbjct: 115 LEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA----VEIPEGETIRGRVGTVGYMAP 170
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ + +YT + D W +GC+ E++ GK F
Sbjct: 171 EVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQ------------------------- 203
Query: 259 RNEKARKYLTEMR-KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALA 312
R EK ++ E R K+ +KF A + ++L+ DP R AEE A
Sbjct: 204 RKEKVKREEVERRVKEDQEEYSEKF---SEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260
Query: 313 DPYFKGL 319
P+F+
Sbjct: 261 HPFFRTA 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 10/204 (4%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+++GKG++G V + +G+ A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 88 KRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV 147
K + F YV + L + ++D TR F+ +++ AL Y+H+ +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTR----FYGAEIVSALDYLHSGKI 116
Query: 148 YHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK 207
+RDLK +N++ + + +K+ DFGL + +D + T Y APE+ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM---KTFCGTPEYLAPEVLED--ND 171
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLF 231
Y A+D W +G + E++ G+ F
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 65/236 (27%), Positives = 113/236 (47%), Gaps = 26/236 (11%)
Query: 8 KELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI 67
+ L D D A ++++EV+G G+YG V TG+ AIK + DV E + I
Sbjct: 1 RSLDDIDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEI 59
Query: 68 RILREVKLLRLLRHPDIVE------IKRIMLPPSKREFKDIYVVFELME----SDLHQVI 117
++ E+ +L+ H + IK+ PP + +++V E +DL +
Sbjct: 60 KL--EINMLKKYSHHRNIATYYGAFIKKS--PPGHDD--QLWLVMEFCGAGSVTDLVKNT 113
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
K N L + + ++LR L ++H V HRD+K +N+L N ++K+ DFG++
Sbjct: 114 KGNA-LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS---- 168
Query: 178 SDTPMTVFWTD-YVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
+ TV + ++ T ++ APE+ + + Y DIWS+G E+ G P
Sbjct: 169 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 31/226 (13%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+L+ IGKG +G V + + G KVA+K I ++ + A L E ++ LRH ++V
Sbjct: 9 KLLQTIGKGEFGDV--MLGDYRGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDD--LTREHHQFFLYQMLRALKYM 142
++ +++ E +Y+V E M + L +++ L + F + A++Y+
Sbjct: 63 QLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS--DT-PMTVFWTDYVATRWYRAPE 199
N HRDL +N+L + + KV DFGL + A S DT + V WT APE
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APE 169
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLT-GK---PLFPGKSVVHQLD 241
K++ D+WS G + E+ + G+ P P K VV +++
Sbjct: 170 ALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 213
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 62/233 (26%), Positives = 104/233 (44%), Gaps = 17/233 (7%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+++ +G G +G V + KVA+K + + L E L++ L+H +V
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQ---AFLEEANLMKTLQHDKLV 64
Query: 86 EIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKAND--DLTREHHQFFLYQMLRALKYM 142
+ ++ +K E IY++ E M + L +K+++ + F Q+ + Y+
Sbjct: 65 RLYAVV---TKEE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI 119
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
N HRDL+ N+L + + K+ DFGLARV D T +W APE
Sbjct: 120 ERKNYIHRDLRAANVLVSESLMCKIADFGLARV-IEDNEYTAREGAKFPIKW-TAPEAIN 177
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254
F +T D+WS G + E++T GK +PG S + + P E
Sbjct: 178 --FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMEN 228
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 56/225 (24%), Positives = 97/225 (43%), Gaps = 20/225 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRH 81
+ + ++G+G +G V + TG+ A+K + + + E + +L +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHH-QFFLYQML 136
P +P + F+D +Y+V E DL ++ +D E QF+L +++
Sbjct: 61 P--------WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELV 112
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
A+ +H HRD+KP+N+L + +K+ DFG A A V V T Y
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA--ARLTANKMVNSKLPVGTPDYI 170
Query: 197 APELC----GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
APE+ G Y D WS+G I E++ G+ F +
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA 215
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 66/317 (20%), Positives = 119/317 (37%), Gaps = 82/317 (25%)
Query: 26 KILEVIGKGSYGVV---CAA--IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
++ +G+GS+G+V A + +VAIK +++ + + I L E +++
Sbjct: 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFN 67
Query: 81 HPDIVEIKRIML---PPSKREFKDIYVVFELM-ESDLHQVIKA---NDD-------LTRE 126
+V + ++ P VV ELM + DL +++ + T +
Sbjct: 68 CHHVVRLLGVVSTGQPT--------LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 127 HHQFFLY--QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
+F ++ + Y+ HRDL +N + + +K+ DFG+ R +
Sbjct: 120 --KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--------DI 169
Query: 185 FWTDY--------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235
+ TDY + RW APE +T D+WS G + E+ T + + G S
Sbjct: 170 YETDYYRKGGKGLLPVRWM-APESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226
Query: 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQR 295
L + D PE P L L L++
Sbjct: 227 NEEVLKFVIDGGHLDLPEN-------------------CPDKL-----------LELMRM 256
Query: 296 LIAFDPKDRPTAEEALA 312
++PK RPT E ++
Sbjct: 257 CWQYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 55/223 (24%), Positives = 106/223 (47%), Gaps = 28/223 (12%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---LREVKLLRLLRHPDIVEI 87
+G G YG V + VA+K + + D + + L+E +++ ++HP++V+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKE------DTMEVEEFLKEAAVMKEIKHPNLVQ- 66
Query: 88 KRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHT 144
+L RE Y++ E M +L ++ + ++ + Q+ A++Y+
Sbjct: 67 ---LLGVCTRE-PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 122
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW---YRAPELC 201
N HRDL +N L N +KV DFGL+R+ DT +T + ++ + APE
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-----YTAHAGAKFPIKWTAPE-- 175
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLI 243
++K++ D+W+ G + E+ T G +PG + +L+
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 11/212 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
+ L V+GKGS+G V A T E AIK + DV D + E ++L L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ L + +Y V E + DL I+ H F+ ++ L ++
Sbjct: 62 FL----TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ + +RDLK N++ ++ +K+ DFG+ + D T + T Y APE+
Sbjct: 118 HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTT---KTFCGTPDYIAPEIIA 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
+ Y ++D W+ G + E+L G+ F G+
Sbjct: 175 --YQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 3e-12
Identities = 61/251 (24%), Positives = 120/251 (47%), Gaps = 21/251 (8%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+++GKG++G V + TG+ A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
K S + + V E +L + + + +F+ +++ AL Y+H+ +
Sbjct: 61 KY-----SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
V +RDLK +N++ + + +K+ DFGL + SD + T Y APE+ +
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLED--N 170
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGK--SVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
Y A+D W +G + E++ G+ F + + +L L+ ++ P T++ +A+
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI---RFPRTLS----PEAK 223
Query: 265 KYLTEMRKKPP 275
L + KK P
Sbjct: 224 SLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 87/351 (24%), Positives = 150/351 (42%), Gaps = 54/351 (15%)
Query: 13 KDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILRE 72
KD T A +Y I V+G G+ G V A GE A+K + +D R E
Sbjct: 22 KDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAE 81
Query: 73 VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTR--- 125
V L IV+ R +++ ++ +++ DL Q IK+ R
Sbjct: 82 VCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFR 141
Query: 126 EHHQFFLY-QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
EH L+ Q+L A+ ++H+ ++ HRD+K NIL +N +K+ DFG +++ ++ T
Sbjct: 142 EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKM-YAATVSDD 200
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244
+ T +Y APE+ Y+ D++S+G + E+LT K F G+++
Sbjct: 201 VGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEE------ 252
Query: 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR 304
V+ A +Y P+P P++ P ++ L++ DPK R
Sbjct: 253 ------------VMHKTLAGRY-------DPLP-----PSISPEMQEIVTALLSSDPKRR 288
Query: 305 PTAEEALADP----YFKGLAKI-EREPSCQPISKLEFEFERRRVTKDDIRE 350
P++ + L P + GL +I + +P F R I++
Sbjct: 289 PSSSKLLNMPICKLFISGLLEIVQTQPG--------FSGPLRDTISRQIQQ 331
|
Length = 496 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 62/289 (21%), Positives = 112/289 (38%), Gaps = 60/289 (20%)
Query: 31 IGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHI-SDAIRILREVKLLRLLRHPDIVE 86
+G G++G V + K VA+K + EHI + LRE ++ L HP IV
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQ--EHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 87 IKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
+ + + +V EL L + +K ++ + +Q+ + Y+ +
Sbjct: 61 LIGVCKGEP------LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-------RWYRAP 198
+ HRDL +N+L + K+ DFG++R + + Y AT +WY AP
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS------DYYRATTAGRWPLKWY-AP 167
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
E C ++ K++ D+WS G E + G + + ++ P PE
Sbjct: 168 E-CINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPE---- 221
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
+ P ++ ++ + P+DRPT
Sbjct: 222 ---------------ECPQEIYS-----------IMLSCWKYRPEDRPT 244
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 3e-12
Identities = 78/328 (23%), Positives = 135/328 (41%), Gaps = 84/328 (25%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
N Y++++ IG G +G V T E K I + +++ EV ++R L+H
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHK 72
Query: 83 DIVE-IKRIMLPPSKREFKDIYVVFELMES-DLHQVIK------------ANDDLTREHH 128
+IV I R + +++ +Y++ E ++ DL + I+ A D+TR
Sbjct: 73 NIVRYIDRFLNKANQK----LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR--- 125
Query: 129 QFFLYQMLRALKYMHT-------ANVYHRDLKPKNILANANCK----------------- 164
Q+L AL Y H V HRDLKP+NI + +
Sbjct: 126 -----QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
K+ DFGL++ + + V T +Y +PEL Y D+W++GCI E+
Sbjct: 181 AKIGDFGLSK----NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
Query: 225 LTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN 284
+GK F + QL ++E+++ P +P+ K
Sbjct: 237 CSGKTPFHKANNFSQL--------------------------ISELKRGPDLPIKGKSKE 270
Query: 285 VDPLALRLLQRLIAFDPKDRPTAEEALA 312
++ L++ L+ K+RP+A + L
Sbjct: 271 LN----ILIKNLLNLSAKERPSALQCLG 294
|
Length = 1021 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 44/145 (30%), Positives = 70/145 (48%), Gaps = 11/145 (7%)
Query: 93 PPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDL 152
P S + D V L+ D + + D L+ F YQ+ R ++++ + N HRDL
Sbjct: 211 PASYKGSNDSEVK-NLLSDDGSEGLTTLDLLS------FTYQVARGMEFLASKNCVHRDL 263
Query: 153 KPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAI 212
+N+L +K+CDFGLAR D+ + ++ +W APE F + YT
Sbjct: 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWM-APE--SIFDNLYTTLS 320
Query: 213 DIWSIGCIFAEVLT-GKPLFPGKSV 236
D+WS G + E+ + G +PG V
Sbjct: 321 DVWSYGILLWEIFSLGGTPYPGMIV 345
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 3e-12
Identities = 79/342 (23%), Positives = 140/342 (40%), Gaps = 66/342 (19%)
Query: 24 RYKILEVIGKGSYG--VVCAAIDTHTGEKVAIKKIHDVFEHISD---------------A 66
+++++ + G++G +CA + T E A + ++ + A
Sbjct: 149 HFRVIDDLPAGAFGKIFICA-LRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAA 207
Query: 67 IRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLH-----QVIKAND 121
I++ E+ L L H +I++I+ I+ + + Y++ + + DL+ + D
Sbjct: 208 IQLENEILALGRLNHENILKIEEILRSEA-----NTYMITQKYDFDLYSFMYDEAFDWKD 262
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181
+ + + Q+L A++Y+H + HRD+K +NI N + K+ + DFG A + F +
Sbjct: 263 RPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA-MPF-EKE 320
Query: 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241
F +V T +PE+ Y DIWS G I ++L+ H
Sbjct: 321 REAFDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLS-----------HDFC 367
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP---------NVDPLALRL 292
I D G P + + ++ + E PP LF +V PL L
Sbjct: 368 PIGDGGGKPGKQLLKIID---SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNL 424
Query: 293 ---------LQRLIAFDPKDRPTAEEALADPYFKGLAKIERE 325
L +++ FD RP A E LA P F A+ E E
Sbjct: 425 GLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS--AEEEEE 464
|
Length = 501 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 4e-12
Identities = 72/286 (25%), Positives = 126/286 (44%), Gaps = 48/286 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
E++GKG++G V VA+K D+ + + I+ L E ++L+ HP+IV++
Sbjct: 1 ELLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELK--IKFLSEARILKQYDHPNIVKL 57
Query: 88 KRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
+ ++R+ IY+V EL+ L + K D+L + F + Y+ +
Sbjct: 58 IGVC---TQRQ--PIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
N HRDL +N L N LK+ DFG++R D + + +W APE +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQE-DDGIYSSSGLKQIPIKW-TAPEALN--Y 168
Query: 206 SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
+Y+ D+WS G + E + G +PG + N++AR
Sbjct: 169 GRYSSESDVWSYGILLWETFSLGVCPYPGMT------------------------NQQAR 204
Query: 265 KYLTE-MRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ + + R P QK P+ +++QR + P++RP E
Sbjct: 205 EQVEKGYRMSCP----QKCPDD---VYKVMQRCWDYKPENRPKFSE 243
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 12/207 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
Y++++ +G G+YG V A + HTGE A+K I E D I +E+ +++ +H +I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V L K +++ E L + L+ + + L+ L Y+H
Sbjct: 69 VAYFGSYLSREK-----LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH 123
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG- 202
+ HRD+K NIL N +K+ DFG VA T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGDVKLADFG---VAAKITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
Y DIW++G E+ +P
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQP 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 72/313 (23%), Positives = 117/313 (37%), Gaps = 43/313 (13%)
Query: 30 VIGKGSYG--VVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVE 86
+IGK +V A T VA+KKI+ D D + +E+ R L+HP+I+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSK-EDLKLLQQEIITSRQLQHPNILP 63
Query: 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH---------QFFLYQMLR 137
+ S ++YVV LM + +DL + H F L +L
Sbjct: 64 YVTSFIVDS-----ELYVVSPLMA------YGSCEDLLKTHFPEGLPELAIAFILKDVLN 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS----DTPMTVFWTDYVATR 193
AL Y+H+ HR +K +IL + + K+ + + + F V
Sbjct: 113 ALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS-- 251
+ +PE+ Y DI+S+G E+ G P K + L+ + GT
Sbjct: 173 PWLSPEVLQQNLQGYNEKSDIYSVGITACELANG--HVPFKDMPATQMLLEKVRGTVPCL 230
Query: 252 ------PETIAVVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDR 304
P + ++ R P + F + LQR DP+ R
Sbjct: 231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR----DPESR 286
Query: 305 PTAEEALADPYFK 317
P+A + L +FK
Sbjct: 287 PSASQLLNHSFFK 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 62/221 (28%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR 77
N + +G G++G V A + KVA+K + H S+ ++ E+K++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT-AHSSEREALMSELKIMS 93
Query: 78 LL-RHPDIVEIKRIMLPPSKREFKDIYVVFEL-MESDLHQVIKANDD--LTREHHQFFLY 133
L H +IV L + I V+ E DL ++ + LT E F Y
Sbjct: 94 HLGNHENIVN-----LLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY 148
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+ + + ++ + N HRDL +N+L +K+CDFGLAR +D+ V + +
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
W APE F YT D+WS G + E+ + G +PG
Sbjct: 209 WM-APE--SIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 77/333 (23%), Positives = 143/333 (42%), Gaps = 44/333 (13%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRL-LRHPDIVEI 87
V+GKGS+G V A T E AIK + DV D + E ++L L HP +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH- 60
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
L + + + ++ V E + DL I+++ +F+ +++ L+++H
Sbjct: 61 ----LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L + + +K+ DFG+ + + + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA---STFCGTPDYIAPEILKG--Q 171
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR-- 264
KY ++D WS G + E+L G+ F G+ E + N++
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGED---------------EDELFDSILNDRPHFP 216
Query: 265 KYLTEMRKKPPVPLFQKFPNVDPLALRL-----LQRLIAFDPKDRPTAEEALADPYFKGL 319
+++++ K LF++ P RL +++ F D E+ P FK
Sbjct: 217 RWISKEAKDCLSKLFERDPTK-----RLGVDGDIRQHPFFRGIDWERLEKREIPPPFK-- 269
Query: 320 AKIEREPSCQPISKLEFEFERRRVTKDDIRELI 352
K++ + EF E+ R++ D ++L+
Sbjct: 270 PKVKSPSDASNFDR-EFTNEKVRLSPVD-KKLL 300
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 7e-12
Identities = 71/293 (24%), Positives = 119/293 (40%), Gaps = 38/293 (12%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+++++ IG G+YG V A + +TGE AIK I E D + +E+ +++ +H +I
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK--LEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
V L K +++ E L + L+ + + L+ L Y+H
Sbjct: 69 VAYFGSYLRRDK-----LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG- 202
+ HRD+K NIL N +K+ DFG V+ T ++ T ++ APE+
Sbjct: 124 SKGKMHRDIKGANILLTDNGHVKLADFG---VSAQITATIAKRKSFIGTPYWMAPEVAAV 180
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y DIW++G E+ +P + L L+T P
Sbjct: 181 ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP----------- 229
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ K + F + +AL +PK RPTAE+ L P+
Sbjct: 230 --------KLKDKMKWSNSFHHFVKMAL-------TKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 19/216 (8%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD--VFEHISDAIRILREVKLLRLLRHP 82
++ V+GKG +G VCA TG+ A K++ + + +++ L E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESM-ALNEKQILEKVNSQ 60
Query: 83 DIVEIKRIMLPPSKREFKD-IYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRA 138
+V + E KD + +V +M DL H N E F+ ++L
Sbjct: 61 FVVNLAYAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCG 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+ +H N +RDLKP+NIL + +++ D GLA P V T Y AP
Sbjct: 115 LEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA----VKIPEGESIRGRVGTVGYMAP 170
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
E+ + +YT + D W +GC+ E++ G+ F G+
Sbjct: 171 EVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 8e-12
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 22/222 (9%)
Query: 28 LEV-IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86
L+V +G+G +G V T KVAIK + L+E ++++ LRH +V
Sbjct: 10 LDVKLGQGCFGEVWMGTWNGT-TKVAIKTLK---PGTMMPEAFLQEAQIMKKLRHDKLVP 65
Query: 87 IKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQF--FLYQMLRALKYMH 143
+ ++ + IY+V E M + L +K D + Q Q+ + Y+
Sbjct: 66 LYAVV------SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE 119
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
N HRDL+ NIL N K+ DFGLAR+ D T +W APE +
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKW-TAPE--AA 175
Query: 204 FFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KSVVHQLD 241
+ ++T D+WS G + E++T G+ +PG + V+ Q++
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 11/211 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
+ L V+GKGS+G V A T E AIK + DV D + E ++L L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ L + +Y V E + DL I+ H F+ ++ L ++
Sbjct: 62 FL----TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ + +RDLK N++ +A +K+ DFG+ + T + T Y APE+
Sbjct: 118 HSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT---RTFCGTPDYIAPEIIA 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
+ Y ++D W+ G + E+L G+P F G
Sbjct: 175 --YQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 65/239 (27%), Positives = 108/239 (45%), Gaps = 40/239 (16%)
Query: 4 DQTKKELKDKDFFTEYGDANRYKILEVIGKGSYG-VVCAAIDTHTGEKVAIKKIHDVFEH 62
+ K++ K K Y D N + +G GS+G V+ A VAIK+ FE
Sbjct: 19 KEPKRKNKMK-----YEDFN---FIRTLGTGSFGRVILATYKNEDFPPVAIKR----FEK 66
Query: 63 ISDAIR------ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFE-LMESD 112
S I+ + E K+L + HP V + FKD +Y+V E ++ +
Sbjct: 67 -SKIIKQKQVDHVFSERKILNYINHPFCVNLYG--------SFKDESYLYLVLEFVIGGE 117
Query: 113 LHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172
++ N + F+ Q++ +Y+ + N+ +RDLKP+N+L + + +K+ DFG
Sbjct: 118 FFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF 177
Query: 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
A+V + T T Y APE+ + + A D W++G E+L G P F
Sbjct: 178 AKVVDTRT------YTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 12/185 (6%)
Query: 46 HTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103
+TGE+VA+K K HI+D + +E+++LR L H +IV+ K I K
Sbjct: 31 NTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNLYHENIVKYKGICTEDGGNGIK--- 84
Query: 104 VVFELMES-DLHQVIKANDDLTREHHQF-FLYQMLRALKYMHTANVYHRDLKPKNILANA 161
++ E + S L + + N + Q + Q+ + + Y+ + HRDL +N+L +
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 144
Query: 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
++K+ DFGL + +D D + ++ APE SK+ A D+WS G
Sbjct: 145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL--IQSKFYIASDVWSFGVTL 202
Query: 222 AEVLT 226
E+LT
Sbjct: 203 YELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 57/223 (25%), Positives = 101/223 (45%), Gaps = 21/223 (9%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
++++ +G G +G V KVA+K + L E ++++ LRH +V
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGN-TKVAVKTLK---PGTMSPESFLEEAQIMKKLRHDKLV 64
Query: 86 EIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQF--FLYQMLRALKYM 142
++ ++ S+ IY+V E M + L +K + + Q+ + Y+
Sbjct: 65 QLYAVV---SEEP---IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 118
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
N HRDL+ NIL K+ DFGLAR+ D T +W APE
Sbjct: 119 ERMNYIHRDLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKW-TAPE--A 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG---KSVVHQLD 241
+ + ++T D+WS G + E++T G+ +PG + V+ Q++
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE 217
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 49/214 (22%), Positives = 91/214 (42%), Gaps = 35/214 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIR-ILREVKLLRLLRHPDI 84
+ +G GS+GVV + +G K VA+K + + +SD + L+E ++ L H ++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS--DKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 85 VEIKRIMLPPSKREFKDIYVVFELME-----SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
+ + ++L + +V EL L + + ++ + Q+ +
Sbjct: 59 IRLYGVVLTHP------LMMVTELAPLGSLLDRLRKDALGHFLISTLCD--YAVQIANGM 110
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR--- 196
+Y+ + HRDL +NIL ++ K+K+ DFGL R A D+ +
Sbjct: 111 RYLESKRFIHRDLAARNILLASDDKVKIGDFGLMR-ALPQN------EDHYVMEEHLKVP 163
Query: 197 ----APELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
APE ++ A D+W G E+ T
Sbjct: 164 FAWCAPESLR--TRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 64/252 (25%), Positives = 115/252 (45%), Gaps = 23/252 (9%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+++GKG++G V + TG A+K + +V + + E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
K + F V E +L + T E +F+ +++ AL+Y+H+ +
Sbjct: 61 KYAFQTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 115
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSD-TPMTVFWTDYVATRWYRAPELCGSFF 205
V +RD+K +N++ + + +K+ DFGL + SD M F T Y APE+
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF----CGTPEYLAPEVLED-- 169
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN--EKA 263
+ Y A+D W +G + E++ G+ F + +LI E I R +A
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL-------MEEIRFPRTLSPEA 222
Query: 264 RKYLTEMRKKPP 275
+ L + KK P
Sbjct: 223 KSLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 28/217 (12%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+++ +G G +G V KVAIK + + L E L++ L+HP +V
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGH-TKVAIKSLK---QGSMSPEAFLAEANLMKQLQHPRLV 64
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLY-------QMLR 137
+ ++ + IY++ E ME+ L +K T E + + Q+
Sbjct: 65 RLYAVVTQ------EPIYIITEYMENGSLVDFLK-----TPEGIKLTINKLIDMAAQIAE 113
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ ++ N HRDL+ NIL + K+ DFGLAR+ D T +W A
Sbjct: 114 GMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARL-IEDNEYTAREGAKFPIKW-TA 171
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
PE + +T D+WS G + E++T G+ +PG
Sbjct: 172 PEAIN--YGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 31 IGKGSYGVVCAAI-DTHTGEK-VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+G G++G V + EK VA+K + + + +LRE +++ L +P IV +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 89 RIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV 147
I E + +V EL E L++ ++ N +T ++ ++Q+ +KY+ N
Sbjct: 63 GIC------EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNF 116
Query: 148 YHRDLKPKNILANANCKLKVCDFGLARVAFSD-----TPMTVFWTDYVATRWYRAPELCG 202
HRDL +N+L K+ DFGL++ +D W +WY APE C
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW----PVKWY-APE-CM 170
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT 226
+++ K++ D+WS G + E +
Sbjct: 171 NYY-KFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 43/139 (30%), Positives = 68/139 (48%), Gaps = 11/139 (7%)
Query: 102 IYVVFELMESDLHQVIKANDDL-----TREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156
++ F+ S + DDL T E + +Q+ R ++++ + HRDL +N
Sbjct: 145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARN 204
Query: 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK-YTPAIDIW 215
IL + N +K+CDFGLAR + D + + +W APE S F K YT D+W
Sbjct: 205 ILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM-APE---SIFDKVYTTQSDVW 260
Query: 216 SIGCIFAEVLT-GKPLFPG 233
S G + E+ + G +PG
Sbjct: 261 SFGVLLWEIFSLGASPYPG 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 60/219 (27%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---DVFEHISDAIRILREVKLLRL 78
A ++++E++G G+YG V TG+ AIK + D E I I +L++ R
Sbjct: 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 64
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQ 134
+ IK+ PP + +++V E +DL + K N L E + +
Sbjct: 65 IATYYGAFIKKN--PPGMDD--QLWLVMEFCGAGSVTDLIKNTKGNT-LKEEWIAYICRE 119
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD-YVATR 193
+LR L ++H V HRD+K +N+L N ++K+ DFG++ + TV + ++ T
Sbjct: 120 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS----AQLDRTVGRRNTFIGTP 175
Query: 194 WYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKP 229
++ APE+ + + Y D+WS+G E+ G P
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 64/286 (22%), Positives = 119/286 (41%), Gaps = 52/286 (18%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
E IG+G++G V + VA+K + A + L+E ++L+ HP+IV +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA-KFLQEARILKQYSHPNIVRL- 58
Query: 89 RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLR-------ALKY 141
I + K+ IY+V EL++ L E + + ++++ ++Y
Sbjct: 59 -IGVCTQKQP---IYIVMELVQGGDFLTF-----LRTEGPRLKVKELIQMVENAAAGMEY 109
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+ + + HRDL +N L LK+ DFG++R + + +W APE
Sbjct: 110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKW-TAPEAL 168
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ +Y+ D+WS G + E + L P + N+
Sbjct: 169 N--YGRYSSESDVWSFGILLWEAFS-------------------LGAVPYAN----LSNQ 203
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPT 306
+ R+ + + + P P + P A+ RL++R +DP RP+
Sbjct: 204 QTREAIEQGVRLPC-------PELCPDAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 12/220 (5%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI--SDAIRILREVKLLRLL 79
A Y++++VIG+G++G V + + KV K+ FE I SD+ E ++
Sbjct: 42 AEDYEVVKVIGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 100
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRAL 139
P +V+ L + ++ + +Y+V E M + +N D+ + +F+ +++ AL
Sbjct: 101 NSPWVVQ-----LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+H+ HRD+KP N+L + + LK+ DFG + V V T Y +PE
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG--MVRCDTAVGTPDYISPE 213
Query: 200 LCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
+ S Y D WS+G E+L G F S+V
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 56/227 (24%), Positives = 99/227 (43%), Gaps = 31/227 (13%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+VIGKGS+G V A H E+ A+++L++ +L+ I+ +
Sbjct: 1 KVIGKGSFGKVLLA--RHKAEEKFY------------AVKVLQKKAILKKKEEKHIMSER 46
Query: 89 RIMLPPSKREF-----------KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
++L K F +Y V + + +L ++ +F+ ++
Sbjct: 47 NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA 106
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL Y+H+ N+ +RDLKP+NIL ++ + + DFGL + T + + T Y
Sbjct: 107 SALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT---STFCGTPEYL 163
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
APE+ Y +D W +G + E+L G P F ++ D I
Sbjct: 164 APEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 4e-11
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 11/212 (5%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
+ L V+GKGS+G V A T E AIK + DV D + E ++L L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ L + +Y V E + DL I+ F+ ++ L ++
Sbjct: 62 FL----TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFL 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + +RDLK N++ ++ +K+ DFG+ + D T + T Y APE+
Sbjct: 118 HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTT---RTFCGTPDYIAPEIIA 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
+ Y ++D W+ G + E+L G+P F G+
Sbjct: 175 --YQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 42/125 (33%), Positives = 62/125 (49%), Gaps = 20/125 (16%)
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
+ LT E + +Q+ R ++++ + HRDL +NIL + N +K+CDFGLAR +
Sbjct: 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 178 SDTPMTVFWTDYVAT-------RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT-GK 228
D DYV +W APE S F K YT D+WS G + E+ + G
Sbjct: 225 KD-------PDYVRKGDARLPLKWM-APE---SIFDKVYTTQSDVWSFGVLLWEIFSLGA 273
Query: 229 PLFPG 233
+PG
Sbjct: 274 SPYPG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 54/217 (24%), Positives = 98/217 (45%), Gaps = 17/217 (7%)
Query: 30 VIGKGSYGVVCAA---IDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIV 85
++GKG +G V A + + +KVA+K + D+F SD LRE ++ HP+++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVI 64
Query: 86 EIKRIML-PPSKREFKDIYVVFELME-SDLHQVIKAND------DLTREHHQFFLYQMLR 137
++ + L +K V+ M+ DLH + + L + F+ +
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
++Y+ + N HRDL +N + N N + V DFGL++ +S + +W
Sbjct: 125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLAL 184
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
L + YT D+W+ G E++T G+ + G
Sbjct: 185 ESLADNV---YTTHSDVWAFGVTMWEIMTRGQTPYAG 218
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-11
Identities = 62/228 (27%), Positives = 111/228 (48%), Gaps = 31/228 (13%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++IL+VIG+G++G V V +K V+ A++IL + ++L+
Sbjct: 3 FEILKVIGRGAFGEVAV---------VKMKNTGQVY-----AMKILNKWEMLKRAETACF 48
Query: 85 VEIKRIMLPPSKR-------EFKD---IYVVFEL-MESDLHQVI-KANDDLTREHHQFFL 132
E + +++ +R F+D +Y+V + + DL ++ K D L + +F+L
Sbjct: 49 REERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYL 108
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
+M+ A+ +H HRD+KP N+L + N +++ DFG +D TV V T
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVAVGT 166
Query: 193 RWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
Y +PE+ + +Y P D WS+G E+L G+ F +S+V
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 5e-11
Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 17/238 (7%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLL 79
+ ++V+G G++G V + GEK VAIK + + ++ IL E ++ +
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANK-EILDEAYVMASV 66
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLR 137
HP +V + I L + ++ +LM L V D++ ++ + Q+ +
Sbjct: 67 DHPHVVRLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK 120
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ Y+ + HRDL +N+L +K+ DFGLA++ D V +W A
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM-A 179
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254
E YT D+WS G E++T G + G V DL+ P P
Sbjct: 180 LESI--LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPI 235
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 6e-11
Identities = 63/242 (26%), Positives = 106/242 (43%), Gaps = 34/242 (14%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---------LREVKLLRLLR 80
+IG+G +G V TG+ A+K + D RI L E +L L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL--------DKKRIKMKQGETLALNERIMLSLVS 52
Query: 81 H---PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
P IV + P K F + +LM DLH + + + + +F+ +++
Sbjct: 53 TGDCPFIVCMTYAFHTPDKLCF-----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII 107
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
L++MH V +RDLKP NIL + + +++ D GLA P V T Y
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYM 162
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--VHQLDLITDLLGTPSPET 254
APE+ + Y + D +S+GC+ ++L G F H++D +T + P++
Sbjct: 163 APEVLQK-GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDS 221
Query: 255 IA 256
+
Sbjct: 222 FS 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 38/115 (33%), Positives = 60/115 (52%), Gaps = 6/115 (5%)
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
LT E + +Q+ + ++++ + HRDL +NIL + N +K+CDFGLAR + D
Sbjct: 174 KVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD- 232
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT-GKPLFPG 233
P V D + APE + F + YT D+WS G + E+ + G +PG
Sbjct: 233 PDYVRKGDARLPLKWMAPE---TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR-ILREVKLLRLL-RHPDIVE 86
+V+GKGS+G V A GE A+K + I D + + E ++L L +P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 87 IKRIMLPPSKREFKD-IYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ + K+ ++ V E + DL H K DL R F+ +++ L+++
Sbjct: 61 LY------CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRA--TFYAAEIVCGLQFL 112
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARV-AFSDTPMTVFWTDYVATRWYRAPELC 201
H+ + +RDLK N++ + + +K+ DFG+ + F D + F T Y APE+
Sbjct: 113 HSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF----CGTPDYIAPEIL 168
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
KYT ++D WS G + E+L G+ F G
Sbjct: 169 QGL--KYTFSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-11
Identities = 65/243 (26%), Positives = 108/243 (44%), Gaps = 45/243 (18%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDA-IRILREVKLLRLLRH 81
++ L+VIG+G++G V TG A+K + D+ E A IR R++ L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDI-----LVE 57
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
D + ++ S ++ +++Y++ E + D+ ++ D L+ E QF++ + + A+
Sbjct: 58 ADGAWVVKMFY--SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAID 115
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLA-------RVAF----SDTPMTVF---- 185
+H HRD+KP N+L +A +K+ DFGL R F + P + F
Sbjct: 116 AIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN 175
Query: 186 ---------WT--------DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
W V T Y APE+ + Y D WS+G I E+L G
Sbjct: 176 MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233
Query: 229 PLF 231
P F
Sbjct: 234 PPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 33/222 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK-----VAIKKIHDVFE-HISDAIRILREVKLLRLL 79
+ LE +G+G++G V T E+ VAIK + + E + R +E +L+ L
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR--QEAELMSDL 65
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQ----------VIKANDDLTREH- 127
+HP+IV + + + + ++FE + DLH+ V + D T +
Sbjct: 66 QHPNIVCLLGVCT-----KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 128 --HQFFL---YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182
FL Q+ ++Y+ + + HRDL +N L +K+ DFGL+R +S
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180
Query: 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
V + RW PE + K+T DIWS G + E+
Sbjct: 181 RVQSKSLLPVRWM-PPE--AILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 8e-11
Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+++ L Y+ + + HRD+KP N+L N ++K+CDFG++ + T YV T
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT-----YVGTNA 158
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232
Y APE +Y D+WS+G F E+ G+ +P
Sbjct: 159 YMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYP 194
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 77/307 (25%), Positives = 128/307 (41%), Gaps = 35/307 (11%)
Query: 24 RYKILEVIGKGSYG--VVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+Y IL + GS G VC +KV +K + + RE+ +L+ + H
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAV-------TGGKTPGREIDILKTISH 145
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
I I L + R + +V + DL + + L E ++L AL Y
Sbjct: 146 RAI-----INLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAY 200
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLA--RVAFSDTPMTVFWTDYVATRWYRAPE 199
+H + HRD+K +NI + + DFG A A DTP W+ + T +PE
Sbjct: 201 LHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET---NSPE 257
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---VHQLDLITDLLGT-----PS 251
L Y DIWS G + E+ GK V QL I + P
Sbjct: 258 L--LALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVP-LFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ + ++ K +Y +R +P + +K+ ++D L+ +++ FD + RP+A++
Sbjct: 316 NGSTNLCKHFK--QYAIVLRPPYTIPPVIRKYGMHMD--VEYLIAKMLTFDQEFRPSAQD 371
Query: 310 ALADPYF 316
L+ P F
Sbjct: 372 ILSLPLF 378
|
Length = 392 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 9e-11
Identities = 53/192 (27%), Positives = 88/192 (45%), Gaps = 28/192 (14%)
Query: 51 VAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108
VA+K + D SD R RE +LL L+H IV+ + + E + +VFE
Sbjct: 38 VAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EGDPLIMVFEY 88
Query: 109 ME-SDLHQVIKAN-------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKP 154
M+ DL++ ++A+ +LT+ Q+ + Y+ + + HRDL
Sbjct: 89 MKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 148
Query: 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214
+N L N +K+ DFG++R +S V + RW PE + K+T D+
Sbjct: 149 RNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDV 205
Query: 215 WSIGCIFAEVLT 226
WS+G + E+ T
Sbjct: 206 WSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 6/146 (4%)
Query: 94 PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQF--FLYQMLRALKYMHTANVYHRD 151
P+K + + ++ D+ I D+L + F YQ+ + + ++ + N HRD
Sbjct: 180 PTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRD 239
Query: 152 LKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPA 211
L +NIL K+CDFGLAR +D+ V + +W APE F YT
Sbjct: 240 LAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWM-APE--SIFNCVYTFE 296
Query: 212 IDIWSIGCIFAEVLT-GKPLFPGKSV 236
D+WS G + E+ + G +PG V
Sbjct: 297 SDVWSYGILLWEIFSLGSSPYPGMPV 322
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 45/222 (20%)
Query: 112 DLHQVIKANDDLTREHHQF-------FLYQMLRALKYMHTANVYHRDLKPKNILANANCK 164
DL++ IK +EH F YQ++ AL +H+ + HRDLK NI
Sbjct: 151 DLNKQIKQR---LKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI 207
Query: 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
+K+ DFG ++ +SD+ + + T +Y APEL +Y+ D+WS+G I E+
Sbjct: 208 IKLGDFGFSK-QYSDSVSLDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYEL 264
Query: 225 LTGKPLFPGKSVVHQLDLITDLL-GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP 283
LT F G S Q +++ +L G P V KA
Sbjct: 265 LTLHRPFKGPS---QREIMQQVLYGKYDPFPCPVSSGMKA-------------------- 301
Query: 284 NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIERE 325
LL L++ +P RPT ++ L + K +A + ++
Sbjct: 302 --------LLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQD 335
|
Length = 478 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 20/218 (9%)
Query: 21 DANRYKILEVIGK---GSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLL 76
D + ++ E+IG+ G++G V A + TG A K I E + D + E+++L
Sbjct: 7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV---EIEIL 63
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQ 134
HP IV++ K ++++ E I D LT Q Q
Sbjct: 64 ATCNHPYIVKLLGAFYWDGK-----LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
ML AL+Y+H+ + HRDLK N+L + +K+ DFG V+ + ++ T +
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFG---VSAKNVKTLQRRDSFIGTPY 175
Query: 195 YRAPELCGSFFSKYTP---AIDIWSIGCIFAEVLTGKP 229
+ APE+ K TP DIWS+G E+ +P
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 53/211 (25%), Positives = 94/211 (44%), Gaps = 16/211 (7%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA---IRILREVKLLRLLRHP 82
K ++V+G G++G V I GE V I + + + + E ++ + HP
Sbjct: 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHP 69
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALK 140
+V + + L P+ I +V +LM L V + D++ + + Q+ + +
Sbjct: 70 HLVRLLGVCLSPT------IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMM 123
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+ + HRDL +N+L + +K+ DFGLAR+ D + +W L
Sbjct: 124 YLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWM---AL 180
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT--GKP 229
+ K+T D+WS G E++T GKP
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 64/246 (26%), Positives = 103/246 (41%), Gaps = 51/246 (20%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHIS-DAIRILREVKLLRLLRH 81
++ L+VIG+G++G V TG A+K + D+ E IR R++
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDI-------- 54
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR 137
+VE + + F+D +Y++ E + D+ ++ D LT E QF++ + +
Sbjct: 55 --LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVL 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-------RVAF---------SDTP 181
A+ +H HRD+KP N+L ++ +K+ DFGL R F SD
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 182 MTVFWTDYVATRWYR----------------APELCGSFFSKYTPAIDIWSIGCIFAEVL 225
+ A W R APE+ + Y D WS+G I E+L
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEML 230
Query: 226 TGKPLF 231
G P F
Sbjct: 231 IGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 2e-10
Identities = 66/244 (27%), Positives = 106/244 (43%), Gaps = 39/244 (15%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI---------LREVKLLRLLR 80
+IG+G +G V TG+ A+K + D RI L E +L L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCL--------DKKRIKMKQGETLALNERIMLSLVS 52
Query: 81 H---PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
P IV + P K F + +LM DLH + + + +F+ +++
Sbjct: 53 TGDCPFIVCMSYAFHTPDKLSF-----ILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
L++MH V +RDLKP NIL + + +++ D GLA P V T Y
Sbjct: 108 LGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYM 162
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV--HQLDLIT-----DLLGT 249
APE+ + Y + D +S+GC+ ++L G F H++D +T +L +
Sbjct: 163 APEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 221
Query: 250 PSPE 253
SPE
Sbjct: 222 FSPE 225
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 62/245 (25%), Positives = 112/245 (45%), Gaps = 55/245 (22%)
Query: 24 RYKILEVIGKGSYGVVCAA----IDTHTGE-KVAIKKIH-DVFEHISDAIRILREVKLLR 77
R + + +G+G++G V A +D VA+K + D E D ++ E+++++
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK--DLSDLVSEMEMMK 70
Query: 78 LL-RHPDIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKAN--------------- 120
++ +H +I+ +L +E +YVV E +L ++A
Sbjct: 71 MIGKHKNIIN----LLGVCTQEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 121 -DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179
+ LT++ F YQ+ R ++++ + HRDL +N+L + +K+ DFGLAR
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----- 180
Query: 180 TPMTVFWTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GK 228
+ DY + +W APE + F + YT D+WS G + E+ T G
Sbjct: 181 ---DIHHIDYYRKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGS 233
Query: 229 PLFPG 233
P +PG
Sbjct: 234 P-YPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 54/226 (23%), Positives = 104/226 (46%), Gaps = 19/226 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLRH 81
++ +++I G+YG V T ++ A+KKI+ + + I ++ E +L +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
P +V + S + + +V E +E D ++K L + + + + + AL+
Sbjct: 61 PFVVS-----MFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALE 115
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA--TRWYRAP 198
Y+H + HRDLKP N+L + +K+ DFGL+++ T + ++ TR +
Sbjct: 116 YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL-TTNLYEGHIEKDTREFLDK 174
Query: 199 ELCGS---------FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235
++CG+ Y +D W++G I E L G F G +
Sbjct: 175 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 220
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 63/251 (25%), Positives = 117/251 (46%), Gaps = 20/251 (7%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+++GKG++G V + TG A+K + +V + L E ++L+ RHP + +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA- 145
K S + + V E +L + + + +F+ +++ AL Y+H+
Sbjct: 61 KY-----SFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSD-TPMTVFWTDYVATRWYRAPELCGSF 204
NV +RDLK +N++ + + +K+ DFGL + D M F T Y APE+
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF----CGTPEYLAPEVLED- 170
Query: 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264
+ Y A+D W +G + E++ G+ F + +LI + P T++ +A+
Sbjct: 171 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL-MEEIRFPRTLS----PEAK 224
Query: 265 KYLTEMRKKPP 275
L+ + KK P
Sbjct: 225 SLLSGLLKKDP 235
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 49/228 (21%), Positives = 92/228 (40%), Gaps = 37/228 (16%)
Query: 29 EVIGKGSYGVVCAAI---DTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDI 84
+++G+G +G V D + KVA+K + D+ + S+ L E ++ HP++
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDHPNV 63
Query: 85 VEIKRIMLPPSKRE-FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQML------ 136
+++ + S + V+ M+ DLH + + + Q L
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSR--LGGLPEKLPLQTLLKFMVD 121
Query: 137 --RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY----- 189
++Y+ N HRDL +N + + + V DFGL++ ++ DY
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK--------KIYSGDYYRQGR 173
Query: 190 ---VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
+ +W L YT D+W+ G E+ T G+ +PG
Sbjct: 174 IAKMPVKWIAIESLADRV---YTSKSDVWAFGVTMWEIATRGQTPYPG 218
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 74/306 (24%), Positives = 127/306 (41%), Gaps = 51/306 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD--VFEHISDAIRILREVKLLRLLRHP 82
++ V+GKG +G VCA TG+ A KK+ + + +++ L E ++L +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESM-ALNEKQILEKVNSR 60
Query: 83 DIVEIKRIMLPPSKREFKD-IYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRA 138
+V + E KD + +V LM DL H F+ ++
Sbjct: 61 FVVSLAYAY------ETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+ +H + +RDLKP+NIL + + +++ D GLA P V T Y AP
Sbjct: 115 LEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA----VHVPEGQTIKGRVGTVGYMAP 170
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ + +YT + D W++GC+ E++ G+ F +
Sbjct: 171 EVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQR------------------------ 204
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALAD 313
+ + R+ + + K+ +KF P A L + L+ DPK+R A E
Sbjct: 205 KKKIKREEVERLVKEVQEEYSEKF---SPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261
Query: 314 PYFKGL 319
P FK +
Sbjct: 262 PLFKQI 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 13/208 (6%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLL-RHPDIVE 86
+++GKGS+G V A T + AIK + DV D + E ++L L HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA 145
L + + ++++ V E + DL I++ F+ +++ L+++H+
Sbjct: 61 -----LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
+ +RDLK NIL + + +K+ DFG+ + T + T Y APE+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT---CTFCGTPDYIAPEIL--LG 170
Query: 206 SKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
KY ++D WS G + E+L G+ F G
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 41/169 (24%), Positives = 76/169 (44%), Gaps = 20/169 (11%)
Query: 70 LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI---KANDDLTR 125
L+E+K++ L+ P+I+ + + + + ++ E ME+ DL+Q + + + +
Sbjct: 67 LKEIKIMSRLKDPNIIRLLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEK 121
Query: 126 EHHQFFLYQMLR--------ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
Y L +KY+ + N HRDL +N L N +K+ DFG++R +
Sbjct: 122 ADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
S + + RW + K+T A D+W+ G E+LT
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESI---LLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 38/123 (30%), Positives = 57/123 (46%), Gaps = 22/123 (17%)
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV 190
F YQ+ ++++ + N HRDL +N+L +K+CDFGLAR D+ + ++
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
+W APE F + YT D+WS G + E+ T L GTP
Sbjct: 304 PLKWM-APE--SIFNNLYTTLSDVWSFGILLWEIFT-------------------LGGTP 341
Query: 251 SPE 253
PE
Sbjct: 342 YPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 36/215 (16%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGE-KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
L+ +G G +GVV G+ VAIK I E + E K++ L H +V
Sbjct: 8 FLKELGTGQFGVV--KYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLSHEKLV 62
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLT---REH-HQFFLYQMLR---- 137
++ + +K+ + IY+V E M +N L REH +F Q+L
Sbjct: 63 QLYGVC---TKQ--RPIYIVTEYM---------SNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 138 ---ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ Y+ + HRDL +N L + +KV DFGL+R D + + + RW
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKF-PVRW 167
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228
PE+ +SK++ D+W+ G + EV + GK
Sbjct: 168 -SPPEVL--LYSKFSSKSDVWAFGVLMWEVYSLGK 199
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 7e-10
Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 32/236 (13%)
Query: 31 IGKGSYGVV----CAAIDTHTGEK-VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+G+G++G V C + + VA+K + + E S RE +LL +L+H IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTVLQHQHIV 70
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND---------------DLTREHHQ 129
+ E + + +VFE M DL++ ++++ LT
Sbjct: 71 RFYGVC-----TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189
Q+ + Y+ + + HRDL +N L +K+ DFG++R +S V
Sbjct: 126 AIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
+ RW PE + K+T DIWS G + E+ T GK + S ++ IT
Sbjct: 186 LPIRWM-PPE--SILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 19/208 (9%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHD--VFEHISDAIRILREVKLLRLLRHPDIVEI 87
V+GKG +G VCA TG+ A KK+ + + +A+ L E ++L + +V +
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM-ALNEKRILEKVNSRFVVSL 65
Query: 88 KRIMLPPSKREFKD-IYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRALKYMH 143
E KD + +V +M DL H N + F+ ++ L+ +
Sbjct: 66 AYAY------ETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
+ +RDLKP+NIL + +++ D GLA P V T Y APE+ +
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLA----VQIPEGETVRGRVGTVGYMAPEVINN 175
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
KYT + D W +GC+ E++ G+ F
Sbjct: 176 --EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 72/316 (22%), Positives = 134/316 (42%), Gaps = 63/316 (19%)
Query: 23 NRYKILEVIGKGSYGVV--CAAID------------THTGEKVAIKKIH-DVFEHISDAI 67
+ ++ E +G+G +G V C A VA+K + DV + +
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARN-- 62
Query: 68 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI--------- 117
L+E+K++ L++P+I+ + + + + ++ E ME+ DL+Q +
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDP-----LCMITEYMENGDLNQFLSQREIESTF 117
Query: 118 -KAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174
AN+ ++ + + Q+ +KY+ + N HRDL +N L + +K+ DFG++R
Sbjct: 118 THANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
+S + + RW + K+T A D+W+ G E+ T P
Sbjct: 178 NLYSGDYYRIQGRAVLPIRWMAWESI---LLGKFTTASDVWAFGVTLWEMFTLCKEQP-Y 233
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKP--PVPLFQKFPNVDPLALRL 292
S++ +I + T RN+ + YL++ P P P+F+ L
Sbjct: 234 SLLSDEQVIEN--------TGEFFRNQGRQIYLSQ---TPLCPSPVFK-----------L 271
Query: 293 LQRLIAFDPKDRPTAE 308
+ R + D KDRPT
Sbjct: 272 MMRCWSRDIKDRPTFN 287
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 9/117 (7%)
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
DDL R F Q+ + + ++ + N HRD+ +N+L K+CDFGLAR +D+
Sbjct: 212 DDLLR-----FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS 266
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236
V + +W APE F YT D+WS G + E+ + GK +PG V
Sbjct: 267 NYVVKGNARLPVKWM-APE--SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 1e-09
Identities = 34/106 (32%), Positives = 54/106 (50%), Gaps = 8/106 (7%)
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV 190
F +Q+ R ++Y+ + HRDL +N+L K+K+ DFGL+R + + +
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI 191
Query: 191 ATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPG 233
+W A E S F YT D+WS G + E++T G P +PG
Sbjct: 192 PVKWM-AIE---SLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 15/210 (7%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
++I+ +G G++G V A + TG A K I E + + E+ +L HP+I
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV--EIDILASCDHPNI 64
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMESDLHQVI--KANDDLTREHHQFFLYQMLRALKYM 142
V+ +L E +++++ E + + LT + Q L AL Y+
Sbjct: 65 VK----LLDAFYYE-NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRDLK NIL + +K+ DFG V+ +T ++ T ++ APE+
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFG---VSAKNTRTIQRRDSFIGTPYWMAPEVVM 176
Query: 203 SFFSKYTP---AIDIWSIGCIFAEVLTGKP 229
SK P D+WS+G E+ +P
Sbjct: 177 CETSKDRPYDYKADVWSLGITLIEMAQIEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 66/294 (22%), Positives = 113/294 (38%), Gaps = 48/294 (16%)
Query: 29 EVIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86
+ +G+G +G V KVA+K + S+ L E ++ HP+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 87 IKRIMLPPSKRE-FKDIYVVFELME-SDLHQVI---KANDD---LTREHHQFFLYQMLRA 138
+ + L + E + V+ M+ DLH + + D L + F+ +
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
++Y+ + + HRDL +N + N N + V DFGL++ ++ + +W
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
L YT D+WS G E+ T G+ +PG
Sbjct: 185 SLADRV---YTTKSDVWSFGVTMWEIATRGQTPYPG------------------------ 217
Query: 258 VRNEKARKYLTEMR--KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
V N + YL + K+PP L D L L+ +PKDRP+ E
Sbjct: 218 VENSEIYDYLRQGNRLKQPPDCL-------DGL-YSLMSSCWLLNPKDRPSFET 263
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 14/218 (6%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI--SDAIRILREVKLLRLLRHP 82
+ +++VIG+G++G V + + A+K + FE I SD+ E ++
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-FEMIKRSDSAFFWEERDIMAHANSE 103
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
IV++ K +Y+V E M DL ++ +N D+ + +F+ +++ AL
Sbjct: 104 WIVQLHYAFQDD-----KYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVVLALDA 157
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ HRD+KP N+L + + LK+ DFG + M T V T Y +PE+
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRCDTA-VGTPDYISPEVL 215
Query: 202 GS--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
S Y D WS+G E+L G F S+V
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 32/218 (14%)
Query: 31 IGKGSYGVV----CAAID-THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+G+G++G V C + T VA+K + D ++ RE +LL L+H IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIV 70
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN--------DDLTREHH-QFFLYQM 135
+ + + + +VFE M+ DL++ ++A+ D R+ + L QM
Sbjct: 71 KFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 136 LR-------ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
L + Y+ + + HRDL +N L AN +K+ DFG++R +S V
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW PE + K+T D+WS G I E+ T
Sbjct: 186 MLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 11/204 (5%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL--RLLRHPDIVEI 87
VIG+GSY V T A+K + + + I ++ K + + HP +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 88 KRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV 147
+ E + +V+ + DL ++ L EH +F+ ++ AL Y+H +
Sbjct: 62 HSCF----QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGI 117
Query: 148 YHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK 207
+RDLK N+L ++ +K+ D+G+ + T + + T Y APE+
Sbjct: 118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEILRG--ED 172
Query: 208 YTPAIDIWSIGCIFAEVLTGKPLF 231
Y ++D W++G + E++ G+ F
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 66/278 (23%), Positives = 125/278 (44%), Gaps = 37/278 (13%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL--RLLRHPDIVEI 87
VIG+GSY V + A+K + H + I ++ K + + +P +V +
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
S+ +++V E + DL ++ L EH +F+ ++ AL ++H
Sbjct: 62 HSCFQTTSR-----LFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG 116
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L +A+ +K+ D+G+ + T + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266
+Y ++D W++G + E++ G+ F D+ITD P T Y
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPF---------DIITD---NPDMNT---------EDY 210
Query: 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR 304
L ++ + P+ + +F +V A +L+ + DPK+R
Sbjct: 211 LFQVILEKPIRI-PRFLSVK--ASHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 13/205 (6%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL--RLLRHPDIVEI 87
VIG+GSY V T A+K I + + I ++ K + HP +V +
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
S+ ++ V E + DL ++ L EH +F+ ++ AL ++H
Sbjct: 62 HSCFQTESR-----LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
+ +RDLK N+L +A +K+ D+G+ + T + + T Y APE+
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRG--E 171
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLF 231
Y ++D W++G + E++ G+ F
Sbjct: 172 DYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
+GKG +G VCA +TG+ A KK+ + S L E ++L + P IV +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 90 IMLPPSKREFKDIYVVFELME-SDL--HQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
SK + +V LM DL H L E + Q+ + ++H+ +
Sbjct: 61 AF--ESKTH---LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
+ +RD+KP+N+L + ++ D GLA V D T T Y APE+
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTI---TQRAGTNGYMAPEILKE--E 169
Query: 207 KYTPAIDIWSIGCIFAEVLTGKPLF 231
Y+ +D +++GC E++ G+ F
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 39/222 (17%)
Query: 24 RY-KILEVIGKGSYGVVCA----AIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLL 76
RY K + V+G+G +G V + TGE VA+K K ++ S + E+ +L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK---EINIL 60
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQ 134
+ L H +IV+ K S++ K + ++ E + S + K +L + F Q
Sbjct: 61 KTLYHENIVKYKGCC---SEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQ--LLLFAQQ 115
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA----------RVAFSDTPMTV 184
+ + Y+H+ + HRDL +N+L + + +K+ DFGLA RV D V
Sbjct: 116 ICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR-EDGDSPV 174
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
FW A E K++ A D+WS G E+LT
Sbjct: 175 FWY---------AVECLKEN--KFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 37/116 (31%), Positives = 57/116 (49%), Gaps = 8/116 (6%)
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
YQ+ R ++Y+ + HRDL +N+L N +K+ DFGLAR + +
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203
Query: 193 RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITD 245
+W APE + F + YT D+WS G + E+ T G P +PG V L+ +
Sbjct: 204 KWM-APE---ALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-YPGIPVEELFKLLKE 254
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 56/201 (27%), Positives = 87/201 (43%), Gaps = 47/201 (23%)
Query: 51 VAIKKIHDVFEHISDAIRI--LREVKLLRLLRHPDIVEIKRIML--PPSKREFKDIYVVF 106
VA+K + SD R L+EVK+L L P+I + + PP + ++
Sbjct: 49 VAVKVLRP---DASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPP-------LCMIM 98
Query: 107 ELME-SDLHQVIKANDDLTREH--------HQFFLY---QMLRALKYMHTANVYHRDLKP 154
E ME DL+Q ++ + T LY Q+ ++Y+ + N HRDL
Sbjct: 99 EYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158
Query: 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY--------VATRWYRAPELCGSFF- 205
+N L N +K+ DFG++R +S +DY + RW A E S
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNLYS--------SDYYRVQGRAPLPIRWM-AWE---SVLL 206
Query: 206 SKYTPAIDIWSIGCIFAEVLT 226
K+T D+W+ G E+LT
Sbjct: 207 GKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 53/213 (24%), Positives = 86/213 (40%), Gaps = 28/213 (13%)
Query: 31 IGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
IG G +G V + H G +V +K++ + + L+EV+ R L HP++
Sbjct: 3 IGNGWFGKVLLG-EAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNV--- 57
Query: 88 KRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR-----ALKY 141
+ E +V E DL +++N + + Q + Q + L +
Sbjct: 58 --LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLW 115
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD---YVATRWYRAP 198
+H A+ H DL +N A+ +K+ D+GL A P + T V RW AP
Sbjct: 116 LHQADFIHSDLALRNCQLTADLSVKIGDYGL---ALEQYPEDYYITKDCHAVPLRWL-AP 171
Query: 199 ELCGSFFS-----KYTPAIDIWSIGCIFAEVLT 226
EL T +IWS+G E+ T
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 25/206 (12%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRI 90
+ KG Y + ID VAIK + + E S ++RE +++ L +P IV + +
Sbjct: 11 VKKGVYKMRKKQID------VAIKVLKNENEK-SVRDEMMREAEIMHQLDNPYIVRMIGV 63
Query: 91 MLPPSKREFKDIYVVFELMESD-LHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVY 148
E + + +V E+ L++ + D++T + ++Q+ +KY+ N
Sbjct: 64 C------EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 149 HRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW---YRAPELCGSFF 205
HRDL +N+L K+ DFGL++ +D ++ A +W + APE F
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDS---YYKARSAGKWPLKWYAPECIN--F 172
Query: 206 SKYTPAIDIWSIGCIFAEVLT--GKP 229
K++ D+WS G E + KP
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 41/226 (18%)
Query: 31 IGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLRHPD 83
IG+G++G V A + VA+K + E S ++ RE L+ HP+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAALMAEFDHPN 69
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND--------------------- 121
IV++ + K + ++FE M DL++ ++
Sbjct: 70 IVKLLGVCA-----VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 122 -DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L+ Q+ + Y+ HRDL +N L N +K+ DFGL+R +S
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
D + RW PE F+++YT D+W+ G + E+ +
Sbjct: 185 YYKASENDAIPIRWM-PPE--SIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 26/212 (12%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHD-----VFEHISDAIRILREVKLL 76
+ L+++G G +G V I G+ VAIK I D F+ I+D + +
Sbjct: 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS---- 65
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQ 134
L H IV + I S + +V +L S L V + D L + + Q
Sbjct: 66 --LDHAYIVRLLGICPGAS------LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ 117
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ + + Y+ + HR+L +NIL ++ +++ DFG+A + + D + +W
Sbjct: 118 IAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
L F +YT D+WS G E+++
Sbjct: 178 M---ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 35/115 (30%), Positives = 56/115 (48%), Gaps = 6/115 (5%)
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
YQ+ R ++Y+ + HRDL +N+L + +K+ DFGLAR + +
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200
Query: 193 RWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITD 245
+W APE + F + YT D+WS G + E+ T G +PG V L+ +
Sbjct: 201 KWM-APE---ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 61/239 (25%), Positives = 108/239 (45%), Gaps = 55/239 (23%)
Query: 31 IGKGSYGVVCAA----IDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLRLL-RHP 82
+G+G +G V A ID ++ VA+K + D D ++ E++L++L+ +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATD-KDLADLISEMELMKLIGKHK 78
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKAND--------DLTREHHQFF-- 131
+I+ + + +YV+ E + +L + ++A D+T+ +
Sbjct: 79 NIINLLGVCTQEGP-----LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 132 ------LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185
YQ+ R ++Y+ + HRDL +N+L + +K+ DFGLAR V
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR--------GVH 185
Query: 186 WTDY--------VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPG 233
DY + +W APE + F + YT D+WS G + E+ T G P +PG
Sbjct: 186 DIDYYKKTSNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGILMWEIFTLGGSP-YPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 45/176 (25%), Positives = 78/176 (44%), Gaps = 28/176 (15%)
Query: 70 LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN-------- 120
L+EVK+L L+ P+I+ + + + + ++ E ME+ DL+Q + ++
Sbjct: 67 LKEVKILSRLKDPNIIRLLGVCVDEDP-----LCMITEYMENGDLNQFLSSHHLDDKEEN 121
Query: 121 -DDLTREHHQFFL--YQML--------RALKYMHTANVYHRDLKPKNILANANCKLKVCD 169
+D H Y L +KY+ + N HRDL +N L N +K+ D
Sbjct: 122 GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIAD 181
Query: 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225
FG++R ++ + + RW A E K+T A D+W+ G E+L
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWM-AWECI--LMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 50/207 (24%), Positives = 93/207 (44%), Gaps = 14/207 (6%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK-KIHDVFEHISDAI--RILREVKLLRLLRH 81
+K ++V+G G++G V + GEKV I I ++ E S IL E ++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRAL 139
P + + I L + + ++ +LM L V + D++ ++ + Q+ + +
Sbjct: 69 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 122
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y+ + HRDL +N+L +K+ DFGLA++ +D V +W
Sbjct: 123 NYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ YT D+WS G E++T
Sbjct: 183 I---LHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 38/124 (30%), Positives = 59/124 (47%), Gaps = 24/124 (19%)
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY--- 189
YQ+ R ++Y+ + HRDL +N+L + +K+ DFGLAR + DY
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--------DIHHIDYYKK 198
Query: 190 -----VATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLD 241
+ +W APE + F + YT D+WS G + E+ T G P +PG V
Sbjct: 199 TTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-YPGVPVEELFK 253
Query: 242 LITD 245
L+ +
Sbjct: 254 LLKE 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 17/206 (8%)
Query: 31 IGKGSYG-VVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
IG G +G V+ + I T TG + K + L++ R+L+HP+I++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 90 IMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQML----RALKYMHT 144
+ E +VFE E DL + R L +M + +MH
Sbjct: 63 QCV-----EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK 117
Query: 145 ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF 204
N H DL +N ++ +KV D+G+ + + + V RW APEL G F
Sbjct: 118 HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL-APELVGEF 176
Query: 205 F-----SKYTPAIDIWSIGCIFAEVL 225
++ T ++W++G E+
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 51/196 (26%), Positives = 90/196 (45%), Gaps = 31/196 (15%)
Query: 51 VAIKKIHDVF--EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE- 107
VAIK + D+ + + +E L+ L HP+IV +L +E + + ++FE
Sbjct: 37 VAIKTLKDINNPQQWGE---FQQEASLMAELHHPNIV----CLLGVVTQE-QPVCMLFEY 88
Query: 108 LMESDLHQVI-----------KANDDLTREH---HQFFLY---QMLRALKYMHTANVYHR 150
L + DLH+ + +++D T + H FL+ Q+ ++Y+ + H+
Sbjct: 89 LNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHK 148
Query: 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP 210
DL +NIL +K+ D GL+R +S V + RW PE + K++
Sbjct: 149 DLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWM-PPE--AIMYGKFSS 205
Query: 211 AIDIWSIGCIFAEVLT 226
DIWS G + E+ +
Sbjct: 206 DSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 70/271 (25%), Positives = 107/271 (39%), Gaps = 46/271 (16%)
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM-------ESDLHQVIKAN-DDL 123
E +LLR L HP ++ + D+ VV L SDL+ + A L
Sbjct: 210 EARLLRRLSHPAVLALL------------DVRVVGGLTCLVLPKYRSDLYTYLGARLRPL 257
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183
Q+L A+ Y+H + HRD+K +N+L N + + DFG A A + T
Sbjct: 258 GLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFA-RGSWST 316
Query: 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG-CIFAEVLTGKPLFPGKS------- 235
F T APE+ YTP++DIWS G IF + LF
Sbjct: 317 PFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPY 374
Query: 236 ------VVHQLDLITDLLGT-PSPETIAVVRNEKARKYLTEMRKKPPV--PLFQKFPNVD 286
++ Q + D ++ R+ AR ++P P + ++ +D
Sbjct: 375 DAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARN------RRPAYTRPAWTRYYKLD 428
Query: 287 PLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
L+ R + FD RP+A E L P F+
Sbjct: 429 LDVEYLVCRALTFDGARRPSAAELLRLPLFQ 459
|
Length = 461 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 26/227 (11%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKV--AIKKIHDVFEHISDAIRILREVKLL-R 77
+ N K +VIG+G++G V A G ++ AIK++ + + D E+++L +
Sbjct: 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCK 63
Query: 78 LLRHPDIVEIK-----------RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTRE 126
L HP+I+ + I P D ++E+D I + T
Sbjct: 64 LGHHPNIINLLGACEHRGYLYLAIEYAPHG-NLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 127 HHQF--FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
Q F + R + Y+ HRDL +NIL N K+ DFGL+R T+
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 182
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 229
+ RW L +S YT D+WS G + E+ L G P
Sbjct: 183 ---GRLPVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 223
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 40/226 (17%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKV--AIKKIHDVFEHISDAIRILREVKLL-RLLRHPDIV 85
+VIG+G++G V A+ G K+ AIK + + F +D E+++L +L HP+I+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNII 66
Query: 86 EIKRIMLPPSKREFKDIYVVFE----------LMESDLHQVIKANDDLTREH---HQFFL 132
+ + R + +Y+ E L +S +V++ + +EH
Sbjct: 67 NL---LGACENRGY--LYIAIEYAPYGNLLDFLRKS---RVLETDPAFAKEHGTASTLTS 118
Query: 133 YQMLR-------ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185
Q+L+ ++Y+ HRDL +N+L N K+ DFGL+R T+
Sbjct: 119 QQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTM- 177
Query: 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 229
+ RW L +S YT D+WS G + E+ L G P
Sbjct: 178 --GRLPVRWMAIESLN---YSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 72/298 (24%), Positives = 115/298 (38%), Gaps = 63/298 (21%)
Query: 31 IGKGSYGVVC--AAID---THTGE-KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI 84
+G G++G V A D +G +VA+K + + L+E L+ HP+I
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK-GATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML------- 136
V++ + L + Y++ ELME DL ++ L ++L
Sbjct: 62 VKLLGVCL-----LNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 137 RALKYMHTANVYHRDLKPKNILA-----NANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
+ Y+ + HRDL +N L +A+ +K+ DFGLAR + +
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 192 TRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLG 248
RW APE L G F T D+WS G + E+LT G+ +P +
Sbjct: 177 VRWM-APESLLDGKF----TTQSDVWSFGVLMWEILTLGQQPYPALN------------- 218
Query: 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
+ E + V R + P N +L+ A DP +RPT
Sbjct: 219 --NQEVLQHVT--------AGGRLQKP-------ENCPDKIYQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 22/222 (9%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIK-KIHDVFEHISDAI--RILREVKLLRLLRHP 82
K ++V+G G++G V I GE V I I + E+ S IL E ++ + P
Sbjct: 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSP 69
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALK 140
+ + I L + + +V +LM L V + D + + + Q+ + +
Sbjct: 70 YVCRLLGICLTST------VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMS 123
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD--YVATRWYRAP 198
Y+ + HRDL +N+L + +K+ DFGLAR+ D T + D V +W
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL--DIDETEYHADGGKVPIKWMALE 181
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPL--FPGKSV 236
+ ++T D+WS G E++T KP P + +
Sbjct: 182 SI---LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 53/221 (23%), Positives = 93/221 (42%), Gaps = 30/221 (13%)
Query: 29 EVIGKGSYGVVCAAIDTHTGEKV--AIKKIHDVFEHISDAIRILREVKLL-RLLRHPDIV 85
+VIG+G++G V A G ++ AIK++ + + D E+++L +L HP+I+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDL-----HQVIKANDDLTREH---HQFFLYQMLR 137
+ + R + + + + + L +V++ + + Q+L
Sbjct: 60 NL---LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 138 -------ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV 190
+ Y+ HRDL +NIL N K+ DFGL+R T+ +
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM---GRL 173
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV--LTGKP 229
RW L +S YT D+WS G + E+ L G P
Sbjct: 174 PVRWMAIESLN---YSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-07
Identities = 67/309 (21%), Positives = 117/309 (37%), Gaps = 75/309 (24%)
Query: 30 VIGKGSYGVVCAA----IDTHTGEKVAIKKIHDVFEHISDAIRIL---REVKLLRLLRHP 82
+G+G +G V A I+ GE + + K + D RE+ + R L H
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVK---ALQKTKDENLQSEFRRELDMFRKLSHK 68
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD---------LTREHHQFFL 132
++V + + RE + Y++ E + DL Q ++A L+ +
Sbjct: 69 NVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY--- 189
Q+ + ++ A HRDL +N L ++ ++KV L++ ++ +Y
Sbjct: 124 TQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS--------EYYKL 175
Query: 190 ----VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
+ RW APE ++ D+WS G + EV T G+ F G S
Sbjct: 176 RNALIPLRWL-APE--AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS--------- 223
Query: 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKD 303
E + ++ K P P L +L+ R A +PKD
Sbjct: 224 ------DEEVLNRLQAGKLE---------------LPVPEGCPSRLYKLMTRCWAVNPKD 262
Query: 304 RPTAEEALA 312
RP+ E ++
Sbjct: 263 RPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDV-------FEHISDAIRILREVKLLRLLRHPD 83
+GKG +G V A TG+ A KK++ +E RIL +V H
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-------HSR 53
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-----DLHQVIKANDDLTREHHQFFLYQMLRA 138
+ + L + + D+ +V +M ++ V + N F+ Q++
Sbjct: 54 FI----VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG 109
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L+++H + +RDLKP+N+L + + +++ D GLA V D Y T + AP
Sbjct: 110 LEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKT--KGYAGTPGFMAP 166
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
EL +Y ++D +++G E++ + F
Sbjct: 167 ELLQG--EEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 23/219 (10%)
Query: 26 KILEVIGKGSYGVVCAA--IDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ +E +G+ +G V T GE+ VAIK + D E E + L+
Sbjct: 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQ 66
Query: 81 HPDIVEI-------KRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLT----REHHQ 129
HP+IV + + + + S D++ F +M S V +DD T E
Sbjct: 67 HPNIVCLLGVVTKEQPLSMIFSYCSHSDLHE-FLVMRSPHSDVGSTDDDKTVKSTLEPAD 125
Query: 130 FF--LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
F + Q+ ++++ + +V H+DL +N+L +K+ D GL R ++ +
Sbjct: 126 FVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW +PE + K++ DIWS G + EV +
Sbjct: 186 SLLPIRWM-SPE--AIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 63/266 (23%), Positives = 102/266 (38%), Gaps = 75/266 (28%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-------HDVFEHISDAIRILREVKL 75
+ ++VIGKG++G V TG+ A+K + D H+ +L E
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD- 59
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFF 131
P +V + F+D ++ +ME DL ++ D + + +F+
Sbjct: 60 -----SPWVVSLYY--------SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY 106
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA------------------ 173
+ + + A++ +H HRD+KP NIL + +K+ DFGL+
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQG 166
Query: 174 -----------RVAFSDTPMTVFWTDYVATRW----------------YRAPELCGSFFS 206
VA +T+ D +AT W Y APE+ F
Sbjct: 167 KSNKNRIDNRNSVAVDSINLTMSSKDQIAT-WKKNRRLMAYSTVGTPDYIAPEI---FLQ 222
Query: 207 K-YTPAIDIWSIGCIFAEVLTGKPLF 231
+ Y D WS+G I E L G P F
Sbjct: 223 QGYGQECDWWSLGAIMFECLIGWPPF 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 32/104 (30%), Positives = 46/104 (44%), Gaps = 22/104 (21%)
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY---- 189
+M+ AL +H + RDL P NIL + +++ F W++
Sbjct: 93 EMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSR-------------WSEVEDSC 139
Query: 190 ---VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
Y APE+ G S+ T A D WS+G I E+LTGK L
Sbjct: 140 DGEAVENMYCAPEVGG--ISEETEACDWWSLGAILFELLTGKTL 181
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 40/159 (25%), Positives = 79/159 (49%), Gaps = 19/159 (11%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK---KIHDVFEHISDAIRILREVKLLRLLRH 81
+ I++ I +G++G V + + A+K K + +++ ++ R+ L L +
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDA--LALSKS 63
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELM-----ESDLHQVIKANDDLTREHHQFFLYQML 136
P IV L S + ++Y+V E + +S LH ++++ ++ ++
Sbjct: 64 PFIVH-----LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAV----KYISEVA 114
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
AL Y+H + HRDLKP N+L + +K+ DFGL++V
Sbjct: 115 LALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 47/216 (21%), Positives = 83/216 (38%), Gaps = 25/216 (11%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRL 78
D KI ++G G +G +C ++ IH + SD R L E L
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQ 62
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQML- 136
H +IV ++ ++ + + +V E M + A D R+H Q Q++
Sbjct: 63 FDHSNIVRLEGVITRGNT-----MMIVTEYMSNG------ALDSFLRKHEGQLVAGQLMG 111
Query: 137 ------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV 190
+KY+ H+ L +L N++ K+ F + S+ T
Sbjct: 112 MLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSP 171
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ APE + ++ A D+WS G + EV++
Sbjct: 172 VL--WAAPEAIQ--YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 82/345 (23%), Positives = 130/345 (37%), Gaps = 90/345 (26%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLRHP 82
+ ++ IG G++G VC T A+K + DV + A + E +L +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMR-NQAAHVKAERDILAEADNE 61
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFEL-----MESDLHQVIKANDDLTREHHQFFLYQMLR 137
+V+ L S ++ ++Y V + M S L ++ +DL R F++ ++
Sbjct: 62 WVVK-----LYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLAR----FYIAELTC 112
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL------------------ARVAFSD 179
A++ +H HRD+KP NIL + + +K+ DFGL R +
Sbjct: 113 AIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 180 TPMTVFWTD----------------------YVATRWYRAPELCGSFFSKYTPAIDIWSI 217
D V T Y APE+ + YT D WS+
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSV 230
Query: 218 GCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVP 277
G I E+L G+P F L TP+ ET V N + T +
Sbjct: 231 GVILYEMLVGQPPF--------------LADTPA-ETQLKVINWE-----TTLHIPSQA- 269
Query: 278 LFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEALADPYFKGL 319
+ A L+ RL +DR A+E A P+FKG+
Sbjct: 270 ------KLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGI 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 4e-06
Identities = 36/119 (30%), Positives = 62/119 (52%), Gaps = 12/119 (10%)
Query: 112 DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVCDF 170
DL ++K L+ + + Q++ AL +H N+ H D+K +N+L + A ++ +CD+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDY 154
Query: 171 GLARVAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
GL ++ TP Y T Y +PE + G Y + D W++G + E+LTGK
Sbjct: 155 GLCKII--GTPSC-----YDGTLDYFSPEKIKGHN---YDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 60/273 (21%), Positives = 106/273 (38%), Gaps = 74/273 (27%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
++ +G G++G VC A T A+K + ++V L + H V+
Sbjct: 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLRK------------KDVLLRNQVAH---VKA 50
Query: 88 KRIMLPPSKRE--------FKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQM 135
+R +L + E F+D +Y V + + D+ ++ + +F++ ++
Sbjct: 51 ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAEL 110
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA----------------RVAFSD 179
A++ +H HRD+KP NIL + + +K+ DFGL V
Sbjct: 111 TCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170
Query: 180 TPMTVFWTD----------------------------YVATRWYRAPELCGSFFSKYTPA 211
+ W D V T Y APE+ + YT
Sbjct: 171 MDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL--LRTGYTQL 228
Query: 212 IDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLI 243
D WS+G I E+L G+P F ++ + Q+ +I
Sbjct: 229 CDWWSVGVILYEMLVGQPPFLAQTPLETQMKVI 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-06
Identities = 56/252 (22%), Positives = 97/252 (38%), Gaps = 57/252 (22%)
Query: 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLR-LLRHPDI 84
++ +G G++G VC A T A+K + DV A VK R +L D
Sbjct: 6 IKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVA-----HVKAERDILAEADN 60
Query: 85 VEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
+ ++ ++ ++Y V + + D+ ++ + +F++ ++ A++ +H
Sbjct: 61 EWVVKLYYSFQDKD--NLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVH 118
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGL----------------ARVAFSDTPMTVFWT 187
HRD+KP NIL + + +K+ DFGL + + + W
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 188 D----------------------------YVATRWYRAPELCGSFFSKYTPAIDIWSIGC 219
D V T Y APE+ YT D WS+G
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL--LRKGYTQLCDWWSVGV 236
Query: 220 IFAEVLTGKPLF 231
I E+L G+P F
Sbjct: 237 ILFEMLVGQPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 45/218 (20%), Positives = 89/218 (40%), Gaps = 25/218 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTG----EKVAIKKIHDVFEHISDAIRILREVKLLRLL 79
R + +++ +G++G + I E+V +K + D I +L+E LL L
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVT-LLLQESCLLYGL 65
Query: 80 RHPDIVEIKR----------IMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHH 128
H +I+ I ++ P + K L E++ Q + T++
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS-----TQQLV 120
Query: 129 QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
+ Q+ + Y+H V H+D+ +N + + ++K+ D L+R F + +
Sbjct: 121 HMAI-QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE 179
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+W L +S A D+WS G + E++T
Sbjct: 180 NRPVKWMALESLVNKEYSS---ASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 58/224 (25%), Positives = 87/224 (38%), Gaps = 60/224 (26%)
Query: 129 QFFLYQMLRALKYMHTANVYHRDLKPKNIL-ANANCKLKVCDFGLA---RVAFSDTPMTV 184
Q + Q+L AL +H+ + HRD+KP+NI+ + + K+ D G A RV + P
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP--- 314
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPA----------------------IDIWSIGCIFA 222
+++ Y APE S TP+ DI+S G IF
Sbjct: 315 --KEFLLDPRYAAPE--QYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL 370
Query: 223 EVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY-LTEMRK----KPPVP 277
++ FP L +D I R K Y L RK +
Sbjct: 371 QM-----AFPN--------LRSD------SNLIQFNRQLKRNDYDLVAWRKLVEPRASPD 411
Query: 278 LFQKFPNVD---PLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
L + F +D LL+ ++ F + R +A+ ALA PYF
Sbjct: 412 LRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDR 455
|
Length = 566 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 8e-05
Identities = 55/247 (22%), Positives = 96/247 (38%), Gaps = 50/247 (20%)
Query: 27 ILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+L +G G++G V + +VA+K + + D L E ++ H
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE-QDESDFLMEALIMSKFNH 68
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR--- 137
+IV + + R +++ ELM DL ++ N + +L
Sbjct: 69 QNIVRLIGVSFERLPR-----FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 138 ----ALKYMHTANVYHRDLKPKNILANANCK-----LKVCDFGLARVAFSDTPMTVFWTD 188
KY+ + HRD+ +N L CK K+ DFG+AR ++
Sbjct: 124 DVAKGCKYLEENHFIHRDIAARNCL--LTCKGPGRVAKIADFGMAR--------DIYRAS 173
Query: 189 Y--------VATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVV 237
Y + +W PE L G F SK D+WS G + E+ + G +PG++
Sbjct: 174 YYRKGGRAMLPIKWM-PPEAFLDGIFTSK----TDVWSFGVLLWEIFSLGYMPYPGRTNQ 228
Query: 238 HQLDLIT 244
++ +T
Sbjct: 229 EVMEFVT 235
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 52/224 (23%), Positives = 94/224 (41%), Gaps = 41/224 (18%)
Query: 27 ILEVIGKGSYGVVCAAI--DTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+L +G+GS+G+V D GE +VA+K +++ + + I L E +++
Sbjct: 10 LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES-ASLRERIEFLNEASVMKGFTC 68
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKA------NDDLTREHHQFFLYQ 134
+V R++ SK + VV ELM DL +++ N+ + Q
Sbjct: 69 HHVV---RLLGVVSKGQ--PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 135 MLR----ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY- 189
M + Y++ HRDL +N + + +K+ DFG+ R ++ TDY
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIYETDYY 175
Query: 190 -------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW L F+ + D+WS G + E+ +
Sbjct: 176 RKGGKGLLPVRWMAPESLKDGVFTTSS---DMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 48/220 (21%), Positives = 93/220 (42%), Gaps = 41/220 (18%)
Query: 31 IGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+G+GS+G+V I +VAIK +++ + + I L E +++ +V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVV 72
Query: 86 EIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKA-NDDLTREHHQFF--LYQMLR---- 137
+ ++ + + V+ ELM DL +++ ++ Q L +M++
Sbjct: 73 RLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 138 ---ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY----- 189
+ Y++ HRDL +N + + +K+ DFG+ R ++ TDY
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR--------DIYETDYYRKGG 179
Query: 190 ---VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 226
+ RW L F+ Y+ D+WS G + E+ T
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYS---DVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 81/342 (23%), Positives = 131/342 (38%), Gaps = 64/342 (18%)
Query: 26 KILEVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR-EVKLLRLLRHP 82
++L VIG+G V A TGE V +++I ++ ++ + L+ E+ + +L HP
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRI-NLEACTNEMVTFLQGELHVSKLFNHP 59
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQMLRA 138
+IV + + + +++VV M DL D ++ + L +L+A
Sbjct: 60 NIVPYRATFIADN-----ELWVVTSFMAYGSAKDL-ICTHFMDGMSELAIAYILQGVLKA 113
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS------------DTPMTVFW 186
L Y+H HR +K +IL + + KV GL R S D P
Sbjct: 114 LDYIHHMGYVHRSVKASHILISVDG--KVYLSGL-RSNLSMINHGQRLRVVHDFPKYS-- 168
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
V + +PE+ Y DI+S+G E+ G P K + L+ L
Sbjct: 169 ---VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH--VPFKDMPATQMLLEKL 223
Query: 247 LGT----------PSPETIAVVRNEKARKYLTEMR----------KKPPVPLFQKF-PNV 285
GT P+ E A L E + P + F P+
Sbjct: 224 NGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHF 283
Query: 286 DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327
+ LQR +P RP+A L +FK +I+R S
Sbjct: 284 HHFVEQCLQR----NPDARPSASTLLNHSFFK---QIKRRAS 318
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 6e-04
Identities = 16/42 (38%), Positives = 28/42 (66%)
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
+ Q+L L+ +H + HRD+KP+N+L + ++K+ DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 46/208 (22%), Positives = 89/208 (42%), Gaps = 20/208 (9%)
Query: 31 IGKGSYG-VVCAAIDT-HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
IG G +G V+ +++ +T +V +K++ V + + ++ L E + R L+H ++++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELR-VSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 89 RIMLPPSKREFKDIYVVFELME-SDLH---QVIKANDDLTREHH--QFFLYQMLRALKYM 142
E +V E DL + + + +T + Q ++ L ++
Sbjct: 62 GQC-----TEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H N H DL +N L A+ +K+ D+GL+ + + +V RW APEL
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI-APELVD 175
Query: 203 SFFSKY-----TPAIDIWSIGCIFAEVL 225
T ++WS+G E+
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 78/332 (23%), Positives = 131/332 (39%), Gaps = 70/332 (21%)
Query: 31 IGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR-EVKLLRLLRHPDIVEI 87
IG+G + V A T TG V ++ I D+ + ++ L+ EV L RHP+I+
Sbjct: 6 IGRGFCNLTSVYLARHTPTGTLVTVR-ITDLENCTEEHLKALQNEVVLSHFFRHPNIMTS 64
Query: 88 KRIMLPPSKREFKDIYVVFELME-SDLHQVIKA------NDDLTREHHQFFLYQMLRALK 140
+ S ++V+ M + ++K ++ L L+ LR L
Sbjct: 65 WTVFTTGSW-----LWVISPFMAYGSANSLLKTYFPEGMSEALIGN----ILFGALRGLN 115
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGL------------ARVAFSDTPMTVFWTD 188
Y+H HR++K +IL + + + + GL A+V + D P F T
Sbjct: 116 YLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVY-DFPQ--FSTS 170
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
+ W +PEL Y DI+S+G E+ TG+ P + ++ L+ L G
Sbjct: 171 VLP--WL-SPELLRQDLYGYNVKSDIYSVGITACELATGR--VPFQDMLRTQMLLQKLKG 225
Query: 249 TP-SPETIAVVRNEKAR----------------------KYLTEMRKKPPVPLFQKFPNV 285
P SP I E++R + +T R + P
Sbjct: 226 PPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSS-----KTF 280
Query: 286 DPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
P L++ + DP+ RP+A L+ +FK
Sbjct: 281 SPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 49/203 (24%), Positives = 92/203 (45%), Gaps = 28/203 (13%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
VI +G G G + +K+I+DV ++I E+ + L+HP+IV++
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDV-----NSIP-SSEIADMGKLQHPNIVKLIG 750
Query: 90 IMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH---TA 145
+ R K Y++ E +E +L +V++ +L+ E + + +AL+++H +
Sbjct: 751 LC-----RSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSP 802
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF 205
V +L P+ I+ + + + L + +DT + + Y APE +
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI-------SSAYVAPETRET-- 852
Query: 206 SKYTPAIDIWSIGCIFAEVLTGK 228
T DI+ G I E+LTGK
Sbjct: 853 KDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 556 | |||
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.73 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.67 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.59 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.52 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.4 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.4 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.4 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.19 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.18 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.16 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.15 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.04 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.02 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.98 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.98 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.87 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.85 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.8 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.73 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.46 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.42 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.41 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.37 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.33 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.29 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.11 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.1 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.03 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.01 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.0 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.93 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.89 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.85 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.83 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.77 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.6 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.53 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.52 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.47 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.4 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.37 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.36 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.26 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.03 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.95 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.94 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.92 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.77 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.67 | |
| PLN02236 | 344 | choline kinase | 96.66 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.51 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.44 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.31 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.12 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.51 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.4 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.22 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.09 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.0 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.8 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 94.6 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.15 | |
| PF07914 | 414 | DUF1679: Protein of unknown function (DUF1679); In | 94.14 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.17 |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-76 Score=584.36 Aligned_cols=340 Identities=58% Similarity=0.984 Sum_probs=321.3
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
+....+|..++.||+|+||+|+.|.++.||+.||||++.+.|.+...+++.+||+++|+.++|+||+.+++++.++..+.
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 44556777789999999999999999999999999999999999999999999999999999999999999999888889
Q ss_pred CceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
++++|+|+|+|+.||+++|+.+..+++++++++++|||+||+|+|+.||+||||||+|||++.+|.+||||||+|+....
T Consensus 98 f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 98 FNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred cceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 99999999999999999999998899999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
. ....++++|+.|+||+|||++... ..|+.++||||+||||+|||+|++.|+|.+..+|+..|.+++|+|+++.+..+
T Consensus 178 ~-~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 178 F-FEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred c-CcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 5 566778999999999999998764 78999999999999999999999999999999999999999999999999999
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhH
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEF 338 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~ 338 (556)
.+++++.|+.++....+.++...|+++++.+.|||++||.+||.+|+|++|+|+||||..+..+++||.+++.... +
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~~~~~~~---~ 332 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVCQPIFDS---F 332 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCCCCCCcc---c
Confidence 9999999999999999999999999999999999999999999999999999999999999999999988887543 4
Q ss_pred hhhcCCHHHHHHHHHHHHHhhChhhh
Q 008729 339 ERRRVTKDDIRELIYREILEYHPQLL 364 (556)
Q Consensus 339 ~~~~~~~~~~~~~~~~e~~~~~~~~~ 364 (556)
+.. .+.+++++++|+|+..+++...
T Consensus 333 ~~~-~~~~~~r~~i~~e~~~~~~~~~ 357 (359)
T KOG0660|consen 333 EHE-LTEEELRELIYKEILDFHPDVS 357 (359)
T ss_pred ccc-ccHHHHHHHHHHHHHhhCcccc
Confidence 445 8899999999999999988654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-61 Score=465.96 Aligned_cols=286 Identities=38% Similarity=0.719 Sum_probs=248.5
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|+.+.++|+|+||+||+++++.||+.||||++....++....+-.+|||++|++|+|+|+|.++++| ...+.+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence 479999999999999999999999999999999986655555566678999999999999999999999 667789
Q ss_pred EEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|||||||+-++.+.+... ..++.+.++.+++|++.|+.|||+++++||||||+||||..+|.+||||||+|+......
T Consensus 77 hLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg- 155 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG- 155 (396)
T ss_pred EEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc-
Confidence 999999997766666654 469999999999999999999999999999999999999999999999999999875432
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
..+++|+.|+||+|||++.+. ..|++++|||++||++.||++|.++|+|.++.+|+-.|...+|...+.-...+...
T Consensus 156 --d~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 156 --DNYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred --chhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 346899999999999998774 68999999999999999999999999999999999999999999888766543211
Q ss_pred HHHHHHHHhh---cCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 262 KARKYLTEMR---KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 262 ~~~~~l~~~~---~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.+|..++ -..+.++...+++++..+.||+++||..||.+|++.+|+|.|+||.++.
T Consensus 233 ---~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~ 291 (396)
T KOG0593|consen 233 ---PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI 291 (396)
T ss_pred ---CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence 1122221 1223455667899999999999999999999999999999999997764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-60 Score=450.65 Aligned_cols=286 Identities=42% Similarity=0.710 Sum_probs=250.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
.+|..+++||+|.||+||+|+|..||+.||||+|+.......-....+|||+.|+.++|+||+.++++| .....+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence 589999999999999999999999999999999985433333345678999999999999999999999 566679
Q ss_pred EEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
.||+|||+.||..+|+.+. .++..+++.|+.++++||+|||++.|+||||||.|+|++.+|.+||+|||+|+.+.....
T Consensus 77 ~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9999999999999998754 699999999999999999999999999999999999999999999999999998765543
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
.. +..+.|+||+|||++.|. ..|+..+||||+|||++||+.|.|.|+|.++.+|+..|+..+|+|.++.|..+..-
T Consensus 157 ~~---~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 157 IQ---THQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred cc---ccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 32 344899999999988774 78999999999999999999999999999999999999999999999988765432
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
. .|. ++......+....|+..+.++.||+.+||.+||.+|+|+.|+|+|+||+...
T Consensus 233 p--dY~-~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P 288 (318)
T KOG0659|consen 233 P--DYV-KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP 288 (318)
T ss_pred c--cHH-HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence 2 111 1223344445568899999999999999999999999999999999999743
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-60 Score=494.41 Aligned_cols=348 Identities=24% Similarity=0.391 Sum_probs=291.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.+-|++++.||+|+.|.|.+|+|..||+.+|||+|.+.. ........+.+||-||+.|.||||+.+|+++ ++..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCc
Confidence 347999999999999999999999999999999998652 2334566789999999999999999999999 7778
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
++|+|.||+. |.|++++...|++++.++.++|+||+.||.|||..+||||||||+|+|+|.++++||+|||+|.....+
T Consensus 86 ~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 8999999999 799999999999999999999999999999999999999999999999999999999999999886554
Q ss_pred CCCcceecccccCcccCCcccccccCCCCC-CcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~-~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
. .+.+.||+++|.|||++.| .+|+ .++||||+|||||.||+|+.||++.+....+.++.
T Consensus 166 k----lLeTSCGSPHYA~PEIV~G--~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~-------------- 225 (786)
T KOG0588|consen 166 K----LLETSCGSPHYAAPEIVSG--RPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQ-------------- 225 (786)
T ss_pred c----cccccCCCcccCCchhhcC--CCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHH--------------
Confidence 4 3467899999999999998 6775 89999999999999999999999877544444332
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCC--Ccchh
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPI--SKLEF 336 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~--~~~~~ 336 (556)
...++...++++++++||++||.+||.+|+|.+||++|||+.+...........+. .....
T Consensus 226 -----------------~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~~~~i~s 288 (786)
T KOG0588|consen 226 -----------------RGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPPVSVPILS 288 (786)
T ss_pred -----------------cCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcCCCcccceee
Confidence 22344556899999999999999999999999999999999987544322111111 11111
Q ss_pred hHhhhcCCHHHHHHHHHHHHHhhChhhhhhhhcCCCCccccChhHHHHHHHHHHHHhhcCCC-----CCCCCCCCCCccC
Q 008729 337 EFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGR-----SGPVIPPERKHVS 411 (556)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~f~~~~~~~~~-----~~~~~~~~~~~~~ 411 (556)
......++.+.++.+...-+......+..++++...+.+++.+..+.+++++...-+..... .+.++++|||.++
T Consensus 289 ~ps~~~IDp~Il~~l~iLwc~~d~~kl~~kLls~~~n~EK~~Y~LLl~~k~r~~~~~~~~~~~kk~~~~s~~~~p~k~~~ 368 (786)
T KOG0588|consen 289 IPSIQEIDPLILQHLCILWCGRDPEKLVEKLLSPDDNDEKTLYFLLLRRKRRDSSQLDDFDENKKDLLGSAADPPRKRVD 368 (786)
T ss_pred cCCcccCCHHHHhhhhheeecCChHHHHHHHcCCCcchhHHHHHHHHHhhccchhhhhhhhhhhhhhhccccCCchhhhh
Confidence 22345678888888887778888888889999999999999999999999877664443222 3478899999999
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-58 Score=478.33 Aligned_cols=338 Identities=89% Similarity=1.434 Sum_probs=307.6
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
+|++.++||+|+||.||+|++..+|+.||||++...........++.+|+.+|+.++||||+++++++..........+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999999976555555667889999999999999999999998766555667899
Q ss_pred EEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCc
Q 008729 104 VVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (556)
Q Consensus 104 lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 183 (556)
+|||||+++|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 160 (338)
T cd07859 81 VVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTA 160 (338)
T ss_pred EEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCcc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999998654443333
Q ss_pred ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHH
Q 008729 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (556)
Q Consensus 184 ~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~ 263 (556)
..+...+||++|+|||++.+....++.++|||||||++|+|++|++||.+.+...++..+.+.+|.|..+.+..+.+...
T Consensus 161 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 240 (338)
T cd07859 161 IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKA 240 (338)
T ss_pred ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhH
Confidence 44566789999999999876435789999999999999999999999999999999999999999999999999998888
Q ss_pred HHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhHhhhcC
Q 008729 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRV 343 (556)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~~~~~~ 343 (556)
..++..+....+.++...++.+++.+.+||.+||..||++|||++++|+||||+++...+..+..++++..++.++++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (338)
T cd07859 241 RRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRL 320 (338)
T ss_pred HHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccccccccCccccccccHHHHhc
Confidence 88888888888888777888899999999999999999999999999999999999888888899999999999999999
Q ss_pred CHHHHHHHHHHHHHhhCh
Q 008729 344 TKDDIRELIYREILEYHP 361 (556)
Q Consensus 344 ~~~~~~~~~~~e~~~~~~ 361 (556)
+.++++..+++++++|||
T Consensus 321 ~~~~~~~~~~~~~~~~~~ 338 (338)
T cd07859 321 TKEDVRELIYREILEYHP 338 (338)
T ss_pred CHHHHHHHHHHHHHhcCC
Confidence 999999999999999886
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-60 Score=482.41 Aligned_cols=289 Identities=38% Similarity=0.679 Sum_probs=252.3
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~ 99 (556)
..+||.++++||-|.||.||+|..+.+|+.||||++++.+....+..+ +||++.|++|+ ||||++|++++.+ .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n-LREvksL~kln~hpniikL~Evi~d----~~ 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN-LREVKSLRKLNPHPNIIKLKEVIRD----ND 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH-HHHHHHHHhcCCCCcchhhHHHhhc----cC
Confidence 446999999999999999999999999999999999987766555544 59999999998 9999999999943 33
Q ss_pred ceEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
..+|+|||||+.+|+++++.+ ..|++..++.|++||+.||+|+|.+|++||||||+|||+..+..|||+|||+||...+
T Consensus 83 ~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 83 RILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred ceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 389999999999999999875 4699999999999999999999999999999999999999888999999999998655
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.. .+++|+.|+||+|||+++.- ..|+.++|||++|||++|+.+-+++|+|.++.+++.+|.+++|+|..+.+...
T Consensus 163 kp----PYTeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 163 KP----PYTEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred CC----CcchhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 44 46899999999999998763 67999999999999999999999999999999999999999999998877643
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
. ..++..--......+.++....++++.++.+||.+||.+||++||||+|+|+||||+.-.
T Consensus 238 ~-~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 238 Y-NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred H-HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 1 112222122334555667778889999999999999999999999999999999998643
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-59 Score=457.06 Aligned_cols=289 Identities=40% Similarity=0.630 Sum_probs=252.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
+.|+.+..|++|.||+||+|+|+.|++.||+|+++...+...--..-+|||++|.+++|||||.+.++.... +.+.+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~---~~d~i 152 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS---NMDKI 152 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc---cccee
Confidence 579999999999999999999999999999999986554444455678999999999999999999998653 34569
Q ss_pred EEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|||||||+.||..++...+ ++...+++.++.|+|+||+|||.+.|+||||||+|+|++..|.+||+|||+||.+.+...
T Consensus 153 y~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 153 YIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred eeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 9999999999999998865 899999999999999999999999999999999999999999999999999998765532
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
.++..+.|.||+|||++.+. ..|+.++|+||+|||+.||++++|.|+|.+..+|+++|++++|+|+...|..+...
T Consensus 233 ---~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 233 ---PYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred ---cCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 35788999999999998875 67999999999999999999999999999999999999999999999998877655
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCC--CCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPN--VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~--~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.+.+.+. ........+...|+. ++....+|++.+|.+||++|.||+|+|+|.||...
T Consensus 309 p~~k~~~-f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 309 PAVKKMT-FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred chhhccc-cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 4443222 222333344445554 45999999999999999999999999999999874
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-59 Score=469.17 Aligned_cols=261 Identities=34% Similarity=0.567 Sum_probs=222.5
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCCh-----hHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-----SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~-----~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
+.|.+.+.||+|+||.|.+|.++.||+.||||++++..... .....+.+|++||++|+|||||+++++| +
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f-----~ 246 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF-----E 246 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-----e
Confidence 47999999999999999999999999999999997543221 1334567999999999999999999999 5
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC---CceEEeeeCcc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFGLA 173 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~vKL~DFGla 173 (556)
.....||||||++ |+|++.+.+++.+.+..-+.+++|||.||+|||++||+||||||+|||++.+ +.+||+|||+|
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 6667899999999 6999999999999999999999999999999999999999999999999766 88999999999
Q ss_pred ccccCCCCCcceecccccCcccCCcccccccCCCCC-CcchhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhhCCCC
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLITDLLGTPS 251 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~-~~~DIWSlG~ilyelltG~~pF~~~~~~~-~~~~i~~~~g~p~ 251 (556)
+.... ..++.+.|||+.|.|||++.+....+. .++||||||||||-+|+|.+||.+..... ..++|
T Consensus 327 K~~g~----~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI-------- 394 (475)
T KOG0615|consen 327 KVSGE----GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI-------- 394 (475)
T ss_pred hcccc----ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH--------
Confidence 98653 336688999999999999976433333 58999999999999999999998765433 33333
Q ss_pred hHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.+....-....|..++.++++||.+||..||++|||++|+|+||||+..
T Consensus 395 -------------------~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 395 -------------------LKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred -------------------hcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 2222222335667899999999999999999999999999999999853
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-59 Score=476.74 Aligned_cols=287 Identities=37% Similarity=0.627 Sum_probs=247.2
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
..|+.+++||+|.||.||+|++..||+.||+|++..............|||.||++|+||||++|.++.... ....+
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~si 193 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGSI 193 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCceE
Confidence 568999999999999999999999999999999986555566677788999999999999999999998643 34679
Q ss_pred EEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|||||||+.||.-++...+ .|++.+++.|++||+.||.|||++||+|||||.+|||||.+|.+||+|||||+++.....
T Consensus 194 YlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 194 YLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 9999999999999998743 799999999999999999999999999999999999999999999999999998765443
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
. .++..+.|.||+|||+++|. ..|+.++|+||+||||.||++|++.|+|.++++|+..|.+++|+|.++.|....-+
T Consensus 274 ~--~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 274 A--PYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred c--ccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 3 36889999999999998885 78999999999999999999999999999999999999999999999987722211
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
.+..+ +. .......+.+.+..++..+.+|+..||..||.+|.||.++|+|+||.
T Consensus 351 ~~~~~-kp-~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 351 HATIF-KP-QQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred ccccc-CC-CCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 11100 00 00001123345678999999999999999999999999999999995
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-56 Score=469.04 Aligned_cols=259 Identities=32% Similarity=0.566 Sum_probs=233.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecC-ccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD-VFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~-~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.+|+..+.||+|||+.||.+++..+|+.||+|++.+ .........++.+||+|.+.|+|||||+++++| ++.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence 689999999999999999999999999999999964 344556778899999999999999999999999 88889
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|||+|+|. ++|..+++.++.++|.++++|++||+.||.|||+.+|+|||||..|||++++.+|||+|||||.....+.
T Consensus 93 VYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred eEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999 8999999999999999999999999999999999999999999999999999999999999998876543
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
... .+.||||.|.|||++.. .+++..+||||+|||||.||.|+|||..++..+.+.+|..
T Consensus 173 Erk---~TlCGTPNYIAPEVl~k--~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~--------------- 232 (592)
T KOG0575|consen 173 ERK---KTLCGTPNYIAPEVLNK--SGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL--------------- 232 (592)
T ss_pred ccc---ceecCCCcccChhHhcc--CCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh---------------
Confidence 332 57899999999999987 8999999999999999999999999999998888887743
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 322 (556)
.. ......++.+|+|||++||..||.+|||++++|.|+||+....+
T Consensus 233 -----------~~-----Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p 278 (592)
T KOG0575|consen 233 -----------NE-----YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTP 278 (592)
T ss_pred -----------cC-----cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcC
Confidence 11 11224689999999999999999999999999999999644333
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-55 Score=437.11 Aligned_cols=259 Identities=32% Similarity=0.545 Sum_probs=229.9
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
..+.|+++++||+|+||+||+++.+.|++.||+|++++.. -...+...+.+|.+||..++||+||+++..| ++.
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~ 97 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTE 97 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccC
Confidence 4568999999999999999999999999999999997542 2224677899999999999999999999999 666
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
..+|||+||+. |+|+.+|...+.+++..+++|+.+|+.||.|||++||+||||||+|||+|.+|+++|+|||+|+....
T Consensus 98 ~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred CeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 77999999999 59999999999999999999999999999999999999999999999999999999999999987554
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
....+ .++|||+.|||||++.+ .+|+.++|+|||||++|+||+|.+||.+.+.....+.|...
T Consensus 178 ~~~~t---~tfcGT~eYmAPEil~~--~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~------------ 240 (357)
T KOG0598|consen 178 DGDAT---RTFCGTPEYMAPEILLG--KGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG------------ 240 (357)
T ss_pred CCCcc---ccccCCccccChHHHhc--CCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC------------
Confidence 43332 56899999999999998 79999999999999999999999999999988887777431
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCC-CCHHHHHHHHHhhhcCCCCCC----CHHHHHhCccccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRP----TAEEALADPYFKGLA 320 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~-~s~~~~dLl~~~L~~dP~~Rp----ta~elL~hp~f~~~~ 320 (556)
+ . ...+. ++.++++||+++|..||++|. +++++-+||||.++.
T Consensus 241 --------------k----~-~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 241 --------------K----L-PLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred --------------c----C-CCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 1 0 11233 899999999999999999995 689999999999875
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-56 Score=438.83 Aligned_cols=285 Identities=38% Similarity=0.659 Sum_probs=243.6
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
.|.-.+++|.|+||+||+|....+++.||||++-.. ..--.+|+.||+.++|||||++..+|......+.-++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d------~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD------KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC------CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 588999999999999999999999999999987421 11123799999999999999999998765433345677
Q ss_pred EEEecCcccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC-CceEEeeeCccccccC
Q 008729 104 VVFELMESDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAFS 178 (556)
Q Consensus 104 lV~E~~~g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~vKL~DFGla~~~~~ 178 (556)
+|||||+.+|.++++. +..++.-+++.+++||++||+|||+.||+||||||+|||+|.+ |.+||||||.|+....
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 8999999999999984 6789999999999999999999999999999999999999976 8999999999998766
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
..+. ..|..|++|+|||++.|. ..|+.++||||.||+++||+-|++.|+|.+..+|+..|.+++|+|+.+.+..+
T Consensus 179 ~epn----iSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 179 GEPN----ISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred CCCc----eeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 6554 578899999999998875 78999999999999999999999999999999999999999999999999876
Q ss_pred hhHHHHHHHHHhhcCCCCCcCC-CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQ-KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~-~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 322 (556)
.......-+. .....++.. .....++++.||+.++|.++|.+|.++.|+|.||||..+...
T Consensus 254 n~~y~~~~~p---~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 254 NPNYTEFKFP---QIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CcccccccCc---ccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 5443211111 112222222 345789999999999999999999999999999999987654
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-54 Score=430.45 Aligned_cols=292 Identities=39% Similarity=0.662 Sum_probs=245.5
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC-cceeeEEEcCCCC-CCCc
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD-IVEIKRIMLPPSK-REFK 100 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn-Iv~l~~v~~~~~~-~~~~ 100 (556)
..|..+++||+|.||+||+|+++.+|+.||+|++.-....+.......||+.+|+.|+|+| ||.+++++..... +...
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4588889999999999999999999999999999865443333445689999999999999 9999999975431 3344
Q ss_pred eEEEEEecCcccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 101 DIYVVFELMESDLHQVIKAND----DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~----~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
.+|+||||++.||..++.... .++...++.+++||+.||+|||++||+||||||+||||+.+|.+||+|||+|+..
T Consensus 91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHh
Confidence 799999999999999998755 5788899999999999999999999999999999999999999999999999964
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
.-... .++..++|.||+|||++.+. ..|+..+||||+|||++||++++++|+|.++.+++..|.+++|+|+.+.|+
T Consensus 171 ~ip~~---~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 171 SIPMR---TYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred cCCcc---cccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 32222 24677899999999998874 479999999999999999999999999999999999999999999998887
Q ss_pred HhhhHHHHHHHHHhhcCC-CCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 257 VVRNEKARKYLTEMRKKP-PVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.+..-...+. ...... +.++....++.++++.||+.+||+.||.+|.|++.+|.||||..+.
T Consensus 247 ~v~~~~~~k~--~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 247 GVSSLPDYKA--PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred Cccccccccc--cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 5432111110 111111 3444455667778999999999999999999999999999998763
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-53 Score=424.28 Aligned_cols=259 Identities=27% Similarity=0.473 Sum_probs=221.2
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
.+.+.++.||+|..|+||+|+|+.|++.+|+|+|.. ..+......+.+|++||+.++||+||++|++|.... ..+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~----~~i 153 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG----EEI 153 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC----ceE
Confidence 367788999999999999999999999999999953 344566778999999999999999999999995432 159
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|+||||+ |+|.++++..+++++.....++++|++||.|||. .+|+||||||+|||++..|.|||||||.+....+.
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999 7999999998999999999999999999999996 89999999999999999999999999999876544
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHhhCCCChHHHHHh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK--SVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~--~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
...+++||..|||||.+.+ ..|+.++||||||++++||.+|+.||... .....++.+......|++
T Consensus 233 ----~a~tfvGT~~YMsPERi~g--~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP------ 300 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISG--ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP------ 300 (364)
T ss_pred ----hcccccccccccChhhhcC--CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC------
Confidence 3478899999999999998 79999999999999999999999999774 222333333222222211
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCC-CCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~-~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
. ... .+++++++||..||++||.+|||+.|+|+|||+++..
T Consensus 301 ------------------~---lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 301 ------------------R---LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred ------------------C---CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 1 112 3899999999999999999999999999999998653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-53 Score=435.28 Aligned_cols=263 Identities=30% Similarity=0.518 Sum_probs=229.1
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~ 98 (556)
..++|++++.||.|+|++|++|+++.+++.||||++.+..- .+....-+.+|-.+|.+| .||.|++|+..| .+
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----QD 145 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----QD 145 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----ec
Confidence 34689999999999999999999999999999999875321 222233466899999999 799999999999 56
Q ss_pred CceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
...+|+|+||+. |+|.++|++-|.|++..+++++.||+.||.|||++|||||||||+|||+|.||++||+|||.|+...
T Consensus 146 ~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 146 EESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 667999999999 8999999999999999999999999999999999999999999999999999999999999998753
Q ss_pred CCCCC----------cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 008729 178 SDTPM----------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (556)
Q Consensus 178 ~~~~~----------~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~ 247 (556)
..... ......++||..|.+||++.. ...++.+|||+||||||.|+.|.+||.+.+....+++|+++.
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~ 303 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--SPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD 303 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcC--CCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence 22111 111256899999999999988 678899999999999999999999999999998888886632
Q ss_pred CCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccc
Q 008729 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (556)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~ 321 (556)
- ...+++++.++|||+++|..||.+|+|+++|-+||||.++..
T Consensus 304 y-------------------------------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 304 Y-------------------------------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred c-------------------------------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 1 223568899999999999999999999999999999998753
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-52 Score=440.55 Aligned_cols=281 Identities=37% Similarity=0.649 Sum_probs=236.4
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CC-----CcceeeEEEcCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HP-----DIVEIKRIMLPPSK 96 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-Hp-----nIv~l~~v~~~~~~ 96 (556)
.||.|+++||+|.||.|.+|.|..|++.||||++++ +.........|++||..|+ |. |||+++++|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN---~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F----- 257 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN---KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF----- 257 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeecc---ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----
Confidence 489999999999999999999999999999999984 3344556678999999997 43 799999999
Q ss_pred CCCceEEEEEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC--CCceEEeeeCc
Q 008729 97 REFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA--NCKLKVCDFGL 172 (556)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~--~~~vKL~DFGl 172 (556)
...+++|||+|+++.+|+++|+.+. .++...++.|+.|||.||.+||..||||+|||||||||.. .+.|||+|||.
T Consensus 258 ~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGS 337 (586)
T KOG0667|consen 258 YFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGS 337 (586)
T ss_pred ccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccc
Confidence 5557799999999999999999874 6899999999999999999999999999999999999964 35799999999
Q ss_pred cccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
|+..... . ..|+.+++|+|||++.| ..|+.++||||||||++||++|.|+|+|.+..+|+..|++++|.|+.
T Consensus 338 Sc~~~q~-----v-ytYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~ 409 (586)
T KOG0667|consen 338 SCFESQR-----V-YTYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPP 409 (586)
T ss_pred ccccCCc-----c-eeeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCH
Confidence 9864321 2 37899999999999999 79999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhhHHHHHHHHH----------------------------hhcCCCCC-----cCCCCC-CCCHHHHHHHHHhhh
Q 008729 253 ETIAVVRNEKARKYLTE----------------------------MRKKPPVP-----LFQKFP-NVDPLALRLLQRLIA 298 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~----------------------------~~~~~~~~-----~~~~~~-~~s~~~~dLl~~~L~ 298 (556)
.++...... ..|+++ .......| +..... .-...+.|||++||+
T Consensus 410 ~mL~~~~~~--~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~ 487 (586)
T KOG0667|consen 410 KMLDTAKKA--HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLE 487 (586)
T ss_pred HHHHhcccc--ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhc
Confidence 988754322 222222 22222222 111222 234567999999999
Q ss_pred cCCCCCCCHHHHHhCcccccccc
Q 008729 299 FDPKDRPTAEEALADPYFKGLAK 321 (556)
Q Consensus 299 ~dP~~Rpta~elL~hp~f~~~~~ 321 (556)
+||.+|+|+.++|+||||.+...
T Consensus 488 ~dP~~R~tp~qal~Hpfl~~~~~ 510 (586)
T KOG0667|consen 488 WDPAERITPAQALNHPFLTGTSL 510 (586)
T ss_pred cCchhcCCHHHHhcCcccccccc
Confidence 99999999999999999997543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-52 Score=417.04 Aligned_cols=259 Identities=32% Similarity=0.512 Sum_probs=223.2
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
...+|.+.+.||+|+||+||+|+++.++..||||.|.+.....+....+..||+||+.++|||||.+++++ ...+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence 44689999999999999999999999999999999986544666777788999999999999999999999 5556
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC------CceEEeeeCcc
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN------CKLKVCDFGLA 173 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~------~~vKL~DFGla 173 (556)
++|||||||+ |||.++|++.+.+++..++.++.||+.||++||+++||||||||+|||++.. -.+||+|||+|
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 7999999999 7999999999999999999999999999999999999999999999999765 45999999999
Q ss_pred ccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
+...... ...+.||++.|||||++.. ..|+.|+|+||+|+|||+|++|++||...+..+.+..|..
T Consensus 163 R~L~~~~----~a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k-------- 228 (429)
T KOG0595|consen 163 RFLQPGS----MAETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKK-------- 228 (429)
T ss_pred hhCCchh----HHHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc--------
Confidence 9875433 2357889999999999976 7999999999999999999999999999887665543321
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
- ....+.. ...++....+|+..+|..++..|.+..+-+.|+++..
T Consensus 229 ----------------~--~~~~~~~--~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 229 ----------------G--NEIVPVL--PAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAA 273 (429)
T ss_pred ----------------c--ccccCch--hhhccCchhhhhhHHHhcCccccCchHHhhhhhhccc
Confidence 1 1111111 1235666779999999999999999999999999875
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=407.65 Aligned_cols=332 Identities=37% Similarity=0.663 Sum_probs=283.9
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC-CCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KRE 98 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~ 98 (556)
....||.-++.+|.|+- .|..|.|..+++.||+|++...+.+...+.+..||+.++..+.|+||++++.+|.+.. .+.
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 34679999999999999 8999999999999999999888888888899999999999999999999999997643 356
Q ss_pred CceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
+.++|+|||+|..+|.+++. -.+.-+.++++++|++.|++|||++||+||||||+||+++.+|.+||+|||+|+....
T Consensus 93 ~~e~y~v~e~m~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 93 FQEVYLVMELMDANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HHhHHHHHHhhhhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence 77899999999999999998 4578899999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
+ ..+++|+.|++|+|||++.+ ..|...+||||+|||+.||++|+..|+|.+..++..+|.+.+|+|.+..+...
T Consensus 171 ~----~~mtpyVvtRyyrapevil~--~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 171 D----FMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred c----cccCchhheeeccCchheec--cCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 3 34589999999999999988 56999999999999999999999999999999999999999999999988765
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCC------------CCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCC
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPN------------VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~------------~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~ 326 (556)
. +.++.|+..+.+.....+...+|+ -...++||+.+||..||++|.+++++|+||||+ ++-.+.++
T Consensus 245 ~-~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~-vw~~~~ev 322 (369)
T KOG0665|consen 245 Q-PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK-VWYDPDEV 322 (369)
T ss_pred h-HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee-eecccccc
Confidence 4 345555554444444444444432 245789999999999999999999999999999 33334444
Q ss_pred CCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhChh
Q 008729 327 SCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362 (556)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~ 362 (556)
..++....+..++.+..+.++++++|++|+.+|.+.
T Consensus 323 ~ap~pe~~d~~~d~~~~t~~e~ke~If~ev~~f~~~ 358 (369)
T KOG0665|consen 323 EAPPPEIYDKQLDEREHTIEEWKELIFKEVQRFEEF 358 (369)
T ss_pred cCCCCchhhhhcccccCCHHHHHHHHHHHHHhhccc
Confidence 444444455667778888999999999999988763
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-52 Score=400.60 Aligned_cols=255 Identities=27% Similarity=0.497 Sum_probs=227.9
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|++++.||.|+||.|.+++++.+|..||+|++++. .-.........+|..+|+.+.||+++++++.+ .+..
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDNS 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccCC
Confidence 45899999999999999999999999999999998742 22345667788999999999999999999998 6777
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
++||||||.+ |.|+.++++.+++++.++++++.||+.||.|||+++|++|||||+|||+|.+|.+||+|||+|+.....
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 8999999999 699999999999999999999999999999999999999999999999999999999999999876443
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
+ .+.||||.|+|||++.. .+|+.++|+|||||++|||+.|.+||.+.+.....++|.+
T Consensus 198 T------~TlCGTPeYLAPEii~s--k~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~-------------- 255 (355)
T KOG0616|consen 198 T------WTLCGTPEYLAPEIIQS--KGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE-------------- 255 (355)
T ss_pred E------EEecCCccccChHHhhc--CCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh--------------
Confidence 2 56789999999999998 8999999999999999999999999999998888887743
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
.+.. ..+.++++++|||+++|+.|-.+|. ..++|-+||||+++.
T Consensus 256 ------------~~v~-----fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 256 ------------GKVK-----FPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred ------------Cccc-----CCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 1111 1245899999999999999999993 578999999999864
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=429.36 Aligned_cols=257 Identities=32% Similarity=0.511 Sum_probs=220.8
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC--C-hhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--H-ISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~--~-~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~ 96 (556)
..++|.+++.||+|+||+|++|.+..+|..||+|++++... . ......+.||+.+++.+. ||||+++++++.
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~---- 90 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA---- 90 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe----
Confidence 34689999999999999999999999999999997765311 1 234556779999999999 999999999994
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC-CceEEeeeCccc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLAR 174 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~vKL~DFGla~ 174 (556)
....+|+|||||. |+|+++|...+++.+.+++.+|+||+.||+|||+.||+||||||+|||++.+ +++||+|||++.
T Consensus 91 -t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 91 -TPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred -cCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 4455999999999 5999999999999999999999999999999999999999999999999999 999999999998
Q ss_pred cccCCCCCcceecccccCcccCCcccccccCCC-CC-CcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK-YT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-y~-~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
... .......+.|||+.|+|||++.+ .. |+ .++||||||||||.|++|+.||...+.......|..
T Consensus 170 ~~~---~~~~~l~t~cGsp~Y~aPEvl~~--~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~------- 237 (370)
T KOG0583|consen 170 ISP---GEDGLLKTFCGSPAYAAPEVLSG--KGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRK------- 237 (370)
T ss_pred ccC---CCCCcccCCCCCcccCCHHHhCC--CCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhc-------
Confidence 763 12234578899999999999988 45 75 899999999999999999999999776655554421
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCC-CHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV-DPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~-s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
... .....+ ++++.+||++||..||.+|+|+.++++||||+.
T Consensus 238 -------------------~~~-----~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 -------------------GEF-----KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -------------------CCc-----cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 111 122335 999999999999999999999999999999985
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=420.20 Aligned_cols=335 Identities=54% Similarity=0.989 Sum_probs=288.8
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++.+.||+|+||+||+|.+..+++.||||++............+.+|+.+|+.++|+||+++++++.........
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 45689999999999999999999999999999999876544445566788999999999999999999988655444556
Q ss_pred eEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 101 DIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
.+|+|+||++++|.+++..++.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 83 DVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred cEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 79999999999999999988899999999999999999999999999999999999999999999999999997653321
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
.....+.++..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....|.+.++.+..+..
T Consensus 163 ---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 163 ---DFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred ---ccccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 123456789999999987642 3588999999999999999999999999999999999999999999988877777
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhHhh
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFER 340 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~~~ 340 (556)
...+.++..+.......+...++.+++.+.+||++||+.||++|||++++|+||||..+.....++..+. .+.+.|+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~~~~~~~--~~~~~~~~ 316 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSDEPVCQT--PFSFDFEE 316 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcccCccCCC--ccchhhhh
Confidence 7777777766555444444556789999999999999999999999999999999998876665655543 55777888
Q ss_pred hcCCHHHHHHHHHHHHHhhCh
Q 008729 341 RRVTKDDIRELIYREILEYHP 361 (556)
Q Consensus 341 ~~~~~~~~~~~~~~e~~~~~~ 361 (556)
...+++++++.++.|.+.|||
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~ 337 (337)
T cd07858 317 DALTEEDIKELIYNEMLAYHP 337 (337)
T ss_pred hhcCHHHHHHHHHHHHhhcCC
Confidence 889999999999999999886
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-53 Score=399.05 Aligned_cols=259 Identities=31% Similarity=0.496 Sum_probs=228.0
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.+.|.+.++||+|.|++|+++.+..||+.+|+|+|+.......+...+.+|+.|-+.|+||||+++.+.+ .....
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccce
Confidence 3579999999999999999999999999999999975544555788899999999999999999999988 66677
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC---CceEEeeeCcccccc
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFGLARVAF 177 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~vKL~DFGla~~~~ 177 (556)
.|||||+|. ++|..-|.++.-+++..+..+++|||+||.|||.+||||||+||+|+|+-.. .-|||+|||+|....
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999999 5998888877788999999999999999999999999999999999998543 459999999998765
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
....|.+++|||.|||||++.. ..|+..+|||++|||||.||.|.+||.+.+..+..+.|...
T Consensus 165 ----~g~~~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g----------- 227 (355)
T KOG0033|consen 165 ----DGEAWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG----------- 227 (355)
T ss_pred ----CccccccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc-----------
Confidence 2335788999999999999988 89999999999999999999999999998887777776431
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
...-....|+++++++++||++||..||.+|+|+.|+|+|||+.+
T Consensus 228 ----------------~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 228 ----------------AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred ----------------ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 111112367899999999999999999999999999999999975
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-52 Score=402.11 Aligned_cols=259 Identities=32% Similarity=0.485 Sum_probs=218.8
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeE-EEcCCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR-IMLPPSKR 97 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~-v~~~~~~~ 97 (556)
......|+|+++||+|+||.||+|.+..+|+.||+|.|+-...+......+..|+.+|++|+|||||++++ .|. +
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~----~ 90 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI----E 90 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh----c
Confidence 33445799999999999999999999999999999999854455666778999999999999999999998 331 3
Q ss_pred CCceEEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeccCCCCcEeecCCCceEEe
Q 008729 98 EFKDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHT--AN--VYHRDLKPKNILANANCKLKVC 168 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs--~g--IvHrDLKP~NILl~~~~~vKL~ 168 (556)
+..-++||||||+ |||.++|+. +..+++..++.++.|+|.||.+||+ .. |+||||||.||+++.+|.|||+
T Consensus 91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLG 170 (375)
T KOG0591|consen 91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLG 170 (375)
T ss_pred cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeec
Confidence 4445999999999 899999964 4579999999999999999999999 44 9999999999999999999999
Q ss_pred eeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC
Q 008729 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (556)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g 248 (556)
|||+++..... ..+.++++|||+||+||++.+ .+|++++|||||||++|||+.-++||.|.+-.....+|.+.--
T Consensus 171 DfGL~r~l~s~---~tfA~S~VGTPyYMSPE~i~~--~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 171 DFGLGRFLSSK---TTFAHSLVGTPYYMSPERIHE--SGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDY 245 (375)
T ss_pred cchhHhHhcch---hHHHHhhcCCCcccCHHHHhc--CCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCC
Confidence 99999987544 345578999999999999988 8999999999999999999999999999987666666643211
Q ss_pred CCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.|-+. ...|.++..||..|+..||..||+. +|++..+.
T Consensus 246 ~~~p~-----------------------------~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~ 283 (375)
T KOG0591|consen 246 PPLPD-----------------------------EHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ 283 (375)
T ss_pred CCCcH-----------------------------HHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence 11110 1367889999999999999999986 66665543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-51 Score=419.67 Aligned_cols=265 Identities=29% Similarity=0.479 Sum_probs=226.3
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|+++++||+|+||.||+|+.+.||+.||+|++++.. ........++.|-.||...++|.||+||..| ++..
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~~ 214 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDKE 214 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCCC
Confidence 468999999999999999999999999999999998642 2334567889999999999999999999999 7778
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC-
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS- 178 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~- 178 (556)
++||||||+. ||+..+|...+.|+++++++++.+++.|+.-||..|+|||||||+|+|||..|++||+||||+.-...
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 8999999999 69999999999999999999999999999999999999999999999999999999999999843211
Q ss_pred ----------------------CCCC-----c----------------ceecccccCcccCCcccccccCCCCCCcchhh
Q 008729 179 ----------------------DTPM-----T----------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 215 (556)
Q Consensus 179 ----------------------~~~~-----~----------------~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIW 215 (556)
+... . ......+|||.|+|||++.+ .+|+..+|+|
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--kgY~~~cDwW 372 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--KGYGKECDWW 372 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--CCCCccccHH
Confidence 0000 0 00134689999999999998 7899999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHH
Q 008729 216 SIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQR 295 (556)
Q Consensus 216 SlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~ 295 (556)
|||||+||||.|.|||.+.+..+...+|... +... ..| .-..++++++|||.+
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nw---------------------r~~l---~fP---~~~~~s~eA~DLI~r 425 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNW---------------------RETL---KFP---EEVDLSDEAKDLITR 425 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH---------------------hhhc---cCC---CcCcccHHHHHHHHH
Confidence 9999999999999999999998888777541 1111 111 112467999999999
Q ss_pred hhhcCCCCCCC---HHHHHhCcccccccc
Q 008729 296 LIAFDPKDRPT---AEEALADPYFKGLAK 321 (556)
Q Consensus 296 ~L~~dP~~Rpt---a~elL~hp~f~~~~~ 321 (556)
||. ||++|.. ++||-+||||+++..
T Consensus 426 ll~-d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 426 LLC-DPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred Hhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence 999 9999975 999999999998753
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=398.31 Aligned_cols=293 Identities=38% Similarity=0.639 Sum_probs=238.3
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCc----EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
+...|++++.||+|.||.||+|..+.++. .||||+++.......-.....||+.+++.|+||||+.+..+|+..
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-- 99 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH-- 99 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc--
Confidence 34479999999999999999997665543 689999875433223344567999999999999999999999743
Q ss_pred CCCceEEEEEecCcccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC----CceEE
Q 008729 97 REFKDIYVVFELMESDLHQVIKAN-----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN----CKLKV 167 (556)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~-----~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~----~~vKL 167 (556)
.+.+|+++||.+.||+++|+-+ ..++...++.|++|||.|+.|||++.|+||||||.|||+..+ |.|||
T Consensus 100 --d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 100 --DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred --CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence 5679999999999999999743 368999999999999999999999999999999999999877 89999
Q ss_pred eeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCC---------hHH
Q 008729 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS---------VVH 238 (556)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~---------~~~ 238 (556)
+|||+|+.+.+.-..-......+.|.||+|||++.|. ..|++++|||++|||+.|||+-.|.|.+.. ..+
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 9999999876544332223457899999999998875 789999999999999999999999997743 467
Q ss_pred HHHHHHHhhCCCChHHHHHhhhHH-HHHHHHHhhcCCCCC-----cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 239 QLDLITDLLGTPSPETIAVVRNEK-ARKYLTEMRKKPPVP-----LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 239 ~~~~i~~~~g~p~~e~i~~~~~~~-~~~~l~~~~~~~~~~-----~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
|+++|++++|+|+.+.|..+.+-. ....+...+.....+ +......-++.+.+||.+||..||.+|+|++++|+
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 999999999999999887665422 223333333222222 22333445667999999999999999999999999
Q ss_pred Cccccc
Q 008729 313 DPYFKG 318 (556)
Q Consensus 313 hp~f~~ 318 (556)
|+||..
T Consensus 337 h~yF~~ 342 (438)
T KOG0666|consen 337 HPYFTE 342 (438)
T ss_pred cccccc
Confidence 999985
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-51 Score=420.86 Aligned_cols=256 Identities=34% Similarity=0.573 Sum_probs=231.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|.+.+.||+|+||.||+|+.+.|.+.||||.+.+.....++...+.+|++|++.|+|||||.+++.| +...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 589999999999999999999999999999999998888888999999999999999999999999999 777889
Q ss_pred EEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCC
Q 008729 103 YVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (556)
Q Consensus 103 ylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 182 (556)
|+|.|||.|+|+.++...+.++++.++.|.++++.||.|||+++|+|||+||.|||++.+|.+|+||||+|+.... .
T Consensus 77 ~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~---~ 153 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST---N 153 (808)
T ss_pred EEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc---C
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999997644 3
Q ss_pred cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHH
Q 008729 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (556)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~ 262 (556)
+...+..-|||.|||||+..+ ..|+..+|+||||||+|||..|+|||...+..+....|.
T Consensus 154 t~vltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~------------------ 213 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL------------------ 213 (808)
T ss_pred ceeeeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh------------------
Confidence 445677889999999999987 899999999999999999999999998777555544442
Q ss_pred HHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.... . ....++..+.+||+.+|.+||.+|+|..++|.|||.++-
T Consensus 214 ---------~d~v-~---~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 214 ---------KDPV-K---PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred ---------cCCC-C---CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 1111 1 123689999999999999999999999999999999864
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-50 Score=407.28 Aligned_cols=286 Identities=36% Similarity=0.657 Sum_probs=236.4
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
|+..++|++++.||.|+||.||+|.+..+++.||+|++.... .......+.+|+.+|+.++||||+++++++ ..
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 74 (288)
T cd07871 1 FGKLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDII-----HT 74 (288)
T ss_pred CCccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cC
Confidence 456678999999999999999999999999999999986432 122334677999999999999999999998 44
Q ss_pred CceEEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 99 FKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
...+|+||||+.++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 75 ERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 56799999999999999987654 57899999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... ......|++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|..+.+..
T Consensus 155 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07871 155 VPTK---TYSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPG 230 (288)
T ss_pred CCCc---cccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhc
Confidence 2221 12445789999999988652 4688999999999999999999999999999999999999999999887765
Q ss_pred hhhH-HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 258 VRNE-KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 258 ~~~~-~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
+... ....++ .......+.....+.+++++.|||++||.+||.+|||++|+|+||||
T Consensus 231 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 231 ITSNEEFRSYL--FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cccchhhhccc--cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 4322 111111 01111222233445688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-50 Score=415.64 Aligned_cols=327 Identities=42% Similarity=0.792 Sum_probs=267.1
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC-CCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KRE 98 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~ 98 (556)
...++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++.... ...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999999999999999998764444445567889999999999999999999886432 233
Q ss_pred CceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
...+|+++|+++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 92 ~~~~~~~~~~~~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 92 FNEVYLVTNLMGADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred cCcEEEEeecCCCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 45689999999999988876 45699999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
. ...++||++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+....+
T Consensus 171 ~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 171 E------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred C------cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 2 2456799999999998652 46889999999999999999999999999999999999999999999888887
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhH
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEF 338 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~ 338 (556)
.....+.++..+.......+...+...++.+.+||.+||..||.+|||+.++|+||||.........+...+ .....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~~~~~~~~~---~~~~~ 320 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEP---YDESP 320 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCCccccccCc---cccch
Confidence 777777776665544444444455667889999999999999999999999999999998655443333222 22222
Q ss_pred hhhcCCHHHHHHHHHHHHH
Q 008729 339 ERRRVTKDDIRELIYREIL 357 (556)
Q Consensus 339 ~~~~~~~~~~~~~~~~e~~ 357 (556)
.....+.+++++..+.+..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~ 339 (343)
T cd07878 321 ENKERTIEEWKELTYEEVS 339 (343)
T ss_pred hhhhccHHHHHHHHHHHHH
Confidence 3344555666666665543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=416.41 Aligned_cols=292 Identities=44% Similarity=0.764 Sum_probs=243.3
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
.|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++..........+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47899999999999999999999999999999876555555667889999999999999999999999665433445799
Q ss_pred EEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCc
Q 008729 104 VVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (556)
Q Consensus 104 lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 183 (556)
+||||+.++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-- 158 (372)
T cd07853 81 VVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-- 158 (372)
T ss_pred EEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc--
Confidence 999999999999998888999999999999999999999999999999999999999999999999999986432221
Q ss_pred ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHH
Q 008729 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (556)
Q Consensus 184 ~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~ 263 (556)
......+++++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..++++.|.+.+|.|..+.+..... ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~ 236 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE-GA 236 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH-HH
Confidence 122455789999999998762 3578999999999999999999999999999999999999999999877655432 23
Q ss_pred HHHHHHhhcCCCC--CcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 264 RKYLTEMRKKPPV--PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 264 ~~~l~~~~~~~~~--~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
+.++.......+. .........++.+.+||.+||+.||++|||++++|+||||.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 3333221111110 0112234568899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-49 Score=411.48 Aligned_cols=326 Identities=37% Similarity=0.657 Sum_probs=256.0
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC-CCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~ 99 (556)
..++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.... ....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457999999999999999999999999999999999865555566778889999999999999999999886432 2344
Q ss_pred ceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
..+|+||||++++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 67899999999999988864 4889999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+...++.|.++.+..+.
T Consensus 180 ~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 180 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C----cccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 1 1245679999999999987 689999999999999999999999999999999999999999999887665443
Q ss_pred hHHHHHHHHHhhcCCCCCcCC------------CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCC
Q 008729 260 NEKARKYLTEMRKKPPVPLFQ------------KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~------------~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~ 327 (556)
.. ...+...........+.. .....+..+++||.+||..||.+|||++++|+||||..+........
T Consensus 254 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~ 332 (364)
T cd07875 254 PT-VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEA 332 (364)
T ss_pred HH-HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCcccCCC
Confidence 22 233332221111111111 11124578999999999999999999999999999986544433322
Q ss_pred CCC-CCcchhhHhhhcCCHHHHHHHHHHHHH
Q 008729 328 CQP-ISKLEFEFERRRVTKDDIRELIYREIL 357 (556)
Q Consensus 328 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~e~~ 357 (556)
..+ +. +...+.+..+.+++++.++.+++
T Consensus 333 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 361 (364)
T cd07875 333 PPPKIP--DKQLDEREHTIEEWKELIYKEVM 361 (364)
T ss_pred CCCCCC--CccchhhhccHHHHHHHHHHHHH
Confidence 111 11 12233345666677777666653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-49 Score=410.84 Aligned_cols=292 Identities=38% Similarity=0.699 Sum_probs=240.3
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC-CCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~ 99 (556)
..++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++.... ....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457999999999999999999999999999999999765555566678889999999999999999999986442 2344
Q ss_pred ceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
..+|+||||++++|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 57899999999999888753 5889999999999999999999999999999999999999999999999999754322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.|..+......
T Consensus 177 ~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 177 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred c----cCCCCcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 1 1245679999999999987 689999999999999999999999999999999999999999999887665443
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCC------------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKF------------PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~------------~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~ 321 (556)
. ....+...........+.+.+ ...++.+.+||.+||..||++|||+.|+|+||||..+..
T Consensus 251 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 251 P-TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred H-HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 2 223333322222222221111 124678999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=409.20 Aligned_cols=334 Identities=50% Similarity=0.872 Sum_probs=274.9
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
..+++|++.+.||+|+||.||+|.+..+|+.||||++... .......++.+|+.+|+.++||||+++++++........
T Consensus 2 ~~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred ccccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-ccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 3457999999999999999999999999999999998642 233445678899999999999999999998876655566
Q ss_pred ceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
..+|+|+||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 77999999999999988864 57999999999999999999999999999999999999999999999999999765433
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
..........+|+..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+....+..+.+.++.|..+.+....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence 3222233456799999999987542 468899999999999999999999999999999999999999999998887777
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhHh
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFE 339 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~~ 339 (556)
....+.++.........++....+..++.+.+||.+||+.||++|||+.++++||||+.+.....++..++...++++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (336)
T cd07849 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELF 318 (336)
T ss_pred chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCCCCcccCCCCCChhhccc
Confidence 77777776655555444544455678899999999999999999999999999999998876655555443333333332
Q ss_pred hhcCCHHHHHHHHHHHHH
Q 008729 340 RRRVTKDDIRELIYREIL 357 (556)
Q Consensus 340 ~~~~~~~~~~~~~~~e~~ 357 (556)
....++.+++.++.+++
T Consensus 319 -~~~~~~~~~~~~~~~~~ 335 (336)
T cd07849 319 -DDLPKEKLKELIFEEIM 335 (336)
T ss_pred -cccCHHHHHHHHHHHhc
Confidence 34557888888877764
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=363.71 Aligned_cols=278 Identities=39% Similarity=0.658 Sum_probs=240.1
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
+|.-.++||+|.||+||+|+++.+++.||+|.+.-...+.......+|||.+|+.|+|.|||+++++.. ..+.+-
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh-----sdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc-----cCceeE
Confidence 577789999999999999999999999999998754444445567889999999999999999999984 446699
Q ss_pred EEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCC
Q 008729 104 VVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (556)
Q Consensus 104 lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 182 (556)
+|||||..+|..+..+ ++.+..+.++.++.|+++||.|||+.++.||||||+|+||+.+|.+|++|||+|+.+.-. .
T Consensus 78 lvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip--v 155 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--V 155 (292)
T ss_pred EeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--e
Confidence 9999999999999876 788999999999999999999999999999999999999999999999999999875322 1
Q ss_pred cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
..++..+.|.||++|.++.+. .-|+..+|+||.|||+.|+.. |+++|+|.+..+|+.+|+.++|+|+.+.|..+.
T Consensus 156 -rcysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t-- 231 (292)
T KOG0662|consen 156 -RCYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT-- 231 (292)
T ss_pred -EeeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc--
Confidence 234567899999999998774 569999999999999999986 899999999999999999999999998876532
Q ss_pred HHHHHHHHhhcCCCCC-------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 262 KARKYLTEMRKKPPVP-------LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~-------~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.+.+..+.| +.+..|+++...+||++++|.-+|.+|++++++|+||||...
T Consensus 232 -------~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 232 -------KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred -------cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 222333322 223445677778999999999999999999999999999864
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=402.28 Aligned_cols=290 Identities=34% Similarity=0.592 Sum_probs=228.4
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
||..++|++++.||+|+||.||+|.++.+++.||||++..... ......+.+|+.+|+.++||||+++++++ .+
T Consensus 1 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 74 (303)
T cd07869 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDII-----HT 74 (303)
T ss_pred CCccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEE-----ec
Confidence 4677899999999999999999999999999999999874322 22334577899999999999999999998 45
Q ss_pred CceEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
...+|+|||||.++|.+++..+ +.++++.++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 75 KETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 5679999999999999888764 568999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhhCCCChHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~-~~~~~~~i~~~~g~p~~e~i~ 256 (556)
... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|.+||.+.. ..+.+..+...++.|....+.
T Consensus 155 ~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 155 VPS---HTYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred CCC---ccCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhcc
Confidence 211 112456789999999988652 457889999999999999999999998754 456777777778887766544
Q ss_pred HhhhHHHHHHH-HHhhcCCCCCcCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 257 VVRNEKARKYL-TEMRKKPPVPLFQKF--PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 257 ~~~~~~~~~~l-~~~~~~~~~~~~~~~--~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
...... .+. .......+......+ ...++.+.+||.+||+.||++|||++|+|+||||+.+.
T Consensus 231 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 231 GVHSLP--HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred chhhcc--ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 322100 000 000000011111111 13567899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-51 Score=387.77 Aligned_cols=291 Identities=42% Similarity=0.721 Sum_probs=249.3
Q ss_pred EEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEE
Q 008729 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (556)
Q Consensus 26 ~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (556)
+--+.||.|+||+||.+.|..+|+.||+|++...+.+....+++.+|+++|..++|.|++..+++..++..+-+..+|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 33578999999999999999999999999999888888889999999999999999999999999988877778899999
Q ss_pred EecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce
Q 008729 106 FELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (556)
Q Consensus 106 ~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (556)
+|+|..||+.+|.+-..++.++++-+++|||+||+|||+.||.||||||.|+|++.||.+||||||+|+....+.. ..
T Consensus 136 TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~--~h 213 (449)
T KOG0664|consen 136 TELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR--LN 213 (449)
T ss_pred HHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh--hh
Confidence 9999999999999999999999999999999999999999999999999999999999999999999997544332 23
Q ss_pred ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 186 ~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
++.-+.|.+|+|||++.|. ..|+.++||||+|||+.|||..+.+|...+..++++.|.+++|+|+.|.+.......-.-
T Consensus 214 MTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H 292 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNH 292 (449)
T ss_pred hHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHH
Confidence 5677899999999998875 789999999999999999999999999999999999999999999999876443322222
Q ss_pred HHHHhhcCCCCCc-CCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 266 YLTEMRKKPPVPL-FQKF--PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 266 ~l~~~~~~~~~~~-~~~~--~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.+..-.+....+. .... ....-++.+++.+||.+||++|.+.++++.|+|+...
T Consensus 293 ~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 293 VLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred hhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 2221111111111 1111 1334578999999999999999999999999998754
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-48 Score=403.20 Aligned_cols=291 Identities=38% Similarity=0.678 Sum_probs=239.5
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC-CCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~ 99 (556)
..++|++++.||+|+||.||+|.+..+++.||||++...........++.+|+.+++.++||||+++++++.... ....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 357999999999999999999999999999999999865555566778889999999999999999999986432 2344
Q ss_pred ceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
..+|+||||++++|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred ceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 57899999999999888864 4889999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+.++.|.++......
T Consensus 173 ~----~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 173 F----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred c----ccCCccccCCccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 1 1245679999999999987 679999999999999999999999999999999999999999998887765543
Q ss_pred hHHHHHHHHHhhcCCCCC-----------cC-CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 260 NEKARKYLTEMRKKPPVP-----------LF-QKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~-----------~~-~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.. ...++.......... .. ......+..+.+||.+||..||++|||+.|+|+||||....
T Consensus 247 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 247 PT-VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred HH-HHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 32 233332211111100 00 11123467889999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-49 Score=393.34 Aligned_cols=252 Identities=29% Similarity=0.542 Sum_probs=226.5
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecC-ccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD-VFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~-~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.||++.+.||+|.||+|.+|.+...|+.||||.|.+ ...+..+..++.|||.||..|+||||+.+|++| ++...
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----ENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----ENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cCCce
Confidence 589999999999999999999999999999998864 456677888999999999999999999999999 67777
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+.|||||.. |+|+++|...+.|++.+++.||+||..|+.|||.++++|||||.+|||+|.||++||+|||++..+...
T Consensus 128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~- 206 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADK- 206 (668)
T ss_pred EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccc-
Confidence 999999999 799999999999999999999999999999999999999999999999999999999999999876543
Q ss_pred CCcceecccccCcccCCcccccccCCCCC-CcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~-~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.+++++||++.|.+||++.| ..|. +.+|.||||++||.|+.|..||+|.+....+.+|..
T Consensus 207 ---kfLqTFCGSPLYASPEIvNG--~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~-------------- 267 (668)
T KOG0611|consen 207 ---KFLQTFCGSPLYASPEIVNG--TPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISR-------------- 267 (668)
T ss_pred ---cHHHHhcCCcccCCccccCC--CCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhc--------------
Confidence 35688999999999999998 6775 899999999999999999999999987766665532
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
..+. -|.-+.++.-||+.||.+||++|.|++++-.|=|++
T Consensus 268 -------------GaYr-----EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 268 -------------GAYR-----EPETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred -------------cccc-----CCCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 1111 134567899999999999999999999999998876
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=394.75 Aligned_cols=274 Identities=28% Similarity=0.415 Sum_probs=228.0
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
...+.|++.++||.|..++||+|+...+++.||||+++-. ....+...+.+|+..|+.++||||++++..|. ..
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLE-kc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv-----v~ 96 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLE-KCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV-----VD 96 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehh-hhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE-----ec
Confidence 3567899999999999999999999999999999999743 23345788999999999999999999999994 44
Q ss_pred ceEEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 100 KDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
..+|+||.||. |+++++|+.. ..++|..+..|++++|+||.|||.+|.||||||+.||||+.+|.|||+|||.+...
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l 176 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL 176 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence 66999999999 8999999873 46999999999999999999999999999999999999999999999999988765
Q ss_pred cCCCCCccee-cccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 177 FSDTPMTVFW-TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 177 ~~~~~~~~~~-~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
.......... ..++||++|||||++...-.+|+.|+||||||++..||.+|..||...-....+ ++.+.|.|+.-..
T Consensus 177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL--l~tLqn~pp~~~t 254 (516)
T KOG0582|consen 177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL--LLTLQNDPPTLLT 254 (516)
T ss_pred cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH--HHHhcCCCCCccc
Confidence 5443332222 778999999999996655578999999999999999999999999877665544 4445555532111
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.....+ .....+..++.+|..||+.||.+||||+++|+|+||+...
T Consensus 255 ~~~~~d-------------------~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 255 SGLDKD-------------------EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred ccCChH-------------------HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 111111 1123566899999999999999999999999999999754
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=394.25 Aligned_cols=284 Identities=35% Similarity=0.602 Sum_probs=230.3
Q ss_pred CCeEEEeeeeecCceeEEEEEECC-CCcEEEEEEecCccCChhHHHHHHHHHHHHHhC---CCCCcceeeEEEcCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~-tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L---~HpnIv~l~~v~~~~~~~~ 98 (556)
++|++++.||+|+||.||+|.+.. +++.||+|++............+.+|+.+++.+ +||||+++++++.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999864 468899999875433333344566788887766 6999999999986443345
Q ss_pred CceEEEEEecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
...+|+||||+.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 160 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEec
Confidence 5679999999999999999763 35899999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..|.+..+.|.++.+.
T Consensus 161 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 161 SFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred cCCc----ccccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 3321 1245569999999999876 678999999999999999999999999999999999999998888766543
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
....-. . .........+.....+.++..+.+||.+||+.||++|||+.++|+||||
T Consensus 235 ~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALP-R---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhccc-c---hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 211100 0 0111222233334446789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=394.08 Aligned_cols=285 Identities=36% Similarity=0.651 Sum_probs=226.7
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++.+.||+|+||.||+|+++.+++.||+|++............+.+|+.+++.++||||+++++++ .....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEE
Confidence 479999999999999999999999999999999875433334456788999999999999999999998 555679
Q ss_pred EEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+||||+++++.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99999999766555543 45799999999999999999999999999999999999999999999999999986532221
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
. ......|++.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+....+..+.+.+......
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07848 156 A--NYTEYVATRWYRSPELLLG--APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSN 231 (287)
T ss_pred c--cccccccccccCCcHHHcC--CCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhcc
Confidence 1 1234679999999999977 67899999999999999999999999999888888888887777665554322111
Q ss_pred HHHHHHHHhhcCCCCCc-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 262 KARKYLTEMRKKPPVPL-FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~-~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
................. ......+++++.+||++||++||++|||++++|+||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00000000000000000 01123478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=401.32 Aligned_cols=329 Identities=56% Similarity=0.974 Sum_probs=283.5
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
+|++.+.||.|+||.||+|++..+++.||||++............+.+|+.+++.++|+||+++++++..........+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 69999999999999999999999999999999986554455667889999999999999999999998665434556799
Q ss_pred EEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCc
Q 008729 104 VVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (556)
Q Consensus 104 lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 183 (556)
+||||+.++|.+++..+..+++..++.++.||+.||+|||+.||+||||||+|||++.++.++|+|||++..........
T Consensus 81 lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~ 160 (330)
T cd07834 81 IVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160 (330)
T ss_pred EEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998754433211
Q ss_pred ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHH
Q 008729 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (556)
Q Consensus 184 ~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~ 263 (556)
.......++.+|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.|..+.+.......+
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 161 GFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred ccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 223456789999999999872 2788999999999999999999999999999999999999999999988887777778
Q ss_pred HHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhHhhhcC
Q 008729 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRV 343 (556)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~~~~~~ 343 (556)
..++.........++....+.+++.+.+||++||++||.+|||++++|+||||+++.....++......++. .|+...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 318 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFD-FFDDDEL 318 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCccccc-ccchhhc
Confidence 888877777766777777788999999999999999999999999999999999987777676655444331 3566678
Q ss_pred CHHHHHHHHHH
Q 008729 344 TKDDIRELIYR 354 (556)
Q Consensus 344 ~~~~~~~~~~~ 354 (556)
++++.++.++.
T Consensus 319 ~~~~~~~~~~~ 329 (330)
T cd07834 319 TEEELKELIYE 329 (330)
T ss_pred CHHHHhHHhhc
Confidence 88888888775
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-48 Score=401.87 Aligned_cols=328 Identities=50% Similarity=0.927 Sum_probs=277.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
..+|++.+.||.|+||.||+|.+..+|+.||+|++............+.+|+.+|+.++||||+++++++.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 46899999999999999999999999999999999765444455667889999999999999999999875443 34567
Q ss_pred EEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 102 IYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
+|+||||++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 83 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 83 VYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999976433221
Q ss_pred -CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 182 -MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 182 -~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
........+|+.+|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+...++..+...+|.|..+.+.....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~ 241 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGS 241 (334)
T ss_pred CCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhch
Confidence 11122345799999999987652 4588999999999999999999999999999999999999999999998887777
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhHhh
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFER 340 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~~~ 340 (556)
...+.+++........++...++..+..+.++|++||+.||.+|||++++|.||||.+....+.++.+.+ .+++.++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 319 (334)
T cd07855 242 DRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDDEPTCPP--PFDFDFEA 319 (334)
T ss_pred hhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCcccccCCC--CCCCChhh
Confidence 7777777666555555555566778999999999999999999999999999999998887777766533 45566666
Q ss_pred hcCCHHHHHHHHH
Q 008729 341 RRVTKDDIRELIY 353 (556)
Q Consensus 341 ~~~~~~~~~~~~~ 353 (556)
...+.+.+.+.|.
T Consensus 320 ~~~~~~~~~~~~~ 332 (334)
T cd07855 320 IELSREQLKEAIV 332 (334)
T ss_pred hhcChhhHHHHhh
Confidence 6677777666553
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=410.84 Aligned_cols=256 Identities=29% Similarity=0.506 Sum_probs=224.7
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
-...|...++||+|+.|.||.|+...+++.||||.+... ......-+++|+.+|+.++|+|||.+++.|+.. .
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~--~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----d 343 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR--KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----D 343 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEec--cCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----c
Confidence 345799999999999999999999999999999999743 333445688999999999999999999998543 5
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+|||||+ |+|.+++... .++|.++..|++++|.||+|||.+||+|||||.+|||+..+|.+||+|||+|......
T Consensus 344 eLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 344 ELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred eeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 6999999999 6888877654 5999999999999999999999999999999999999999999999999999887655
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
... ....+||++|||||+... ..|++++||||||++++||+-|.+||-..+....+.+|..
T Consensus 423 ~~K---R~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~-------------- 483 (550)
T KOG0578|consen 423 QSK---RSTMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-------------- 483 (550)
T ss_pred cCc---cccccCCCCccchhhhhh--cccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh--------------
Confidence 443 367889999999999988 7999999999999999999999999988777666655532
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
...+.......+|+.++|||.+||++|+.+|++|.|||+||||+
T Consensus 484 --------------ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 484 --------------NGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred --------------cCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 33444455667999999999999999999999999999999995
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=415.53 Aligned_cols=286 Identities=36% Similarity=0.599 Sum_probs=228.9
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC---CC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK---RE 98 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~---~~ 98 (556)
.++|+++++||+|+||.||+|.+..+++.||||++... .....+|+.+|+.++||||+++++++..... ..
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 45899999999999999999999999999999988532 1234479999999999999999998754322 22
Q ss_pred CceEEEEEecCcccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC-ceEEeeeCcc
Q 008729 99 FKDIYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLA 173 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~----~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~vKL~DFGla 173 (556)
...+|+|||||+++|.+++. ....+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+|||+|
T Consensus 139 ~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 139 NIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred ceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 34578999999998887775 346799999999999999999999999999999999999998665 6999999999
Q ss_pred ccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
+....... ...++||+.|+|||++.+. ..|+.++||||||||||+|++|.+||.+.+..+++..+...+|.|..+
T Consensus 219 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 219 KNLLAGQR----SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred hhccCCCC----cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 86543222 2356789999999987652 468999999999999999999999999999999999999999999887
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~ 321 (556)
.+.........-. ........+...+ ...++++.+||.+||.+||.+|||+.|+|+||||..+..
T Consensus 294 ~~~~~~~~~~~~~---~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 294 QLKEMNPNYADIK---FPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHHhchhhhccc---CCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 6653321110000 0000011111112 247889999999999999999999999999999987643
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-48 Score=394.50 Aligned_cols=291 Identities=38% Similarity=0.670 Sum_probs=239.7
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
++..++|.+++.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++ ..
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 75 (309)
T cd07872 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIV-----HT 75 (309)
T ss_pred CCCCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEE-----ee
Confidence 4556789999999999999999999999999999999864322 22234567899999999999999999998 44
Q ss_pred CceEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
...+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 76 DKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 5679999999999999988764 458999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|..+.+..
T Consensus 156 ~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (309)
T cd07872 156 VPTK---TYSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPG 231 (309)
T ss_pred CCcc---ccccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhh
Confidence 2221 12345689999999988652 4688999999999999999999999999999999999999999998887765
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
+.......... .......+.....+.+++++.+||++||..||.+|||++|+|+||||+.+.
T Consensus 232 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 232 ISSNDEFKNYN-FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hcchhhhhhhh-cCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 44322111111 112223333345567899999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-49 Score=399.26 Aligned_cols=269 Identities=26% Similarity=0.431 Sum_probs=219.3
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc------------CChhHHHHHHHHHHHHHhCCCCCcce
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF------------EHISDAIRILREVKLLRLLRHPDIVE 86 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~------------~~~~~~~~~~rEi~iL~~L~HpnIv~ 86 (556)
.-..++|++++.||+|.||+|.+|++..+++.||||++.+.. .......++++||.||++|+|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 445679999999999999999999999999999999996421 11123457899999999999999999
Q ss_pred eeEEEcCCCCCCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCce
Q 008729 87 IKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (556)
Q Consensus 87 l~~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~v 165 (556)
|+++.-++ ....+|||+|||. |.+...-.....+++.+++.|++.++.||.|||.+||+||||||+|+|++.+|+|
T Consensus 173 LiEvLDDP---~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 173 LIEVLDDP---ESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EEEeecCc---ccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence 99998543 4467999999999 5554332222339999999999999999999999999999999999999999999
Q ss_pred EEeeeCccccccC--CCCCcceecccccCcccCCcccccccC--CCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHH
Q 008729 166 KVCDFGLARVAFS--DTPMTVFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241 (556)
Q Consensus 166 KL~DFGla~~~~~--~~~~~~~~~~~~gt~~Y~APE~~~~~~--~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~ 241 (556)
||+|||.+..... +......+...+|||.|+|||.|.+.. ...+.+.||||+||+||.|+.|+.||-+....+..+
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~ 329 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD 329 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence 9999999875421 222233345578999999999987621 224579999999999999999999999988887777
Q ss_pred HHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 242 ~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
+|.+. ... +...+.+.++++|||.+||++||.+|++..++-.|||...-
T Consensus 330 KIvn~--------------------------pL~---fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 330 KIVND--------------------------PLE---FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred HHhcC--------------------------ccc---CCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 77431 111 12234678999999999999999999999999999998753
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=412.34 Aligned_cols=257 Identities=25% Similarity=0.481 Sum_probs=223.8
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~ 99 (556)
.+.|+++++||+|.||+|++|..+.+++.||||++++. .-...+...+..|.+|+.... ||.++.++.+| +..
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----QT~ 441 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----QTK 441 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----ccC
Confidence 35799999999999999999999999999999999753 233456677889999998885 99999999999 666
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.++|+||||+. ||+. ++...+.+++..+++|+..|+.||+|||++||||||||.+|||+|.+|++||+|||+++....
T Consensus 442 ~~l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred CeEEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 78999999999 5743 444557899999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.... ..++||||.|||||++.+ ..|+.++|+|||||+|||||.|..||+|.+..+..+.|..
T Consensus 521 ~g~~---TsTfCGTpey~aPEil~e--~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~------------- 582 (694)
T KOG0694|consen 521 QGDR---TSTFCGTPEFLAPEVLTE--QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVN------------- 582 (694)
T ss_pred CCCc---cccccCChhhcChhhhcc--CcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc-------------
Confidence 3333 268999999999999998 8999999999999999999999999999999888887732
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHhCccccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGLA 320 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-----a~elL~hp~f~~~~ 320 (556)
.....| ..++.++.++++++|.+||++|.. +++|.+||||+.+.
T Consensus 583 -------------d~~~yP-----~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 583 -------------DEVRYP-----RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred -------------CCCCCC-----CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 222222 348999999999999999999985 58899999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-49 Score=395.12 Aligned_cols=263 Identities=30% Similarity=0.455 Sum_probs=214.7
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
..+|..++.||+|+||.||++.+..+|..+|||.+... +......+.+|+.+|+.|+|||||++++..... +. ..
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~--~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~--~~-~~ 90 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE--DSPTSESLEREIRILSRLNHPNIVQYYGSSSSR--EN-DE 90 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc--cchhHHHHHHHHHHHHhCCCCCEEeeCCccccc--cC-ee
Confidence 45799999999999999999999999999999988743 222266788999999999999999999975322 11 46
Q ss_pred EEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC-CCceEEeeeCccccccC
Q 008729 102 IYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFS 178 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~vKL~DFGla~~~~~ 178 (556)
++|+|||+. |+|.++++..+ .+++..++.+.+||++||+|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999 79999999877 7999999999999999999999999999999999999999 79999999999987653
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC-ChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-SVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~-~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
............||+.|||||++... ....+++|||||||++.||+||++||... .....+..|
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~i-------------- 235 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLI-------------- 235 (313)
T ss_pred ccccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHH--------------
Confidence 11111223457899999999999851 22335999999999999999999999773 222111111
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.... ..| .....+++++++||.+||.+||++||||+++|+|||.++.
T Consensus 236 ------------g~~~-~~P--~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 236 ------------GRED-SLP--EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred ------------hccC-CCC--CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 1111 222 3445699999999999999999999999999999999763
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=407.07 Aligned_cols=281 Identities=27% Similarity=0.373 Sum_probs=223.3
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||.||+|++..+++.||||+.. ...+.+|+.+|+.|+||||+++++++ ......
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~ 158 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTF-----TYNKFT 158 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEE-----EECCee
Confidence 57999999999999999999999999999999754 23467899999999999999999998 445678
Q ss_pred EEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCC
Q 008729 103 YVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (556)
Q Consensus 103 ylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 182 (556)
|+|||++.++|..++.....+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 159 ~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 159 CLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred EEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 99999999999999988888999999999999999999999999999999999999999999999999999753222111
Q ss_pred cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC-------ChHHHHHHHHHhhCCCChHHH
Q 008729 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-------SVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~-------~~~~~~~~i~~~~g~p~~e~i 255 (556)
.....+||+.|+|||++.+ ..|+.++||||||||+|+|++|..||.+. ....++..|...+|.++.+..
T Consensus 239 --~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 239 --KYYGWAGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred --ccccccCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 1245679999999999987 68999999999999999999999776543 234577778777887654432
Q ss_pred HHhhhHHHHHHHHHhhcCCC----CCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 256 AVVRNEKARKYLTEMRKKPP----VPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~----~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
..........+......... .+.+.....++.++.+||.+||++||.+|||++|+|+||||+.+.
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 11111111111111111111 111112224677899999999999999999999999999998754
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=396.82 Aligned_cols=259 Identities=29% Similarity=0.489 Sum_probs=229.8
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++-|.+.+.||+|-|.+|.+|+|.-||+.||||+|++...+.-....++.|+++|+..+|||||++|+++ +...
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQT 90 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQT 90 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccc
Confidence 45679999999999999999999999999999999998766666677899999999999999999999999 4445
Q ss_pred eEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee-cCCCceEEeeeCcccccc
Q 008729 101 DIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA-NANCKLKVCDFGLARVAF 177 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl-~~~~~vKL~DFGla~~~~ 177 (556)
.+|||+|+-+ |||+++|.++ ..+.++.++.||.||+.|+.|||...+|||||||+|+++ ..-|-|||+|||++..+.
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 6999999998 6999999775 479999999999999999999999999999999999865 567899999999998765
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCC-CcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~-~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
.... +++.||+..|-|||++.| ..|+ +++||||||||||-|+||++||...++.+.+.+|++..-
T Consensus 171 PG~k----L~TsCGSLAYSAPEILLG--DsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-------- 236 (864)
T KOG4717|consen 171 PGKK----LTTSCGSLAYSAPEILLG--DSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-------- 236 (864)
T ss_pred Ccch----hhcccchhhccCchhhhc--CccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc--------
Confidence 4443 467899999999999998 6787 899999999999999999999999999999888866321
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~ 321 (556)
.....++.+|+|||.+||..||++|.+.++|..|+|++.+..
T Consensus 237 -----------------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 237 -----------------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred -----------------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 223458999999999999999999999999999999997653
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=378.87 Aligned_cols=262 Identities=28% Similarity=0.474 Sum_probs=222.6
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCC-----hh-HHHHHHHHHHHHHhCC-CCCcceeeEEEcCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-----IS-DAIRILREVKLLRLLR-HPDIVEIKRIMLPPS 95 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~-----~~-~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~ 95 (556)
+.|.-.+.||+|..++|.+++++.+|+.+|+|+|...... .. -.....+|+.||+++. ||+|+++.++|.+
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes-- 94 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES-- 94 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC--
Confidence 3688889999999999999999999999999999643211 11 1234568999999995 9999999999954
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
...+++|||.|. |.|++++...-.+++...+.|++||++|+.|||..+||||||||+|||++++.++||+|||+|+
T Consensus 95 ---~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 95 ---DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred ---cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceee
Confidence 455999999999 9999999998889999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcceecccccCcccCCcccccc----cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGS----FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~----~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p 250 (556)
....... ..+.||||.|.|||.+.- ...+|+..+|+|++|||+|.||.|.+||......-++..|++
T Consensus 172 ~l~~Gek----LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime----- 242 (411)
T KOG0599|consen 172 QLEPGEK----LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME----- 242 (411)
T ss_pred ccCCchh----HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh-----
Confidence 7654433 467899999999998742 225689999999999999999999999987665555555533
Q ss_pred ChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.....-...|.+++..++|||.+||+.||.+|+|++|+|+||||.++.
T Consensus 243 ----------------------GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 243 ----------------------GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred ----------------------cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 223333456788999999999999999999999999999999998764
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=387.58 Aligned_cols=283 Identities=35% Similarity=0.598 Sum_probs=228.1
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC---CCCCcceeeEEEcCCCCCCCc
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L---~HpnIv~l~~v~~~~~~~~~~ 100 (556)
+|++++.||+|+||+||+|.++.+++.||+|.+............+.+|+.+++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999999875332222233455777777665 699999999998654444556
Q ss_pred eEEEEEecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 101 DIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.+|+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC 160 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccC
Confidence 79999999999999988764 3589999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
... .....||..|+|||++.+ ..++.++|||||||++|+|++|++||.+....+.+..+....+.+....+...
T Consensus 161 ~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 161 QMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred ccc----CCCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 221 234568999999999877 67999999999999999999999999999888888888888887765543321
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
..... .........+.....+.++..+.+||.+||+.||++|||+.++|.||||
T Consensus 235 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPR----GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccc----cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 10000 0011112222333446788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=414.99 Aligned_cols=285 Identities=27% Similarity=0.424 Sum_probs=227.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCC------CCcceeeEEEcCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH------PDIVEIKRIMLPPS 95 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H------pnIv~l~~v~~~~~ 95 (556)
.++|+++++||+|+||+||+|.+..+++.||||++.... .....+.+|+.+++.++| .+|+++++++.
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~--- 201 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ--- 201 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE---
Confidence 468999999999999999999999999999999986421 223345567777777654 45888888874
Q ss_pred CCCCceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEeecCCC-----------
Q 008729 96 KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANC----------- 163 (556)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~----------- 163 (556)
.+..++|||||+++++|.+++...+.+++..++.|+.||+.||.|||+ .||+||||||+|||++.++
T Consensus 202 -~~~~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 202 -NETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred -cCCceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 234579999999999999999988899999999999999999999998 5999999999999998765
Q ss_pred -----ceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHH
Q 008729 164 -----KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH 238 (556)
Q Consensus 164 -----~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~ 238 (556)
.+||+|||++...... ....+||+.|+|||++.+ ..|+.++||||||||||||++|++||.+.+..+
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~~------~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERHS------RTAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred CCCCceEEECCCCccccCccc------cccccCCccccCcHHhhc--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 4999999987643211 245679999999999987 689999999999999999999999999999999
Q ss_pred HHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcC---------CCC--CCCCHHHHHHHHHhhhcCCCCCCCH
Q 008729 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLF---------QKF--PNVDPLALRLLQRLIAFDPKDRPTA 307 (556)
Q Consensus 239 ~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~---------~~~--~~~s~~~~dLl~~~L~~dP~~Rpta 307 (556)
.+..|...+|.++.+..........+.++.......+.... ..+ ...++.+.|||.+||++||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 99999999999877665544334444443332211110000 000 0125678899999999999999999
Q ss_pred HHHHhCcccccccc
Q 008729 308 EEALADPYFKGLAK 321 (556)
Q Consensus 308 ~elL~hp~f~~~~~ 321 (556)
+|+|+||||.....
T Consensus 433 ~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 433 RQMTTHPYVLKYYP 446 (467)
T ss_pred HHHhcCccccccCC
Confidence 99999999987543
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=395.96 Aligned_cols=330 Identities=44% Similarity=0.826 Sum_probs=280.4
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC-CCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~ 99 (556)
..++|++.+.||+|+||.||+|++..+++.||||++............+.+|+.+++.++||||+++++++..... ...
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4578999999999999999999999999999999987544444455678899999999999999999998754432 344
Q ss_pred ceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
..+|+|+||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 93 ~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred ccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 56999999999999998875 56999999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
...+.++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.|.+..+..+.
T Consensus 172 ------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (343)
T cd07851 172 ------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244 (343)
T ss_pred ------ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence 2455789999999987652 367889999999999999999999999999999999999999999998888888
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhHh
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFE 339 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~~ 339 (556)
.+....++..+.......+...+...++.+.+||++||..||++|||+.++|+||||......+.++.. ......++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~---~~~~~~~~ 321 (343)
T cd07851 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPEDEPVA---PPYDQSFE 321 (343)
T ss_pred chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCcccccc---cccCcchh
Confidence 877777777665555555555556779999999999999999999999999999999987766555542 23345677
Q ss_pred hhcCCHHHHHHHHHHHHHhhCh
Q 008729 340 RRRVTKDDIRELIYREILEYHP 361 (556)
Q Consensus 340 ~~~~~~~~~~~~~~~e~~~~~~ 361 (556)
...++.+.++.++|.++..|.|
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07851 322 SRDLTVDEWKELVYKEIMNFKP 343 (343)
T ss_pred hhhcCHHHHHHHhHHHHHhccC
Confidence 8889999999999999988754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=389.60 Aligned_cols=253 Identities=24% Similarity=0.401 Sum_probs=216.1
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCe
Confidence 37999999999999999999999999999999986421 2223455688999999999999999999887 55567
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|+||||+. ++|.+++..++.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence 999999998 6999999988899999999999999999999999999999999999999999999999999997653221
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 156 ------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~--------------- 212 (291)
T cd05612 156 ------WTLCGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA--------------- 212 (291)
T ss_pred ------ccccCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------------
Confidence 23569999999999987 6789999999999999999999999988776554444321
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHhCcccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-----a~elL~hp~f~~~ 319 (556)
... .....+++.+++||++||+.||.+|++ ++++++||||..+
T Consensus 213 -----------~~~-----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 213 -----------GKL-----EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred -----------CCc-----CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 000 112346889999999999999999995 9999999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=398.72 Aligned_cols=261 Identities=32% Similarity=0.526 Sum_probs=226.8
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCC-hhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~ 97 (556)
.....|++.+.||+|.||+||+|+++.||+.||+|++.+.... ..+...+.+|+.||+++. |||||.++++| +
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e 106 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----E 106 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----E
Confidence 3456899999999999999999999999999999999754332 234567889999999998 99999999999 5
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC----CceEEeeeCc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN----CKLKVCDFGL 172 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~----~~vKL~DFGl 172 (556)
+...+|+|||+|. |+|++.|.+. .+++..+..++.||+.|++|||+.||+||||||+|||+... +.+|++|||+
T Consensus 107 ~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 107 DPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred cCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 6668999999999 6999999877 49999999999999999999999999999999999998533 5799999999
Q ss_pred cccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
|...... ......+||+.|+|||++.. ..|+..+||||+|||+|.|++|.+||.+.+.......|.
T Consensus 186 a~~~~~~----~~~~~~~Gtp~y~APEvl~~--~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~-------- 251 (382)
T KOG0032|consen 186 AKFIKPG----ERLHTIVGTPEYVAPEVLGG--RPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAIL-------- 251 (382)
T ss_pred ceEccCC----ceEeeecCCccccCchhhcC--CCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHH--------
Confidence 9886542 23478899999999999987 789999999999999999999999999988666554442
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
..........|+.++..+++||++||.+||.+|+|+.++|+|||+++.
T Consensus 252 -------------------~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 252 -------------------RGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred -------------------cCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 222233446788999999999999999999999999999999999864
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=393.77 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=216.7
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.+.|++.+.||+|+||.||+|.++.+++.||||++.... ........+.+|+.+|+.++||||+++++++ .+..
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence 468999999999999999999999999999999986421 2223456788999999999999999999998 5556
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+||||+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 7999999998 699999998889999999999999999999999999999999999999999999999999999765322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
. ...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 172 ~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~-------------- 229 (329)
T PTZ00263 172 T------FTLCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA-------------- 229 (329)
T ss_pred c------ceecCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------
Confidence 1 23569999999999987 6789999999999999999999999988765444433311
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHhCcccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-----a~elL~hp~f~~~ 319 (556)
... .....++..+.+||++||+.||.+|++ ++++++||||++.
T Consensus 230 ------------~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 230 ------------GRL-----KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred ------------CCc-----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 111 112347889999999999999999997 7999999999863
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=391.97 Aligned_cols=325 Identities=38% Similarity=0.670 Sum_probs=253.5
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC-CCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~ 99 (556)
..++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++.... ..+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999999999999999998765555556677889999999999999999999986442 2344
Q ss_pred ceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
..+|+||||+.++|.+.+... +++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 94 QDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred CcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 578999999999999988754 899999999999999999999999999999999999999999999999999865332
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.. .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...+|.|.++....+.
T Consensus 172 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 172 FM----MTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CC----CCCCcccccccCHHHHhC--CCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 21 234568899999999987 689999999999999999999999999999999999999999999887665543
Q ss_pred hHHHHHHHHHhhcCCCCCcCCC-------------CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCC
Q 008729 260 NEKARKYLTEMRKKPPVPLFQK-------------FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~-------------~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~ 326 (556)
.. ...+..........++... ....+..+.+||.+||..||++|||+.|+|+||||+.+.......
T Consensus 246 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~~~~ 324 (353)
T cd07850 246 PT-VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVE 324 (353)
T ss_pred hh-hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCccCC
Confidence 22 2222222111111111111 113466789999999999999999999999999998654332211
Q ss_pred CCCCCCcchhhHhhhcCCHHHHHHHHHHH
Q 008729 327 SCQPISKLEFEFERRRVTKDDIRELIYRE 355 (556)
Q Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e 355 (556)
. +.....+...+.+..+.+.+++.++.+
T Consensus 325 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T cd07850 325 A-PPPAPYDHSIDEREHTVEEWKELIYKE 352 (353)
T ss_pred C-CCCCccccccccccccHHHHHHHHHhh
Confidence 1 111112233344556666776665543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=393.38 Aligned_cols=250 Identities=26% Similarity=0.462 Sum_probs=212.4
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEe
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (556)
+.||+|+||.||+|.+..+|+.||||++.... ........+++|+.+|+.++||||+++++++ .....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence 47999999999999999999999999987432 2233456788999999999999999999998 55567999999
Q ss_pred cCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCccee
Q 008729 108 LME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (556)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (556)
|+. ++|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~ 152 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC---cc
Confidence 998 69999999888999999999999999999999999999999999999999999999999999875332221 12
Q ss_pred cccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHH
Q 008729 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (556)
Q Consensus 187 ~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~ 266 (556)
...+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05571 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (323)
T ss_pred cceecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc---------------------
Confidence 45679999999999987 6899999999999999999999999988765444433311
Q ss_pred HHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCcccccc
Q 008729 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (556)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 319 (556)
.. ......+++.+.+||++||..||++|| ++.++++||||.++
T Consensus 210 -----~~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 210 -----EE-----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred -----CC-----CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 00 112245889999999999999999999 89999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=390.35 Aligned_cols=261 Identities=26% Similarity=0.470 Sum_probs=220.3
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|..++||||+++++++ .+...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCE
Confidence 47999999999999999999999999999999987432 1223455688999999999999999999998 55667
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|||||||. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999998 69999999888999999999999999999999999999999999999999999999999999976433
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.....
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~------------ 215 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE------------ 215 (333)
T ss_pred ----ccCCcccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc------------
Confidence 1245679999999999987 6899999999999999999999999998876655544422100
Q ss_pred HHHHHHHHHhhcCCCCCc-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 261 EKARKYLTEMRKKPPVPL-FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~-~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
....+. ......+++++.+||.+||..+|.+||+++++++||||....
T Consensus 216 ------------~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 216 ------------TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred ------------cccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 000010 011135789999999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=385.70 Aligned_cols=330 Identities=40% Similarity=0.747 Sum_probs=273.3
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC-CCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~ 99 (556)
..++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++..... ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 4568999999999999999999999999999999986544444445678899999999999999999999864421 223
Q ss_pred ceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
..+|+||||++++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred ceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 46799999998899888864 57999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.....+++.|+|||.+.+. ..++.++|+|||||++|+|++|++||.+.+....+..+....+.+..+....+.
T Consensus 172 ------~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 172 ------MTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred ------ccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 1345688999999988652 357889999999999999999999999998888888888888888777777776
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhHh
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFE 339 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~~ 339 (556)
......+...+.......+....+.+++.+.+||.+||..||++|||+.+++.||||+.....+.++... .+...++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~---~~~~~~~ 321 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAP---PYDDSFD 321 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCC---CccccHH
Confidence 6666666666554444444445567899999999999999999999999999999999876655544333 3455677
Q ss_pred hhcCCHHHHHHHHHHHHHhhCh
Q 008729 340 RRRVTKDDIRELIYREILEYHP 361 (556)
Q Consensus 340 ~~~~~~~~~~~~~~~e~~~~~~ 361 (556)
....+-++++...+-+++.++|
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~ 343 (343)
T cd07880 322 EVDQSLEEWKRLTFTEILSFQP 343 (343)
T ss_pred hhccchHHHHHHHHHHHHhcCC
Confidence 7788889999999999987754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=391.97 Aligned_cols=256 Identities=27% Similarity=0.486 Sum_probs=227.3
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
+-|.+.+.||+|.|++|.+|++..|+..||||.|++...+......+.+|+++|+.|+|||||+++.++ +....+
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~-----~t~~~l 130 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVI-----ETEATL 130 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeee-----eeccee
Confidence 469999999999999999999999999999999998877777777899999999999999999999999 555679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+||||+. |++++++.+++++.+..++.+|.|++.|++|||+++|+|||||.+|||++.+.++||+|||++..+....
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~- 209 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL- 209 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccc-
Confidence 99999998 7999999999999999999999999999999999999999999999999999999999999998765333
Q ss_pred CcceecccccCcccCCcccccccCCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y-~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
...++||++.|.|||++.+ ..| ++.+|+||+|++||-|+.|..||+|.+.
T Consensus 210 ---~lqt~cgsppyAaPEl~~g--~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l------------------------ 260 (596)
T KOG0586|consen 210 ---MLQTFCGSPPYAAPELFNG--KKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL------------------------ 260 (596)
T ss_pred ---cccccCCCCCccChHhhcC--cccCCcceehhhhhhhheeeeecccccCCccc------------------------
Confidence 3467899999999999998 445 5999999999999999999999999873
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
+.++.+.........-.++.++.+||+++|..+|.+|++.+++..|.|.....
T Consensus 261 -------k~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 261 -------KELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred -------ccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 22333333333333345899999999999999999999999999999997554
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=385.28 Aligned_cols=281 Identities=35% Similarity=0.600 Sum_probs=216.5
Q ss_pred EeeeeecCceeEEEEEEC--CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEE
Q 008729 28 LEVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (556)
.++||+|+||+||+|+++ .+++.||+|.+.... ....+.+|+.+|+.++||||+++++++... ....+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv 78 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLL 78 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEE
Confidence 468999999999999965 467899999986431 123467899999999999999999988542 33568999
Q ss_pred EecCcccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee----cCCCceEEeeeCc
Q 008729 106 FELMESDLHQVIKAN---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCKLKVCDFGL 172 (556)
Q Consensus 106 ~E~~~g~L~~~i~~~---------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl----~~~~~vKL~DFGl 172 (556)
|||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 79 FDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 999999999988632 258999999999999999999999999999999999999 4567899999999
Q ss_pred cccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh---------HHHHHHH
Q 008729 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---------VHQLDLI 243 (556)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~---------~~~~~~i 243 (556)
|+...............+||+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+... .+++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence 98654332222223456799999999988652 4588999999999999999999999976442 4678888
Q ss_pred HHhhCCCChHHHHHhhhHH-HHHHHHHhhcCCCC--C----cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 244 TDLLGTPSPETIAVVRNEK-ARKYLTEMRKKPPV--P----LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~-~~~~l~~~~~~~~~--~----~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
...+|.|....+....... .............. . ........+..+.+||++||++||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 9999998877665432111 01111111111000 0 001112356789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=393.69 Aligned_cols=262 Identities=25% Similarity=0.399 Sum_probs=214.6
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.++..++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCe
Confidence 369999999999999999999999999999999874321 223345678899999999999999999998 55667
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|||||||. |+|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 999999998 6999999988899999999999999999999999999999999999999999999999999987532211
Q ss_pred CC--------------------------------cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCC
Q 008729 181 PM--------------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (556)
Q Consensus 181 ~~--------------------------------~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~ 228 (556)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHHHHHHhCC
Confidence 00 001134689999999999987 68999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCC---CCC
Q 008729 229 PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPK---DRP 305 (556)
Q Consensus 229 ~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~---~Rp 305 (556)
+||.+.+..+....|..... ... ......+++++.+||.+|+. +|. .||
T Consensus 234 ~Pf~~~~~~~~~~~i~~~~~--------------------------~~~-~p~~~~~s~~~~~li~~l~~-~~~~r~~r~ 285 (363)
T cd05628 234 PPFCSETPQETYKKVMNWKE--------------------------TLI-FPPEVPISEKAKDLILRFCC-EWEHRIGAP 285 (363)
T ss_pred CCCCCCCHHHHHHHHHcCcC--------------------------ccc-CCCcCCCCHHHHHHHHHHcC-ChhhcCCCC
Confidence 99998876655554432100 000 11122478999999999876 555 458
Q ss_pred CHHHHHhCcccccc
Q 008729 306 TAEEALADPYFKGL 319 (556)
Q Consensus 306 ta~elL~hp~f~~~ 319 (556)
+++|+++||||+++
T Consensus 286 ~~~ei~~hp~f~~~ 299 (363)
T cd05628 286 GVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHhCCCCCCCC
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=380.88 Aligned_cols=265 Identities=26% Similarity=0.397 Sum_probs=224.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|++++.||.|.-|+||+|..+.++..+|+|++.+... ......++..|-.||..++||.++.||..| +..+
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et~~ 150 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ETDK 150 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----eccc
Confidence 3578999999999999999999999999999999986432 244566788899999999999999999999 6777
Q ss_pred eEEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 101 DIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
++|+|||||. |||+.+.++. ..+++..+++|+.+++.||.|||-.|||+|||||+||||.++|+|.|+||.|+....
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 8999999999 6999998874 579999999999999999999999999999999999999999999999999874320
Q ss_pred C----------------------------------CC-------------------CCcceecccccCcccCCccccccc
Q 008729 178 S----------------------------------DT-------------------PMTVFWTDYVATRWYRAPELCGSF 204 (556)
Q Consensus 178 ~----------------------------------~~-------------------~~~~~~~~~~gt~~Y~APE~~~~~ 204 (556)
- .. +.......++||-.|.|||++.|
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G- 309 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG- 309 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec-
Confidence 0 00 00011235789999999999999
Q ss_pred CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCC
Q 008729 205 FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN 284 (556)
Q Consensus 205 ~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 284 (556)
.+.+.++|+|+|||.|||||.|..||.|.+..+.+..|.. +....+ ..+.
T Consensus 310 -~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~--------------------------~~l~Fp---~~~~ 359 (459)
T KOG0610|consen 310 -EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG--------------------------QPLKFP---EEPE 359 (459)
T ss_pred -CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc--------------------------CCCcCC---CCCc
Confidence 7899999999999999999999999999998777655521 111111 2236
Q ss_pred CCHHHHHHHHHhhhcCCCCCCC----HHHHHhCccccccccc
Q 008729 285 VDPLALRLLQRLIAFDPKDRPT----AEEALADPYFKGLAKI 322 (556)
Q Consensus 285 ~s~~~~dLl~~~L~~dP~~Rpt----a~elL~hp~f~~~~~~ 322 (556)
++..++|||+++|.+||.+|.. |.||-+||||+++.+.
T Consensus 360 vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWa 401 (459)
T KOG0610|consen 360 VSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWA 401 (459)
T ss_pred chhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChh
Confidence 7899999999999999999998 9999999999998643
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=384.25 Aligned_cols=329 Identities=42% Similarity=0.803 Sum_probs=270.3
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC-CCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~ 99 (556)
..++|.+++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.... ....
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 447899999999999999999999999999999999764444445567889999999999999999999885432 1234
Q ss_pred ceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
..+|+|+++++++|.+++.. ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 95 ~~~~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~ 173 (345)
T cd07877 95 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 173 (345)
T ss_pred ccEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccccc
Confidence 56899999999999888765 46999999999999999999999999999999999999999999999999998754321
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.....++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+....+.+.++....+.
T Consensus 174 ------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 174 ------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred ------ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 1345689999999987652 467889999999999999999999999998888888999999999888887777
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhHh
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFE 339 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~~ 339 (556)
....+.++..+.......+...+...++.+.+||.+||..||.+|||+.++|+||||.++..++.++...+ .+..+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~~~~~~~~---~~~~~~ 323 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQSFE 323 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCCccccCCC---ccCcch
Confidence 76677776666554444444445567899999999999999999999999999999998776665654332 334444
Q ss_pred hhcCCHHHHHHHHHHHHHhhC
Q 008729 340 RRRVTKDDIRELIYREILEYH 360 (556)
Q Consensus 340 ~~~~~~~~~~~~~~~e~~~~~ 360 (556)
.+..-.+++....|.++..|-
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~ 344 (345)
T cd07877 324 SRDLLIDEWKSLTYDEVISFV 344 (345)
T ss_pred hcccCHHHHHHHHHHHHHhcC
Confidence 445555777778888876553
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=394.27 Aligned_cols=262 Identities=25% Similarity=0.433 Sum_probs=216.1
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||+||+|++..+|+.||||++.... ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCe
Confidence 47999999999999999999999999999999987421 2223445678899999999999999999999 55667
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|||||||. |+|.+++..++.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 999999998 6999999988899999999999999999999999999999999999999999999999999986532111
Q ss_pred CCc-----------------------------------ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHH
Q 008729 181 PMT-----------------------------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225 (556)
Q Consensus 181 ~~~-----------------------------------~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyell 225 (556)
... ......+||+.|+|||++.+ ..|+.++||||||||+|+|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHHHHhh
Confidence 000 01123579999999999987 68999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 008729 226 TGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305 (556)
Q Consensus 226 tG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp 305 (556)
+|.+||.+.+..+.+..+... ...... .....+++.+.+||++||. ||.+|+
T Consensus 234 ~G~~Pf~~~~~~~~~~~i~~~------------------------~~~~~~---~~~~~~s~~~~~li~~ll~-~p~~R~ 285 (364)
T cd05599 234 VGYPPFCSDNPQETYRKIINW------------------------KETLQF---PDEVPLSPEAKDLIKRLCC-EAERRL 285 (364)
T ss_pred cCCCCCCCCCHHHHHHHHHcC------------------------CCccCC---CCCCCCCHHHHHHHHHHcc-CHhhcC
Confidence 999999887765544433210 000011 1112578999999999997 999999
Q ss_pred C---HHHHHhCcccccc
Q 008729 306 T---AEEALADPYFKGL 319 (556)
Q Consensus 306 t---a~elL~hp~f~~~ 319 (556)
+ ++++|+||||++.
T Consensus 286 ~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 286 GNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHhcCCCcCCC
Confidence 8 9999999999875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=384.16 Aligned_cols=326 Identities=47% Similarity=0.815 Sum_probs=265.9
Q ss_pred CeEEEeeeeecCceeEEEEEECCC--CcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCc
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHT--GEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~t--g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 100 (556)
+|++.+.||+|+||.||+|.+..+ +..||||++............+.+|+.+++.+ +||||+++++...... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 589999999999999999999988 99999999875444444456788999999999 5999999998754321 3345
Q ss_pred eEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 101 DIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
.+|+++||++++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 80 ELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred cEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 68999999999999999888889999999999999999999999999999999999999999999999999997643221
Q ss_pred CC-cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 181 PM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 181 ~~-~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.. .......+|+..|+|||++.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...+|.|..+.+..+.
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred ccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 1112346799999999987552 468899999999999999999999999999999999999999999988877777
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhHh
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFE 339 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~~ 339 (556)
.+....++..+......++....+..+..+.+||.+||+.||++|||+.+++.||||+.+..+...+.|.....+.|+-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~- 317 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDPDDEPVCQKPFDFSFES- 317 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCccccccccccccCCccc-
Confidence 7666666665555555555555667899999999999999999999999999999999887766666665444333322
Q ss_pred hhcCCHHHHHHHHHH
Q 008729 340 RRRVTKDDIRELIYR 354 (556)
Q Consensus 340 ~~~~~~~~~~~~~~~ 354 (556)
..+.++++.+|..
T Consensus 318 --~~~~~~~~~~~~~ 330 (332)
T cd07857 318 --EDSMEELRDMIIE 330 (332)
T ss_pred --cccHHHHHHHHhh
Confidence 2345566666543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=395.69 Aligned_cols=263 Identities=24% Similarity=0.384 Sum_probs=214.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|+++++||+|+||.||+|++..+++.||||++.... ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~-----~~~~~ 75 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN 75 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE-----EeCCE
Confidence 36999999999999999999999999999999987421 1223456788999999999999999999999 45567
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|+|||||. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 76 LYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred C--------------------------------------------CcceecccccCcccCCcccccccCCCCCCcchhhh
Q 008729 181 P--------------------------------------------MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (556)
Q Consensus 181 ~--------------------------------------------~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWS 216 (556)
. ........+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwS 233 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCCeeeEEe
Confidence 0 0000123579999999999987 68999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHh
Q 008729 217 IGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296 (556)
Q Consensus 217 lG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~ 296 (556)
||||||+|++|++||.+.+.......+... ...........+++++.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~---------------------------~~~~~~p~~~~~s~~~~~li~~l 286 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTPLETQMKVINW---------------------------QTSLHIPPQAKLSPEASDLIIKL 286 (382)
T ss_pred chHHHHHHHhCCCCCCCCCHHHHHHHHHcc---------------------------CCCcCCCCcccCCHHHHHHHHHH
Confidence 999999999999999887755444333210 00011112245889999999998
Q ss_pred hhcCCCCCCC---HHHHHhCccccccc
Q 008729 297 IAFDPKDRPT---AEEALADPYFKGLA 320 (556)
Q Consensus 297 L~~dP~~Rpt---a~elL~hp~f~~~~ 320 (556)
+ .||++|++ ++++++||||+.+.
T Consensus 287 ~-~~p~~R~~~~~~~ei~~hp~f~~~~ 312 (382)
T cd05625 287 C-RGPEDRLGKNGADEIKAHPFFKTID 312 (382)
T ss_pred c-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence 6 59999997 99999999998753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=381.01 Aligned_cols=291 Identities=37% Similarity=0.643 Sum_probs=233.4
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
++..++|++++.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++ ..
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~-----~~ 75 (301)
T cd07873 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDII-----HT 75 (301)
T ss_pred CccccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEE-----ec
Confidence 3556789999999999999999999999999999999864322 22334577899999999999999999998 45
Q ss_pred CceEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
...+|+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++....
T Consensus 76 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 76 EKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred CCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 5679999999999999988764 568999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... ......+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+...++.|....+..
T Consensus 156 ~~~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (301)
T cd07873 156 IPTK---TYSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG 231 (301)
T ss_pred CCCC---cccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh
Confidence 2221 12344678999999988652 4578899999999999999999999999999999999999998887766543
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
+.......... .............+.+++.+.+||.+||+.||.+|||++++|+||||+.+.
T Consensus 232 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 232 ILSNEEFKSYN-YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred hhccccccccc-cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 32111000000 000000001122346889999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=394.66 Aligned_cols=262 Identities=22% Similarity=0.371 Sum_probs=213.3
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
.|++++.||+|+||+||+|++..+++.||||++... .........+.+|+.+|+.++||||+++++++ .+...+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~-----~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE-----ecCCEE
Confidence 699999999999999999999999999999998643 22334556788999999999999999999999 455679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+|||||. |+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999998 69999999888899999999999999999999999999999999999999999999999999753210000
Q ss_pred --------------------------------------------CcceecccccCcccCCcccccccCCCCCCcchhhhH
Q 008729 182 --------------------------------------------MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 217 (556)
Q Consensus 182 --------------------------------------------~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSl 217 (556)
........+||+.|+|||++.+ ..|+.++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSl 234 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceeeh
Confidence 0001124579999999999987 679999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhh
Q 008729 218 GCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLI 297 (556)
Q Consensus 218 G~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L 297 (556)
|||+|+|++|.+||.+.+..+....+... ...........+++++.+||.+||
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~---------------------------~~~~~~~~~~~~s~~~~dli~~ll 287 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINW---------------------------ENTLHIPPQVKLSPEAVDLITKLC 287 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHcc---------------------------ccccCCCCCCCCCHHHHHHHHHHc
Confidence 99999999999999887654443333210 000111122358899999999976
Q ss_pred hc--CCCCCCCHHHHHhCcccccc
Q 008729 298 AF--DPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 298 ~~--dP~~Rpta~elL~hp~f~~~ 319 (556)
.. ++..|++++++++||||.++
T Consensus 288 ~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 288 CSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred cCcccccCCCCHHHHhcCcccCCC
Confidence 54 44459999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=394.43 Aligned_cols=262 Identities=26% Similarity=0.420 Sum_probs=213.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCe
Confidence 37999999999999999999999999999999986421 1223456788999999999999999999999 55567
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|||||||. |+|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 999999998 6999999988899999999999999999999999999999999999999999999999999996321100
Q ss_pred CC------------c--------------------------------ceecccccCcccCCcccccccCCCCCCcchhhh
Q 008729 181 PM------------T--------------------------------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWS 216 (556)
Q Consensus 181 ~~------------~--------------------------------~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWS 216 (556)
.. . ......+||+.|+|||++.+ ..|+.++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS 233 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCCCceeeEe
Confidence 00 0 00013579999999999987 68999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHh
Q 008729 217 IGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296 (556)
Q Consensus 217 lG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~ 296 (556)
||||||+|++|.+||.+.+..+.+..|... ..... ......++.++.+||.+|
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~------------------------~~~~~---~p~~~~~s~~~~dli~~l 286 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINW------------------------RETLY---FPDDIHLSVEAEDLIRRL 286 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHcc------------------------CCccC---CCCCCCCCHHHHHHHHHH
Confidence 999999999999999887765555444211 00001 111234789999999999
Q ss_pred hhcCCCCC---CCHHHHHhCcccccc
Q 008729 297 IAFDPKDR---PTAEEALADPYFKGL 319 (556)
Q Consensus 297 L~~dP~~R---pta~elL~hp~f~~~ 319 (556)
|. +|.+| +|+.++|+||||++.
T Consensus 287 L~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 287 IT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 98 77765 599999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=378.12 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=212.8
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
.|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+|+.++|+||+++++++ .+...+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeE
Confidence 3889999999999999999999999999999986432 2223344678999999999999999999998 455679
Q ss_pred EEEEecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 103 YVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
|+|||||. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999998 689887754 336899999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
. .....+||..|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.........+...
T Consensus 156 ~----~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~------------- 216 (285)
T cd05631 156 E----TVRGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR------------- 216 (285)
T ss_pred C----eecCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH-------------
Confidence 1 1245579999999999987 68999999999999999999999999876543222222110
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHhCccccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGLA 320 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-----a~elL~hp~f~~~~ 320 (556)
+. .........++..+.+||++||..||++||+ ++++++||||.++.
T Consensus 217 ----------~~----~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 217 ----------VK----EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred ----------hh----cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 10 0111223458899999999999999999997 99999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=389.11 Aligned_cols=256 Identities=23% Similarity=0.385 Sum_probs=216.3
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCC-cEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg-~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
..++|++++.||+|+||.||+|.+..++ ..||+|++.... ........+.+|+.+|+.++||||+++++++ .+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~ 102 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KD 102 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----Ee
Confidence 3457999999999999999999877655 689999986421 2233456788999999999999999999998 45
Q ss_pred CceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
...+|+|||||. |+|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 567999999997 6999999998899999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.. ....+||+.|+|||++.+ ..++.++||||||||+|+|++|.+||.+.+.......+..
T Consensus 183 ~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~------------ 242 (340)
T PTZ00426 183 TR------TYTLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE------------ 242 (340)
T ss_pred CC------cceecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc------------
Confidence 21 134579999999999987 6789999999999999999999999988775544443321
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
... .....+++.+.+||++||+.||.+|+ |++++++||||.++.
T Consensus 243 --------------~~~-----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 243 --------------GII-----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred --------------CCC-----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 000 11245788999999999999999995 899999999998753
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=382.16 Aligned_cols=325 Identities=40% Similarity=0.752 Sum_probs=260.0
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC-CCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~~ 100 (556)
.++|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++.... .....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36899999999999999999999999999999998754333334456789999999999999999999986432 12345
Q ss_pred eEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 101 DIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
.+|+|+||+..+|..++. ..++++.+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~- 170 (342)
T cd07879 94 DFYLVMPYMQTDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE- 170 (342)
T ss_pred eEEEEecccccCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-
Confidence 689999999988877653 46899999999999999999999999999999999999999999999999998754221
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
.....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....|.+.++.......
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 171 -----MTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred -----CCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 2345688999999987652 3578899999999999999999999999998888999999999888888776666
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhHhh
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFER 340 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~~~ 340 (556)
.....+...+.......+...++..++.+.+||++||+.||++||+++++|.||||+.+...+.++...+ +....+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~~~---~~~~~~~ 321 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQP---YDDSLEN 321 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCCCc---ccchhhh
Confidence 5555555444333333334445678899999999999999999999999999999998866544443222 3333344
Q ss_pred hcCCHHHHHHHHHHHHHh
Q 008729 341 RRVTKDDIRELIYREILE 358 (556)
Q Consensus 341 ~~~~~~~~~~~~~~e~~~ 358 (556)
.....+++...+|++...
T Consensus 322 ~~~~~~~~~~~~~~~~~~ 339 (342)
T cd07879 322 EKLSVDEWKKHIYKEVKS 339 (342)
T ss_pred hhCCHHHHHHHhhhhhhc
Confidence 455566666677766543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=383.61 Aligned_cols=248 Identities=31% Similarity=0.476 Sum_probs=210.2
Q ss_pred eeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEecC
Q 008729 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (556)
Q Consensus 31 LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 109 (556)
||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+|+.++||||+++++++ .+...+|+|||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence 799999999999999999999999986432 2334556788999999999999999999998 4556799999999
Q ss_pred c-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcceecc
Q 008729 110 E-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188 (556)
Q Consensus 110 ~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~ 188 (556)
. |+|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ....
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~ 152 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNT 152 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC---cccc
Confidence 8 69999999888999999999999999999999999999999999999999999999999999975432221 1245
Q ss_pred cccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHH
Q 008729 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLT 268 (556)
Q Consensus 189 ~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~ 268 (556)
.+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......+..
T Consensus 153 ~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~----------------------- 207 (312)
T cd05585 153 FCGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ----------------------- 207 (312)
T ss_pred ccCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----------------------
Confidence 679999999999987 6899999999999999999999999988765444333211
Q ss_pred HhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC---CHHHHHhCcccccc
Q 008729 269 EMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP---TAEEALADPYFKGL 319 (556)
Q Consensus 269 ~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp---ta~elL~hp~f~~~ 319 (556)
.. ......+++.+.+||.+||..||++|| ++.++|+||||...
T Consensus 208 ---~~-----~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 208 ---EP-----LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred ---CC-----CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 11 112245889999999999999999997 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-46 Score=393.81 Aligned_cols=262 Identities=24% Similarity=0.382 Sum_probs=214.3
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
+.|++++.||+|+||.||+|++..+++.||||++.+.. ........+.+|+.+|+.++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCE
Confidence 47999999999999999999999999999999986421 1223345678999999999999999999998 55567
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|+|||||. |+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999998 6999999988889999999999999999999999999999999999999999999999999975321000
Q ss_pred C----------------------------------------CcceecccccCcccCCcccccccCCCCCCcchhhhHHHH
Q 008729 181 P----------------------------------------MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220 (556)
Q Consensus 181 ~----------------------------------------~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~i 220 (556)
. ........+||+.|+|||++.+ ..++.++||||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvi 233 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCcceeeeeccce
Confidence 0 0000123579999999999987 689999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcC
Q 008729 221 FAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300 (556)
Q Consensus 221 lyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~d 300 (556)
+|+|++|+.||.+.+..+....+.. ............+++.+.+||.+|+ .+
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~---------------------------~~~~~~~~~~~~~s~~~~~li~~l~-~~ 285 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVIN---------------------------WETTLHIPSQAKLSREASDLILRLC-CG 285 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhc---------------------------cCccccCCCCCCCCHHHHHHHHHHh-cC
Confidence 9999999999988776544433311 0000111122468899999999977 59
Q ss_pred CCCCC---CHHHHHhCcccccc
Q 008729 301 PKDRP---TAEEALADPYFKGL 319 (556)
Q Consensus 301 P~~Rp---ta~elL~hp~f~~~ 319 (556)
|.+|+ |+.++++||||+++
T Consensus 286 p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 286 AEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred HhhcCCCCCHHHHhCCCCcCCC
Confidence 99999 99999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=383.51 Aligned_cols=329 Identities=44% Similarity=0.770 Sum_probs=265.6
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (556)
..++|++.+.||+|+||.||+|.+..+|+.||+|++...+........+.+|+.+++.+ +||||+++++++.. .+.
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence 34689999999999999999999999999999999876555555566788999999999 99999999998743 233
Q ss_pred ceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
..+|+||||+.++|.+++..+ .+.+..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 568999999999999999876 7899999999999999999999999999999999999999999999999999865433
Q ss_pred CCC--cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 180 TPM--TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 180 ~~~--~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
... ......++|+.+|+|||++.+. ..++.++|||||||++|+|++|++||.+....+....+....+.+..+.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES 239 (337)
T ss_pred cccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 211 1223456799999999987552 4578899999999999999999999999999999999999999998888777
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhh
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFE 337 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~ 337 (556)
+........+.........+.....+.++..+.+||.+||+.||.+|||+.++|+||||+++.....++.........+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (337)
T cd07852 240 IKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSDEPVLPYPITIPLD 319 (337)
T ss_pred HHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCCCCCCCCCccCCcc
Confidence 76666666666555555555566667789999999999999999999999999999999988655445433222222221
Q ss_pred HhhhcCCHHHHHHHHHHH
Q 008729 338 FERRRVTKDDIRELIYRE 355 (556)
Q Consensus 338 ~~~~~~~~~~~~~~~~~e 355 (556)
+.+++...+.+..+|.+
T Consensus 320 -~~~~~~~~~~~~~~~~~ 336 (337)
T cd07852 320 -DNVKLSVAEYRNKLYEE 336 (337)
T ss_pred -ccceeeHHHHHhhhhhc
Confidence 33344444555555543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-46 Score=388.41 Aligned_cols=263 Identities=30% Similarity=0.497 Sum_probs=219.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|..++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCe
Confidence 479999999999999999999999999999999874321 223455688999999999999999999988 55667
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999998 6999999988899999999999999999999999999999999999999999999999999997654322
Q ss_pred C--------------------------CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC
Q 008729 181 P--------------------------MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (556)
Q Consensus 181 ~--------------------------~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~ 234 (556)
. ........+||+.|+|||++.+ ..++.++||||||||||+|++|+.||.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 0 0011234679999999999987 68999999999999999999999999888
Q ss_pred ChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-HHHHHhC
Q 008729 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-AEEALAD 313 (556)
Q Consensus 235 ~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-a~elL~h 313 (556)
+.......+.... .....+ ....+++.+.+||.+||. ||.+|++ ++++|+|
T Consensus 234 ~~~~~~~~i~~~~------------------------~~~~~p---~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKIINWK------------------------ESLRFP---PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHHhccC------------------------CcccCC---CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 7555444432210 011111 122378999999999998 9999999 9999999
Q ss_pred ccccccc
Q 008729 314 PYFKGLA 320 (556)
Q Consensus 314 p~f~~~~ 320 (556)
|||+++.
T Consensus 286 p~~~~~~ 292 (350)
T cd05573 286 PFFKGID 292 (350)
T ss_pred CCcCCCC
Confidence 9998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=383.98 Aligned_cols=250 Identities=24% Similarity=0.456 Sum_probs=211.4
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEe
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (556)
+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+|+.++||||+++++++ .....+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999987432 2234456788999999999999999999998 55567999999
Q ss_pred cCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCccee
Q 008729 108 LME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (556)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (556)
|+. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---~~ 152 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TM 152 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc---cc
Confidence 998 69999998888899999999999999999999999999999999999999999999999999875432211 12
Q ss_pred cccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHH
Q 008729 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (556)
Q Consensus 187 ~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~ 266 (556)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--------------------- 209 (328)
T cd05593 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--------------------- 209 (328)
T ss_pred ccccCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc---------------------
Confidence 44679999999999987 6789999999999999999999999987765444333210
Q ss_pred HHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCcccccc
Q 008729 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (556)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 319 (556)
.. ......+++++.+||++||..||++|+ ++.++++||||.+.
T Consensus 210 -----~~-----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 210 -----ED-----IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred -----CC-----ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 00 112245889999999999999999997 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=382.61 Aligned_cols=250 Identities=26% Similarity=0.456 Sum_probs=211.5
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEe
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (556)
+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+|+.++||||+++++++ .....+|||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence 479999999999999999999999999874321 223455678899999999999999999998 44567999999
Q ss_pred cCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCccee
Q 008729 108 LME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (556)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (556)
||+ ++|..++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~~ 152 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TM 152 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC---cc
Confidence 998 69999998888899999999999999999999999999999999999999999999999999875332221 12
Q ss_pred cccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHH
Q 008729 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (556)
Q Consensus 187 ~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~ 266 (556)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~--------------------- 209 (323)
T cd05595 153 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------------- 209 (323)
T ss_pred ccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------------
Confidence 34679999999999977 6789999999999999999999999988775544433311
Q ss_pred HHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCcccccc
Q 008729 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (556)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 319 (556)
... .....+++.+.+||++||..||++|+ ++.++++|+||.+.
T Consensus 210 -----~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 210 -----EEI-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred -----CCC-----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 000 11235789999999999999999998 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-48 Score=366.91 Aligned_cols=303 Identities=32% Similarity=0.513 Sum_probs=249.1
Q ss_pred cccccCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCC
Q 008729 15 FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (556)
Q Consensus 15 ~~~~~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~ 94 (556)
++.-....+.|+-+.+||+|.||.||+|+.+.+|+.||+|++-...+....-...++|+++|..|+|+|++.+++++...
T Consensus 9 ~~P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk 88 (376)
T KOG0669|consen 9 YEPFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK 88 (376)
T ss_pred cCCceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhc
Confidence 34445567899999999999999999999999999999998754333444455678999999999999999999987533
Q ss_pred ---CCCCCceEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeee
Q 008729 95 ---SKREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (556)
Q Consensus 95 ---~~~~~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DF 170 (556)
...+...+|+||.+|+.||..++... .+++..+++.++.+++.||.|+|.+.|+|||+|+.|+||+.+|.+||+||
T Consensus 89 ~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 89 ATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred cCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence 22344569999999999999999765 68999999999999999999999999999999999999999999999999
Q ss_pred CccccccC-CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC
Q 008729 171 GLARVAFS-DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (556)
Q Consensus 171 Gla~~~~~-~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~ 249 (556)
|+|+.... .......++..+.|.||++||++.|. ..|+++.|||..|||+.||++|.+.|.+.+..+++..|..++|.
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs 247 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS 247 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence 99976432 22223346778899999999998875 78999999999999999999999999999999999999999999
Q ss_pred CChHHHHHhhhHHHHHHHHHh--hcCCCCCcCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 250 PSPETIAVVRNEKARKYLTEM--RKKPPVPLFQ--KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~--~~~~~~~~~~--~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
-..+.|+.+.+-...+.+..- .+........ ..-.-++++.||+.+||..||.+|++++++|+|.||..
T Consensus 248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhc
Confidence 999999887765544443211 1110000000 00123678999999999999999999999999999974
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=369.52 Aligned_cols=282 Identities=37% Similarity=0.618 Sum_probs=227.6
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
.|++++.||.|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++ .+...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVL-----MQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEE-----eeCCeEE
Confidence 48999999999999999999999999999999865333333445678999999999999999999998 4456799
Q ss_pred EEEecCcccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 104 VVFELMESDLHQVIKAN---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 104 lV~E~~~g~L~~~i~~~---~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+||||+.++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 99999999998888652 568999999999999999999999999999999999999999999999999987543221
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
.......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+.....
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 ---RVYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ---ccccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 112344678999999987652 4578899999999999999999999999988888877777777776655543222
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
. ..+..................+++++.+||++||..||.+|||+.++++||||
T Consensus 232 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 L--PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred h--HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 1 11111111111111222345689999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=372.40 Aligned_cols=282 Identities=38% Similarity=0.602 Sum_probs=225.3
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
+|++.+.||+|+||.||+|++..+|+.||+|++............+.+|+.+++.++||||+++++++ .+...+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence 69999999999999999999999999999999864322223335677899999999999999999998 4556799
Q ss_pred EEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCC
Q 008729 104 VVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (556)
Q Consensus 104 lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 182 (556)
+|+||++++|.+++.. .+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.......
T Consensus 76 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred EEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 9999999999988865 56799999999999999999999999999999999999999999999999999875432211
Q ss_pred cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~p-F~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
......++..|+|||.+.+. ..++.++|||||||++|+|++|..| |.+.+....+..+...++.+....+......
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CcCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 12345688999999987652 4578999999999999999998766 6777778888888888888766654332211
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.....+.. ......+.+..+.+++.+.+||++||..||.+|||++++|+||||
T Consensus 232 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYPM--YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccCC--CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 00000000 000011123345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=378.79 Aligned_cols=255 Identities=24% Similarity=0.415 Sum_probs=214.1
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCC-CcceeeEEEcCCCCCCCce
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHP-DIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~Hp-nIv~l~~v~~~~~~~~~~~ 101 (556)
+|++++.||+|+||.||+|.+..+++.||||++.... ........+..|+.++..+.|+ +|+.+++++ .+...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEE-----EcCCE
Confidence 4899999999999999999999999999999987432 1233456778899999999765 588888888 44567
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|+||||+. |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999987532221
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--------------- 215 (324)
T cd05587 156 K---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME--------------- 215 (324)
T ss_pred C---ceeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 1235679999999999987 6789999999999999999999999988776555544321
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----HHHHhCcccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-----EEALADPYFKGL 319 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta-----~elL~hp~f~~~ 319 (556)
.. ......+++.+.+||++||..||.+|++. +++++||||+..
T Consensus 216 -----------~~-----~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 216 -----------HN-----VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred -----------CC-----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 00 01123578999999999999999999976 899999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=380.02 Aligned_cols=251 Identities=24% Similarity=0.417 Sum_probs=211.2
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCceEEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (556)
+.||+|+||.||+|.++.+++.||||++.... ........+.+|+.++..+ +||||+++++++ .....+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence 47999999999999999999999999987432 2223455677899999877 699999999998 5556799999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce
Q 008729 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (556)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (556)
|||. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---~ 152 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---T 152 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---c
Confidence 9998 69999998888999999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 186 ~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..|..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-------------------- 210 (320)
T cd05590 153 TSTFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-------------------- 210 (320)
T ss_pred ccccccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc--------------------
Confidence 244679999999999987 6789999999999999999999999998876655544421
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH------HHHHhCccccccc
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA------EEALADPYFKGLA 320 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta------~elL~hp~f~~~~ 320 (556)
... .....++.++.+||++||+.||++|+++ +++++||||..+.
T Consensus 211 ------~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 211 ------DEV-----VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred ------CCC-----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 000 1123478999999999999999999998 9999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=382.35 Aligned_cols=262 Identities=24% Similarity=0.403 Sum_probs=216.4
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|.+.+.||+|+||.||+|.++.+|+.||||++..... .......+.+|+.+++.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCe
Confidence 479999999999999999999999999999999875322 223445678899999999999999999998 45567
Q ss_pred EEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
+|+||||++ ++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999997 6999999876 67999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcceecccccCcccCCccccccc----CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~----~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
... .....+||+.|+|||++... ...++.++||||||||+|+|++|+.||.+.+....+..|...
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--------- 224 (330)
T cd05601 156 KMV--NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--------- 224 (330)
T ss_pred Cce--eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC---------
Confidence 221 12345799999999998631 146788999999999999999999999887765544443221
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.........+.+++.+.+||++||. ||++|||++++++||||..+
T Consensus 225 ------------------~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 225 ------------------QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred ------------------CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 1111112234688999999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=378.80 Aligned_cols=253 Identities=26% Similarity=0.449 Sum_probs=210.3
Q ss_pred eEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHH---HhCCCCCcceeeEEEcCCCCCCCc
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLL---RLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL---~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|++++ +.++||||+++++++ ....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence 789999999999999999999999999999987432 1223445677777765 456799999999998 5556
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+||||+. ++|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 7999999999 588887764 57999999999999999999999999999999999999999999999999998753322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.. .....+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 155 ~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------------- 215 (324)
T cd05589 155 GD---RTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN-------------- 215 (324)
T ss_pred CC---cccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Confidence 21 1245679999999999987 6789999999999999999999999998876555444321
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCcccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 319 (556)
... .....+++.+.+||++||..||.+|| +++++++||||+++
T Consensus 216 ------------~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 216 ------------DEV-----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred ------------CCC-----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 111 11235789999999999999999999 79999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=381.34 Aligned_cols=250 Identities=26% Similarity=0.464 Sum_probs=210.7
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEe
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (556)
+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+++++.++||||+++++++ .....+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence 46999999999999999999999999987532 2233456678899999999999999999998 55567999999
Q ss_pred cCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce
Q 008729 108 LME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (556)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (556)
|+. ++|..++.....+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---T 152 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---c
Confidence 998 6999999888889999999999999999999997 7999999999999999999999999999875332221 1
Q ss_pred ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 186 ~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05594 153 MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------------------- 210 (325)
T ss_pred cccccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc--------------------
Confidence 244679999999999977 6789999999999999999999999988765444433311
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCcccccc
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 319 (556)
... .....+++.+.+||++||+.||++|+ ++.++|+||||.+.
T Consensus 211 ------~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 211 ------EEI-----RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred ------CCC-----CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 000 11235789999999999999999997 99999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=385.90 Aligned_cols=257 Identities=29% Similarity=0.463 Sum_probs=221.8
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
....|..++.||+|+||.||+|++..+++.||||++.-. ....+...+..|+.+|..++++||.++|+.|+...
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~----- 84 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGT----- 84 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecc-----
Confidence 345788899999999999999999999999999999743 33445678899999999999999999999996554
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|++||||+ |++.+.++....+.+.++..++++++.||.|||+.+.+|||||+.|||+..+|.+||+|||.+......
T Consensus 85 ~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 85 KLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred cHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 4999999999 699999998888899999999999999999999999999999999999999999999999999765444
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
... ..+++||++|||||++.+ ..|+.++||||||++.|||++|.|||.....+..+..|
T Consensus 165 ~~r---r~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI---------------- 223 (467)
T KOG0201|consen 165 VKR---RKTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI---------------- 223 (467)
T ss_pred hhc---cccccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec----------------
Confidence 333 267899999999999987 89999999999999999999999999887654433222
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
.+..+ |..+ ..+++.+++|+..||++||+.||+|.++|+|+|++.
T Consensus 224 -----------pk~~P-P~L~--~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 224 -----------PKSAP-PRLD--GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred -----------cCCCC-Cccc--cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 11111 2211 268999999999999999999999999999999985
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=385.38 Aligned_cols=264 Identities=25% Similarity=0.371 Sum_probs=216.0
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
..++|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++ .+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~ 115 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDD 115 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecC
Confidence 3468999999999999999999999999999999986421 2223445577899999999999999999998 556
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
..+|+|||||. |+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 67999999998 699998865 4689999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcceecccccCcccCCccccccc--CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
... ......+||+.|+|||++.+. ...++.++|||||||++|+|++|++||.+.+....+..|..
T Consensus 195 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~----------- 261 (370)
T cd05596 195 NGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMD----------- 261 (370)
T ss_pred CCc--ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHc-----------
Confidence 221 112356799999999998652 12478999999999999999999999998876554444321
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHHHHHhCcccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~--Rpta~elL~hp~f~~~ 319 (556)
.... ........++.++.+||++||..+|++ |+|++++++||||++.
T Consensus 262 ---------------~~~~-~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 262 ---------------HKNS-LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred ---------------CCCc-CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 0000 111122357899999999999999998 9999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=378.39 Aligned_cols=251 Identities=29% Similarity=0.500 Sum_probs=210.4
Q ss_pred EeeeeecCceeEEEEEEC---CCCcEEEEEEecCcc--CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 28 LEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~---~tg~~vAiK~i~~~~--~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++.||+|+||.||+|.+. .+++.||||++.... ........+.+|+.+|+.++||||+++++++ .....+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~ 75 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAF-----QTGGKL 75 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEE-----ecCCeE
Confidence 468999999999999864 578899999987431 2223445678899999999999999999998 455679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+||||+. ++|.+++...+.+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 76 YLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred EEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999 69999999888899999999999999999999999999999999999999999999999999875432221
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 156 ~---~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~---------------- 214 (323)
T cd05584 156 V---THTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK---------------- 214 (323)
T ss_pred c---ccccCCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc----------------
Confidence 1 234679999999999987 6788999999999999999999999988775544443321
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCcccccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 319 (556)
.. ....+.+++.+.+||++||+.||++|| +++++++||||...
T Consensus 215 ----------~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 215 ----------GK-----LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred ----------CC-----CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 11 122345789999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=379.13 Aligned_cols=261 Identities=24% Similarity=0.404 Sum_probs=210.8
Q ss_pred CeEEEeeeeecCceeEEEEEEC---CCCcEEEEEEecCcc--CChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCC
Q 008729 24 RYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~---~tg~~vAiK~i~~~~--~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~ 97 (556)
.|++++.||+|+||+||+|.+. .+++.||+|++.+.. ........+.+|+.+|+.+ +||||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence 4899999999999999999864 578999999986421 2233455678999999999 599999999998 5
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
....+|+|||||. |+|.+++..+..++++.++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 5567999999998 699999988888999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
....... ....+||+.|+|||++.+. ..++.++||||||||+|+|++|+.||...........+.
T Consensus 156 ~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~------------ 220 (332)
T cd05614 156 LSEEKER--TYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS------------ 220 (332)
T ss_pred cccCCCc--cccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH------------
Confidence 3322211 2346799999999998752 357889999999999999999999997543221111110
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCcccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 319 (556)
..+.... ......+++.+.+||.+||..||++|| +++++++||||++.
T Consensus 221 -----------~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 221 -----------RRILKCD----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred -----------HHHhcCC----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 0111111 112245889999999999999999999 88999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=373.87 Aligned_cols=321 Identities=46% Similarity=0.839 Sum_probs=265.0
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
+...++|++++.||.|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.. .
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~----~ 81 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS----P 81 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec----C
Confidence 345678999999999999999999999999999999986543333455678899999999999999999998842 2
Q ss_pred CceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
....|+|+||++++|.+++.. ..+++..+..++.||+.||+|||+.||+||||+|+|||++.++.+||+|||++.....
T Consensus 82 ~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 82 LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred CCcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 346899999999999888864 4688999999999999999999999999999999999999999999999999875322
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
. .....++..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.........+.+.+|.+..+.+..+
T Consensus 161 ~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 161 Q------MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred C------cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 1 1345688899999987542 46889999999999999999999999999988888889999999998888776
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhH
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEF 338 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~ 338 (556)
......+++..+......+.....+.++..+.++|++||+.||++|||++++|.||||.....+..++.. ..++++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~~~~--~~~~~~~~ 311 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVA--EEKFDWSF 311 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccccCc--hhhcCCch
Confidence 6666666666666555566666667789999999999999999999999999999999877655444332 23566666
Q ss_pred hhhcCCHHHHHHHHH
Q 008729 339 ERRRVTKDDIRELIY 353 (556)
Q Consensus 339 ~~~~~~~~~~~~~~~ 353 (556)
+......+.++-+.|
T Consensus 312 ~~~~~~~~~~~~~~~ 326 (328)
T cd07856 312 NDADLPVDTWKVMMY 326 (328)
T ss_pred hcccCCHHHHHHHhc
Confidence 666666677665554
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=385.03 Aligned_cols=263 Identities=25% Similarity=0.417 Sum_probs=215.7
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
+.|++++.||+|+||.||+|.++.+++.||||++.... ........+.+|+.+|..++||+|+++++.+ .+...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 36999999999999999999999999999999986421 1223455788899999999999999999998 55677
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|||||||. |+|.+++...+.+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 999999998 6999999988899999999999999999999999999999999999999999999999999987532111
Q ss_pred CC--------------------------------cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCC
Q 008729 181 PM--------------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (556)
Q Consensus 181 ~~--------------------------------~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~ 228 (556)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceeccccceeeecccCC
Confidence 00 000124579999999999987 78999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC---
Q 008729 229 PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP--- 305 (556)
Q Consensus 229 ~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp--- 305 (556)
+||.+.+.......+... ..... ......+++.+++||.+|+ .||.+|+
T Consensus 234 ~Pf~~~~~~~~~~~i~~~--------------------------~~~~~-~p~~~~~s~~~~~li~~l~-~~p~~R~~~~ 285 (360)
T cd05627 234 PPFCSETPQETYRKVMNW--------------------------KETLV-FPPEVPISEKAKDLILRFC-TDSENRIGSN 285 (360)
T ss_pred CCCCCCCHHHHHHHHHcC--------------------------CCcee-cCCCCCCCHHHHHHHHHhc-cChhhcCCCC
Confidence 999888765554444210 00000 1111247899999999987 4999998
Q ss_pred CHHHHHhCccccccc
Q 008729 306 TAEEALADPYFKGLA 320 (556)
Q Consensus 306 ta~elL~hp~f~~~~ 320 (556)
+++++++||||+++.
T Consensus 286 ~~~ei~~hp~f~~~~ 300 (360)
T cd05627 286 GVEEIKSHPFFEGVD 300 (360)
T ss_pred CHHHHhcCCCCCCCC
Confidence 589999999999763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=375.38 Aligned_cols=279 Identities=24% Similarity=0.382 Sum_probs=219.4
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||+|+||.||+|.+..+|..||+|++.... .......+.+|+.+|+.++||||+++++++ .....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 77 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGE 77 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCE
Confidence 358999999999999999999999999999999987432 233456789999999999999999999998 44567
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
+|+||||++ ++|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 78 ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred EEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 999999999 69999999888899999999999999999999986 6999999999999999999999999998754322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH----
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI---- 255 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i---- 255 (556)
. ....+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.... ++.+.....
T Consensus 158 ~-----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~ 226 (331)
T cd06649 158 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI----FGRPVVDGEEGEP 226 (331)
T ss_pred c-----cccCCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----hcccccccccCCc
Confidence 1 234579999999999987 6799999999999999999999999987765443222 222110000
Q ss_pred -------------------HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 256 -------------------AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 256 -------------------~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
...........+..+........ ....+++++++||.+||.+||++|||++++|+||||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKL--PNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccCcccccccccccccccccccchhHHHHHHHHHhCCCcCC--CCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 00000011122222222111111 112478899999999999999999999999999999
Q ss_pred ccc
Q 008729 317 KGL 319 (556)
Q Consensus 317 ~~~ 319 (556)
+..
T Consensus 305 ~~~ 307 (331)
T cd06649 305 KRS 307 (331)
T ss_pred hhc
Confidence 853
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=384.81 Aligned_cols=263 Identities=26% Similarity=0.392 Sum_probs=214.1
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
..++|++++.||+|+||.||+|.+..+++.||+|++.+. .........+.+|+.+++.++||||+++++++ .+.
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcC
Confidence 346899999999999999999999999999999998642 12223445678999999999999999999998 556
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
..+|+|||||. |+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 77999999998 6999988754 689999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcceecccccCcccCCcccccccC--CCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~--~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
... ......+||+.|+|||++.+.. ..++.++|||||||+||+|++|++||.+.+....+..|.....
T Consensus 195 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~-------- 264 (370)
T cd05621 195 TGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN-------- 264 (370)
T ss_pred CCc--eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc--------
Confidence 211 1124567999999999986521 2378899999999999999999999998876555544432110
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHHHHHhCccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKG 318 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~--Rpta~elL~hp~f~~ 318 (556)
... ......++..+++||.+||..++.+ |+|++++++||||+.
T Consensus 265 ------------------~~~-~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 265 ------------------SLN-FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred ------------------ccC-CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 001 1112357899999999999866544 899999999999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=376.65 Aligned_cols=264 Identities=25% Similarity=0.433 Sum_probs=214.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||.||+|.+..+++.||||++.+. .........+.+|+.++..++|+||+.+++++ .+..+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCe
Confidence 4799999999999999999999999999999998642 12223445678899999999999999999998 55577
Q ss_pred EEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999997 699999976 457999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCcceecccccCcccCCccccccc---CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~---~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
... .....+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+....|..
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~----------- 222 (331)
T cd05597 156 GTV--QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----------- 222 (331)
T ss_pred CCc--cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHc-----------
Confidence 211 11234699999999998631 13578899999999999999999999988776555444321
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHHHHHhCcccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~--Rpta~elL~hp~f~~~ 319 (556)
......+....+.++..+++||++||..++++ |++++++|+||||.++
T Consensus 223 ---------------~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 223 ---------------HKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred ---------------CCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 11111222233458999999999999765554 7899999999999864
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=362.20 Aligned_cols=276 Identities=32% Similarity=0.481 Sum_probs=223.7
Q ss_pred ccccccccCCCCCeEEE-eeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeE
Q 008729 12 DKDFFTEYGDANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKR 89 (556)
Q Consensus 12 ~~~~~~~~~~~~~Y~i~-~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~ 89 (556)
..+| .++...++|.|- ++||-|-.|.|..+.++.|++++|+|++.+ ..+..||+.+.-.. .|||||.+++
T Consensus 51 ~m~~-k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~Iid 122 (400)
T KOG0604|consen 51 DMDF-KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIID 122 (400)
T ss_pred hcch-hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeeh
Confidence 3444 678888899886 579999999999999999999999998853 34667899886655 5999999999
Q ss_pred EEcCCCCCCCceEEEEEecCc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec---CCC
Q 008729 90 IMLPPSKREFKDIYVVFELME-SDLHQVIKANDD--LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN---ANC 163 (556)
Q Consensus 90 v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~~--l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~---~~~ 163 (556)
+|.. ++...+.+.+|||.|+ |+|+..|..++. +++.++..|++||..||.|||+.+|.||||||+|+|+. .|+
T Consensus 123 VyeN-s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na 201 (400)
T KOG0604|consen 123 VYEN-SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNA 201 (400)
T ss_pred hhhh-hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCc
Confidence 9843 3356678999999999 699999998775 99999999999999999999999999999999999986 456
Q ss_pred ceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 008729 164 KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243 (556)
Q Consensus 164 ~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i 243 (556)
.+||+|||+|+..... ..+.+.|-|++|.|||+++. .+|+..+|+||+|||+|.||+|.+||......-.
T Consensus 202 ~lKLtDfGFAK~t~~~----~~L~TPc~TPyYvaPevlg~--eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---- 271 (400)
T KOG0604|consen 202 PLKLTDFGFAKETQEP----GDLMTPCFTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---- 271 (400)
T ss_pred ceEecccccccccCCC----ccccCCcccccccCHHHhCc--hhcCCCCCccchhHHHHHhhcCCCcccccCCccC----
Confidence 7999999999865432 23456789999999999998 7899999999999999999999999976542110
Q ss_pred HHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccccc
Q 008729 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (556)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e 323 (556)
++.+-. .++......-...|..+|.+++|||++||..+|.+|.|++++++|||+.+.....
T Consensus 272 -------spgMk~------------rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp 332 (400)
T KOG0604|consen 272 -------SPGMKR------------RIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVP 332 (400)
T ss_pred -------ChhHHh------------HhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCC
Confidence 111100 0111112222345677999999999999999999999999999999999865444
Q ss_pred CC
Q 008729 324 RE 325 (556)
Q Consensus 324 ~~ 325 (556)
..
T Consensus 333 ~t 334 (400)
T KOG0604|consen 333 QT 334 (400)
T ss_pred CC
Confidence 33
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=377.30 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=211.2
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCceEEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (556)
++||+|+||.||+|.+..+++.||||++.... ........+..|+.++..+ +||||+++++++ .....+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence 46999999999999999999999999987432 2233455677899999876 799999999999 4556799999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce
Q 008729 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (556)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (556)
||++ ++|...+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---T 152 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---c
Confidence 9998 69999998888899999999999999999999999999999999999999999999999999875432221 1
Q ss_pred ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 186 ~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~-------------------- 210 (321)
T cd05591 153 TTTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH-------------------- 210 (321)
T ss_pred ccccccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245679999999999987 6899999999999999999999999998886665554421
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-------CHHHHHhCcccccc
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-------TAEEALADPYFKGL 319 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-------ta~elL~hp~f~~~ 319 (556)
... .....++.++.+||++||..||++|+ +++++++||||..+
T Consensus 211 ------~~~-----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 211 ------DDV-----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred ------CCC-----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 110 11234789999999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=351.62 Aligned_cols=258 Identities=25% Similarity=0.399 Sum_probs=224.6
Q ss_pred ccCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 18 ~~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
.....++|++++.||+|-||.||+|+.+.++-.||+|++.+. .........+.||+.|-..|+||||+++|+.|
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f----- 91 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF----- 91 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----
Confidence 345567899999999999999999999999999999998653 22333445688999999999999999999999
Q ss_pred CCCceEEEEEecCc-ccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcc
Q 008729 97 REFKDIYVVFELME-SDLHQVIK--ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~--~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla 173 (556)
-+...+||++||.. |+|+..+. ....+++..+..+++|++.||.|||.++|+||||||+|+|++..+.+||+|||-+
T Consensus 92 hd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGws 171 (281)
T KOG0580|consen 92 HDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWS 171 (281)
T ss_pred eccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCce
Confidence 45567999999999 89999998 5678999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
...... .....|||..|.+||...+ ..++..+|+|++|++.||++.|.+||...+..+...+|.++-
T Consensus 172 V~~p~~-----kR~tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~------ 238 (281)
T KOG0580|consen 172 VHAPSN-----KRKTLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD------ 238 (281)
T ss_pred eecCCC-----CceeeecccccCCHhhcCC--CCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc------
Confidence 764321 1256789999999999988 789999999999999999999999999888777776664311
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
. ...+.++..+.|||.+||.++|.+|.+..|++.|||+..
T Consensus 239 --------------------~-----~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 239 --------------------L-----KFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred --------------------c-----cCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 1 112579999999999999999999999999999999864
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=384.76 Aligned_cols=258 Identities=29% Similarity=0.440 Sum_probs=227.9
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|.++++||+|+||.+++++++..++.||+|+|.-.............|+.++++++|||||.+++.|. ++...
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~ 78 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQL 78 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCce
Confidence 45899999999999999999999999999999999865555555557889999999999999999999994 34445
Q ss_pred EEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
+||||+||+ |+|.+.|+.. ..++++.+..|+.||+.||.|||+++|+|||||+.||+++.++.|||+|||+|+....
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 999999999 6999999764 4689999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
+.. +...++||+.||+||++.+ .+|+.++|||||||++|||++-+++|.+.+....+.+|...+..|
T Consensus 159 ~~~---~a~tvvGTp~YmcPEil~d--~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P-------- 225 (426)
T KOG0589|consen 159 EDS---LASTVVGTPYYMCPEILSD--IPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP-------- 225 (426)
T ss_pred chh---hhheecCCCcccCHHHhCC--CCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC--------
Confidence 542 3367899999999999999 899999999999999999999999999999888888876544333
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
.....+.+++.||+.||..+|..||++.++|.+|.+..
T Consensus 226 ----------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 226 ----------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred ----------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 22347889999999999999999999999999988763
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=377.21 Aligned_cols=250 Identities=27% Similarity=0.467 Sum_probs=208.3
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHH-HHHhCCCCCcceeeEEEcCCCCCCCceEEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~-iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (556)
+.||+|+||+||+|.+..+|+.||||++.... ........+.+|.. +++.++||||+++++.+ .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~-----~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEE-----EeCCEEEEEE
Confidence 47999999999999999999999999986431 22233455666665 46789999999999998 4556799999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce
Q 008729 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (556)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (556)
||+. ++|..++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK---T 152 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---c
Confidence 9999 69999999888999999999999999999999999999999999999999999999999999875332221 1
Q ss_pred ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 186 ~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~-------------------- 210 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN-------------------- 210 (323)
T ss_pred cccccCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245679999999999887 6799999999999999999999999988776554443321
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH----HHHHhCcccccc
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGL 319 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta----~elL~hp~f~~~ 319 (556)
. .....+.+++.+.+||++||+.||.+||++ .++++||||..+
T Consensus 211 -------~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 211 -------K----PLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred -------C----CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 0 012235679999999999999999999987 699999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=370.80 Aligned_cols=292 Identities=42% Similarity=0.654 Sum_probs=232.4
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++.+.||.|+||.||+|.+..+|+.||+|++............+.+|+.+|+.++|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCC
Confidence 34689999999999999999999999999999999864333322334566899999999999999999998532 235
Q ss_pred eEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+||||++++|.+++.. ...+++..++.++.||+.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred eEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 6899999999999988876 367899999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.. ......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.+....+..+.
T Consensus 162 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 162 AK---PMTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred cC---CCCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence 21 12334568899999988652 457899999999999999999999999999999999999999888766544322
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.-.....+. ........+...+...++.+.+||.+||.+||++|||++++|.||||++..
T Consensus 238 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 238 DLPLVGKFT-LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred ccccccccc-ccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 111000000 000011111122344689999999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=374.78 Aligned_cols=255 Identities=23% Similarity=0.403 Sum_probs=214.7
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCce
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.|.+++.||+|+||.||+|++..+++.||||++.+... .......+..|..++..+ +|++|+.+++++ .....
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence 48999999999999999999999999999999875321 223445577888888887 589999999998 55567
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|+||||+. |+|.+.+...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 999999998 6999999888889999999999999999999999999999999999999999999999999987543222
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..|..
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--------------- 215 (323)
T cd05616 156 V---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--------------- 215 (323)
T ss_pred C---ccccCCCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh---------------
Confidence 1 1245679999999999987 6899999999999999999999999998876655544422
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHhCcccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-----a~elL~hp~f~~~ 319 (556)
... .....++..+.+|+.+||+.||.+|++ ..++++||||+.+
T Consensus 216 -----------~~~-----~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 216 -----------HNV-----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred -----------CCC-----CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 011 112357899999999999999999997 4899999999865
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=371.62 Aligned_cols=281 Identities=35% Similarity=0.591 Sum_probs=214.1
Q ss_pred EeeeeecCceeEEEEEECC--CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEE
Q 008729 28 LEVIGKGSYGVVCAAIDTH--TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (556)
..+||+|+||.||+|.+.. ++..||+|.+.... ....+.+|+.+|+.++||||+++++++... ....+|+|
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv 78 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLL 78 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEE
Confidence 4689999999999999654 66899999886431 223567899999999999999999998542 33568999
Q ss_pred EecCcccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee----cCCCceEEeeeCc
Q 008729 106 FELMESDLHQVIKAN---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCKLKVCDFGL 172 (556)
Q Consensus 106 ~E~~~g~L~~~i~~~---------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl----~~~~~vKL~DFGl 172 (556)
|||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 79 FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred EeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 999999999888532 248899999999999999999999999999999999999 5667899999999
Q ss_pred cccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh---------HHHHHHH
Q 008729 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---------VHQLDLI 243 (556)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~---------~~~~~~i 243 (556)
++...............+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+... ..++..+
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 237 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence 98654332222223456789999999988652 4588999999999999999999999975432 4567788
Q ss_pred HHhhCCCChHHHHHhhhHH-HHHHHHHhhcCCC-----C-CcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 244 TDLLGTPSPETIAVVRNEK-ARKYLTEMRKKPP-----V-PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~-~~~~l~~~~~~~~-----~-~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
...+|.+..+.+..+.... ............. . .........+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 8888888777665432110 0000000000000 0 0011112356789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-45 Score=374.46 Aligned_cols=250 Identities=24% Similarity=0.396 Sum_probs=207.8
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCceEEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (556)
++||+|+||.||+|.++.+|+.||+|++..... .......+..|..++..+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence 479999999999999999999999999875321 123345567788888765 899999999998 5556799999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce
Q 008729 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (556)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (556)
|||. ++|.+++..++.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN---R 152 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC---c
Confidence 9998 69999998888899999999999999999999999999999999999999999999999999874321111 2
Q ss_pred ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 186 ~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~-------------------- 210 (316)
T cd05620 153 ASTFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV-------------------- 210 (316)
T ss_pred eeccCCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------------
Confidence 245679999999999987 6899999999999999999999999988775444433311
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-HHHHhCcccccc
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-EEALADPYFKGL 319 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta-~elL~hp~f~~~ 319 (556)
.. ......++..+.+||++||..||++|+++ +++++||||+..
T Consensus 211 -------~~----~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 211 -------DT----PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred -------CC----CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 10 01123478899999999999999999997 588899999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=377.28 Aligned_cols=251 Identities=28% Similarity=0.468 Sum_probs=211.4
Q ss_pred EeeeeecCceeEEEEEE---CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEE
Q 008729 28 LEVIGKGSYGVVCAAID---THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~---~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (556)
++.||+|+||.||++.+ ..+|+.||+|++............+.+|+.+|+.++||||+++++++ .+...+|+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~l 75 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYL 75 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEE
Confidence 36899999999999986 36789999999975433334455678899999999999999999998 45567999
Q ss_pred EEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCc
Q 008729 105 VFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (556)
Q Consensus 105 V~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 183 (556)
||||+. ++|.+++.++..+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 999998 79999998888899999999999999999999999999999999999999999999999999876433221
Q ss_pred ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHH
Q 008729 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (556)
Q Consensus 184 ~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~ 263 (556)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 154 -~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~------------------ 212 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK------------------ 212 (318)
T ss_pred -ceecccCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc------------------
Confidence 1235679999999999987 6789999999999999999999999988776555444321
Q ss_pred HHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHhCcccccc
Q 008729 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (556)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-----a~elL~hp~f~~~ 319 (556)
... .....+++.+.+||++||+.||++||+ +++++.||||..+
T Consensus 213 --------~~~-----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 213 --------AKL-----GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred --------CCC-----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 111 122357899999999999999999999 7889999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=374.38 Aligned_cols=264 Identities=25% Similarity=0.415 Sum_probs=214.6
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|+++++||+|+||.||+++++.+++.||+|++.+.. ........+.+|+.++..++|++|+++++++ .+...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCE
Confidence 37999999999999999999999999999999986421 1222344577899999999999999999998 55567
Q ss_pred EEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
+|+||||+. |+|.+++.. ...+++..++.|+.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999998 799999977 467999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcceecccccCcccCCccccccc---CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~---~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
... .....+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.+..+.+..|..
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----------- 222 (332)
T cd05623 156 GTV--QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----------- 222 (332)
T ss_pred Ccc--eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhC-----------
Confidence 211 12345799999999988531 14688999999999999999999999998876655554421
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHHHHHhCcccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~--Rpta~elL~hp~f~~~ 319 (556)
.....++......+++.+.+||++||..++++ |++++++++||||.++
T Consensus 223 ---------------~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 223 ---------------HKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred ---------------CCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 11111222333568999999999999765554 6899999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=363.07 Aligned_cols=285 Identities=41% Similarity=0.708 Sum_probs=232.9
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
+|++.+.||.|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++ .....+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVF-----PHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeeE
Confidence 59999999999999999999999999999999875433334456788999999999999999999998 4456799
Q ss_pred EEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCC
Q 008729 104 VVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (556)
Q Consensus 104 lV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 182 (556)
+||||++++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 76 ~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred EEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9999998899999865 45689999999999999999999999999999999999999999999999999976543322
Q ss_pred cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHH
Q 008729 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (556)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~ 262 (556)
.......|+.+|+|||.+.+. ..++.++|||||||++|+|++|.++|.+.+....+..+...++.+....+..+....
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 112345689999999987652 457899999999999999999999999999988999998888888776554332211
Q ss_pred HHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
....+. .......++...+++.+..+.+||++||..||.+|||++++|+||||.
T Consensus 233 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 233 DYNKIT-FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhhccc-CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 100000 111111222334567789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=373.17 Aligned_cols=251 Identities=24% Similarity=0.411 Sum_probs=207.9
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCceEEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (556)
+.||+|+||.||+|.+..+++.||||++..... ..........|..++..+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTF-----QTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEE-----EeCCEEEEEE
Confidence 479999999999999999999999999875321 123345567788888764 899999999998 4556799999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce
Q 008729 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (556)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (556)
||+. |+|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---K 152 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---c
Confidence 9998 69999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 186 ~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~--------------------- 209 (316)
T cd05619 153 TCTFCGTPDYIAPEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR--------------------- 209 (316)
T ss_pred eeeecCCccccCHHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH---------------------
Confidence 234679999999999987 679999999999999999999999998877544443321
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHH-HHHhCccccccc
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE-EALADPYFKGLA 320 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~-elL~hp~f~~~~ 320 (556)
... + .....++..+.+||.+||..||++|+++. ++++||||+.+.
T Consensus 210 ------~~~--~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 210 ------MDN--P--CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred ------hCC--C--CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 110 0 01134788999999999999999999996 899999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=362.13 Aligned_cols=282 Identities=38% Similarity=0.624 Sum_probs=228.1
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
.|++++.||.|++|.||+|.+..+|+.||||++............+.+|+.+++.++||||+++++++ .+...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhc-----ccCCcEE
Confidence 48999999999999999999999999999999864333333445788999999999999999999998 4556799
Q ss_pred EEEecCcccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 104 VVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 104 lV~E~~~g~L~~~i~~--~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
+||||+.++|..++.. ...+++..++.++.||+.||+|||+.|++|+||+|+||+++.++.+||+|||++........
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 9999999899988865 35689999999999999999999999999999999999999999999999999875432211
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
......++..|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+......
T Consensus 156 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 ---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred ---ccccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 12334578899999987652 34688999999999999999999999999988888888888888876554432221
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
..+................+.+++.+.+||.+||+.||.+|||++++|+||||
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 --PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred --HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 11111111111222222345688999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=360.52 Aligned_cols=258 Identities=34% Similarity=0.583 Sum_probs=213.9
Q ss_pred eEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEE
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (556)
|++++.||+|+||+||+|++..+++.||+|++..............+|+.+++.++||||+++++++ .....+|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVF-----QDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEE-----EESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccc-----cccccccc
Confidence 8999999999999999999999999999999986533334444456799999999999999999999 44677999
Q ss_pred EEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCc
Q 008729 105 VFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (556)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 183 (556)
||||+.+ +|.+++...+.+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||.+..... ..
T Consensus 76 v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~---~~ 152 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE---NN 152 (260)
T ss_dssp EEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS---TT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc
Confidence 9999996 9999999888899999999999999999999999999999999999999999999999999875411 11
Q ss_pred ceecccccCcccCCccccc-ccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHH
Q 008729 184 VFWTDYVATRWYRAPELCG-SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (556)
Q Consensus 184 ~~~~~~~gt~~Y~APE~~~-~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~ 262 (556)
.......++..|+|||++. + ..++.++|||||||++|+|++|..||......+....+........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~----------- 219 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL----------- 219 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH-----------
T ss_pred ccccccccccccccccccccc--ccccccccccccccccccccccccccccccchhhhhhhhhcccccc-----------
Confidence 2335677999999999987 5 6789999999999999999999999988755555544433221110
Q ss_pred HHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
..... ........+.+||++||+.||++|||+.++++||||
T Consensus 220 ----~~~~~---------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 220 ----PSSSQ---------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp ----HHHTT---------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ----ccccc---------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 00000 001123789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=372.19 Aligned_cols=250 Identities=26% Similarity=0.447 Sum_probs=207.4
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCceEEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (556)
++||+|+||.||+|.+..+++.||||++..... .......+..|..++..+ +||||+++++++ .....+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 479999999999999999999999999874321 223344566777777654 799999999998 4556799999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce
Q 008729 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (556)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (556)
||+. |+|.+++...+.+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~---~ 152 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG---K 152 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC---c
Confidence 9998 69999998888999999999999999999999999999999999999999999999999999976432221 2
Q ss_pred ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 186 ~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~-------------------- 210 (316)
T cd05592 153 ASTFCGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-------------------- 210 (316)
T ss_pred cccccCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245679999999999987 6789999999999999999999999998876554433311
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-HHHHhCcccccc
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-EEALADPYFKGL 319 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta-~elL~hp~f~~~ 319 (556)
.. + .....++.++.+||++||..||.+||++ .++++||||...
T Consensus 211 -------~~--~--~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 211 -------DR--P--HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred -------CC--C--CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 00 0 1123478899999999999999999986 588899999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=369.14 Aligned_cols=279 Identities=33% Similarity=0.597 Sum_probs=225.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCC--CC----cceeeEEEcCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH--PD----IVEIKRIMLPPS 95 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H--pn----Iv~l~~v~~~~~ 95 (556)
.+||.+++.+|+|.||.|..+.|..++..||||+++.. ....+ ..+-||++|+++.+ |+ +|.+.++|
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYre--Aa~iEi~vLqki~~~DP~g~~rcv~m~~wF---- 160 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYRE--AALIEIEVLQKINESDPNGKFRCVQMRDWF---- 160 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhh--HHHHHHHHHHHHHhcCCCCceEEEeeehhh----
Confidence 57999999999999999999999999999999998742 22223 34459999999943 22 55666666
Q ss_pred CCCCceEEEEEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC------------
Q 008729 96 KREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA------------ 161 (556)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~------------ 161 (556)
+-.+++|||+|.++.++++.+++|+ +++..+++.+.+||+.+++|||+.+++|.||||+|||+..
T Consensus 161 -dyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 -DYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred -hccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 6678899999999999999999875 6899999999999999999999999999999999999732
Q ss_pred --------CCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCC
Q 008729 162 --------NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (556)
Q Consensus 162 --------~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~ 233 (556)
+..|+|+|||.|+...... +..+.|+.|+|||++++ -+++.++||||+||||+||.+|..+|.+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLg--LGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILG--LGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheec--cCcCCccCceeeeeEEEEeeccceeccc
Confidence 2359999999998754332 56789999999999999 6899999999999999999999999999
Q ss_pred CChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcC---------------CCCCcCCCCCCCC---HHHHHHHHH
Q 008729 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKK---------------PPVPLFQKFPNVD---PLALRLLQR 295 (556)
Q Consensus 234 ~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~---------------~~~~~~~~~~~~s---~~~~dLl~~ 295 (556)
.++.+.+.+|...+|..+...+...+ ..+|+...+-. .+.++.......+ ..+.|||++
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~---~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTR---KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhh---hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 99999999999999966666665443 33444332111 1122221111222 357899999
Q ss_pred hhhcCCCCCCCHHHHHhCcccccc
Q 008729 296 LIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 296 ~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
||.+||.+|+|+.|+|.||||+.+
T Consensus 389 mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 389 MLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HHccCccccccHHHHhcCHHhhcC
Confidence 999999999999999999999865
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=373.44 Aligned_cols=259 Identities=23% Similarity=0.408 Sum_probs=207.2
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCceEEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (556)
++||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.+ +||||+++++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence 479999999999999999999999999975322 233455688999999998 699999999998 4556799999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce
Q 008729 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (556)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (556)
|||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~---~ 152 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---c
Confidence 9998 69999998888999999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 186 ~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+ .+.... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~----------~~~~~~-----~~~~-- 213 (329)
T cd05588 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD----------NPDQNT-----EDYL-- 213 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCcccccccc----------cccccc-----hHHH--
Confidence 245679999999999987 688999999999999999999999996432110 000000 0000
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC------HHHHHhCcccccc
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT------AEEALADPYFKGL 319 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt------a~elL~hp~f~~~ 319 (556)
...+.... ......++..+.+||++||+.||.+|+| ++++++||||..+
T Consensus 214 -~~~~~~~~----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 214 -FQVILEKQ----IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred -HHHHHcCC----CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 11111111 1122457899999999999999999987 7999999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=378.68 Aligned_cols=264 Identities=25% Similarity=0.379 Sum_probs=213.8
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
..++|++++.||+|+||.||+|+++.+++.||+|++... .........+.+|+.+++.++||||+++++++ .+.
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence 347999999999999999999999999999999998642 12223445678899999999999999999998 455
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
..+|+|||||+ |+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~ 194 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 194 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence 67999999998 6999988754 589999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcceecccccCcccCCcccccccC--CCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~--~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
.... .....+||+.|+|||++.+.. ..++.++|||||||++|+|++|.+||.+.+.......|...
T Consensus 195 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~---------- 262 (371)
T cd05622 195 EGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH---------- 262 (371)
T ss_pred CCcc--cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC----------
Confidence 2211 123567999999999986521 23789999999999999999999999988765554444211
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHHHHHhCcccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~--Rpta~elL~hp~f~~~ 319 (556)
..... ......++..+.+||.+||..++.+ |++++++++|+||++.
T Consensus 263 ----------------~~~~~-~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 263 ----------------KNSLT-FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred ----------------CCccc-CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 11111 1223468999999999999844433 7899999999999863
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=381.98 Aligned_cols=280 Identities=23% Similarity=0.288 Sum_probs=218.3
Q ss_pred CCeEEEeeeeecCceeEEEEEEC--CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.+|++++.||+|+||.||+|... .++..||+|.+... ....+|+.+|+.|+||||+++++++ ....
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~ 159 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAY-----RWKS 159 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeE-----eeCC
Confidence 47999999999999999999754 45678999987632 2345899999999999999999998 4556
Q ss_pred eEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 101 DIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
.+|+|||++.++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 160 ~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 160 TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 79999999999999999878889999999999999999999999999999999999999999999999999997643322
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhhCCCChHHHHH
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS---VVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~---~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.. ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.. ...++..|...++....+....
T Consensus 240 ~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 240 DT-PQCYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN 316 (392)
T ss_pred cc-ccccccccccCccCHhHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence 11 11235679999999999987 679999999999999999999999997754 3455666666665543332111
Q ss_pred hhhHHHHHHHHHhhcCC--CCCcCCC--CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 258 VRNEKARKYLTEMRKKP--PVPLFQK--FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~--~~~~~~~--~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
.. ......+....... ....... ...++.++.+||++||.+||++|||+.++|+||||..
T Consensus 317 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~ 380 (392)
T PHA03207 317 GS-TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTK 380 (392)
T ss_pred cc-hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhc
Confidence 11 11111111111110 0111111 1245778999999999999999999999999999975
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=372.04 Aligned_cols=250 Identities=24% Similarity=0.436 Sum_probs=210.1
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCceEEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (556)
+.||+|+||+||+|.+..+++.||||++.... ........+.+|+.++..+ +||||+++++++ .....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~-----~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCF-----QTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence 47999999999999999999999999987432 2223455677899999888 699999999998 4556799999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce
Q 008729 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (556)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (556)
||+. ++|...+...+.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---T 152 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---c
Confidence 9998 69999998888999999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 186 ~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
....+|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 153 ~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-------------------- 210 (318)
T cd05570 153 TSTFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-------------------- 210 (318)
T ss_pred ccceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc--------------------
Confidence 234579999999999987 6899999999999999999999999988775544433311
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----HHHHhCcccccc
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-----EEALADPYFKGL 319 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta-----~elL~hp~f~~~ 319 (556)
... .....++..+.+||++||..||++|||+ .++++||||+..
T Consensus 211 ------~~~-----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 211 ------DEV-----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred ------CCC-----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 010 1123578999999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-46 Score=360.67 Aligned_cols=257 Identities=26% Similarity=0.446 Sum_probs=226.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
+.|..+++||+|.||+|-+++.+.+++.||||++++.. -...+....+.|-++|+..+||.+..+...| +....
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~dr 242 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQDR 242 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccCce
Confidence 56889999999999999999999999999999997643 2334567788999999999999999998888 55567
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|+||||.. |+|+-++.....+++..++++...|+.||.|||+.+||+||||.+|+|+|.+|++||+|||+++......
T Consensus 243 lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence 999999998 6999999988899999999999999999999999999999999999999999999999999998755444
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
.. ...+||||.|.|||++.. ..|+.++|+|.+||++|||+||+.||.+.+....++.|..
T Consensus 323 ~t---~kTFCGTPEYLAPEVleD--nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~--------------- 382 (516)
T KOG0690|consen 323 DT---TKTFCGTPEYLAPEVLED--NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILM--------------- 382 (516)
T ss_pred ce---eccccCChhhcCchhhcc--ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHh---------------
Confidence 33 368999999999999988 7899999999999999999999999999998777776632
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
... .....++++++.||..+|.+||++|. .+.|+.+|+||.++.
T Consensus 383 -----------ed~-----kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 383 -----------EDL-----KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred -----------hhc-----cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 011 11236899999999999999999997 489999999999874
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=364.88 Aligned_cols=285 Identities=43% Similarity=0.672 Sum_probs=232.2
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCC---hhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH---ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
+|++++.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+++.++|+||+++++++ .+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVF-----GHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhhee-----ecCC
Confidence 589999999999999999999999999999998753322 22345577899999999999999999998 4456
Q ss_pred eEEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+||||+.++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++......
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 799999999889999998776 7999999999999999999999999999999999999999999999999999765433
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
... .....++..|+|||.+.+. ..++.++|||||||++|+|++|.++|.+.+..+.+..+...++.|....+....
T Consensus 156 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 156 NRK---MTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred Ccc---ccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 211 2334578899999987542 467899999999999999999999999998888888888877777665543221
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
... .+ .........+....+...+..+.+||.+||.+||++|||+.++|.|+||++..
T Consensus 232 ~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 232 SLP--DY-VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred ccc--cc-ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 110 11 01111222233344567789999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=370.12 Aligned_cols=255 Identities=23% Similarity=0.407 Sum_probs=213.2
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCCce
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 101 (556)
+|++.+.||+|+||.||+|.++.+|+.||||++..... .......+..|+.++..+. |++|+++++++ .+...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence 47889999999999999999999999999999874321 2234456778999998886 57788898888 45567
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|+||||+. |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 999999998 6999999988899999999999999999999999999999999999999999999999999987543221
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......|..
T Consensus 156 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--------------- 215 (323)
T cd05615 156 V---TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME--------------- 215 (323)
T ss_pred c---cccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh---------------
Confidence 1 1234569999999999987 6789999999999999999999999998776555444321
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHhCcccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-----a~elL~hp~f~~~ 319 (556)
.. ......++..+.+|+.+||..||.+|++ .+++++||||..+
T Consensus 216 -----------~~-----~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 216 -----------HN-----VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred -----------CC-----CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 00 0122457889999999999999999997 5899999999875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-44 Score=362.94 Aligned_cols=287 Identities=38% Similarity=0.687 Sum_probs=226.3
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
+|..++|++.+.||.|+||.||+|.++.+++.||||.+...... .....+.+|+.+++.++|+||+++++++ .+
T Consensus 1 ~~~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~ 74 (291)
T cd07844 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDII-----HT 74 (291)
T ss_pred CCCccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEE-----ec
Confidence 45668999999999999999999999999999999998643221 1223467899999999999999999998 45
Q ss_pred CceEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
....|+||||+.++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 75 KKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred CCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 5679999999999999988764 468999999999999999999999999999999999999999999999999987542
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhhCCCChHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~-~~~~~~~i~~~~g~p~~e~i~ 256 (556)
.... ......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.. ..+++..+.+.++.+.++.+.
T Consensus 155 ~~~~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 155 VPSK---TYSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred CCCc---cccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhh
Confidence 2111 11233578889999987652 457889999999999999999999998776 667778888888888776654
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCC--HHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVD--PLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s--~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
........... ........+.....+.++ ..+.+||.+||..||++|||+.++|+||||
T Consensus 231 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 231 GVSSNPEFKPY-SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred hhhhccccccc-cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 33211000000 000011111222333455 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=364.45 Aligned_cols=297 Identities=33% Similarity=0.512 Sum_probs=229.2
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC--
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-- 96 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~-- 96 (556)
..+.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+++.++||||+++++++.....
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 445678999999999999999999999999999999986433333334456789999999999999999998865421
Q ss_pred -CCCceEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 97 -REFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 97 -~~~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
......|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.
T Consensus 88 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 88 NRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred cCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 233567999999999998888764 368999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCC-cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 175 VAFSDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 175 ~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
........ ........++..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+.......+..+.|...++
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 65332211 1122345688899999987652 347889999999999999999999999999888888888888877666
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCC-CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQK-FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.............+.............. ....++.+.+||.+||..||.+|||++++|+||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 5433321111110000000000000000 11246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=361.37 Aligned_cols=282 Identities=39% Similarity=0.707 Sum_probs=219.9
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++ .....+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF-----RRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE-----eeCCEE
Confidence 479999999999999999999999999999998864322222334577999999999999999999998 455679
Q ss_pred EEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+||||+++ .|..++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred EEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999999996 5555666666799999999999999999999999999999999999999999999999999986543221
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
......++.+|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++...+.........
T Consensus 156 ---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 156 ---DYTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred ---cccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 12345688999999987652 45788999999999999999999999998877777666655544333211111000
Q ss_pred HHHHHHHHhhcCC---CCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 262 KARKYLTEMRKKP---PVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 262 ~~~~~l~~~~~~~---~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.+...+.... ..+....++.++..+.+||.+||..||++|||+.++|.||||
T Consensus 232 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 232 ---QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ---cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000000000 011112245678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=373.17 Aligned_cols=250 Identities=28% Similarity=0.496 Sum_probs=207.6
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHH-HHHhCCCCCcceeeEEEcCCCCCCCceEEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~-iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (556)
+.||+|+||.||+|.+..+|+.||||++.... ........+.+|.. +++.++||||+++++++ .....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence 46999999999999999999999999986432 12234455666665 46779999999999998 5556799999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce
Q 008729 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (556)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (556)
||+. ++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~---~ 152 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD---T 152 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---C
Confidence 9998 69999998888999999999999999999999999999999999999999999999999999875332221 1
Q ss_pred ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 186 ~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~-------------------- 210 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH-------------------- 210 (325)
T ss_pred cccccCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc--------------------
Confidence 245679999999999987 6789999999999999999999999988775544433311
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH----HHHHhCcccccc
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGL 319 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta----~elL~hp~f~~~ 319 (556)
.. ....+..+..+.+||++||..||.+||++ .++++||||...
T Consensus 211 -------~~----~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 211 -------KP----LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred -------CC----ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 00 11234688999999999999999999976 699999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=371.63 Aligned_cols=258 Identities=23% Similarity=0.419 Sum_probs=206.3
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCceEEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (556)
+.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.++..+ +||||+++++++ .....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEE-----EeCCEEEEEE
Confidence 47999999999999999999999999997542 2334455678899998877 799999999998 4556799999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce
Q 008729 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (556)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (556)
|||. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~---~ 152 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---T 152 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---c
Confidence 9999 69999998888999999999999999999999999999999999999999999999999999875332221 1
Q ss_pred ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 186 ~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........ +.. ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~----------~~~---------~~~~ 211 (329)
T cd05618 153 TSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN----------PDQ---------NTED 211 (329)
T ss_pred cccccCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCccCCCcCC----------ccc---------ccHH
Confidence 235679999999999987 6789999999999999999999999953211000 000 0000
Q ss_pred H-HHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC------HHHHHhCcccccc
Q 008729 266 Y-LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT------AEEALADPYFKGL 319 (556)
Q Consensus 266 ~-l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt------a~elL~hp~f~~~ 319 (556)
+ ...+... . ......++..+.+||++||..||++|+| ++++++||||+..
T Consensus 212 ~~~~~i~~~-~---~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 212 YLFQVILEK-Q---IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHHHHHhcC-C---CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 0 0111111 0 1123457899999999999999999998 5899999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=370.93 Aligned_cols=264 Identities=25% Similarity=0.400 Sum_probs=214.4
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.++..++|++|+.+++++ .+.+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCE
Confidence 47999999999999999999999999999999986421 2223344577899999999999999999998 55677
Q ss_pred EEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
+|+||||+. |+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999998 699999987 467999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcceecccccCcccCCcccccccC---CCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~---~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
... .....+||+.|+|||++.+.. ..++.++|||||||+||+|++|+.||.+.+..+.+..|..
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~----------- 222 (331)
T cd05624 156 GTV--QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN----------- 222 (331)
T ss_pred Cce--eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHc-----------
Confidence 211 113356999999999886421 2578899999999999999999999988776554444321
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHHHHHhCcccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGL 319 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~--Rpta~elL~hp~f~~~ 319 (556)
.....++...+..++..+.+||.+||..++++ |++++++++|+||++.
T Consensus 223 ---------------~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 223 ---------------HEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred ---------------CCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 11112222334567899999999999976654 4699999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=385.92 Aligned_cols=281 Identities=25% Similarity=0.318 Sum_probs=213.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
...|.+.+.||+|+||.||+|.+..+++.||||... ...+.+|+.+|+.|+|+||+++++++ .....
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~-----~~~~~ 234 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVR-----VVGGL 234 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEE-----EECCE
Confidence 457999999999999999999999999999999643 12356899999999999999999998 44466
Q ss_pred EEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
.|+|||++.++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 235 ~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 235 TCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred EEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 8999999999999988764 469999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCC-CCCCC------hHHHHHHHHHhhCCCChH
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKS------VVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~p-F~~~~------~~~~~~~i~~~~g~p~~e 253 (556)
.. ......+||+.|+|||++.+ ..++.++||||||||||||++|..+ |.... ...++..+....+....+
T Consensus 315 ~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 315 ST-PFHYGIAGTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cc-ccccccCCCcCCcCHHHHcC--CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 11 12234679999999999987 6799999999999999999998754 43321 123344444433322111
Q ss_pred HHHHhhhHHHHHHHHH----hhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 254 TIAVVRNEKARKYLTE----MRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~----~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
............+... .......+.+..+..++..+.+||.+||.+||.+|||++|+|+||||+.
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 1100001111111111 1111112222334467789999999999999999999999999999974
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=363.14 Aligned_cols=253 Identities=23% Similarity=0.360 Sum_probs=204.9
Q ss_pred eeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEecC
Q 008729 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (556)
Q Consensus 31 LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 109 (556)
||+|+||+||+|.+..+++.||+|++.... ........+..|+.+|+.++|+||+++++++ .....+|+|||||
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence 799999999999999999999999986432 2222345678899999999999999999998 4556799999999
Q ss_pred c-ccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcc
Q 008729 110 E-SDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (556)
Q Consensus 110 ~-g~L~~~i~----~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 184 (556)
. |+|.+++. .+..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-- 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-- 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence 8 68987774 2456899999999999999999999999999999999999999999999999999764332221
Q ss_pred eecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHH
Q 008729 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (556)
Q Consensus 185 ~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~ 264 (556)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.
T Consensus 154 -~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~-------------------- 210 (280)
T cd05608 154 -TKGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-------------------- 210 (280)
T ss_pred -ccccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH--------------------
Confidence 234579999999999987 688999999999999999999999997654321111110
Q ss_pred HHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 265 ~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
..+.. ........+++.+.+|+.+||+.||++|| |++++++||||+++.
T Consensus 211 ---~~~~~----~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 211 ---QRILN----DSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred ---Hhhcc----cCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 00000 01122245889999999999999999999 899999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=388.21 Aligned_cols=270 Identities=26% Similarity=0.353 Sum_probs=222.1
Q ss_pred cccCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 17 ~~~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
+.-...++|.+.+.||+|+||+||+|.+..+|+.||||++............+.+|+.+|..++|+||+++++.+.....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 33345579999999999999999999999999999999997654455666778899999999999999999887753321
Q ss_pred ---CCCceEEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEe
Q 008729 97 ---REFKDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (556)
Q Consensus 97 ---~~~~~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~ 168 (556)
.....+++||||+. |+|.+++.. ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEE
Confidence 12235789999999 799998865 3468999999999999999999999999999999999999999999999
Q ss_pred eeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC
Q 008729 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (556)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g 248 (556)
|||+++........ ......+||+.|+|||++.+ ..|+.++|||||||+||+|++|+.||.+.+..+.+..+..
T Consensus 186 DFGls~~~~~~~~~-~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~--- 259 (496)
T PTZ00283 186 DFGFSKMYAATVSD-DVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA--- 259 (496)
T ss_pred ecccCeeccccccc-cccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc---
Confidence 99999765332111 11245679999999999987 6799999999999999999999999988775544433211
Q ss_pred CCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
... ....+.+++.+.+||.+||..||.+||++.++|+|||++.+
T Consensus 260 ------------------------~~~---~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 260 ------------------------GRY---DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred ------------------------CCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 111 11235688999999999999999999999999999998754
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=360.74 Aligned_cols=288 Identities=37% Similarity=0.628 Sum_probs=227.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++.+.||.|+||.||+|.+..+++.||||++............+.+|+.+++.+. ||||+++++++..........
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4799999999999999999999999999999998654333333456788999999995 699999999986544333445
Q ss_pred EEEEEecCcccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC-CCceEEeeeCcccc
Q 008729 102 IYVVFELMESDLHQVIKAN-----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARV 175 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~~-----~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~vKL~DFGla~~ 175 (556)
+|+||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeeccccee
Confidence 8999999999999888652 35799999999999999999999999999999999999998 88999999999875
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
....... .....++++|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+....+..+...++.|....+
T Consensus 161 ~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 161 FSIPVKS---YTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred cCCCccc---cCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 4322111 1234578899999987542 45789999999999999999999999999988888888888887776554
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
.......... ..............+.++..+.+||.+||..||.+|||++++|.||||+
T Consensus 237 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWH---EFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchh---hcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 3221111000 0011111111223356889999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=361.45 Aligned_cols=258 Identities=26% Similarity=0.398 Sum_probs=211.3
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
.|++.++||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++.+ .....+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence 4899999999999999999999999999999986422 2222334577899999999999999999998 444679
Q ss_pred EEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 103 YVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
|+|||||. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||++++++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999998 6898887643 46899999999999999999999999999999999999999999999999998764322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.. ....+|+..|+|||++.+ ..++.++||||+||++|+|++|+.||.+.........+..
T Consensus 156 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~-------------- 215 (285)
T cd05605 156 ET----IRGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER-------------- 215 (285)
T ss_pred Cc----cccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH--------------
Confidence 11 134578999999999977 6789999999999999999999999987664333322211
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCcccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 319 (556)
.+... .......+++.+.+||.+||..||++|| +++++++||||...
T Consensus 216 ---------~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 216 ---------RVKED----QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred ---------Hhhhc----ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 01000 0112245788999999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=370.19 Aligned_cols=250 Identities=28% Similarity=0.465 Sum_probs=206.8
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHH-HHHhCCCCCcceeeEEEcCCCCCCCceEEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~-iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (556)
+.||+|+||+||+|++..+++.||+|++.... ........+.+|.. +++.++||||+++++++ .....+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~-----~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEE-----EcCCeEEEEE
Confidence 47999999999999999999999999986421 11223344555554 46888999999999998 5556799999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce
Q 008729 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (556)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (556)
|||. ++|.+++...+.+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---~ 152 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---T 152 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---C
Confidence 9999 59999999888899999999999999999999999999999999999999999999999999975432221 1
Q ss_pred ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 186 ~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.+..+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-------------------- 210 (325)
T ss_pred cccccCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh--------------------
Confidence 245679999999999987 6799999999999999999999999988776554443321
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHH----HHHhCcccccc
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE----EALADPYFKGL 319 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~----elL~hp~f~~~ 319 (556)
. . ....+.+++.+.+||++||+.||.+|+++. ++++|+||..+
T Consensus 211 -------~-~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 211 -------K-P---LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred -------C-C---cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 0 0 112356899999999999999999999865 89999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=368.84 Aligned_cols=298 Identities=40% Similarity=0.677 Sum_probs=228.1
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC---
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK--- 96 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~--- 96 (556)
+.+++|.+.+.||.|+||.||+|.++.+|+.||+|++... .......+.+|+.+|+.++||||+++++++.....
T Consensus 2 ~~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~--~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred CcCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecC--CCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 4568999999999999999999999999999999998643 22445668899999999999999999988754321
Q ss_pred ------CCCceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC-CCceEEee
Q 008729 97 ------REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCD 169 (556)
Q Consensus 97 ------~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~vKL~D 169 (556)
.+...+|+||||++++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 12346899999999999988864 46899999999999999999999999999999999999974 56789999
Q ss_pred eCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC
Q 008729 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (556)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~ 249 (556)
||+++................++..|+|||.+.+. ..++.++|||||||++|+|++|+.||.+.+.......+......
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99997643222211122334688999999986542 46888999999999999999999999988877776666554444
Q ss_pred CChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccc
Q 008729 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (556)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 322 (556)
+..+......+... ............+.....+.++.++.+||++||..||++|||++++|.||||+.+..+
T Consensus 238 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~ 309 (342)
T cd07854 238 VREEDRNELLNVIP-SFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309 (342)
T ss_pred CChHHhhhhhhhhh-hhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence 43332222211111 1111111112222233345788999999999999999999999999999999876433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=375.33 Aligned_cols=258 Identities=24% Similarity=0.314 Sum_probs=204.8
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++|+||+++++++ .....
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 146 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNGE 146 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCCe
Confidence 357899999999999999999999999999999986432 233456788999999999999999999998 55667
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|+|||||. ++|.+. ....+..+..+++||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 147 IQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred EEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 999999999 576542 345778888999999999999999999999999999999999999999999998653222
Q ss_pred CCcceecccccCcccCCccccccc---CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~---~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
. .....+||..|+|||++... ...++.++|||||||++|+|++|+.||......+....+.
T Consensus 223 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~------------- 286 (353)
T PLN00034 223 D---PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC------------- 286 (353)
T ss_pred c---cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH-------------
Confidence 1 12456799999999987431 1234568999999999999999999997433222111111
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
..... ........++..+.+||++||..||++|||+.|+|+||||.+-
T Consensus 287 -----------~~~~~---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 287 -----------AICMS---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred -----------HHhcc---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 01000 0112234678999999999999999999999999999999864
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=369.46 Aligned_cols=250 Identities=28% Similarity=0.443 Sum_probs=206.1
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHH-HHHhCCCCCcceeeEEEcCCCCCCCceEEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~-iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (556)
++||+|+||.||+|.+..+++.||+|++.... ........+.+|+. +++.++||||+++++++ .+...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence 47999999999999999999999999986432 12233445666665 57889999999999998 5556799999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce
Q 008729 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (556)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (556)
|||+ ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---T 152 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---c
Confidence 9998 69999998888899999999999999999999999999999999999999999999999999875322221 1
Q ss_pred ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 186 ~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.....+.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-------------------- 210 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-------------------- 210 (321)
T ss_pred cccccCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc--------------------
Confidence 245679999999999977 6789999999999999999999999988775444433311
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH----HHHHhCcccccc
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGL 319 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta----~elL~hp~f~~~ 319 (556)
. . ....+..+..+.+||.+||+.||.+|+++ .++++|+||..+
T Consensus 211 -------~-~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 211 -------K-P---LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred -------C-C---CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 1 0 11224578899999999999999999875 599999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=362.57 Aligned_cols=287 Identities=41% Similarity=0.671 Sum_probs=230.8
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.+.|++.+.||.|+||.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++... +...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~ 80 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDK 80 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCc
Confidence 3579999999999999999999999999999999874333333334567899999999999999999988533 2367
Q ss_pred EEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|+||||+.++|.+++.... .+++..++.++.||+.||+|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 81 IYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 99999999999999887644 58999999999999999999999999999999999999999999999999988654332
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
. ......++..|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+...++.|.++.+..+..
T Consensus 161 ~---~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 161 K---PYTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred c---ccccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 1 12345688999999988652 3468899999999999999999999999999999999999999888776654321
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCC--CCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPN--VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~--~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
-..... ..............++. +++.+.+||++||..||++|||+.|+|+||||
T Consensus 237 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 237 LPGAKK-KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhcc-cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 110000 00001111112233444 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-44 Score=372.97 Aligned_cols=277 Identities=25% Similarity=0.335 Sum_probs=209.9
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
..|++++.||+|+||.||+|.+..+++.||+|+.... ....|+.+|+.++||||+++++++ ......
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 132 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTL-----VSGAIT 132 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheE-----EeCCee
Confidence 4699999999999999999999999999999975421 235699999999999999999998 445668
Q ss_pred EEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+|||++.++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 133 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 133 CMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred EEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 99999999999998865 4579999999999999999999999999999999999999999999999999997533221
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCC-CCCCCCCh---------HHHHHHHHHhhCCCC
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSV---------VHQLDLITDLLGTPS 251 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~-~pF~~~~~---------~~~~~~i~~~~g~p~ 251 (556)
......||..|+|||++.+ ..|+.++|||||||++|+|+++. ++|.+... ...+..+...++..+
T Consensus 212 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 286 (357)
T PHA03209 212 ---AFLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP 286 (357)
T ss_pred ---ccccccccccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh
Confidence 1234569999999999987 67999999999999999999854 55544221 122333334444332
Q ss_pred hHHHHHhhhHHHHHHHHHhhcCCCCCcCC----CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQ----KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~----~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.+............++... .....+... ...+++.++.+||.+||.+||++|||+.|+|+||||+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 287 EEFPRDPGSRLVRGFIEYA-SLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred hhcCCCCccHHHHHHHhhc-ccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 2211100111112222111 011111100 112567889999999999999999999999999999863
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=360.01 Aligned_cols=287 Identities=39% Similarity=0.670 Sum_probs=228.3
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++.+.||+|++|.||+|.++.+|+.||||++............+.+|+++++.++||||+++++++ .+....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV-----HSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE-----ecCCeE
Confidence 579999999999999999999999999999999864333333345678899999999999999999998 455679
Q ss_pred EEEEecCcccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC-CCceEEeeeCccccccCC
Q 008729 103 YVVFELMESDLHQVIKANDD--LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 103 ylV~E~~~g~L~~~i~~~~~--l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~vKL~DFGla~~~~~~ 179 (556)
|+||||++++|.+.+..... +++..++.++.||+.||+|||++||+||||+|+||+++. ++.+||+|||++......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 99999999999988876543 578888999999999999999999999999999999985 567999999999754322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.. ......++..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.|....+....
T Consensus 157 ~~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 VR---TFTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred cc---ccccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 11 12345678999999987652 457889999999999999999999999988888888888888887665544221
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.. ..+................+.+++.+.++|.+||+.||++||+++++|+||||.++.
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 233 SL--PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred cc--hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 11 111111111111111223456889999999999999999999999999999998753
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=358.81 Aligned_cols=282 Identities=38% Similarity=0.708 Sum_probs=222.6
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+|+.++||||+++++++ ......
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeE
Confidence 479999999999999999999999999999998865433333445678899999999999999999998 555679
Q ss_pred EEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+||||+.+ .|..++.....+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred EEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999995 666666666679999999999999999999999999999999999999999999999999987643322
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
.....+.++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+......-......
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred --cccCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 123456789999999988652 45778999999999999999999999988877777776665555432211111000
Q ss_pred HHHHHHHHhh---cCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 262 KARKYLTEMR---KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 262 ~~~~~l~~~~---~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.. +..+. .....+....++.++..+.+|+++||..||++|||+.++|+||||
T Consensus 232 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 232 PL---FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred hH---hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 00 00000 000111222356789999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=356.72 Aligned_cols=281 Identities=40% Similarity=0.666 Sum_probs=229.5
Q ss_pred eEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEE
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (556)
|++.+.||.|++|.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++ .+....|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~-----~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVV-----HSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhhee-----ccCCeEEE
Confidence 7889999999999999999999999999999874433333345678899999999999999999998 44567999
Q ss_pred EEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCC
Q 008729 105 VFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (556)
Q Consensus 105 V~E~~~g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 182 (556)
||||++++|.+++.... .+++..+..++.||+.||.|||+.+++||||+|+||+++.++.++|+|||++........
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 99999999999998765 789999999999999999999999999999999999999999999999999875432211
Q ss_pred cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHH
Q 008729 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (556)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~ 262 (556)
......++..|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+.+..++|..+.+......
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL- 230 (283)
T ss_pred --ccCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhc-
Confidence 11334578899999987652 35788999999999999999999999999888888888888888877665432211
Q ss_pred HHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
..+................+.++..+.+||.+||+.||.+|||++++++||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 231 -PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred -hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 11112222222222233456788999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=351.09 Aligned_cols=258 Identities=26% Similarity=0.426 Sum_probs=212.9
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCC---hhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH---ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
+.|++.+.||+|++|.||.|.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++++ .+.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCL-----RDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ccC
Confidence 4699999999999999999999999999999988643222 12345688999999999999999999998 445
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
..+|+|+||+. ++|.+++...+.+++..++.+++||+.||.|||+.||+||||+|+||+++.++.++|+|||+++....
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 58999999998 59999999888899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
............|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------- 221 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT------------- 221 (263)
T ss_pred cccccccccCCCcCccccCcceecc--CCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc-------------
Confidence 2211111134568899999999987 5689999999999999999999999976554333222110
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.. ........++..+.+||++||..||.+|||+.++|+|+||
T Consensus 222 --------------~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 222 --------------QP--TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred --------------cC--CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 00 0112224578899999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=372.88 Aligned_cols=250 Identities=25% Similarity=0.424 Sum_probs=205.2
Q ss_pred eeecCceeEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhC---CCCCcceeeEEEcCCCCCCCceEEEEE
Q 008729 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 31 LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L---~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (556)
||+|+||+||+|++..+++.||||++... ...........+|..++..+ .||||+++++++ .+...+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence 79999999999999999999999998642 12223445566788887766 699999999998 5556799999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce
Q 008729 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (556)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (556)
||+. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~---~ 152 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK---T 152 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---C
Confidence 9998 69999999888999999999999999999999999999999999999999999999999999875432221 1
Q ss_pred ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 186 ~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~-------------------- 211 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF-------------------- 211 (330)
T ss_pred ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc--------------------
Confidence 2456799999999988652 4588999999999999999999999988765444433311
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC----CHHHHHhCcccccc
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP----TAEEALADPYFKGL 319 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp----ta~elL~hp~f~~~ 319 (556)
.....+ ...+++.+.+||++||..||.+|| +++++++||||...
T Consensus 212 ------~~~~~~----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 212 ------GKVRFP----KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred ------CCCCCC----CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 001111 124788999999999999999998 79999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=358.19 Aligned_cols=281 Identities=38% Similarity=0.680 Sum_probs=227.4
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
+|++++.||.|++|.||+|.+..+|+.||||++..... ......+.+|+.+++.++|+||+++++.+ .+...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 74 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVI-----HTENKLM 74 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeE-----eeCCcEE
Confidence 59999999999999999999999999999999874322 22345677899999999999999999998 4456789
Q ss_pred EEEecCcccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 104 VVFELMESDLHQVIKAN---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 104 lV~E~~~g~L~~~i~~~---~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+||||++++|.+++... ..++++.+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 75 LVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred EEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 99999999999988764 358999999999999999999999999999999999999999999999999997543221
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
. ......++..|++||.+.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.|....+..+..
T Consensus 155 ~---~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 155 N---TFSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred c---ccccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1 11345678999999987552 4578899999999999999999999999999999999988888887776554431
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
. ..+................+.+++.+.++|.+||+.||.+||+++++++||||
T Consensus 231 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 L--PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred C--chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 1 01101111111111112234578899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=367.21 Aligned_cols=282 Identities=23% Similarity=0.365 Sum_probs=216.7
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++.+.||+|+||.||+|.+..++..||+|++.... .......+.+|+++|+.++||||+++++++ .+...+
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 78 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 78 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEE-----EECCEE
Confidence 58999999999999999999999999999999887532 233456788999999999999999999999 445679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 99999998 69999999888899999999999999999999985 79999999999999999999999999987543221
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH-hhCCCChHHHH---
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD-LLGTPSPETIA--- 256 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~-~~g~p~~e~i~--- 256 (556)
....+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+.. ..+.+......
T Consensus 159 -----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (333)
T cd06650 159 -----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRP 231 (333)
T ss_pred -----cccCCCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCccc
Confidence 134569999999999987 6789999999999999999999999987664333222110 11111110000
Q ss_pred --------Hhh-----hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 257 --------VVR-----NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 257 --------~~~-----~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
... ..........+........ .....+.++.+||.+||++||++|||++|+|.||||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKL--PSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred CCccchhhhhcccccccccHHHHHHHHhcCCCccC--CCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 000 0000111111111111111 012367889999999999999999999999999999853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=368.23 Aligned_cols=253 Identities=30% Similarity=0.418 Sum_probs=208.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcE-EEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEK-VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~-vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.....+.+.||.|+||+||+|... |+. ||+|++............+.+|+.+|.+|+|||||++++++..+. .
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~ 113 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----G 113 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----C
Confidence 345566777999999999999765 666 999999865444444778999999999999999999999995432 1
Q ss_pred eEEEEEecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCcEeecCCC-ceEEeeeCcccc
Q 008729 101 DIYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTAN-VYHRDLKPKNILANANC-KLKVCDFGLARV 175 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~QIl~aL~yLHs~g-IvHrDLKP~NILl~~~~-~vKL~DFGla~~ 175 (556)
.++||||||. |+|.+++.. ...++...+..|+.||++|+.|||+++ ||||||||+|||++.++ ++||||||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 6899999999 799999987 678999999999999999999999999 99999999999999998 999999999987
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
..... ...+...||..|||||++.+....|+.++||||||++||||+||+.||.+.........+...
T Consensus 194 ~~~~~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~--------- 261 (362)
T KOG0192|consen 194 KVISK---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVG--------- 261 (362)
T ss_pred ecccc---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc---------
Confidence 54321 112446799999999999841158999999999999999999999999998874443333211
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
..... .....++.+..|+.+||..||.+||+..+++.
T Consensus 262 ---------------~~Rp~-----~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 262 ---------------GLRPP-----IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ---------------CCCCC-----CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 11111 11238899999999999999999999999875
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=362.82 Aligned_cols=294 Identities=38% Similarity=0.627 Sum_probs=230.9
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC---C
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK---R 97 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~---~ 97 (556)
..++|++.+.||+|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++..... .
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 4579999999999999999999999999999999886432222223456789999999999999999998754321 2
Q ss_pred CCceEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 98 EFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
....+|+||||++++|...+.. ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++..
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 3456899999999998888765 457999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCC--------CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC
Q 008729 177 FSDTP--------MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (556)
Q Consensus 177 ~~~~~--------~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g 248 (556)
..... .....+...+++.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......+....+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 33221 11122445688999999987652 4588999999999999999999999999999999999988888
Q ss_pred CCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.+.+..+..+..-..... .......+......+..+++.+.+||.+||..||++|||+.++|.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 245 TPTEETWPGWRSLPGCEG-VHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCChhhchhhhhcccccc-cccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 877665443211000000 0000111111222345567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=355.03 Aligned_cols=280 Identities=39% Similarity=0.727 Sum_probs=222.7
Q ss_pred eEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCCceEE
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
|++++.||+|+||.||+|.+..+++.||+|++........ .....+|+.+++.+. |+||+++++++... ....+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~ 76 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLA 76 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEE
Confidence 7899999999999999999999999999999875433322 234568999999885 99999999998532 225689
Q ss_pred EEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCC
Q 008729 104 VVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (556)
Q Consensus 104 lV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 182 (556)
+||||++++|.+.+... ..+++..+..++.||+.||.|||+.||+||||||+||+++. +.+||+|||+++.......
T Consensus 77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 77 LVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred EEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 99999999999888763 57899999999999999999999999999999999999999 9999999999976543322
Q ss_pred cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHH
Q 008729 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (556)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~ 262 (556)
.....++..|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+..+.+..+.+.++.+..+.........
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR 230 (282)
T ss_pred ---cCCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence 1345689999999976442 457889999999999999999999999999988889998888888776533221111
Q ss_pred HHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
...+ ..............+.++..+.+||.+||..||++|||++++|+||||
T Consensus 231 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 231 HMNY--NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccc--cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000 000000001111234578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=369.06 Aligned_cols=258 Identities=21% Similarity=0.387 Sum_probs=207.3
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCceEEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (556)
+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.++..+ +||||+.+++++ .+...+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence 479999999999999999999999999975322 233456688999999888 699999999998 5556799999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce
Q 008729 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (556)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (556)
|||. ++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~ 152 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD---T 152 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---c
Confidence 9998 69999998888899999999999999999999999999999999999999999999999999875322211 1
Q ss_pred ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 186 ~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
....+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||........... .+ .
T Consensus 153 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~---------~~-----------~ 210 (327)
T cd05617 153 TSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT---------ED-----------Y 210 (327)
T ss_pred eecccCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc---------HH-----------H
Confidence 245679999999999987 6889999999999999999999999964321110000 00 0
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC------HHHHHhCccccccc
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT------AEEALADPYFKGLA 320 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt------a~elL~hp~f~~~~ 320 (556)
....+.. .+. .....++..+.+||++||..||++|++ ++++++||||+.+.
T Consensus 211 ~~~~~~~-~~~---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 211 LFQVILE-KPI---RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred HHHHHHh-CCC---CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 0011111 111 122357899999999999999999998 57999999998754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=357.26 Aligned_cols=286 Identities=41% Similarity=0.700 Sum_probs=224.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++.+.||.|+||.||+|.+..+++.||+|+++...........+.+|+++++.++|+||+++++++ .....+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAF-----RRKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheE-----EECCEE
Confidence 479999999999999999999999999999998875433444456788999999999999999999998 445679
Q ss_pred EEEEecCcccHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELMESDLHQ-VIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~g~L~~-~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+||||+++++.+ ++.....+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++........
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 76 YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred EEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 9999999975544 445556799999999999999999999999999999999999999999999999999887544332
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
.....++++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++...+.........
T Consensus 156 --~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 156 --SPLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred --ccccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 122456789999999998772 27889999999999999999999999998888877777777776655433222110
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCC-CCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~-~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
....-...............++. ++..+.+||++||..||++|||++++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00000000000000001111222 48899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=353.61 Aligned_cols=285 Identities=37% Similarity=0.609 Sum_probs=220.3
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
|..++|++++.||+|+||.||+|.+..+|+.||||++..... ......+.+|+.+|+.++|+||+++++++ ...
T Consensus 2 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~ 75 (291)
T cd07870 2 GAATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDII-----HTK 75 (291)
T ss_pred CccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEE-----ecC
Confidence 556789999999999999999999999999999999864321 22233567899999999999999999998 445
Q ss_pred ceEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
...|+||||+.++|.+.+.. ...+.+..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++....
T Consensus 76 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 76 ETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred CeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 67999999999888887765 35688899999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~-~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
... ......++..|+|||.+.+. ..++.++|||||||++|+|++|..||.+.+ ..+.+..+...+|.|..+....
T Consensus 156 ~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (291)
T cd07870 156 PSQ---TYSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231 (291)
T ss_pred CCC---CCCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence 211 11334578999999988652 457889999999999999999999997655 3456666777777776665433
Q ss_pred hhhHHHHHHHHHh-hcCCCCCcCCCCC--CCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 258 VRNEKARKYLTEM-RKKPPVPLFQKFP--NVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 258 ~~~~~~~~~l~~~-~~~~~~~~~~~~~--~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
+... ..+.... ...........+. ..++.+.+||.+||..||++|||++++|.||||
T Consensus 232 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 232 VSKL--PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hhhc--ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 2210 0000000 0000111111111 136789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=359.07 Aligned_cols=288 Identities=37% Similarity=0.610 Sum_probs=220.0
Q ss_pred CeEEEeeeeecCceeEEEEEECC--CCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTH--TGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~--tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
+|++.+.||+|+||.||+|.+.. +++.||||.+.... ........+.+|+.+++.++||||+++++++... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 59999999999999999999988 89999999987532 1122235677899999999999999999998542 236
Q ss_pred eEEEEEecCcccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC----CCceEEeeeC
Q 008729 101 DIYVVFELMESDLHQVIKAN-----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA----NCKLKVCDFG 171 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~-----~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~----~~~vKL~DFG 171 (556)
.+|+||||++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||
T Consensus 78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 79999999999888877532 36899999999999999999999999999999999999999 8999999999
Q ss_pred ccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChH---------HHHHH
Q 008729 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV---------HQLDL 242 (556)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~---------~~~~~ 242 (556)
++................+++.+|+|||++.+. ..++.++|||||||++|+|++|++||.+.... ..+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 998654332211122345789999999987652 45789999999999999999999999876542 35566
Q ss_pred HHHhhCCCChHHHHHhhhHH-HHHHHHHhhcCCCCC------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 008729 243 ITDLLGTPSPETIAVVRNEK-ARKYLTEMRKKPPVP------LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (556)
Q Consensus 243 i~~~~g~p~~e~i~~~~~~~-~~~~l~~~~~~~~~~------~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~ 315 (556)
+...++.+............ .....+. ......+ ....+...+..+.++|.+||..||++|||+.++++|||
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~ 315 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKD-FKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhh-ccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence 66777766555443221110 1111011 1111111 00111257788999999999999999999999999999
Q ss_pred c
Q 008729 316 F 316 (556)
Q Consensus 316 f 316 (556)
|
T Consensus 316 f 316 (316)
T cd07842 316 F 316 (316)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=359.15 Aligned_cols=253 Identities=25% Similarity=0.444 Sum_probs=220.7
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
-|.++++||+|+||.||+|+|+.+|+.+|||++.. ..+...+..||.||++++.|++|++|+.|. ...++|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYF-----K~sDLW 104 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYF-----KHSDLW 104 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhc-----cCCceE
Confidence 47889999999999999999999999999998753 367888999999999999999999999984 345699
Q ss_pred EEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 104 VVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
||||||+ |+..++++. +..++++++..+++..|.||.|||...-+|||||..|||++.+|..||+|||.|-.......
T Consensus 105 IVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA 184 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA 184 (502)
T ss_pred eehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence 9999999 899999976 56899999999999999999999999999999999999999999999999999866433222
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
...+.+||+.|||||++.. .+|+.++||||||++..||..|++||.+-..+..+..|
T Consensus 185 ---KRNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI------------------ 241 (502)
T KOG0574|consen 185 ---KRNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI------------------ 241 (502)
T ss_pred ---hhCccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCcccccccceeEec------------------
Confidence 2256789999999999987 78999999999999999999999999775544333222
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
...+.|.+.+...++.++-|+|++||.+.|++|-||-++++|||+++
T Consensus 242 ----------PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~Fikn 288 (502)
T KOG0574|consen 242 ----------PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKN 288 (502)
T ss_pred ----------cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcC
Confidence 23444555566678999999999999999999999999999999985
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=345.01 Aligned_cols=279 Identities=26% Similarity=0.410 Sum_probs=223.8
Q ss_pred eEE-EeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCCceE
Q 008729 25 YKI-LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 25 Y~i-~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~l 102 (556)
|++ .+.||+|+|+.|-.+....||..||||+|.+... -...+++||++++.+++ |+||+.++++| ++...+
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--HsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~F 151 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--HSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRF 151 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCc--hHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceE
Confidence 554 4689999999999999999999999999987533 34568999999999996 99999999999 677789
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC---ceEEeeeCccccccC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLKVCDFGLARVAFS 178 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~vKL~DFGla~~~~~ 178 (556)
|||||-|. |.|...|.++..+++.++..++..|..||+|||.+||.||||||+|||..... -||||||.++.-...
T Consensus 152 YLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~ 231 (463)
T KOG0607|consen 152 YLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL 231 (463)
T ss_pred EEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc
Confidence 99999998 69999999999999999999999999999999999999999999999986543 489999998765322
Q ss_pred CCC----CcceecccccCcccCCccccc---ccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 008729 179 DTP----MTVFWTDYVATRWYRAPELCG---SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (556)
Q Consensus 179 ~~~----~~~~~~~~~gt~~Y~APE~~~---~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (556)
..+ .+....+.+|+..|||||+.. +....|+.++|.||||+|||.||+|.+||.|....+. |=-.
T Consensus 232 ~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC--------GWdr 303 (463)
T KOG0607|consen 232 NNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC--------GWDR 303 (463)
T ss_pred CCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC--------CccC
Confidence 221 122345678999999999753 3235699999999999999999999999987643110 0000
Q ss_pred hHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccc
Q 008729 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (556)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 322 (556)
.+ ....=-..++..+.......-...|..++.+++|||..+|..|+..|.++.++|+|||++.....
T Consensus 304 Ge----~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 304 GE----VCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred CC----ccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 00 00000123455566555555566788899999999999999999999999999999999976543
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=379.56 Aligned_cols=257 Identities=24% Similarity=0.320 Sum_probs=213.7
Q ss_pred CCeEEEeeeeecCceeEEEEEECCC-CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHT-GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~t-g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
..|.+.+.||+|+||.||+|.+..+ ++.||+|++.. ........+.+|+.+|+.++||||+++++.+ .....
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~-----~~~~~ 139 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDF-----KSDDK 139 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE-----EECCE
Confidence 3599999999999999999998888 78899997643 3344556678899999999999999999998 45567
Q ss_pred EEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 102 IYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
+|||||||. |+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 140 ~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~ 219 (478)
T PTZ00267 140 LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY 219 (478)
T ss_pred EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence 999999998 699887753 456899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+..
T Consensus 220 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~----------- 285 (478)
T PTZ00267 220 SDSVS-LDVASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY----------- 285 (478)
T ss_pred CCccc-cccccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Confidence 33221 112345679999999999987 6899999999999999999999999988775544443311
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.... .....+++.+.+||.+||..||++||+++++|.|+|++.+
T Consensus 286 ----------------~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 286 ----------------GKYD---PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred ----------------CCCC---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 1111 1123578899999999999999999999999999999753
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=354.54 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=209.0
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+|+.++|++|+.+++.+ .....+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEE
Confidence 4889999999999999999999999999999986432 2223345577899999999999999999998 445679
Q ss_pred EEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 103 YVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999998 6999888643 35899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.. .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+..........
T Consensus 156 ~~----~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---------------- 213 (285)
T cd05630 156 QT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---------------- 213 (285)
T ss_pred cc----ccCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH----------------
Confidence 21 123469999999999977 67899999999999999999999999765421111111
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHhCcccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-----a~elL~hp~f~~~ 319 (556)
...+..... .....+++.+.+||++||+.||++||| ++++++||||+++
T Consensus 214 ----~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 214 ----ERLVKEVQE-------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred ----Hhhhhhhhh-------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 001111100 112357889999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=393.42 Aligned_cols=262 Identities=27% Similarity=0.416 Sum_probs=213.7
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||+||+|.+..++..||+|++............+.+|+.+|+.|+|||||+++++|... ...
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~~~ 87 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---ANQ 87 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---CCC
Confidence 44689999999999999999999999999999999875544555667889999999999999999999988542 335
Q ss_pred eEEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-------CceeccCCCCcEeecC-------
Q 008729 101 DIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTA-------NVYHRDLKPKNILANA------- 161 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~-------gIvHrDLKP~NILl~~------- 161 (556)
.+|||||||. ++|.++|.. .+.+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 6999999999 699998865 35799999999999999999999995 4999999999999964
Q ss_pred ----------CCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCC
Q 008729 162 ----------NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231 (556)
Q Consensus 162 ----------~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF 231 (556)
...+||+|||++........ ....+||+.|+|||++.+....++.++||||||||||+|++|..||
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESM----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccccc----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 23489999999976432221 2345799999999998653346889999999999999999999999
Q ss_pred CCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 008729 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (556)
Q Consensus 232 ~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL 311 (556)
...+....+..+ +...... .....+..+.+||.+||..||.+||++.|+|
T Consensus 244 ~~~~~~~qli~~--------------------------lk~~p~l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL 293 (1021)
T PTZ00266 244 HKANNFSQLISE--------------------------LKRGPDL----PIKGKSKELNILIKNLLNLSAKERPSALQCL 293 (1021)
T ss_pred CcCCcHHHHHHH--------------------------HhcCCCC----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHh
Confidence 766543332111 1111111 1234688999999999999999999999999
Q ss_pred hCcccccc
Q 008729 312 ADPYFKGL 319 (556)
Q Consensus 312 ~hp~f~~~ 319 (556)
.|+||+.+
T Consensus 294 ~h~~ik~i 301 (1021)
T PTZ00266 294 GYQIIKNV 301 (1021)
T ss_pred ccHHHhhc
Confidence 99999754
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=342.71 Aligned_cols=254 Identities=29% Similarity=0.459 Sum_probs=211.6
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
.|++++.||+|++|.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++.+. .....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence 499999999999999999999999999999998754444455667889999999999999999998773 2234689
Q ss_pred EEEecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 104 VVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999998 699999876 3468999999999999999999999999999999999999999999999999997653322
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
. ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~--------------- 216 (257)
T cd08223 157 D---MASTLIGTPYYMSPELFSN--KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE--------------- 216 (257)
T ss_pred C---ccccccCCcCccChhHhcC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh---------------
Confidence 1 2234568999999999887 6788999999999999999999999987664433322211
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.. .......+++.+.+||.+||..||.+|||+.++++||||
T Consensus 217 -----------~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 217 -----------GK----LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred -----------cC----CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 011224578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=352.47 Aligned_cols=253 Identities=24% Similarity=0.356 Sum_probs=201.9
Q ss_pred eeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEecC
Q 008729 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (556)
Q Consensus 31 LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 109 (556)
||+|+||.||+|.++.+|+.||+|++..... .......+..|+.+|+.++||||+++++++ .....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence 7999999999999999999999999864221 122234456799999999999999999998 5556799999999
Q ss_pred c-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCccee
Q 008729 110 E-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (556)
Q Consensus 110 ~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (556)
. ++|.+++...+ .+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++....... ..
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~ 151 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----TI 151 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc----ee
Confidence 8 69988886543 58899999999999999999999999999999999999999999999999987653322 12
Q ss_pred cccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHH
Q 008729 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (556)
Q Consensus 187 ~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~ 266 (556)
....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~----------------------- 206 (277)
T cd05607 152 TQRAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL----------------------- 206 (277)
T ss_pred eccCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH-----------------------
Confidence 34568999999999877 56999999999999999999999999765421111111
Q ss_pred HHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH----HHHHhCccccccc
Q 008729 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGLA 320 (556)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta----~elL~hp~f~~~~ 320 (556)
........ .. .....+++++.+||++||+.||++||++ ++++.|+||+++.
T Consensus 207 ~~~~~~~~-~~--~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~ 261 (277)
T cd05607 207 KRRTLEDE-VK--FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTIN 261 (277)
T ss_pred HHHhhccc-cc--cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCC
Confidence 00000000 00 1123578999999999999999999999 7788999998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=350.67 Aligned_cols=282 Identities=47% Similarity=0.756 Sum_probs=232.7
Q ss_pred eEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEE
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (556)
|++.+.||.|++|.||+|.+..+++.|++|++............+.+|+.+|+.++|+||+++++++ .....+|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVF-----RHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhh-----ccCCCEEE
Confidence 7788999999999999999999999999999875444434556788999999999999999999998 44467999
Q ss_pred EEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCc
Q 008729 105 VFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (556)
Q Consensus 105 V~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 183 (556)
|+||++++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||.+.......
T Consensus 76 v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--- 152 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--- 152 (283)
T ss_pred EEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc---
Confidence 999999999988876 4579999999999999999999999999999999999999999999999999987654432
Q ss_pred ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHH
Q 008729 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (556)
Q Consensus 184 ~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~ 263 (556)
.......++.+|+|||.+.+. ..++.++|||||||++|+|++|+.||++.+..+.+..+...++.+.++.+.....-..
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 122345688999999998762 3688999999999999999999999999999999999888888887766554333111
Q ss_pred HHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.. ................+.++..+.+||.+||..||.+||+++++++||||
T Consensus 232 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 232 NY-KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hh-hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 11 11111222222233445688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=354.38 Aligned_cols=283 Identities=25% Similarity=0.386 Sum_probs=216.9
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+++++.++||||+++++++ .+...+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 74 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAF-----YSDGEI 74 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCEE
Confidence 36999999999999999999999999999999987432 233455688999999999999999999999 455679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999998 6999999988889999999999999999999998 599999999999999999999999999987543221
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH-----
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI----- 255 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i----- 255 (556)
....+|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+............
T Consensus 155 -----~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 155 -----ANSFVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred -----cccCCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccccc
Confidence 134578999999999876 67889999999999999999999999876643332222111000000000
Q ss_pred ----HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 256 ----AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 256 ----~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
...........++.+..... +. .....++.++.+|+.+||..||++|||+.++++||||.+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 294 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPP-PK-LPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAE 294 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCC-cc-CcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcc
Confidence 00000001111111111111 11 11123788999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=364.77 Aligned_cols=260 Identities=27% Similarity=0.420 Sum_probs=206.5
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~ 100 (556)
+..|++++.||+||.+.||+++.. ....||+|++.....+.....-+.+||.+|.+|+ |.+||.|+++-+. +.
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-----d~ 433 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-----DG 433 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-----Cc
Confidence 367999999999999999999754 3467888888766677778888999999999996 9999999998754 46
Q ss_pred eEEEEEecCcccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~~-l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
++||||||-+-||..+|++... +..-.+++|..|||.|++++|..||||.||||.|+|+- .|.+||+|||.|.....+
T Consensus 434 ~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 434 YLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred eEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 6999999988999999987654 33348899999999999999999999999999999985 568999999999887665
Q ss_pred CCCcceecccccCcccCCcccccccC---------CCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFF---------SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~---------~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p 250 (556)
+.. +.....+||+.||+||.+.... .+.++++||||||||||+|+.|++||..-- .++.++..+
T Consensus 513 TTs-I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI---- 585 (677)
T KOG0596|consen 513 TTS-IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAI---- 585 (677)
T ss_pred ccc-eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhh----
Confidence 533 3446789999999999875421 126689999999999999999999994321 111111110
Q ss_pred ChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCC--HHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVD--PLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s--~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
+.-...++ |+.++ .++.++++.||.+||++|||+.++|+|||+..
T Consensus 586 -------------------~~P~~~Ie----fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 586 -------------------TDPNHEIE----FPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred -------------------cCCCcccc----ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 00111122 23332 23999999999999999999999999999974
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=350.82 Aligned_cols=258 Identities=25% Similarity=0.400 Sum_probs=211.6
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
.|++.+.||+|+||+||+|.+..+++.||+|++.... ........+.+|+.+|+.++|+||+.+++.+ .....+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEE
Confidence 4888999999999999999999999999999986432 2223344578899999999999999999998 455679
Q ss_pred EEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 103 YVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999999 5898887643 36999999999999999999999999999999999999999999999999998654322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
. ......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+...
T Consensus 156 ~----~~~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~------------- 216 (285)
T cd05632 156 E----SIRGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR------------- 216 (285)
T ss_pred C----cccCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-------------
Confidence 1 1234579999999999977 67899999999999999999999999876654333322110
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHhCcccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGL 319 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-----a~elL~hp~f~~~ 319 (556)
... ........+++.+.+|+.+||..||++||+ +.++++|+||+..
T Consensus 217 ----------~~~----~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 217 ----------VLE----TEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred ----------hhc----cccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 000 001122457889999999999999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=361.07 Aligned_cols=291 Identities=39% Similarity=0.582 Sum_probs=230.9
Q ss_pred CCCCCeEE-EeeeeecCceeEEEEEECCCCcEEEEEEecCccCChh------------HHHHHHHHHHHHHhCCCCCcce
Q 008729 20 GDANRYKI-LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS------------DAIRILREVKLLRLLRHPDIVE 86 (556)
Q Consensus 20 ~~~~~Y~i-~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~------------~~~~~~rEi~iL~~L~HpnIv~ 86 (556)
...++|.. .+.||.|+||+||+|.+..+++.||||++........ ....+.+|+.+|+.++|+||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 34568875 5779999999999999999999999999864321110 0124678999999999999999
Q ss_pred eeEEEcCCCCCCCceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceE
Q 008729 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLK 166 (556)
Q Consensus 87 l~~v~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vK 166 (556)
+++++ .....+|+||||+.++|.+++.....+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+|
T Consensus 85 ~~~~~-----~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 85 LVDVY-----VEGDFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICK 159 (335)
T ss_pred eeEEE-----ecCCcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEE
Confidence 99998 4456799999999999999999888899999999999999999999999999999999999999999999
Q ss_pred EeeeCccccccCCC-----------CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCC
Q 008729 167 VCDFGLARVAFSDT-----------PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235 (556)
Q Consensus 167 L~DFGla~~~~~~~-----------~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~ 235 (556)
|+|||++....... ..........++..|+|||.+.+. ..++.++|||||||++|+|++|.+||.+.+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999997653111 011112334578899999988652 357899999999999999999999999999
Q ss_pred hHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 008729 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (556)
Q Consensus 236 ~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~ 315 (556)
..+.+..+...++.|....+....... .+ .......+......++..+..+.+||.+||+.||++|||++++|.|||
T Consensus 239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~ 315 (335)
T PTZ00024 239 EIDQLGRIFELLGTPNEDNWPQAKKLP--LY-TEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY 315 (335)
T ss_pred HHHHHHHHHHHhCCCchhhCcchhhcc--cc-cccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence 999999999988888765443211100 00 000011111222334567889999999999999999999999999999
Q ss_pred cccc
Q 008729 316 FKGL 319 (556)
Q Consensus 316 f~~~ 319 (556)
|++.
T Consensus 316 ~~~~ 319 (335)
T PTZ00024 316 FKSD 319 (335)
T ss_pred cCCC
Confidence 9865
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=366.41 Aligned_cols=256 Identities=29% Similarity=0.535 Sum_probs=218.3
Q ss_pred CeEE--EeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 24 RYKI--LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 24 ~Y~i--~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
-|+| .++||+|.||+||-|+++.+|+.||||+|++.....+....+.+|+.||+.+.||.||.+-..| +....
T Consensus 563 vYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~er 637 (888)
T KOG4236|consen 563 VYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPER 637 (888)
T ss_pred HHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCce
Confidence 4666 4799999999999999999999999999987655555667888999999999999999999998 45556
Q ss_pred EEEEEecCcccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC---ceEEeeeCccccc
Q 008729 102 IYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLKVCDFGLARVA 176 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~--~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~vKL~DFGla~~~ 176 (556)
+++|||-+.||..+.|.+ .+++++...++++.|||.||.|||.+||+|+||||+|||+.... .+||||||+|++.
T Consensus 638 vFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI 717 (888)
T KOG4236|consen 638 VFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARII 717 (888)
T ss_pred EEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeec
Confidence 999999999999888865 57899999999999999999999999999999999999997553 5999999999987
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
.... |....+||+.|.|||++.+ .+|+..-|+||+|||+|--|.|..||....+. -++|.+
T Consensus 718 gEks----FRrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQN----------- 778 (888)
T KOG4236|consen 718 GEKS----FRRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQN----------- 778 (888)
T ss_pred chhh----hhhhhcCCccccCHHHHhh--ccccccccceeeeEEEEEEecccccCCCccch--hHHhhc-----------
Confidence 5432 4567899999999999998 89999999999999999999999999654322 222221
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
....--...|..+++.+.|||..+|++.-.+|.|.+..|.|||+++.
T Consensus 779 ----------------AaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 779 ----------------AAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred ----------------cccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 11111123456799999999999999999999999999999999875
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=349.81 Aligned_cols=254 Identities=25% Similarity=0.471 Sum_probs=216.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+++|+.++||||+++++++ .+...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSF-----QDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCe
Confidence 47999999999999999999999999999999986421 2234456788999999999999999999998 55677
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+|+||+|.|||++.++.+||+|||++......
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 999999996 799999998889999999999999999999999999999999999999999999999999999875433
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
.....|++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.......+..
T Consensus 155 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 212 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILS--KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILE--------------- 212 (290)
T ss_pred -----CCCCCCCccccChhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc---------------
Confidence 134468999999999876 5788999999999999999999999987764333332210
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
... .....++..+.++|++||..||.+|+ +++++++||||+.+.
T Consensus 213 -----------~~~-----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 213 -----------GKV-----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred -----------CCc-----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 011 11234688999999999999999999 999999999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=349.86 Aligned_cols=281 Identities=43% Similarity=0.720 Sum_probs=232.5
Q ss_pred eEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEE
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (556)
|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++ .+...+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVI-----HTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhh-----hcCCceEE
Confidence 7788999999999999999999999999999875443334456677899999999999999999998 44467999
Q ss_pred EEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCc
Q 008729 105 VFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (556)
Q Consensus 105 V~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 183 (556)
||||++++|.+++... ..+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||+++.......
T Consensus 76 v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 76 VFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred EecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 9999999999999876 5799999999999999999999999999999999999999999999999999876533221
Q ss_pred ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHH
Q 008729 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (556)
Q Consensus 184 ~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~ 263 (556)
......++..|+|||.+.+. ..++.++|||||||++|+|++|++||.+.+....+..+...++.+....+..+.+..
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 230 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP- 230 (282)
T ss_pred -ccCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-
Confidence 12334567889999998662 378899999999999999999999999999999999999999988877665443221
Q ss_pred HHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.+-..............++.++..+.++|++||..||++||++++++.||||
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 231 -DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred -cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0001111112222234456678999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=359.37 Aligned_cols=285 Identities=21% Similarity=0.291 Sum_probs=207.8
Q ss_pred EEeeeeec--CceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEE
Q 008729 27 ILEVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (556)
Q Consensus 27 i~~~LG~G--~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (556)
++++||+| +||+||++.++.+|+.||||++............+.+|+.+++.++||||+++++++ .....+|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~-----~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATF-----IADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----EECCEEEE
Confidence 57889999 678999999999999999999975444444455677899999999999999999999 44467999
Q ss_pred EEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 105 VFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 105 V~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|||||+ ++|.+++..+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+........
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999 6999998653 4589999999999999999999999999999999999999999999999986544321111
Q ss_pred C----cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH-
Q 008729 182 M----TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA- 256 (556)
Q Consensus 182 ~----~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~- 256 (556)
. ........++..|+|||++.+....|+.++|||||||++|+|++|+.||.+.......... ..+... ..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~-~~~~~ 233 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--LNGTVP-CLLDT 233 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH--hcCCcc-ccccc
Confidence 0 0011223577889999998753346899999999999999999999999876543322221 111110 0000
Q ss_pred -HhhhHHHHHHH------HHhhcC----------CCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 257 -VVRNEKARKYL------TEMRKK----------PPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 257 -~~~~~~~~~~l------~~~~~~----------~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
....+...... ...... ...........+++.+.+||++||+.||++|||++++|+||||+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 00000000000 000000 0000001122467899999999999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=361.88 Aligned_cols=275 Identities=27% Similarity=0.390 Sum_probs=223.2
Q ss_pred chhhhhhccccccccc---cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHh
Q 008729 3 QDQTKKELKDKDFFTE---YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRL 78 (556)
Q Consensus 3 ~~~~~~~~~~~~~~~~---~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~ 78 (556)
....+..+++.+...- -+..+.|.-++.||.|+||-||-|+|..+.+.||||++.-... .......|+.|+.+|+.
T Consensus 3 a~~r~GslKDPeiA~LF~k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~ 82 (948)
T KOG0577|consen 3 AGGRPGSLKDPEIADLFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQ 82 (948)
T ss_pred CCCCCCCCCCchHHHHHccCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHh
Confidence 3344455555442221 2223468889999999999999999999999999999974332 33445689999999999
Q ss_pred CCCCCcceeeEEEcCCCCCCCceEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 008729 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNI 157 (556)
Q Consensus 79 L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 157 (556)
|.|||++.+.++|+-. ...|||||||-|+-.+++.- ..++.+.++..|+.+.|.||+|||+.+.||||||..||
T Consensus 83 l~HPntieYkgCyLre-----~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNI 157 (948)
T KOG0577|consen 83 LRHPNTIEYKGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNI 157 (948)
T ss_pred ccCCCcccccceeecc-----chHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccce
Confidence 9999999999999644 34799999999866666643 35799999999999999999999999999999999999
Q ss_pred eecCCCceEEeeeCccccccCCCCCcceecccccCcccCCccccccc-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh
Q 008729 158 LANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236 (556)
Q Consensus 158 Ll~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~ 236 (556)
|+.+.|.|||+|||.|.... ....++|||+|||||++... .+.|+-++||||||++..||.-.+||+-+.+.
T Consensus 158 LLse~g~VKLaDFGSAsi~~-------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA 230 (948)
T KOG0577|consen 158 LLSEPGLVKLADFGSASIMA-------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 230 (948)
T ss_pred EecCCCeeeeccccchhhcC-------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH
Confidence 99999999999999987642 23678999999999987642 25699999999999999999999999888777
Q ss_pred HHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 237 ~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
+..+--|.. +..+ .. .-+.++..+..||..||++-|.+|||.+++|.|+|.
T Consensus 231 MSALYHIAQ--------------------------NesP--tL-qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv 281 (948)
T KOG0577|consen 231 MSALYHIAQ--------------------------NESP--TL-QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFV 281 (948)
T ss_pred HHHHHHHHh--------------------------cCCC--CC-CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchh
Confidence 666655532 1111 11 124688999999999999999999999999999998
Q ss_pred cc
Q 008729 317 KG 318 (556)
Q Consensus 317 ~~ 318 (556)
..
T Consensus 282 ~R 283 (948)
T KOG0577|consen 282 LR 283 (948)
T ss_pred cc
Confidence 64
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=348.42 Aligned_cols=259 Identities=24% Similarity=0.390 Sum_probs=209.9
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++.+.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++.+ ....
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~-----~~~~ 79 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGSY-----LRRD 79 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC--chhHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EeCC
Confidence 345899999999999999999999999999999998643 223445678899999999999999999998 4556
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+||||++ ++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 7999999999 699999998889999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcceecccccCcccCCcccccc-cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.. ......|+..|+|||++.. ....++.++|+|||||++|+|++|.+||........+..+..
T Consensus 160 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~------------- 223 (267)
T cd06645 160 IA---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK------------- 223 (267)
T ss_pred cc---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc-------------
Confidence 11 1234579999999998742 114588999999999999999999999865543222211100
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~ 315 (556)
.....+.......++..+.+||++||..||++|||++++++|||
T Consensus 224 -------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 224 -------------SNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -------------cCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 00001111112246788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=360.32 Aligned_cols=254 Identities=26% Similarity=0.444 Sum_probs=200.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEE-----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (556)
.++|+++++||+|+||.||+|.+ ..+++.||||++... ........+.+|+.+|..+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~-- 82 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACTK-- 82 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEecC--
Confidence 35899999999999999999975 245578999998743 2334456788999999999 89999999998742
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHhC------------------------------------------------------
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 120 (556)
....+|+|||||. |+|.+++...
T Consensus 83 --~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 83 --PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred --CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 2345899999999 7999998753
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcceecccccC
Q 008729 121 --------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192 (556)
Q Consensus 121 --------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt 192 (556)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........ .......++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~ 239 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGSARLP 239 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch-hcccCCCCC
Confidence 23778889999999999999999999999999999999999999999999999764322111 111233466
Q ss_pred cccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhh
Q 008729 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMR 271 (556)
Q Consensus 193 ~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~ 271 (556)
..|+|||++.+ ..|+.++|||||||+||||++ |..||.+......+... +.
T Consensus 240 ~~y~aPE~~~~--~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~--------------------------~~ 291 (338)
T cd05102 240 LKWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQR--------------------------LK 291 (338)
T ss_pred ccccCcHHhhc--CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH--------------------------Hh
Confidence 78999999877 678999999999999999997 99999876532222111 11
Q ss_pred cCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 272 KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 272 ~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... ......+++.+.+|+.+||..||++|||+.++++
T Consensus 292 ~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 292 DGTR---MRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred cCCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1111 1112457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=339.89 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=212.9
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
.|.+.+.||+|+||.||+|.+..+++.|++|.+............+.+|+.+++.++||||+++++.+ .+....|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESF-----LDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeee-----ccCCEEE
Confidence 48899999999999999999999999999999875434455667888999999999999999999998 4456799
Q ss_pred EEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 104 VVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.......
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999998 6999999774 578999999999999999999999999999999999999999999999999987654322
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
. ......|+.+|+|||++.+ ..++.++|+|||||++|+|++|+.||...+.......+..
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08529 156 N---FANTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR--------------- 215 (256)
T ss_pred c---hhhccccCccccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 1234568899999999987 6788999999999999999999999987765443332211
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.... .....++..+.++|++||+.+|++||++.++++|||+
T Consensus 216 ------------~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 216 ------------GVFP---PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ------------CCCC---CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 1111 1112578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=394.41 Aligned_cols=265 Identities=26% Similarity=0.399 Sum_probs=227.9
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..+|.|+++||+|+||.|.+++++.|++.||+|++++.. ....+...|..|-.||-.-+.+=|+.++-.| .+.+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCcc
Confidence 357999999999999999999999999999999998632 2234566788899999988899999999998 7788
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
++|+|||||. |||..++.+.+.+++..+++|+..|+.||.-||+.|+|||||||+|||+|..|+|||+|||.|-....+
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 9999999998 699999999889999999999999999999999999999999999999999999999999998765544
Q ss_pred CCCcceecccccCcccCCccccccc---CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~---~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
. .......+|||-|.+||++... ...|++.+|+|||||++||||.|..||...+.++.+.+|++.
T Consensus 229 G--~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h---------- 296 (1317)
T KOG0612|consen 229 G--TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH---------- 296 (1317)
T ss_pred C--cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch----------
Confidence 3 2344678899999999998432 146999999999999999999999999999988888877542
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC---HHHHHhCcccccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT---AEEALADPYFKGLAK 321 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt---a~elL~hp~f~~~~~ 321 (556)
+....|. .-..+|..+++||+++|. +|+.|.. ++++-+||||.++.+
T Consensus 297 ----------------k~~l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 297 ----------------KESLSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred ----------------hhhcCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 2222222 123599999999999886 8889998 999999999998754
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=348.05 Aligned_cols=262 Identities=24% Similarity=0.392 Sum_probs=212.2
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
...+.|++++.||.|+||.||+|.+..+++.||+|++.. ........+.+|+.+++.++||||+++++++. ..
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~ 81 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET--KSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WD 81 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eC
Confidence 344689999999999999999999999999999999864 33445667889999999999999999999983 44
Q ss_pred ceEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
..+|+||||++ ++|..++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 82 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 161 (292)
T cd06644 82 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNV 161 (292)
T ss_pred CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecc
Confidence 57999999999 577777654 4568999999999999999999999999999999999999999999999999987532
Q ss_pred CCCCCcceecccccCcccCCccccccc---CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~---~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
.... ......++..|+|||++.+. ...++.++|||||||++|+|++|.+||...+.......+.
T Consensus 162 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~---------- 228 (292)
T cd06644 162 KTLQ---RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---------- 228 (292)
T ss_pred cccc---ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHh----------
Confidence 2211 12345688999999988531 1457889999999999999999999997765433222211
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.. ..+.......++..+.+||++||..||++||+++++|+||||..+
T Consensus 229 -----------------~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 229 -----------------KS-EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred -----------------cC-CCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00 011112234578899999999999999999999999999999865
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=351.50 Aligned_cols=262 Identities=27% Similarity=0.445 Sum_probs=215.7
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCC-hhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.+|+.++||||+++++.+ .+...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCE
Confidence 4799999999999999999999999999999998753222 23556788999999999999999999998 55667
Q ss_pred EEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999998 5999998764 5789999999999999999999999999999999999999999999999999865422
Q ss_pred CCCC--------------------------cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCC
Q 008729 179 DTPM--------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232 (556)
Q Consensus 179 ~~~~--------------------------~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~ 232 (556)
.... .......+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 1110 001123578999999999987 678999999999999999999999998
Q ss_pred CCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC----HH
Q 008729 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT----AE 308 (556)
Q Consensus 233 ~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt----a~ 308 (556)
+.+....+..+.. .... ......++..+.+||++||..||++||| ++
T Consensus 234 ~~~~~~~~~~~~~--------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 234 GSNRDETFSNILK--------------------------KEVT---FPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CCchHHHHHHHhc--------------------------CCcc---CCCccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 8775444333211 1111 1111237899999999999999999999 99
Q ss_pred HHHhCccccccc
Q 008729 309 EALADPYFKGLA 320 (556)
Q Consensus 309 elL~hp~f~~~~ 320 (556)
++|+||||++..
T Consensus 285 ~ll~~~~~~~~~ 296 (316)
T cd05574 285 EIKQHPFFRGVN 296 (316)
T ss_pred HHHcCchhhcCC
Confidence 999999999764
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=364.92 Aligned_cols=260 Identities=24% Similarity=0.409 Sum_probs=217.5
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.+.|.|+..||-|+||.||+|..+.++-.-|.|+|.. ....+...++-||.||..++||+||+|++.|+.. +.
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~e-----nk 103 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE-----NK 103 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc-----Cc
Confidence 3468899999999999999999999998889998863 4456677889999999999999999999998543 55
Q ss_pred EEEEEecCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 102 IYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 102 lylV~E~~~g-~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
+||+.|||+| -...++.. ...|++.+++.+++|+|.||.|||+++|||||||..|||+.-+|.++|+|||.+......
T Consensus 104 LwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 104 LWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred eEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH
Confidence 9999999995 45555544 457999999999999999999999999999999999999999999999999987653322
Q ss_pred CCCcceecccccCcccCCcccccc---cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~---~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
.. ....++|||+|||||+... ...+|+.++||||||++|.||..+.||...-+.+..+-+|.+
T Consensus 184 ~q---kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaK----------- 249 (1187)
T KOG0579|consen 184 RQ---KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK----------- 249 (1187)
T ss_pred Hh---hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhh-----------
Confidence 21 2356889999999998532 126799999999999999999999999988888777655532
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
...|..-....++..+.|+|++||.+||..||++.++|+||||.+.
T Consensus 250 -----------------SePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 250 -----------------SEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred -----------------cCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 1112223345688899999999999999999999999999999864
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=347.97 Aligned_cols=283 Identities=40% Similarity=0.698 Sum_probs=227.3
Q ss_pred eEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEE
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (556)
|++++.||.|+||.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++.... ...+|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 78999999999999999999999999999999754333344556889999999999999999999984321 367999
Q ss_pred EEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCc
Q 008729 105 VFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (556)
Q Consensus 105 V~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 183 (556)
||||++++|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.+||+|||++........
T Consensus 78 v~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 78 VFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred EeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9999999999998765 5799999999999999999999999999999999999999999999999999986543321
Q ss_pred ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHH
Q 008729 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (556)
Q Consensus 184 ~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~ 263 (556)
...+...++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...+....+..+.+..+.+....+.....-.
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 233 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP- 233 (287)
T ss_pred ccccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch-
Confidence 112344578899999977642 467899999999999999999999999999888888888888887665543322110
Q ss_pred HHHHHHhhcCCC--CCcCCCCCC-CCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 264 RKYLTEMRKKPP--VPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 264 ~~~l~~~~~~~~--~~~~~~~~~-~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
+......... ..+...+.. .++.+.++|++||..||.+||+++++++||||
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 234 --WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred --hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0000000000 001112223 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=344.98 Aligned_cols=260 Identities=24% Similarity=0.379 Sum_probs=209.0
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
+..++|++++.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++.+ ...
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~--~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~-----~~~ 78 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGSY-----LSR 78 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC--ccchHHHHHHHHHHHHhcCCCCeeeeeEEE-----EeC
Confidence 3446799999999999999999999999999999998642 223445678999999999999999999998 444
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
..+|+||||++ ++|.+++..++.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.....
T Consensus 79 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 79 EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 67999999999 69999998888899999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcceecccccCcccCCccccccc-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... .....|+..|+|||.+... ...++.++|||||||++|+|++|..||......+....+..
T Consensus 159 ~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~------------ 223 (267)
T cd06646 159 TIAK---RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK------------ 223 (267)
T ss_pred cccc---cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec------------
Confidence 2111 1345688999999987431 14578899999999999999999999965443222111100
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~ 315 (556)
.....+.......++..+.+||++||..||++|||++++|+|+|
T Consensus 224 --------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 224 --------------SNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred --------------CCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00001111112347889999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=345.40 Aligned_cols=282 Identities=37% Similarity=0.623 Sum_probs=223.9
Q ss_pred eEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC---CCCCcceeeEEEcCCCCCCCce
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L---~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
|++++.||.|+||.||+|.++.+++.||+|++............+.+|+.+++.+ +||||+++++++..........
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999999999999999975433333344566788887766 5999999999986544333445
Q ss_pred EEEEEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 102 IYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
+|+||||+.++|.+++.... .+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~ 160 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCC
Confidence 99999999999999887643 5899999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.. .....++..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+..+.+....+....
T Consensus 161 ~~----~~~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 161 MA----LTSVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred cc----cccccccccccChHHhcc--CCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 21 133457889999999987 678899999999999999999999999999888888887776665443322111
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.... ...............+.+++.+.+||++||..||++||+++++|+||||
T Consensus 235 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPR----SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccch----hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0000 0001111122223334577889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=352.00 Aligned_cols=291 Identities=38% Similarity=0.627 Sum_probs=227.9
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC-----C
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-----K 96 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~-----~ 96 (556)
.++|++.+.||+|+||.||+|.++.+|+.||+|++............+.+|+.+++.++||||+++++++.... .
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 35799999999999999999999999999999998643322233456778999999999999999999885432 1
Q ss_pred CCCceEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 97 REFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
.+...+|+|+||++++|...+... ..+++..+..++.||+.||+|||+.||+|+||||+||+++.++.+||+|||++..
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 165 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence 123479999999999888888764 4689999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
....... ......++..|+|||.+.+. ..++.++|||||||++|+|++|++||...+....+..+....+.+.+..+
T Consensus 166 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (302)
T cd07864 166 YNSEESR--PYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242 (302)
T ss_pred ccCCccc--ccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence 5433221 12233567889999987642 45788999999999999999999999998888888888888888766544
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
..+.........+.. ..........+..++..+.+||.+||..||.+|||++++|.||||
T Consensus 243 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 243 PDVIKLPYFNTMKPK-KQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccccccccccccccc-cccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 322111000000000 000011112344578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=342.43 Aligned_cols=260 Identities=25% Similarity=0.407 Sum_probs=208.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC---ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
..|++.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 469999999999999999999999999999998864322 223455688999999999999999999987432 23
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
..+|+|+||+. ++|.+++...+.+++...+.++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 57899999998 59999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
............++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~-------------- 222 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIA-------------- 222 (266)
T ss_pred ccccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHh--------------
Confidence 1111111233458889999999877 678899999999999999999999997654332221110
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
..... ......+++.+.+|| +||..||++||+++++++||||+
T Consensus 223 -------------~~~~~--~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 223 -------------TQPTN--PQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred -------------cCCCC--CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 00000 111234678899999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=348.67 Aligned_cols=258 Identities=27% Similarity=0.478 Sum_probs=212.9
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
+...+|++++.||+|+||.||+|++..+++.||+|.+... .......+.+|+.+++.+.|+||+++++.+. ..
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~ 89 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSYL-----VG 89 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecC--CcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eC
Confidence 3447999999999999999999999999999999998743 2234567889999999999999999999984 44
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
...|+||||+. ++|.+++.. ..+++.++..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 57999999998 699998864 4689999999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|++||...+....+..+.
T Consensus 169 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~-------------- 229 (296)
T cd06654 169 EQS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-------------- 229 (296)
T ss_pred ccc---ccCcccCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHh--------------
Confidence 211 1234568899999999877 678899999999999999999999997765433221110
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
. ...+.......++..+.+||.+||..||++|||+.++++||||..
T Consensus 230 ------------~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 230 ------------T--NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred ------------c--CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 0 011111223457889999999999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=347.83 Aligned_cols=258 Identities=28% Similarity=0.501 Sum_probs=214.6
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
...+|++++.||.|+||.||+|++..+++.||||.+... .......+.+|+.+++.++||||+++++.+ ....
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~ 89 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ--KQPKKELIINEILVMKELKNPNIVNFLDSF-----LVGD 89 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecc--cCchHHHHHHHHHHHHhcCCCceeeeeeeE-----ecCc
Confidence 346899999999999999999999999999999998642 223456788999999999999999999998 4456
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+|+||+. ++|..++.. ..+++.++..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 7999999998 588888865 46899999999999999999999999999999999999999999999999998764332
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
... .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~-------------- 229 (296)
T cd06655 169 QSK---RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-------------- 229 (296)
T ss_pred ccc---CCCcCCCccccCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Confidence 211 133468899999999877 6788999999999999999999999988765443322211
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
...+.......+++.+.+||++||..||.+|||+.+++.||||+..
T Consensus 230 --------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 230 --------------NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred --------------cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 0111122334688899999999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=330.03 Aligned_cols=287 Identities=31% Similarity=0.603 Sum_probs=230.7
Q ss_pred ccCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCC
Q 008729 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (556)
Q Consensus 18 ~~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~ 96 (556)
..|..+.|++++++|+|.|+.||.|++..++++++||+++. -..+++.||++||+.|. ||||++++++..++.
T Consensus 33 ~wg~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~- 106 (338)
T KOG0668|consen 33 DWGNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE- 106 (338)
T ss_pred eccccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc-
Confidence 46788899999999999999999999999999999999874 34568999999999997 999999999987643
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC-CceEEeeeCccc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLAR 174 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~vKL~DFGla~ 174 (556)
.+...|||||++ .|...+.. .++...++.+++|||.||.|||+.||+|||+||.|++||.. -.++|+|||+|.
T Consensus 107 --SktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 107 --SKTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred --ccCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence 355789999999 47666554 58889999999999999999999999999999999999854 569999999998
Q ss_pred cccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhhCCCChH
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~-~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
+...... ..-.+.+++|.-||++... ..|+..-|+|||||+|+.|+..+ |.|.|.++.+|+.+|.+++|+-...
T Consensus 182 FYHp~~e----YnVRVASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 182 FYHPGKE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY 256 (338)
T ss_pred hcCCCce----eeeeeehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence 8654332 3456799999999999875 68999999999999999999977 5568999999999999999974322
Q ss_pred H-HHHhhhHHHHHHHHHhhcCCCCCcCCCC-----CCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 254 T-IAVVRNEKARKYLTEMRKKPPVPLFQKF-----PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 254 ~-i~~~~~~~~~~~l~~~~~~~~~~~~~~~-----~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
. +..+.-....+|-.-+......++.... --.++++.|||.++|..|..+|+||.|++.||||..+.
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 1 1111111112222222222222222111 12579999999999999999999999999999998654
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=336.56 Aligned_cols=253 Identities=27% Similarity=0.465 Sum_probs=215.2
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
+|++++.||.|+||.||.+.+..+++.|++|++............+.+|+.+|+.++|+||+++++++ .+...++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHF-----MDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEE-----ecCCeEE
Confidence 69999999999999999999999999999999875444455667788999999999999999999999 4556799
Q ss_pred EEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 104 VVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|||||. ++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++.......
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999998 6999999765 468999999999999999999999999999999999999999999999999997654332
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
. ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 156 ~---~~~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08221 156 S---MAETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ--------------- 215 (256)
T ss_pred c---cccccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc---------------
Confidence 1 2245668999999999877 5688899999999999999999999988765544443311
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.... .....++..+.++|.+||..||.+||+++++|+|+|+
T Consensus 216 ------------~~~~---~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 216 ------------GNYT---PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred ------------CCCC---CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 1111 1114578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=348.90 Aligned_cols=259 Identities=28% Similarity=0.473 Sum_probs=213.3
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||.||+|.+..+++.||+|.+... .......+.+|+.+++.++|+||+++++.+ ....
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 89 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKNPNIVNYLDSY-----LVGD 89 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecC--ccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCC
Confidence 347899999999999999999999999999999998642 223445678999999999999999999998 4556
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred EEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 7999999998 689998865 46899999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.. ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+....+..+.
T Consensus 169 ~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~--------------- 228 (297)
T cd06656 169 QS---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--------------- 228 (297)
T ss_pred cc---CcCcccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec---------------
Confidence 21 1134568899999999887 678899999999999999999999997765432221110
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
....+.......++..+.+||.+||..||++||+++++|+||||+...
T Consensus 229 -------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 229 -------------TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred -------------cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 001111122345788899999999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=338.61 Aligned_cols=257 Identities=28% Similarity=0.449 Sum_probs=211.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++.+.||.|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++.+ .+...+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~ 75 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFGSY-----LRRDKL 75 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC--chhhHHHHHHHHHHHHhCCCCChhceEEEE-----EeCCEE
Confidence 5899999999999999999999999999999998743 223566788999999999999999999988 455679
Q ss_pred EEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 103 YVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++.......
T Consensus 76 ~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 76 WIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred EEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 99999999 5899988776 789999999999999999999999999999999999999999999999999987643322
Q ss_pred CCcceecccccCcccCCccccccc-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~-~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
. ......++..|+|||.+.+. ...++.++|||||||++|+|++|.+||.+.+.......+..
T Consensus 156 ~---~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~-------------- 218 (262)
T cd06613 156 A---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK-------------- 218 (262)
T ss_pred h---ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Confidence 1 11345688999999998661 01688899999999999999999999987765443332211
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~ 315 (556)
.....+.......++..+.+||++||..||.+|||+.+++.|+|
T Consensus 219 ------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 219 ------------SNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ------------ccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00000111112345778999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=344.44 Aligned_cols=256 Identities=23% Similarity=0.364 Sum_probs=209.2
Q ss_pred eEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEE
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (556)
|++++.||.|+||.||+|.+..++..+++|.+.. ........+.+|+.+++.++||||+++++++. .....|+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~ 79 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWI 79 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCC--CCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEE
Confidence 7889999999999999999999999999999864 23345667889999999999999999999984 4457899
Q ss_pred EEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCC
Q 008729 105 VFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (556)
Q Consensus 105 V~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 182 (556)
|+||+. ++|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 80 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~- 158 (282)
T cd06643 80 LIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ- 158 (282)
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-
Confidence 999999 588777754 46799999999999999999999999999999999999999999999999999875432211
Q ss_pred cceecccccCcccCCcccccc---cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 183 TVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~~~~---~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
......++..|+|||++.. ....++.++|||||||++|+|++|++||...+.......+..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------------- 222 (282)
T cd06643 159 --RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-------------- 222 (282)
T ss_pred --ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh--------------
Confidence 1234568999999998742 114577899999999999999999999987665443332211
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
.. .+.......++..+.+||.+||..||.+|||++++++||||..
T Consensus 223 ------------~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 267 (282)
T cd06643 223 ------------SE--PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV 267 (282)
T ss_pred ------------cC--CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEec
Confidence 00 0111122357889999999999999999999999999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=345.30 Aligned_cols=260 Identities=27% Similarity=0.414 Sum_probs=213.2
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||.|+||.||+|.+..+++.||+|.+.. ........+.+|+.+++.++||||+++++.+ .....
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 76 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQI--ESEEELEDFMVEIDILSECKHPNIVGLYEAY-----FYENK 76 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEee--CCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----ecCCe
Confidence 4579999999999999999999999999999999863 3445566788999999999999999999998 44567
Q ss_pred EEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++......
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 77 LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred EEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 999999999 5999888764 56999999999999999999999999999999999999999999999999998764332
Q ss_pred CCCcceecccccCcccCCccccccc---CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~---~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
... .....++..|+|||++... ...++.++|||||||++|+|++|++||.+.+....+..+.
T Consensus 157 ~~~---~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------ 221 (280)
T cd06611 157 LQK---RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL------------ 221 (280)
T ss_pred ccc---cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHh------------
Confidence 221 1345689999999987521 1346789999999999999999999998765443332221
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.. ..+.......++..+.+||.+||..||.+||+++++|+||||...
T Consensus 222 ---------------~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 222 ---------------KS-EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ---------------cC-CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 00 111112223578899999999999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=342.95 Aligned_cols=262 Identities=25% Similarity=0.411 Sum_probs=209.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|.+.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.+ +||||+++++++.........
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 97 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG 97 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence 46799999999999999999999999999999998642 12334677899999999 799999999998654333446
Q ss_pred eEEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 101 DIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
.+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus 98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~ 177 (291)
T cd06639 98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177 (291)
T ss_pred eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence 7999999998 599888753 45789999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCcceecccccCcccCCcccccccC---CCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~---~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
....... .....|+..|+|||.+.... ..++.++|||||||++|+|++|++||...+....+..+..
T Consensus 178 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~------- 247 (291)
T cd06639 178 LTSTRLR---RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR------- 247 (291)
T ss_pred ccccccc---ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc-------
Confidence 4322211 12346889999999875411 2368899999999999999999999987654333322210
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
.. .+.......++..+.+||.+||..||++||++.++|+||||+
T Consensus 248 --------------------~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 248 --------------------NP-PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred --------------------CC-CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 00 011111234667899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=339.73 Aligned_cols=256 Identities=26% Similarity=0.466 Sum_probs=210.3
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCCh-------hHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-------SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~-------~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
+|.+.+.||.|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++.++||||+++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----- 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSS----- 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----
Confidence 5888999999999999999999999999999886432221 1234678999999999999999999998
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
.+....|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||+++.
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 45567899999998 59999998888899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCC---cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 176 AFSDTPM---TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 176 ~~~~~~~---~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
....... ........|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------- 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE------- 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhcc--CCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-------
Confidence 5422111 111123458899999999877 6788999999999999999999999987654332222110
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
. ........++..+.+||++||+.||.+||++.++++||||
T Consensus 227 --------------------~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 227 --------------------N---ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred --------------------c---CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0 0111223578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=342.08 Aligned_cols=260 Identities=23% Similarity=0.399 Sum_probs=208.3
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCC-CC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR-EF 99 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~-~~ 99 (556)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +|+||+++++.+...... ..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 357999999999999999999999999999999986432 2345678899999998 699999999998654322 23
Q ss_pred ceEEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 100 KDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
..+|+||||+. ++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 56899999998 6999998863 46899999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCcceecccccCcccCCccccccc---CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~---~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
..... ......|+..|+|||++.+. ...|+.++|||||||++|+|++|..||...........+.
T Consensus 162 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~--------- 229 (272)
T cd06637 162 DRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP--------- 229 (272)
T ss_pred ccccc---cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh---------
Confidence 32211 12345689999999988531 1458889999999999999999999996554322221110
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
... ........++..+.+||.+||..||.+|||+.+++.||||
T Consensus 230 -----------------~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 230 -----------------RNP---APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred -----------------cCC---CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 000 0011123578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=338.09 Aligned_cols=262 Identities=27% Similarity=0.422 Sum_probs=212.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||.|+||+||+|.+..++..||+|++....... ....+.+|+.+|+.++|+||+++++.+ ......
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 74 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSF-----VVGDEL 74 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEE-----eeCCEE
Confidence 47999999999999999999999999999999986432222 567789999999999999999999988 455679
Q ss_pred EEEEecCc-ccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 103 YVVFELME-SDLHQVIKAN---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~---~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
|+|||++. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||++++++.++|+|||++.....
T Consensus 75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 99999998 5999999764 4589999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCc-ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMT-VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~-~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
..... ......+|+..|+|||.+... ..++.++|+|||||++|+|++|+.||...+....+..+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~---~-------- 222 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ---N-------- 222 (267)
T ss_pred CccccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc---C--------
Confidence 32211 112345689999999998762 3688999999999999999999999977654332222211 0
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
..........+..+++.+.+||.+||..||++|||++++++||||
T Consensus 223 --------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 223 --------------DPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred --------------CCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 000011111134678999999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=338.96 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=209.5
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC----ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE----HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
+|++.+.||+|+||.||+|.+ .+++.||+|.+..... .......+.+|+.+|+.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence 588999999999999999986 4788999998863221 123345688999999999999999999998 455
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
..+|+|+||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 77999999998 59999998888899999999999999999999999999999999999999999999999999875421
Q ss_pred C---CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 179 D---TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 179 ~---~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
. ...........|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~---------- 222 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA---------- 222 (265)
T ss_pred ccccccccccccccCCCccccChhhhcC--CCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh----------
Confidence 1 111112234568999999999987 6788999999999999999999999976553322211110
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.. .........++..+.+||++||..||.+|||+.++|+||||
T Consensus 223 ----------------~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 223 ----------------HR--GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ----------------cc--CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 01112234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=345.86 Aligned_cols=262 Identities=24% Similarity=0.405 Sum_probs=213.4
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
+.|++++.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++.+ .....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCE
Confidence 369999999999999999999999999999999864321 223455788999999999999999999998 55567
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 999999998 5999999988889999999999999999999999999999999999999999999999999987421110
Q ss_pred CC------------cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC
Q 008729 181 PM------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (556)
Q Consensus 181 ~~------------~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g 248 (556)
.. ........|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~--- 230 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS--- 230 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---
Confidence 00 000112457889999999876 6789999999999999999999999987765443332211
Q ss_pred CCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC---HHHHHhCcccccc
Q 008729 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT---AEEALADPYFKGL 319 (556)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt---a~elL~hp~f~~~ 319 (556)
.....+ .....++..+.+||++||..||++||+ +.++|+||||...
T Consensus 231 -----------------------~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 231 -----------------------DDIEWP--EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred -----------------------cccCCC--CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 000111 111257889999999999999999998 7999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=375.57 Aligned_cols=286 Identities=23% Similarity=0.304 Sum_probs=205.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCC-cEEEEEEe--------------cCc-cCChhHHHHHHHHHHHHHhCCCCCcce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKI--------------HDV-FEHISDAIRILREVKLLRLLRHPDIVE 86 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg-~~vAiK~i--------------~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~ 86 (556)
++|++++.||+|+||+||+|..+... ..+++|.+ .+. .........+.+|+.+|+.++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 58999999999999999998765332 22222211 111 112223456789999999999999999
Q ss_pred eeEEEcCCCCCCCceEEEEEecCcccHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC
Q 008729 87 IKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN-----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (556)
Q Consensus 87 l~~v~~~~~~~~~~~lylV~E~~~g~L~~~i~~~-----~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~ 161 (556)
+++++ ......|+|+|++.++|.+++... .......++.|+.||+.||.|||++||+||||||+|||++.
T Consensus 228 l~~~~-----~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 228 IEEIL-----RSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred EeEEE-----EECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 99998 455678999999999998887543 23446778889999999999999999999999999999999
Q ss_pred CCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCC-CCC--CChHH
Q 008729 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPG--KSVVH 238 (556)
Q Consensus 162 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~p-F~~--~~~~~ 238 (556)
++.+||+|||+++........ .....+||..|+|||++.+ ..|+.++|||||||+||||++|..+ |.+ .....
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREA--FDYGWVGTVATNSPEILAG--DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred CCCEEEEeCCCceecCccccc--ccccccCCcCCCCchhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 999999999999865432211 1234679999999999987 6899999999999999999998854 432 23445
Q ss_pred HHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcC-CCCCcCC--CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 008729 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKK-PPVPLFQ--KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (556)
Q Consensus 239 ~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~-~~~~~~~--~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~ 315 (556)
++..+...++.+..+... .......++...... ....... ....++.++.++|.+||.+||++|||+.|+|+|||
T Consensus 379 ~~~~~~~~~~~~~~~~p~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPD--PPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHHHHhcccChhhcCC--cHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 555555555543322110 011122222211100 0000000 11236778899999999999999999999999999
Q ss_pred cccc
Q 008729 316 FKGL 319 (556)
Q Consensus 316 f~~~ 319 (556)
|...
T Consensus 457 f~~~ 460 (501)
T PHA03210 457 FSAE 460 (501)
T ss_pred hhcC
Confidence 9753
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=342.96 Aligned_cols=256 Identities=29% Similarity=0.442 Sum_probs=212.6
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++.+.||.|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.++|+||+++++.+. +...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 74 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKL 74 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeE
Confidence 47999999999999999999999999999999986432 2344566889999999999999999999883 44679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+|+||+. ++|.+++..+ .+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||+++.......
T Consensus 75 ~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 75 WIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred EEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999998 5999999865 789999999999999999999999999999999999999999999999999977543321
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
. .....++..|+|||.+.+ ..++.++|||||||++|+|++|++||.+.+.......+..
T Consensus 154 ~---~~~~~~~~~y~~PE~~~~--~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~---------------- 212 (274)
T cd06609 154 K---RNTFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK---------------- 212 (274)
T ss_pred c---cccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh----------------
Confidence 1 134568899999999987 5689999999999999999999999977654333222211
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
....... ...++..+.++|.+||..||++|||++++++||||...
T Consensus 213 -----------~~~~~~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~ 257 (274)
T cd06609 213 -----------NNPPSLE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA 257 (274)
T ss_pred -----------cCCCCCc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence 1010000 11278899999999999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=337.40 Aligned_cols=260 Identities=25% Similarity=0.417 Sum_probs=209.5
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC---ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
..|++.+.||+|+||.||.|.+..++..||||++..... .......+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence 479999999999999999999999999999998853211 223456788999999999999999999987432 23
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
..+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 46899999998 69999998878899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
............|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+......+..+ ...+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~-------- 225 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI---ATQP-------- 225 (265)
T ss_pred ccccccccccCCCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHH---hcCC--------
Confidence 1111111234568899999999877 67899999999999999999999999765433322211 1100
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
.. ......++..+.++|.+||. +|++||+++++++|||+.
T Consensus 226 ----------------~~--~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 226 ----------------TN--PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ----------------CC--CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 00 11223567889999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=339.15 Aligned_cols=261 Identities=28% Similarity=0.456 Sum_probs=210.4
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCC-CCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK-REF 99 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~-~~~ 99 (556)
.++|++.+.||.|+||.||+|.++.+++.|++|++... ......+.+|+.+++.+ .|+||+++++++..... ...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII---EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 46899999999999999999999999999999998642 22345688999999999 69999999999865443 345
Q ss_pred ceEEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 100 KDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
..+|+||||++ ++|.+++.. +..+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 67999999999 588888764 3579999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcceecccccCcccCCccccccc---CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~---~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (556)
....... ......|+..|+|||++... ...++.++|||||||+||+|++|++||........+..+..
T Consensus 162 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------ 232 (275)
T cd06608 162 QLDSTLG---RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR------ 232 (275)
T ss_pred ecccchh---hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc------
Confidence 6433221 12345689999999987531 13577899999999999999999999976554333322210
Q ss_pred hHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
. ..+.......++..+.+||++||..||.+|||++++++|||+
T Consensus 233 ---------------------~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 233 ---------------------N-PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred ---------------------c-CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0 011111112367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=340.47 Aligned_cols=261 Identities=24% Similarity=0.418 Sum_probs=211.3
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCC----hhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH----ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~----~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
+|+..+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+++|+.++|+||+++++++ .+.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence 488899999999999999999999999999998643211 12356788999999999999999999998 555
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC-ceEEeeeCcccccc
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAF 177 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~vKL~DFGla~~~~ 177 (556)
..+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++|++|+||||+||+++.++ .+||+|||++....
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 67999999999 59999998888899999999999999999999999999999999999998775 59999999987654
Q ss_pred CCCCC-cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 178 SDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 178 ~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
..... ........|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------- 223 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKI---------- 223 (268)
T ss_pred cccccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHH----------
Confidence 33211 111123468889999999876 67889999999999999999999999765433322222110
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
.... ........+++.+.+++.+||..||.+|||+.++|+||||+
T Consensus 224 --------------~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 224 --------------ASAT--TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred --------------hccC--CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 0000 11122235788999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=343.19 Aligned_cols=258 Identities=23% Similarity=0.380 Sum_probs=205.2
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|+++++||+|+||.||+|++..+++.||+|++.... .......+.+|+++|+.++||||+++++.+ ......
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 74 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAF-----FVENRI 74 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----EECCEE
Confidence 36899999999999999999999999999999986432 233456788999999999999999999998 445678
Q ss_pred EEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+||||+++ +|..+ ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.......
T Consensus 75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999999995 66433 357899999999999999999999999999999999999999999999999997643221
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
....+|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||......+.. +..
T Consensus 150 ----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~---------~~~--------- 205 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS---------LMP--------- 205 (279)
T ss_pred ----ccCCCCChhhcCceeecC--CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccc---------cch---------
Confidence 234579999999999987 67899999999999999999999999653211100 000
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
......+..... ........++.+.+||.+||..||++||+++++++||||...
T Consensus 206 --~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 206 --LQLLQCIVDEDP--PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred --HHHHHHHhccCC--CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 000111111111 111123478899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=335.65 Aligned_cols=253 Identities=26% Similarity=0.446 Sum_probs=211.5
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
+|++.+.||+|+||.||.+.+..+|+.||+|++............+.+|+.+++.++||||+++++++ ......|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence 69999999999999999999999999999999864333344556788999999999999999999998 5556799
Q ss_pred EEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 104 VVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+||||+. ++|.+++.... .+++..+..|+.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999998 69999987643 57899999999999999999999999999999999999999999999999997653322
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
.. .....|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||...+..+....+..
T Consensus 156 ~~---~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~--------------- 215 (256)
T cd08218 156 EL---ARTCIGTPYYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR--------------- 215 (256)
T ss_pred hh---hhhccCCccccCHHHhCC--CCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc---------------
Confidence 11 123458889999999877 6788999999999999999999999987665444333211
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.. . ......++..+.++|.+||+.||.+||++.++|+||||
T Consensus 216 -----------~~-~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 216 -----------GS-Y---PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----------CC-C---CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 00 0 11123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=335.27 Aligned_cols=255 Identities=32% Similarity=0.505 Sum_probs=213.3
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
+|++++.||.|+||.||+|.+..+++.||+|++...........++.+|+.+++.++||||+++++.+... ....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 58999999999999999999999999999999875444455667788999999999999999999987532 345689
Q ss_pred EEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----HCCceeccCCCCcEeecCCCceEEeeeCcc
Q 008729 104 VVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMH-----TANVYHRDLKPKNILANANCKLKVCDFGLA 173 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLH-----s~gIvHrDLKP~NILl~~~~~vKL~DFGla 173 (556)
+||||+. ++|.+++.. ...+++..+..++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999998 699998875 467899999999999999999999 999999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
........ ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+.......+.
T Consensus 158 ~~~~~~~~---~~~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------- 223 (265)
T cd08217 158 KILGHDSS---FAKTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK--------- 223 (265)
T ss_pred ccccCCcc---cccccccCCCccChhhhcC--CCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHh---------
Confidence 87543321 1244578999999999877 568899999999999999999999998776433322221
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
... .......++..+.+|+.+||..||++|||++++|+|||+
T Consensus 224 ------------------~~~---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 224 ------------------EGK---FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ------------------cCC---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 111 111223578899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=344.42 Aligned_cols=260 Identities=24% Similarity=0.407 Sum_probs=210.7
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||.||+|++..+++.||+|.+.... .......+.+|+.+|+.++||||+++++.+ .....+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 74 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAF-----FIEGAV 74 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhhe-----ecCCeE
Confidence 36999999999999999999999999999999886432 334456788999999999999999999988 445679
Q ss_pred EEEEecCc-ccHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 103 YVVFELME-SDLHQVIKAN---DDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~---~~l~~~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
|+||||+. ++|..++... ..+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999999 5898888763 378999999999999999999997 599999999999999999999999999987543
Q ss_pred CCCCCcceecccccCcccCCcccccccC----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~----~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
... .....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||...........+..
T Consensus 155 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-------- 221 (286)
T cd06622 155 ASL-----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSA-------- 221 (286)
T ss_pred CCc-----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHH--------
Confidence 221 13345888999999885421 2357899999999999999999999976543332222211
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
+.... .....+.++.++.+||.+||..||++||+++++++||||....
T Consensus 222 ----------------~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 222 ----------------IVDGD---PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred ----------------HhhcC---CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 11111 1122345889999999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=341.74 Aligned_cols=280 Identities=42% Similarity=0.736 Sum_probs=225.5
Q ss_pred eEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCCceEE
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
|++.+.||.|+||+||+|.+..+++.||||++...... .+.....+|+..++.++ |+||+++++++ ......|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-----~~~~~~~ 74 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVF-----RENDELY 74 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHh-----hcCCcEE
Confidence 78999999999999999999999999999998754332 23334568999999999 99999999998 4456799
Q ss_pred EEEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 104 VVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 104 lV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
+||||++++|.+++.... .+++..+..++.||+.+|.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 75 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 75 FVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred EEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 999999999999998764 789999999999999999999999999999999999999999999999999976543221
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
.....++..|+|||++.+. ..++.++|+|||||++|+|++|++||++.+..+.+..+...++.|..+.+......
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 ----YTDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred ----cCCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 2446689999999987542 45789999999999999999999999999999999999888888876643321100
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
. ...-..............++..+..+.+||++||..||++|||++|++.||||
T Consensus 230 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 A-SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred h-ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 00000000111111122234457899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=338.84 Aligned_cols=254 Identities=28% Similarity=0.481 Sum_probs=212.7
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
+|++.+.||.|+||.||+|.+..+++.||+|++..... .......+.+|+++++.++||||+++++++ .+...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence 59999999999999999999999999999999875322 224567888999999999999999999988 566779
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+|+||+. ++|.+++.....+++..+..|+.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999998 5999999888789999999999999999999999999999999999999999999999999987654332
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+... .+.+
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~------------------ 210 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCR--QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-RDQI------------------ 210 (258)
T ss_pred ---cccccCCChhhcCHHHHcc--cCCCCcccchhhHHHHHHHHhCCCCCCCCCccH-HHHH------------------
Confidence 1234568889999999877 568999999999999999999999998766321 1111
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH--HHHHhCccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA--EEALADPYF 316 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta--~elL~hp~f 316 (556)
...... ........++..+.++|.+||..||.+||++ .++++||||
T Consensus 211 -----~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 211 -----RAKQET----ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -----HHHhcc----ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 000110 1112224577999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=332.93 Aligned_cols=252 Identities=28% Similarity=0.470 Sum_probs=210.4
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
+|++.+.||+|+||.||+|.+..+++.||||.+............+.+|+.+|+.++||||+++++.+ .....+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENF-----LEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeE-----ecCCEEE
Confidence 59999999999999999999999999999999875433445567788999999999999999999988 4556799
Q ss_pred EEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC-CceEEeeeCccccccCC
Q 008729 104 VVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAFSD 179 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~vKL~DFGla~~~~~~ 179 (556)
+||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+|+||||+||+++.+ +.+||+|||++......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999998 5999999764 358999999999999999999999999999999999999865 45899999999865433
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
... ....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 156 ~~~----~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-------------- 215 (256)
T cd08220 156 SKA----YTVVGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-------------- 215 (256)
T ss_pred ccc----cccccCCcccCchhccC--CCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh--------------
Confidence 221 23568899999999877 6788999999999999999999999987765443332211
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.. .......+++.+.+++.+||..||++|||+.++|+||||
T Consensus 216 -------------~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 216 -------------GT---FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred -------------cC---CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 00 111223578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=339.79 Aligned_cols=262 Identities=24% Similarity=0.412 Sum_probs=208.3
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (556)
..++|++++.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.+ +||||+++++++........
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 447899999999999999999999999999999987642 12234577899999999 69999999998864433455
Q ss_pred ceEEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 100 KDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
..+|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||+|||+++
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~ 172 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCcee
Confidence 67999999998 689887753 3568899999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcceecccccCcccCCccccccc---CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~---~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (556)
....... ......|+..|+|||++... ...++.++|||||||++|+|++|+.||........+..+
T Consensus 173 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~-------- 241 (286)
T cd06638 173 QLTSTRL---RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI-------- 241 (286)
T ss_pred ecccCCC---ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc--------
Confidence 6432211 12344689999999987531 145788999999999999999999999765543322111
Q ss_pred hHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.... .+.......++..+.+||.+||..||++|||+.++|+|+||
T Consensus 242 -------------------~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 242 -------------------PRNP-PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred -------------------cccC-CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 0000 01111112357789999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=333.10 Aligned_cols=261 Identities=29% Similarity=0.447 Sum_probs=213.2
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
||++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++ .....+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence 69999999999999999999999999999999875544445677899999999999999999999987 4456799
Q ss_pred EEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCC
Q 008729 104 VVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 182 (556)
+|+||+. ++|.+++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.........
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred EEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 9999998 699999988878999999999999999999999999999999999999999999999999998775433222
Q ss_pred cce-ecccccCcccCCcccccccC-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 183 TVF-WTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 183 ~~~-~~~~~gt~~Y~APE~~~~~~-~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
... .....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||............
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~----------------- 218 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH----------------- 218 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH-----------------
Confidence 111 22456888999999987631 23788999999999999999999999765322111110
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
... ...+.......+++.+.+||++||+.||.+|||+++++.|||+
T Consensus 219 ---------~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 219 ---------VGA-GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ---------Hhc-CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 1111112233468899999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=343.20 Aligned_cols=259 Identities=21% Similarity=0.321 Sum_probs=200.7
Q ss_pred CCCeEEEeeeeecCceeEEEEEECC----------------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTH----------------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~----------------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv 85 (556)
.++|++.++||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+|..++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 3589999999999999999998532 34579999987432 233456788999999999999999
Q ss_pred eeeEEEcCCCCCCCceEEEEEecCc-ccHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHHC
Q 008729 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND-------------------DLTREHHQFFLYQMLRALKYMHTA 145 (556)
Q Consensus 86 ~l~~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~-------------------~l~~~~~~~i~~QIl~aL~yLHs~ 145 (556)
++++++. +...+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.
T Consensus 83 ~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 83 RLLGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred EEEEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 9999984 4456899999998 69999886532 357788899999999999999999
Q ss_pred CceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHH
Q 008729 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225 (556)
Q Consensus 146 gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyell 225 (556)
||+||||||+|||++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|+
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCcee-EecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHH
Confidence 9999999999999999999999999999764322211 11123346788999999876 67899999999999999998
Q ss_pred h--CCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCC
Q 008729 226 T--GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303 (556)
Q Consensus 226 t--G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~ 303 (556)
+ +..||.+.+..+.+..+... +. ...........+.++..+.+|+.+||..||++
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~~~--------------------~~---~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~ 291 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAGEF--------------------FR---DQGRQVYLFRPPPCPQGLYELMLQCWSRDCRE 291 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHHHH--------------------hh---hccccccccCCCCCCHHHHHHHHHHccCCchh
Confidence 7 56788776654444332211 11 11111111223467889999999999999999
Q ss_pred CCCHHHHHh
Q 008729 304 RPTAEEALA 312 (556)
Q Consensus 304 Rpta~elL~ 312 (556)
|||++++.+
T Consensus 292 RPs~~~i~~ 300 (304)
T cd05096 292 RPSFSDIHA 300 (304)
T ss_pred CcCHHHHHH
Confidence 999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=338.59 Aligned_cols=258 Identities=26% Similarity=0.458 Sum_probs=204.2
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHH-HHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKL-LRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~i-L~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||.||+|.+..+|+.||||++...... .....+..|+.+ ++.++||||+++++++ .....
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~-----~~~~~ 74 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFYGAL-----FREGD 74 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHHHHHHHHHHHHHHHcCCCCeeeeeEEE-----ecCCc
Confidence 3699999999999999999999999999999998754332 234456667765 6677899999999998 44456
Q ss_pred EEEEEecCcccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 102 IYVVFELMESDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
+|+||||++++|.+++.. ...+++..++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 75 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 75 VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred EEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 999999999988887754 34689999999999999999999997 9999999999999999999999999998765
Q ss_pred cCCCCCcceecccccCcccCCccccccc--CCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhhCCCChH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSF--FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~y~~~~DIWSlG~ilyelltG~~pF~~~~-~~~~~~~i~~~~g~p~~e 253 (556)
..... .+...|+..|+|||.+.+. ...++.++|+|||||++|+|++|+.||.... ..+.+..+
T Consensus 155 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---------- 220 (283)
T cd06617 155 VDSVA----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV---------- 220 (283)
T ss_pred ccccc----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH----------
Confidence 32211 1234588999999987541 1357889999999999999999999996432 11111111
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
. ....... ....++.++.+||.+||..||++|||++++++||||...
T Consensus 221 -------------~----~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 221 -------------V----EEPSPQL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred -------------H----hcCCCCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 0 0000000 112478899999999999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=339.84 Aligned_cols=261 Identities=24% Similarity=0.417 Sum_probs=208.8
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCC-CC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK-RE 98 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~-~~ 98 (556)
..+.|++.+.||.|+||.||+|.+..+++.||+|++... ......+.+|+.+++.+ +|+||+++++++..... ..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 346899999999999999999999999999999988532 23445678899999998 69999999999864321 23
Q ss_pred CceEEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
...+|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 567999999998 5999988753 4588889999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCcceecccccCcccCCccccccc---CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~---~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
...... ......|+..|+|||.+... ...++.++|||||||++|+|++|.+||........+..+.
T Consensus 171 ~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~-------- 239 (282)
T cd06636 171 LDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP-------- 239 (282)
T ss_pred hhcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh--------
Confidence 432111 12345689999999987521 1467889999999999999999999997655332222110
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
... ........++..+.+||++||..||.+|||+.++|+||||
T Consensus 240 -------------------~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 240 -------------------RNP--PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred -------------------hCC--CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 000 0111123578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=334.67 Aligned_cols=252 Identities=30% Similarity=0.520 Sum_probs=209.6
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++.+.||.|+||.||+|++..+++.||+|.+... .....+.+|+.+++.++||||+++++.+. +...+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~ 73 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE----EDLQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDL 73 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH----HHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcE
Confidence 5799999999999999999999999999999998642 22567889999999999999999999984 44679
Q ss_pred EEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 103 YVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
|+|+||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 74 ~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred EEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 99999999 599999875 4578999999999999999999999999999999999999999999999999987654322
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
.. .....++..|+|||.+.+ ..++.++||||||||+|+|++|++||...+.......+
T Consensus 154 ~~---~~~~~~~~~y~~PE~~~~--~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~----------------- 211 (256)
T cd06612 154 AK---RNTVIGTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI----------------- 211 (256)
T ss_pred cc---cccccCCccccCHHHHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-----------------
Confidence 11 133458889999999877 67899999999999999999999999876543222111
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.. ...+.......++..+.++|.+||+.||++|||+.++|+||||
T Consensus 212 ----------~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 212 ----------PN-KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ----------cc-CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 00 0111111223577899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=352.38 Aligned_cols=261 Identities=26% Similarity=0.437 Sum_probs=218.2
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.+.|..-++||+|+||.||.++.+.||+.||+|++.+. ..........++|-.||.+++.+.||.+-.+| +...
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-----eTkd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-----ETKD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-----cCCC
Confidence 46788999999999999999999999999999998642 22223444578999999999999999999988 5556
Q ss_pred eEEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 101 DIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
.+|+||..|. |||+-+|-..+ .++++.+.+++.+|+.||.+||..+||+|||||+|||+|+.|+|+|+|+|+|....
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 7999999999 69998887765 89999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
...+. ...+||..|||||++.+ ..|+...|+|||||+||||+.|+.||........-+.
T Consensus 339 ~g~~~----~~rvGT~GYMAPEvl~n--e~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE--------------- 397 (591)
T KOG0986|consen 339 EGKPI----RGRVGTVGYMAPEVLQN--EVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE--------------- 397 (591)
T ss_pred CCCcc----ccccCcccccCHHHHcC--CcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH---------------
Confidence 54433 56689999999999988 6799999999999999999999999965443222111
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
++.+..... .+....+|+++++|.+.+|.+||++|. +++++-+||||+.+.
T Consensus 398 ---------vdrr~~~~~---~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ln 453 (591)
T KOG0986|consen 398 ---------VDRRTLEDP---EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLN 453 (591)
T ss_pred ---------HHHHHhcch---hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCC
Confidence 111111111 222356899999999999999999997 578999999999875
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=335.44 Aligned_cols=262 Identities=26% Similarity=0.454 Sum_probs=209.1
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCC--------hhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH--------ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~--------~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (556)
+|.+.+.||.|+||.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~---- 77 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE---- 77 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence 699999999999999999999999999999987532111 11234577899999999999999999988
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
.....+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||+++
T Consensus 78 -~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 78 -TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred -ccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 45567999999998 6999999888889999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
........ .......|+..|+|||.+......++.++|+|||||++|+|++|..||........+..+..
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------- 226 (272)
T cd06629 157 KSDDIYDN-DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN--------- 226 (272)
T ss_pred cccccccc-cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhc---------
Confidence 64322111 11234568899999999876323478999999999999999999999965543222211100
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
. ...........+.++..+.+||.+||..||.+|||++++|+||||
T Consensus 227 ---------------~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 227 ---------------K-RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ---------------c-ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0 001111112234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=345.04 Aligned_cols=258 Identities=24% Similarity=0.415 Sum_probs=221.8
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (556)
...|.++.+||+|+||+|.+|..+.|.+.||||++++.. -...+..-.+.|-++|... +-|.++.++.+| +..
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF-----QTm 422 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF-----QTM 422 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh-----hhh
Confidence 457889999999999999999999999999999987532 2223444556788888877 467899999988 555
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
..+|+||||+. |+|--.|+.-+.+.+.++.+++..|+-||-|||++||++||||.+|||++.+|++||+|||+++....
T Consensus 423 DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 423 DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence 67999999999 69999999999999999999999999999999999999999999999999999999999999986544
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
+... ..++||||.|+|||++.- .+|+.++|+||+||+|||||.|++||+|.+..+.+..|++.-
T Consensus 503 ~~~T---TkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn----------- 566 (683)
T KOG0696|consen 503 DGVT---TKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN----------- 566 (683)
T ss_pred CCcc---eeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-----------
Confidence 3333 257899999999999865 799999999999999999999999999999988887775421
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHhCccccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGLA 320 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-----a~elL~hp~f~~~~ 320 (556)
......+|.++.++.+.+|.+.|.+|.. -.++-.||||+.+.
T Consensus 567 --------------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 567 --------------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred --------------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence 1223568999999999999999999975 37788999999764
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=357.69 Aligned_cols=252 Identities=32% Similarity=0.497 Sum_probs=210.1
Q ss_pred eeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEecC
Q 008729 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (556)
Q Consensus 30 ~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 109 (556)
+||+|.||+||.|+|..|...+|||.|.. .+......+..||.+.+.|+|.|||++++.+ .+.+++-|.||-+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqV 654 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQV 654 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecC
Confidence 69999999999999999999999999864 3445667788999999999999999999998 5666789999999
Q ss_pred c-ccHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec-CCCceEEeeeCccccccCCCCCcc
Q 008729 110 E-SDLHQVIKAN-DDL--TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTV 184 (556)
Q Consensus 110 ~-g~L~~~i~~~-~~l--~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~-~~~~vKL~DFGla~~~~~~~~~~~ 184 (556)
. |+|..+++.. |++ ++..+.++.+|||+||+|||.+.|||||||-+|+|++ ..|.+||+|||.++....-.+.+
T Consensus 655 PGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T- 733 (1226)
T KOG4279|consen 655 PGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT- 733 (1226)
T ss_pred CCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccc-
Confidence 8 6999999874 677 7888999999999999999999999999999999997 57899999999998765544443
Q ss_pred eecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHH
Q 008729 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (556)
Q Consensus 185 ~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~ 264 (556)
.++.||..|||||++.....+|++++|||||||++.||.||+|||..... |- +.
T Consensus 734 --ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs-------------pq-----------AA 787 (1226)
T KOG4279|consen 734 --ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS-------------PQ-----------AA 787 (1226)
T ss_pred --cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC-------------hh-----------Hh
Confidence 56779999999999987668899999999999999999999999954322 11 11
Q ss_pred HHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 265 ~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.|--.|-+.. ......++.+++.+|.+|+..||.+||+|.++|++||++.-
T Consensus 788 MFkVGmyKvH----P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 788 MFKVGMYKVH----PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred hhhhcceecC----CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 1111111111 12223577889999999999999999999999999999853
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=343.30 Aligned_cols=287 Identities=28% Similarity=0.462 Sum_probs=226.8
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-----CC---CcceeeEEEcC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-----HP---DIVEIKRIMLP 93 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-----Hp---nIv~l~~v~~~ 93 (556)
.+||.++++||+|-|++||+|.|..+.+.||+|+++. ........+.||++|++++ |+ +||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 3799999999999999999999999999999999873 2334455779999999984 32 59999999865
Q ss_pred CCCCCCceEEEEEecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEeecCC--------
Q 008729 94 PSKREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANAN-------- 162 (556)
Q Consensus 94 ~~~~~~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~-------- 162 (556)
.+ .++.++|+|||+++.+|..+|+.. ..++...++.|++|||.||.|||.. ||||.||||+|||+..+
T Consensus 154 sG-pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 154 SG-PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred cC-CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhh
Confidence 54 678899999999999999999874 4799999999999999999999976 99999999999997100
Q ss_pred --------------------------------------------------------------------------------
Q 008729 163 -------------------------------------------------------------------------------- 162 (556)
Q Consensus 163 -------------------------------------------------------------------------------- 162 (556)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred ------------------------------------------------------------------------------Cc
Q 008729 163 ------------------------------------------------------------------------------CK 164 (556)
Q Consensus 163 ------------------------------------------------------------------------------~~ 164 (556)
.+
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 02
Q ss_pred eEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC------ChHH
Q 008729 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK------SVVH 238 (556)
Q Consensus 165 vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~------~~~~ 238 (556)
|||+|||.|+..... ++.-+.|+.|+|||++.+ .+|+..+||||++|++|||+||..+|.-. .+.+
T Consensus 393 vKIaDlGNACW~~kh------FT~DIQTRQYRapEVllG--sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDED 464 (590)
T KOG1290|consen 393 VKIADLGNACWVHKH------FTEDIQTRQYRAPEVLLG--SGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDED 464 (590)
T ss_pred EEEeeccchhhhhhh------hchhhhhhhccCcceeec--CCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHH
Confidence 566667666654322 356679999999999999 89999999999999999999999999533 3567
Q ss_pred HHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCC---------CC----CHHHHHHHHHhhhcCCCCCC
Q 008729 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP---------NV----DPLALRLLQRLIAFDPKDRP 305 (556)
Q Consensus 239 ~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~---------~~----s~~~~dLl~~~L~~dP~~Rp 305 (556)
.+..|++++|..+...+.. ....+.||..-.....+.....|+ .+ ..++.|||.-||+++|++|+
T Consensus 465 HiA~i~ELLG~iPr~ia~~--Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~ 542 (590)
T KOG1290|consen 465 HIALIMELLGKIPRKIALG--GKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRP 542 (590)
T ss_pred HHHHHHHHHhhccHHHHhc--CcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccc
Confidence 8999999999987776542 223445544322222222111111 12 34678999999999999999
Q ss_pred CHHHHHhCccccccccc
Q 008729 306 TAEEALADPYFKGLAKI 322 (556)
Q Consensus 306 ta~elL~hp~f~~~~~~ 322 (556)
||.++|+|||+..+...
T Consensus 543 tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 543 TAAQCLKHPWLNPVAGP 559 (590)
T ss_pred cHHHHhcCccccCCCCC
Confidence 99999999999976543
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=330.98 Aligned_cols=254 Identities=29% Similarity=0.494 Sum_probs=210.3
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC---ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
+|+..+.||+|+||.||+|.+..+++.|++|.+..... .......+.+|+.+++.++|+||+++++.+ .+..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence 58889999999999999999998999999998864221 123456788999999999999999999988 4556
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+|+||+. ++|.+++...+.+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 7999999998 599999988888999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
. ......|+..|++||.+... ..++.++|+|||||++|+|++|+.||...........+.
T Consensus 156 ~----~~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~--------------- 215 (258)
T cd06632 156 S----FAKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIG--------------- 215 (258)
T ss_pred c----cccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHH---------------
Confidence 2 12345689999999998762 238899999999999999999999997655332222111
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.. .........+++.+.+|+++||..||.+|||+.++|.|||+
T Consensus 216 ------------~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 216 ------------RS--KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred ------------hc--ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 00 01112234578999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=341.11 Aligned_cols=261 Identities=26% Similarity=0.454 Sum_probs=205.5
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCCceE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~l 102 (556)
.|..++.||+|+||.||++.+..+++.||||++...... .....+.+|+.++.++. |+||+++++++. .....
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~~ 78 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGDC 78 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCcE
Confidence 577788999999999999999999999999998743222 45567889999999996 999999999883 44568
Q ss_pred EEEEecCcccHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 103 YVVFELMESDLHQVIK-----ANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 103 ylV~E~~~g~L~~~i~-----~~~~l~~~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
|++|||+.++|.++.. ....+++..+..++.|++.||+|||+. ||+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 79 WICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred EEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 9999999976554432 246799999999999999999999985 9999999999999999999999999999764
Q ss_pred cCCCCCcceecccccCcccCCcccccccC-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
...... ....|+..|+|||++.+.. ..++.++|||||||++|+|++|++||..... ....+.+.
T Consensus 159 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~--------- 223 (288)
T cd06616 159 VDSIAK----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQV--------- 223 (288)
T ss_pred ccCCcc----ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhh---------
Confidence 332211 2345889999999987621 2688999999999999999999999976541 11111111
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
+....+.........++..+.+||.+||..||++|||++++++||||+..
T Consensus 224 --------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~ 273 (288)
T cd06616 224 --------------VKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY 273 (288)
T ss_pred --------------cCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence 11111111111223578899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=339.31 Aligned_cols=246 Identities=20% Similarity=0.247 Sum_probs=201.6
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCccCChhH-HHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEe
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD-AIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~-~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (556)
..||+|++|.||+|.. +|+.||||++......... ...+.+|+.+|+.++||||+++++++.... .....+|+|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 5799999999999986 6899999998754332222 456779999999999999999999985411 22456899999
Q ss_pred cCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce
Q 008729 108 LME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (556)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (556)
||. |+|.+++..++.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~----- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP----- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----
Confidence 999 69999999888899999999999999999999984 99999999999999999999999999987643221
Q ss_pred ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 186 ~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
...+|+..|+|||++.+....|+.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~------------------- 237 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK------------------- 237 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc-------------------
Confidence 234688999999998764457899999999999999999999999887755544433210
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... ......++.+.+|+.+||+.||++|||++++++
T Consensus 238 -------~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 238 -------NNSL---KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -------CCCC---CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0011 111257889999999999999999999999985
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=344.35 Aligned_cols=257 Identities=28% Similarity=0.515 Sum_probs=210.7
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
+.|.....||.|+||.||++.+..++..||||++.. ........+.+|+.+++.++|+||+++++.+ ......
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~-----~~~~~~ 94 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL--RKQQRRELLFNEVVIMRDYHHENVVDMYNSY-----LVGDEL 94 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEec--chHHHHHHHHHHHHHHHhCCCCcHHHHHHhe-----ecCCeE
Confidence 456667889999999999999999999999999864 2334456688999999999999999999988 445679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+||||+. ++|.+++. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 95 ~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~ 173 (292)
T cd06658 95 WVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP 173 (292)
T ss_pred EEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence 99999998 57888775 45789999999999999999999999999999999999999999999999999875432221
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
. .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 174 ~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~--------------- 233 (292)
T cd06658 174 K---RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN--------------- 233 (292)
T ss_pred c---CceeecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---------------
Confidence 1 134568999999999877 67899999999999999999999999876654433222110
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
+ .+........+..+.+||.+||..||.+|||++++|+||||....
T Consensus 234 --------~-----~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 234 --------L-----PPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred --------C-----CCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 0 011111234788899999999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=330.95 Aligned_cols=259 Identities=30% Similarity=0.467 Sum_probs=215.1
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
+.|++.+.||+|++|.||+|.+..+++.||||++...... .....+.+|+.++..++|+||+++++++ .....+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 74 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAF-----YKEGEI 74 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEE-----ccCCeE
Confidence 3699999999999999999999999999999998753222 4566788999999999999999999998 444679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
|+||||+. ++|.+++.....+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++.......
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999 7999999888889999999999999999999999 999999999999999999999999999988654333
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
... ....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||.........+.+
T Consensus 155 ~~~---~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~----------------- 212 (264)
T cd06623 155 DQC---NTFVGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM----------------- 212 (264)
T ss_pred Ccc---cceeecccccCHhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH-----------------
Confidence 221 34568899999999877 67889999999999999999999999776421111111
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCC-CCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~-~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
..+..... ...... ++..+.++|++||..+|++|||+.++|+||||+..
T Consensus 213 -------~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 213 -------QAICDGPP---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred -------HHHhcCCC---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 11111111 111233 78899999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=336.05 Aligned_cols=257 Identities=28% Similarity=0.477 Sum_probs=211.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++.+.||.|+||.||+|.++.+++.||+|.+..... ......+.+|+++++.++||||+++++++ .....+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~ 74 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAF-----YNNGDI 74 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheee-----ecCCEE
Confidence 368899999999999999999999999999999875432 24556788999999999999999999998 444679
Q ss_pred EEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 103 YVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
|+|+||+. ++|.+++... ..+++..+..++.||+.||.|||+ .|++|+||||+||+++.++.++|+|||.+......
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999 6999999876 789999999999999999999999 99999999999999999999999999998764322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhhCCCChHHHHH
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--VHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~--~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.. ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+. ....+.
T Consensus 155 ~~-----~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--------------- 212 (265)
T cd06605 155 LA-----KTFVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFEL--------------- 212 (265)
T ss_pred Hh-----hcccCChhccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHH---------------
Confidence 11 12568889999999877 6889999999999999999999999975431 001111
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCC-CCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~-~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
++.+..... ...... ++..+.+||.+||..||++|||+.+++.||||+.+
T Consensus 213 ---------~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 213 ---------LQYIVNEPP---PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred ---------HHHHhcCCC---CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 111111111 011112 78899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=334.42 Aligned_cols=251 Identities=19% Similarity=0.276 Sum_probs=202.9
Q ss_pred CCCeEEEeeeeecCceeEEEEEEC---CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
.++|++.+.||+|+||.||+|.+. ..+..||+|.++... .......+.+|+.+|+.++||||+++++++ ..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~ 77 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVI-----TR 77 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----ec
Confidence 357999999999999999999765 456689999987532 233445788999999999999999999998 44
Q ss_pred CceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
...+|+||||++ |+|.+++... +.+++..+..++.||+.||+|||++|++||||||+|||++.++.+|++|||.+...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 78 GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 567999999999 6899988764 57899999999999999999999999999999999999999999999999987653
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
...... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+.+
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~---------- 223 (266)
T cd05064 158 KSEAIY--TTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVED---------- 223 (266)
T ss_pred cccchh--cccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC----------
Confidence 221111 0112235678999999877 688999999999999999775 9999988776554443321
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... .....++..+.+++.+||..||.+|||++++++
T Consensus 224 -----------------~~~~---~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 224 -----------------GFRL---PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -----------------CCCC---CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 1111 123457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=329.94 Aligned_cols=253 Identities=29% Similarity=0.487 Sum_probs=209.1
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
+|.+.+.||+|+||.||+|.++.+|..||+|.+............+.+|+.+++.++|+||+++++.+ .....+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence 58999999999999999999999999999999864322334455678999999999999999999988 4556799
Q ss_pred EEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCc-eEEeeeCccccccCC
Q 008729 104 VVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK-LKVCDFGLARVAFSD 179 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-vKL~DFGla~~~~~~ 179 (556)
+|+||+. ++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+||+++.++. +||+|||.+......
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999998 69999987643 4799999999999999999999999999999999999998864 699999999765432
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
... .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+..+....+.
T Consensus 156 ~~~---~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------------- 215 (257)
T cd08225 156 MEL---AYTCVGTPYYLSPEICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC--------------- 215 (257)
T ss_pred ccc---ccccCCCccccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh---------------
Confidence 221 133468899999999876 578899999999999999999999998765433332211
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.. ......+.++..+.++|.+||..+|++|||+.++++||||
T Consensus 216 ------------~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 216 ------------QG---YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred ------------cc---cCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 00 0112234678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=335.98 Aligned_cols=257 Identities=29% Similarity=0.540 Sum_probs=212.1
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
..|...+.||+|++|.||+|.+..+++.||+|++.. ........+.+|+.+++.++||||+++++.+. .....
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~ 91 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDL--RKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDEL 91 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEec--cchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeE
Confidence 356677899999999999999999999999998863 22234456889999999999999999999884 44668
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+|+||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++........
T Consensus 92 ~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~ 170 (285)
T cd06648 92 WVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP 170 (285)
T ss_pred EEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence 99999998 599998887 6799999999999999999999999999999999999999999999999998875433322
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
. .....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 171 ~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~---------------- 229 (285)
T cd06648 171 R---RKSLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD---------------- 229 (285)
T ss_pred c---cccccCCccccCHHHhcC--CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHh----------------
Confidence 1 133568999999999877 5788999999999999999999999987665443333211
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
. ..+.......++..+.+||++||..||++|||+.++|+|+||+...
T Consensus 230 -----------~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 230 -----------N-LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred -----------c-CCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 1 1111112234788999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=336.69 Aligned_cols=252 Identities=23% Similarity=0.362 Sum_probs=205.7
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCC-----cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
++|++++.||+|+||.||+|.+...+ ..||+|.+... ........+.+|+.+|+.++||||+++++++ .
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~ 78 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVC-----T 78 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEE-----c
Confidence 47999999999999999999876655 68999988643 2233455688999999999999999999998 4
Q ss_pred CCceEEEEEecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~ 160 (556)
.....|++|||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 4456899999998 6999999764 4578899999999999999999999999999999999999
Q ss_pred CCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHH
Q 008729 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (556)
Q Consensus 161 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~ 239 (556)
.++.+||+|||+++....... ........+++.|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+.
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADY-YRVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEECCCcceeecccccc-ccccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999976432211 111234457889999999876 678999999999999999998 9999988775544
Q ss_pred HHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 240 ~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
...|. ..... .....+++.+.+|+.+||+.||.+||++.+++++
T Consensus 236 ~~~i~---------------------------~~~~~---~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 236 IEMIR---------------------------SRQLL---PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHH---------------------------cCCcC---CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 33321 11111 1224578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=332.18 Aligned_cols=250 Identities=25% Similarity=0.429 Sum_probs=207.2
Q ss_pred eeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEecC
Q 008729 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (556)
Q Consensus 31 LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 109 (556)
||.|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++.+ .+...+|+||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTF-----KDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeE-----EcCCccEEEEecC
Confidence 7999999999999999999999999874322 233456788999999999999999999988 4556799999999
Q ss_pred c-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcceecc
Q 008729 110 E-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188 (556)
Q Consensus 110 ~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~ 188 (556)
. ++|.+++.....+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~----~~~ 151 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK----TWT 151 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc----ccc
Confidence 8 69999998888899999999999999999999999999999999999999999999999999986543321 133
Q ss_pred cccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHhhCCCChHHHHHhhhHHHHHH
Q 008729 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS--VVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (556)
Q Consensus 189 ~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~--~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~ 266 (556)
..|+..|++||.+.+ ..++.++|+|||||++|+|++|..||.... ..+....+.
T Consensus 152 ~~~~~~~~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---------------------- 207 (262)
T cd05572 152 FCGTPEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL---------------------- 207 (262)
T ss_pred ccCCcCccChhHhcC--CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh----------------------
Confidence 568899999999876 678999999999999999999999997765 222222111
Q ss_pred HHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHhCccccccc
Q 008729 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGLA 320 (556)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-----a~elL~hp~f~~~~ 320 (556)
..... .......++.+.++|.+||..||++|++ ++|+++||||+++.
T Consensus 208 ----~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 259 (262)
T cd05572 208 ----KGNGK---LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFD 259 (262)
T ss_pred ----ccCCC---CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCC
Confidence 00001 1112235789999999999999999999 99999999998753
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=329.38 Aligned_cols=249 Identities=29% Similarity=0.452 Sum_probs=207.3
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
+|++.+.||.|+||.||++.+..+++.||+|.+... ........+.+|+.+++.++|+||+++++.+ .+...+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~ 74 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLP-KSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLY 74 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcC-cchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEE
Confidence 589999999999999999999999999999998643 2334566788999999999999999999998 5556799
Q ss_pred EEEecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 104 VVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 9999998 699988865 3458999999999999999999999999999999999999999999999999987653322
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
. ......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...+.......+.
T Consensus 155 ~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~---------------- 213 (255)
T cd08219 155 A---YACTYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC---------------- 213 (255)
T ss_pred c---ccccccCCccccCHHHHcc--CCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh----------------
Confidence 1 1234668999999999877 678999999999999999999999998766443332221
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
..... .....++..+.+||++||..||++|||+.++|+-
T Consensus 214 -----------~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 214 -----------QGSYK---PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -----------cCCCC---CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11111 1123477889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=339.44 Aligned_cols=257 Identities=28% Similarity=0.490 Sum_probs=212.0
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||+|+||.||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++.+ .....
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~ 90 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSY-----LVGDE 90 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhhee-----eeCCc
Confidence 46899999999999999999999999999999998632 223456788999999999999999999998 44456
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
.|+|+||+. ++|.+++... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 91 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred EEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 899999998 6999988754 58899999999999999999999999999999999999999999999999886543222
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
. ......|++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+..+.+..+.
T Consensus 170 ~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~---------------- 228 (293)
T cd06647 170 S---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---------------- 228 (293)
T ss_pred c---ccccccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh----------------
Confidence 1 1234568899999999876 678899999999999999999999998765433322110
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
....+.......++..+.+||++||..||.+||++.+++.|+||+..
T Consensus 229 ------------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 229 ------------TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred ------------cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcC
Confidence 01111122233577889999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=351.19 Aligned_cols=281 Identities=31% Similarity=0.517 Sum_probs=227.4
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC------CCCcceeeEEEcCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR------HPDIVEIKRIMLPPSK 96 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~------HpnIv~l~~v~~~~~~ 96 (556)
++|.|....|+|-||+|..|.|..-|..||||+|.+ +..-.+.=++|+.||++|+ --|+++|+..|
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn---NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F----- 503 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN---NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF----- 503 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeec---chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----
Confidence 689999999999999999999999999999999974 2233344568999999995 23788888877
Q ss_pred CCCceEEEEEecCcccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC-CceEEeeeCc
Q 008729 97 REFKDIYVVFELMESDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGL 172 (556)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~---~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~vKL~DFGl 172 (556)
...+++|||||-+.-+|.+++++-| .|....++.|..||+.||+.|-..||+|.||||+|||+++. ..+||||||.
T Consensus 504 ~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 504 KHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 6668899999999999999999744 68899999999999999999999999999999999999976 4689999999
Q ss_pred cccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
|....... .+.|..++.|+|||++.| ..|+...|+||+||+||||.||+.+|+|.++.+++...+++.|..+.
T Consensus 584 A~~~~ene-----itPYLVSRFYRaPEIiLG--~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 584 ASFASENE-----ITPYLVSRFYRAPEIILG--LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred cccccccc-----ccHHHHHHhccCcceeec--CcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 97654332 367889999999999999 78999999999999999999999999999999999999999999888
Q ss_pred HHHHHhhhHH--H---HHHH----HH---------hhcCCC-CCc----------CCCCCCCCHHHHHHHHHhhhcCCCC
Q 008729 253 ETIAVVRNEK--A---RKYL----TE---------MRKKPP-VPL----------FQKFPNVDPLALRLLQRLIAFDPKD 303 (556)
Q Consensus 253 e~i~~~~~~~--~---~~~l----~~---------~~~~~~-~~~----------~~~~~~~s~~~~dLl~~~L~~dP~~ 303 (556)
.++....... + ..|+ +. |....+ ..+ ...-+.+-..+.+||.+||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 7765432110 0 0000 00 000000 000 0001122346789999999999999
Q ss_pred CCCHHHHHhCccccc
Q 008729 304 RPTAEEALADPYFKG 318 (556)
Q Consensus 304 Rpta~elL~hp~f~~ 318 (556)
|.|..++|.||||.+
T Consensus 737 Rit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 737 RITVNQALKHPFITE 751 (752)
T ss_pred cCCHHHHhcCCcccC
Confidence 999999999999974
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=359.04 Aligned_cols=258 Identities=23% Similarity=0.416 Sum_probs=206.2
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEE-EcCCCCCC-C
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRI-MLPPSKRE-F 99 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v-~~~~~~~~-~ 99 (556)
.+++|.++|.+|||+.||+|.+...|..||+|++-.. +......+.+||.+|++|+ |+|||.+++. ........ .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 4788999999999999999999998899999998643 5566777889999999997 9999999994 33222222 3
Q ss_pred ceEEEEEecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 100 KDIYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
..++|.||||. |.|-+++.. ...|++.+++.||+++++||++||... |||||||-|||||+.+|..||||||.|.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 56899999999 699999974 346999999999999999999999998 9999999999999999999999999986
Q ss_pred cccCCCCCcc---ee---cccccCcccCCccccccc-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 008729 175 VAFSDTPMTV---FW---TDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (556)
Q Consensus 175 ~~~~~~~~~~---~~---~~~~gt~~Y~APE~~~~~-~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~ 247 (556)
-......... .. -....|+.|+|||.+.-. ....+.|+|||+|||+||-||....||.+......
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI-------- 266 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI-------- 266 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE--------
Confidence 5332221100 00 113478999999976311 15688999999999999999999999987632111
Q ss_pred CCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 008729 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (556)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~ 315 (556)
+...-.+| .++..+..+.+||+.||+.||++||++-|++.+-+
T Consensus 267 ----------------------lng~Y~~P---~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 267 ----------------------LNGNYSFP---PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred ----------------------EeccccCC---CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 11111222 33678899999999999999999999999987644
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=328.67 Aligned_cols=259 Identities=26% Similarity=0.420 Sum_probs=210.6
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc---CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~---~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
..|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++|+||+++++.+... ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence 47999999999999999999999999999999875321 1233456788999999999999999999987432 23
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
..+++|+||+. ++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 56899999998 58999998878899999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
............|+..|+|||.+.+ ..++.++|+|||||++|+|++|++||........+..+ ...+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~-------- 225 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKI---ATQP-------- 225 (264)
T ss_pred ccccCccccccCCcccccCHhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHH---HcCC--------
Confidence 2111111234568999999999877 67889999999999999999999999766543332221 1111
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
........+++.+.++|++||. +|.+|||+.++|.|||.
T Consensus 226 ------------------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 226 ------------------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ------------------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 0112234688999999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=338.37 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=210.0
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++. +..
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-----~~~ 88 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-----REH 88 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-----eCC
Confidence 357999999999999999999999999999999986432 22334567889999999999999999999984 445
Q ss_pred eEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
..|+||||+.|+|.+++.. .+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++......
T Consensus 89 ~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 89 TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred eEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 6899999999998888764 457899999999999999999999999999999999999999999999999998654221
Q ss_pred CCCcceecccccCcccCCccccccc-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
....++..|+|||++.+. ...++.++|||||||++|+|++|.+||.+.+....+..+..
T Consensus 169 -------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~------------- 228 (307)
T cd06607 169 -------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------- 228 (307)
T ss_pred -------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhc-------------
Confidence 234688899999987431 14588899999999999999999999987665433322210
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
..... .....++..+.+||.+||..||++||++.+++.||||..
T Consensus 229 --------------~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 272 (307)
T cd06607 229 --------------NDSPT--LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLR 272 (307)
T ss_pred --------------CCCCC--CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 00000 011236788999999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.70 Aligned_cols=256 Identities=30% Similarity=0.548 Sum_probs=214.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCCc
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~ 100 (556)
++|.+.+.||+|+||.||+|.+..+|+.||+|++... .........+.+|+.+++.++ ||||+++++++ .+..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCc
Confidence 4799999999999999999999999999999998752 223344567889999999998 99999999988 4556
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+|||++. ++|.+++.+.+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 7999999996 799999998889999999999999999999999999999999999999999999999999999765432
Q ss_pred CCC-----------------cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 008729 180 TPM-----------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242 (556)
Q Consensus 180 ~~~-----------------~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~ 242 (556)
... ........++..|+|||.+.+ ..++.++|||||||++++|++|+.||...+....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 211 011234567899999999877 5688999999999999999999999987764333322
Q ss_pred HHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH----HHHHhCccc
Q 008729 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYF 316 (556)
Q Consensus 243 i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta----~elL~hp~f 316 (556)
+.. . .......+++.+.+||++||..||.+|||+ +++|+||||
T Consensus 234 ~~~--------------------------~-----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILK--------------------------L-----EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHh--------------------------c-----CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 211 0 011224568899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=336.56 Aligned_cols=252 Identities=26% Similarity=0.390 Sum_probs=198.4
Q ss_pred eeeecCceeEEEEEECCCCcEEEEEEecCccCC-hhHHHHHHHHHHHHHh---CCCCCcceeeEEEcCCCCCCCceEEEE
Q 008729 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRL---LRHPDIVEIKRIMLPPSKREFKDIYVV 105 (556)
Q Consensus 30 ~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~---L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (556)
.||+|+||.||+|.+..+++.||+|.+...... ........+|..+++. .+||||+.+++.+ ...+.+|+|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAF-----HTPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEE-----ecCCeEEEE
Confidence 489999999999999999999999988643222 1222334455544443 4799999999998 444569999
Q ss_pred EecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcc
Q 008729 106 FELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (556)
Q Consensus 106 ~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 184 (556)
|||+. ++|.+++..++.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--- 152 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---
Confidence 99999 69999998888899999999999999999999999999999999999999999999999999865432211
Q ss_pred eecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHH
Q 008729 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (556)
Q Consensus 185 ~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~ 264 (556)
....|+..|+|||.+.+. ..++.++|||||||++|+|++|..||.+....... .+
T Consensus 153 --~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~--------------------- 207 (279)
T cd05633 153 --HASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EI--------------------- 207 (279)
T ss_pred --cCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HH---------------------
Confidence 234699999999988531 46889999999999999999999999764321111 00
Q ss_pred HHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 265 ~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
...... ........+++.+.+||++||..||++|+ |++++++||||+++.
T Consensus 208 ---~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 208 ---DRMTLT---VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred ---HHHhhc---CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 000000 01122346789999999999999999999 699999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=341.18 Aligned_cols=256 Identities=28% Similarity=0.531 Sum_probs=211.2
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
..|.....||+|+||.||+|.+..+++.||+|++... .......+.+|+.+++.++||||+++++.+ .....+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~ 93 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHQNVVEMYKSY-----LVGEEL 93 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEec--ccchHHHHHHHHHHHHhCCCCchhhhhhhe-----eeCCeE
Confidence 4566677899999999999999999999999998642 223345688999999999999999999988 445679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+||||+. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 94 ~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred EEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 99999999 588887654 5689999999999999999999999999999999999999999999999999875433221
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
. ....+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+....+..+..
T Consensus 173 ~---~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---------------- 231 (297)
T cd06659 173 K---RKSLVGTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD---------------- 231 (297)
T ss_pred c---ccceecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc----------------
Confidence 1 234668999999999977 6789999999999999999999999987665444332210
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
...+.......++..+.++|++||..||.+||+++++++||||.+.
T Consensus 232 ------------~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 232 ------------SPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred ------------cCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 1111122334678899999999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=335.16 Aligned_cols=252 Identities=26% Similarity=0.388 Sum_probs=204.5
Q ss_pred eeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEecC
Q 008729 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (556)
Q Consensus 31 LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 109 (556)
||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+|+.++||||+++++++ .....+|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence 6999999999999999999999999864321 222344567899999999999999999998 4556799999999
Q ss_pred c-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCccee
Q 008729 110 E-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (556)
Q Consensus 110 ~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (556)
. ++|.+++...+ .+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++........ .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~----~ 151 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK----I 151 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc----c
Confidence 9 69999997765 799999999999999999999999999999999999999999999999999876433211 1
Q ss_pred cccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHH
Q 008729 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (556)
Q Consensus 187 ~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~ 266 (556)
....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 152 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------------- 208 (277)
T cd05577 152 KGRAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--------------------- 208 (277)
T ss_pred ccccCCCCcCCHHHhcC--CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---------------------
Confidence 34568889999999877 5688999999999999999999999976553211111100
Q ss_pred HHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
.... ........+++.+.+||++||+.||.+|| ++.++++||||..+.
T Consensus 209 ---~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 209 ---RTLE---MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred ---cccc---ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 0000 01122345789999999999999999999 999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=324.88 Aligned_cols=253 Identities=31% Similarity=0.507 Sum_probs=213.8
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
+|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+++++.++|||++++++.+. .....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence 599999999999999999999999999999999765445566677889999999999999999999984 346799
Q ss_pred EEEecCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 104 VVFELME-SDLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
+|+||++ ++|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 155 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS 155 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc
Confidence 9999998 5999998763 6799999999999999999999999999999999999999999999999999976544
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
... ......|++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+.......+.
T Consensus 156 ~~~---~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-------------- 216 (258)
T cd08215 156 TVD---LAKTVVGTPYYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL-------------- 216 (258)
T ss_pred Ccc---eecceeeeecccChhHhcc--CCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh--------------
Confidence 321 2234568999999999877 678899999999999999999999997766433322211
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.... ......++..+.+++++||..||++|||+.++|+||||
T Consensus 217 -------------~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 217 -------------KGQY---PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -------------cCCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 1111 11223578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=335.16 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=211.1
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
..|++++.||.|+||.||+|.+..++..||||++... ........+.+|+.+++.+.||||+++++++ .+...+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 77 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKGTKL 77 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCEE
Confidence 4688999999999999999999999999999988643 2234566788999999999999999999998 455679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+||||++ ++|.+++.. +.+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 78 WIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999998 599998875 5689999999999999999999999999999999999999999999999999976533221
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
......++..|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+.......+.
T Consensus 157 ---~~~~~~~~~~y~apE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~----------------- 214 (277)
T cd06640 157 ---KRNTFVGTPFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP----------------- 214 (277)
T ss_pred ---ccccccCcccccCHhHhcc--CCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhh-----------------
Confidence 1133468889999999876 678899999999999999999999998765433222110
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
... .......++..+.+||.+||..||++||+++++++|+||...
T Consensus 215 ----------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 215 ----------KNN---PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ----------cCC---CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence 000 011223467889999999999999999999999999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=337.08 Aligned_cols=265 Identities=26% Similarity=0.390 Sum_probs=211.5
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||+||+|.+..+|+.||+|++... ........+.+|+.+++.++||||+++++.+ .....+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 78 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG-AKSSVRKQILRELQIMHECRSPYIVSFYGAF-----LNENNI 78 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec-CcchHHHHHHHHHHHHHHcCCCCcceEeeeE-----ecCCEE
Confidence 4799999999999999999999999999999988643 2234456788999999999999999999998 444679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
|+||||+. ++|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||+++.++.++|+|||++.......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999 6999999888889999999999999999999997 599999999999999999999999999986542221
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
. ...+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||........... ..
T Consensus 159 ~-----~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~----------------~~ 215 (284)
T cd06620 159 A-----DTFVGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD----------------DP 215 (284)
T ss_pred c-----CccccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh----------------hh
Confidence 1 23468999999999876 5788999999999999999999999986553211000 00
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
......+..+........ ....++..+.+||.+||..||++|||++++++|+||.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 216 MGILDLLQQIVQEPPPRL--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred hHHHHHHHHHhhccCCCC--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 000111122211111111 01136788999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=350.41 Aligned_cols=253 Identities=24% Similarity=0.385 Sum_probs=199.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCC-----cEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (556)
.++|++++.||+|+||.||+|++..+| ..||||++.... .......+.+|+.+|+.+ +|+||+++++.+
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~---- 111 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGAC---- 111 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEe----
Confidence 457999999999999999999865444 579999987532 233456788999999999 899999999998
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHhC------------------------------------------------------
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 120 (556)
.....+|+|||||. |+|.+++...
T Consensus 112 -~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 112 -THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred -cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 44567999999999 7999988542
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcc
Q 008729 121 ----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (556)
Q Consensus 121 ----------------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 184 (556)
..+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~-~ 269 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-V 269 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce-e
Confidence 24788889999999999999999999999999999999999999999999999765332211 1
Q ss_pred eecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHH
Q 008729 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (556)
Q Consensus 185 ~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~ 263 (556)
......++..|+|||++.+ ..|+.++|||||||++|+|++ |+.||........+..+.
T Consensus 270 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~------------------- 328 (374)
T cd05106 270 VKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMV------------------- 328 (374)
T ss_pred eccCCCCccceeCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHH-------------------
Confidence 1122335667999999876 679999999999999999997 999997654322221111
Q ss_pred HHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
...... .....+++++.+|+.+||..||++|||++++++
T Consensus 329 -------~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 329 -------KRGYQM---SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred -------HcccCc---cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000000 011236889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=350.34 Aligned_cols=245 Identities=28% Similarity=0.422 Sum_probs=203.5
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
.+++++.||+|-||.||+|.... ...||+|.++.. .-....+++|++||++|+|++||++++++ .....+|
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~-----~~~~piy 277 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVC-----TKQEPIY 277 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEE-----ecCCceE
Confidence 46678899999999999998653 237999998743 22334677999999999999999999999 4444699
Q ss_pred EEEecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 104 VVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
||||||. |+|.++|+. ...+.......++.||++|++||+++++|||||-..||||++++.+||+|||+|+...++.
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 9999999 999999997 4578999999999999999999999999999999999999999999999999999543222
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
-. ...+.--..-|.|||.+.. ..++.++|||||||+||||+| |+.||++.+..+.++.+.+...-|
T Consensus 358 Y~--~~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp--------- 424 (468)
T KOG0197|consen 358 YT--ASEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP--------- 424 (468)
T ss_pred ee--ecCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC---------
Confidence 11 1111112245999999976 789999999999999999999 999999999988887775432221
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL 311 (556)
....+++.+-+|+..||..+|++|||++.++
T Consensus 425 ---------------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 425 ---------------------RPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ---------------------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 2346899999999999999999999998665
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=328.31 Aligned_cols=248 Identities=23% Similarity=0.431 Sum_probs=204.2
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
..|.+.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+|+.++|+||+++++++ .....+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 77 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF 77 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEE-----cCCCCc
Confidence 4699999999999999999999999999999998642 23456788999999999999999999998 445568
Q ss_pred EEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 103 YVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
|+||||+. ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999998 6999999764 35899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||++.+..+....+..
T Consensus 158 ~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~------------- 220 (263)
T cd05052 158 TYTA--HAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------- 220 (263)
T ss_pred eeec--cCCCCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-------------
Confidence 2111 112234567999999876 678999999999999999998 9999988765443333211
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
... ......++..+.+||.+||..||++|||+.++++
T Consensus 221 --------------~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 221 --------------GYR---MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred --------------CCC---CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 000 1122457899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=323.28 Aligned_cols=253 Identities=31% Similarity=0.509 Sum_probs=213.9
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
+|++.+.||+|++|.||+|.+..+++.||+|.+............+.+|+++++.++|+||+++++++ .+...+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSI-----ETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEE-----EeCCEEE
Confidence 58999999999999999999999999999999976544445667889999999999999999999998 4456799
Q ss_pred EEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCC
Q 008729 104 VVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 182 (556)
+||||++ ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.........
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 76 IILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred EEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999998 599999988888999999999999999999999999999999999999999999999999999875443321
Q ss_pred cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHH
Q 008729 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (556)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~ 262 (556)
.....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.......+
T Consensus 156 ---~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~------------------- 211 (254)
T cd06627 156 ---DASVVGTPYWMAPEVIEM--SGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI------------------- 211 (254)
T ss_pred ---ccccccchhhcCHhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-------------------
Confidence 234468899999999877 55889999999999999999999999765532222111
Q ss_pred HHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
. .. ........++..+.++|.+||..||++|||+.+++.||||
T Consensus 212 -------~-~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 212 -------V-QD---DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred -------h-cc---CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0 00 1112234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=331.71 Aligned_cols=262 Identities=25% Similarity=0.401 Sum_probs=207.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|+..+.||.|++|.||+|.+..+++.||+|.+... .......++.+|+++|+.++||||+++++++... ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 76 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD-PNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSI 76 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecC-CchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeE
Confidence 4799999999999999999999999999999988743 2224556788999999999999999999988532 33568
Q ss_pred EEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 103 YVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
|+||||++ ++|.+++.. ...+++..+..++.||+.||+|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 77 GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 99999998 588877643 4568999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhhCCCChHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--VHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~--~~~~~~i~~~~g~p~~e~i 255 (556)
.... ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... ....+...
T Consensus 157 ~~~~-----~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----------- 218 (287)
T cd06621 157 NSLA-----GTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS----------- 218 (287)
T ss_pred cccc-----ccccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH-----------
Confidence 2221 23457889999999877 6789999999999999999999999976532 01111110
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCC---CCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKF---PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~---~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.+............ ..+++.+.+||.+||..||.+|||+.|++.||||+..
T Consensus 219 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 219 -------------YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred -------------HHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 01110000000000 1356789999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=349.58 Aligned_cols=253 Identities=25% Similarity=0.381 Sum_probs=199.8
Q ss_pred CCeEEEeeeeecCceeEEEEEE-----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~ 96 (556)
++|++.++||+|+||.||+|.+ ..++..||||+++... .......+.+|+.+|..+ +||||+++++++
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~----- 108 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGAC----- 108 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence 4799999999999999999964 4567789999987432 234456788999999999 899999999998
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhCC------------------------------------------------------
Q 008729 97 REFKDIYVVFELME-SDLHQVIKAND------------------------------------------------------ 121 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~------------------------------------------------------ 121 (556)
......|+|||||. |+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 45566899999999 79999886421
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 122 ---------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 122 ---------------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
.+++..+..|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 46788899999999999999999999999999999999999999999999997653322
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+......+..+
T Consensus 269 ~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~---------------- 329 (375)
T cd05104 269 NYV-VKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM---------------- 329 (375)
T ss_pred ccc-ccCCCCCCcceeChhHhcC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH----------------
Confidence 111 1122335667999999977 689999999999999999998 89999775433222111
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
+...... ......+.++.+||.+||..||++|||+.++++.
T Consensus 330 ----------~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 330 ----------IKEGYRM---LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred ----------HHhCccC---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 1111000 1123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=333.30 Aligned_cols=251 Identities=25% Similarity=0.392 Sum_probs=198.3
Q ss_pred eeeecCceeEEEEEECCCCcEEEEEEecCccCC-hhHHHHHHHH---HHHHHhCCCCCcceeeEEEcCCCCCCCceEEEE
Q 008729 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILRE---VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (556)
Q Consensus 30 ~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~~rE---i~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (556)
+||+|+||.||+|.+..+++.||+|++...... .........| +.+++...||+|+.+++.+ .....+|+|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence 489999999999999999999999998643222 1112223334 3445556899999999998 455679999
Q ss_pred EecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcc
Q 008729 106 FELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (556)
Q Consensus 106 ~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 184 (556)
|||+. ++|.+++...+.+++..++.|+.||+.||.|||+.+|+||||||+||+++.++.+||+|||++........
T Consensus 76 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--- 152 (278)
T cd05606 76 LDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--- 152 (278)
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---
Confidence 99998 69999998888899999999999999999999999999999999999999999999999999875432211
Q ss_pred eecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHH
Q 008729 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (556)
Q Consensus 185 ~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~ 264 (556)
...+|+..|+|||++.+. ..++.++||||+||++|+|++|+.||.+..........
T Consensus 153 --~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~--------------------- 208 (278)
T cd05606 153 --HASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------------- 208 (278)
T ss_pred --cCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---------------------
Confidence 245699999999998642 46889999999999999999999999775322111100
Q ss_pred HHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCcccccc
Q 008729 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGL 319 (556)
Q Consensus 265 ~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~ 319 (556)
...... .......+++.+.+||.+||..||.+|+ +++++++||||+..
T Consensus 209 ----~~~~~~---~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 209 ----RMTLTM---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred ----HHhhcc---CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 000000 1112234689999999999999999999 99999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=328.71 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=202.0
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHH-HhCCCCCcceeeEEEcCCCCCCCceEEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL-~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (556)
+.||.|+||.||+|.+..+|+.||+|++..... .......+..|..++ ..++|+||+++++++ .....+|+|+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF-----QSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeE-----EcCCeEEEEE
Confidence 679999999999999999999999999864321 112233445565554 445899999999998 4556799999
Q ss_pred ecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce
Q 008729 107 ELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (556)
Q Consensus 107 E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (556)
||+. ++|.+++...+.+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++.....
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 149 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------- 149 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-------
Confidence 9998 69999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 186 ~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
.....|+..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+.......+..
T Consensus 150 ~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------------- 207 (260)
T cd05611 150 NKKFVGTPDYLAPETILG--VGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-------------------- 207 (260)
T ss_pred cccCCCCcCccChhhhcC--CCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh--------------------
Confidence 123458889999999877 5589999999999999999999999987765443333211
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC---HHHHHhCcccccc
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT---AEEALADPYFKGL 319 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt---a~elL~hp~f~~~ 319 (556)
............+++.+.++|.+||..||++||+ ++|+|.||||+.+
T Consensus 208 -------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 208 -------RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred -------cccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence 0000111122357899999999999999999994 5899999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=331.68 Aligned_cols=256 Identities=31% Similarity=0.486 Sum_probs=209.3
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC---CCCcceeeEEEcCCCCCCCc
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~---HpnIv~l~~v~~~~~~~~~~ 100 (556)
.|++++.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++ ||||+++++++ .+..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~-----~~~~ 75 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSY-----LKGP 75 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeee-----eeCC
Confidence 5889999999999999999999999999999986432 2334567889999999996 99999999988 4456
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
..|+||||+. ++|.+++.. +.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 76 RLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred EEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 7999999998 589988865 47899999999999999999999999999999999999999999999999999765433
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.. ......|+..|+|||.+.+. ..++.++|+|||||++|+|++|..||.+.........+
T Consensus 155 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~---------------- 214 (277)
T cd06917 155 SS---KRSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI---------------- 214 (277)
T ss_pred cc---ccccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc----------------
Confidence 22 12345689999999987642 45788999999999999999999999876543322111
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
....+... ....++.++.+++.+||..||++||++.+++.|+||+..
T Consensus 215 -----------~~~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 215 -----------PKSKPPRL--EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred -----------ccCCCCCC--CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence 00001000 011267899999999999999999999999999999754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=337.22 Aligned_cols=255 Identities=27% Similarity=0.385 Sum_probs=208.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
..|++++.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++||||+++++++ .....+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 77 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSY-----LKGTKL 77 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhccc-----ccCCce
Confidence 35788899999999999999999999999999886432 223456788999999999999999999998 445669
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 78 WIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999 589888864 5689999999999999999999999999999999999999999999999999876432211
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...........+
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------------------ 213 (277)
T cd06642 157 ---KRNTFVGTPFWMAPEVIKQ--SAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI------------------ 213 (277)
T ss_pred ---hhhcccCcccccCHHHhCc--CCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh------------------
Confidence 1123468899999999987 67889999999999999999999999765433222111
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
..... ......++..+.+||.+||..+|++|||+.++|+||||..+
T Consensus 214 ---------~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 214 ---------PKNSP---PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred ---------hcCCC---CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 00000 11123467889999999999999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=369.12 Aligned_cols=148 Identities=24% Similarity=0.445 Sum_probs=134.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|.++++||+|+||+||+|.+..+++.||||++... .........+.+|+.++..++||||++++.++ ....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence 46899999999999999999999999999999998743 22334456788999999999999999999988 5556
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
++|||||||. ++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 7999999997 6999999888889999999999999999999999999999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=327.51 Aligned_cols=251 Identities=29% Similarity=0.435 Sum_probs=200.6
Q ss_pred EeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEe
Q 008729 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (556)
...||+|+||.||+|.+..++..||+|.+... .......+.+|+.+++.++|+||+++++++ .....+|+|+|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e 85 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENGFFKIFME 85 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCCEEEEEEe
Confidence 35799999999999999999999999988642 334566788999999999999999999998 44567999999
Q ss_pred cCc-ccHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC-CCceEEeeeCccccccCCCCC
Q 008729 108 LME-SDLHQVIKAN-DDL--TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPM 182 (556)
Q Consensus 108 ~~~-g~L~~~i~~~-~~l--~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~vKL~DFGla~~~~~~~~~ 182 (556)
|+. ++|.+++... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||++.........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 165 (268)
T cd06624 86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165 (268)
T ss_pred cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence 998 6999999764 455 88889999999999999999999999999999999976 678999999998764332221
Q ss_pred cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHH
Q 008729 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (556)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~ 262 (556)
.....|+..|+|||++.+....++.++|||||||++|+|++|++||............
T Consensus 166 ---~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~------------------- 223 (268)
T cd06624 166 ---TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK------------------- 223 (268)
T ss_pred ---cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-------------------
Confidence 2334588999999998653345789999999999999999999999654321111000
Q ss_pred HHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
..... ........+++.+.+|+++||..+|.+|||+.+++.||||
T Consensus 224 -----~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 224 -----VGMFK----IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----hhhhc----cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00000 0011223578899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=342.64 Aligned_cols=285 Identities=20% Similarity=0.239 Sum_probs=205.4
Q ss_pred eeeeec--CceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEE
Q 008729 29 EVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 29 ~~LG~G--~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (556)
..||+| +||+||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++ .....+|+||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~-----~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVF-----TTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeE-----ecCCceEEEE
Confidence 456766 999999999999999999999875444444567788999999999999999999999 4456799999
Q ss_pred ecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCc
Q 008729 107 ELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (556)
Q Consensus 107 E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 183 (556)
||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++||+.+..........
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 9999 6999988764 358999999999999999999999999999999999999999999999998654322211110
Q ss_pred -ce---ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 184 -VF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 184 -~~---~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.. .....++..|+|||++.+....++.++|||||||++|+|++|++||.+......+..+.. +.+.........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK--GPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhc--CCCCCCcccccc
Confidence 00 011235567999999876334578999999999999999999999988765444332221 111100000000
Q ss_pred hHHHHH-------H----HHHhhc-----CCC-CC-cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 260 NEKARK-------Y----LTEMRK-----KPP-VP-LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 260 ~~~~~~-------~----l~~~~~-----~~~-~~-~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
...... . ...... ... .. ........++.+.+||++||..||++|||++++|+||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 000000 0 000000 000 00 0011224677899999999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=331.39 Aligned_cols=259 Identities=22% Similarity=0.378 Sum_probs=205.0
Q ss_pred CCCeEEEeeeeecCceeEEEEEECC-----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
.++|++.+.||+|+||.||+|.++. .+..||+|.+... ........+.+|+.+++.++||||+++++++
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~----- 78 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES-ASLRERIEFLNEASVMKGFTCHHVVRLLGVV----- 78 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 4589999999999999999997652 3458999988643 2234455688999999999999999999998
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCce
Q 008729 97 REFKDIYVVFELME-SDLHQVIKAN----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~----------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~v 165 (556)
.+....|+||||+. |+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 79 SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred cCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 44456899999998 7999999753 234667888999999999999999999999999999999999999
Q ss_pred EEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 008729 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244 (556)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~ 244 (556)
||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+..+.+.
T Consensus 159 ~L~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 159 KIGDFGMTRDIYETDYYR-KGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred EECcCCcccccccccccc-ccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999987643222111 1122345678999999876 678999999999999999998 789998766544333221
Q ss_pred HhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh------Cccccc
Q 008729 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA------DPYFKG 318 (556)
Q Consensus 245 ~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~------hp~f~~ 318 (556)
. ... .......++.+.+++.+||+.||++|||+.++++ ||||.+
T Consensus 236 ~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 236 D---------------------------GGY---LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred c---------------------------CCC---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 1 000 1112346789999999999999999999999987 899987
Q ss_pred c
Q 008729 319 L 319 (556)
Q Consensus 319 ~ 319 (556)
+
T Consensus 286 ~ 286 (288)
T cd05061 286 V 286 (288)
T ss_pred C
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=354.04 Aligned_cols=263 Identities=28% Similarity=0.460 Sum_probs=219.9
Q ss_pred cccccCCCCCe-EEEeeeeecCceeEEEEEECCCCcEEEEEEec--CccCChhHHHHHHHHHHHHHhCCCCCcceeeEEE
Q 008729 15 FFTEYGDANRY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIM 91 (556)
Q Consensus 15 ~~~~~~~~~~Y-~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~--~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~ 91 (556)
.+-+....+|| +...+||+|+|-+||+|.|..+|..||+-.++ +.........++..|+.+|+.|+||||+++|..+
T Consensus 31 ~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW 110 (632)
T KOG0584|consen 31 EFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSW 110 (632)
T ss_pred cccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeehe
Confidence 34455566677 56678999999999999999999999987553 4456667788999999999999999999999999
Q ss_pred cCCCCCCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEeecCC-CceEE
Q 008729 92 LPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANAN-CKLKV 167 (556)
Q Consensus 92 ~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~-~~vKL 167 (556)
.+... +.+-+|+|+|. |+|..|+++.+.++...++.|++|||+||.|||++. |+|||||.+||+|+.+ |.|||
T Consensus 111 ~d~~n---~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKI 187 (632)
T KOG0584|consen 111 VDTDN---KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKI 187 (632)
T ss_pred ecCCC---ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceee
Confidence 76432 67889999998 899999999999999999999999999999999996 9999999999999865 89999
Q ss_pred eeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHH-HHHHHh
Q 008729 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDL 246 (556)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~-~~i~~~ 246 (556)
+|+|||....... ....+|||.|||||++. ..|+..+||||||.+++||+|+..||.-....-++ .++
T Consensus 188 GDLGLAtl~r~s~-----aksvIGTPEFMAPEmYE---E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV--- 256 (632)
T KOG0584|consen 188 GDLGLATLLRKSH-----AKSVIGTPEFMAPEMYE---ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV--- 256 (632)
T ss_pred cchhHHHHhhccc-----cceeccCccccChHHHh---hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH---
Confidence 9999998764433 24578999999999987 48999999999999999999999999766554443 222
Q ss_pred hCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 247 ~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
....++..+. .--++++++||.+||.. .+.|+|+.|+|+||||..
T Consensus 257 -----------------------~SGiKP~sl~---kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 257 -----------------------TSGIKPAALS---KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred -----------------------HcCCCHHHhh---ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 1122222221 11378999999999999 999999999999999985
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=330.54 Aligned_cols=246 Identities=22% Similarity=0.381 Sum_probs=197.1
Q ss_pred CCeEEEeee--eecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCC
Q 008729 23 NRYKILEVI--GKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 23 ~~Y~i~~~L--G~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (556)
+.|++.+.+ |.|+||.||++.++.++..||+|.+....... .|+.+...+ +||||+++++.+ ...
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~-----~~~ 81 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSV-----TTL 81 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEE-----ecC
Confidence 366776666 99999999999999999999999986421111 123333323 699999999999 444
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC-ceEEeeeCcccccc
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAF 177 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~vKL~DFGla~~~~ 177 (556)
..+|+||||+. ++|.+++..+..+++..++.++.||+.||.|||+.||+||||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 57999999998 69999999888899999999999999999999999999999999999999998 99999999987543
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhhCCCChHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ-LDLITDLLGTPSPETIA 256 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~-~~~i~~~~g~p~~e~i~ 256 (556)
.. ....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||........ ...+
T Consensus 162 ~~-------~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~------------- 219 (267)
T PHA03390 162 TP-------SCYDGTLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESL------------- 219 (267)
T ss_pred CC-------ccCCCCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHH-------------
Confidence 22 23458899999999977 6789999999999999999999999975543210 0000
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-HHHHHhCcccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-AEEALADPYFK 317 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-a~elL~hp~f~ 317 (556)
.... .......+.+++.+.+||.+||+.||.+|++ ++++|+||||+
T Consensus 220 ----------~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 220 ----------LKRQ-----QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred ----------HHhh-----cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 0101 0111223468999999999999999999996 59999999996
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=327.22 Aligned_cols=256 Identities=22% Similarity=0.346 Sum_probs=204.3
Q ss_pred eEEEeeeeecCceeEEEEEECCC---CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC-CCCc
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REFK 100 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~~ 100 (556)
|++++.||+|+||.||+|.+..+ +..||||++............+.+|+.+|+.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67899999999999999987653 4789999987544445566778999999999999999999998865432 3345
Q ss_pred eEEEEEecCc-ccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcc
Q 008729 101 DIYVVFELME-SDLHQVIKAN------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla 173 (556)
..++||||+. ++|..++... ..+++..+..++.||+.||.|||+.||+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 6899999999 6998888542 36899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
+......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||.+....+.++.+.
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~-------- 229 (273)
T cd05035 161 KKIYSGDYYR-QGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR-------- 229 (273)
T ss_pred eecccccccc-ccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--------
Confidence 8654322110 0112235667999999876 678999999999999999999 899998766544333221
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.... ......++..+.+++.+||..||++|||+.+++.+
T Consensus 230 -------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 230 -------------------HGNR---LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred -------------------cCCC---CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1111 11234578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=329.88 Aligned_cols=254 Identities=26% Similarity=0.392 Sum_probs=209.6
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
-|++++.||+|+||.||+|.+..+++.||||++... ........+.+|+.+++.++||||+++++.+ .+...+|
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 78 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSY-----LKDTKLW 78 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc-cchHHHHHHHHHHHHHHhcCCCCEeEEEEEE-----EeCCeEE
Confidence 488899999999999999999999999999987632 2234456788999999999999999999998 4556799
Q ss_pred EEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCC
Q 008729 104 VVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 182 (556)
+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 79 lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 79 IIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred EEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999999 588888864 5689999999999999999999999999999999999999999999999999875432211
Q ss_pred cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHH
Q 008729 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (556)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~ 262 (556)
......++.+|+|||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.
T Consensus 157 --~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------------------ 214 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP------------------ 214 (277)
T ss_pred --hhccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh------------------
Confidence 1234568899999999876 678889999999999999999999997655433222211
Q ss_pred HHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
... .......++..+.++|.+||..||.+||++.++++||||...
T Consensus 215 ---------~~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 215 ---------KNN---PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ---------cCC---CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 000 011123578899999999999999999999999999999853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=329.23 Aligned_cols=253 Identities=20% Similarity=0.379 Sum_probs=202.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
.++|++.+.||+|+||.||+|.+. .++..||||++... ........+.+|+.+++.++||||+++++++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~----- 78 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVV----- 78 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----
Confidence 468999999999999999999865 24568999988642 2334556788999999999999999999998
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCce
Q 008729 97 REFKDIYVVFELME-SDLHQVIKAND----------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~----------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~v 165 (556)
......|+||||+. ++|.+++.... .++...+..++.||+.||.|||+.|++||||||+|||++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence 45567999999998 69999987532 35678889999999999999999999999999999999999999
Q ss_pred EEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 008729 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244 (556)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~ 244 (556)
||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+.+..+.
T Consensus 159 ~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 159 KIGDFGMTRDIYETDYYR-KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred EECCCCCccccCCcceee-cCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999987543221110 1112345778999999876 678999999999999999999 789998776544443321
Q ss_pred HhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 245 ~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
. ... ......++..+.+|+.+||+.||++|||+.+++++
T Consensus 236 ~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 236 E---------------------------GGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred c---------------------------CCc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 000 11123467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=325.91 Aligned_cols=247 Identities=26% Similarity=0.392 Sum_probs=200.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||.||+|..+ .+..||+|.+... ......+.+|+.+|+.++||||+++++++ .....+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 74 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEG---AMSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPL 74 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccC---CccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCE
Confidence 47999999999999999999875 4568999987632 12235678899999999999999999998 445669
Q ss_pred EEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 103 YVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
|+||||+. |+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 75 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE 154 (256)
T ss_pred EEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence 99999998 799999875 3568999999999999999999999999999999999999999999999999987643222
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |++||.+.+..+.+..+...
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~------------- 217 (256)
T cd05114 155 YTS--SSGAKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG------------- 217 (256)
T ss_pred eec--cCCCCCchhhCChhhccc--CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-------------
Confidence 111 122335568999999876 678999999999999999999 99999887765555444221
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
... ......+..+.+|+.+||..||++||+++++++
T Consensus 218 --------------~~~---~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 218 --------------FRL---YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred --------------CCC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 000 011235678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=330.78 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=203.9
Q ss_pred CCeEEEeeeeecCceeEEEEEECC-----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
++|.+.+.||+|+||.||+|.+.. +++.||||++.... .......+.+|+++|+.++|+||+++++++ .
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~ 78 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVC-----T 78 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEE-----e
Confidence 479999999999999999998753 46789999987532 223456788999999999999999999998 4
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCC--------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAND--------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN 162 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~--------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~ 162 (556)
.....|+||||+. ++|.+++..++ .+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~ 158 (280)
T cd05049 79 EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYD 158 (280)
T ss_pred cCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCC
Confidence 4467999999998 69999997643 47888999999999999999999999999999999999999
Q ss_pred CceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 008729 163 CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLD 241 (556)
Q Consensus 163 ~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~ 241 (556)
+.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.....+
T Consensus 159 ~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~ 235 (280)
T cd05049 159 LVVKIGDFGMSRDVYTTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235 (280)
T ss_pred CeEEECCcccceecccCcce-ecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999998754322211 11123346788999999877 679999999999999999998 999998776554443
Q ss_pred HHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 242 ~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.+.. ... ......++..+.+|+++||..||++|||+.|+++
T Consensus 236 ~~~~---------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 236 CITQ---------------------------GRL---LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHc---------------------------CCc---CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3311 111 1112357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=320.50 Aligned_cols=259 Identities=27% Similarity=0.431 Sum_probs=213.7
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
+|++.+.||+|++|.||+|.+..+++.|++|++............+.+|+.+++.++||||+++++.+.... ...+|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 588999999999999999999999999999998754444456678889999999999999999999984321 26799
Q ss_pred EEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCC
Q 008729 104 VVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 182 (556)
+|+||+. ++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 9999996 699999988879999999999999999999999999999999999999999999999999999876543321
Q ss_pred cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHH
Q 008729 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (556)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~ 262 (556)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|..||..... ....+..
T Consensus 158 -~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~----------------- 215 (260)
T cd06606 158 -EGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAALYK----------------- 215 (260)
T ss_pred -ccccCCCCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHHHh-----------------
Confidence 01134568889999999877 5688999999999999999999999977651 1111111
Q ss_pred HHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
... ..........++..+.+||.+||..||.+||++.++++||||
T Consensus 216 -------~~~--~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 216 -------IGS--SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred -------ccc--cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 110 011112234568999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=324.49 Aligned_cols=245 Identities=22% Similarity=0.331 Sum_probs=198.5
Q ss_pred eeeecCceeEEEEEE--CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEe
Q 008729 30 VIGKGSYGVVCAAID--THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (556)
Q Consensus 30 ~LG~G~~g~V~~a~~--~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (556)
.||+|+||.||+|.+ ..++..||+|++............+.+|+.+|+.++||||+++++++. ....++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence 689999999999964 467889999998754444455667889999999999999999999873 234699999
Q ss_pred cCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCccee
Q 008729 108 LME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (556)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (556)
|+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||.|||++.++.+||+|||+++............
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 76 LAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 999 6899999887889999999999999999999999999999999999999999999999999997654332211111
Q ss_pred cccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 187 ~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
....++..|+|||.+.. ..++.++|||||||++|||++ |.+||.+.+..+....+.
T Consensus 156 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~--------------------- 212 (257)
T cd05116 156 THGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE--------------------- 212 (257)
T ss_pred CCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---------------------
Confidence 22234578999998876 678899999999999999998 999998776544443331
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... ......+++.+.+||.+||+.||++||++++|..
T Consensus 213 ------~~~~---~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 213 ------SGER---MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred ------CCCC---CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 1111 1122458899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=331.08 Aligned_cols=263 Identities=23% Similarity=0.395 Sum_probs=210.3
Q ss_pred CeEEEeeeeecCceeEEEEEEC---CCCcEEEEEEecCcc--CChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCC
Q 008729 24 RYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~---~tg~~vAiK~i~~~~--~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~ 97 (556)
.|++.+.||.|+||.||.|.+. .+|+.||+|++.... ........+.+|+++|+.+ +|+||+++++++ .
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence 4899999999999999999875 478999999986421 2223456678899999999 599999999998 4
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
....+|+||||+. ++|.+++.....+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++...
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 5567999999999 699999998888999999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
...... ......|+..|+|||.+.+....++.++|||||||++|+|++|..||...........+.
T Consensus 156 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~------------ 221 (290)
T cd05613 156 HEDEVE--RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS------------ 221 (290)
T ss_pred cccccc--ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHH------------
Confidence 332211 123456899999999987533457889999999999999999999996543222111111
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
..+.... .+ ....+++.+.+|+++||..||++|+ ++++++.||||+...
T Consensus 222 -----------~~~~~~~-~~---~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 222 -----------RRILKSE-PP---YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred -----------HHhhccC-CC---CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 1111110 01 1234788999999999999999997 899999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=326.20 Aligned_cols=256 Identities=22% Similarity=0.361 Sum_probs=203.0
Q ss_pred eEEEeeeeecCceeEEEEEECCCCc--EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC-CCCce
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REFKD 101 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg~--~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~~~ 101 (556)
|.+.+.||+|+||.||+|.+..++. .||+|.+............+.+|+.+|+.++|+||+++++.+..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578999999999999999887775 69999887554455667788899999999999999999997753321 23346
Q ss_pred EEEEEecCc-ccHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 102 IYVVFELME-SDLHQVIKA------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~------~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
.++||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 899999998 799888742 2347899999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
......... ......+++.|+|||.+.+ ..++.++|||||||++|+|++ |++||.+.......+.+.
T Consensus 161 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--------- 228 (272)
T cd05075 161 KIYNGDYYR-QGRIAKMPVKWIAIESLAD--RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR--------- 228 (272)
T ss_pred ccCccccee-cCCcccCCcccCCHHHccC--CCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---------
Confidence 653322110 0122245678999999887 678999999999999999999 899998766543332221
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
..... ...+.++..+.++|.+||+.||++|||+++++++
T Consensus 229 ------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 229 ------------------QGNRL---KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ------------------cCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11111 1224578889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=322.35 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=211.1
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
+|++.+.||.|+||.||+|.+..+++.||+|++............+.+|+.+++.++|+||+++++++. +....|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence 599999999999999999999999999999998754444455667889999999999999999999883 446799
Q ss_pred EEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 104 VVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++.....
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~ 155 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK 155 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc
Confidence 9999998 599998866 35689999999999999999999999999999999999999999999999999977544
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.. .....++..|++||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+.
T Consensus 156 ~~-----~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-------------- 214 (256)
T cd08530 156 NM-----AKTQIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-------------- 214 (256)
T ss_pred CC-----cccccCCccccCHHHHCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--------------
Confidence 31 123458889999999877 678899999999999999999999998776443322221
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.... ......++.++.++|.+||..+|++|||+.++|+||++
T Consensus 215 -------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 215 -------------RGKY---PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -------------cCCC---CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 1111 11123577889999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=334.56 Aligned_cols=252 Identities=22% Similarity=0.364 Sum_probs=202.4
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcE----EEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~----vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
..+|++.+.||+|+||.||+|.+..+++. ||||++... ........+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC---
Confidence 45799999999999999999998766664 899988642 2334556788999999999999999999998532
Q ss_pred CCceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
..++|+||+. |+|.+++..+ ..++...+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 82 ---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred ---CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 3689999998 7999999874 4688999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
........ ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~---------- 225 (316)
T cd05108 159 LGADEKEY-HAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---------- 225 (316)
T ss_pred ccCCCcce-eccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh----------
Confidence 54332211 1122334667999999877 678999999999999999997 999998765433222111
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
..... ...+..+..+.+++.+||..||.+|||+.+++.+
T Consensus 226 -----------------~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 226 -----------------KGERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -----------------CCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11111 1123467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=325.18 Aligned_cols=253 Identities=31% Similarity=0.514 Sum_probs=207.7
Q ss_pred eeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEecC
Q 008729 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (556)
Q Consensus 31 LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 109 (556)
||.|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++.+ .....+|+|+||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence 689999999999999999999999986432 2224456788999999999999999999888 5567799999999
Q ss_pred c-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCC-----c
Q 008729 110 E-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM-----T 183 (556)
Q Consensus 110 ~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~-----~ 183 (556)
. ++|.+++.+.+.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++......... .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 8 599999988778999999999999999999999999999999999999999999999999998765433211 1
Q ss_pred ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHH
Q 008729 184 VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (556)
Q Consensus 184 ~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~ 263 (556)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~------------------ 215 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN------------------ 215 (265)
T ss_pred ccccCcccCccccCHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc------------------
Confidence 11234568889999999877 5688999999999999999999999987765443333211
Q ss_pred HHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH---HHHHhCcccccc
Q 008729 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA---EEALADPYFKGL 319 (556)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta---~elL~hp~f~~~ 319 (556)
.. ... .....++..+.+|+++||+.||++|||+ .++|+||||+.+
T Consensus 216 ---------~~-~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 216 ---------GK-IEW-PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred ---------CC-cCC-CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 00 011 0111258899999999999999999999 999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=327.97 Aligned_cols=252 Identities=22% Similarity=0.386 Sum_probs=201.9
Q ss_pred CCeEEEeeeeecCceeEEEEEECC-----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
+.|.+.+.||+|+||.||+|.+.. ++..||+|.+... ........+.+|+.+++.++|+||+++++++.
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----- 79 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSF----- 79 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----
Confidence 479999999999999999999987 7789999987643 22334456889999999999999999999884
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC---ceE
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAND-------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLK 166 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~-------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~vK 166 (556)
+....|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++|++||||||+|||++.++ .+|
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceE
Confidence 3455799999997 69999997653 488999999999999999999999999999999999998765 599
Q ss_pred EeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHH
Q 008729 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITD 245 (556)
Q Consensus 167 L~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~ 245 (556)
|+|||+++........ ........+..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+..+.+..
T Consensus 160 l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 160 IADFGMARDIYRASYY-RKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred eccCccccccCCccce-ecCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 9999999765221110 00112223567999999876 679999999999999999997 9999988776544333211
Q ss_pred hhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 246 ~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
... ......++..+.+++.+||+.||++|||+.++|+|
T Consensus 237 ---------------------------~~~---~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 237 ---------------------------GGR---LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred ---------------------------CCc---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 11124578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=340.95 Aligned_cols=255 Identities=25% Similarity=0.409 Sum_probs=201.5
Q ss_pred CCCeEEEeeeeecCceeEEEEEECC-----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (556)
.++|+++++||+|+||.||+|.+.. +++.||+|++.... .......+.+|+.++..+ +|+||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~-- 82 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTK-- 82 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEec--
Confidence 4589999999999999999997543 45789999987432 234456788999999999 79999999998742
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHhC------------------------------------------------------
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 120 (556)
....+|+||||+. ++|.+++...
T Consensus 83 --~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 83 --PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred --CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 3356899999999 6999888642
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcceecccccCc
Q 008729 121 -------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193 (556)
Q Consensus 121 -------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~ 193 (556)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........ .......++.
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-~~~~~~~~~~ 239 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-VRKGDARLPL 239 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch-hhccCCCCCc
Confidence 25788999999999999999999999999999999999999999999999999865332211 1112344677
Q ss_pred ccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhc
Q 008729 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRK 272 (556)
Q Consensus 194 ~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~ 272 (556)
.|+|||++.+ ..++.++|||||||+||+|++ |..||.+....+.+... +..
T Consensus 240 ~y~aPE~~~~--~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~--------------------------~~~ 291 (337)
T cd05054 240 KWMAPESIFD--KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRR--------------------------LKE 291 (337)
T ss_pred cccCcHHhcC--CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHH--------------------------Hhc
Confidence 8999999877 689999999999999999998 99999875432222111 111
Q ss_pred CCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 273 KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 273 ~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.... ......++.+.+++.+||+.+|++||+++++++|
T Consensus 292 ~~~~---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 292 GTRM---RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred cCCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1110 1123467899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=314.28 Aligned_cols=265 Identities=25% Similarity=0.385 Sum_probs=208.2
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
-+.+||+|.+.||.|||+.||++.+..++..||+|+|.. ....+....++|+...++++|||++++++..+....+..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c--~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILC--HSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeec--cchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 356899999999999999999999999999999999974 335677889999999999999999999998766555566
Q ss_pred ceEEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEeecCCCceEEeeeCc
Q 008729 100 KDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGL 172 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~vKL~DFGl 172 (556)
...||+++|.. |+|.+.|.. ...+++.++..|+.+|++||++||+.. ..||||||.|||+.+.+.++|.|||.
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence 77999999998 899998864 236999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC------cceecccccCcccCCccccccc-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 008729 173 ARVAFSDTPM------TVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245 (556)
Q Consensus 173 a~~~~~~~~~------~~~~~~~~gt~~Y~APE~~~~~-~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~ 245 (556)
++...-.... -..|..-.-|..|+|||++.-. ....+.++|||||||+||.|+.|..||.. +.+
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~---------~~~ 246 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER---------IYQ 246 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH---------Hhh
Confidence 8763211111 1113344578899999997531 13467899999999999999999999942 111
Q ss_pred hhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 246 ~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.-|+-.-. + .... ..+... ...+..+.+||+.||+.||.+||++.++|.+
T Consensus 247 ~GgSlaLA----v-----------~n~q--~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 247 QGGSLALA----V-----------QNAQ--ISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred cCCeEEEe----e-----------eccc--cccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 00000000 0 0000 111111 2378999999999999999999999999874
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=328.21 Aligned_cols=252 Identities=21% Similarity=0.378 Sum_probs=202.7
Q ss_pred CCeEEEeeeeecCceeEEEEEEC----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDT----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
..|++.+.||+|+||+||+|... .++..||+|.+... ........+.+|+.+++.++||||+++++++ ..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 78 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVV-----TQ 78 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE-----ec
Confidence 46999999999999999999853 45678999998743 2334456788999999999999999999998 44
Q ss_pred CceEEEEEecCc-ccHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec
Q 008729 99 FKDIYVVFELME-SDLHQVIKAN-----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-----------------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~ 160 (556)
....|+||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 456899999998 6999998532 2478888999999999999999999999999999999999
Q ss_pred CCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHH
Q 008729 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (556)
Q Consensus 161 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~ 239 (556)
.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+....
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYR-VQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred CCCcEEeccccccccccCCccee-cccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 99999999999997653322111 1133446678999999876 678999999999999999998 9999988765443
Q ss_pred HHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 240 ~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
...+. .... ......+++.+.+++.+||+.||.+||++.+++++
T Consensus 236 ~~~~~---------------------------~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 236 IEMVR---------------------------KRQL---LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHH---------------------------cCCc---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 33321 1111 11224578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.63 Aligned_cols=282 Identities=22% Similarity=0.254 Sum_probs=203.9
Q ss_pred EEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEE
Q 008729 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (556)
Q Consensus 26 ~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (556)
.+++.+| ++|.||.+++..+++.||||++............+.+|+.+|+.++|+||+++++++ .+....|++
T Consensus 5 ~i~~~~~--~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~-----~~~~~~~~~ 77 (314)
T cd08216 5 LIGKCFE--DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF-----IVDSELYVV 77 (314)
T ss_pred hhhHhhc--CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhhee-----ecCCeEEEE
Confidence 3444444 445566667778999999999976434455677899999999999999999999998 445668999
Q ss_pred EecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC-
Q 008729 106 FELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP- 181 (556)
Q Consensus 106 ~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~- 181 (556)
|||+. ++|.+++... ..+++..+..+++||+.||+|||++||+||||||+|||++.++.+||+|||.+........
T Consensus 78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~ 157 (314)
T cd08216 78 SPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR 157 (314)
T ss_pred EeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence 99999 6899998763 4689999999999999999999999999999999999999999999999998875432211
Q ss_pred ---CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 182 ---MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 182 ---~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.........++..|+|||++.+....|+.++||||+||++|+|++|..||........+. ....+........ .
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~-~ 234 (314)
T cd08216 158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL--EKVRGTVPCLLDK-S 234 (314)
T ss_pred ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhccCcccccc-C
Confidence 111123345788999999987633468899999999999999999999998765433221 1122211100000 0
Q ss_pred hhHHHHHHHHHhhc--------CCCC-CcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 259 RNEKARKYLTEMRK--------KPPV-PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 259 ~~~~~~~~l~~~~~--------~~~~-~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
... .....+.. .... ........++.++.+|+++||..||++|||++++|+||||+++.
T Consensus 235 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 235 TYP---LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred chh---hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000 00000000 0000 00011123467899999999999999999999999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=325.00 Aligned_cols=251 Identities=26% Similarity=0.395 Sum_probs=203.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++.+.||+|+||.||+|++..+++.||||++... .........+.+|+.+|+.++||||+++++.+ .+.+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSF-----IEDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeE-----EECCe
Confidence 5799999999999999999999999999999988642 22344456788999999999999999999988 44467
Q ss_pred EEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 102 IYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
+|+|+||++ ++|.+++.. ...++++.+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 999999999 589888753 345899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhhCCCChHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV--VHQLDLITDLLGTPSPET 254 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~--~~~~~~i~~~~g~p~~e~ 254 (556)
..... ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..... ......
T Consensus 157 ~~~~~---~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~------------ 219 (267)
T cd08228 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK------------ 219 (267)
T ss_pred cchhH---HHhcCCCCccccChhhhcc--CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH------------
Confidence 33221 1234568899999999877 6788999999999999999999999865432 111111
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
+......+ ......+..+.+|+.+||..||.+||++.++|+
T Consensus 220 ---------------~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 220 ---------------IEQCDYPP--LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred ---------------HhcCCCCC--CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 11111101 011246788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=328.78 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=202.9
Q ss_pred CCeEEEeeeeecCceeEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
..|.+.+.||+|+||.||++.+. .++..||+|.+... .......+.+|+.+|+.++||||+++++++ .
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~ 77 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVC-----V 77 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----e
Confidence 47999999999999999999853 34567999988642 234456788999999999999999999998 4
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAND-------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC 163 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~-------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~ 163 (556)
....+|+||||+. ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 157 (288)
T ss_pred cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 4566899999998 79999997543 489999999999999999999999999999999999999999
Q ss_pred ceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 008729 164 KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDL 242 (556)
Q Consensus 164 ~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~ 242 (556)
.+||+|||+++....... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..
T Consensus 158 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred cEEeccCCccccccCCce-eecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999976432211 111233446778999999877 678999999999999999998 9999987765544433
Q ss_pred HHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 243 i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
+.. .... .....++..+.+|+.+||+.||.+|||+.++++
T Consensus 235 i~~---------------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 235 ITQ---------------------------GRVL---QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHc---------------------------CCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 321 1111 112347789999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=324.27 Aligned_cols=248 Identities=23% Similarity=0.373 Sum_probs=201.9
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|+++++||+|+||.||+|.+. ++..||+|.+... ......+.+|+.+++.++|+||+++++++ .+...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEP 75 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCC
Confidence 458999999999999999999864 5677999987632 22356788999999999999999999998 44566
Q ss_pred EEEEEecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 102 IYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.|+||||+. ++|.+++.. ...++...+..++.||+.||+|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 76 IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 899999997 699999875 35688899999999999999999999999999999999999999999999999976533
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 156 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~------------ 219 (261)
T cd05072 156 NEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR------------ 219 (261)
T ss_pred Ccee--ccCCCccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc------------
Confidence 2211 1123345678999999876 678899999999999999998 9999987665444333211
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... .....++..+.+|+.+||..||++|||++++++
T Consensus 220 ---------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 220 ---------------GYRM---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred ---------------CCCC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1111 122457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=329.12 Aligned_cols=259 Identities=32% Similarity=0.537 Sum_probs=214.9
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
+..+.|++.+.||.|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++|+||+++++.+. ..
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~ 87 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYL-----VG 87 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEE-----EC
Confidence 445679999999999999999999999999999999874322 4567889999999999999999999984 44
Q ss_pred ceEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 100 KDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
..+|+|+||++ ++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 88 DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 67999999999 69999998876 89999999999999999999999999999999999999999999999999886543
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... ......++..|++||.+.+ ..++.++|+||||||+|+|++|+.||.+.+.......+..
T Consensus 168 ~~~~---~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~------------ 230 (286)
T cd06614 168 KEKS---KRNSVVGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT------------ 230 (286)
T ss_pred cchh---hhccccCCcccCCHhHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh------------
Confidence 2211 1123457889999999877 6789999999999999999999999987654433322211
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.. .+.......++..+.+||.+||+.||.+|||+.++|+|+||...
T Consensus 231 ---------------~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 231 ---------------KG-IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred ---------------cC-CCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 01 11111223478899999999999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=322.49 Aligned_cols=245 Identities=22% Similarity=0.374 Sum_probs=195.5
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEec
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~ 108 (556)
+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+|+.++||||+++++++ .....+|+||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~ 74 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQPIYIVMEL 74 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCCCCeEEEEee
Confidence 46999999999999999999999999876432 233456788999999999999999999998 445669999999
Q ss_pred Cc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCccee
Q 008729 109 ME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (556)
Q Consensus 109 ~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (556)
+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......... ...
T Consensus 75 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~ 153 (252)
T cd05084 75 VQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA-STG 153 (252)
T ss_pred ccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccccccc-ccC
Confidence 98 6999999764 46899999999999999999999999999999999999999999999999998754321110 000
Q ss_pred cccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 187 ~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+.......+.
T Consensus 154 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~--------------------- 210 (252)
T cd05084 154 GMKQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE--------------------- 210 (252)
T ss_pred CCCCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH---------------------
Confidence 11123456999999877 678999999999999999998 889997655433222211
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
..... ......+..+.+|+.+||..||++|||+.++++
T Consensus 211 ------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 211 ------QGVRL---PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ------cCCCC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111 112346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=332.73 Aligned_cols=249 Identities=25% Similarity=0.381 Sum_probs=198.9
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcE--EEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEK--VAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~--vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (556)
+.|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.+|..+ +||||+++++++ ...
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~ 80 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR 80 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCC
Confidence 4799999999999999999999888764 577776532 2234456788999999999 899999999998 445
Q ss_pred ceEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC
Q 008729 100 KDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN 162 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~ 162 (556)
..+|+||||+. ++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 67999999998 69999997542 57899999999999999999999999999999999999999
Q ss_pred CceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 008729 163 CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLD 241 (556)
Q Consensus 163 ~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~ 241 (556)
+.+||+|||++......... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+..+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 234 (303)
T cd05088 161 YVAKIADFGLSRGQEVYVKK----TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234 (303)
T ss_pred CcEEeCccccCcccchhhhc----ccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence 99999999998632111100 11224567999999876 578899999999999999998 999998766543332
Q ss_pred HHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 242 ~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.+. ... .......+++.+.+||.+||+.||++||+++++|++
T Consensus 235 ~~~---------------------------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 235 KLP---------------------------QGY---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHh---------------------------cCC---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 221 100 001123467899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=333.27 Aligned_cols=255 Identities=26% Similarity=0.399 Sum_probs=209.5
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
..|...+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++ .+...
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 95 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCY-----LKEHT 95 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEE-----EeCCE
Confidence 458888999999999999999999999999999864322 233445788999999999999999999998 45567
Q ss_pred EEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
.|+||||+.++|.+++.. ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++.....
T Consensus 96 ~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 96 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 999999999999888865 45689999999999999999999999999999999999999999999999998864321
Q ss_pred CCcceecccccCcccCCccccccc-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~-~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.....|+..|+|||++... ...++.++|||||||++|+|++|.+||.+.+....+..+..
T Consensus 174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------------- 234 (313)
T cd06633 174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------- 234 (313)
T ss_pred -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--------------
Confidence 1345688999999987421 14578899999999999999999999987765443332211
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
... + ......++..+.+||.+||+.+|.+||++.++|.||||..
T Consensus 235 ------------~~~--~-~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 235 ------------NDS--P-TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred ------------cCC--C-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 000 0 1112346788999999999999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=317.19 Aligned_cols=251 Identities=29% Similarity=0.514 Sum_probs=209.4
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
.|.+.+.||+|++|.||+|.+..+++.|++|++..... .....+.+|+.+++.++|+||+++++++. .....|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~ 73 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELW 73 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEE
Confidence 48899999999999999999999999999999875322 35667889999999999999999999984 446699
Q ss_pred EEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 104 VVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
+|+||++ ++|.+++... ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 74 l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 74 IVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred EEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 9999999 6999998876 5799999999999999999999999999999999999999999999999999877544322
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
.....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+....+..+..
T Consensus 154 ----~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---------------- 211 (253)
T cd05122 154 ----RNTMVGTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---------------- 211 (253)
T ss_pred ----ccceecCCcccCHHHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----------------
Confidence 134568899999999877 5688999999999999999999999987654333322211
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~ 315 (556)
...+.......++..+.++|.+||..||++|||+.++|+|||
T Consensus 212 ------------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 212 ------------NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ------------cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 001111111224788999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=330.20 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=200.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCc--EEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~--~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (556)
++|++.+.||+|+||.||+|.++.++. .+++|.+.. .........+.+|+.++.++ +||||+++++++ ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~ 75 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENR 75 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccC
Confidence 479999999999999999999887775 468887763 23334556788999999999 799999999998 444
Q ss_pred ceEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC
Q 008729 100 KDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN 162 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~ 162 (556)
..+|+||||+. ++|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.+
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~ 155 (297)
T cd05089 76 GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGEN 155 (297)
T ss_pred CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCC
Confidence 56899999998 79999997542 47889999999999999999999999999999999999999
Q ss_pred CceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 008729 163 CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLD 241 (556)
Q Consensus 163 ~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~ 241 (556)
+.+||+|||++........ ......+..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 156 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 156 LASKIADFGLSRGEEVYVK----KTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred CeEEECCcCCCccccceec----cCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999864221111 011123456999999876 678999999999999999997 999998876544433
Q ss_pred HHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 242 ~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.+. .... ......++..+.+||.+||..||.+|||++++++.
T Consensus 230 ~~~---------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 230 KLP---------------------------QGYR---MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHh---------------------------cCCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 321 1100 11223578899999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=321.11 Aligned_cols=246 Identities=26% Similarity=0.425 Sum_probs=204.5
Q ss_pred eeeeecCceeEEEEEECCC---CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (556)
+.||+|+||.||+|.+... +..||+|.+....... ....+.+|+.+++.++|+||+++++++. ....+|+|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv 74 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLV 74 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEE
Confidence 4799999999999999866 8899999987543332 4677889999999999999999999984 45679999
Q ss_pred EecCc-ccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 106 FELME-SDLHQVIKAN---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 106 ~E~~~-g~L~~~i~~~---------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
|||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||.+..
T Consensus 75 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 75 LEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred EEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccc
Confidence 99996 7999999875 7899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
...... ........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+..
T Consensus 155 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--------- 222 (262)
T cd00192 155 VYDDDY-YRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK--------- 222 (262)
T ss_pred cccccc-cccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------
Confidence 544321 111234557889999999877 578999999999999999999 6999988765444433311
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.. .......++..+.+++.+||..||.+|||+++++++
T Consensus 223 ------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 223 ------------------GY---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ------------------CC---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 11 112234568999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=332.08 Aligned_cols=257 Identities=29% Similarity=0.525 Sum_probs=210.3
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
..|....+||+|+||.||+|.+..+++.||||++.. ........+.+|+.+++.++|+||+++++.+ ......
T Consensus 20 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~ 92 (292)
T cd06657 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDL--RKQQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDEL 92 (292)
T ss_pred HHhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecc--cchhHHHHHHHHHHHHHhcCCcchhheeeEE-----EeCCEE
Confidence 345556789999999999999999999999999853 2233456788999999999999999999998 455679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+||||+. ++|.+++. ...+++..+..++.||+.||+|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 93 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 93 WVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred EEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 99999998 58887765 45689999999999999999999999999999999999999999999999999875433221
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
......|+..|+|||.+.+ ..++.++|+||+||++|+|++|.+||.+......+..+..
T Consensus 172 ---~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~---------------- 230 (292)
T cd06657 172 ---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---------------- 230 (292)
T ss_pred ---cccccccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------------
Confidence 1234568899999999876 6788999999999999999999999987765444333211
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
..+ ........+++.+.+++.+||..||.+||++.++|+||||....
T Consensus 231 -----------~~~-~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 231 -----------NLP-PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred -----------hCC-cccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 000 11112345788999999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=323.46 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=204.3
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCC---CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
.++|++.+.||+|+||.||+|.+..+ ...||||++.... .......+.+|+.+|+.++||||+++++.+ ..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 76 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVV-----TK 76 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEE-----ec
Confidence 35799999999999999999998754 4589999886432 333456788999999999999999999988 44
Q ss_pred CceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
...+|+||||+. ++|.+++..+ +.+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||+++..
T Consensus 77 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 77 SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred CCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 566899999998 5999998764 47899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
....... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||......+....+.+
T Consensus 157 ~~~~~~~-~~~~~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~---------- 223 (266)
T cd05033 157 EDSEATY-TTKGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED---------- 223 (266)
T ss_pred cccccce-eccCCCCCccccChhhhcc--CCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc----------
Confidence 4221111 1112335678999999877 678999999999999999998 9999977665444333321
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
....+ .....+..+.+|+.+||..||++||++++++++
T Consensus 224 -----------------~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 224 -----------------GYRLP---PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -----------------CCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 10111 123568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=365.45 Aligned_cols=256 Identities=26% Similarity=0.375 Sum_probs=202.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|+++++||+|+||.||+|.+..+|+.||||++..... ......++.+|+.+++.++||||+++++++ .+...
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~-----~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSIC-----SDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEE-----eeCCE
Confidence 589999999999999999999999999999999975432 233456789999999999999999999998 45567
Q ss_pred EEEEEecCc-ccHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEee
Q 008729 102 IYVVFELME-SDLHQVIKAN-----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCD 169 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-----------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~D 169 (556)
.|+||||++ ++|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 999999998 5999988641 2345667788999999999999999999999999999999999999999
Q ss_pred eCccccccCCCCC---------------cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC
Q 008729 170 FGLARVAFSDTPM---------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234 (556)
Q Consensus 170 FGla~~~~~~~~~---------------~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~ 234 (556)
||+++........ .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVILyELLTG~~PF~~~ 234 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPYRRK 234 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999765211100 001123579999999999887 67899999999999999999999999775
Q ss_pred ChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 235 ~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
........ .... .+. ....+..+++.+.+++.+||..||++|++..+.|.+
T Consensus 235 ~~~ki~~~--~~i~-------------------------~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 235 KGRKISYR--DVIL-------------------------SPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred chhhhhhh--hhcc-------------------------Chh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 43221110 0000 000 011224678899999999999999999887666654
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=328.76 Aligned_cols=258 Identities=23% Similarity=0.322 Sum_probs=204.3
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCC----------------cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTG----------------EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg----------------~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~ 86 (556)
++|++++.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+++|+.++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 58999999999999999999877644 458999887432 2345667889999999999999999
Q ss_pred eeEEEcCCCCCCCceEEEEEecCc-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 008729 87 IKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND-----------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKP 154 (556)
Q Consensus 87 l~~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~-----------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP 154 (556)
+++++ .....+|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+||||||
T Consensus 84 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp 158 (296)
T cd05051 84 LLGVC-----TVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLAT 158 (296)
T ss_pred EEEEE-----ecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccch
Confidence 99998 34467899999998 69999997765 689999999999999999999999999999999
Q ss_pred CcEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh--CCCCCC
Q 008729 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFP 232 (556)
Q Consensus 155 ~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt--G~~pF~ 232 (556)
+||+++.++.++|+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSSDYY-RVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred hceeecCCCceEEccccceeecccCcce-eecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 9999999999999999998764322211 11223456778999999876 678999999999999999998 678887
Q ss_pred CCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 233 ~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
..+..+.+..+.... ............+.++.++.+|+.+||+.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 236 HLTDQQVIENAGHFF-----------------------RDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CcChHHHHHHHHhcc-----------------------ccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 766544433322110 001111111223456789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=369.06 Aligned_cols=263 Identities=32% Similarity=0.476 Sum_probs=203.6
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCC---------
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP--------- 94 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~--------- 94 (556)
+|+.++.||+||||.||+|+++-+|..||||+|.-.. ......++.||+++|.+|+|||||++|..+...
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 4678899999999999999999999999999998654 556677899999999999999999998855100
Q ss_pred ---------------------------------------------C-------C------------CC------------
Q 008729 95 ---------------------------------------------S-------K------------RE------------ 98 (556)
Q Consensus 95 ---------------------------------------------~-------~------------~~------------ 98 (556)
. . ++
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 0 0 00
Q ss_pred ---------------------C--------ceEEEEEecCcccH-HHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHHCCc
Q 008729 99 ---------------------F--------KDIYVVFELMESDL-HQVIKANDDL-TREHHQFFLYQMLRALKYMHTANV 147 (556)
Q Consensus 99 ---------------------~--------~~lylV~E~~~g~L-~~~i~~~~~l-~~~~~~~i~~QIl~aL~yLHs~gI 147 (556)
. ..+||-||||+.+| .++|..+... ....++.+|+||++||+|+|++||
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence 0 24899999999655 5555544433 478899999999999999999999
Q ss_pred eeccCCCCcEeecCCCceEEeeeCcccccc--------------C-CCCCcceecccccCcccCCcccccccCC-CCCCc
Q 008729 148 YHRDLKPKNILANANCKLKVCDFGLARVAF--------------S-DTPMTVFWTDYVATRWYRAPELCGSFFS-KYTPA 211 (556)
Q Consensus 148 vHrDLKP~NILl~~~~~vKL~DFGla~~~~--------------~-~~~~~~~~~~~~gt~~Y~APE~~~~~~~-~y~~~ 211 (556)
|||||||.||++++++.|||+|||+|.... . ........+..+||--|+|||++.+... .|+.|
T Consensus 719 IHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K 798 (1351)
T KOG1035|consen 719 IHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK 798 (1351)
T ss_pred eeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch
Confidence 999999999999999999999999998721 0 0111223577899999999999987421 69999
Q ss_pred chhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcC-CCCCCCCHHHH
Q 008729 212 IDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLF-QKFPNVDPLAL 290 (556)
Q Consensus 212 ~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~s~~~~ 290 (556)
+||||||+||+||+. ||.. .++....| ..++ ....|.. ..+.+--+...
T Consensus 799 iDmYSLGIVlFEM~y---PF~T--sMERa~iL------------------------~~LR-~g~iP~~~~f~~~~~~~e~ 848 (1351)
T KOG1035|consen 799 IDMYSLGIVLFEMLY---PFGT--SMERASIL------------------------TNLR-KGSIPEPADFFDPEHPEEA 848 (1351)
T ss_pred hhhHHHHHHHHHHhc---cCCc--hHHHHHHH------------------------Hhcc-cCCCCCCcccccccchHHH
Confidence 999999999999984 4643 33433333 3333 2222222 22333445678
Q ss_pred HHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 291 RLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 291 dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
.+|+.||+.||.+||||.|+|++.||-
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 999999999999999999999999986
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=324.45 Aligned_cols=253 Identities=27% Similarity=0.398 Sum_probs=204.0
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCc---EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
..+|++.+.||+|+||.||+|.+..++. .||+|.+.... .......+.+|+.+|+.++||||+++++++ ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~ 76 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TK 76 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----ec
Confidence 4589999999999999999999875554 79999886432 233456788999999999999999999998 44
Q ss_pred CceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
...+|+||||+. ++|.+++... +.++...+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++...
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 77 SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred CCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 567899999998 6999999765 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
..............++..|+|||.+.+ ..++.++|+|||||++|++++ |..||.+.+..+....+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~--------- 225 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG--------- 225 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC---------
Confidence 432211111112223567999999977 678999999999999999886 99999877655444433211
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
...+ ....+++.+.+|+.+||+.+|.+||++.++++
T Consensus 226 ------------------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 226 ------------------YRLP---APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ------------------CcCC---CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 1111 12356889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=347.24 Aligned_cols=258 Identities=24% Similarity=0.403 Sum_probs=226.9
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
...+++..||-|+||.|=++.-......+|+|++++. .-+......+..|-+||..++.|.||++|..| .+.++
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence 4677889999999999999987666666999998753 23345567889999999999999999999999 78889
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|++||-|= |+|+.++..++.+.+..+++++..+++|+.|||++|||+|||||+|++++.+|.+||.|||+|+......
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999886 7999999999999999999999999999999999999999999999999999999999999999876655
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
.. .++|||+.|.|||++.+ .+.+.++|.||||+++||||+|++||.+.+.+...+.|.+.+.
T Consensus 575 KT----wTFcGTpEYVAPEIILn--KGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid------------ 636 (732)
T KOG0614|consen 575 KT----WTFCGTPEYVAPEIILN--KGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID------------ 636 (732)
T ss_pred ce----eeecCCcccccchhhhc--cCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh------------
Confidence 43 56899999999999998 7899999999999999999999999999999998888854221
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHhCccccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGLA 320 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-----a~elL~hp~f~~~~ 320 (556)
.......++..+.+||+++-..+|.+|.. +.+|-.|.||.++.
T Consensus 637 -----------------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 637 -----------------KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred -----------------hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 11122358889999999999999999986 89999999999874
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.19 Aligned_cols=243 Identities=31% Similarity=0.472 Sum_probs=203.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 100 (556)
...|.+...+|.|+||.|..+.+..+++.+++|++.+. .....+|+.++... +||||+++++++ .+..
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~ 389 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGK 389 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeeccee-----cCCc
Confidence 45799999999999999999999999999999999764 12234577665544 799999999999 7778
Q ss_pred eEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee-cCCCceEEeeeCccccccC
Q 008729 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA-NANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl-~~~~~vKL~DFGla~~~~~ 178 (556)
++|+|||++.| .|.+.|.....+. .++..|++||+.||.|||++||+||||||+|||+ +..++++|+|||.++....
T Consensus 390 ~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 390 EIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred eeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 89999999994 7778887766555 7888899999999999999999999999999999 6889999999999986544
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
+ +...+-|..|.|||++.. ..|++++||||||++||+||+|+.||...... ..|...++.+
T Consensus 469 ~------~~tp~~t~~y~APEvl~~--~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~-------- 529 (612)
T KOG0603|consen 469 S------CDTPALTLQYVAPEVLAI--QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMP-------- 529 (612)
T ss_pred h------hcccchhhcccChhhhcc--CCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCC--------
Confidence 3 234467889999999986 89999999999999999999999999766543 1111111111
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
++. ..+|..++|||+.||++||.+|+++.+++.||||
T Consensus 530 ------------------~~s---~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 530 ------------------KFS---ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ------------------ccc---cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 111 4699999999999999999999999999999999
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=323.28 Aligned_cols=249 Identities=21% Similarity=0.318 Sum_probs=200.3
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||+|+||.||.|.+.. +..||+|.+.... .....+.+|+.+++.++||||+++++++ .....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 73 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVC-----TKQRP 73 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEE-----ccCCC
Confidence 3579999999999999999997654 4469999886422 2235688999999999999999999998 34456
Q ss_pred EEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++.....
T Consensus 74 ~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 74 IYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred cEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 899999998 6899999764 46899999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 154 ~~~~--~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~------------- 216 (256)
T cd05113 154 EYTS--SVGSKFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ------------- 216 (256)
T ss_pred ceee--cCCCccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc-------------
Confidence 2111 112335678999999876 578999999999999999998 9999987665444333311
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
..... .....+..+.+++.+||..||.+|||+.+++.+
T Consensus 217 --------------~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 217 --------------GLRLY---RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred --------------CCCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 11111 112357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=328.52 Aligned_cols=253 Identities=25% Similarity=0.428 Sum_probs=203.5
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCC-----cEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (556)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+... ........+.+|+.+++.+ +|+||+++++++
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---- 85 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC---- 85 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC-CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE----
Confidence 358999999999999999999876443 68999988753 2334556788999999999 799999999998
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEe
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKA----------------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL 158 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~----------------~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NIL 158 (556)
.....+|+||||+. ++|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 86 -~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 86 -TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred -cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 44456999999998 699999864 246889999999999999999999999999999999999
Q ss_pred ecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChH
Q 008729 159 ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVV 237 (556)
Q Consensus 159 l~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~ 237 (556)
++.++.+||+|||+++......... ......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+....
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYR-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred EcCCCeEEeCcccccccccccccee-ccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 9999999999999998654322111 1122235567999999876 678999999999999999997 99999887654
Q ss_pred HHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 238 ~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
+....+. ... ........+..+.+|+.+||..||++|||+.+++++
T Consensus 242 ~~~~~~~---------------------------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 242 ELFKLLK---------------------------EGY---RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HHHHHHH---------------------------cCC---cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 4433221 111 011223568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=323.03 Aligned_cols=249 Identities=23% Similarity=0.356 Sum_probs=200.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
..+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|+.+++.++||||+++++++ .....
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 73 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRP 73 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCc
Confidence 346999999999999999999876 467899998864222 234577899999999999999999998 44456
Q ss_pred EEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.|+||||++ ++|.+++..+ +.+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 74 IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred eEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 899999997 6899999764 46899999999999999999999999999999999999999999999999998765332
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |++||.+.+..+....+..
T Consensus 154 ~~~~--~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------------- 216 (256)
T cd05059 154 QYTS--SQGTKFPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA------------- 216 (256)
T ss_pred cccc--cCCCCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc-------------
Confidence 2111 112223457999999877 678999999999999999999 8999987665443333211
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.... ......+..+.+|+.+||..+|++|||+.++++.
T Consensus 217 --------------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 217 --------------GYRL---YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred --------------CCcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 1000 1123478899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=321.46 Aligned_cols=247 Identities=26% Similarity=0.398 Sum_probs=200.9
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++.+.||+|+||.||+|.+. +++.||+|.+.... .....+.+|+.+++.++||||+++++++ ...+.+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 76 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVC-----TLEEPI 76 (261)
T ss_pred hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEE-----ecCCCe
Confidence 57999999999999999999875 45789999986432 2345678999999999999999999988 455668
Q ss_pred EEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 103 YVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999996 79999997654 6899999999999999999999999999999999999999999999999999875422
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+..
T Consensus 157 ~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~------------- 219 (261)
T cd05068 157 IYEA--REGAKFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ------------- 219 (261)
T ss_pred cccc--cCCCcCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-------------
Confidence 1111 111223457999999877 678999999999999999999 9999988765444433311
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... ......+..+.+|+.+||..||.+||++.++++
T Consensus 220 --------------~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 220 --------------GYRM---PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred --------------CCCC---CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 1111 112357789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=331.75 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=209.3
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
..|...+.||+|+||.||+|.+..++..||+|++.... ........+.+|+.+++.++|||++++++++ .+...
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~ 99 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCY-----LREHT 99 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCCe
Confidence 45899999999999999999999999999999986432 2334456788999999999999999999998 44456
Q ss_pred EEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
.|+||||+.|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++......
T Consensus 100 ~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 100 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred EEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 899999999998888764 456899999999999999999999999999999999999999999999999998653221
Q ss_pred CCcceecccccCcccCCccccccc-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~-~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
....|+..|+|||.+... ...++.++|||||||++|+|++|++||.+.+....+..+..
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-------------- 238 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------- 238 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh--------------
Confidence 234588999999987421 14578899999999999999999999977654443333211
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
.... ......+++.+.+||.+||..||.+||++.++++|+|+..
T Consensus 239 ------------~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 239 ------------NESP---TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ------------ccCC---CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0000 0112346788999999999999999999999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=320.36 Aligned_cols=245 Identities=20% Similarity=0.321 Sum_probs=197.5
Q ss_pred eeeeecCceeEEEEEECCCC---cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (556)
++||+|+||.||+|....++ ..||+|.+...... .....+.+|+.+++.++||||+++++++. ...+|+|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v 73 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLV 73 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEE
Confidence 47999999999999876555 78999998754322 45567889999999999999999999873 2357999
Q ss_pred EecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcc
Q 008729 106 FELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (556)
Q Consensus 106 ~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 184 (556)
|||+. ++|.+++..+..+++..+..++.||+.||.|||+.|++|+||||+|||++.++.+||+|||+++..........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 74 MELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred EEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99998 69999999888899999999999999999999999999999999999999999999999999986533222111
Q ss_pred eecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHH
Q 008729 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263 (556)
Q Consensus 185 ~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~ 263 (556)
......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~------------------ 213 (257)
T cd05060 154 ATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES------------------ 213 (257)
T ss_pred cccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc------------------
Confidence 1111223457999999877 678999999999999999998 9999987665443333211
Q ss_pred HHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 264 ~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
... ......++..+.+||.+||..||++||++.++++
T Consensus 214 ---------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 214 ---------GER---LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ---------CCc---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111 1123457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=316.13 Aligned_cols=259 Identities=24% Similarity=0.413 Sum_probs=211.2
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCCceE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~l 102 (556)
..+++..||.|..|+||+++.+.+|...|||.+.+. .+..+.+++++.+.++...+ .|+||+.+++|..+ .++
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n-----~dV 166 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN-----TDV 166 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC-----chH
Confidence 335678899999999999999999999999999864 45567789999999877664 89999999999654 458
Q ss_pred EEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 103 YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 103 ylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|.||.|..-+..+++. .++++|..+-++...++.||.||..+ ||+|||+||+|||+|+.|++||||||.+-......
T Consensus 167 ~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 167 FICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 99999999655555544 46799999999999999999999876 79999999999999999999999999987654433
Q ss_pred CCcceecccccCcccCCccccccc-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhhCCCChHHHHHh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~-~~~y~~~~DIWSlG~ilyelltG~~pF~~~~-~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.. +...|-+.|||||.+.-. ...|+-.+||||||++|+||.||..||.+.+ +.+.+.+|.
T Consensus 247 Ah----trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl-------------- 308 (391)
T KOG0983|consen 247 AH----TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL-------------- 308 (391)
T ss_pred cc----ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH--------------
Confidence 22 455688999999988643 3579999999999999999999999999854 333333332
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
+..+ |....-..+++++.+|+..||.+|+.+||...++|+|||+....
T Consensus 309 -------------n~eP-P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 309 -------------NEEP-PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred -------------hcCC-CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 1122 22222234899999999999999999999999999999998653
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=323.15 Aligned_cols=252 Identities=21% Similarity=0.368 Sum_probs=202.9
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCC-----cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
.++|.+.+.||+|+||.||+|.+...+ ..||+|.+... ........+.+|+.+|+.++||||+++++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~----- 78 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-ASMRERIEFLNEASVMKEFNCHHVVRLLGVV----- 78 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc-cCHHHHHHHHHHHHHHHhCCCCceeEEEEEE-----
Confidence 358999999999999999999986544 78999998643 2334456788999999999999999999998
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCce
Q 008729 97 REFKDIYVVFELME-SDLHQVIKAN----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~----------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~v 165 (556)
......|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+
T Consensus 79 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 79 STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred cCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 44467999999998 7999998653 236788899999999999999999999999999999999999999
Q ss_pred EEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 008729 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244 (556)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~ 244 (556)
||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+.......+.
T Consensus 159 kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 235 (277)
T cd05032 159 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235 (277)
T ss_pred EECCcccchhhccCccc-ccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh
Confidence 99999998764332211 11123446788999999876 678999999999999999998 999998776544333221
Q ss_pred HhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 245 ~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... .......+..+.+||.+||..||++|||+.++++
T Consensus 236 ---------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 236 ---------------------------DGGH---LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred ---------------------------cCCC---CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 1111 1122346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=322.09 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=203.2
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCc---EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
++|+..+.||+|+||.||+|.++.++. .||+|++.... .......+.+|+.+++.++||||+++++++ ...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVV-----TKF 78 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----ccC
Confidence 478999999999999999999887665 79999886432 234456788999999999999999999998 455
Q ss_pred ceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
...|+||||++ ++|.+++..+ +.+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++....
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 66899999999 6999998764 578999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
..............+..|+|||++.+ ..++.++|||||||++|+|++ |+.||...+..+....|...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~---------- 226 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG---------- 226 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcC----------
Confidence 32221111111223457999999876 678999999999999999997 99999877655444443211
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
...+ .....+..+.+|+.+||..||++||++.++++
T Consensus 227 -----------------~~~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 227 -----------------FRLP---APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -----------------CCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1111 11246788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=327.95 Aligned_cols=261 Identities=25% Similarity=0.393 Sum_probs=206.1
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~ 99 (556)
..+.|++.+.||+|+||.||+|.+..+++.||||.+..... ......+.+|+.++..+. ||||+++++++ .+.
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~ 86 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYF-----ITD 86 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheee-----ecC
Confidence 34579999999999999999999999999999999875322 233456777888776665 99999999998 455
Q ss_pred ceEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
..+|+||||+++.|.+++.. ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++....
T Consensus 87 ~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 87 SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 67999999999888887765 4578999999999999999999997 599999999999999999999999999987643
Q ss_pred CCCCCcceecccccCcccCCcccccccC--CCCCCcchhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhhCCCChHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV-VHQLDLITDLLGTPSPET 254 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~~y~~~~DIWSlG~ilyelltG~~pF~~~~~-~~~~~~i~~~~g~p~~e~ 254 (556)
..... ....++..|+|||.+.+.. ..++.++|||||||++|+|++|+.||..... .+.+..+.
T Consensus 167 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---------- 232 (296)
T cd06618 167 DSKAK----TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL---------- 232 (296)
T ss_pred CCCcc----cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHh----------
Confidence 32211 2335788899999986521 3478899999999999999999999965322 11111110
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.. . .+.......++..+.+||.+||..||.+||++++++.|+||...
T Consensus 233 ----------------~~-~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 233 ----------------QE-E-PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred ----------------cC-C-CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 00 0 01111112467899999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=326.82 Aligned_cols=258 Identities=22% Similarity=0.346 Sum_probs=201.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCC--------------cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceee
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTG--------------EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg--------------~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~ 88 (556)
++|++.+.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+++|+.++|+||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 48999999999999999999875432 359999987432 233455788999999999999999999
Q ss_pred EEEcCCCCCCCceEEEEEecCc-ccHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 008729 89 RIMLPPSKREFKDIYVVFELME-SDLHQVIKAND------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPK 155 (556)
Q Consensus 89 ~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~ 155 (556)
+++ .....+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+
T Consensus 84 ~~~-----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 158 (295)
T cd05097 84 GVC-----VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATR 158 (295)
T ss_pred EEE-----cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChh
Confidence 998 44456899999998 69999886532 3678889999999999999999999999999999
Q ss_pred cEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh--CCCCCCC
Q 008729 156 NILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPG 233 (556)
Q Consensus 156 NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt--G~~pF~~ 233 (556)
|||++.++.+||+|||++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||..
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hEEEcCCCcEEecccccccccccCcce-eccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 999999999999999998764322111 11122345678999999876 678999999999999999988 6688887
Q ss_pred CChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 234 ~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.+..+.+..+... +.... ........+..++.+.+|+.+||..||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~--------------------~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEF--------------------FRNQG---RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHh--------------------hhhcc---ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 6655444332211 11110 11111223457889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=328.46 Aligned_cols=257 Identities=26% Similarity=0.397 Sum_probs=208.8
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..+|...+.||+|+||.||+|++..+++.||+|.+... ........++.+|+.+++.++|+|++++++++. ...
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 88 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REH 88 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCC
Confidence 34688999999999999999999999999999998642 223334567889999999999999999999984 445
Q ss_pred eEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
..|+||||+.++|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus 89 ~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 89 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred eeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 6899999999998887754 456899999999999999999999999999999999999999999999999998754321
Q ss_pred CCCcceecccccCcccCCccccccc-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
....|+..|+|||.+.+. ...++.++|||||||++|+|++|..||.+.+.......+..
T Consensus 169 -------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------- 228 (308)
T cd06634 169 -------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ------------- 228 (308)
T ss_pred -------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhh-------------
Confidence 234588999999987531 13578899999999999999999999976543332222110
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.. .+. .....++..+.+||++||..+|++||+++++++|+|+...
T Consensus 229 -------------~~--~~~-~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 229 -------------NE--SPA-LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred -------------cC--CCC-cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 00 011 1123577889999999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=342.99 Aligned_cols=254 Identities=24% Similarity=0.378 Sum_probs=200.2
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCC-----CcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHT-----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPP 94 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~t-----g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~ 94 (556)
..++|++++.||+|+||.||+|.+... +..||||++... ........+.+|+.+|+.+. ||||+++++++
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~--- 110 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGAC--- 110 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE---
Confidence 346899999999999999999987433 357999998643 23344567899999999996 99999999999
Q ss_pred CCCCCceEEEEEecCc-ccHHHHHHhC-----------------------------------------------------
Q 008729 95 SKREFKDIYVVFELME-SDLHQVIKAN----------------------------------------------------- 120 (556)
Q Consensus 95 ~~~~~~~lylV~E~~~-g~L~~~i~~~----------------------------------------------------- 120 (556)
.+...+|||||||. |+|.++|..+
T Consensus 111 --~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 111 --TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred --ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 45567999999998 7999888642
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 008729 121 -------------------------------------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNI 157 (556)
Q Consensus 121 -------------------------------------------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 157 (556)
..+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 2377888899999999999999999999999999999
Q ss_pred eecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCCh
Q 008729 158 LANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236 (556)
Q Consensus 158 Ll~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~ 236 (556)
|++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+...
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~ 345 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNY-VSKGSTFLPVKWMAPESIFD--NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIV 345 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccc-cccCCcCCCcceEChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCcccch
Confidence 9999999999999999865332211 11123456788999999877 678999999999999999997 9999976543
Q ss_pred HHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 237 ~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.+.+.. .+...... .....++..+.+|+.+||..||++|||+.++.+
T Consensus 346 ~~~~~~--------------------------~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 346 DSTFYN--------------------------KIKSGYRM---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred hHHHHH--------------------------HHhcCCCC---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 222111 01111111 122457889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=325.63 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=201.9
Q ss_pred CCeEEEeeeeecCceeEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
.+|.+.+.||+|+||.||+|.+. .++..|++|.+.. ........+.+|+.+++.++|+||+++++++ .
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~ 77 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIVKFYGVC-----G 77 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC--ccHHHHHHHHHHHHHHhcCCCCCcceEEEEE-----c
Confidence 46999999999999999999854 3456799998763 2334446688999999999999999999998 4
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~ 160 (556)
.....++||||+. ++|.+++..++ .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 78 DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 4456899999998 69999997543 378999999999999999999999999999999999999
Q ss_pred CCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHH
Q 008729 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (556)
Q Consensus 161 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~ 239 (556)
.++.+||+|||++........ ........++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||...+..+.
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDY-YRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred cCCcEEECCCCcccccCCCce-eecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999976433221 111234557888999999877 678999999999999999998 9999977665443
Q ss_pred HHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 240 ~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
++.+.. .. ........+..+.+|+.+||..||++|||+.++++
T Consensus 235 ~~~~~~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 235 IECITQ---------------------------GR---VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHhC---------------------------CC---CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 332211 11 11122346788999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=327.08 Aligned_cols=251 Identities=21% Similarity=0.329 Sum_probs=202.2
Q ss_pred CeEEEeeeeecCceeEEEEEECCC-----CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHT-----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~t-----g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
+|++++.||+|+||.||+|.+..+ ++.||||++.... .......+.+|+.++..++||||+++++++ ..
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~ 79 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----TK 79 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cC
Confidence 688999999999999999987643 5789999987432 223345688999999999999999999998 44
Q ss_pred CceEEEEEecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC
Q 008729 99 FKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~ 161 (556)
...+++++||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~ 159 (283)
T cd05091 80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD 159 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence 456899999998 6899888532 34788889999999999999999999999999999999999
Q ss_pred CCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 008729 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQL 240 (556)
Q Consensus 162 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~ 240 (556)
++.+||+|||+++....... ........+++.|+|||.+.+ ..++.++|||||||++|||++ |..||.+....+.+
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 160 KLNVKISDLGLFREVYAADY-YKLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred CCceEecccccccccccchh-eeeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999876432221 111233456788999999876 678999999999999999998 88999887765554
Q ss_pred HHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 241 ~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
+.+.. .... .....++..+.+|+.+||+.||++||++.++++.
T Consensus 237 ~~i~~---------------------------~~~~---~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 237 EMIRN---------------------------RQVL---PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHc---------------------------CCcC---CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 44322 1111 1124578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=323.11 Aligned_cols=247 Identities=25% Similarity=0.390 Sum_probs=204.1
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
..|++++.||.|+||.||+|.+.. +..+|+|++... .......+.+|+.+|+.++||||+++++++ .+...+
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~ 77 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVC-----SVGEPV 77 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeE-----ecCCCe
Confidence 369999999999999999999987 889999998742 233455688999999999999999999998 445568
Q ss_pred EEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 103 YVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||++......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999998 5999999763 46899999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+...
T Consensus 158 ~~~---~~~~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~------------ 220 (261)
T cd05148 158 VYL---SSDKKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG------------ 220 (261)
T ss_pred ccc---ccCCCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhC------------
Confidence 211 123345678999999877 678899999999999999998 89999887755544443210
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
... ......++.+.+++.+||..||.+|||+.++++
T Consensus 221 ---------------~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 221 ---------------YRM---PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred ---------------CcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 000 112457889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=328.68 Aligned_cols=252 Identities=24% Similarity=0.396 Sum_probs=201.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECC-------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~ 94 (556)
++|.+++.||+|+||.||+|.+.. +...||+|.+... ........+.+|+.+++.+ +||||+++++++
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~--- 93 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC--- 93 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-CChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE---
Confidence 589999999999999999998643 2357999998743 2334556788999999999 799999999998
Q ss_pred CCCCCceEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 008729 95 SKREFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNI 157 (556)
Q Consensus 95 ~~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 157 (556)
.....+|+||||+. ++|.+++.... .++...++.++.||+.||+|||+.|++||||||+||
T Consensus 94 --~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 94 --TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred --ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 44456999999998 69999997642 478899999999999999999999999999999999
Q ss_pred eecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCCh
Q 008729 158 LANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236 (556)
Q Consensus 158 Ll~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~ 236 (556)
|++.++.+||+|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+...
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred EEcCCCcEEECCCcccccccccchh-hccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 9999999999999998754321110 00112234568999999877 678999999999999999998 8899987664
Q ss_pred HHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 237 ~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.+....+. .... ......++..+.+||.+||..+|.+|||+.+++++
T Consensus 249 ~~~~~~~~---------------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 249 EELFKLLK---------------------------EGHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHH---------------------------cCCC---CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 33332221 1111 11224578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=317.77 Aligned_cols=253 Identities=30% Similarity=0.464 Sum_probs=203.2
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++.+.||+|+||.||+|.+..+|+.||+|.++.. .........+.+|+.+++.++|+||+++++.+. ....
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence 5799999999999999999999999999999988632 223334667889999999999999999999984 4467
Q ss_pred EEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 102 IYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
.|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 899999998 699988864 345899999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ..+ +
T Consensus 157 ~~~~~~---~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~-~------------- 216 (267)
T cd08224 157 SSKTTA---AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYS-L------------- 216 (267)
T ss_pred cCCCcc---cceecCCccccCHHHhcc--CCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHH-H-------------
Confidence 332211 134568899999999876 67899999999999999999999999654311 000 0
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.+........+. ....++..+.++|.+||..+|++|||+.++++
T Consensus 217 ----------~~~~~~~~~~~~--~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 217 ----------CKKIEKCDYPPL--PADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ----------HhhhhcCCCCCC--ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 111111111111 11256788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=322.52 Aligned_cols=268 Identities=22% Similarity=0.332 Sum_probs=199.8
Q ss_pred CCe-EEEeeeeecCceeEEEEE----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 23 NRY-KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 23 ~~Y-~i~~~LG~G~~g~V~~a~----~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
+|| ++++.||+|+||+||++. ...++..||+|.+.... .......+.+|+.+|+.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~ 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSE---Q 78 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---C
Confidence 466 999999999999998764 34578899999987432 22345677899999999999999999998743 2
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
....+|+||||+. ++|.+++..+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 3356899999999 6899988764 5999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
..............++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... +..+ +.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~---~~~~~~---- 226 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEM---IGPKQG---- 226 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhh---hccccc----
Confidence 432221111122346677999999876 67899999999999999999999998654311 1111 000000
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.......... +...... .....++..+.+|+.+||..||++|||++++++
T Consensus 227 ~~~~~~~~~~---~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 227 QMTVVRLIEL---LERGMRL---PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred ccchhhhhhh---hhcCCCC---CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000001111 1111111 122457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=320.30 Aligned_cols=247 Identities=27% Similarity=0.384 Sum_probs=198.8
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++.++||+|+||.||+|.+..+ ..||+|++..... ....+.+|+.+++.++||||+++++.+. . ..
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-----~-~~ 74 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EP 74 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC-----C-CC
Confidence 35799999999999999999988765 4599999874222 2346789999999999999999998762 1 34
Q ss_pred EEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++....
T Consensus 75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 75 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 799999998 6999999763 3578999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.........+..
T Consensus 155 ~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~------------ 218 (262)
T cd05071 155 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------------ 218 (262)
T ss_pred cccc--cccCCcccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc------------
Confidence 2211 1123346678999998876 678999999999999999999 8899987765444333211
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
....+ ....++..+.+|+.+||+.||++||++.++++
T Consensus 219 ---------------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 219 ---------------GYRMP---CPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred ---------------CCCCC---CccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00111 12357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=320.29 Aligned_cols=253 Identities=26% Similarity=0.406 Sum_probs=203.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCc---EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
.+.|++.+.||+|+||.||+|.++.+++ .||||++.... .......+.+|+.+++.++||||+++++++ .+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~ 76 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TK 76 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CC
Confidence 3579999999999999999999887765 59999987532 344566789999999999999999999998 45
Q ss_pred CceEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
...+|+||||++ ++|.+++.. .+.+++..+..++.|++.||.|||++|++|+||||+|||++.++.+||+|||++...
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 566899999998 589998876 356899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcceeccc--ccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 177 FSDTPMTVFWTDY--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 177 ~~~~~~~~~~~~~--~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
............. ..+..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.+..+....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~------- 227 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQD------- 227 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-------
Confidence 3322211111111 12457999999876 678999999999999999886 99999877654444333211
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
...+ ....++..+.+++.+||..||.+||++++++.
T Consensus 228 --------------------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 228 --------------------YRLP---PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred --------------------CcCC---CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 12356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=321.08 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=201.5
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCc----EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
.++|+++++||+|+||+||+|.+..+++ .||+|++... ........+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~---- 80 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT---- 80 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC----
Confidence 4579999999999999999999877776 4899988643 233445678899999999999999999998843
Q ss_pred CCceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
...++++||+. |+|.+++..+ +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 81 --STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred --CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceee
Confidence 23689999998 7999999764 5689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
....... .......++..|+|||.+.+ ..++.++|||||||++|||++ |.+||...........+.
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---------- 225 (279)
T cd05109 159 LDIDETE-YHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE---------- 225 (279)
T ss_pred cccccce-eecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----------
Confidence 5332211 11122235678999999876 678999999999999999998 999997655433222211
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
..... ......+..+.+++.+||..||++||++.+++.
T Consensus 226 -----------------~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 226 -----------------KGERL---PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred -----------------CCCcC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111 112457889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=318.81 Aligned_cols=248 Identities=27% Similarity=0.411 Sum_probs=201.9
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|.+.+.||+|+||.||+|.+. .+..||||.+.... .....+.+|+.+++.++|+||+++++++ .....
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 75 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVC-----SEEEP 75 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeee-----ecCCc
Confidence 458999999999999999999975 45789999987422 2345688999999999999999999988 44456
Q ss_pred EEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 102 IYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
+|+||||++ ++|.+++.... .++...+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 76 ~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 76 IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 899999998 69999997653 689999999999999999999999999999999999999999999999999876532
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
..... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |+.||.+.+....+..+....
T Consensus 156 ~~~~~--~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~---------- 221 (261)
T cd05034 156 DEYTA--REGAKFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY---------- 221 (261)
T ss_pred hhhhh--hhccCCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 21110 112234567999999887 678999999999999999998 999998877655554432111
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.. ......+..+.+++.+||..||++||+++++++
T Consensus 222 -----------------~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 222 -----------------RM---PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred -----------------CC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 00 112345788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=377.06 Aligned_cols=262 Identities=28% Similarity=0.419 Sum_probs=215.3
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
|+.-...||.|.||.||.|.+..||+..|+|-|.-..........+-+|+++|..|+|||+|++|++-.. ...+|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH-----Rekv~ 1310 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH-----REKVY 1310 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeec-----HHHHH
Confidence 6777889999999999999999999999999876332333445567799999999999999999999743 34589
Q ss_pred EEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC-C
Q 008729 104 VVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT-P 181 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~-~ 181 (556)
|.||||+ |+|.+++...+-..+...+.+..|++.||.|||+.|||||||||.||+++.+|.+|++|||.|....+.. .
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 9999999 7999999877667777778888999999999999999999999999999999999999999998865543 2
Q ss_pred CcceecccccCcccCCcccccccC-CCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~-~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
...-..+++||+-|||||++.+-. .+...++|||||||++.||+||+.||...+..-++ |
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI--M----------------- 1451 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI--M----------------- 1451 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH--H-----------------
Confidence 223346789999999999987632 34668999999999999999999999766543322 1
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
|--.+..+...| ..++++.+|||.+||+.||++|+++.|+|+|-|-+..
T Consensus 1452 -----y~V~~gh~Pq~P-----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1452 -----YHVAAGHKPQIP-----ERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred -----hHHhccCCCCCc-----hhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 111122232222 3599999999999999999999999999999997753
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=316.10 Aligned_cols=243 Identities=26% Similarity=0.437 Sum_probs=201.2
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.+.|++.+.||.|+||.||+|.+. |+.||+|++.... ....++.+|+.+++.++|+||+++++++. +...
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~ 74 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNP 74 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccch---hHHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCC
Confidence 457999999999999999999764 8899999987532 25667889999999999999999999984 3566
Q ss_pred EEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 102 IYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.|+||||+. ++|.+++.... .+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+||+|||+++....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 75 LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 899999999 69999998765 699999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.. ....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+.
T Consensus 155 ~~------~~~~~~~~~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------------- 213 (256)
T cd05039 155 GQ------DSGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE------------- 213 (256)
T ss_pred cc------ccCCCcccccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-------------
Confidence 21 12234567999998876 678899999999999999997 999997765443322221
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... ......+++.+.+||.+||..+|++|||++++++
T Consensus 214 --------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 214 --------------KGYR---MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred --------------cCCC---CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 1000 1122357889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=321.41 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=203.7
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.+|++.+.||+|+||.||+|.+..+++.||||.+... .........+.+|+.+++.++||||+++++++ .....
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-----IEDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhhee-----EeCCe
Confidence 4799999999999999999999999999999987642 22334456788999999999999999999998 44567
Q ss_pred EEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 102 IYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
+|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++...
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 999999998 589988863 456899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
..... ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+..... .. +
T Consensus 157 ~~~~~---~~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~-~------------- 216 (267)
T cd08229 157 SSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YS-L------------- 216 (267)
T ss_pred ccCCc---ccccccCCcCccCHHHhcC--CCccchhhHHHHHHHHHHHHhCCCCcccccchH-HH-H-------------
Confidence 33221 1234568999999999877 678899999999999999999999997643211 00 0
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
...+......+ ......+..+.+||.+||..||.+|||+.++++
T Consensus 217 ----------~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 217 ----------CKKIEQCDYPP--LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ----------hhhhhcCCCCC--CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 01111111111 112347889999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=317.11 Aligned_cols=242 Identities=26% Similarity=0.427 Sum_probs=197.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
.+|++.+.||+|+||.||+|... |..||+|.+... .....+.+|+.+++.++|+||+++++++. .....+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~ 75 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIV----EEKGGL 75 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEE----cCCCce
Confidence 47999999999999999999754 888999988632 23456889999999999999999999763 334568
Q ss_pred EEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 103 YVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
|+||||+. ++|.+++..++ .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999998 69999998654 4789999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
. ....++..|+|||++.+ ..++.++|||||||++|+|++ |++||...+..+....+.
T Consensus 156 ~------~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-------------- 213 (256)
T cd05082 156 Q------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------------- 213 (256)
T ss_pred C------CCCccceeecCHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh--------------
Confidence 2 12234567999999877 678999999999999999997 999998765433322221
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... ......+++.+.+|+.+||..||++|||+.++++
T Consensus 214 -------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 214 -------------KGYK---MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred -------------cCCC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1100 1122457899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=322.57 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=201.3
Q ss_pred CCeEEEeeeeecCceeEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
.+|++.++||+|+||.||+|... .++..||+|.+... .......+.+|+++++.++|+||+++++++ .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~ 77 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVC-----T 77 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEE-----e
Confidence 47899999999999999999743 35678999987642 334556788999999999999999999988 4
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAND---------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~---------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~ 161 (556)
+....|+||||+. ++|.+++...+ .+++..+..++.||+.||+|||+.||+||||||+|||+++
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~ 157 (280)
T cd05092 78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157 (280)
T ss_pred cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcC
Confidence 4456899999998 69999997643 4788999999999999999999999999999999999999
Q ss_pred CCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 008729 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQL 240 (556)
Q Consensus 162 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~ 240 (556)
++.+||+|||+++....... ........+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||......+.+
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 234 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDY-YRVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234 (280)
T ss_pred CCCEEECCCCceeEcCCCce-eecCCCccccccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 99999999999875432211 111123345678999999877 678999999999999999998 99999776654443
Q ss_pred HHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 241 ~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
..+.. ... ......+++.+.+||.+||+.||.+||+++++++
T Consensus 235 ~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 235 ECITQ---------------------------GRE---LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHc---------------------------Ccc---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 33211 111 0122357889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=319.79 Aligned_cols=246 Identities=24% Similarity=0.372 Sum_probs=198.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+++.++|+||+++++++.. ...
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~ 75 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EPI 75 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEECC------CCc
Confidence 47999999999999999999865 566799999874322 23468899999999999999999998721 347
Q ss_pred EEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 103 YVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
|+||||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 99999998 6999999763 35899999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 156 ~~~~--~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~------------- 218 (260)
T cd05070 156 EYTA--RQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER------------- 218 (260)
T ss_pred cccc--ccCCCCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-------------
Confidence 1111 122335667999999876 678999999999999999999 8999988765554443321
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... ......+..+.+|+.+||..||++|||+.++++
T Consensus 219 --------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 219 --------------GYRM---PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred --------------CCCC---CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 1111 112357789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=319.55 Aligned_cols=252 Identities=28% Similarity=0.483 Sum_probs=203.4
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc---CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~---~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
||.+.+.||+|+||.||+|.+..++..+++|+++... ........+.+|+.+++.++||||+++++.+. +..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence 6999999999999999999998888777777765321 12234456778999999999999999999883 445
Q ss_pred eEEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 101 DIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
..|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++. +.+||+|||++..
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~ 154 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRL 154 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceee
Confidence 6899999998 588887753 457899999999999999999999999999999999999975 5699999999876
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
....... .....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+.......+..
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~---------- 219 (260)
T cd08222 155 LMGSCDL---ATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---------- 219 (260)
T ss_pred cCCCccc---ccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc----------
Confidence 5433221 234558889999998876 6788899999999999999999999977654333322210
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
. ........++..+.++|.+||..||++||++.++++||||
T Consensus 220 -----------------~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 220 -----------------G---PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -----------------C---CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 0 0111123577899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=324.21 Aligned_cols=263 Identities=23% Similarity=0.383 Sum_probs=207.4
Q ss_pred CeEEEeeeeecCceeEEEEEEC---CCCcEEEEEEecCcc--CChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCC
Q 008729 24 RYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~---~tg~~vAiK~i~~~~--~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~ 97 (556)
.|++.+.||+|+||.||+|.+. .+++.||||++.+.. ........+.+|+.++..+ +||||+++++++ .
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence 4899999999999999999864 467899999986421 1223445678999999999 599999999988 4
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
....+|+||||+. ++|.+++..+..+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||+++..
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 5567999999998 699999988788999999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
....... .....|+..|+|||.+.+....++.++||||||+++|+|++|..||...........+.
T Consensus 156 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~------------ 221 (288)
T cd05583 156 LAEEEER--AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS------------ 221 (288)
T ss_pred ccccccc--cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHH------------
Confidence 3322111 12346889999999987632347889999999999999999999996443221111110
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC---HHHHHhCccccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT---AEEALADPYFKGLA 320 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt---a~elL~hp~f~~~~ 320 (556)
..+.... ......+++.+.+||.+||+.||++||| +.++|+||||+.+.
T Consensus 222 -----------~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 222 -----------RRILKSK----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred -----------HHHHccC----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 0010110 1122347889999999999999999998 57789999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=326.12 Aligned_cols=251 Identities=25% Similarity=0.409 Sum_probs=200.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECC-------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~ 94 (556)
.+|.+++.||+|+||.||+|.+.. ....||+|.+.... .......+.+|+.+++.+ +||||+++++++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--- 87 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVC--- 87 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEE---
Confidence 589999999999999999998642 34579999887432 234566788999999999 699999999998
Q ss_pred CCCCCceEEEEEecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 008729 95 SKREFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNI 157 (556)
Q Consensus 95 ~~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 157 (556)
.....+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||
T Consensus 88 --~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 88 --TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred --ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 44456899999998 6999999753 3478899999999999999999999999999999999
Q ss_pred eecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCCh
Q 008729 158 LANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236 (556)
Q Consensus 158 Ll~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~ 236 (556)
|++.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+...
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYK-KTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred EEcCCCcEEEcccccccccccccccc-ccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999997643221111 0111224467999999877 678999999999999999999 8999988765
Q ss_pred HHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 237 ~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.+....+.. ... ......++..+.+|+.+||..||++|||+.++++
T Consensus 243 ~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 243 EELFKLLRE---------------------------GHR---MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHHHHc---------------------------CCC---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 444433311 110 1123457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=318.07 Aligned_cols=246 Identities=25% Similarity=0.377 Sum_probs=199.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|+++++||+|+||.||+|.+. +++.||+|.+.... .....+.+|+.+++.++|+||+++++++. ...+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~ 75 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPI 75 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCc
Confidence 47999999999999999999864 57889999987432 23456889999999999999999998862 1348
Q ss_pred EEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 103 YVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
|+||||+. ++|.+++... ..+++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999998 6999998753 36899999999999999999999999999999999999999999999999998765422
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |++||.+.+..+....+..
T Consensus 156 ~~~--~~~~~~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------- 218 (260)
T cd05067 156 EYT--AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER------------- 218 (260)
T ss_pred Ccc--cccCCcccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-------------
Confidence 111 1123345678999999876 678899999999999999999 9999988775544433311
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... ......+..+.+||.+||..||++|||++++++
T Consensus 219 --------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 219 --------------GYRM---PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred --------------CCCC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1111 122346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=315.04 Aligned_cols=245 Identities=31% Similarity=0.488 Sum_probs=205.6
Q ss_pred eeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEecC
Q 008729 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELM 109 (556)
Q Consensus 31 LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~ 109 (556)
||.|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++|+||+++++.+ .....+|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence 699999999999999999999999986432 2223556788999999999999999999988 5667799999999
Q ss_pred c-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcceecc
Q 008729 110 E-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188 (556)
Q Consensus 110 ~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~ 188 (556)
. ++|.+++.....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~ 152 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNT 152 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC---cccC
Confidence 5 79999999888899999999999999999999999999999999999999999999999999977543321 1234
Q ss_pred cccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHH
Q 008729 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLT 268 (556)
Q Consensus 189 ~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~ 268 (556)
..++..|++||.+.+ ..++.++|+|||||++|+|++|..||...+.......+.
T Consensus 153 ~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~------------------------ 206 (250)
T cd05123 153 FCGTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL------------------------ 206 (250)
T ss_pred CcCCccccChHHhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh------------------------
Confidence 568889999999877 567889999999999999999999997766433222221
Q ss_pred HhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH---HHHHhCccc
Q 008729 269 EMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA---EEALADPYF 316 (556)
Q Consensus 269 ~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta---~elL~hp~f 316 (556)
. ........++..+.++|++||..||++|||+ +++++||||
T Consensus 207 ---~----~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 207 ---K----DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ---c----CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 1 0111223458899999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=324.73 Aligned_cols=253 Identities=24% Similarity=0.399 Sum_probs=202.9
Q ss_pred CCCeEEEeeeeecCceeEEEEEEC-------CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDT-------HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~-------~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~ 93 (556)
..+|.+.+.||+|+||.||+|++. .++..||+|++.... .......+.+|+.+++.+ +||||+++++++
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-- 90 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 90 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEE--
Confidence 458999999999999999999753 234579999886432 234556788999999999 799999999998
Q ss_pred CCCCCCceEEEEEecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 008729 94 PSKREFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (556)
Q Consensus 94 ~~~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (556)
.....+|+||||+. ++|.+++... ..++...+..++.||+.||.|||++||+||||||+|
T Consensus 91 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 91 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred ---ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 44567899999998 6999999753 246778899999999999999999999999999999
Q ss_pred EeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCC
Q 008729 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (556)
Q Consensus 157 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~ 235 (556)
||++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred EEEcCCCcEEECCCccceeccccccc-ccccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999765332211 11123345678999999877 678999999999999999998 889998876
Q ss_pred hHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 236 ~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
..+....+.. ... ......++..+.+||.+||..+|.+|||+.++++.
T Consensus 245 ~~~~~~~~~~---------------------------~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 245 VEELFKLLKE---------------------------GHR---MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHc---------------------------CCc---CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 5544433311 111 11224578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=336.36 Aligned_cols=236 Identities=26% Similarity=0.396 Sum_probs=196.3
Q ss_pred EeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEe
Q 008729 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (556)
++-||+|+.|-||+|+.. ++.||||+++.. -..+|+-|++|+||||+.++++| ...-.+|||||
T Consensus 129 LeWlGSGaQGAVF~Grl~--netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiME 192 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLH--NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIME 192 (904)
T ss_pred hhhhccCcccceeeeecc--CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeee-----cCCceeEEeee
Confidence 678999999999999654 789999988631 12478899999999999999999 44455899999
Q ss_pred cCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCccee
Q 008729 108 LME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (556)
Q Consensus 108 ~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (556)
||. |-|.++|++...++......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++....... .
T Consensus 193 fCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ST----k 268 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKST----K 268 (904)
T ss_pred ccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhh----h
Confidence 999 89999999999999999999999999999999999999999999999999999999999999876533211 2
Q ss_pred cccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHH
Q 008729 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (556)
Q Consensus 187 ~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~ 266 (556)
-.++||..|||||++.+ ...+.++|||||||+|||||||..||.+-+.. ..|.- .|+.+
T Consensus 269 MSFaGTVaWMAPEvIrn--ePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AIIwG-VGsNs--------------- 327 (904)
T KOG4721|consen 269 MSFAGTVAWMAPEVIRN--EPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AIIWG-VGSNS--------------- 327 (904)
T ss_pred hhhhhhHhhhCHHHhhc--CCcccccceehhHHHHHHHHhcCCCccccchh---eeEEe-ccCCc---------------
Confidence 46789999999999998 78999999999999999999999999764421 11100 01100
Q ss_pred HHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCc
Q 008729 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (556)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp 314 (556)
-.. .....+++.++=||+.||+-.|..||++.+||.|-
T Consensus 328 -----L~L-----pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 328 -----LHL-----PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred -----ccc-----cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 001 12235788899999999999999999999999993
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=319.42 Aligned_cols=269 Identities=22% Similarity=0.389 Sum_probs=201.9
Q ss_pred CCeEEEeeeeecCceeEEEEE----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~----~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
++|++++.||+|+||.||+|. +..++..||||++... .......+.+|+.+|+.++||||+++++++... +
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---G 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---C
Confidence 479999999999999999997 4567889999998642 334556788999999999999999999987532 2
Q ss_pred CceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
...+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 346899999998 7999999764 46899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
..............++..|+|||.+.+ ..++.++|||||||++|||++|..++...... .... .+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~----~~~~~~~--- 228 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRM----MGNDKQG--- 228 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhh----ccccccc---
Confidence 432221111112234456999999876 67899999999999999999998776443211 1111 1110000
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
........+.+...... .....++..+.+||.+||..||++|||+.++++
T Consensus 229 ---~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 229 ---QMIVYHLIELLKNNGRL---PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred ---ccchHHHHHHHhcCCcC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00001111112111111 123467889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=339.25 Aligned_cols=263 Identities=24% Similarity=0.407 Sum_probs=215.3
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.-|..++.||-|+||.|++++...|...||+|.+.+. ......+..+..|-.||..-+.+-||+||..| .+...
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdn 703 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDN 703 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCc
Confidence 4588999999999999999999999999999988642 23334566788899999999999999999999 67778
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC-
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD- 179 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~- 179 (556)
+|+||+|+. ||+-.+|-..+.|.|..+++++..|.+|+.+.|..|+|||||||+|||||.+|++||+|||||.-+...
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999 699999988999999999999999999999999999999999999999999999999999998432110
Q ss_pred -------CC-------------------------------CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHH
Q 008729 180 -------TP-------------------------------MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221 (556)
Q Consensus 180 -------~~-------------------------------~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~il 221 (556)
.. ..+.....+||+.|+|||++.. .+|+..+|+||.||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--TGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--cCccccchhhHhhHHH
Confidence 00 0011134689999999999988 7999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCC
Q 008729 222 AEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDP 301 (556)
Q Consensus 222 yelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP 301 (556)
|||+.|++||-..+..+...+|.+ ++.+ -......++++++.+||.++ ..++
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~n-----------------w~~~----------l~~~~~~~ls~e~~~li~kL-c~sa 913 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVIN-----------------WRNF----------LHIPYQGNLSKEALDLIQKL-CCSA 913 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeee-----------------hhhc----------cccccccccCHHHHHHHHHH-hcCh
Confidence 999999999977665443322211 1111 11223357999999999995 4588
Q ss_pred CCCCC---HHHHHhCccccccc
Q 008729 302 KDRPT---AEEALADPYFKGLA 320 (556)
Q Consensus 302 ~~Rpt---a~elL~hp~f~~~~ 320 (556)
+.|.. ++++-.||||+++.
T Consensus 914 d~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 914 DSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred hhhhcccchhhhhcCccccccc
Confidence 88974 78899999999874
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=319.37 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=199.4
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCc----EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
.++|++++.||+|+||+||+|.+..+++ .|++|.+... ........+..|+.++..+.||||+++++++.
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~----- 79 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP----- 79 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----
Confidence 3579999999999999999999887776 4677776432 22234456778999999999999999999873
Q ss_pred CCceEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
....++|+||+. |+|.+++.. .+.+++..+..|+.||+.||.|||+.|++||||||+|||++.++.+||+|||+++.
T Consensus 80 -~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 80 -GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred -CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 234689999998 799999976 45789999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
...... ........++..|+|||.+.+ ..++.++|||||||++|||++ |..||.+.......+.+.
T Consensus 159 ~~~~~~-~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~---------- 225 (279)
T cd05111 159 LYPDDK-KYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE---------- 225 (279)
T ss_pred ccCCCc-ccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----------
Confidence 533221 111234457778999999876 678999999999999999998 999998776433322221
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.....+ .....+..+.+++.+||..||++|||+.++++
T Consensus 226 -----------------~~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 226 -----------------KGERLA---QPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred -----------------CCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111111 11235678899999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=314.35 Aligned_cols=246 Identities=23% Similarity=0.339 Sum_probs=199.1
Q ss_pred eeeeecCceeEEEEEECC-CCc--EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTH-TGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~-tg~--~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (556)
+.||+|+||.||+|.+.. .++ .||||.+...... .....+.+|+.+++.++||||+++++++. + ..+|+|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v 73 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMV 73 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEE
Confidence 468999999999999865 333 6999998754333 55678889999999999999999999984 3 678999
Q ss_pred EecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCC
Q 008729 106 FELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (556)
Q Consensus 106 ~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 182 (556)
|||+. ++|.+++..+. .+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++........
T Consensus 74 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~ 153 (257)
T cd05040 74 TELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH 153 (257)
T ss_pred EEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence 99997 79999998764 6899999999999999999999999999999999999999999999999999875432221
Q ss_pred cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
........++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---------------- 215 (257)
T cd05040 154 YVMEEHLKVPFAWCAPESLRT--RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK---------------- 215 (257)
T ss_pred eecccCCCCCceecCHHHhcc--cCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh----------------
Confidence 111123457788999999877 678999999999999999998 9999987765544433311
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
. . .........+..+.+|+.+||..+|++|||+.++++
T Consensus 216 --------~--~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 216 --------E--G---ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred --------c--C---CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 0 0 001112346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=322.02 Aligned_cols=258 Identities=22% Similarity=0.365 Sum_probs=198.6
Q ss_pred CCeEEEeeeeecCceeEEEEEECC----------------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTH----------------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVE 86 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~----------------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~ 86 (556)
++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+|+.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 579999999999999999986432 3457999988643 23344567889999999999999999
Q ss_pred eeEEEcCCCCCCCceEEEEEecCc-ccHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 008729 87 IKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND-----------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKP 154 (556)
Q Consensus 87 l~~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~-----------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP 154 (556)
+++++. ....+|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.||+||||||
T Consensus 84 ~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp 158 (296)
T cd05095 84 LLAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLAT 158 (296)
T ss_pred EEEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCCh
Confidence 999983 4456899999998 69999987643 366778999999999999999999999999999
Q ss_pred CcEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh--CCCCCC
Q 008729 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFP 232 (556)
Q Consensus 155 ~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt--G~~pF~ 232 (556)
+|||++.++.++|+|||+++......... ......++..|++||...+ ..++.++|||||||++|+|++ |..||.
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCccee-ccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 99999999999999999987643322111 1122334678999998766 578999999999999999998 778887
Q ss_pred CCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 233 ~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
..+..+.+.... .++....... .......+++.+.+|+.+||..||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~--------------------~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 236 QLSDEQVIENTG--------------------EFFRDQGRQV---YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccChHHHHHHHH--------------------HHHhhccccc---cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 765544332211 0111110111 11122456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=322.75 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=201.1
Q ss_pred CCeEEEeeeeecCceeEEEEEE-----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~ 96 (556)
++|.+.+.||+|+||.||+|.+ ..++..||+|++.... .......+.+|+.+++.+ +||||+++++.+
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----- 108 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGAC----- 108 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEE-----
Confidence 4799999999999999999975 3355689999887432 234456788999999999 799999999998
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla 173 (556)
.....+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 44456999999998 79999997643 3899999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
+........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+..+
T Consensus 189 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~--------- 256 (302)
T cd05055 189 RDIMNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL--------- 256 (302)
T ss_pred ccccCCCce-eecCCCCcccccCCHhhhcc--CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH---------
Confidence 765332211 11122346788999999876 678999999999999999998 99999776543322111
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
+. ..... ......++.+.+|+.+||..||++|||+.++++
T Consensus 257 --------------~~---~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 257 --------------IK---EGYRM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred --------------HH---cCCcC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 00 00000 112346889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=314.85 Aligned_cols=246 Identities=26% Similarity=0.352 Sum_probs=198.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++.+.||+|+||.||+|.+..+ ..||+|++.... .....+.+|+.+++.++|+||+++++++. ....
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~ 75 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPI 75 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCc
Confidence 5799999999999999999987655 469999876422 22356788999999999999999998872 1347
Q ss_pred EEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 103 YVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++.....
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 99999998 5999999764 34789999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+....+....+..
T Consensus 156 ~~~--~~~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~------------- 218 (260)
T cd05069 156 EYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER------------- 218 (260)
T ss_pred ccc--ccCCCccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------------
Confidence 111 1122346678999998876 678899999999999999999 9999988765444433211
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... ......+..+.+|+++||..||++||+++++++
T Consensus 219 --------------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 219 --------------GYRM---PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred --------------CCCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1111 112357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=331.05 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=198.8
Q ss_pred CCCeEEEeeeeecCceeEEEEEE-----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (556)
.++|++++.||+|+||+||+|.+ ..+++.||||++.... .......+.+|+.+|..+ +||||+++++++.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~--- 81 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT--- 81 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceee---
Confidence 35899999999999999999984 3567899999987432 233456788999999999 6899999999874
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHhC------------------------------------------------------
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKAN------------------------------------------------------ 120 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------------------------------------ 120 (556)
.....+|+|||||+ |+|.+++...
T Consensus 82 -~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 82 -KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred -cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 23346899999999 6999988643
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcceec
Q 008729 121 -------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187 (556)
Q Consensus 121 -------------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 187 (556)
..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~-~~~ 239 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV-RKG 239 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh-hcC
Confidence 136777888999999999999999999999999999999999999999999997643221111 112
Q ss_pred ccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHH
Q 008729 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (556)
Q Consensus 188 ~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~ 266 (556)
...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+...
T Consensus 240 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----------------------- 294 (343)
T cd05103 240 DARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR----------------------- 294 (343)
T ss_pred CCCCCcceECcHHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH-----------------------
Confidence 2335677999999876 678999999999999999997 99999775432221111
Q ss_pred HHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
+...... ......++.+.+++.+||..||++|||+.++++|
T Consensus 295 ---~~~~~~~---~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 295 ---LKEGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ---HhccCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1111110 1112367889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=318.98 Aligned_cols=248 Identities=28% Similarity=0.453 Sum_probs=197.3
Q ss_pred EEEeeeeecCceeEEEEEEC----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 26 KILEVIGKGSYGVVCAAIDT----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 26 ~i~~~LG~G~~g~V~~a~~~----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++.+.||.|.||.||+|... ..+..|+||.++. .........+.+|+++|+.++||||+++++++. ....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEP 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccc-----cccc
Confidence 57889999999999999987 4567899999964 234455788999999999999999999999995 3344
Q ss_pred EEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
+++|+|||. |+|.+++... ..+++.....|+.||+.||.|||+++|+|+||+++|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999998 7999999987 6899999999999999999999999999999999999999999999999999987632
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... .......+...|+|||.+.+ ..++.++||||||+++|||++ |+.||.+.+..+....+.+
T Consensus 156 ~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~------------ 220 (259)
T PF07714_consen 156 KSKY-KNDSSQQLPLRYLAPEVLKD--GEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQ------------ 220 (259)
T ss_dssp SSSE-EESTTSESGGGGS-HHHHHH--SEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHT------------
T ss_pred cccc-cccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccc------------
Confidence 2111 11233446778999999877 568999999999999999999 7899988776554444321
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
... ......++..+.+||.+||..||++|||++++++
T Consensus 221 ---------------~~~---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 221 ---------------GQR---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ---------------TEE---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ---------------ccc---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111 1122357889999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=321.47 Aligned_cols=250 Identities=22% Similarity=0.380 Sum_probs=198.6
Q ss_pred CeEEEeeeeecCceeEEEEEECC-----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
+|++.+.||+|+||.||+|.+.. ....+|+|.+... ........+.+|+.+|+.++||||+++++.+ ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-ASSSELRDLLSEFNLLKQVNHPHVIKLYGAC-----SQ 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ec
Confidence 48899999999999999998753 2357888887643 2234456788999999999999999999998 44
Q ss_pred CceEEEEEecCc-ccHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 008729 99 FKDIYVVFELME-SDLHQVIKAN------------------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLK 153 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~------------------------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLK 153 (556)
....|+|+||+. ++|.+++... ..+++..+..++.||+.||.|||++||+|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 456899999999 7999988642 247888999999999999999999999999999
Q ss_pred CCcEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCC
Q 008729 154 PKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFP 232 (556)
Q Consensus 154 P~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~ 232 (556)
|+|||+++++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.
T Consensus 155 p~nill~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 155 ARNVLVAEGRKMKISDFGLSRDVYEEDSYV-KRSKGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred hheEEEcCCCcEEeccccccccccCccchh-cccCCCCCccccCHHHHcc--CCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 999999999999999999997643222110 0122345678999998876 678999999999999999998 999998
Q ss_pred CCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 233 ~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
+.......+.+. ..... .....++..+.+|+.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~---------------------------~~~~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 232 GIAPERLFNLLK---------------------------TGYRM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCCHHHHHHHHh---------------------------CCCCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 776443332221 00000 112357889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=319.74 Aligned_cols=251 Identities=22% Similarity=0.333 Sum_probs=200.2
Q ss_pred CCeEEEeeeeecCceeEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
++|++++.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++ .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~-----~ 78 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVC-----A 78 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEE-----c
Confidence 47999999999999999999875 367899999987432 233445688999999999999999999998 4
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAND----------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKP 154 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~----------------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP 154 (556)
+...+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++|++||||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 4556899999999 69999997432 367888999999999999999999999999999
Q ss_pred CcEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCC
Q 008729 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233 (556)
Q Consensus 155 ~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~ 233 (556)
+|||++.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYK-ASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred hheEecCCCceEECccccceecccCcccc-ccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999987543222110 0122234567999999877 678999999999999999998 8889977
Q ss_pred CChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 234 ~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.+..+....+. ..... ......+..+.+||.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~---------------------------~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 MAHEEVIYYVR---------------------------DGNVL---SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCHHHHHHHHh---------------------------cCCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 66544332221 11111 112357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=321.34 Aligned_cols=265 Identities=16% Similarity=0.190 Sum_probs=196.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCC---CcEEEEEEecCccCChhH---------HHHHHHHHHHHHhCCCCCcceeeE
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISD---------AIRILREVKLLRLLRHPDIVEIKR 89 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~t---g~~vAiK~i~~~~~~~~~---------~~~~~rEi~iL~~L~HpnIv~l~~ 89 (556)
.++|++.+.||+|+||+||+|.+..+ +..+|+|+.......... ......++..+..+.|++|+.+++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999998877 667788764321111100 011233445566778999999998
Q ss_pred EEcCCCCCCCceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEee
Q 008729 90 IMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCD 169 (556)
Q Consensus 90 v~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~D 169 (556)
+..... ......|+++|++..++.+.+......++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|
T Consensus 91 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~D 169 (294)
T PHA02882 91 CGSFKR-CRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIID 169 (294)
T ss_pred eeeEec-CCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEE
Confidence 764322 1223468899998888888887666678899999999999999999999999999999999999999999999
Q ss_pred eCccccccCCCCCc----ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 008729 170 FGLARVAFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245 (556)
Q Consensus 170 FGla~~~~~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~ 245 (556)
||+|+......... .......||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+......+....
T Consensus 170 FGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~- 246 (294)
T PHA02882 170 YGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA- 246 (294)
T ss_pred cCCceeeccCCcccccccccccccCCCccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh-
Confidence 99998653222110 11123469999999999987 689999999999999999999999998764322211110
Q ss_pred hhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 246 ~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
...++..+..... ..+..++.+.++++.|+..+|++||+.+++++
T Consensus 247 -----------------~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 -----------------KCDFIKRLHEGKI-----KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred -----------------HHHHHHHhhhhhh-----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0111122211111 22456889999999999999999999999975
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=327.22 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=201.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCC-------CcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHT-------GEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~t-------g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~ 94 (556)
.+|++++.||+|+||.||+|.+... +..||+|.+... ........+.+|+.+++.+ +||||+++++++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--- 87 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC--- 87 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE---
Confidence 4799999999999999999986432 236899987643 2334566788999999999 799999999998
Q ss_pred CCCCCceEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 008729 95 SKREFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNI 157 (556)
Q Consensus 95 ~~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 157 (556)
.....+|+||||+. ++|.+++.... .++...+..++.||+.||.|||++||+||||||+||
T Consensus 88 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 165 (334)
T cd05100 88 --TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNV 165 (334)
T ss_pred --ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceE
Confidence 44456999999998 69999997532 367788899999999999999999999999999999
Q ss_pred eecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCCh
Q 008729 158 LANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236 (556)
Q Consensus 158 Ll~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~ 236 (556)
|++.++.+||+|||+++........ .......++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEcCCCcEEECCcccceeccccccc-ccccCCCcCceEcCHHHhcc--CCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 9999999999999999764332111 11122334567999999977 678999999999999999998 8899988765
Q ss_pred HHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 237 ~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.+....+.. ... .......+..+.+|+.+||..+|.+|||+.+++++
T Consensus 243 ~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 243 EELFKLLKE---------------------------GHR---MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHc---------------------------CCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 444433211 111 11224567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=320.52 Aligned_cols=270 Identities=23% Similarity=0.375 Sum_probs=204.2
Q ss_pred CCeEEEeeeeecCceeEEEEEE----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAID----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~----~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
.-|++++.||+|+||.||+|.. ..++..||+|.+... ........+.+|+.+|+.++||||+++++++... +
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~ 79 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHENIVKYKGICTED---G 79 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---C
Confidence 3579999999999999999974 467889999998643 2334456788999999999999999999988532 2
Q ss_pred CceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
...+|+||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccc
Confidence 356899999997 6999999764 35899999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
..............++..|+|||.+.+ ..++.++|||||||++|+|++++.|+..... .+.+..+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~ellt~~~~~~~~~~-----~~~~~~~~~~~~~~- 231 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASDVWSFGVTLYELLTYCDSESSPMT-----LFLKMIGPTHGQMT- 231 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhcc--CCCCccccchhhhhhhhhhhcCCCCCccccc-----hhhhhccccccccc-
Confidence 433222122234557778999999877 6789999999999999999998876533211 11111111111100
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.......+...... .....++..+.+|+.+||+.||++|||+++++++
T Consensus 232 ------~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 232 ------VTRLVRVLEEGKRL---PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ------HHHHHHHHHcCccC---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00111112221111 2234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=313.51 Aligned_cols=244 Identities=21% Similarity=0.328 Sum_probs=193.5
Q ss_pred eeeecCceeEEEEEEC--CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEe
Q 008729 30 VIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (556)
Q Consensus 30 ~LG~G~~g~V~~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (556)
.||+|+||.||+|.+. .++..||+|++... ........+.+|+.+|+.++||||+++++++. ....|+|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e 74 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVME 74 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEE
Confidence 3899999999999765 44567999988643 22334567889999999999999999999873 235799999
Q ss_pred cCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce
Q 008729 108 LME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF 185 (556)
Q Consensus 108 ~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~ 185 (556)
|++ ++|.+++.. ...+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++............
T Consensus 75 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 75 MASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred eCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 998 699999875 457899999999999999999999999999999999999999999999999999754332221111
Q ss_pred ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHH
Q 008729 186 WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (556)
Q Consensus 186 ~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~ 264 (556)
.....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus 155 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------------------- 212 (257)
T cd05115 155 RSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-------------------- 212 (257)
T ss_pred cCCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH--------------------
Confidence 112223568999999876 678999999999999999996 999998776544333221
Q ss_pred HHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 265 ~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
..... ...+..++++.+||.+||..||++||++.++++
T Consensus 213 -------~~~~~---~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 213 -------QGKRL---DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred -------CCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111 122457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=313.12 Aligned_cols=249 Identities=27% Similarity=0.410 Sum_probs=200.5
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
..+|++.+.||+|+||.||+|.+. .+..+|+|++..... ....+.+|+++++.++||||+++++++ .....
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~ 73 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSP 73 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCc
Confidence 457999999999999999999875 467899998864322 234678899999999999999999998 44556
Q ss_pred EEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.|+||||+. ++|.+++... +.++++.+..++.||+.||+|||+.|++|+||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 74 ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred eEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 899999998 6899988764 46899999999999999999999999999999999999999999999999998764332
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||........+..+.+
T Consensus 154 ~~~~--~~~~~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------------- 216 (256)
T cd05112 154 QYTS--STGTKFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA------------- 216 (256)
T ss_pred cccc--cCCCccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC-------------
Confidence 1111 122335568999999876 678899999999999999998 9999987665444433211
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
... . ......+..+.+|+.+||..+|++|||+.+++++
T Consensus 217 --------------~~~-~--~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 217 --------------GFR-L--YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred --------------CCC-C--CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 000 0 0112357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=315.82 Aligned_cols=253 Identities=19% Similarity=0.327 Sum_probs=203.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEECC----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTH----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
.++|++.+.||+|+||.||+|.+.. ++..|++|++... ........+.+|+.+|+.++||||+++++++..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~---- 79 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIE---- 79 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----
Confidence 4689999999999999999999876 3578999987643 344556778899999999999999999998743
Q ss_pred CCceEEEEEecCc-ccHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEe
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAN--------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~--------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~ 168 (556)
.....++++||+. ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence 2345799999998 7999998653 458999999999999999999999999999999999999999999999
Q ss_pred eeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhh
Q 008729 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247 (556)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~ 247 (556)
|||+++........ .......++..|+|||.+.+ ..++.++|||||||++|++++ |++||...+..+....+.
T Consensus 160 d~g~~~~~~~~~~~-~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~--- 233 (280)
T cd05043 160 DNALSRDLFPMDYH-CLGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK--- 233 (280)
T ss_pred CCCCcccccCCceE-EeCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH---
Confidence 99999764332211 11122346678999999877 678999999999999999999 999998765433222211
Q ss_pred CCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
..... .....+++.+.+++.+||..||++|||+.++++
T Consensus 234 ------------------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 234 ------------------------DGYRL---AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred ------------------------cCCCC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11111 112346789999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=315.88 Aligned_cols=242 Identities=25% Similarity=0.378 Sum_probs=192.2
Q ss_pred eeeeecCceeEEEEEECCCCc--EEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCceEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYVV 105 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~--~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lylV 105 (556)
+.||+|+||.||+|.+..++. .+|+|.+... ........+.+|+.++..+ +||||+++++++ .....+|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~~~~~~~lv 74 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLA 74 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-----ecCCCceEE
Confidence 468999999999999988876 4688887632 2234456788999999999 799999999998 444568999
Q ss_pred EecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEe
Q 008729 106 FELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (556)
Q Consensus 106 ~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~ 168 (556)
|||+. ++|.+++..+. .+++..+..++.||+.||+|||+.|++||||||+|||++.++.+||+
T Consensus 75 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 75 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred EEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence 99998 79999997543 47889999999999999999999999999999999999999999999
Q ss_pred eeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhh
Q 008729 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247 (556)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~ 247 (556)
|||++........ ......+..|+|||++.. ..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 155 dfgl~~~~~~~~~----~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~---- 224 (270)
T cd05047 155 DFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---- 224 (270)
T ss_pred CCCCccccchhhh----ccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH----
Confidence 9999863211110 111223567999999876 678999999999999999997 99999776543333222
Q ss_pred CCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
..... ......++..+.+|+.+||..||.+|||++++++
T Consensus 225 -----------------------~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 225 -----------------------PQGYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -----------------------hCCCC---CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 11101 1122347789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=313.23 Aligned_cols=250 Identities=25% Similarity=0.410 Sum_probs=201.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCC---CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
++|.+.+.||+|+||.||+|.+... ...||||.+... ........+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------ 78 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------ 78 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc-CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------
Confidence 4699999999999999999987654 346899987643 223455678899999999999999999998742
Q ss_pred ceEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 100 KDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
...|+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.|++||||||+|||++.++.+||+|||+++...
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 33689999998 79999998744 58999999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
..... ..+...++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 159 ~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~----------- 223 (270)
T cd05056 159 DESYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN----------- 223 (270)
T ss_pred cccce--ecCCCCccccccChhhhcc--CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-----------
Confidence 33111 1122334567999999876 678999999999999999996 9999988775544433211
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.... ...+.++..+.+|+.+||..+|.+|||+.+++..
T Consensus 224 ----------------~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 224 ----------------GERL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred ----------------CCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1111 1234678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=315.63 Aligned_cols=252 Identities=23% Similarity=0.372 Sum_probs=202.2
Q ss_pred CCeEEEeeeeecCceeEEEEEECC-----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
++|++++.||+|+||.||+|+.+. +.+.|++|.+... ........+.+|+.+|+.++|+||+++++++ .
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 78 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----R 78 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----C
Confidence 479999999999999999999754 3467999987642 2223456788999999999999999999988 4
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEE
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAND---------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~---------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL 167 (556)
+....|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 79 EAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred CCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE
Confidence 4556899999998 79999998765 6899999999999999999999999999999999999999999999
Q ss_pred eeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHh
Q 008729 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDL 246 (556)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~ 246 (556)
+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+......+..+.
T Consensus 159 ~~~~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~-- 232 (275)
T cd05046 159 SLLSLSKDVYNSEY--YKLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQ-- 232 (275)
T ss_pred cccccccccCcccc--cccCCceeEEeecChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHH--
Confidence 99999875432211 11233456778999998876 567899999999999999998 788997655433222211
Q ss_pred hCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 247 ~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
... . .......++..+.+++.+||..||.+|||+.+++++
T Consensus 233 -------------------------~~~-~-~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 233 -------------------------AGK-L-ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred -------------------------cCC-c-CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 000 0 011223578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=310.33 Aligned_cols=248 Identities=29% Similarity=0.475 Sum_probs=202.5
Q ss_pred eEEEeeeeecCceeEEEEEECCCC----cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTG----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg----~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
+++.+.||.|+||.||+|.+..++ ..||+|++... ........+.+|+.+|+.++|+||+++++++. +.+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED-ADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEE 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC-CChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCC
Confidence 357889999999999999998776 89999998643 22225667889999999999999999999984 446
Q ss_pred eEEEEEecCc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 101 DIYVVFELME-SDLHQVIKANDD--LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~--l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
..|+||||+. ++|.+++..... +++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence 7999999998 699999976554 9999999999999999999999999999999999999999999999999997654
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
....... ....++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+.......+.
T Consensus 155 ~~~~~~~--~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~------------ 218 (258)
T smart00219 155 DDDYYKK--KGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK------------ 218 (258)
T ss_pred ccccccc--ccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh------------
Confidence 3311110 11236788999999866 678999999999999999998 889998766544433321
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
..... ......+..+.+++.+||..||++|||+.++++
T Consensus 219 ---------------~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 219 ---------------KGYRL---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ---------------cCCCC---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 11111 112347889999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=310.68 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=199.2
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++.+.||+|+||.||+|.+. .+..||+|.+... ......+.+|+.+++.++|+||+++++++. . ..
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~ 74 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EP 74 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CC
Confidence 468999999999999999999754 4567999987632 234457889999999999999999999883 2 45
Q ss_pred EEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.|+||||+. ++|.+++... ..++...+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus 75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 75 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 899999998 6999999763 3578889999999999999999999999999999999999999999999999876432
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... ......++..|+|||++.+ ..++.++|+|||||++|+|++ |++||.+.+..+....+..
T Consensus 155 ~~~~--~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~------------ 218 (260)
T cd05073 155 NEYT--AREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER------------ 218 (260)
T ss_pred CCcc--cccCCcccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC------------
Confidence 2111 1122345677999999876 678999999999999999999 9999988765444333211
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
... .......+..+.+++.+||..||++||++.++++
T Consensus 219 ---------------~~~---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 219 ---------------GYR---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ---------------CCC---CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 101 1122457889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=314.49 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=202.4
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCc----EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
..+|++++.||+|+||.||+|.++.+|+ .||+|.+... ........+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---- 80 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE-TSPKANKEILDEAYVMASVDHPHVVRLLGICLS---- 80 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 4689999999999999999999877765 5899987643 223455678899999999999999999999853
Q ss_pred CCceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
...|+||||+. |+|.+++..+ ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 81 --~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 81 --SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred --CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 45899999998 7999998764 4689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
........ ......++..|+|||.+.. ..++.++|||||||++|+|++ |+.||.+....+....+.
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---------- 225 (279)
T cd05057 159 LDVDEKEY-HAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE---------- 225 (279)
T ss_pred ccCcccce-ecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh----------
Confidence 54222111 1112223567999998876 678899999999999999998 999998876544333221
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
..... ......+..+.+++.+||..||++|||+.++++
T Consensus 226 -----------------~~~~~---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 226 -----------------KGERL---PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -----------------CCCCC---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11111 112346788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.71 Aligned_cols=281 Identities=21% Similarity=0.248 Sum_probs=185.5
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCC----CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC-
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHT----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS- 95 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~t----g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~- 95 (556)
..++|++.+.||+|+||.||+|.+..+ +..||||++...... .....| .++...+.++..+...+....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 456899999999999999999999998 999999988642211 111111 122222333333333322211
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHhCCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKANDD--------------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKP 154 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~--------------------l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP 154 (556)
......+|||+||++ ++|.+++..... .....+..++.||+.||.|||+.||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 145567999999999 689998875421 12345678999999999999999999999999
Q ss_pred CcEeecC-CCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccC--------------------CCCCCcch
Q 008729 155 KNILANA-NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF--------------------SKYTPAID 213 (556)
Q Consensus 155 ~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--------------------~~y~~~~D 213 (556)
+|||++. ++.+||+|||+|+....... .....+++++.|+|||.+.... ..++.++|
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~--~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGIN--YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccc--cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 9999986 57899999999975432211 1224577999999999653210 12445679
Q ss_pred hhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHH
Q 008729 214 IWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLL 293 (556)
Q Consensus 214 IWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl 293 (556)
|||||||||||+++..++ .+...++..+....+...... +..+...........++.....+..+.|||
T Consensus 362 VwSlGviL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi 430 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAW---------RKLVEPRASPDLRRGFEVLDLDGGAGWELL 430 (566)
T ss_pred cHHHHHHHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHH---------HHhhccccchhhhhhhhhccccchHHHHHH
Confidence 999999999999866543 343444444333322221110 111000000000000111222345677999
Q ss_pred HHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 294 QRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 294 ~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
++||++||++|||+.++|+||||++..
T Consensus 431 ~~mL~~dP~kR~ta~e~L~Hpff~~~~ 457 (566)
T PLN03225 431 KSMMRFKGRQRISAKAALAHPYFDREG 457 (566)
T ss_pred HHHccCCcccCCCHHHHhCCcCcCCCC
Confidence 999999999999999999999998753
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=308.24 Aligned_cols=244 Identities=25% Similarity=0.421 Sum_probs=195.0
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEec
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~ 108 (556)
++||+|+||.||+|.+. ++..||+|++..... ......+.+|+.+++.++||||+++++++ ......|+||||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~lv~e~ 73 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVC-----TQRQPIYIVMEL 73 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEE-----ecCCccEEEEEC
Confidence 47999999999999864 688999999875432 23345688999999999999999999998 444568999999
Q ss_pred Cc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCccee
Q 008729 109 ME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (556)
Q Consensus 109 ~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (556)
+. ++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......... .
T Consensus 74 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~--~ 151 (250)
T cd05085 74 VPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS--S 151 (250)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc--C
Confidence 98 6999988753 468999999999999999999999999999999999999999999999999987532221110 0
Q ss_pred cccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 187 ~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.+.........+.
T Consensus 152 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~--------------------- 208 (250)
T cd05085 152 GLKQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE--------------------- 208 (250)
T ss_pred CCCCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH---------------------
Confidence 11234567999999876 678899999999999999998 999998776443332221
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.... ......++..+.+|+.+||..||++||++.++++.
T Consensus 209 ------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 247 (250)
T cd05085 209 ------KGYR---MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKE 247 (250)
T ss_pred ------cCCC---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 1101 11234578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=310.45 Aligned_cols=244 Identities=26% Similarity=0.403 Sum_probs=195.9
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEec
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFEL 108 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~ 108 (556)
++||.|+||.||+|.+.. ++.||+|++...... .....+.+|+++++.++|+||+++++++ .+....|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v~e~ 73 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVC-----VQKQPIYIVMEL 73 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEE-----ecCCCeEEEEEc
Confidence 479999999999999887 999999988754322 3556788999999999999999999998 445668999999
Q ss_pred Cc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCccee
Q 008729 109 ME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186 (556)
Q Consensus 109 ~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~ 186 (556)
+. ++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.......... ..
T Consensus 74 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~ 152 (251)
T cd05041 74 VPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV-SD 152 (251)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCccee-cc
Confidence 97 689999865 4568999999999999999999999999999999999999999999999999987543211100 00
Q ss_pred cccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHH
Q 008729 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265 (556)
Q Consensus 187 ~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~ 265 (556)
....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+.........+..
T Consensus 153 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-------------------- 210 (251)
T cd05041 153 GLKQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-------------------- 210 (251)
T ss_pred ccCcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc--------------------
Confidence 11223566999999876 678999999999999999999 8899987764433332211
Q ss_pred HHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 266 ~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... .....++..+.+|+.+||..+|++|||++++|+
T Consensus 211 -------~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 211 -------GYRM---PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -------CCCC---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0000 112346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=312.23 Aligned_cols=251 Identities=24% Similarity=0.317 Sum_probs=189.4
Q ss_pred eeeeecCceeEEEEEECC--CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTH--TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (556)
+.||+|+||.||+|.... ....+|+|.+... ........+.+|+.+++.++|+||+++++.+ .....+|+||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~-----~~~~~~~lv~ 74 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQC-----IESIPYLLVL 74 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEE-----CCCCceEEEE
Confidence 369999999999996432 4457888877542 2333455678999999999999999999998 4445689999
Q ss_pred ecCc-ccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 107 ELME-SDLHQVIKAND-----DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 107 E~~~-g~L~~~i~~~~-----~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
||+. |+|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence 9998 69999997643 24677888999999999999999999999999999999999999999999986532221
Q ss_pred CCcceecccccCcccCCccccccc-----CCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~-----~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
... ......++..|+|||++... ...++.++|||||||++|+|++ |..||......+.+..+...
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-------- 225 (269)
T cd05042 155 YYI-TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVRE-------- 225 (269)
T ss_pred hee-ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhc--------
Confidence 110 01223456779999987431 1356789999999999999999 78999876654433332110
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.....+.......++..+.+++..|+ .||++|||++++++
T Consensus 226 -----------------~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 226 -----------------QDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred -----------------cCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 01111111223457888999999998 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=337.26 Aligned_cols=255 Identities=23% Similarity=0.294 Sum_probs=203.9
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++..+++.||+|.||+||+|++-. .||||+++.........+.|.+|+..|++-+|.||+=+.+++..+.
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~------ 461 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP------ 461 (678)
T ss_pred HHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc------
Confidence 3467889999999999999997643 4999999877777778889999999999999999999999985442
Q ss_pred EEEEEecCcc-cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 102 IYVVFELMES-DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 102 lylV~E~~~g-~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
+.||+.+|+| +|+.+|.- ...|.....+.|++||++|+.|||.++|||||||..||++.++++|||+|||++....--
T Consensus 462 ~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w 541 (678)
T KOG0193|consen 462 LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW 541 (678)
T ss_pred eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence 4999999997 89998864 346888999999999999999999999999999999999999999999999999763211
Q ss_pred CCCcceecccccCcccCCccccccc-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
. ........-|...|||||++... ...|++.+|||||||++|||++|..||...+....+-++-...+.|
T Consensus 542 ~-g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~p-------- 612 (678)
T KOG0193|consen 542 S-GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMP-------- 612 (678)
T ss_pred c-cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCc--------
Confidence 1 11112334477889999998532 2469999999999999999999999999544333322221111111
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.......+.+.++++|+..||.+++++||.+.+||.
T Consensus 613 ------------------d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 613 ------------------DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ------------------cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 112233457779999999999999999999999987
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=312.88 Aligned_cols=256 Identities=22% Similarity=0.354 Sum_probs=201.2
Q ss_pred eEEEeeeeecCceeEEEEEEC---CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC-Cc
Q 008729 25 YKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE-FK 100 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~-~~ 100 (556)
|++.++||+|+||.||+|.+. .+++.||||++............+.+|+++|+.++||||+++++++....... ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999865 35789999999765555566778899999999999999999999886432211 22
Q ss_pred eEEEEEecCc-ccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcc
Q 008729 101 DIYVVFELME-SDLHQVIKAN------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla 173 (556)
..++++||+. ++|.+++... ..++...++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 3578999998 7998877532 24788999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
+......... ......++..|++||.+.+ ..++.++|||||||++|+|++ |++||.+.+..+....+..
T Consensus 161 ~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~------- 230 (273)
T cd05074 161 KKIYSGDYYR-QGCASKLPVKWLALESLAD--NVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK------- 230 (273)
T ss_pred ccccCCccee-cCCCccCchhhcCHhHHhc--CccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc-------
Confidence 8653222110 1122335677999999876 678899999999999999999 8999987665433322211
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
... ....+..+..+.+|+.+||..+|++|||+.+++++
T Consensus 231 --------------------~~~---~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 231 --------------------GNR---LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred --------------------CCc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 01123577899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=332.14 Aligned_cols=253 Identities=24% Similarity=0.355 Sum_probs=199.7
Q ss_pred CCeEEEeeeeecCceeEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~ 96 (556)
++|.+++.||+|+||.||+|++. .+++.||||++.... .......+.+|+.+|..+. ||||+++++++.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~---- 111 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACT---- 111 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc----
Confidence 46889999999999999999853 456789999997532 2233456889999999997 999999999984
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhCC------------------------------------------------------
Q 008729 97 REFKDIYVVFELME-SDLHQVIKAND------------------------------------------------------ 121 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~------------------------------------------------------ 121 (556)
....+|+|||||. |+|.+++..++
T Consensus 112 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 112 -KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred -cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 4456999999999 79999996532
Q ss_pred --------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 008729 122 --------------------------------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNI 157 (556)
Q Consensus 122 --------------------------------------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 157 (556)
.++...+..|+.||+.||.|||+.||+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 256667888999999999999999999999999999
Q ss_pred eecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCCh
Q 008729 158 LANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236 (556)
Q Consensus 158 Ll~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~ 236 (556)
|++.++.+||+|||+++......... ......++..|+|||.+.+ ..++.++|||||||++|||++ |..||.....
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYI-SKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccc-cCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999999999997643222111 1123457788999999877 678999999999999999998 8899976553
Q ss_pred HHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 237 ~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.+.+... +..... ......++..+.+|+.+||..||.+||++.++++.
T Consensus 348 ~~~~~~~--------------------------~~~~~~---~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 348 NEQFYNA--------------------------IKRGYR---MAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred hHHHHHH--------------------------HHcCCC---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3322111 001000 01224578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=311.12 Aligned_cols=228 Identities=26% Similarity=0.361 Sum_probs=186.8
Q ss_pred cCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEecCc-cc
Q 008729 34 GSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SD 112 (556)
Q Consensus 34 G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~-g~ 112 (556)
|.||.||+|+++.+++.||+|++.... ...+|...+....||||+++++.+ .+...+|+||||+. ++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYI-----VSEDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhhe-----ecCCeEEEEEecCCCCC
Confidence 899999999999999999999986421 223455555566799999999988 45567999999999 69
Q ss_pred HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcceecccccC
Q 008729 113 LHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192 (556)
Q Consensus 113 L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt 192 (556)
|.+++.....+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||.+...... .....++
T Consensus 72 L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~------~~~~~~~ 145 (237)
T cd05576 72 LWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS------CDGEAVE 145 (237)
T ss_pred HHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc------cccCCcC
Confidence 9999988778999999999999999999999999999999999999999999999999987654322 1234467
Q ss_pred cccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhc
Q 008729 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRK 272 (556)
Q Consensus 193 ~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~ 272 (556)
..|+|||.+.+ ..++.++|+||+||++|+|++|+.||...... + ..
T Consensus 146 ~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~---------------------------~~ 191 (237)
T cd05576 146 NMYCAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVECHPSG-----I---------------------------NT 191 (237)
T ss_pred ccccCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----c---------------------------cc
Confidence 78999999876 67889999999999999999999887532110 0 00
Q ss_pred CCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----HHHHhCccc
Q 008729 273 KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-----EEALADPYF 316 (556)
Q Consensus 273 ~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta-----~elL~hp~f 316 (556)
.. .....+.+++.+.+||.+||+.||++|+|+ +++++||||
T Consensus 192 ~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 192 HT---TLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cc---ccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 00 001223578899999999999999999985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=314.33 Aligned_cols=238 Identities=18% Similarity=0.272 Sum_probs=187.5
Q ss_pred eeeeecCceeEEEEEECCCCc-------EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 29 EVIGKGSYGVVCAAIDTHTGE-------KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~-------~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
+.||+|+||.||+|.+..++. .||+|.+... .......+.+|+.+|+.++||||+++++++. ....
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~ 73 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCV-----CGDE 73 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEE-----eCCC
Confidence 469999999999999876554 3888877532 2334557888999999999999999999984 3456
Q ss_pred EEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCc--------eEEeeeC
Q 008729 102 IYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK--------LKVCDFG 171 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~--------vKL~DFG 171 (556)
.|+||||+. |+|.+++..++ .+++..+..++.||+.||+|||++||+||||||+|||++.++. ++++|||
T Consensus 74 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 74 SIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred cEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 899999998 69999997654 5899999999999999999999999999999999999987764 6999999
Q ss_pred ccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhhCCC
Q 008729 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTP 250 (556)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~-~pF~~~~~~~~~~~i~~~~g~p 250 (556)
++...... ....++..|+|||++.+. ..++.++|||||||++|+|++|. +||...+........
T Consensus 154 ~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~------- 218 (258)
T cd05078 154 ISITVLPK-------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY------- 218 (258)
T ss_pred cccccCCc-------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-------
Confidence 88654221 234588899999998752 35788999999999999999984 666554432221110
Q ss_pred ChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.... ......+..+.+||.+||+.||++|||++++++.
T Consensus 219 --------------------~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 219 --------------------EDRH-----QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred --------------------Hccc-----cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 0111 1112356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=309.51 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=189.8
Q ss_pred eeeeecCceeEEEEEEC--CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEE
Q 008729 29 EVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~ 106 (556)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.+++.++||||+++++.+ .+...+|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~ 74 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQC-----TEVTPYLLVM 74 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCCcEEEE
Confidence 46999999999999754 4567899998875432 23445788999999999999999999988 4445689999
Q ss_pred ecCc-ccHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 107 ELME-SDLHQVIKAND-----DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 107 E~~~-g~L~~~i~~~~-----~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
||+. ++|.+++.... .+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||+++......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~ 154 (269)
T cd05087 75 EFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED 154 (269)
T ss_pred ECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence 9999 79999987532 35677888999999999999999999999999999999999999999999987543221
Q ss_pred CCcceecccccCcccCCcccccccC-----CCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~-----~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
. ........++..|+|||++.+.. ..++.++|||||||++|+|++ |+.||......+......
T Consensus 155 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~---------- 223 (269)
T cd05087 155 Y-YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV---------- 223 (269)
T ss_pred e-eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh----------
Confidence 1 11112345778899999986421 135789999999999999996 999998765443322110
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.. .....+........++.+.+++++|+ .||++|||+++++.
T Consensus 224 -------------~~--~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 224 -------------RE--QQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred -------------hc--ccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 00 00111111112246788999999998 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=308.84 Aligned_cols=248 Identities=23% Similarity=0.373 Sum_probs=191.7
Q ss_pred eeeeecCceeEEEEEECC---CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVV 105 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~---tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV 105 (556)
+.||+|+||.||+|.+.. .+..||||.+... ........+.+|+.+++.++||||+++++++.. .....|+|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEE
Confidence 468999999999998653 3457999987632 334456678899999999999999999997742 23457899
Q ss_pred EecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCc
Q 008729 106 FELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183 (556)
Q Consensus 106 ~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~ 183 (556)
|||+. ++|.+++... ..++...+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.........
T Consensus 76 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 76 LPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99998 7999999764 456778888999999999999999999999999999999999999999999997543221100
Q ss_pred -ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 184 -VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 184 -~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
.......++..|+|||.+.+ ..++.++|||||||++|+|++ |.+||...+..+....+.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~----------------- 216 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL----------------- 216 (262)
T ss_pred ecccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-----------------
Confidence 01123346678999999876 678999999999999999999 567887665433222211
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.....+ ....+++.+.+++.+||..||++||++.++++.
T Consensus 217 ----------~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 217 ----------QGRRLL---QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred ----------cCCCCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 111111 112367889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=316.34 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=200.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCc----EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
.++|++++.||+|+||.||+|.+..+|. .||+|.+... ........+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET-TGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC---
Confidence 4578999999999999999999888776 4788887643 2233344678999999999999999999988432
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
..++|+||+. |+|.+++..+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 82 ---~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 ---TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred ---CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccc
Confidence 3579999998 79999987754 689999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.+....+..+.+.
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~---------- 225 (303)
T cd05110 159 LEGDEKE-YNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE---------- 225 (303)
T ss_pred ccCcccc-cccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----------
Confidence 5332211 11123446778999999876 678999999999999999997 899998765333222211
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.....+ ..+..+..+.+++.+||..||++||+++++++.
T Consensus 226 -----------------~~~~~~---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 226 -----------------KGERLP---QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred -----------------CCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111111 123467889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=311.00 Aligned_cols=238 Identities=21% Similarity=0.291 Sum_probs=185.7
Q ss_pred eeeeecCceeEEEEEECC------------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 29 EVIGKGSYGVVCAAIDTH------------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~------------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
+.||+|+||.||+|.... ....||+|++... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~---- 74 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCV---- 74 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe----
Confidence 468999999999997432 2336889987642 2334456788999999999999999999984
Q ss_pred CCCceEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCc-------eEE
Q 008729 97 REFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK-------LKV 167 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-------vKL 167 (556)
.....|+||||++ +.|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +|+
T Consensus 75 -~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 75 -RDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred -cCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 3345799999999 578777765 456899999999999999999999999999999999999987664 899
Q ss_pred eeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHh
Q 008729 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL-TGKPLFPGKSVVHQLDLITDL 246 (556)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyell-tG~~pF~~~~~~~~~~~i~~~ 246 (556)
+|||++...... ....++..|+|||.+.+. ..++.++|||||||++|+|+ +|..||.+....+.....
T Consensus 154 ~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--- 222 (262)
T cd05077 154 SDPGIPITVLSR-------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY--- 222 (262)
T ss_pred CCCCCCccccCc-------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH---
Confidence 999998654321 234588899999988632 56889999999999999998 588888765432211100
Q ss_pred hCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 247 ~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
. .. .......+.++.+||.+||+.||.+||++.+||++
T Consensus 223 ---------------------~----~~----~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 223 ---------------------E----GQ----CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ---------------------h----cC----ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0 00 01112345788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=311.96 Aligned_cols=259 Identities=23% Similarity=0.417 Sum_probs=214.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (556)
.+.|.++++||+|+|.+|.+++++.|.+.||+|++++..- ...+..=+..|-.+..+. +||.+|.++.+| ...
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-----qte 323 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-----QTE 323 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-----ccc
Confidence 3589999999999999999999999999999999986533 334444566777777766 699999999999 445
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
..+++|.||+. |+|--.++....+++++++++...|+.||.|||+.||++||||.+|+|+|..|++||+|+|+++....
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 56999999999 69887888888899999999999999999999999999999999999999999999999999987655
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCC--C-----ChHHHHHHHHHhhCCCC
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG--K-----SVVHQLDLITDLLGTPS 251 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~--~-----~~~~~~~~i~~~~g~p~ 251 (556)
+...+ +++||||.|.|||++.+ ..|+..+|+|+||++++||+.|+.||+- . +..+.+.++
T Consensus 404 ~gd~t---stfcgtpnyiapeilrg--eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv-------- 470 (593)
T KOG0695|consen 404 PGDTT---STFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV-------- 470 (593)
T ss_pred CCccc---ccccCCCcccchhhhcc--cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------
Confidence 54443 67899999999999999 8999999999999999999999999952 1 111111111
Q ss_pred hHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC------CHHHHHhCccccccc
Q 008729 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP------TAEEALADPYFKGLA 320 (556)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp------ta~elL~hp~f~~~~ 320 (556)
.+.+...+| ..++-.+..+|+..|.+||++|. ...++-.|+||+.+.
T Consensus 471 -----------------ilekqirip-----rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id 523 (593)
T KOG0695|consen 471 -----------------ILEKQIRIP-----RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID 523 (593)
T ss_pred -----------------Hhhhccccc-----ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence 011222222 34777888999999999999996 478999999999764
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=306.69 Aligned_cols=240 Identities=26% Similarity=0.440 Sum_probs=196.3
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++.+.||+|+||.||++. .+++.||+|++... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~ 73 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILH------NGL 73 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCc
Confidence 579999999999999999985 57889999998642 234568899999999999999999998842 236
Q ss_pred EEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 103 YVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
|+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 74 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 74 YIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred EEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 99999998 69999997643 5789999999999999999999999999999999999999999999999998754321
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
. .....+..|+|||.+.+ ..++.++|+|||||++|+|++ |++||.+.+..+....+.
T Consensus 154 ~------~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------------- 211 (254)
T cd05083 154 V------DNSKLPVKWTAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-------------- 211 (254)
T ss_pred C------CCCCCCceecCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh--------------
Confidence 1 12234567999999876 678899999999999999997 999998776543332221
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
..... .....++..+.+|+++||..+|++||++++++.
T Consensus 212 -------------~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 212 -------------KGYRM---EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred -------------CCCCC---CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11000 112357889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=337.38 Aligned_cols=265 Identities=25% Similarity=0.435 Sum_probs=221.8
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~ 98 (556)
.....|+|.++||.|.||.||+++++.+++..|+|+.+... .....+..|.+||+.+ .|||++.+|++|.......
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 34467999999999999999999999999999999887432 2234566799999988 5999999999998666677
Q ss_pred CceEEEEEecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
.+.+|||||||+ |+.-++++. ..++.|+.+.+|++.+|.||.|||.+.++|||||-.|||++.++.|||+|||.+..
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 788999999999 688888865 46799999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCcceecccccCcccCCccccccc---CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~---~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
...... ...+++||++|||||++... ...|+..+|+||||++..||--|.||+-+......+..|
T Consensus 173 ldsT~g---rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I--------- 240 (953)
T KOG0587|consen 173 LDSTVG---RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI--------- 240 (953)
T ss_pred eecccc---cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---------
Confidence 543222 23578899999999998542 235778999999999999999999999776655444332
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
...+.|....+..++..+.++|..||.+|..+||+..++|.|||+..
T Consensus 241 -------------------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 241 -------------------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred -------------------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 22334444456678999999999999999999999999999999973
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=323.15 Aligned_cols=274 Identities=27% Similarity=0.400 Sum_probs=215.1
Q ss_pred cccccCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecC--c---cCChhHHHHHHHHHHHHHhCCCCCcceeeE
Q 008729 15 FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD--V---FEHISDAIRILREVKLLRLLRHPDIVEIKR 89 (556)
Q Consensus 15 ~~~~~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~--~---~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~ 89 (556)
|-+--...+||-++..||+|||+.||+|.|....+.||+|+-.. . .......+...||..|.+.|+||.||++|+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 33334455799999999999999999999999999999997531 1 122234556789999999999999999999
Q ss_pred EEcCCCCCCCceEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEeecC---CC
Q 008729 90 IMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANA---NC 163 (556)
Q Consensus 90 v~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~---~~ 163 (556)
+|.-+ ...+|.|+|||+| ||.-+++.+..+++.+++.|+.||+.||.||.... |+|-||||.|||+.. -|
T Consensus 535 yfslD----tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacG 610 (775)
T KOG1151|consen 535 YFSLD----TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACG 610 (775)
T ss_pred eeeec----cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccc
Confidence 98533 3458999999997 89889999999999999999999999999999885 999999999999853 47
Q ss_pred ceEEeeeCccccccCCCCCc----ceecccccCcccCCcccccc--cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChH
Q 008729 164 KLKVCDFGLARVAFSDTPMT----VFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237 (556)
Q Consensus 164 ~vKL~DFGla~~~~~~~~~~----~~~~~~~gt~~Y~APE~~~~--~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~ 237 (556)
.+||+|||++++...+.... .......||-||++||.+.- ...+.+.++||||+|||+|.++.|+.||......
T Consensus 611 eIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ 690 (775)
T KOG1151|consen 611 EIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ 690 (775)
T ss_pred eeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence 79999999999875544331 12345789999999996532 2245788999999999999999999999654332
Q ss_pred HHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 238 ~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
..+-.- .. +.+...+. +..-|-+++++++||++||.+--++|..+.++-.||||.
T Consensus 691 QdILqe-----------------------NT-IlkAtEVq-FP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 691 QDILQE-----------------------NT-ILKATEVQ-FPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred HHHHhh-----------------------hc-hhcceecc-CCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 211100 00 11111111 122356899999999999999999999999999999996
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=309.79 Aligned_cols=245 Identities=27% Similarity=0.393 Sum_probs=194.0
Q ss_pred eeeeecCceeEEEEEECCCC------cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 29 EVIGKGSYGVVCAAIDTHTG------EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg------~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
+.||+|+||.||+|.+.... +.||||.+.... .......+.+|+.+|+.++||||+++++++. .....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQ 74 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCe
Confidence 36999999999999876544 689999876432 2234557889999999999999999999984 44568
Q ss_pred EEEEecCc-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC-----ceEEee
Q 008729 103 YVVFELME-SDLHQVIKAN-------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-----KLKVCD 169 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~-------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-----~vKL~D 169 (556)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+++|+||||+||+++.++ .+||+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 99999998 6999998642 3478899999999999999999999999999999999999887 899999
Q ss_pred eCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhC
Q 008729 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLG 248 (556)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g 248 (556)
||++.......... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||...+..+....+..
T Consensus 155 fg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--- 228 (269)
T cd05044 155 FGLARDIYKSDYYR-KEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA--- 228 (269)
T ss_pred cccccccccccccc-cCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc---
Confidence 99987643221111 1122345678999999877 678999999999999999998 9999987665443332210
Q ss_pred CCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.. .......++..+.+||.+||..+|.+||+++++++
T Consensus 229 ------------------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 229 ------------------------GG---RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ------------------------CC---ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 00 11122457889999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=311.64 Aligned_cols=269 Identities=23% Similarity=0.401 Sum_probs=203.3
Q ss_pred CCeEEEeeeeecCceeEEEEEEC----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDT----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
..|++.+.||+|+||.||+|... .+++.||||++...... .....+.+|+++++.++|+||+++++++... .
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~ 79 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKP---G 79 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecC---C
Confidence 47889999999999999999864 34889999998754332 3466788999999999999999999987432 2
Q ss_pred CceEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
....|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++...
T Consensus 80 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 80 GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 456899999998 69999997754 6899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
..............++..|+|||.+.+ ..++.++|||||||++|+|++|..||....... ....+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-----~~~~~~~~~~--- 229 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRT--SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-----LRMIGIAQGQ--- 229 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHcc--CCCCcccchHHHhhhhheeeccCCCcccccchh-----cccccccccc---
Confidence 432221111122345667999999876 578899999999999999999999986543211 0111110000
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.........+......+ ....++..+.+|+.+||..||.+|||+.++++
T Consensus 230 ----~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 230 ----MIVTRLLELLKEGERLP---RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ----ccHHHHHHHHHcCCcCC---CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00011111121111111 12346788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=311.87 Aligned_cols=237 Identities=19% Similarity=0.262 Sum_probs=185.0
Q ss_pred eeeecCceeEEEEEECCC------------------------CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcc
Q 008729 30 VIGKGSYGVVCAAIDTHT------------------------GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85 (556)
Q Consensus 30 ~LG~G~~g~V~~a~~~~t------------------------g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv 85 (556)
.||+|+||.||+|....+ ...||+|++... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 599999999999974322 235889987632 223445688899999999999999
Q ss_pred eeeEEEcCCCCCCCceEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC
Q 008729 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC 163 (556)
Q Consensus 86 ~l~~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~ 163 (556)
++++++. .....|+||||++ ++|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 80 ~~~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 80 FVHGVCV-----RGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred eEEEEEE-----eCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 9999984 4456899999999 688888865 46789999999999999999999999999999999999997643
Q ss_pred -------ceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHH-hCCCCCCCCC
Q 008729 164 -------KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL-TGKPLFPGKS 235 (556)
Q Consensus 164 -------~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyell-tG~~pF~~~~ 235 (556)
.+||+|||++...... ....++..|+|||.+.+. ..++.++|||||||++|+|+ +|..||.+..
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~-------~~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR-------EERVERIPWIAPECVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cccCccceeeecCCccccccccc-------cccccCCcccCchhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3899999987643221 223577889999988653 46889999999999999995 6999997765
Q ss_pred hHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 236 ~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
..+.... +.. .... ....++.+.+||.+||..||++|||+.++|++
T Consensus 227 ~~~~~~~------------------------~~~---~~~~-----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 227 PSEKERF------------------------YEK---KHRL-----PEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hHHHHHH------------------------HHh---ccCC-----CCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 4322111 110 0111 12345789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=305.43 Aligned_cols=236 Identities=19% Similarity=0.288 Sum_probs=187.9
Q ss_pred eeeeecCceeEEEEEECCCC----------cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 29 EVIGKGSYGVVCAAIDTHTG----------EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg----------~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
+.||+|+||.||+|.+..++ ..|++|.+.... .....+.+|+.+|+.++||||+++++++..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----- 72 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR----- 72 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-----
Confidence 46999999999999998777 357888765321 225678899999999999999999998843
Q ss_pred CceEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC-------ceEEee
Q 008729 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-------KLKVCD 169 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-------~vKL~D 169 (556)
...|+||||+. ++|.+++.... .++...+..++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 73 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 73 -DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred -CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 34699999999 69999998766 789999999999999999999999999999999999999887 799999
Q ss_pred eCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhC
Q 008729 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLG 248 (556)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g 248 (556)
||++...... ....++..|+|||++.+....++.++|||||||++|+|++ |..||...+........
T Consensus 152 fg~a~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~----- 219 (259)
T cd05037 152 PGIPITVLSR-------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY----- 219 (259)
T ss_pred CCcccccccc-------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-----
Confidence 9998764331 2334677899999987622368899999999999999999 57888665422211111
Q ss_pred CCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
. .....+ ......+.+||.+||..||.+|||+.++++
T Consensus 220 -------------------~---~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 220 -------------------Q---DQHRLP-----MPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred -------------------h---cCCCCC-----CCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 000011 112378899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=305.89 Aligned_cols=250 Identities=28% Similarity=0.457 Sum_probs=201.1
Q ss_pred CeEEEeeeeecCceeEEEEEECC-CCcEEEEEEecCcc--------CChhHHHHHHHHHHHHHh-CCCCCcceeeEEEcC
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVF--------EHISDAIRILREVKLLRL-LRHPDIVEIKRIMLP 93 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~-tg~~vAiK~i~~~~--------~~~~~~~~~~rEi~iL~~-L~HpnIv~l~~v~~~ 93 (556)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+.... .......++.+|+.++.. ++||||+++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~-- 78 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF-- 78 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence 38899999999999999999987 78899999875321 222344567789998875 7999999999998
Q ss_pred CCCCCCceEEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEeecCCCceEE
Q 008729 94 PSKREFKDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKV 167 (556)
Q Consensus 94 ~~~~~~~~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL 167 (556)
......|+||||++ ++|.+++.. ...+++..++.++.||+.||.|||+ .||+|+||||+|||++.++.+||
T Consensus 79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l 155 (269)
T cd08528 79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTI 155 (269)
T ss_pred ---ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEE
Confidence 45567999999998 588877642 4568999999999999999999996 68999999999999999999999
Q ss_pred eeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 008729 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (556)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~ 247 (556)
+|||++....... ......|+..|+|||.+.+ ..++.++|+|||||++|+|++|++||...+.......+.+
T Consensus 156 ~dfg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~-- 227 (269)
T cd08528 156 TDFGLAKQKQPES----KLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE-- 227 (269)
T ss_pred ecccceeeccccc----ccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhh--
Confidence 9999997644322 2245568899999999977 6789999999999999999999999976654443333211
Q ss_pred CCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
....+. ....+++.+.+||++||..||++||++.|+.++
T Consensus 228 -------------------------~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 228 -------------------------AVYEPL--PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -------------------------ccCCcC--CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 111111 112467899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=302.94 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=187.4
Q ss_pred eeeecCceeEEEEEECCC--CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEe
Q 008729 30 VIGKGSYGVVCAAIDTHT--GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE 107 (556)
Q Consensus 30 ~LG~G~~g~V~~a~~~~t--g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (556)
.||+|+||.||+|..... ...+++|.+... ........+.+|+.+++.++||||+++++.+. ....+|+|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e 75 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFE 75 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEe
Confidence 699999999999975433 335667766532 22345567899999999999999999999984 4456899999
Q ss_pred cCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCC
Q 008729 108 LME-SDLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (556)
Q Consensus 108 ~~~-g~L~~~i~~~----~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 182 (556)
|+. ++|.+++... ..+....++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++.........
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 76 YCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred cCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 999 6999999753 24567778899999999999999999999999999999999999999999998643211110
Q ss_pred cceecccccCcccCCccccccc-----CCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 183 TVFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~~~~~-----~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
......+++..|+|||++... ...++.++|||||||++|+|++ |.+||...+..+.+..+..
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~----------- 223 (268)
T cd05086 156 -ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK----------- 223 (268)
T ss_pred -hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-----------
Confidence 011345688899999987531 1245789999999999999997 5788977665444433211
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
... ...........+++.+.++++.|| .||++||+++++++
T Consensus 224 ------------~~~--~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 224 ------------DQQ--VKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ------------hcc--cccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 000 000111122347788999999999 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=338.24 Aligned_cols=249 Identities=28% Similarity=0.427 Sum_probs=208.4
Q ss_pred CeEEEeeeeecCceeEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 24 RYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
.-++.+.||+|+||+||+|+-. .....||||.+++. ........|.||+.+|..|+|||||+|++++ .+
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-a~~~~~~dF~REaeLla~l~H~nIVrLlGVC-----~~ 560 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-AENQARQDFRREAELLAELQHPNIVRLLGVC-----RE 560 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-ccHHHHHHHHHHHHHHHhccCCCeEEEEEEE-----cc
Confidence 4567889999999999999743 23468999999864 3334567899999999999999999999999 66
Q ss_pred CceEEEEEecCc-ccHHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC
Q 008729 99 FKDIYVVFELME-SDLHQVIKAND----------D----LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC 163 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~----------~----l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~ 163 (556)
++-+|+|||||. |||+++|+.+. + ++..+...|+.||+.|+.||-++.+|||||-..|+||.++.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 677999999999 99999997532 3 88899999999999999999999999999999999999999
Q ss_pred ceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHH
Q 008729 164 KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDL 242 (556)
Q Consensus 164 ~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~ 242 (556)
.|||+|||+++...+..--. +.....-...||+||-+.- .+|+.++||||+||+|||+++ |+.||.|.++.+.++.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk-~~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~ 717 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYK-VRGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC 717 (774)
T ss_pred EEEecccccchhhhhhhhhc-ccCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence 99999999999765432111 0011223467999998865 789999999999999999998 9999999999888887
Q ss_pred HHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 008729 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (556)
Q Consensus 243 i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL 311 (556)
|.+. ...+...+.++++.+|+..||+.+|++||++.||-
T Consensus 718 i~~g------------------------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 718 IRAG------------------------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHcC------------------------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 7431 11234457999999999999999999999999974
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=319.63 Aligned_cols=262 Identities=27% Similarity=0.430 Sum_probs=195.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc-e
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK-D 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~-~ 101 (556)
+.|.-...||+|+||.||+|.-.. |..||||++....... ...|.+|+.+|.+++|||+|+|+++|. +.. .
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~-----e~~~~ 146 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCL-----EGGEH 146 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEe-----cCCce
Confidence 356667899999999999998654 4899999887532221 445999999999999999999999994 444 5
Q ss_pred EEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 102 IYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTAN---VYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~g---IvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
.+||+|||. |+|.+++.... .++|.....|+.++++||+|||... |+||||||+|||+|++...||+|||+|+.
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence 899999999 89999998754 8999999999999999999999965 99999999999999999999999999976
Q ss_pred ccC-CCCCcceeccc-ccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 176 AFS-DTPMTVFWTDY-VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 176 ~~~-~~~~~~~~~~~-~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
... ... .... .||..|+|||.+.. ...+.++||||||++|.||++|+.+.+......... +.+..
T Consensus 227 ~~~~~~~----~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~-l~~w~------ 293 (361)
T KOG1187|consen 227 GPEGDTS----VSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS-LVEWA------ 293 (361)
T ss_pred CCccccc----eeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCccccc-HHHHH------
Confidence 543 211 1122 79999999999876 678999999999999999999998886543111110 00000
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCC--CCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFP--NVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
...+... .+..+.+..... ..++ ..-..+..+..+|+..+|.+||++.|++.
T Consensus 294 -~~~~~~~----~~~eiiD~~l~~--~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 294 -KPLLEEG----KLREIVDPRLKE--GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred -HHHHHCc----chhheeCCCccC--CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 0000111 111111111100 1111 11123667889999999999999999754
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=303.80 Aligned_cols=260 Identities=24% Similarity=0.394 Sum_probs=207.8
Q ss_pred EEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCceEEE
Q 008729 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIYV 104 (556)
Q Consensus 26 ~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~lyl 104 (556)
+-+..||.|+||+|++..++.+|+..|||+|.... ...+..+++.|.....+- +.||||++|++.. ..++.||
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n-~~keq~rll~e~d~~mks~~cp~IVkfyGa~F-----~EGdcWi 140 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN-IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF-----SEGDCWI 140 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc-chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh-----cCCceee
Confidence 34668999999999999999999999999997542 346778899999876554 6999999999983 4456899
Q ss_pred EEecCcccHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 105 VFELMESDLHQVIK-----ANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 105 V~E~~~g~L~~~i~-----~~~~l~~~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.||+|+-+|..+.+ .+..++++.+-.|.-..+.||.||... +|+|||+||+|||++..|.|||||||.+-...+
T Consensus 141 CMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 141 CMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred eHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 99999976655443 356799999999999999999999865 899999999999999999999999999866543
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh-hCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL-LGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~-~g~p~~e~i~~ 257 (556)
.... +.-.|-+.|||||.+.....+|+-++|+||||++|||+.||+.||.+.+. .++++..+ .|.|+
T Consensus 221 SiAk----T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp------ 288 (361)
T KOG1006|consen 221 SIAK----TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPP------ 288 (361)
T ss_pred HHHh----hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCC------
Confidence 3222 34568899999999876556799999999999999999999999987654 33333221 12211
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
........-..+..+..+|.-||.+|-.+||...+++.+||++-..
T Consensus 289 -----------------~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 289 -----------------ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred -----------------eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 0111122235788999999999999999999999999999998654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.58 Aligned_cols=251 Identities=23% Similarity=0.364 Sum_probs=203.9
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCc---E-EEEEEecC-ccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGE---K-VAIKKIHD-VFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~---~-vAiK~i~~-~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
++-.+.++||+|+||.||+|..+..+. . ||+|.... ..........+++|.++|+.++|||||++||+...
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~---- 232 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL---- 232 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC----
Confidence 345567999999999999998765432 3 89998874 22445667789999999999999999999999844
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~-l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
..-+|||||+|. |+|.++|++++. ++..+...++++.+.||+|||+++++||||-..|+|+..++.+||+|||+++.
T Consensus 233 -~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 233 -EEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred -CCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 445999999999 699999999874 99999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
........ ...--...|+|||.+.. ..|+.++||||+||++||+++ |..||++....+....|..
T Consensus 312 ~~~~~~~~---~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~--------- 377 (474)
T KOG0194|consen 312 GSQYVMKK---FLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVK--------- 377 (474)
T ss_pred Ccceeecc---ccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHh---------
Confidence 43111110 01124467999999987 689999999999999999999 8899999987766655521
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.....+ .....+..+..++.+|+..||++|||+.++.+
T Consensus 378 -----------------~~~r~~---~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 378 -----------------NGYRMP---IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred -----------------cCccCC---CCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 111111 11256778999999999999999999999875
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=333.83 Aligned_cols=251 Identities=23% Similarity=0.413 Sum_probs=206.9
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCC-----cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
..-++.+.||+|+||.||.|.-.... ..||||.+.+. .+..+...|++|..+|+.++|||||++++++++.
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--- 767 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--- 767 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC---
Confidence 45778999999999999999855332 35999998853 5567788999999999999999999999999753
Q ss_pred CCceEEEEEecCc-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEee
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAN-------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCD 169 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~D 169 (556)
...+|++|||+ |||..+|++. ..++......++.+|++|++||+++++|||||-..|+|++....|||+|
T Consensus 768 --~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 768 --GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred --CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 44799999999 7999999875 3589999999999999999999999999999999999999999999999
Q ss_pred eCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhC
Q 008729 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLG 248 (556)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g 248 (556)
||+|+.......... ...-.-...|||||.+.. ..++.++|||||||+|||+++ |..||++.++.+.+....+
T Consensus 846 FGlArDiy~~~yyr~-~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~--- 919 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRK-HGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE--- 919 (1025)
T ss_pred cchhHhhhhchheec-cCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh---
Confidence 999995432221110 001112246999999987 789999999999999999999 8999999987666543211
Q ss_pred CCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.. .......++..+.+|+..||+.+|++||++..|++
T Consensus 920 -----------------------gg----RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 920 -----------------------GG----RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred -----------------------CC----ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 11 22334678889999999999999999999999987
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=327.02 Aligned_cols=206 Identities=30% Similarity=0.449 Sum_probs=174.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC-CCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~~ 100 (556)
..-+..-+.||+||||.||+++++.||+.||||.++... ......+..+|+++|++|+|+|||+++++-.+.. .-...
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 345677889999999999999999999999999987643 4566778889999999999999999999753321 01123
Q ss_pred eEEEEEecCc-ccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec--CCCc--eEEeeeCc
Q 008729 101 DIYVVFELME-SDLHQVIKA---NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN--ANCK--LKVCDFGL 172 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~---~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~--~~~~--vKL~DFGl 172 (556)
.-.+|||||. |+|+.++.. ...|++.++..++..+..||.|||.+||+||||||.||++- .+|+ -||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 4579999999 799999975 34699999999999999999999999999999999999863 4344 79999999
Q ss_pred cccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCC
Q 008729 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (556)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~ 233 (556)
|+....+. .++..+||+.|.+||++.. ...|+..+|.|||||++|++.||..||-.
T Consensus 171 Arel~d~s----~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 171 ARELDDNS----LFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred cccCCCCC----eeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 99765444 4578899999999999874 16799999999999999999999999943
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=313.98 Aligned_cols=278 Identities=15% Similarity=0.232 Sum_probs=188.8
Q ss_pred CCCCeEEEeeeeecCceeEEEEEEC----------------CCCcEEEEEEecCccCChh------------HHHHHHHH
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDT----------------HTGEKVAIKKIHDVFEHIS------------DAIRILRE 72 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~----------------~tg~~vAiK~i~~~~~~~~------------~~~~~~rE 72 (556)
..++|++.++||+|+||+||+|.+. ..++.||||++........ .......|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 3568999999999999999999752 3456799999863211100 01123347
Q ss_pred HHHHHhCCCCCc-----ceeeEEEcCCC---CCCCceEEEEEecCc-ccHHHHHHhC-----------------------
Q 008729 73 VKLLRLLRHPDI-----VEIKRIMLPPS---KREFKDIYVVFELME-SDLHQVIKAN----------------------- 120 (556)
Q Consensus 73 i~iL~~L~HpnI-----v~l~~v~~~~~---~~~~~~lylV~E~~~-g~L~~~i~~~----------------------- 120 (556)
+.++.+++|.++ +++++++.... .......||||||++ ++|.+++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 56666654321 112346899999999 6998888632
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcc
Q 008729 121 -DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199 (556)
Q Consensus 121 -~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE 199 (556)
..+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++......... .....+|+.|+|||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~g~~tp~Y~aPE 380 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--PLYGMLDPRYSPPE 380 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--ccccCCCcceeChh
Confidence 123567788999999999999999999999999999999999999999999997543222111 11223578999999
Q ss_pred cccccCC------------------CCC--CcchhhhHHHHHHHHHhCCC-CCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 200 LCGSFFS------------------KYT--PAIDIWSIGCIFAEVLTGKP-LFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 200 ~~~~~~~------------------~y~--~~~DIWSlG~ilyelltG~~-pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.+..... .|+ ...||||+|||+|+|++|.. ||.+....... + ...
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~--~------------~~~ 446 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE--L------------RQY 446 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH--H------------hhc
Confidence 8754210 122 34799999999999999984 77543211110 0 000
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCC---CCCCCHHHHHhCccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDP---KDRPTAEEALADPYFKG 318 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP---~~Rpta~elL~hp~f~~ 318 (556)
......+..... .. ..+..+...++.++||+++||..+| .+|+|++|+|+||||..
T Consensus 447 --~~~~~~~r~~~~-~~-~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 447 --DNDLNRWRMYKG-QK-YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred --cchHHHHHhhcc-cC-CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 000011111111 11 1223456789999999999999876 68999999999999963
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=283.57 Aligned_cols=242 Identities=39% Similarity=0.650 Sum_probs=198.2
Q ss_pred CceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEecCcc-cH
Q 008729 35 SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DL 113 (556)
Q Consensus 35 ~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g-~L 113 (556)
+||.||+|.+..+|+.||+|++........ ...+.+|+..++.++|+||+++++.+. .....++|+||+++ +|
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L 74 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDL 74 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCH
Confidence 589999999999999999999875322211 567889999999999999999999884 44679999999995 99
Q ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcceecccccCc
Q 008729 114 HQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193 (556)
Q Consensus 114 ~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~ 193 (556)
.+++.....++...+..++.+|+.+|.|||+.||+|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~ 150 (244)
T smart00220 75 FDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTP 150 (244)
T ss_pred HHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCc
Confidence 9999877668999999999999999999999999999999999999999999999999998754432 123456888
Q ss_pred ccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhc
Q 008729 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRK 272 (556)
Q Consensus 194 ~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~-~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~ 272 (556)
.|++||.+.+ ..++.++||||||+++|+|++|..||....... ..+.+ ..
T Consensus 151 ~~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~---------------------------~~ 201 (244)
T smart00220 151 EYMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI---------------------------GK 201 (244)
T ss_pred CCCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH---------------------------hc
Confidence 9999999876 678889999999999999999999997733222 22111 11
Q ss_pred CCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 273 KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 273 ~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
...........++..+.+++.+||..||++||++.++++||||
T Consensus 202 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 202 -PKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred -cCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 1111111112277899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=299.85 Aligned_cols=286 Identities=29% Similarity=0.438 Sum_probs=213.5
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECC---CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~---tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~ 96 (556)
..+.|.++++||.|.|++||+|.+.. ..+.||+|.|... +...++.+|+++|..+. +.||+++.+++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t----s~p~ri~~El~~L~~~gG~~ni~~~~~~~----- 104 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT----SSPSRILNELEMLYRLGGSDNIIKLNGCF----- 104 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc----cCchHHHHHHHHHHHhccchhhhcchhhh-----
Confidence 34679999999999999999999888 7889999998643 34567999999999995 99999999998
Q ss_pred CCCceEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC-CceEEeeeCccc
Q 008729 97 REFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLAR 174 (556)
Q Consensus 97 ~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~vKL~DFGla~ 174 (556)
.....+.+||||++. +..+++. .++...++.+++.++.||+++|.+|||||||||+|+|.+.. ++-.|+|||+|.
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 677789999999994 6666665 36789999999999999999999999999999999999854 678899999997
Q ss_pred cccC--------------CCC-----------------C----------cceecccccCcccCCcccccccCCCCCCcch
Q 008729 175 VAFS--------------DTP-----------------M----------TVFWTDYVATRWYRAPELCGSFFSKYTPAID 213 (556)
Q Consensus 175 ~~~~--------------~~~-----------------~----------~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~D 213 (556)
.... ..+ . ....-...||+.|+|||++... ..-++++|
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiD 260 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAID 260 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccc
Confidence 2100 000 0 0001235799999999998763 55688999
Q ss_pred hhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHHhhCCCChHHHHHhhh-------------HHHHHHHHHh-----hcCC
Q 008729 214 IWSIGCIFAEVLTGKPLF-PGKSVVHQLDLITDLLGTPSPETIAVVRN-------------EKARKYLTEM-----RKKP 274 (556)
Q Consensus 214 IWSlG~ilyelltG~~pF-~~~~~~~~~~~i~~~~g~p~~e~i~~~~~-------------~~~~~~l~~~-----~~~~ 274 (556)
|||.|+|+..+++++.|| ...++.+.+..|..++|.-.-........ ...+.-+..+ .+..
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 999999999999999776 55666666766666665432221111100 0111111111 1111
Q ss_pred CC-CcCCCCC-CCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 275 PV-PLFQKFP-NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 275 ~~-~~~~~~~-~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.. -....+. ..+..+.|||.+||+.||.+|+||+++|.||||...
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 10 0111222 355699999999999999999999999999999854
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=317.21 Aligned_cols=248 Identities=29% Similarity=0.439 Sum_probs=191.7
Q ss_pred EeeeeecCcee-EEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCCceEEEE
Q 008729 28 LEVIGKGSYGV-VCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIYVV 105 (556)
Q Consensus 28 ~~~LG~G~~g~-V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~lylV 105 (556)
.+++|.|+-|+ ||+|.- .|+.||||.+-. .....+.|||..|+.-+ |||||++|+.- .+.+.+||.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIa 581 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIA 581 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEE
Confidence 45789999986 699964 588999998753 33456789999999884 99999999986 566779999
Q ss_pred EecCcccHHHHHHhC-CC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC---C--CceEEeeeCccccc
Q 008729 106 FELMESDLHQVIKAN-DD---LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---N--CKLKVCDFGLARVA 176 (556)
Q Consensus 106 ~E~~~g~L~~~i~~~-~~---l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~--~~vKL~DFGla~~~ 176 (556)
.|+|..+|.++++.. .. ........++.|+..||+|||+.+||||||||.||||.. + .+++|+|||+++..
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999999999999874 11 122445788999999999999999999999999999975 3 46899999999886
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG-~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
..+...-....+..||-.|+|||++.. ..-+.++||||||||+|..++| ..||...-. .+.+.+.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~--~~~~~avDiFslGCvfyYvltgG~HpFGd~~~-R~~NIl~----------- 727 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRE--DRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE-RQANILT----------- 727 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhc--cccCcccchhhcCceEEEEecCCccCCCchHH-hhhhhhc-----------
Confidence 554433333466789999999999987 5556799999999999999996 899954321 1211110
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.. ..+...-+..+.++.|||.+||.+||..||+|.++|.||+|-..
T Consensus 728 ----------------~~--~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 728 ----------------GN--YTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred ----------------Cc--cceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 00 01111112222389999999999999999999999999999653
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=311.80 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=219.7
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCc---EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
.+..+|.++||.|.||.||+|+.+..|+ .||||.++. ...++....|+.|..||-+++||||++|.++. ..
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-----Tk 701 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-----TK 701 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-----ec
Confidence 4456899999999999999999887775 699999984 34556677899999999999999999999998 55
Q ss_pred CceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
.+-+.||.|||+ |.|..+|+.+ +.|+..+.-.+++.|+.|++||-+.|.|||||-..|||+|.+-.+||+|||++|..
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 667999999999 8999999875 57898999999999999999999999999999999999999999999999999977
Q ss_pred cCCCCCcceecccccC--cccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 177 FSDTPMTVFWTDYVAT--RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt--~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
.++.+.. ++...|- ..|.|||.+.- .+++.++||||+|++|||.++ |..||.+.++.+.++.|.+-.+-|+
T Consensus 782 edd~~~~--ytt~GGKIPiRWTAPEAIa~--RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp-- 855 (996)
T KOG0196|consen 782 EDDPEAA--YTTLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP-- 855 (996)
T ss_pred ccCCCcc--ccccCCccceeecChhHhhh--cccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC--
Confidence 6555322 2333333 46999999876 799999999999999999887 9999999999999999877555443
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC--cccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD--PYFK 317 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h--p~f~ 317 (556)
..+++..+..|+..||++|...||.+.||+++ ..++
T Consensus 856 ----------------------------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 856 ----------------------------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred ----------------------------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 23588899999999999999999999999864 4444
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.58 Aligned_cols=252 Identities=26% Similarity=0.397 Sum_probs=207.6
Q ss_pred CCeEEEeeeeecCceeEEEEEECCC-Cc--EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHT-GE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~t-g~--~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
++.++.++||+|.||+|++|.++.- |+ .||||++....... ....|++|+.+|.+|+|+|+++||++.++
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~------ 182 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD------ 182 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc------
Confidence 3567788999999999999988753 33 69999998643332 66789999999999999999999999964
Q ss_pred ceEEEEEecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 100 KDIYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
+-+.+|||++. |+|++.|.+ .+.|-......|+.||+.|+.||.++++|||||-..|||+-..-.||||||||.+..
T Consensus 183 qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 33789999999 899999987 346788888999999999999999999999999999999988889999999999986
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
........+-...--...|.|||-+.. ..++.++|+|++||+||||++ |..||.|......++.|-+.
T Consensus 263 g~ned~Yvm~p~rkvPfAWCaPEsLrh--~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~--------- 331 (1039)
T KOG0199|consen 263 GENEDMYVMAPQRKVPFAWCAPESLRH--RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG--------- 331 (1039)
T ss_pred CCCCcceEecCCCcCcccccCHhHhcc--ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc---------
Confidence 554443322222223346999999987 789999999999999999998 78999999987777665211
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
......+.++.++.++++.||..+|.+|||+..|-+.
T Consensus 332 ---------------------erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 332 ---------------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred ---------------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 1112335688999999999999999999999888644
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=299.58 Aligned_cols=242 Identities=26% Similarity=0.466 Sum_probs=197.8
Q ss_pred EEeeeeecCceeEEEEEECC--CC--cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 27 ILEVIGKGSYGVVCAAIDTH--TG--EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 27 i~~~LG~G~~g~V~~a~~~~--tg--~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
+.++||.|.||.||.|.-.. .| -.||||..+.. ....+...|+.|.-+|+.++||||+++++++.. .-+
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfdHphIikLIGv~~e------~P~ 465 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE------QPM 465 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCCCcchhheeeeeec------cce
Confidence 35689999999999997543 23 36899987753 344567889999999999999999999999843 348
Q ss_pred EEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 103 YVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
|||||++. |+|..+++.+. .++......+++||+.||+|||+.++|||||-..|||+.....|||+|||+++....+.
T Consensus 466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 99999999 99999998764 68888999999999999999999999999999999999999999999999999764432
Q ss_pred CCcceecccccC--cccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 181 PMTVFWTDYVAT--RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 181 ~~~~~~~~~~gt--~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
- ++...|. .-|||||.+.- ..++.++|||.|||++||++. |..||.|-.+.+.+-.|.+
T Consensus 546 y----YkaS~~kLPIKWmaPESINf--RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn------------ 607 (974)
T KOG4257|consen 546 Y----YKASRGKLPIKWMAPESINF--RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN------------ 607 (974)
T ss_pred h----hhccccccceeecCccccch--hcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC------------
Confidence 1 1222232 35999999865 789999999999999999987 8999988776555433321
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL 311 (556)
.......+++++.+-.|+.+||.+||.+||++.++.
T Consensus 608 ------------------GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 608 ------------------GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred ------------------CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 111224478999999999999999999999987764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=296.80 Aligned_cols=257 Identities=23% Similarity=0.349 Sum_probs=202.4
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++..++++||+|-||.|.++.- ..+.+||+|+++.. .+......|.+||++|.+|+||||++++++|..+ +-+
T Consensus 538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D-----ePi 610 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQD-----DPL 610 (807)
T ss_pred hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecC-----Cch
Confidence 3568899999999999999974 33689999998753 2223346799999999999999999999999644 448
Q ss_pred EEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 103 YVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
|+|+|||+ |+|.+++.++. .+.......|+.||..|++||.+.++|||||-+.|+|++.++++||+|||+++-....
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999 99999999873 3344555679999999999999999999999999999999999999999999864433
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh--CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt--G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
..-. .-...+-...|||+|.+.. .+++.++|+|++|+++||+++ ...||...++.+..+....++..+.
T Consensus 691 ~yy~-vqgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~------ 761 (807)
T KOG1094|consen 691 DYYR-VQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG------ 761 (807)
T ss_pred Ccee-eecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC------
Confidence 2211 1122345578999997765 689999999999999999875 6789987776655554433332221
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
..-.....+-++..+.+|+-+|+..|-++||+++++..
T Consensus 762 -----------------~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 762 -----------------RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred -----------------cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 11122334557888999999999999999999999844
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=288.66 Aligned_cols=244 Identities=24% Similarity=0.435 Sum_probs=203.9
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
+..+..+||-|.||.||.+.++.-.-.||||.++ ++.-....|+.|..+|+.++|||+|+|+++|. ...-+|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK---EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT-----~EpPFY 339 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----HEPPFY 339 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhh---hcchhHHHHHHHHHHHHhhcCccHHHHhhhhc-----cCCCeE
Confidence 3456779999999999999999999999999987 45567788999999999999999999999994 444589
Q ss_pred EEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 104 VVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
||+|||. |+|.++++... .++.-...+++.||..|+.||..+++|||||-..|.|+.++..|||+|||++++...++
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT 419 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT 419 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence 9999999 89999998743 46666777888999999999999999999999999999999999999999999976665
Q ss_pred CCcceecccccC---cccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 181 PMTVFWTDYVAT---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 181 ~~~~~~~~~~gt---~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
-. ...|. .-|.|||-+.- ..++.++|||+|||+|||+.| |-.||+|-+..+....+.+..
T Consensus 420 YT-----AHAGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy--------- 483 (1157)
T KOG4278|consen 420 YT-----AHAGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY--------- 483 (1157)
T ss_pred ee-----cccCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc---------
Confidence 32 22233 45999998754 578999999999999999998 889999987655555442211
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
+ ......+++.+.+|++.||++.|.+||++.|+-+
T Consensus 484 --------------R-------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 484 --------------R-------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred --------------c-------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 0 1223468999999999999999999999998843
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=307.35 Aligned_cols=268 Identities=26% Similarity=0.408 Sum_probs=221.0
Q ss_pred ccccccCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcC
Q 008729 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLP 93 (556)
Q Consensus 14 ~~~~~~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~ 93 (556)
|.+.. .-..+|+++..+|+|.||.||+|+|+.+++..|+|+++- +...+..-+..||-+++.++|||||.+++.|+.
T Consensus 7 disrr-nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkL--ep~dd~~~iqqei~~~~dc~h~nivay~gsylr 83 (829)
T KOG0576|consen 7 DISRR-NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKL--EPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR 83 (829)
T ss_pred hhhhc-CCccchhheeeecCCcccchhhhcccccCchhhheeeec--cCCccccccccceeeeecCCCcChHHHHhhhhh
Confidence 33433 556789999999999999999999999999999999984 334456678899999999999999999999964
Q ss_pred CCCCCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCc
Q 008729 94 PSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (556)
Q Consensus 94 ~~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGl 172 (556)
. ..+|++||||+ |+|.+...-.+.+++.++.+..+..++||+|||+.|-+|||||-.|||+++.|.+|++|||.
T Consensus 84 ~-----dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgv 158 (829)
T KOG0576|consen 84 R-----DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGV 158 (829)
T ss_pred h-----cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCc
Confidence 4 34899999999 69999888889999999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCCCcceecccccCcccCCcccc-cccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 008729 173 ARVAFSDTPMTVFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (556)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~~-~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (556)
+-.+..... ...+++||++|||||+. .+....|+..+|||++|+...|+---++|-.....+..+..+.+-.-.
T Consensus 159 saqitati~---KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~q-- 233 (829)
T KOG0576|consen 159 SAQITATIA---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQ-- 233 (829)
T ss_pred hhhhhhhhh---hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCC--
Confidence 866543222 23678899999999974 222267999999999999999998888776665555544444321111
Q ss_pred hHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
-+.......+++.+.+|++.+|.++|++|||++.+|+|||..+
T Consensus 234 ------------------------pp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~ 276 (829)
T KOG0576|consen 234 ------------------------PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ 276 (829)
T ss_pred ------------------------CCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence 1122233457889999999999999999999999999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=259.78 Aligned_cols=209 Identities=25% Similarity=0.437 Sum_probs=173.0
Q ss_pred eEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCceEE
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
...+..||+|+||.|-+.++..+|+..|+|.+..... ....+++++|+.+.... ..|.+|.+|+.+ ....++|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~-----~regdvw 121 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGAL-----FREGDVW 121 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhh-----hccccEE
Confidence 3446789999999999999999999999999986543 45667888999986655 699999999988 4556799
Q ss_pred EEEecCcccHHHH----HHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 104 VVFELMESDLHQV----IKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 104 lV~E~~~g~L~~~----i~~~~~l~~~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
|.||.|+.+|..+ ++..+.++|..+-.|+..++.||.|||++ .|+|||+||+|||+|.+|+|||||||.+-...+
T Consensus 122 IcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 122 ICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred EeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9999999877654 45677899999999999999999999987 899999999999999999999999999876544
Q ss_pred CCCCcceecccccCcccCCcccccc--cCCCCCCcchhhhHHHHHHHHHhCCCCCCC-CChHHHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQLDLI 243 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~y~~~~DIWSlG~ilyelltG~~pF~~-~~~~~~~~~i 243 (556)
.... +-..|-..|||||.+.. ....|+-++||||||++++||.+++.||+. .+.-+++.++
T Consensus 202 SiAk----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 202 SIAK----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred hhHH----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 3322 22347789999998753 224799999999999999999999999964 4555555554
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=294.90 Aligned_cols=202 Identities=25% Similarity=0.422 Sum_probs=175.0
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc--CChh----HHHHHHHHHHHHHhCC---CCCcceeeEE
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF--EHIS----DAIRILREVKLLRLLR---HPDIVEIKRI 90 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~--~~~~----~~~~~~rEi~iL~~L~---HpnIv~l~~v 90 (556)
.....|..++.||.|+||.|++|+++.+...|+||.|.+.. .+.. ..-.+-.||+||..|+ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 33456999999999999999999999999999999987531 1111 1112346999999997 9999999999
Q ss_pred EcCCCCCCCceEEEEEecCc-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEe
Q 008729 91 MLPPSKREFKDIYVVFELME-S-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (556)
Q Consensus 91 ~~~~~~~~~~~lylV~E~~~-g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~ 168 (556)
| ++..++||+||--+ | ||+++|..+..+++.+++.|++|+..|+++||+.||+|||||-+|++++.+|-+||+
T Consensus 638 F-----Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 638 F-----EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred e-----ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEe
Confidence 9 77788999999988 5 999999999999999999999999999999999999999999999999999999999
Q ss_pred eeCccccccCCCCCcceecccccCcccCCcccccccCCCC-CCcchhhhHHHHHHHHHhCCCCCCC
Q 008729 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPG 233 (556)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y-~~~~DIWSlG~ilyelltG~~pF~~ 233 (556)
|||.|....+. .+..++||..|.|||+++| .+| +..-|||+||++||.++....||.+
T Consensus 713 dfgsaa~~ksg-----pfd~f~gtv~~aapevl~g--~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 713 DFGSAAYTKSG-----PFDVFVGTVDYAAPEVLGG--EKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eccchhhhcCC-----CcceeeeeccccchhhhCC--CccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99998765433 2356789999999999998 565 5789999999999999998888853
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=324.74 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=185.0
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
.|...++||+|+||.||+|.+..++..||||++...... ...|+.+++.++|||||++++++. +....|
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~-----~~~~~~ 759 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCR-----SEKGAY 759 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEE-----cCCCCE
Confidence 466778999999999999999999999999998643211 124688999999999999999994 445689
Q ss_pred EEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 104 VVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH---TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLH---s~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
+|||||+ |+|.++++ .+++..+..|+.||+.||+||| +.+|+||||||+||+++.++..+++ ||.+......
T Consensus 760 lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~ 835 (968)
T PLN00113 760 LIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835 (968)
T ss_pred EEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence 9999998 79999996 3889999999999999999999 6699999999999999998888775 6665432211
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV-HQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~-~~~~~i~~~~g~p~~e~i~~~ 258 (556)
....||..|+|||++.+ ..|+.++|||||||++|||++|+.||...... ..+....... .
T Consensus 836 -------~~~~~t~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~----------~ 896 (968)
T PLN00113 836 -------TKCFISSAYVAPETRET--KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYC----------Y 896 (968)
T ss_pred -------CCccccccccCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHh----------c
Confidence 23368899999999887 68999999999999999999999999542210 0000000000 0
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
........++ ................+.+++.+||+.||++|||+.|+++.
T Consensus 897 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 897 SDCHLDMWID----PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CccchhheeC----ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0000000000 00000000001112356789999999999999999999874
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=275.82 Aligned_cols=268 Identities=23% Similarity=0.321 Sum_probs=195.9
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC--CCCCcceeeEEEcCCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL--RHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L--~HpnIv~l~~v~~~~~~~~~ 99 (556)
....+++++||+|.||.||+|. -+++.||||++.. .+.+.+.+|-+|.... +|+||+++++.-.-.+ ...
T Consensus 209 l~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhh--ccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccc
Confidence 3467889999999999999995 4579999999763 4556677888887655 7999999988754333 225
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCcEeecCCCceEEee
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA---------NVYHRDLKPKNILANANCKLKVCD 169 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~---------gIvHrDLKP~NILl~~~~~vKL~D 169 (556)
..++||+||.+ |+|.++++.+ .+++.....++..|.+||+|||+- .|+|||||..||||..|++.-|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 57999999999 9999999976 589999999999999999999974 599999999999999999999999
Q ss_pred eCccccccCCCCCcceecccccCcccCCcccccccCCCCC-----CcchhhhHHHHHHHHHhCCCCCC-CCChHHHHHHH
Q 008729 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYT-----PAIDIWSIGCIFAEVLTGKPLFP-GKSVVHQLDLI 243 (556)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~-----~~~DIWSlG~ilyelltG~~pF~-~~~~~~~~~~i 243 (556)
||+|.......+... ....+||..|||||++.+. ..+. ..+||||+|.|||||++....+. +.-..-++---
T Consensus 360 FGLAl~~~p~~~~~d-~~~qVGT~RYMAPEvLEga-inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGD-THGQVGTRRYMAPEVLEGA-INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred cceeEEecCCCCCcc-hhhhhhhhhhcCHHHHhhh-cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 999988764443332 3458999999999999763 2222 36999999999999999765553 22221122111
Q ss_pred HHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCC--CCCHHHHHHHHHhhhcCCCCCCCHHHH
Q 008729 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP--NVDPLALRLLQRLIAFDPKDRPTAEEA 310 (556)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~--~~s~~~~dLl~~~L~~dP~~Rpta~el 310 (556)
.++-..|+-+.+.. +.-..+.+...+ ..|. ..-..+.+.+..|+..|++.|.|+.=+
T Consensus 438 ~evG~hPt~e~mq~--------~VV~kK~RP~~p--~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQE--------LVVRKKQRPKIP--DAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred HHhcCCCCHHHHHH--------HHHhhccCCCCh--hhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 22333444443321 111111111111 1111 223567899999999999999997544
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=288.11 Aligned_cols=247 Identities=28% Similarity=0.459 Sum_probs=198.2
Q ss_pred EEEeeeeecCceeEEEEEEC----C---CCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCC
Q 008729 26 KILEVIGKGSYGVVCAAIDT----H---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 26 ~i~~~LG~G~~g~V~~a~~~----~---tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~ 97 (556)
.+.+.||+|+||.|++|.-. . ....||||.++..... .+...+..|+++|+.+ .|+||+.+++++.
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t----- 372 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACT----- 372 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeec-----
Confidence 67779999999999999733 1 1457999998865444 7778899999999999 5999999999994
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~ 160 (556)
....+++|+||+. |+|..+++.+. .++......+.+||+.|+.||++..++||||-..|||+.
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 3567999999999 89999998765 388899999999999999999999999999999999999
Q ss_pred CCCceEEeeeCccccccCCCCCcceecccccC--cccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCC-h
Q 008729 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT--RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS-V 236 (556)
Q Consensus 161 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt--~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~-~ 236 (556)
.+..+||+|||+|+.......-.. ....|+ ..|||||.+.. ..|+.++||||+|++|||+++ |..||++-. .
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~--~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRT--KSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred CCCEEEEccccceeccCCCCceEe--cCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 999999999999986543322110 112222 34999999987 789999999999999999999 889998843 2
Q ss_pred HHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 237 ~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.+.++. ++. ... ......+++++.++++.|+..+|++||++.++.+
T Consensus 529 ~~l~~~------------------------l~~---G~r---~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 529 EELLEF------------------------LKE---GNR---MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHH------------------------Hhc---CCC---CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 222221 111 111 1223457899999999999999999999999865
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-30 Score=241.98 Aligned_cols=212 Identities=37% Similarity=0.624 Sum_probs=181.8
Q ss_pred eeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEecCc
Q 008729 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME 110 (556)
Q Consensus 31 LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~ 110 (556)
||.|++|.||++.+..+++.+++|++....... ....+.+|+.+++.++|++|+++++++. .....++|+|++.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~ 74 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCE 74 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCC
Confidence 689999999999998889999999987432211 3567889999999999999999999984 3367899999999
Q ss_pred -ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC-CCceEEeeeCccccccCCCCCcceec
Q 008729 111 -SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVFWT 187 (556)
Q Consensus 111 -g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~ 187 (556)
++|.+++... ..++...+..++.+++.+|++||+.|++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 75 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~~~ 151 (215)
T cd00180 75 GGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---LLK 151 (215)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---hhh
Confidence 7999999875 57899999999999999999999999999999999999999 89999999999976543321 123
Q ss_pred ccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHH
Q 008729 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYL 267 (556)
Q Consensus 188 ~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l 267 (556)
...+...|++||.+... ..++.+.|+|+||+++++|
T Consensus 152 ~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 45578889999998762 2778899999999999998
Q ss_pred HHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCc
Q 008729 268 TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (556)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp 314 (556)
..+.+++.+||..||++||+++++++|+
T Consensus 188 -------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2367899999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=257.60 Aligned_cols=259 Identities=27% Similarity=0.439 Sum_probs=198.8
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.+.|.|.+.||+|.||.+-+|.|+.+++.+++|.+.+. ......|.||...--.| .|.||+.-|++.. +..+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF----qt~d 95 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAF----QTSD 95 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHh----hcCc
Confidence 35799999999999999999999999999999998753 34566788999876666 4899999998753 4445
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee-cC-CCceEEeeeCcccccc
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA-NA-NCKLKVCDFGLARVAF 177 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl-~~-~~~vKL~DFGla~~~~ 177 (556)
.+.+++||+. |||..-+..+| +.+...+.++.|++.||.|+|++++||||||.+|||| +. .-+|||||||+.+...
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 6888999999 89999887754 8889999999999999999999999999999999997 33 3479999999987643
Q ss_pred CCCCCcceecccccCcccCCccccccc---CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~---~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
..-. -.--+..|.+||++... .-...+..|||.||+|+|.+|||++||......
T Consensus 175 ~tV~------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~----------------- 231 (378)
T KOG1345|consen 175 TTVK------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM----------------- 231 (378)
T ss_pred ceeh------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-----------------
Confidence 2111 11134568999987431 123568899999999999999999999743322
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCC---CCHHHHHhCcccc
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEALADPYFK 317 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~R---pta~elL~hp~f~ 317 (556)
+....++..-..++.+ .....|..+++.+..+.++-|..++++| .++......-|..
T Consensus 232 -----d~~Y~~~~~w~~rk~~-~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 232 -----DKPYWEWEQWLKRKNP-ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred -----CchHHHHHHHhcccCc-cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 2222333332222222 3445677899999999999999999999 5555555556654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=263.35 Aligned_cols=259 Identities=25% Similarity=0.334 Sum_probs=188.3
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHH--hCCCCCcceeeEEEcCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR--LLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~--~L~HpnIv~l~~v~~~~~~~~ 98 (556)
.+++..+++.||+|.||.||+|... |+.||||++... +.....||..|.+ .|+|+||+.+++.=..+. ..
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs 280 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDN-GS 280 (513)
T ss_pred hhheeEEEEEecCccccceeecccc--CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCC-Cc
Confidence 4468899999999999999999765 999999998742 3344556666655 569999999988654332 33
Q ss_pred CceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEeecCCCceEEee
Q 008729 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA--------NVYHRDLKPKNILANANCKLKVCD 169 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~--------gIvHrDLKP~NILl~~~~~vKL~D 169 (556)
-..+|||.+|-+ |+|+|+|.. ..++.+....++..++.||+|||.. .|.|||||..|||+..++.+-|+|
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 457999999999 999999987 5689999999999999999999964 499999999999999999999999
Q ss_pred eCccccccCCC-CCcceecccccCcccCCcccccccC--CCCC--CcchhhhHHHHHHHHHhC----------CCCCCCC
Q 008729 170 FGLARVAFSDT-PMTVFWTDYVATRWYRAPELCGSFF--SKYT--PAIDIWSIGCIFAEVLTG----------KPLFPGK 234 (556)
Q Consensus 170 FGla~~~~~~~-~~~~~~~~~~gt~~Y~APE~~~~~~--~~y~--~~~DIWSlG~ilyelltG----------~~pF~~~ 234 (556)
+|||....++. ......+..+||..|||||++...- ..+. ..+||||||.|+||+... .+||.+-
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 99998766553 2344456789999999999986410 1111 358999999999999852 3677543
Q ss_pred ChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCC-cCCCCCCCC--HHHHHHHHHhhhcCCCCCCCHHHH
Q 008729 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVP-LFQKFPNVD--PLALRLLQRLIAFDPKDRPTAEEA 310 (556)
Q Consensus 235 ~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~s--~~~~dLl~~~L~~dP~~Rpta~el 310 (556)
-.. -|+.+.+..+ ...+...| ....|.+.+ ..+..|++.||..||.-|.||--+
T Consensus 440 Vp~-----------DPs~eeMrkV-----------VCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 440 VPS-----------DPSFEEMRKV-----------VCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred CCC-----------CCCHHHHhcc-----------eeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 211 1111111100 11111111 112222222 235678999999999999997655
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=243.92 Aligned_cols=199 Identities=37% Similarity=0.673 Sum_probs=172.6
Q ss_pred eEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEE
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYV 104 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lyl 104 (556)
|.+.+.||.|++|.||+|.+..+++.+|+|.+...... .....+.+|+..++.++|+|++++++.+ ......|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~-----~~~~~~~~ 74 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVF-----EDPEPLYL 74 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeee-----ecCCceEE
Confidence 67889999999999999999988999999998753222 2566788999999999999999999988 34456899
Q ss_pred EEecCcc-cHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCC
Q 008729 105 VFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (556)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~-l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 182 (556)
++|++.+ +|.+++..... +++..+..++.|++.+|.|||+.+++|+||+|.||+++.++.++|+|||++.........
T Consensus 75 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 75 VMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred EEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999996 99999988766 899999999999999999999999999999999999999999999999999876543211
Q ss_pred cceecccccCcccCCcccc-cccCCCCCCcchhhhHHHHHHHHHhCCCCCCC
Q 008729 183 TVFWTDYVATRWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (556)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~~-~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~ 233 (556)
......++..|++||.+ .. ..++.++|+|+|||++|+|++|+.||++
T Consensus 155 --~~~~~~~~~~~~~pe~~~~~--~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 --LLKTVKGTPFYLAPEVLLGG--KGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --cccceeccCCcCCHhHhcCC--CCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12345688899999998 44 6788899999999999999999999977
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=277.11 Aligned_cols=248 Identities=25% Similarity=0.404 Sum_probs=202.8
Q ss_pred eEEEeeeeecCceeEEEEEECCCCc----EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.+..++||+|+||+||+|.....|+ +||||++.. +...+....++.|.-+|..|+|||+++|++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~----- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST----- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence 4456799999999999999876665 688888763 344455678999999999999999999999986543
Q ss_pred eEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 101 DIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
+-||++||. |.|.++++.+ +.+-.+....|.+||++|++|||.++++||||-..|||+..-..+||.|||+|+....
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 689999999 8999999864 5789999999999999999999999999999999999999999999999999998655
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
+..... ....-..+-|||-|.+.. ..|+.++||||+||++||++| |..|+.+....+.-+.+..
T Consensus 851 d~~ey~-~~~gK~pikwmale~i~~--~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~------------ 915 (1177)
T KOG1025|consen 851 DEKEYS-APGGKVPIKWMALESIRI--RKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK------------ 915 (1177)
T ss_pred cccccc-ccccccCcHHHHHHHhhc--cCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc------------
Confidence 443211 112223355888898876 789999999999999999999 9999998876554433311
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
..+ ....+..+-++.-++-+||..|++.||+++++-.
T Consensus 916 -------------geR-----LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 916 -------------GER-----LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred -------------ccc-----CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 111 2344678889999999999999999999998764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=300.41 Aligned_cols=208 Identities=15% Similarity=0.193 Sum_probs=148.1
Q ss_pred hCCC-CCcceeeEEEcCCCC--CCCceEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 008729 78 LLRH-PDIVEIKRIMLPPSK--REFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLK 153 (556)
Q Consensus 78 ~L~H-pnIv~l~~v~~~~~~--~~~~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLK 153 (556)
.++| +||+.+++.|..... .....++++||+++++|+++|.. ...+++.+++.|++||+.||.|||++||+|||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 3445 577777776632211 12245788999999999999975 3469999999999999999999999999999999
Q ss_pred CCcEeecCC-------------------CceEEeeeCccccccCCC-------------CCcceecccccCcccCCcccc
Q 008729 154 PKNILANAN-------------------CKLKVCDFGLARVAFSDT-------------PMTVFWTDYVATRWYRAPELC 201 (556)
Q Consensus 154 P~NILl~~~-------------------~~vKL~DFGla~~~~~~~-------------~~~~~~~~~~gt~~Y~APE~~ 201 (556)
|+||||+.. +.+||+|||+++...... +........+||++|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999654 445566666654321000 000011235689999999998
Q ss_pred cccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCC
Q 008729 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQK 281 (556)
Q Consensus 202 ~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~ 281 (556)
.+ ..|+.++||||||||||||++|.+||..... .+..+.. ... + ..
T Consensus 188 ~~--~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~---------------------------~~~-~--~~ 233 (793)
T PLN00181 188 NG--SSSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRH---------------------------RVL-P--PQ 233 (793)
T ss_pred cc--CCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHH---------------------------hhc-C--hh
Confidence 87 6899999999999999999999888753211 1111100 000 0 00
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 282 FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 282 ~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.....+.+.+++.+||..||.+||++.|+|+||||...
T Consensus 234 ~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 234 ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred hhhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 01123456789999999999999999999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-30 Score=285.63 Aligned_cols=270 Identities=26% Similarity=0.328 Sum_probs=207.4
Q ss_pred CCe-EEEeeeeecCceeEEEEEECCCCcEEEEEEec----CccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 23 NRY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 23 ~~Y-~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~----~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
..| .-..++|.|++|.|+.+......+.++.|... ...........+..|+.+-..|.||||+.....+.
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~----- 391 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ----- 391 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh-----
Confidence 446 45778999999999998888777777777654 11111122223667888889999999988877763
Q ss_pred CCceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
+....+-+||||.+||+..+...+.++..++..++.||+.||+|||+.||.||||||+|+|+..+|.+||+|||.+....
T Consensus 392 ~~~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 392 EIDGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeec
Confidence 23334445999999999999998899999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCC-cceecccccCcccCCcccccccCCCCC-CcchhhhHHHHHHHHHhCCCCCCCCChHHHHH-HHHHhhCCCChHH
Q 008729 178 SDTPM-TVFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD-LITDLLGTPSPET 254 (556)
Q Consensus 178 ~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~~y~-~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~-~i~~~~g~p~~e~ 254 (556)
..... .....+.+|+..|+|||++.+ ..|+ ..+||||+|+|+..|.+|+.||.-....++.. .+
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~--~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~----------- 538 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTG--KEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN----------- 538 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccc--cccCcchhhhhhccceEEEEecCCCccccccccccchhhh-----------
Confidence 44332 233467899999999999988 6787 57999999999999999999996543222110 00
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccc
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 322 (556)
...............+..++...+.+|.+||+.||.+|.|+++|++++||+.+...
T Consensus 539 ------------~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 539 ------------NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECC 594 (601)
T ss_pred ------------ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceE
Confidence 00001111112222334577788999999999999999999999999999976543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=226.73 Aligned_cols=165 Identities=22% Similarity=0.263 Sum_probs=127.9
Q ss_pred ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcceeccc
Q 008729 111 SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189 (556)
Q Consensus 111 g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~ 189 (556)
|+|.+++..+ ..+++..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||+++..... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~--------~~ 64 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE--------QS 64 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc--------cC
Confidence 6899999874 46999999999999999999999999 999999999999999 9998765332 12
Q ss_pred ccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhhCCCChHHHHHhhhHHHHHHHH
Q 008729 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLITDLLGTPSPETIAVVRNEKARKYLT 268 (556)
Q Consensus 190 ~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~-~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~ 268 (556)
.||+.|+|||++.+ ..|+.++|||||||++|||++|+.||....... .+..+. .
T Consensus 65 ~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~-----------------------~ 119 (176)
T smart00750 65 RVDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILL-----------------------N 119 (176)
T ss_pred CCcccccChHHhcC--CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHH-----------------------H
Confidence 58999999999987 689999999999999999999999997654321 111111 1
Q ss_pred HhhcCCCCCcCCCCCCCCH--HHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 269 EMRKKPPVPLFQKFPNVDP--LALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 269 ~~~~~~~~~~~~~~~~~s~--~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
.+....... ......++. .+.+||.+||..||++|||+.++++|+|+.
T Consensus 120 ~~~~~~~~~-~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 120 GMPADDPRD-RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HhccCCccc-cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 111110000 000112233 689999999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-25 Score=225.27 Aligned_cols=265 Identities=34% Similarity=0.521 Sum_probs=204.9
Q ss_pred eEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChh-HHHHHHHHHHHHHhCCCC-CcceeeEEEcCCCCCCCceE
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS-DAIRILREVKLLRLLRHP-DIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~-~~~~~~rEi~iL~~L~Hp-nIv~l~~v~~~~~~~~~~~l 102 (556)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.++..+.|+ +|+++++.+. .....
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEE
Confidence 889999999999999999887 7899999876544443 567789999999999988 7999999993 33448
Q ss_pred EEEEecCc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC-ceEEeeeCcccccc
Q 008729 103 YVVFELME-SDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAF 177 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~vKL~DFGla~~~~ 177 (556)
+++++++. ++|.+++.... .+....+..++.|++.++.|+|+.|++||||||+||+++..+ .++++|||.++...
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 99999999 58887777765 799999999999999999999999999999999999999988 79999999998543
Q ss_pred CCCCCc---ceecccccCcccCCcccccccC-CCCCCcchhhhHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhhCCC
Q 008729 178 SDTPMT---VFWTDYVATRWYRAPELCGSFF-SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---VHQLDLITDLLGTP 250 (556)
Q Consensus 178 ~~~~~~---~~~~~~~gt~~Y~APE~~~~~~-~~y~~~~DIWSlG~ilyelltG~~pF~~~~~---~~~~~~i~~~~g~p 250 (556)
...... ......+|+.+|++||.+.+.. ..+....|+||+|++++++++|..||..... .............+
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 332211 1346778999999999987621 3678899999999999999999999877663 12222111111111
Q ss_pred ChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCC-CCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~-~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.......... ......+.+++.+++..+|..|.+..+...++|....
T Consensus 234 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 234 ----------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred ----------------------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 0000000000 1123578999999999999999999999998776543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.6e-26 Score=236.03 Aligned_cols=180 Identities=21% Similarity=0.217 Sum_probs=134.6
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECC-CCcEEEEEEecCccC---ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFE---HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~-tg~~vAiK~i~~~~~---~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
..++|.+.+.||+|+||+||+|++.. +++.||||++..... .......+.+|+.+|+.|+|+||+..+..+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence 34689999999999999999999886 678889998753211 223455688999999999999998533221
Q ss_pred CCCceEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCcEeecCCCceEEeeeCccc
Q 008729 97 REFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDL-KPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 97 ~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDL-KP~NILl~~~~~vKL~DFGla~ 174 (556)
...|||||||.| +|. .+... . ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+
T Consensus 91 ---~~~~LVmE~~~G~~L~-~~~~~---~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLH-LARPH---G---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred ---CCcEEEEEccCCCCHH-HhCcc---c---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 237999999985 675 22211 1 1468899999999999999999999 9999999999999999999998
Q ss_pred cccCCCCCcc-----eecccccCcccCCcccccccCCC----CCCcchhh
Q 008729 175 VAFSDTPMTV-----FWTDYVATRWYRAPELCGSFFSK----YTPAIDIW 215 (556)
Q Consensus 175 ~~~~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~----y~~~~DIW 215 (556)
.......... ..+..++++.|+|||.+...... .+...|-|
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 7543321111 12456788899999988542222 23346766
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-25 Score=226.20 Aligned_cols=256 Identities=21% Similarity=0.210 Sum_probs=191.3
Q ss_pred CeEEEeeeeecCceeEEEEEECCCC-cEEEEEEecCccCChhHHHHHHHHHHHHHhCCC----CCcceeeEEEcCCCCCC
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVFEHISDAIRILREVKLLRLLRH----PDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg-~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H----pnIv~l~~v~~~~~~~~ 98 (556)
+|++.+.||+|+||.||.|.+..++ ..+|+|......... .. .+..|+.+|..+.. .++..+++... ..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~-~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~ 92 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK-PS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGR----ST 92 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC-Cc-cchhHHHHHHHHhhhcCCCCCCEEEEecc----CC
Confidence 8999999999999999999988775 678999776432211 11 56678999888873 58888888773 24
Q ss_pred CceEEEEEecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC-----CceEEeeeC
Q 008729 99 FKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-----CKLKVCDFG 171 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-----~~vKL~DFG 171 (556)
..+-||||+.++.+|.++.+.. +.++...+..++.|++.+|.+||+.|++||||||+|+++... ..+.|.|||
T Consensus 93 ~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 93 EDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred CceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 4567999999999999988654 579999999999999999999999999999999999999765 369999999
Q ss_pred ccc--cccCCCCC-----cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 008729 172 LAR--VAFSDTPM-----TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244 (556)
Q Consensus 172 la~--~~~~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~ 244 (556)
+|+ ........ ......+.||..|.++....+ ...++..|+||++.++.+|+.|..||.+.........+.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--IEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--CccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 998 43222211 111134669999999999988 788999999999999999999999997765433322221
Q ss_pred HhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 245 ~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.. ........ .....+..+.++...+-..+...+|....+...
T Consensus 251 ~~-----------------------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 251 KD-----------------------PRKLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HH-----------------------hhhhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 10 00000000 122344566777777777888888887776554
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=223.70 Aligned_cols=252 Identities=18% Similarity=0.299 Sum_probs=196.9
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCC-----cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTG-----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg-----~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
.|+++...+-+|.||.||.|+++... +.|-+|.++.. ...-....++.|-..|..+.|||+..+.++.. +
T Consensus 284 ~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V~i----e 358 (563)
T KOG1024|consen 284 CRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGVSI----E 358 (563)
T ss_pred hheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEEEe----e
Confidence 36888889999999999999876433 34566655532 33345667889999999999999999999985 3
Q ss_pred CCceEEEEEecCc-ccHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEe
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAN--------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~--------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~ 168 (556)
+...-++++.+++ |+|..++.-. ..++..+.-.++.||..|+.|||+.||+|.||-..|.+|++.-+|||+
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 4455788999999 8999999721 246677777889999999999999999999999999999999999999
Q ss_pred eeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhh
Q 008729 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247 (556)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~ 247 (556)
|=.++|..+...-.... ..--....||+||.+.+ ..|+.++|+||||++||||+| |+.|+..-+..+....+.+.
T Consensus 439 DsaLSRDLFP~DYhcLG-DnEnRPvkWMslEal~n--~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG- 514 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLG-DNENRPVKWMSLEALQN--SHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG- 514 (563)
T ss_pred cchhccccCcccccccC-CCCCCcccccCHHHHhh--hhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc-
Confidence 99999986543321110 01113346999999988 789999999999999999998 89999776655544433221
Q ss_pred CCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.+. ...-++++++..++.-||..+|++||+.+|+..
T Consensus 515 ------------------------yRl-----aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 515 ------------------------YRL-----AQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ------------------------cee-----cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 111 223479999999999999999999999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-26 Score=244.87 Aligned_cols=241 Identities=24% Similarity=0.401 Sum_probs=198.8
Q ss_pred eeeecCceeEEEEEE---CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCCceEEEE
Q 008729 30 VIGKGSYGVVCAAID---THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIYVV 105 (556)
Q Consensus 30 ~LG~G~~g~V~~a~~---~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~lylV 105 (556)
++|.|+||.|++++. ...|..||+|+.++.-.......+...|-.++...+ ||.+|++...+ +....+|++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHh
Confidence 479999999998753 345778999998765444333335567888898887 99999999999 445569999
Q ss_pred EecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcc
Q 008729 106 FELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184 (556)
Q Consensus 106 ~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~ 184 (556)
+++.. |+|+..+.....+.+...+.+...++.|+.++|+.+|+|||+|++||+++.+|++|+.|||+++.......
T Consensus 76 ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--- 152 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--- 152 (612)
T ss_pred hhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence 99998 59999999888999999999999999999999999999999999999999999999999999987654322
Q ss_pred eecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHH
Q 008729 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKAR 264 (556)
Q Consensus 185 ~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~ 264 (556)
.|||..|||||++. ++..++|+||+|+++++|++|..||.+ +....|..
T Consensus 153 ----~cgt~eymApEI~~----gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~------------------- 201 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN----GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILK------------------- 201 (612)
T ss_pred ----cccchhhhhhHhhh----ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhh-------------------
Confidence 28999999999986 467899999999999999999999987 33333321
Q ss_pred HHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHhCcccccccc
Q 008729 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGLAK 321 (556)
Q Consensus 265 ~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-----a~elL~hp~f~~~~~ 321 (556)
..... ...++..+++++..++..+|..|.. +.++++|+||..+..
T Consensus 202 -------~~~~~-----p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 202 -------AELEM-----PRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred -------hccCC-----chhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeH
Confidence 11111 1347788999999999999999975 589999999997653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=204.60 Aligned_cols=209 Identities=26% Similarity=0.348 Sum_probs=169.3
Q ss_pred ccCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCC-CCcceeeEEEcCCCC
Q 008729 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH-PDIVEIKRIMLPPSK 96 (556)
Q Consensus 18 ~~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H-pnIv~l~~v~~~~~~ 96 (556)
++-.++.|+++++||.|+||.+|+|+...+|+.||||+-.....+ ..+..|.++.+.|++ ..|..+..+.
T Consensus 10 ~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~----- 80 (341)
T KOG1163|consen 10 ELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYG----- 80 (341)
T ss_pred hheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhc-----
Confidence 355678999999999999999999999999999999986543332 246789999999975 5666666665
Q ss_pred CCCceEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC---CceEEeeeCc
Q 008729 97 REFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFGL 172 (556)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~vKL~DFGl 172 (556)
.+..+-.+||++++.+|.+++.- +..++...+..++-|++.-|.|+|..+++||||||+|+|+.-+ ..+.++|||+
T Consensus 81 ~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 81 TEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred cccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence 55566789999999888888764 4579999999999999999999999999999999999997532 4599999999
Q ss_pred cccccCCCCC-cce---ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChH
Q 008729 173 ARVAFSDTPM-TVF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237 (556)
Q Consensus 173 a~~~~~~~~~-~~~---~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~ 237 (556)
|+.+.+.... ... -....||..|.+--...+ ..-+...|+-|+|.+|..+..|..||.|-...
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--IEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhh--hhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 9876543221 111 134679999999887766 45678899999999999999999999886543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-24 Score=209.83 Aligned_cols=242 Identities=21% Similarity=0.283 Sum_probs=193.9
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~ 99 (556)
.+-.|+|+++||.|+||++++|...-+++.||||.-... +++-.+..|.+..+.|. .++|...|-+- .++
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk----S~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG 96 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK----SEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEG 96 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc----CCcchHHHHHHHHHHHcCCCCCCceeeec-----ccc
Confidence 345799999999999999999999999999999964322 34556777888888885 68888776655 666
Q ss_pred ceEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC-----ceEEeeeCcc
Q 008729 100 KDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-----KLKVCDFGLA 173 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-----~vKL~DFGla 173 (556)
.+-.||+|+++.+|.+++.-. ..|+...+..++.|++.-+.|+|++++|.|||||+|+||..-+ .|.|+|||+|
T Consensus 97 ~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 97 KYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred chhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 777899999998888877654 4699999999999999999999999999999999999997543 4899999999
Q ss_pred ccccCCCC-Ccce---ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC---ChHHHHHHHHHh
Q 008729 174 RVAFSDTP-MTVF---WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK---SVVHQLDLITDL 246 (556)
Q Consensus 174 ~~~~~~~~-~~~~---~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~---~~~~~~~~i~~~ 246 (556)
+.+.+... ..+. .....||..||+-....| ..-+...|+-|||.++..+|.|..||.|. +..+..++|-+.
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeecccc--chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 88654322 1222 234679999999998888 67789999999999999999999999874 566777777776
Q ss_pred hCCCChHHHHHhhhHHHHHHHHHhhcC
Q 008729 247 LGTPSPETIAVVRNEKARKYLTEMRKK 273 (556)
Q Consensus 247 ~g~p~~e~i~~~~~~~~~~~l~~~~~~ 273 (556)
...-+.+.++.--.+....|+.-.+..
T Consensus 255 Kr~T~i~~Lc~g~P~efa~Yl~yvR~L 281 (449)
T KOG1165|consen 255 KRSTPIEVLCEGFPEEFATYLRYVRRL 281 (449)
T ss_pred cccCCHHHHHhcCHHHHHHHHHHHHhc
Confidence 666666666655556666666665544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.5e-25 Score=241.36 Aligned_cols=229 Identities=27% Similarity=0.421 Sum_probs=172.1
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
.....|..++.|..|+||-||+++|+.+.+.+|+| |++. .-++|- ||.....|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq-------~lilRn--ilt~a~np----------------- 132 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQ-------NLILRN--ILTFAGNP----------------- 132 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhc-cccc-------chhhhc--cccccCCc-----------------
Confidence 34467899999999999999999999999999994 4431 111111 22222222
Q ss_pred ceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
++| ||=...++..+.++.+. +.+++|||+.||+|||+||+|+||..-|++|++|||+.+.....
T Consensus 133 ---fvv-----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 133 ---FVV-----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ---cee-----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 233 55555666656666544 78999999999999999999999999999999999998764322
Q ss_pred CCCc-----------ce-ecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 008729 180 TPMT-----------VF-WTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (556)
Q Consensus 180 ~~~~-----------~~-~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~ 247 (556)
.... .+ -...|||+.|+|||++.. .+|+..+|+|++|+|+|+++-|..||.|.+..+.+..+..-.
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr--qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~ 274 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 274 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhh--hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence 1110 01 124589999999999987 789999999999999999999999999998877665542211
Q ss_pred CCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC---CHHHHHhCcccccccc
Q 008729 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP---TAEEALADPYFKGLAK 321 (556)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp---ta~elL~hp~f~~~~~ 321 (556)
+.+.+.-...+++++++|.++|..+|..|. .+-++-+|+||+.+..
T Consensus 275 ----------------------------i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 275 ----------------------------IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred ----------------------------ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence 111122345789999999999999999994 5777889999998753
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-25 Score=243.78 Aligned_cols=252 Identities=27% Similarity=0.422 Sum_probs=187.0
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc--CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.|...+.||++.|=+|++|+|.+ |. |+||++.+.. -......+.++|++ ...++|||.+.+..+. ...+.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence 79999999999999999997653 44 9999986533 22344555667777 6667999999988876 45567
Q ss_pred EEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc--CC
Q 008729 102 IYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF--SD 179 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~--~~ 179 (556)
.|||-+|...+|+|.|..++-+..-+.+.|+.|||.||+-||..||+|+|||.+||||..=+.+.|+||..-+... .+
T Consensus 96 AylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 8999999999999999998889999999999999999999999999999999999999998899999998765532 22
Q ss_pred CCC--cceecccccCcccCCcccccccC--------CC-CCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhh
Q 008729 180 TPM--TVFWTDYVATRWYRAPELCGSFF--------SK-YTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247 (556)
Q Consensus 180 ~~~--~~~~~~~~gt~~Y~APE~~~~~~--------~~-y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~ 247 (556)
.+. ..++.+...-..|.|||.+.... .. .+++.||||+||+++||++ |+|||.-. |+-....
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~-- 249 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRS-- 249 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhc--
Confidence 221 12222222334699999764310 11 5678999999999999998 79999421 1110000
Q ss_pred CCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
|. .......++++ -+...+.||..|++.||.+|.+|++.|+-
T Consensus 250 ~~----------~~~~e~~Le~I--------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 250 GN----------ADDPEQLLEKI--------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cC----------ccCHHHHHHhC--------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 00 00011112211 23468999999999999999999999976
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=209.15 Aligned_cols=240 Identities=21% Similarity=0.278 Sum_probs=152.7
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCC----------CCcceeeEEEc
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRH----------PDIVEIKRIML 92 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~H----------pnIv~l~~v~~ 92 (556)
.+...+.||.|+++.||.+.|..||+.+|+|++..... .......+.+|.-....+.+ -.++.-+++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46778899999999999999999999999998753322 22345556666544444322 12333333322
Q ss_pred CCCC-------C--CCc---eEEEEEecCcccHHHHHHh---CCCC----CHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 008729 93 PPSK-------R--EFK---DIYVVFELMESDLHQVIKA---NDDL----TREHHQFFLYQMLRALKYMHTANVYHRDLK 153 (556)
Q Consensus 93 ~~~~-------~--~~~---~lylV~E~~~g~L~~~i~~---~~~l----~~~~~~~i~~QIl~aL~yLHs~gIvHrDLK 153 (556)
.... . ..- +.+++|+-+.+||.+++.. .... .......+..|+++.+++||+.||+|+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 1110 0 011 3578999999998887652 2222 222234455899999999999999999999
Q ss_pred CCcEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCccccccc------CCCCCCcchhhhHHHHHHHHHhC
Q 008729 154 PKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTG 227 (556)
Q Consensus 154 P~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~------~~~y~~~~DIWSlG~ilyelltG 227 (556)
|+|++++.+|.++|+||+......... .....+..|.+||+.... ...++.+.|.|+||+++|.|+||
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRY------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEE------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred eeeEEEcCCCCEEEcChHHHeecCcee------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 999999999999999998776543211 113355779999976431 13578899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 008729 228 KPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR 304 (556)
Q Consensus 228 ~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~R 304 (556)
+.||........ ....+..+.+++..+++||+.||++||.+|
T Consensus 247 ~lPf~~~~~~~~-----------------------------------~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEAD-----------------------------------PEWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGST-----------------------------------SGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCcccc-----------------------------------ccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999976542110 000223334789999999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-23 Score=201.63 Aligned_cols=176 Identities=11% Similarity=0.114 Sum_probs=133.2
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhH-HHH------HHHHHHHHHhCCCCCcceeeEEEcCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD-AIR------ILREVKLLRLLRHPDIVEIKRIMLPP 94 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~-~~~------~~rEi~iL~~L~HpnIv~l~~v~~~~ 94 (556)
.++|+++++||.|+||.||++.+ ++..||||++......... ..+ +.+|++.+.++.|++|..+.+.+...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 47999999999999999999654 4778999999754333222 223 56899999999999999999886543
Q ss_pred CCC---CCceEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeee
Q 008729 95 SKR---EFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (556)
Q Consensus 95 ~~~---~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DF 170 (556)
... .....||||||++| +|.++.. +++ ..+.+|+.+|..||..|++||||||+||+++.+| ++|+||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 211 12458999999997 7877632 333 3466999999999999999999999999999988 999999
Q ss_pred CccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHH
Q 008729 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225 (556)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyell 225 (556)
|..+....+.... .+... ..|+.++|+||||+++..+.
T Consensus 179 g~~~~~~e~~a~d---------------~~vle--r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAKD---------------RIDLE--RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhHH---------------HHHHH--hHhcccccccceeEeehHHH
Confidence 9876542221110 02233 46778999999999887664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-23 Score=197.16 Aligned_cols=140 Identities=21% Similarity=0.243 Sum_probs=109.3
Q ss_pred EeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhH------------------------HHHHHHHHHHHHhCCCCC
Q 008729 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD------------------------AIRILREVKLLRLLRHPD 83 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~------------------------~~~~~rEi~iL~~L~Hpn 83 (556)
...||+|+||.||+|.+. +|+.||||+++........ .....+|+++|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999987 8999999998643211100 112345999999998887
Q ss_pred cceeeEEEcCCCCCCCceEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCcEeecC
Q 008729 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM-HTANVYHRDLKPKNILANA 161 (556)
Q Consensus 84 Iv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yL-Hs~gIvHrDLKP~NILl~~ 161 (556)
+.....+.. ...||||||++| +|...+...+.++.+.+..++.||+.+|.|| |+.||+||||||+|||++
T Consensus 81 v~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~- 152 (190)
T cd05147 81 IPCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH- 152 (190)
T ss_pred CCCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-
Confidence 744333221 113899999996 5555544567899999999999999999999 799999999999999998
Q ss_pred CCceEEeeeCccccc
Q 008729 162 NCKLKVCDFGLARVA 176 (556)
Q Consensus 162 ~~~vKL~DFGla~~~ 176 (556)
++.++|+|||+|...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 578999999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=201.83 Aligned_cols=255 Identities=28% Similarity=0.376 Sum_probs=175.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCC-----------------------------------cEEEEEEecCccCChhHH
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-----------------------------------EKVAIKKIHDVFEHISDA 66 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg-----------------------------------~~vAiK~i~~~~~~~~~~ 66 (556)
.++|+|++.||+|.-..||.|....+| -..|||.+.+. ++.+..
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~-~~~s~~ 234 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNF-EHDSGD 234 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccc-ccCCch
Confidence 457999999999999999999754322 13566655432 222222
Q ss_pred HHHHH----HH------HHH--------H-------h-CCCCCcceeeEEEcCC----------------------CCCC
Q 008729 67 IRILR----EV------KLL--------R-------L-LRHPDIVEIKRIMLPP----------------------SKRE 98 (556)
Q Consensus 67 ~~~~r----Ei------~iL--------~-------~-L~HpnIv~l~~v~~~~----------------------~~~~ 98 (556)
..+++ |+ ..+ + + -+|||||.+..+|.+. ....
T Consensus 235 ~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~ 314 (598)
T KOG4158|consen 235 AHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGE 314 (598)
T ss_pred HHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCC
Confidence 23322 21 011 1 1 2599999999887432 1234
Q ss_pred CceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec--CCC--ceEEeeeCccc
Q 008729 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN--ANC--KLKVCDFGLAR 174 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~--~~~--~vKL~DFGla~ 174 (556)
...+|+||.....+|++++-.+ ..+.....-++.|+|+|+.|||.+||.|||||.+|||+. +|+ .++|+|||++-
T Consensus 315 ~~tlylvMkrY~~tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 315 PKTLYLVMKRYRQTLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred CceEEEehhcchhhHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 4679999999999999999865 467777788999999999999999999999999999974 443 38899999874
Q ss_pred cccCCC---CCcceecccccCcccCCcccccccCCC---CC-CcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 008729 175 VAFSDT---PMTVFWTDYVATRWYRAPELCGSFFSK---YT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (556)
Q Consensus 175 ~~~~~~---~~~~~~~~~~gt~~Y~APE~~~~~~~~---y~-~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~ 247 (556)
-..... +-....-+..|.-..||||+......+ .+ .++|.|++|.+-||++....||.+......-
T Consensus 394 Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~------- 466 (598)
T KOG4158|consen 394 ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD------- 466 (598)
T ss_pred eccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec-------
Confidence 322211 111111244577889999997642111 12 4799999999999999999999874422110
Q ss_pred CCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH
Q 008729 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307 (556)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta 307 (556)
.+.| ....+......+++.+++|+..+|+.||++|+++
T Consensus 467 ---------------~r~Y-------qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 467 ---------------TRTY-------QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred ---------------hhhh-------hhhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 0001 1111122334689999999999999999999984
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=189.64 Aligned_cols=141 Identities=21% Similarity=0.189 Sum_probs=111.3
Q ss_pred EEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChh------------------------HHHHHHHHHHHHHhCCCC
Q 008729 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS------------------------DAIRILREVKLLRLLRHP 82 (556)
Q Consensus 27 i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~------------------------~~~~~~rEi~iL~~L~Hp 82 (556)
+.+.||+|+||.||+|.+. +|+.||||++........ ....+.+|+..+..+.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 899999999874321100 012345799999999999
Q ss_pred CcceeeEEEcCCCCCCCceEEEEEecCccc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEeec
Q 008729 83 DIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILAN 160 (556)
Q Consensus 83 nIv~l~~v~~~~~~~~~~~lylV~E~~~g~-L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~ 160 (556)
+|.....+... ..||||||++|. +...+.....++...+..++.|++.+|.+||+ .||+||||||+|||++
T Consensus 80 ~i~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 80 GVPVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred CCCCceEEEec-------CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 87554444311 138999999963 43333344678889999999999999999999 9999999999999998
Q ss_pred CCCceEEeeeCccccc
Q 008729 161 ANCKLKVCDFGLARVA 176 (556)
Q Consensus 161 ~~~~vKL~DFGla~~~ 176 (556)
++.++|+|||+|...
T Consensus 153 -~~~~~liDFG~a~~~ 167 (190)
T cd05145 153 -DGKPYIIDVSQAVEL 167 (190)
T ss_pred -CCCEEEEEcccceec
Confidence 789999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-21 Score=182.61 Aligned_cols=191 Identities=15% Similarity=0.067 Sum_probs=138.1
Q ss_pred EEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCC--hhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCCceE
Q 008729 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH--ISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 26 ~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~l 102 (556)
.+...|++|+||+|+++.. .+.+++.+.+.....- ......+.+|+++|++|. |++|++++++. ..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CE
Confidence 4678899999999998854 6778887776532111 112235789999999995 58899988752 26
Q ss_pred EEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCcEeecCCCceEEeeeCccccccCCC
Q 008729 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDL-KPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDL-KP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
|++|||+.| +|.+.+.. . ...++.|++.+|++||++||+|||| ||+|||++.++.++|+|||+|.......
T Consensus 74 ~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred EEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999999997 66554321 1 2357899999999999999999999 7999999999999999999998543322
Q ss_pred CCc-cee---------cccccCcccCCcccccccCCCCC-CcchhhhHHHHHHHHHhCCCCCCCCC
Q 008729 181 PMT-VFW---------TDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKS 235 (556)
Q Consensus 181 ~~~-~~~---------~~~~gt~~Y~APE~~~~~~~~y~-~~~DIWSlG~ilyelltG~~pF~~~~ 235 (556)
... ... .-...++.|+.|+...-. ...+ ...++++.|+-+|.++|+..++.+.+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 100 000 011256778888753321 1233 56788999999999999998886554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.2e-21 Score=183.87 Aligned_cols=134 Identities=21% Similarity=0.244 Sum_probs=106.4
Q ss_pred EeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-----CCCCcceeeEEEcCCCCCCCceE
Q 008729 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-----RHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-----~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
.+.||+|+||.||. ++.++.. +||++... .......+.+|+.+++.| .||||+++++++.+.. ....+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~--~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v 79 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHR--GDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV 79 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecc--ccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence 56899999999995 7877776 69988642 223445789999999999 5799999999996542 22344
Q ss_pred E-EEEecCc---ccHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHHCCceeccCCCCcEeecCC----CceEEeeeC
Q 008729 103 Y-VVFELME---SDLHQVIKANDDLTREHHQFFLYQMLRAL-KYMHTANVYHRDLKPKNILANAN----CKLKVCDFG 171 (556)
Q Consensus 103 y-lV~E~~~---g~L~~~i~~~~~l~~~~~~~i~~QIl~aL-~yLHs~gIvHrDLKP~NILl~~~----~~vKL~DFG 171 (556)
| +|+||++ ++|.++++.. .+++. ..++.|++.++ +|||+++|+||||||+|||++.+ ..++|+||+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 4 7899955 6999999763 46655 46788999888 89999999999999999999743 379999955
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.1e-20 Score=183.36 Aligned_cols=146 Identities=17% Similarity=0.143 Sum_probs=112.8
Q ss_pred CCCeEEEeeeeecCceeEEEEE-ECCCCcEEEEEEecCccCCh--------------------h--HHHHHHHHHHHHHh
Q 008729 22 ANRYKILEVIGKGSYGVVCAAI-DTHTGEKVAIKKIHDVFEHI--------------------S--DAIRILREVKLLRL 78 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~-~~~tg~~vAiK~i~~~~~~~--------------------~--~~~~~~rEi~iL~~ 78 (556)
+.-|.+.+.||+|+||.||+|. +..+|+.||||++....... . ....+.+|+.+++.
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458999999999999999999 77899999999986421100 0 11235689999999
Q ss_pred CCCCCcceeeEEEcCCCCCCCceEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCc
Q 008729 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN-VYHRDLKPKN 156 (556)
Q Consensus 79 L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~g-IvHrDLKP~N 156 (556)
+.+. ++.+..++.. ...|+||||++| +|...+..+..+....+..++.||+.+|++||+.| |+||||||+|
T Consensus 107 L~~~-~i~~p~~~~~------~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~N 179 (237)
T smart00090 107 LYEA-GVPVPKPIAW------RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYN 179 (237)
T ss_pred HHhc-CCCCCeeeEe------cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhh
Confidence 9763 2332233311 124899999997 56555544556777778899999999999999999 9999999999
Q ss_pred EeecCCCceEEeeeCcccc
Q 008729 157 ILANANCKLKVCDFGLARV 175 (556)
Q Consensus 157 ILl~~~~~vKL~DFGla~~ 175 (556)
|+++ ++.++|+|||.|..
T Consensus 180 Ili~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EEEE-CCCEEEEEChhhhc
Confidence 9999 88999999998864
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.9e-20 Score=209.64 Aligned_cols=192 Identities=24% Similarity=0.321 Sum_probs=152.4
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC---CCCcceeeEEEcCCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~---HpnIv~l~~v~~~~~~~~~ 99 (556)
..|.|-+.||+|+||.||.|.+.. |+.||||+-+... ...++--.+++.+|+ -+.|..+..+++..
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~-----~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~----- 766 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPN-----PWEFYICLQVMERLKPQMLPSIMHISSAHVFQ----- 766 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCC-----ceeeeehHHHHHhhchhhhcchHHHHHHHccC-----
Confidence 579999999999999999999877 9999999755321 112222233444444 24555555555332
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC-------CCceEEeeeC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-------NCKLKVCDFG 171 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-------~~~vKL~DFG 171 (556)
+.-+||+||.+ |+|.+++..++.+++..+.+|..|+|+.|.+||..+|||+||||+|+||.. +--++|+|||
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 23589999999 999999999999999999999999999999999999999999999999842 2349999999
Q ss_pred ccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCC
Q 008729 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (556)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~ 228 (556)
.+....--.+. ..+...++|-.+-.+|...| ..++..+|.|.|+.+++-||.|+
T Consensus 847 ~siDm~lfp~~-~~F~~~~~td~f~C~EM~~g--rpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 847 RSIDMKLFPDG-TKFKAVWHTDLFDCIEMREG--RPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cceeeeEcCCC-cEEeeeeccccchhHHHhcC--CCCchhhhhHHHHHHHHHHHHHH
Confidence 98654322222 23467789999999999988 79999999999999999999997
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-21 Score=214.52 Aligned_cols=265 Identities=23% Similarity=0.324 Sum_probs=210.2
Q ss_pred CCCeEEEeeeeecCceeEEEEEECC-CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~-tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~ 99 (556)
...|.+.+.||+|+|+.|-++.... +...+|.|.+...........++..|..+-+.+. |.|++.+++.. .+.
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSP 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCC
Confidence 3579999999999999999887643 3446788877654434445556667888888887 99999999987 555
Q ss_pred ceEEEEEecCc-ccHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEeecCCC-ceEEeeeCccc
Q 008729 100 KDIYVVFELME-SDLHQVI-KAND-DLTREHHQFFLYQMLRALKYMH-TANVYHRDLKPKNILANANC-KLKVCDFGLAR 174 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i-~~~~-~l~~~~~~~i~~QIl~aL~yLH-s~gIvHrDLKP~NILl~~~~-~vKL~DFGla~ 174 (556)
...+++++|.. ++++..+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .+++.|||+|.
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhc
Confidence 67899999987 5899888 5544 6788889999999999999999 99999999999999999999 99999999998
Q ss_pred cccCCCCCcceeccccc-CcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 175 VAFSDTPMTVFWTDYVA-TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~g-t~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
...............+| ++.|+|||...+. ....+..|+||+|+++..+++|..||......+..
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~------------- 239 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR------------- 239 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCcccccccccc-------------
Confidence 87652333334567788 9999999998773 23458899999999999999999999665432210
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
|...+ ..........|..++..+.+++.++|..+|..|.+.+++-.++|+..
T Consensus 240 ------------~~~~~-~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 240 ------------YSSWK-SNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ------------ceeec-ccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 00101 11111223456788999999999999999999999999999999987
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.2e-19 Score=171.77 Aligned_cols=136 Identities=21% Similarity=0.276 Sum_probs=110.2
Q ss_pred EeeeeecCceeEEEEEECCCCcEEEEEEecCccCCh------hHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI------SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~------~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++.||+|++|.||+|.+ .|..|++|+........ ....++.+|+.++..+.|++|.....++. +...
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~ 73 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPEN 73 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCC
Confidence 36799999999999986 67889999865322111 12346788999999999998877666653 2345
Q ss_pred EEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 102 lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
.++||||++| +|.+++..... ....++.+|+.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus 74 ~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 74 FIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 7899999985 89988865432 7788999999999999999999999999999999 78899999999875
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.7e-20 Score=193.96 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=170.5
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCC---CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeE-------EE
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR-------IM 91 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~-------v~ 91 (556)
...+.+.+..+..++|.++...-... .+.++-|..+ ..+........+++-.+....|-+..-+.+ .+
T Consensus 243 ~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~--~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~ 320 (516)
T KOG1033|consen 243 SGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRAD--VDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESS 320 (516)
T ss_pred cccccccccccccccCCchhhhhcccchhhhhccchhhh--ccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhc
Confidence 34566677777777777766543333 2333333322 122233445556777666665544333333 11
Q ss_pred cCCCCCCCceEEEEEecCc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEE
Q 008729 92 LPPSKREFKDIYVVFELME-SDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167 (556)
Q Consensus 92 ~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL 167 (556)
....-....++||.|++|. .+|.++|..+. ..+.-..+.|+.||..|++| +|.+|||+||.||++..++.+||
T Consensus 321 ~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 321 KRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred cccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhh
Confidence 1111112346899999999 79999997533 46778889999999999999 99999999999999999999999
Q ss_pred eeeCccccccCCC---CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHH
Q 008729 168 CDFGLARVAFSDT---PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLI 243 (556)
Q Consensus 168 ~DFGla~~~~~~~---~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG-~~pF~~~~~~~~~~~i 243 (556)
.|||+........ +.....+..+||.|||+||.+.+ ..|+.++||||||+|||||+.- ...|. ...
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--~~y~~kvdIyaLGlil~EL~~~f~T~~e------r~~-- 467 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG--QQYSEKVDIYALGLILAELLIQFSTQFE------RIA-- 467 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh--hhhhhhcchhhHHHHHHHHHHHhccHHH------HHH--
Confidence 9999987654443 11122466789999999999998 7899999999999999999972 21221 111
Q ss_pred HHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.+..+++....+ .+..-.+...+||.+||...|.+||++.+.--|.|.
T Consensus 468 ----------------------t~~d~r~g~ip~---~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 468 ----------------------TLTDIRDGIIPP---EFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred ----------------------hhhhhhcCCCCh---HHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 112222221111 011123456799999999999999977777677664
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.1e-19 Score=171.22 Aligned_cols=244 Identities=15% Similarity=0.230 Sum_probs=182.5
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
...++.+|...-.|..|+++.. |..++.|++....-.......|..|.-.|+.+.||||+.+++.+ ....++.
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-----nsppnlv 263 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-----NSPPNLV 263 (448)
T ss_pred hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-----cCCCCce
Confidence 3456778899999999999754 66788888764333333445677889999999999999999999 4446689
Q ss_pred EEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 104 VVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
++..||. |+|+.++.... ..+..++..++..|++|++|||+.. |.---|....+++|++.+.+|. .+-+++.+.
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsfq 342 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ 342 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeeee
Confidence 9999999 89999997644 3566778889999999999999985 4444688899999999776653 111111111
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCC-CcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~-~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
..+..-.+.||+||.+.......+ .++|+|||+++||||.|...||...+.++.--+|.
T Consensus 343 -------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia------------- 402 (448)
T KOG0195|consen 343 -------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA------------- 402 (448)
T ss_pred -------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh-------------
Confidence 123345688999999876322222 68999999999999999999998887766443331
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL 311 (556)
++.++- ...|.+++....|+.-|+..||.+||.++.+.
T Consensus 403 ---------leglrv-------~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 403 ---------LEGLRV-------HIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ---------hccccc-------cCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 122221 34578999999999999999999999977653
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.8e-18 Score=162.91 Aligned_cols=131 Identities=27% Similarity=0.370 Sum_probs=102.2
Q ss_pred eeeecCceeEEEEEECCCCcEEEEEEecCc-cCCh-----hHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHI-----SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 30 ~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~-----~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
.||+|+||.||+|. .+|..|++|+.... .... ....++.+|+++++.+.|+++....-++. .....+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKT 73 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCE
Confidence 48999999999997 46788999986432 1111 12356789999999999886544433332 123468
Q ss_pred EEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 104 VVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 104 lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
+||||++| +|.+++..... .++.||+.+|.+||+.|++|+|++|.||+++ ++.++|+|||++..
T Consensus 74 lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999984 88887754321 7899999999999999999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.5e-18 Score=162.28 Aligned_cols=137 Identities=21% Similarity=0.200 Sum_probs=105.7
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCCh--------------------hHHHHHHHHHHHHHhCCCCC
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI--------------------SDAIRILREVKLLRLLRHPD 83 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~--------------------~~~~~~~rEi~iL~~L~Hpn 83 (556)
.|.+.+.||+|+||.||+|.+. +|+.||||++....... .......+|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4889999999999999999875 79999999875321100 01123568999999998874
Q ss_pred --cceeeEEEcCCCCCCCceEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec
Q 008729 84 --IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (556)
Q Consensus 84 --Iv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~ 160 (556)
+...++. ...|+||||++| +|..+.. ......++.+|+.++.++|+.||+||||||+||+++
T Consensus 95 i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~ 159 (198)
T cd05144 95 FPVPKPIDW---------NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD 159 (198)
T ss_pred CCCCceeec---------CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc
Confidence 3333321 235899999996 6655432 144567899999999999999999999999999999
Q ss_pred CCCceEEeeeCccccc
Q 008729 161 ANCKLKVCDFGLARVA 176 (556)
Q Consensus 161 ~~~~vKL~DFGla~~~ 176 (556)
.++.++|+|||++...
T Consensus 160 ~~~~~~liDfg~~~~~ 175 (198)
T cd05144 160 DDEKIYIIDWPQMVST 175 (198)
T ss_pred CCCcEEEEECCccccC
Confidence 9999999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.5e-17 Score=181.76 Aligned_cols=138 Identities=22% Similarity=0.282 Sum_probs=107.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEec-CccCC-----hhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEH-----ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~-~~~~~-----~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
..|...+.||+|+||+||++... +..+++|+.. +.... .....++.+|+++++.++|++|+..+.+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~--- 407 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD--- 407 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe---
Confidence 34567899999999999999764 3445555432 11111 1224568899999999999999877665532
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
....++||||++ ++|.+++. ....++.||+.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 408 --~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 408 --PEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred --CCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 234689999998 58988875 346789999999999999999999999999999 677899999999976
Q ss_pred c
Q 008729 176 A 176 (556)
Q Consensus 176 ~ 176 (556)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 4
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.8e-17 Score=175.94 Aligned_cols=211 Identities=24% Similarity=0.327 Sum_probs=154.0
Q ss_pred HHhCCCCCcceeeEEEcCCCCCCCceEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccC
Q 008729 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANV-YHRDL 152 (556)
Q Consensus 76 L~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gI-vHrDL 152 (556)
|+.+.|.|+.++++++... ..+++|.+||. |+|.+.+.. ...++.-....+++.|+.||.|||+.-| +|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 4678999999999999543 66999999999 899999987 4468888889999999999999999876 99999
Q ss_pred CCCcEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccC--CC---CCCcchhhhHHHHHHHHHhC
Q 008729 153 KPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF--SK---YTPAIDIWSIGCIFAEVLTG 227 (556)
Q Consensus 153 KP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~~---y~~~~DIWSlG~ilyelltG 227 (556)
+..|.+++....+||+|||+........ .........-...|.|||++.+.. .. .+.+.||||+|+|++|+++.
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~-~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETA-EPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccc-cccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999987653210 001111222345699999987621 11 46779999999999999999
Q ss_pred CCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH
Q 008729 228 KPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307 (556)
Q Consensus 228 ~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta 307 (556)
..||+........+.|... ++........|.......+.+.+..++++|+..+|.+||++
T Consensus 155 ~~~~~~~~~~~~~~eii~~--------------------~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILR--------------------VKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI 214 (484)
T ss_pred cCccccccccCChHHHHHH--------------------HHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence 9999764322111111100 11111111222222122456689999999999999999999
Q ss_pred HHHHh
Q 008729 308 EEALA 312 (556)
Q Consensus 308 ~elL~ 312 (556)
+++-.
T Consensus 215 ~~i~~ 219 (484)
T KOG1023|consen 215 EQIRS 219 (484)
T ss_pred HHHHh
Confidence 98853
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.6e-17 Score=153.84 Aligned_cols=136 Identities=24% Similarity=0.249 Sum_probs=98.0
Q ss_pred EeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHH----------------------HHHHHHHHHhCCCCC--
Q 008729 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR----------------------ILREVKLLRLLRHPD-- 83 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~----------------------~~rEi~iL~~L~Hpn-- 83 (556)
.+.||+|+||.||+|.+. +|+.||||++............ ...|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999986 8999999988643221111111 135677777665443
Q ss_pred cceeeEEEcCCCCCCCceEEEEEecCcc-cHH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEeec
Q 008729 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLH-QVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILAN 160 (556)
Q Consensus 84 Iv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~-~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~ 160 (556)
+.+.+.+. ..++||||+++ .+. ..+.... . ...++.++.+++.++.++|. .||+||||||+||+++
T Consensus 81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~~-~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKDVR-L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred CCceEecC---------CCEEEEEEeCCCCccChhhhhhh-h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 34443321 25999999996 221 1121111 1 16778899999999999999 9999999999999999
Q ss_pred CCCceEEeeeCccccc
Q 008729 161 ANCKLKVCDFGLARVA 176 (556)
Q Consensus 161 ~~~~vKL~DFGla~~~ 176 (556)
++.++|+|||.+...
T Consensus 150 -~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 -DGKVYIIDVPQAVEI 164 (187)
T ss_pred -CCcEEEEECcccccc
Confidence 889999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.67 E-value=7.2e-16 Score=152.49 Aligned_cols=139 Identities=21% Similarity=0.277 Sum_probs=103.3
Q ss_pred eeee-ecCceeEEEEEECCCCcEEEEEEecCc------cC-----ChhHHHHHHHHHHHHHhCCCCCc--ceeeEEEcCC
Q 008729 29 EVIG-KGSYGVVCAAIDTHTGEKVAIKKIHDV------FE-----HISDAIRILREVKLLRLLRHPDI--VEIKRIMLPP 94 (556)
Q Consensus 29 ~~LG-~G~~g~V~~a~~~~tg~~vAiK~i~~~------~~-----~~~~~~~~~rEi~iL~~L~HpnI--v~l~~v~~~~ 94 (556)
..|| .|+.|+||.+... +..++||.+... .. ......++.+|+.++..|.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 7888888888653 788999977421 01 11234578899999999998875 5666654221
Q ss_pred CCCCCceEEEEEecCcc--cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCc
Q 008729 95 SKREFKDIYVVFELMES--DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (556)
Q Consensus 95 ~~~~~~~lylV~E~~~g--~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGl 172 (556)
. ......++|||+++| +|.+++.. ..+++. .+.||+.+|.+||++||+||||||+|||++.++.++|+|||.
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 1 111123599999995 88888764 455554 367899999999999999999999999999989999999998
Q ss_pred ccc
Q 008729 173 ARV 175 (556)
Q Consensus 173 a~~ 175 (556)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.7e-16 Score=168.64 Aligned_cols=257 Identities=25% Similarity=0.238 Sum_probs=201.3
Q ss_pred CCeEEEeeeee--cCceeEEEEEE--CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCC
Q 008729 23 NRYKILEVIGK--GSYGVVCAAID--THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 23 ~~Y~i~~~LG~--G~~g~V~~a~~--~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~ 97 (556)
..+.+.+.+|. |.+|.||.+.. ..++..+|+|+-+..+.......+-++|+.-.+.++ |+|.++.+..+ +
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e 188 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----E 188 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----c
Confidence 35678889999 99999999998 889999999986544444445555667888877775 99999977777 6
Q ss_pred CCceEEEEEecCcccHHHHHHhCCC-CCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCCcEeecCC-CceEEeeeC
Q 008729 98 EFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLR----ALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFG 171 (556)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~-l~~~~~~~i~~QIl~----aL~yLHs~gIvHrDLKP~NILl~~~-~~vKL~DFG 171 (556)
+.+.+|+-+|+|+.+|..+...-.. +++..++.++.+.+. ||.++|+.+|+|-|+||.||++..+ +..+++|||
T Consensus 189 ~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 189 GSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred cCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence 6778999999999999988876544 889999999999999 9999999999999999999999999 889999999
Q ss_pred ccccccCCCCCccee--cccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC--ChHHHHHHHHHhh
Q 008729 172 LARVAFSDTPMTVFW--TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK--SVVHQLDLITDLL 247 (556)
Q Consensus 172 la~~~~~~~~~~~~~--~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~--~~~~~~~~i~~~~ 247 (556)
+............+. ....|...|++||+..+ -++.+.||+++|.++.+..+|..++... +...++..
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~----- 340 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ----- 340 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-----
Confidence 988765444222211 12247778999999986 5789999999999999999987665433 21111111
Q ss_pred CCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.. . ..+.+...+..+..++..|++.||..|++++.+++|+++...
T Consensus 341 -------------------------~~-i-p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 341 -------------------------GY-I-PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred -------------------------cc-C-chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 10 1 112234556667779999999999999999999999998753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.5e-15 Score=135.67 Aligned_cols=131 Identities=22% Similarity=0.237 Sum_probs=107.3
Q ss_pred EEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCC--CCcceeeEEEcCCCCCCCceEEE
Q 008729 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH--PDIVEIKRIMLPPSKREFKDIYV 104 (556)
Q Consensus 27 i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H--pnIv~l~~v~~~~~~~~~~~lyl 104 (556)
+++.||.|.++.||++.+.. ..+++|.+..... ...+.+|+.+++.++| .++++++..+ ......|+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYL 70 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEE
Confidence 46889999999999998753 7899998864322 4567899999999976 5888888876 33356899
Q ss_pred EEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 105 VFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA---NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~---gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
+|||+.| .+..+ +......++.+++.+|++||.. +++|+||+|+||+++.++.++++|||.++.
T Consensus 71 v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 71 LMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 9999986 44332 5566677899999999999985 699999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.5e-16 Score=172.99 Aligned_cols=264 Identities=23% Similarity=0.250 Sum_probs=199.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCCh-hHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~-~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
..+.+.+.+-+|++|.++.+.-..+|...++|+....-.-. .+...+.++-+++-...+|.++....-+ .....
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rsP 878 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRSP 878 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCCC
Confidence 45778889999999999999888888777777654221111 1233444555555555667766554432 33456
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
.+||++|.. ++|...+.+.+..+.+-++.++..+..++.|||+..+.|||++|.|+|+..++..++.|||.......-.
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence 899999998 6999999988889999999999999999999999999999999999999999999999998443211000
Q ss_pred C---C------------------c-------ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCC
Q 008729 181 P---M------------------T-------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 232 (556)
Q Consensus 181 ~---~------------------~-------~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~ 232 (556)
+ . . ..-...+||+.|.+||.+.+ ....+++|+|++|+++++.++|.+||.
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--RRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--ccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 0 0 00123579999999999988 678899999999999999999999998
Q ss_pred CCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHH---H
Q 008729 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE---E 309 (556)
Q Consensus 233 ~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~---e 309 (556)
.......++.|. . ...++..-....+..+++++.++|..+|.+|..+. +
T Consensus 1037 a~tpq~~f~ni~---------------------------~-~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e 1088 (1205)
T KOG0606|consen 1037 AETPQQIFENIL---------------------------N-RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAE 1088 (1205)
T ss_pred Ccchhhhhhccc---------------------------c-CCCCCCCCccccChhhhhhhhhhhccCchhccCcccccc
Confidence 877655443331 1 11223333345788999999999999999998877 8
Q ss_pred HHhCcccccccc
Q 008729 310 ALADPYFKGLAK 321 (556)
Q Consensus 310 lL~hp~f~~~~~ 321 (556)
.-.|+||+....
T Consensus 1089 ~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1089 VKGHPFFQDVDW 1100 (1205)
T ss_pred cccCCccCCCCc
Confidence 889999997653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.9e-13 Score=144.44 Aligned_cols=185 Identities=24% Similarity=0.338 Sum_probs=137.5
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
-|.+ ...+-++.+..-.|..+.++..|.|.+.+..-. .....+.+-++-|+.|+||||+++++.+ +....+|
T Consensus 14 pY~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~y 85 (690)
T KOG1243|consen 14 PYDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLY 85 (690)
T ss_pred Cccc-ccccCCCcccccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceE
Confidence 4777 556666666443566778899999998875322 3455677889999999999999999998 5666899
Q ss_pred EEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCC
Q 008729 104 VVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH-TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (556)
Q Consensus 104 lV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLH-s~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 182 (556)
||+|-+.. |..+++. +....+...++||+.||.||| .++++|++|.-+.|+++..|.+||++|.++.........
T Consensus 86 lvTErV~P-l~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~ 161 (690)
T KOG1243|consen 86 LVTERVRP-LETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP 161 (690)
T ss_pred EEeecccc-HHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc
Confidence 99998762 3334443 337888889999999999997 678999999999999999999999999988654322211
Q ss_pred cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhC
Q 008729 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 227 (556)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG 227 (556)
.....---.|..|+.+.. .. -..|.|.|||++++++.|
T Consensus 162 ---~~~~~~~~s~~~P~~~~~--s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 ---AKSLYLIESFDDPEEIDP--SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ---cccchhhhcccChhhcCc--cc--cchhhhhHHHHHHHHhCc
Confidence 011112223666766543 11 357999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.9e-14 Score=138.20 Aligned_cols=247 Identities=19% Similarity=0.202 Sum_probs=160.7
Q ss_pred eEEEEEECCCCcEEEEEEecCcc-CChhH-HHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEecCc-ccHH
Q 008729 38 VVCAAIDTHTGEKVAIKKIHDVF-EHISD-AIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLH 114 (556)
Q Consensus 38 ~V~~a~~~~tg~~vAiK~i~~~~-~~~~~-~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~-g~L~ 114 (556)
.||++.++..|..|+.-.+.-.. .+... ..+...-..-|-.+-|-|||+++.++.+...++...+.++.|||+ |+|.
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~ 160 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK 160 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence 46677777777666655432100 01000 011111223344557999999999886665557778999999999 8998
Q ss_pred HHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcce-ec
Q 008729 115 QVIKA----NDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF-WT 187 (556)
Q Consensus 115 ~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~-~~ 187 (556)
++|+. ...+.....++|+-||+.||.|||+.. |+|+++..+.|++..+|-+||.--.-......-...... ..
T Consensus 161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~ 240 (458)
T KOG1266|consen 161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKS 240 (458)
T ss_pred HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhh
Confidence 88864 346888899999999999999999986 999999999999999998887532211110000000000 01
Q ss_pred ccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHH
Q 008729 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (556)
Q Consensus 188 ~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~p-F~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~ 266 (556)
-..+-++|.+||.-.. .+.+-++|||++|....+|..|..- -.+.+....-..|...
T Consensus 241 ~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~-------------------- 298 (458)
T KOG1266|consen 241 VNTSLPGFSAPESGTT--TNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV-------------------- 298 (458)
T ss_pred ccccCCccccCCcCcc--cccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh--------------------
Confidence 1235678999997544 4567799999999999999877632 2222211111111100
Q ss_pred HHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.+..-.+.-++++++||+-.|..||++.++|-||.+-.++
T Consensus 299 --------------i~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 299 --------------IIGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred --------------eeeccCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 0011123346789999999999999999999999887654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=8.7e-14 Score=151.35 Aligned_cols=141 Identities=20% Similarity=0.311 Sum_probs=96.5
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCCh--------------------------------hHHH----
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI--------------------------------SDAI---- 67 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~--------------------------------~~~~---- 67 (556)
.|.. +.||+|++|.||+|+.+.+|+.||||++....... ....
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 78999999999999998889999999986321100 0011
Q ss_pred --HHHHHHHHHHhCC----CCCcceeeEEEcCCCCCCCceEEEEEecCcc-cHHHH--HHhCC----CCCHHHHHHHHHH
Q 008729 68 --RILREVKLLRLLR----HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQV--IKAND----DLTREHHQFFLYQ 134 (556)
Q Consensus 68 --~~~rEi~iL~~L~----HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~--i~~~~----~l~~~~~~~i~~Q 134 (556)
.+.+|...+.++. +.+.+.+-.+|.+ -....+||||||.| .+.++ +.+.+ .+.+..+..++.|
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d----~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWD----YCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecc----cCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 2334444444442 4444444444421 12346899999996 77653 34433 3555556666777
Q ss_pred HHHHHHHHHHCCceeccCCCCcEeecCCC----ceEEeeeCccccc
Q 008729 135 MLRALKYMHTANVYHRDLKPKNILANANC----KLKVCDFGLARVA 176 (556)
Q Consensus 135 Il~aL~yLHs~gIvHrDLKP~NILl~~~~----~vKL~DFGla~~~ 176 (556)
|+ ..|++|+|+||.||+++.++ .++++|||++...
T Consensus 276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 65 48999999999999999888 9999999998654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.8e-13 Score=144.24 Aligned_cols=249 Identities=22% Similarity=0.224 Sum_probs=181.0
Q ss_pred CCeEEEeeeeecCceeEEEEEEC-CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCc
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDT-HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~-~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.+|.++..||.|.|+.|+.+... .++..|++|...+......+...-+.|+-+...+ .|.+++.++..+ ....
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-----~~~r 339 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW-----SQLR 339 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc-----cccc
Confidence 46788999999999999987655 6788999998876555444545556788777777 489999988877 4455
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC-CceEEeeeCccccccC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAFS 178 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~vKL~DFGla~~~~~ 178 (556)
..|+-.|||+ +++...+.....+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||.+....-
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 6789999998 4554444444568888899999999999999999999999999999999876 7889999998853110
Q ss_pred CCCCcceecccccCcccC-CcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYR-APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~-APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
. .......-++. ..|++... ..+..+.|++|||..+.+.++|.+.=........
T Consensus 420 ~------~~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~------------------ 474 (524)
T KOG0601|consen 420 S------SGVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT------------------ 474 (524)
T ss_pred e------cccccccccccccchhhccc-cccccccccccccccccccccCcccCccccccee------------------
Confidence 0 11122334444 25544432 5677899999999999999998754332221100
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
++ .......+.....+..+.+.++..|+..|+.+.++..|.-|.
T Consensus 475 ------------i~----~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 475 ------------IR----SGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ------------ee----cccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 00 001112234447788999999999999999999998887664
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.7e-12 Score=139.36 Aligned_cols=141 Identities=19% Similarity=0.258 Sum_probs=94.5
Q ss_pred EeeeeecCceeEEEEEECCCCcEEEEEEecCccCChh--------------------------------------HHHHH
Q 008729 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS--------------------------------------DAIRI 69 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~--------------------------------------~~~~~ 69 (556)
.+.||.|++|.||+|+.+ +|+.||||+........- ....+
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 357999999999999864 799999999753211100 00123
Q ss_pred HHHHHHHHhC----CCCCcceeeEEEcCCCCCCCceEEEEEecCcc-cHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHH
Q 008729 70 LREVKLLRLL----RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN-DDLTREHHQFFLYQMLR-ALKYM 142 (556)
Q Consensus 70 ~rEi~iL~~L----~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~-~~l~~~~~~~i~~QIl~-aL~yL 142 (556)
.+|...+..+ +|.+-+.+-.++.. ....-+|||||++| +|.++.... .... ...++.+++. .+..+
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~----~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWD----RTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQV 273 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehh----hcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHH
Confidence 4455555554 23333444444421 12235899999996 776665432 1222 2345556655 47889
Q ss_pred HHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 143 Hs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
|..|++|+|+||.||+++.++.++|+|||++...
T Consensus 274 ~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 274 LRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 9999999999999999999999999999998653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.1e-12 Score=122.98 Aligned_cols=139 Identities=21% Similarity=0.241 Sum_probs=100.7
Q ss_pred EeeeeecCceeEEEEEECC------CCcEEEEEEecCc---cCC-----------------hhHHHHH----HHHHHHHH
Q 008729 28 LEVIGKGSYGVVCAAIDTH------TGEKVAIKKIHDV---FEH-----------------ISDAIRI----LREVKLLR 77 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~------tg~~vAiK~i~~~---~~~-----------------~~~~~~~----~rEi~iL~ 77 (556)
..+||.|-=+.||.|.... .+..+|||+.... +.. .+....+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4579999999999998653 3579999976411 100 1111122 37999999
Q ss_pred hCCC--CCcceeeEEEcCCCCCCCceEEEEEecCccc-HHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCC
Q 008729 78 LLRH--PDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRALKYM-HTANVYHRDLK 153 (556)
Q Consensus 78 ~L~H--pnIv~l~~v~~~~~~~~~~~lylV~E~~~g~-L~~~i~~~~~l~~~~~~~i~~QIl~aL~yL-Hs~gIvHrDLK 153 (556)
++.. -++.+++.+. .-+|||||++++ +..-..+...++++....++.|++.+|..| |..||+|+||+
T Consensus 82 rl~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 82 RMQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 9953 4666666542 248999999963 322222233466677788899999999999 89999999999
Q ss_pred CCcEeecCCCceEEeeeCccccc
Q 008729 154 PKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 154 P~NILl~~~~~vKL~DFGla~~~ 176 (556)
+.|||+. ++.+.|+|||.|...
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeC
Confidence 9999997 467999999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.40 E-value=1e-12 Score=122.20 Aligned_cols=126 Identities=18% Similarity=0.171 Sum_probs=93.0
Q ss_pred EeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcc-eeeEEEcCCCCCCCceEEEEE
Q 008729 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV-EIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv-~l~~v~~~~~~~~~~~lylV~ 106 (556)
++.|+.|.++.||++... +..|++|....... ....+.+|+.+++.+.+.+++ +++... . ..-++||
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~--~~~~lv~ 70 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD-----P--ETGVLIT 70 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe-----C--CCCeEEE
Confidence 567899999999999754 78899998754321 122456899999998755544 444433 1 1237999
Q ss_pred ecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCcEeecCCCceEEeeeCccc
Q 008729 107 ELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANV-----YHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 107 E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gI-----vHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
||++| .+.+. ......++.+++.+|+.||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 71 e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 71 EFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 99997 44322 11123467899999999999985 9999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.6e-10 Score=116.97 Aligned_cols=215 Identities=16% Similarity=0.203 Sum_probs=156.9
Q ss_pred CceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEecCc--cc
Q 008729 35 SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SD 112 (556)
Q Consensus 35 ~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~--g~ 112 (556)
.-.+.|+|....+|..|++|+++-. .. ....+.-.-+.+++++.|+|||++.++|....+ ....+++|++|.. ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~-r~-~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF-~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGD-RD-QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTF-GDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccc-cc-cCcccchHHHHHHHHhccCceeehhhhhhhhcc-CcceEEEEEecCCCCch
Confidence 3457899999999999999999421 11 111122245778899999999999999985543 4567899999998 58
Q ss_pred HHHHHHh---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 113 LHQVIKA---------------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 113 L~~~i~~---------------~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
|.++.-. +...+++.++.|+.||..||.+||+.|+.-+-|.|.+||++.+.+++|...|...+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 8876632 2246789999999999999999999999999999999999999889998888765543
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-hHHH-HHHHHHhhCCCChHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQ-LDLITDLLGTPSPETI 255 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~-~~~~-~~~i~~~~g~p~~e~i 255 (556)
.+.. |.+.+ -.+-|.=.||.+++.|.||..-=...+ .... ++.|
T Consensus 445 ~d~~-----------------~~le~-----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I------------ 490 (655)
T KOG3741|consen 445 EDPT-----------------EPLES-----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI------------ 490 (655)
T ss_pred CCCC-----------------cchhH-----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh------------
Confidence 3320 11211 235799999999999999974321111 1111 1111
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.+..+.+++++|.-+...++++ -++.+++.|
T Consensus 491 --------------------------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 --------------------------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred --------------------------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 1346788899999988888886 688888876
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.3e-10 Score=104.56 Aligned_cols=143 Identities=23% Similarity=0.304 Sum_probs=105.3
Q ss_pred EEeeeeecCceeEEEEEECCCCcEEEEEEe-cCccCCh-----hHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-HDVFEHI-----SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 27 i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i-~~~~~~~-----~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.+..|-+|+-+.|+++. ..|+.++||.- .+...+. -...+..+|+++|.++.--.|.-..-++.+ ..
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D-----~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFID-----TY 83 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEe-----cC
Confidence 67889999999999995 56999899853 2223332 234577889999998864444333333322 22
Q ss_pred eEEEEEecCcc--cHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCc---eEEeeeCcc
Q 008729 101 DIYVVFELMES--DLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFGLA 173 (556)
Q Consensus 101 ~lylV~E~~~g--~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---vKL~DFGla 173 (556)
.-.|+|||++| .+.+++... ....++-...++.+|-+.|.-||.++|+|+||..+||++..++. +.++|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 34799999998 888888753 23333444788999999999999999999999999999976653 589999998
Q ss_pred ccc
Q 008729 174 RVA 176 (556)
Q Consensus 174 ~~~ 176 (556)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.16 E-value=2e-10 Score=111.36 Aligned_cols=143 Identities=17% Similarity=0.254 Sum_probs=101.3
Q ss_pred EeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCC--CCcceeeEEEcCCCCCCCceEEEE
Q 008729 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH--PDIVEIKRIMLPPSKREFKDIYVV 105 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H--pnIv~l~~v~~~~~~~~~~~lylV 105 (556)
++.|+.|.++.||++.... |+.|++|+....... .....+.+|+.+++.+.+ ..+.+++.+.... ......|+|
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v 78 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYV 78 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEE
Confidence 3678999999999997643 688999987542211 134467899999999975 3456666654221 112356899
Q ss_pred EecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 008729 106 FELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT---------------------------------------- 144 (556)
Q Consensus 106 ~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs---------------------------------------- 144 (556)
|||++| .+.+.+.. ..++.+....++.+++++|..||+
T Consensus 79 ~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 79 MERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 999996 45443321 346666666777777777777773
Q ss_pred ----------------CCceeccCCCCcEeecC--CCceEEeeeCcccc
Q 008729 145 ----------------ANVYHRDLKPKNILANA--NCKLKVCDFGLARV 175 (556)
Q Consensus 145 ----------------~gIvHrDLKP~NILl~~--~~~vKL~DFGla~~ 175 (556)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24699999999999998 56689999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3e-10 Score=105.31 Aligned_cols=130 Identities=22% Similarity=0.326 Sum_probs=94.2
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEE-ecCccCChh-----HHHHHHHHHHHHHhCCCC--CcceeeEEEcCCCCCCCc
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKK-IHDVFEHIS-----DAIRILREVKLLRLLRHP--DIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~-i~~~~~~~~-----~~~~~~rEi~iL~~L~Hp--nIv~l~~v~~~~~~~~~~ 100 (556)
..+++|+=+.++.+.. -|..+++|. +.+...+.. ...+..+|.++|..+.-- +..-++++. ..
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD-------~~ 72 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD-------PD 72 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc-------CC
Confidence 4678999999999854 355577774 333333332 234567899999988643 334444443 12
Q ss_pred eEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
...|+|||++| .|.+.+... ...+++.+-.-+.-||.+||+|+||.++||++..++ +.++|||++..
T Consensus 73 ~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 73 NGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 35799999998 566677654 245777888888899999999999999999997664 99999999874
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=3.9e-09 Score=105.94 Aligned_cols=135 Identities=15% Similarity=0.112 Sum_probs=93.3
Q ss_pred eEEEEEECCCCcEEEEEEecCccCCh---------hHHHHHHHHHHHHHhCCCCCc--ceeeEEEcCCCCCCCceEEEEE
Q 008729 38 VVCAAIDTHTGEKVAIKKIHDVFEHI---------SDAIRILREVKLLRLLRHPDI--VEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 38 ~V~~a~~~~tg~~vAiK~i~~~~~~~---------~~~~~~~rEi~iL~~L~HpnI--v~l~~v~~~~~~~~~~~lylV~ 106 (556)
.|+++. ..|+.|.||......... .-...+.+|...+..|..-+| +.++.+...........-|||+
T Consensus 37 rvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 355553 357789999764211000 011136789999888853333 3333333211111134578999
Q ss_pred ecCcc--cHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC-------CCceEEeeeCccc
Q 008729 107 ELMES--DLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-------NCKLKVCDFGLAR 174 (556)
Q Consensus 107 E~~~g--~L~~~i~~--~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-------~~~vKL~DFGla~ 174 (556)
|++++ +|.+++.. ...........++.+|...+.-||.+||+|+||++.|||++. +..+.|+||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99996 78888864 345667788899999999999999999999999999999975 4679999999775
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.9e-10 Score=124.40 Aligned_cols=152 Identities=23% Similarity=0.333 Sum_probs=113.0
Q ss_pred HHHHHHHHC-CceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcceec--------ccccCcccCCcccccccCCC
Q 008729 137 RALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT--------DYVATRWYRAPELCGSFFSK 207 (556)
Q Consensus 137 ~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~--------~~~gt~~Y~APE~~~~~~~~ 207 (556)
.|+.|+|.. ++||++|.|++|.++.++.+||+.|+++....+... .++. -..-...|.|||++.+ ..
T Consensus 110 dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~--~p~~~yd~~lp~~~~~~~~f~apE~~~~--~~ 185 (700)
T KOG2137|consen 110 DGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE--YPFSEYDPPLPLLLQPHLNFLAPEYLLG--TT 185 (700)
T ss_pred chhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc--cccccCCCCCChhhccCcccccchhhcc--cc
Confidence 899999965 899999999999999999999999998865443211 1111 1234457999999987 67
Q ss_pred CCCcchhhhHHHHHHHHH-hCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCC
Q 008729 208 YTPAIDIWSIGCIFAEVL-TGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVD 286 (556)
Q Consensus 208 y~~~~DIWSlG~ilyell-tG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s 286 (556)
.++++|++||||++|.+. .|+..|.+.........-. ............+++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~---------------------------~~~~~~~~~~s~~~p 238 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR---------------------------NLLNAGAFGYSNNLP 238 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh---------------------------cccccccccccccCc
Confidence 789999999999999999 5777776554221111100 000111112225789
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 287 PLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 287 ~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
+++++=|.++|..|+..||++.+++..|||.+.
T Consensus 239 ~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~ 271 (700)
T KOG2137|consen 239 SELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP 271 (700)
T ss_pred HHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence 999999999999999999999999999999864
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.7e-09 Score=100.94 Aligned_cols=129 Identities=22% Similarity=0.300 Sum_probs=94.3
Q ss_pred CCCcEEEEEEecCcc-----CChhHHHHHHHHHHHHHhCCCCC--cceeeEEEcCCCCCCCceEEEEEecCcc--cHHHH
Q 008729 46 HTGEKVAIKKIHDVF-----EHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFKDIYVVFELMES--DLHQV 116 (556)
Q Consensus 46 ~tg~~vAiK~i~~~~-----~~~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~~lylV~E~~~g--~L~~~ 116 (556)
..++.|-+|...... .......+..+|...+..|..-+ ..+.+.+..... ......|||+|++++ +|.++
T Consensus 30 ~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~ 108 (206)
T PF06293_consen 30 LVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDL 108 (206)
T ss_pred ccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHH
Confidence 345667777543211 11133456788999888885333 444445443221 112456899999985 79999
Q ss_pred HHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC---ceEEeeeCcccc
Q 008729 117 IKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLKVCDFGLARV 175 (556)
Q Consensus 117 i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~vKL~DFGla~~ 175 (556)
+.....++......++.++...++-||.+||+|+|+++.|||++.++ .+.|+||+.++.
T Consensus 109 ~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 109 LQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 98755577888889999999999999999999999999999999887 799999997764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.4e-09 Score=99.87 Aligned_cols=127 Identities=27% Similarity=0.295 Sum_probs=82.4
Q ss_pred eEEEEEECCCCcEEEEEEecC----------------ccC------Ch--hHHHHHHHHHHHHHhCCCC--CcceeeEEE
Q 008729 38 VVCAAIDTHTGEKVAIKKIHD----------------VFE------HI--SDAIRILREVKLLRLLRHP--DIVEIKRIM 91 (556)
Q Consensus 38 ~V~~a~~~~tg~~vAiK~i~~----------------~~~------~~--~~~~~~~rEi~iL~~L~Hp--nIv~l~~v~ 91 (556)
.||.|.. ..|..+|||+... .+. .. .......+|.+.|..+..- ++.+++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888976 4578999997641 000 00 1123467899999999755 566666553
Q ss_pred cCCCCCCCceEEEEEecCc--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCcEeecCCCceEEe
Q 008729 92 LPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLRALKY-MHTANVYHRDLKPKNILANANCKLKVC 168 (556)
Q Consensus 92 ~~~~~~~~~~lylV~E~~~--g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~y-LHs~gIvHrDLKP~NILl~~~~~vKL~ 168 (556)
.-+|||||++ |.....+... .++.+....++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+
T Consensus 80 ---------~~~ivME~I~~~G~~~~~l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---------RNVIVMEYIGEDGVPLPRLKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---------TTEEEEE--EETTEEGGCHHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---------CCEEEEEecCCCccchhhHHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence 1379999999 6332333322 12245567788888885555 689999999999999999887 89999
Q ss_pred eeCccccc
Q 008729 169 DFGLARVA 176 (556)
Q Consensus 169 DFGla~~~ 176 (556)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=6e-08 Score=99.69 Aligned_cols=262 Identities=17% Similarity=0.141 Sum_probs=162.6
Q ss_pred eEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHH-hCCCCCcceeeEE---EcCCCCCCCc
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR-LLRHPDIVEIKRI---MLPPSKREFK 100 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~-~L~HpnIv~l~~v---~~~~~~~~~~ 100 (556)
....+.||+|+-+.+|..-.. +. .+.|+.+..-. ...... +..|- .-.||.+-.-+.+ -+. +.+...
T Consensus 13 i~~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Ppp--a~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~-G~~~~~ 83 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPP--AAQAQK---VAELAATPDAPLLNYRVAWPQATLH-GGRRGK 83 (637)
T ss_pred cCCCccccCCccceeeecchh--hc-hhheeecCCCc--hHHHHH---HHHhccCCCCcchhhhhcccHHHhh-CCCccc
Confidence 345778999999999976322 22 34577654211 111111 22222 2246644320110 001 113344
Q ss_pred eEEEEEecCcc--cHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCc
Q 008729 101 DIYVVFELMES--DLHQVIKA------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (556)
Q Consensus 101 ~lylV~E~~~g--~L~~~i~~------~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGl 172 (556)
.+.++|..+.| -.+.++.. .....+.......+.|..+.+.||..|.+-+|++++|+|+.+++.|.|.|=..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 48889998885 45555532 23577889999999999999999999999999999999999999999998543
Q ss_pred cccccCCCCCcceecccccCcccCCccccc-ccC--CCCCCcchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhhC
Q 008729 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCG-SFF--SKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLITDLLG 248 (556)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~--~~y~~~~DIWSlG~ilyelltG-~~pF~~~~~~~~~~~i~~~~g 248 (556)
-.+.. ....+...+|...|.+||+-. +.+ -.-+...|.|.||+++++||.| +.||.|--. +. -.+
T Consensus 164 fqi~~----ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~------~~-~ap 232 (637)
T COG4248 164 FQINA----NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPL------IS-DAP 232 (637)
T ss_pred eeecc----CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccc------cC-CCC
Confidence 32221 222345568999999999753 211 2345789999999999999997 899987321 00 001
Q ss_pred CCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcC--CCCCCCHHH
Q 008729 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD--PKDRPTAEE 309 (556)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~d--P~~Rpta~e 309 (556)
.|-+..|.......+.+ .-+...+.|..-.|.-++++++.|..+|+..- +.-|||++.
T Consensus 233 ~p~E~~Ia~g~f~ya~~---~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 233 NPLETDIAHGRFAYASD---QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred Ccchhhhhcceeeechh---ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 11111222222111111 22334445555556678999999999998753 568999754
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=1e-08 Score=100.52 Aligned_cols=136 Identities=29% Similarity=0.291 Sum_probs=101.4
Q ss_pred eEEEeeeeecCceeEEEEEECCCCcEEEEEEec-------Ccc---------CChh----HHHHHHHHHHHHHhCCCC--
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-------DVF---------EHIS----DAIRILREVKLLRLLRHP-- 82 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~-------~~~---------~~~~----~~~~~~rEi~iL~~L~Hp-- 82 (556)
+.++..||-|-=|.||.|.+. .|.++|||.=. +.. .+.+ ......+|..+|..|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 457889999999999999876 68899999421 000 1111 123467899999999644
Q ss_pred CcceeeEEEcCCCCCCCceEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC
Q 008729 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (556)
Q Consensus 83 nIv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~ 161 (556)
.+.+.++. +.-.+|||+++| .|... +++.+.+..++.-|++-+.-+-..||+|+|+.+-|||+++
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence 55555443 345899999998 44322 2245666778888888888888999999999999999999
Q ss_pred CCceEEeeeCcccc
Q 008729 162 NCKLKVCDFGLARV 175 (556)
Q Consensus 162 ~~~vKL~DFGla~~ 175 (556)
||.+.++||-.+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999987653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.80 E-value=8.2e-08 Score=92.03 Aligned_cols=142 Identities=18% Similarity=0.150 Sum_probs=102.6
Q ss_pred eeecCceeEEEEEECCCCcEEEEEEecC----ccCChhHHHHHHHHHHHHHhCCCCC--cceeeEEEcCCCCCCCceEEE
Q 008729 31 IGKGSYGVVCAAIDTHTGEKVAIKKIHD----VFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFKDIYV 104 (556)
Q Consensus 31 LG~G~~g~V~~a~~~~tg~~vAiK~i~~----~~~~~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~~lyl 104 (556)
-|+||.|-|+.... .|+.|=+|.-.. ..........+.+|+..|+.|..-+ +.+.. ++........-.-+|
T Consensus 26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 36789999998753 355788887642 1121334567889999999996433 33333 111011112334789
Q ss_pred EEecCc--ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCc--eEEeeeCcccc
Q 008729 105 VFELME--SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK--LKVCDFGLARV 175 (556)
Q Consensus 105 V~E~~~--g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~--vKL~DFGla~~ 175 (556)
|+|-++ -+|.+++... .+.+......++.+|..+|.-||+.|+.|+|+.+.|||++.++. ++++||.-++.
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 999888 4999988653 35677878899999999999999999999999999999987777 99999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.1e-07 Score=91.41 Aligned_cols=141 Identities=19% Similarity=0.249 Sum_probs=90.4
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhH-HH------HHHHHHHHHHhCCCCCcc---eeeEEEc
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD-AI------RILREVKLLRLLRHPDIV---EIKRIML 92 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~-~~------~~~rEi~iL~~L~HpnIv---~l~~v~~ 92 (556)
++|++++++-......|.+. ..+|+.+++|........... .. ...+++..+..+....+. .++-+..
T Consensus 31 ~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 58999999998888878766 466899999987643211111 11 123455545444333332 3222222
Q ss_pred CCCCCCCceEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeC
Q 008729 93 PPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171 (556)
Q Consensus 93 ~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFG 171 (556)
-....-....+|||||++| .|.+... +++ .+...|..++.-||..|++|+|.+|.|+++..++ ++++||+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence 1111222345689999998 5554432 232 2445677788999999999999999999998654 9999998
Q ss_pred ccc
Q 008729 172 LAR 174 (556)
Q Consensus 172 la~ 174 (556)
..+
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.7e-06 Score=82.66 Aligned_cols=139 Identities=18% Similarity=0.227 Sum_probs=80.5
Q ss_pred EeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC--cceeeEEEcCCCCCCCceEEEE
Q 008729 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFKDIYVV 105 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~~lylV 105 (556)
++.|+.|..+.||++.... ..+++|..... .....+.+|..+++.|.... +.+++...... ......|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEE
Confidence 5789999999999997654 48999986532 45667889999999885333 45565533211 223347999
Q ss_pred EecCcc-cHHH----------------HHH---hC----CCCCHHH------HHHH---------------HHHHHH-HH
Q 008729 106 FELMES-DLHQ----------------VIK---AN----DDLTREH------HQFF---------------LYQMLR-AL 139 (556)
Q Consensus 106 ~E~~~g-~L~~----------------~i~---~~----~~l~~~~------~~~i---------------~~QIl~-aL 139 (556)
|+++.| .+.. .+. .. ..+.... ...+ ...+.. .+
T Consensus 74 ~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (239)
T PF01636_consen 74 MEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL 153 (239)
T ss_dssp EEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred EEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence 999986 4444 111 11 0111000 0000 011122 23
Q ss_pred HHHHH-------CCceeccCCCCcEeec-CCCceEEeeeCccc
Q 008729 140 KYMHT-------ANVYHRDLKPKNILAN-ANCKLKVCDFGLAR 174 (556)
Q Consensus 140 ~yLHs-------~gIvHrDLKP~NILl~-~~~~vKL~DFGla~ 174 (556)
..++. ..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 33332 3599999999999999 66677899998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.7e-06 Score=81.94 Aligned_cols=136 Identities=19% Similarity=0.156 Sum_probs=93.6
Q ss_pred eeeecCceeEEEEEECCCCcEEEEEEecCcc---C-----------------ChhHHHH--HHHHHHHHHhCC--CCCcc
Q 008729 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---E-----------------HISDAIR--ILREVKLLRLLR--HPDIV 85 (556)
Q Consensus 30 ~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~---~-----------------~~~~~~~--~~rEi~iL~~L~--HpnIv 85 (556)
.|+.|.-+.||+|.. .++..||+|+..... . +...... ..+|+.-|+++. +-.+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 566777778999964 568899999875211 0 1111111 236888888874 44555
Q ss_pred eeeEEEcCCCCCCCceEEEEEecCcccH--HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEeecCC
Q 008729 86 EIKRIMLPPSKREFKDIYVVFELMESDL--HQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANAN 162 (556)
Q Consensus 86 ~l~~v~~~~~~~~~~~lylV~E~~~g~L--~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~ 162 (556)
+-+.+. .-.|||||++.+- .-.|+. -.+..+++..+..++++.+.-|-. +|+||+||..-|||+. +
T Consensus 134 ~Pi~~~---------~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~ 202 (268)
T COG1718 134 EPIAFR---------NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-D 202 (268)
T ss_pred Cceeec---------CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-C
Confidence 555544 2479999998541 111111 123444788888999999998877 9999999999999999 7
Q ss_pred CceEEeeeCcccccc
Q 008729 163 CKLKVCDFGLARVAF 177 (556)
Q Consensus 163 ~~vKL~DFGla~~~~ 177 (556)
+.+.|+|||.|....
T Consensus 203 ~~p~iID~~QaV~~~ 217 (268)
T COG1718 203 GEPYIIDVSQAVTID 217 (268)
T ss_pred CeEEEEECccccccC
Confidence 789999999986543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.9e-06 Score=83.32 Aligned_cols=133 Identities=16% Similarity=0.176 Sum_probs=80.4
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC--cceeeEEEcCCCCCCCceEEEEE
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~~lylV~ 106 (556)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..-. +.+.+++. +.....++||
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeee
Confidence 57899999999984 25568889765321 2345688999999886433 45666665 3344578899
Q ss_pred ecCccc--HHHHH---------------------HhC--CCCCHHHH-HHHHHHH----------HHH-HHHHHH----C
Q 008729 107 ELMESD--LHQVI---------------------KAN--DDLTREHH-QFFLYQM----------LRA-LKYMHT----A 145 (556)
Q Consensus 107 E~~~g~--L~~~i---------------------~~~--~~l~~~~~-~~i~~QI----------l~a-L~yLHs----~ 145 (556)
|+++|. +...+ ..- ........ ..+..+| ... ..+|.. .
T Consensus 74 e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~ 153 (226)
T TIGR02172 74 ELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS 153 (226)
T ss_pred eecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence 999983 11111 000 01111111 1111111 111 122221 2
Q ss_pred CceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 146 NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 146 gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
.++|+|+.|.||+++.++ +.|+||+.+..
T Consensus 154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 478999999999999888 99999997753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.37 E-value=2.1e-06 Score=98.28 Aligned_cols=205 Identities=16% Similarity=0.216 Sum_probs=142.3
Q ss_pred HHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 008729 68 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146 (556)
Q Consensus 68 ~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~g 146 (556)
...-|+..+.++.|+|++.++.+-+...... .-+.+..|+|.. ++...+..-+..+.+..+.+..++++||.|+|+..
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 3445777788889999999988865432211 234556678884 88999988889999999999999999999999997
Q ss_pred ceeccCCCC---cEeecCCCceEEe--eeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHH
Q 008729 147 VYHRDLKPK---NILANANCKLKVC--DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221 (556)
Q Consensus 147 IvHrDLKP~---NILl~~~~~vKL~--DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~il 221 (556)
..|.-|... +-..+..+.+.+. ||+.......... .....-+..+.++|.............|+|++|..+
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~----~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK----SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCccc----chhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 666655554 4445566667766 8887665432211 122334556788888766323333457999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCC-HHHHHHHHHhhhcC
Q 008729 222 AEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVD-PLALRLLQRLIAFD 300 (556)
Q Consensus 222 yelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s-~~~~dLl~~~L~~d 300 (556)
..+..|..+-.... .+..+ .+..+ ....+++.+|+.-|
T Consensus 383 ~~~~~~~~i~~~~~------~~~~~-----------------------------------l~~~~~~~~~d~~~~~~~~~ 421 (1351)
T KOG1035|consen 383 LQLSQGEDISEKSA------VPVSL-----------------------------------LDVLSTSELLDALPKCLDED 421 (1351)
T ss_pred hhhhhcCccccccc------chhhh-----------------------------------hccccchhhhhhhhhhcchh
Confidence 99998764321110 00000 01111 16788999999999
Q ss_pred CCCCCCHHHHHhCccccc
Q 008729 301 PKDRPTAEEALADPYFKG 318 (556)
Q Consensus 301 P~~Rpta~elL~hp~f~~ 318 (556)
.++|+++.++|.|+|.+-
T Consensus 422 ~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 422 SEERLSALELLTHPFLRF 439 (1351)
T ss_pred hhhccchhhhhhchhccc
Confidence 999999999999999874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=6.4e-08 Score=104.07 Aligned_cols=243 Identities=16% Similarity=0.119 Sum_probs=163.3
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC-cceeeEEEcCCCCCCCceE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD-IVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn-Iv~l~~v~~~~~~~~~~~l 102 (556)
-|....-+++|+++++++.+...+...+ .+.+... ....-++.+|.+++||| .+..++-+ +.+.+.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~-----~~E~~~ 309 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDY-----DGEDYL 309 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccC-----Cccccc
Confidence 4667788999999999999877766655 6665421 33445889999999999 44443333 566779
Q ss_pred EEEEecCccc--HHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 103 YVVFELMESD--LHQVI-KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 103 ylV~E~~~g~--L~~~i-~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
+++++++++. -...+ .+.-.+.+-+...+.+.-+++++++|+.-=+|+| |||..+ +..|..||+.+......
T Consensus 310 ~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred chhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc
Confidence 9999999843 22111 1112344455566777788899999999889999 887765 57999999987654322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
. ..+...+++.++|||+... ..+....|.|++|.--.+|--|-+|-... ......+ |...
T Consensus 385 ~----~~~t~~~~~~~~~pev~~~--~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~----g~~p-------- 444 (829)
T KOG0576|consen 385 M----KPRTAIGTPEPLAPEVIQE--NTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMI----GNGP-------- 444 (829)
T ss_pred c----ccccCCCCCCCCCchhhcc--cccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCC----CCCC--------
Confidence 2 1256679999999999887 67889999999998777777777665331 1111000 0000
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHH-HHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLA-LRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~-~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
....+... ..+++.. .++...|+..-|..|++...++-|.+|.+.
T Consensus 445 --------------~s~~L~~~-~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 445 --------------NSPMLTDK-SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred --------------Cccccchh-hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 00000000 0011111 257788999999999999999999999874
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=4.5e-06 Score=90.88 Aligned_cols=140 Identities=20% Similarity=0.320 Sum_probs=87.7
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCccCC---------------------------h-----------hHHHHHH
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH---------------------------I-----------SDAIRIL 70 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~---------------------------~-----------~~~~~~~ 70 (556)
+.|+.++-|.||+|+... |+.||||+....... . .....+.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 789999999999998754 999999987521100 0 0111234
Q ss_pred HHHHHHHhCC----CCCcceeeEEEcCCCCCCCceEEEEEecCcc-cHHHH--HHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 008729 71 REVKLLRLLR----HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQV--IKANDDLTREHHQFFLYQMLRALKYMH 143 (556)
Q Consensus 71 rEi~iL~~L~----HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~--i~~~~~l~~~~~~~i~~QIl~aL~yLH 143 (556)
+|...+.++. ...-+.+=.+|.. -...-.|+|||++| .+.+. +++ ..++...+...+.++. +..+-
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we----~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~ 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWE----YTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLL 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehh----ccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHH
Confidence 5555555552 2233344444432 11235799999997 55554 444 3344333322221111 22233
Q ss_pred HCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 144 s~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
..|++|.|.+|.||+++.+|++.+.|||+....
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 489999999999999999999999999987543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.11 E-value=3e-05 Score=76.77 Aligned_cols=70 Identities=13% Similarity=0.078 Sum_probs=46.3
Q ss_pred eeeecCc-eeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCCceEEEEEe
Q 008729 30 VIGKGSY-GVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIYVVFE 107 (556)
Q Consensus 30 ~LG~G~~-g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (556)
.|-.|.+ ..||++... +..+.+|...... ...+.+|+.+++.+. +--+.++++... ....-++|||
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~lv~e 72 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGS-----DDGRAWLLTS 72 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEe-----cCCccEEEEE
Confidence 4555655 788999543 4678888765321 335678999998884 444556666552 2234689999
Q ss_pred cCcc
Q 008729 108 LMES 111 (556)
Q Consensus 108 ~~~g 111 (556)
+++|
T Consensus 73 ~i~G 76 (244)
T cd05150 73 AVPG 76 (244)
T ss_pred eeCC
Confidence 9987
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.4e-05 Score=73.94 Aligned_cols=131 Identities=19% Similarity=0.267 Sum_probs=90.4
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
.-++.+.||+|.+|.||++... |..+|+|+-.. ......+..|.++|..++--++..=+-.+ ...+
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~y--------g~~~ 88 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWR--GGEVALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFY--------GEDF 88 (201)
T ss_pred hhhhhhhhhcccccEEEEeecc--CceEEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEe--------chhh
Confidence 4456788999999999999654 67899997542 23345678899999999877765533333 1135
Q ss_pred EEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC-CCcEeecCCCceEEeeeCcccc
Q 008729 104 VVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLK-PKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 104 lV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLK-P~NILl~~~~~vKL~DFGla~~ 175 (556)
+.|||+.| .|.+.-... +.++ +..++++---|-..||-|..|. |..+++-.++.+.|+||..|+.
T Consensus 89 i~me~i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 89 IRMEYIDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 66999998 666544321 2233 3455565445777899999996 5544444455899999998874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.03 E-value=5.7e-05 Score=87.97 Aligned_cols=83 Identities=17% Similarity=0.255 Sum_probs=56.2
Q ss_pred EEeeeeecCceeEEEEEECCCC--cEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCc--ceeeEEEcCCCCCCCce
Q 008729 27 ILEVIGKGSYGVVCAAIDTHTG--EKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDI--VEIKRIMLPPSKREFKD 101 (556)
Q Consensus 27 i~~~LG~G~~g~V~~a~~~~tg--~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnI--v~l~~v~~~~~~~~~~~ 101 (556)
-++.|+.|.++.+|+......+ ..+++|+.... ........+.+|+.+|+.|. |.+| .+++.++.+. .....
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~-~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~ 118 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPG-KLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGT 118 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCC-ccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCC
Confidence 3677899999999998765432 46888875422 11123446789999999996 6665 6666665332 22345
Q ss_pred EEEEEecCccc
Q 008729 102 IYVVFELMESD 112 (556)
Q Consensus 102 lylV~E~~~g~ 112 (556)
.|+||||++|.
T Consensus 119 ~flVME~v~G~ 129 (822)
T PLN02876 119 AFYIMEYLEGR 129 (822)
T ss_pred ceEEEEecCCc
Confidence 78999999874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.6e-05 Score=74.38 Aligned_cols=132 Identities=27% Similarity=0.325 Sum_probs=92.4
Q ss_pred CCeEEEeeeeecCc-eeEEEEEECCCCcEEEEEEecC-----------ccC-Ch-------hHHHHHHHHHHHHHhCC--
Q 008729 23 NRYKILEVIGKGSY-GVVCAAIDTHTGEKVAIKKIHD-----------VFE-HI-------SDAIRILREVKLLRLLR-- 80 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~-g~V~~a~~~~tg~~vAiK~i~~-----------~~~-~~-------~~~~~~~rEi~iL~~L~-- 80 (556)
..++.++.||.|.- |.||++. ..|+.||||.+.. .+. .. .....|..|.+..-+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 9999996 4688999999321 000 00 12235677888766664
Q ss_pred -CCCc--ceeeEEEcCCC-C------------CCCceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 008729 81 -HPDI--VEIKRIMLPPS-K------------REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144 (556)
Q Consensus 81 -HpnI--v~l~~v~~~~~-~------------~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs 144 (556)
+.++ |+.++++.-.. . .......||.||....- .++. .-+.+|++-|..+|.
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~~----~~~~~~~~dl~~~~k 182 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQI----RDIPQMLRDLKILHK 182 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccch----hHHHHHHHHHHHHHH
Confidence 5566 88888774331 0 11123468888877432 2232 235688888999999
Q ss_pred CCceeccCCCCcEeecCCCceEEeeeCcc
Q 008729 145 ANVYHRDLKPKNILANANCKLKVCDFGLA 173 (556)
Q Consensus 145 ~gIvHrDLKP~NILl~~~~~vKL~DFGla 173 (556)
.||+-+|+++.|.. .-||+|||.+
T Consensus 183 ~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 183 LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred CCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999986 3589999964
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.00 E-value=4.5e-05 Score=83.01 Aligned_cols=139 Identities=22% Similarity=0.313 Sum_probs=86.6
Q ss_pred EeeeeecCceeEEEEEECCCCcEEEEEEecCccCChh-----------------------------------HHHHHHHH
Q 008729 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS-----------------------------------DAIRILRE 72 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~-----------------------------------~~~~~~rE 72 (556)
-+.||.-+.|.||+|+.+. |+.||||+-+....... ....+.+|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 4689999999999999776 99999998653222110 00123334
Q ss_pred HHHHH----hCCCCC---cceeeEEEcCCCCCCCceEEEEEecCcc----cHHHHHHhCCCCCHHHHHHHHHHHHHHH-H
Q 008729 73 VKLLR----LLRHPD---IVEIKRIMLPPSKREFKDIYVVFELMES----DLHQVIKANDDLTREHHQFFLYQMLRAL-K 140 (556)
Q Consensus 73 i~iL~----~L~Hpn---Iv~l~~v~~~~~~~~~~~lylV~E~~~g----~L~~~i~~~~~l~~~~~~~i~~QIl~aL-~ 140 (556)
.+-.. .+.|-+ -|.+=.+|..- ...-.|+||||+| || +.|.+++ ++...+ +.-+.++. .
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl-~~i~~~g-i~~~~i---~~~l~~~~~~ 315 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDL-DAIDKRG-ISPHDI---LNKLVEAYLE 315 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCH-HHHHHcC-CCHHHH---HHHHHHHHHH
Confidence 43333 334545 12233333211 1235899999996 55 5666554 444433 33333332 2
Q ss_pred HHHHCCceeccCCCCcEeecC----CCceEEeeeCccccc
Q 008729 141 YMHTANVYHRDLKPKNILANA----NCKLKVCDFGLARVA 176 (556)
Q Consensus 141 yLHs~gIvHrDLKP~NILl~~----~~~vKL~DFGla~~~ 176 (556)
-|=..|++|+|-+|.||++.. ++.+.+.|||+....
T Consensus 316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 234578999999999999983 678999999998654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00018 Score=68.93 Aligned_cols=128 Identities=20% Similarity=0.246 Sum_probs=89.9
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCcc--------------CChhHHHHHHHHHHHHHhCC------CCCcceee
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF--------------EHISDAIRILREVKLLRLLR------HPDIVEIK 88 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~--------------~~~~~~~~~~rEi~iL~~L~------HpnIv~l~ 88 (556)
..||+|+.=.||.- . ......||++.... ..........+|+.....+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 56899999888865 3 34456799886533 11123455667777777666 78899999
Q ss_pred EEEcCCCCCCCceEEEEEecCc---c----cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC
Q 008729 89 RIMLPPSKREFKDIYVVFELME---S----DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (556)
Q Consensus 89 ~v~~~~~~~~~~~lylV~E~~~---g----~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~ 161 (556)
++. +....+.+|+|.+. | +|.++++. +.+++ .. ...|-+-..||-..+|+.+||+|.||++..
T Consensus 84 G~v-----eT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 84 GFV-----ETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQR 153 (199)
T ss_pred EEE-----ecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence 999 45556889999864 3 68888854 44665 33 333444556889999999999999999864
Q ss_pred CC----ceEEee
Q 008729 162 NC----KLKVCD 169 (556)
Q Consensus 162 ~~----~vKL~D 169 (556)
+. .+.|+|
T Consensus 154 ~~~~~~~lvlID 165 (199)
T PF10707_consen 154 RDSGEFRLVLID 165 (199)
T ss_pred cCCCceEEEEEe
Confidence 32 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.89 E-value=6.9e-05 Score=73.85 Aligned_cols=73 Identities=15% Similarity=0.186 Sum_probs=43.3
Q ss_pred EeeeeecCce-eEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCC---CcceeeEEEcCCCCCCCceEE
Q 008729 28 LEVIGKGSYG-VVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP---DIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 28 ~~~LG~G~~g-~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hp---nIv~l~~v~~~~~~~~~~~ly 103 (556)
++.|+.|+.. .||+. +..+++|.... ......+.+|..+|+.|... .+.+.+...... +.....|
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~----~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~--~~~~~~~ 70 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSA----AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPG--EGYPWPW 70 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCc----cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCc--cCCCcce
Confidence 3567877776 58876 33578886542 12344788999999988632 233333322111 1112458
Q ss_pred EEEecCcc
Q 008729 104 VVFELMES 111 (556)
Q Consensus 104 lV~E~~~g 111 (556)
+||++++|
T Consensus 71 ~l~~~i~G 78 (235)
T cd05155 71 SVYRWLEG 78 (235)
T ss_pred EEEEeecC
Confidence 89999886
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.0001 Score=78.38 Aligned_cols=177 Identities=24% Similarity=0.373 Sum_probs=118.9
Q ss_pred hHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q 008729 64 SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143 (556)
Q Consensus 64 ~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLH 143 (556)
.....++--..+++.+.|+|...++++.... .....+|||+++.+|.+.++.+. +-... ++
T Consensus 24 ~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~----~~r~IVV~e~~~~Sled~~~~~~-l~~~s-------~~------- 84 (725)
T KOG1093|consen 24 PNSIQILGRFQYLKSLQHDNLCQYLDFSRGK----HERVIVVMEHYTMSLEDILKTGN-LKDES-------LL------- 84 (725)
T ss_pred CcHHHHhhhhHHHHhhcCccceeeEeeecCc----cceEEEEehhhccchHHHHHhcc-cchhh-------hc-------
Confidence 3456777889999999999999988876432 23388999999999999988654 22111 11
Q ss_pred HCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHH
Q 008729 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 223 (556)
Q Consensus 144 s~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilye 223 (556)
.+|+.| .|| ++++| -++ +. | | ....+++||||+|.|+.+
T Consensus 85 ~~~~~~-----~~~-------~~~td-~~~-------------t~------~--~-------~~~~pKsdVwsl~~i~~e 123 (725)
T KOG1093|consen 85 AHGVLH-----LNI-------IYITD-HFL-------------TK------Y--P-------SPIGPKSDVWSLGFIILE 123 (725)
T ss_pred ccccce-----ehh-------hhccc-ccc-------------cc------C--C-------CCCCcchhhhhHHHHHHH
Confidence 222222 222 33333 110 00 1 1 122259999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCC
Q 008729 224 VLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303 (556)
Q Consensus 224 lltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~ 303 (556)
+.-|...|......+++..|.++.-.+..-. ...... . +. -.++....+++.+|+-..|..
T Consensus 124 l~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~-~~a~e~---~-~~--------------~~~d~~~~~~~~~c~~~~~~i 184 (725)
T KOG1093|consen 124 LYLGISLEAELTESEYLEILLKYYTDDQELL-STAMEH---L-IQ--------------LLADKKRLPLLKKCLWLEPII 184 (725)
T ss_pred HHHhhHHHHHHHHHHHHHHHHHhccCchhHH-HHHHHH---H-HH--------------HhhhHhHHHHhccCCcccccc
Confidence 9999999998888888888776554432221 111111 0 00 125667789999999999999
Q ss_pred CCCHHHHHhCcccccc
Q 008729 304 RPTAEEALADPYFKGL 319 (556)
Q Consensus 304 Rpta~elL~hp~f~~~ 319 (556)
||...++.+++-|..+
T Consensus 185 r~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 185 RPLPMELSKRCSFTEV 200 (725)
T ss_pred ccchhHHhcCccHHHH
Confidence 9999999999999765
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.83 E-value=4.5e-06 Score=97.35 Aligned_cols=155 Identities=18% Similarity=0.139 Sum_probs=116.4
Q ss_pred HHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEecCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH
Q 008729 69 ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN----DDLTREHHQFFLYQMLRALKYMH 143 (556)
Q Consensus 69 ~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~QIl~aL~yLH 143 (556)
.+.|...++.+.|+++...+.-..+ ......|.+++|+. |+++++|-+. ..+...-+.....+.+.+..-+|
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~p---s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPP---SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCC---CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 3445556667789998776654432 34456799999999 7999998653 23444444333344477777777
Q ss_pred HCC-----ceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHH
Q 008729 144 TAN-----VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 218 (556)
Q Consensus 144 s~g-----IvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG 218 (556)
+.. .+|++||+-|.+|..+-.+|++++|+.+.... ...+....++++.|+.+++... -.++.++|+|..|
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp---~~sf~Gl~l~sp~~v~qli~N~--ik~t~rsdilr~s 1427 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP---VLSFFGLELCSPIYVLQLIKNE--IKFTKRSDILRRS 1427 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCc---hHhhhhhhhCCHHHHHHHHHHH--HhhhhHHHHHHHH
Confidence 652 79999999999999999999999999984322 2233456678899999999877 6788889999999
Q ss_pred HHHHHHHhCCCCC
Q 008729 219 CIFAEVLTGKPLF 231 (556)
Q Consensus 219 ~ilyelltG~~pF 231 (556)
|.+|.+..|..+|
T Consensus 1428 ~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1428 LSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHhcccHHH
Confidence 9999999998877
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00032 Score=68.82 Aligned_cols=72 Identities=13% Similarity=0.212 Sum_probs=45.8
Q ss_pred EeeeeecCceeEEEEEECC-CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC-cceeeEEEcCCCCCCCceEEEE
Q 008729 28 LEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD-IVEIKRIMLPPSKREFKDIYVV 105 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~-tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn-Iv~l~~v~~~~~~~~~~~lylV 105 (556)
++.|..|-...||++.... .++.|++|+...... ......+|+.+++.+...+ ..+++... .. .+|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l 70 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLI 70 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEE
Confidence 5678889999999996433 357899997653211 1122347999999885333 44444432 11 379
Q ss_pred EecCcc
Q 008729 106 FELMES 111 (556)
Q Consensus 106 ~E~~~g 111 (556)
|||++|
T Consensus 71 ~e~i~G 76 (235)
T cd05157 71 YEFIPG 76 (235)
T ss_pred EEeeCC
Confidence 999886
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00019 Score=68.29 Aligned_cols=97 Identities=22% Similarity=0.230 Sum_probs=77.5
Q ss_pred HHHHHHHHhCCC-CCcceeeEEEcCCCCCCCceEEEEEecCc-ccHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHH
Q 008729 70 LREVKLLRLLRH-PDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQV---IKANDDLTREHHQFFLYQMLRALKYMHT 144 (556)
Q Consensus 70 ~rEi~iL~~L~H-pnIv~l~~v~~~~~~~~~~~lylV~E~~~-g~L~~~---i~~~~~l~~~~~~~i~~QIl~aL~yLHs 144 (556)
..|.-+|+.+++ +++.+++|.+ + -++|.||.+ ++++.. +..--..+++.+..|+.++++.+.+|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C--------G-~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC--------G-RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC--------C-CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 358889999976 6999999998 1 266889998 455421 1111235899999999999999999998
Q ss_pred ---CCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 145 ---ANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 145 ---~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
..+.-.|++|+|+-+++++++|++|...+..
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 3588899999999999999999999987654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00032 Score=69.96 Aligned_cols=132 Identities=17% Similarity=0.251 Sum_probs=75.6
Q ss_pred eeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCc-ceeeEEEcCCCCCCCceEEEEEec
Q 008729 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKREFKDIYVVFEL 108 (556)
Q Consensus 30 ~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~v~~~~~~~~~~~lylV~E~ 108 (556)
.+..|-.+.+|+.. .+++.|++|......... .....+|..+|+.+..-.+ .+++... . -++||||
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~ 69 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEW 69 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEe
Confidence 35678888999885 457789998754321110 0134679999998864333 3333332 1 2689999
Q ss_pred Cccc-HH--------------HHHHh-C------CCCCH-HHHHHHHHHH---------HHHHHHHHH--------CCce
Q 008729 109 MESD-LH--------------QVIKA-N------DDLTR-EHHQFFLYQM---------LRALKYMHT--------ANVY 148 (556)
Q Consensus 109 ~~g~-L~--------------~~i~~-~------~~l~~-~~~~~i~~QI---------l~aL~yLHs--------~gIv 148 (556)
++|. +. +.+.+ + ..++. ..+..+..++ ...+..+-. ..++
T Consensus 70 i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 149 (256)
T TIGR02721 70 LEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPL 149 (256)
T ss_pred ccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeee
Confidence 9862 21 11111 1 11121 2222222222 111222222 2589
Q ss_pred eccCCCCcEeecCCCceEEeeeCcccc
Q 008729 149 HRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 149 HrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
|+|+.|.|||++.++ +.|+||+.|..
T Consensus 150 H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 150 HMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 999999999999877 89999997753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0006 Score=70.01 Aligned_cols=145 Identities=15% Similarity=0.114 Sum_probs=82.2
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC--cceeeEEEcCC-CCCCCc
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPP-SKREFK 100 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~v~~~~-~~~~~~ 100 (556)
....++.++.|....||++.. . +..+++|+.... .....+..|+.++..|..-+ +.+++...... .....+
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~----~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKR----VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred CceeccccCCccccceEEEEe-C-CCcEEEEEecCC----CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 455677888888889998853 3 446889976531 11234556788888875322 33433311000 001234
Q ss_pred eEEEEEecCccc-H-----H------HHH---Hh-CCCC--------CHHH-----HH----------HHHHHHHHHHHH
Q 008729 101 DIYVVFELMESD-L-----H------QVI---KA-NDDL--------TREH-----HQ----------FFLYQMLRALKY 141 (556)
Q Consensus 101 ~lylV~E~~~g~-L-----~------~~i---~~-~~~l--------~~~~-----~~----------~i~~QIl~aL~y 141 (556)
..|+||||++|. + . ..+ .. ...+ .... .. .....+...+.+
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 578999998761 1 1 111 00 0011 0000 00 001122334555
Q ss_pred HHH-------CCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 142 MHT-------ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 142 LHs-------~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
+.. .++||+|+++.||+++.++.+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 542 589999999999999988777899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0019 Score=68.49 Aligned_cols=77 Identities=18% Similarity=0.151 Sum_probs=53.0
Q ss_pred EeeeeecCceeEEEEEECCCCcEEEEEEecCccC---C--hhHHHHHHHHHHHHHhCC---CCCcceeeEEEcCCCCCCC
Q 008729 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---H--ISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~---~--~~~~~~~~rEi~iL~~L~---HpnIv~l~~v~~~~~~~~~ 99 (556)
.+.||.|.+..||++.+...++.|+||.-..... . .-...+...|...|+.+. -.++.+++.+- .
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-------~ 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-------E 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-------C
Confidence 5779999999999999864446899997431111 1 124557778888888873 24566776652 1
Q ss_pred ceEEEEEecCcc
Q 008729 100 KDIYVVFELMES 111 (556)
Q Consensus 100 ~~lylV~E~~~g 111 (556)
...++|||++++
T Consensus 104 ~~~~lVME~L~~ 115 (401)
T PRK09550 104 ELAVTVMEDLSD 115 (401)
T ss_pred CCCEEEEecCCC
Confidence 336899999984
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00088 Score=68.50 Aligned_cols=72 Identities=17% Similarity=0.135 Sum_probs=45.4
Q ss_pred EeeeeecCceeEEEEEECC------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCc-ceeeEEEcCCCCCCCc
Q 008729 28 LEVIGKGSYGVVCAAIDTH------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKREFK 100 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~v~~~~~~~~~~ 100 (556)
++.|..|-...||++.... +++.|++|+..... .......+|..+++.+..-++ .+++..+ .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-----~~-- 72 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIF-----PN-- 72 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEe-----CC--
Confidence 4567778788999886433 25789999865421 223355689999988853333 3444443 11
Q ss_pred eEEEEEecCcc
Q 008729 101 DIYVVFELMES 111 (556)
Q Consensus 101 ~lylV~E~~~g 111 (556)
.+|+||++|
T Consensus 73 --~~v~e~i~G 81 (302)
T cd05156 73 --GRIEEFIPS 81 (302)
T ss_pred --CchhheeCC
Confidence 257888775
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0026 Score=65.15 Aligned_cols=79 Identities=14% Similarity=0.105 Sum_probs=53.5
Q ss_pred eEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCC---CCcceeeEEEcCCCCCCCce
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH---PDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H---pnIv~l~~v~~~~~~~~~~~ 101 (556)
-.-.+.||.|..+.||...+. +..+++|..+. ......+.+|...|+.|.- -.+.++++++... ...+.
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~----~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~ 87 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDS--QGNPMPLMARS----FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGP 87 (297)
T ss_pred hheeeecCCccceeEEEEEcC--CCCEEEEEecc----cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCC
Confidence 344678999999999998532 23577776432 1123467789999998853 3577777766332 22344
Q ss_pred EEEEEecCcc
Q 008729 102 IYVVFELMES 111 (556)
Q Consensus 102 lylV~E~~~g 111 (556)
-|||||+++|
T Consensus 88 ~~LVmE~i~G 97 (297)
T PRK10593 88 DVLLLERLRG 97 (297)
T ss_pred eEEEEeccCC
Confidence 7999999885
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00073 Score=68.79 Aligned_cols=142 Identities=15% Similarity=0.053 Sum_probs=81.6
Q ss_pred EEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC--cceeeEEEcCC-CCCCCceE
Q 008729 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPP-SKREFKDI 102 (556)
Q Consensus 26 ~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~v~~~~-~~~~~~~l 102 (556)
.-++.|..|....+|++.. .+..+++|+... .....+..|+.++..|.+-+ +.+++...... .....+..
T Consensus 17 ~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 17 LSFEGISAGIENTNYFVTT--DSGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred hheecccCccccceEEEEe--CCCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 3367788888889999853 345789998753 12345667888888885333 34443311000 00122456
Q ss_pred EEEEecCccc-H--------HHHHH------h-CCCC----------CH--HHHH--------HHHHHHHHHHHHHHH--
Q 008729 103 YVVFELMESD-L--------HQVIK------A-NDDL----------TR--EHHQ--------FFLYQMLRALKYMHT-- 144 (556)
Q Consensus 103 ylV~E~~~g~-L--------~~~i~------~-~~~l----------~~--~~~~--------~i~~QIl~aL~yLHs-- 144 (556)
++|+++++|. + ..+.+ . ...+ .+ .... .....+..++.++..
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 8999999862 1 11110 0 0000 00 0000 011112334445543
Q ss_pred -----CCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 145 -----ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 145 -----~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 379999999999999988777899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0055 Score=63.13 Aligned_cols=30 Identities=30% Similarity=0.296 Sum_probs=25.6
Q ss_pred CCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 145 ~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
.++||+|++|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 389999999999999866555899999764
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.00045 Score=69.92 Aligned_cols=136 Identities=18% Similarity=0.237 Sum_probs=93.6
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEec--C-ccCC------------h--h---HHHHHHHHHHHHHhCC-CC
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--D-VFEH------------I--S---DAIRILREVKLLRLLR-HP 82 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~--~-~~~~------------~--~---~~~~~~rEi~iL~~L~-Hp 82 (556)
-|.++..||-|.-+-||.+-+. .|+.+++|.-. + .|.+ . + ......+|...|+.|. |.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 3678899999999999999764 58888998421 0 0000 0 0 1123457999999885 33
Q ss_pred C-cceeeEEEcCCCCCCCceEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec
Q 008729 83 D-IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (556)
Q Consensus 83 n-Iv~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~ 160 (556)
. +.+.+ +...-++|||++.| -|.++-.- ..+..+...|..-+.-|...|+||+|..-=||++.
T Consensus 172 fpVPkpi---------D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 172 FPVPKPI---------DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCCcc---------cccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEe
Confidence 2 33332 33446899999986 55543321 12234555666667789999999999999999999
Q ss_pred CCCceEEeeeCcccc
Q 008729 161 ANCKLKVCDFGLARV 175 (556)
Q Consensus 161 ~~~~vKL~DFGla~~ 175 (556)
+++.++++||-....
T Consensus 237 dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVS 251 (465)
T ss_pred cCCCEEEeechHhhc
Confidence 999999999976543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.01 Score=61.00 Aligned_cols=147 Identities=18% Similarity=0.218 Sum_probs=84.5
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC--cceeeEEEcCCCCCCCce
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~~ 101 (556)
.-.+++.+..|..-.+|...+. ++.+++. ...............+|+.+++.+.--. +...++++.... -..
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~---~g~ 99 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY---LGT 99 (321)
T ss_pred CCceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC---CCC
Confidence 3455666645544556666544 8888888 3322334455667778999988875322 233344442211 246
Q ss_pred EEEEEecCccc-------------------HHHHHHh-------C-------CCCCHHHHHHHHHHH-------------
Q 008729 102 IYVVFELMESD-------------------LHQVIKA-------N-------DDLTREHHQFFLYQM------------- 135 (556)
Q Consensus 102 lylV~E~~~g~-------------------L~~~i~~-------~-------~~l~~~~~~~i~~QI------------- 135 (556)
.|.||+|++|. |-++|.. . +.....++..+..+.
T Consensus 100 pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 100 PFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred ceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 79999999872 1111110 0 001111122222222
Q ss_pred -HHHHHHHHHC--------CceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 136 -LRALKYMHTA--------NVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 136 -l~aL~yLHs~--------gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
..-..+|+.+ .++|+|+++.||+++.++.+=|.||+++...
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 2223444443 4899999999999999988999999998754
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0045 Score=62.63 Aligned_cols=30 Identities=30% Similarity=0.517 Sum_probs=25.2
Q ss_pred CceeccCCCCcEeecCCCc-eEEeeeCcccc
Q 008729 146 NVYHRDLKPKNILANANCK-LKVCDFGLARV 175 (556)
Q Consensus 146 gIvHrDLKP~NILl~~~~~-vKL~DFGla~~ 175 (556)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0064 Score=62.75 Aligned_cols=140 Identities=23% Similarity=0.326 Sum_probs=94.8
Q ss_pred EEEeeeeecCceeEEEEEECCCCcEEEEEEecCc----------------c------CChhHHHHHH--HHHHHHHhCCC
Q 008729 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV----------------F------EHISDAIRIL--REVKLLRLLRH 81 (556)
Q Consensus 26 ~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~----------------~------~~~~~~~~~~--rEi~iL~~L~H 81 (556)
.|-.+|.-|--+.||.|. ..+|..+|||+.+.. | .+.....+++ .|++-|++|+.
T Consensus 147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 455678888889999997 456888999987521 0 1111222333 57778888876
Q ss_pred CCcceeeEEEcCCCCCCCceEEEEEecCccc--HHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCcEe
Q 008729 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESD--LHQVIKANDDLTREHHQFFLYQMLRALKYM-HTANVYHRDLKPKNIL 158 (556)
Q Consensus 82 pnIv~l~~v~~~~~~~~~~~lylV~E~~~g~--L~~~i~~~~~l~~~~~~~i~~QIl~aL~yL-Hs~gIvHrDLKP~NIL 158 (556)
-.|.-..-+++ +.-.|||++++.+ -.-.|+ .-.++...+..+-.|++.-+.-| |.+++||.||.--|+|
T Consensus 226 aGIP~PePIlL-------k~hVLVM~FlGrdgw~aPkLK-d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~L 297 (520)
T KOG2270|consen 226 AGIPCPEPILL-------KNHVLVMEFLGRDGWAAPKLK-DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLL 297 (520)
T ss_pred cCCCCCCceee-------ecceEeeeeccCCCCcCcccc-cccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhhe
Confidence 66554433332 2247999999943 122222 34577777777777777777666 4568999999999999
Q ss_pred ecCCCceEEeeeCcccc
Q 008729 159 ANANCKLKVCDFGLARV 175 (556)
Q Consensus 159 l~~~~~vKL~DFGla~~ 175 (556)
+- +|.|.|+|.+.+..
T Consensus 298 yh-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 298 YH-DGKLYIIDVSQSVE 313 (520)
T ss_pred EE-CCEEEEEEcccccc
Confidence 95 56899999998754
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.015 Score=59.49 Aligned_cols=29 Identities=28% Similarity=0.384 Sum_probs=25.3
Q ss_pred CCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 145 ~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
.+++|+|+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 578999999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.014 Score=60.78 Aligned_cols=135 Identities=14% Similarity=0.198 Sum_probs=75.4
Q ss_pred EeeeeecCceeEEEEEECCC---CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCc-ceeeEEEcCCCCCCCceEE
Q 008729 28 LEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~v~~~~~~~~~~~ly 103 (556)
++.|..|-...+|++..... +..|++|+...... ....-.+|+.+++.+..-++ .++++.+ .. .
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~~IdR~~E~~il~~l~~~gl~P~~l~~~-----~~----G 86 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---YVIDRERELQAIKYLSAAGFGAKLLGVF-----GN----G 86 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---eEechHHHHHHHHHHHhcCCCCceeEEe-----CC----c
Confidence 45566688889998864332 34899998754211 12233479999998865444 3455444 11 1
Q ss_pred EEEecCccc-H-----------HHH---HHh-C-CC------C-CHHHHHHHHHHH----------------------HH
Q 008729 104 VVFELMESD-L-----------HQV---IKA-N-DD------L-TREHHQFFLYQM----------------------LR 137 (556)
Q Consensus 104 lV~E~~~g~-L-----------~~~---i~~-~-~~------l-~~~~~~~i~~QI----------------------l~ 137 (556)
+|.+|++|. | ..+ +++ + .. . -...+..++.++ ..
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 477777642 1 111 111 0 01 1 122333333222 11
Q ss_pred HHHHH----HHCC----ceeccCCCCcEeecC-CCceEEeeeCccc
Q 008729 138 ALKYM----HTAN----VYHRDLKPKNILANA-NCKLKVCDFGLAR 174 (556)
Q Consensus 138 aL~yL----Hs~g----IvHrDLKP~NILl~~-~~~vKL~DFGla~ 174 (556)
-+..+ .+.+ ++|.||.+.|||+++ ++.++++||..|.
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 12222 1222 799999999999974 5789999999763
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.015 Score=60.82 Aligned_cols=138 Identities=13% Similarity=0.142 Sum_probs=78.1
Q ss_pred CeEEEeeeeecCceeEEEEEECC----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCc-ceeeEEEcCCCCCC
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTH----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKRE 98 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~v~~~~~~~~ 98 (556)
... ++.|..|-...+|++.... .++.|++|+..... .....-.+|+.+++.+..-++ .++++.+ ..
T Consensus 38 ~~~-i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR~~E~~~~~~l~~~gl~P~~~~~~-----~~ 108 (344)
T PLN02236 38 ALQ-VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDRDDEIRTFECMSRHGQGPRLLGRF-----PN 108 (344)
T ss_pred cEE-EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---CeeechHHHHHHHHHHHHcCCCCceEEEE-----CC
Confidence 344 4556668889999986432 34789999875421 111123579999988864333 3455554 21
Q ss_pred CceEEEEEecCcc-cHH-----------HH---HH---hCC------CCCHHHHHHHHHHHH-----------------H
Q 008729 99 FKDIYVVFELMES-DLH-----------QV---IK---AND------DLTREHHQFFLYQML-----------------R 137 (556)
Q Consensus 99 ~~~lylV~E~~~g-~L~-----------~~---i~---~~~------~l~~~~~~~i~~QIl-----------------~ 137 (556)
..|.||++| .|. .+ +. .-. ....+.+..++.++. .
T Consensus 109 ----g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~ 184 (344)
T PLN02236 109 ----GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLED 184 (344)
T ss_pred ----ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHH
Confidence 147888764 221 11 11 100 111233334432221 1
Q ss_pred HHHHH----H----HCCceeccCCCCcEeecC-CCceEEeeeCccc
Q 008729 138 ALKYM----H----TANVYHRDLKPKNILANA-NCKLKVCDFGLAR 174 (556)
Q Consensus 138 aL~yL----H----s~gIvHrDLKP~NILl~~-~~~vKL~DFGla~ 174 (556)
.+..| . ...++|+|+++.|||++. ++.+.|+||..|.
T Consensus 185 ~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 185 EINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11122 1 225899999999999976 4679999998774
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.021 Score=59.58 Aligned_cols=82 Identities=15% Similarity=0.074 Sum_probs=52.4
Q ss_pred eeeecCceeEEEEEECCCCcEEEEEEecCcc-----CChhHHHHHHHHHHHHHhCC--CC-CcceeeEEEcCCCCCCCce
Q 008729 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-----EHISDAIRILREVKLLRLLR--HP-DIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 30 ~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-----~~~~~~~~~~rEi~iL~~L~--Hp-nIv~l~~v~~~~~~~~~~~ 101 (556)
.||-|....||++.+...++.|+||.-.... ...-...+...|...|+... -| .+.++|.+ +...
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-------D~e~ 74 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-------DTEM 74 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-------cccc
Confidence 5789999999999976444689999642111 12334556778888888764 34 45555553 2223
Q ss_pred EEEEEecCcc--cHHHHHH
Q 008729 102 IYVVFELMES--DLHQVIK 118 (556)
Q Consensus 102 lylV~E~~~g--~L~~~i~ 118 (556)
..+|||+++. .|.+.+.
T Consensus 75 ~~~vMEdL~~~~ilR~~Li 93 (370)
T TIGR01767 75 AVTVMEDLSHHKIARKGLI 93 (370)
T ss_pred ceehHhhCccchHHHHHHH
Confidence 4699999973 5555553
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.018 Score=60.84 Aligned_cols=87 Identities=21% Similarity=0.201 Sum_probs=56.7
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCc----cCChhHHHHHHHHHHHHHhCC--CC-CcceeeEEEcCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV----FEHISDAIRILREVKLLRLLR--HP-DIVEIKRIMLPPS 95 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~----~~~~~~~~~~~rEi~iL~~L~--Hp-nIv~l~~v~~~~~ 95 (556)
..+. ++.||-|--..||++.+...++.|+||.--.. ..-.-...|..-|..+|+.+. -| .+.++|.+
T Consensus 30 ~~~~-~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~----- 103 (409)
T PRK12396 30 KGLQ-CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF----- 103 (409)
T ss_pred ccce-eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-----
Confidence 3444 77899999999999988544678999953211 122335667778999998774 34 45555553
Q ss_pred CCCCceEEEEEecCcc--cHHHHH
Q 008729 96 KREFKDIYVVFELMES--DLHQVI 117 (556)
Q Consensus 96 ~~~~~~lylV~E~~~g--~L~~~i 117 (556)
+.....+|||+++. .|.+.+
T Consensus 104 --D~e~~~~vMEdL~~~~ilR~~L 125 (409)
T PRK12396 104 --DSVMNCCVMEDLSDHTILRTAL 125 (409)
T ss_pred --CcHHhhHHHHhCcccHHHHHHH
Confidence 22335789999863 455554
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.035 Score=57.04 Aligned_cols=30 Identities=17% Similarity=0.118 Sum_probs=27.4
Q ss_pred CceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 146 NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 146 gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
++||+|+.+.|||++.++.+.|+||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999998999999997754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.073 Score=56.59 Aligned_cols=76 Identities=14% Similarity=0.162 Sum_probs=50.7
Q ss_pred EEeeeeecCceeEEEEEECCCCcEEEEEEecCccC---C--hhHHHHHHHHHHHHHhCC---CCCcceeeEEEcCCCCCC
Q 008729 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---H--ISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 27 i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~---~--~~~~~~~~rEi~iL~~L~---HpnIv~l~~v~~~~~~~~ 98 (556)
..+.||-|....||++.+. +..|+||.-..... . .-...+...|...|+.+. ...+.+++.+..
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de------ 107 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR------ 107 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC------
Confidence 4778999999999999763 45699996541111 1 113455666777777664 246777777652
Q ss_pred CceEEEEEecCcc
Q 008729 99 FKDIYVVFELMES 111 (556)
Q Consensus 99 ~~~lylV~E~~~g 111 (556)
..-++|||++++
T Consensus 108 -d~~vlvME~L~~ 119 (418)
T PLN02756 108 -TMALIGMRYLEP 119 (418)
T ss_pred -CCCEEEEeecCC
Confidence 225788999975
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.14 Score=54.27 Aligned_cols=74 Identities=19% Similarity=0.144 Sum_probs=43.1
Q ss_pred EEEeeeeecCceeEEEEEECCC-CcE-----EEEEEecCccCChhHHHHHHHHHHHHHhCCCCCc-ceeeEEEcCCCCCC
Q 008729 26 KILEVIGKGSYGVVCAAIDTHT-GEK-----VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKRE 98 (556)
Q Consensus 26 ~i~~~LG~G~~g~V~~a~~~~t-g~~-----vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~v~~~~~~~~ 98 (556)
..++.|..|-...+|++..... +.. |.+.... ........-.+|+.+++.|..-++ .++++.+ .
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g---~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f-----~- 123 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS---TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRF-----G- 123 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEecc---CCCceEeccHHHHHHHHHHHhCCCCCeEEEec-----C-
Confidence 3455676799999999964332 223 3333221 111111223469999999975444 4555555 2
Q ss_pred CceEEEEEecCcc
Q 008729 99 FKDIYVVFELMES 111 (556)
Q Consensus 99 ~~~lylV~E~~~g 111 (556)
-++|.||++|
T Consensus 124 ---~g~l~efIeG 133 (383)
T PTZ00384 124 ---DFTIQEWVEG 133 (383)
T ss_pred ---CEEEEEEecc
Confidence 2689999886
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.40 E-value=0.035 Score=57.43 Aligned_cols=75 Identities=24% Similarity=0.375 Sum_probs=59.7
Q ss_pred CCCceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
.+..+.|++|++-++.|.- ++ --..+++..|+++-+..+.-+..+ ..=||||.-.||||+ +|+|.|+||-++|.
T Consensus 296 de~~y~yl~~kdhgt~is~-ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 296 DETLYLYLHFKDHGTPISI-IK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CCceEEEEEEecCCceeee-ee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 4556789999998876542 22 235677888888888877777665 589999999999999 99999999999986
Q ss_pred c
Q 008729 176 A 176 (556)
Q Consensus 176 ~ 176 (556)
.
T Consensus 371 ~ 371 (488)
T COG5072 371 S 371 (488)
T ss_pred c
Confidence 4
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.22 E-value=0.1 Score=53.06 Aligned_cols=75 Identities=15% Similarity=0.134 Sum_probs=44.5
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC---CCCcceeeEEEcCCCCCCCc
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~---HpnIv~l~~v~~~~~~~~~~ 100 (556)
.-+-.+.|+.|....+|+.. .+++.|.||+-.. .....+..|..-|+.|. --.+.+.+.+.... .
T Consensus 18 ~i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~-----~ 85 (288)
T PF03881_consen 18 KITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD-----D 85 (288)
T ss_dssp ---EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S-----S
T ss_pred ceeeeEecCCCChhheEEEE--CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec-----C
Confidence 34557789999999999985 7788999997652 22235667888888884 33466777765322 2
Q ss_pred eEEEEEecCc
Q 008729 101 DIYVVFELME 110 (556)
Q Consensus 101 ~lylV~E~~~ 110 (556)
.-||||||++
T Consensus 86 ~~fLlle~l~ 95 (288)
T PF03881_consen 86 DAFLLLEFLE 95 (288)
T ss_dssp CCEEEEE---
T ss_pred CceEEEEeec
Confidence 3499999987
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.39 Score=49.79 Aligned_cols=28 Identities=32% Similarity=0.323 Sum_probs=23.7
Q ss_pred CCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 145 ~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
.++||+|+.+.|||++ + .+.|+||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3689999999999995 4 58899999764
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.27 Score=58.79 Aligned_cols=31 Identities=39% Similarity=0.518 Sum_probs=26.4
Q ss_pred CCceeccCCCCcEeecCCC--ceE-EeeeCcccc
Q 008729 145 ANVYHRDLKPKNILANANC--KLK-VCDFGLARV 175 (556)
Q Consensus 145 ~gIvHrDLKP~NILl~~~~--~vK-L~DFGla~~ 175 (556)
.++||+|+++.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 565 999998754
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.12 Score=50.02 Aligned_cols=98 Identities=19% Similarity=0.230 Sum_probs=64.4
Q ss_pred EEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEEEEEecCcc--cHHHHHHhCCCCCHHHH
Q 008729 51 VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES--DLHQVIKANDDLTREHH 128 (556)
Q Consensus 51 vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~g--~L~~~i~~~~~l~~~~~ 128 (556)
..+|++...-... ....+.++..++.++. .|+++.. ++.-.+.++.|+|-. .+..
T Consensus 88 L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~N-------Dn~~~yGvIlE~Cy~~~i~~~------------- 144 (308)
T PF07387_consen 88 LFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKN-------DNNYKYGVILERCYKIKINFS------------- 144 (308)
T ss_pred hhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeec-------CCCceeEEEEeeccCcccchh-------------
Confidence 4566665322221 2234567888887764 5777653 344457899999873 2111
Q ss_pred HHHHHHHHHHHHHHHHC--CceeccCCCCcEeecCCCceEEeeeCc
Q 008729 129 QFFLYQMLRALKYMHTA--NVYHRDLKPKNILANANCKLKVCDFGL 172 (556)
Q Consensus 129 ~~i~~QIl~aL~yLHs~--gIvHrDLKP~NILl~~~~~vKL~DFGl 172 (556)
.++--=+.+|.-.|+. +.+|+|-.|+||+-|..|.+||.|-+.
T Consensus 145 -N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 145 -NFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred -HHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 1111124567777843 699999999999999999999999874
|
The function of this family is unknown. |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.12 Score=52.52 Aligned_cols=28 Identities=36% Similarity=0.499 Sum_probs=23.9
Q ss_pred ceeccCCCCcEeecCC--C---ceEEeeeCccc
Q 008729 147 VYHRDLKPKNILANAN--C---KLKVCDFGLAR 174 (556)
Q Consensus 147 IvHrDLKP~NILl~~~--~---~vKL~DFGla~ 174 (556)
++|+|++..|||+..+ | .++++||.+++
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeecccccc
Confidence 8999999999999665 3 58999998764
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.15 E-value=0.36 Score=47.15 Aligned_cols=72 Identities=17% Similarity=0.189 Sum_probs=44.2
Q ss_pred EEEeeeeecCceeEEEEEECCCC-cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC---cceeeEEEcCCCCCCCce
Q 008729 26 KILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD---IVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 26 ~i~~~LG~G~~g~V~~a~~~~tg-~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn---Iv~l~~v~~~~~~~~~~~ 101 (556)
+-.+.+.-|.--..|.. .+| ..|.+|+-. ......+..|+.-|+.|.--| +.+.+.+- ....+
T Consensus 19 ~er~~v~gG~inea~~v---~dg~~~~FvK~n~-----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G-----~~~~~ 85 (286)
T COG3001 19 KEREEVSGGDINEAWRL---RDGTDPFFVKCNQ-----REQLSMFTAEADGLELLARSNTITVPKVIAVG-----ASRDH 85 (286)
T ss_pred hcccccCCccccceeEe---ecCCcceEEEecc-----hhhHHHHHHHHHHHHHHHhcCCccccceEEec-----CCCCe
Confidence 33444544444444444 444 478888643 233456777888888875444 44554443 56678
Q ss_pred EEEEEecCc
Q 008729 102 IYVVFELME 110 (556)
Q Consensus 102 lylV~E~~~ 110 (556)
.|+||||++
T Consensus 86 sylVle~L~ 94 (286)
T COG3001 86 SYLVLEYLP 94 (286)
T ss_pred eEEEEeecc
Confidence 999999987
|
|
| >PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat | Back alignment and domain information |
|---|
Probab=94.14 E-value=0.26 Score=52.81 Aligned_cols=29 Identities=24% Similarity=0.326 Sum_probs=23.0
Q ss_pred ceeccCCCCcEeecCCCc-----eEEeeeCcccc
Q 008729 147 VYHRDLKPKNILANANCK-----LKVCDFGLARV 175 (556)
Q Consensus 147 IvHrDLKP~NILl~~~~~-----vKL~DFGla~~ 175 (556)
++|+||...|||.+.++. ..|+||-++..
T Consensus 270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~ 303 (414)
T PF07914_consen 270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHR 303 (414)
T ss_pred eecCCccHHheeeecCCchhHHHHHHHHHHHhhc
Confidence 799999999999987443 46889876543
|
In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO). |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.17 E-value=1.3 Score=47.92 Aligned_cols=73 Identities=8% Similarity=0.029 Sum_probs=44.7
Q ss_pred EEeeeeecCceeEEEEEECC--------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcc-eeeEEEcCCCCC
Q 008729 27 ILEVIGKGSYGVVCAAIDTH--------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV-EIKRIMLPPSKR 97 (556)
Q Consensus 27 i~~~LG~G~~g~V~~a~~~~--------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv-~l~~v~~~~~~~ 97 (556)
-++.|..|-.-.+|++.... .++.|.+++..... .....-.+|..+++.+..-+|- ++++.+ .
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lIdR~~E~~v~~~ls~~gi~P~l~~~f-----~ 180 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELYNPISEFEVYKTMSKYRIAPQLLNTF-----S 180 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---cceeCHHHHHHHHHHHHHCCCCCceEEEe-----C
Confidence 56778888888999986442 25689998875321 1112334688888887644443 455544 1
Q ss_pred CCceEEEEEecCcc
Q 008729 98 EFKDIYVVFELMES 111 (556)
Q Consensus 98 ~~~~lylV~E~~~g 111 (556)
-+.|.||++|
T Consensus 181 ----gg~I~efi~g 190 (442)
T PTZ00296 181 ----GGRIEEWLYG 190 (442)
T ss_pred ----CCEEEEeeCC
Confidence 1456777764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 556 | ||||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-89 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-89 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-82 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-82 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-82 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-82 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-82 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-82 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-82 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-82 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-82 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-82 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-82 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 7e-82 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-81 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-81 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-81 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-81 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-81 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-80 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-80 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-80 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-80 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-79 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-79 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-77 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-77 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-76 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-76 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-74 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-74 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-74 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-74 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-74 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-74 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-74 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-74 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-74 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-74 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-74 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-74 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-74 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-74 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-74 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-74 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-74 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-74 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-74 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-74 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-74 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-74 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-74 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-74 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-74 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-74 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-74 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-74 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-74 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-74 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-74 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-74 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-74 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-74 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-74 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-74 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-74 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-74 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-74 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-74 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-74 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-73 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-73 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-73 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-73 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-73 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-73 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-73 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-73 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-73 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-73 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-73 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-73 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-73 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-73 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-73 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-73 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-72 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-72 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-71 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-71 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-70 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-66 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-66 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-66 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-65 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-63 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-58 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-56 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-56 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-55 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-55 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-55 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-55 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-55 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-55 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-55 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-55 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-55 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-55 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-55 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-54 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-54 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-54 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-54 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-54 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-54 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-54 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-54 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-54 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-54 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-54 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-53 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-53 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-53 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-53 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-53 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-53 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-53 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-53 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-53 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-52 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-51 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-51 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-48 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-48 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-46 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-45 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-43 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-43 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-43 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-43 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-43 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-43 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-43 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-43 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-43 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-43 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-43 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-43 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-43 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-43 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-43 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-43 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-43 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-43 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-43 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-43 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-43 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-43 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-43 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-43 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-43 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-43 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-43 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-42 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-42 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-42 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-42 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-42 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-42 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-42 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-42 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-42 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-42 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-42 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-42 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-42 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-42 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-41 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-40 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-39 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-39 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-39 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-39 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-39 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-39 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-39 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 3e-39 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-39 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-39 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-39 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 8e-39 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-39 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-38 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-38 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-38 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-38 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-38 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-38 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-38 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-38 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 3e-38 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 3e-38 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-38 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-38 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-38 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-38 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-38 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-38 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-38 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-38 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-37 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-36 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-36 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-35 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-35 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-34 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 9e-30 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-28 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-28 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-27 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-27 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-26 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-26 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-26 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-26 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-26 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-26 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-26 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 5e-26 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-26 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-26 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-25 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-25 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-25 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-25 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-25 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 2e-24 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-24 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-24 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-24 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-24 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-24 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-24 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-24 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-24 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-24 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-24 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-24 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 8e-24 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 8e-24 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 9e-24 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-23 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-23 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-23 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-23 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-23 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-23 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-23 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-23 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-23 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-23 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-23 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-23 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-22 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-22 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 3e-22 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-22 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-21 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 2e-21 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-21 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-21 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-21 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 4e-21 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 4e-21 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-21 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-21 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-21 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-21 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-21 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-21 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-21 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-21 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-21 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-21 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-20 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-20 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-20 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-20 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-20 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-20 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-20 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-20 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-20 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-20 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-20 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-20 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-20 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-20 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-20 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-20 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-20 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 9e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-19 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-19 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-19 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-19 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-19 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-19 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-19 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-19 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-19 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-19 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-19 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-19 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-19 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-19 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-19 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-19 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 6e-19 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-19 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-19 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-19 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-19 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-19 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-18 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-18 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-18 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-18 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-18 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-18 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-18 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-18 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-18 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-18 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 9e-18 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-17 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-17 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-17 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-17 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-17 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-17 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-17 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-17 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-17 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-17 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-17 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-17 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-17 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-17 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-17 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-16 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-16 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-16 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-16 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-16 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-16 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-16 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-16 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-16 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-16 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-16 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 7e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-16 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 9e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-15 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-15 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-15 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-15 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-15 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-15 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-15 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-14 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-14 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-14 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-14 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-14 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-14 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-14 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-14 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-14 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-14 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-14 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-14 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-14 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-14 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 7e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-14 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-14 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-14 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-14 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-14 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 8e-14 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-14 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-14 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 9e-14 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-13 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-13 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-13 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-13 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-13 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-13 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-13 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-13 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-13 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-13 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-13 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-13 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-13 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-13 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-13 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-13 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-13 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-13 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 6e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-13 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-13 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 7e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 8e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 9e-13 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-13 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-12 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-12 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-12 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-12 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-12 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-12 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-12 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-12 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-12 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-12 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-12 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-12 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-12 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-12 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-12 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-12 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-12 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-11 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-11 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-11 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-11 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-11 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-11 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-11 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-11 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 8e-11 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-11 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 8e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-10 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-10 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-10 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-10 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-10 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-10 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 3e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-10 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-10 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-10 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-10 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-10 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-10 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 5e-10 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-10 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-10 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-10 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-10 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-10 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-10 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-09 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-09 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-09 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-09 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-09 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 4e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-09 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-09 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-08 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-08 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-08 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-08 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-08 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-08 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-08 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-08 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-08 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 7e-08 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-08 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 9e-08 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-07 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-07 |
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 563 bits (1454), Expect = 0.0
Identities = 134/426 (31%), Positives = 214/426 (50%), Gaps = 52/426 (12%)
Query: 1 MQQDQTKKELKDKDFFTEYGDAN---RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH 57
M ++ +F + + Y I +IG+GSYG V A D +T + VAIKK++
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN 60
Query: 58 DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVI 117
+FE + D RILRE+ +L L+ I+ + +++P +F ++Y+V E+ +SDL ++
Sbjct: 61 RMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLF 120
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
K LT EH + LY +L ++H + + HRDLKP N L N +C +KVCDFGLAR
Sbjct: 121 KTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180
Query: 178 SDTPMTV-------------------FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIG 218
S+ + T +V TRWYRAPEL YT +IDIWS G
Sbjct: 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELI-LLQENYTKSIDIWSTG 239
Query: 219 CIFAEVLTG-----------KPLFPG-----------------KSVVHQLDLITDLLGTP 250
CIFAE+L PLFPG KS QL++I +++GTP
Sbjct: 240 CIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTP 299
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
+ + + + + KY+ + P+ L QK+P++ + LL+ ++ F+P R T ++A
Sbjct: 300 TEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQA 359
Query: 311 LADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYING 370
L PY K + K + E L F+ + +++ +R + +E+ +HP+L+ +
Sbjct: 360 LDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELVIPSVFT 418
Query: 371 TEGTNF 376
NF
Sbjct: 419 IHENNF 424
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 558 bits (1440), Expect = 0.0
Identities = 148/351 (42%), Positives = 220/351 (62%), Gaps = 13/351 (3%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
Y ++ +++ ++G+G+YGVVC+A TGE VAIKKI + F+ A+R LRE+K+L
Sbjct: 5 IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRTLREIKIL 63
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQML 136
+ +H +I+ I I P S F ++Y++ ELM++DLH+VI L+ +H Q+F+YQ L
Sbjct: 64 KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQM-LSDDHIQYFIYQTL 122
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD-------TPMTVFWTDY 189
RA+K +H +NV HRDLKP N+L N+NC LKVCDFGLAR+ T ++
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
VATRWYRAPE+ + +KY+ A+D+WS GCI AE+ +P+FPG+ HQL LI ++GT
Sbjct: 183 VATRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241
Query: 250 PSPE-TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
P + + + + +AR+Y+ + P PL + FP V+P + LLQR++ FDP R TA+
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301
Query: 309 EALADPYFKGLAKIEREPSCQPISKLEFEF--ERRRVTKDDIRELIYREIL 357
EAL PY + EP +PI FEF + +T D+++LI+ EI
Sbjct: 302 EALEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF 352
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 558 bits (1441), Expect = 0.0
Identities = 156/362 (43%), Positives = 219/362 (60%), Gaps = 5/362 (1%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
+ + RY L IG+G+YG+VC+A D +VAIKKI FE
Sbjct: 6 HMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFE 64
Query: 62 HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND 121
H + R LRE+K+L RH +I+ I I+ P+ + KD+Y+V +LME+DL++++K
Sbjct: 65 HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH 124
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181
L+ +H +FLYQ+LR LKY+H+ANV HRDLKP N+L N C LK+CDFGLARVA D
Sbjct: 125 -LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241
T F T+YVATRWYRAPE+ + YT +IDIWS+GCI AE+L+ +P+FPGK + QL+
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDP 301
I +LG+PS E + + N KAR YL + K VP + FPN D AL LL +++ F+P
Sbjct: 243 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP 302
Query: 302 KDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
R E+ALA PY + EP + +F+ E + K+ ++ELI+ E + P
Sbjct: 303 HKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQP 360
Query: 362 QL 363
Sbjct: 361 GY 362
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 539 bits (1391), Expect = 0.0
Identities = 120/368 (32%), Positives = 183/368 (49%), Gaps = 21/368 (5%)
Query: 5 QTKKELKDKDFF-TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHD----- 58
Q K E +D + + Y + I GSYG VCA +D+ G VAIK++ +
Sbjct: 3 QAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDG 61
Query: 59 ----VFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLH 114
+ R+LRE++LL HP+I+ ++ I + + +Y+V ELM +DL
Sbjct: 62 RTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA 121
Query: 115 QVIKANDD-LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
QVI ++ +H Q+F+Y +L L +H A V HRDL P NIL N + +CDF LA
Sbjct: 122 QVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
R +D T YV RWYRAPEL F +T +D+WS GC+ AE+ K LF G
Sbjct: 182 REDTADANK----THYVTHRWYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMFNRKALFRG 236
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMR-KKPPVPLFQKFPNVDPLALRL 292
+ +QL+ I +++GTP E + + + AR YL P P DP+AL L
Sbjct: 237 STFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDL 296
Query: 293 LQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELI 352
+ +++ F+P+ R + E+AL PYF+ L F F+ D+ ++
Sbjct: 297 IAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSE---RFHFDESVTDVYDMHKIF 353
Query: 353 YREILEYH 360
E+ ++
Sbjct: 354 TAEVERFN 361
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 538 bits (1388), Expect = 0.0
Identities = 136/385 (35%), Positives = 213/385 (55%), Gaps = 43/385 (11%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HP 82
+Y++++ +GKG+YG+V +ID TGE VA+KKI D F++ +DA R RE+ +L L H
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+IV + ++ + +D+Y+VF+ ME+DLH VI+AN L H Q+ +YQ+++ +KY+
Sbjct: 70 NIVNLLNVLRADN---DRDVYLVFDYMETDLHAVIRANI-LEPVHKQYVVYQLIKVIKYL 125
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARV------------------AFSDTPMTV 184
H+ + HRD+KP NIL NA C +KV DFGL+R +
Sbjct: 126 HSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 185 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
TDYVATRWYRAPE L GS +KYT ID+WS+GCI E+L GKP+FPG S ++QL+ I
Sbjct: 186 ILTDYVATRWYRAPEILLGS--TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKF----------------PNVDP 287
++ PS E + +++ A+ + +++K + K + +
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDD 347
AL LL +L+ F+P R +A +AL P+ EP+C I + + + + DD
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSIDD 362
Query: 348 IRELIYREILEYHPQLLKDYINGTE 372
R L+Y EI +L+ + +
Sbjct: 363 YRNLVYSEISRRKRELISNKHQNVQ 387
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 534 bits (1378), Expect = 0.0
Identities = 132/341 (38%), Positives = 203/341 (59%), Gaps = 12/341 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y+ L+ +G G+YG VC+A+D TG KVAIKK++ F+ A R RE++LL+ +RH
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 83 DIVEIKRIMLP-PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+++ + + P + +F D Y+V M +DL +++K L + QF +YQML+ L+Y
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRY 143
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H A + HRDLKP N+ N +C+LK+ DFGLAR A S+ T YV TRWYRAPE+
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE------MTGYVVTRWYRAPEVI 197
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
++ +YT +DIWS+GCI AE++TGK LF G + QL I + GTP E + ++++
Sbjct: 198 LNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
+A+ Y+ + + N PLA+ LL++++ D + R TA EALA PYF+ L
Sbjct: 257 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316
Query: 322 IEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362
E EP Q + F+ T D+ + + Y+E+L + P
Sbjct: 317 TEDEPQVQKY---DDSFDDVDRTLDEWKRVTYKEVLSFKPP 354
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 533 bits (1374), Expect = 0.0
Identities = 131/340 (38%), Positives = 195/340 (57%), Gaps = 12/340 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y +G G+YG VC+AID +GEKVAIKK+ F+ A R RE+ LL+ ++H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 83 DIVEIKRIMLPPSK-REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+++ + + P S R F D Y+V M++DL +++ + E Q+ +YQML+ LKY
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQMLKGLKY 141
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+A V HRDLKP N+ N +C+LK+ DFGLAR A ++ T YV TRWYRAPE+
Sbjct: 142 IHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE------MTGYVVTRWYRAPEVI 195
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
S+ Y +DIWS+GCI AE+LTGK LF GK + QL I + G P E + + ++
Sbjct: 196 LSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
A+ Y+ + + P Q FP P A LL++++ D R TA +AL P+F+
Sbjct: 255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314
Query: 322 IEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
E E Q + E ++T D+ ++ IY+EI+ + P
Sbjct: 315 PEEETEAQQ--PFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 536 bits (1382), Expect = 0.0
Identities = 145/417 (34%), Positives = 207/417 (49%), Gaps = 57/417 (13%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
Q +K +++ +RY+I +IG GSYG VC A D VAIKKI VFE
Sbjct: 32 QHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE 91
Query: 62 HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND 121
+ D RILRE+ +L L H +V++ I++P +F ++YVV E+ +SD ++ +
Sbjct: 92 DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPV 151
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA----- 176
LT H + LY +L +KY+H+A + HRDLKP N L N +C +KVCDFGLAR
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 177 -------------------FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSI 217
+ T +V TRWYRAPEL YT AID+WSI
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-QENYTEAIDVWSI 270
Query: 218 GCIFAEVLT-----------GKPLFPGKSVV--------------------HQLDLITDL 246
GCIFAE+L PLFPG S QL++I ++
Sbjct: 271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI 330
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
LGTPS E I + E A++Y+ K+ L ++FP A+ LL+R++ F+P R T
Sbjct: 331 LGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT 390
Query: 307 AEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQL 363
E LA P+FK + E E + +L F + + + +R +EI YHP++
Sbjct: 391 INECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHPEI 446
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 529 bits (1365), Expect = 0.0
Identities = 142/372 (38%), Positives = 210/372 (56%), Gaps = 18/372 (4%)
Query: 1 MQQDQTKKELKDKDFF------TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIK 54
M + F+ T + RY+ L +G G+YG VCAA DT TG +VA+K
Sbjct: 1 MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60
Query: 55 KIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE-FKDIYVVFELMESDL 113
K+ F+ I A R RE++LL+ ++H +++ + + P E F D+Y+V LM +DL
Sbjct: 61 KLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL 120
Query: 114 HQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
+ ++K LT +H QF +YQ+LR LKY+H+A++ HRDLKP N+ N +C+LK+ DFGLA
Sbjct: 121 NNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
R T YVATRWYRAPE+ ++ Y +DIWS+GCI AE+LTG+ LFPG
Sbjct: 180 RHTAD------EMTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPG 232
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLL 293
+ QL LI L+GTP E + + +E AR Y+ + + P + F +PLA+ LL
Sbjct: 233 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 292
Query: 294 QRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIY 353
++++ D R TA +ALA YF + EP P + E R + D+ + L Y
Sbjct: 293 EKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---DQSLESRDLLIDEWKSLTY 349
Query: 354 REILEYHPQLLK 365
E++ + P L
Sbjct: 350 DEVISFVPPPLD 361
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 517 bits (1332), Expect = 0.0
Identities = 132/444 (29%), Positives = 213/444 (47%), Gaps = 36/444 (8%)
Query: 1 MQQDQTKKELKDKDFFT-EYGDAN-----RYKILEVIGKGSYGVVCAAIDTHTGEKVAIK 54
+ K D F++ E GD+ RY+ L+ IG G+ G+VCAA D VAIK
Sbjct: 34 AKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK 93
Query: 55 KIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE-FKDIYVVFELMESDL 113
K+ F++ + A R RE+ L++ + H +I+ + + P E F+D+Y+V ELM+++L
Sbjct: 94 KLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL 153
Query: 114 HQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
QVI+ +L E + LYQML +K++H+A + HRDLKP NI+ ++C LK+ DFGLA
Sbjct: 154 CQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
R A + T YV TR+YRAPE+ Y +DIWS+GCI E++ K LFPG
Sbjct: 212 RTAGTSF----MMTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV-------- 285
+ + Q + + + LGTP PE + + R Y+ K + + FP+
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 324
Query: 286 ----DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERR 341
A LL +++ DP R + ++AL PY P + + + R
Sbjct: 325 NKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVE-APPPQIYDKQLDER 383
Query: 342 RVTKDDIRELIYREILEYHPQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGGRSGP 401
T ++ +ELIY+E++ + + G PS G L + +
Sbjct: 384 EHTIEEWKELIYKEVMNSEEKTKNGVVKGQ-------PSPSGAAVNSSESLPPSSSVNDI 436
Query: 402 VIPPERKHVSLPRSTVHSGTTPPI 425
+ ++ + + P+
Sbjct: 437 SSMSTDQTLASDTDSSLEASAGPL 460
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 511 bits (1319), Expect = e-180
Identities = 122/353 (34%), Positives = 188/353 (53%), Gaps = 23/353 (6%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
RY+ L+ IG G+ G+VCAA D VAIKK+ F++ + A R RE+ L++ + H
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 83 DIVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+I+ + + P S EF+D+Y+V ELM+++L QVI+ +L E + LYQML +K+
Sbjct: 85 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKH 142
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+A + HRDLKP NI+ ++C LK+ DFGLAR A + T YV TR+YRAPE+
Sbjct: 143 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPYVVTRYYRAPEVI 198
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y +DIWS+GCI E++ G LFPG + Q + + + LGTP PE + +
Sbjct: 199 LGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL-QP 255
Query: 262 KARKYLTEMRKKPPVPLFQKFPNV------------DPLALRLLQRLIAFDPKDRPTAEE 309
R Y+ K + FP+V A LL +++ D R + +E
Sbjct: 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 315
Query: 310 ALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQ 362
AL PY + P + + + R T ++ +ELIY+E+++
Sbjct: 316 ALQHPYINVWYDPSEAEAP-PPKIPDKQLDEREHTIEEWKELIYKEVMDLEHH 367
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 499 bits (1288), Expect = e-176
Identities = 119/315 (37%), Positives = 174/315 (55%), Gaps = 15/315 (4%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+RY L+ +G G G+V +A+D ++VAIKKI V LRE+K++R L H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI--VLTDPQSVKHALREIKIIRRLDH 67
Query: 82 PDIVEIKRIMLPPSKR---------EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL 132
+IV++ I+ P + E +Y+V E ME+DL V++ L EH + F+
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHARLFM 126
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
YQ+LR LKY+H+ANV HRDLKP N+ N + LK+ DFGLAR+ ++ +
Sbjct: 127 YQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV 186
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T+WYR+P L S + YT AID+W+ GCIFAE+LTGK LF G + Q+ LI + +
Sbjct: 187 TKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVH 245
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
E + + Y+ +P PL Q P + A+ L++++ F P DR TAEEAL
Sbjct: 246 EEDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEAL 304
Query: 312 ADPYFKGLAKIEREP 326
+ PY + EP
Sbjct: 305 SHPYMSIYSFPMDEP 319
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 464 bits (1197), Expect = e-162
Identities = 107/350 (30%), Positives = 172/350 (49%), Gaps = 27/350 (7%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+R+++ + G+G++G V + TG VAIKK+ + R L+ ++ L +L H
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRNRELQIMQDLAVLHH 78
Query: 82 PDIVEIKRIMLPPSKREFKDIY--VVFELMESDLHQVIK----ANDDLTREHHQFFLYQM 135
P+IV+++ +R+ +DIY VV E + LH+ + + FL+Q+
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 136 LRALKYMH--TANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
+R++ +H + NV HRD+KP N+L N A+ LK+CDFG A+ P Y+ +
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV----AYICS 194
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
R+YRAPEL YT A+DIWS+GCIFAE++ G+P+F G + QL I +LG PS
Sbjct: 195 RYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR 253
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKF----PNVDPLALRLLQRLIAFDPKDRPTAE 308
E + + L +P F A LL L+ + P++R
Sbjct: 254 EVLRKLNPSHTDVDL---YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY 310
Query: 309 EALADPYFKGLAKIERE-PSCQPISKLEFEFERR--RVTKDDIRELIYRE 355
EAL PYF L + P+ + + + F F V + + + R+
Sbjct: 311 EALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 430 bits (1109), Expect = e-148
Identities = 116/376 (30%), Positives = 191/376 (50%), Gaps = 31/376 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y +VIG GS+GVV A + E VAIKK+ D RE++++R+++HP
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVL------QDKRFKNRELQIMRIVKHP 92
Query: 83 DIVEIKRIMLPPS-KREFKDIYVVFELMESDLHQVI----KANDDLTREHHQFFLYQMLR 137
++V++K K++ + +V E + +++ K + + ++YQ+LR
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 138 ALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
+L Y+H+ + HRD+KP+N+L + LK+ DFG A++ + P Y+ +R+YR
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV----SYICSRYYR 208
Query: 197 APELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APEL G+ + YT IDIWS GC+ AE++ G+PLFPG+S + QL I +LGTPS E I
Sbjct: 209 APELIFGA--TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ + P P + F P P A+ L+ RL+ + P R TA EAL P
Sbjct: 267 KTMNPNYMEHKF---PQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323
Query: 315 YFKGLAKIE-REPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEG 373
+F L E R P+ + + L F + + + +R + ++ H + + G +
Sbjct: 324 FFDELRTGEARMPNGRELPPL-FNWTKE---ELSVRPDLISRLVPQHAE-AELLSRGIDV 378
Query: 374 TNFLYPSAIGQFRKQF 389
NF P + +
Sbjct: 379 HNFQ-PIPLESLKVTL 393
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 426 bits (1096), Expect = e-146
Identities = 99/384 (25%), Positives = 180/384 (46%), Gaps = 69/384 (17%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+ +Y + + +G GS+G+VC D +G++ A+KK+ D RE+ ++++L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59
Query: 82 PDIVEIKRIM---------------------------------LPPSKREFKDIYVVFEL 108
+I+++ + + + K + V+ E
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 109 MESDLHQVI----KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-C 163
+ LH+V+ ++ + ++YQ+ RA+ ++H+ + HRD+KP+N+L N+
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 164 KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA 222
LK+CDFG A+ P Y+ +R+YRAPEL G+ ++YTP+ID+WSIGC+F
Sbjct: 180 TLKLCDFGSAKKLIPSEPSV----AYICSRFYRAPELMLGA--TEYTPSIDLWSIGCVFG 233
Query: 223 EVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKF 282
E++ GKPLF G++ + QL I ++GTP+ E + + +
Sbjct: 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF---PTLKAKDWRKIL 290
Query: 283 PNVDP-LALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSC----------QPI 331
P P LA+ LL++++ ++P R EA+A P+F L Q I
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNI 350
Query: 332 SKLEFEF---ERRRVTKDDIRELI 352
+L F F E + + + ++
Sbjct: 351 PQL-FNFSPYELSIIPGNVLNRIL 373
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 414 bits (1067), Expect = e-141
Identities = 108/339 (31%), Positives = 169/339 (49%), Gaps = 25/339 (7%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCN 108
Query: 84 IVEIKRIMLPPS-KREFKDIYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRA 138
IV ++ K++ + +V + + +++V + A L + + ++YQ+ R+
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 139 LKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L Y+H+ + HRD+KP+N+L + + LK+CDFG A+ P Y+ +R+YRA
Sbjct: 169 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV----SYICSRYYRA 224
Query: 198 PELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PEL G+ + YT +ID+WS GC+ AE+L G+P+FPG S V QL I +LGTP+ E I
Sbjct: 225 PELIFGA--TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKF-PNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ + P + F P P A+ L RL+ + P R T EA A +
Sbjct: 283 EMNPNYTEFKF---PQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
Query: 316 FKGLAKIE-REPSCQPISKL-EFEFERRRVTKDDIRELI 352
F L + P+ + L F + LI
Sbjct: 340 FDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILI 378
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 383 bits (987), Expect = e-131
Identities = 91/318 (28%), Positives = 155/318 (48%), Gaps = 24/318 (7%)
Query: 15 FFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK 74
E+G+ + Y+++ +G+G Y V AI+ EKV +K + V +I RE+K
Sbjct: 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIK 82
Query: 75 LLRLLR-HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY 133
+L LR P+I+ + I+ P V + +D Q+ + LT +F++Y
Sbjct: 83 ILENLRGGPNIITLADIVKDPV--SRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMY 137
Query: 134 QMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
++L+AL Y H+ + HRD+KP N++ + + KL++ D+GLA V VA+
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV----RVAS 193
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPS 251
R+++ PEL + Y ++D+WS+GC+ A ++ K P F G QL I +LGT
Sbjct: 194 RYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 252
Query: 252 PET-IAVVRNEKARKYLTEMRKKPPVPLFQKFPN-----VDPLALRLLQRLIAFDPKDRP 305
I E ++ + + + + V P AL L +L+ +D + R
Sbjct: 253 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 312
Query: 306 TAEEALADPYFKGLAKIE 323
TA EA+ PYF + K +
Sbjct: 313 TAREAMEHPYFYTVVKDQ 330
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 364 bits (937), Expect = e-123
Identities = 109/307 (35%), Positives = 167/307 (54%), Gaps = 12/307 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y+ + IG+GSYGVV + TG+ VAIKK + + LRE+++L+ L+HP
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKY 141
++V + + R + +++VFE + + + + + +Q L+A+ +
Sbjct: 63 NLVNLLEVF-----RRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
H N HRD+KP+NIL + +K+CDFG AR + P + D VATRWYR+PE L
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFAR-LLTG-PSDYY-DDEVATRWYRSPELL 174
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G ++Y P +D+W+IGC+FAE+L+G PL+PGKS V QL LI LG P V
Sbjct: 175 VGD--TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320
+ + + PL KFPN+ AL LL+ + DP +R T E+ L PYF+ +
Sbjct: 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292
Query: 321 KIEREPS 327
+IE
Sbjct: 293 EIEDLAK 299
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 346 bits (889), Expect = e-116
Identities = 99/297 (33%), Positives = 161/297 (54%), Gaps = 12/297 (4%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y+ L ++G+GSYG+V + TG VAIKK + + +RE+KLL+ LRH
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKY 141
++V + + ++ K Y+VFE ++ + ++ + L + Q +L+Q++ + +
Sbjct: 85 NLVNLLEVC-----KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGF 139
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H+ N+ HRD+KP+NIL + + +K+CDFG AR + P V+ D VATRWYRAPEL
Sbjct: 140 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR-TLAA-PGEVY-DDEVATRWYRAPELL 196
Query: 202 -GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G KY A+D+W+IGC+ E+ G+PLFPG S + QL I LG P +
Sbjct: 197 VGD--VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ K PL +++P + + + L ++ + DP RP E L +F+
Sbjct: 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = e-104
Identities = 101/303 (33%), Positives = 146/303 (48%), Gaps = 18/303 (5%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRI--LREVKLLRLL 79
+RY+ + IG G+YG V A D H+G VA+K + + I +REV LLR L
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68
Query: 80 R---HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQ 134
HP++V + + + +VFE ++ DL + L E + + Q
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
LR L ++H + HRDLKP+NIL + +K+ DFGLAR +S M T V T W
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR-IYSY-QMA--LTPVVVTLW 184
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
YRAPE+ S Y +D+WS+GCIFAE+ KPLF G S QL I DL+G P +
Sbjct: 185 YRAPEVL--LQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ + P P+ P ++ +LL ++ F+P R +A AL
Sbjct: 243 WPRD--VSLPRG--AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHS 298
Query: 315 YFK 317
Y
Sbjct: 299 YLH 301
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 315 bits (809), Expect = e-104
Identities = 115/301 (38%), Positives = 159/301 (52%), Gaps = 18/301 (5%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRI--LREVKLLRL 78
A RY+ L+ +G+G + V A D +T + VAIKKI D I LRE+KLL+
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLR 137
L HP+I+ + S I +VF+ ME+DL +IK N LT H + ++ L+
Sbjct: 69 LSHPNIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L+Y+H + HRDLKP N+L + N LK+ DFGLA+ +F P + T V TRWYRA
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK-SFGS-PNRAY-THQVVTRWYRA 180
Query: 198 PE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE L G+ Y +D+W++GCI AE+L P PG S + QL I + LGTP+ E
Sbjct: 181 PELLFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ Y + P +PL F L L+Q L F+P R TA +AL YF
Sbjct: 239 DMC--SLPDY-VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295
Query: 317 K 317
Sbjct: 296 S 296
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-103
Identities = 114/299 (38%), Positives = 165/299 (55%), Gaps = 19/299 (6%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLR 80
+Y LE IG+G+YGVV A + GE A+KKI E + I +RE+ +L+ L+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR--LEKEDEGIPSTTIREISILKELK 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRAL 139
H +IV++ ++ + + +VFE ++ DL +++ L + FL Q+L +
Sbjct: 59 HSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y H V HRDLKP+N+L N +LK+ DFGLAR AF P+ + T + T WYRAP+
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR-AFGI-PVRKY-THEIVTLWYRAPD 170
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L GS KY+ IDIWS+GCIFAE++ G PLFPG S QL I +LGTP+ + V
Sbjct: 171 VLMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV 228
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ KY P+P +D + LL +++ DP R TA++AL YFK
Sbjct: 229 T--ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 312 bits (802), Expect = e-103
Identities = 119/325 (36%), Positives = 174/325 (53%), Gaps = 24/325 (7%)
Query: 4 DQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI 63
++ G +Y+ LE +G+G+YGVV A D+ G VA+K+I +
Sbjct: 2 HHHHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR--LDAE 58
Query: 64 SDAIRI--LREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-N 120
+ I +RE+ LL+ L HP+IV + ++ + +VFE ME DL +V+
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC-----LTLVFEFMEKDLKKVLDENK 113
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L + +LYQ+LR + + H + HRDLKP+N+L N++ LK+ DFGLAR AF
Sbjct: 114 TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGI- 171
Query: 181 PMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ 239
P+ + T V T WYRAP+ L GS KY+ ++DIWSIGCIFAE++TGKPLFPG + Q
Sbjct: 172 PVRSY-THEVVTLWYRAPDVLMGS--KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ 228
Query: 240 LDLITDLLGTPSPET---IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
L I +LGTP+P + + K R + + P P + LL +
Sbjct: 229 LPKIFSILGTPNPREWPQVQELPLWKQRTF----QVFEKKPWSSIIPGFCQEGIDLLSNM 284
Query: 297 IAFDPKDRPTAEEALADPYFKGLAK 321
+ FDP R +A +A+ PYFK L
Sbjct: 285 LCFDPNKRISARDAMNHPYFKDLDP 309
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = e-102
Identities = 113/331 (34%), Positives = 169/331 (51%), Gaps = 28/331 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLR 80
Y L+ +G+G+Y V T VA+K+I E + +REV LL+ L+
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLK 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRAL 139
H +IV + I+ + +VFE ++ DL Q + + + + + FL+Q+LR L
Sbjct: 59 HANIVTLHDIIHTEKS-----LTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGL 113
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y H V HRDLKP+N+L N +LK+ DFGLAR A S P + + V T WYR P+
Sbjct: 114 AYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSI-PTKTY-DNEVVTLWYRPPD 170
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET---I 255
L GS + Y+ ID+W +GCIF E+ TG+PLFPG +V QL I +LGTP+ ET I
Sbjct: 171 ILLGS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 228
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
K Y K L P +D LL +L+ F+ ++R +AE+A+ P+
Sbjct: 229 LSNEEFKTYNY----PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284
Query: 316 FKGL----AKIEREPSCQPISKLEFEFERRR 342
F L K+ S + +++ + E
Sbjct: 285 FLSLGERIHKLPDTTSIFALKEIQLQKEASL 315
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 309 bits (795), Expect = e-102
Identities = 115/302 (38%), Positives = 166/302 (54%), Gaps = 19/302 (6%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLR 80
+Y+ LE IG+G+YG V A + T E VA+K++ + + + LRE+ LL+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR--LDDDDEGVPSSALREICLLKELK 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRAL 139
H +IV + ++ K + +VFE + DL + + N DL E + FL+Q+L+ L
Sbjct: 60 HKNIVRLHDVLHSDKK-----LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+ H+ NV HRDLKP+N+L N N +LK+ +FGLAR AF P+ + + V T WYR P+
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGI-PVRCY-SAEVVTLWYRPPD 171
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
L G+ Y+ +ID+WS GCIFAE+ G+PLFPG V QL I LLGTP+ E
Sbjct: 172 VLFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ K Y L P ++ LLQ L+ +P R +AEEAL PYF
Sbjct: 230 MT--KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
Query: 318 GL 319
Sbjct: 288 DF 289
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 309 bits (793), Expect = e-101
Identities = 112/306 (36%), Positives = 167/306 (54%), Gaps = 23/306 (7%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLR 80
+RY+ + +G+G+YG V AIDT T E VAIK+I EH + + +REV LL+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR--LEHEEEGVPGTAIREVSLLKELQ 91
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
H +I+E+K ++ + ++++FE E+DL + + N D++ + FLYQ++ +
Sbjct: 92 HRNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 141 YMHTANVYHRDLKPKNILANANCK-----LKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
+ H+ HRDLKP+N+L + + LK+ DFGLAR AF P+ F T + T WY
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGI-PIRQF-THEIITLWY 203
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
R PE L GS Y+ ++DIWSI CI+AE+L PLFPG S + QL I ++LG P T
Sbjct: 204 RPPEILLGS--RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALAD 313
V + K L + +D L LL ++ DP R +A+ AL
Sbjct: 262 WPGV--TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319
Query: 314 PYFKGL 319
PYF
Sbjct: 320 PYFSHN 325
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 307 bits (790), Expect = e-101
Identities = 104/323 (32%), Positives = 161/323 (49%), Gaps = 28/323 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDT-HTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLL 79
+Y+ + IG+G+YG V A D + G VA+K++ + + + + +REV +LR L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHL 68
Query: 80 R---HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQ 134
HP++V + + + +VFE ++ DL + + E + ++Q
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+LR L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR +S M T V T W
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSF-QMA--LTSVVVTLW 184
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
YRAPE L S Y +D+WS+GCIFAE+ KPLF G S V QL I D++G P E
Sbjct: 185 YRAPEVLLQS---SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+ K P+ + ++D L LL + + F+P R +A AL+
Sbjct: 242 DWPRD--VALPRQ--AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297
Query: 314 PYFKGLAKIEREPSCQPISKLEF 336
PYF+ L C+
Sbjct: 298 PYFQDL------ERCKENLDSHL 314
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = e-101
Identities = 112/338 (33%), Positives = 165/338 (48%), Gaps = 24/338 (7%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRL 78
+ ++Y+ L IG+G++G V A TG+KVA+KK+ E+ + I LRE+K+L+L
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITALREIKILQL 72
Query: 79 LRHPDIVEIKRIM---LPPSKREFKDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQ 134
L+H ++V + I P R IY+VF+ E DL ++ T + +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY---VA 191
+L L Y+H + HRD+K N+L + LK+ DFGLAR AFS Y V
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR-AFSL-AKNSQPNRYTNRVV 190
Query: 192 TRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
T WYR PE L G Y P ID+W GCI AE+ T P+ G + HQL LI+ L G+
Sbjct: 191 TLWYRPPELLLGE--RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248
Query: 251 SPET-IAVVRNEKARKYLTEMRKKPPVPLFQKFPNV--DPLALRLLQRLIAFDPKDRPTA 307
+PE V E K E+ K + + DP AL L+ +L+ DP R +
Sbjct: 249 TPEVWPNVDNYELYEKL--ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 306
Query: 308 EEALADPYFKGL---AKIEREPSCQPISKLEFEFERRR 342
++AL +F + ++ S S E+ RR
Sbjct: 307 DDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRR 344
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 304 bits (780), Expect = e-100
Identities = 113/312 (36%), Positives = 174/312 (55%), Gaps = 29/312 (9%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHI-SDAIRILREVKLLRLL 79
++++K LE +G G+Y V ++ TG VA+K++ D E S AIR E+ L++ L
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---EISLMKEL 60
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN------DDLTREHHQFFLY 133
+H +IV + ++ +K + +VFE M++DL + + + L ++F +
Sbjct: 61 KHENIVRLYDVIHTENK-----LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
Q+L+ L + H + HRDLKP+N+L N +LK+ DFGLAR AF P+ F + V T
Sbjct: 116 QLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGI-PVNTF-SSEVVTL 172
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
WYRAP+ L GS Y+ +IDIWS GCI AE++TGKPLFPG + QL LI D++GTP+
Sbjct: 173 WYRAPDVLMGS--RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNE 230
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKF-----PNVDPLALRLLQRLIAFDPKDRPTA 307
V K KY ++++PP L Q +D + L L+ +P R +A
Sbjct: 231 SLWPSV--TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288
Query: 308 EEALADPYFKGL 319
++AL P+F
Sbjct: 289 KQALHHPWFAEY 300
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 1e-85
Identities = 105/368 (28%), Positives = 170/368 (46%), Gaps = 58/368 (15%)
Query: 22 ANRYKIL-EVIGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL 78
+ ++ +G+G+YG V A D + A+K+I IS + RE+ LLR
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG--TGISMSA--CREIALLRE 74
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQF-------- 130
L+HP+++ ++++ L + + ++++F+ E DL +IK +
Sbjct: 75 LKHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 131 -FLYQMLRALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVF 185
LYQ+L + Y+H V HRDLKP NIL ++K+ D G AR F+ P+
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNS-PLKPL 189
Query: 186 --WTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS------- 235
V T WYRAPE L G+ YT AIDIW+IGCIFAE+LT +P+F +
Sbjct: 190 ADLDPVVVTFWYRAPELLLGA--RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSN 247
Query: 236 --VVHQLDLITDLLGTPS----------PETIAVVRNEKARKYLTEMRKKPPVPLFQKFP 283
QLD I +++G P+ PE ++++ + Y + +
Sbjct: 248 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY---TNCSLIKYMEKHKV 304
Query: 284 NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQP-ISKLEFEFERRR 342
D A LLQ+L+ DP R T+E+A+ DPYF E + + + +R
Sbjct: 305 KPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL-----EDPLPTSDVFAGCQIPYPKRE 359
Query: 343 VTKDDIRE 350
++ +
Sbjct: 360 FLTEEEPD 367
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 3e-75
Identities = 93/398 (23%), Positives = 153/398 (38%), Gaps = 65/398 (16%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR-LLRHP 82
+ +V+G G+ G + VA+K+I +D REV+LLR HP
Sbjct: 25 SFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHP 78
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKY 141
+++ ++++ + Y+ EL + L + ++ D L Q L +
Sbjct: 79 NVIRYFC-----TEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 142 MHTANVYHRDLKPKNIL-----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
+H+ N+ HRDLKP NIL A+ K + DFGL + + T +
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 197 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE L T +DI+S GC+F V++ GKS+ Q +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------------- 239
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ + + D +A L++++IA DP+ RP+A+ L P+
Sbjct: 240 -------------ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286
Query: 316 FKGLAK-----------IEREPSCQPISKLEFEFERRRVTKDDIRELIYREILE------ 358
F L K IE+E PI K + E R V K D RE I +
Sbjct: 287 FWSLEKQLQFFQDVSDRIEKESLDGPIVK-QLERGGRAVVKMDWRENITVPLQTDLRKFR 345
Query: 359 -YHPQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEEN 395
Y ++D + Y + R+ L ++
Sbjct: 346 TYKGGSVRDLLRAMRNKKHHYRELPAEVRETLGTLPDD 383
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 2e-65
Identities = 47/343 (13%), Positives = 90/343 (26%), Gaps = 61/343 (17%)
Query: 15 FFTEYGDANR-YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILRE 72
+ R K++E + G VV D E A+K S+ R+
Sbjct: 53 VDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEA 112
Query: 73 VKLLRLLRHPDIVE---------------------IKRIMLPPSKREFKDIYVVFELMES 111
L E ++ + ++
Sbjct: 113 TFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASV 172
Query: 112 DLHQVIKANDDLTREHH-------QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK 164
DL + D + Q++R + + + H P N+ + +
Sbjct: 173 DLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR 232
Query: 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 224
L + D + P + Y E + + +T A++ W +G V
Sbjct: 233 LMLGDVSALWKVGTRGPASSV------PVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286
Query: 225 LTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN 284
F + + L P ++ F
Sbjct: 287 WCLFLPFGLVTPGIKGSWKRPSLRVPGTDS----------------------LAFGSCTP 324
Query: 285 VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327
+ L+ R + FD + R EA+ P F +++ E S
Sbjct: 325 LPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL---QLQNEIS 364
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 5e-64
Identities = 93/344 (27%), Positives = 151/344 (43%), Gaps = 48/344 (13%)
Query: 11 KDKDFFTEYGD--ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
+ D A RY++L+VIGKGS+G V A D + VA+K + + +
Sbjct: 83 DQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAA 141
Query: 69 ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD--LTR 125
E+++L LR D ++ F++ I + FEL+ +L+++IK N +
Sbjct: 142 E--EIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSL 199
Query: 126 EHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMT 183
+ F + +L+ L +H + H DLKP+NIL +KV DFG + + +
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVY 257
Query: 184 VFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242
Y+ +R+YRAPE + G+ +Y ID+WS+GCI AE+LTG PL PG+ QL
Sbjct: 258 T----YIQSRFYRAPEVILGA---RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310
Query: 243 ITDLLGTPSPETI---------------------------AVVRNEKARKYLTEMRKKPP 275
+ +LLG PS + + +VV N +
Sbjct: 311 MIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPES 370
Query: 276 VPLFQKFPNVDPLALR-LLQRLIAFDPKDRPTAEEALADPYFKG 318
D L++ + +DP R T +AL P+ +
Sbjct: 371 REWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRR 414
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 2e-61
Identities = 70/358 (19%), Positives = 136/358 (37%), Gaps = 69/358 (19%)
Query: 11 KDKDFFTEYGD--ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
+ F + G N + ++ +G G++G V + A+K + ++ + + + +
Sbjct: 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAK 79
Query: 69 ILREVKLLRLLRHPD-----IVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD 122
I E +L+ +++ D IV+ + D + ++FE + L+++I N+
Sbjct: 80 I--EADILKKIQNDDINNNNIVKYHGKF------MYYDHMCLIFEPLGPSLYEIITRNNY 131
Query: 123 --LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---------------------- 158
E + + ++L+AL Y+ ++ H DLKP+NIL
Sbjct: 132 NGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191
Query: 159 ---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDI 214
+ +K+ DFG A F + TR YRAPE + + + D+
Sbjct: 192 QIYRTKSTGIKLIDFGCA--TFKSDYHG----SIINTRQYRAPEVILNL---GWDVSSDM 242
Query: 215 WSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYL------- 267
WS GC+ AE+ TG LF + L ++ ++ + KY+
Sbjct: 243 WSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKL 302
Query: 268 ------TEMRKKPPVPLFQKFPNV--DPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + V + L L ++ DP RP+ E L + +
Sbjct: 303 AWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 5e-61
Identities = 93/354 (26%), Positives = 154/354 (43%), Gaps = 57/354 (16%)
Query: 11 KDKDFFTEYGD--ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI--HDVFEHISDA 66
+ D+ + G+ +RY+I +IGKGS+G V A D E VAIK I F + +
Sbjct: 40 DNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-- 97
Query: 67 IRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD--L 123
EV+LL L+ D I+ F++ + +VFE++ +L+ +++ + +
Sbjct: 98 ---QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGV 154
Query: 124 TREHHQFFLYQMLRALKYMHT--ANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSD 179
+ + F QM AL ++ T ++ H DLKP+NIL +K+ DFG +
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLG 212
Query: 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ 239
+ Y+ +R+YR+PE+ Y AID+WS+GCI E+ TG+PLF G + V Q
Sbjct: 213 QRIY----QYIQSRFYRSPEVL--LGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266
Query: 240 LDLITDLLGTPSPETI--------------------------AVVRNEKARKYLTEMRKK 273
++ I ++LG P + + L +
Sbjct: 267 MNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGV 326
Query: 274 PPVPLFQKFPN------VDPLALR-LLQRLIAFDPKDRPTAEEALADPYFKGLA 320
+ D L + L+ R++ +DPK R AL +FK A
Sbjct: 327 ETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA 380
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 6e-61
Identities = 72/327 (22%), Positives = 113/327 (34%), Gaps = 47/327 (14%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
++ F + Y IL+ IG G V ++ + AIK ++
Sbjct: 7 HSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA 65
Query: 62 HISDAIRILREVKLLRLLRHP--DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKA 119
E+ L L+ I+ + + IY+V E DL+ +K
Sbjct: 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKK 120
Query: 120 NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179
+ + + ML A+ +H + H DLKP N L + LK+ DFG+A D
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 179
Query: 180 TPMTVFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
T V + V T Y PE G SK +P D+WS+GCI + GK
Sbjct: 180 TTSVVKDS-QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
Query: 231 FPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL 290
F I+ + + + P +
Sbjct: 239 FQQII-----------------NQISKLHAIIDPNH------EIEFP-----DIPEKDLQ 270
Query: 291 RLLQRLIAFDPKDRPTAEEALADPYFK 317
+L+ + DPK R + E LA PY +
Sbjct: 271 DVLKCCLKRDPKQRISIPELLAHPYVQ 297
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 1e-60
Identities = 94/356 (26%), Positives = 145/356 (40%), Gaps = 51/356 (14%)
Query: 11 KDKDFFTEYGD--ANRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVFEHISDAI 67
K+ GD RY+I+ +G+G++G V +D G +VA+K I +V +A
Sbjct: 5 KEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAA 63
Query: 68 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD--LT 124
R+ E+ +L+ ++ D +L F + + FEL+ + + +K N+
Sbjct: 64 RL--EINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYP 121
Query: 125 REHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL-------------------ANANCKL 165
H + YQ+ AL+++H + H DLKP+NIL + N +
Sbjct: 122 LPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEV 224
+V DFG A F T VATR YR PE + + D+WSIGCI E
Sbjct: 182 RVADFGSA--TFDHEHHT----TIVATRHYRPPEVILEL---GWAQPCDVWSIGCILFEY 232
Query: 225 LTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK-------------ARKYLTEMR 271
G LF L ++ +LG I R +K + +
Sbjct: 233 YRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKEN 292
Query: 272 KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPS 327
KP + L++R++ FDP R T EAL P+F GL ER
Sbjct: 293 CKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFH 348
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 3e-59
Identities = 91/340 (26%), Positives = 144/340 (42%), Gaps = 55/340 (16%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ RY+I++ +G+G++G V ID G VA+K + +V + +A R E+++L L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARS--EIQVLEHLN 69
Query: 81 HPDIVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVIKANDD--LTREHHQFFLYQMLR 137
D R + E I +VFEL+ + IK N +H + YQ+ +
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICK 129
Query: 138 ALKYMHTANVYHRDLKPKNIL-------------------ANANCKLKVCDFGLARVAFS 178
++ ++H+ + H DLKP+NIL N +KV DFG A +
Sbjct: 130 SVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYD 187
Query: 179 DTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
D + V+TR YRAPE + ++ D+WSIGCI E G +FP
Sbjct: 188 DEHHS----TLVSTRHYRAPEVILAL---GWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240
Query: 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQK---FPNVDPLA----- 289
L ++ +LG +++ + RKY R PL
Sbjct: 241 EHLAMMERILGPLPKH---MIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLS 297
Query: 290 --------LRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
L+Q+++ +DP R T EAL P+F L K
Sbjct: 298 QDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 3e-58
Identities = 71/331 (21%), Positives = 116/331 (35%), Gaps = 47/331 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y IL+ IG G V ++ + AIK ++ E+ L L+
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67
Query: 83 --DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
I+ + + IY+V E DL+ +K + + + ML A+
Sbjct: 68 SDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 122
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+H + H DLKP N L + LK+ DFG+A DT V + V T Y PE
Sbjct: 123 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEA 180
Query: 201 ---------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
G SK +P D+WS+GCI + GK F
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---------------- 224
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
I+ + + + P + +L+ + DPK R + E L
Sbjct: 225 -NQISKLHAIIDPNH------EIEFP-----DIPEKDLQDVLKCCLKRDPKQRISIPELL 272
Query: 312 ADPYFKGLAKIEREPSCQPISKLEFEFERRR 342
A PY + + + ++++ +
Sbjct: 273 AHPYVQIQTHPVNQMAKGTTEEMKYVLGQLV 303
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-56
Identities = 80/377 (21%), Positives = 126/377 (33%), Gaps = 57/377 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y IL+ IG G V ++ + AIK ++ E+ L L+
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114
Query: 83 --DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
I+ + + IY+V E DL+ +K + + + ML A+
Sbjct: 115 SDKIIRLYDYEITDQY-----IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+H + H DLKP N L + LK+ DFG+A DT V + V Y PE
Sbjct: 170 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDS-QVGAVNYMPPEA 227
Query: 201 ---------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
G SK +P D+WS+GCI + GK F
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII---------------- 271
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
I+ + + + P + +L+ + DPK R + E L
Sbjct: 272 -NQISKLHAIIDPNH------EIEFP-----DIPEKDLQDVLKCCLKRDPKQRISIPELL 319
Query: 312 ADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGT 371
A PY +I+ P Q E + + +L+ + K
Sbjct: 320 AHPYV----QIQTHPVNQMAKGTTEEMKYV------LGQLVGLNSPNSILKAAKTLYEHY 369
Query: 372 EGTNFLYPSAIGQFRKQ 388
G S+ F K+
Sbjct: 370 SGGESHNSSSSKTFEKK 386
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 2e-56
Identities = 74/341 (21%), Positives = 125/341 (36%), Gaps = 61/341 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
RY ++ +G G + V A D VA+K + + ++A E+KLL+ +
Sbjct: 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAED--EIKLLQRVN 73
Query: 81 HPDIVEIKRIMLPPSKR---------EFKDIYV-----VFELMESDLHQVIKANDD--LT 124
D + K VFE++ +L +IK + +
Sbjct: 74 DADNTKED----SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 125 REHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCK------LKVCDFGLARVAF 177
+ + Q+L L YMH + H D+KP+N+L +K+ D G A +
Sbjct: 130 LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CW 187
Query: 178 SDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
D T+ + TR YR+PE L G + + DIWS C+ E++TG LF
Sbjct: 188 YDEHY----TNSIQTREYRSPEVLLG---APWGCGADIWSTACLIFELITGDFLFEPDEG 240
Query: 237 ------VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL 290
+ I +LLG + + R + + + +P D L
Sbjct: 241 HSYTKDDDHIAQIIELLGELPSYLLR--NGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE 298
Query: 291 R-------------LLQRLIAFDPKDRPTAEEALADPYFKG 318
+ L ++ DP+ R A + P+ K
Sbjct: 299 KYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 7e-56
Identities = 72/296 (24%), Positives = 104/296 (35%), Gaps = 46/296 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHP 82
++ L +G GSYG V G A+K+ F D R L EV ++ +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKY 141
V +++ + E +Y+ EL L Q +A E +L L AL +
Sbjct: 118 CCVRLEQ-----AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ + H D+KP NI + K+ DFGL + V Y APEL
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ----EGDPRYMAPELL 228
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y A D++S+G EV L G QL
Sbjct: 229 Q---GSYGTAADVFSLGLTILEVACNMELPHGGEGWQQL--------------------- 264
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ P +L ++ DPK R TAE LA P +
Sbjct: 265 --------RQGYLPPEFTAGLS---SELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 9e-56
Identities = 88/310 (28%), Positives = 134/310 (43%), Gaps = 55/310 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH------DVFEHISDAIRILREVKLLR 77
Y + + +G G+ G V A + T +KVAI+ I A+ + E+++L+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
L HP I++IK + +D Y+V ELME +L + N L + + YQML
Sbjct: 196 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 137 RALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
A++Y+H + HRDLKP+N+L +C +K+ DFG +++ + M T
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM----RTLCGTP 305
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGT-- 249
Y APE L + Y A+D WS+G I L+G P F L D I G
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--TSGKYN 363
Query: 250 -PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
+ V AL L+++L+ DPK R T E
Sbjct: 364 FIPEV----------------------------WAEVSEKALDLVKKLLVVDPKARFTTE 395
Query: 309 EALADPYFKG 318
EAL P+ +
Sbjct: 396 EALRHPWLQD 405
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-55
Identities = 56/314 (17%), Positives = 108/314 (34%), Gaps = 24/314 (7%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ + + +++G+G+ V TG+ AIK + + +RE ++L+ L H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHK 67
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN---DDLTREHHQFFLYQMLRA 138
+IV++ I + R ++ E L+ V++ L L ++
Sbjct: 68 NIVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 139 LKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ ++ + HR++KP NI+ + K+ DFG AR D T
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL----YGTEE 180
Query: 195 YRAPEL------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
Y P++ KY +D+WSIG F TG F + + +
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
T P + + P + L +L ++ D + +
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLS--RGLQVLLTPVLANILEADQEKCWGFD 298
Query: 309 EALADPYFKGLAKI 322
+ A+
Sbjct: 299 QFFAETSDILHRGN 312
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-55
Identities = 75/323 (23%), Positives = 124/323 (38%), Gaps = 54/323 (16%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
A+ ++ + V+G+G++G V A + AIKKI E +S IL EV LL L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS---TILSEVMLLASLNH 61
Query: 82 PDIVEIK--------RIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHH-QFF 131
+V + + ++ +++ E E L+ +I + + +
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW----- 186
Q+L AL Y+H+ + HRDLKP NI + + +K+ DFGLA+ +
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 187 ------TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
T + T Y A E+ Y ID++S+G IF E++ P G V+ L
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDG-TGHYNEKIDMYSLGIIFFEMIY--PFSTGMERVNIL 238
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
+ R N + ++++ LI D
Sbjct: 239 KKL---------------------------RSVSIEFPPDFDDNKMKVEKKIIRLLIDHD 271
Query: 301 PKDRPTAEEALADPYFKGLAKIE 323
P RP A L + + E
Sbjct: 272 PNKRPGARTLLNSGWLPVKHQDE 294
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-55
Identities = 71/323 (21%), Positives = 117/323 (36%), Gaps = 65/323 (20%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
+K +E+IG G +G V A G+ IK++ + + REVK L L H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK------YNNEKAEREVKALAKLDH 63
Query: 82 PDIVE-----------IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKA--NDDLTREH 127
+IV + S+ + K +++ E + L Q I+ + L +
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 128 HQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187
Q+ + + Y+H+ + +RDLKP NI ++K+ DFGL +D T
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS-- 181
Query: 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDL 246
T Y +PE S Y +D++++G I AE+L F L
Sbjct: 182 --KGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL------ 231
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
+ + D LLQ+L++ P+DRP
Sbjct: 232 -------------------------RDGIIS-----DIFDKKEKTLLQKLLSKKPEDRPN 261
Query: 307 AEEALADPYFKGLAK--IEREPS 327
E L + ER +
Sbjct: 262 TSEILRTLTVWKKSPEKNERHTA 284
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-55
Identities = 82/312 (26%), Positives = 126/312 (40%), Gaps = 62/312 (19%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
Y++L IG GSYG G+ + K++ + +++A + ++ EV LLR L+
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELD--YGSMTEAEKQMLVSEVNLLRELK 63
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFF-------- 131
HP+IV ++ R +Y+V E E DL VI + Q+
Sbjct: 64 HPNIVRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKG----TKERQYLDEEFVLRV 116
Query: 132 LYQMLRALKYMHTAN-----VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW 186
+ Q+ ALK H + V HRDLKP N+ + +K+ DFGLAR+ DT
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--- 173
Query: 187 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
+V T +Y +PE Y DIWS+GC+ E+ P F S
Sbjct: 174 KTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---------- 221
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-LLQRLIAFDPKDRP 305
E +R K F++ P L ++ R++ RP
Sbjct: 222 -----KELAGKIREGK----------------FRRIPYRYSDELNEIITRMLNLKDYHRP 260
Query: 306 TAEEALADPYFK 317
+ EE L +P
Sbjct: 261 SVEEILENPLIL 272
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 7e-55
Identities = 70/324 (21%), Positives = 122/324 (37%), Gaps = 55/324 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++ ++ +G+G +GVV A + AIK+I + +++REVK L L HP
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHP 63
Query: 83 DIV-------EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF---F 131
IV E +Y+ +L +L + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT---------PM 182
Q+ A++++H+ + HRDLKP NI + +KV DFGL D P
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242
T V T+ Y +PE + Y+ +DI+S+G I E+L P
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY--PFSTQM-------- 231
Query: 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPK 302
E + + + + K+ PP+ P ++Q +++ P
Sbjct: 232 ----------ERVRTLTDVRNLKF-------PPLF-----TQKYPCEYVMVQDMLSPSPM 269
Query: 303 DRPTAEEALADPYFKGLAKIEREP 326
+RP A + + F+ L +
Sbjct: 270 ERPEAINIIENAVFEDLDFPGKTV 293
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 8e-55
Identities = 89/319 (27%), Positives = 135/319 (42%), Gaps = 55/319 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH------DVFEHISDAIRILREVKLLR 77
Y + + +G G+ G V A + T +KVAIK I A+ + E+++L+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQML 136
L HP I++IK + +D Y+V ELME +L + N L + + YQML
Sbjct: 71 KLNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 137 RALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
A++Y+H + HRDLKP+N+L +C +K+ DFG +++ + T T
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGE---TSLMRTLCGTP 180
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGT-- 249
Y APE L + Y A+D WS+G I L+G P F L D I G
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI--TSGKYN 238
Query: 250 -PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
+ V AL L+++L+ DPK R T E
Sbjct: 239 FIPEV----------------------------WAEVSEKALDLVKKLLVVDPKARFTTE 270
Query: 309 EALADPYFKGLAKIEREPS 327
EAL P+ + +
Sbjct: 271 EALRHPWLQDEDMKRKFQD 289
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 9e-55
Identities = 79/347 (22%), Positives = 134/347 (38%), Gaps = 49/347 (14%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
+ + +Y L+ IG+GS+G T G + IK+I+
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN--IS 60
Query: 62 HISDAIR--ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK 118
+S R REV +L ++HP+IV+ + S E +Y+V + E DL + I
Sbjct: 61 RMSSKEREESRREVAVLANMKHPNIVQYRE-----SFEENGSLYIVMDYCEGGDLFKRIN 115
Query: 119 -ANDDLTREHH-QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176
L +E + Q+ ALK++H + HRD+K +NI + +++ DFG+ARV
Sbjct: 116 AQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175
Query: 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
S + + T +Y +PE+C + Y DIW++GC+ E+ T K F S+
Sbjct: 176 NSTVELA---RACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSM 230
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR-LLQR 295
+ + I P+ LR L+ +
Sbjct: 231 KNLVLKI---------------------------ISGSFPPV----SLHYSYDLRSLVSQ 259
Query: 296 LIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRR 342
L +P+DRP+ L + + P F +
Sbjct: 260 LFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFG 306
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 3e-53
Identities = 65/351 (18%), Positives = 126/351 (35%), Gaps = 31/351 (8%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ + + +++G+G+ V TG+ AIK + + +RE ++L+ L H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-NNISFLRPVDVQMREFEVLKKLNHK 67
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN---DDLTREHHQFFLYQMLRA 138
+IV++ I + R ++ E L+ V++ L L ++
Sbjct: 68 NIVKLFAIEEETTTRH---KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 139 LKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ ++ + HR++KP NI+ + K+ DFG AR D T
Sbjct: 125 MNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL----YGTEE 180
Query: 195 YRAPEL------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD--L 246
Y P++ KY +D+WSIG F TG F + + +
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 247 LGTPSPETIAVVRNEKAR-KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305
G PS V + E + +M + + L +L ++ D +
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-----RGLQVLLTPVLANILEADQEKCW 295
Query: 306 TAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREI 356
++ A+ + S Q ++ + T EL+Y++
Sbjct: 296 GFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYN-TATIFHELVYKQT 345
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 3e-52
Identities = 91/337 (27%), Positives = 143/337 (42%), Gaps = 51/337 (15%)
Query: 5 QTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS 64
++ + + A RY I+ ++GKGS+G V D T ++ A+K I+
Sbjct: 4 HHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 65 DAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKAN 120
D ILREV+LL+ L HP+I+++ I +D Y+V EL +L I
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEI--------LEDSSSFYIVGELYTGGELFDEIIKR 115
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAF 177
+ + Q+ + YMH N+ HRDLKP+NIL +C +K+ DFGL+
Sbjct: 116 KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175
Query: 178 SDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
+T M D + T +Y APE L G Y D+WS G I +L+G P F GK+
Sbjct: 176 QNTKM----KDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
L + + KY + + A L++++
Sbjct: 228 YDILKRV------------------ETGKY--AFDLPQ-------WRTISDDAKDLIRKM 260
Query: 297 IAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISK 333
+ F P R TA + L P+ + + S P +
Sbjct: 261 LTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLE 297
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-52
Identities = 81/320 (25%), Positives = 137/320 (42%), Gaps = 50/320 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
+RYK V+GKGS+G V D TG++ A+K I + +D +LREV+LL+ L H
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLR 137
P+I+++ F+D Y+V E+ +L I + + + Q+L
Sbjct: 86 PNIMKLYEF--------FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 138 ALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ YMH + HRDLKP+N+L + + +++ DFGL+ + M D + T +
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM----KDKIGTAY 193
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
Y APE+ Y D+WS G I +L+G P F G + L +
Sbjct: 194 YIAPEV---LHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV----------- 239
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ KY + V A L+++++ + P R +A +AL
Sbjct: 240 -------EKGKY--TFELPQ-------WKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283
Query: 315 YFKGLAKIEREPSCQPISKL 334
+ + K + +
Sbjct: 284 WIQTYTKEQISVDVPSLDNA 303
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 5e-52
Identities = 83/318 (26%), Positives = 136/318 (42%), Gaps = 49/318 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
Y+ ++ +G G+YG V D T + AIK I S ++L EV +L+LL HP
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHP 96
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
+I+++ F+D Y+V E + +L I + Q+L
Sbjct: 97 NIMKLYDF--------FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 139 LKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
+ Y+H N+ HRDLKP+N+L + +K+ DFGL+ V + M + + T +Y
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM----KERLGTAYY 204
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ KY D+WSIG I +L G P F G++ L +
Sbjct: 205 IAPEV---LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV------------ 249
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ KY + NV A L+++++ FD + R +A++AL P+
Sbjct: 250 ------EKGKY--TFDSPE-------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW 294
Query: 316 FKGLAKIEREPSCQPISK 333
K + + P
Sbjct: 295 IKEMCSKKESGIELPSLA 312
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 6e-52
Identities = 72/304 (23%), Positives = 124/304 (40%), Gaps = 53/304 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRLLR 80
++I + IG+G + V A G VA+KK+ +F+ + R ++E+ LL+ L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKV-QIFDLMDAKARADCIKEIDLLKQLN 90
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFF-------- 131
HP++++ S E ++ +V EL ++ DL ++IK ++ +
Sbjct: 91 HPNVIKYYA-----SFIEDNELNIVLELADAGDLSRMIKHF----KKQKRLIPERTVWKY 141
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
Q+ AL++MH+ V HRD+KP N+ A +K+ D GL R S T V
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA---HSLVG 198
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T +Y +PE + Y DIWS+GC+ E+ + F G +
Sbjct: 199 TPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY------------ 244
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
++ + + Y PP+P + L + DP+ RP
Sbjct: 245 ----SLCKKIEQCDY-------PPLPSDHYSEELRQLVNMCINP----DPEKRPDVTYVY 289
Query: 312 ADPY 315
Sbjct: 290 DVAK 293
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-50
Identities = 75/360 (20%), Positives = 132/360 (36%), Gaps = 74/360 (20%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR-LLRH 81
N +++G GS G V + G VA+K++ F I L E+KLL H
Sbjct: 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDI-----ALMEIKLLTESDDH 68
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELMESDLHQVIKANDDLTREHHQF-------F 131
P+++ +Y+ EL +L ++++ +
Sbjct: 69 PNVIRYYCS--------ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNIL-------------ANANCKLKVCDFGLAR-VAF 177
L Q+ + ++H+ + HRDLKP+NIL N ++ + DFGL + +
Sbjct: 121 LRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 178 SDTPMTVFWTDYVATRWYRAPEL-----CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLF 231
+ + T +RAPEL + T +IDI+S+GC+F +L+ GK F
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240
Query: 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR 291
+ + + + + ++ A
Sbjct: 241 GD-------------------------KYSRESNIIRGIFSLDEMK-CLHDRSLIAEATD 274
Query: 292 LLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
L+ ++I DP RPTA + L P F +K + +S E E R + +
Sbjct: 275 LISQMIDHDPLKRPTAMKVLRHPLFWPKSK--KLEFLLKVSD-RLEIENRDPPSALLMKF 331
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-50
Identities = 89/321 (27%), Positives = 141/321 (43%), Gaps = 51/321 (15%)
Query: 11 KDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL 70
++ + + A RY I+ ++GKGS+G V D T ++ A+K I+ D IL
Sbjct: 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL 69
Query: 71 REVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQ 129
REV+LL+ L HP+I+++ I+ + Y+V EL +L I +
Sbjct: 70 REVELLKKLDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA 124
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFW 186
+ Q+ + YMH N+ HRDLKP+NIL +C +K+ DFGL+ +T M
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---- 180
Query: 187 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
D + T +Y APE L G Y D+WS G I +L+G P F GK+ L +
Sbjct: 181 KDRIGTAYYIAPEVLRG----TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-- 234
Query: 246 LLGT---PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPK 302
G P+ + + A L+++++ F P
Sbjct: 235 ETGKYAFDLPQ----------------------------WRTISDDAKDLIRKMLTFHPS 266
Query: 303 DRPTAEEALADPYFKGLAKIE 323
R TA + L P+ + + E
Sbjct: 267 LRITATQCLEHPWIQKYSSEE 287
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 7e-50
Identities = 81/331 (24%), Positives = 130/331 (39%), Gaps = 62/331 (18%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-----------HDVFEHISDAIRILR 71
Y + +G G+YG V + + + AIK I D I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREH 127
E+ LL+ L HP+I+++ + F+D Y+V E E +L + I
Sbjct: 96 EISLLKSLDHPNIIKLFDV--------FEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 128 HQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTV 184
+ Q+L + Y+H N+ HRD+KP+NIL N+ +K+ DFGL+ D +
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL-- 205
Query: 185 FWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
D + T +Y APE L KY D+WS G I +L G P F G++ + +
Sbjct: 206 --RDRLGTAYYIAPEVLKK----KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303
+ KY + N+ A L++ ++ +D
Sbjct: 260 ------------------EKGKY--YFDFND-------WKNISDEAKELIKLMLTYDYNK 292
Query: 304 RPTAEEALADPYFKGLAKIEREPSCQPISKL 334
R TAEEAL + K A + + +
Sbjct: 293 RCTAEEALNSRWIKKYANNINKSDQKTLCGA 323
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-49
Identities = 78/349 (22%), Positives = 126/349 (36%), Gaps = 85/349 (24%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI---HDVFEHISDAIRILREVKLLRLL 79
+Y + IG+GSYGVV AI+ T AIK + + D RI EV+L++ L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQF-------- 130
HP+I + + + + I +V EL L + D +
Sbjct: 86 HHPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 131 --------------------------------FLYQMLRALKYMHTANVYHRDLKPKNIL 158
+ Q+ AL Y+H + HRD+KP+N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 159 --ANANCKLKVCDFGLARVAFSDTPMTVF-WTDYVATRWYRAPELCGSFFSKYTPAIDIW 215
N + ++K+ DFGL++ + + T T ++ APE+ + Y P D W
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260
Query: 216 SIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---PSPETIAVVRNEKARKYLTEMRK 272
S G + +L G FPG + + + L +P
Sbjct: 261 SAGVLLHLLLMGAVPFPGVNDADTISQV--LNKKLCFENPN------------------- 299
Query: 273 KPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
+ + PLA LL L+ + +R A AL P+ +
Sbjct: 300 ---------YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-49
Identities = 69/321 (21%), Positives = 125/321 (38%), Gaps = 42/321 (13%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
+ Q + + + R+ K IG+GS+ V +DT T +VA ++ D
Sbjct: 4 RNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK 63
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKA 119
S+ R E ++L+ L+HP+IV K + K I +V ELM S L +K
Sbjct: 64 LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKR 122
Query: 120 NDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANA-NCKLKVCDFGLARVA 176
+ + + + Q+L+ L+++HT + HRDLK NI +K+ D GLA +
Sbjct: 123 FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182
Query: 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
+ V T + APE+ KY ++D+++ G E+ T + +
Sbjct: 183 RASFAKAVIGTPE----FM-APEMYE---EKYDESVDVYAFGMCMLEMATSEYPYSECQN 234
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
Q+ Y P + P +++
Sbjct: 235 AAQI-------------------------YRRVTSGVKPASFDK---VAIPEVKEIIEGC 266
Query: 297 IAFDPKDRPTAEEALADPYFK 317
I + +R + ++ L +F+
Sbjct: 267 IRQNKDERYSIKDLLNHAFFQ 287
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 180 bits (457), Expect = 2e-49
Identities = 78/343 (22%), Positives = 132/343 (38%), Gaps = 22/343 (6%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+++ E +G G +G V I TGE+VAIK+ + R E+++++ L HP+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPN 73
Query: 84 IVEIKRIMLPPSKREFKD-IYVVFELMES-DLHQVIKANDD---LTREHHQFFLYQMLRA 138
+V + + K D + E E DL + + ++ L + L + A
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 139 LKYMHTANVYHRDLKPKNILANANCK---LKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
L+Y+H + HRDLKP+NI+ + K+ D G A+ T F V T Y
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF----VGTLQY 189
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APEL KYT +D WS G + E +TG F Q
Sbjct: 190 LAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV----REKSNEH 243
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
VV ++ P L + R LQ ++ + + R T +
Sbjct: 244 IVVYDDLTGAVKFSSVLPTPNHL---SGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILE 358
F+ L I ++ + VT+++ + + + +
Sbjct: 301 FQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQ 343
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-49
Identities = 82/340 (24%), Positives = 128/340 (37%), Gaps = 63/340 (18%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
RY +GKG + D T E A K + + ++ E+ + R L H
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+V ++VV EL L ++ K LT +++L Q++ +Y
Sbjct: 102 HVVGFHGFFEDNDF-----VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD---------TPMTVFWTDYVAT 192
+H V HRDLK N+ N + ++K+ DFGLA D TP +Y+
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP------NYI-- 208
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
APE+ ++ +D+WSIGCI +L GKP F +
Sbjct: 209 ----APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------------K 247
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEAL 311
ET K +Y P ++P+A L+Q+++ DP RPT E L
Sbjct: 248 ETY---LRIKKNEY--------------SIPKHINPVAASLIQKMLQTDPTARPTINELL 290
Query: 312 ADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
D +F R P F + + + L
Sbjct: 291 NDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 330
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-49
Identities = 78/306 (25%), Positives = 122/306 (39%), Gaps = 63/306 (20%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
RY +GKG + D T E A K + + ++ E+ + R L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+V ++VV EL L ++ K LT +++L Q++ +Y
Sbjct: 76 HVVGFHGFFEDNDF-----VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD---------TPMTVFWTDYVAT 192
+H V HRDLK N+ N + ++K+ DFGLA D TP +Y+
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP------NYI-- 182
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
APE+ ++ +D+WSIGCI +L GKP F +
Sbjct: 183 ----APEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---------------K 221
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDRPTAEEAL 311
ET K +Y P +++P+A L+Q+++ DP RPT E L
Sbjct: 222 ETY---LRIKKNEY--------------SIPKHINPVAASLIQKMLQTDPTARPTINELL 264
Query: 312 ADPYFK 317
D +F
Sbjct: 265 NDEFFT 270
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-49
Identities = 81/300 (27%), Positives = 126/300 (42%), Gaps = 47/300 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y + IG+GS+G V A+ T + A KKI + D R +E+++++ L HP+
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK--YFVEDVDRFKQEIEIMKSLDHPN 67
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
I+ + + DIY+V EL +L + + + +L A+ Y
Sbjct: 68 IIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 143 HTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H NV HRDLKP+N L + + LK+ DFGLA M V T +Y +P+
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM----RTKVGTPYYVSPQ 178
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L G Y P D WS G + +L G P F + + I
Sbjct: 179 VLEG----LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI--------------- 219
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
+ + +K + NV P A L++RL+ PK R T+ +AL +F+
Sbjct: 220 ---REGTF--TFPEKD-------WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 1e-48
Identities = 82/315 (26%), Positives = 136/315 (43%), Gaps = 50/315 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y + E +GKG++ VV + TG + A K I+ D ++ RE ++ R L+HP
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP 65
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+IV + + +E Y+VF+L+ +L + I A + + + Q+L ++ Y
Sbjct: 66 NIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 142 MHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
H+ + HR+LKP+N+L +K+ DFGLA +D + W + T Y +P
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VND---SEAWHGFAGTPGYLSP 176
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---PSPET 254
E L Y+ +DIW+ G I +L G P F + I G PSPE
Sbjct: 177 EVLKK---DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPE- 230
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ V P A L+ ++ +PK R TA++AL P
Sbjct: 231 ---------------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263
Query: 315 YFKGLAKIEREPSCQ 329
+ ++ Q
Sbjct: 264 WICNRERVASAIHRQ 278
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 4e-48
Identities = 68/299 (22%), Positives = 123/299 (41%), Gaps = 49/299 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
++I +GKG +G V A + + +A+K + E ++ REV++ LRH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
P+I+ + ++ +Y++ E +++ ++ + ++ ++ AL
Sbjct: 69 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT-DYVATRWYRAPE 199
Y H+ V HRD+KP+N+L + +LK+ DFG + A S + T DY+ PE
Sbjct: 124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------PPE 177
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ + +D+WS+G + E L GKP F + I
Sbjct: 178 MIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI---------------- 219
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
++ FP+ V A L+ RL+ +P RP E L P+
Sbjct: 220 --SRVEF--------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 5e-48
Identities = 79/320 (24%), Positives = 130/320 (40%), Gaps = 55/320 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI-------HDVFEHISDAIRILREVKL 75
Y+ E++G+G VV I T ++ A+K I E L+EV +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 76 LRLL-RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLY 133
LR + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 77 LRKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR 131
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+L + +H N+ HRDLKP+NIL + + +K+ DFG + + + T
Sbjct: 132 ALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTP 187
Query: 194 WYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
Y APE + S Y +D+WS G I +L G P F + + L +I + G
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI--MSGN 245
Query: 250 ---PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
SPE + + L+ R + P+ R T
Sbjct: 246 YQFGSPE----------------------------WDDYSDTVKDLVSRFLVVQPQKRYT 277
Query: 307 AEEALADPYFKGLAKIEREP 326
AEEALA P+F+ E
Sbjct: 278 AEEALAHPFFQQYVVEEVRH 297
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-47
Identities = 85/327 (25%), Positives = 139/327 (42%), Gaps = 50/327 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y + E +GKG++ VV + TG + A K I+ D ++ RE ++ R L+HP+
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV + + +E Y+VF+L+ +L + I A + + + Q+L ++ Y
Sbjct: 90 IVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 143 HTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H+ + HR+LKP+N+L +K+ DFGLA +D + W + T Y +PE
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VND---SEAWHGFAGTPGYLSPE 200
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---PSPETI 255
L Y+ +DIW+ G I +L G P F + I G PSPE
Sbjct: 201 VLKK---DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI--KAGAYDYPSPE-- 253
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ V P A L+ ++ +PK R TA++AL P+
Sbjct: 254 --------------------------WDTVTPEAKSLIDSMLTVNPKKRITADQALKVPW 287
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRR 342
++ Q +F RR
Sbjct: 288 ICNRERVASAIHRQDTVDCLKKFNARR 314
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-47
Identities = 82/327 (25%), Positives = 134/327 (40%), Gaps = 49/327 (14%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y++ E +GKG++ VV + G++ A I+ D ++ RE ++ RLL+HP+
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN 71
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV + + E Y++F+L+ +L + I A + + + Q+L A+ +
Sbjct: 72 IVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126
Query: 143 HTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H V HR+LKP+N+L +K+ DFGLA + W + T Y +PE
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA---WFGFAGTPGYLSPE 183
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---PSPETI 255
L Y +D+W+ G I +L G P F + I G PSPE
Sbjct: 184 VLRK---DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQI--KAGAYDFPSPE-- 236
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ V P A L+ +++ +P R TA EAL P+
Sbjct: 237 --------------------------WDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRR 342
+ + Q +F RR
Sbjct: 271 ISHRSTVASCMHRQETVDCLKKFNARR 297
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 7e-47
Identities = 68/313 (21%), Positives = 121/313 (38%), Gaps = 49/313 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
+ + I +GKG +G V A + +A+K + E ++ RE+++ LRH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
P+I+ + + IY++ E +L++ ++ + + F+ ++ AL
Sbjct: 74 PNILRMYNYFHDRKR-----IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALH 128
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT-DYVATRWYRAPE 199
Y H V HRD+KP+N+L +LK+ DFG + A S T+ T DY+ PE
Sbjct: 129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------PPE 182
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ + +D+W G + E L G P F S I
Sbjct: 183 MIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI---------------- 224
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
KFP + + L+ +L+ + P R + + P+ K
Sbjct: 225 --VNVDL--------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268
Query: 319 LAKIEREPSCQPI 331
++ P Q
Sbjct: 269 NSRRVLPPVYQST 281
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-46
Identities = 75/317 (23%), Positives = 124/317 (39%), Gaps = 53/317 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y++ E +G G + +V TG++ A K I I REV +LR
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
+RHP+I+ + I D+ ++ EL+ +L + + LT + FL Q+L
Sbjct: 65 IRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 119
Query: 138 ALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ Y+H+ + H DLKP+NI+ N ++K+ DFG+A + T
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI----FGTP 175
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---P 250
+ APE+ + D+WSIG I +L+G F G++ L I
Sbjct: 176 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI--SAVNYDFD 231
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
F N LA ++RL+ DPK R T ++
Sbjct: 232 EEY----------------------------FSNTSELAKDFIRRLLVKDPKRRMTIAQS 263
Query: 311 LADPYFKGLAKIEREPS 327
L + K + +
Sbjct: 264 LEHSWIKAIRRRNVRGE 280
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-46
Identities = 62/303 (20%), Positives = 105/303 (34%), Gaps = 43/303 (14%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y ++ +G+G + V H G A+K+I E D RE + RL HP+
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI-LCHEQ-QDREEAQREADMHRLFNHPN 87
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKA----NDDLTREHHQFFLYQMLRA 138
I+ + L + + +++ + L I+ + LT + + L + R
Sbjct: 88 ILRLVAYCLRERGAKHE-AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP------MTVFWTDYVAT 192
L+ +H HRDLKP NIL + + D G A W T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 193 RWYRAPELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
YRAPEL D+WS+GC+ ++ G+ +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV----------------- 249
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
+K ++ + +P + +LL ++ DP RP L
Sbjct: 250 --------FQKGDSVALAVQNQLSIPQSPRHS---SALWQLLNSMMTVDPHQRPHIPLLL 298
Query: 312 ADP 314
+
Sbjct: 299 SQL 301
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-46
Identities = 73/308 (23%), Positives = 130/308 (42%), Gaps = 64/308 (20%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
+K+ ++GKGS+ V A HTG +VAIK I R+ EVK+ L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRAL 139
P I+E+ + +Y+V E+ + ++++ +K + + F++Q++ +
Sbjct: 71 PSILELYNYFEDSNY-----VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD---------TPMTVFWTDYV 190
Y+H+ + HRDL N+L N +K+ DFGLA TP +Y+
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTP------NYI 179
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
+PE+ S + D+WS+GC+F +L G+P F +V + L+ +
Sbjct: 180 ------SPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------- 224
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN-VDPLALRLLQRLIAFDPKDRPTAEE 309
Y + P+ + A L+ +L+ +P DR +
Sbjct: 225 -----------VLADY--------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSS 259
Query: 310 ALADPYFK 317
L P+
Sbjct: 260 VLDHPFMS 267
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 5e-46
Identities = 75/358 (20%), Positives = 136/358 (37%), Gaps = 62/358 (17%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV 59
++ E K + Y++ +V+G G G V TG+K A+K +
Sbjct: 12 LEVLFQGPEPKKYAVT------DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL--- 62
Query: 60 FEHISDAIRILREVKLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVI 117
D+ + +EV + P IV I + + + + ++ E ME +L I
Sbjct: 63 ----YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGK-RCLLIIMECMEGGELFSRI 117
Query: 118 KANDDLTREHHQF-------FLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKV 167
+ R F + + A++++H+ N+ HRD+KP+N+L + LK+
Sbjct: 118 QE-----RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKL 172
Query: 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 227
DFG A+ + + T +Y APE+ G KY + D+WS+G I +L G
Sbjct: 173 TDFGFAKE-TTQNAL----QTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCG 225
Query: 228 KPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP 287
P F T + + R + +Y + V
Sbjct: 226 FPPFYSN--------------TGQAISPGMKRRIRLGQY--GFPNPE-------WSEVSE 262
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK 345
A +L++ L+ DP +R T + + P+ + + P E + V +
Sbjct: 263 DAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEVKE 320
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 5e-46
Identities = 52/335 (15%), Positives = 102/335 (30%), Gaps = 81/335 (24%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR-EVKLLRLLR-- 80
V+G+ A D TGE + + S+AI+ ++ EV LRLLR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 81 --------------------HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAN 120
P ++ R+ L + ++ M+S+L +
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 121 DDLTREHHQF-------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
+ H Q++R L +H + H L+P +I+ + + + F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPEL---------CGSFFSKYTPAIDIWSIGCIFAEV 224
+ +V +R + PEL + T + D W++G + +
Sbjct: 254 VRDGARVVSSV-------SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 225 LTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPN 284
+ + + I R +P
Sbjct: 307 WCADLPITKDAALGGSEWI--------------------------FRSCKNIP------- 333
Query: 285 VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
LL+ + + +DR +A+ P ++ L
Sbjct: 334 --QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 7e-46
Identities = 77/317 (24%), Positives = 136/317 (42%), Gaps = 53/317 (16%)
Query: 11 KDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL 70
++ + + + + +G G++G V + +G + IK I + +I
Sbjct: 10 GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTI-NKDRSQVPMEQIE 68
Query: 71 REVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD----LTR 125
E+++L+ L HP+I++I + ++ ++Y+V E E +L + I + L+
Sbjct: 69 AEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSE 123
Query: 126 EHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPM 182
+ + QM+ AL Y H+ +V H+DLKP+NIL + + +K+ DFGLA + SD
Sbjct: 124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS 183
Query: 183 TVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLD 241
T+ T Y APE T DIWS G + +LTG F G S+
Sbjct: 184 ----TNAAGTALYMAPEVFKR----DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFD 300
P+ + + P A+ LL++++ D
Sbjct: 236 KA--TYKEPN---------------------------YAVECRPLTPQAVDLLKQMLTKD 266
Query: 301 PKDRPTAEEALADPYFK 317
P+ RP+A + L +FK
Sbjct: 267 PERRPSAAQVLHHEWFK 283
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 9e-46
Identities = 80/337 (23%), Positives = 133/337 (39%), Gaps = 63/337 (18%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI---HDVFEHISDAIRILREVKLLRLLR 80
Y++ EVIGKG + VV I+ TG++ A+K + + RE + +L+
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLY------ 133
HP IVE+ +Y+VFE M+ +DL ++ + F+Y
Sbjct: 85 HPHIVELLETY-----SSDGMLYMVFEFMDGADLC------FEIVKRADAGFVYSEAVAS 133
Query: 134 ----QMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFW 186
Q+L AL+Y H N+ HRD+KP +L + +K+ FG+A +
Sbjct: 134 HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLV---A 190
Query: 187 TDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
V T + APE + Y +D+W G I +L+G F G
Sbjct: 191 GGRVGTPHFMAPEVVKR---EPYGKPVDVWGCGVILFILLSGCLPFYG------------ 235
Query: 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305
+ KY +M + + ++ A L++R++ DP +R
Sbjct: 236 -------TKERLFEGIIKGKY--KMNPRQ-------WSHISESAKDLVRRMLMLDPAERI 279
Query: 306 TAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRR 342
T EAL P+ K + + + +F RR
Sbjct: 280 TVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARR 316
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 52/335 (15%), Positives = 97/335 (28%), Gaps = 73/335 (21%)
Query: 22 ANRYKIL---EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLR 77
R + L V+G+ A D TGE + + S+AI ++ EV LR
Sbjct: 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 133
Query: 78 LLR----------------------HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQ 115
LLR P ++ R+ L + ++ M+S+L
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193
Query: 116 VIKANDDLTREHHQ-------FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168
+ + H Q++R L +H + H L+P +I+ + + +
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 253
Query: 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELC---GSFFSKYTPAIDIWSIGCIFAEVL 225
F A A + + T A D W++G +
Sbjct: 254 GFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
Query: 226 TGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV 285
+ + + I R +P
Sbjct: 312 CADLPNTDDAALGGSEWI--------------------------FRSCKNIP-------- 337
Query: 286 DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320
LL+ + + +DR +A+ P ++ L
Sbjct: 338 -QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-45
Identities = 77/347 (22%), Positives = 132/347 (38%), Gaps = 62/347 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y E +G G + VV + TG + A K I I REV +L+
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 79 LRHPDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQ 134
++HP+++ + + +++ + ++ EL+ +L + + LT E FL Q
Sbjct: 71 IQHPNVITLHEV--------YENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 122
Query: 135 MLRALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYV 190
+L + Y+H+ + H DLKP+NI+ ++K+ DFGLA
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI----F 178
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT- 249
T + APE+ + D+WSIG I +L+G F G + L +
Sbjct: 179 GTPEFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV--SAVNY 234
Query: 250 --PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
F N LA ++RL+ DPK R T
Sbjct: 235 EFEDEY----------------------------FSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 308 EEALADPYFKGL---AKIEREPSCQPISKLEFEFERRRVTKDDIREL 351
+++L P+ K + R+ S + K + R++ L
Sbjct: 267 QDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSNNGSGGGL 313
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-45
Identities = 71/325 (21%), Positives = 122/325 (37%), Gaps = 53/325 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y I E +G G + +V + TG + A K I I REV +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
+ H +++ + + D+ ++ EL+ +L + + L+ E F+ Q+L
Sbjct: 72 VLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 138 ALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ Y+HT + H DLKP+NI+ +K+ DFGLA T
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI----FGTP 182
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---P 250
+ APE+ + D+WSIG I +L+G F G + L I +
Sbjct: 183 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--TSVSYDFD 238
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
F + LA +++L+ + + R T +EA
Sbjct: 239 EEF----------------------------FSHTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 311 LADPYFKGLAKIEREPSCQPISKLE 335
L P+ + + + + LE
Sbjct: 271 LRHPWITPVDNQQAMVRRESVVNLE 295
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 76/310 (24%), Positives = 128/310 (41%), Gaps = 54/310 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI------HDVFEHISDAIRILREVKLL 76
+Y +VIG+G VV + TG + A+K + + RE +L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 77 RLLR-HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQ 134
R + HP I+ + +++VF+LM +L + L+ + + +
Sbjct: 154 RQVAGHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS 208
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+L A+ ++H N+ HRDLKP+NIL + N ++++ DFG + + + T
Sbjct: 209 LLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL----RELCGTPG 264
Query: 195 YRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT- 249
Y APE L S Y +D+W+ G I +L G P F + + L +I + G
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI--MEGQY 322
Query: 250 --PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
SPE + + L+ RL+ DP+ R TA
Sbjct: 323 QFSSPE----------------------------WDDRSSTVKDLISRLLQVDPEARLTA 354
Query: 308 EEALADPYFK 317
E+AL P+F+
Sbjct: 355 EQALQHPFFE 364
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 3e-45
Identities = 73/325 (22%), Positives = 122/325 (37%), Gaps = 53/325 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y I E +G G + +V + TG + A K I I REV +LR
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
+ HP+I+ + + D+ ++ EL+ +L + + L+ E F+ Q+L
Sbjct: 72 VLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126
Query: 138 ALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ Y+HT + H DLKP+NI+ +K+ DFGLA T
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNI----FGTP 182
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT---P 250
+ APE+ + D+WSIG I +L+G F G + L I +
Sbjct: 183 EFVAPEIVN--YEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI--TAVSYDFD 238
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
F LA +++L+ + + R T +EA
Sbjct: 239 EEF----------------------------FSQTSELAKDFIRKLLVKETRKRLTIQEA 270
Query: 311 LADPYFKGLAKIEREPSCQPISKLE 335
L P+ + + + + LE
Sbjct: 271 LRHPWITPVDTQQAMVRRESVVNLE 295
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-45
Identities = 60/325 (18%), Positives = 101/325 (31%), Gaps = 71/325 (21%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL-RLLR 80
+ LE IG G +G V + G AIK+ D LREV L +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTR---EHH-QFFLYQM 135
H +V + E + + E L I N + E + L Q+
Sbjct: 70 HSHVVRYFS-----AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 136 LRALKYMHTANVYHRDLKPKNIL-------------------ANANCKLKVCDFGLARVA 176
R L+Y+H+ ++ H D+KP NI A+ K+ D G
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
+P + A E+ ++ + P DI+++ +PL
Sbjct: 185 --SSPQVE-----EGDSRFLANEVLQENYT-HLPKADIFALALTVVCAAGAEPLPRNGDQ 236
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
H++ R+ + Q LL+ +
Sbjct: 237 WHEI------------------------------RQGRLPRIPQVLS---QEFTELLKVM 263
Query: 297 IAFDPKDRPTAEEALADPYFKGLAK 321
I DP+ RP+A + ++
Sbjct: 264 IHPDPERRPSAMALVKHSVLLSASR 288
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 5e-45
Identities = 78/339 (23%), Positives = 152/339 (44%), Gaps = 54/339 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y++L+ IGKG++ V A TG +VAIK I + + ++ REV+++++L HP+
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV++ ++ K +Y++ E ++ + A+ + + + Q++ A++Y
Sbjct: 76 IVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRDLK +N+L +A+ +K+ DFG + + F Y APEL
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF----CGAPPYAAPEL-- 184
Query: 203 SFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
F KY P +D+WS+G I +++G F G++
Sbjct: 185 --FQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN------------------------ 218
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK-G 318
L E+R++ ++ + LL+R + +P R T E+ + D + G
Sbjct: 219 -------LKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271
Query: 319 LAKIEREPSCQPISKLEFEF-----ERRRVTKDDIRELI 352
+ E +P +P + + ++++I+E +
Sbjct: 272 HEEDELKPFVEPELDISDQKRIDIMVGMGYSQEEIQESL 310
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 7e-45
Identities = 62/321 (19%), Positives = 129/321 (40%), Gaps = 62/321 (19%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI------------------------HD 58
N+Y + + IGKGSYGVV A + + A+K +
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 59 VFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI 117
+ ++ +E+ +L+ L HP++V++ ++ P++ +Y+VFEL+ + +V
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH---LYMVFELVNQGPVMEVP 129
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
L+ + +F+ +++ ++Y+H + HRD+KP N+L + +K+ DFG++
Sbjct: 130 T-LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS--NE 186
Query: 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSV 236
+ V T + APE ++ A+D+W++G + G+ F + +
Sbjct: 187 FKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
+ I + P P++ L+ R+
Sbjct: 246 MCLHSKI--------------------------KSQALEFP---DQPDIAEDLKDLITRM 276
Query: 297 IAFDPKDRPTAEEALADPYFK 317
+ +P+ R E P+
Sbjct: 277 LDKNPESRIVVPEIKLHPWVT 297
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 9e-45
Identities = 76/345 (22%), Positives = 136/345 (39%), Gaps = 51/345 (14%)
Query: 10 LKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI 69
+KD F+ Y + + +G+GS+ + + + + A+K I E
Sbjct: 1 MKDSPFYQHY---DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA-----NT 52
Query: 70 LREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVIKANDDLT 124
+E+ L+L HP+IV++ + F D ++V EL+ +L + IK +
Sbjct: 53 QKEITALKLCEGHPNIVKLHEV--------FHDQLHTFLVMELLNGGELFERIKKKKHFS 104
Query: 125 REHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTP 181
+ + +++ A+ +MH V HRDLKP+N+L N N ++K+ DFG AR+ D
Sbjct: 105 ETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164
Query: 182 MTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
T Y APE L + Y + D+WS+G I +L+G+ F
Sbjct: 165 P---LKTPCFTLHYAAPELLNQ---NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC 218
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
+++ + I K + + + NV A L+Q L+ D
Sbjct: 219 TSAVEIM-----KKI------KKGDF--SFEGEA-------WKNVSQEAKDLIQGLLTVD 258
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK 345
P R + + + +++ P P K
Sbjct: 259 PNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVK 303
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-44
Identities = 69/306 (22%), Positives = 129/306 (42%), Gaps = 40/306 (13%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+ +++ +G+G+YG V A++ T E VA+K I D+ + I +E+ + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+V+ + Y+ E +L I+ + + Q F +Q++ + Y+
Sbjct: 67 VVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LK+ DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPELLK 180
Query: 203 SFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
++ +D+WS G + +L G+ + S D +
Sbjct: 181 R--REFHAEPVDVWSCGIVLTAMLAGELPWDQPS-----DSCQEY--------------- 218
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF-KGLA 320
+ + P + +D L LL +++ +P R T + D ++ K L
Sbjct: 219 --SDWKEKKTYLNP------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270
Query: 321 KIEREP 326
K + P
Sbjct: 271 KGAKRP 276
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-44
Identities = 54/340 (15%), Positives = 117/340 (34%), Gaps = 56/340 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---------------DVFEHISDAI 67
N Y+I+ + +G + + + A+KK D S
Sbjct: 31 NDYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 68 RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTRE 126
E++++ +++ + + I+ ++Y+++E ME+ + + + L +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKN 143
Query: 127 HHQ--------FFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
+ + +L + Y+H N+ HRD+KP NIL + N ++K+ DFG +
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203
Query: 178 SDTPMTVFWT-DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
T +++ PE + S +DIWS+G + F K
Sbjct: 204 DKKIKGSRGTYEFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKAR---KYLTEMRKKPPVPLFQKFPNVDPLALRLL 293
+ E +R + + + + L
Sbjct: 258 L--------------VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFL 303
Query: 294 QRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISK 333
+ + +P +R T+E+AL + + + + K
Sbjct: 304 KLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYK 343
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-44
Identities = 68/362 (18%), Positives = 122/362 (33%), Gaps = 100/362 (27%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++ ++ +G+G +GVV A + AIK+I + +++REVK L L HP
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRI-RLPNRELAREKVMREVKALAKLEHP 64
Query: 83 DIV-------------------------------------------------EIKRIMLP 93
IV
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124
Query: 94 PSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQ---FFLYQMLRALKYMHTAN 146
+ ++ M+ +L + L H Q+ A++++H+
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARV---------AFSDTPMTVFWTDYVATRWYRA 197
+ HRDLKP NI + +KV DFGL + P T V T+ Y +
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE + Y+ +DI+S+G I E+L E + +
Sbjct: 245 PEQIHG--NNYSHKVDIFSLGLILFELLYSFS--------------------TQMERVRI 282
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + + K+ P + F P ++Q +++ P +RP A + + + F+
Sbjct: 283 ITDVRNLKF-------PLL-----FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330
Query: 318 GL 319
L
Sbjct: 331 NL 332
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-44
Identities = 78/306 (25%), Positives = 126/306 (41%), Gaps = 55/306 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+++ +G+G+ +V T + A+K + + D + E+ +L L HP+
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVL----KKTVDKKIVRTEIGVLLRLSHPN 109
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
I+++K I P++ I +V EL+ +L I + + Q+L A+ Y+
Sbjct: 110 IIKLKEIFETPTE-----ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYL 164
Query: 143 HTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H + HRDLKP+N+L + LK+ DFGL+++ M T Y APE
Sbjct: 165 HENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM----KTVCGTPGYCAPE 220
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGT---PSPET 254
L G Y P +D+WS+G I +L G F + + I L SP
Sbjct: 221 ILRG---CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI--LNCEYYFISPW- 274
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
+ V A L+++LI DPK R T +AL P
Sbjct: 275 ---------------------------WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP 307
Query: 315 YFKGLA 320
+ G A
Sbjct: 308 WVTGKA 313
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 4e-44
Identities = 83/375 (22%), Positives = 139/375 (37%), Gaps = 71/375 (18%)
Query: 9 ELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR 68
++K +Y +V+G G G V + T EK A+K + D +
Sbjct: 53 QIKKNAIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPK 100
Query: 69 ILREVKLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTRE 126
REV+L R + P IV I + K + +V E ++ +L +
Sbjct: 101 ARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELF------SRIQDR 153
Query: 127 HHQFF--------LYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARV 175
Q F + + A++Y+H+ N+ HRD+KP+N+L N LK+ DFG A+
Sbjct: 154 GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213
Query: 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS 235
S + T T +Y APE+ G KY + D+WS+G I +L G P F
Sbjct: 214 TTSHNSL----TTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267
Query: 236 VVHQLDLITD--LLGT---PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL 290
+ + +G P+PE + V
Sbjct: 268 GLAISPGMKTRIRMGQYEFPNPE----------------------------WSEVSEEVK 299
Query: 291 RLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRE 350
L++ L+ +P R T E + P+ K+ + P E + V ++
Sbjct: 300 MLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSA 359
Query: 351 LIYREILEYHPQLLK 365
L + ++ K
Sbjct: 360 LATMRVDYEQIKIKK 374
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 73/336 (21%), Positives = 130/336 (38%), Gaps = 62/336 (18%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y ILE +G G++GVV ++ TG K I+ + D + E+ ++ L HP
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 108
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVIKANDDLTREHHQF-------F 131
++ + F+D + ++ E + +L D + E ++ +
Sbjct: 109 KLINLHDA--------FEDKYEMVLILEFLSGGELF------DRIAAEDYKMSEAEVINY 154
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189
+ Q LK+MH ++ H D+KP+NI+ +K+ DFGLA D + V
Sbjct: 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT---- 210
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
AT + APE+ D+W+IG + +L+G F G+
Sbjct: 211 TATAEFAAPEIVD--REPVGFYTDMWAIGVLGYVLLSGLSPFAGED-------------- 254
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
ET+ V+ + E F +V P A ++ L+ +P+ R T +
Sbjct: 255 -DLETLQNVK--RCDWEFDE----------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHD 301
Query: 310 ALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK 345
AL P+ KG + + +
Sbjct: 302 ALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 337
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-43
Identities = 70/317 (22%), Positives = 130/317 (41%), Gaps = 44/317 (13%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
+ +++ +G+G+YG V A++ T E VA+K I D+ + I +E+ + ++L H +
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+V+ + Y+ E +L I+ + + Q F +Q++ + Y+
Sbjct: 67 VVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRD+KP+N+L + LK+ DFGLA V + + T Y APEL
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAPEL-- 178
Query: 203 SFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
++ +D+WS G + +L G+ + S D +
Sbjct: 179 --LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS-----DSCQEY------------- 218
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF-KG 318
+ + P + +D L LL +++ +P R T + D ++ K
Sbjct: 219 ----SDWKEKKTYLNP------WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268
Query: 319 LAKIEREPSCQPISKLE 335
L K + P E
Sbjct: 269 LKKGAKRPRVTSGGVSE 285
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-43
Identities = 75/313 (23%), Positives = 126/313 (40%), Gaps = 38/313 (12%)
Query: 24 RYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-H 81
Y++ +V+G+G++ V I+ T ++ A+K I HI + REV++L + H
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF--REVEMLYQCQGH 70
Query: 82 PDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
+++E+ F++ Y+VFE M + I + +
Sbjct: 71 RNVLELIEF--------FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS 122
Query: 138 ALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARV----AFSDTPMTVFWTDYV 190
AL ++H + HRDLKP+NIL N +K+CDF L T
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182
Query: 191 ATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247
+ Y APE+ S Y D+WS+G I +L+G P F G+ +
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
+ + KY E K + ++ A L+ +L+ D K R +A
Sbjct: 243 PACQNMLFESI---QEGKY--EFPDKD-------WAHISCAAKDLISKLLVRDAKQRLSA 290
Query: 308 EEALADPYFKGLA 320
+ L P+ +G A
Sbjct: 291 AQVLQHPWVQGCA 303
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-42
Identities = 60/319 (18%), Positives = 127/319 (39%), Gaps = 54/319 (16%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI--HDVFEHISDAIRILREVKLLRLLRH 81
+Y + +++G+GSYG V +D+ T + A+K + + + + +E++LLR LRH
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME---SDLHQVIKANDDLTREHHQFFLYQMLRA 138
+++++ ++ K + +Y+V E ++ + + H +F Q++
Sbjct: 66 KNVIQLVDVLYNEEK---QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF-CQLIDG 121
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW---- 194
L+Y+H+ + H+D+KP N+L LK+ G+A + F D
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA------LHPFAADDTCRTSQGSP 175
Query: 195 -YRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
++ PE+ + ++ +DIWS G + TG F G +
Sbjct: 176 AFQPPEIA-NGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN----------------- 217
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ ++ + + + P LL+ ++ ++P R + +
Sbjct: 218 --------------IYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263
Query: 313 DPYF-KGLAKIEREPSCQP 330
+F K E P
Sbjct: 264 HSWFRKKHPPAEAPVPIPP 282
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-42
Identities = 62/307 (20%), Positives = 128/307 (41%), Gaps = 53/307 (17%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y I E +G+G +G+V ++T + + K + + +E+ +L + RH
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL---VKKEISILNIARHR 61
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELME-SDLH-QVIKANDDLTREHHQFFLYQMLR 137
+I+ + F+ + ++FE + D+ ++ + +L +++Q+
Sbjct: 62 NILHLHES--------FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCE 113
Query: 138 ALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
AL+++H+ N+ H D++P+NI+ + +K+ +FG AR + Y
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL----FTAPEY 169
Query: 196 RAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE + A D+WS+G + +L+G F + T+ +
Sbjct: 170 YAPEVHQHDV---VSTATDMWSLGTLVYVLLSGINPFLAE---------TN------QQI 211
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
I + +Y ++ F + A+ + RL+ + K R TA EAL P
Sbjct: 212 IENI---MNAEY--TFDEEA-------FKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259
Query: 315 YFKGLAK 321
+ K +
Sbjct: 260 WLKQKIE 266
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 5e-42
Identities = 73/327 (22%), Positives = 132/327 (40%), Gaps = 50/327 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y I E +G G++GVV + TG A K + H SD + +E++ + +LRHP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 214
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELME-SDL-HQVIKANDDLTREHHQFFLYQMLR 137
+V + F+D + +++E M +L +V ++ ++ + ++ Q+ +
Sbjct: 215 TLVNLHDA--------FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 138 ALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
L +MH N H DLKP+NI+ + +LK+ DFGL + V T +
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT----TGTAEF 322
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ D+WS+G + +L+G F G++ ET+
Sbjct: 323 AAPEVAE--GKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---------------DDETL 365
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
V K+ + M F + +++L+ DP R T +AL P+
Sbjct: 366 RNV---KSCDW--NMDDSA-------FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRR 342
R+ + +
Sbjct: 414 LTPGNAPGRDSQIPSSRYTKIRDSIKT 440
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-42
Identities = 75/324 (23%), Positives = 123/324 (37%), Gaps = 62/324 (19%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHP 82
Y++ E IG GSY V I T + A+K I E++ LLR +HP
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK------SKRDPTEEIEILLRYGQHP 76
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
+I+ +K + + D +YVV ELM+ +L I + L+ + +
Sbjct: 77 NIITLKDV--------YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 139 LKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
++Y+H V HRDLKP NIL + +++CDFG A+ ++ T
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE---NGLLMTPCYTAN 185
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD-LLGT--- 249
+ APE L Y A DIWS+G + +LTG F +++ G
Sbjct: 186 FVAPEVLER---QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL 242
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ +V A L+ +++ DP R TA
Sbjct: 243 SGGY----------------------------WNSVSDTAKDLVSKMLHVDPHQRLTAAL 274
Query: 310 ALADPYFKGLAKIEREPSCQPISK 333
L P+ ++ + + +
Sbjct: 275 VLRHPWIVHWDQLPQYQLNRQDAP 298
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-41
Identities = 76/360 (21%), Positives = 126/360 (35%), Gaps = 90/360 (25%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH 62
++ ++K +Y +V+G G G V + T EK A+K +
Sbjct: 3 HVKSGLQIKKNAIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKML------ 51
Query: 63 ISDAIRILREVKLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN 120
D + REV+L R + P IV I + K + +V E ++ +L I+
Sbjct: 52 -QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQD- 108
Query: 121 DDLTREHHQF-------FLYQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDF 170
R F + + A++Y+H+ N+ HRD+KP+N+L N LK+ DF
Sbjct: 109 ----RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164
Query: 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230
G A E G KY + D+WS+G I +L G P
Sbjct: 165 GF------------------------AKETTG---EKYDKSCDMWSLGVIMYILLCGYPP 197
Query: 231 FPGKSVVHQLDLITD--LLGT---PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNV 285
F + + +G P+PE + V
Sbjct: 198 FYSNHGLAISPGMKTRIRMGQYEFPNPE----------------------------WSEV 229
Query: 286 DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTK 345
L++ L+ +P R T E + P+ K+ + P E + V +
Sbjct: 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKE 289
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-41
Identities = 70/310 (22%), Positives = 118/310 (38%), Gaps = 48/310 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + +G+GS+G V D TG + A+KK+ E E+ L
Sbjct: 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRV-----EELVACAGLS 108
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLRA 138
P IV + + RE + + EL+E S L Q+IK L + ++L Q L
Sbjct: 109 SPRIVPLYG-----AVREGPWVNIFMELLEGGS-LGQLIKQMGCLPEDRALYYLGQALEG 162
Query: 139 LKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLA-RVAFSDTPMTVFWTDYVA-TRWY 195
L+Y+HT + H D+K N+L +++ + +CDFG A + ++ DY+ T +
Sbjct: 163 LEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE+ +DIWS C+ +L G + + L + P P
Sbjct: 223 MAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQ---YFRGPLCLKIASEPPP--- 274
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+P P+ PL + +Q + +P R +A E
Sbjct: 275 -----------------IREIP-----PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312
Query: 316 FKGLAKIERE 325
+
Sbjct: 313 KALQEVGGLK 322
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 78/315 (24%), Positives = 127/315 (40%), Gaps = 55/315 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + V+GKG+YG+V A D ++AIK+I + S + E+ L + L+
Sbjct: 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLH--EEIALHKHLK 77
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDDLTREHHQFFLYQML 136
H +IV+ S E I + E + S L + + F+ Q+L
Sbjct: 78 HKNIVQYLG-----SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 137 RALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPM------TVFWTDY 189
LKY+H + HRD+K N+L N + LK+ DFG ++ P T+ +
Sbjct: 133 EGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM-- 190
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
APE+ Y A DIWS+GC E+ TGKP F ++L
Sbjct: 191 -------APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF------YELG-------- 229
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
E A + + + P +P ++ A + + DP R A +
Sbjct: 230 ---EPQAAMF------KVGMFKVHPEIP-----ESMSAEAKAFILKCFEPDPDKRACAND 275
Query: 310 ALADPYFKGLAKIER 324
L D + K +K ++
Sbjct: 276 LLVDEFLKVSSKKKK 290
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 3e-41
Identities = 71/297 (23%), Positives = 123/297 (41%), Gaps = 45/297 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
Y + + +G G++G V TG KVA+K ++ + +I RE++ L+L RHP
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
I+++ +++ P+ ++V E + +L I + + + Q+L A+ Y
Sbjct: 72 HIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H V HRDLKP+N+L +A+ K+ DFGL+ + + + Y APE+
Sbjct: 127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS----CGSPNYAAPEVI 182
Query: 202 GSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
Y P +DIWS G I +L G F +
Sbjct: 183 SG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEH------------------------- 215
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + KK +F ++ LL ++ DP R T ++ +FK
Sbjct: 216 ------VPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-41
Identities = 80/296 (27%), Positives = 132/296 (44%), Gaps = 44/296 (14%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
Y I E +G+GS+G V A T +KVA+K I + + +R+ RE+ L+LLRHP
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
I+++ ++ P DI +V E +L I +T + + F Q++ A++Y
Sbjct: 70 HIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRDLKP+N+L + N +K+ DFGL+ + + + Y APE+
Sbjct: 125 HRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS----CGSPNYAAPEVIN 180
Query: 203 SFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y P +D+WS G + +L G+ F +
Sbjct: 181 G--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-------------------------- 212
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + KK ++ + P A L++R+I DP R T +E DP+F
Sbjct: 213 -----IPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFN 263
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 9e-41
Identities = 74/327 (22%), Positives = 121/327 (37%), Gaps = 62/327 (18%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRLL 79
Y++ ++GKG +G V A +VAIK I + +SD++ EV LL +
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 80 R----HPDIVEIKRIMLPPSKREFKDIYVVFELMES--DLHQVIKANDDLTREHHQFFLY 133
HP ++ + +V E DL I L + F
Sbjct: 92 GAGGGHPGVIRLLDWFETQEG-----FMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFG 146
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
Q++ A+++ H+ V HRD+K +NIL + K+ DFG + D P T F T
Sbjct: 147 QVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL-LHDEPYTDF----DGT 201
Query: 193 RWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
R Y PE +Y +WS+G + +++ G F +
Sbjct: 202 RVYSPPEWIS--RHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-------------- 245
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
+ + P +V P L++R +A P RP+ EE L
Sbjct: 246 ------------------LEAELHFP-----AHVSPDCCALIRRCLAPKPSSRPSLEEIL 282
Query: 312 ADPYFK-GLAKIEREPSCQPISKLEFE 337
DP+ + + PS + L +
Sbjct: 283 LDPWMQTPAEDVPLNPSKGGPAPLAWS 309
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-40
Identities = 67/309 (21%), Positives = 120/309 (38%), Gaps = 58/309 (18%)
Query: 23 NRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
N Y + + +G+G + VV I TG++ A K + IL E+ +L L +
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 82 -PDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVI--KANDDLTREHHQFFLYQ 134
P ++ + + +++ I ++ E ++ + + + ++ + Q
Sbjct: 88 CPRVINLHEV--------YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQ 139
Query: 135 MLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
+L + Y+H N+ H DLKP+NIL +K+ DFG++R + +
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREI----MG 195
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT-- 249
T Y APE+ + T A D+W+IG I +LT F G+ I
Sbjct: 196 TPEYLAPEILN--YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI--SQVNVD 251
Query: 250 -PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
F +V LA +Q L+ +P+ RPTAE
Sbjct: 252 YSEET----------------------------FSSVSQLATDFIQSLLVKNPEKRPTAE 283
Query: 309 EALADPYFK 317
L+ + +
Sbjct: 284 ICLSHSWLQ 292
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-40
Identities = 66/331 (19%), Positives = 123/331 (37%), Gaps = 58/331 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HP 82
R ++ V+ +G + V A D +G + A+K++ + I++EV ++ L HP
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRL--LSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME---SDLHQVI---KANDDLTREHHQFFLYQML 136
+IV+ + L E L + + ++ L+ + YQ
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 137 RALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA--- 191
RA+++MH + HRDLK +N+L + +K+CDFG A +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE 206
Query: 192 ------TRWYRAPELCGSFFSK--YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243
T YR PE+ +S DIW++GCI + + F + +
Sbjct: 207 EITRNTTPMYRTPEII-DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL------ 259
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303
+V KY PP + L++ ++ +P++
Sbjct: 260 ------------RIVN----GKY-----SIPP------HDTQYTVFHSLIRAMLQVNPEE 292
Query: 304 RPTAEEALADPYFKGLAKIEREPSCQPISKL 334
R + E + + +A PI++L
Sbjct: 293 RLSIAEVVHQL--QEIAAARNVNPKSPITEL 321
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 4e-40
Identities = 60/305 (19%), Positives = 110/305 (36%), Gaps = 61/305 (20%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI------HDVFEHISDAIRILREVKLLR 77
+Y + +G G++G V A+D ++V +K I D + ++ E+ +L
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES--DLHQVIKANDDLTREHHQFFLYQM 135
+ H +I+++ I +V E S DL I + L + Q+
Sbjct: 85 RVEHANIIKVLDIFENQGF-----FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
+ A+ Y+ ++ HRD+K +NI+ + +K+ DFG A F T Y
Sbjct: 140 VSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF----CGTIEY 195
Query: 196 RAPELCGSFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
APE+ Y P +++WS+G ++ + F
Sbjct: 196 CAPEV----LMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------------------- 232
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ PP V + L+ L+ P+ R T E+ +
Sbjct: 233 -----LEETVEAAI------HPP-------YLVSKELMSLVSGLLQPVPERRTTLEKLVT 274
Query: 313 DPYFK 317
DP+
Sbjct: 275 DPWVT 279
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-40
Identities = 85/362 (23%), Positives = 136/362 (37%), Gaps = 55/362 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
RY ++ IG G++GV D T E VA+K I D + RE+ R LRHP+
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDE-NVQREIINHRSLRHPN 77
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
IV K ++L P+ + ++ E +L++ I + + +FF Q+L + Y
Sbjct: 78 IVRFKEVILTPTH-----LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 143 HTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
H+ + HRDLK +N L + +LK+CDFG ++ + + V T Y APE+
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VGTPAYIAPEV 188
Query: 201 CGSFFS--KYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
+Y D+WS G +L G F
Sbjct: 189 ----LLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY----------------- 227
Query: 258 VRNEKARKYLTE-MRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
RK + + K +P + P L+ R+ DP R + E +F
Sbjct: 228 ------RKTIQRILSVKYSIP---DDIRISPECCHLISRIFVADPATRISIPEIKTHSWF 278
Query: 317 -KGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKDYINGTEGTN 375
K L S E E + + D I ++I P + ++ N
Sbjct: 279 LKNLPADLMNESNTGSQFQEPEQPMQSL--DTIMQIISEAT---IPAVRNRCLDDFMTDN 333
Query: 376 FL 377
Sbjct: 334 LD 335
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-40
Identities = 69/305 (22%), Positives = 117/305 (38%), Gaps = 59/305 (19%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRLL 79
+Y++ ++G G +G V + I VAIK + + + + R+ EV LL+ +
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 80 RH--PDIVEIKRIMLPPSKREFKDIYVVFELMES--DLHQVIKANDDLTREHHQFFLYQM 135
++ + P ++ E E DL I L E + F +Q+
Sbjct: 104 SSGFSGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFWQV 158
Query: 136 LRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
L A+++ H V HRD+K +NIL + N +LK+ DFG + DT T F TR
Sbjct: 159 LEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL-LKDTVYTDF----DGTRV 213
Query: 195 YRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y PE + +Y + +WS+G + +++ G F +
Sbjct: 214 YSPPEWIR--YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------------- 255
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+R + V L++ +A P DRPT EE
Sbjct: 256 ----------------IRGQVFFR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294
Query: 314 PYFKG 318
P+ +
Sbjct: 295 PWMQD 299
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 9e-40
Identities = 75/315 (23%), Positives = 132/315 (41%), Gaps = 54/315 (17%)
Query: 23 NRYKI--LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ Y + E++G G +G V +T TG K+A K I + D + E+ ++ L
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLD 144
Query: 81 HPDIVEIKRIMLPPSKREF---KDIYVVFELME-SDLH-QVIKANDDLTREHHQFFLYQM 135
H +++++ F DI +V E ++ +L ++I + +LT F+ Q+
Sbjct: 145 HANLIQLYDA--------FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196
Query: 136 LRALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+++MH + H DLKP+NIL ++K+ DFGLAR + V T
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN----FGTP 252
Query: 194 WYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
+ APE + F + D+WS+G I +L+G F G D
Sbjct: 253 EFLAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSPFLGD---------ND------A 294
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
ET+ + R L + ++F ++ A + +L+ + R +A EAL
Sbjct: 295 ETLNNIL--ACRWDLED----------EEFQDISEEAKEFISKLLIKEKSWRISASEALK 342
Query: 313 DPYFKGLAKIEREPS 327
P+ R +
Sbjct: 343 HPWLSDHKLHSRLSA 357
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-39
Identities = 89/347 (25%), Positives = 143/347 (41%), Gaps = 63/347 (18%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D ++ EV+G+G++GVVC A + VAIK+I E A E++ L +
Sbjct: 6 DYKEIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQIES--ESERKAFI--VELRQLSRVN 59
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI---KANDDLTREHHQFFLYQML 136
HP+IV++ L P + +V E E L+ V+ + T H + Q
Sbjct: 60 HPNIVKLYGACLNP-------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 137 RALKYMHTAN---VYHRDLKPKNILANANCK-LKVCDFGLARVAFSDTPMTVFWTDYVAT 192
+ + Y+H+ + HRDLKP N+L A LK+CDFG A T M T+ +
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHM----TNNKGS 166
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
+ APE+ S Y+ D++S G I EV+T + F +G P+
Sbjct: 167 AAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDE-------------IGGPAF 211
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ V N +PP+ N+ L+ R + DP RP+ EE +
Sbjct: 212 RIMWAVHN----------GTRPPLI-----KNLPKPIESLMTRCWSKDPSQRPSMEEIV- 255
Query: 313 DPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEY 359
K + + R L++ + +D R Y + E+
Sbjct: 256 ----KIMTHLMRYFPGADE-PLQYPCQHSLPPGEDGRVEPYVDFAEF 297
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-39
Identities = 68/298 (22%), Positives = 109/298 (36%), Gaps = 54/298 (18%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-----REVKLLRLLR 80
+ + IGKG +G+V VAIK + + REV ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVI-KANDDLTREHHQFFLYQMLRA 138
HP+IV++ +M P +V E + DL+ + + + +
Sbjct: 82 HPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 139 LKYMHTAN--VYHRDLKPKNIL-----ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
++YM N + HRDL+ NI NA KV DFGL++ + +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-SVHSVSGLLGN---- 189
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
+W APE G+ YT D +S I +LTG+ F S
Sbjct: 190 FQW-MAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK------------- 235
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
+ I ++R E R P +P + P +++ + DPK RP
Sbjct: 236 IKFINMIREEGLR---------PTIP-----EDCPPRLRNVIELCWSGDPKKRPHFSY 279
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-37
Identities = 60/287 (20%), Positives = 107/287 (37%), Gaps = 38/287 (13%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+ + IG GS+G V G+ VA+K ++ EV +LR RH +I+
Sbjct: 27 TVGQRIGSGSFGTVYKG--KWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-LTREHHQFFLYQMLRALKYMH 143
P + +V + E S L+ + A++ + Q R + Y+H
Sbjct: 84 LFMGYSTAP------QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCG 202
++ HRDLK NI + + +K+ DFGLA S + + + + APE +
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE-KSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+ Y+ D+++ G + E++TG+ + + I +V
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI--------------NNRDQIIEMV---- 238
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
R L V N RL+ + +RP+
Sbjct: 239 GRGSL--SPDLSKVR-----SNCPKRMKRLMAECLKKKRDERPSFPR 278
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-37
Identities = 75/297 (25%), Positives = 126/297 (42%), Gaps = 45/297 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
Y + + +G G++G V TG KVA+K ++ + +I RE++ L+L RHP
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
I+++ +++ P DI++V E + +L I N L + + Q+L + Y
Sbjct: 77 HIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H V HRDLKP+N+L +A+ K+ DFGL+ + + + Y APE+
Sbjct: 132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS----CGSPNYAAPEVI 187
Query: 202 GSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
Y P +DIWS G I +L G F
Sbjct: 188 SG--RLYAGPEVDIWSSGVILYALLCGTLPFDDDH------------------------- 220
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ + KK +F ++P + LL+ ++ DP R T ++ +FK
Sbjct: 221 ------VPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 77/339 (22%), Positives = 134/339 (39%), Gaps = 33/339 (9%)
Query: 4 DQTKKELKDKDFFTEYG---DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
+Q +K L+ + + ++ + +G G+ GVV +G +A K IH +
Sbjct: 11 EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LE 69
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKA 119
+ +I+RE+++L P IV +I + E M+ L QV+K
Sbjct: 70 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-----EISICMEHMDGGSLDQVLKK 124
Query: 120 NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178
+ + +++ L Y+ + HRD+KP NIL N+ ++K+CDFG++
Sbjct: 125 AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-LI 183
Query: 179 DTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
D+ F V TR Y +PE L G + Y+ DIWS+G E+ G+ P
Sbjct: 184 DSMANSF----VGTRSYMSPERLQG---THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236
Query: 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLF---QKFPNVDPLALRLLQ 294
+ + + ET R M +PP+ +F N P L
Sbjct: 237 ELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGV 296
Query: 295 RLIAF----------DPKDRPTAEEALADPYFKGLAKIE 323
+ F +P +R ++ + + K E
Sbjct: 297 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEE 335
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-37
Identities = 66/314 (21%), Positives = 119/314 (37%), Gaps = 53/314 (16%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+I E+IGKG +G V GE VAI+ I ++ REV R RH ++V
Sbjct: 36 EIGELIGKGRFGQVYHG--RWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV 92
Query: 86 E-IKRIMLPPSKREFKDIYVVFELME-SDLHQVI-KANDDLTREHHQFFLYQMLRALKYM 142
+ M PP + ++ L + L+ V+ A L + ++++ + Y+
Sbjct: 93 LFMGACMSPP------HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR--APEL 200
H + H+DLK KN+ + N K+ + DFGL ++ + W APE+
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
Query: 201 -------CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
++ D++++G I+ E+ + F + P+
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ---------------PAEA 250
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
I + KP + + +L AF+ ++RPT + +
Sbjct: 251 IIWQMGT----------GMKPNLSQ----IGMGKEISDILLFCWAFEQEERPTFTKLMD- 295
Query: 314 PYFKGLAKIEREPS 327
+ L K R S
Sbjct: 296 -MLEKLPKRNRRLS 308
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-37
Identities = 67/287 (23%), Positives = 116/287 (40%), Gaps = 47/287 (16%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
I E IG GS+G V A G VA+K + + H LREV +++ LRHP+IV
Sbjct: 40 NIKEKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD---LTREHHQFFLYQMLRALKY 141
+ P + +V E + L++++ + L Y + + + Y
Sbjct: 98 LFMGAVTQPPN-----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNY 152
Query: 142 MHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+H N + HR+LK N+L + +KVCDFGL+R+ S + T + APE
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS---KSAAGTPEWMAPE 209
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ D++S G I E+ T + + ++ ++ AV
Sbjct: 210 VLRD--EPSNEKSDVYSFGVILWELATLQQPWGN---LNPAQVV-----------AAVGF 253
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
K+ +P N++P +++ +P RP+
Sbjct: 254 K----------CKRLEIP-----RNLNPQVAAIIEGCWTNEPWKRPS 285
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-37
Identities = 71/385 (18%), Positives = 133/385 (34%), Gaps = 53/385 (13%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVF 60
+ L + + + Y++L VIGKG V A TGE V +++I ++
Sbjct: 5 HHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI-NLE 63
Query: 61 EHISDAIR-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVI 117
++ + + E+ + +L HP+IV + + ++ ++VV M S +I
Sbjct: 64 ACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE-----LWVVTSFMAYGS-AKDLI 117
Query: 118 KA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
D + + L +L+AL Y+H HR +K +IL + + K+ +
Sbjct: 118 CTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177
Query: 176 AFSD----TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP-- 229
S + F V + +PE+ Y DI+S+G E+ G
Sbjct: 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 237
Query: 230 --------LF----------PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMR 271
L S + +L + + ++ +
Sbjct: 238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDS 297
Query: 272 KKPPV-----PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326
P P F F V+ + LQR +P RP+A L +FK + + E
Sbjct: 298 PSHPYHRTFSPHFHHF--VE----QCLQR----NPDARPSASTLLNHSFFKQIKRRASEA 347
Query: 327 SCQPISKLEFEFERRRVTKDDIREL 351
+ + + D +
Sbjct: 348 LPELLRPVTPITNFEGSQSQDHSGI 372
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 4e-37
Identities = 84/374 (22%), Positives = 141/374 (37%), Gaps = 91/374 (24%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
RY ++ +G G + V + D + VA+K + EH ++ E++LL+ +R+
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETAL--DEIRLLKSVRN 92
Query: 82 PDIVEIKRIMLPPSKREFKD-------IYVVFELMESDLHQVIKANDD--LTREHHQFFL 132
D + R M+ +FK I +VFE++ L + I ++ L + +
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII 152
Query: 133 YQMLRALKYMHT-ANVYHRDLKPKNILANAN----------------------------- 162
Q+L+ L Y+HT + H D+KP+NIL + N
Sbjct: 153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 163 --------------------CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
K+K+ D G A + T TR YR+ E+
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNAC--WVHKHFTEDIQ----TRQYRSLEVL- 265
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS------VVHQLDLITDLLGTPSPETIA 256
S Y DIWS C+ E+ TG LF S + LI +LLG + I
Sbjct: 266 -IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324
Query: 257 VVRNEKARKY------LTEMRKKPPVPLFQ------KFPNVD-PLALRLLQRLIAFDPKD 303
+ ++++ L + K P LF+ ++ + L ++ P+
Sbjct: 325 --AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEK 382
Query: 304 RPTAEEALADPYFK 317
R TA E L P+
Sbjct: 383 RATAAECLRHPWLN 396
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-37
Identities = 75/299 (25%), Positives = 120/299 (40%), Gaps = 60/299 (20%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIR-ILREVKLLRLLRHPD 83
+ E+IG G +G V A G++VA+K D E IS I + +E KL +L+HP+
Sbjct: 10 TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 84 IVEIKRI-MLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
I+ ++ + + P ++ +V E L++V+ + + + Q+ R + Y
Sbjct: 68 IIALRGVCLKEP------NLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNY 120
Query: 142 MHTANVY---HRDLKPKNIL--------ANANCKLKVCDFGLARVAFSDTPMTVFWTDYV 190
+H + HRDLK NIL +N LK+ DFGLAR T M+
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGA--- 177
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
W APE+ + S ++ D+WS G + E+LTG+ F G
Sbjct: 178 -YAW-MAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGID--------------- 218
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
V K P+P +L++ DP RP+
Sbjct: 219 GLAVAYGVAMNKLA---------LPIP-----STCPEPFAKLMEDCWNPDPHSRPSFTN 263
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-37
Identities = 66/332 (19%), Positives = 114/332 (34%), Gaps = 51/332 (15%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
EV+GKG +G TGE + +K++ E L+EVK++R L HP+++
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTF--LKEVKVMRCLEHPNVL 70
Query: 86 E-IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYM 142
+ I + + + E ++ L +IK+ D F + + Y+
Sbjct: 71 KFIGVLYKDK------RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ N+ HRDL N L N + V DFGLAR+ + + + G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 203 SF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
+ Y +D++S G + E++ P P
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD--------------YLPRTM 230
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA- 312
+ P PN P + R DP+ RP+ +
Sbjct: 231 DFGLNVRGFLD---------RYCP-----PNCPPSFFPITVRCCDLDPEKRPSFVKLEHW 276
Query: 313 -DPYFKGLAK-IEREPSCQPISKLEFEFERRR 342
+ LA + P + + + +E RR
Sbjct: 277 LETLRMHLAGHLPLGPQLEQLDRGFWETYRRG 308
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 48/289 (16%), Positives = 93/289 (32%), Gaps = 52/289 (17%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
L + + G + G + +K + + E LR+ HP+++
Sbjct: 13 NFLTKLNENHSGELWKG--RWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 86 EIKRIML-PPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRALKY 141
+ PP+ ++ M L+ V+ + + Q F M R + +
Sbjct: 71 PVLGACQSPPAPH----PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 142 MHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM-TVFWTDYVATRWYRAP 198
+HT + L ++++ + + ++ + S M W AP
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWV---------AP 177
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
E L + D+WS + E++T + F S + E
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS---------------NMEIGMK 222
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT 306
V E R P +P P + P +L++ + DP RP
Sbjct: 223 VALEGLR---------PTIP-----PGISPHVSKLMKICMNEDPAKRPK 257
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-36
Identities = 82/303 (27%), Positives = 132/303 (43%), Gaps = 54/303 (17%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLR 80
RYKI++ +G G V A DT KVAIK I + + R REV L
Sbjct: 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 81 HPDIVEIKRIMLPPSKREFKDI-------YVVFELME-SDLHQVIKANDDLTREHHQFFL 132
H +IV + D+ Y+V E +E L + I+++ L+ + F
Sbjct: 70 HQNIVSMI------------DVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFT 117
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV-A 191
Q+L +K+ H + HRD+KP+NIL ++N LK+ DFG+A+ A S+T +T T++V
Sbjct: 118 NQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQ--TNHVLG 174
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T Y +PE DI+SIG + E+L G+P F G++
Sbjct: 175 TVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGET---------------- 216
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEEA 310
+++ A K++ + P ++ ++ R D +R T +E
Sbjct: 217 --AVSI-----AIKHIQD---SVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEM 266
Query: 311 LAD 313
D
Sbjct: 267 KDD 269
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 85/383 (22%), Positives = 140/383 (36%), Gaps = 88/383 (22%)
Query: 1 MQQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI---H 57
M D + L + D A ++++E++G G+YG V TG+ AIK +
Sbjct: 2 MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG 61
Query: 58 DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD-IYVVFELME----SD 112
D E I I +L++ H +I + + D +++V E +D
Sbjct: 62 DEEEEIKQEINMLKKYS-----HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD 116
Query: 113 LHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172
L + K N L E + ++LR L ++H V HRD+K +N+L N ++K+ DFG+
Sbjct: 117 LIKNTKGN-TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175
Query: 173 A---------RVAFSDTPMTVFWTDYVATRWYRAPE--LCGSFF-SKYTPAIDIWSIGCI 220
+ R F TP +W APE C + Y D+WS+G I
Sbjct: 176 SAQLDRTVGRRNTFIGTP---YWM---------APEVIACDENPDATYDFKSDLWSLG-I 222
Query: 221 FA-EVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPV--- 276
A E+ G P + L LI R P
Sbjct: 223 TAIEMAEGAPPLCDMHPMRALFLIP--------------------------RNPAPRLKS 256
Query: 277 ----PLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPIS 332
FQ F ++ L + + RP E+ + P+ + Q
Sbjct: 257 KKWSKKFQSF--IE----SCLVK----NHSQRPATEQLMKHPFIRDQPNER-----QVRI 301
Query: 333 KLEFEFERRRVTKDDIRELIYRE 355
+L+ +R + + + E Y
Sbjct: 302 QLKDHIDRTKKKRGEKDETEYEY 324
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-36
Identities = 66/313 (21%), Positives = 113/313 (36%), Gaps = 47/313 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVK-LLRL 78
+ N + L +G G+ G V TG +A+K++ + RIL ++ +L+
Sbjct: 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR--RSGNKEENKRILMDLDVVLKS 80
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTRE-HHQFFLYQMLR 137
P IV+ + + D+++ ELM + ++ K E +++
Sbjct: 81 HDCPYIVQCFGTFITNT-----DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135
Query: 138 ALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL Y+ V HRD+KP NIL + ++K+CDFG++ Y
Sbjct: 136 ALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD----DKAKDRSAGCAAYM 191
Query: 197 APE---LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPSP 252
APE Y D+WS+G E+ TG+ P K+ L + P
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ---EEPP 248
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ + FQ F L + D + RP + L
Sbjct: 249 ------LLPGHMGFSGD---------FQSFVK------DCLTK----DHRKRPKYNKLLE 283
Query: 313 DPYFKGLAKIERE 325
+ K +E +
Sbjct: 284 HSFIKRYETLEVD 296
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 85/375 (22%), Positives = 144/375 (38%), Gaps = 70/375 (18%)
Query: 1 MQQDQTKKELKDKDFFTEYGDAN---RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH 57
M LKD D + + + L IG GS+G V A D E VAIKK+
Sbjct: 29 MPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMS 88
Query: 58 DVFEHISDAIR-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQV 116
+ ++ + I++EV+ L+ LRHP+ ++ + L ++V E +
Sbjct: 89 YSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDL 143
Query: 117 IKANDDLTREHH-QFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-- 173
++ + +E + L+ L Y+H+ N+ HRD+K NIL + +K+ DFG A
Sbjct: 144 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 203
Query: 174 ---RVAFSDTPMTVFWTDYVATRWYRAPEL-CGSFFSKYTPAIDIWSIGCIFA-EVLTGK 228
+F TP +W APE+ +Y +D+WS+G I E+ K
Sbjct: 204 MAPANSFVGTP---YWM---------APEVILAMDEGQYDGKVDVWSLG-ITCIELAERK 250
Query: 229 -PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP 287
PLF N A L + + P Q +
Sbjct: 251 PPLF----------------------------NMNAMSALYHIAQNES-PALQS-GHWSE 280
Query: 288 LALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDD 347
+ + P+DRPT+E L + +P + + +R + +
Sbjct: 281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVL---------RERPPTVIMDLIQRTKDAVRE 331
Query: 348 IRELIYREILEYHPQ 362
+ L YR++ + Q
Sbjct: 332 LDNLQYRKMKKILFQ 346
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 72/299 (24%), Positives = 118/299 (39%), Gaps = 52/299 (17%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLRHP 82
Y++ ++G+G G V A DT VA+K + + R+ RE + L+ P
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 83 DIV------EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQM 135
+V EI + YV L+ DL +++ L + Q+
Sbjct: 95 HVVPIHDFGEIDGQL-----------YVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQI 143
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
AL H A HRD+KP+NIL +A+ + DFG+A A +D +T V T +Y
Sbjct: 144 GSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGN-TVGTLYY 201
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
APE S T DI+++ C+ E LTG P + G + +
Sbjct: 202 MAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQG-------------------DQL 240
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-PTAEEALAD 313
+V ++ + P + ++ R +A +P+DR T + A
Sbjct: 241 SV-----MGAHINQ----AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAA 290
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-35
Identities = 70/311 (22%), Positives = 128/311 (41%), Gaps = 46/311 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLL 79
A+ + + +G+G+YGVV +G+ +A+K+I + R+L ++ +R +
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS-QEQKRLLMDLDISMRTV 63
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELM----ESDLHQVIKANDDLTREHHQFFLYQM 135
P V + D+++ ELM + QVI + + +
Sbjct: 64 DCPFTVTFYGALFREG-----DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 136 LRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
++AL+++H+ +V HRD+KP N+L NA ++K+CDFG++ D + +
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID----AGCKP 174
Query: 195 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
Y APE Y+ DIWS+G E+ + FP S + ++ PSP
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPSP 232
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+ L + F F + + L++ + K+RPT E +
Sbjct: 233 Q-------------LPADKFSAE---FVDFTS------QCLKK----NSKERPTYPELMQ 266
Query: 313 DPYFKGLAKIE 323
P+F
Sbjct: 267 HPFFTLHESKG 277
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 80/320 (25%), Positives = 121/320 (37%), Gaps = 39/320 (12%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
++++ IGKG YG V GEKVA+K + R E+ L+RH +I+
Sbjct: 40 QMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFT--TEEASWFR-ETEIYQTVLMRHENIL 94
Query: 86 E-IKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMH 143
I + +Y++ + E+ L+ +K+ L + Y + L ++H
Sbjct: 95 GFIAADIKGTGSW--TQLYLITDYHENGSLYDYLKSTT-LDAKSMLKLAYSSVSGLCHLH 151
Query: 144 TANVY--------HRDLKPKNILANANCKLKVCDFGLARVAFSDT-PMTVFWTDYVATRW 194
T HRDLK KNIL N + D GLA SDT + + V T+
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 195 YRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
Y PE L S + + D++S G I EV G +QL + P
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG-GIVEEYQLPYHDLVPSDP 270
Query: 251 SPETI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
S E + +V +K R P P +L+ A +P R TA
Sbjct: 271 SYEDMREIVCIKKLR---------PSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
Query: 310 ALADPYFKGLAKIEREPSCQ 329
K LAK+ +
Sbjct: 322 VK-----KTLAKMSESQDIK 336
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-35
Identities = 80/329 (24%), Positives = 139/329 (42%), Gaps = 66/329 (20%)
Query: 1 MQQDQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV 59
+ +Q K L+ + GD IG+GS G+VC A + H+G +VA+K +
Sbjct: 25 VTHEQFKAALRM---VVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD-- 79
Query: 60 FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK 118
+ EV ++R +H ++VE+ + L + ++V+ E ++ L ++
Sbjct: 80 LRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE-----LWVLMEFLQGGALTDIVS 134
Query: 119 ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA----- 173
L E +L+AL Y+H V HRD+K +IL + ++K+ DFG
Sbjct: 135 QVR-LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 193
Query: 174 ----RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EVLTGK 228
R + TP +W APE+ S Y +DIWS+G I E++ G+
Sbjct: 194 DVPKRKSLVGTP---YWM---------APEVISR--SLYATEVDIWSLG-IMVIEMVDGE 238
Query: 229 PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPL 288
P + ++ + + +R PP P + V P+
Sbjct: 239 PPY---------------------------FSDSPVQAMKRLRDSPP-PKLKNSHKVSPV 270
Query: 289 ALRLLQRLIAFDPKDRPTAEEALADPYFK 317
L+R++ DP++R TA+E L P+
Sbjct: 271 LRDFLERMLVRDPQERATAQELLDHPFLL 299
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 73/307 (23%), Positives = 122/307 (39%), Gaps = 46/307 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLL 79
A K L IG+G+YG V + +G+ +A+K+I + ++L ++ ++R
Sbjct: 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDLDVVMRSS 78
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELM----ESDLHQVIKANDDLTREHH-QFFLYQ 134
P IV+ + D ++ ELM + V DD+ E
Sbjct: 79 DCPYIVQFYGALFREG-----DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 135 MLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
++AL ++ + HRD+KP NIL + + +K+CDFG++ ++ T R
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD----SIAKTRDAGCR 189
Query: 194 WYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTP 250
Y APE + Y D+WS+G E+ TG+ P SV QL +
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK---GD 246
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
P+ + N + R++ F F N L + D RP +E
Sbjct: 247 PPQ----LSNSEEREFSPS---------FINFVN------LCLTK----DESKRPKYKEL 283
Query: 311 LADPYFK 317
L P+
Sbjct: 284 LKHPFIL 290
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-35
Identities = 77/326 (23%), Positives = 133/326 (40%), Gaps = 66/326 (20%)
Query: 4 DQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH 62
++ ++L+ GD +Y E IG+G+ G V A+D TG++VAI++++ +
Sbjct: 3 EEILEKLRS---IVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQ 57
Query: 63 ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND 121
I+ E+ ++R ++P+IV L + ++VV E + L V+
Sbjct: 58 QPKKELIINEILVMRENKNPNIVNYLDSYLVGDE-----LWVVMEYLAGGSLTDVVTETC 112
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-------- 173
+ + L+AL+++H+ V HRD+K NIL + +K+ DFG
Sbjct: 113 -MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171
Query: 174 -RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EVLTGKPLF 231
R TP +W APE+ Y P +DIWS+G I A E++ G+P +
Sbjct: 172 KRSTMVGTP---YWM---------APEVVTR--KAYGPKVDIWSLG-IMAIEMIEGEPPY 216
Query: 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR 291
NE + L + P Q + +
Sbjct: 217 ---------------------------LNENPLRALYLIATNGT-PELQNPEKLSAIFRD 248
Query: 292 LLQRLIAFDPKDRPTAEEALADPYFK 317
L R + D + R +A+E L + K
Sbjct: 249 FLNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 37/277 (13%), Positives = 81/277 (29%), Gaps = 49/277 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKL 75
+ + ++G+G++ V A D +K +K + + + ++
Sbjct: 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP--ANPWEFYIGTQLMER 120
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIK-----ANDDLTREHHQ 129
L+ ++ L + +V EL L I + +
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNG-----SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNIL-----------ANANCKLKVCDFGLARVAFS 178
F +ML ++ +H + H D+KP N + + + L + D G +
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 179 DTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237
T+F T ++ E L + ID + + +L G +
Sbjct: 236 FPKGTIFTAK-CETSGFQCVEMLSN---KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291
Query: 238 HQL---------------DLITDLLGTPSPETIAVVR 259
+ +L P + +
Sbjct: 292 ECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLD 328
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 79/304 (25%), Positives = 129/304 (42%), Gaps = 51/304 (16%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-RILREVKLLRLLR 80
++RY++ E++G G V A D VA+K + R RE + L
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 81 HPDIVEI--------KRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFF 131
HP IV + LP Y+V E ++ L ++ +T +
Sbjct: 71 HPAIVAVYDTGEAETPAGPLP---------YIVMEYVDGVTLRDIVHTEGPMTPKRAIEV 121
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYV- 190
+ +AL + H + HRD+KP NI+ +A +KV DFG+AR A +D+ +V T V
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVTQTAAVI 180
Query: 191 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
T Y +PE D++S+GC+ EVLTG+P F G S
Sbjct: 181 GTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------------- 223
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEE 309
++V A +++ E P+P + + ++ + +A +P++R TA E
Sbjct: 224 ---PVSV-----AYQHVRE----DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271
Query: 310 ALAD 313
AD
Sbjct: 272 MRAD 275
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-34
Identities = 76/308 (24%), Positives = 132/308 (42%), Gaps = 39/308 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + Y++ EVIG G+ VV AA EKVAIK+I ++ + + +L+E++ +
Sbjct: 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCH 71
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDD-----LTREHHQFF 131
HP+IV + + +++V +L+ D+ + I A + L
Sbjct: 72 HPNIVSYYTSFVVKDE-----LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 132 LYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDY 189
L ++L L+Y+H HRD+K NIL + +++ DFG++ D +
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
V T + APE+ Y DIWS G E+ TG + + ++ L
Sbjct: 187 VGTPCWMAPEVMEQ-VRGYDFKADIWSFGITAIELATGAAPY---HKYPPMKVLMLTLQN 242
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
P V++++ K F+K ++L L + DP+ RPTA E
Sbjct: 243 DPPSLETGVQDKEMLKKYG--------KSFRKM-----ISLCLQK-----DPEKRPTAAE 284
Query: 310 ALADPYFK 317
L +F+
Sbjct: 285 LLRHKFFQ 292
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 73/324 (22%), Positives = 119/324 (36%), Gaps = 47/324 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+ E IGKG +G V GE+VA+K R E+ +LRH +I+
Sbjct: 45 VLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS--REERSWFR-EAEIYQTVMLRHENIL 99
Query: 86 -----EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
+ K +++V + E L + +T E L
Sbjct: 100 GFIAADNKDNGTWT------QLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGL 152
Query: 140 KYMHTA--------NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW-TDYV 190
++H + HRDLK KNIL N + D GLA S T V
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 191 ATRWYRAPE-LCGSFFSKYTPA---IDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
T+ Y APE L S K+ + DI+++G +F E+ + G +QL +
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLV 271
Query: 247 LGTPSPETI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305
PS E + VV +K R P +P + + ++++ + R
Sbjct: 272 PSDPSVEEMRKVVCEQKLR---------PNIPNRWQSCEALRVMAKIMRECWYANGAARL 322
Query: 306 TAEEALADPYFKGLAKIEREPSCQ 329
TA K L+++ ++ +
Sbjct: 323 TALRIK-----KTLSQLSQQEGIK 341
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-34
Identities = 86/342 (25%), Positives = 130/342 (38%), Gaps = 84/342 (24%)
Query: 1 MQQDQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV 59
M + L D + LE IGKGS+G V ID T + VAIK I D+
Sbjct: 1 MAHSPVQSGLPGMQNLKA--DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII-DL 57
Query: 60 FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQ 115
E + I +E+ +L P + + L +K ++++ E + DL +
Sbjct: 58 EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK-----LWIIMEYLGGGSALDLLE 112
Query: 116 VIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-- 173
L L ++L+ L Y+H+ HRD+K N+L + + ++K+ DFG+A
Sbjct: 113 ----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQ 168
Query: 174 -------RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EVL 225
R F TP FW APE+ S Y DIWS+G I A E+
Sbjct: 169 LTDTQIKRNTFVGTP---FWM---------APEVIKQ--SAYDSKADIWSLG-ITAIELA 213
Query: 226 TGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPV------PLF 279
G+P + L LI + PP
Sbjct: 214 RGEPPHSELHPMKVLFLIP--------------------------KNNPPTLEGNYSKPL 247
Query: 280 QKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
++F V+ L + +P RPTA+E L + AK
Sbjct: 248 KEF--VE----ACLNK----EPSFRPTAKELLKHKFILRNAK 279
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-34
Identities = 81/331 (24%), Positives = 134/331 (40%), Gaps = 69/331 (20%)
Query: 2 QQDQTKKELKDKDFFTEYGD-ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF 60
++ +++LK D + + +LE +G+GSYG V AI TG+ VAIK++ V
Sbjct: 7 LRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVE 65
Query: 61 EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQV 116
+ + I++E+ +++ P +V+ + +++V E SD+ ++
Sbjct: 66 SDLQE---IIKEISIMQQCDSPHVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRL 117
Query: 117 IKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA--- 173
N LT + L L+ L+Y+H HRD+K NIL N K+ DFG+A
Sbjct: 118 R--NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL 175
Query: 174 ------RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFA-EVLT 226
R TP FW APE+ Y DIWS+G I A E+
Sbjct: 176 TDTMAKRNTVIGTP---FWM---------APEVIQE--IGYNCVADIWSLG-ITAIEMAE 220
Query: 227 GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVD 286
GKP P + + + + PP P F+K
Sbjct: 221 GKP--P-------------------------YADIHPMRAIFMIPTNPP-PTFRKPELWS 252
Query: 287 PLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+++ + P+ R TA + L P+ +
Sbjct: 253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-33
Identities = 67/312 (21%), Positives = 113/312 (36%), Gaps = 59/312 (18%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
A +Y++ I G G + A+D + G V +K + + + E + L +
Sbjct: 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA-EAQAMAMAERQFLAEVV 137
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP IV+I + + Y+V E + L + L +L ++L AL
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPAL 195
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
Y+H+ + + DLKP+NI+ +LK+ D G + T ++APE
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGYL------YGTPGFQAPE 247
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ + T A DI+++G A + P G+ V P
Sbjct: 248 IVR---TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LP--------- 285
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEEALADPYFKG 318
P+ + + + L R + DP+ R TAEE A
Sbjct: 286 --------------EDDPVLKTYDSYGRLLRRAIDP----DPRQRFTTAEEMSAQ----- 322
Query: 319 LAKIEREPSCQP 330
L + RE Q
Sbjct: 323 LTGVLREVVAQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 71/318 (22%), Positives = 114/318 (35%), Gaps = 47/318 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
+LE +GKG YG V + GE VA+K R E+ +LRH +I+
Sbjct: 11 TLLECVGKGRYGEVWRG--SWQGENVAVKIFSS--RDEKSWFR-ETELYNTVMLRHENIL 65
Query: 86 -----EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
++ ++++ E L+ ++ L + + L
Sbjct: 66 GFIASDMTSRHSST------QLWLITHYHEMGSLYDYLQLTT-LDTVSCLRIVLSIASGL 118
Query: 140 KYMHTANVY--------HRDLKPKNILANANCKLKVCDFGLARV-AFSDTPMTVFWTDYV 190
++H HRDLK KNIL N + + D GLA + + S + V V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 191 ATRWYRAPE-LCGSFFS---KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
T+ Y APE L + +DIW+ G + EV G ++ +
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSN-GIVEDYKPPFYDVV 237
Query: 247 LGTPSPETI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP 305
PS E + VV ++ R P +P +L++ +P R
Sbjct: 238 PNDPSFEDMRKVVCVDQQR---------PNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288
Query: 306 TAEEALADPYFKGLAKIE 323
TA K L KI+
Sbjct: 289 TALRIK-----KTLTKID 301
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 68/335 (20%), Positives = 124/335 (37%), Gaps = 69/335 (20%)
Query: 7 KKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA 66
+K + + + ++I+ +G G++G V A + TG A K I + +
Sbjct: 3 RKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEEL 60
Query: 67 IRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME----SDLHQVIKANDD 122
+ E+++L HP IV++ K ++++ E + +++ +
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAI--MLELDRG 113
Query: 123 LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA--------- 173
LT Q QML AL ++H+ + HRDLK N+L +++ DFG++
Sbjct: 114 LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK---YTPAIDIWSIGCIFA-EVLTGK- 228
R +F TP +W APE+ K Y DIWS+G I E+ +
Sbjct: 174 RDSFIGTP---YWM---------APEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEP 220
Query: 229 PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPL 288
P + L ++ K P P
Sbjct: 221 PHH----------------------------ELNPMRVLLKIAKSDP-PTLLTPSKWSVE 251
Query: 289 ALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323
L+ + +P+ RP+A + L P+ + +
Sbjct: 252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 66/311 (21%), Positives = 127/311 (40%), Gaps = 63/311 (20%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHP 82
+K +++G+GS+ V A + T + AIK + + + + + RE ++ L HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHP 90
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELME-----SDLHQVIKANDDLTREHHQFFLYQ 134
V++ F+D +Y + + ++ ++ TR F+ +
Sbjct: 91 FFVKLYF--------TFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTR----FYTAE 138
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
++ AL+Y+H + HRDLKP+NIL N + +++ DFG A+V ++ + +V T
Sbjct: 139 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS-FVGTAQ 197
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
Y +PEL + D+W++GCI +++ G P F + I
Sbjct: 198 YVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI----------- 244
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT------AE 308
++ + P P A L+++L+ D R
Sbjct: 245 ---------------IKLEYDFP-----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 284
Query: 309 EALADPYFKGL 319
A P+F+ +
Sbjct: 285 PLKAHPFFESV 295
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 71/325 (21%), Positives = 120/325 (36%), Gaps = 49/325 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ ++LEV +G +G V A E VA+K + + EV L ++
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKA--QLLNEYVAVKIF---PIQDKQSWQNEYEVYSLPGMK 76
Query: 81 HPDIVE-IKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRA 138
H +I++ I S D++++ E L +KAN ++ M R
Sbjct: 77 HENILQFIGAEKRGTSVD--VDLWLITAFHEKGSLSDFLKANV-VSWNELCHIAETMARG 133
Query: 139 LKYMHTANVY----------HRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
L Y+H HRD+K KN+L N + DFGLA F
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK-FEAGKSAGDTHG 192
Query: 189 YVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245
V TR Y APE+ +F ID++++G + E+ + G + L +
Sbjct: 193 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252
Query: 246 LLGTPSPETI-AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP-LALRLLQRLIAF---- 299
+ PS E + VV ++K R P + + +L I
Sbjct: 253 IGQHPSLEDMQEVVVHKKKR---------PVLR-----DYWQKHAGMAMLCETIEECWDH 298
Query: 300 DPKDRPTAEEALADPYFKGLAKIER 324
D + R +A + + +++R
Sbjct: 299 DAEARLSAGCVG-----ERITQMQR 318
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 70/328 (21%), Positives = 135/328 (41%), Gaps = 63/328 (19%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE 61
+++ F +IL IGKGS+G VC T + A+K ++ +
Sbjct: 4 PVFDENEDVNFDHF----------EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNK--Q 51
Query: 62 HI--SDAIR-ILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DLH 114
+ +R + +E+++++ L HP +V + F+D +++V +L+ DL
Sbjct: 52 KCVERNEVRNVFKELQIMQGLEHPFLVNLWY--------SFQDEEDMFMVVDLLLGGDLR 103
Query: 115 QVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174
++ N E + F+ +++ AL Y+ + HRD+KP NIL + + + + DF +A
Sbjct: 104 YHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA 163
Query: 175 VAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
+ +T +T T+ Y APE + Y+ A+D WS+G E+L G+ +
Sbjct: 164 MLPRETQITTM----AGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP-NVDPLALRL 292
R+ + K + + V +P + L
Sbjct: 220 -------------------------RSSTSSKEIVHTFETTVV----TYPSAWSQEMVSL 250
Query: 293 LQRLIAFDPKDR-PTAEEALADPYFKGL 319
L++L+ +P R + PY +
Sbjct: 251 LKKLLEPNPDQRFSQLSDVQNFPYMNDI 278
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 9e-29
Identities = 78/343 (22%), Positives = 132/343 (38%), Gaps = 54/343 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D + K+LE+IG+G YG V + VA+K + + + L+
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKG--SLDERPVAVKVF---SFANRQNFINEKNIYRVPLME 65
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
H +I + + +V E + L + + + + + R L
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGL 124
Query: 140 KYMHTANVY---------HRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY- 189
Y+HT HRDL +N+L + + DFGL+ + + D
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 190 ----VATRWYRAPE-LCGSF----FSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVV-H 238
V T Y APE L G+ +D++++G I+ E+ LFPG+SV +
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 239 QLDLITDLLGTPSPET-IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLI 297
Q+ T++ P+ E +V EK R P P + + LA+R L+ I
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQR---------PKFP---EAWKENSLAVRSLKETI 292
Query: 298 ----AFDPKDRPTAEEALADPYFKGLAKI----EREPSCQPIS 332
D + R TA+ A + +A++ ER S P +
Sbjct: 293 EDCWDQDAEARLTAQXAE-----ERMAELMMIWERNKSVSPTA 330
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 68/301 (22%), Positives = 128/301 (42%), Gaps = 45/301 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAA----IDTHTGEKVAIKKI-HDVFEHISDAIRILREVKL 75
+ K L+ +GKG++G V + +TGE VA+KK+ H EH+ D RE+++
Sbjct: 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---FEREIEI 64
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLY 133
L+ L+H +IV+ K + +R ++ ++ E + L ++ + + + +
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT- 192
Q+ + ++Y+ T HRDL +NIL ++K+ DFGL +V D +
Sbjct: 122 QICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF------FKVKE 175
Query: 193 ------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
WY APE SK++ A D+WS G + E+ T + KS + + +
Sbjct: 176 PGESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMI 228
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRP 305
+ + + L + P P+ P + ++ + RP
Sbjct: 229 GNDKQGQ----MIVFHLIELLKNNGRLPR-------PDGCPDEIYMIMTECWNNNVNQRP 277
Query: 306 T 306
+
Sbjct: 278 S 278
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 69/301 (22%), Positives = 128/301 (42%), Gaps = 45/301 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAA----IDTHTGEKVAIKKI-HDVFEHISDAIRILREVKL 75
+ K L+ +GKG++G V + +TGE VA+KK+ H EH+ D RE+++
Sbjct: 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD---FEREIEI 95
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLY 133
L+ L+H +IV+ K + +R ++ ++ E + L ++ + + + +
Sbjct: 96 LKSLQHDNIVKYKGVCYSAGRR---NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 152
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT- 192
Q+ + ++Y+ T HRDL +NIL ++K+ DFGL +V D Y
Sbjct: 153 QICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY------YKVKE 206
Query: 193 ------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246
WY APE SK++ A D+WS G + E+ T + KS + + +
Sbjct: 207 PGESPIFWY-APE--SLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMI 259
Query: 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRP 305
+ + + L + P P+ P + ++ + RP
Sbjct: 260 GNDKQGQ----MIVFHLIELLKNNGRLPR-------PDGCPDEIYMIMTECWNNNVNQRP 308
Query: 306 T 306
+
Sbjct: 309 S 309
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 71/297 (23%), Positives = 128/297 (43%), Gaps = 47/297 (15%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLL 79
K + +G+G +G V +TGE+VA+K K HI+D + +E+++LR L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD---LKKEIEILRNL 80
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLR 137
H +IV+ K I ++ I ++ E + S L + + N + + + + Q+ +
Sbjct: 81 YHENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICK 137
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT----- 192
+ Y+ + HRDL +N+L + ++K+ DFGL + +D Y
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY------YTVKDDRDS 191
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
WY APE SK+ A D+WS G E+LT S + L ++G
Sbjct: 192 PVFWY-APE--CLMQSKFYIASDVWSFGVTLHELLTY-----CDSDSSPMALFLKMIGPT 243
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPT 306
+ + + L E ++ P P P + +L+++ F P +R +
Sbjct: 244 HGQ----MTVTRLVNTLKEGKRLPC-------PPNCPDEVYQLMRKCWEFQPSNRTS 289
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 71/332 (21%), Positives = 118/332 (35%), Gaps = 67/332 (20%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH---- 57
+ + L DF + +IG+G +G V TG+ A+K +
Sbjct: 178 KNVELNIHLTMNDF----------SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI 227
Query: 58 ---DVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DL 113
+ +L V P IV + P K + + +LM DL
Sbjct: 228 KMKQGETLALNERIMLSLVSTGD---CPFIVCMSYAFHTPDK-----LSFILDLMNGGDL 279
Query: 114 HQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173
H + + + +F+ +++ L++MH V +RDLKP NIL + + +++ D GLA
Sbjct: 280 HYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339
Query: 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
P V T Y APE+ Y + D +S+GC+ ++L G F
Sbjct: 340 CDFSKKKPHA-----SVGTHGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP-NVDPLALRL 292
K + + M V + P + P L
Sbjct: 394 -------------------------HKTKDKHEIDRMTLTMAV----ELPDSFSPELRSL 424
Query: 293 LQRLIAFDPKDR-----PTAEEALADPYFKGL 319
L+ L+ D R A+E P+F+ L
Sbjct: 425 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 62/234 (26%), Positives = 97/234 (41%), Gaps = 33/234 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D + ++ IG G +G+V + KVAIK I E + E +++ L
Sbjct: 6 DPSELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIR---EGAMSEEDFIEEAEVMMKLS 61
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRA 138
HP +V++ + L E I +V E ME L ++ E +
Sbjct: 62 HPKLVQLYGVCL-----EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 116
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
+ Y+ A V HRDL +N L N +KV DFG+ R D Y ++
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--------QYTSSTGTKFP 168
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W +PE FS+Y+ D+WS G + EV + GK + +S VV +
Sbjct: 169 VKWA-SPE--VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 219
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 55/235 (23%), Positives = 104/235 (44%), Gaps = 33/235 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + +G G YG V + VA+K + E + L+E +++ ++
Sbjct: 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIK 67
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLR 137
HP++V++ + ++ Y++ E M +L ++ + +++ + Q+
Sbjct: 68 HPNLVQLLGVC---TREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 122
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT----- 192
A++Y+ N HRDL +N L N +KV DFGL+R+ DT Y A
Sbjct: 123 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--------YTAHAGAKF 174
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 175 PIKWT-APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-26
Identities = 61/231 (26%), Positives = 104/231 (45%), Gaps = 31/231 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ K+L+ IGKG +G V + G KVA+K I + + A L E ++ LR
Sbjct: 19 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLR 72
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLR 137
H ++V++ +++ E +Y+V E M L +++ L + F +
Sbjct: 73 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVF---WTDYVATRW 194
A++Y+ N HRDL +N+L + + KV DFGL + A S WT
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT------- 181
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
APE K++ D+WS G + E+ + G+ +P VV +++
Sbjct: 182 --APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 53/234 (22%), Positives = 95/234 (40%), Gaps = 33/234 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+L+ +G G +GVV VA+K I E +E + + L
Sbjct: 6 KREEITLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIK---EGSMSEDEFFQEAQTMMKLS 61
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRA 138
HP +V+ + + IY+V E + + L ++++ L Y +
Sbjct: 62 HPKLVKFYGVCS-----KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG 116
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
+ ++ + HRDL +N L + + +KV DFG+ R D YV++
Sbjct: 117 MAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--------QYVSSVGTKFP 168
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE + KY+ D+W+ G + EV + GK + + VV ++
Sbjct: 169 VKWS-APE--VFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 51/233 (21%), Positives = 98/233 (42%), Gaps = 34/233 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
K ++V+G G++G V + GEK VAIK++ + IL E ++ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDN 76
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRAL 139
P + + I L + + ++ +LM L ++ + D + ++ + Q+ + +
Sbjct: 77 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------- 192
Y+ + HRDL +N+L +K+ DFGLA++ ++
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEGGKVPI 183
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W A E YT D+WS G E++T G + G + L+
Sbjct: 184 KWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 8e-26
Identities = 75/329 (22%), Positives = 125/329 (37%), Gaps = 59/329 (17%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFE 61
+ L +DF +IL+VIG+G++G V + + A+K ++
Sbjct: 64 SKVKQMRLHREDF----------EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML 113
Query: 62 HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DL-HQV 116
++ E +L I + F+D +Y+V + DL +
Sbjct: 114 KRAETACFREERDVLVNGDSKWITTLHY--------AFQDDNNLYLVMDYYVGGDLLTLL 165
Query: 117 IKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176
K D L E +F+L +M+ A+ +H + HRD+KP NIL + N +++ DFG
Sbjct: 166 SKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225
Query: 177 FSDTPMTVFWTDYVATRWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233
D + V T Y +PE+ +Y P D WS+G E+L G+ F
Sbjct: 226 MEDGTVQS-SV-AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283
Query: 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLL 293
+S+V I M K + +V A L+
Sbjct: 284 ESLVETYGKI--------------------------MNHKERFQFPTQVTDVSENAKDLI 317
Query: 294 QRLIAFDPKDR---PTAEEALADPYFKGL 319
+RLI + R E+ P+F G+
Sbjct: 318 RRLIC-SREHRLGQNGIEDFKKHPFFSGI 345
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 72/331 (21%), Positives = 120/331 (36%), Gaps = 61/331 (18%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFE 61
+ L+ DF +IL+VIG+G++ V TG+ A+K ++
Sbjct: 51 VRLKEVRLQRDDF----------EILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDML 100
Query: 62 HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELMES-DL-HQV 116
+ E +L I ++ F+D +Y+V E DL +
Sbjct: 101 KRGEVSCFREERDVLVNGDRRWITQLHF--------AFQDENYLYLVMEYYVGGDLLTLL 152
Query: 117 IKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176
K + + E +F+L +++ A+ +H HRD+KP NIL + +++ DFG
Sbjct: 153 SKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL 212
Query: 177 FSDTPMTVFWTDYVATRWYRAPEL-----CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231
+D + V T Y +PE+ G Y P D W++G E+ G+ F
Sbjct: 213 RADGTVRS-LV-AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270
Query: 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR 291
S I + K + L V A
Sbjct: 271 YADSTAETYGKI--------------------------VHYKEHLSLPLVDEGVPEEARD 304
Query: 292 LLQRLIAFDPKDR---PTAEEALADPYFKGL 319
+QRL+ P+ R A + P+F GL
Sbjct: 305 FIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 55/234 (23%), Positives = 95/234 (40%), Gaps = 34/234 (14%)
Query: 26 KILEVIGKGSYGVVCAAI---DTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
++LE +G GS+GVV + VA+K + DV +REV + L H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRAL 139
+++ + ++L P + +V EL L ++ + + Q+ +
Sbjct: 81 RNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------- 192
Y+ + HRDL +N+L +K+ DFGL R + YV
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH------YVMQEHRKVPF 188
Query: 193 RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
W APE S ++ A D W G E+ T G+ + G + ++H++D
Sbjct: 189 AWC-APE---SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-25
Identities = 56/249 (22%), Positives = 107/249 (42%), Gaps = 33/249 (13%)
Query: 8 KELKDKDFFTEYGDANRYKILE-VIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHIS 64
+E++ K+ + D + + +G G++G V VA+K + + +
Sbjct: 4 EEIRPKEVYL---DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPA 60
Query: 65 DAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDL 123
+L E +++ L +P IV + I S +V E+ E L++ ++ N +
Sbjct: 61 LKDELLAEANVMQQLDNPYIVRMIGICEAES------WMLVMEMAELGPLNKYLQQNRHV 114
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183
++ ++Q+ +KY+ +N HRDL +N+L K+ DFGL++ +D
Sbjct: 115 KDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--- 171
Query: 184 VFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235
Y A +WY APE + K++ D+WS G + E + G+ + G
Sbjct: 172 ---NYYKAQTHGKWPVKWY-APE--CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225
Query: 236 ---VVHQLD 241
V L+
Sbjct: 226 GSEVTAMLE 234
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 60/240 (25%), Positives = 100/240 (41%), Gaps = 40/240 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRI--LREVKL 75
R ++ IG+G +G V I VAIK SD++R L+E
Sbjct: 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK---NCTSDSVREKFLQEALT 69
Query: 76 LRLLRHPDIVEIKRIML-PPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFL 132
+R HP IV++ ++ P ++++ EL +L ++ L +
Sbjct: 70 MRQFDHPHIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
YQ+ AL Y+ + HRD+ +N+L ++N +K+ DFGL+R Y
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKA 174
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 175 SKGKLPIKWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 57/251 (22%), Positives = 105/251 (41%), Gaps = 33/251 (13%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKI-HDVFEHISDAIRILREVKLLRLLR 80
K + +GKG++G V +TG VA+K++ H + D RE+++L+ L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRD---FQREIQILKALH 82
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRA 138
IV+ + + P + + + +V E + S L ++ + L + Q+ +
Sbjct: 83 SDFIVKYRGVSYGPGR---QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
++Y+ + HRDL +NIL + +K+ DFGLA++ D YV
Sbjct: 140 MEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK------DYYVVREPGQSP 193
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITDLLGT 249
WY APE + ++ D+WS G + E+ T K P + + D
Sbjct: 194 IFWY-APE--SLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD--VP 248
Query: 250 PSPETIAVVRN 260
+ ++
Sbjct: 249 ALSRLLELLEE 259
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 67/238 (28%), Positives = 106/238 (44%), Gaps = 33/238 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRI--LREVKL 75
DA I +V+G G +G VC+ +K VAIK + ++ R L E +
Sbjct: 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK---VGYTEKQRRDFLGEASI 99
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLY 133
+ HP+I+ ++ ++ + K + +V E ME+ L ++ +D T L
Sbjct: 100 MGQFDHPNIIRLEGVVT-----KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT- 192
+ +KY+ HRDL +NIL N+N KV DFGL RV D Y
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----EAAYTTRG 209
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
RW +PE + K+T A D+WS G + EV++ G+ + S V+ +D
Sbjct: 210 GKIPIRWT-SPE--AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD 264
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 71/328 (21%), Positives = 122/328 (37%), Gaps = 61/328 (18%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFE 61
+K +D+ ++++VIG+G++G V T + A+K +
Sbjct: 59 NKIRDLRMKAEDY----------EVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI 108
Query: 62 HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELME-SDLHQVI 117
SD+ E ++ P +V++ F+D +Y+V E M DL ++
Sbjct: 109 KRSDSAFFWEERDIMAFANSPWVVQLFY--------AFQDDRYLYMVMEYMPGGDLVNLM 160
Query: 118 KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA-RVA 176
N D+ + +F+ +++ AL +H+ HRD+KP N+L + + LK+ DFG ++
Sbjct: 161 S-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219
Query: 177 FSDTPMTVFWTDYVATRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 234
T V T Y +PE Y D WS+G E+L G F
Sbjct: 220 KEGMVRC--DT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 276
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
S+V I M K + F ++ A L+
Sbjct: 277 SLVGTYSKI--------------------------MNHKNSLT-FPDDNDISKEAKNLIC 309
Query: 295 RLIAFDPKDR---PTAEEALADPYFKGL 319
+ D + R EE +FK
Sbjct: 310 AFLT-DREVRLGRNGVEEIKRHLFFKND 336
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 62/236 (26%), Positives = 102/236 (43%), Gaps = 29/236 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLR 77
+A+R I ++IG G G VC G+ VAIK + + L E ++
Sbjct: 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE-RQRRDFLSEASIMG 105
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQM 135
HP+I+ ++ ++ + +V E ME+ L ++ +D T L +
Sbjct: 106 QFDHPNIIRLEGVVT-----RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT--- 192
++Y+ HRDL +N+L ++N KV DFGL+RV D Y T
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----DAAYTTTGGK 215
Query: 193 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
RW APE F ++ A D+WS G + EVL G+ + + V+ ++
Sbjct: 216 IPIRWT-APE--AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-25
Identities = 67/344 (19%), Positives = 126/344 (36%), Gaps = 71/344 (20%)
Query: 7 KKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISD 65
+ + + F V+G+G +G V A TG+ A KK++ +
Sbjct: 179 AQPMGEDWF----------LDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG 228
Query: 66 AIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DL----HQVIKAN 120
+ E K+L + IV + + + +V +M D+ + V + N
Sbjct: 229 YQGAMVEKKILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 121 DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFS 178
F+ Q++ L+++H N+ +RDLKP+N+L + + +++ D GLA A
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343
Query: 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH 238
Y T + APEL +Y ++D +++G E++ + F
Sbjct: 344 TKTKG-----YAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRA----- 391
Query: 239 QLDLITDLLGTPSPETIAVVRNEKA-RKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRL 296
R EK K L + + V +P P + + L
Sbjct: 392 --------------------RGEKVENKELKQRVLEQAV----TYPDKFSPASKDFCEAL 427
Query: 297 IAFDPKDR-----PTAEEALADPYFKGL--AKIER---EPSCQP 330
+ DP+ R + + P F+ + ++E P P
Sbjct: 428 LQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVP 471
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 51/238 (21%), Positives = 91/238 (38%), Gaps = 34/238 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLL 76
+ L+V+G G +G V + GE V IK I D + + +
Sbjct: 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAI 69
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQ 134
L H IV + + S + +V + + L ++ + L + + Q
Sbjct: 70 GSLDHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-- 192
+ + + Y+ + HR+L +N+L + +++V DFG+A + D +
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-------DKQLLYSE 176
Query: 193 -----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W A E F KYT D+WS G E++T G + G V L+
Sbjct: 177 AKTPIKWM-ALE--SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 54/235 (22%), Positives = 95/235 (40%), Gaps = 35/235 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE-KVAIKKIHDVFEHISDAIRILREVKLLRLL 79
D L+ +G G +GVV G+ VAIK I E + E K++ L
Sbjct: 22 DPKDLTFLKELGTGQFGVVKYG--KWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNL 76
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLR 137
H +V++ + + + I+++ E M + L ++ + +
Sbjct: 77 SHEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT----- 192
A++Y+ + HRDL +N L N +KV DFGL+R D +Y ++
Sbjct: 132 AMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD--------EYTSSVGSKF 183
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
RW PE +SK++ DIW+ G + E+ + GK + + +
Sbjct: 184 PVRWS-PPE--VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 235
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-25
Identities = 54/235 (22%), Positives = 102/235 (43%), Gaps = 33/235 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + +G G YG V + VA+K + E + L+E +++ ++
Sbjct: 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIK 274
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQMLR 137
HP++V++ + Y++ E M +L ++ + +++ + Q+
Sbjct: 275 HPNLVQLLGVCT-----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 329
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT----- 192
A++Y+ N HR+L +N L N +KV DFGL+R+ DT Y A
Sbjct: 330 AMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--------YTAHAGAKF 381
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE ++K++ D+W+ G + E+ T G +PG V L+
Sbjct: 382 PIKWT-APE--SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-25
Identities = 73/307 (23%), Positives = 121/307 (39%), Gaps = 53/307 (17%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
++ V+GKG +G VCA TG+ A KK+ + L E ++L +
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DL--HQVIKANDDLTREHHQFFLYQMLRALK 140
+V + + +V LM DL H F+ ++ L+
Sbjct: 246 VVSLAYAYETKDA-----LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLAR-VAFSDTPMTVFWTDYVATRWYRAPE 199
+H + +RDLKP+NIL + + +++ D GLA V T V T Y APE
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG-----RVGTVGYMAPE 355
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ + +YT + D W++GC+ E++ G+ F R
Sbjct: 356 VVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQ-------------------------R 388
Query: 260 NEKA-RKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDR-----PTAEEALA 312
+K R+ + + K+ P ++ P A L +L+ DP +R +A E
Sbjct: 389 KKKIKREEVERLVKEVPE----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444
Query: 313 DPYFKGL 319
P FK L
Sbjct: 445 HPLFKKL 451
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 21/225 (9%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRHPD 83
+ E IG+G++G V + VA+K E + ++ L+E ++L+ HP+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCR---ETLPPDLKAKFLQEARILKQYSHPN 173
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQMLRALKY 141
IV + + ++++ IY+V EL++ D ++ L + + ++Y
Sbjct: 174 IVRLIGVC---TQKQ--PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+ + HRDL +N L LK+ DFG++R V +W APE
Sbjct: 229 LESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT-APE-- 285
Query: 202 GSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+ + +Y+ D+WS G + E + G +P S ++
Sbjct: 286 -ALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE 329
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 54/240 (22%), Positives = 101/240 (42%), Gaps = 40/240 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRI--LREVKL 75
+ ++G+G +G V + T+ VA+K + + + + E +
Sbjct: 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCK---KDCTLDNKEKFMSEAVI 66
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLY 133
++ L HP IV++ I+ +++ EL +L ++ N + L +
Sbjct: 67 MKNLDHPHIVKLIGIIEEEP------TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT- 192
Q+ +A+ Y+ + N HRD+ +NIL + +K+ DFGL+R + DY
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE--------DYYKAS 172
Query: 193 ------RWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W +PE S F ++T A D+W E+L+ GK F V+ L+
Sbjct: 173 VTRLPIKWM-SPE---SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE 228
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 63/237 (26%), Positives = 105/237 (44%), Gaps = 30/237 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLL 76
+ +VIG G +G V + + K VAIK + + + L E ++
Sbjct: 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIM 100
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQ 134
H +I+ ++ ++ SK + + ++ E ME+ L + ++ D + L
Sbjct: 101 GQFSHHNIIRLEGVI---SKYK--PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-- 192
+ +KY+ N HRDL +NIL N+N KV DFGL+RV D Y +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTTSGG 210
Query: 193 ----RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
RW APE + K+T A D+WS G + EV+T G+ + S V+ ++
Sbjct: 211 KIPIRWT-APE--AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN 264
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
++ +G+G +G V T +VAIK + L+E ++++ LR
Sbjct: 182 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEA---FLQEAQVMKKLR 237
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLR 137
H +V++ ++ + IY+V E M L +K Q Q+
Sbjct: 238 HEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 291
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT----- 192
+ Y+ N HRDL+ NIL N KV DFGLAR+ + +Y A
Sbjct: 292 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--------EYTARQGAKF 343
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE + + ++T D+WS G + E+ T G+ +PG V+ Q++
Sbjct: 344 PIKWT-APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 61/230 (26%), Positives = 104/230 (45%), Gaps = 29/230 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIR--ILREVKLLRL 78
+ K+L+ IGKG +G V + G KVA+K I + DA L E ++
Sbjct: 191 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKN------DATAQAFLAEASVMTQ 242
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND--DLTREHHQFFLYQM 135
LRH ++V++ +++ E +Y+V E M L +++ L + F +
Sbjct: 243 LRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
A++Y+ N HRDL +N+L + + KV DFGL + A S +W
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWT 353
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
APE K++ D+WS G + E+ + G+ +P VV +++
Sbjct: 354 -APE--ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 37/291 (12%), Positives = 69/291 (23%), Gaps = 65/291 (22%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLR 80
RY++L G A+DT +VA+ + L L +
Sbjct: 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID 89
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
P + + ++ VV E + L +V + + + + A
Sbjct: 90 KPGVARVLDVV-----HTRAGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAA 142
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
H A V P + + + + + A
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA----------------------- 179
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
P DI IG +L + P V +A
Sbjct: 180 ---------NPQDDIRGIGASLYALLVNRWPLPEAGV---------------RSGLAPAE 215
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
+ A P+ ++ + R + D R +
Sbjct: 216 RDTA---------GQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 66/296 (22%), Positives = 110/296 (37%), Gaps = 47/296 (15%)
Query: 26 KILEVIGKGSYGVVCAAI----DTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLL 79
K + +G+G +G V + TGE VA+K K +H S +E+ +LR L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSG---WKQEIDILRTL 90
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRA 138
H I++ K + +V E + L + + + F Q+
Sbjct: 91 YHEHIIKYKGCC---EDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICEG 146
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------ 192
+ Y+H + HRDL +N+L + + +K+ DFGLA+ Y
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY------YRVREDGDSP 200
Query: 193 -RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
WY APE K+ A D+WS G E+LT S +L+G
Sbjct: 201 VFWY-APE--CLKEYKFYYASDVWSFGVTLYELLTH-----CDSSQSPPTKFLELIGIAQ 252
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLAL-RLLQRLIAFDPKDRPT 306
+ + + + L + P P+ P + L++ + RPT
Sbjct: 253 GQ----MTVLRLTELLERGERLPR-------PDKCPAEVYHLMKNCWETEASFRPT 297
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 51/233 (21%), Positives = 98/233 (42%), Gaps = 34/233 (14%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
K ++V+G G++G V + GEK VAIK++ + IL E ++ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDN 76
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRAL 139
P + + I L + + ++ +LM L ++ + D + ++ + Q+ + +
Sbjct: 77 PHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM 130
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------- 192
Y+ + HRDL +N+L +K+ DFGLA++ ++
Sbjct: 131 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-------EKEYHAEGGKVPI 183
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W A E YT D+WS G E++T G + G + L+
Sbjct: 184 KWM-ALE--SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 56/241 (23%), Positives = 99/241 (41%), Gaps = 32/241 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLR 77
+ EVIG+G +G V K A+K ++ + + I + + L E +++
Sbjct: 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMK 81
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQM 135
HP+++ + I L VV M+ DL I+ + T + F Q+
Sbjct: 82 DFSHPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT--- 192
+ +KY+ + HRDL +N + + +KV DFGLAR ++ +Y +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEYYSVHNK 189
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
+W A E K+T D+WS G + E++T G P +P + +
Sbjct: 190 TGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 246
Query: 245 D 245
Sbjct: 247 Q 247
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-24
Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
++ +G+G +G V T +VAIK + L+E ++++ LR
Sbjct: 265 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEA---FLQEAQVMKKLR 320
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLR 137
H +V++ ++ + IY+V E M L +K Q Q+
Sbjct: 321 HEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 374
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT----- 192
+ Y+ N HRDL+ NIL N KV DFGLAR+ + +Y A
Sbjct: 375 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN--------EYTARQGAKF 426
Query: 193 --RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE + + ++T D+WS G + E+ T G+ +PG V+ Q++
Sbjct: 427 PIKWT-APE--AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 37/236 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
K++E +G G +G V KVA+K + + L E L++ L+
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLK---QGSMSPDAFLAEANLMKQLQ 66
Query: 81 HPDIVEIKRIML-PPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQML 136
H +V + ++ P IY++ E ME+ L +K LT Q+
Sbjct: 67 HQRLVRLYAVVTQEP-------IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT---- 192
+ ++ N HRDL+ NIL + K+ DFGLAR+ + +Y A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN--------EYTAREGAK 171
Query: 193 ---RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE + +T D+WS G + E++T G+ +PG + V+ L+
Sbjct: 172 FPIKWT-APE--AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 33/227 (14%)
Query: 31 IGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIK 88
+G G++G V + + VAIK + E +D ++RE +++ L +P IV +
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 89 RIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTAN 146
+ + + +V E+ LH+ + + + + L+Q+ +KY+ N
Sbjct: 77 GVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-------RWYRAPE 199
HRDL +N+L K+ DFGL++ +D Y A +WY APE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY-APE 183
Query: 200 LCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 184 ---CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 60/244 (24%), Positives = 105/244 (43%), Gaps = 51/244 (20%)
Query: 3 QDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVF 60
+ ++ + F ++ +G GS+G V +G A+K V
Sbjct: 31 ETPSQNTAQLDQF----------DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 61 -----EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD---IYVVFELME-- 110
EH + RIL+ V P +V+++ FKD +Y+V E +
Sbjct: 81 KLKQIEHTLNEKRILQAV------NFPFLVKLEF--------SFKDNSNLYMVMEYVAGG 126
Query: 111 ---SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKV 167
S L ++ + ++ R F+ Q++ +Y+H+ ++ +RDLKP+N+L + ++V
Sbjct: 127 EMFSHLRRIGRFSEPHAR----FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 227
DFG A+ T WT T APE+ S Y A+D W++G + E+ G
Sbjct: 183 TDFGFAKRVKGRT-----WT-LCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAG 234
Query: 228 KPLF 231
P F
Sbjct: 235 YPPF 238
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 49/244 (20%), Positives = 92/244 (37%), Gaps = 30/244 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLR 77
D N + +++G+G +G V KVA+K + + L E ++
Sbjct: 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK 91
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN------DDLTREHHQF 130
HP+++ + + + S + V+ M+ DLH + + + +
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLK 151
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD-Y 189
F+ + ++Y+ N HRDL +N + + + V DFGL++ ++ D Y
Sbjct: 152 FMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK--------IYSGDYY 203
Query: 190 VAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLD 241
+W A E YT D+W+ G E+ T G +PG D
Sbjct: 204 RQGRIAKMPVKWI-AIE--SLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD 260
Query: 242 LITD 245
+
Sbjct: 261 YLLH 264
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 54/241 (22%), Positives = 99/241 (41%), Gaps = 32/241 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLR 77
+ EVIG+G +G V K A+K ++ + + I + + L E +++
Sbjct: 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMK 145
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFLYQM 135
HP+++ + I L VV M+ DL I+ + T + F Q+
Sbjct: 146 DFSHPNVLSLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT--- 192
+ +K++ + HRDL +N + + +KV DFGLAR ++ ++ +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD--------MYDKEFDSVHNK 253
Query: 193 -------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244
+W A E K+T D+WS G + E++T G P +P + +
Sbjct: 254 TGAKLPVKWM-ALE--SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 310
Query: 245 D 245
Sbjct: 311 Q 311
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 60/230 (26%), Positives = 105/230 (45%), Gaps = 35/230 (15%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
K+ + +G G +G V A KVA+K + + L E +++ L+H +V
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLV 246
Query: 86 EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF--FLYQMLRALKYM 142
++ ++ + IY++ E M L +K+++ + + F Q+ + ++
Sbjct: 247 KLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI 300
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-------RWY 195
N HRDL+ NIL +A+ K+ DFGLARV + +Y A +W
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN--------EYTAREGAKFPIKWT 352
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
APE F +T D+WS G + E++T G+ +PG S V+ L+
Sbjct: 353 -APE--AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 74/315 (23%), Positives = 125/315 (39%), Gaps = 77/315 (24%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLRHP 82
++IL +G GS+G V H G A+K K V E +L ++ HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRL-KQVEHTNDERLMLSIVTHP 66
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELME-----SDLHQVIKANDDLTREHHQFFLYQ 134
I+ + F+D I+++ + +E S L + + + + + F+ +
Sbjct: 67 FIIRMWG--------TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK----FYAAE 114
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT-----DY 189
+ AL+Y+H+ ++ +RDLKP+NIL + N +K+ DFG A+ T +T DY
Sbjct: 115 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDY 169
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249
+ APE+ + Y +ID WS G + E+L G F + + + I
Sbjct: 170 I------APEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------ 215
Query: 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----- 304
+ + P P + LL RLI D R
Sbjct: 216 --------------------LNAELRFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQ 250
Query: 305 PTAEEALADPYFKGL 319
E+ P+FK +
Sbjct: 251 NGTEDVKNHPWFKEV 265
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 3e-22
Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 31/227 (13%)
Query: 30 VIGKGSYGVVCAAIDTHTGE--KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+G G++G V + + VAIK + E +D ++RE +++ L +P IV +
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRL 401
Query: 88 KRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTA 145
+ + + +V E+ LH+ + + + + L+Q+ +KY+
Sbjct: 402 IGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 146 NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-------RWYRAP 198
N HR+L +N+L K+ DFGL++ +D Y A +WY AP
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY------YTARSAGKWPLKWY-AP 508
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
E F K++ D+WS G E L+ G+ + V+ ++
Sbjct: 509 E--CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 63/243 (25%), Positives = 100/243 (41%), Gaps = 41/243 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLR 77
+ VIGKG +GVV + + AIK + + E + LRE L+R
Sbjct: 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE-MQQVEAFLREGLLMR 77
Query: 78 LLRHPDIVEIKRIML---PPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQFFL 132
L HP+++ + IML +V+ M DL Q I++ + T + F
Sbjct: 78 GLNHPNVLALIGIMLPPEGL-------PHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFG 130
Query: 133 YQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
Q+ R ++Y+ HRDL +N + + + +KV DFGLAR +Y +
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR--------EYYSV 182
Query: 193 ----------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVH 238
+W A E ++T D+WS G + E+LT G P + + H
Sbjct: 183 QQHRHARLPVKWT-ALE--SLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTH 239
Query: 239 QLD 241
L
Sbjct: 240 FLA 242
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 3e-22
Identities = 57/233 (24%), Positives = 97/233 (41%), Gaps = 36/233 (15%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++ IG+G +G V I VAIK + S + L+E +R HP
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD-SVREKFLQEALTMRQFDHP 451
Query: 83 DIVEIKRIML-PPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQMLRAL 139
IV++ ++ P ++++ EL +L ++ L + YQ+ AL
Sbjct: 452 HIVKLIGVITENP-------VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT------- 192
Y+ + HRD+ +N+L ++N +K+ DFGL+R Y
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS--------TYYKASKGKLPI 556
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
+W APE F ++T A D+W G E+L G F G V+ +++
Sbjct: 557 KWM-APE--SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 54/245 (22%), Positives = 99/245 (40%), Gaps = 31/245 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLR 77
++ + ++GKG +G V A KVA+K + SD LRE ++
Sbjct: 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 78 LLRHPDIVEIKRIMLPP-SKREFKDIYVVFELMES-DLHQVIKAN------DDLTREHHQ 129
HP + ++ + L +K V+ M+ DLH + A+ +L +
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189
F+ + ++Y+ + N HRDL +N + + + V DFGL+R ++ DY
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK--------IYSGDY 192
Query: 190 --------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQL 240
+ +W A E + YT D+W+ G E++T G+ + G
Sbjct: 193 YRQGCASKLPVKWL-ALE--SLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249
Query: 241 DLITD 245
+ +
Sbjct: 250 NYLIG 254
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 37/239 (15%), Positives = 76/239 (31%), Gaps = 40/239 (16%)
Query: 26 KILEVIGKGSYGVVCAAIDTHTGE-------KVAIKKIHDVFEHISDAIRILREVKLLRL 78
E +G+G++ + + G+ +V +K + H + + ++
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK--AHRNYSESFFEAASMMSK 68
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD-LTREHHQFFLYQML 136
L H +V + + + +V E ++ L +K N + + Q+
Sbjct: 69 LSHKHLVLNYGVCV-----CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLA 123
Query: 137 RALKYMHTANVYHRDLKPKNIL--------ANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
A+ ++ + H ++ KNIL +K+ D G++ D
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--------D 175
Query: 189 Y--VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS---VVHQLD 241
W PE C A D WS G E+ + G + +
Sbjct: 176 ILQERIPWV-PPE-CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE 232
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-21
Identities = 78/311 (25%), Positives = 133/311 (42%), Gaps = 64/311 (20%)
Query: 26 KILEVIGKGSYGVVCAA---IDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLR 80
++L V+GKG YG V +TG+ A+K K + + D E +L ++
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVF------ELMESDLHQVIKANDDLTREHHQFFLYQ 134
HP IV++ K +Y++ EL + ++ + F+L +
Sbjct: 80 HPFIVDLIYAFQTGGK-----LYLILEYLSGGELF---MQ--LEREGIFMEDTACFYLAE 129
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ AL ++H + +RDLKP+NI+ N +K+ DFGL + + D +T + T
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT---HTFCGTIE 186
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y APE L S + A+D WS+G + ++LTG P F G++ +D I
Sbjct: 187 YMAPEILMR---SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI---------- 233
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----PT-AE 308
++ K +P P + A LL++L+ + R P A
Sbjct: 234 ----------------LKCKLNLP-----PYLTQEARDLLKKLLKRNAASRLGAGPGDAG 272
Query: 309 EALADPYFKGL 319
E A P+F+ +
Sbjct: 273 EVQAHPFFRHI 283
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 5e-21
Identities = 68/303 (22%), Positives = 127/303 (41%), Gaps = 50/303 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
+ L+++GKG++G V + TG A+K + +V + + E ++L+ RHP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+ +K + + V E +L + T E +F+ +++ AL+Y+
Sbjct: 67 LTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LC 201
H+ +V +RD+K +N++ + + +K+ DFGL + SD + T Y APE L
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLE 178
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ Y A+D W +G + E++ G+ F + +LI
Sbjct: 179 D---NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------------------ 217
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADPYF 316
+ ++ P + P A LL L+ DPK R A+E + +F
Sbjct: 218 --------LMEEIRFP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
Query: 317 KGL 319
+
Sbjct: 265 LSI 267
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 70/324 (21%), Positives = 125/324 (38%), Gaps = 59/324 (18%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVF 60
++ + +LK +DF + +++GKGS+G V A T + AIK + DV
Sbjct: 6 ERPSLQIKLKIEDF----------ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV 55
Query: 61 EHISDAIRILREVKLLRL-LRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIK 118
D + E ++L L HP + + ++ V E + DL I+
Sbjct: 56 LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN-----LFFVMEYLNGGDLMYHIQ 110
Query: 119 ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VA 176
+ F+ +++ L+++H+ + +RDLK NIL + + +K+ DFG+ + +
Sbjct: 111 SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170
Query: 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236
T + T Y APE+ KY ++D WS G + E+L G+ F G+
Sbjct: 171 GDAKTNT-----FCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223
Query: 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRL 296
I P P ++ A LL +L
Sbjct: 224 EELFHSI--------------------------RMDNPFYP-----RWLEKEAKDLLVKL 252
Query: 297 IAFDPKDR-PTAEEALADPYFKGL 319
+P+ R + P F+ +
Sbjct: 253 FVREPEKRLGVRGDIRQHPLFREI 276
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 68/301 (22%), Positives = 125/301 (41%), Gaps = 49/301 (16%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPDIV 85
L+++GKG++G V + TG A+K + +V + L E ++L+ RHP +
Sbjct: 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLT 211
Query: 86 EIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT 144
+K + + V E +L + + + +F+ +++ AL Y+H+
Sbjct: 212 ALKYSFQTHDR-----LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 266
Query: 145 A-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203
NV +RDLK +N++ + + +K+ DFGL + D + T Y APE+
Sbjct: 267 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM---KTFCGTPEYLAPEVLED 323
Query: 204 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKA 263
+ Y A+D W +G + E++ G+ F + +LI
Sbjct: 324 --NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-------------------- 361
Query: 264 RKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADPYFKG 318
+ ++ P + P A LL L+ DPK R A+E + +F G
Sbjct: 362 ------LMEEIRFP-----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410
Query: 319 L 319
+
Sbjct: 411 I 411
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 8e-20
Identities = 70/311 (22%), Positives = 127/311 (40%), Gaps = 66/311 (21%)
Query: 26 KILEVIGKGSYGVVCAA---IDTHTGEKVAIK--KIHDVFEHISDAIRILREVKLLRLLR 80
++L+V+G+GS+G V + + A+K K + D +R E +L +
Sbjct: 27 ELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR--DRVRTKMERDILVEVN 84
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVF------ELMESDLHQVIKANDDLTREHHQFFLYQ 134
HP IV++ K +Y++ +L + L + + ++ + F+L +
Sbjct: 85 HPFIVKLHYAFQTEGK-----LYLILDFLRGGDLF-TRLSKEVMFTEEDVK----FYLAE 134
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ AL ++H+ + +RDLKP+NIL + +K+ DFGL++ + + T
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA---YSFCGTVE 191
Query: 195 YRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y APE + +T + D WS G + E+LTG F GK + +I
Sbjct: 192 YMAPEVVNR---RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI---------- 238
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAE 308
++ K +P + P A LL+ L +P +R E
Sbjct: 239 ----------------LKAKLGMP-----QFLSPEAQSLLRMLFKRNPANRLGAGPDGVE 277
Query: 309 EALADPYFKGL 319
E +F +
Sbjct: 278 EIKRHSFFSTI 288
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 91.6 bits (227), Expect = 1e-19
Identities = 60/306 (19%), Positives = 112/306 (36%), Gaps = 55/306 (17%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHP 82
+ L V+GKGS+G V + T E A+K + DV D + E + L + P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+ ++ + +Y V E + DL I+ H F+ ++ L +
Sbjct: 403 FLTQLHSCFQTMDR-----LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLAR--VAFSDTPMTVFWTDYVATRWYRAPE 199
+ + + +RDLK N++ ++ +K+ DFG+ + + T T + T Y APE
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-----FCGTPDYIAPE 512
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
+ Y ++D W+ G + E+L G+ F G+ I
Sbjct: 513 IIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI--------------- 554
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALAD 313
M P ++ A+ + + L+ P R +
Sbjct: 555 -----------MEHNVAYP-----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598
Query: 314 PYFKGL 319
+F+ +
Sbjct: 599 AFFRYI 604
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 65/306 (21%), Positives = 123/306 (40%), Gaps = 45/306 (14%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHP 82
+ +L VIG+GSY V T A+K + ++ D + E + HP
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+V + S+ ++ V E + DL ++ L EH +F+ ++ AL Y
Sbjct: 71 FLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
+H + +RDLK N+L ++ +K+ D+G+ + T + + T Y APE L
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEIL 182
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G Y ++D W++G + E++ G+ F D
Sbjct: 183 RG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------------------- 220
Query: 261 EKARKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDR------PTAEEALAD 313
+ YL ++ + + + P ++ A +L+ + DPK+R +
Sbjct: 221 QNTEDYLFQVILEKQI----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276
Query: 314 PYFKGL 319
P+F+ +
Sbjct: 277 PFFRNV 282
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 3e-19
Identities = 64/337 (18%), Positives = 115/337 (34%), Gaps = 81/337 (24%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI----- 56
+ + +K DF L V+GKGS+G V + T E A+K +
Sbjct: 9 DNNGNRDRMKLTDF----------NFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVV 58
Query: 57 --HDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFE------L 108
D E R+L + P + ++ + +Y V E L
Sbjct: 59 IQDDDVECTMVEKRVLALPG-----KPPFLTQLHSCFQTMDR-----LYFVMEYVNGGDL 108
Query: 109 MESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168
M H I+ H F+ ++ L ++ + + +RDLK N++ ++ +K+
Sbjct: 109 M---YH--IQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIA 163
Query: 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTG 227
DFG+ + D T + T Y APE + Y ++D W+ G + E+L G
Sbjct: 164 DFGMCKENIWDGVTT---KTFCGTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAG 217
Query: 228 KPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDP 287
+ F G+ I M P ++
Sbjct: 218 QAPFEGEDEDELFQSI--------------------------MEHNVAYP-----KSMSK 246
Query: 288 LALRLLQRLIAFDPKDR----PT-AEEALADPYFKGL 319
A+ + + L+ P R P + +F+ +
Sbjct: 247 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 59/257 (22%), Positives = 101/257 (39%), Gaps = 52/257 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREV 73
+ +G+G++G V A VA+K + + S++ R RE
Sbjct: 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE----ASESARQDFQREA 94
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF-- 130
+LL +L+H IV + E + + +VFE M DL++ ++++ +
Sbjct: 95 ELLTMLQHQHIVRFFGVCT-----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 131 -------------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
Q+ + Y+ + HRDL +N L +K+ DFG++R
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRD-- 207
Query: 178 SDTPMTVFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GK 228
++ TDY RW PE + K+T D+WS G + E+ T GK
Sbjct: 208 ------IYSTDYYRVGGRTMLPIRWM-PPE--SILYRKFTTESDVWSFGVVLWEIFTYGK 258
Query: 229 PLFPGKSVVHQLDLITD 245
+ S +D IT
Sbjct: 259 QPWYQLSNTEAIDCITQ 275
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 6e-19
Identities = 65/251 (25%), Positives = 105/251 (41%), Gaps = 49/251 (19%)
Query: 26 KILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ +G+G++G V A T VA+K + D + RE +LL L+
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAELLTNLQ 75
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN---------DDLTREHHQF 130
H IV+ + + + +VFE M+ DL++ ++A+ + +
Sbjct: 76 HEHIVKFYGVCG-----DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130
Query: 131 FLYQML-------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT 183
L QML + Y+ + + HRDL +N L AN +K+ DFG++R
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD-------- 182
Query: 184 VFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234
V+ TDY RW PE + K+T D+WS G I E+ T GK +
Sbjct: 183 VYSTDYYRVGGHTMLPIRWM-PPE--SIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 239
Query: 235 SVVHQLDLITD 245
S ++ IT
Sbjct: 240 SNTEVIECITQ 250
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 64/306 (20%), Positives = 123/306 (40%), Gaps = 45/306 (14%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHP 82
+ +L VIG+GSY V T A++ + ++ D + E + HP
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+V + S+ ++ V E + DL ++ L EH +F+ ++ AL Y
Sbjct: 114 FLVGLHSCFQTESR-----LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE-L 200
+H + +RDLK N+L ++ +K+ D+G+ + T + + T Y APE L
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---STFCGTPNYIAPEIL 225
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
G Y ++D W++G + E++ G+ F D
Sbjct: 226 RG---EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------------------- 263
Query: 261 EKARKYLTEMRKKPPVPLFQKFP-NVDPLALRLLQRLIAFDPKDR------PTAEEALAD 313
+ YL ++ + + + P ++ A +L+ + DPK+R +
Sbjct: 264 QNTEDYLFQVILEKQI----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319
Query: 314 PYFKGL 319
P+F+ +
Sbjct: 320 PFFRNV 325
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 37/167 (22%), Positives = 67/167 (40%), Gaps = 30/167 (17%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-REVKLLRLLR 80
+++ + IG G++G + + +T E VAIK E + L E + + L
Sbjct: 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLG 62
Query: 81 H-PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL------- 132
I ++ K +V EL+ L + D F L
Sbjct: 63 SGDGIPQVYY-----FGPCGKYNAMVLELLGPSLEDLFDLCD------RTFSLKTVLMIA 111
Query: 133 YQMLRALKYMHTANVYHRDLKPKNIL-----ANANCKLKVCDFGLAR 174
Q++ ++Y+H+ N+ +RD+KP+N L + + DF LA+
Sbjct: 112 IQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 72/305 (23%), Positives = 116/305 (38%), Gaps = 58/305 (19%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHPDI 84
L+VIGKGS+G V A A+K + + I+ E LL+ ++HP +
Sbjct: 42 FLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 101
Query: 85 VEIKRIMLPPSKREFKDIYVVF------ELMESDLHQVIKANDDLTREHHQFFLYQMLRA 138
V + K +Y V EL H ++ +F+ ++ A
Sbjct: 102 VGLHFSFQTADK-----LYFVLDYINGGELF---YH--LQRERCFLEPRARFYAAEIASA 151
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
L Y+H+ N+ +RDLKP+NIL ++ + + DFGL + T T + T Y AP
Sbjct: 152 LGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT--ST-FCGTPEYLAP 208
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ Y +D W +G + E+L G P F ++ D I
Sbjct: 209 EVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--------------- 251
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----PTAEEALADP 314
+ K + PN+ A LL+ L+ D R E +
Sbjct: 252 -----------LNKPLQLK-----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHV 295
Query: 315 YFKGL 319
+F +
Sbjct: 296 FFSLI 300
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 68/305 (22%), Positives = 134/305 (43%), Gaps = 46/305 (15%)
Query: 27 ILEVIGKGSYG---VVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLRH 81
+L+V+G G+YG +V TG+ A+K + + + E ++L +R
Sbjct: 58 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 117
Query: 82 -PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
P +V + +K ++++ + + +L + + T Q ++ +++ AL
Sbjct: 118 SPFLVTLHYAFQTETK-----LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 172
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+++H + +RD+K +NIL ++N + + DFGL++ +D + + T Y AP+
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA-YD-FCGTIEYMAPD 230
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ S + A+D WS+G + E+LTG F + I+ +
Sbjct: 231 IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI------------ 278
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR----PT-AEEALADP 314
++ +PP P + LA L+QRL+ DPK R P A+E
Sbjct: 279 ----------LKSEPPYP-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323
Query: 315 YFKGL 319
+F+ +
Sbjct: 324 FFQKI 328
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 54/259 (20%), Positives = 100/259 (38%), Gaps = 54/259 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREV 73
+ + +E +G+ +G V + VAIK + + +R E
Sbjct: 7 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLK---DKAEGPLREEFRHEA 63
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN---------DDL 123
L L+HP++V + ++ +K + + ++F DLH+ + DD
Sbjct: 64 MLRARLQHPNVVCLLGVV---TKDQ--PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 124 TREHHQFFLYQML-------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176
+ ++Y+ + +V H+DL +N+L +K+ D GL R
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE- 177
Query: 177 FSDTPMTVFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-- 226
V+ DY RW APE + K++ DIWS G + EV +
Sbjct: 178 -------VYAADYYKLLGNSLLPIRWM-APE--AIMYGKFSIDSDIWSYGVVLWEVFSYG 227
Query: 227 GKPLFPGKSVVHQLDLITD 245
+P + G S +++I +
Sbjct: 228 LQP-YCGYSNQDVVEMIRN 245
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 67/307 (21%), Positives = 118/307 (38%), Gaps = 56/307 (18%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVK-LLRLLRHP 82
++ + V+GKGS+G V A TG+ A+K + DV D + E + L HP
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+ ++ P + ++ V E + DL I+ + +F+ +++ AL +
Sbjct: 85 FLTQLFCCFQTPDR-----LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMF 139
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLA--RVAFSDTPMTVFWTDYVATRWYRAPE 199
+H + +RDLK N+L + K+ DFG+ + T T + T Y APE
Sbjct: 140 LHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-----FCGTPDYIAPE 194
Query: 200 -LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
L Y PA+D W++G + E+L G F ++ + I
Sbjct: 195 ILQE---MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI--------------- 236
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR------PTAEEALA 312
+ + P + A +L+ + +P R L
Sbjct: 237 -----------LNDEVVYP-----TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280
Query: 313 DPYFKGL 319
P+FK +
Sbjct: 281 HPFFKEI 287
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 49/252 (19%), Positives = 91/252 (36%), Gaps = 46/252 (18%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREV 73
++ +G G++G V + + +VA+K + E S+ + L E
Sbjct: 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEA 84
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFL 132
++ H +IV + L + +++ ELM DL ++ + +
Sbjct: 85 LIISKFNHQNIVRCIGVSL-----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 133 YQML-------RALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGLARVAFSDTPM 182
+L +Y+ + HRD+ +N L K+ DFG+AR
Sbjct: 140 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD------- 192
Query: 183 TVFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
++ Y +W PE +T D WS G + E+ + G +P
Sbjct: 193 -IYRASYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248
Query: 234 KSVVHQLDLITD 245
KS L+ +T
Sbjct: 249 KSNQEVLEFVTS 260
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 84.2 bits (207), Expect = 6e-18
Identities = 52/349 (14%), Positives = 93/349 (26%), Gaps = 75/349 (21%)
Query: 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKI------------HDVFEHI 63
F+ + + E IG+G +G V I HT VAIK I FE I
Sbjct: 13 FSHCLPTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEI 70
Query: 64 SDAIRILREVKLLRLL---RHPDIVEIKRIML-------------------------PPS 95
I I +E+ LL R + + + P
Sbjct: 71 LPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPD 130
Query: 96 KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKP 154
+ +++V E + + + L+Q+ +L + HRDL
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190
Query: 155 KNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDI 214
N+L K+ + T+ + YT +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGK------SSTIPSCGLQVSII------------DYTLSRLE 232
Query: 215 WSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK-------ARKYL 267
+F +V + LF G +Q D I L+ + +
Sbjct: 233 RDGIVVFCDVSMDEDLFTGDG-DYQFD-IYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM 290
Query: 268 TEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ + + ++ F +A + L
Sbjct: 291 LKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 51/256 (19%), Positives = 96/256 (37%), Gaps = 58/256 (22%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRI--LREVKL 75
+ + +G+GS+G+V + + +VAIK ++ E S RI L E +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN---EAASMRERIEFLNEASV 81
Query: 76 LRLLRHPDIVEIKRIML--PPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF-- 130
++ +V + ++ P V+ ELM DL +++ +
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQP-------TLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 131 --------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182
++ + Y++ HRDL +N + + +K+ DFG+ R
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD------- 187
Query: 183 TVFWTDYVATRWYR------------APELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229
++ TDY YR +PE +T D+WS G + E+ T +
Sbjct: 188 -IYETDY-----YRKGGKGLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQ 239
Query: 230 LFPGKSVVHQLDLITD 245
+ G S L + +
Sbjct: 240 PYQGLSNEQVLRFVME 255
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 46/166 (27%), Positives = 71/166 (42%), Gaps = 30/166 (18%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-REVKLLRLLR 80
NRY++ IG GS+G + D GE+VAIK E + L E K+ ++++
Sbjct: 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQ 62
Query: 81 H-PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL------- 132
I I+ E +V EL+ L + +F L
Sbjct: 63 GGVGIPTIRW-----CGAEGDYNVMVMELLGPSLEDLFNFCS------RKFSLKTVLLLA 111
Query: 133 YQMLRALKYMHTANVYHRDLKPKNIL----ANANCKLKVCDFGLAR 174
QM+ ++Y+H+ N HRD+KP N L N + + DFGLA+
Sbjct: 112 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAK 156
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 49/252 (19%), Positives = 91/252 (36%), Gaps = 46/252 (18%)
Query: 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREV 73
++ +G G++G V + + +VA+K + E S+ + L E
Sbjct: 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSEQDELDFLMEA 125
Query: 74 KLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFL 132
++ H +IV + L + +++ ELM DL ++ + +
Sbjct: 126 LIISKFNHQNIVRCIGVSL-----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 133 YQML-------RALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGLARVAFSDTPM 182
+L +Y+ + HRD+ +N L K+ DFG+AR
Sbjct: 181 LDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD------- 233
Query: 183 TVFWTDYVAT--------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPG 233
++ Y +W PE +T D WS G + E+ + G +P
Sbjct: 234 -IYRAGYYRKGGCAMLPVKWM-PPE--AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289
Query: 234 KSVVHQLDLITD 245
KS L+ +T
Sbjct: 290 KSNQEVLEFVTS 301
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 41/168 (24%), Positives = 69/168 (41%), Gaps = 32/168 (19%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-REVKLLRLLR 80
YK+ IG+GS+GV+ + ++VAIK FE L E + +LL
Sbjct: 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLLA 63
Query: 81 H-PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL------- 132
I + +E +V +L+ L ++ +F +
Sbjct: 64 GCTGIPNVYY-----FGQEGLHNVLVIDLLGPSLEDLLDLCG------RKFSVKTVAMAA 112
Query: 133 YQMLRALKYMHTANVYHRDLKPKNIL------ANANCKLKVCDFGLAR 174
QML ++ +H ++ +RD+KP N L NAN + V DFG+ +
Sbjct: 113 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNAN-MIYVVDFGMVK 159
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 34/177 (19%), Positives = 68/177 (38%), Gaps = 35/177 (19%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
N++ + + IG G +G++ A T+ EK A + E+ + + E+K + +
Sbjct: 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVK--VEY-QENGPLFSELKFYQRVAK 92
Query: 82 PDIVEIKRIMLPPSKREFKDIY--------------VVFELMESDLHQVIKANDDLTREH 127
D ++ Y +V E + DL ++ ++
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDL-------QKISGQN 145
Query: 128 HQFFL-------YQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLAR 174
F +ML L+Y+H H D+K N+L N + ++ + D+GL+
Sbjct: 146 GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD-QVYLADYGLSY 201
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 62/251 (24%), Positives = 110/251 (43%), Gaps = 50/251 (19%)
Query: 23 NRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRI--LREVKL 75
+R K+ + +G+G++G V A T T VA+K + E + + + E+K+
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKI 83
Query: 76 L-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN------------- 120
L + H ++V +L + + V+ E + +L +++
Sbjct: 84 LIHIGHHLNVVN----LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 121 ---DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
D LT EH + +Q+ + ++++ + HRDL +NIL + +K+CDFGLAR +
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 178 SDTPMTVFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229
D DYV +W APE F YT D+WS G + E+ + G
Sbjct: 200 KD-------PDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 230 LFPGKSVVHQL 240
+PG + +
Sbjct: 250 PYPGVKIDEEF 260
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 8e-16
Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 28/165 (16%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRIL-REVKLLRLLR 80
N++++ IG GS+G + + T E+VAIK E++ L E K+ R+L+
Sbjct: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLLYESKIYRILQ 60
Query: 81 -HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL------- 132
I ++ E +V +L+ L + + L
Sbjct: 61 GGTGIPNVRW-----FGVEGDYNVLVMDLLGPSLEDLFNFCS------RKLSLKTVLMLA 109
Query: 133 YQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLAR 174
QM+ ++++H+ + HRD+KP N L ++ + DFGLA+
Sbjct: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 62/279 (22%), Positives = 102/279 (36%), Gaps = 62/279 (22%)
Query: 2 QQDQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEK--VAIKKIHDV 59
K D + D N K +VIG+G++G V A G + AIK++ +
Sbjct: 5 HHHHHGKNNPDPTIYPVL-DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY 63
Query: 60 FEHISDAIRILREVKLL-RLLRHPDIVEIKRIML------PPSKREFKDIYVVFELMES- 111
D E+++L +L HP+I+ +L +Y+ E
Sbjct: 64 ASK-DDHRDFAGELEVLCKLGHHPNIIN----LLGACEHRGY-------LYLAIEYAPHG 111
Query: 112 DLHQVIKANDDLTREHHQF----------------FLYQMLRALKYMHTANVYHRDLKPK 155
+L ++ + L + F + R + Y+ HRDL +
Sbjct: 112 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 171
Query: 156 NILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVAT-------RWYRAPELCGSFFSKY 208
NIL N K+ DFGL+R + YV RW A E +S Y
Sbjct: 172 NILVGENYVAKIADFGLSR--GQEV--------YVKKTMGRLPVRWM-AIE--SLNYSVY 218
Query: 209 TPAIDIWSIGCIFAEVLT--GKPLFPGKSVVHQLDLITD 245
T D+WS G + E+++ G P + G + + +
Sbjct: 219 TTNSDVWSYGVLLWEIVSLGGTP-YCGMTCAELYEKLPQ 256
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 56/272 (20%), Positives = 105/272 (38%), Gaps = 76/272 (27%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE-KVAIKKIHDVFEHISDAIRI--LREVKL 75
N + + IG+G++G V A + + VA+K + E S ++ RE L
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK---EEASADMQADFQREAAL 103
Query: 76 LRLLRHPDIVEIKRIML--PPSKREFKDIYVVFELMES-DLHQVIKANDD---------- 122
+ +P+IV++ + P + ++FE M DL++ +++
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKP-------MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 123 --------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168
L+ Q+ + Y+ HRDL +N L N +K+
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIA 216
Query: 169 DFGLARVAFSDTPMTVFWTDYVATRWYR------------APELCGS-FFSKYTPAIDIW 215
DFGL+R ++ DY Y+ PE S F+++YT D+W
Sbjct: 217 DFGLSRN--------IYSADY-----YKADGNDAIPIRWMPPE---SIFYNRYTTESDVW 260
Query: 216 SIGCIFAEVLT--GKPLFPGKSVVHQLDLITD 245
+ G + E+ + +P + G + + + D
Sbjct: 261 AYGVVLWEIFSYGLQP-YYGMAHEEVIYYVRD 291
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 62/251 (24%), Positives = 98/251 (39%), Gaps = 49/251 (19%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE-KVAIKKIHDVFEHISDAIRILREVKLL- 76
NR + +G G++G V A + VA+K + H+++ ++ E+K+L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKVLS 81
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQF----- 130
L H +IV +L V+ E DL ++ D
Sbjct: 82 YLGNHMNIVN----LLGACTIG-GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 131 -------------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177
F YQ+ + + ++ + N HRDL +NIL K+CDFGLAR
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 178 SDTPMTVFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229
+D ++YV +W APE F YT D+WS G E+ + G
Sbjct: 197 ND-------SNYVVKGNARLPVKWM-APESI--FNCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 230 LFPGKSVVHQL 240
+PG V +
Sbjct: 247 PYPGMPVDSKF 257
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 57/254 (22%), Positives = 98/254 (38%), Gaps = 59/254 (23%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKLL- 76
N + + +G G++G V A G+ KVA+K + H + ++ E+K++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMS 104
Query: 77 RLLRHPDIVEIKRIML------PPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQ 129
L +H +IV +L P + V+ E DL ++ +
Sbjct: 105 HLGQHENIVN----LLGACTHGGP-------VLVITEYCCYGDLLNFLRRKSRVLETDPA 153
Query: 130 F--------------FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR- 174
F F Q+ + + ++ + N HRD+ +N+L K+ DFGLAR
Sbjct: 154 FAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 213
Query: 175 -------VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT- 226
+ + + V W APE F YT D+WS G + E+ +
Sbjct: 214 IMNDSNYIVKGNARLPVKWM---------APE--SIFDCVYTVQSDVWSYGILLWEIFSL 262
Query: 227 GKPLFPGKSVVHQL 240
G +PG V +
Sbjct: 263 GLNPYPGILVNSKF 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 59/266 (22%), Positives = 105/266 (39%), Gaps = 64/266 (24%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE-KVAIKKIHDVFEHISDAIRI--LREVKL 75
+ + +G+G +G V A + G VA+K + E+ S + L E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNV 79
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN-------------- 120
L+ + HP +++ + ++ + ++ E + L ++ +
Sbjct: 80 LKQVNHPHVIK----LYGACSQD-GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 121 ----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170
LT F +Q+ + ++Y+ + HRDL +NIL K+K+ DF
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDF 194
Query: 171 GLARVAFSDTPMTVFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIF 221
GL+R V+ D YV +W A E S F YT D+WS G +
Sbjct: 195 GLSRD--------VYEEDSYVKRSQGRIPVKWM-AIE---SLFDHIYTTQSDVWSFGVLL 242
Query: 222 AEVLT--GKPLFPGKSVVHQLDLITD 245
E++T G P +PG +L+
Sbjct: 243 WEIVTLGGNP-YPGIPPERLFNLLKT 267
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 26/180 (14%), Positives = 61/180 (33%), Gaps = 40/180 (22%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTG--------EKVAIKKIHDVFEHISDAIRILREVK 74
++K+ + + G++ A T T +K ++K + R+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-----LDAKDG--RLFNEQN 94
Query: 75 LL-RLLRHPDIVEIKRIMLPPS----------KREFKDIYVVFELMESDLHQVIKANDDL 123
R + + + K++ P + K ++V + L + +
Sbjct: 95 FFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSP-- 152
Query: 124 TREHHQFFL-------YQMLRALKYMHTANVYHRDLKPKNILANANCKLKV--CDFGLAR 174
H ++L AL+++H H ++ +NI + + +V +G A
Sbjct: 153 ---KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 62/263 (23%), Positives = 110/263 (41%), Gaps = 63/263 (23%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE---KVAIKKIHDVFEHISDAIRILREVKL 75
++ + + +G+G++G V A ID + VA+K + D D ++ E+++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEM 93
Query: 76 L-RLLRHPDIVEIKRIML------PPSKREFKDIYVVFELMES-DLHQVIKAN------- 120
+ + +H +I+ +L P +YV+ E +L + ++A
Sbjct: 94 MKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLRARRPPGMEY 142
Query: 121 ---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171
+ +T + YQ+ R ++Y+ + HRDL +N+L N +K+ DFG
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 202
Query: 172 LARVAFSDTPMTVFWTD-YVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 223
LAR + D Y T +W APE F YT D+WS G + E
Sbjct: 203 LARDINNI--------DYYKKTTNGRLPVKWM-APE--ALFDRVYTHQSDVWSFGVLMWE 251
Query: 224 VLT-GKPLFPGKSVVHQLDLITD 245
+ T G +PG V L+ +
Sbjct: 252 IFTLGGSPYPGIPVEELFKLLKE 274
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 37/177 (20%), Positives = 69/177 (38%), Gaps = 32/177 (18%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
A +K+ IG+G +G + A D ++ E V V SD + E+K +
Sbjct: 34 AAAWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAK 92
Query: 82 PDIVEIKRIMLPPS--------------KREFKDIYVVFELMESDLHQVIKANDDLTREH 127
P+ ++ K +++ + SDL ++ +AN
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA------ 146
Query: 128 HQFFL-------YQMLRALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLAR 174
+F ++L L+Y+H H D+K N+L N + ++ + D+GLA
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-QVYLVDYGLAY 202
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 59/260 (22%), Positives = 111/260 (42%), Gaps = 57/260 (21%)
Query: 23 NRYKILEVIGKGSYGVVCAA----IDTHTGE---KVAIKKIHDVFEHISDAIRI--LREV 73
++ + + +G+G +G V A ID + VA+K + + ++ + E+
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEM 137
Query: 74 KLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAN----------- 120
+++ + +H +I+ +L ++ +YV+ E +L + ++A
Sbjct: 138 EMMKMIGKHKNIIN----LLGACTQD-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 121 -----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
+ +T + YQ+ R ++Y+ + HRDL +N+L N +K+ DFGLAR
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD 252
Query: 176 AFSDTPMTVFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLT 226
+ D Y T +W APE + F YT D+WS G + E+ T
Sbjct: 253 INNI--------DYYKKTTNGRLPVKWM-APE---ALFDRVYTHQSDVWSFGVLMWEIFT 300
Query: 227 -GKPLFPGKSVVHQLDLITD 245
G +PG V L+ +
Sbjct: 301 LGGSPYPGIPVEELFKLLKE 320
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 60/264 (22%), Positives = 109/264 (41%), Gaps = 65/264 (24%)
Query: 23 NRYKILEVIGKGSYGVVCAAI-------DTHTGEKVAIKKIHDVFEHISDAIRILREVKL 75
+R + + +G+G++G V A + KVA+K + D ++ E+++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEM 127
Query: 76 L-RLLRHPDIVEIKRIML------PPSKREFKDIYVVFELMES-DLHQVIKAN------- 120
+ + +H +I+ +L P +YV+ E +L + ++A
Sbjct: 128 MKMIGKHKNIIN----LLGACTQDGP-------LYVIVEYASKGNLREYLQARRPPGLEY 176
Query: 121 ---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171
+ L+ + YQ+ R ++Y+ + HRDL +N+L + +K+ DFG
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFG 236
Query: 172 LARVAFSDTPMTVFWTD-YVAT-------RWYRAPELCGS-FFSKYTPAIDIWSIGCIFA 222
LAR + D Y T +W APE + F YT D+WS G +
Sbjct: 237 LARD--------IHHIDYYKKTTNGRLPVKWM-APE---ALFDRIYTHQSDVWSFGVLLW 284
Query: 223 EVLT-GKPLFPGKSVVHQLDLITD 245
E+ T G +PG V L+ +
Sbjct: 285 EIFTLGGSPYPGVPVEELFKLLKE 308
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 61/258 (23%), Positives = 102/258 (39%), Gaps = 58/258 (22%)
Query: 23 NRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLL- 76
+ +V+G G++G V A T +VA+K + + S+ ++ E+K++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMT 103
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME------------------------SD 112
+L H +IV +L IY++FE
Sbjct: 104 QLGSHENIVN----LLGACTLS-GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 113 LHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172
+ + + LT E F YQ+ + ++++ + HRDL +N+L +K+CDFGL
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 173 AR-VAFSDTPMTVFWTDYVAT-------RWYRAPELCGSFF-SKYTPAIDIWSIGCIFAE 223
AR + YV +W APE S F YT D+WS G + E
Sbjct: 219 ARDIMSDSN--------YVVRGNARLPVKWM-APE---SLFEGIYTIKSDVWSYGILLWE 266
Query: 224 VLT-GKPLFPGKSVVHQL 240
+ + G +PG V
Sbjct: 267 IFSLGVNPYPGIPVDANF 284
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 56/241 (23%), Positives = 91/241 (37%), Gaps = 88/241 (36%)
Query: 30 VIGKGSYGVV-CAAIDTHTGEKVAIKKIHDV-------FEHISDAIRILREVKLLRLLRH 81
+IG G +G V + G KVA+K+ F E++ L RH
Sbjct: 46 LIGHGVFGKVYKGVLRD--GAKVALKRRTPESSQGIEEF---------ETEIETLSFCRH 94
Query: 82 PDIV-------EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLY- 133
P +V E ++L +++ ME N +L + H LY
Sbjct: 95 PHLVSLIGFCDERNEMIL------------IYKYME---------NGNL--KRH---LYG 128
Query: 134 -----QML-------------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
+ R L Y+HT + HRD+K NIL + N K+ DFG+++
Sbjct: 129 SDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK- 187
Query: 176 AFSDTPMTVFWTDYVATRW-----YRAPELCGSFFS--KYTPAIDIWSIGCIFAEVLTGK 228
++ T +++T Y PE +F + T D++S G + EVL +
Sbjct: 188 KGTELDQT-----HLSTVVKGTLGYIDPE----YFIKGRLTEKSDVYSFGVVLFEVLCAR 238
Query: 229 P 229
Sbjct: 239 S 239
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 4e-12
Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 61/228 (26%)
Query: 30 VIGKGSYGVV-CAAIDTHTGEKVAIKKIHDVFEHISDAIRI--LREVKLLRLLRHPDIV- 85
+G+G +GVV ++ VA+KK+ + + ++ ++ +E+K++ +H ++V
Sbjct: 38 KMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 86 ------EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFL--YQML- 136
+ + L V+ M N L L L
Sbjct: 95 LLGFSSDGDDLCL------------VYVYMP---------NGSL--LDRLSCLDGTPPLS 131
Query: 137 ------------RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA--FSDTPM 182
+ ++H + HRD+K NIL + K+ DFGLAR + F+ T M
Sbjct: 132 WHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 183 TVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229
T + V T Y APE L G + TP DI+S G + E++TG P
Sbjct: 192 T---SRIVGTTAYMAPEALRG----EITPKSDIYSFGVVLLEIITGLP 232
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 41/140 (29%), Positives = 65/140 (46%), Gaps = 18/140 (12%)
Query: 109 MESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168
+E + D LT EH + +Q+ + ++++ + HRDL +NIL + +K+C
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 235
Query: 169 DFGLARVAFSDTPMTVFWTDYVAT-------RWYRAPELCGSFFSKYTPAIDIWSIGCIF 221
DFGLAR + D DYV +W APE F YT D+WS G +
Sbjct: 236 DFGLARDIYKD-------PDYVRKGDARLPLKWM-APE--TIFDRVYTIQSDVWSFGVLL 285
Query: 222 AEVLT-GKPLFPGKSVVHQL 240
E+ + G +PG + +
Sbjct: 286 WEIFSLGASPYPGVKIDEEF 305
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 51/219 (23%), Positives = 95/219 (43%), Gaps = 43/219 (19%)
Query: 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKR 89
++G+G +G V G VA+K++ + + + EV+++ + H +++ ++
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGEL-QFQTEVEMISMAVHRNLLRLRG 94
Query: 90 IMLPPSKREFKDIYVVFELM-----ESDLHQVIKANDDL---TREHHQFFLYQM------ 135
+ P++R +V+ M S L + ++ L R
Sbjct: 95 FCMTPTER-----LLVYPYMANGSVASCLRERPESQPPLDWPKR---------QRIALGS 140
Query: 136 LRALKYMH---TANVYHRDLKPKNILANANCKLKVCDFGLARVA-FSDTPMTVFWTDYVA 191
R L Y+H + HRD+K NIL + + V DFGLA++ + DT +T T
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT---TAVRG 197
Query: 192 TRWYRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228
T + APE G K + D++ G + E++TG+
Sbjct: 198 TIGHIAPEYLSTG----KSSEKTDVFGYGVMLLELITGQ 232
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 8e-09
Identities = 61/406 (15%), Positives = 113/406 (27%), Gaps = 119/406 (29%)
Query: 43 IDTHTGE-KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101
+D TGE + K I VFE DA + K D+ ++ + +L SK E
Sbjct: 7 MDFETGEHQYQYKDILSVFE---DAFVDNFDCK--------DVQDMPKSIL--SKEEIDH 53
Query: 102 I----------YVVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLRA---------LK 140
I +F + S ++++ + L + FL ++
Sbjct: 54 IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYK--FLMSPIKTEQRQPSMMTRM 111
Query: 141 YMHTANVYHRD-----------LKPKNILANANCKLKVCD---------FG---LARVAF 177
Y+ + + D L+P L A +L+ G +A
Sbjct: 112 YIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVC 171
Query: 178 SDT------PMTVFWTDYVATRWYRAPE--------LCGSFFSKYTPAIDIWSIGCIFAE 223
+FW + + +PE L +T D S +
Sbjct: 172 LSYKVQCKMDFKIFW---LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH 228
Query: 224 VLTGKP--LFPGKSVVHQLDLITD-----------------LLGTPSPETIAVVRNEKAR 264
+ + L K + L L+ LL T + +
Sbjct: 229 SIQAELRRLLKSKPYENCL-LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTT 287
Query: 265 KYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA-DPYFKGL-AKI 322
+ LL + + P+D P E L +P + A+
Sbjct: 288 HISLDHHSMT----LTP-----DEVKSLLLKYLDCRPQDLP--REVLTTNPRRLSIIAES 336
Query: 323 EREPSCQPISKLEFEFER-RRVTKDDIRELIYREILEYHPQLLKDY 367
R+ ++ + V D + +I + P +
Sbjct: 337 IRDGLAT--------WDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 556 | |||
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.73 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.34 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.21 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.86 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.57 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.48 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.33 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.31 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.15 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.15 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.92 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.69 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.64 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.52 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.35 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.3 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.29 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.25 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.16 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.16 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.15 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.06 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.99 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.71 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.62 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.73 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.12 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.92 |
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-69 Score=567.20 Aligned_cols=342 Identities=48% Similarity=0.870 Sum_probs=298.1
Q ss_pred cccCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCC-C
Q 008729 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP-S 95 (556)
Q Consensus 17 ~~~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~-~ 95 (556)
..+..+++|++++.||+|+||+||+|+++.+|+.||||++.+.........++++|+++|+.|+|||||++++++... .
T Consensus 48 ~~~~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 127 (398)
T 4b99_A 48 VTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVP 127 (398)
T ss_dssp CCCCCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSC
T ss_pred CCCCCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccc
Confidence 344566799999999999999999999999999999999987766777788899999999999999999999998653 3
Q ss_pred CCCCceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 96 KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
+.+.+.+|||||||+|+|.++|..++.+++.+++.|++||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.
T Consensus 128 ~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 128 YGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp TTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred cccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence 35667899999999999999999999999999999999999999999999999999999999999999999999999986
Q ss_pred ccCCC-CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 176 AFSDT-PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 176 ~~~~~-~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
..... ........++||++|||||++.+. ..|+.++||||||||||||++|++||.+.+..+++..|....|.|+.+.
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHH
Confidence 53322 122234678999999999998763 4579999999999999999999999999999999999999999999998
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcc
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKL 334 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~ 334 (556)
+..........++..+....+.++...++.+++++.|||++||.+||++|||++|+|+||||+....++.+|.+.+ .+
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p~~~p~~~~--~~ 364 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDPDDEPDCAP--PF 364 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCGGGSCCCSS--CC
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCCccccCCCC--CC
Confidence 8887777788888888888888887888899999999999999999999999999999999999887777776554 45
Q ss_pred hhhHhhhcCCHHHHHHHHHHHHHhhCh
Q 008729 335 EFEFERRRVTKDDIRELIYREILEYHP 361 (556)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~e~~~~~~ 361 (556)
++.++....+.++++++++.|+.++|.
T Consensus 365 ~~~~~~~~~~~~~~k~~i~~ei~~~~~ 391 (398)
T 4b99_A 365 DFAFDREALTRERIKEAIVAEIEDFHA 391 (398)
T ss_dssp CCHHHHSCCCHHHHHHHHHHHHHHHHH
T ss_pred CCccchhhcCHHHHHHHHHHHHHHHHH
Confidence 667788889999999999999988764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-63 Score=503.64 Aligned_cols=259 Identities=25% Similarity=0.441 Sum_probs=225.7
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|+++++||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+++|+.|+|||||+++++| ++...
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 46999999999999999999999999999999997431 1223356789999999999999999999999 56678
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|||||||+ |+|.++|++.+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 999999999 6999999999999999999999999999999999999999999999999999999999999998754332
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
.. ....+.+||+.|||||++.+ ..|+.++||||||||||+|++|++||.+.+....+..|..
T Consensus 187 ~~-~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~--------------- 248 (311)
T 4aw0_A 187 KQ-ARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK--------------- 248 (311)
T ss_dssp TC-CCBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------------
T ss_pred Cc-ccccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc---------------
Confidence 22 22357899999999999988 7899999999999999999999999999887776666532
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHH------HHhCccccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE------ALADPYFKGLA 320 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~e------lL~hp~f~~~~ 320 (556)
... .....+++++++||++||++||++|||++| +++||||+++.
T Consensus 249 -----------~~~-----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id 298 (311)
T 4aw0_A 249 -----------LEY-----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 298 (311)
T ss_dssp -----------TCC-----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred -----------CCC-----CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence 111 122468999999999999999999999987 68999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-62 Score=507.35 Aligned_cols=256 Identities=29% Similarity=0.502 Sum_probs=223.2
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
+.|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+|+.+|+.|+|||||+++++| .+.+.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~ 146 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDEL 146 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 469999999999999999999999999999999964322 2334678999999999999999999999 555679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|||||||+ |+|.+++.. +.+++.+++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.......
T Consensus 147 ~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp EEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 99999999 699998876 5699999999999999999999999999999999999999999999999999987644322
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
..+..+||++|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|.+.
T Consensus 226 ---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~--------------- 285 (346)
T 4fih_A 226 ---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--------------- 285 (346)
T ss_dssp ---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---------------
T ss_pred ---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---------------
Confidence 2356889999999999987 78999999999999999999999999998877776665321
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
..+....+..+++++++||.+||++||++|||++|+|+||||+..
T Consensus 286 -------------~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 286 -------------LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp -------------SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -------------CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 111223345689999999999999999999999999999999864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-62 Score=491.06 Aligned_cols=254 Identities=31% Similarity=0.538 Sum_probs=208.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||+||+|+++.+|+.||||++++... ......++.+|+.+|+.|+|||||++++++ .+...
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECCE
Confidence 589999999999999999999999999999999975432 223355789999999999999999999999 55677
Q ss_pred EEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 102 IYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
+|||||||+|+|.+++..++.+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 88 ~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 88 IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp EEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998654322
Q ss_pred CcceecccccCcccCCcccccccCCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y-~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
...+.+||+.|||||++.+ ..| +.++|||||||+||+|++|++||.+.+....+..|..
T Consensus 167 ---~~~~~~GT~~Y~APE~~~~--~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~--------------- 226 (275)
T 3hyh_A 167 ---FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN--------------- 226 (275)
T ss_dssp -----------CTTSCHHHHSS--SSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------------
T ss_pred ---ccCCeeECcccCChhhhcC--CCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc---------------
Confidence 2356789999999999987 555 5899999999999999999999998876655554422
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
... .....+++++++||++||+.||++|||++|+|+||||+.
T Consensus 227 -----------~~~-----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 227 -----------GVY-----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -----------TCC-----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -----------CCC-----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 111 122458999999999999999999999999999999973
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-62 Score=508.31 Aligned_cols=258 Identities=27% Similarity=0.430 Sum_probs=220.6
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.|+|||||++++++ .+..
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~-----~~~~ 96 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESF-----EENG 96 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEE-----EECC
Confidence 45799999999999999999999999999999999986655666778899999999999999999999999 5567
Q ss_pred eEEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 101 DIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
.+|||||||+ |+|.++|... ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+...
T Consensus 97 ~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 176 (350)
T 4b9d_A 97 SLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLN 176 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCC
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeec
Confidence 7999999998 6999999764 357999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
... ...+..+||++|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|...
T Consensus 177 ~~~---~~~~~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~----------- 240 (350)
T 4b9d_A 177 STV---ELARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISG----------- 240 (350)
T ss_dssp HHH---HHHHHHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-----------
T ss_pred CCc---ccccccCCCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-----------
Confidence 221 12356789999999999988 78999999999999999999999999999877766665321
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
.. ......+++++.+||.+||+.||++|||++|+|+||||+.
T Consensus 241 ----------------~~---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 241 ----------------SF---PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK 282 (350)
T ss_dssp ----------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred ----------------CC---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence 11 1223568999999999999999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-61 Score=509.25 Aligned_cols=256 Identities=29% Similarity=0.497 Sum_probs=223.9
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
+.|++++.||+|+||+||+|+++.+|+.||||++.... ......+.+|+.+|+.|+|||||+++++| .+.+.+
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~-----~~~~~~ 223 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSY-----LVGDEL 223 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EECCEE
Confidence 57999999999999999999999999999999997432 22345688999999999999999999999 455679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|||||||+ |+|.++++. +.+++..++.|++||+.||+|||++||+||||||+||||+.+|.|||+|||+|+.......
T Consensus 224 ~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp EEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred EEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 99999999 699999875 5699999999999999999999999999999999999999999999999999987544322
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
..+..+||++|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|...
T Consensus 303 ---~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~--------------- 362 (423)
T 4fie_A 303 ---RRKSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN--------------- 362 (423)
T ss_dssp ---CBCCCEECTTTCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS---------------
T ss_pred ---cccccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC---------------
Confidence 2357789999999999987 78999999999999999999999999998877776665321
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
..+....+..+++++++||.+||++||++|||++|+|+||||+..
T Consensus 363 -------------~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 363 -------------LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp -------------CCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred -------------CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 112233456789999999999999999999999999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-60 Score=509.58 Aligned_cols=345 Identities=41% Similarity=0.718 Sum_probs=286.4
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
+...++|+++++||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.++||||+++++++.....+.
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 49 WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CCSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred CccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 34567999999999999999999999999999999999877777778889999999999999999999999997766667
Q ss_pred CceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
...+|+||||++++|.+++.....+++.+++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 129 ~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 129 FDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp CCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred CceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 78899999999999999999988999999999999999999999999999999999999999999999999999987532
Q ss_pred CCCC------------------------cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh--------
Q 008729 179 DTPM------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-------- 226 (556)
Q Consensus 179 ~~~~------------------------~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-------- 226 (556)
.... ....+.++||++|+|||++... ..|+.++||||||||||||++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 2111 1134677899999999986432 579999999999999999999
Q ss_pred ---CCCCCCCCC--------------------hHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCC
Q 008729 227 ---GKPLFPGKS--------------------VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP 283 (556)
Q Consensus 227 ---G~~pF~~~~--------------------~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 283 (556)
|+++|+|.+ ..+++..|.+++|.|+.+.+..+....+..++..+.......+...++
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 889998876 368899999999999999999999999999998888888888888899
Q ss_pred CCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhChhh
Q 008729 284 NVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQL 363 (556)
Q Consensus 284 ~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~ 363 (556)
.+++++.+||++||.+||++|||++|+|+||||+++...+.++.......+.+. +...++.+++++.+++|+..+++.+
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~~ 446 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFN-DWMNMDEPQLRYAFVKEIQRYHPEI 446 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSC-TTSCCCHHHHHHHHHHHHTTTCTTC
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhCccc
Confidence 999999999999999999999999999999999998776666544332222222 2356889999999999999998865
Q ss_pred hh
Q 008729 364 LK 365 (556)
Q Consensus 364 ~~ 365 (556)
..
T Consensus 447 ~~ 448 (458)
T 3rp9_A 447 QL 448 (458)
T ss_dssp CC
T ss_pred cC
Confidence 54
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-60 Score=482.40 Aligned_cols=260 Identities=25% Similarity=0.350 Sum_probs=218.5
Q ss_pred CCCe-EEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y-~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++| ++.++||+|+||+||+|+++.++..||||++...........++.+|+.+|+.|+|||||+++++|.... ....
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~ 102 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKK 102 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCc
Confidence 3455 8888999999999999999999999999999765556666778999999999999999999999985321 2346
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEeecC-CCceEEeeeCccccc
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANA-NCKLKVCDFGLARVA 176 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~-~~~vKL~DFGla~~~ 176 (556)
.+|||||||+ |+|.+++...+.+++..++.|+.||+.||+|||++| |+||||||+|||++. ++.+||+|||+|+..
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~ 182 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence 7999999999 699999999899999999999999999999999999 999999999999984 789999999999864
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
... .....+||+.|||||++.+ .|+.++||||||||||||+||++||.+.+....+...
T Consensus 183 ~~~-----~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~------------- 241 (290)
T 3fpq_A 183 RAS-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR------------- 241 (290)
T ss_dssp CTT-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH-------------
T ss_pred CCC-----ccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHH-------------
Confidence 322 2356789999999999865 6999999999999999999999999876654433221
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
+..... + ......+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 242 -------------i~~~~~-~-~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 242 -------------VTSGVK-P-ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp -------------HTTTCC-C-GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred -------------HHcCCC-C-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 111111 0 1112357899999999999999999999999999999974
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-62 Score=494.88 Aligned_cols=259 Identities=27% Similarity=0.452 Sum_probs=217.2
Q ss_pred CCCCeEEEeeeeecCceeEEEEEEC---CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
+.++|++++.||+|+||+||+|++. .+++.||||++++......+..++.+|+.+|+.|+|||||++++++ .
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~ 96 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF-----Q 96 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE-----E
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----E
Confidence 3468999999999999999999984 4788999999975433333344678999999999999999999999 5
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
+...+|||||||+ |+|.++|.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 97 ~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 97 TEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp ETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred ECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 5677999999999 699999999999999999999999999999999999999999999999999999999999999864
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
..... .....+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|.+
T Consensus 177 ~~~~~---~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~----------- 240 (304)
T 3ubd_A 177 IDHEK---KAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK----------- 240 (304)
T ss_dssp ----C---CCCSCCCCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-----------
T ss_pred cCCCc---cccccccCcccCCHHHhcc--CCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc-----------
Confidence 33222 2356789999999999987 7899999999999999999999999999987776666532
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHhCccccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGLA 320 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-----a~elL~hp~f~~~~ 320 (556)
... ..+..+++++++||++||++||++||| ++|+|+||||+++.
T Consensus 241 ---------------~~~-----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 241 ---------------AKL-----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp ---------------CCC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ---------------CCC-----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 111 123468999999999999999999998 58999999999764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-59 Score=502.22 Aligned_cols=347 Identities=37% Similarity=0.676 Sum_probs=296.4
Q ss_pred cccCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 17 ~~~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
..+...++|++++.||+|+||.||+|++..+++.||||++...+.......++.+|+.+|+.++||||+++++++.....
T Consensus 20 ~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 20 KNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp GGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence 34556789999999999999999999999999999999998777777788899999999999999999999999977655
Q ss_pred CCCceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 97 REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
.....+|+|||||+++|.+++.....+++.+++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 100 ~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 100 LKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp TTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred CcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 56678999999999999999999888999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCC-------------------cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-----------
Q 008729 177 FSDTPM-------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT----------- 226 (556)
Q Consensus 177 ~~~~~~-------------------~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt----------- 226 (556)
...... ....+.++||++|+|||++... ..|+.++||||||||||||++
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhccccccccccc
Confidence 433211 0234678999999999986432 579999999999999999997
Q ss_pred CCCCCCCCC-----------------hHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHH
Q 008729 227 GKPLFPGKS-----------------VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLA 289 (556)
Q Consensus 227 G~~pF~~~~-----------------~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~ 289 (556)
|.++|++.+ ..+++..|.+++|.|+.+.+..+....+..++..+......++...++.+++.+
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 338 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 677777765 478999999999999999999999999999999888888888878888999999
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhChhhhh
Q 008729 290 LRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLK 365 (556)
Q Consensus 290 ~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~ 365 (556)
.+||++||.+||++|||++|+|+||||+++.....++.+.....+.+. +....+.+++++.+++|+..+++++..
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~e~~~~~~~~~~ 413 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD-DWMVLSETQLRYIFLKEVQSFHPELVI 413 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSC-TTCCCCHHHHHHHHHHHHHHHCTTCCC
T ss_pred HHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChh-hcccCCHHHHHHHHHHHHHHhCccccC
Confidence 999999999999999999999999999998776666544322222222 225689999999999999999987653
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-60 Score=486.57 Aligned_cols=257 Identities=26% Similarity=0.352 Sum_probs=217.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+|+.|+|||||++++++ .+...
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~-----~~~~~ 124 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAV-----REGPW 124 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEE-----EETTE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEE-----EECCE
Confidence 4579999999999999999999999999999999975321 24799999999999999999999 55677
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC-ceEEeeeCccccccCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAFSD 179 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~vKL~DFGla~~~~~~ 179 (556)
+|||||||+ |+|.++|+..+.+++.+++.|+.||+.||+|||++||+||||||+||||+.+| .+||+|||+|+....+
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999 69999999989999999999999999999999999999999999999999987 6999999999875433
Q ss_pred CCCcc--eecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 180 TPMTV--FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 180 ~~~~~--~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
..... .....+||+.|||||++.+ ..|+.++||||||||||||++|++||.+.+....+..|..
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------------ 270 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------------ 270 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------------
T ss_pred CcccceecCCccccCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------------
Confidence 22111 1234679999999999988 7899999999999999999999999998776555544422
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHH-------------HhCccccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA-------------LADPYFKGLA 320 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~el-------------L~hp~f~~~~ 320 (556)
...+....++.+++.+.+||.+||++||++|||+.|+ |+|||+....
T Consensus 271 ----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 271 ----------------EPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp ----------------SCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred ----------------CCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 1122334557899999999999999999999999997 5799997654
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-58 Score=478.67 Aligned_cols=334 Identities=40% Similarity=0.742 Sum_probs=283.7
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC-CC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KR 97 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~-~~ 97 (556)
+...++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++.... ..
T Consensus 21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 45568999999999999999999999999999999999776666667788999999999999999999999996542 23
Q ss_pred CCceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
+...+|+|||||+++|.+++.. +.+++.+++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 101 DFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp TCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 4467899999999899999986 579999999999999999999999999999999999999999999999999998753
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.. .+.++||++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..+++..|.+.+|.|+.+.+..
T Consensus 180 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 252 (367)
T 1cm8_A 180 SE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 252 (367)
T ss_dssp SS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred cc------cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 22 2567899999999988753 4689999999999999999999999999999999999999999999999999
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhh
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFE 337 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~ 337 (556)
+.....+.++..+.......+...++.+++.+.+||.+||.+||.+|||++++|+||||+.+...+.++... .+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~---~~~~~ 329 (367)
T 1cm8_A 253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ---KYDDS 329 (367)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC---CCCCC
T ss_pred hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCCccCCCCC---CCCCC
Confidence 999999999998888777788888889999999999999999999999999999999999988777666654 34556
Q ss_pred HhhhcCCHHHHHHHHHHHHHhhChhh
Q 008729 338 FERRRVTKDDIRELIYREILEYHPQL 363 (556)
Q Consensus 338 ~~~~~~~~~~~~~~~~~e~~~~~~~~ 363 (556)
++....+.+++++.++.++..++++.
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (367)
T 1cm8_A 330 FDDVDRTLDEWKRVTYKEVLSFKPPR 355 (367)
T ss_dssp -----CCHHHHHHHHHHHHHTCCC--
T ss_pred hhhhcCCHHHHHHHHHHHHHHhcccc
Confidence 67778899999999999999988763
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-58 Score=483.52 Aligned_cols=338 Identities=39% Similarity=0.738 Sum_probs=271.5
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.+. ||||+++++++... +...
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~~ 85 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDRD 85 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSSC
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCCE
Confidence 5899999999999999999999999999999999877777788889999999999997 99999999998642 3457
Q ss_pred EEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC-
Q 008729 102 IYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT- 180 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~- 180 (556)
+|+|||||+++|.+++.. +.+++.+++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 86 VYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 999999999999999986 479999999999999999999999999999999999999999999999999998643211
Q ss_pred -----------------CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 008729 181 -----------------PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243 (556)
Q Consensus 181 -----------------~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i 243 (556)
......+.++||++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..+++..|
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 111234567899999999998753 56899999999999999999999999999999999999
Q ss_pred HHhhCCCChHHHHHhhhHHHHHHHHHhhcCC---CCCcCCCC-------------CCCCHHHHHHHHHhhhcCCCCCCCH
Q 008729 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKP---PVPLFQKF-------------PNVDPLALRLLQRLIAFDPKDRPTA 307 (556)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~---~~~~~~~~-------------~~~s~~~~dLl~~~L~~dP~~Rpta 307 (556)
...+|.|..+.+..+.......++..+.... .......+ ..+++.+.+||++||++||++|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 9999999999988777666666655544332 22222222 2689999999999999999999999
Q ss_pred HHHHhCccccccccccCCCCCCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhChhhhhh
Q 008729 308 EEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLKD 366 (556)
Q Consensus 308 ~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~ 366 (556)
+|+|+||||+.+.....++.+.......+. +....+.+++++.+|.++.++++++..+
T Consensus 324 ~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (388)
T 3oz6_A 324 NDALKHPFVSIFHNPNEEPNCDHIITIPIN-DNVKHSIDDYRNLVYSEISRRKRELISN 381 (388)
T ss_dssp HHHTTSTTTTTTCCGGGCCCCSSCCCCC-------CCHHHHHHHHHHHHHHHHHHHTCC
T ss_pred HHHhCCHHHHHhcCCccCCCCCCCCCCCcc-ccccCCHHHHHHHHHHHHHHhhhhhhhh
Confidence 999999999998877777766554333332 2345788999999999999988876654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=483.68 Aligned_cols=285 Identities=28% Similarity=0.449 Sum_probs=224.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEEC---CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~ 97 (556)
.++|++++.||+|+||+||+|+++ .+++.||||++... ....++.+|+++|+.+ +||||++++++| .
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~-----~ 90 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCF-----R 90 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEE-----E
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEE-----E
Confidence 368999999999999999999875 46789999998643 2345688999999998 699999999999 5
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC-CceEEeeeCcccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARV 175 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~vKL~DFGla~~ 175 (556)
+..++|||||||+ |+|.+++. .+++.+++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 5678999999998 69999984 59999999999999999999999999999999999999877 7999999999976
Q ss_pred ccCCCCC-------------------------cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCC
Q 008729 176 AFSDTPM-------------------------TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230 (556)
Q Consensus 176 ~~~~~~~-------------------------~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~p 230 (556)
....... ....+..+||++|||||++.+. ..|+.++||||+|||+|+|++|++|
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCC
Confidence 4322110 1123457899999999998762 4589999999999999999999988
Q ss_pred C-CCCChHHHHHHHHHhhCCCChHHHHHhh-----------hHHHHHHHHHhhcC------------CCCCcCCCCCCCC
Q 008729 231 F-PGKSVVHQLDLITDLLGTPSPETIAVVR-----------NEKARKYLTEMRKK------------PPVPLFQKFPNVD 286 (556)
Q Consensus 231 F-~~~~~~~~~~~i~~~~g~p~~e~i~~~~-----------~~~~~~~l~~~~~~------------~~~~~~~~~~~~s 286 (556)
| .+.+..+++..|..++|++......... ....+...+.+... ........+..++
T Consensus 247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is 326 (361)
T 4f9c_A 247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP 326 (361)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence 7 6778889999999999976443322110 01111111111110 0111223467899
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 287 PLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 287 ~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
++++|||++||++||++|+|++|+|+||||+++
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 999999999999999999999999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-57 Score=476.34 Aligned_cols=333 Identities=42% Similarity=0.797 Sum_probs=279.4
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCC-CCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP-SKRE 98 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~-~~~~ 98 (556)
...++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+.+|+.++||||+++++++... ....
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 345799999999999999999999999999999999987666667788899999999999999999999998654 2234
Q ss_pred CceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
...+|+|||+++++|.+++.. +.+++.+++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 106 FNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 567899999999999998876 5799999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
. .+.++||++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..+++..|.+.+|.|..+.+..+
T Consensus 185 ~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 185 E------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp ------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred c------CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 2 2457899999999998753 56899999999999999999999999999999999999999999999999999
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhH
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEF 338 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~ 338 (556)
....++.++..+......++...++.+++.+.+||++||.+||++|||++++|+||||+.+..++.++...+ +++.+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~~~~~~~~---~~~~~ 334 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADP---YDQSL 334 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGGGCCCCCC---CCGGG
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCCCCCCCCC---CCcch
Confidence 999999999888777777777778889999999999999999999999999999999999887777766553 45666
Q ss_pred hhhcCCHHHHHHHHHHHHHhhChhh
Q 008729 339 ERRRVTKDDIRELIYREILEYHPQL 363 (556)
Q Consensus 339 ~~~~~~~~~~~~~~~~e~~~~~~~~ 363 (556)
+......+.+++++|.|+..+++..
T Consensus 335 ~~~~~~~~~~~~~~~~e~~~~~~~~ 359 (367)
T 2fst_X 335 ESRDLLIDEWKSLTYDEVISFVPPP 359 (367)
T ss_dssp SSCCCCHHHHHHHHHHHHHHCCCCC
T ss_pred hhccCCHHHHHHHHHHHHHHhccCc
Confidence 7778899999999999999988764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-57 Score=488.51 Aligned_cols=330 Identities=36% Similarity=0.675 Sum_probs=262.7
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC-CCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~~ 100 (556)
.++|++++.||+|+||+||+|++..+|+.||||++...........++.+|+.+|+.++||||+++++++..... ++..
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 579999999999999999999999999999999998766677778889999999999999999999999975432 4557
Q ss_pred eEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 101 DIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
.+|||||||+++|.+.+.. .+++.+++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 141 ~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 218 (464)
T 3ttj_A 141 DVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218 (464)
T ss_dssp EEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC
T ss_pred eEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc
Confidence 8999999999999988854 59999999999999999999999999999999999999999999999999998654322
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
..+.++||++|+|||++.+ ..|+.++||||||||||+|++|++||.+.+..+++..|.+.+|.|.++.+..+.
T Consensus 219 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~- 291 (464)
T 3ttj_A 219 ----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ- 291 (464)
T ss_dssp ----CC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC-
T ss_pred ----ccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc-
Confidence 2356789999999999988 689999999999999999999999999999999999999999999999877654
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCC------------CHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCC
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNV------------DPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSC 328 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~------------s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~ 328 (556)
...+.++..........+...++.. ++.+.+||++||.+||++|||++|+|+||||+.+........
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~~~~~- 370 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEA- 370 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHSC-
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccCcccccC-
Confidence 4455555443333333322222221 578999999999999999999999999999997654432221
Q ss_pred CCCCcchhhHhhhcCCHHHHHHHHHHHHHhhCh
Q 008729 329 QPISKLEFEFERRRVTKDDIRELIYREILEYHP 361 (556)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 361 (556)
.+....++.++....+.+++++.+++++..++.
T Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 403 (464)
T 3ttj_A 371 PPPQIYDKQLDEREHTIEEWKELIYKEVMNSEE 403 (464)
T ss_dssp CC-----------CCCHHHHHHHHHHHHHC---
T ss_pred CCCccCCcchhhccCCHHHHHHHHHHHHHHhhh
Confidence 112234455667778899999999999876543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-57 Score=459.46 Aligned_cols=262 Identities=27% Similarity=0.433 Sum_probs=200.8
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC-------
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK------- 96 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~------- 96 (556)
+|++++.||+|+||+||+|+++.+|+.||||+++.. .......++.+|+.+|+.|+|||||++++++...+.
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC-SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 599999999999999999999999999999998643 234455678999999999999999999999864321
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKANDD---LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~---l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGl 172 (556)
....++|||||||. |+|.+++...+. ..+..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGl 164 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGL 164 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCcc
Confidence 12346899999998 699999987654 34566889999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCc---------ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 008729 173 ARVAFSDTPMT---------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLI 243 (556)
Q Consensus 173 a~~~~~~~~~~---------~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i 243 (556)
|+......... ...++.+||+.|||||++.+ ..|+.++||||||||||||++ ||.+. .+....+
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~ 237 (299)
T 4g31_A 165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY---PFSTQ--MERVRTL 237 (299)
T ss_dssp C--------------------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHH
T ss_pred ceecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHH
Confidence 98754332211 12345789999999999988 789999999999999999996 77543 2223222
Q ss_pred HHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
........+ ..++..++.+.+||++||+.||++|||++|+|+||||+++.
T Consensus 238 ~~~~~~~~p---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~ 287 (299)
T 4g31_A 238 TDVRNLKFP---------------------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287 (299)
T ss_dssp HHHHTTCCC---------------------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred HHHhcCCCC---------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence 221111111 11123567789999999999999999999999999998763
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-55 Score=458.07 Aligned_cols=339 Identities=46% Similarity=0.824 Sum_probs=288.8
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
+..+++|++++.||+|+||.||+|.+..+++.||||++... ........+.+|+.+|+.++||||+++++++.......
T Consensus 23 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp CCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred ccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 45668999999999999999999999999999999999742 34455678899999999999999999999997665556
Q ss_pred CceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
...+|+||||++++|.+++.. +.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 102 MKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 180 (364)
T ss_dssp CCCEEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred cceEEEEEcccCcCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence 678999999999999999976 4699999999999999999999999999999999999999999999999999987544
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
...........+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..|...+|.|..+.+..+
T Consensus 181 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 181 DHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 33322233566899999999987542 56899999999999999999999999999999999999999999999999988
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhH
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEF 338 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~ 338 (556)
.+.....+...+......++...++.+++.+.+||++||++||++|||++|+|+||||+.......++.... .+.+..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~--~~~~~~ 337 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEA--PFKFDM 337 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSS--CCCCC-
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCcccccCCCC--cCCccc
Confidence 888888888877777777777777889999999999999999999999999999999998765444443332 233444
Q ss_pred hhhcCCHHHHHHHHHHHHHhhChh
Q 008729 339 ERRRVTKDDIRELIYREILEYHPQ 362 (556)
Q Consensus 339 ~~~~~~~~~~~~~~~~e~~~~~~~ 362 (556)
+...+.++++++.+++++..+++.
T Consensus 338 ~~~~~~~~~~~~~~~~e~~~~~~~ 361 (364)
T 3qyz_A 338 ELDDLPKEKLKELIFEETARFQPG 361 (364)
T ss_dssp ----CCHHHHHHHHHHHTGGGCC-
T ss_pred ccccCCHHHHHHHHHHHHHHhhhh
Confidence 566788999999999999887765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=487.23 Aligned_cols=259 Identities=25% Similarity=0.407 Sum_probs=226.7
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||+||+|+++.+|+.||||++.. ....+...+.+|+.+|+.|+|||||+++++| .+...+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~ 229 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEM 229 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEec--cchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEE
Confidence 589999999999999999999999999999999875 3445667789999999999999999999999 566789
Q ss_pred EEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC--CceEEeeeCccccccC
Q 008729 103 YVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN--CKLKVCDFGLARVAFS 178 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~--~~vKL~DFGla~~~~~ 178 (556)
|||||||+ |+|+++|.. .+.+++.+++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+....
T Consensus 230 ~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 230 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp EEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred EEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 99999998 699999964 4689999999999999999999999999999999999999854 8999999999987643
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.. .....+||++|||||++.+ ..|+.++||||||||||+|++|++||.+.+..+.+..|.....
T Consensus 310 ~~----~~~~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~---------- 373 (573)
T 3uto_A 310 KQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW---------- 373 (573)
T ss_dssp TS----EEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCC----------
T ss_pred CC----ceeeeEECccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCC----------
Confidence 32 2356789999999999988 7899999999999999999999999999988777766643211
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~ 321 (556)
......++.+++++++||++||++||.+|||++|+|+||||+....
T Consensus 374 -----------------~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 374 -----------------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp -----------------CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred -----------------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 1122345679999999999999999999999999999999987543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=485.93 Aligned_cols=261 Identities=24% Similarity=0.356 Sum_probs=215.5
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc----CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF----EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~----~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
..++|+++++||+|+||+||+|+++.+|+.||||++.+.. ..........+++.+++.++|||||+++++|
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f----- 261 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF----- 261 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE-----
Confidence 3468999999999999999999999999999999996421 1112222333456677778999999999999
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
.+...+|||||||. |+|+++|...+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.
T Consensus 262 ~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 262 HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 55677999999999 69999999999999999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
..... ....+||+.|||||++.+. ..|+.++||||||||||||++|++||.+.+..+....+...
T Consensus 342 ~~~~~-----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i--------- 406 (689)
T 3v5w_A 342 FSKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--------- 406 (689)
T ss_dssp CSSCC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH---------
T ss_pred cCCCC-----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh---------
Confidence 54332 2457899999999998641 57999999999999999999999999875433222111100
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHhCccccccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGLA 320 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-----a~elL~hp~f~~~~ 320 (556)
+.... ..+..+++++++||.+||+.||.+|++ ++||++||||+++.
T Consensus 407 --------------~~~~~-----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 407 --------------LTMAV-----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp --------------HHCCC-----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred --------------cCCCC-----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 11111 223568999999999999999999998 89999999999874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=442.63 Aligned_cols=257 Identities=25% Similarity=0.346 Sum_probs=213.7
Q ss_pred CCCeEEEeeeeecCceeEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
.++|.+.+.||+|+||+||+|.+. .++..||||+++. ........+.+|+++|++|+|||||++++++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~----- 84 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIVKFYGVC----- 84 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC--CChHHHHHHHHHHHHHHhCCCCCCccEEEEE-----
Confidence 457999999999999999999875 4688999999975 3445567899999999999999999999999
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC
Q 008729 97 REFKDIYVVFELME-SDLHQVIKAN-------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN 162 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~-------------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~ 162 (556)
.+...+|||||||+ |+|.++|..+ ..+++..+..|+.||+.||.|||+++|+||||||+|||++.+
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 44567999999999 7999999764 369999999999999999999999999999999999999999
Q ss_pred CceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHH
Q 008729 163 CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLD 241 (556)
Q Consensus 163 ~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~ 241 (556)
+.+||+|||+|+........ ......+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+.
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 241 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYY-RVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 241 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCE-EETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred CcEEECCcccceecCCCCce-eecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999865332211 11234569999999999987 789999999999999999998 899999988766655
Q ss_pred HHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 242 ~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.|... .. ......+++++.+|+.+||+.||++|||++++ |+|++.+.
T Consensus 242 ~i~~~---------------------------~~---~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~~ 288 (299)
T 4asz_A 242 CITQG---------------------------RV---LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNLA 288 (299)
T ss_dssp HHHHT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHHH
T ss_pred HHHcC---------------------------CC---CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHHH
Confidence 54321 11 11234689999999999999999999999999 45777653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=440.85 Aligned_cols=258 Identities=22% Similarity=0.283 Sum_probs=208.3
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
+.++|++.+.||+|+||+||+|++. ..||||+++...........+.+|+.+|+.|+|||||++++++.. .
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~------~ 104 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK------D 104 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS------S
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC------C
Confidence 3468999999999999999999754 359999997655566677789999999999999999999998732 3
Q ss_pred eEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 101 DIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.+|||||||+ |+|.++|... +.+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 4899999999 7999999764 5799999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcceecccccCcccCCccccccc-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... ......+||+.|||||++.+. ...|+.++|||||||+||||+||+.||.+.+....+..+..
T Consensus 185 ~~~~-~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~------------ 251 (307)
T 3omv_A 185 WSGS-QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVG------------ 251 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH------------
T ss_pred CCcc-eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHh------------
Confidence 2211 123557899999999998642 24689999999999999999999999998776554433321
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
...........++++++.+.+|+.+||+.||++|||+.|++++
T Consensus 252 -------------~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 252 -------------RGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp -------------TTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred -------------cCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0111112234456789999999999999999999999988654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-53 Score=446.77 Aligned_cols=331 Identities=40% Similarity=0.735 Sum_probs=279.4
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC-CC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-RE 98 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~ 98 (556)
...++|.+++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++..... ..
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 34579999999999999999999999999999999998766666667889999999999999999999999965432 22
Q ss_pred CceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
...+|+||||++++|.+++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 119 ~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 119 FYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred ceeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 23459999999999998884 4599999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
. ....+||++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....|.|..+.+..+
T Consensus 197 ~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 197 E------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred C------cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence 2 2456799999999988653 46899999999999999999999999999999999999999999999998888
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhH
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEF 338 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~ 338 (556)
.......++..+.......+...++.+++.+.+||++||+.||++|||++|+|+||||+.+...+.+..... .+....
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~~--~~~~~~ 347 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFDDSL 347 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CCCCTT
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCccccccccc--CcCcch
Confidence 877777888777766666666667789999999999999999999999999999999998765444332221 122234
Q ss_pred hhhcCCHHHHHHHHHHHHHhhCh
Q 008729 339 ERRRVTKDDIRELIYREILEYHP 361 (556)
Q Consensus 339 ~~~~~~~~~~~~~~~~e~~~~~~ 361 (556)
+....+.+++++.+++++.+++|
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~ 370 (371)
T 4exu_A 348 EHEKLTVDEWKQHIYKEIVNFSP 370 (371)
T ss_dssp SSCCCCHHHHHHHHHHHHHHCCC
T ss_pred hhcccchHHHHHHHHHHHHhccc
Confidence 55678899999999999988765
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-54 Score=442.31 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=205.4
Q ss_pred CCeEEEeeeeecCceeEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
++|.+.++||+|+||+||+|++. .+++.||||+++. ........+.+|+.+|+.|+|||||++++++ .
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~-----~ 113 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVC-----T 113 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 57899999999999999999865 4688999999975 3445567899999999999999999999999 4
Q ss_pred CCceEEEEEecCc-ccHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAN---------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~---------------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~ 161 (556)
+...+|||||||+ |+|.+++... +.+++.++..|+.||+.||.|||+++|+||||||+|||++.
T Consensus 114 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 114 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 5567999999999 7999999754 35899999999999999999999999999999999999999
Q ss_pred CCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 008729 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQL 240 (556)
Q Consensus 162 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~ 240 (556)
++.+||+|||+|+........ ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |+.||.+.+..+.+
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~-~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 270 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270 (329)
T ss_dssp TTEEEECCCC-----------------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred CCcEEEcccccceeccCCCcc-eecCcccccccccChhhhcC--CCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 999999999999865332211 12245679999999999988 789999999999999999999 89999998876666
Q ss_pred HHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 241 ~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
..|... .. ......+++++.+|+.+||+.||++|||++|++++
T Consensus 271 ~~i~~g---------------------------~~---~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 271 DCITQG---------------------------RE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHT---------------------------CC---CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHcC---------------------------CC---CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 554321 01 11234689999999999999999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=435.03 Aligned_cols=336 Identities=43% Similarity=0.806 Sum_probs=275.4
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
+...++|++++.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+|+.++||||+++++++.......
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence 34567999999999999999999999999999999999642 34455667889999999999999999999987665556
Q ss_pred CceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
...+|+||||++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 86 FNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred cceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 678999999999999999986 5799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCc-------ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 008729 179 DTPMT-------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (556)
Q Consensus 179 ~~~~~-------~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (556)
..... ......+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+++..+....|.|.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ---------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred ccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 22111 112346799999999987542 5689999999999999999999999999999999999999999886
Q ss_pred hH-HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCC
Q 008729 252 PE-TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQP 330 (556)
Q Consensus 252 ~e-~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~ 330 (556)
.. ............++..+......+....++.+++.+.+||++||..||++|||++++|+||||+.......++...+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~ 323 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPNDEPEGEP 323 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSSCCCCC
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcccccccCC
Confidence 43 33334445556666655554444455556789999999999999999999999999999999998776555554444
Q ss_pred CC--cchhhHhhhcCCHHHHHHHHHHHHH
Q 008729 331 IS--KLEFEFERRRVTKDDIRELIYREIL 357 (556)
Q Consensus 331 ~~--~~~~~~~~~~~~~~~~~~~~~~e~~ 357 (556)
++ .+++.......+.+++++.++.|+.
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 2b9h_A 324 IPPSFFEFDHYKEALTTKDLKKLIWNEIF 352 (353)
T ss_dssp CCGGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred CCcceeeecchhhcCCHHHHHHHHHHHhh
Confidence 43 3444445667899999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-53 Score=437.00 Aligned_cols=252 Identities=21% Similarity=0.332 Sum_probs=210.2
Q ss_pred CCeEEEeeeeecCceeEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
..+++++.||+|+||+||+|... .+++.||||+++... .......+.+|+.+|+.|+|||||++++++ .
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~-----~ 99 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVV-----T 99 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE-----C
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEE-----E
Confidence 46999999999999999999853 467899999997542 223446789999999999999999999999 4
Q ss_pred CCceEEEEEecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~ 160 (556)
+...+|||||||+ |+|.++|..+ ..+++..+..|+.||+.||.|||+++|+||||||+|||++
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 4556899999999 7999999753 3589999999999999999999999999999999999999
Q ss_pred CCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHH
Q 008729 161 ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239 (556)
Q Consensus 161 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~ 239 (556)
+++.+||+|||+|+........ ...+..+||+.|||||++.+ ..|+.++|||||||+||||+| |..||.+.+..+.
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~ 256 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYY-KLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 256 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCB-CSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred CCCCEEECCcccceeccCCCce-eEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999865432211 12245679999999999987 789999999999999999998 8999999887666
Q ss_pred HHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 240 ~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
+..|.. .... .....+++.+.+|+.+||+.||++|||+.|++++
T Consensus 257 ~~~i~~---------------------------~~~~---~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 257 VEMIRN---------------------------RQVL---PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHT---------------------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHc---------------------------CCCC---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 555422 1111 1234689999999999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=436.04 Aligned_cols=330 Identities=40% Similarity=0.735 Sum_probs=278.9
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC-CCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~ 99 (556)
..++|.+.+.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++..... ...
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 3478999999999999999999999999999999998665566667788999999999999999999999965421 123
Q ss_pred ceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
..+|+||||++++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 102 ~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 102 YDFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp CCCEEEEECCSEEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eeEEEEeccccCCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 4579999999999988774 35999999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....|.|..+.+..+.
T Consensus 180 ------~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 180 ------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp ----------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred ------ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 2456799999999988652 468899999999999999999999999999999999999999999999888888
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhHh
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFE 339 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~~ 339 (556)
......++..+.......+...++.+++.+.+||.+||..||++|||++++|+||||+.+...+.++.... .+....+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~--~~~~~~~ 330 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPEEETEAQQ--PFDDSLE 330 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGGGCCCCSS--CCCCTTT
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCccccccCCC--CCccchh
Confidence 77777787777666666666677889999999999999999999999999999999998765544433221 2334455
Q ss_pred hhcCCHHHHHHHHHHHHHhhCh
Q 008729 340 RRRVTKDDIRELIYREILEYHP 361 (556)
Q Consensus 340 ~~~~~~~~~~~~~~~e~~~~~~ 361 (556)
....+.+++++.+++++.++++
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T 3coi_A 331 HEKLTVDEWKQHIYKEIVNFSP 352 (353)
T ss_dssp TCCCCHHHHHHHHHHHHHTCCC
T ss_pred hccCCHHHHHHHHHHHHHhhcc
Confidence 6788999999999999987654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=440.79 Aligned_cols=328 Identities=37% Similarity=0.670 Sum_probs=254.2
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC-CCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~~ 100 (556)
.++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++.... ..+..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 47999999999999999999999999999999999866556667778999999999999999999999996543 23445
Q ss_pred eEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 101 DIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
.+|+|||||+++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 104 ~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 104 DVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181 (371)
T ss_dssp EEEEEEECCSEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred ceEEEEEcCCCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence 899999999999999986 458999999999999999999999999999999999999999999999999998653321
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
.....+||+.|+|||++.+ ..|+.++||||||||+|+|++|+.||.+.+..+++..+.+.+|.|.++.+..+..
T Consensus 182 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 255 (371)
T 2xrw_A 182 ----MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP 255 (371)
T ss_dssp ------------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred ----ccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 2245679999999999987 6899999999999999999999999999999999999999999998887765432
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCC------------CCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccC-CCC
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPN------------VDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIER-EPS 327 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~------------~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~-~~~ 327 (556)
....++..........+...++. .++.+.+||++||..||++|||++|+|+||||+....... +..
T Consensus 256 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~ 334 (371)
T 2xrw_A 256 -TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAP 334 (371)
T ss_dssp -HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCHHHHTCC
T ss_pred -HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCccccCCC
Confidence 23333332221111111111111 2568999999999999999999999999999987543221 111
Q ss_pred CCCCCcchhhHhhhcCCHHHHHHHHHHHHHhhC
Q 008729 328 CQPISKLEFEFERRRVTKDDIRELIYREILEYH 360 (556)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 360 (556)
.+.+ .....+.+..+.++++++++.++..+.
T Consensus 335 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (371)
T 2xrw_A 335 PPKI--PDKQLDEREHTIEEWKELIYKEVMDLE 365 (371)
T ss_dssp CCCC--CTTTTCCCCCCHHHHHHHHHHHHHHHC
T ss_pred CCCC--CChhhccccCcHHHHHHHHHHHHHHHh
Confidence 1111 122334556788999999999987653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=429.10 Aligned_cols=290 Identities=39% Similarity=0.661 Sum_probs=236.4
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
-+..++|++++.||+|+||+||+|.+. +|+.||||++............+.+|+.+|+.++||||+++++++ .+
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~ 90 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HS 90 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CC
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----cc
Confidence 356689999999999999999999985 599999999975444444556788999999999999999999999 55
Q ss_pred CceEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
...+|+|||||+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 91 ERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp SSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred CCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 5679999999999999988775 459999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... .....+||+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+.+..+...++.|.+..+..
T Consensus 171 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 171 IPVR---SYTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246 (311)
T ss_dssp SCCC------CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGG
T ss_pred CCcc---cccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhh
Confidence 3221 12456799999999998652 4689999999999999999999999999999999999999999998776654
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
......... .........++....+.+++++.+||++||++||++|||++|+|+||||+++
T Consensus 247 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 247 VQELPLWKQ-RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp GTTSHHHHS-CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hhccchhhh-cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 432211100 0000111112223345788999999999999999999999999999999975
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-52 Score=430.20 Aligned_cols=258 Identities=26% Similarity=0.483 Sum_probs=226.2
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||.||+|.+..+|+.||||++...........++.+|+++|+.++||||+++++++ ....
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECC
Confidence 34689999999999999999999999999999999987666667778899999999999999999999999 5567
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+|||||+ ++|.+++..++.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 7999999997 699999998889999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcceecccccCcccCCcccccccCCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y-~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
. .....+||++|+|||++.+ ..+ +.++|||||||++|+|++|++||.+.+..+....+..
T Consensus 168 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~------------- 228 (328)
T 3fe3_A 168 G----KLDAFCGAPPYAAPELFQG--KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR------------- 228 (328)
T ss_dssp C----GGGTTSSSGGGCCHHHHHT--CCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------------
T ss_pred C----ccccccCCcceeCcccccC--CCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------------
Confidence 2 2356789999999999987 455 4899999999999999999999999887665555422
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.... ....+++++.+||++||..||.+|||++|+|+||||+...
T Consensus 229 -------------~~~~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 229 -------------GKYR-----IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp -------------CCCC-----CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred -------------CCCC-----CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 1111 1235789999999999999999999999999999998654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-52 Score=421.87 Aligned_cols=279 Identities=38% Similarity=0.643 Sum_probs=236.3
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||+||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++ .+...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEE-----EeCCEE
Confidence 589999999999999999999999999999999976555555667888999999999999999999999 455679
Q ss_pred EEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+|||||+++|.+.+.. ++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 156 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred EEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence 99999999988887765 67899999999999999999999999999999999999999999999999999986533222
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCC-CCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~-~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
.....+||+.|+|||++.+. ..|+.++|||||||++|+|++|. ++|.+.+..+.+..+...++.|..+.+.....
T Consensus 157 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 157 ---CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp ---CCCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred ---cccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 22456799999999998762 34899999999999999999876 45788888999999999999988776543221
Q ss_pred HHHHHHHHHhhcCC-------CCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 261 EKARKYLTEMRKKP-------PVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 261 ~~~~~~l~~~~~~~-------~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
+.... ........+.+++.+.+||++||+.||++|||++|+|+||||+++
T Consensus 233 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 233 ---------LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp ---------STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ---------cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 11111 111223445789999999999999999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=435.55 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=210.8
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCC-----CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCC-CCcceeeEEEcCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHT-----GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH-PDIVEIKRIMLPPS 95 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~t-----g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H-pnIv~l~~v~~~~~ 95 (556)
.++|++++.||+|+||+||+|.+..+ ++.||||++... ........+.+|+++|..+.| ||||++++++..
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~-- 139 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK-- 139 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC--
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEe--
Confidence 35899999999999999999997654 368999999753 334556779999999999965 999999999842
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEe
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL 158 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NIL 158 (556)
....+|||||||+ |+|.++|++. ..+++.++..|+.||+.||+|||+++|+||||||+|||
T Consensus 140 --~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 140 --PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp --TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred --cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 2345899999999 7999999763 34899999999999999999999999999999999999
Q ss_pred ecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChH
Q 008729 159 ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVV 237 (556)
Q Consensus 159 l~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~ 237 (556)
++.++.+||+|||+|+....+... ......+||+.|||||++.+ ..|+.++|||||||+||||+| |++||.+.+..
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~-~~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred eCCCCCEEECcchhhhhcccCCCc-eeeccccccccccCHHHHhc--CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999875443322 22356789999999999987 789999999999999999998 99999987644
Q ss_pred HHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 238 ~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
+.+..+. . .... ......+++++.+|+.+||+.||++|||+.|+++|
T Consensus 295 ~~~~~~i-----------------------~---~g~~---~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 295 EEFCRRL-----------------------K---EGTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHH-----------------------H---HTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHH-----------------------H---cCCC---CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 4332221 1 1111 11224588999999999999999999999999987
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=419.10 Aligned_cols=284 Identities=38% Similarity=0.641 Sum_probs=230.5
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||.||+|.+ .+|+.||||++............+.+|+.+|+.++||||+++++++ .....+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE-----ccCCeE
Confidence 5899999999999999999998 6799999999975433333345678999999999999999999999 445679
Q ss_pred EEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+||||++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 999999999999999864 6799999999999999999999999999999999999999999999999999986532221
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
.....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+...++.+....+......
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 ---KYTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ---ccccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 12455799999999998652 45899999999999999999999999999999999999988888766544322110
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
..+........+.++......+++.+.+||++||+.||++|||++|+|+||||++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 232 --PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp --TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred --cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 0000001111222333445678999999999999999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-51 Score=424.49 Aligned_cols=331 Identities=35% Similarity=0.656 Sum_probs=262.6
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC---------ChhHHHHHHHHHHHHHhCCCCCcceeeEEE
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---------HISDAIRILREVKLLRLLRHPDIVEIKRIM 91 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~---------~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~ 91 (556)
..++|++++.||+|+||.||+|.+.. |+.||||++..... .......+.+|+.+|+.++||||+++++++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 45689999999999999999999865 99999999864222 223357789999999999999999999998
Q ss_pred cCCCCCCCceEEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeee
Q 008729 92 LPPSKREFKDIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (556)
Q Consensus 92 ~~~~~~~~~~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DF 170 (556)
..........+|+|||||+++|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 99 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp EECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred EeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 765545566899999999999999988653 6999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC
Q 008729 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (556)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p 250 (556)
|+++....... ....+||++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.|
T Consensus 179 g~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 179 NLAREDTADAN----KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp TC-------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred Ccccccccccc----cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99975433222 2456799999999988653 468999999999999999999999999999999999999999999
Q ss_pred ChHHHHHhhhHHHHHHHHHhhcCCC-CCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCC
Q 008729 251 SPETIAVVRNEKARKYLTEMRKKPP-VPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQ 329 (556)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~ 329 (556)
..+.+..........++.......+ ..+....+..++.+.+||.+||+.||.+|||++|+|+||||+++..........
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~~~~~~~ 333 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGL 333 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGGGGTTTC
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcccccccc
Confidence 9988877777766666544322222 222334567899999999999999999999999999999999875432221111
Q ss_pred CCCcchhhHhhhcCCHHHHHHHHHHHHHhhC
Q 008729 330 PISKLEFEFERRRVTKDDIRELIYREILEYH 360 (556)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 360 (556)
.-.+.++....+..++++.++.|+.+++
T Consensus 334 ---~~~~~~~~~~~~~~~~~~~~~~e~~~~~ 361 (362)
T 3pg1_A 334 ---SERFHFDESVTDVYDMHKIFTAEVERFN 361 (362)
T ss_dssp ---CCCCCCCTTCCCHHHHHHHHHHHHHHHC
T ss_pred ---ccccChhhhhhhHHHHHHHHHHHHHHhc
Confidence 1123445566788899999999987753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=417.14 Aligned_cols=289 Identities=38% Similarity=0.683 Sum_probs=231.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||+|+||.||+|.+..+|+.||||++............+.+|+.+|+.++||||+++++++ .+...
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVF-----RRKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhhee-----ecCCe
Confidence 3689999999999999999999999999999999876545555566788999999999999999999999 45567
Q ss_pred EEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|+|||||++ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 9999999995 778888878889999999999999999999999999999999999999999999999999998654322
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
. .....+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+.+.++...+.....+..
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 157 D---YYDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp ------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred c---ccCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 1 22456799999999998652 4689999999999999999999999999999999999998888876654332211
Q ss_pred HHHHHHHHHhhcC---CCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccc
Q 008729 261 EKARKYLTEMRKK---PPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (556)
Q Consensus 261 ~~~~~~l~~~~~~---~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 322 (556)
.. ++...... ...+....++.+++.+.+||++||..||.+|||++|+|+||||+++...
T Consensus 233 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 233 NQ---YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp CG---GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred cc---ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 10 00000000 0011112346789999999999999999999999999999999987544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=426.07 Aligned_cols=262 Identities=27% Similarity=0.441 Sum_probs=224.9
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCCh----hHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~----~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (556)
...++|++++.||+|+||+||+|.++.+|+.||+|++....... .....+.+|+.+|+.++||||+++++++
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~---- 84 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY---- 84 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE----
Confidence 34468999999999999999999999999999999997543221 1346788999999999999999999999
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC----ceEEeee
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLKVCDF 170 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~----~vKL~DF 170 (556)
.+...+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 85 -~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 85 -ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp -ECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred -EeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 55677999999997 79999999888999999999999999999999999999999999999998877 7999999
Q ss_pred CccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC
Q 008729 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (556)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p 250 (556)
|++........ ....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|.......
T Consensus 164 G~a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~ 237 (361)
T 2yab_A 164 GLAHEIEDGVE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237 (361)
T ss_dssp SSCEECCTTCC----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC
T ss_pred CCceEcCCCCc----cccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC
Confidence 99987543322 245679999999999987 689999999999999999999999999988777666654322211
Q ss_pred ChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.. ..+..+++.+.+||++||..||.+|||++|+|+||||+..
T Consensus 238 ~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 279 (361)
T 2yab_A 238 DE---------------------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (361)
T ss_dssp CH---------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred Cc---------------------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence 11 1235689999999999999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=420.60 Aligned_cols=288 Identities=34% Similarity=0.567 Sum_probs=231.7
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC---ChhHHHHHHHHHHHHHhCC---CCCcceeeEEEcCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---HISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPS 95 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~~rEi~iL~~L~---HpnIv~l~~v~~~~~ 95 (556)
.++|++++.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+++.++ ||||+++++++....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~ 87 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR 87 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence 4689999999999999999999999999999999863221 1111234567777777664 999999999996554
Q ss_pred CCCCceEEEEEecCcccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcc
Q 008729 96 KREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (556)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~~~--l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla 173 (556)
......+|+||||++++|.+++..... +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 88 TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 344457899999999999999987654 999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
+....... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|.+.++.+...
T Consensus 168 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 168 RIYSYQMA----LTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp TTSTTCCC----SGGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccCCCcc----cCCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 86543222 255679999999999977 679999999999999999999999999999999999999999888766
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.+........ .........+.....+.+++.+.+||.+||++||++|||++|+|+||||++.
T Consensus 242 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 242 DWPRDVSLPR----GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp TSCSSCSSCG----GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hccchhhccc----cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 5432110000 0011111222233446789999999999999999999999999999999863
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=425.00 Aligned_cols=288 Identities=36% Similarity=0.630 Sum_probs=231.1
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++||||+++++++ .+...+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~ 75 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDII-----HTEKSL 75 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEE-----ECSSCE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc-ccccchhHHHHHHHHHhcCCCCCCeeeeEE-----eeCCEE
Confidence 58999999999999999999999999999999986422 111122455899999999999999999999 455679
Q ss_pred EEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+|||||+++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 76 TLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred EEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 9999999999999998754 599999999999999999999999999999999999999999999999999976432221
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
.....+||++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+++..+...+|.|..+.+......
T Consensus 156 ---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 ---TYDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred ---ccccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 22456789999999998652 46899999999999999999999999999999999999999999988776544332
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~ 321 (556)
.....+ ..............+.+++.+.+||++||+.||++|||++|+|+||||.++..
T Consensus 232 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 232 EEFKTY-NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHHT-CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hhhccc-ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 111110 01111112222345678999999999999999999999999999999997653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-51 Score=419.98 Aligned_cols=288 Identities=36% Similarity=0.575 Sum_probs=224.8
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||+||+|++..+++.||||++............+.+|+.+|+.++||||+++++++ .+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 106 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVI-----HHNH 106 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEE-----EETT
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEE-----ecCC
Confidence 44689999999999999999999999999999999975544444456678999999999999999999999 5556
Q ss_pred eEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec-----CCCceEEeeeCcccc
Q 008729 101 DIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-----ANCKLKVCDFGLARV 175 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~-----~~~~vKL~DFGla~~ 175 (556)
.+|||||||+++|.+++..++.+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 107 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~ 186 (329)
T 3gbz_A 107 RLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186 (329)
T ss_dssp EEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHH
T ss_pred EEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccc
Confidence 799999999999999999999999999999999999999999999999999999999994 455699999999986
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
...... .....+||+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+.+..+.+.++.|....+
T Consensus 187 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 262 (329)
T 3gbz_A 187 FGIPIR---QFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW 262 (329)
T ss_dssp HC--------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cCCccc---ccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence 543221 12456789999999998762 35899999999999999999999999999999999999999988876654
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCC-CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQ-KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
........ +.............. ....+++.+.+||++||+.||++|||++|+|+||||++.
T Consensus 263 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 263 PGVTALPD--WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TTGGGSTT--CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhh--hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 32211000 000000000000000 001278999999999999999999999999999999875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=418.92 Aligned_cols=257 Identities=26% Similarity=0.459 Sum_probs=221.1
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++ .....
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~~ 79 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSSE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCCE
Confidence 589999999999999999999999999999999864211 122345788999999999999999999999 45567
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 999999998 6999999988899999999999999999999999999999999999999999999999999998643322
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......|..
T Consensus 160 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~--------------- 219 (337)
T 1o6l_A 160 A---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------- 219 (337)
T ss_dssp C---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------------
T ss_pred C---cccccccChhhCChhhhcC--CCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc---------------
Confidence 2 1246789999999999987 6899999999999999999999999998876655544421
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
... .....+++.+.+||++||..||++|| +++++++||||+++.
T Consensus 220 -----------~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 220 -----------EEI-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp -----------CCC-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred -----------CCC-----CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 111 11235899999999999999999999 999999999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=425.73 Aligned_cols=258 Identities=24% Similarity=0.422 Sum_probs=218.4
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (556)
.++|+++++||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.+ +||||+++++++ .+.
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QTP 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----EeC
Confidence 468999999999999999999999999999999987421 1223445678999999988 699999999999 555
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
..+|+|||||. |+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 67999999998 69999999888999999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|..
T Consensus 177 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------------- 238 (353)
T 3txo_A 177 NGV---TTATFCGTPDYIAPEILQE--MLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN------------- 238 (353)
T ss_dssp ------------CCGGGCCHHHHHH--HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------------
T ss_pred CCc---cccccCCCcCeEChhhcCC--CCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc-------------
Confidence 221 2256789999999999987 6799999999999999999999999999887776666532
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH------HHHHhCccccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA------EEALADPYFKGLA 320 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta------~elL~hp~f~~~~ 320 (556)
.... ....+++.+.+||++||..||.+||++ +++++||||+++.
T Consensus 239 -------------~~~~-----~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 239 -------------DEVV-----YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp -------------CCCC-----CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred -------------CCCC-----CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 1111 123488999999999999999999998 9999999999764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=440.12 Aligned_cols=319 Identities=26% Similarity=0.424 Sum_probs=241.9
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||+||+|+++.++..||||++............+.+|+.+|+.++||||+++++++ .+...+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~ 111 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRNY 111 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCEE
Confidence 379999999999999999999999999999999975443334456788999999999999999999999 556779
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC---CceEEeeeCccccccC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFGLARVAFS 178 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~vKL~DFGla~~~~~ 178 (556)
|+|||||. |+|.+.+.....+++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 99999998 6999999888899999999999999999999999999999999999999764 4599999999987543
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.. .....+||++|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+....
T Consensus 192 ~~----~~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----------- 253 (494)
T 3lij_A 192 QK----KMKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK----------- 253 (494)
T ss_dssp TB----CBCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----------
T ss_pred Cc----cccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 32 2245679999999999864 68999999999999999999999999988776665553311
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccccc-CCCCCCCCCcchhh
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE-REPSCQPISKLEFE 337 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e-~~~~~~~~~~~~~~ 337 (556)
.......+..+++.+.+||++||+.||.+|||++++|+||||+...... .....+.....- .
T Consensus 254 ----------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~-~ 316 (494)
T 3lij_A 254 ----------------YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAI-E 316 (494)
T ss_dssp ----------------CCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHH-H
T ss_pred ----------------CCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHH-H
Confidence 1112233467899999999999999999999999999999998653221 111111111111 1
Q ss_pred HhhhcCCHHHHHHHHHHHHHhhChhhhhhhhcCCCCccccChhHHHHHHHHHHHHhhcCC
Q 008729 338 FERRRVTKDDIRELIYREILEYHPQLLKDYINGTEGTNFLYPSAIGQFRKQFAYLEENGG 397 (556)
Q Consensus 338 ~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~f~~~~~~~~ 397 (556)
.-+.......++......+. ....++..+.++++.|..+|.+++
T Consensus 317 ~~~~~~~~~~l~qa~l~~ia----------------~~~~~~~~~~~l~~~F~~~D~d~d 360 (494)
T 3lij_A 317 NMRKFQNSQKLAQAALLYMA----------------SKLTSQEETKELTDIFRHIDKNGD 360 (494)
T ss_dssp HHHTTTTCCHHHHHHHHHHH----------------HHSCCHHHHHHHHHHHHHHCTTCS
T ss_pred HHHHHHHhHHHHHHHHHHHH----------------HhcccHHHHHHHHHHHHHhCcCCC
Confidence 11111112223322222221 122357888999999999998855
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=421.55 Aligned_cols=288 Identities=34% Similarity=0.617 Sum_probs=220.2
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||+|+||.||+|.++.+|+.||||++.... .......+.+|+.+|+.++||||+++++++ .....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 77 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENK 77 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCe
Confidence 468999999999999999999999999999999986432 222345678999999999999999999999 45567
Q ss_pred EEEEEecCcccHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 102 IYVVFELMESDLHQVIKAN------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~~------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
+|+|||||+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 78 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 78 LTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157 (317)
T ss_dssp EEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCcccee
Confidence 9999999999999999753 3589999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
...... .....+||+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+.+..|.+..|.|....+
T Consensus 158 ~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 158 FGIPVN---TFSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp TTSCCC---CCCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred cCCCcc---cCCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 533221 12456799999999998652 46899999999999999999999999999999999999999998876654
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCc-----CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPL-----FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~-----~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~ 321 (556)
..+.... .+...+........ ......++..+.+||++||+.||++|||++|+|+||||++...
T Consensus 234 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 234 PSVTKLP--KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GGGGGCT--TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhhhhh--hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 4321100 00000000000000 0112357899999999999999999999999999999997643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=432.49 Aligned_cols=260 Identities=28% Similarity=0.474 Sum_probs=224.2
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||+||+|.++.+|+.||+|++........+...+.+|+.+|+.++||||+++++++ .+...+
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~~~ 85 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEGHH 85 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSSEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECCEE
Confidence 479999999999999999999999999999999976544455667789999999999999999999999 566779
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec---CCCceEEeeeCccccccC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN---ANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~---~~~~vKL~DFGla~~~~~ 178 (556)
|+|||||. |+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 99999998 69999999999999999999999999999999999999999999999998 457899999999976543
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|..
T Consensus 166 ~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~------------- 227 (444)
T 3soa_A 166 EQQ---AWFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA------------- 227 (444)
T ss_dssp TCC---BCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------------
T ss_pred CCc---eeecccCCcccCCHHHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh-------------
Confidence 322 2356789999999999987 6899999999999999999999999998887666555432
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.........++.+++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 228 --------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 228 --------------GAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp --------------TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred --------------CCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 11111223456789999999999999999999999999999999754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=441.79 Aligned_cols=259 Identities=32% Similarity=0.546 Sum_probs=220.9
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||+||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++ .+...+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~~ 96 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSF 96 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcCCEE
Confidence 489999999999999999999999999999999864333333456788999999999999999999999 556779
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec---CCCceEEeeeCccccccC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN---ANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~---~~~~vKL~DFGla~~~~~ 178 (556)
|+|||||. ++|.+.+...+.+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999998 69999998888999999999999999999999999999999999999995 456799999999986543
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
... ....+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+....
T Consensus 177 ~~~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~----------- 238 (486)
T 3mwu_A 177 NTK----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK----------- 238 (486)
T ss_dssp C--------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-----------
T ss_pred CCc----cCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence 322 245679999999999876 58999999999999999999999999988776666553311
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.......+..+++.+.+||++||..||.+|||+.++|+||||+...
T Consensus 239 ----------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 239 ----------------YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp ----------------CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred ----------------CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence 1111223456899999999999999999999999999999998653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=420.44 Aligned_cols=255 Identities=31% Similarity=0.519 Sum_probs=216.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCC-hhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||.||+|.+..+++.||||++...... .....++.+|+.+|+.++||||+++++++ .....
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~~~ 83 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVI-----TTPTD 83 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence 5899999999999999999999999999999998642111 11234688999999999999999999999 45567
Q ss_pred EEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 102 IYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
+|+||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~- 162 (336)
T 3h4j_B 84 IVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN- 162 (336)
T ss_dssp EEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-
T ss_pred EEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-
Confidence 9999999999999999988899999999999999999999999999999999999999999999999999998654322
Q ss_pred CcceecccccCcccCCcccccccCCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y-~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
.....+||+.|+|||++.+ ..+ ++++|||||||++|+|++|+.||.+......
T Consensus 163 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--------------------- 216 (336)
T 3h4j_B 163 ---FLKTSCGSPNYAAPEVING--KLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--------------------- 216 (336)
T ss_dssp ---TTCCCTTSTTTSCGGGSCC--SGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------------
T ss_pred ---ccccccCCcCcCCHHHHcC--CCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------------
Confidence 2245679999999999987 455 6899999999999999999999987653221
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
..............+++.+.+||++||..||.+|||++|+++||||+..
T Consensus 217 ----------~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 217 ----------FKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp ----------BCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred ----------HHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 1111111222334589999999999999999999999999999999853
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=428.06 Aligned_cols=286 Identities=35% Similarity=0.636 Sum_probs=231.4
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC-CCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~~~ 101 (556)
.+|+++++||+|+||+||+|.+..+++ ||+|++..... ...+|+.+|+.++||||+++++++..... .+...
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 479999999999999999999987776 88888753211 12379999999999999999999865432 34456
Q ss_pred EEEEEecCcccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec-CCCceEEeeeCccccc
Q 008729 102 IYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVCDFGLARVA 176 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~----~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~-~~~~vKL~DFGla~~~ 176 (556)
+|+|||||++++...+. ....+++..++.|++||+.||+|||++||+||||||+|||++ .++.+||+|||+|+..
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 89999999987766554 367899999999999999999999999999999999999999 7999999999999875
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
...... ..++||++|+|||++.+. ..|+.++||||||||+|+|++|++||.+.+..+++..|.+.+|+|..+.+.
T Consensus 193 ~~~~~~----~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 193 IAGEPN----VSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp CTTCCC----CSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cCCCCC----cccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 433322 456799999999998652 468999999999999999999999999999999999999999999988775
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCC-CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQK-FPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~-~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e 323 (556)
......... ........++... .+.+++++.+||.+||++||.+|||+.|+|+||||+++....
T Consensus 268 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 332 (394)
T 4e7w_A 268 TMNPNYMEH---KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE 332 (394)
T ss_dssp HHCGGGSSS---CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred hhChhhhhh---ccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence 432210000 0001111111111 234889999999999999999999999999999999876543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=428.27 Aligned_cols=287 Identities=35% Similarity=0.605 Sum_probs=231.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC-CCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~~~ 101 (556)
.+|++++.||+|+||+||+|++..+|+.||||++.... ....+|+.+|+.|+||||+++++++.... ..+..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 36999999999999999999999999999999986421 12347999999999999999999985432 133456
Q ss_pred EEEEEecCcccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC-CceEEeeeCccccc
Q 008729 102 IYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVA 176 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~----~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~vKL~DFGla~~~ 176 (556)
+|+||||++++|.+++. ....+++..++.|++||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..
T Consensus 128 ~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhc
Confidence 78999999998877765 35689999999999999999999999999999999999999965 56899999999875
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
..... ...++||++|+|||++.+. ..|+.++||||||||||||++|++||.+.+..+++..|.+.+|.|..+.+.
T Consensus 208 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 208 VRGEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp CTTCC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCC----ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 43322 2456799999999998652 478999999999999999999999999999999999999999999888765
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCC-CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQ-KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e 323 (556)
...... ..+ .+......++.. ..+.+++++.+||++||.+||.+|||++|+|+||||+.+....
T Consensus 283 ~~~~~~-~~~--~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 283 EMNPNY-TEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPN 347 (420)
T ss_dssp HHCSCC-CCC--CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTT
T ss_pred hhChhh-hhh--ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccccc
Confidence 321100 000 000000001111 1245789999999999999999999999999999999875443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=411.54 Aligned_cols=257 Identities=24% Similarity=0.445 Sum_probs=222.2
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||+|+||.||+|.+..+++.||+|++.. .......+.+|+.+|+.++||||+++++++ .+...
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~ 75 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHESF-----ESMEE 75 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---CTHHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec---CcccHHHHHHHHHHHHhCCCCCCCeEeEEE-----ecCCE
Confidence 4689999999999999999999999999999999873 234556788999999999999999999999 55567
Q ss_pred EEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC--CCceEEeeeCcccccc
Q 008729 102 IYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA--NCKLKVCDFGLARVAF 177 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~--~~~vKL~DFGla~~~~ 177 (556)
+|+|||||+ ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 76 LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp EEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 999999998 59999997654 7999999999999999999999999999999999999987 7899999999998754
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+....+..+......+.
T Consensus 156 ~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~------ 223 (321)
T 1tki_A 156 PGD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD------ 223 (321)
T ss_dssp TTC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC------
T ss_pred CCC----ccccccCChhhcCcHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCC------
Confidence 322 2345679999999999987 6789999999999999999999999999887776666644222211
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
...++.+++.+.+||++||..||.+|||++|+|+||||+..
T Consensus 224 ---------------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 224 ---------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ---------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ---------------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 11235689999999999999999999999999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-50 Score=408.26 Aligned_cols=258 Identities=27% Similarity=0.466 Sum_probs=219.3
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||+||+|.+..+|+.||||++..... .....+.+|+.+++.++||||+++++++ ....
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~ 90 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSY-----LVGD 90 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc--cHHHHHHHHHHHHhcCCCCCCCeEeEEE-----EECC
Confidence 44689999999999999999999999999999999864322 2345688999999999999999999999 4456
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+|||||. ++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 7999999997 6999999865 6999999999999999999999999999999999999999999999999999765433
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..+....
T Consensus 170 ~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~------------ 232 (297)
T 3fxz_A 170 QSK---RSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG------------ 232 (297)
T ss_dssp TCC---BCCCCSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC------------
T ss_pred ccc---cCCccCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC------------
Confidence 222 245679999999999987 689999999999999999999999999887665554432110
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.+.......+++.+.+||.+||+.||++|||++|+|+||||+..
T Consensus 233 ----------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 233 ----------------TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp ----------------SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ----------------CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 11112234588999999999999999999999999999999854
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=419.37 Aligned_cols=259 Identities=29% Similarity=0.476 Sum_probs=223.5
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||.||+|.++.+|+.||+|++............+.+|+.+|+.|+||||+++++++ .+...+
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~ 103 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESFH 103 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCEE
Confidence 479999999999999999999999999999999976555556677899999999999999999999999 555679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC---ceEEeeeCccccccC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLKVCDFGLARVAFS 178 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~vKL~DFGla~~~~~ 178 (556)
|+|||||. ++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 99999998 59999999888899999999999999999999999999999999999998654 599999999976543
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.. .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+.......|...
T Consensus 184 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~------------ 245 (362)
T 2bdw_A 184 SE----AWHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG------------ 245 (362)
T ss_dssp CC----SCCCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------------
T ss_pred Cc----ccccCCCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC------------
Confidence 22 2345679999999999987 68999999999999999999999999988766555544321
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
........+..+++.+.+||.+||..||++|||++++|+||||...
T Consensus 246 ---------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 246 ---------------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp ---------------CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred ---------------CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 1111112345689999999999999999999999999999999754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=420.02 Aligned_cols=285 Identities=32% Similarity=0.652 Sum_probs=229.9
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC-----
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK----- 96 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~----- 96 (556)
.++|++++.||+|+||+||+|.+..+|+.||||++..... ...+|+.+|+.++||||+++++++.....
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 4689999999999999999999999999999999864321 12379999999999999999999864332
Q ss_pred ----------------------------CCCceEEEEEecCcccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHH
Q 008729 97 ----------------------------REFKDIYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMHT 144 (556)
Q Consensus 97 ----------------------------~~~~~lylV~E~~~g~L~~~i~----~~~~l~~~~~~~i~~QIl~aL~yLHs 144 (556)
.+..++|+|||||+++|.+.+. .+..+++..++.|++||+.||+|||+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 159 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS 159 (383)
T ss_dssp ------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3345689999999998877765 35789999999999999999999999
Q ss_pred CCceeccCCCCcEeec-CCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHH
Q 008729 145 ANVYHRDLKPKNILAN-ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 223 (556)
Q Consensus 145 ~gIvHrDLKP~NILl~-~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilye 223 (556)
+||+||||||+|||++ .++.+||+|||+|+....... ....+||+.|+|||++.+. ..|+.++|||||||++|+
T Consensus 160 ~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 160 LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHH
T ss_pred CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHH
Confidence 9999999999999998 688999999999986543322 2456799999999988762 458999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCC-CCCCCCHHHHHHHHHhhhcCCC
Q 008729 224 VLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQ-KFPNVDPLALRLLQRLIAFDPK 302 (556)
Q Consensus 224 lltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~s~~~~dLl~~~L~~dP~ 302 (556)
|++|++||.+.+..+++..|...+|.|..+.+.......... .........+.. ....+++.+.+||.+||+.||.
T Consensus 235 ll~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEV---RFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--C---CCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccc---cCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999999999999999999999999988765432210000 000000001111 1235889999999999999999
Q ss_pred CCCCHHHHHhCccccccc
Q 008729 303 DRPTAEEALADPYFKGLA 320 (556)
Q Consensus 303 ~Rpta~elL~hp~f~~~~ 320 (556)
+|||+.|+|+||||+.+.
T Consensus 312 ~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp GSCCHHHHHTSGGGHHHH
T ss_pred hCCCHHHHhcCHHHHHHH
Confidence 999999999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=420.88 Aligned_cols=301 Identities=22% Similarity=0.288 Sum_probs=224.4
Q ss_pred ccccCCCCCeEEEeeeeec--CceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcC
Q 008729 16 FTEYGDANRYKILEVIGKG--SYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLP 93 (556)
Q Consensus 16 ~~~~~~~~~Y~i~~~LG~G--~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~ 93 (556)
..-.+.+++|+++++||+| +||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++
T Consensus 18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-- 95 (389)
T 3gni_B 18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF-- 95 (389)
T ss_dssp CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE--
Confidence 3345678899999999999 999999999999999999999986555556667888999999999999999999999
Q ss_pred CCCCCCceEEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeee
Q 008729 94 PSKREFKDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (556)
Q Consensus 94 ~~~~~~~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DF 170 (556)
.+...+|+|||||. ++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 96 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~df 172 (389)
T 3gni_B 96 ---IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGL 172 (389)
T ss_dssp ---EETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCG
T ss_pred ---EECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccc
Confidence 45567999999998 6999999875 67999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCC----cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHh
Q 008729 171 GLARVAFSDTPM----TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDL 246 (556)
Q Consensus 171 Gla~~~~~~~~~----~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~ 246 (556)
|++......... .......+||+.|+|||++.+....|+.++||||||||+|+|++|++||.+.+....+..+...
T Consensus 173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 252 (389)
T 3gni_B 173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG 252 (389)
T ss_dssp GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence 998654322111 1112335799999999998764346899999999999999999999999987766555433211
Q ss_pred h--------CCCChHHHHHh----hhHHHHHHHHH---hhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 008729 247 L--------GTPSPETIAVV----RNEKARKYLTE---MRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (556)
Q Consensus 247 ~--------g~p~~e~i~~~----~~~~~~~~l~~---~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL 311 (556)
. ..+..+..... ........+.. .......+.......+++.+.+||++||+.||++|||++|+|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 0 00000000000 00000000000 000000111123456899999999999999999999999999
Q ss_pred hCcccccccc
Q 008729 312 ADPYFKGLAK 321 (556)
Q Consensus 312 ~hp~f~~~~~ 321 (556)
+||||+++..
T Consensus 333 ~hp~f~~~~~ 342 (389)
T 3gni_B 333 NHSFFKQIKR 342 (389)
T ss_dssp TSGGGGGC--
T ss_pred cCHHHHHHhh
Confidence 9999997643
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-50 Score=410.92 Aligned_cols=255 Identities=26% Similarity=0.462 Sum_probs=221.0
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|++++.||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++ .+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence 3589999999999999999999999999999999864211 112345678999999999999999999999 5556
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 7999999998 699999999889999999999999999999999999999999999999999999999999999864322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+.......|..
T Consensus 160 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~-------------- 217 (318)
T 1fot_A 160 ------TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN-------------- 217 (318)
T ss_dssp ------BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH--------------
T ss_pred ------cccccCCccccCHhHhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--------------
Confidence 135679999999999987 6899999999999999999999999998887666555432
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
... ...+.+++++.+||++||..||.+|| +++++++||||+++.
T Consensus 218 ------------~~~-----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 218 ------------AEL-----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp ------------CCC-----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred ------------CCC-----CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 111 11245889999999999999999999 999999999999764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-50 Score=414.20 Aligned_cols=298 Identities=34% Similarity=0.546 Sum_probs=235.0
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC---
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK--- 96 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~--- 96 (556)
+..++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccc
Confidence 45579999999999999999999999999999999987544444445567899999999999999999999864321
Q ss_pred CCCceEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 97 REFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 97 ~~~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
.....+|+|||||+++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp ---CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 124579999999999998888764 5799999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCC-CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 176 AFSDTP-MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 176 ~~~~~~-~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
...... ........+||+.|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+.+..|....+.+.++.
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp CCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 532211 12223556799999999988652 4689999999999999999999999999999999999999999887766
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKF--PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
+...........+..... ........+ ...++.+.+||.+||+.||++|||++|+|+||||...
T Consensus 253 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKG-QKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp STTGGGCGGGTSSCCCSS-CCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred ccccccchhhcccccccc-cccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 543322110000000000 000000000 0137889999999999999999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=415.46 Aligned_cols=273 Identities=22% Similarity=0.216 Sum_probs=195.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
+++|.+.++||+|+||+||+|++ +|+.||||+++.. ........+|+.++..++|||||++++++.... .....
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceE
Confidence 45799999999999999999987 5899999998742 122223345777778899999999999986432 12346
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEeecCCCceEEeeeCc
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA--------NVYHRDLKPKNILANANCKLKVCDFGL 172 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~--------gIvHrDLKP~NILl~~~~~vKL~DFGl 172 (556)
+|||||||+ |+|.++++.. .++++.+..|+.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 899999999 7999999864 689999999999999999999987 999999999999999999999999999
Q ss_pred cccccCCCCC-cceecccccCcccCCcccccccC----CCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 008729 173 ARVAFSDTPM-TVFWTDYVATRWYRAPELCGSFF----SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (556)
Q Consensus 173 a~~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~----~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~ 247 (556)
|+........ .......+||++|||||++.+.. ..|+.++||||||||||||+||.+||........... ....
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~-~~~~ 233 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-DLVP 233 (303)
T ss_dssp CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-TTSC
T ss_pred CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch-hccc
Confidence 9875443322 11224568999999999986521 1367899999999999999999988754332110000 0000
Q ss_pred CCCChHHHHHhhhHHHHHHHHHhhcCCCCC-cCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVP-LFQKF--PNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~-~~~~~--~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
..+..+ .....+......+ ....+ ...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~-----------~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 234 SDPSVE-----------EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHH-----------HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccchHH-----------HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 000000 0011111111111 11111 1233568899999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=416.95 Aligned_cols=259 Identities=24% Similarity=0.404 Sum_probs=220.9
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~ 98 (556)
..++|++++.||+|+||.||+|+++.+|+.||||++++... .......+.+|..+|..+ +||||+++++++ .+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~~ 89 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QT 89 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----Ee
Confidence 34689999999999999999999999999999999974211 112345677899999877 899999999999 55
Q ss_pred CceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
...+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 90 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 90 KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 567999999998 6999999988899999999999999999999999999999999999999999999999999997643
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|..
T Consensus 170 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------------ 232 (345)
T 1xjd_A 170 LGDA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM------------ 232 (345)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------
T ss_pred cCCC---cccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh------------
Confidence 2221 1256789999999999987 6899999999999999999999999998887665555422
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHH-HHHhCccccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE-EALADPYFKGLA 320 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~-elL~hp~f~~~~ 320 (556)
... .....+++.+.+||++||..||++||++. ++++||||+++.
T Consensus 233 --------------~~~-----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 233 --------------DNP-----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp --------------CCC-----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred --------------CCC-----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 111 11235889999999999999999999998 999999999864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=415.67 Aligned_cols=288 Identities=23% Similarity=0.391 Sum_probs=231.5
Q ss_pred ccccccCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-----CCCcceee
Q 008729 14 DFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-----HPDIVEIK 88 (556)
Q Consensus 14 ~~~~~~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-----HpnIv~l~ 88 (556)
.+-...-..++|+++++||+|+||.||+|.+..+++.||||++.. .......+.+|+.+|+.+. ||||++++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 333334456799999999999999999999999999999999873 3344556778999999997 99999999
Q ss_pred EEEcCCCCCCCceEEEEEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC-----
Q 008729 89 RIMLPPSKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA----- 161 (556)
Q Consensus 89 ~v~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~----- 161 (556)
+++ .....+|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 103 ~~~-----~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 103 GKF-----MYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEE-----EETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCE
T ss_pred cee-----eECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccc
Confidence 999 4456799999999889999998754 5999999999999999999999999999999999999975
Q ss_pred --------------------CCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHH
Q 008729 162 --------------------NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF 221 (556)
Q Consensus 162 --------------------~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~il 221 (556)
++.+||+|||+|+...... ...+||+.|+|||++.+ ..|+.++||||||||+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il 249 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH------GSIINTRQYRAPEVILN--LGWDVSSDMWSFGCVL 249 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC------CSCCSCGGGCCHHHHTT--CCCCTTHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCCC------cCccCcccccCcHHHcC--CCCCCccchHHHHHHH
Confidence 7889999999998643221 35679999999999987 6899999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCc---------------CCCCCCCC
Q 008729 222 AEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPL---------------FQKFPNVD 286 (556)
Q Consensus 222 yelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~---------------~~~~~~~s 286 (556)
|+|++|++||.+.+..+.+..+....+.++...+..........++.........+. .......+
T Consensus 250 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 329 (360)
T 3llt_A 250 AELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH 329 (360)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred HHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence 999999999999999999999999888887766543221110000000000000000 00001234
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 287 PLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 287 ~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
+.+.+||++||+.||++|||++|+|+||||+
T Consensus 330 ~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 330 ELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 7888999999999999999999999999995
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=408.86 Aligned_cols=259 Identities=28% Similarity=0.456 Sum_probs=221.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCCh----hHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~----~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
++|++++.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.+|+.++||||+++++++ .+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~ 85 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----EN 85 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence 47999999999999999999999999999999987532221 1356788999999999999999999999 45
Q ss_pred CceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC----ceEEeeeCcc
Q 008729 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLKVCDFGLA 173 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~----~vKL~DFGla 173 (556)
...+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 567999999997 69999998888999999999999999999999999999999999999999887 7999999999
Q ss_pred ccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
+....... ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 166 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-- 237 (326)
T 2y0a_A 166 HKIDFGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE-- 237 (326)
T ss_dssp EECCTTSC----CCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC--
T ss_pred eECCCCCc----cccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC--
Confidence 87543221 245679999999999987 6899999999999999999999999998887666655543221111
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
...++.+++.+.+||++||..||++|||++++|+||||+..
T Consensus 238 -------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 238 -------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp -------------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred -------------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 11234688999999999999999999999999999999853
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=432.46 Aligned_cols=260 Identities=29% Similarity=0.447 Sum_probs=219.6
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCCh-----------hHHHHHHHHHHHHHhCCCCCcceeeE
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI-----------SDAIRILREVKLLRLLRHPDIVEIKR 89 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~-----------~~~~~~~rEi~iL~~L~HpnIv~l~~ 89 (556)
..++|+++++||+|+||+||+|.++.+++.||||++....... .....+.+|+.+|+.++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3468999999999999999999999999999999987532111 23457889999999999999999999
Q ss_pred EEcCCCCCCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC---ce
Q 008729 90 IMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KL 165 (556)
Q Consensus 90 v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~v 165 (556)
++ .+...+|||||||. |+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 114 ~~-----~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EE-----ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSE
T ss_pred EE-----EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccE
Confidence 99 55677999999998 69999998888999999999999999999999999999999999999998776 69
Q ss_pred EEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Q 008729 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITD 245 (556)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~ 245 (556)
||+|||++........ ....+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..|..
T Consensus 189 kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYK----LRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261 (504)
T ss_dssp EECCCTTCEECCTTSC----BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEEECCCCEEcCCCCc----cccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 9999999987543322 245679999999999865 689999999999999999999999999888777666543
Q ss_pred hhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 246 ~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
..... ....+..+++.+.+||++||.+||.+|||++|+|+||||+..
T Consensus 262 ~~~~~---------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 262 GKYYF---------------------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY 308 (504)
T ss_dssp CCCCC---------------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHT
T ss_pred CCCCC---------------------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhc
Confidence 21111 112235689999999999999999999999999999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=420.99 Aligned_cols=268 Identities=22% Similarity=0.396 Sum_probs=216.1
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~ 98 (556)
..++|+++++||+|+||+||+|+++.+++.||||++.+... .......+.+|..+|..+ +||||+++++++ .+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~ 124 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QT 124 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----EE
Confidence 34689999999999999999999999999999999975432 223345678999999887 899999999999 45
Q ss_pred CceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
...+|||||||. |+|..++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 125 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 125 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 567999999998 6999999988899999999999999999999999999999999999999999999999999998633
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+....+.... .
T Consensus 205 ~~~~---~~~~~~gt~~Y~aPE~l~~--~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-------~------- 265 (396)
T 4dc2_A 205 RPGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------N------- 265 (396)
T ss_dssp CTTC---CBCCCCBCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-------------C-------
T ss_pred cCCC---ccccccCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-------h-------
Confidence 2222 2356789999999999988 7899999999999999999999999975432111000 0
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH------HHHHhCccccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA------EEALADPYFKGLA 320 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta------~elL~hp~f~~~~ 320 (556)
..... ...+.... ......+++.+.+||++||+.||.+||++ +|+++||||+++.
T Consensus 266 -~~~~~---~~~i~~~~----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 266 -TEDYL---FQVILEKQ----IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp -CHHHH---HHHHHHCC----CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred -hHHHH---HHHHhccc----cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 00000 11111111 11224689999999999999999999985 8999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=411.02 Aligned_cols=267 Identities=22% Similarity=0.399 Sum_probs=217.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (556)
.++|++++.||+|+||.||+|+++.+++.||||++.+.. ........+.+|+.+|+.+ +||||+++++++ .+.
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----QTE 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----EeC
Confidence 358999999999999999999999999999999997543 3445566788999999988 899999999999 455
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
..+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 67999999998 69999999888999999999999999999999999999999999999999999999999999986432
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+......... .
T Consensus 163 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~----------~----- 222 (345)
T 3a8x_A 163 PGD---TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ----------N----- 222 (345)
T ss_dssp TTC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------------------
T ss_pred CCC---cccccCCCccccCccccCC--CCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc----------c-----
Confidence 221 1256789999999999987 6899999999999999999999999975321110000 0
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH------HHHHhCccccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA------EEALADPYFKGLA 320 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta------~elL~hp~f~~~~ 320 (556)
..... ...+..... .....+++.+.+||++||..||.+||++ +++++||||+++.
T Consensus 223 ~~~~~---~~~i~~~~~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 223 TEDYL---FQVILEKQI----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp CHHHH---HHHHHHCCC----CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred cHHHH---HHHHHcCCC----CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 00000 111111111 1224689999999999999999999995 8999999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=433.91 Aligned_cols=259 Identities=29% Similarity=0.495 Sum_probs=223.2
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|+++++||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+|+.++||||+++++++ .+...
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~ 100 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----EDKGY 100 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCCE
Confidence 589999999999999999999999999999999864322 234466788999999999999999999999 55677
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee---cCCCceEEeeeCcccccc
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARVAF 177 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl---~~~~~vKL~DFGla~~~~ 177 (556)
+|+|||||. ++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999998 6999999998999999999999999999999999999999999999999 567899999999998754
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... ....+||++|+|||++.+ .|+.++||||||||+|+|++|.+||.+.+..+.+..+...
T Consensus 181 ~~~~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~----------- 242 (484)
T 3nyv_A 181 ASKK----MKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKG----------- 242 (484)
T ss_dssp CCCS----HHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-----------
T ss_pred cccc----cccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC-----------
Confidence 3322 245679999999999875 5899999999999999999999999998877666655331
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
........+..+++.+.+||++||..||.+|||++++|+||||+...
T Consensus 243 ----------------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 243 ----------------KYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp ----------------CCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred ----------------CCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 11111223456899999999999999999999999999999998654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=423.79 Aligned_cols=280 Identities=32% Similarity=0.545 Sum_probs=231.2
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC------CCCCcceeeEEEcCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL------RHPDIVEIKRIMLPPS 95 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L------~HpnIv~l~~v~~~~~ 95 (556)
..+|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+|+.+ .|+||+++++++
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~---- 168 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF---- 168 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE----
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeec----
Confidence 4689999999999999999999999999999999974 234445677888888887 577999999998
Q ss_pred CCCCceEEEEEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCc--eEEeeeC
Q 008729 96 KREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK--LKVCDFG 171 (556)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~--vKL~DFG 171 (556)
.....+|+|||||+++|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 169 -~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 169 -TFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp -EETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred -ccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 4556799999999999999998764 4999999999999999999999999999999999999999987 9999999
Q ss_pred ccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 008729 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (556)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (556)
+|+..... ....+||+.|+|||++.+ ..|+.++||||||||||+|++|++||.+.+..+++..|.+.+|.|.
T Consensus 248 ~a~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~ 319 (429)
T 3kvw_A 248 SSCYEHQR------VYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPS 319 (429)
T ss_dssp TCEETTCC------CCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred cceecCCc------ccccCCCCCccChHHHhC--CCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 99764322 245679999999999987 6799999999999999999999999999999999999999999999
Q ss_pred hHHHHHhhhHHHHHHHHHhhcCCC-------------------------CCcC-----CCCCCCCHHHHHHHHHhhhcCC
Q 008729 252 PETIAVVRNEKARKYLTEMRKKPP-------------------------VPLF-----QKFPNVDPLALRLLQRLIAFDP 301 (556)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~-------------------------~~~~-----~~~~~~s~~~~dLl~~~L~~dP 301 (556)
.+.+..... ...++........ .+.. ......++.+.+||++||++||
T Consensus 320 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP 397 (429)
T 3kvw_A 320 QKLLDASKR--AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDP 397 (429)
T ss_dssp HHHHHTBTT--HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSST
T ss_pred HHHHHhhhh--hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCCh
Confidence 887654332 1122111000000 0000 0112347889999999999999
Q ss_pred CCCCCHHHHHhCcccccc
Q 008729 302 KDRPTAEEALADPYFKGL 319 (556)
Q Consensus 302 ~~Rpta~elL~hp~f~~~ 319 (556)
++|||++|+|+||||+..
T Consensus 398 ~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 398 AVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp TTSCCHHHHHTSTTTC--
T ss_pred hhCCCHHHHhCChhhccC
Confidence 999999999999999864
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=404.14 Aligned_cols=299 Identities=39% Similarity=0.644 Sum_probs=233.3
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC---
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS--- 95 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~--- 95 (556)
+...++|++++.||+|+||.||+|.+..+|+.||||++.. ........+.+|+.+++.++||||+++++++....
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL--TDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEEC--CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEec--CChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 3446799999999999999999999999999999999864 34456678899999999999999999999985432
Q ss_pred ------CCCCceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec-CCCceEEe
Q 008729 96 ------KREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVC 168 (556)
Q Consensus 96 ------~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~-~~~~vKL~ 168 (556)
..+...+|+||||++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp CC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred ccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence 134567999999999999999864 5799999999999999999999999999999999999997 56799999
Q ss_pred eeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC
Q 008729 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (556)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g 248 (556)
|||+++................+|++|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+....+
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 242 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999998754332222223456789999999987642 4688999999999999999999999999999888888888777
Q ss_pred CCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccc
Q 008729 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (556)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 322 (556)
.+..+........ ...++.........+....++.++..+.+||++||+.||.+|||++++|+||||+....+
T Consensus 243 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 243 VVHEEDRQELLSV-IPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp CCCHHHHHHHHTT-SCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred CCchhhhhhhhhc-CcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 6665544322111 111122222222333334456789999999999999999999999999999999876443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=414.47 Aligned_cols=259 Identities=22% Similarity=0.386 Sum_probs=221.1
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~ 98 (556)
..++|+++++||+|+||.||+|+++.+|+.||||++.+... .......+.+|..+|..+ +||||+++++++ .+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~ 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence 34689999999999999999999999999999999874211 112345678999999988 799999999999 55
Q ss_pred CceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
...+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 567999999998 6999999988899999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..|..
T Consensus 173 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------------ 235 (353)
T 2i0e_A 173 WDGV---TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME------------ 235 (353)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------------
T ss_pred cCCc---ccccccCCccccChhhhcC--CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh------------
Confidence 2221 1246789999999999987 6899999999999999999999999999887666655532
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
... .....+++.+.+||++||..||.+|| +++++++||||+++.
T Consensus 236 --------------~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 236 --------------HNV-----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp --------------CCC-----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred --------------CCC-----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 111 11246899999999999999999999 479999999999764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=413.74 Aligned_cols=256 Identities=21% Similarity=0.395 Sum_probs=221.9
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
..++|++++.||+|+||.||+|+++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++ .+.
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~ 113 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDN 113 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence 4468999999999999999999999999999999986421 1112345788999999999999999999999 455
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
..+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 114 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 114 SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 67999999997 69999999888999999999999999999999999999999999999999999999999999986533
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
. ....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+....|..
T Consensus 194 ~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------------- 252 (350)
T 1rdq_E 194 R------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS------------- 252 (350)
T ss_dssp C------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------------
T ss_pred C------cccccCCccccCHHHhcC--CCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc-------------
Confidence 2 135679999999999987 6899999999999999999999999998877665555432
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHhCccccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGLA 320 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-----a~elL~hp~f~~~~ 320 (556)
... .....+++.+.+||++||+.||.+||+ ++++++||||+++.
T Consensus 253 -------------~~~-----~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 253 -------------GKV-----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp -------------CCC-----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred -------------CCC-----CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 111 112458999999999999999999998 99999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=430.57 Aligned_cols=266 Identities=25% Similarity=0.395 Sum_probs=222.3
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|+++++||+|+||+||+|+++.+++.||||++.+... .......+.+|+.+|..++||||+++++++ .+..
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~ 147 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDDN 147 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCC
Confidence 4689999999999999999999999999999999864210 111122377899999999999999999999 5567
Q ss_pred eEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 101 DIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.+|||||||. |+|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 148 ~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 148 NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp EEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 7999999997 799999987 57899999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCcceecccccCcccCCcccccc---cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~---~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
... ......+||++|+|||++.. ....|+.++|||||||++|||++|++||.+.+..+.+..|....
T Consensus 228 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------- 297 (437)
T 4aw2_A 228 DGT--VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-------- 297 (437)
T ss_dssp TSC--EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--------
T ss_pred CCC--cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc--------
Confidence 322 12245689999999999862 11568999999999999999999999999998877776664210
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHHHHHhCccccccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGLA 320 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~--Rpta~elL~hp~f~~~~ 320 (556)
....+...+..+++++++||++||..+|++ |++++|+++||||+++.
T Consensus 298 ------------------~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 298 ------------------ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp ------------------HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred ------------------ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 001122234568999999999999999888 99999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=413.64 Aligned_cols=286 Identities=34% Similarity=0.628 Sum_probs=230.6
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||.||+|++..+|+.||||++............+.+|+.+|+.++||||+++++++ .+..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 97 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVC-----KKKK 97 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETT
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEe-----ecCC
Confidence 45699999999999999999999999999999999876555555566788999999999999999999999 5556
Q ss_pred eEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+||||+++ .|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 98 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 79999999995 66666676778999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.. .....+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.+.+.....+.
T Consensus 178 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 178 GE---VYDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred cc---ccCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence 21 12456799999999998762 368899999999999999999999999999999999998888887665433221
Q ss_pred hHHHHHHHHHhh---cCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 260 NEKARKYLTEMR---KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 260 ~~~~~~~l~~~~---~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
.... +.... .....+....++.+++.+.+||.+||..||++|||++|+|+||||+.
T Consensus 254 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 254 KNPV---FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HCGG---GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hccc---cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 1000 00000 00011112234578999999999999999999999999999999985
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-50 Score=414.67 Aligned_cols=287 Identities=38% Similarity=0.605 Sum_probs=228.4
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCCh---hHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI---SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
.++|++++.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+|+.++||||+++++++ .+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 83 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GH 83 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----ee
Confidence 468999999999999999999999999999999986432111 1123678999999999999999999999 45
Q ss_pred CceEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 99 FKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
...+|+|||||+++|.+++..+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 84 KSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163 (346)
T ss_dssp TTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred CCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence 5679999999999999998765 368999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... .....+||++|+|||++.+. ..|+.++|||||||++|+|++|.+||.+.+..+.+..|.+..+.|..+.+..
T Consensus 164 ~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 239 (346)
T 1ua2_A 164 SPNR---AYTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD 239 (346)
T ss_dssp SCCC---CCCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred CCcc---cCCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence 3221 22456799999999998652 4588999999999999999999999999999999999999888887665432
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
..... .++ ........+....+..+++.+.+||++||..||.+|||++|+|+||||....
T Consensus 240 ~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 240 MCSLP--DYV-TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp TTSST--TCC-CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hccCc--ccc-cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 21100 000 0000011111223456789999999999999999999999999999998653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=406.01 Aligned_cols=258 Identities=28% Similarity=0.481 Sum_probs=211.5
Q ss_pred CCCeEEEeeeeecCceeEEEEEEC---CCCcEEEEEEecCcc--CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~---~tg~~vAiK~i~~~~--~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
.++|++++.||+|+||.||+|++. .+|+.||||++.... ........+.+|+.+|+.++||||+++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~----- 90 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF----- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE-----
Confidence 468999999999999999999985 689999999997542 1233455678999999999999999999999
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
.....+|+|||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 45567999999998 69999999888899999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..|...
T Consensus 171 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--------- 236 (327)
T 3a62_A 171 SIHDGT---VTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--------- 236 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT---------
T ss_pred cccCCc---cccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC---------
Confidence 432221 1245679999999999987 67899999999999999999999999988876665554321
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
.. ...+.+++.+.+||++||..||.+|| +++++|+||||+++.
T Consensus 237 -----------------~~-----~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 237 -----------------KL-----NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp -----------------CC-----CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred -----------------CC-----CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 11 12245889999999999999999999 899999999998764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=390.87 Aligned_cols=262 Identities=29% Similarity=0.484 Sum_probs=225.4
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++ .+...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCCE
Confidence 4689999999999999999999999999999999976555666677889999999999999999999999 55567
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCc---eEEeeeCcccccc
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFGLARVAF 177 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---vKL~DFGla~~~~ 177 (556)
.|+||||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 899999998 599999988888999999999999999999999999999999999999987665 9999999997654
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 160 ~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~----------- 222 (284)
T 3kk8_A 160 DSEA----WHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG----------- 222 (284)
T ss_dssp SSCB----CCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-----------
T ss_pred cCcc----ccCCCCCcCCcCchhhcC--CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc-----------
Confidence 3222 245679999999999987 67899999999999999999999999888766555444221
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~ 321 (556)
........+..+++.+.+||.+||+.||++|||++|+|+||||++...
T Consensus 223 ----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 223 ----------------AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp ----------------CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred ----------------cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 111112234568999999999999999999999999999999987543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=415.30 Aligned_cols=262 Identities=25% Similarity=0.455 Sum_probs=218.3
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++||||+++++++ .+..
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSF-----QDEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeCC
Confidence 358999999999999999999999999999999986421 1122346788999999999999999999999 5556
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+|||||. |+|.+++..++.+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 7999999997 699999999889999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcceecccccCcccCCccccccc-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.. ....+||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 169 ~~----~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~------------- 231 (384)
T 4fr4_A 169 TQ----ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT------------- 231 (384)
T ss_dssp CC----BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHH-------------
T ss_pred Cc----eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHH-------------
Confidence 22 3567899999999998642 14589999999999999999999999986543222211110
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-HHHHHhCccccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-AEEALADPYFKGLA 320 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-a~elL~hp~f~~~~ 320 (556)
+. ... ......+++.+.+||++||..||.+||+ ++++++||||+++.
T Consensus 232 --------~~--~~~-----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 232 --------FE--TTV-----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp --------HH--HCC-----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred --------Hh--hcc-----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 00 011 1122468999999999999999999998 99999999999764
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=410.48 Aligned_cols=262 Identities=26% Similarity=0.409 Sum_probs=204.6
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
....++|++++.||+|+||+||+|++..+++.||||++..... ....+.+|+.+++.++||||+++++++ .+
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~ 87 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVI-----LT 87 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEE-----ee
Confidence 3456799999999999999999999999999999999974322 224577999999999999999999999 44
Q ss_pred CceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCc--eEEeeeCcccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK--LKVCDFGLARV 175 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~--vKL~DFGla~~ 175 (556)
...+|+|||||. ++|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 88 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 88 PTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred CCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 567999999997 699999988889999999999999999999999999999999999999987765 99999999975
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCC-CcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~-~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
...... ....+||++|+|||++.+ ..++ .++|||||||++|+|++|++||.+.........+.
T Consensus 168 ~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---------- 231 (361)
T 3uc3_A 168 SVLHSQ----PKSTVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI---------- 231 (361)
T ss_dssp -----------------CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHH----------
T ss_pred ccccCC----CCCCcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHH----------
Confidence 322221 245679999999999877 5565 45999999999999999999998765432222211
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
..+..... .......+++.+.+||++||..||++|||++|+|+||||...
T Consensus 232 -------------~~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 232 -------------QRILSVKY--SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp -------------HHHHTTCC--CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred -------------HHHhcCCC--CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 11111100 011223578999999999999999999999999999999653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=405.69 Aligned_cols=262 Identities=25% Similarity=0.410 Sum_probs=215.0
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+++.++||||+++++++ .+..
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~ 78 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHR-----REGN 78 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc-ccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCC
Confidence 4568999999999999999999999999999999986421 122335678999999999999999999998 5567
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+|||||. ++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 79 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 7999999998 599999988888999999999999999999999999999999999999999999999999999764322
Q ss_pred CCCcceecccccCcccCCcccccccCCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y-~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.. .......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+.........
T Consensus 159 ~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-------------- 221 (323)
T 3tki_A 159 NR-ERLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-------------- 221 (323)
T ss_dssp TE-ECCBCSCCSCGGGSCHHHHHC--SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH--------------
T ss_pred Cc-ccccCCCccCcCccCcHHhcc--CCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH--------------
Confidence 21 112345689999999999876 444 788999999999999999999998766432221110
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
... ......+..+++.+.+||++||..||++|||++|+|+||||+..
T Consensus 222 ------------~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 222 ------------KEK--KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp ------------HTT--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred ------------hcc--cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 000 11112235689999999999999999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-49 Score=413.46 Aligned_cols=259 Identities=26% Similarity=0.444 Sum_probs=213.6
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHH-HHhCCCCCcceeeEEEcCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKL-LRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~i-L~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
..++|+++++||+|+||.||+|+++.+++.||||++.+.. ........+.+|..+ ++.++||||+++++++ .+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~~ 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----QT 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----EC
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----Ee
Confidence 3468999999999999999999999999999999997542 223345567788887 5778999999999999 45
Q ss_pred CceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
...+|+|||||. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 567999999998 5999999988899999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+....|..
T Consensus 191 ~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~------------ 253 (373)
T 2r5t_A 191 EHNS---TTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN------------ 253 (373)
T ss_dssp CCCC---CCCSBSCCCCCCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHH------------
T ss_pred cCCC---ccccccCCccccCHHHhCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh------------
Confidence 3222 1256789999999999987 6899999999999999999999999998887666555432
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH----HHHHhCccccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA----EEALADPYFKGLA 320 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta----~elL~hp~f~~~~ 320 (556)
.. ....+.+++.+.+||++||+.||.+||++ +++++||||+++.
T Consensus 254 --------------~~-----~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 254 --------------KP-----LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp --------------SC-----CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred --------------cc-----cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 11 11234689999999999999999999986 7999999999764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=421.71 Aligned_cols=267 Identities=24% Similarity=0.348 Sum_probs=219.2
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
..++|+++++||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|..++||||+++++++ .+.
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDE 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence 3468999999999999999999999999999999986421 1112233477899999999999999999999 555
Q ss_pred ceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
..+|||||||. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 67999999997 7999999875 479999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcceecccccCcccCCccccccc-----CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-----~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
..... .....+||+.|+|||++.+. ...|+.++||||||||+|||++|++||.+.+..+....|....
T Consensus 214 ~~~~~--~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~----- 286 (412)
T 2vd5_A 214 ADGTV--RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK----- 286 (412)
T ss_dssp TTSCE--ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-----
T ss_pred CCCcc--ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----
Confidence 33221 12346899999999998621 1468999999999999999999999999988777666654210
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCC---CCHHHHHhCcccccccc
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR---PTAEEALADPYFKGLAK 321 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~R---pta~elL~hp~f~~~~~ 321 (556)
.... +......+++++++||++||. ||.+| ++++|+++||||+++..
T Consensus 287 -------------------~~~~--~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w 336 (412)
T 2vd5_A 287 -------------------EHLS--LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW 336 (412)
T ss_dssp -------------------HHCC--CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred -------------------cCcC--CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence 0000 111124689999999999999 99998 59999999999998753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=410.47 Aligned_cols=259 Identities=29% Similarity=0.438 Sum_probs=213.1
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc---CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~---~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
++|++++.||+|+||+||+|.++.+|+.||||++.... ........+.+|+.+|+.++||||+++++++ .+.
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~ 98 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY-----SSD 98 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EET
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE-----EeC
Confidence 57999999999999999999999999999999986321 1111346788999999999999999999999 455
Q ss_pred ceEEEEEecCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCc---eEEeeeC
Q 008729 100 KDIYVVFELME-SDLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFG 171 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---vKL~DFG 171 (556)
..+|+|||||+ ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 67999999999 6998887542 35899999999999999999999999999999999999987655 9999999
Q ss_pred ccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 008729 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (556)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (556)
+++....... .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+.. ......+...
T Consensus 179 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~----- 247 (351)
T 3c0i_A 179 VAIQLGESGL---VAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKG----- 247 (351)
T ss_dssp TCEECCTTSC---BCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHT-----
T ss_pred ceeEecCCCe---eecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcC-----
Confidence 9987543221 2245679999999999987 679999999999999999999999998753 2222222211
Q ss_pred hHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
........+..+++.+.+||++||..||++|||+.++|+||||+..
T Consensus 248 ----------------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 248 ----------------------KYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp ----------------------CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ----------------------CCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 1111111234689999999999999999999999999999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=421.46 Aligned_cols=265 Identities=25% Similarity=0.361 Sum_probs=220.0
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
..++|+++++||+|+||.||+|+++.+++.||||++.+... .......+.+|+.+|+.++||||+++++++ .+.
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EEC
Confidence 34689999999999999999999999999999999864210 111123477899999999999999999999 556
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
..+|||||||. |+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 77999999997 699999876 4699999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCcceecccccCcccCCcccccccCC--CCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFS--KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~--~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
... ......+||+.|+|||++.+... .|+.++|||||||++|+|++|++||.+.+....+..|.....
T Consensus 221 ~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~-------- 290 (410)
T 3v8s_A 221 EGM--VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKN-------- 290 (410)
T ss_dssp TSE--EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--------
T ss_pred CCc--ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccc--------
Confidence 221 12346789999999999876211 188999999999999999999999999888777766643100
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCC--CCCHHHHHhCccccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD--RPTAEEALADPYFKGLA 320 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~--Rpta~elL~hp~f~~~~ 320 (556)
... ......+++.+++||++||..+|.+ |++++|+++||||+++.
T Consensus 291 ----------------~~~---~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 291 ----------------SLT---FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp ----------------HCC---CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred ----------------ccc---CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 001 1123468999999999999999988 99999999999999763
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=423.48 Aligned_cols=258 Identities=26% Similarity=0.466 Sum_probs=212.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|+++++||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++ ....
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~-----~~~~ 221 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHD 221 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEE-----EETT
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEE-----eeCC
Confidence 368999999999999999999999999999999987432 2233455678999999999999999999999 4556
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.+|||||||+ ++|.+++...+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+|+....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 7999999998 6999999988899999999999999999999998 9999999999999999999999999999976432
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
... .....+||+.|+|||++.+ ..|+.++||||||||||+|++|+.||.+.+.......|..
T Consensus 302 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------------- 363 (446)
T 4ejn_A 302 DGA---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------------- 363 (446)
T ss_dssp --------CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------------
T ss_pred CCc---ccccccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh-------------
Confidence 221 2356789999999999987 6899999999999999999999999998887665555422
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
... .....+++.+.+||.+||..||.+|| |++|+|+||||+++.
T Consensus 364 -------------~~~-----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 364 -------------EEI-----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp -------------CCC-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred -------------CCC-----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 111 11245889999999999999999999 999999999999863
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=407.87 Aligned_cols=255 Identities=29% Similarity=0.443 Sum_probs=212.7
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||.||+|.++.+|+.||||++..... ...+|+.+|..+ +||||+++++++ .+...
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~ 90 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVY-----DDGKY 90 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCE
Confidence 579999999999999999999999999999999975422 234688888888 799999999999 55678
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC----CceEEeeeCccccc
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN----CKLKVCDFGLARVA 176 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~----~~vKL~DFGla~~~ 176 (556)
+|+|||||. |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+..+ +.+||+|||+++..
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999998 6999999998899999999999999999999999999999999999998433 35999999999865
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHhhCCCChH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS---VVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~---~~~~~~~i~~~~g~p~~e 253 (556)
..... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.. ..+.+..|
T Consensus 171 ~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i---------- 235 (342)
T 2qr7_A 171 RAENG---LLMTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI---------- 235 (342)
T ss_dssp BCTTC---CBCCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH----------
T ss_pred cCCCC---ceeccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH----------
Confidence 43322 1245679999999999987 568999999999999999999999998642 22222222
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
...........++.+++.+.+||++||..||++|||++++|+||||.+..
T Consensus 236 -----------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 236 -----------------GSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp -----------------HHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred -----------------ccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 11222222234567999999999999999999999999999999997654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=401.21 Aligned_cols=289 Identities=35% Similarity=0.594 Sum_probs=234.4
Q ss_pred CCeEEEeeeeecCceeEEEEEEC-CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC---CCCCcceeeEEEcCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDT-HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~-~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L---~HpnIv~l~~v~~~~~~~~ 98 (556)
++|++++.||+|+||.||+|.+. .+|+.||||++............+.+|+.+++.+ +||||+++++++.......
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 58999999999999999999995 6789999999864332222223456777777766 8999999999985332235
Q ss_pred CceEEEEEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
...+|+||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 170 (326)
T 1blx_A 91 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 170 (326)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccc
Confidence 67799999999999999998754 4999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.+.++.|..+.+.
T Consensus 171 ~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (326)
T 1blx_A 171 SFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244 (326)
T ss_dssp CGGG----GGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred cCCC----CccccccccceeCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCc
Confidence 3221 1245679999999999987 679999999999999999999999999999999999999988888766543
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~ 321 (556)
...... -.........+.....+.++..+.+||.+||..||.+|||++++|+||||+++..
T Consensus 245 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 245 RDVALP----RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp TTCSSC----GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cccccc----hhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 211000 0001112222334455678999999999999999999999999999999987643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=410.96 Aligned_cols=257 Identities=26% Similarity=0.447 Sum_probs=220.3
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||.||+|.+..+|+.||+|++... ...+...+.+|+.+|+.++||||+++++++ .+...+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~ 123 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEM 123 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEE-----EeCCEE
Confidence 5899999999999999999999999999999998743 234556788999999999999999999999 555779
Q ss_pred EEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC--CCceEEeeeCccccccC
Q 008729 103 YVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA--NCKLKVCDFGLARVAFS 178 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~--~~~vKL~DFGla~~~~~ 178 (556)
|+|||||. ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999998 69999997654 7999999999999999999999999999999999999974 46799999999987543
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
... ....+||+.|+|||++.+ ..++.++||||||||+|+|++|..||.+.+..+.+..+...
T Consensus 204 ~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~------------ 265 (387)
T 1kob_A 204 DEI----VKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC------------ 265 (387)
T ss_dssp TSC----EEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC------------
T ss_pred Ccc----eeeeccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence 321 244579999999999987 67999999999999999999999999998876655544221
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
........+..+++.+.+||++||..||.+|||++++|+||||++.
T Consensus 266 ---------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 311 (387)
T 1kob_A 266 ---------------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 311 (387)
T ss_dssp ---------------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ---------------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCC
Confidence 1111223456789999999999999999999999999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=420.33 Aligned_cols=290 Identities=34% Similarity=0.583 Sum_probs=214.7
Q ss_pred CCeEE-EeeeeecCceeEEEEEEC--CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 23 NRYKI-LEVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 23 ~~Y~i-~~~LG~G~~g~V~~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
+.|++ .++||+|+||+||+|+++ .+++.||||++..... ...+.+|+.+|+.|+||||+++++++... ..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~ 92 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSH---AD 92 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEET---TT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecC---CC
Confidence 35777 558999999999999966 5788999999875322 23577999999999999999999998542 34
Q ss_pred ceEEEEEecCcccHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee----cCCCceE
Q 008729 100 KDIYVVFELMESDLHQVIKAN---------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCKLK 166 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~---------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl----~~~~~vK 166 (556)
..+||||||++++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+|
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 93 RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp TEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred CeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 679999999999999988632 249999999999999999999999999999999999999 6778999
Q ss_pred EeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh---------H
Q 008729 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV---------V 237 (556)
Q Consensus 167 L~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~---------~ 237 (556)
|+|||+|+...............+||++|+|||++.+. ..|+.++||||||||||+|++|++||.+... .
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 251 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence 99999998754332222233567899999999998762 3589999999999999999999999987664 4
Q ss_pred HHHHHHHHhhCCCChHHHHHhhhH-HHHHHHHHhhcCCCCC------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHH
Q 008729 238 HQLDLITDLLGTPSPETIAVVRNE-KARKYLTEMRKKPPVP------LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310 (556)
Q Consensus 238 ~~~~~i~~~~g~p~~e~i~~~~~~-~~~~~l~~~~~~~~~~------~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~el 310 (556)
+++..|...+|.|....+..+..- .........+...... ........++.+.+||++||.+||.+|||++|+
T Consensus 252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~ 331 (405)
T 3rgf_A 252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA 331 (405)
T ss_dssp HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 789999999999988766544321 1111111111110000 001122347789999999999999999999999
Q ss_pred HhCccccccc
Q 008729 311 LADPYFKGLA 320 (556)
Q Consensus 311 L~hp~f~~~~ 320 (556)
|+||||.+..
T Consensus 332 L~hp~f~~~~ 341 (405)
T 3rgf_A 332 MQDPYFLEDP 341 (405)
T ss_dssp HTSGGGTSSS
T ss_pred hcChhhccCC
Confidence 9999998643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=397.72 Aligned_cols=259 Identities=27% Similarity=0.445 Sum_probs=221.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCCh----hHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~----~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
++|++++.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+|+.++||||+++++++ .+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~ 86 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVY-----EN 86 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEE-----ec
Confidence 57999999999999999999999999999999987532221 1356788999999999999999999999 45
Q ss_pred CceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC----ceEEeeeCcc
Q 008729 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLKVCDFGLA 173 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~----~vKL~DFGla 173 (556)
...+|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 567999999997 69999999888899999999999999999999999999999999999999887 7999999999
Q ss_pred ccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+.........
T Consensus 167 ~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~- 239 (321)
T 2a2a_A 167 HEIEDGVE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE- 239 (321)
T ss_dssp EECCTTCC----CCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCH-
T ss_pred eecCcccc----ccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccCh-
Confidence 86543322 245679999999999987 67899999999999999999999999988876666555432211111
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
..+..+++.+.+||++||..||++|||++++|+||||+..
T Consensus 240 --------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 240 --------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp --------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred --------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 1124678999999999999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=396.38 Aligned_cols=260 Identities=24% Similarity=0.457 Sum_probs=209.2
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCC------------------------hhHHHHHHHHHHHHH
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH------------------------ISDAIRILREVKLLR 77 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~------------------------~~~~~~~~rEi~iL~ 77 (556)
.++|++++.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36899999999999999999999999999999998643211 112346889999999
Q ss_pred hCCCCCcceeeEEEcCCCCCCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 008729 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (556)
Q Consensus 78 ~L~HpnIv~l~~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (556)
.++||||+++++++... ....+|+||||++ ++|.+++ ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 99999999999998542 2467999999998 5777654 34579999999999999999999999999999999999
Q ss_pred EeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCC-CCCcchhhhHHHHHHHHHhCCCCCCCCC
Q 008729 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSIGCIFAEVLTGKPLFPGKS 235 (556)
Q Consensus 157 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-y~~~~DIWSlG~ilyelltG~~pF~~~~ 235 (556)
||++.++.+||+|||+++....... .....+||+.|+|||++.+.... ++.++|||||||++|+|++|+.||.+.+
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSC---EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEECCCCCEEEecCCCccccccccc---cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 9999999999999999986543221 23456799999999998762111 4788999999999999999999998876
Q ss_pred hHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 008729 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (556)
Q Consensus 236 ~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~ 315 (556)
.......+.. .... ....+.+++.+.+||.+||..||++|||++|+|+|||
T Consensus 245 ~~~~~~~~~~--------------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~ 295 (298)
T 2zv2_A 245 IMCLHSKIKS--------------------------QALE---FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295 (298)
T ss_dssp HHHHHHHHHH--------------------------CCCC---CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred HHHHHHHHhc--------------------------ccCC---CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence 5443333211 1111 1123568999999999999999999999999999999
Q ss_pred cc
Q 008729 316 FK 317 (556)
Q Consensus 316 f~ 317 (556)
|+
T Consensus 296 ~~ 297 (298)
T 2zv2_A 296 VT 297 (298)
T ss_dssp HH
T ss_pred cc
Confidence 96
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=405.38 Aligned_cols=255 Identities=27% Similarity=0.438 Sum_probs=202.5
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|+.+|+.++||||+++++++ .+...+
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~ 123 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIF-----ETPTEI 123 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCCCCCCcceeeeE-----ecCCeE
Confidence 5799999999999999999999999999999998743 2345677899999999999999999999 455679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC---CCceEEeeeCccccccC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGLARVAFS 178 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~vKL~DFGla~~~~~ 178 (556)
|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 99999998 699999998888999999999999999999999999999999999999975 88999999999986533
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~-~~~~i~~~~g~p~~e~i~~ 257 (556)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... .+..+
T Consensus 204 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i-------------- 263 (349)
T 2w4o_A 204 QV----LMKTVCGTPGYCAPEILRG--CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI-------------- 263 (349)
T ss_dssp -------------CGGGSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHH--------------
T ss_pred cc----ccccccCCCCccCHHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHH--------------
Confidence 22 1245679999999999987 679999999999999999999999997765433 22222
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
...........+..++..+.+||++||..||++|||++++|+||||.+.
T Consensus 264 -------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 264 -------------LNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312 (349)
T ss_dssp -------------HTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred -------------HhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 1111112223446789999999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=398.19 Aligned_cols=252 Identities=27% Similarity=0.303 Sum_probs=208.7
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|+++++||+|+||+||+|++..+|+.||||++.............++|+..+..+ +||||+++++++ .+...
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~-----~~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-----EEGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEE-----EeCCE
Confidence 579999999999999999999999999999999876656666666777777777666 899999999999 55677
Q ss_pred EEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|+|||||+++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 132 ~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 132 LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence 9999999999999988764 469999999999999999999999999999999999999999999999999987654322
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
. .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..... .+.
T Consensus 212 ~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---~~~---------------- 265 (311)
T 3p1a_A 212 A----GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGEGWQ---QLR---------------- 265 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---HHT----------------
T ss_pred C----CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---HHh----------------
Confidence 2 234569999999999875 68999999999999999999977765533211 111
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
..... ......+++.+.+||.+||+.||++|||++++|+||||++
T Consensus 266 -----------~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 266 -----------QGYLP--PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -----------TTCCC--HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -----------ccCCC--cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 00000 0112457899999999999999999999999999999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=405.84 Aligned_cols=262 Identities=25% Similarity=0.444 Sum_probs=194.8
Q ss_pred CeEEE---eeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCC
Q 008729 24 RYKIL---EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 24 ~Y~i~---~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~ 99 (556)
+|++. +.||+|+||.||+|.+..+++.||||++... ....+.+|+.+|+.+. ||||+++++++ .+.
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~ 78 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVF-----HDQ 78 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcC
Confidence 67775 7899999999999999999999999998642 3456778999999997 99999999999 556
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC---ceEEeeeCcccc
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLKVCDFGLARV 175 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~vKL~DFGla~~ 175 (556)
..+|+|||||+ ++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~ 158 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence 77999999998 59999999999999999999999999999999999999999999999997765 799999999986
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
...... .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+......
T Consensus 159 ~~~~~~---~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------------- 219 (325)
T 3kn6_A 159 KPPDNQ---PLKTPCFTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT-------------- 219 (325)
T ss_dssp CCC---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC--------------
T ss_pred cCCCCC---cccccCCCcCccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc--------------
Confidence 433221 2345678999999999987 689999999999999999999999998754311000
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.....+..+...........+..+++.+.+||++||..||.+|||++++|+||||++..
T Consensus 220 ------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 220 ------SAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp ------CHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred ------cHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 00011122222222111222346899999999999999999999999999999998643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=420.08 Aligned_cols=256 Identities=30% Similarity=0.508 Sum_probs=219.5
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|.+++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+|+.++||||+++++++ ....
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~-----~~~~ 89 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVI-----STPS 89 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECC
Confidence 4689999999999999999999999999999999864211 112345788999999999999999999999 4556
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+|||||. ++|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 7999999997 699999998889999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcceecccccCcccCCcccccccCCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y-~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
. .....+||+.|+|||++.+ ..+ +.++||||||||+|+|++|+.||.+.+.......|...
T Consensus 170 ~----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~------------ 231 (476)
T 2y94_A 170 E----FLRTSCGSPNYAAPEVISG--RLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG------------ 231 (476)
T ss_dssp C----CBCCCCSCSTTCCHHHHTT--CCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT------------
T ss_pred c----cccccCCCcCeEChhhccC--CCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC------------
Confidence 2 2345689999999999987 444 68999999999999999999999988766555444221
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
. ......+++.+.+||++||..||.+|||++++++||||+..
T Consensus 232 --------------~-----~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 232 --------------I-----FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp --------------C-----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred --------------C-----cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 0 11223578999999999999999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=406.96 Aligned_cols=290 Identities=33% Similarity=0.571 Sum_probs=222.1
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC--CCCc
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK--REFK 100 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~--~~~~ 100 (556)
++|++++.||+|+||.||+|.+..+|+.||||++.... ....+..+|++.+..++||||+++++++..... ....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 99 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDI 99 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccce
Confidence 58999999999999999999999999999999885422 222345678888899999999999999864322 2334
Q ss_pred eEEEEEecCcccHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCcEeecC-CCceEEeeeCcc
Q 008729 101 DIYVVFELMESDLHQVIK----ANDDLTREHHQFFLYQMLRALKYMH--TANVYHRDLKPKNILANA-NCKLKVCDFGLA 173 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~----~~~~l~~~~~~~i~~QIl~aL~yLH--s~gIvHrDLKP~NILl~~-~~~vKL~DFGla 173 (556)
.+|+|||||+++|.+.+. ....+++..++.++.||+.||.||| +.||+||||||+|||++. ++.+||+|||++
T Consensus 100 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 100 YLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTC
T ss_pred eEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCc
Confidence 588999999998776654 4567999999999999999999999 999999999999999996 899999999999
Q ss_pred ccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
+....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+....+..+...++.|..+
T Consensus 180 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 180 KKLSPSEP----NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSRE 254 (360)
T ss_dssp BCCCTTSC----CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred eecCCCCC----cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHH
Confidence 86543322 2456799999999998652 458999999999999999999999999999999999999999999888
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcC----CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLF----QKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIE 323 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~----~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e 323 (556)
.+..+....... ........++. ......++.+.+||.+||+.||.+|||+.|+|+||||+++....
T Consensus 255 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 325 (360)
T 3e3p_A 255 VLRKLNPSHTDV---DLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA 325 (360)
T ss_dssp HHHHHCTTCCCG---GGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred HHHhcccchhhc---cccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence 765432110000 00001111111 11223678999999999999999999999999999999876543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=387.16 Aligned_cols=256 Identities=31% Similarity=0.479 Sum_probs=220.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+|+.++||||+++++++ .+...+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~ 81 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDI 81 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--chHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeE
Confidence 579999999999999999999999999999999875332 2355788999999999999999999999 555679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee---cCCCceEEeeeCccccccC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl---~~~~~vKL~DFGla~~~~~ 178 (556)
|+||||++ ++|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999998 5999999988889999999999999999999999999999999999999 7888999999999976543
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+......+..
T Consensus 162 ~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 228 (277)
T 3f3z_A 162 GKM----MRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPE------ 228 (277)
T ss_dssp TSC----BCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH------
T ss_pred ccc----hhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCc------
Confidence 322 245679999999999875 4899999999999999999999999998876666555432222111
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
..+..+++.+.+||++||+.||++|||+.++|+||||++.
T Consensus 229 ---------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 229 ---------------------KDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp ---------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred ---------------------hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 1123578999999999999999999999999999999853
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=399.89 Aligned_cols=287 Identities=31% Similarity=0.578 Sum_probs=223.4
Q ss_pred ccCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCC
Q 008729 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (556)
Q Consensus 18 ~~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~ 96 (556)
.++..++|++++.||+|+||.||+|++..+++.||||++... ....+.+|+.+|+.++ ||||+++++++...
T Consensus 31 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~-- 103 (330)
T 3nsz_A 31 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDP-- 103 (330)
T ss_dssp CCEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT--
T ss_pred cccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccC--
Confidence 455668999999999999999999999999999999998742 2356889999999997 99999999998542
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC-ceEEeeeCccc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLAR 174 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~vKL~DFGla~ 174 (556)
.....|+||||+. ++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++
T Consensus 104 -~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 104 -VSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp -TTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred -CCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 2466899999999 68888875 489999999999999999999999999999999999999776 89999999998
Q ss_pred cccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCC-CCCChHHHHHHHHHhhCCCChH
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF-~~~~~~~~~~~i~~~~g~p~~e 253 (556)
....... ....+||+.|+|||++.+. ..++.++|||||||++|+|++|+.|| .+.+..+.+..+...++.+...
T Consensus 180 ~~~~~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~ 254 (330)
T 3nsz_A 180 FYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 254 (330)
T ss_dssp ECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred EcCCCCc----cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhh
Confidence 6543322 2455799999999998653 46899999999999999999999888 5666777777777766643221
Q ss_pred HHHHhhh-HHHHHHHHHhhcCCCCCcCC-----CCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 254 TIAVVRN-EKARKYLTEMRKKPPVPLFQ-----KFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 254 ~i~~~~~-~~~~~~l~~~~~~~~~~~~~-----~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
....... .....+...........+.. ....+++.+.+||++||+.||.+|||++|+|+||||+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 1110000 00000011111111111111 1123799999999999999999999999999999999764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=387.18 Aligned_cols=263 Identities=24% Similarity=0.310 Sum_probs=219.7
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
...+..|++.+.||+|+||.||+|.+..++..||+|++............+.+|+.+|+.++||||+++++++.... .+
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~ 100 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KG 100 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SS
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CC
Confidence 34566799999999999999999999999999999999865556667788999999999999999999999885332 34
Q ss_pred CceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEeec-CCCceEEeeeCccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILAN-ANCKLKVCDFGLAR 174 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~-~~~~vKL~DFGla~ 174 (556)
...+|+||||++ ++|.+++...+.+++..++.|+.||+.||.|||+.| |+||||||+|||++ .++.+||+|||++.
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 567999999997 699999998888999999999999999999999999 99999999999997 78999999999997
Q ss_pred cccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...
T Consensus 181 ~~~~~~-----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----------- 241 (290)
T 1t4h_A 181 LKRASF-----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR----------- 241 (290)
T ss_dssp GCCTTS-----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH-----------
T ss_pred cccccc-----cccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH-----------
Confidence 543321 234579999999998865 5899999999999999999999999876544333211
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
+..... ........++.+.+||.+||..||.+|||++++|+||||++
T Consensus 242 ---------------~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 242 ---------------VTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ---------------HTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ---------------HhccCC--ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 111100 11112346789999999999999999999999999999985
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=395.11 Aligned_cols=282 Identities=30% Similarity=0.522 Sum_probs=229.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEE-CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC------cceeeEEEcCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAID-THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD------IVEIKRIMLPP 94 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~-~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn------Iv~l~~v~~~~ 94 (556)
.++|++++.||+|+||.||+|.+ ..+++.||||++.. .......+.+|+.+++.++|++ |+++++++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~--- 86 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF--- 86 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE---
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec---CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc---
Confidence 46999999999999999999998 56889999999874 2344567889999999987654 99999998
Q ss_pred CCCCCceEEEEEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC-----------
Q 008729 95 SKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA----------- 161 (556)
Q Consensus 95 ~~~~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~----------- 161 (556)
.....+|+||||++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 87 --~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 87 --EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp --EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC---
T ss_pred --ccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcc
Confidence 4556799999999999999998765 6899999999999999999999999999999999999987
Q ss_pred --------CCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCC
Q 008729 162 --------NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (556)
Q Consensus 162 --------~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~ 233 (556)
++.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhC--CCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 668999999999864322 134579999999999987 6799999999999999999999999999
Q ss_pred CChHHHHHHHHHhhCCCChHHHHHhhhH--------------HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhc
Q 008729 234 KSVVHQLDLITDLLGTPSPETIAVVRNE--------------KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF 299 (556)
Q Consensus 234 ~~~~~~~~~i~~~~g~p~~e~i~~~~~~--------------~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~ 299 (556)
.+..+.+..+....+.++...+...... ....+...... ............++.+.+||++||+.
T Consensus 237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK-PLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCc-chhhhcccchhhHHHHHHHHHHHhCc
Confidence 9999999999999988877665433211 11111111111 00111111223467899999999999
Q ss_pred CCCCCCCHHHHHhCccccccc
Q 008729 300 DPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 300 dP~~Rpta~elL~hp~f~~~~ 320 (556)
||.+|||++|+|+||||+.+.
T Consensus 316 dP~~Rpt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 316 DPAKRITLREALKHPFFDLLK 336 (339)
T ss_dssp STTTSCCHHHHTTSGGGGGGG
T ss_pred CcccccCHHHHhcCHHHHHHh
Confidence 999999999999999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=388.58 Aligned_cols=255 Identities=31% Similarity=0.484 Sum_probs=209.6
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.+|+.++||||+++++++ .+...+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~ 95 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNM 95 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCeE
Confidence 58999999999999999999999999999999987542 223456788999999999999999999999 555679
Q ss_pred EEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee---cCCCceEEeeeCccc
Q 008729 103 YVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLAR 174 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl---~~~~~vKL~DFGla~ 174 (556)
|+|||||. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 99999998 599988854 3679999999999999999999999999999999999999 456789999999997
Q ss_pred cccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
....... ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 176 ~~~~~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~--------- 239 (285)
T 3is5_A 176 LFKSDEH----STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY--------- 239 (285)
T ss_dssp C--------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------
T ss_pred ecCCccc----CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc---------
Confidence 6543221 245679999999999864 688999999999999999999999998775544433211
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
. ..........+++.+.+||++||+.||++|||++|+|+||||++
T Consensus 240 -----------------~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 240 -----------------K--EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp -----------------C--CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred -----------------C--CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 0 01111122347899999999999999999999999999999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=405.43 Aligned_cols=283 Identities=27% Similarity=0.411 Sum_probs=226.0
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC--------CCCcceeeEEEcC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR--------HPDIVEIKRIMLP 93 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~--------HpnIv~l~~v~~~ 93 (556)
.++|++++.||+|+||+||+|++..+++.||||++.. .......+.+|+.+|+.++ |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 3789999999999999999999999999999999873 3345567889999999995 7889999999853
Q ss_pred CCCCCCceEEEEEecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEeecCCC-------
Q 008729 94 PSKREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANC------- 163 (556)
Q Consensus 94 ~~~~~~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~------- 163 (556)
.. .....+|||||||+++|.+.+... +.+++..++.|+.||+.||+|||++ ||+||||||+|||++.++
T Consensus 113 ~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SG-VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EE-TTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cC-CCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 21 245679999999999988888764 4699999999999999999999998 999999999999999775
Q ss_pred ------------------------------------------ceEEeeeCccccccCCCCCcceecccccCcccCCcccc
Q 008729 164 ------------------------------------------KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201 (556)
Q Consensus 164 ------------------------------------------~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 201 (556)
.+||+|||+++..... ....+||+.|+|||++
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCSCGGGCCHHHH
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCCCCcccCChhh
Confidence 7999999999865432 2455799999999999
Q ss_pred cccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCC
Q 008729 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS------VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPP 275 (556)
Q Consensus 202 ~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~------~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~ 275 (556)
.+ ..|+.++||||||||||+|++|++||.+.+ ..+.+..+.+.+|.++...+...... ..++........
T Consensus 266 ~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~ 341 (397)
T 1wak_A 266 IG--SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS--KEFFTKKGDLKH 341 (397)
T ss_dssp HT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG--GGTBCTTSSBSS
T ss_pred cC--CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc--ccccCCcccccc
Confidence 87 679999999999999999999999998765 56778888899998877665322110 000000000000
Q ss_pred CCc-------------CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 276 VPL-------------FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 276 ~~~-------------~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
... .......++.+.+||++||+.||++|||++|+|+||||++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 000 0011123567899999999999999999999999999973
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=410.81 Aligned_cols=257 Identities=29% Similarity=0.439 Sum_probs=204.7
Q ss_pred CCCeEEE-eeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHH-HhCCCCCcceeeEEEcCCCCCCC
Q 008729 22 ANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL-RLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 22 ~~~Y~i~-~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL-~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
.++|.+. ++||+|+||+||+|.++.+|+.||||++... ..+.+|+.++ +.++||||+++++++.... .+.
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLY-AGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCC
Confidence 4578887 7899999999999999999999999998632 3566899987 4558999999999884311 235
Q ss_pred ceEEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC---CCceEEeeeCcc
Q 008729 100 KDIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGLA 173 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~vKL~DFGla 173 (556)
..+|||||||. |+|.+++...+ .+++..++.|+.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 67999999998 69999998754 5999999999999999999999999999999999999997 788999999999
Q ss_pred ccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHH----HHHHHHHhhCC
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH----QLDLITDLLGT 249 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~----~~~~i~~~~g~ 249 (556)
+...... .....+||+.|+|||++.+ ..|+.++||||||||||+|++|++||.+.+... ....+
T Consensus 212 ~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i------ 279 (400)
T 1nxk_A 212 KETTSHN----SLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI------ 279 (400)
T ss_dssp EECC---------------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH------
T ss_pred cccCCCC----ccccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH------
Confidence 8654322 1246679999999999987 789999999999999999999999998765322 11111
Q ss_pred CChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
...........+..+++.+.+||++||..||++|||++++|+||||.+.
T Consensus 280 ---------------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 280 ---------------------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp ---------------------HHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ---------------------HcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 1111111122346789999999999999999999999999999999864
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=401.66 Aligned_cols=280 Identities=33% Similarity=0.519 Sum_probs=227.5
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCC-----cceeeEEEcCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPD-----IVEIKRIMLPPS 95 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-Hpn-----Iv~l~~v~~~~~ 95 (556)
.++|++++.||+|+||+||+|++..+++.||||++.. .......+.+|+.+++.++ |++ |+++++++
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~---- 125 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF---- 125 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE----
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee----
Confidence 4689999999999999999999999999999999973 2344556778999998885 553 89999988
Q ss_pred CCCCceEEEEEecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCcEeec--CCCceEEee
Q 008729 96 KREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMH--TANVYHRDLKPKNILAN--ANCKLKVCD 169 (556)
Q Consensus 96 ~~~~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLH--s~gIvHrDLKP~NILl~--~~~~vKL~D 169 (556)
.....+||||||++++|.+++... ..+++..++.++.||+.||.||| ..||+||||||+|||++ .++.+||+|
T Consensus 126 -~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 126 -MFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp -EETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred -ccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 445679999999999999999875 46999999999999999999999 57999999999999994 477899999
Q ss_pred eCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC
Q 008729 170 FGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (556)
Q Consensus 170 FGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~ 249 (556)
||+++..... ....+||+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+..+++..|...++.
T Consensus 205 FG~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 205 FGSSCQLGQR------IYQYIQSRFYRSPEVLLG--MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp CTTCEETTCC------CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred ccCceecccc------cccccCCccccChHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999875322 245679999999999987 67999999999999999999999999999999999999999999
Q ss_pred CChHHHHHhhhHHHHHHHHHhhcCCC------CCcCC-CCC---------------------C-------CCHHHHHHHH
Q 008729 250 PSPETIAVVRNEKARKYLTEMRKKPP------VPLFQ-KFP---------------------N-------VDPLALRLLQ 294 (556)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~------~~~~~-~~~---------------------~-------~s~~~~dLl~ 294 (556)
|....+... +..+.++..+..... ..... ..+ . ..+.+.+||+
T Consensus 277 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 354 (382)
T 2vx3_A 277 PPAHILDQA--PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLIL 354 (382)
T ss_dssp CCHHHHTTC--TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHH
T ss_pred CCHHHHHhh--HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHH
Confidence 987766432 223333332211100 00000 000 0 0147899999
Q ss_pred HhhhcCCCCCCCHHHHHhCcccccc
Q 008729 295 RLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 295 ~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
+||++||++|||++|+|+||||++.
T Consensus 355 ~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 355 RMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HhcCCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=386.59 Aligned_cols=255 Identities=27% Similarity=0.457 Sum_probs=215.5
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++ .+...
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~ 83 (279)
T 3fdn_A 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR 83 (279)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred ccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheE-----ecCCE
Confidence 58999999999999999999999999999999986421 1112245688999999999999999999999 45567
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|+||||++ ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 999999999 6999999988889999999999999999999999999999999999999999999999999986543221
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 164 -----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 223 (279)
T 3fdn_A 164 -----RTDLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE------------- 223 (279)
T ss_dssp ---------CCCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC-------------
T ss_pred -----ccccCCCCCccCHhHhcc--CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC-------------
Confidence 245579999999999987 678999999999999999999999999887665555442210
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
......+++.+.+||.+||..||.+|||++|+|+||||+...
T Consensus 224 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 224 ------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp ------------------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred ------------------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 011234789999999999999999999999999999998643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=391.92 Aligned_cols=255 Identities=29% Similarity=0.520 Sum_probs=215.8
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
.|...+.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+|+.++||||+++++++ .....+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~ 118 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSY-----LVGEELW 118 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEE
Confidence 4889999999999999999999999999999986432 23345688999999999999999999998 4456799
Q ss_pred EEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCC
Q 008729 104 VVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 182 (556)
+||||+. ++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 119 lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 197 (321)
T 2c30_A 119 VLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK 197 (321)
T ss_dssp EEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred EEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc
Confidence 9999998 689988764 57999999999999999999999999999999999999999999999999999865433222
Q ss_pred cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHH
Q 008729 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (556)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~ 262 (556)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+...
T Consensus 198 ---~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~---------------- 256 (321)
T 2c30_A 198 ---RKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---------------- 256 (321)
T ss_dssp ---BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS----------------
T ss_pred ---cccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC----------------
Confidence 245679999999999987 67999999999999999999999999887765554443221
Q ss_pred HHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
..+.......+++.+.+||.+||..||++|||++++|+||||.+.
T Consensus 257 ------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 257 ------------PPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp ------------SCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred ------------CCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 111111223578999999999999999999999999999999854
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=396.66 Aligned_cols=261 Identities=27% Similarity=0.342 Sum_probs=209.0
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCC--CCcceeeEEEcCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH--PDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H--pnIv~l~~v~~~~~~~~ 98 (556)
.+++|++++.||+|+||.||+|.+ .+++.||||++............+.+|+.+|+.++| |||+++++++ ..
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~ 80 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----IT 80 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE-----ee
Confidence 356899999999999999999987 468999999997655555666788999999999986 9999999998 45
Q ss_pred CceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
...+|||||+++++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 81 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 81 DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp SSEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred CCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 56799999988899999999999999999999999999999999999999999999999997 67899999999986543
Q ss_pred CCCCcceecccccCcccCCccccccc---------CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhhC
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV-HQLDLITDLLG 248 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~---------~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~-~~~~~i~~~~g 248 (556)
... .......+||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.+.... ..+..+
T Consensus 160 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~----- 233 (343)
T 3dbq_A 160 DTT-SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI----- 233 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH-----
T ss_pred ccc-cccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH-----
Confidence 321 1122456799999999998531 146888999999999999999999999764321 111111
Q ss_pred CCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
+... .........+..+.+||.+||..||.+|||++++|+||||+.
T Consensus 234 ---------------------~~~~---~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~ 279 (343)
T 3dbq_A 234 ---------------------IDPN---HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI 279 (343)
T ss_dssp ---------------------HCTT---SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHS
T ss_pred ---------------------hcCC---cccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccc
Confidence 1001 111122346788999999999999999999999999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=433.79 Aligned_cols=259 Identities=22% Similarity=0.388 Sum_probs=223.2
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~ 98 (556)
..++|+++++||+|+||.||+|+++.+++.||||++.+.. ........+.+|..+|..+ +||+|+.+++++ .+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~ 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence 3468999999999999999999999999999999987421 1122345678899999988 699999999998 55
Q ss_pred CceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
...+|||||||. |+|.+++...+.+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 677999999998 6999999988899999999999999999999999999999999999999999999999999998643
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
..... ....+||+.|+|||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..|..
T Consensus 494 ~~~~~---~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~------------ 556 (674)
T 3pfq_A 494 WDGVT---TKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME------------ 556 (674)
T ss_dssp CTTCC---BCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHS------------
T ss_pred cCCcc---cccccCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHh------------
Confidence 32222 256789999999999987 7899999999999999999999999999887776666532
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH-----HHHHhCccccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA-----EEALADPYFKGLA 320 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta-----~elL~hp~f~~~~ 320 (556)
... .....+++++.+||++||+.||.+|+++ ++|++||||+++.
T Consensus 557 --------------~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 557 --------------HNV-----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp --------------SCC-----CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred --------------CCC-----CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 111 1224689999999999999999999997 9999999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=396.29 Aligned_cols=269 Identities=25% Similarity=0.359 Sum_probs=216.3
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
..++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++.... ...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 88 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG 88 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCC
Confidence 45689999999999999999999999999999999975432 3345567889999999999999999999985432 122
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
...|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 35699999997 69999999888999999999999999999999999999999999999999999999999999986544
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
...........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~------------ 234 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE------------ 234 (311)
T ss_dssp -------------CCTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC------------
T ss_pred cccccccccccCcCcccCCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcC------------
Confidence 3322222345679999999999987 68999999999999999999999999988765554433221
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
...+.......+++.+.+||.+||+.||.+||++.++|.|+|++..
T Consensus 235 ---------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 235 ---------------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ---------------CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ---------------CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 1111122235689999999999999999999999999999999754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=387.27 Aligned_cols=256 Identities=28% Similarity=0.460 Sum_probs=217.2
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||.||+|.+..+|+.||||++... .......+.+|+.+|+.++||||+++++++ .+...+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 81 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS--PAFRDSSLENEIAVLKKIKHENIVTLEDIY-----ESTTHY 81 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEE-----ECSSEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecc--cccchHHHHHHHHHHHhCCCCCeeehhhhc-----ccCCEE
Confidence 4899999999999999999999999999999998743 222345688999999999999999999998 455679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee---cCCCceEEeeeCccccccC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl---~~~~~vKL~DFGla~~~~~ 178 (556)
|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999998 6999999888889999999999999999999999999999999999999 7788999999999875432
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+...
T Consensus 162 ~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~------------ 222 (304)
T 2jam_A 162 G-----IMSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG------------ 222 (304)
T ss_dssp B-----TTHHHHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHC------------
T ss_pred C-----ccccccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC------------
Confidence 2 1244579999999999987 67999999999999999999999999888766555444321
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
........+..+++.+.+||.+||..||++|||++++|+||||++.
T Consensus 223 ---------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 223 ---------------YYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp ---------------CCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ---------------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 1111122345689999999999999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-48 Score=403.81 Aligned_cols=256 Identities=27% Similarity=0.403 Sum_probs=213.0
Q ss_pred CeEE--EeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 24 RYKI--LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 24 ~Y~i--~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.|.+ .+.||+|+||.||+|.+..+|+.||+|++.. ........+.+|+.+|+.|+||||+++++++ .+...
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~ 160 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT--RGMKDKEEVKNEISVMNQLDHANLIQLYDAF-----ESKND 160 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEEC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcc--cccccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCE
Confidence 4555 6789999999999999999999999999875 2335567789999999999999999999999 45567
Q ss_pred EEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee--cCCCceEEeeeCcccccc
Q 008729 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA--NANCKLKVCDFGLARVAF 177 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl--~~~~~vKL~DFGla~~~~ 177 (556)
+|||||||+ ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++...
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~ 240 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence 999999998 6998888654 469999999999999999999999999999999999999 567889999999998754
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... ....+||+.|+|||++.+ ..++.++||||||||+|+|++|+.||.+.+..+.+..|.....
T Consensus 241 ~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~--------- 305 (373)
T 2x4f_A 241 PREK----LKVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW--------- 305 (373)
T ss_dssp TTCB----CCCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC---------
T ss_pred Cccc----cccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC---------
Confidence 3322 234579999999999977 6789999999999999999999999999887776666543211
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
......+..+++.+.+||.+||..||.+|||++|+|+||||+..
T Consensus 306 ------------------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 306 ------------------DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ------------------CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ------------------CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 11122345789999999999999999999999999999999864
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=398.67 Aligned_cols=266 Identities=28% Similarity=0.442 Sum_probs=214.5
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc---CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~---~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
++|++++.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+|+.++||||+++++++ .+.
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~ 100 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----EDE 100 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-----ccC
Confidence 57999999999999999999999999999999986421 1234567889999999999999999999999 555
Q ss_pred ceEEEEEecCc-ccHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHH
Q 008729 100 KDIYVVFELME-SDLHQVIKA----------------------------------------NDDLTREHHQFFLYQMLRA 138 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~----------------------------------------~~~l~~~~~~~i~~QIl~a 138 (556)
..+|+|||||+ ++|.+++.. ...+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 67999999997 699998842 1123678889999999999
Q ss_pred HHHHHHCCceeccCCCCcEeecCCC--ceEEeeeCccccccCCCC-CcceecccccCcccCCcccccccCCCCCCcchhh
Q 008729 139 LKYMHTANVYHRDLKPKNILANANC--KLKVCDFGLARVAFSDTP-MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIW 215 (556)
Q Consensus 139 L~yLHs~gIvHrDLKP~NILl~~~~--~vKL~DFGla~~~~~~~~-~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIW 215 (556)
|.|||++||+||||||+|||++.++ .+||+|||+++....... .........||+.|+|||++.+....++.++|||
T Consensus 181 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 9999999999999999999998776 899999999986533221 1112345679999999999865335789999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHH
Q 008729 216 SIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQR 295 (556)
Q Consensus 216 SlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~ 295 (556)
||||++|+|++|+.||.+.+..+.+..+.... .......+..+++.+.+||.+
T Consensus 261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~li~~ 313 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKK---------------------------LCFENPNYNVLSPLARDLLSN 313 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------------------------CCTTSGGGGGSCHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcc---------------------------cccCCcccccCCHHHHHHHHH
Confidence 99999999999999999988766665543211 111112234578999999999
Q ss_pred hhhcCCCCCCCHHHHHhCccccccc
Q 008729 296 LIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 296 ~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
||..||.+|||+.++|+||||+++.
T Consensus 314 ~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 314 LLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HcCCChhHCCCHHHHhcChhhccCh
Confidence 9999999999999999999998764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=394.32 Aligned_cols=283 Identities=30% Similarity=0.505 Sum_probs=229.3
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCC-cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC------cceeeEEEcCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD------IVEIKRIMLPP 94 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg-~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn------Iv~l~~v~~~~ 94 (556)
.++|++++.||+|+||.||+|.+..++ +.||||++.. .......+.+|+.+|+.++|++ ++.+++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~--- 91 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF--- 91 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE---
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee---
Confidence 479999999999999999999998887 6899999873 2345567888999999997765 88888888
Q ss_pred CCCCCceEEEEEecCcccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee-------------
Q 008729 95 SKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA------------- 159 (556)
Q Consensus 95 ~~~~~~~lylV~E~~~g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl------------- 159 (556)
.....+||||||++++|.+.+.... .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 92 --~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 92 --NFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp --EETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred --eeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccc
Confidence 4556799999999999998887754 69999999999999999999999999999999999999
Q ss_pred ------cCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCC
Q 008729 160 ------NANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (556)
Q Consensus 160 ------~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~ 233 (556)
+.++.+||+|||+++...... ...+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEHH------TTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSCC------CSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccCCCcEEEeecCccccccccc------cCCcCCCcccCCeeeec--CCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 567899999999998643221 34579999999999987 6899999999999999999999999999
Q ss_pred CChHHHHHHHHHhhCCCChHHHHHhhhH--------------HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhc
Q 008729 234 KSVVHQLDLITDLLGTPSPETIAVVRNE--------------KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF 299 (556)
Q Consensus 234 ~~~~~~~~~i~~~~g~p~~e~i~~~~~~--------------~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~ 299 (556)
.+..+.+..+....+.++...+...... ....++...... ...........++.+.+||++||..
T Consensus 242 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 242 HENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKP-LKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC-GGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCc-ccccccccchhHHHHHHHHHHHhcC
Confidence 9999999999999988877665433211 011111111100 0001111122356889999999999
Q ss_pred CCCCCCCHHHHHhCcccccccc
Q 008729 300 DPKDRPTAEEALADPYFKGLAK 321 (556)
Q Consensus 300 dP~~Rpta~elL~hp~f~~~~~ 321 (556)
||++|||++|+|+||||+++..
T Consensus 321 dP~~Rpt~~e~l~hp~f~~~~~ 342 (355)
T 2eu9_A 321 DPAQRITLAEALLHPFFAGLTP 342 (355)
T ss_dssp STTTSCCHHHHTTSGGGGGCCH
T ss_pred ChhhCcCHHHHhcChhhcCCCh
Confidence 9999999999999999998653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=391.06 Aligned_cols=280 Identities=25% Similarity=0.384 Sum_probs=209.1
Q ss_pred CCCeEEE-eeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCC
Q 008729 22 ANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 22 ~~~Y~i~-~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (556)
.++|++. +.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+|..+ +||||+++++++ .+.
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~-----~~~ 83 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFF-----EEE 83 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EET
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeC
Confidence 4689996 78999999999999999999999999997532 23355788999999985 799999999999 455
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCc---eEEeeeCcccc
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFGLARV 175 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---vKL~DFGla~~ 175 (556)
..+|+|||||. ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++..
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 67999999998 799999998888999999999999999999999999999999999999998776 99999999876
Q ss_pred ccCCCC----CcceecccccCcccCCccccccc---CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC
Q 008729 176 AFSDTP----MTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (556)
Q Consensus 176 ~~~~~~----~~~~~~~~~gt~~Y~APE~~~~~---~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g 248 (556)
...... ........+||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.+.+..+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-------- 235 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG-------- 235 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC--------
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc--------
Confidence 432211 11112345699999999998641 024788999999999999999999999876532100
Q ss_pred CCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
....+ .........+..+...........+..+++.+.+||++||..||++|||++|+|+||||++..
T Consensus 236 ~~~~~----~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 236 WDRGE----ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp C--------CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred ccccc----cchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 00000 000000111122222211111112346889999999999999999999999999999998753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=383.47 Aligned_cols=260 Identities=28% Similarity=0.472 Sum_probs=218.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCC----hhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH----ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~----~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
++|++++.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+|+.++||||+++++++ .+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIF-----EN 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhee-----cC
Confidence 4799999999999999999999999999999998643221 12356788999999999999999999999 45
Q ss_pred CceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC----ceEEeeeCcc
Q 008729 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLKVCDFGLA 173 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~----~vKL~DFGla 173 (556)
...+|+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 567999999997 79999998888899999999999999999999999999999999999998877 7999999999
Q ss_pred ccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+..+........
T Consensus 160 ~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 231 (283)
T 3bhy_A 160 HKIEAGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFD-- 231 (283)
T ss_dssp EECC------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC--
T ss_pred eeccCCCc----ccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc--
Confidence 86543221 244569999999999987 6789999999999999999999999998887665555432211111
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
...++.+++.+.+||++||..||++|||++++|+||||+.+.
T Consensus 232 -------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 232 -------------------------EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp -------------------------HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred -------------------------chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 112246789999999999999999999999999999998764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=396.27 Aligned_cols=262 Identities=26% Similarity=0.410 Sum_probs=219.9
Q ss_pred CCCCeEEE-eeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCC
Q 008729 21 DANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 21 ~~~~Y~i~-~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~ 98 (556)
..++|.+. +.||+|+||.||+|++..+++.||||++............+.+|+.+|+.+. ||||+++++++ .+
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~~ 100 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----EN 100 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----Ee
Confidence 34579988 8999999999999999999999999999865444455667889999999995 69999999999 55
Q ss_pred CceEEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC---CCceEEeeeCc
Q 008729 99 FKDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGL 172 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~vKL~DFGl 172 (556)
...+|+|||||. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 667999999998 5999988543 67999999999999999999999999999999999999987 78999999999
Q ss_pred cccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 181 a~~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~---- 250 (327)
T 3lm5_A 181 SRKIGHACE----LREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNV---- 250 (327)
T ss_dssp CEEC-------------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----
T ss_pred ccccCCccc----cccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhccc----
Confidence 987543322 244679999999999987 6899999999999999999999999999887666555433211
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
......+..+++.+.+||++||..||.+|||++++|+||||+++.
T Consensus 251 -----------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 251 -----------------------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp -----------------------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred -----------------------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 112234467899999999999999999999999999999998764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=401.45 Aligned_cols=248 Identities=22% Similarity=0.382 Sum_probs=211.6
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCCh------hHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI------SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~------~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
++|++++.||+|+||.||+|++..+++.||||++....... .....+.+|+.+|+.++||||+++++++
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~----- 98 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF----- 98 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----
Confidence 58999999999999999999999999999999987532211 1234567899999999999999999999
Q ss_pred CCCceEEEEEecCc-c-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 97 REFKDIYVVFELME-S-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
.+...+|+||||+. | +|.+++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~ 178 (335)
T 3dls_A 99 ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178 (335)
T ss_dssp ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence 55677999999987 5 999999998899999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcceecccccCcccCCcccccccCCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y-~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
....... ....+||+.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+....
T Consensus 179 ~~~~~~~----~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 179 YLERGKL----FYTFCGTIEYCAPEVLMG--NPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp ECCTTCC----BCEECSCGGGCCHHHHTT--CCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred ECCCCCc----eeccCCCccccChhhhcC--CCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 7543322 245679999999999877 455 78999999999999999999999653210
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
.... ......+++.+.+||.+||..||++|||++++|+||||++
T Consensus 237 ----------------~~~~-----~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 237 ----------------VEAA-----IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp ----------------TTTC-----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred ----------------Hhhc-----cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 0000 1112347899999999999999999999999999999985
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=390.93 Aligned_cols=262 Identities=26% Similarity=0.403 Sum_probs=206.4
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC------
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK------ 96 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~------ 96 (556)
++|++++.||+|+||.||+|+++.+|+.||||++.... .......+.+|+.+|+.++||||+++++++.....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 47999999999999999999999999999999987432 33456778999999999999999999998854321
Q ss_pred ----------------------------------------------CCCceEEEEEecCc-ccHHHHHHhCCC---CCHH
Q 008729 97 ----------------------------------------------REFKDIYVVFELME-SDLHQVIKANDD---LTRE 126 (556)
Q Consensus 97 ----------------------------------------------~~~~~lylV~E~~~-g~L~~~i~~~~~---l~~~ 126 (556)
.....+|+|||||+ ++|.+++..... ..+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 12235899999999 599999987643 5566
Q ss_pred HHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCc---------ceecccccCcccCC
Q 008729 127 HHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMT---------VFWTDYVATRWYRA 197 (556)
Q Consensus 127 ~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~---------~~~~~~~gt~~Y~A 197 (556)
.++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......... ......+||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 789999999999999999999999999999999999999999999998754432111 12245679999999
Q ss_pred cccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCC
Q 008729 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVP 277 (556)
Q Consensus 198 PE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~ 277 (556)
||++.+ ..++.++|||||||++|+|++|..|+.. ....+.......
T Consensus 245 PE~~~~--~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~--------------------------- 290 (332)
T 3qd2_B 245 PEQIHG--NNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLK--------------------------- 290 (332)
T ss_dssp HHHHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTC---------------------------
T ss_pred hHHhcC--CCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccC---------------------------
Confidence 999987 6899999999999999999998766521 111111111110
Q ss_pred cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 278 LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 278 ~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
....+...++.+.+||++||+.||++|||++|+|+||||+++
T Consensus 291 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 291 FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 001112356788999999999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=395.79 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=215.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCC-hhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||.||+|++..+|+.||||++...... ......+.+|+.+|+.++||||+++++++ .....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCe
Confidence 4699999999999999999999999999999998754322 23446788999999999999999999999 44567
Q ss_pred EEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|||||||.|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 129 ~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 129 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred EEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 999999999999988864 567999999999999999999999999999999999999999999999999999764321
Q ss_pred CCcceecccccCcccCCccccccc-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~-~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
...+||+.|+|||++.+. ...|+.++||||||||+|+|++|++||.+.+....+..+..
T Consensus 208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~-------------- 267 (348)
T 1u5q_A 208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-------------- 267 (348)
T ss_dssp ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------------
T ss_pred ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh--------------
Confidence 345799999999998521 25789999999999999999999999988876555443321
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
...+. .....+++.+.+||.+||+.||++|||++++|+||||..
T Consensus 268 ------------~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~ 311 (348)
T 1u5q_A 268 ------------NESPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311 (348)
T ss_dssp ------------SCCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred ------------cCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence 11111 112457899999999999999999999999999999974
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=384.97 Aligned_cols=263 Identities=29% Similarity=0.364 Sum_probs=214.4
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|++++.||+|+||.||+|.+..+++.||+|++.... .......++.+|+.+++.++||||+++++++ .+..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence 468999999999999999999999999999999985432 3445567889999999999999999999998 5567
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 7999999998 599999998889999999999999999999999999999999999999999999999999999765332
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+........
T Consensus 165 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~---------------- 224 (294)
T 4eqm_A 165 SLT--QTNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKH---------------- 224 (294)
T ss_dssp ------------CCSSCCHHHHHT--CCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHH----------------
T ss_pred ccc--ccCccccCccccCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----------------
Confidence 211 1234679999999999987 67899999999999999999999999988765443222
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
+....+.......+.+++.+.++|.+||..||.+||+..+.+.+.|..-+
T Consensus 225 ----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 225 ----------IQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp ----------HSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred ----------hhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 11111111122345689999999999999999999977777777776543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=382.53 Aligned_cols=261 Identities=28% Similarity=0.441 Sum_probs=223.0
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
....++|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++ .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~ 85 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----E 85 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----E
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeee-----c
Confidence 345578999999999999999999999999999999986543 3345567788999999999999999999999 4
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
+...+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 86 DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 5567999999999 699999988888999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+..
T Consensus 166 ~~~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----------- 229 (294)
T 2rku_A 166 EYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK----------- 229 (294)
T ss_dssp CSTTCC---BCCCCSCCSSCCHHHHTT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-----------
T ss_pred ccCccc---cccccCCCCcCCcchhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhh-----------
Confidence 432221 234679999999999987 6789999999999999999999999988775544433211
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.. ......+++.+.+||++||..||++|||++++|+||||....
T Consensus 230 ---------------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 230 ---------------NE-----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp ---------------TC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred ---------------cc-----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence 11 112245789999999999999999999999999999998654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-47 Score=391.86 Aligned_cols=261 Identities=28% Similarity=0.441 Sum_probs=223.4
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
....++|.+++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++ .
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 111 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFF-----E 111 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----E
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----e
Confidence 345578999999999999999999999999999999986542 3445567788999999999999999999999 4
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
+...+|+|||||+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 112 DNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 5567999999999 699999988888999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 192 ~~~~~~---~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----------- 255 (335)
T 2owb_A 192 EYDGER---KKVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK----------- 255 (335)
T ss_dssp CSTTCC---BCCCCSCCSSCCHHHHHT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH-----------
T ss_pred ccCccc---ccccCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc-----------
Confidence 432221 244679999999999987 6789999999999999999999999988776554433321
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.. ......+++.+.+||++||..||++|||++++|+||||....
T Consensus 256 ---------------~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 256 ---------------NE-----YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp ---------------TC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred ---------------CC-----CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 11 112245789999999999999999999999999999998654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=414.43 Aligned_cols=254 Identities=17% Similarity=0.222 Sum_probs=203.0
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHH---HHhCCCCCcceee-------EE
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKL---LRLLRHPDIVEIK-------RI 90 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~i---L~~L~HpnIv~l~-------~v 90 (556)
.++|++++.||+|+||.||+|.+..+|+.||||++... .........+.+|+.+ |+.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46899999999999999999999999999999998743 2334456778899954 5555799999998 55
Q ss_pred EcCCCC-------CCCc-----eEEEEEecCcccHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHHCCceecc
Q 008729 91 MLPPSK-------REFK-----DIYVVFELMESDLHQVIKANDDLTR-------EHHQFFLYQMLRALKYMHTANVYHRD 151 (556)
Q Consensus 91 ~~~~~~-------~~~~-----~lylV~E~~~g~L~~~i~~~~~l~~-------~~~~~i~~QIl~aL~yLHs~gIvHrD 151 (556)
+...+. .+.. ..|||||||+|+|.+++...+.+++ ..+..|+.||+.||+|||++||+|||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 533211 0111 3899999999999999987655555 77888999999999999999999999
Q ss_pred CCCCcEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCC-----------CCCCcchhhhHHHH
Q 008729 152 LKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS-----------KYTPAIDIWSIGCI 220 (556)
Q Consensus 152 LKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-----------~y~~~~DIWSlG~i 220 (556)
|||+|||++.++.+||+|||+|+.... .....+| +.|+|||++.+ . .|+.++|||||||+
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~g-~~y~aPE~~~~--~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVS-RGFEPPELEAR--RATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC------EEECCCC-TTCCCHHHHHH--HTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC------cccCCCC-cCccChhhhcc--cccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999985322 2345678 99999999876 4 68999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcC
Q 008729 221 FAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300 (556)
Q Consensus 221 lyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~d 300 (556)
||+|++|+.||.+.+....... ....++.+++.+.+||.+||..|
T Consensus 303 l~elltg~~Pf~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~li~~~L~~d 347 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGSEW-----------------------------------IFRSCKNIPQPVRALLEGFLRYP 347 (377)
T ss_dssp HHHHHHSSCCC------CCSGG-----------------------------------GGSSCCCCCHHHHHHHHHHTCSS
T ss_pred HHHHHHCCCCCcccccccchhh-----------------------------------hhhhccCCCHHHHHHHHHHcCCC
Confidence 9999999999976553221111 11223578999999999999999
Q ss_pred CCCCCCHHHHHhCcccccc
Q 008729 301 PKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 301 P~~Rpta~elL~hp~f~~~ 319 (556)
|++|||+.++|+||||+++
T Consensus 348 p~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 348 KEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp GGGCCCHHHHHTSHHHHHH
T ss_pred chhCCCHHHHhhChHHHHH
Confidence 9999999999999999865
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=383.52 Aligned_cols=256 Identities=24% Similarity=0.413 Sum_probs=218.3
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++ .+..
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF-----HDRK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE-----EcCC
Confidence 4589999999999999999999999999999999864211 111235688999999999999999999999 4556
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 7999999998 599999998888999999999999999999999999999999999999999999999999998754332
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
. .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 168 ~-----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-------------- 226 (284)
T 2vgo_A 168 R-----RRTMCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN-------------- 226 (284)
T ss_dssp C-----BCCCCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--------------
T ss_pred c-----cccccCCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc--------------
Confidence 1 134579999999999987 6789999999999999999999999988776554443321
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.. ....+.++..+.+||.+||..||.+|||++++|+||||+...
T Consensus 227 ------------~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 227 ------------VD-----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp ------------TC-----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred ------------cc-----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 00 112245889999999999999999999999999999998643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=401.58 Aligned_cols=260 Identities=27% Similarity=0.344 Sum_probs=209.1
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC--CCCcceeeEEEcCCCCCCCc
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR--HPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~--HpnIv~l~~v~~~~~~~~~~ 100 (556)
.+|++++.||+|+||.||+|.+.. ++.||||++............+.+|+.+|+.|+ ||||+++++++. ...
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCC
Confidence 469999999999999999999865 999999999765455566778999999999996 599999999984 445
Q ss_pred eEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 101 DIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
.+|||||+++++|.+++.....+++..++.|+.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus 130 ~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 699999977789999999988999999999999999999999999999999999999995 5789999999998654322
Q ss_pred CCcceecccccCcccCCccccccc---------CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhhCCC
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV-HQLDLITDLLGTP 250 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~---------~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~-~~~~~i~~~~g~p 250 (556)
. .......+||+.|+|||++.+. ...|+.++||||||||||+|++|++||.+.... ..+..+.
T Consensus 209 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~------ 281 (390)
T 2zmd_A 209 T-SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII------ 281 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH------
T ss_pred c-cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh------
Confidence 1 1122456799999999998641 135889999999999999999999999765421 2221111
Q ss_pred ChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
...... ......+..+.+||++||..||++|||+.|+|+||||+..
T Consensus 282 --------------------~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 327 (390)
T 2zmd_A 282 --------------------DPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327 (390)
T ss_dssp --------------------CTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred --------------------CccccC---CCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence 011111 1123357899999999999999999999999999999853
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=420.31 Aligned_cols=262 Identities=26% Similarity=0.430 Sum_probs=217.1
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
..++|+++++||+|+||.||+|.++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++ .+.
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~ 256 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETK 256 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----eeC
Confidence 3468999999999999999999999999999999986421 1112345678999999999999999999999 555
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 100 KDIYVVFELME-SDLHQVIKANDD--LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~--l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
..+|+|||||. |+|.+++...+. +++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 67999999997 699999987543 999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
..... ....+||+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+.......+..
T Consensus 337 ~~~~~----~~~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~----------- 399 (576)
T 2acx_A 337 PEGQT----IKGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER----------- 399 (576)
T ss_dssp CTTCC----EECCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH-----------
T ss_pred ccCcc----ccccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH-----------
Confidence 43221 245689999999999987 6899999999999999999999999987643211111110
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
.+... .. .....+++.+.+||++||..||.+|| +++|+++||||+++.
T Consensus 400 ---------~i~~~----~~---~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 400 ---------LVKEV----PE---EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp ---------HHHHC----CC---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred ---------Hhhcc----cc---cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 01111 11 12246899999999999999999999 899999999999764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=410.21 Aligned_cols=260 Identities=33% Similarity=0.534 Sum_probs=204.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC------ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE------HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~------~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (556)
.++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~--- 210 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD--- 210 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence 3689999999999999999999999999999999864321 1122335789999999999999999999973
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC---ceEEeeeC
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KLKVCDFG 171 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~vKL~DFG 171 (556)
...+|+|||||. ++|.+++..++.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||
T Consensus 211 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG 287 (419)
T 3i6u_A 211 ---AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287 (419)
T ss_dssp ---SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred ---cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecc
Confidence 234799999998 69999998888999999999999999999999999999999999999997544 59999999
Q ss_pred ccccccCCCCCcceecccccCcccCCcccccc-cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHH-HHHHHhhCC
Q 008729 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGT 249 (556)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~-~~i~~~~g~ 249 (556)
+|+...... .....+||+.|+|||++.+ ....|+.++|||||||++|+|++|++||.+......+ ..+.
T Consensus 288 ~a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~----- 358 (419)
T 3i6u_A 288 HSKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT----- 358 (419)
T ss_dssp TTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH-----
T ss_pred cceecCCCc----cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh-----
Confidence 998754322 2245679999999999853 1256889999999999999999999999875433222 2221
Q ss_pred CChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
..........+..+++.+.+||++||..||++|||++|+|+||||++
T Consensus 359 ----------------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 359 ----------------------SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp ----------------------TTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred ----------------------cCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 11111111233568999999999999999999999999999999985
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=383.09 Aligned_cols=260 Identities=23% Similarity=0.372 Sum_probs=198.5
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||+|+||.||+|.+..+|+.||||++............+..+...++.++||||+++++++ .+...
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~-----~~~~~ 80 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGAL-----FREGD 80 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSS
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeee-----eccCC
Confidence 3589999999999999999999999999999999975433333333444555568888999999999999 44566
Q ss_pred EEEEEecCcccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 102 IYVVFELMESDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
+|+||||++++|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 81 VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999999988777653 56899999999999999999999998 9999999999999999999999999999765
Q ss_pred cCCCCCcceecccccCcccCCcccccc--cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhhCCCChH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV-VHQLDLITDLLGTPSPE 253 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~-~~~~~~i~~~~g~p~~e 253 (556)
...... ....||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+... ...+..+.
T Consensus 161 ~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------- 227 (290)
T 3fme_A 161 VDDVAK----DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV--------- 227 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH---------
T ss_pred cccccc----cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh---------
Confidence 433221 33469999999999621 115688999999999999999999999986432 22222111
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
..... ......+++.+.+||.+||..||++|||++++|+||||+..
T Consensus 228 -----------------~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 228 -----------------EEPSP---QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp -----------------HSCCC---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred -----------------ccCCC---CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 11111 11123578999999999999999999999999999999853
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=393.30 Aligned_cols=259 Identities=28% Similarity=0.486 Sum_probs=217.6
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCCh------hHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI------SDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~------~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (556)
++|++.+.||+|+||.||+|.+..+|+.||||++....... .....+.+|+.+|+.+ +||||+++++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~---- 169 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY---- 169 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE----
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE----
Confidence 47999999999999999999999999999999986433211 1244678999999999 799999999998
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
.....+|+|||||+ ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 170 -~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 170 -ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248 (365)
T ss_dssp -EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred -eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccc
Confidence 45567999999998 5999999988889999999999999999999999999999999999999999999999999997
Q ss_pred cccCCCCCcceecccccCcccCCccccccc----CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSF----FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p 250 (556)
....... ....+||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.+.+....+..+......+
T Consensus 249 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 324 (365)
T 2y7j_A 249 HLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324 (365)
T ss_dssp ECCTTCC----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred ccCCCcc----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 6543322 2456799999999988631 1358899999999999999999999998877666555543321111
Q ss_pred ChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
. ...+..+++.+.+||++||..||++|||++++|+||||+
T Consensus 325 ~---------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 325 S---------------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp C---------------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred C---------------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 1 112245788999999999999999999999999999997
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=416.01 Aligned_cols=262 Identities=21% Similarity=0.339 Sum_probs=216.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|+++++||+|+||.||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++++ .+..
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ETKT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----eeCC
Confidence 3689999999999999999999999999999999964211 112345688999999999999999999999 5556
Q ss_pred eEEEEEecCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 101 DIYVVFELME-SDLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
.+|+|||||. |+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 7999999998 6999999764 3699999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
....... ....+||+.|+|||++.+ ..|+.++||||||||+|+|++|++||.+.+.......+.
T Consensus 339 ~~~~~~~---~~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~----------- 402 (543)
T 3c4z_A 339 LKAGQTK---TKGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK----------- 402 (543)
T ss_dssp CCTTCCC---BCCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH-----------
T ss_pred ccCCCcc---cccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH-----------
Confidence 5433221 245689999999999987 789999999999999999999999998764211111110
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHhCccccccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGLA 320 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-----a~elL~hp~f~~~~ 320 (556)
..+.... ......+++.+.+||++||..||.+||+ ++++++||||+++.
T Consensus 403 ------------~~i~~~~----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 403 ------------QRVLEQA----VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp ------------HHHHHCC----CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred ------------HHHhhcc----cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 0011110 1122468999999999999999999995 59999999999864
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=380.55 Aligned_cols=264 Identities=27% Similarity=0.426 Sum_probs=220.5
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC---C----hhHHHHHHHHHHHHHhCC-CCCcceeeEEEc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE---H----ISDAIRILREVKLLRLLR-HPDIVEIKRIML 92 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~---~----~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~ 92 (556)
..++|++++.||+|+||.||+|.++.+|+.||||++..... . ......+.+|+.+|+.+. ||||+++++++
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~- 93 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY- 93 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE-
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee-
Confidence 45699999999999999999999999999999999864321 1 123456789999999996 99999999999
Q ss_pred CCCCCCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeC
Q 008729 93 PPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171 (556)
Q Consensus 93 ~~~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFG 171 (556)
.....+|+||||++ ++|.+++..+..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 94 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 94 ----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp ----ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred ----ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEeccc
Confidence 55577999999998 6999999988889999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCcccCCcccccc----cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 008729 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGS----FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (556)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~----~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~ 247 (556)
++........ .....|++.|+|||++.+ ....++.++|||||||++|+|++|+.||.+.+.......+...
T Consensus 170 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~- 244 (298)
T 1phk_A 170 FSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG- 244 (298)
T ss_dssp TCEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-
T ss_pred chhhcCCCcc----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcC-
Confidence 9976543222 245679999999998752 1246889999999999999999999999887765555444221
Q ss_pred CCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
........+..++..+.+||.+||..||.+|||++++|+||||++..
T Consensus 245 --------------------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 245 --------------------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp --------------------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred --------------------------CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 11111122346889999999999999999999999999999998753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=379.78 Aligned_cols=251 Identities=23% Similarity=0.287 Sum_probs=208.7
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.++..+ +||||+++++++ .+...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~-----~~~~~ 85 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAW-----AEDDH 85 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEE-----EETTE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeee-----ecCCe
Confidence 479999999999999999999999999999999986655556677889999999999 899999999999 45567
Q ss_pred EEEEEecCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC--------------
Q 008729 102 IYVVFELME-SDLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-------------- 162 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-------------- 162 (556)
+|+||||++ ++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999998 5999999764 679999999999999999999999999999999999999844
Q ss_pred -----CceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChH
Q 008729 163 -----CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV 237 (556)
Q Consensus 163 -----~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~ 237 (556)
..+||+|||++...... ....||+.|+|||++.+. ..+++++|||||||++|+|++|.+++.....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~-------~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~- 236 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP-------QVEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGDQ- 236 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS-------CCCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-
T ss_pred ccCCceEEEEcccccccccCCc-------cccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchhH-
Confidence 47999999999865432 223599999999998762 3567899999999999999999988754432
Q ss_pred HHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 238 ~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
...+ .... .......+++.+.+||.+||..||++|||++++|+||||.
T Consensus 237 --~~~~---------------------------~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 284 (289)
T 1x8b_A 237 --WHEI---------------------------RQGR---LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284 (289)
T ss_dssp --HHHH---------------------------HTTC---CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred --HHHH---------------------------HcCC---CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence 1111 1111 1122346899999999999999999999999999999998
Q ss_pred cc
Q 008729 318 GL 319 (556)
Q Consensus 318 ~~ 319 (556)
+.
T Consensus 285 ~~ 286 (289)
T 1x8b_A 285 SA 286 (289)
T ss_dssp --
T ss_pred hh
Confidence 53
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=382.03 Aligned_cols=257 Identities=27% Similarity=0.479 Sum_probs=193.2
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++ .+..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccCC
Confidence 3589999999999999999999999999999999863211 111235788999999999999999999998 4556
Q ss_pred eEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 101 DIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 7999999998 6999999875 6799999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.+..+
T Consensus 165 ~~~~---~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------------- 224 (278)
T 3cok_A 165 PHEK---HYTLCGTPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--------------- 224 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C---------------
T ss_pred CCCc---ceeccCCCCcCCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH---------------
Confidence 2211 134579999999999987 67899999999999999999999999876643322211
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
. .........++..+.+||.+||..||++|||++++|+||||.+.
T Consensus 225 ------------~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 225 ------------V----LADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp ------------C----SSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred ------------h----hcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 0 01112234578999999999999999999999999999999853
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=395.90 Aligned_cols=284 Identities=22% Similarity=0.334 Sum_probs=220.9
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||+|+||.||+|.+..+++.||+|++... ........+.+|+.+|+.++||||+++++++ .....
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~ 105 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGE 105 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEE-----EETTE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEE-----EECCE
Confidence 46899999999999999999999999999999998753 2345567789999999999999999999998 44567
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
+|+|||||+ ++|.+++...+.+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999998 59999999888999999999999999999999996 9999999999999999999999999999754322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC-CCChHHHHH-
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG-TPSPETIAV- 257 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g-~p~~e~i~~- 257 (556)
. ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..... .+.......
T Consensus 186 ~-----~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3eqc_A 186 M-----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 258 (360)
T ss_dssp C---------CCCCTTCCHHHHTT--CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred c-----ccCCCCCCCeECHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence 1 234679999999999987 6899999999999999999999999998776554333211111 110000000
Q ss_pred -------------hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 258 -------------VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 258 -------------~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.........++.+........ ....++..+.+||++||..||++|||++++|+||||++..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp ---------------CCCHHHHHHHHHHSCCCCC--CTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cCCCcccccccCCCCcccchhhhhHHhccCCCCC--CcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 000001122222222222111 1234789999999999999999999999999999998653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=382.48 Aligned_cols=265 Identities=20% Similarity=0.401 Sum_probs=217.5
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc--CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
.++|++++.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+|+.++||||+++++++.. .+.
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence 368999999999999999999999999999999987421 112345678899999999999999999999853 233
Q ss_pred ceEEEEEecCcccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 100 KDIYVVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~--~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
..+|+|||||+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 81 QKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp -CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 56899999999888888876 4579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
..... .......||+.|+|||++.+....++.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 161 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~------------ 227 (305)
T 2wtk_C 161 PFAAD-DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGK------------ 227 (305)
T ss_dssp TTCSS-CEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH------------
T ss_pred ccccc-cccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhc------------
Confidence 32221 22345679999999999876323457899999999999999999999998776554443321
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~ 321 (556)
.. ......+++.+.+||++||..||.+|||++++|+||||+....
T Consensus 228 ---------------~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 228 ---------------GS----YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp ---------------CC----CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred ---------------CC----CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 10 1122468899999999999999999999999999999987543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=379.09 Aligned_cols=259 Identities=25% Similarity=0.429 Sum_probs=215.5
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+++.++||||+++++++ .+...+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 80 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNIQ 80 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEE-----EcCCEE
Confidence 47999999999999999999999999999999986432 224456788999999999999999999998 455679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+||||++ ++|.+++..+..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999998 59999998878899999999999999999999999999999999999999999999999999976432221
Q ss_pred CcceecccccCcccCCcccccccCCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChHHHH-HHHHHhhCCCChHHHHHhh
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL-DLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y-~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~-~~i~~~~g~p~~e~i~~~~ 259 (556)
.......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+..... ..+
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---------------- 221 (276)
T 2yex_A 161 -ERLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW---------------- 221 (276)
T ss_dssp -ECCBCCCCSCGGGCCGGGGTC--SSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH----------------
T ss_pred -hhcccCCccccCccChHHHhc--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh----------------
Confidence 112245679999999999876 444 78899999999999999999999876543211 111
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
... ......+..+++.+.+||++||..||.+|||++++|+||||++.
T Consensus 222 -----------~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 222 -----------KEK--KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp -----------HTT--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred -----------hhc--ccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 010 01112234689999999999999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=381.59 Aligned_cols=259 Identities=32% Similarity=0.552 Sum_probs=219.6
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||.||+|.+..+++.||||++............+.+|+.+|+.++||||+++++++ .+...+
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~ 96 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDSSSF 96 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE-----eCCCeE
Confidence 489999999999999999999999999999999975544445567789999999999999999999998 455679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC---CceEEeeeCccccccC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CKLKVCDFGLARVAFS 178 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~vKL~DFGla~~~~~ 178 (556)
|+||||+. ++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 99999997 6999999888889999999999999999999999999999999999999764 4699999999986543
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+..
T Consensus 177 ~~~----~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------- 236 (287)
T 2wei_A 177 NTK----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET------------- 236 (287)
T ss_dssp CSS----CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------------
T ss_pred CCc----cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-------------
Confidence 322 234568999999999876 488999999999999999999999998876655544422
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.........+..+++.+.+||++||..||.+|||++++|+||||++..
T Consensus 237 --------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 237 --------------GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp --------------CCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred --------------CCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 111111123356899999999999999999999999999999998653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=384.90 Aligned_cols=280 Identities=22% Similarity=0.384 Sum_probs=214.3
Q ss_pred hhhhhccccccccccCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCC
Q 008729 5 QTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPD 83 (556)
Q Consensus 5 ~~~~~~~~~~~~~~~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~Hpn 83 (556)
.....+.+.++..-....++|++++.||+|+||.||+|.+..+|+.||||++.... .....+.+|+.+|+.+ +|||
T Consensus 6 ~~~~~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~ 82 (326)
T 2x7f_A 6 SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRN 82 (326)
T ss_dssp ----------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTT
T ss_pred CCCCcchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCC
Confidence 33444455555555567789999999999999999999999999999999986432 2335678999999999 7999
Q ss_pred cceeeEEEcCCCC-CCCceEEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee
Q 008729 84 IVEIKRIMLPPSK-REFKDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA 159 (556)
Q Consensus 84 Iv~l~~v~~~~~~-~~~~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl 159 (556)
|+++++++..... .....+|+||||++ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 83 i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~ 162 (326)
T 2x7f_A 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL 162 (326)
T ss_dssp BCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred eeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE
Confidence 9999999864321 12467999999998 5999999874 579999999999999999999999999999999999999
Q ss_pred cCCCceEEeeeCccccccCCCCCcceecccccCcccCCccccccc---CCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh
Q 008729 160 NANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236 (556)
Q Consensus 160 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~---~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~ 236 (556)
+.++.+||+|||++........ .....+||+.|+|||++... ...++.++|||||||++|+|++|..||.+.+.
T Consensus 163 ~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 239 (326)
T 2x7f_A 163 TENAEVKLVDFGVSAQLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239 (326)
T ss_dssp CTTCCEEECCCTTTC----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred cCCCCEEEeeCcCceecCcCcc---ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence 9999999999999876532211 12345799999999998621 14688999999999999999999999988775
Q ss_pred HHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 237 ~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
...+..+.. ...+ ......+++.+.+||++||..||.+|||++++|+||||
T Consensus 240 ~~~~~~~~~--------------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~ 290 (326)
T 2x7f_A 240 MRALFLIPR--------------------------NPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290 (326)
T ss_dssp HHHHHHHHH--------------------------SCCC---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHH
T ss_pred HHHHHHhhc--------------------------Cccc---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHH
Confidence 544433211 1111 01224578999999999999999999999999999999
Q ss_pred ccc
Q 008729 317 KGL 319 (556)
Q Consensus 317 ~~~ 319 (556)
+..
T Consensus 291 ~~~ 293 (326)
T 2x7f_A 291 RDQ 293 (326)
T ss_dssp HCC
T ss_pred hhC
Confidence 853
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=393.75 Aligned_cols=285 Identities=23% Similarity=0.356 Sum_probs=224.4
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-----------CCCcceeeEE
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-----------HPDIVEIKRI 90 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-----------HpnIv~l~~v 90 (556)
.++|++++.||+|+||.||+|.+..+++.||||++.. .......+.+|+.+|+.++ ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 4689999999999999999999999999999999873 3344566789999999886 8999999999
Q ss_pred EcCCCCCCCceEEEEEecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEeec------C
Q 008729 91 MLPPSKREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILAN------A 161 (556)
Q Consensus 91 ~~~~~~~~~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~------~ 161 (556)
+.... .....+|+||||++++|.+++... ..+++..++.++.||+.||+|||++ ||+||||||+|||++ .
T Consensus 95 ~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 95 FNHKG-PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEEEE-TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred hhccC-CCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence 85432 233479999999988999999873 4599999999999999999999998 999999999999994 4
Q ss_pred CCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCC------
Q 008729 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS------ 235 (556)
Q Consensus 162 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~------ 235 (556)
.+.+||+|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 174 ~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp EEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred cceEEEcccccccccCCC------CCCCCCCccccCcHHHhC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 447999999999765432 234579999999999987 679999999999999999999999998765
Q ss_pred hHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCc-------------CCCCCCCCHHHHHHHHHhhhcCCC
Q 008729 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPL-------------FQKFPNVDPLALRLLQRLIAFDPK 302 (556)
Q Consensus 236 ~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~-------------~~~~~~~s~~~~dLl~~~L~~dP~ 302 (556)
..+.+..+.+.+|.++...+...... ..++........... .......++.+.+||++||+.||+
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTH--HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchh--hhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence 56678888888998887665432211 111110000000000 001123467889999999999999
Q ss_pred CCCCHHHHHhCccccccc
Q 008729 303 DRPTAEEALADPYFKGLA 320 (556)
Q Consensus 303 ~Rpta~elL~hp~f~~~~ 320 (556)
+|||++|+|+||||++..
T Consensus 324 ~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 324 KRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp TCBCHHHHHTCGGGTTCT
T ss_pred ccCCHHHHhhChhhhccc
Confidence 999999999999999754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=389.66 Aligned_cols=259 Identities=33% Similarity=0.533 Sum_probs=208.2
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC------ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE------HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~------~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--- 86 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--- 86 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES---
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC---
Confidence 479999999999999999999999999999999864321 11223457899999999999999999999832
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCc---eEEeeeCc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFGL 172 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---vKL~DFGl 172 (556)
..+|+||||+. ++|.+++..+..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 87 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 87 ---EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp ---SSEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred ---CceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 23899999998 599999988889999999999999999999999999999999999999987664 99999999
Q ss_pred cccccCCCCCcceecccccCcccCCcccccc-cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhhCCC
Q 008729 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ-LDLITDLLGTP 250 (556)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~-~~~i~~~~g~p 250 (556)
++...... .....+||+.|+|||++.+ ....++.++|||||||++|+|++|..||.+...... ...+...
T Consensus 164 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---- 235 (322)
T 2ycf_A 164 SKILGETS----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG---- 235 (322)
T ss_dssp CEECCCCH----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT----
T ss_pred ceeccccc----ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC----
Confidence 98653221 1245679999999998742 115688999999999999999999999976543221 2222111
Q ss_pred ChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
........+..++..+.+||++||..||++|||++++|+||||++
T Consensus 236 -----------------------~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 236 -----------------------KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp -----------------------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred -----------------------ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 011111123468899999999999999999999999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=375.82 Aligned_cols=256 Identities=28% Similarity=0.471 Sum_probs=208.2
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++ ....
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 84 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVI-----STPT 84 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSS
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEE-----ecCC
Confidence 3689999999999999999999999999999999864211 112245788999999999999999999998 4556
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+||||+. ++|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 7999999998 699999998888999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcceecccccCcccCCcccccccCCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y-~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
. ......||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 165 ~----~~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------- 225 (276)
T 2h6d_A 165 E----FLRTSCGSPNYAAPEVISG--RLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG------------- 225 (276)
T ss_dssp ----------------CCTGGGTT--SCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------------
T ss_pred c----ceecccCCccccCHHHHcC--CCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc-------------
Confidence 2 1234579999999999876 444 6899999999999999999999988765544433321
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.. ......++..+.+||.+||..||.+|||++++|+||||++.
T Consensus 226 --------------~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 226 --------------GV----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp --------------CC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred --------------Cc----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 10 01123578999999999999999999999999999999753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=380.98 Aligned_cols=263 Identities=23% Similarity=0.392 Sum_probs=212.4
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
....++|++++.||+|+||.||+|.+..+++.||+|++... .......+.+|+.+|+.++||||+++++++. .
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~ 87 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYY-----H 87 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-----e
Confidence 44557899999999999999999999999999999998643 2234567889999999999999999999994 4
Q ss_pred CceEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
...+|+|||||+ ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 88 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 456999999998 589888875 567999999999999999999999999999999999999999999999999997643
Q ss_pred cCCCCCcceecccccCcccCCcccccc---cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
..... ......||+.|+|||++.. ....++.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 168 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------- 236 (302)
T 2j7t_A 168 LKTLQ---KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-------- 236 (302)
T ss_dssp HHHHH---C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------
T ss_pred ccccc---ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc--------
Confidence 21110 1134569999999998731 115788999999999999999999999988776554433321
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
... +.......++..+.+||++||..||.+|||++++|+||||+.+
T Consensus 237 ------------------~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 237 ------------------SDP--PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp ------------------SCC--CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred ------------------cCC--cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 110 1111223578899999999999999999999999999999865
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=396.61 Aligned_cols=269 Identities=17% Similarity=0.171 Sum_probs=196.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhC--CCCCcceee-------EEEc
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLL--RHPDIVEIK-------RIML 92 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L--~HpnIv~l~-------~v~~ 92 (556)
..|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 359999999999999999999999999999999986443 234455677885555544 699988755 3432
Q ss_pred CCCCC------------CCceEEEEEecCcccHHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHHHHCCceeccCC
Q 008729 93 PPSKR------------EFKDIYVVFELMESDLHQVIKAND-DLTREHH------QFFLYQMLRALKYMHTANVYHRDLK 153 (556)
Q Consensus 93 ~~~~~------------~~~~lylV~E~~~g~L~~~i~~~~-~l~~~~~------~~i~~QIl~aL~yLHs~gIvHrDLK 153 (556)
..... ....+|||||||+++|.+++...+ .+.+... ..++.||+.||+|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 22110 114589999999999999998643 3444444 5667999999999999999999999
Q ss_pred CCcEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCC
Q 008729 154 PKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 233 (556)
Q Consensus 154 P~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~ 233 (556)
|+|||++.++.+||+|||+|+..... .....+|+.|+|||++.+....|+.++|||||||+||+|++|+.||.+
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTR------GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCE------EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred HHHEEECCCCCEEEEecceeeecCCC------ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999865321 124557799999999865324689999999999999999999999987
Q ss_pred CChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 234 KSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 234 ~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
....... ..... ..............++.+++.+.+||.+||+.||++|||++++|+|
T Consensus 296 ~~~~~~~-----~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 296 VTPGIKG-----SWKRP-----------------SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp CCTTCTT-----CCCBC-----------------CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred cCccccc-----chhhh-----------------hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 6421100 00000 0000001111223345789999999999999999999999999999
Q ss_pred cccccc
Q 008729 314 PYFKGL 319 (556)
Q Consensus 314 p~f~~~ 319 (556)
|||+++
T Consensus 354 p~f~~~ 359 (371)
T 3q60_A 354 PEFLQL 359 (371)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999865
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=379.79 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=206.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||+|+||+||+|.+ +|+.||||++............+.+|+.+|+.++||||+++++++ .+...
T Consensus 36 ~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 108 (309)
T 3p86_A 36 WCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQPPN 108 (309)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSTTC
T ss_pred hhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EECCc
Confidence 35899999999999999999976 588999999986655566677899999999999999999999999 45556
Q ss_pred EEEEEecCc-ccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 102 IYVVFELME-SDLHQVIKANDD---LTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~---l~~~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
+|+|||||. ++|.+++...+. +++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 899999998 599999987654 999999999999999999999999 99999999999999999999999999976
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 189 ~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~---------- 253 (309)
T 3p86_A 189 KASTFL---SSKSAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF---------- 253 (309)
T ss_dssp ----------------CCTTSCHHHHTT--CCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH----------
T ss_pred cccccc---ccccCCCCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------
Confidence 433221 1245679999999999987 6789999999999999999999999988876554433311
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh--Cccccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DPYFKG 318 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~--hp~f~~ 318 (556)
.. ........+++.+.+||++||..||.+|||++++++ +++++.
T Consensus 254 ----------------~~---~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 254 ----------------KC---KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ----------------SC---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ----------------cC---CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 111223568999999999999999999999999997 455543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=380.41 Aligned_cols=257 Identities=28% Similarity=0.470 Sum_probs=211.1
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||.||+|.+..+|+.||||++... .....+.+|+.+|+.++||||+++++++ ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 97 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSY-----FKNT 97 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEE-----EETT
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEE-----EeCC
Confidence 346899999999999999999999999999999998743 2235688999999999999999999998 4456
Q ss_pred eEEEEEecCc-ccHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 101 DIYVVFELME-SDLHQVIK-ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~-~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.+|+||||++ ++|.+++. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred EEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 7999999998 59999997 466899999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 178 ~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~------------- 239 (314)
T 3com_A 178 TMA---KRNTVIGTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPT------------- 239 (314)
T ss_dssp TBS---CBCCCCSCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------------
T ss_pred hcc---ccCccCCCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhc-------------
Confidence 221 1245579999999999987 6789999999999999999999999988765443322211
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
. ..+.......++..+.+||.+||..||.+|||++++|+||||+..
T Consensus 240 --------------~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 240 --------------N-PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp --------------S-CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred --------------C-CCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 0 111112233478999999999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=375.81 Aligned_cols=259 Identities=31% Similarity=0.456 Sum_probs=216.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+|+.++||||+++++++.. .....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE---GGGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEec---CCCce
Confidence 358999999999999999999999999999999997654455667789999999999999999999998743 23457
Q ss_pred EEEEEecCc-ccHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCcEeecCCCceEEeeeC
Q 008729 102 IYVVFELME-SDLHQVIKAN----DDLTREHHQFFLYQMLRALKYMHTAN-----VYHRDLKPKNILANANCKLKVCDFG 171 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~----~~l~~~~~~~i~~QIl~aL~yLHs~g-----IvHrDLKP~NILl~~~~~vKL~DFG 171 (556)
+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999998 5999999753 34999999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 008729 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (556)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (556)
+++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 162 ~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~------ 230 (279)
T 2w5a_A 162 LARILNHDTS---FAKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------ 230 (279)
T ss_dssp HHHHC---CH---HHHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------
T ss_pred hheeeccccc---cccccCCCccccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh------
Confidence 9976543221 1234579999999999987 6789999999999999999999999988776544443321
Q ss_pred hHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
... ......+++.+.+||.+||..||.+|||++++|+|+|+.+
T Consensus 231 ---------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 231 ---------------------GKF---RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp ---------------------TCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ---------------------ccc---ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 111 1122357899999999999999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=394.95 Aligned_cols=264 Identities=24% Similarity=0.391 Sum_probs=212.5
Q ss_pred CCeEEEeeeeecCceeEEEEEEC---CCCcEEEEEEecCcc--CChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~---~tg~~vAiK~i~~~~--~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~ 96 (556)
++|++++.||+|+||.||+|++. .+++.||||++.... ........+.+|+.+|+.+ +||||+++++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~----- 128 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF----- 128 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE-----
Confidence 68999999999999999999984 589999999986421 1112334566899999999 699999999998
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
.....+|||||||. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 45567999999998 69999999888999999999999999999999999999999999999999999999999999986
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
...... ......+||+.|+|||++.+....++.++||||||||||+|++|+.||...........+..
T Consensus 209 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~---------- 276 (355)
T 1vzo_A 209 FVADET--ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---------- 276 (355)
T ss_dssp CCGGGG--GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHH----------
T ss_pred cccCCC--CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHH----------
Confidence 432221 11245679999999999875334578999999999999999999999976543222211111
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
.+.... ......++..+.+||++||..||.+|| |++++++||||+.+.
T Consensus 277 -------------~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 277 -------------RILKSE----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp -------------HHHHCC----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred -------------HHhccC----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 011110 112346889999999999999999999 999999999998753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=385.00 Aligned_cols=283 Identities=19% Similarity=0.321 Sum_probs=209.8
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||+++++++... ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~ 82 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTR 82 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTC
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCc
Confidence 4568999999999999999999999999999999987432 122355678999999999999999999998542 234
Q ss_pred eEEEEEecCc-ccHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee----cCCCceEEeeeCc
Q 008729 101 DIYVVFELME-SDLHQVIKANDD---LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCKLKVCDFGL 172 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~---l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl----~~~~~vKL~DFGl 172 (556)
.+|+|||||. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~ 162 (319)
T 4euu_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (319)
T ss_dssp CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence 6899999998 699999986443 9999999999999999999999999999999999999 7888899999999
Q ss_pred cccccCCCCCcceecccccCcccCCccccccc------CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHH
Q 008729 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLITD 245 (556)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~------~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~-~~~~i~~ 245 (556)
++....... ....+||+.|+|||++... ...|+.++||||||||+|+|++|+.||....... ....+..
T Consensus 163 a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~ 238 (319)
T 4euu_A 163 ARELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (319)
T ss_dssp CEECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHH
T ss_pred ceecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHH
Confidence 987544332 2356799999999987521 1578999999999999999999999997544322 1122221
Q ss_pred hhCCCChHHHHHhhhHHHHHHHHHhhcCCCCC-cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 008729 246 LLGTPSPETIAVVRNEKARKYLTEMRKKPPVP-LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (556)
Q Consensus 246 ~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~ 315 (556)
.+...+...+..+..... ....-....+ .......++..+.+||++||+.||++|||++|+|+||=
T Consensus 239 ~~~~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 239 IITGKPSGAISGVQKAEN----GPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHCCTTCCEEEECSTT----CCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HhcCCCcccchhhhcccC----CccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 111111100000000000 0000000000 00111235568899999999999999999999999974
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=382.39 Aligned_cols=254 Identities=24% Similarity=0.334 Sum_probs=211.3
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCc---EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
..++|++++.||+|+||.||+|.+..+++ .||||++... ........+.+|+.+|+.++||||+++++++ .
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~ 120 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----T 120 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence 34689999999999999999999986665 4999999753 2445567789999999999999999999999 5
Q ss_pred CCceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
+...+|+|||||+ ++|.+++... +.+++..+..|+.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 5667999999997 5999999764 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
...............+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+...
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-------- 270 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-------- 270 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT--------
T ss_pred cccCccceeeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC--------
Confidence 6544333323344557889999999987 679999999999999999999 99999888776655444221
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
... .....+++.+.+||.+||..||++|||+.++++
T Consensus 271 -------------------~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 271 -------------------YRL---PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp -------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCC---CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111 122468899999999999999999999999986
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-47 Score=382.10 Aligned_cols=272 Identities=26% Similarity=0.397 Sum_probs=194.8
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++||||+++++++. ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 86 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFV-----VKD 86 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEE-----SSS
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEe-----ecC
Confidence 4578999999999999999999999999999999886432 1234556889999999999999999999994 445
Q ss_pred eEEEEEecCc-ccHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeC
Q 008729 101 DIYVVFELME-SDLHQVIKA--------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFG 171 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~--------~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFG 171 (556)
.+|+||||+. ++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 6999999997 699999874 4569999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCC--CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC
Q 008729 172 LARVAFSDTP--MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (556)
Q Consensus 172 la~~~~~~~~--~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~ 249 (556)
++........ .........||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+......+..... +.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~ 243 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ--ND 243 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT--SS
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc--cC
Confidence 9976533221 11122346799999999998642 3588999999999999999999999988776554432211 10
Q ss_pred CChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
+.. .............++..+.+||.+||..||.+|||++++|+||||+...
T Consensus 244 ~~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 244 PPS-------------------LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CCC-------------------TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred CCc-------------------cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 000 0000011223456889999999999999999999999999999998653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=374.25 Aligned_cols=256 Identities=26% Similarity=0.393 Sum_probs=216.5
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++||||+++++++. +..
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~ 93 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDT 93 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT-CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETT
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCC
Confidence 3457999999999999999999999999999999987432 2234567889999999999999999999984 456
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+||||++ ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 94 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 94 KLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp EEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 7999999998 599998864 57999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..
T Consensus 173 ~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------------- 233 (303)
T 3a7i_A 173 QI---KRNTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK-------------- 233 (303)
T ss_dssp BC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH--------------
T ss_pred cc---ccCccCCCcCccCHHHHhc--CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc--------------
Confidence 21 1245679999999999987 6789999999999999999999999987765444333211
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
... ......++..+.+||.+||..||.+|||++++|+||||..
T Consensus 234 -------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 234 -------------NNP---PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp -------------SCC---CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred -------------CCC---CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 111 1123468899999999999999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=380.32 Aligned_cols=267 Identities=22% Similarity=0.352 Sum_probs=197.6
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCc---EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
-..++|++++.||+|+||.||+|.+..++. .||||++............+.+|+.+|+.++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 445689999999999999999999887775 89999997654455667789999999999999999999999865422
Q ss_pred C-CCceEEEEEecCc-ccHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEe
Q 008729 97 R-EFKDIYVVFELME-SDLHQVIKAND------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (556)
Q Consensus 97 ~-~~~~lylV~E~~~-g~L~~~i~~~~------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~ 168 (556)
. .....|+||||+. ++|.+++.... .+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~ 179 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVA 179 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEe
Confidence 1 1123599999999 59999996532 59999999999999999999999999999999999999999999999
Q ss_pred eeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhh
Q 008729 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247 (556)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~ 247 (556)
|||+++......... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 180 Dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-- 254 (323)
T 3qup_A 180 DFGLSRKIYSGDYYR-QGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG-- 254 (323)
T ss_dssp CCCC------------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT--
T ss_pred ecccccccccccccc-ccccccCcccccCchhhcC--CCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc--
Confidence 999998654322111 1234457889999999987 679999999999999999999 9999998877665544421
Q ss_pred CCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-------HHHHHhCcccccc
Q 008729 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-------AEEALADPYFKGL 319 (556)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-------a~elL~hp~f~~~ 319 (556)
.. .....+.+++.+.+||.+||..||.+||| ++++++|+|+...
T Consensus 255 -------------------------~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 255 -------------------------GN---RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp -------------------------TC---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred -------------------------CC---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 11 11223568899999999999999999999 7889999999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=384.56 Aligned_cols=253 Identities=24% Similarity=0.404 Sum_probs=210.3
Q ss_pred CCCeEEEeeeeecCceeEEEEEEC-------CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDT-------HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~-------~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~ 93 (556)
.++|++++.||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.+ +||||+++++++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-- 156 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-- 156 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE--
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--
Confidence 368999999999999999999875 34568999999754 3345567899999999999 899999999999
Q ss_pred CCCCCCceEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 008729 94 PSKREFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (556)
Q Consensus 94 ~~~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (556)
.....+|+|||||. |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 157 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 157 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp ---CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred ---ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 44566999999998 59999998753 47899999999999999999999999999999999
Q ss_pred EeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCC
Q 008729 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (556)
Q Consensus 157 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~ 235 (556)
||++.++.+||+|||+++......... ......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+..
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYK-KTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTC-TTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEECCCCCEEEccccCCcccCccccee-cccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999999999998654322111 1234567889999999987 689999999999999999999 999999877
Q ss_pred hHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 236 ~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
..+....+.. ... ......+++.+.+||.+||..||.+|||+.|++++
T Consensus 311 ~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 311 VEELFKLLKE---------------------------GHR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp GGGHHHHHHT---------------------------TCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhc---------------------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6554443321 111 12234688999999999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=374.27 Aligned_cols=263 Identities=22% Similarity=0.330 Sum_probs=196.0
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||.||+|.+..+|+.||||++............+..+..+++.++||||+++++++ ....
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~-----~~~~ 97 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF-----ITNT 97 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSS
T ss_pred hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEE-----ecCC
Confidence 34689999999999999999999999999999999975433323333344555678888999999999999 4456
Q ss_pred eEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 101 DIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.+|+||||+++.+..++.. .+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 98 ~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 98 DVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 7999999997777666654 56899999999999999999999996 999999999999999999999999999976533
Q ss_pred CCCCcceecccccCcccCCcccccc---cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhhCCCChHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGS---FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~---~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~-~~~~~~~i~~~~g~p~~e~ 254 (556)
... .....||+.|+|||++.+ ....++.++|||||||++|+|++|+.||.+.. ..+.+..+..
T Consensus 178 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--------- 244 (318)
T 2dyl_A 178 DKA----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ--------- 244 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH---------
T ss_pred Ccc----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc---------
Confidence 221 234569999999999842 11468899999999999999999999998643 3222222211
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
. ..+.......+++.+.+||.+||..||.+|||++++|+||||++..
T Consensus 245 -----------------~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 245 -----------------E--EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp -----------------S--CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred -----------------c--CCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 1 1111222346899999999999999999999999999999998653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=387.36 Aligned_cols=257 Identities=21% Similarity=0.323 Sum_probs=211.4
Q ss_pred CCCeEEEeeeeecCceeEEEEE-----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~-----~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
.++|++++.||+|+||.||+|. +..+++.||||++... ........+.+|+.+|+.++||||+++++++
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~----- 143 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVS----- 143 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----
Confidence 3689999999999999999999 5567889999998643 3445566788999999999999999999999
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC---ce
Q 008729 97 REFKDIYVVFELME-SDLHQVIKAN-------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC---KL 165 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~-------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~---~v 165 (556)
......|+|||||. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 44556899999997 6999999864 3589999999999999999999999999999999999999555 49
Q ss_pred EEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 008729 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244 (556)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~ 244 (556)
||+|||+|+......... ......||+.|+|||++.+ ..|+.++|||||||++|+|++ |.+||.+.+..+.+..+.
T Consensus 224 kL~DFG~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~ 300 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYYR-KGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300 (367)
T ss_dssp EECCCHHHHHHHHHSSCT-TCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred EECCCccccccccccccc-cCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999997543221111 1234568999999999977 689999999999999999998 999999888766555442
Q ss_pred HhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 245 ~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
.. .. ......+++.+.+||++||+.||.+|||++++++|.|+.
T Consensus 301 ~~---------------------------~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SG---------------------------GR---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TT---------------------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cC---------------------------CC---CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 21 11 112346789999999999999999999999999998864
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=380.50 Aligned_cols=263 Identities=25% Similarity=0.415 Sum_probs=192.9
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHH-HHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~-iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
..++|++++.||+|+||.||+|.++.+|+.||||++.... .......+.+|+. +++.++||||+++++++. ..
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~ 93 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----RE 93 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CS
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eC
Confidence 4579999999999999999999999999999999997542 3344456666776 677789999999999994 45
Q ss_pred ceEEEEEecCcccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEeecCCCceEEeeeCcc
Q 008729 100 KDIYVVFELMESDLHQVIKA-----NDDLTREHHQFFLYQMLRALKYMHTA-NVYHRDLKPKNILANANCKLKVCDFGLA 173 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~-----~~~l~~~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP~NILl~~~~~vKL~DFGla 173 (556)
..+|+||||++++|.+++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~ 173 (327)
T 3aln_A 94 GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173 (327)
T ss_dssp SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence 67999999999999888864 56899999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCcccCCcccccc--cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGS--FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (556)
+....... .....||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+.+... +.+
T Consensus 174 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~-------- 239 (327)
T 3aln_A 174 GQLVDSIA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQL-------- 239 (327)
T ss_dssp CC----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------------
T ss_pred eecccccc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HHH--------
Confidence 76543221 133469999999999832 11568899999999999999999999998654211 000
Q ss_pred hHHHHHhhhHHHHHHHHHhhcCCC-CCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 252 PETIAVVRNEKARKYLTEMRKKPP-VPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~-~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
..+..... .........+++.+.+||++||..||++|||+.++|+||||...
T Consensus 240 ----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 240 ----------------TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp ----------------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred ----------------HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 00111111 11112234689999999999999999999999999999999754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=378.93 Aligned_cols=264 Identities=25% Similarity=0.388 Sum_probs=185.8
Q ss_pred cCCCCCeEEEe-eeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 19 YGDANRYKILE-VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 19 ~~~~~~Y~i~~-~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
+...++|.+++ +||+|+||.||+|.++.+|+.||||++... ... .......++.+.||||+++++++.... .
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~-~ 96 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKA---RQEVDHHWQASGGPHIVCILDVYENMH-H 96 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEE-T
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHH---HHHHHHHHHhcCCCChHHHHHHHhhcc-C
Confidence 44557899965 699999999999999999999999998642 111 112233466779999999999984321 2
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC---CCceEEeeeC
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFG 171 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~vKL~DFG 171 (556)
....+|+|||||+ ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 2456899999998 59999998764 6999999999999999999999999999999999999976 4459999999
Q ss_pred ccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 008729 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (556)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (556)
+++...... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.
T Consensus 177 ~~~~~~~~~-----~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------- 242 (336)
T 3fhr_A 177 FAKETTQNA-----LQTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK------- 242 (336)
T ss_dssp TCEEC-----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred cceeccccc-----cccCCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH-------
Confidence 997643221 234578999999999976 678999999999999999999999997765432211110
Q ss_pred hHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
..+...........+..+++.+.+||++||..||.+|||++++|+||||++.
T Consensus 243 ----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 243 ----------------RRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp ------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred ----------------HhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 0011111111122345789999999999999999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=368.76 Aligned_cols=262 Identities=27% Similarity=0.405 Sum_probs=202.7
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC-------
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS------- 95 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~------- 95 (556)
++|++++.||+|+||.||+|.+..+|+.||||++.. .......+.+|+.+|+.++||||+++++++....
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 479999999999999999999999999999999863 2345567889999999999999999999885421
Q ss_pred -CCCCceEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCc
Q 008729 96 -KREFKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (556)
Q Consensus 96 -~~~~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGl 172 (556)
......+|+||||++ ++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 123567999999998 69999998654 578899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCC-----------CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCC-ChHHHH
Q 008729 173 ARVAFSDTP-----------MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK-SVVHQL 240 (556)
Q Consensus 173 a~~~~~~~~-----------~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~-~~~~~~ 240 (556)
+........ .........||+.|+|||++.+. ..++.++|||||||++|+|++ ||... +.....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 976532210 01122456799999999998752 368999999999999999998 45322 111111
Q ss_pred HHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 241 ~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
. .+...............++.+.+||++||..||.+|||++++|+||||..
T Consensus 239 ~---------------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (303)
T 1zy4_A 239 K---------------------------KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV 289 (303)
T ss_dssp H---------------------------HHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred H---------------------------hccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence 1 11111111111223457788999999999999999999999999999974
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=380.42 Aligned_cols=256 Identities=25% Similarity=0.403 Sum_probs=210.2
Q ss_pred CCCCeEEEeeeeecCceeEEEEE-----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~-----~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~ 94 (556)
..++|++++.||+|+||.||+|. +..+++.||||++... ........+.+|+.+|..+ +||||+++++++..
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~- 97 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK- 97 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec-
Confidence 34689999999999999999999 5667799999999753 3344566789999999999 79999999999853
Q ss_pred CCCCCceEEEEEecCc-ccHHHHHHhCCC---------------------------------------------------
Q 008729 95 SKREFKDIYVVFELME-SDLHQVIKANDD--------------------------------------------------- 122 (556)
Q Consensus 95 ~~~~~~~lylV~E~~~-g~L~~~i~~~~~--------------------------------------------------- 122 (556)
....+|+|||||. |+|.+++.....
T Consensus 98 ---~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 98 ---PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ---TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred ---CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 2345899999999 699999986543
Q ss_pred ---------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcceec
Q 008729 123 ---------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT 187 (556)
Q Consensus 123 ---------------l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~ 187 (556)
+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ ....
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~ 253 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-VRKG 253 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC-EEC-
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc-hhcc
Confidence 899999999999999999999999999999999999999999999999999865433221 2234
Q ss_pred ccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHH
Q 008729 188 DYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKY 266 (556)
Q Consensus 188 ~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~ 266 (556)
...||+.|+|||++.+ ..|+.++||||||||+|+|++ |..||.+....+.+.....
T Consensus 254 ~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~--------------------- 310 (359)
T 3vhe_A 254 DARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK--------------------- 310 (359)
T ss_dssp -CEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH---------------------
T ss_pred ccCCCceeEChhhhcC--CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH---------------------
Confidence 5678999999999887 689999999999999999998 9999988765443322211
Q ss_pred HHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 267 LTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 267 l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.... ......+++.+.+||.+||..||.+|||++++++|
T Consensus 311 -----~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 311 -----EGTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp -----HTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----cCCC---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 1111 11224588999999999999999999999999986
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=375.08 Aligned_cols=257 Identities=18% Similarity=0.210 Sum_probs=206.1
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (556)
.+++|++++.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+|+.| +||||+++++++ ...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~-----~~~ 77 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFG-----PCG 77 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEE-----EET
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEE-----ecC
Confidence 35789999999999999999999999999999999864321 23577899999999 899999999998 455
Q ss_pred ceEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCc-----eEEeeeCcc
Q 008729 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK-----LKVCDFGLA 173 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-----vKL~DFGla 173 (556)
..+|+||||++++|.+++.. .+.+++..+..|+.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a 157 (330)
T 2izr_A 78 KYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157 (330)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred CccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence 67999999998899999987 468999999999999999999999999999999999999999887 999999999
Q ss_pred ccccCCCCCcc----eecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC
Q 008729 174 RVAFSDTPMTV----FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (556)
Q Consensus 174 ~~~~~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~ 249 (556)
+.......... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~-- 233 (330)
T 2izr_A 158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG-- 233 (330)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHH--
T ss_pred eeeecCCCCccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHH--
Confidence 87543322111 1245679999999999988 679999999999999999999999998855433322221110
Q ss_pred CChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
... ...+.......++ .+.+||.+||..||.+||+++++++
T Consensus 234 ----------~~~-----------~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 234 ----------DTK-----------RATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp ----------HHH-----------HHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ----------hhh-----------ccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 000 0000000112234 8999999999999999999999876
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=381.94 Aligned_cols=273 Identities=19% Similarity=0.314 Sum_probs=212.5
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCCh---------------hHHHHHHHHHHHHHhCCCCCcce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI---------------SDAIRILREVKLLRLLRHPDIVE 86 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~---------------~~~~~~~rEi~iL~~L~HpnIv~ 86 (556)
.++|++++.||+|+||.||+|.+ +|+.||||++....... .....+.+|+.+|+.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 36999999999999999999998 89999999986321111 11267889999999999999999
Q ss_pred eeEEEcCCCCCCCceEEEEEecCcc-cHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCc
Q 008729 87 IKRIMLPPSKREFKDIYVVFELMES-DLHQV------IKA--NDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKN 156 (556)
Q Consensus 87 l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~------i~~--~~~l~~~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~N 156 (556)
+++++ .+...+|+||||+++ +|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus 108 ~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN 182 (348)
T ss_dssp CSEEE-----ESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred EEEEE-----eeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence 99999 445679999999995 99988 665 5689999999999999999999999 999999999999
Q ss_pred EeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCC-cchhhhHHHHHHHHHhCCCCCCCCC
Q 008729 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTP-AIDIWSIGCIFAEVLTGKPLFPGKS 235 (556)
Q Consensus 157 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~-~~DIWSlG~ilyelltG~~pF~~~~ 235 (556)
||++.++.+||+|||++...... ......||+.|+|||++.+. ..++. ++|||||||++|+|++|..||.+.+
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 256 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999865332 23456799999999999772 25665 9999999999999999999998876
Q ss_pred h-HHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCc
Q 008729 236 V-VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (556)
Q Consensus 236 ~-~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp 314 (556)
. .+....+........... ... ...............+++.+.+||++||+.||.+|||++++|+||
T Consensus 257 ~~~~~~~~i~~~~~~~~~~~-~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp 324 (348)
T 2pml_X 257 SLVELFNNIRTKNIEYPLDR-NHF-----------LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHE 324 (348)
T ss_dssp CSHHHHHHHTSCCCCCCCSS-SSS-----------TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred cHHHHHHHHhccCcCCccch-hhh-----------hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 6 444433321100000000 000 000000000111256899999999999999999999999999999
Q ss_pred ccccc
Q 008729 315 YFKGL 319 (556)
Q Consensus 315 ~f~~~ 319 (556)
||++.
T Consensus 325 ~f~~~ 329 (348)
T 2pml_X 325 WLADT 329 (348)
T ss_dssp GGTTC
T ss_pred cccCC
Confidence 99864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=364.97 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=208.5
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.+|+.++||||+++++++ .+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~ 78 (269)
T 4hcu_A 8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQA 78 (269)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSS
T ss_pred ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC---HHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCC
Confidence 3468999999999999999999987 5778999999753322 35688999999999999999999999 4556
Q ss_pred eEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 101 DIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.+|+||||++ ++|.+++... +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 6999999998 6999999764 4689999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+...
T Consensus 159 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~----------- 223 (269)
T 4hcu_A 159 DQY--TSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG----------- 223 (269)
T ss_dssp HHH--HSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-----------
T ss_pred ccc--ccccCcccccccCCHHHhcC--CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-----------
Confidence 211 11234457788999999987 679999999999999999999 99999988766555444221
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.. .......++.+.+||.+||..||++|||++++++|
T Consensus 224 ----------------~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 224 ----------------FR---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp ----------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------cc---CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 00 11123478999999999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=370.40 Aligned_cols=262 Identities=27% Similarity=0.336 Sum_probs=208.0
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC--CCCcceeeEEEcCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR--HPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~--HpnIv~l~~v~~~~~~~~ 98 (556)
..++|++++.||+|+||.||+|.+. +++.||||++............+.+|+.+|+.++ ||||+++++++ ..
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~-----~~ 99 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE-----IT 99 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE-----EC
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEe-----ec
Confidence 4568999999999999999999985 5899999999765455566778999999999997 59999999998 44
Q ss_pred CceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
...+|+|||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 100 ~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 100 DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 178 (313)
T ss_dssp SSEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred CCEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence 56799999988899999999988999999999999999999999999999999999999996 47899999999986543
Q ss_pred CCCCcceecccccCcccCCccccccc---------CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChH-HHHHHHHHhhC
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSF---------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV-HQLDLITDLLG 248 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~---------~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~-~~~~~i~~~~g 248 (556)
.... ......+||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.... ..+..+
T Consensus 179 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~----- 252 (313)
T 3cek_A 179 DTTS-VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI----- 252 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH-----
T ss_pred cccc-ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHH-----
Confidence 2211 122355799999999998641 136788999999999999999999999765422 111111
Q ss_pred CCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
+..... .......+..+.+||++||..||.+|||++++|+||||+..
T Consensus 253 ---------------------~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 253 ---------------------IDPNHE---IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp ---------------------HCTTSC---CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred ---------------------Hhcccc---cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence 101111 11223467899999999999999999999999999999853
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=369.32 Aligned_cols=259 Identities=24% Similarity=0.400 Sum_probs=210.9
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||+|+||+||+|.+..+++.||+|++.. ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~ 81 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVL-----YKDKR 81 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEE-----ecCCe
Confidence 4689999999999999999999999999999999864 3455667899999999999999999999999 45567
Q ss_pred EEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 102 IYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
+|+|||||. ++|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 82 LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 999999998 599999987 567999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCc-----------ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC
Q 008729 180 TPMT-----------VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (556)
Q Consensus 180 ~~~~-----------~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g 248 (556)
.... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~------- 232 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF------- 232 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-------
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-------
Confidence 2211 01124679999999999987 789999999999999999999999997643211000
Q ss_pred CCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.......+.. ...+.+++.+.+||.+||+.||++|||++++++ |++.+
T Consensus 233 -----------~~~~~~~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l 280 (310)
T 3s95_A 233 -----------GLNVRGFLDR----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETL 280 (310)
T ss_dssp -----------SBCHHHHHHH----------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHH
T ss_pred -----------hhhhhccccc----------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHH
Confidence 0000011111 112457888999999999999999999999987 66554
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=365.46 Aligned_cols=255 Identities=19% Similarity=0.230 Sum_probs=208.9
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|++++.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+++.+ +|+||+++++++ .+..
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 79 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGL 79 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETT
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC----ccHHHHHHHHHHHHHhcCCCCCeEEeec-----CCCc
Confidence 468999999999999999999999999999999986432 223577899999999 799999999998 5566
Q ss_pred eEEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCc-----eEEeeeCccc
Q 008729 101 DIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK-----LKVCDFGLAR 174 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-----vKL~DFGla~ 174 (556)
..|+||||++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++
T Consensus 80 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 80 HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 799999999889999998754 5999999999999999999999999999999999999987776 9999999998
Q ss_pred cccCCCCCc----ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhh
Q 008729 175 VAFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV---HQLDLITDLL 247 (556)
Q Consensus 175 ~~~~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~---~~~~~i~~~~ 247 (556)
......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.. ..+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 754432211 11245679999999999987 67899999999999999999999999885432 2222221110
Q ss_pred CCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
. ..+.....+.+++.+.+||.+||..||++|||++++++.
T Consensus 238 ~--------------------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 238 Q--------------------------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp H--------------------------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred c--------------------------CccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 0 011112234688999999999999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=366.39 Aligned_cols=258 Identities=28% Similarity=0.395 Sum_probs=205.4
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
+|....+||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.++||||+++++++ .....+|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~ 95 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSF-----SENGFIK 95 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEE-----EETTEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEE-----EeCCcEE
Confidence 344455899999999999999999999999998753 234456788999999999999999999999 4456799
Q ss_pred EEEecCc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC-CCceEEeeeCccccccC
Q 008729 104 VVFELME-SDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-NCKLKVCDFGLARVAFS 178 (556)
Q Consensus 104 lV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-~~~vKL~DFGla~~~~~ 178 (556)
+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999997 69999998652 4678999999999999999999999999999999999987 89999999999976543
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
... ......||+.|+|||++.+....++.++|||||||++|+|++|+.||.+..........
T Consensus 176 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--------------- 237 (295)
T 2clq_A 176 INP---CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK--------------- 237 (295)
T ss_dssp --------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH---------------
T ss_pred CCC---cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh---------------
Confidence 221 12455799999999998653234889999999999999999999999754332211000
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
....... ......+++.+.+||.+||..||++|||++++|+||||+..
T Consensus 238 ---------~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 238 ---------VGMFKVH----PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp ---------HHHHCCC----CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred ---------hcccccc----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 0000110 12234688999999999999999999999999999999854
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=370.67 Aligned_cols=254 Identities=22% Similarity=0.379 Sum_probs=212.1
Q ss_pred CCCCeEEEeeeeecCceeEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (556)
..++|++.+.||+|+||.||+|.+. .+++.||||++... ........+.+|+.+|+.++||||+++++++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---- 95 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGAC---- 95 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE----
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEE----
Confidence 3468999999999999999999983 45689999998743 3445667889999999999999999999999
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHhCCC------------------------CCHHHHHHHHHHHHHHHHHHHHCCceec
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKANDD------------------------LTREHHQFFLYQMLRALKYMHTANVYHR 150 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~~------------------------l~~~~~~~i~~QIl~aL~yLHs~gIvHr 150 (556)
.+...+|+||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||
T Consensus 96 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 96 -SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred -ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 45566999999998 799999987543 8999999999999999999999999999
Q ss_pred cCCCCcEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCC
Q 008729 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229 (556)
Q Consensus 151 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~ 229 (556)
||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSY-VKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCE-ECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccchheEEEcCCCCEEEccccccccccccccc-eeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999865432211 11234457889999999887 678999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHH
Q 008729 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309 (556)
Q Consensus 230 pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~e 309 (556)
||.+.........+.. .. .......+++.+.+||.+||..||.+|||+++
T Consensus 252 p~~~~~~~~~~~~~~~---------------------------~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 301 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKT---------------------------GH---RMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301 (314)
T ss_dssp SSTTCCGGGHHHHHHT---------------------------TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCCHHHHHHHhhc---------------------------CC---cCCCCccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 9988776554443321 11 11223468999999999999999999999999
Q ss_pred HHhC
Q 008729 310 ALAD 313 (556)
Q Consensus 310 lL~h 313 (556)
++++
T Consensus 302 l~~~ 305 (314)
T 2ivs_A 302 ISKD 305 (314)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=362.14 Aligned_cols=249 Identities=21% Similarity=0.318 Sum_probs=207.8
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||+|+||.||+|.+. ++..||+|++..... ....+.+|+.+|+.++||||+++++++ .+...
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~ 77 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYP 77 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSS
T ss_pred hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCc
Confidence 358999999999999999999876 577899999975322 235688999999999999999999999 55567
Q ss_pred EEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 102 IYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
+|+||||++ ++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999997 68999998754 5999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
... ......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+..
T Consensus 158 ~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------------- 220 (268)
T 3sxs_A 158 QYV--SSVGTKFPVKWSAPEVFHY--FKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ------------- 220 (268)
T ss_dssp CEE--ECCSCCCCGGGCCHHHHHH--SEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-------------
T ss_pred hhh--cccCCCcCcccCCHHHHhc--cCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc-------------
Confidence 221 1234457788999999977 678999999999999999999 9999988876555443321
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
... .......++.+.+||.+||..||.+|||+.+++++
T Consensus 221 --------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 221 --------------GHR---LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp --------------TCC---CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --------------CCC---CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 110 11123468899999999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=369.22 Aligned_cols=271 Identities=21% Similarity=0.353 Sum_probs=207.6
Q ss_pred CCCCeEEEeeeeecCceeEEEEE----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~----~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
..++|++++.||+|+||+||+|+ +..+++.||||++.. ........+.+|+.+|+.++||||+++++++...
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 83 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA-- 83 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH--
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--
Confidence 34689999999999999999998 677899999999874 3445567789999999999999999999998432
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
+...+|+|||||. ++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 84 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 84 -GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp -HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred -CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 2345899999997 69999998754 59999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
................++..|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~ 235 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDKQGQ 235 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH-----HHHHHHCTTCCTH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcC--CCCChHHHHHHHHHHHHHHHhcccccCCChH-----HHHhhhcCccccc
Confidence 75443322222334567888999999987 6799999999999999999999999865321 1111122211111
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
. ........+...... .....+++.+.+||++||..||++|||++++++
T Consensus 236 ~------~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 236 M------IVFHLIELLKNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp H------HHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred h------hHHHHHHHHhccCcC---CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 011112222222222 223568899999999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=365.85 Aligned_cols=251 Identities=22% Similarity=0.315 Sum_probs=207.0
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
-..++|++++.||+|+||.||+|.+. ++..||||++...... ...+.+|+.+|+.++||||+++++++ .+.
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~ 91 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS---EDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQ 91 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC---HHHHHHHHHHHHTCCCTTBCCEEEEE-----CSS
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC---HHHHHHHHHHHhcCCCCCEeeEEEEE-----ecC
Confidence 35579999999999999999999876 6778999999753222 35688999999999999999999999 555
Q ss_pred ceEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
..+|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 92 RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 67999999997 699999986 5679999999999999999999999999999999999999999999999999997653
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.....
T Consensus 172 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-------- 239 (283)
T 3gen_A 172 DDEY--TSSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR-------- 239 (283)
T ss_dssp CHHH--HSTTSTTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--------
T ss_pred cccc--ccccCCccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC--------
Confidence 2211 11133457788999999987 679999999999999999998 9999998876655554422110
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.......++.+.+||.+||..||.+|||++++|+|
T Consensus 240 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 240 ----------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 01123468899999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=376.63 Aligned_cols=251 Identities=26% Similarity=0.427 Sum_probs=210.2
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCCh----hHHHHHHHHHHHHHhCC--CCCcceeeEEEcCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLLR--HPDIVEIKRIMLPP 94 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~----~~~~~~~rEi~iL~~L~--HpnIv~l~~v~~~~ 94 (556)
..++|++++.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+|+.++ |+||+++++++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~--- 117 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF--- 117 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE---
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE---
Confidence 4568999999999999999999999999999999986432211 12245668999999996 59999999999
Q ss_pred CCCCCceEEEEEecCc--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec-CCCceEEeeeC
Q 008729 95 SKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVCDFG 171 (556)
Q Consensus 95 ~~~~~~~lylV~E~~~--g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~-~~~~vKL~DFG 171 (556)
.....+|+|||++. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 118 --~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 118 --ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp --ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred --ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 45567999999997 69999999888999999999999999999999999999999999999999 77899999999
Q ss_pred ccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCC
Q 008729 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251 (556)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~ 251 (556)
+++...... .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+... +
T Consensus 196 ~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~-------- 255 (320)
T 3a99_A 196 SGALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------I-------- 255 (320)
T ss_dssp TCEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------H--------
T ss_pred ccccccccc-----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChhh------h--------
Confidence 998754322 2456799999999998762 2346889999999999999999999965321 0
Q ss_pred hHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
..... .....+++.+.+||++||..||++|||++++|+||||++.
T Consensus 256 ------------------~~~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 256 ------------------IRGQV-----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp ------------------HHCCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ------------------hcccc-----cccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 00111 1224688999999999999999999999999999999865
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=372.51 Aligned_cols=254 Identities=22% Similarity=0.311 Sum_probs=210.4
Q ss_pred CCCCeEEEeeeeecCceeEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (556)
..++|++++.||+|+||.||+|.+. .+++.||||++... ........+.+|+.+|+.++||||+++++++
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~---- 119 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVC---- 119 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE----
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE----
Confidence 3468999999999999999999987 45689999998753 2344566789999999999999999999999
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKAN------------------------DDLTREHHQFFLYQMLRALKYMHTANVYHR 150 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~------------------------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHr 150 (556)
.+...+|+|||||+ ++|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 120 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 120 -AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp -CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred -ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 44567999999998 5999999874 568999999999999999999999999999
Q ss_pred cCCCCcEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCC
Q 008729 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229 (556)
Q Consensus 151 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~ 229 (556)
||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccc-cccCCCcccceecChhhhcc--CCcCcccccHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999765322111 11234568899999999887 679999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHH
Q 008729 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309 (556)
Q Consensus 230 pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~e 309 (556)
||.+.+..+....+.+ ... ......+++.+.+||++||..||.+|||+.+
T Consensus 276 p~~~~~~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 325 (343)
T 1luf_A 276 PYYGMAHEEVIYYVRD---------------------------GNI---LACPENCPLELYNLMRLCWSKLPADRPSFCS 325 (343)
T ss_dssp TTTTSCHHHHHHHHHT---------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCCCCChHHHHHHHhC---------------------------CCc---CCCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 9988776554443321 111 1123468899999999999999999999999
Q ss_pred HHhC
Q 008729 310 ALAD 313 (556)
Q Consensus 310 lL~h 313 (556)
++++
T Consensus 326 ~~~~ 329 (343)
T 1luf_A 326 IHRI 329 (343)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=363.09 Aligned_cols=251 Identities=26% Similarity=0.415 Sum_probs=199.2
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCC---CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
.++|++++.||+|+||.||+|.+..+ +..||+|++... ........+.+|+.+|+.++||||+++++++..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 87 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 87 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-----
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc-----
Confidence 46899999999999999999998754 457999988743 334456678999999999999999999999732
Q ss_pred CceEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
..+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 88 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 88 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred -CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 34799999999 59999998754 6999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+.+..+..
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~---------- 232 (281)
T 1mp8_A 167 EDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---------- 232 (281)
T ss_dssp --------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT----------
T ss_pred Cccccc--ccccCCCcccccChhhccc--CCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHc----------
Confidence 432211 1133457789999999977 679999999999999999997 9999998876655544421
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
... ....+.+++.+.+||.+||..||++|||+.+++++
T Consensus 233 -----------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 233 -----------------GER---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp -----------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 111 11235689999999999999999999999999874
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=377.32 Aligned_cols=253 Identities=24% Similarity=0.397 Sum_probs=211.5
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCC-------CcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHT-------GEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~t-------g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~ 93 (556)
.++|++++.||+|+||.||+|.+..+ +..||||++... ........+.+|+.+|+.+ +||||+++++++
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~-- 144 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGAC-- 144 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhheeee--
Confidence 36899999999999999999997543 358999999754 3445667889999999999 899999999999
Q ss_pred CCCCCCceEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 008729 94 PSKREFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (556)
Q Consensus 94 ~~~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (556)
.....+|+|||||. ++|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|
T Consensus 145 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 145 ---TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp ---CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred ---ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 44566899999998 59999998754 49999999999999999999999999999999999
Q ss_pred EeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCC
Q 008729 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (556)
Q Consensus 157 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~ 235 (556)
||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYY-KKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTT-CCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EEEcCCCcEEEcccCccccccccccc-ccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999865432211 11234567889999999987 689999999999999999999 999999887
Q ss_pred hHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 236 ~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
..+....+.. ... ......+++.+.+||++||..||++|||+++++++
T Consensus 299 ~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 299 VEELFKLLKE---------------------------GHR---MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHT---------------------------TCC---CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHc---------------------------CCC---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 6554443321 111 11234688999999999999999999999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=362.55 Aligned_cols=250 Identities=22% Similarity=0.422 Sum_probs=213.1
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++.+.||+|+||.||+|.+..++..||+|++.. .......+.+|+.+|+.++||||+++++++ .+..
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~ 82 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREP 82 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS---CSTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSS
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCC
Confidence 45689999999999999999999999999999999874 334566788999999999999999999999 4556
Q ss_pred eEEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 101 DIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
.+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 6999999999 6999999874 459999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+.......+..
T Consensus 163 ~~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~----------- 227 (288)
T 3kfa_A 163 GDTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK----------- 227 (288)
T ss_dssp SSSS--EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-----------
T ss_pred CCcc--ccccCCccccCcCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc-----------
Confidence 3322 22344567889999999987 678999999999999999999 9999988776554443321
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.. .......+++.+.+||++||..||.+|||++++++
T Consensus 228 ----------------~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 228 ----------------DY---RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ----------------TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------cC---CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 10 11223468899999999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=363.06 Aligned_cols=255 Identities=20% Similarity=0.291 Sum_probs=208.8
Q ss_pred CCCCCeEEEe-eeeecCceeEEEEE--ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 20 GDANRYKILE-VIGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 20 ~~~~~Y~i~~-~LG~G~~g~V~~a~--~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
-+.++|++.+ .||+|+||.||+|. +..+++.||||++............+.+|+.+++.++||||+++++++.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---- 88 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE---- 88 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE----
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC----
Confidence 3456899998 99999999999995 4567889999999865444455678999999999999999999999982
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
...+|+||||+. ++|.+++..++.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 89 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 89 --AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp --SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred --CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 235899999998 69999999988899999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
...............+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~--------- 235 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--------- 235 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT---------
T ss_pred eccCCCcccccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc---------
Confidence 5443332222233457788999999977 678999999999999999999 9999988776544433311
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 236 ------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 236 ------------------GER---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ------------------TCC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 111 1123468999999999999999999999999986
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=366.39 Aligned_cols=255 Identities=27% Similarity=0.360 Sum_probs=201.6
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
..++|++++.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++ ...
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~ 106 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG-----EID 106 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EET
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEE-----eeC
Confidence 34689999999999999999999999999999999875432 333456788999999999999999999998 445
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
..+|+||||++ ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 67999999998 59999999888899999999999999999999999999999999999999999999999999976543
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus 187 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--------------- 247 (309)
T 2h34_A 187 EKLT--QLGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI--------------- 247 (309)
T ss_dssp ------------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH---------------
T ss_pred cccc--cccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh---------------
Confidence 2211 1245679999999999987 67899999999999999999999999876543211111
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-CHHHHHh
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEEALA 312 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-ta~elL~ 312 (556)
.. .........+.+++.+.+||.+||..||++|| |++++++
T Consensus 248 ------------~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 248 ------------NQ-AIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp ------------HS-CCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ------------cc-CCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 11 11112233467899999999999999999999 7888775
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=375.82 Aligned_cols=275 Identities=23% Similarity=0.242 Sum_probs=209.0
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
+-..++|+++++||+|+||+||+|.+. ++.||||++... ........+|+.+|+.++||||+++++++.... ..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~ 93 (322)
T 3soc_A 20 YFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-SV 93 (322)
T ss_dssp EETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SS
T ss_pred ccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCC-CC
Confidence 345679999999999999999999875 899999998632 234455667999999999999999999986432 22
Q ss_pred CceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC----------CceeccCCCCcEeecCCCceEE
Q 008729 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA----------NVYHRDLKPKNILANANCKLKV 167 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~----------gIvHrDLKP~NILl~~~~~vKL 167 (556)
...+|+|||||. |+|.+++..+ .+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred CceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence 456899999998 5999999864 599999999999999999999999 9999999999999999999999
Q ss_pred eeeCccccccCCCCCcceecccccCcccCCcccccccC---CCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHH
Q 008729 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFF---SKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLIT 244 (556)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~---~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~ 244 (556)
+|||+++........ ......+||+.|+|||++.+.. ..++.++|||||||++|+|++|+.||.+...........
T Consensus 173 ~DFg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 251 (322)
T 3soc_A 173 ADFGLALKFEAGKSA-GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE 251 (322)
T ss_dssp CCCTTCEEECTTSCC-CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred ccCCcccccccccCc-cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence 999999775433221 1224567999999999987521 245668899999999999999999998765433322222
Q ss_pred HhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCC-cCCCCC--CCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVP-LFQKFP--NVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 245 ~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~-~~~~~~--~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
...+.|..+.+. .........+ ....+. ..+..+.+||++||+.||++|||+.++++
T Consensus 252 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 252 EIGQHPSLEDMQ-----------EVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHCSSCCHHHHH-----------HHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhccCCchhhhh-----------hhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 233333333221 1111111111 111111 23456999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=366.45 Aligned_cols=260 Identities=21% Similarity=0.307 Sum_probs=203.3
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECC---CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~---tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
..++|++++.||+|+||.||+|.+.. ++..||||++............+.+|+.+|+.++||||+++++++......
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 45789999999999999999998765 566899999976555566677899999999999999999999998765433
Q ss_pred CCceEEEEEecCc-ccHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeee
Q 008729 98 EFKDIYVVFELME-SDLHQVIKA------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~------~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DF 170 (556)
.....|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df 191 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF 191 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence 3446799999999 699999853 356999999999999999999999999999999999999999999999999
Q ss_pred CccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCC
Q 008729 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGT 249 (556)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~ 249 (556)
|+++........ .......+++.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.........+..
T Consensus 192 g~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~---- 264 (313)
T 3brb_A 192 GLSKKIYSGDYY-RQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH---- 264 (313)
T ss_dssp SCC-----------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT----
T ss_pred Ccceeccccccc-CcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHc----
Confidence 999765332211 11233457889999999987 689999999999999999999 9999988776555444321
Q ss_pred CChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
... ......+++.+.+||.+||..||.+|||+.+++++
T Consensus 265 -----------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 265 -----------------------GHR---LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp -----------------------TCC---CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------------CCC---CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111 11234688999999999999999999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=357.80 Aligned_cols=250 Identities=25% Similarity=0.331 Sum_probs=204.6
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHH-----HHHHHHHHHHHhCCCCCcceeeEEEcCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDA-----IRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~-----~~~~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (556)
..++|++.+.||+|+||.||+|.+..+++.||||++.......... ..+.+|+.+++.++||||+++++++...
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 95 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP- 95 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT-
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC-
Confidence 4579999999999999999999999999999999986432222211 5788999999999999999999998432
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEeecCCCc-----eE
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCK-----LK 166 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~-----vK 166 (556)
.|+||||+. ++|.+.+... ..+++..+..++.||+.||.|||++| |+||||||+|||++.++. +|
T Consensus 96 ------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 96 ------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp ------TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred ------CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 279999998 7998888754 47999999999999999999999999 999999999999988776 99
Q ss_pred EeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHH--HHHHH
Q 008729 167 VCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQ--LDLIT 244 (556)
Q Consensus 167 L~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~--~~~i~ 244 (556)
|+|||+++..... .....||+.|+|||++.+....++.++|||||||++|+|++|+.||.+.+.... ...+
T Consensus 170 l~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~- 242 (287)
T 4f0f_A 170 VADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI- 242 (287)
T ss_dssp ECCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH-
T ss_pred eCCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH-
Confidence 9999999753321 245679999999999854335688999999999999999999999987654322 1111
Q ss_pred HhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 245 ~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
...... ......+++.+.+||.+||+.||.+|||++++++
T Consensus 243 --------------------------~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 243 --------------------------REEGLR--PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp --------------------------HHSCCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------hccCCC--CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111111 1223468899999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=370.33 Aligned_cols=249 Identities=28% Similarity=0.446 Sum_probs=202.7
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCCh----hHHHHHHHHHHHHHhC----CCCCcceeeEEEcC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----SDAIRILREVKLLRLL----RHPDIVEIKRIMLP 93 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~----~~~~~~~rEi~iL~~L----~HpnIv~l~~v~~~ 93 (556)
.++|++++.||+|+||.||+|.+..+++.||||++....... .....+.+|+.+++.+ +||||+++++++
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~-- 107 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF-- 107 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE--
Confidence 368999999999999999999999999999999986432211 2233466899999999 899999999998
Q ss_pred CCCCCCceEEEEEec-Cc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec-CCCceEEeee
Q 008729 94 PSKREFKDIYVVFEL-ME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN-ANCKLKVCDF 170 (556)
Q Consensus 94 ~~~~~~~~lylV~E~-~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~-~~~~vKL~DF 170 (556)
......|+|||+ +. ++|.+++..++.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 108 ---~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 108 ---ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp --------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred ---ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 445668999998 55 79999999888899999999999999999999999999999999999999 8899999999
Q ss_pred CccccccCCCCCcceecccccCcccCCcccccccCCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC
Q 008729 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (556)
Q Consensus 171 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y-~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~ 249 (556)
|+++...... .....||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+... +.
T Consensus 185 g~~~~~~~~~-----~~~~~~~~~y~aPE~~~~--~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~----- 246 (312)
T 2iwi_A 185 GSGALLHDEP-----YTDFDGTRVYSPPEWISR--HQYHALPATVWSLGILLYDMVCGDIPFERDQE------IL----- 246 (312)
T ss_dssp SSCEECCSSC-----BCCCCSCTTTSCHHHHHH--SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH-----
T ss_pred chhhhcccCc-----ccccCCcccccCceeeec--CCCCCccchHHHHHHHHHHHHHCCCCCCChHH------Hh-----
Confidence 9998754322 245669999999999876 344 4689999999999999999999965311 10
Q ss_pred CChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
. .. ......+++.+.+||.+||..||++|||++++|+||||+..
T Consensus 247 ------------------~---~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 247 ------------------E---AE-----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp ------------------H---TC-----CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred ------------------h---hc-----cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence 0 00 11224688999999999999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=388.95 Aligned_cols=258 Identities=27% Similarity=0.386 Sum_probs=196.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.+|.+.++||+|+||+||. ....+|+.||||++..... ..+.+|+.+|+.+ +||||+++++++ .+...
T Consensus 24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~-----~~~~~ 92 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTE-----KDRQF 92 (432)
T ss_dssp EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEE-----EETTE
T ss_pred EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCE
Confidence 4799999999999999763 4457899999999864321 1345899999999 799999999998 55567
Q ss_pred EEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC---C--CceEEeeeCcccc
Q 008729 102 IYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---N--CKLKVCDFGLARV 175 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~--~~vKL~DFGla~~ 175 (556)
+|||||||+|+|.+++.... .+.+..+..|+.||+.||.|||++||+||||||+|||++. + ..+||+|||+|+.
T Consensus 93 ~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 93 QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 99999999999999998754 4566677899999999999999999999999999999953 2 3578999999987
Q ss_pred ccCCCCCcceecccccCcccCCccccccc-CCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
..............+||++|+|||++.+. ...++.++||||||||+|+|++ |..||....... ...+ .
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~~---~------ 242 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANIL---L------ 242 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHHH---T------
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHHH---h------
Confidence 54333222233567899999999998641 1467789999999999999999 899996544322 1111 1
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
..............+..+.+||.+||+.||.+|||++++|+||||..+
T Consensus 243 ------------------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 243 ------------------GACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp ------------------TCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ------------------ccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 111111111112345678999999999999999999999999999865
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=363.35 Aligned_cols=254 Identities=26% Similarity=0.374 Sum_probs=210.5
Q ss_pred CCCeEEEeeeeecCceeEEEEEE-----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (556)
.++|++++.||+|+||.||+|.+ ..+++.||||++... ........+.+|+.+|+.+ +||||+++++++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~---- 96 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGAC---- 96 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEE----
Confidence 46899999999999999999985 467889999999743 3345567889999999999 899999999999
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKAND------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~------------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (556)
.....+|+|||||. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 97 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred -ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 44556899999998 59999998754 48999999999999999999999999999999999
Q ss_pred EeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCC
Q 008729 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (556)
Q Consensus 157 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~ 235 (556)
||++.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+..
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNY-VVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS-EECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred EEEcCCCCEEEccccccccccccccc-eeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999999875443321 12234567889999999877 679999999999999999999 999998876
Q ss_pred hHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 236 ~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
....+..+.. .. .. ......++..+.+||.+||..||.+|||+++++++
T Consensus 253 ~~~~~~~~~~-----------------------~~---~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 253 VDSKFYKMIK-----------------------EG---FR---MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp SSHHHHHHHH-----------------------HT---CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhHHHHHhc-----------------------cC---CC---CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 5443322211 10 00 01124578999999999999999999999999974
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=370.03 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=208.4
Q ss_pred CCCCeEEEeeeeecCceeEEEEEE-----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~ 94 (556)
..++|++++.||+|+||.||+|.+ ..++..||||++... ........+.+|+.+|+.+ +||||+++++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~--- 118 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSELKMMTQLGSHENIVNLLGAC--- 118 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE---
Confidence 346899999999999999999997 346678999999743 2233456788999999999 899999999999
Q ss_pred CCCCCceEEEEEecCc-ccHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 008729 95 SKREFKDIYVVFELME-SDLHQVIKAND-----------------------DLTREHHQFFLYQMLRALKYMHTANVYHR 150 (556)
Q Consensus 95 ~~~~~~~lylV~E~~~-g~L~~~i~~~~-----------------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHr 150 (556)
.....+|+|||||+ |+|.+++.... .+++..+..++.||+.||.|||++||+||
T Consensus 119 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 119 --TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp --CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred --eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 44556899999998 69999998653 27999999999999999999999999999
Q ss_pred cCCCCcEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCC
Q 008729 151 DLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229 (556)
Q Consensus 151 DLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~ 229 (556)
||||+|||++.++.+||+|||++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccc-eeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999865443322 22345568889999999877 679999999999999999998 999
Q ss_pred CCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHH
Q 008729 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309 (556)
Q Consensus 230 pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~e 309 (556)
||.+......+..+.. .... ......+++.+.+||.+||..||.+|||+.+
T Consensus 274 p~~~~~~~~~~~~~~~--------------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 324 (344)
T 1rjb_A 274 PYPGIPVDANFYKLIQ--------------------------NGFK---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 324 (344)
T ss_dssp SSTTCCCSHHHHHHHH--------------------------TTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CcccCCcHHHHHHHHh--------------------------cCCC---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 9988765433322211 1111 1122457899999999999999999999999
Q ss_pred HHhCcc
Q 008729 310 ALADPY 315 (556)
Q Consensus 310 lL~hp~ 315 (556)
+++|..
T Consensus 325 l~~~l~ 330 (344)
T 1rjb_A 325 LTSFLG 330 (344)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998643
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=379.62 Aligned_cols=253 Identities=21% Similarity=0.365 Sum_probs=208.6
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||.||+|.+..+++.||||++... ........+.+|+.+|+.++||||+++++++ ....
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~ 185 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVC-----TQKQ 185 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE-----CSSS
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----ecCC
Confidence 346899999999999999999999999999999998743 2334455788999999999999999999999 4445
Q ss_pred eEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 101 DIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.+|+|||||+ |+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 6899999998 79999998654 699999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... .......++..|+|||++.+ ..|+.++|||||||++|||++ |..||.+.+.......+..
T Consensus 266 ~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~------------ 330 (377)
T 3cbl_A 266 GVYA-ASGGLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK------------ 330 (377)
T ss_dssp SEEE-CCSSCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT------------
T ss_pred Ccee-ecCCCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------
Confidence 2110 00012235678999999977 678999999999999999998 9999998776544433311
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... .....+++.+.+||.+||..||++|||++++++
T Consensus 331 ---------------~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 331 ---------------GGRL---PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp ---------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1111 122457899999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=366.21 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=203.7
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCC----cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTG----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg----~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
..++|++.+.||+|+||.||+|.+..++ ..||||++... ........+.+|+.+|+.++||||+++++++
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~----- 115 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI----- 115 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----
Confidence 4579999999999999999999987654 35999998743 2344566788999999999999999999999
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
.....+|||||||+ ++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence 55567999999998 5999999864 679999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
................+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~-------- 265 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-------- 265 (333)
T ss_dssp ---------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT--------
T ss_pred hhccccccccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHC--------
Confidence 75443222222233456889999999977 679999999999999999999 9999988776554443321
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.... .....+++.+.+||.+||..||++||++.+++++
T Consensus 266 -------------------~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 266 -------------------GFRL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp -------------------TCCC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred -------------------CCcC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1111 1224578999999999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=359.93 Aligned_cols=257 Identities=22% Similarity=0.286 Sum_probs=198.9
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||.||+|.+. ..||+|++............+.+|+.+|+.++||||++++++. ...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~------~~~ 92 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS------TAP 92 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE------CSS
T ss_pred CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec------cCC
Confidence 3468999999999999999999754 3599999986656666778899999999999999999999965 234
Q ss_pred eEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 101 DIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.+|+|||||. ++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 5799999998 699999964 45799999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcceecccccCcccCCccccccc-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
... ........||+.|+|||++... ...++.++|||||||++|+|++|+.||.+....+.+..+..
T Consensus 173 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~------------ 239 (289)
T 3og7_A 173 WSG-SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG------------ 239 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHH------------
T ss_pred ccc-cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhc------------
Confidence 211 1122456799999999998521 15688899999999999999999999988765544433211
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
..............+++.+.+||.+||..||.+|||++++++
T Consensus 240 -------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 240 -------------RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -------------HTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------ccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111112223344578899999999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=366.24 Aligned_cols=253 Identities=20% Similarity=0.381 Sum_probs=210.3
Q ss_pred CCCeEEEeeeeecCceeEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
.++|++.+.||+|+||.||+|.+. .+++.||||++... ........+.+|+.+|+.++||||+++++++
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~----- 97 (322)
T 1p4o_A 24 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVV----- 97 (322)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-----
T ss_pred hhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE-----
Confidence 468999999999999999999877 46789999998743 3345566788999999999999999999999
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCce
Q 008729 97 REFKDIYVVFELME-SDLHQVIKAN----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~----------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~v 165 (556)
.+...+|+|||||. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeE
Confidence 44566899999998 6999999752 457999999999999999999999999999999999999999999
Q ss_pred EEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 008729 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLIT 244 (556)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~ 244 (556)
||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 178 kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYY-RKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp EECCTTCCCGGGGGGCE-EGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EECcCcccccccccccc-ccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 99999999764332211 11233457899999999987 679999999999999999999 899998877655444332
Q ss_pred HhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 245 ~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
. .. .......+++.+.+||++||..||.+|||+.++++|
T Consensus 255 ~---------------------------~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 255 E---------------------------GG---LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp T---------------------------TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c---------------------------CC---cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1 11 112234688999999999999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=369.74 Aligned_cols=253 Identities=21% Similarity=0.357 Sum_probs=200.9
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEE----EEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKV----AIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~v----AiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
..++|++++.||+|+||.||+|++..+++.| |+|.+... ........+.+|+.+|+.++||||+++++++..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--- 88 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLT--- 88 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEES---
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec---
Confidence 3468999999999999999999998888765 77766532 222344678899999999999999999999853
Q ss_pred CCCceEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
...++|+||+. |+|.+++.. .+.+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+
T Consensus 89 ---~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 89 ---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp ---SSEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred ---CCeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCccee
Confidence 23788999998 799999987 4579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
......... ......||..|+|||++.+ ..|+.++|||||||++|+|++ |+.||.+.+.......+..
T Consensus 166 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-------- 234 (327)
T 3poz_A 166 LLGAEEKEY-HAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------- 234 (327)
T ss_dssp HHTTTCC--------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT--------
T ss_pred EccCCcccc-cccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc--------
Confidence 754332221 1234557889999999987 789999999999999999999 9999988776554433321
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
... ....+.++..+.+|+.+||..||.+|||+.+++++
T Consensus 235 -------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 235 -------------------GER---LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -------------------TCC---CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -------------------CCC---CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 111 11234578899999999999999999999999976
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=367.76 Aligned_cols=259 Identities=22% Similarity=0.347 Sum_probs=191.7
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCC---CC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPS---KR 97 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~---~~ 97 (556)
..+|+++++||+|+||.||+|.+..+++.||||++.. ........+.+|+.+|+.+. ||||+++++++.... ..
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC--CchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3489999999999999999999999999999998853 34455667889999999996 999999999985321 13
Q ss_pred CCceEEEEEecCcccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEeecCCCceEEeeeCc
Q 008729 98 EFKDIYVVFELMESDLHQVIKA---NDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGL 172 (556)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~---~~~l~~~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~vKL~DFGl 172 (556)
....+|+||||++|+|.+++.. .+.+++..++.|+.||+.||.|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 4566899999999999998865 567999999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCc---------ceecccccCcccCCcccccc-cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHH
Q 008729 173 ARVAFSDTPMT---------VFWTDYVATRWYRAPELCGS-FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDL 242 (556)
Q Consensus 173 a~~~~~~~~~~---------~~~~~~~gt~~Y~APE~~~~-~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~ 242 (556)
++......... ......+||+.|+|||++.. ....++.++|||||||++|+|++|+.||.+......+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 264 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG 264 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence 98754322111 01124569999999999831 115688999999999999999999999976543221110
Q ss_pred HHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 008729 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (556)
Q Consensus 243 i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~ 315 (556)
... .......+..+.+||++||+.||.+|||++++++|-+
T Consensus 265 ------------------------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 265 ------------------------------KYS---IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp -------------------------------CC---CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred ------------------------------ccc---CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 001 1112346677999999999999999999999999744
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=362.38 Aligned_cols=271 Identities=22% Similarity=0.373 Sum_probs=210.8
Q ss_pred CCCCeEEEeeeeecCceeEEEEE----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~----~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
..++|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-- 95 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTED-- 95 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC--
Confidence 34579999999999999999998 67789999999987432 223446788999999999999999999998542
Q ss_pred CCCceEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
....+|+||||++ ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 96 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 96 -GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred -CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 2356899999998 599999954 5679999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
................||..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+....+......
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~ 247 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHGQM 247 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCGGG
T ss_pred cccCCCcceeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCccccc
Confidence 76544332233345678899999999977 678899999999999999999999874321 22222222222111
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
........+...... ...+.+++.+.+||++||..||.+|||++++++
T Consensus 248 -------~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 248 -------TVTRLVNTLKEGKRL---PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp -------HHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred -------CHHHHHHHHhccCCC---CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 111222222222222 233568999999999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=357.28 Aligned_cols=256 Identities=21% Similarity=0.242 Sum_probs=206.3
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||.||+|++..+|+.||||++...... ..+.+|+.+++.++|++++..+..+. ....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~~ 78 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCG----AEGD 78 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEE----EETT
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCcccccc----CCCC
Confidence 457999999999999999999999999999999998643222 35779999999999988777776653 3446
Q ss_pred eEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee---cCCCceEEeeeCccccc
Q 008729 101 DIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARVA 176 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl---~~~~~vKL~DFGla~~~ 176 (556)
..|+||||++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 79 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 79 YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 7899999998899999974 5579999999999999999999999999999999999999 48889999999999875
Q ss_pred cCCCCCc----ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChH---HHHHHHHHhhCC
Q 008729 177 FSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV---HQLDLITDLLGT 249 (556)
Q Consensus 177 ~~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~---~~~~~i~~~~g~ 249 (556)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.. ..+..+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCChhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence 4432211 11245679999999999987 67999999999999999999999999874422 222222110000
Q ss_pred CChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.+.......+++.+.+||++||+.||++|||++++++
T Consensus 237 --------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 237 --------------------------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp --------------------------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred --------------------------CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 0111112458899999999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=378.86 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=197.8
Q ss_pred CCCeEEEeeeeecCceeEEEEEEC---CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~---~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
.++|++.+.||+|+||.||+|++. .++..||||++... ........+.+|+.+|+.++||||+++++++ .+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~ 117 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVV-----TK 117 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----CS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----ee
Confidence 458999999999999999999877 46778999998753 2445566799999999999999999999999 44
Q ss_pred CceEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
...+|+|||||+ ++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 567899999997 69999998754 6999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
..............++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~-------- 267 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY-------- 267 (373)
T ss_dssp ----------------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTE--------
T ss_pred ccCCccceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--------
Confidence 433222211223346788999999987 689999999999999999998 999998877655544432110
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
. ......++..+.+||.+||..||.+||+++++++
T Consensus 268 -------------------~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 268 -------------------R---LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp -------------------E---CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------C---CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 0 0112357889999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=362.98 Aligned_cols=257 Identities=20% Similarity=0.228 Sum_probs=203.2
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
...++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+..+. ...
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~----~~~ 77 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCG----AEG 77 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEE----EET
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeec----CCC
Confidence 34579999999999999999999999999999999875422 2234778999999999988887777663 345
Q ss_pred ceEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee---cCCCceEEeeeCcccc
Q 008729 100 KDIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARV 175 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl---~~~~~vKL~DFGla~~ 175 (556)
...|+||||++++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 78 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 78 DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred CceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 67899999998899999985 5679999999999999999999999999999999999999 7889999999999987
Q ss_pred ccCCCCCc----ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHH---HHHHHHHhhC
Q 008729 176 AFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH---QLDLITDLLG 248 (556)
Q Consensus 176 ~~~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~---~~~~i~~~~g 248 (556)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+... .+..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~- 234 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK- 234 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH-
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcC--CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc-
Confidence 54432211 11235679999999999987 679999999999999999999999998754322 222211100
Q ss_pred CCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
...+.......+++.+.+||.+||+.||++|||++++++
T Consensus 235 -------------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 235 -------------------------MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -------------------------HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -------------------------ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 000111122457899999999999999999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=368.93 Aligned_cols=273 Identities=21% Similarity=0.327 Sum_probs=215.1
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEE----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~----~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~ 94 (556)
+-..++|++++.||+|+||.||+|+ +..+++.||||++.. ........+.+|+.+|+.++||||+++++++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 95 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH--SGPDQQRDFQREIQILKALHSDFIVKYRGVSYG- 95 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESS--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEecc--CCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec-
Confidence 3445799999999999999999998 577899999999975 344556678999999999999999999998853
Q ss_pred CCCCCceEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCc
Q 008729 95 SKREFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (556)
Q Consensus 95 ~~~~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGl 172 (556)
.+...+|+|||||+ ++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 96 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 96 --PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp --SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred --CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccc
Confidence 24467999999997 699999986 45699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
++................||..|+|||++.+ ..++.++|||||||++|+|++|..||......... ......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-----~~~~~~- 245 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSD--NIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR-----MMGCER- 245 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-----HCC----
T ss_pred ceecccCCccceeeccCCccccccCHHHhcc--CCCChHHhHHHHHHHHHHHHhCCCCCccccchhhh-----hccccc-
Confidence 9876544333223345668899999999987 67899999999999999999999999754321110 000000
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
...........+...... ...+.+++.+.+||++||..||.+|||+++++++
T Consensus 246 ------~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 246 ------DVPALSRLLELLEEGQRL---PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp -------CCHHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------ccccHHHHHHHhhcccCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000111122222222222 2235689999999999999999999999999764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=354.30 Aligned_cols=247 Identities=15% Similarity=0.217 Sum_probs=207.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||+|+||.||+|.+. ++.||||++............+.+|+.+|+.++||||+++++++... ....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 83 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPH 83 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCC
Confidence 358999999999999999999885 88999999986555566677899999999999999999999998543 2356
Q ss_pred EEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 102 IYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
+|+||||++ ++|.+++.... .+++..+..|+.||+.||.|||+.| |+||||||+|||++.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 899999998 69999998765 4899999999999999999999999 999999999999999999999999887542
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCC---CcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYT---PAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~---~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
.. ....||+.|+|||++.+ ..++ .++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 164 ~~--------~~~~~t~~y~aPE~~~~--~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-------- 225 (271)
T 3kmu_A 164 QS--------PGRMYAPAWVAPEALQK--KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL-------- 225 (271)
T ss_dssp SC--------TTCBSCGGGSCHHHHHS--CGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHH--------
T ss_pred cc--------cCccCCccccChhhhcc--CCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHh--------
Confidence 21 33568999999999876 3333 479999999999999999999988776554433321
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... ......+++.+.+||.+||..||++|||++++++
T Consensus 226 ------------------~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 226 ------------------EGLR---PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ------------------SCCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------cCCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 1223468999999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=371.23 Aligned_cols=255 Identities=21% Similarity=0.301 Sum_probs=205.5
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcE----EEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~----vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~ 94 (556)
.-..++|++++.||+|+||.||+|.+..+++. ||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-- 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-- 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC--
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc--
Confidence 34457899999999999999999999988876 6777664321 1122345678999999999999999999883
Q ss_pred CCCCCceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCc
Q 008729 95 SKREFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (556)
Q Consensus 95 ~~~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGl 172 (556)
...+|+||||+. ++|.+++... +.+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 86 ----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 161 (325)
T 3kex_A 86 ----GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGV 161 (325)
T ss_dssp ----BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred ----CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCc
Confidence 245899999998 7999999874 5799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCC
Q 008729 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPS 251 (556)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~ 251 (556)
++........ .......||..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+....+....+..
T Consensus 162 a~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~------ 232 (325)
T 3kex_A 162 ADLLPPDDKQ-LLYSEAKTPIKWMALESIHF--GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK------ 232 (325)
T ss_dssp GGGSCCCTTC-CC-----CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT------
T ss_pred ccccCccccc-ccccCCCCcccccChHHhcc--CCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc------
Confidence 9875433222 22345668889999999987 679999999999999999999 9999988775554443321
Q ss_pred hHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
... ......+++.+.+||.+||..||.+|||+.++++|
T Consensus 233 ---------------------~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 233 ---------------------GER---LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp ---------------------TCB---CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred ---------------------CCC---CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111 11123467788999999999999999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=367.75 Aligned_cols=258 Identities=21% Similarity=0.327 Sum_probs=207.5
Q ss_pred CCCCeEEEeeeeecCceeEEEEE-----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAI-----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~-----~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (556)
..++|++++.||+|+||.||+|. +..+++.||||++... ........+.+|+.+|+.++||||+++++++
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~---- 102 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVS---- 102 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEE----
Confidence 34689999999999999999999 5678889999998643 3445566788999999999999999999999
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC---Cc
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKAND-------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---CK 164 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~-------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~---~~ 164 (556)
.....+|+|||||+ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+ ..
T Consensus 103 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 103 -LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred -cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 44456899999996 69999998753 48999999999999999999999999999999999999844 46
Q ss_pred eEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHH
Q 008729 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLI 243 (556)
Q Consensus 165 vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i 243 (556)
+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.+..+....+
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYR-KGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp EEECCCHHHHHHHC-------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred EEECccccccccccccccc-cCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 9999999997643322111 1234568899999999877 678999999999999999998 99999887765544433
Q ss_pred HHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
.. ... ......+++.+.+||.+||..||.+|||++++++|.|+-
T Consensus 259 ~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 TS---------------------------GGR---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp HT---------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hc---------------------------CCC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 21 111 112346889999999999999999999999999998874
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=353.51 Aligned_cols=248 Identities=26% Similarity=0.410 Sum_probs=195.3
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCC--hhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH--ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
.++|++.+.||+|+||.||+|.+. ++.||||++...... ......+.+|+.+++.++||||+++++++ .+.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecC
Confidence 458999999999999999999875 889999998643221 12346788999999999999999999999 445
Q ss_pred ceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCCCcEeecC--------CCceEE
Q 008729 100 KDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN---VYHRDLKPKNILANA--------NCKLKV 167 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~g---IvHrDLKP~NILl~~--------~~~vKL 167 (556)
..+|+||||++ ++|.+++. ...+++..+..++.||+.||.|||++| |+||||||+|||++. ++.+||
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp --CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 66899999998 68888875 567999999999999999999999999 999999999999986 678999
Q ss_pred eeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 008729 168 CDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (556)
Q Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~ 247 (556)
+|||++........ ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 158 ~Dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--- 227 (271)
T 3dtc_A 158 TDFGLAREWHRTTK-----MSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVA--- 227 (271)
T ss_dssp CCCCC------------------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH---
T ss_pred ccCCcccccccccc-----cCCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhh---
Confidence 99999976533221 24569999999999987 678999999999999999999999998877554433221
Q ss_pred CCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
..... ......+++.+.+||.+||..||.+|||+.++++|
T Consensus 228 -----------------------~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 228 -----------------------MNKLA---LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -----------------------TSCCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------cCCCC---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 11111 11234678999999999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=364.86 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=209.4
Q ss_pred CCCCeEEEeeeeecCceeEEEEEEC-------CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDT-------HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIML 92 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~-------~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~ 92 (556)
..++|++++.||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.+ +||||+++++++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~- 110 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC- 110 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE-
Confidence 3468999999999999999999986 46778999998753 3445567789999999999 899999999999
Q ss_pred CCCCCCCceEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 008729 93 PPSKREFKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPK 155 (556)
Q Consensus 93 ~~~~~~~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~ 155 (556)
.....+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+
T Consensus 111 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 111 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp ----CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred ----ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 44567899999998 59999998654 3899999999999999999999999999999999
Q ss_pred cEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCC
Q 008729 156 NILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234 (556)
Q Consensus 156 NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~ 234 (556)
|||++.++.+||+|||+++........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~ 263 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYY-KKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 263 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSE-ECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred eEEEcCCCCEEEccccccccccccccc-cccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence 999999999999999999865432211 11234457889999999877 678999999999999999999 99999887
Q ss_pred ChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 235 ~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
+..+....+.. ... ......+++.+.+||++||..||.+|||+++++++
T Consensus 264 ~~~~~~~~~~~---------------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 264 PVEELFKLLKE---------------------------GHR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CHHHHHHHHHH---------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHhc---------------------------CCC---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 76554433321 111 11234688999999999999999999999999975
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=362.91 Aligned_cols=256 Identities=25% Similarity=0.399 Sum_probs=210.3
Q ss_pred CCCCeEEEeeeeecCceeEEEEEE-----CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~-----~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~ 94 (556)
..++|++++.||+|+||.||+|.+ ..+++.||||++... ........+.+|+.+|+.+ +||||+++++++..
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 102 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACTK- 102 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC-
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec-
Confidence 446899999999999999999985 457789999999753 3344556788999999999 69999999999853
Q ss_pred CCCCCceEEEEEecCc-ccHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 008729 95 SKREFKDIYVVFELME-SDLHQVIKANDD----------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNI 157 (556)
Q Consensus 95 ~~~~~~~lylV~E~~~-g~L~~~i~~~~~----------------l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NI 157 (556)
....+|+|||||. ++|.+++..... +++..+..++.||+.||.|||+.||+||||||+||
T Consensus 103 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 103 ---PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ---TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ---CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 2345899999998 699999987654 89999999999999999999999999999999999
Q ss_pred eecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCCh
Q 008729 158 LANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSV 236 (556)
Q Consensus 158 Ll~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~ 236 (556)
|++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+...
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT-SEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred EECCCCCEEECCCccccccccCcc-ceeccCCCcceeecCchhhcc--ccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 999999999999999986543322 122345668899999999977 679999999999999999998 9999987664
Q ss_pred HHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 237 ~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
...+.... . .... ......+++.+.+||.+||..||.+|||++++++|
T Consensus 257 ~~~~~~~~-----------------------~---~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 257 DEEFCRRL-----------------------K---EGTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp SHHHHHHH-----------------------H---HTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHh-----------------------c---cCcc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33222111 1 1111 11224578999999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=361.78 Aligned_cols=245 Identities=17% Similarity=0.267 Sum_probs=201.4
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCC-------cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-------EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP 94 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg-------~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~ 94 (556)
.++|++.+.||+|+||.||+|.+..++ ..||+|++... .......+.+|+.+|+.++||||+++++++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-- 82 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCV-- 82 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC--
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE--
Confidence 358999999999999999999998887 47999998643 2344567889999999999999999999994
Q ss_pred CCCCCceEEEEEecCc-ccHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCc--------
Q 008729 95 SKREFKDIYVVFELME-SDLHQVIKANDD-LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK-------- 164 (556)
Q Consensus 95 ~~~~~~~lylV~E~~~-g~L~~~i~~~~~-l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~-------- 164 (556)
+....|+|||||. ++|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 83 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 83 ---CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp ---CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred ---eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccce
Confidence 4456899999998 699999987654 999999999999999999999999999999999999998887
Q ss_pred eEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHH
Q 008729 165 LKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLI 243 (556)
Q Consensus 165 vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG-~~pF~~~~~~~~~~~i 243 (556)
+||+|||++...... ....||+.|+|||++.+. ..++.++|||||||++|+|++| .+||...........+
T Consensus 160 ~kl~Dfg~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~ 231 (289)
T 4fvq_A 160 IKLSDPGISITVLPK-------DILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231 (289)
T ss_dssp EEECCCCSCTTTSCH-------HHHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred eeeccCcccccccCc-------cccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHh
Confidence 999999998654221 334589999999998752 4688999999999999999995 5666555443322211
Q ss_pred HHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 244 ~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
. ... ......++.+.+||++||+.||++|||++++++|
T Consensus 232 ~---------------------------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 232 E---------------------------DRH-----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp H---------------------------TTC-----CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred h---------------------------ccC-----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1 111 1123456789999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=354.51 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=207.9
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
+.++|++++.||+|+||.||+|.+. +++.||+|++...... ...+.+|+.+++.++||||+++++++ .+..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~ 76 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQA 76 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSS
T ss_pred chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCC
Confidence 3468999999999999999999986 6788999999753322 35688999999999999999999999 4445
Q ss_pred eEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 101 DIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.+|+||||++ ++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 77 PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp SCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 6899999998 6999999875 5689999999999999999999999999999999999999999999999999976532
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.. ........++..|+|||++.+ ..++.++|||||||++|+|++ |++||.+.+.......+..
T Consensus 157 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~------------ 220 (267)
T 3t9t_A 157 DQ--YTSSTGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST------------ 220 (267)
T ss_dssp HH--HHSTTSTTCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT------------
T ss_pred cc--ccccccccccccccChhhhcC--CCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhc------------
Confidence 11 111134457889999999987 678999999999999999999 8999988776554444321
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
... .......++.+.+||.+||..||++|||+++++++
T Consensus 221 ---------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 221 ---------------GFR---LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp ---------------TCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCc---CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 100 11123578999999999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=371.04 Aligned_cols=268 Identities=16% Similarity=0.146 Sum_probs=203.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCC-----CcEEEEEEecCccCChhHH---------HHHHHHHHHHHhCCCCCccee
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHT-----GEKVAIKKIHDVFEHISDA---------IRILREVKLLRLLRHPDIVEI 87 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~t-----g~~vAiK~i~~~~~~~~~~---------~~~~rEi~iL~~L~HpnIv~l 87 (556)
.++|++++.||+|+||.||+|.+..+ ++.||||++.......... ..+.+|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45899999999999999999998765 5889999986432111111 123456667778889999999
Q ss_pred eEEEcCCCCCCCceEEEEEecCcccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec--CCCc
Q 008729 88 KRIMLPPSKREFKDIYVVFELMESDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN--ANCK 164 (556)
Q Consensus 88 ~~v~~~~~~~~~~~lylV~E~~~g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~--~~~~ 164 (556)
++++.... .....+|||||||+++|.+++... +.+++..+..|+.||+.||.|||++||+||||||+|||++ .++.
T Consensus 114 ~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred Eeeeeecc-CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 99985432 233568999999988999999876 6799999999999999999999999999999999999999 8899
Q ss_pred eEEeeeCccccccCCCCC----cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHH
Q 008729 165 LKVCDFGLARVAFSDTPM----TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240 (556)
Q Consensus 165 vKL~DFGla~~~~~~~~~----~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~ 240 (556)
+||+|||+++........ .......+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.......
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~ 270 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--VAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKY 270 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCccccccCHHH
Confidence 999999999765332211 111234569999999999987 67999999999999999999999999864432222
Q ss_pred HHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 241 ~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
....... ........+..... ...+++.+.+||..||..||.+||+++++++
T Consensus 271 ~~~~~~~-----------~~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 271 VRDSKIR-----------YRENIASLMDKCFP---------AANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHH-----------HHHCHHHHHHHHSC---------TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHH-----------hhhhHHHHHHHhcc---------cccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 2111100 00111112221110 1457899999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=369.87 Aligned_cols=268 Identities=15% Similarity=0.143 Sum_probs=202.1
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECC---CCcEEEEEEecCccCChhH---------HHHHHHHHHHHHhCCCCCcceee
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISD---------AIRILREVKLLRLLRHPDIVEIK 88 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~---tg~~vAiK~i~~~~~~~~~---------~~~~~rEi~iL~~L~HpnIv~l~ 88 (556)
..++|++++.||+|+||.||+|.+.. ++..||||++......... ...+.+|+.+++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 34689999999999999999999987 8889999998743211111 12356789999999999999999
Q ss_pred EEEcCCCCCCCceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC--ceE
Q 008729 89 RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC--KLK 166 (556)
Q Consensus 89 ~v~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~--~vK 166 (556)
+++.... .+...+|+|||||+++|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred ccccccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 9985422 2357799999999889999998888899999999999999999999999999999999999999887 999
Q ss_pred EeeeCccccccCCCCC----cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCC--hHHHH
Q 008729 167 VCDFGLARVAFSDTPM----TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS--VVHQL 240 (556)
Q Consensus 167 L~DFGla~~~~~~~~~----~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~--~~~~~ 240 (556)
|+|||+++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.. .....
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 9999999765322111 111245679999999999987 679999999999999999999999996532 21111
Q ss_pred HHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 241 ~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
............. +... .....+++.+.+||.+||..||++|||++++++.
T Consensus 272 ~~~~~~~~~~~~~-------------~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 272 TAKTNLLDELPQS-------------VLKW---------APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHHTTTHH-------------HHHH---------SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHhhcccccHH-------------HHhh---------ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 1111111100000 0000 0012588999999999999999999999999873
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=382.41 Aligned_cols=261 Identities=27% Similarity=0.361 Sum_probs=194.0
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (556)
..+.|.+.+.||+|+||+||.+ ...+|+.||||++... ....+.+|+.+|+.+ +||||+++++++ .+.
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~ 81 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSE-----TTD 81 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECS
T ss_pred hhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecC
Confidence 3457888899999999999875 4568999999998642 234567999999876 899999999998 555
Q ss_pred ceEEEEEecCcccHHHHHHhCCCCC-------HHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC----------
Q 008729 100 KDIYVVFELMESDLHQVIKANDDLT-------REHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN---------- 162 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~-------~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~---------- 162 (556)
..+|||||||+|+|.+++....... +..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 82 ~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 82 RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence 7799999999999999998765332 23456799999999999999999999999999999754
Q ss_pred ---CceEEeeeCccccccCCCCC-cceecccccCcccCCccccccc-----CCCCCCcchhhhHHHHHHHHHh-CCCCCC
Q 008729 163 ---CKLKVCDFGLARVAFSDTPM-TVFWTDYVATRWYRAPELCGSF-----FSKYTPAIDIWSIGCIFAEVLT-GKPLFP 232 (556)
Q Consensus 163 ---~~vKL~DFGla~~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~-----~~~y~~~~DIWSlG~ilyellt-G~~pF~ 232 (556)
+.+||+|||+++........ .......+||+.|+|||++.+. ...++.++||||||||+|+|++ |..||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 47999999999875433211 1112456799999999998641 1468899999999999999999 999997
Q ss_pred CCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 233 GKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 233 ~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
+..... . .+.. ......... ......+++.+.+||.+||+.||.+|||+.++|+
T Consensus 242 ~~~~~~-~-~i~~-----------------------~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 242 DKYSRE-S-NIIR-----------------------GIFSLDEMK-CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp STTTHH-H-HHHH-----------------------TCCCCCCCT-TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CchhhH-H-HHhc-----------------------CCCCccccc-ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 654322 1 1110 000000000 0011234578999999999999999999999999
Q ss_pred Cccccc
Q 008729 313 DPYFKG 318 (556)
Q Consensus 313 hp~f~~ 318 (556)
||||..
T Consensus 296 hp~f~~ 301 (434)
T 2rio_A 296 HPLFWP 301 (434)
T ss_dssp SGGGSC
T ss_pred CCccCC
Confidence 999974
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=357.40 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=210.0
Q ss_pred CCCeEEEe-eeeecCceeEEEEEEC--CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 22 ANRYKILE-VIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 22 ~~~Y~i~~-~LG~G~~g~V~~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
.++|.+++ .||+|+||.||+|.+. .++..||||++... ........+.+|+.+|+.++||||+++++++..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 81 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----- 81 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-----
Confidence 35788887 9999999999999864 46788999999753 344566788999999999999999999999832
Q ss_pred CceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
..+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 82 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 82 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred -CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 34899999999 5999999654 56999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
..............||+.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~---------- 228 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---------- 228 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT----------
T ss_pred ccCcceeeccccccccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc----------
Confidence 433322222234457899999999977 678999999999999999998 9999988776554433321
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~ 315 (556)
... ....+.+++.+.+||.+||..||.+|||+.++++|.+
T Consensus 229 -----------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 229 -----------------GKR---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp -----------------TCC---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -----------------CCc---CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 111 1223568999999999999999999999999998744
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=367.68 Aligned_cols=250 Identities=25% Similarity=0.376 Sum_probs=205.2
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEE--EEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKV--AIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~v--AiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~ 98 (556)
.++|++.+.||+|+||.||+|++..++..+ |+|++... ........+.+|+.+|+.+ +||||+++++++ .+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~ 97 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EH 97 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceee-----ee
Confidence 368999999999999999999999999865 99988643 2334456788999999999 899999999999 45
Q ss_pred CceEEEEEecCc-ccHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC
Q 008729 99 FKDIYVVFELME-SDLHQVIKAND----------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA 161 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~----------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~ 161 (556)
...+|+||||++ ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~ 177 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence 567999999997 69999998754 6999999999999999999999999999999999999999
Q ss_pred CCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHH
Q 008729 162 NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQL 240 (556)
Q Consensus 162 ~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~ 240 (556)
++.+||+|||+++....... .....+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+..
T Consensus 178 ~~~~kL~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 251 (327)
T 1fvr_A 178 NYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251 (327)
T ss_dssp GGCEEECCTTCEESSCEECC----C----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred CCeEEEcccCcCcccccccc----ccCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence 99999999999874322111 133457889999999977 678999999999999999998 99999888765444
Q ss_pred HHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 241 ~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
..+. .... ......+++.+.+||.+||..||.+|||+++++++
T Consensus 252 ~~~~---------------------------~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 252 EKLP---------------------------QGYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHGG---------------------------GTCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhh---------------------------cCCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3321 1111 12234678999999999999999999999999986
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=362.84 Aligned_cols=254 Identities=23% Similarity=0.372 Sum_probs=209.0
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCc-----EEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPP 94 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~-----~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~ 94 (556)
..++|++++.||+|+||.||+|.+..+++ .||+|++... ........+.+|+.+|+.+ +||||+++++++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~--- 119 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-AHADEKEALMSELKIMSHLGQHENIVNLLGAC--- 119 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE---
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc-cChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE---
Confidence 34689999999999999999999987665 7999998753 3345567789999999999 899999999999
Q ss_pred CCCCCceEEEEEecCc-ccHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee
Q 008729 95 SKREFKDIYVVFELME-SDLHQVIKA--------------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA 159 (556)
Q Consensus 95 ~~~~~~~lylV~E~~~-g~L~~~i~~--------------~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl 159 (556)
.....+|+|||||+ |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 120 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 120 --THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp --CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred --ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 44566999999998 599999975 3468999999999999999999999999999999999999
Q ss_pred cCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHH
Q 008729 160 NANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVH 238 (556)
Q Consensus 160 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~ 238 (556)
+.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.+.....
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNY-IVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTS-EECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred CCCCeEEECccccccccccccce-eecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 99999999999999865433221 12234567889999999887 679999999999999999998 999998876544
Q ss_pred HHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 239 ~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.+..+.. . ... .......++.+.+||.+||..||.+|||++++++
T Consensus 275 ~~~~~~~-----------------------~---~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 275 KFYKLVK-----------------------D---GYQ---MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHH-----------------------H---TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHh-----------------------c---CCC---CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 3332211 1 000 0112347899999999999999999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=355.21 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=205.0
Q ss_pred CCCeEEEeeeeecCceeEEEEEECC---CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~---tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
.++|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+|+.++||||+++++++..
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 84 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE----- 84 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-----
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-----
Confidence 3589999999999999999998654 3456999998753 244566788999999999999999999999842
Q ss_pred CceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
...|+||||+. ++|.+++..+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred -CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 23699999999 6999999764 46999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
...... ......+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+....+....+...
T Consensus 164 ~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~--------- 230 (281)
T 3cc6_A 164 EDEDYY--KASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG--------- 230 (281)
T ss_dssp -----------CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT---------
T ss_pred cccccc--ccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC---------
Confidence 432211 1233457889999999977 678999999999999999998 99999877665554443221
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
... .....+++.+.+||.+||..||++|||+.+++++
T Consensus 231 ------------------~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 231 ------------------DRL---PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------CCC---CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 111 1224578999999999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=364.79 Aligned_cols=252 Identities=21% Similarity=0.360 Sum_probs=201.2
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEE----EEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKV----AIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~v----AiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
..++|++++.||+|+||.||+|.+..+++.| |+|.+... ........+.+|+.+|+.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-- 89 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-- 89 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS--
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC--
Confidence 4568999999999999999999999888765 66666432 2233456788999999999999999999998532
Q ss_pred CCCceEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
..++|+||+. ++|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 90 ----~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 90 ----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp ----SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred ----CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 3788999998 699999987 4579999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
........ .......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |..||.+.........+..
T Consensus 166 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~-------- 234 (327)
T 3lzb_A 166 LLGAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------- 234 (327)
T ss_dssp ---------------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT--------
T ss_pred EccCcccc-ccccCCCccccccCHHHHcC--CCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc--------
Confidence 75432221 11234557889999999987 689999999999999999999 9999988776554443321
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
... ....+.++..+.+||++||..||.+|||+.++++
T Consensus 235 -------------------~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 235 -------------------GER---LPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp -------------------TCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CCC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111 1123458899999999999999999999999987
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=355.89 Aligned_cols=259 Identities=26% Similarity=0.398 Sum_probs=199.2
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCc-cCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDV-FEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~-~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
...++|++++.||+|+||.||+|.+..+|+.||||++... .........+.+|+.+|+.++||||+++++++ ..
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~ 103 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF-----IE 103 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----Ec
Confidence 3456899999999999999999999999999999999742 23445667789999999999999999999999 44
Q ss_pred CceEEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcc
Q 008729 99 FKDIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla 173 (556)
...+|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 567999999999 599998864 467999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhhCCCC
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVV--HQLDLITDLLGTPS 251 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~--~~~~~i~~~~g~p~ 251 (556)
........ ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... .....
T Consensus 184 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--------- 249 (310)
T 2wqm_A 184 RFFSSKTT---AAHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK--------- 249 (310)
T ss_dssp ------------------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHH---------
T ss_pred eeecCCCc---cccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHH---------
Confidence 76543221 1234579999999999987 67899999999999999999999999764321 11111
Q ss_pred hHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 252 ~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
+......+ .....+++.+.+||.+||..||.+|||+++++++ ++.+
T Consensus 250 ------------------~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~--l~~l 295 (310)
T 2wqm_A 250 ------------------IEQCDYPP--LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV--AKRM 295 (310)
T ss_dssp ------------------HHTTCSCC--CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHH
T ss_pred ------------------hhcccCCC--CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH--HHHH
Confidence 11111111 1124578999999999999999999999999973 4444
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=360.22 Aligned_cols=263 Identities=25% Similarity=0.320 Sum_probs=197.7
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHh--CCCCCcceeeEEEcCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL--LRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~--L~HpnIv~l~~v~~~~~~~~ 98 (556)
..++|++++.||+|+||.||+|.+ +++.||||++.. .....+.+|..++.. ++||||+++++++.... ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~ 77 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HS 77 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TT
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecc-----ccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CC
Confidence 346899999999999999999987 689999999864 233456677777777 78999999999865322 34
Q ss_pred CceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCcEeecCCCceEEee
Q 008729 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH--------TANVYHRDLKPKNILANANCKLKVCD 169 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLH--------s~gIvHrDLKP~NILl~~~~~vKL~D 169 (556)
...+|+||||++ |+|.++++. ..+++..+..++.||+.||+||| +.||+||||||+|||++.++.+||+|
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred CceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence 567899999998 699999954 57999999999999999999999 99999999999999999999999999
Q ss_pred eCccccccCCCCCc-ceecccccCcccCCcccccccCC----CCCCcchhhhHHHHHHHHHhC----------CCCCCCC
Q 008729 170 FGLARVAFSDTPMT-VFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTG----------KPLFPGK 234 (556)
Q Consensus 170 FGla~~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~----~y~~~~DIWSlG~ilyelltG----------~~pF~~~ 234 (556)
||+|+......... ......+||+.|+|||++.+... .++.++|||||||++|+|++| ..||.+.
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997654332221 11234579999999999876211 355789999999999999999 8888653
Q ss_pred ChHH-HHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 235 SVVH-QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 235 ~~~~-~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... ....+... ..........+........++.+.+||++||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 237 VPNDPSFEDMRKV--------------------VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp SCSSCCHHHHHHH--------------------HTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCcchhhhhHH--------------------HhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 2111 01111000 0000001111100011224578999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=369.21 Aligned_cols=255 Identities=14% Similarity=0.168 Sum_probs=201.8
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCC--------CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCccee------
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHT--------GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI------ 87 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~t--------g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l------ 87 (556)
.++|++++.||+|+||.||+|.+..+ ++.||||++... ..+.+|+.+|+.++||||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 57999999999999999999999884 889999998742 357799999999999999984
Q ss_pred ---------eEEEcCCCCCCCceEEEEEecCcccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 008729 88 ---------KRIMLPPSKREFKDIYVVFELMESDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (556)
Q Consensus 88 ---------~~v~~~~~~~~~~~lylV~E~~~g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (556)
++++. .....+|+|||||+++|.+++... ..+++..+..|+.||+.||.|||++||+||||||+|
T Consensus 114 ~~~~~i~~~~~~~~----~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~N 189 (352)
T 2jii_A 114 TPLLAIPTCMGFGV----HQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAEN 189 (352)
T ss_dssp CTTCSCCCCCEEEE----ETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGG
T ss_pred CCccCccchhhccc----cCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHH
Confidence 44442 234679999999988999999986 789999999999999999999999999999999999
Q ss_pred EeecCCC--ceEEeeeCccccccCCCCC----cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCC
Q 008729 157 ILANANC--KLKVCDFGLARVAFSDTPM----TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 230 (556)
Q Consensus 157 ILl~~~~--~vKL~DFGla~~~~~~~~~----~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~p 230 (556)
||++.++ .+||+|||+++........ ........||+.|+|||++.+ ..++.++|||||||+||+|++|+.|
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999998 8999999999765332211 111234579999999999987 6799999999999999999999999
Q ss_pred CCCCC-hHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCC--CCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCH
Q 008729 231 FPGKS-VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPP--VPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307 (556)
Q Consensus 231 F~~~~-~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~--~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta 307 (556)
|.+.. ....+.... ........ ......+..+++.+.+||.+||..||.+|||+
T Consensus 268 f~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 324 (352)
T 2jii_A 268 WTNCLPNTEDIMKQK-----------------------QKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPY 324 (352)
T ss_dssp TGGGTTCHHHHHHHH-----------------------HHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCH
T ss_pred cccCCcCHHHHHHHH-----------------------HhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCH
Confidence 98754 222211110 00111100 01111224578999999999999999999999
Q ss_pred HHHHh
Q 008729 308 EEALA 312 (556)
Q Consensus 308 ~elL~ 312 (556)
+++++
T Consensus 325 ~~l~~ 329 (352)
T 2jii_A 325 AMLRN 329 (352)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=354.96 Aligned_cols=254 Identities=23% Similarity=0.345 Sum_probs=204.5
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCC---cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
..+|++.+.||+|+||.||+|.+..++ ..||+|++... ........+.+|+.+|+.++||||+++++++. ..
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----~~ 98 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RS 98 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC----CS
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE----cC
Confidence 347999999999999999999976443 36899998752 44456678899999999999999999999864 33
Q ss_pred CceEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
....|+||||++ ++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 456899999999 599999986 446899999999999999999999999999999999999999999999999999765
Q ss_pred cCCCC-CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 177 FSDTP-MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 177 ~~~~~-~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
..... .........||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~--------- 247 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ--------- 247 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHT---------
T ss_pred cccchhccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhc---------
Confidence 33221 1112245568889999999987 679999999999999999999 6788887765554433321
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
... ......+++.+.+||.+||..||.+|||++++++
T Consensus 248 ------------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 248 ------------------GRR---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp ------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCC---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 1112357889999999999999999999999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=385.32 Aligned_cols=249 Identities=22% Similarity=0.412 Sum_probs=210.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
..+|++.+.||+|+||.||+|.++.++..||||++.... .....+.+|+.+|+.++||||+++++++ .....
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~-----~~~~~ 290 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPP 290 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSS
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEE-----ecCCc
Confidence 357999999999999999999999999999999987532 2356788999999999999999999999 44566
Q ss_pred EEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
+|||||||. |+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 899999999 7999999864 4589999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
... .......++..|+|||++.+ ..|+.++|||||||+||||++ |..||.+.+..+....+..
T Consensus 371 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~------------ 434 (495)
T 1opk_A 371 DTY--TAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------------ 434 (495)
T ss_dssp CCE--ECCTTCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT------------
T ss_pred Cce--eecCCCcCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------
Confidence 221 11234456788999999987 679999999999999999999 9999998876554443321
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
... ......+++.+.+||.+||..||++|||+.++++
T Consensus 435 ---------------~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 435 ---------------DYR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ---------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCC---CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 111 1223468899999999999999999999999986
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=353.00 Aligned_cols=253 Identities=26% Similarity=0.371 Sum_probs=205.0
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCc---EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
+|++.++||+|+||.||+|.+..+++ .||+|++... ........+.+|+.+|+.++||||+++++++... ..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~ 96 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP----EG 96 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----SS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC----CC
Confidence 68889999999999999999766554 7999998752 3445667889999999999999999999999532 23
Q ss_pred eEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 101 DIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
..|+||||+. ++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred CcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 3599999997 799999987 45689999999999999999999999999999999999999999999999999975432
Q ss_pred CCC-CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 179 DTP-MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 179 ~~~-~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
... .........+++.|+|||.+.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~----------- 243 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ----------- 243 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT-----------
T ss_pred CcccccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc-----------
Confidence 211 1111234568899999999987 678999999999999999999 5566766665544433321
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
... ......+++.+.+||++||..||.+|||++++++.
T Consensus 244 ----------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 244 ----------------GRR---LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp ----------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCC---CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 111 11224578999999999999999999999999873
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=352.34 Aligned_cols=248 Identities=28% Similarity=0.390 Sum_probs=205.7
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC-------
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS------- 95 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~------- 95 (556)
++|++++.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.+++.++||||+++++++....
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 47999999999999999999999999999999987431 24668999999999999999999874311
Q ss_pred ----CCCCceEEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEe
Q 008729 96 ----KREFKDIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (556)
Q Consensus 96 ----~~~~~~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~ 168 (556)
......+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 122456899999999 5999999764 579999999999999999999999999999999999999999999999
Q ss_pred eeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC
Q 008729 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (556)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g 248 (556)
|||++........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .
T Consensus 165 Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~---------- 226 (284)
T 2a19_B 165 DFGLVTSLKNDGK----RTRSKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAFETS--K---------- 226 (284)
T ss_dssp CCTTCEESSCCSC----CCCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--H----------
T ss_pred cchhheecccccc----ccccCCcccccChhhhcc--CCCcchhhhHHHHHHHHHHHhcCCcchhHH--H----------
Confidence 9999987544322 234569999999999987 678999999999999999999998873211 0
Q ss_pred CCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
.+..+.... ....++..+.+||.+||..||.+|||+.++++|.|.-
T Consensus 227 -----------------~~~~~~~~~------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 227 -----------------FFTDLRDGI------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp -----------------HHHHHHTTC------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----------------HHHHhhccc------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011111111 1235789999999999999999999999999998764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=361.65 Aligned_cols=262 Identities=23% Similarity=0.392 Sum_probs=205.1
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||.||+|.+..+|+.||||++.. ........+.+|+.+++.++||||+++++++.... ....
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCc
Confidence 45689999999999999999999999999999998864 34456677889999999999999999999985321 2345
Q ss_pred eEEEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 101 DIYVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
.+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 7899999999 599999875 46799999999999999999999999999999999999999999999999999875
Q ss_pred ccCCCCCc------ceecccccCcccCCccccccc-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhC
Q 008729 176 AFSDTPMT------VFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248 (556)
Q Consensus 176 ~~~~~~~~------~~~~~~~gt~~Y~APE~~~~~-~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g 248 (556)
........ ..+....||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--------- 254 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--------- 254 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS---------
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc---------
Confidence 42211100 011345689999999998652 12368899999999999999999999943110000
Q ss_pred CCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 249 ~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.. .......... ...+.+++.+.+||.+||..||.+|||+++++++
T Consensus 255 -------------~~---~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 255 -------------SV---ALAVQNQLSI---PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -------------CH---HHHHHCC--C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------hh---hHHhhccCCC---CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 00 0001111111 1234688999999999999999999999999986
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=351.47 Aligned_cols=244 Identities=25% Similarity=0.415 Sum_probs=197.9
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||.||+|.+. |+.||||++... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~ 88 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKG 88 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--
T ss_pred ChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCC
Confidence 4568999999999999999999874 889999998743 245678899999999999999999998743 334
Q ss_pred eEEEEEecCc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 101 DIYVVFELME-SDLHQVIKANDD--LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~--l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
.+|+||||++ ++|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 6899999998 599999986543 8999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
... ....+++.|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+....+.
T Consensus 169 ~~~------~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~------------ 228 (278)
T 1byg_A 169 STQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE------------ 228 (278)
T ss_dssp -------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT------------
T ss_pred ccc------cCCCccccccCHHHhCC--CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh------------
Confidence 221 23357889999999977 678999999999999999998 999998876554443321
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
... .......+++.+.+||++||..||.+|||+.++++
T Consensus 229 ---------------~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 229 ---------------KGY---KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp ---------------TTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------cCC---CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 111 11223568899999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=356.11 Aligned_cols=238 Identities=27% Similarity=0.447 Sum_probs=190.5
Q ss_pred CCCCeEEE-eeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHH-HhCCCCCcceeeEEEcCCCCCC
Q 008729 21 DANRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL-RLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 21 ~~~~Y~i~-~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL-~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
..++|.++ +.||+|+||.||+|.+..+++.||||++.. ...+.+|+.++ +.++||||+++++++.... ..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~ 86 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-AG 86 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TT
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhc-CC
Confidence 33578888 789999999999999999999999999863 13566899988 6668999999999984311 23
Q ss_pred CceEEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC---CCceEEeeeCc
Q 008729 99 FKDIYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGL 172 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~vKL~DFGl 172 (556)
...+|+|||||. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 87 RKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred CceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 567999999998 59999998764 6999999999999999999999999999999999999998 78899999998
Q ss_pred cccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
+.... + ..|+.++|||||||++|+|++|+.||.+.+.......+
T Consensus 167 a~~~~-------------------------~--~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~--------- 210 (299)
T 3m2w_A 167 AKETT-------------------------G--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--------- 210 (299)
T ss_dssp CEECT-------------------------T--CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS---------
T ss_pred ccccc-------------------------c--ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH---------
Confidence 85421 1 35788999999999999999999999776532211100
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcC----CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLF----QKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~----~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
......... ..+..+++.+.+||.+||..||.+|||++|+|+||||++..
T Consensus 211 ------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 211 ------------------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp ------------------CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred ------------------HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 000000000 11146899999999999999999999999999999998654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=350.80 Aligned_cols=247 Identities=25% Similarity=0.376 Sum_probs=205.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||+|+||.||+|.+. ++..||||++..... ....+.+|+.+|+.++||||+++++++.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~ 81 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EP 81 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SS
T ss_pred HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcC------CC
Confidence 468999999999999999999975 567899999874322 34578899999999999999999999832 34
Q ss_pred EEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 102 IYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
+|+||||+. ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 799999997 69999997543 699999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... ......++..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+..
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~------------ 225 (279)
T 1qpc_A 162 NEYT--AREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------ 225 (279)
T ss_dssp SCEE--CCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT------------
T ss_pred cccc--cccCCCCccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhc------------
Confidence 2211 1234457889999999976 678999999999999999999 9999998776554443321
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
... ......+++.+.+||.+||..||++|||++++++
T Consensus 226 ---------------~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 226 ---------------GYR---MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ---------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------ccC---CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 101 1122468899999999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=354.25 Aligned_cols=256 Identities=22% Similarity=0.334 Sum_probs=200.3
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECC-CCc--EEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTH-TGE--KVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~-tg~--~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (556)
-..++|++++.||+|+||.||+|.+.. +++ .||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 93 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 93 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC-
Confidence 345689999999999999999998643 333 68999886432 2334567889999999999999999999998532
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcc
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla 173 (556)
..|+||||+. ++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 94 -----~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 94 -----PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp -----SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred -----CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccc
Confidence 2799999998 6999999764 57999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
.................+|..|+|||++.+ ..++.++|||||||++|+|++ |+.||.+.+..+.+..+..
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------- 239 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK------- 239 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-------
T ss_pred ccccccccchhhhccCCCCceeeCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHc-------
Confidence 876443332222334568889999999977 678999999999999999999 9999998876554443321
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... ......++..+.+||.+||..||.+|||+.++++
T Consensus 240 -------------------~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 240 -------------------EGER---LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp -------------------SCCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------cCCC---CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1111 1123468899999999999999999999999997
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=375.56 Aligned_cols=244 Identities=25% Similarity=0.413 Sum_probs=203.9
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||.||+|.+. |+.||||+++... ....+.+|+.+|+.++||||+++++++.. ...
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~ 260 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKG 260 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TTS
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEc----CCC
Confidence 4468999999999999999999875 7899999997532 34578899999999999999999999743 234
Q ss_pred eEEEEEecCc-ccHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 101 DIYVVFELME-SDLHQVIKANDD--LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~--l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
.+|||||||. |+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 6999999998 699999987553 7999999999999999999999999999999999999999999999999998543
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
... ....++..|+|||++.+ ..++.++|||||||+||||++ |+.||.+.+..+....+..
T Consensus 341 ~~~------~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~----------- 401 (450)
T 1k9a_A 341 STQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----------- 401 (450)
T ss_dssp ------------CCCTTTSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT-----------
T ss_pred ccc------cCCCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----------
Confidence 211 22357889999999987 689999999999999999998 9999988776554443321
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
... ......+++.+.+||.+||..||.+|||+.++++
T Consensus 402 ----------------~~~---~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 402 ----------------GYK---MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ----------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------CCC---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111 1123468899999999999999999999999975
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=368.65 Aligned_cols=264 Identities=22% Similarity=0.304 Sum_probs=206.8
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+.+|+.++||||+++++++ .+..
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~ 108 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFC-----DERN 108 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-----CCTT
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCC
Confidence 4578999999999999999999964 6899999988753 334566788999999999999999999998 4556
Q ss_pred eEEEEEecCc-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 101 DIYVVFELME-SDLHQVIKAND----DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~----~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
.+|+|||||+ ++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 7899999998 69999886543 589999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+..
T Consensus 189 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~---------- 255 (321)
T 2qkw_B 189 GTELDQT-HLSTVVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW---------- 255 (321)
T ss_dssp CSSSSCC-CCBCCCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH----------
T ss_pred ccccccc-ccccccCCCccccCHHHhcC--CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH----------
Confidence 4322211 11244569999999999877 6799999999999999999999999976543221111100
Q ss_pred HHhhhHHHHHHHHHhhcCC-CC----C-cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 008729 256 AVVRNEKARKYLTEMRKKP-PV----P-LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~-~~----~-~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~ 315 (556)
. ........ .. . .....+..+..+.+|+.+||..||++|||+.++++|..
T Consensus 256 ---~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 256 ---A-------VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp ---T-------HHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ---h-------hhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 0 00000000 00 0 00111234567899999999999999999999998643
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=377.17 Aligned_cols=279 Identities=21% Similarity=0.313 Sum_probs=205.5
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++.++||+|+||.||+|++..+|+.||||++.... .......+.+|+.+|+.++||||+++++++... ...
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~ 82 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTR 82 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTC
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCC
Confidence 3468999999999999999999999999999999997432 122345678999999999999999999998542 234
Q ss_pred eEEEEEecCc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee----cCCCceEEeeeCc
Q 008729 101 DIYVVFELME-SDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA----NANCKLKVCDFGL 172 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl----~~~~~vKL~DFGl 172 (556)
.+|+|||||. ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~ 162 (396)
T 4eut_A 83 HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA 162 (396)
T ss_dssp CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence 6899999998 69999997643 39999999999999999999999999999999999999 7788899999999
Q ss_pred cccccCCCCCcceecccccCcccCCccccccc------CCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh----HHHHHH
Q 008729 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSF------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV----VHQLDL 242 (556)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~------~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~----~~~~~~ 242 (556)
++...... .....+||+.|+|||++.+. ...|+.++|||||||++|+|++|+.||.+... .+.+..
T Consensus 163 a~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~ 238 (396)
T 4eut_A 163 ARELEDDE----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYK 238 (396)
T ss_dssp CEECCCGG----GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHH
T ss_pred ceEccCCC----ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHH
Confidence 98653322 12456799999999987531 03577899999999999999999999965332 222222
Q ss_pred HHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 243 ITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 243 i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
+. .+.|.. .+..+...... .+. ..............++..+.+||++||+.||++|||+++++++
T Consensus 239 ~~--~~~p~~-~~~~~~~~~~~-~~~--~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 239 II--TGKPSG-AISGVQKAENG-PID--WSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HH--HSCCTT-CCEEEECSTTC-CEE--EESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred Hh--cCCCcc-cchhheeccCC-Ccc--cCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 21 122211 10000000000 000 0000000001112345678999999999999999999998664
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=390.51 Aligned_cols=251 Identities=20% Similarity=0.297 Sum_probs=205.0
Q ss_pred CeEEE-eeeeecCceeEEEEEE--CCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 24 RYKIL-EVIGKGSYGVVCAAID--THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 24 ~Y~i~-~~LG~G~~g~V~~a~~--~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.+.+. +.||+|+||.||+|.+ +.+++.||||+++...........+.+|+.+|+.|+|||||++++++.. .
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~ 442 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------E 442 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------S
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------C
Confidence 34443 4899999999999954 4667899999998655555556789999999999999999999999832 3
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|||||||. |+|.+++..++.+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 443 ~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 443 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred CEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 4799999998 699999999889999999999999999999999999999999999999999999999999999876443
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
...........+|+.|+|||++.+ ..|+.++|||||||+||||++ |+.||.+.+..+....+..
T Consensus 523 ~~~~~~~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~------------- 587 (635)
T 4fl3_A 523 ENYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK------------- 587 (635)
T ss_dssp ------------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-------------
T ss_pred ccccccccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------------
Confidence 322222334557889999999977 689999999999999999998 9999999887655544422
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
... ......+++.+.+||.+||..||++|||++++++
T Consensus 588 --------------~~~---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 588 --------------GER---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp --------------TCC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------CCC---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 111 1123468899999999999999999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=360.91 Aligned_cols=268 Identities=22% Similarity=0.332 Sum_probs=207.3
Q ss_pred CCe-EEEeeeeecCceeEEEEE----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 23 NRY-KILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 23 ~~Y-~i~~~LG~G~~g~V~~a~----~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
++| ++++.||+|+||.||+|. +..+++.||||++... ........+.+|+.+|+.++||||+++++++...
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--- 105 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA--- 105 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---
Confidence 455 999999999999998775 4458899999999754 3445567789999999999999999999998542
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
....+|+||||+. ++|.+++... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 2467999999998 6999999765 4999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
..............||..|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+......
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~-----~~~~~~~~~~~~-- 255 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKE--YKFYYASDVWSFGVTLYELLTHCDSSQSPPTK-----FLELIGIAQGQM-- 255 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-----HHHHHCSCCHHH--
T ss_pred cccccccccccCCCCCceeeChHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCcccccchh-----hhhhhcccccch--
Confidence 544332222345668899999999987 67889999999999999999999999653221 111111111110
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
........+...... .....+++.+.+||++||..||++|||++++++
T Consensus 256 -----~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 256 -----TVLRLTELLERGERL---PRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp -----HHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----hHHHHHHHHhcccCC---CCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 011111222222221 223568899999999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=378.20 Aligned_cols=247 Identities=25% Similarity=0.374 Sum_probs=205.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++.+.||+|+||.||+|.+. ++..||||++.... .....+.+|+.+|+.++||||+++++++. ...
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~ 256 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEP 256 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCc
Confidence 358999999999999999999985 46789999997532 23567889999999999999999999983 235
Q ss_pred EEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
+|||||||. |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 899999998 6999999754 3689999999999999999999999999999999999999999999999999986532
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
... .......++..|+|||++.. ..|+.++|||||||+||||++ |+.||.+.+..+.+..+....
T Consensus 337 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~---------- 402 (454)
T 1qcf_A 337 NEY--TAREGAKFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY---------- 402 (454)
T ss_dssp HHH--HTTCSSSSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC----------
T ss_pred Cce--eccCCCcccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC----------
Confidence 111 11123446788999999976 679999999999999999999 999999888666554442211
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.. .....+++.+.+||.+||..||++|||++++++
T Consensus 403 -----------------~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 403 -----------------RM---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp -----------------CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------CC---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 11 112468899999999999999999999999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=380.07 Aligned_cols=255 Identities=18% Similarity=0.202 Sum_probs=196.9
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCC-CCc---------ceeeEEE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRH-PDI---------VEIKRIM 91 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~H-pnI---------v~l~~v~ 91 (556)
..|++.+.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+++.+.| .|+ +...++.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 34899999999999999999999999999999987322 222235678899999999987 321 1111111
Q ss_pred ------------cCCCCCCCceEEEEEecCcccHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 008729 92 ------------LPPSKREFKDIYVVFELMESDLHQVIKA-------NDDLTREHHQFFLYQMLRALKYMHTANVYHRDL 152 (556)
Q Consensus 92 ------------~~~~~~~~~~lylV~E~~~g~L~~~i~~-------~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDL 152 (556)
..........+|++|+++.++|.+++.. ...+++..+..++.||+.||+|||++||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 1111111345899999999999998852 234778888999999999999999999999999
Q ss_pred CCCcEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccc--------cCCCCCCcchhhhHHHHHHHH
Q 008729 153 KPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS--------FFSKYTPAIDIWSIGCIFAEV 224 (556)
Q Consensus 153 KP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--------~~~~y~~~~DIWSlG~ilyel 224 (556)
||+|||++.++.+||+|||+++..... ....+| +.|+|||++.+ ....|+.++|||||||++|+|
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 999999999999999999998764322 245678 99999999831 114688899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 008729 225 LTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR 304 (556)
Q Consensus 225 ltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~R 304 (556)
++|+.||.+.+...... ........+++.+.+||.+||..||++|
T Consensus 311 ltg~~Pf~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~R 355 (413)
T 3dzo_A 311 WCADLPNTDDAALGGSE-----------------------------------WIFRSCKNIPQPVRALLEGFLRYPKEDR 355 (413)
T ss_dssp HHSSCCCCTTGGGSCSG-----------------------------------GGGSSCCCCCHHHHHHHHHHTCSSGGGS
T ss_pred HHCCCCCCCcchhhhHH-----------------------------------HHHhhcccCCHHHHHHHHHHccCChhhC
Confidence 99999998765322111 1122334688999999999999999999
Q ss_pred CCHHHHHhCcccccc
Q 008729 305 PTAEEALADPYFKGL 319 (556)
Q Consensus 305 pta~elL~hp~f~~~ 319 (556)
||+.++|+||||+.+
T Consensus 356 pt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 356 LLPLQAMETPEYEQL 370 (413)
T ss_dssp CCHHHHTTSHHHHHH
T ss_pred cCHHHHHhCHHHHHH
Confidence 999999999999753
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=352.97 Aligned_cols=244 Identities=30% Similarity=0.440 Sum_probs=194.8
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
+.++|++.+.||+|+||.||+|.+. ++.||||++.. ......+.+|+.+|+.++||||+++++++. .
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~ 72 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACL-------N 72 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-------T
T ss_pred CHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------C
Confidence 3458999999999999999999874 78999999863 235567889999999999999999999874 2
Q ss_pred eEEEEEecCc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCCCcEeecCCCc-eEEeeeCc
Q 008729 101 DIYVVFELME-SDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHT---ANVYHRDLKPKNILANANCK-LKVCDFGL 172 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~QIl~aL~yLHs---~gIvHrDLKP~NILl~~~~~-vKL~DFGl 172 (556)
.+|+||||++ ++|.+++.... .++...+..++.||+.||.|||+ +||+||||||+|||++.++. +||+|||+
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~ 152 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT 152 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC
T ss_pred CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccc
Confidence 3799999998 69999998765 37899999999999999999999 89999999999999998886 79999999
Q ss_pred cccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .+
T Consensus 153 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~--------- 214 (307)
T 2eva_A 153 ACDIQTH------MTNNKGSAAWMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IM--------- 214 (307)
T ss_dssp ------------------CCTTSSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HH---------
T ss_pred ccccccc------cccCCCCCceEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HH---------
Confidence 9754322 134469999999999987 68999999999999999999999999764322110 00
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
........ ......+++.+.+||.+||..||.+|||+++++++
T Consensus 215 ---------------~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 215 ---------------WAVHNGTR---PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp ---------------HHHHTTCC---CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------HHHhcCCC---CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 00111111 12235688999999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=364.95 Aligned_cols=270 Identities=21% Similarity=0.295 Sum_probs=204.6
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
...++|++.+.||+|+||.||+|.+ .+|+.||||++..... ......+.+|+.+|+.++||||+++++++ ...
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~ 99 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLRGFC-----MTP 99 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEE-----CCS
T ss_pred HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceEEEE-----ecC
Confidence 3557899999999999999999975 4689999999874321 11223588999999999999999999999 445
Q ss_pred ceEEEEEecCc-ccHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCcEeecCCCceEEeeeC
Q 008729 100 KDIYVVFELME-SDLHQVIKAND----DLTREHHQFFLYQMLRALKYMHTA---NVYHRDLKPKNILANANCKLKVCDFG 171 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~~----~l~~~~~~~i~~QIl~aL~yLHs~---gIvHrDLKP~NILl~~~~~vKL~DFG 171 (556)
...|+|||||. ++|.+++.... .+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 179 (326)
T 3uim_A 100 TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179 (326)
T ss_dssp SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCS
T ss_pred CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCc
Confidence 56899999998 59999998643 499999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHh
Q 008729 172 LARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-----VVHQLDLITDL 246 (556)
Q Consensus 172 la~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~-----~~~~~~~i~~~ 246 (556)
+++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .....+.+...
T Consensus 180 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 180 LAKLMDYKDT--HVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp SCEECCSSSS--CEECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cccccCcccc--cccccccCCcCccCHHHhcc--CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9986543222 22345669999999999877 678999999999999999999999995211 11111111000
Q ss_pred hCCCChHHHHHhhhHHHHHHHHHhhcCCCCCc-CCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 247 LGTPSPETIAVVRNEKARKYLTEMRKKPPVPL-FQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 247 ~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
..... +........ .......+..+.+|+.+||+.||.+|||+.++++|-+-.+
T Consensus 256 ~~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 256 LKEKK------------------LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TSSCC------------------STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hhchh------------------hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 00000 000000000 0011123467899999999999999999999999866443
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=366.56 Aligned_cols=254 Identities=22% Similarity=0.337 Sum_probs=197.6
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCC---cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
.+|++.+.||+|+||.||+|.+..++ ..||+|.+... ........+.+|+.+|+.++||||+++++++. ...
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~----~~~ 163 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICL----RSE 163 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEEC----CCS
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEE----cCC
Confidence 36899999999999999999876433 46899988753 34456778999999999999999999999874 233
Q ss_pred ceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 100 KDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
...|+|||||+ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 164 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 164 GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 56899999998 5999999865 458999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCC-cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 178 SDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 178 ~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
..... ........+|+.|+|||++.+ ..++.++|||||||++|+|++ |.+||.+.+..+....+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~---------- 311 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---------- 311 (373)
T ss_dssp --------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT----------
T ss_pred ccccccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc----------
Confidence 32211 111234567889999999987 689999999999999999999 7899987765444333211
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
... ......+++.+.+||.+||..||++|||+++++++
T Consensus 312 -----------------~~~---~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 312 -----------------GRR---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp -----------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------CCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 110 11124578999999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=364.38 Aligned_cols=246 Identities=15% Similarity=0.191 Sum_probs=196.1
Q ss_pred CCCeEEEeeeeecCceeEEEE-----EECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC---CCCcceeeEEEcC
Q 008729 22 ANRYKILEVIGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIVEIKRIMLP 93 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a-----~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~---HpnIv~l~~v~~~ 93 (556)
.++|++.+.||+|+||+||+| .+..+++.||||++... ....+.+|+.+++.++ |+||+.+++++
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~-- 136 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAH-- 136 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE--
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheee--
Confidence 467999999999999999999 47788999999998742 2345678888888887 99999999999
Q ss_pred CCCCCCceEEEEEecCc-ccHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC------
Q 008729 94 PSKREFKDIYVVFELME-SDLHQVIKA-----NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA------ 161 (556)
Q Consensus 94 ~~~~~~~~lylV~E~~~-g~L~~~i~~-----~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~------ 161 (556)
......|||||||+ |+|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 137 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 ---LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ---ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred ---ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 44566899999998 799999974 567999999999999999999999999999999999999998
Q ss_pred -----CCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCCh
Q 008729 162 -----NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV 236 (556)
Q Consensus 162 -----~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~ 236 (556)
++.+||+|||+|+....... .......+||+.|+|||++.+ ..|+.++||||||||+|+|++|+.||.....
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPK-GTIFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCT-TEEECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred ccccccCCEEEeeCchhhhhhccCC-CceeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 89999999999976432222 223466789999999999988 6799999999999999999999999954321
Q ss_pred HHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcc
Q 008729 237 VHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315 (556)
Q Consensus 237 ~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~ 315 (556)
... . ....... ...++.+.+++.+||..+|.+|++..+.|.+.+
T Consensus 291 ~~~-------------------------------~---~~~~~~~-~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l 334 (365)
T 3e7e_A 291 GEC-------------------------------K---PEGLFRR-LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334 (365)
T ss_dssp TEE-------------------------------E---ECSCCTT-CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHH
T ss_pred Cce-------------------------------e---echhccc-cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHH
Confidence 100 0 0000001 124677899999999999999976655555433
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=375.96 Aligned_cols=258 Identities=19% Similarity=0.251 Sum_probs=204.0
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|+++++||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.|+|++++..+..+. .....
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~----~~~~~ 77 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFG----VEGDY 77 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEE----EETTE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEE----eeCCE
Confidence 46899999999999999999999999999999987643222 24778999999998755554444442 34567
Q ss_pred EEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee---cCCCceEEeeeCcccccc
Q 008729 102 IYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA---NANCKLKVCDFGLARVAF 177 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl---~~~~~vKL~DFGla~~~~ 177 (556)
.|||||||+++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+++...
T Consensus 78 ~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 78 NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp EEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred EEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 899999999999999985 5679999999999999999999999999999999999999 688999999999998754
Q ss_pred CCCCCc----ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 178 SDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 178 ~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
...... ......+||+.|+|||++.+ ..++.++||||||||||+|++|+.||.+.........+...
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i------- 228 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI------- 228 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH-------
T ss_pred CCccccccccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHH-------
Confidence 433211 11235679999999999988 68999999999999999999999999886543332222111
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
........+. .....++.++.+||.+||..||++||++++|++
T Consensus 229 -----~~~~~~~~~~-----------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 229 -----SEKKVATSIE-----------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp -----HHHHHHSCHH-----------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred -----hhccccccHH-----------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0011111111 111357899999999999999999999998875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=358.51 Aligned_cols=274 Identities=21% Similarity=0.269 Sum_probs=195.0
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHH--HHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILR--EVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~r--Ei~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
..++|++++.||+|+||.||+|.+ +++.||||++... ....+.. |+..+..++||||+++++.+.......
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccccCC
Confidence 456999999999999999999976 6899999998632 1223333 444455689999999998665433355
Q ss_pred CceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeccCCCCcEeecCCCceEEe
Q 008729 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA---------NVYHRDLKPKNILANANCKLKVC 168 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~---------gIvHrDLKP~NILl~~~~~vKL~ 168 (556)
...+|+|||||+ |+|.+++.... +++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred CceEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 567899999997 69999997654 58999999999999999999999 99999999999999999999999
Q ss_pred eeCccccccCCCC-----CcceecccccCcccCCcccccccC-----CCCCCcchhhhHHHHHHHHHhCCCC-CCCCChH
Q 008729 169 DFGLARVAFSDTP-----MTVFWTDYVATRWYRAPELCGSFF-----SKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVV 237 (556)
Q Consensus 169 DFGla~~~~~~~~-----~~~~~~~~~gt~~Y~APE~~~~~~-----~~y~~~~DIWSlG~ilyelltG~~p-F~~~~~~ 237 (556)
|||+++....... ........+||+.|+|||++.+.. ..++.++|||||||++|+|++|..| |++....
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999986543211 111223567999999999986521 2456789999999999999999654 4444322
Q ss_pred HHHHHHHH-hhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCC---CCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 238 HQLDLITD-LLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFP---NVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 238 ~~~~~i~~-~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~---~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.....+.. ....|..+.+. .... .......+...+. .+++.+.+||.+||..||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~--------~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQ--------VLVS--REKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHH--------HHHT--TSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHH--------hhhc--ccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 21111111 11222221111 1111 1111111112222 24568999999999999999999999954
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=373.07 Aligned_cols=247 Identities=26% Similarity=0.368 Sum_probs=200.8
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++.+.||+|+||.||+|.+.. +..||||++..... ....+.+|+.+|+.++||||+++++++. + ..
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~-~~ 252 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EP 252 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SS
T ss_pred hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEc-----C-Cc
Confidence 4579999999999999999999875 46799999875322 2456889999999999999999999983 2 45
Q ss_pred EEEEEecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 102 IYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
+|||||||. |+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 899999998 699999964 35699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... ......++..|+|||++.+ ..++.++|||||||+||+|++ |+.||.+.+..+.+..+..
T Consensus 333 ~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~------------ 396 (452)
T 1fmk_A 333 NEYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------------ 396 (452)
T ss_dssp ------------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT------------
T ss_pred Ccee--cccCCcccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------
Confidence 2211 1133457788999999877 679999999999999999999 9999998876655544321
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... ...+.+++.+.+||.+||..||++|||++++++
T Consensus 397 ---------------~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 397 ---------------GYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp ---------------TCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------CCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1111 122468899999999999999999999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=352.73 Aligned_cols=271 Identities=21% Similarity=0.363 Sum_probs=210.2
Q ss_pred CCCCeEEEeeeeecCceeEEEEE----ECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAI----DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~----~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
..++|++++.||+|+||.||+|. +..+|+.||||++.. ........+.+|+.+|+.++||||+++++++...
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 114 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA-- 114 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS--CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec--
Confidence 34679999999999999999998 467899999999875 3345567789999999999999999999998542
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
+...+|+||||++ ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 115 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 115 -GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred -CCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 2346899999998 5999999876 469999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
................++..|+|||++.+ ..++.++|||||||++|+|++|..||.... ..+.+..+......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~~~-----~~~~~~~~~~~~~~ 266 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKSPP-----AEFMRMIGNDKQGQ 266 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGSHH-----HHHHHHHCTTCCTH
T ss_pred hccccccccccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCCCH-----HHHHHhhccccchh
Confidence 76443322222234557888999999987 678999999999999999999999986421 11122222221111
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
. ........+......+ ....+++.+.+||++||..||++|||+.++++
T Consensus 267 ~------~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 267 M------IVFHLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp H------HHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred h------hHHHHHHHhhcCCCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 0111112222222111 23568899999999999999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=352.77 Aligned_cols=268 Identities=21% Similarity=0.294 Sum_probs=205.7
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc--CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
+.....|...+.||+|+||.||+|.+ +++.||||++.... ........+.+|+.+|+.++||||+++++++
T Consensus 27 f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~----- 99 (307)
T 2nru_A 27 FDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS----- 99 (307)
T ss_dssp TCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred cccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEE-----
Confidence 33444567779999999999999975 68899999987532 2334566788999999999999999999999
Q ss_pred CCCceEEEEEecCc-ccHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKA---NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~---~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGl 172 (556)
.+...+|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~ 179 (307)
T 2nru_A 100 SDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGL 179 (307)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTT
T ss_pred ecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 44566899999997 699999974 34699999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
++....... ........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......+..+.........
T Consensus 180 ~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 255 (307)
T 2nru_A 180 ARASEKFAQ-TVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEK 255 (307)
T ss_dssp CEECCSCSS-CEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSC
T ss_pred ccccccccc-cccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhh
Confidence 986543222 112234679999999999875 5889999999999999999999999876543322222211100000
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
. +...... .........+..+.+|+.+||..||.+|||+.+++++
T Consensus 256 ~-------------~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 256 T-------------IEDYIDK---KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp C-------------HHHHSCS---SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred h-------------hhhhccc---cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 0000000 0111112345678999999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=381.40 Aligned_cols=252 Identities=21% Similarity=0.334 Sum_probs=201.6
Q ss_pred CCCeEEEe-eeeecCceeEEEEEECC--CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 22 ANRYKILE-VIGKGSYGVVCAAIDTH--TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 22 ~~~Y~i~~-~LG~G~~g~V~~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
.++|.+.+ .||+|+||.||+|.+.. ++..||||+++.. ........+.+|+++|+.++||||+++++++..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~----- 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----- 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-----
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-----
Confidence 34667666 89999999999998763 5567999999754 223356678999999999999999999999842
Q ss_pred CceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
..+|||||||. |+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 34899999998 6999999754 46999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
..............+++.|+|||++.+ ..|+.++|||||||+||||++ |+.||.+.+..+....|..
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~---------- 554 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---------- 554 (613)
T ss_dssp C--------------CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT----------
T ss_pred cCCCceeeeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc----------
Confidence 433221111223346688999999977 689999999999999999998 9999998876655544421
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
... ......+++.+.+||.+||..||++|||++++++
T Consensus 555 -----------------~~~---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 555 -----------------GKR---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp -----------------TCC---CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred -----------------CCC---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111 1123468899999999999999999999999853
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=353.65 Aligned_cols=260 Identities=25% Similarity=0.333 Sum_probs=191.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC--CCCCcceeeEEEcCCCCCCCc
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL--RHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L--~HpnIv~l~~v~~~~~~~~~~ 100 (556)
++|++++.||+|+||.||+|.+. ++.||||++... ......+|..++..+ +||||+++++++.... ....
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~ 108 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWT 108 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGC
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCC
Confidence 58999999999999999999875 899999998532 233445566666554 8999999999985432 2236
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeccCCCCcEeecCCCceEEeeeC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA--------NVYHRDLKPKNILANANCKLKVCDFG 171 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~--------gIvHrDLKP~NILl~~~~~vKL~DFG 171 (556)
.+|+|||||+ ++|.++++.. .+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 7999999998 5999999765 699999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCCCC-cceecccccCcccCCcccccccCCCCCCc------chhhhHHHHHHHHHhC----------CCCCCCC
Q 008729 172 LARVAFSDTPM-TVFWTDYVATRWYRAPELCGSFFSKYTPA------IDIWSIGCIFAEVLTG----------KPLFPGK 234 (556)
Q Consensus 172 la~~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~~y~~~------~DIWSlG~ilyelltG----------~~pF~~~ 234 (556)
+++........ .......+||+.|+|||++.+ ..++.. +|||||||++|+|++| ..||...
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTT--CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CceeeccccccccCCCCCCccCcceeChhhccc--ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 99765433221 111235679999999999876 444444 9999999999999999 6666543
Q ss_pred ChHH-HHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 235 SVVH-QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 235 ~~~~-~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.... ....+ .............+.......+++.+.+||.+||+.||.+|||++++++|
T Consensus 266 ~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 266 VPSDPSYEDM--------------------REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp SCSSCCHHHH--------------------HHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cCCCCchhhh--------------------HHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 2110 00000 00000000001111100112356779999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=378.19 Aligned_cols=248 Identities=26% Similarity=0.363 Sum_probs=205.2
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++.+.||+|+||.||+|.+.. +..||||+++.... ....+.+|+.+|+.|+||||+++++++. + ..
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~-~~ 335 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-----E-EP 335 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SS
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEe-----e-cc
Confidence 4579999999999999999999875 46799999975322 2456889999999999999999999983 2 45
Q ss_pred EEEEEecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 102 IYVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
+|||||||. |+|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 899999998 699999964 34699999999999999999999999999999999999999999999999999976432
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.. ........++..|+|||++.+ ..|+.++|||||||+||||++ |+.||.+....+.+..+..
T Consensus 416 ~~--~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~------------ 479 (535)
T 2h8h_A 416 NE--YTARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------------ 479 (535)
T ss_dssp HH--HHTTCSTTSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT------------
T ss_pred Cc--eecccCCcCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc------------
Confidence 11 011123446788999999877 679999999999999999999 9999998876655544321
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.... .....++..+.+||.+||..||++|||++++++.
T Consensus 480 ---------------~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 480 ---------------GYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp ---------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1111 1224688999999999999999999999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=391.58 Aligned_cols=280 Identities=26% Similarity=0.352 Sum_probs=211.6
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC-CCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~~~ 101 (556)
++|++++.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+|+.++||||+++++++.... ......
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 6899999999999999999999999999999998753 34455677899999999999999999999875421 223567
Q ss_pred EEEEEecCc-ccHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCc---eEEeeeCccc
Q 008729 102 IYVVFELME-SDLHQVIKAND---DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCK---LKVCDFGLAR 174 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~---~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~---vKL~DFGla~ 174 (556)
.|+|||||. ++|.+++.... .+++..++.|+.||+.||+|||+.||+||||||+|||++.++. +||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 899999997 69999998754 6999999999999999999999999999999999999997765 9999999998
Q ss_pred cccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.......... ........
T Consensus 173 ~~~~~~~----~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~~ 243 (676)
T 3qa8_A 173 ELDQGEL----CTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNEH 243 (676)
T ss_dssp BTTSCCC----CCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTT---CC------
T ss_pred ccccccc----cccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhh---hhcccchh
Confidence 7543322 245679999999999987 68999999999999999999999999775432211000 00000000
Q ss_pred HHHhhhHHHHHHHHHhhcCCCC----C-cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccc
Q 008729 255 IAVVRNEKARKYLTEMRKKPPV----P-LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~----~-~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~ 321 (556)
+.. .......... + .......+++.+.+||++||.+||++|||++++|+||||+.+..
T Consensus 244 ~~~---------~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 244 IVV---------YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp CCS---------CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred hhh---------hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 000 0000000000 0 01122346788999999999999999999999999999987653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-44 Score=369.28 Aligned_cols=253 Identities=17% Similarity=0.178 Sum_probs=191.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC------ChhHHHHHHHHHHHHHhCC---------CCCcce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE------HISDAIRILREVKLLRLLR---------HPDIVE 86 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~------~~~~~~~~~rEi~iL~~L~---------HpnIv~ 86 (556)
.++|++++.||+|+||+||+|++ +|+.||||++..... .......+.+|+.+|+.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 46899999999999999999988 689999999975321 2233467889999998886 777777
Q ss_pred eeEEEcCCC-------------------------CCCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Q 008729 87 IKRIMLPPS-------------------------KREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALK 140 (556)
Q Consensus 87 l~~v~~~~~-------------------------~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~ 140 (556)
+++++.... ..+...+|||||||. |++.+.+.. +.+++..++.|++||+.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 777653110 112567999999997 555555543 57899999999999999999
Q ss_pred HHH-HCCceeccCCCCcEeecCCC--------------------ceEEeeeCccccccCCCCCcceecccccCcccCCcc
Q 008729 141 YMH-TANVYHRDLKPKNILANANC--------------------KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199 (556)
Q Consensus 141 yLH-s~gIvHrDLKP~NILl~~~~--------------------~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE 199 (556)
||| ++||+||||||+|||++.++ .+||+|||+|+.... ...+||+.|+|||
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~--------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD--------GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET--------TEEECCCCTTCSG
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC--------CcEEEeecccChh
Confidence 999 99999999999999999887 899999999987542 2347999999999
Q ss_pred cccccCCCCCCcchhhhHHHH-HHHHHhCCCCCCCCChHH-HHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCC
Q 008729 200 LCGSFFSKYTPAIDIWSIGCI-FAEVLTGKPLFPGKSVVH-QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVP 277 (556)
Q Consensus 200 ~~~~~~~~y~~~~DIWSlG~i-lyelltG~~pF~~~~~~~-~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~ 277 (556)
++.+ .. +.++||||||++ .+++++|..||.+..... ..+.+ +... ......
T Consensus 248 ~~~g--~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~-----------------------~~~~-~~~~~~ 300 (336)
T 2vuw_A 248 LFTG--DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKM-----------------------LKQM-TFKTKC 300 (336)
T ss_dssp GGCC--CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHH-----------------------HHTC-CCSSCC
T ss_pred hhcC--CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhh-----------------------hhhh-ccCccc
Confidence 9987 33 889999998777 888899999984321100 11111 1100 111111
Q ss_pred cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHH-hCcccc
Q 008729 278 LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL-ADPYFK 317 (556)
Q Consensus 278 ~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL-~hp~f~ 317 (556)
....++.+++++.+||++||++| |++|+| +||||+
T Consensus 301 ~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 301 NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 11122357889999999999987 999999 999995
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=351.56 Aligned_cols=254 Identities=20% Similarity=0.239 Sum_probs=200.3
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||.||+|.+.. .||+|++............+.+|+.+++.++||||+++++++. +..
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~ 102 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM-----SPP 102 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE-----CSS
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCC
Confidence 45789999999999999999998764 4999998754333334455778999999999999999999994 445
Q ss_pred eEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 101 DIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.+|+||||+. ++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 6999999998 69999998754 699999999999999999999999999999999999998 67999999999875421
Q ss_pred CC--CCcceecccccCcccCCccccccc-------CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC
Q 008729 179 DT--PMTVFWTDYVATRWYRAPELCGSF-------FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (556)
Q Consensus 179 ~~--~~~~~~~~~~gt~~Y~APE~~~~~-------~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~ 249 (556)
.. ..........||+.|+|||++.+. ...++.++|||||||++|+|++|+.||.+.........+..
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~---- 257 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT---- 257 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHT----
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc----
Confidence 11 111122345699999999998641 13578899999999999999999999988776544433311
Q ss_pred CChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
..... .....++..+.+||.+||..||.+|||++++++
T Consensus 258 -----------------------~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 258 -----------------------GMKPN--LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp -----------------------TCCCC--CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred -----------------------CCCCC--CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 11101 111257788999999999999999999999997
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-41 Score=375.10 Aligned_cols=250 Identities=26% Similarity=0.411 Sum_probs=205.4
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCC---CcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~t---g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
.++|++++.||+|+||.||+|.+..+ +..||||++... ........+.+|+.+|+.++||||+++++++..
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~----- 462 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE----- 462 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-----
Confidence 35799999999999999999998654 457999988643 334455678999999999999999999999832
Q ss_pred CceEEEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
..+|+|||||. |+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 463 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 463 -NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred -CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 34799999999 79999998654 6999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
...... ......+|+.|+|||++.+ ..|+.++|||||||++|+|++ |.+||.+.+..+.+..+...
T Consensus 542 ~~~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~--------- 608 (656)
T 2j0j_A 542 EDSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------- 608 (656)
T ss_dssp CC------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHT---------
T ss_pred CCCcce--eccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC---------
Confidence 432211 1233457889999999977 689999999999999999997 99999988776655444221
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
... ...+.+++.+.+||.+||..||.+|||+.++++
T Consensus 609 ------------------~~~---~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 609 ------------------ERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp ------------------CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------CCC---CCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 111 123468899999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=347.74 Aligned_cols=259 Identities=21% Similarity=0.254 Sum_probs=198.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHh--CCCCCcceeeEEEcCCCCCCCc
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL--LRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~--L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
++|++++.||+|+||.||+|.+ +|+.||||++.. .....+.+|+.+++. ++||||+++++++.... ....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-Cccc
Confidence 5899999999999999999987 589999999864 234567789999988 78999999999986443 2224
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeccCCCCcEeecCCCceEEeeeC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMH--------TANVYHRDLKPKNILANANCKLKVCDFG 171 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLH--------s~gIvHrDLKP~NILl~~~~~vKL~DFG 171 (556)
.+|+||||+. ++|.+++... .+++..+..++.||+.||.||| +.||+||||||+|||++.++.+||+|||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eeEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 7999999999 5999999764 6999999999999999999999 8999999999999999999999999999
Q ss_pred ccccccCCCCCc-ceecccccCcccCCcccccccCC----CCCCcchhhhHHHHHHHHHhC----------CCCCCCCCh
Q 008729 172 LARVAFSDTPMT-VFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTG----------KPLFPGKSV 236 (556)
Q Consensus 172 la~~~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~----~y~~~~DIWSlG~ilyelltG----------~~pF~~~~~ 236 (556)
++.......... .......||+.|+|||++.+... .++.++|||||||++|+|++| ..||.....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 997754433211 11245579999999999876211 233689999999999999999 778865431
Q ss_pred HH-HHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCC-CCcCCC--CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 237 VH-QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPP-VPLFQK--FPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 237 ~~-~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~-~~~~~~--~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.+ ....+ ...+..... ...... ...++..+.+||.+||..||++|||++++++
T Consensus 273 ~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 273 SDPSVEEM-----------------------RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp SSCCHHHH-----------------------HHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CcccHHHH-----------------------HHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 10 00011 001111111 011111 1123467899999999999999999999998
Q ss_pred C
Q 008729 313 D 313 (556)
Q Consensus 313 h 313 (556)
|
T Consensus 330 ~ 330 (342)
T 1b6c_B 330 T 330 (342)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=337.20 Aligned_cols=228 Identities=16% Similarity=0.095 Sum_probs=185.3
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCC-hhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|++++.||+|+||.||+|.+..+|+.||||++...... ......+.+|+.++..++||||+++++++ .+.+
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~ 104 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV-----HTRA 104 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----EETT
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE-----EECC
Confidence 46899999999999999999999999999999999754332 44557789999999999999999999998 4456
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+|||||+ ++|.++++. + ....++..|+.||+.||+|||++||+||||||+|||++.++.+||+++|
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred cEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence 7999999998 699999854 3 4667788999999999999999999999999999999999999998554
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
|++ .++.++|||||||++|+|++|+.||.+.+....+.....
T Consensus 175 ---------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~-------------- 216 (286)
T 3uqc_A 175 ---------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER-------------- 216 (286)
T ss_dssp ---------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCB--------------
T ss_pred ---------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHH--------------
Confidence 222 367899999999999999999999988664321100000
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.......+.....+.+++.+.+||.+||+.||++| |++++++.
T Consensus 217 ----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 217 ----------DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp ----------CTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred ----------HhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 00001111112335789999999999999999999 99999873
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=377.03 Aligned_cols=246 Identities=26% Similarity=0.358 Sum_probs=199.6
Q ss_pred CCCeEEEeeeeecCceeEEEEEECC-CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTH-TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~-tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|++++.||+|+||+||+|.+.. +|+.||||++... ........+.+|+.+|+.++||||+++++++.........
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3799999999999999999999986 7899999998642 3344556788999999999999999999998654322223
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|||||||+ ++|.+++.. .+++..++.|+.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 3799999998 588887754 79999999999999999999999999999999999999886 8999999999865332
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
...+||+.|+|||++.+ .++.++||||||||||+|++|.+||.+.... +.+..
T Consensus 235 -------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------~~~~~------- 287 (681)
T 2pzi_A 235 -------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVD----------GLPED------- 287 (681)
T ss_dssp -------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECS----------SCCTT-------
T ss_pred -------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCcccccc----------ccccc-------
Confidence 34569999999999876 3588999999999999999999998753210 00000
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
......++.+.+||.+||..||.+||+..+++.|+|+.-
T Consensus 288 --------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 288 --------------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp --------------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred --------------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 000124577899999999999999999999999998754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=318.73 Aligned_cols=186 Identities=17% Similarity=0.128 Sum_probs=134.4
Q ss_pred eeeecCceeEEEEEECCCCcEEEEEEecCccC--------ChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCCc
Q 008729 30 VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--------HISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 30 ~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~--------~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++.|+.|.+..++...+|+.||+|++.+... .......+.+|+++|+++ .|+||+++++++ ++..
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ 315 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence 35678888888888888899999999864321 123445689999999999 699999999999 7778
Q ss_pred eEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|||||||+| +|.++|...+.+++. .|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 89999999995 999999999988865 47899999999999999999999999999999999999999999875433
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCC
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKP 229 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~ 229 (556)
.. ...+.+||+.|+|||++.+ .+..++|+||+|+++++|+++..
T Consensus 393 ~~---~~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 393 CS---WPTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -C---CSHHHHHHHHHHHHHHC--------------------CCCCTTHH
T ss_pred Cc---cccCceechhhccHHHhCC---CCCCcccccccccchhhhccccc
Confidence 22 2356789999999999976 46778999999999998876643
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-28 Score=269.59 Aligned_cols=187 Identities=20% Similarity=0.267 Sum_probs=142.2
Q ss_pred EEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-Ch-----hHHHHHHHHHHHHHhCCCCCcc--eeeEEEcCCCCC
Q 008729 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HI-----SDAIRILREVKLLRLLRHPDIV--EIKRIMLPPSKR 97 (556)
Q Consensus 26 ~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~-----~~~~~~~rEi~iL~~L~HpnIv--~l~~v~~~~~~~ 97 (556)
...+.||+|+||.||+| ...++.+|+|++..... .. ....++.+|+.+|+.++||||+ .++++.
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~------ 410 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD------ 410 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE------
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe------
Confidence 45679999999999999 45688999998653221 11 1234588999999999999999 555542
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
....|||||||+ ++|.+++.. +..|+.||+.||.|||++||+||||||+|||++. .+||+|||+|+..
T Consensus 411 -~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 411 -LDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp -TTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred -CCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 233599999998 799999875 5689999999999999999999999999999998 9999999999875
Q ss_pred cCCCCCc----ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCC
Q 008729 177 FSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF 231 (556)
Q Consensus 177 ~~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF 231 (556)
....... ......+||++|+|||++.+....|+..+|+||..+-..+.+.++.+|
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 4321110 012467899999999999765456888999999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=225.48 Aligned_cols=147 Identities=16% Similarity=0.180 Sum_probs=116.9
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCCh----------------hHHHHHHHHHHHHHhCCCCCcce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI----------------SDAIRILREVKLLRLLRHPDIVE 86 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~----------------~~~~~~~rEi~iL~~L~HpnIv~ 86 (556)
..|.+++.||+|+||.||+|.+ .+|+.||||++....... .....+.+|+.+|+.++ | ++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 3466669999999999999999 889999999986321110 13456889999999999 4 66
Q ss_pred eeEEEcCCCCCCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCce
Q 008729 87 IKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (556)
Q Consensus 87 l~~v~~~~~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~v 165 (556)
+++++. .+..|+|||||+ ++|.+ +. ......++.||+.||.|||++||+||||||+|||++ ++.+
T Consensus 166 v~~~~~------~~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~v 231 (282)
T 1zar_A 166 VPKVYA------WEGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGI 231 (282)
T ss_dssp SCCEEE------EETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEE
T ss_pred cCeEEe------ccceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcE
Confidence 666552 134699999998 48887 42 134557999999999999999999999999999999 9999
Q ss_pred EEeeeCccccccCCCCCcceecccccCcccCCcccccc
Q 008729 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGS 203 (556)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 203 (556)
||+|||+|+ .+..|+|||++.+
T Consensus 232 kl~DFG~a~----------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 232 WIIDFPQSV----------------EVGEEGWREILER 253 (282)
T ss_dssp EECCCTTCE----------------ETTSTTHHHHHHH
T ss_pred EEEECCCCe----------------ECCCCCHHHHHHH
Confidence 999999986 3445789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=9.6e-22 Score=195.37 Aligned_cols=140 Identities=18% Similarity=0.151 Sum_probs=110.2
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcE--EEEEEecCccCCh----------------------hHHHHHHHHHHHHHh
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEK--VAIKKIHDVFEHI----------------------SDAIRILREVKLLRL 78 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~--vAiK~i~~~~~~~----------------------~~~~~~~rEi~iL~~ 78 (556)
.-|.+.+.||+|+||.||+|.+..+|+. ||||++....... .....+.+|+.+|+.
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 3589999999999999999998778999 9999875321110 112357899999999
Q ss_pred CCCCCc--ceeeEEEcCCCCCCCceEEEEEecCcc------cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-HCCcee
Q 008729 79 LRHPDI--VEIKRIMLPPSKREFKDIYVVFELMES------DLHQVIKANDDLTREHHQFFLYQMLRALKYMH-TANVYH 149 (556)
Q Consensus 79 L~HpnI--v~l~~v~~~~~~~~~~~lylV~E~~~g------~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLH-s~gIvH 149 (556)
|.|++| ..++.. ...||||||+++ .|.+++.. .++..+..++.||+.||.||| +.||+|
T Consensus 127 l~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givH 194 (258)
T 1zth_A 127 AKEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVH 194 (258)
T ss_dssp HHHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEEC
T ss_pred HHhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 988864 333332 236999999963 67776542 235577889999999999999 999999
Q ss_pred ccCCCCcEeecCCCceEEeeeCccccc
Q 008729 150 RDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 150 rDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
|||||+|||++. .++|+|||+|...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999988 8999999999653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.73 E-value=6.8e-18 Score=175.87 Aligned_cols=136 Identities=15% Similarity=0.171 Sum_probs=99.4
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc---CC------------hhH---HHH--HHHHHHHHHhCCCCC
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF---EH------------ISD---AIR--ILREVKLLRLLRHPD 83 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~---~~------------~~~---~~~--~~rEi~iL~~L~Hpn 83 (556)
-|.|++.||.|++|.||+|.+. +|+.||||+++... .. ... ..+ ..+|...|.+|.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4999999999999999999975 69999999875210 00 001 111 235777888776554
Q ss_pred cc--eeeEEEcCCCCCCCceEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec
Q 008729 84 IV--EIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN 160 (556)
Q Consensus 84 Iv--~l~~v~~~~~~~~~~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~ 160 (556)
+. ..++.. ..+|||||++| .|.++. ..+.+..++.||+.+|.|||++|||||||||.|||++
T Consensus 175 v~vp~p~~~~---------~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQS---------RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEEE---------TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE
T ss_pred CCCCeeeecc---------CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe
Confidence 42 222221 23799999996 664432 2234567889999999999999999999999999998
Q ss_pred CCC----------ceEEeeeCcccc
Q 008729 161 ANC----------KLKVCDFGLARV 175 (556)
Q Consensus 161 ~~~----------~vKL~DFGla~~ 175 (556)
.++ .+.|+||+.+..
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCCcccccccccceEEEEeCCccc
Confidence 876 389999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.34 E-value=2.9e-12 Score=126.45 Aligned_cols=137 Identities=12% Similarity=0.150 Sum_probs=106.7
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCCceE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~l 102 (556)
.|++...++.|+.+.||++.. .+..|++|+...... .....+.+|+.+|+.|. +..+.+++++. .+....
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~-----~~~~~~ 85 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWS 85 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEE
T ss_pred cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEE-----ecCCce
Confidence 599999999999999999964 368999999864211 11235789999999995 67788888887 344668
Q ss_pred EEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------
Q 008729 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT------------------------------------- 144 (556)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs------------------------------------- 144 (556)
|+|||+++| +|.+.+. +......++.++..+|..||+
T Consensus 86 ~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999997 7766531 222345788999999999999
Q ss_pred ----------------------CCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 145 ----------------------ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 145 ----------------------~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876556799999764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.21 E-value=2.5e-11 Score=122.68 Aligned_cols=184 Identities=18% Similarity=0.288 Sum_probs=121.0
Q ss_pred EeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCC--cceeeEEEcCCCCCCCceEEE
Q 008729 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPD--IVEIKRIMLPPSKREFKDIYV 104 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-Hpn--Iv~l~~v~~~~~~~~~~~lyl 104 (556)
++.++.|....||++. ..+++|+... ......+.+|..+|+.+. +.. +.+++..... .......|+
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~--~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMP--SETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCC--CSSCSCSCE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCC--CCCCCcceE
Confidence 4569999999999872 5689998653 244567889999999884 333 3334333211 122234589
Q ss_pred EEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 008729 105 VFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT--------------------------------------- 144 (556)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs--------------------------------------- 144 (556)
|||+++| .|.+... ..++.++...++.|+...|+.||+
T Consensus 94 vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp EEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred EEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 9999997 5544332 247788888888999999988886
Q ss_pred -------------------CCceeccCCCCcEeecC--CCceEEeeeCccccccCCCCCcceecccccCccc---CCccc
Q 008729 145 -------------------ANVYHRDLKPKNILANA--NCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY---RAPEL 200 (556)
Q Consensus 145 -------------------~gIvHrDLKP~NILl~~--~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y---~APE~ 200 (556)
..++|+|++|.|||++. ++.+.|+||+.+....... +......+ ..|+.
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-------Dl~~~~~~~~~~~~~~ 244 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-------DFISLMEDDEEYGMEF 244 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-------HHHTTCCTTTSCCHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-------HHHHHHhhccccCHHH
Confidence 13799999999999998 4568899999987542111 11111111 22332
Q ss_pred ccccCCCCC------------CcchhhhHHHHHHHHHhCCCCC
Q 008729 201 CGSFFSKYT------------PAIDIWSIGCIFAEVLTGKPLF 231 (556)
Q Consensus 201 ~~~~~~~y~------------~~~DIWSlG~ilyelltG~~pF 231 (556)
.......|. .-.+.|++|.++|.+.+|.++|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111101111 1258999999999999998776
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=2.4e-11 Score=118.87 Aligned_cols=133 Identities=17% Similarity=0.083 Sum_probs=95.4
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC--cceeeEEEcCCCCCCCc
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPSKREFK 100 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~v~~~~~~~~~~ 100 (556)
..|.+....+.|..+.||++. ..+|..|++|+.... ....+.+|+.+|+.+.+.+ +.+++.+.. ...
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~ 88 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAG 88 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSS
T ss_pred CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCC
Confidence 357765554566679999995 456788999987642 1235678999999986444 456777763 335
Q ss_pred eEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------
Q 008729 101 DIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--------------------------------- 146 (556)
Q Consensus 101 ~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~g--------------------------------- 146 (556)
..|+||||++| .| . . .... ...++.++...|..||+..
T Consensus 89 ~~~~v~e~i~G~~l-~-~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 89 RDWLLLGEVPGQDL-L-S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp CEEEEEECCSSEET-T-T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred CCEEEEEecCCccc-C-c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 58999999997 55 3 1 1122 2356777888888888754
Q ss_pred -------------------------ceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 147 -------------------------VYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 147 -------------------------IvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877666799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.9e-10 Score=118.97 Aligned_cols=145 Identities=15% Similarity=0.228 Sum_probs=105.0
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEec--CccCChhHHHHHHHHHHHHHhCC--CCCcceeeEEEcCCCCCCC
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--DVFEHISDAIRILREVKLLRLLR--HPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~--~~~~~~~~~~~~~rEi~iL~~L~--HpnIv~l~~v~~~~~~~~~ 99 (556)
...-++.|+.|.++.||++... +..+++|+.. .. ........+.+|+.+|+.|. +..+.+++..+... ...
T Consensus 39 ~~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~-~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~ 113 (359)
T 3dxp_A 39 GPLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKS-KLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVI 113 (359)
T ss_dssp CCCEEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTT
T ss_pred CCceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCC-CCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--Ccc
Confidence 3445788999999999998643 5688999765 21 11123446789999999997 45578888877433 222
Q ss_pred ceEEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH----------------------------------
Q 008729 100 KDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT---------------------------------- 144 (556)
Q Consensus 100 ~~lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs---------------------------------- 144 (556)
+..|+||||++| .+.+. .-..++......++.++..+|..||+
T Consensus 114 g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 114 GRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp SSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred CCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 457999999997 44321 12347788888999999999999997
Q ss_pred ------------------------CCceeccCCCCcEeecCCCc--eEEeeeCcccc
Q 008729 145 ------------------------ANVYHRDLKPKNILANANCK--LKVCDFGLARV 175 (556)
Q Consensus 145 ------------------------~gIvHrDLKP~NILl~~~~~--vKL~DFGla~~ 175 (556)
..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36999999999999997753 68999998865
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.57 E-value=6.9e-07 Score=90.21 Aligned_cols=134 Identities=20% Similarity=0.234 Sum_probs=91.8
Q ss_pred EeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCC---CcceeeEEEcCCCCCCCceEEE
Q 008729 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP---DIVEIKRIMLPPSKREFKDIYV 104 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hp---nIv~l~~v~~~~~~~~~~~lyl 104 (556)
++.++.|....||++ |..+++|+.. .......+.+|..+|+.|.+. .+.+.+.+.. ...+..|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEE
Confidence 556889999999998 5678999853 223456788999999999753 2445555442 12345689
Q ss_pred EEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC--------------------------------------
Q 008729 105 VFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA-------------------------------------- 145 (556)
Q Consensus 105 V~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~-------------------------------------- 145 (556)
|||+++| .|.+... ..++......+..|+...|+.||+.
T Consensus 91 v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 91 GYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp EEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred EEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9999997 4544221 1245555555556666665555542
Q ss_pred ----------------------CceeccCCCCcEeecC---CCce-EEeeeCccccc
Q 008729 146 ----------------------NVYHRDLKPKNILANA---NCKL-KVCDFGLARVA 176 (556)
Q Consensus 146 ----------------------gIvHrDLKP~NILl~~---~~~v-KL~DFGla~~~ 176 (556)
.++|+|++|.|||++. ++.+ .|+||+.+...
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3599999999999987 4554 89999988653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=1.7e-06 Score=85.03 Aligned_cols=132 Identities=17% Similarity=0.206 Sum_probs=92.9
Q ss_pred eeeecCce-eEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCCceEEEEEe
Q 008729 30 VIGKGSYG-VVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIYVVFE 107 (556)
Q Consensus 30 ~LG~G~~g-~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~lylV~E 107 (556)
.+..|..| .||+......+..+++|+-.. .....+.+|..+|+.|. +--+.+++.+. .+...-|+|||
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~-----~~~~~~~lvme 100 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFI-----RTPDDAWLLTT 100 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEEEEEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEE-----EECCeEEEEEE
Confidence 45556555 689988777788899997542 34567889999999885 33366677766 33456899999
Q ss_pred cCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 008729 108 LMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTA----------------------------------------- 145 (556)
Q Consensus 108 ~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~----------------------------------------- 145 (556)
+++| .+.+..... ......+..++...|.-||+.
T Consensus 101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 9997 666555431 222334556666666666641
Q ss_pred -----------------CceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 146 -----------------NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 146 -----------------gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
.++|+|+++.|||++.++.+-|+||+.+..
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 169999999999999877677999997743
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=2.5e-06 Score=89.09 Aligned_cols=78 Identities=17% Similarity=0.081 Sum_probs=49.1
Q ss_pred EEeeeeecCceeEEEEEECCCCcEEEEEEecCccC--C---hhHHHHHHHHHHHHHhCCC--CC-cceeeEEEcCCCCCC
Q 008729 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE--H---ISDAIRILREVKLLRLLRH--PD-IVEIKRIMLPPSKRE 98 (556)
Q Consensus 27 i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~--~---~~~~~~~~rEi~iL~~L~H--pn-Iv~l~~v~~~~~~~~ 98 (556)
-++.||.|..+.||++.+..+++.|+||....... . .....++.+|..+|+.+.. +. +.+++.+. .
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-----~- 107 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-----T- 107 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-----T-
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-----C-
Confidence 46789999999999997666678999998653211 0 0123456789999988742 33 34555432 1
Q ss_pred CceEEEEEecCcc
Q 008729 99 FKDIYVVFELMES 111 (556)
Q Consensus 99 ~~~lylV~E~~~g 111 (556)
...++|||+++|
T Consensus 108 -~~~~lvmE~l~g 119 (397)
T 2olc_A 108 -EMAVTVMEDLSH 119 (397)
T ss_dssp -TTTEEEECCCTT
T ss_pred -CccEEEEEeCCC
Confidence 224899999985
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.15 E-value=6.1e-06 Score=83.66 Aligned_cols=30 Identities=27% Similarity=0.348 Sum_probs=27.1
Q ss_pred CCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 145 ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 145 ~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
.+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888889999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.92 E-value=4.5e-06 Score=85.64 Aligned_cols=85 Identities=8% Similarity=0.135 Sum_probs=53.3
Q ss_pred eEEEeee-eecCceeEEEEEEC--C----CCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCC-C--CCcceeeEEEcC
Q 008729 25 YKILEVI-GKGSYGVVCAAIDT--H----TGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLR-H--PDIVEIKRIMLP 93 (556)
Q Consensus 25 Y~i~~~L-G~G~~g~V~~a~~~--~----tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~-H--pnIv~l~~v~~~ 93 (556)
...++.| +.|....+|++... . ++..+++|+...... .......+.+|+.+|+.|. + -.+.+++.+...
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4456778 88989999988643 0 266899997643210 0001135678899988884 3 346677776632
Q ss_pred CCCCCCceEEEEEecCcc
Q 008729 94 PSKREFKDIYVVFELMES 111 (556)
Q Consensus 94 ~~~~~~~~lylV~E~~~g 111 (556)
. ......|+|||+++|
T Consensus 102 ~--~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 102 G--DVLGTPFFLMDYVEG 117 (357)
T ss_dssp S--TTTSSCEEEEECCCC
T ss_pred C--CccCCceEEEEecCC
Confidence 2 112346899999986
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.69 E-value=0.0003 Score=73.96 Aligned_cols=32 Identities=16% Similarity=0.272 Sum_probs=27.8
Q ss_pred HHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 143 Hs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
+...++|+|++|.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 356799999999999998876 99999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00014 Score=72.68 Aligned_cols=68 Identities=12% Similarity=-0.003 Sum_probs=42.8
Q ss_pred EeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCc-ceeeEEEcCCCCCCCceEEEEE
Q 008729 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~v~~~~~~~~~~~lylV~ 106 (556)
++.|+.|....+|++ ..|++|+..... .......+|+.+++.+..-++ .+++... . ..-++|+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~--~~~~~v~ 86 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVD-----P--ATGVMVT 86 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC-----T--TTCCEEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEE-----C--CCCEEEE
Confidence 788999999999999 458899875321 111123468888887753233 4555443 1 1136899
Q ss_pred ecC-cc
Q 008729 107 ELM-ES 111 (556)
Q Consensus 107 E~~-~g 111 (556)
||+ +|
T Consensus 87 e~i~~g 92 (301)
T 3dxq_A 87 RYIAGA 92 (301)
T ss_dssp ECCTTC
T ss_pred eecCCC
Confidence 999 65
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00099 Score=63.14 Aligned_cols=98 Identities=17% Similarity=0.113 Sum_probs=66.2
Q ss_pred cHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCCcceeccc
Q 008729 112 DLHQVIKA-NDDLTREHHQFFLYQMLRALKYMH-TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189 (556)
Q Consensus 112 ~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLH-s~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~ 189 (556)
+|.++|.. +.++++++++.+++|.+.+|.-+- .+.-..+=+.|..|++..+|.|-+.+ +.+.
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------- 97 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------- 97 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence 79999976 568999999999999999987762 22222333457899999999987764 2110
Q ss_pred ccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCC
Q 008729 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 228 (556)
Q Consensus 190 ~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~ 228 (556)
.....+.+||... ...+.+.=|||||++||.-+--.
T Consensus 98 ~~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 AGEPPPVAGKLGY---SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp ---------CCSS---SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred ccccCCCChhhcc---ccchHHHHHHHHHHHHHHHhhcC
Confidence 1223466888763 24567889999999999998543
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.0011 Score=66.96 Aligned_cols=74 Identities=18% Similarity=0.102 Sum_probs=55.0
Q ss_pred EEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC---CCCcceeeEEEcCCCCCCCceE
Q 008729 26 KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR---HPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 26 ~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~---HpnIv~l~~v~~~~~~~~~~~l 102 (556)
.-++.|+.|....+|++.. .+..|++|+... .....+.+|...|+.|. ...+.+++.... .....
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~ 106 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINER-----SYRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHS 106 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEG-----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCc-----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCce
Confidence 4467899999999999963 477899997653 12456788999998884 245777777652 33568
Q ss_pred EEEEecCcc
Q 008729 103 YVVFELMES 111 (556)
Q Consensus 103 ylV~E~~~g 111 (556)
|+|||+++|
T Consensus 107 ~lvme~l~G 115 (312)
T 3jr1_A 107 FLLLEALNK 115 (312)
T ss_dssp EEEEECCCC
T ss_pred EEEEEeccC
Confidence 999999985
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0012 Score=66.14 Aligned_cols=148 Identities=14% Similarity=0.097 Sum_probs=79.3
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC--cceeeEEEcCCC-
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPS- 95 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~v~~~~~- 95 (556)
|+. ....-++.|+.|....+|++... +| .+++|+.... .....+..|+.+++.|...+ +.+++... ...
T Consensus 19 ~~~-~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~-~g~~ 90 (322)
T 2ppq_A 19 YDV-GSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPLPLPRK-DGEL 90 (322)
T ss_dssp BCC-CCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBT-TCCS
T ss_pred CCC-CcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCcccCCC-CCCE
Confidence 444 34445677888999999998643 33 6889987642 12234557888888774222 23333211 000
Q ss_pred -CCCCceEEEEEecCccc-H-----H------HH---HH-hCCC--------CCHHHHHHH---------------HHHH
Q 008729 96 -KREFKDIYVVFELMESD-L-----H------QV---IK-ANDD--------LTREHHQFF---------------LYQM 135 (556)
Q Consensus 96 -~~~~~~lylV~E~~~g~-L-----~------~~---i~-~~~~--------l~~~~~~~i---------------~~QI 135 (556)
....+..++||++++|. + . .. +. .... ......... -..+
T Consensus 91 ~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l 170 (322)
T 2ppq_A 91 LGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEI 170 (322)
T ss_dssp CEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHH
T ss_pred EEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHH
Confidence 01124568999999862 1 0 00 11 1001 111100000 0113
Q ss_pred HHHHHHHHH-------CCceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 136 LRALKYMHT-------ANVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 136 l~aL~yLHs-------~gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
...+.+++. .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 171 ~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 171 RPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 344555553 369999999999999887656899999764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00083 Score=67.95 Aligned_cols=31 Identities=29% Similarity=0.441 Sum_probs=26.8
Q ss_pred CCceeccCCCCcEeecCC----CceEEeeeCcccc
Q 008729 145 ANVYHRDLKPKNILANAN----CKLKVCDFGLARV 175 (556)
Q Consensus 145 ~gIvHrDLKP~NILl~~~----~~vKL~DFGla~~ 175 (556)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999874 6799999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0022 Score=63.46 Aligned_cols=76 Identities=12% Similarity=0.018 Sum_probs=52.4
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCC---CcceeeEEEcCCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP---DIVEIKRIMLPPSKREF 99 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hp---nIv~l~~v~~~~~~~~~ 99 (556)
.+..-++.+|.|..+.||++.. .+|+.|++|+...... .....+.+|...|+.|.-- -+.+++.+-
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~-------- 83 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP--ALDGLFRAEALGLDWLGRSFGSPVPQVAGWD-------- 83 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC--CCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--------
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc--chhhHHHHHHHHHHHHHhhCCCCcceEEecc--------
Confidence 4566788999999999999974 5789999998643211 1123466899999988522 244444432
Q ss_pred ceEEEEEecCc
Q 008729 100 KDIYVVFELME 110 (556)
Q Consensus 100 ~~lylV~E~~~ 110 (556)
.-++|||++.
T Consensus 84 -~~~lv~e~l~ 93 (288)
T 3f7w_A 84 -DRTLAMEWVD 93 (288)
T ss_dssp -TTEEEEECCC
T ss_pred -CceEEEEeec
Confidence 1378999986
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0023 Score=66.39 Aligned_cols=135 Identities=13% Similarity=0.162 Sum_probs=80.8
Q ss_pred EeeeeecCceeEEEEEECC-------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCC
Q 008729 28 LEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~ 99 (556)
++.|..|....+|++.... +++.|++|+.... ......+.+|..+++.|. +.-..++++.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT-
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC-
Confidence 4568788899999997532 3578999986421 122445568999998885 33345666665 22
Q ss_pred ceEEEEEecCcc-cH-----------HHH---HH---hC-----CCC--CHHHHHHHHHHHHH-----------------
Q 008729 100 KDIYVVFELMES-DL-----------HQV---IK---AN-----DDL--TREHHQFFLYQMLR----------------- 137 (556)
Q Consensus 100 ~~lylV~E~~~g-~L-----------~~~---i~---~~-----~~l--~~~~~~~i~~QIl~----------------- 137 (556)
.+||||++| .| ..+ +. .. ... -...+..|+.|+-.
T Consensus 126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 202 (379)
T 3feg_A 126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL 202 (379)
T ss_dssp ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence 289999985 11 111 11 11 111 23556666655432
Q ss_pred --HHHHHH----HC----CceeccCCCCcEeecCC----CceEEeeeCccc
Q 008729 138 --ALKYMH----TA----NVYHRDLKPKNILANAN----CKLKVCDFGLAR 174 (556)
Q Consensus 138 --aL~yLH----s~----gIvHrDLKP~NILl~~~----~~vKL~DFGla~ 174 (556)
.+..|. .. .++|+|+.+.|||++.+ +.+.|+||..|.
T Consensus 203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 233332 22 59999999999999876 789999999774
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0029 Score=66.71 Aligned_cols=72 Identities=14% Similarity=0.114 Sum_probs=49.1
Q ss_pred EEeeeeecCceeEEEEEECC-------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC-cceeeEEEcCCCCCC
Q 008729 27 ILEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD-IVEIKRIMLPPSKRE 98 (556)
Q Consensus 27 i~~~LG~G~~g~V~~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn-Iv~l~~v~~~~~~~~ 98 (556)
-++.|+.|....||++.... .+..|++|+.... .. ...+.+|..+++.|...+ ..++++.+ .+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~--~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~ 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET--ESHLVAESVIFTLLSERHLGPKLYGIF-----SG 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC--HHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc--HHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC
Confidence 36678899999999997643 3578999987431 11 134557999999885333 35666665 22
Q ss_pred CceEEEEEecCcc
Q 008729 99 FKDIYVVFELMES 111 (556)
Q Consensus 99 ~~~lylV~E~~~g 111 (556)
.+|+||++|
T Consensus 148 ----g~v~e~l~G 156 (429)
T 1nw1_A 148 ----GRLEEYIPS 156 (429)
T ss_dssp ----EEEECCCCE
T ss_pred ----CEEEEEeCC
Confidence 389999875
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0016 Score=65.58 Aligned_cols=76 Identities=13% Similarity=0.046 Sum_probs=46.0
Q ss_pred eeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC--cceeeEEEcCCC--CCCCceEEE
Q 008729 29 EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD--IVEIKRIMLPPS--KREFKDIYV 104 (556)
Q Consensus 29 ~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn--Iv~l~~v~~~~~--~~~~~~lyl 104 (556)
+.|+ |....||++.. .+|+.+++|+..... .....+..|+.+++.|.... +++++.. ... ....+..|+
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~ 104 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFA 104 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEE
Confidence 4566 88889998743 346679999886321 12345667888888885222 3444332 110 011345688
Q ss_pred EEecCcc
Q 008729 105 VFELMES 111 (556)
Q Consensus 105 V~E~~~g 111 (556)
||++++|
T Consensus 105 l~~~i~G 111 (328)
T 1zyl_A 105 VFPSVGG 111 (328)
T ss_dssp EEECCCC
T ss_pred EEEecCC
Confidence 9999986
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0011 Score=68.18 Aligned_cols=73 Identities=7% Similarity=0.005 Sum_probs=43.2
Q ss_pred EEeeeeecCceeEEEEEECC--------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCC-cceeeEEEcCCCCC
Q 008729 27 ILEVIGKGSYGVVCAAIDTH--------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD-IVEIKRIMLPPSKR 97 (556)
Q Consensus 27 i~~~LG~G~~g~V~~a~~~~--------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~Hpn-Iv~l~~v~~~~~~~ 97 (556)
-++.|+.|....+|++.... .+..|++|+..... .......+|..+|+.|...+ +.++++.. .
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~ 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF-----N 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec-----C
Confidence 35678889899999997543 13688999765311 11112357888888885333 44666554 1
Q ss_pred CCceEEEEEecCcc
Q 008729 98 EFKDIYVVFELMES 111 (556)
Q Consensus 98 ~~~~lylV~E~~~g 111 (556)
-++||||++|
T Consensus 109 ----~~~v~e~i~G 118 (369)
T 3c5i_A 109 ----GGRIEEWLYG 118 (369)
T ss_dssp ----TEEEEECCCS
T ss_pred ----CcEEEEEecC
Confidence 1689999985
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.014 Score=61.97 Aligned_cols=73 Identities=21% Similarity=0.226 Sum_probs=47.2
Q ss_pred EEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCc-ceeeEEEcCCCCCCCceEEEE
Q 008729 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDI-VEIKRIMLPPSKREFKDIYVV 105 (556)
Q Consensus 27 i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnI-v~l~~v~~~~~~~~~~~lylV 105 (556)
-++.|+.|-...+|++.....+..|++|+........ ....+|..+|+.|...++ .++++++ .+ .+|
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~---idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v 179 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI---INREREKKISCILYNKNIAKKIYVFF-----TN----GRI 179 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC---SCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEE
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh---cCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEE
Confidence 3567888999999999865445789999874321111 112479999999975444 5666665 21 259
Q ss_pred EecCcc
Q 008729 106 FELMES 111 (556)
Q Consensus 106 ~E~~~g 111 (556)
|||++|
T Consensus 180 ~e~I~G 185 (458)
T 2qg7_A 180 EEFMDG 185 (458)
T ss_dssp EECCCS
T ss_pred EEeeCC
Confidence 999875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.005 Score=62.61 Aligned_cols=31 Identities=16% Similarity=0.300 Sum_probs=27.5
Q ss_pred CCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 145 ANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 145 ~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999888899999987754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.73 E-value=0.051 Score=57.00 Aligned_cols=73 Identities=10% Similarity=-0.012 Sum_probs=47.0
Q ss_pred EEeeeeecCceeEEEEEECCC-------CcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCC
Q 008729 27 ILEVIGKGSYGVVCAAIDTHT-------GEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 27 i~~~LG~G~~g~V~~a~~~~t-------g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~ 98 (556)
-++.|..|....+|++..... +..|++++....... .....+|..+++.|. +.-..++++.+ .
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~---~idR~~E~~~l~~L~~~gi~P~l~~~~-----~- 144 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK---FYDSKVELDVFRYLSNINIAPNIIADF-----P- 144 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C---CCCHHHHHHHHHHHHHTTSSCCEEEEE-----T-
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch---hcCHHHHHHHHHHHHhcCCCCCEEEEc-----C-
Confidence 356677888899999976521 578999986432111 112347888888885 33345555543 1
Q ss_pred CceEEEEEecCcc
Q 008729 99 FKDIYVVFELMES 111 (556)
Q Consensus 99 ~~~lylV~E~~~g 111 (556)
-++|+||++|
T Consensus 145 ---~~~I~efI~G 154 (424)
T 3mes_A 145 ---EGRIEEFIDG 154 (424)
T ss_dssp ---TEEEEECCCS
T ss_pred ---CCEEEEEeCC
Confidence 1789999986
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.12 E-value=0.25 Score=51.16 Aligned_cols=29 Identities=31% Similarity=0.416 Sum_probs=24.7
Q ss_pred ceeccCCCCcEee------cCCCceEEeeeCcccc
Q 008729 147 VYHRDLKPKNILA------NANCKLKVCDFGLARV 175 (556)
Q Consensus 147 IvHrDLKP~NILl------~~~~~vKL~DFGla~~ 175 (556)
++|+|+.+.|||+ +++..+.|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4456799999998754
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.92 E-value=0.07 Score=56.64 Aligned_cols=63 Identities=14% Similarity=0.077 Sum_probs=17.7
Q ss_pred EEEeeeeecCceeEEEEEECCCCcEEEE------EEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEE
Q 008729 26 KILEVIGKGSYGVVCAAIDTHTGEKVAI------KKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIM 91 (556)
Q Consensus 26 ~i~~~LG~G~~g~V~~a~~~~tg~~vAi------K~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~ 91 (556)
.+.+.|| ||.||++........||+ |..............+.+|..+++.++|||+++.+.+.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 3455676 999999987665567888 66543222223345678899999999999999998865
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 556 | ||||
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-97 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-90 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-88 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-78 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-77 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-75 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-73 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-73 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-72 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-71 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-70 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-69 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-69 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-68 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-68 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-67 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-67 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-67 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-66 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-66 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-66 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-65 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-65 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-64 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-64 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-62 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-62 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-59 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-59 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-58 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-56 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-55 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-55 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-54 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-51 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-51 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-50 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-50 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-50 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-49 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-48 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-48 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-48 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-47 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-45 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-43 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-42 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-41 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-40 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-23 |
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 297 bits (761), Expect = 2e-97
Identities = 155/342 (45%), Positives = 215/342 (62%), Gaps = 5/342 (1%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
RY L IG+G+YG+VC+A D +VAIKKI FEH + R LRE+K+L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRH 65
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+I+ I I+ P+ + KD+Y+V LM +DL++++K L+ +H +FLYQ+LR LKY
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKY 124
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ANV HRDLKP N+L N C LK+CDFGLARVA D T F T+YVATRWYRAPE+
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ YT +IDIWS+GCI AE+L+ +P+FPGK + QL+ I +LG+PS E + + N
Sbjct: 185 LNSK-GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
KAR YL + K VP + FPN D AL LL +++ F+P R E+ALA PY +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303
Query: 322 IEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQL 363
EP + +F+ E + K+ ++ELI+ E + P
Sbjct: 304 PSDEPIAEA--PFKFDMELDDLPKEKLKELIFEETARFQPGY 343
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 279 bits (715), Expect = 2e-90
Identities = 141/346 (40%), Positives = 207/346 (59%), Gaps = 12/346 (3%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
T + RY+ L +G G+YG VCAA DT TG +VA+KK+ F+ I A R RE++LL
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 77 RLLRHPDIVEIKRIMLPP-SKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ ++H +++ + + P S EF D+Y+V LM +DL+ ++K LT +H QF +YQ+
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQI 130
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
LR LKY+H+A++ HRDLKP N+ N +C+LK+ DFGLAR T YVATRWY
Sbjct: 131 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR------HTDDEMTGYVATRWY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
RAPE+ + + Y +DIWS+GCI AE+LTG+ LFPG + QL LI L+GTP E +
Sbjct: 185 RAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+ +E AR Y+ + + P + F +PLA+ LL++++ D R TA +ALA Y
Sbjct: 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
F + EP P + FE R + D+ + L Y E++ + P
Sbjct: 304 FAQYHDPDDEPVADPY---DQSFESRDLLIDEWKSLTYDEVISFVP 346
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 274 bits (701), Expect = 2e-88
Identities = 134/346 (38%), Positives = 207/346 (59%), Gaps = 12/346 (3%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
T + Y+ L+ +G G+YG VC+A+D TG KVAIKK++ F+ A R RE++LL
Sbjct: 12 TAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 71
Query: 77 RLLRHPDIVEIKRIMLPPSKRE-FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ +RH +++ + + P + F D Y+V M +DL +++K ++ L + QF +YQM
Sbjct: 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQM 130
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
L+ L+Y+H A + HRDLKP N+ N +C+LK+ DFGLAR A S+ T YV TRWY
Sbjct: 131 LKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------TGYVVTRWY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
RAPE+ + + +YT +DIWS+GCI AE++TGK LF G + QL I + GTP E +
Sbjct: 185 RAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPY 315
+++++A+ Y+ + + N PLA+ LL++++ D + R TA EALA PY
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303
Query: 316 FKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHP 361
F+ L E EP Q K + F+ T D+ + + Y+E+L + P
Sbjct: 304 FESLHDTEDEPQVQ---KYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (633), Expect = 4e-78
Identities = 121/354 (34%), Positives = 190/354 (53%), Gaps = 23/354 (6%)
Query: 17 TEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLL 76
+ + RY+ L+ IG G+ G+VCAA D VAIKK+ F++ + A R RE+ L+
Sbjct: 11 STFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 70
Query: 77 RLLRHPDIVEIKRIMLPPSK-REFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQM 135
+ + H +I+ + + P EF+D+Y+V ELM+++L QVI+ D E + LYQM
Sbjct: 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--HERMSYLLYQM 128
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
L +K++H+A + HRDLKP NI+ ++C LK+ DFGLAR A + M T YV TR+Y
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM----TPYVVTRYY 184
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255
RAPE+ Y +DIWS+GCI E++ K LFPG+ + Q + + + LGTP PE +
Sbjct: 185 RAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPN------------VDPLALRLLQRLIAFDPKD 303
+ R Y+ K + + FP+ A LL +++ DP
Sbjct: 243 KKL-QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 304 RPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREIL 357
R + ++AL PY + P + + + R T ++ +ELIY+E++
Sbjct: 302 RISVDDALQHPYINVWYDPAEVEAPPP-QIYDKQLDEREHTIEEWKELIYKEVM 354
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (625), Expect = 2e-77
Identities = 102/301 (33%), Positives = 155/301 (51%), Gaps = 7/301 (2%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
++Y+ L IG+G++G V A TG+KVA+KK+ E I LRE+K+L+LL+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 83 DIVEIKRIMLPPSKREFKD---IYVVFELMESDLHQV-IKANDDLTREHHQFFLYQMLRA 138
++V + I + + IY+VF+ E DL + T + + +L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLAR-VAFSDTPMTVFWTDYVATRWYRA 197
L Y+H + HRD+K N+L + LK+ DFGLAR + + +T+ V T WYR
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PEL Y P ID+W GCI AE+ T P+ G + HQL LI+ L G+ +PE
Sbjct: 190 PELL-LGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 258 VRNEKARKYLTEMR-KKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
V N + + L ++ +K V K DP AL L+ +L+ DP R +++AL +F
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
Query: 317 K 317
Sbjct: 309 W 309
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 240 bits (613), Expect = 4e-75
Identities = 102/330 (30%), Positives = 168/330 (50%), Gaps = 19/330 (5%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
Y +VIG GS+GVV A +GE VAIKK+ D RE++++R L H +
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCN 74
Query: 84 IVEIKRIMLPPSKREFKD-IYVVFELMESDLHQVI----KANDDLTREHHQFFLYQMLRA 138
IV ++ +++ + + +V + + +++V +A L + + ++YQ+ R+
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 139 LKYMHTANVYHRDLKPKNILANANCKL-KVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L Y+H+ + HRD+KP+N+L + + + K+CDFG A+ P Y+ +R+YRA
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP----NVSYICSRYYRA 190
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PEL YT +ID+WS GC+ AE+L G+P+FPG S V QL I +LGTP+ E I
Sbjct: 191 PELIFGAT-DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ +++ P +F P P A+ L RL+ + P R T EA A +F
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVF--RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
Query: 318 GLAKIEREPSCQPISKLEFEFERRRVTKDD 347
L + + F F + ++ +
Sbjct: 308 ELRDPNVKLPNGRDTPALFNFTTQELSSNP 337
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (596), Expect = 2e-73
Identities = 100/307 (32%), Positives = 157/307 (51%), Gaps = 16/307 (5%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHT-GEKVAIKKIHDVFEHISDAIRILREVKLLRLL-- 79
+Y+ + IG+G+YG V A D G VA+K++ + +REV +LR L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 80 -RHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQFFLYQML 136
HP++V + + + +VFE ++ DL + + + E + ++Q+L
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
R L ++H+ V HRDLKP+NIL ++ ++K+ DFGLAR+ T V T WYR
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA----LTSVVVTLWYR 182
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
APE+ S Y +D+WS+GCIFAE+ KPLF G S V QL I D++G P E
Sbjct: 183 APEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ + K P+ + ++D L LL + + F+P R +A AL+ PYF
Sbjct: 241 RDVALPRQAF----HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
Query: 317 KGLAKIE 323
+ L + +
Sbjct: 297 QDLERCK 303
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (594), Expect = 5e-73
Identities = 108/312 (34%), Positives = 153/312 (49%), Gaps = 22/312 (7%)
Query: 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI---RILREVKLLRLLRHPD 83
L+ +G+G + V A D +T + VAIKKI + LRE+KLL+ L HP+
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKYM 142
I+ + S I +VF+ ME+DL +IK N + H + ++ L+ L+Y+
Sbjct: 62 IIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 116
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H + HRDLKP N+L + N LK+ DFGLA+ S +T V TRWYRAPEL
Sbjct: 117 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA---YTHQVVTRWYRAPELL- 172
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y +D+W++GCI AE+L P PG S + QL I + LGTP+ E + +
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322
+ P +PL F L L+Q L F+P R TA +AL YF
Sbjct: 233 DYVT---FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN---- 285
Query: 323 EREPSCQPISKL 334
P P +L
Sbjct: 286 --RPGPTPGCQL 295
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 1e-72
Identities = 65/311 (20%), Positives = 123/311 (39%), Gaps = 28/311 (9%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ ++ + +G G+ GVV +G +A K IH + + +I+RE+++L P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP-AIRNQIIRELQVLHECNSP 64
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKY 141
IV +I + E M+ L QV+K + + +++ L Y
Sbjct: 65 YIVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 142 MHTAN-VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
+ + + HRD+KP NIL N+ ++K+CDFG++ + +V TR Y +PE
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-----FVGTRSYMSPER 174
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
+ Y+ DIWS+G E+ G+ P + + + ET R
Sbjct: 175 L--QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 261 EKARKYLTEMRKKPPVPLFQKFPN-------------VDPLALRLLQRLIAFDPKDRPTA 307
M +PP+ +F+ + + + +P +R
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 308 EEALADPYFKG 318
++ + + K
Sbjct: 293 KQLMVHAFIKR 303
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 2e-71
Identities = 107/300 (35%), Positives = 161/300 (53%), Gaps = 13/300 (4%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPD 83
++ +E IG+G+YGVV A + TGE VA+KKI E +RE+ LL+ L HP+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKAND--DLTREHHQFFLYQMLRALKY 141
IV++ ++ +K +Y+VFE + DL + + A+ + + +L+Q+L+ L +
Sbjct: 63 IVKLLDVIHTENK-----LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H+ V HRDLKP+N+L N +K+ DFGLAR +T V T WYRAPE+
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT---YTHEVVTLWYRAPEIL 174
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y+ A+DIWS+GCIFAE++T + LFPG S + QL I LGTP
Sbjct: 175 LG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP--GVT 231
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321
Y K + P +D LL +++ +DP R +A+ ALA P+F+ + K
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 224 bits (572), Expect = 5e-70
Identities = 106/296 (35%), Positives = 154/296 (52%), Gaps = 13/296 (4%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y LE IG+G+YGVV A + + GE A+KKI E +RE+ +L+ L+H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELM-ESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+IV++ ++ K + +VFE + + + L + FL Q+L + Y
Sbjct: 61 NIVKLYDVI-----HTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
H V HRDLKP+N+L N +LK+ DFGLAR +T + T WYRAP++
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK---YTHEIVTLWYRAPDVL 172
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
KY+ IDIWS+GCIFAE++ G PLFPG S QL I +LGTP+ + V
Sbjct: 173 MG-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT-- 229
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
+ KY P+P +D + LL +++ DP R TA++AL YFK
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 4e-69
Identities = 105/298 (35%), Positives = 148/298 (49%), Gaps = 11/298 (3%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y+ LE IG+G+YG V A + T E VA+K++ + LRE+ LL+ L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+IV + ++ + K V + N DL E + FL+Q+L+ L +
Sbjct: 62 NIVRLHDVL----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ NV HRDLKP+N+L N N +LK+ +FGLAR + V T WYR P++
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY---SAEVVTLWYRPPDVLF 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
Y+ +ID+WS GCIFAE+ PLFPG V QL I LLGTP+ E +
Sbjct: 175 G-AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT-- 231
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
K Y L P ++ LLQ L+ +P R +AEEAL PYF
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 222 bits (567), Expect = 8e-69
Identities = 95/326 (29%), Positives = 164/326 (50%), Gaps = 27/326 (8%)
Query: 7 KKELKDKDFFT-EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISD 65
+E D + E+G+ + Y+++ +G+G Y V AI+ EKV +K + V +
Sbjct: 18 PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK--- 74
Query: 66 AIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDL 123
+I RE+K+L LR P+I+ + I+ P R +VFE + +D Q+ + L
Sbjct: 75 --KIKREIKILENLRGGPNIITLADIVKDPVSRT---PALVFEHVNNTDFKQLYQT---L 126
Query: 124 TREHHQFFLYQMLRALKYMHTANVYHRDLKPKNIL-ANANCKLKVCDFGLARVAFSDTPM 182
T +F++Y++L+AL Y H+ + HRD+KP N++ + + KL++ D+GLA
Sbjct: 127 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE- 185
Query: 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLD 241
+ VA+R+++ PEL + Y ++D+WS+GC+ A ++ K P F G QL
Sbjct: 186 ---YNVRVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241
Query: 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKF------PNVDPLALRLLQR 295
I +LGT N + ++ + +++F V P AL L +
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301
Query: 296 LIAFDPKDRPTAEEALADPYFKGLAK 321
L+ +D + R TA EA+ PYF + K
Sbjct: 302 LLRYDHQSRLTAREAMEHPYFYTVVK 327
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (562), Expect = 2e-68
Identities = 67/295 (22%), Positives = 123/295 (41%), Gaps = 40/295 (13%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+Y E IG+G+ G V A+D TG++VAI++++ + I+ E+ ++R ++P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN--LQQQPKKELIINEILVMRENKNP 77
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYM 142
+IV +++VV E + + + + L+AL+++
Sbjct: 78 NIVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFL 132
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ V HRD+K NIL + +K+ DFG + + V T ++ APE+
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---STMVGTPYWMAPEVVT 189
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
Y P +DIWS+G + E++ G+P + ++ + L LI
Sbjct: 190 R--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------------------- 228
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
P Q + + L R + D + R +A+E L + K
Sbjct: 229 ---------ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 220 bits (561), Expect = 4e-68
Identities = 75/327 (22%), Positives = 137/327 (41%), Gaps = 43/327 (13%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y +V+G G++ V A D T + VAIK I + E+ +L ++HP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHP 67
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
+IV + I +Y++ +L+ +L I T ++Q+L A+KY
Sbjct: 68 NIVALDDIYESGGH-----LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 142 MHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+H + HRDLKP+N+L + + K+ + DFGL+++ + ++ T Y AP
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS----TACGTPGYVAP 178
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ Y+ A+D WSIG I +L G P F ++ + I
Sbjct: 179 EVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI--------------- 221
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
K + ++ A ++ L+ DP+ R T E+AL P+ G
Sbjct: 222 ------------LKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269
Query: 319 LAKIEREPSCQPISKLEFEFERRRVTK 345
+++ +++ F + + +
Sbjct: 270 DTALDKNIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 4e-67
Identities = 74/344 (21%), Positives = 149/344 (43%), Gaps = 54/344 (15%)
Query: 13 KDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILRE 72
K+ + +Y I E +G+G +G+V ++T + + K + +D + + +E
Sbjct: 1 KELY------EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK---VKGTDQVLVKKE 51
Query: 73 VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKAND-DLTREHHQF 130
+ +L + RH +I+ + +++ ++FE + D+ + I + +L
Sbjct: 52 ISILNIARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVS 106
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTD 188
+++Q+ AL+++H+ N+ H D++P+NI+ + +K+ +FG AR + +T
Sbjct: 107 YVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT- 165
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLG 248
Y APE+ + A D+WS+G + +L+G F ++ ++ I +
Sbjct: 166 ---APEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY 220
Query: 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
T E F + A+ + RL+ + K R TA
Sbjct: 221 TFDEE---------------------------AFKEISIEAMDFVDRLLVKERKSRMTAS 253
Query: 309 EALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELI 352
EAL P+ K KIER S + I L+ + K D+ ++
Sbjct: 254 EALQHPWLKQ--KIER-VSTKVIRTLKHRRYYHTLIKKDLNMVV 294
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 4e-67
Identities = 68/298 (22%), Positives = 119/298 (39%), Gaps = 45/298 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
++I +GKG +G V A + + +A+K + E ++ REV++ LRH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALK 140
P+I+ + ++ +Y++ E +++ ++ + ++ ++ AL
Sbjct: 66 PNILRLYGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 120
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y H+ V HRD+KP+N+L + +LK+ DFG + A S T T Y PE+
Sbjct: 121 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-----LCGTLDYLPPEM 175
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
+ +D+WS+G + E L GKP F + I
Sbjct: 176 IEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----------------- 216
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
R + P V A L+ RL+ +P RP E L P+
Sbjct: 217 ---------SRVEFTFP-----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 5e-67
Identities = 64/296 (21%), Positives = 117/296 (39%), Gaps = 37/296 (12%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ +++ +G+G+YG V A++ T E VA+K + D+ + I +E+ + ++L H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-DMKRAVDCPENIKKEICINKMLNHE 63
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELMESDLH-QVIKANDDLTREHHQFFLYQMLRALKY 141
++V+ + Y+ E I+ + + Q F +Q++ + Y
Sbjct: 64 NVVKFYGHRREGNI-----QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H + HRD+KP+N+L + LK+ DFGLA V F T Y APEL
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATV-FRYNNRERLLNKMCGTLPYVAPELL 177
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ +D+WS G + +L G+ + S Q
Sbjct: 178 KR-REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD------------------ 218
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317
K + +D L LL +++ +P R T + D ++
Sbjct: 219 ----------WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 214 bits (547), Expect = 2e-66
Identities = 73/307 (23%), Positives = 124/307 (40%), Gaps = 49/307 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAI-------RILREVKLL 76
Y+ E++G+G VV I T ++ A+K I A L+EV +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 77 RLLR-HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQ 134
R + HP+I+++K ++VF+LM+ +L + L+ + + +
Sbjct: 64 RKVSGHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 118
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+L + +H N+ HRDLKP+NIL + + +K+ DFG + + + T
Sbjct: 119 LLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL----REVCGTPS 174
Query: 195 YRAPELC----GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250
Y APE+ Y +D+WS G I +L G P F + + L +I
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227
Query: 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA 310
++ + L+ R + P+ R TAEEA
Sbjct: 228 --------------------MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
Query: 311 LADPYFK 317
LA P+F+
Sbjct: 268 LAHPFFQ 274
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 216 bits (551), Expect = 4e-66
Identities = 70/332 (21%), Positives = 131/332 (39%), Gaps = 45/332 (13%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y I E +G G++GVV + TG A K + H SD + +E++ + +LRHP
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHP 83
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVI-KANDDLTREHHQFFLYQMLRALK 140
+V + + ++ +++E M +L + + ++ ++ + ++ Q+ + L
Sbjct: 84 TLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138
Query: 141 YMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+MH N H DLKP+NI+ + +LK+ DFGL + V T + AP
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV----TTGTAEFAAP 194
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ D+WS+G + +L+G F G++ L +
Sbjct: 195 EVA--EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV--------------- 237
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
+ F + +++L+ DP R T +AL P+
Sbjct: 238 ------------KSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP 285
Query: 319 LAKIEREPSCQPISKLEFEFERRRVTKDDIRE 350
R+ P S+ + + D E
Sbjct: 286 GNAPGRDSQI-PSSRYTKIRDSIKTKYDAWPE 316
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 214 bits (546), Expect = 9e-66
Identities = 76/355 (21%), Positives = 134/355 (37%), Gaps = 50/355 (14%)
Query: 4 DQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI 63
D EL KD + + L IG GS+G V A D E VAIKK+ +
Sbjct: 1 DPDVAELFFKDDPEK-----LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS 55
Query: 64 SDAI-RILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAND 121
++ I++EV+ L+ LRHP+ ++ + L ++V E S +
Sbjct: 56 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKK 110
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181
L + L+ L Y+H+ N+ HRD+K NIL + +K+ DFG A +
Sbjct: 111 PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168
Query: 182 MTVFWTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQL 240
+V T ++ APE + +Y +D+WS+G E+ KP + + L
Sbjct: 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
Query: 241 DLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFD 300
I + + P + + + +
Sbjct: 224 YHI--------------------------AQNESPAL---QSGHWSEYFRNFVDSCLQKI 254
Query: 301 PKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYRE 355
P+DRPT+E L + +K + E + +++++++E
Sbjct: 255 PQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTK-DAVRELDNLQYRKMKKILFQE 308
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 214 bits (547), Expect = 2e-65
Identities = 68/300 (22%), Positives = 123/300 (41%), Gaps = 44/300 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
+ Y ILE +G G++GVV ++ TG K I+ + D + E+ ++ L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT--PYPLDKYTVKNEISIMNQLHHP 86
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-LTREHHQFFLYQMLRALK 140
++ + + ++ ++ E + +L I A D ++ ++ Q LK
Sbjct: 87 KLINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 141 YMHTANVYHRDLKPKNIL--ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+MH ++ H D+KP+NI+ +K+ DFGLA D + AT + AP
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV----KVTTATAEFAAP 197
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258
E+ D+W+IG + +L+G F G+ + L +
Sbjct: 198 EIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV--------------- 240
Query: 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318
++ F +V P A ++ L+ +P+ R T +AL P+ KG
Sbjct: 241 ------------KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 7e-65
Identities = 63/320 (19%), Positives = 114/320 (35%), Gaps = 52/320 (16%)
Query: 4 DQTKKELKDKDFFTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHI 63
+ ++L +DF ++I+ +G G++G V A + T A K I +
Sbjct: 2 EHVTRDLNPEDF---------WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT--KSE 50
Query: 64 SDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVI--KAND 121
+ + E+ +L HP+IV++ +++++ E + +
Sbjct: 51 EELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNLWILIEFCAGGAVDAVMLELER 105
Query: 122 DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181
LT Q Q L AL Y+H + HRDLK NIL + +K+ DFG++
Sbjct: 106 PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165
Query: 182 MTVFWTDYVATRWYRAPELCGSFFSK---YTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH 238
++ T ++ APE+ SK Y D+WS+G E+ +P + +
Sbjct: 166 RR---DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR 222
Query: 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIA 298
L I K P + L++ +
Sbjct: 223 VLLKIA----------------------------KSEPPTLAQPSRWSSNFKDFLKKCLE 254
Query: 299 FDPKDRPTAEEALADPYFKG 318
+ R T + L P+
Sbjct: 255 KNVDARWTTSQLLQHPFVTV 274
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 1e-64
Identities = 79/304 (25%), Positives = 117/304 (38%), Gaps = 48/304 (15%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
A Y++L IG GSYG G+ + K++ ++ ++ EV LLR L+H
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 62
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD----LTREHHQFFLYQML 136
P+IV ++ + +Y+V E E DL VI L E + Q+
Sbjct: 63 PNIVRYYDRIIDRTNTT---LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 137 RALKYMH-----TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVA 191
ALK H V HRDLKP N+ + +K+ DFGLAR+ DT +V
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA---KAFVG 176
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T +Y +PE Y DIWS+GC+ E+ P F S I +
Sbjct: 177 TPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------ 228
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
K +P ++ R++ RP+ EE L
Sbjct: 229 -------------------GKFRRIP-----YRYSDELNEIITRMLNLKDYHRPSVEEIL 264
Query: 312 ADPY 315
+P
Sbjct: 265 ENPL 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 1e-64
Identities = 83/351 (23%), Positives = 141/351 (40%), Gaps = 46/351 (13%)
Query: 23 NRYKIL-EVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVK-LLRLLR 80
+ YK+ +V+G G G V + T EK A+K + D + REV+ R +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQ 63
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDD--LTREHHQFFLYQMLR 137
P IV I + K + +V E ++ +L I+ D T + +
Sbjct: 64 CPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 138 ALKYMHTANVYHRDLKPKNIL---ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
A++Y+H+ N+ HRD+KP+N+L N LK+ DFG A+ S +T T +
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY----TPY 178
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254
Y APE+ G KY + D+WS+G I +L G P F + +
Sbjct: 179 YVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----------- 225
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314
T +R ++ V L++ L+ +P R T E + P
Sbjct: 226 ------------KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 273
Query: 315 YFKGLAKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILEYHPQLLK 365
+ K+ + P L+ + ER K+++ + ++Y +K
Sbjct: 274 WIMQSTKVPQTPLHTSRV-LKEDKERWEDVKEEMTSALATMRVDYEQIKIK 323
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 1e-62
Identities = 68/301 (22%), Positives = 122/301 (40%), Gaps = 41/301 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D K IG+GS+ V +DT T +VA ++ D S+ R E ++L+ L+
Sbjct: 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ 66
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP+IV K + K I +V ELM S L +K + + + + Q+L+ L
Sbjct: 67 HPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGL 125
Query: 140 KYMHTAN--VYHRDLKPKNIL-ANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
+++HT + HRDLK NI +K+ D GLA + + V + T +
Sbjct: 126 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-----IGTPEFM 180
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
APE+ + KY ++D+++ G E+ T + + Q+
Sbjct: 181 APEM---YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------- 221
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316
+ +T K P +++ I + +R + ++ L +F
Sbjct: 222 -------YRRVTSGVKPASFD-----KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
Query: 317 K 317
+
Sbjct: 270 Q 270
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 5e-62
Identities = 67/304 (22%), Positives = 123/304 (40%), Gaps = 47/304 (15%)
Query: 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHP 82
+K +++G+GS+ V A + T + AIK + + + RE ++ L HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 83 DIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
V++ K +Y + +L + I+ +F+ +++ AL+Y
Sbjct: 69 FFVKLYFTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H + HRDLKP+NIL N + +++ DFG A+V ++ +V T Y +PEL
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA-RANSFVGTAQYVSPELL 182
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ D+W++GCI +++ G P F + I
Sbjct: 183 TE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------------------ 222
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA------LADPY 315
++ + P P A L+++L+ D R EE A P+
Sbjct: 223 --------IKLEYDFP-----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
Query: 316 FKGL 319
F+ +
Sbjct: 270 FESV 273
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-59
Identities = 74/305 (24%), Positives = 121/305 (39%), Gaps = 47/305 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
+ Y E +G G + VV + TG + A K I I REV +L+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLR 137
++HP+++ + + D+ ++ EL+ L + + LT E FL Q+L
Sbjct: 70 IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 138 ALKYMHTANVYHRDLKPKNILAN----ANCKLKVCDFGLARVAFSDTPMTVFWTDYVATR 193
+ Y+H+ + H DLKP+NI+ ++K+ DFGLA + T
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF----KNIFGTP 180
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
+ APE+ D+WSIG I +L+G F G + L ++ + E
Sbjct: 181 EFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE 238
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
F N LA ++RL+ DPK R T +++L
Sbjct: 239 ---------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271
Query: 314 PYFKG 318
P+ K
Sbjct: 272 PWIKP 276
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 195 bits (496), Expect = 6e-59
Identities = 72/295 (24%), Positives = 120/295 (40%), Gaps = 33/295 (11%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLR 80
++RY++ E++G G V A D VA+K + D+ S +R RE + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP IV + + Y+V E ++ L ++ +T + + +AL
Sbjct: 66 HPAIVAVYDTGEAETPAG-PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+ H + HRD+KP NI+ +A +KV DFG+AR + T Y +PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
D++S+GC+ EVLTG+P F G S V
Sbjct: 185 QARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV--------------- 227
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-TAEEALAD 313
++ P+P + + ++ + +A +P++R TA E AD
Sbjct: 228 ------------REDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 8e-58
Identities = 57/295 (19%), Positives = 104/295 (35%), Gaps = 38/295 (12%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + + IG GS+G V VA+K ++ EV +LR R
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-LTREHHQFFLYQMLRA 138
H +I+ + +V + E S L+ + + Q +
Sbjct: 63 HVNILLFMGYS------TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ Y+H ++ HRDLK NI + + +K+ DFGLA V + F + + AP
Sbjct: 117 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF-EQLSGSILWMAP 175
Query: 199 E-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
E + + Y+ D+++ G + E++TG+ + + Q+ +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV------------- 222
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
R L + N RL+ + +RP + LA
Sbjct: 223 ------------GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 1e-56
Identities = 64/301 (21%), Positives = 117/301 (38%), Gaps = 45/301 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLL-RLLR 80
+ + +++GKGS+G V A T + AIK + DV D + E ++L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRAL 139
HP + + + ++++ V E + DL I++ F+ +++ L
Sbjct: 62 HPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 116
Query: 140 KYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPE 199
+++H+ + +RDLK NIL + + +K+ DFG+ + + T Y APE
Sbjct: 117 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAPE 173
Query: 200 LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+ KY ++D WS G + E+L G+ F G+ I
Sbjct: 174 ILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI---------------- 215
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE-EALADPYFKG 318
P P ++ A LL +L +P+ R + P F+
Sbjct: 216 ----------RMDNPFYP-----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260
Query: 319 L 319
+
Sbjct: 261 I 261
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 1e-55
Identities = 66/307 (21%), Positives = 118/307 (38%), Gaps = 57/307 (18%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLR 77
++Y++ ++G G +G V + I VAIK + + + + R+ EV LL+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 78 LLR--HPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLY 133
+ ++ + P ++ E E DL I L E + F +
Sbjct: 63 KVSSGFSGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERGALQEELARSFFW 117
Query: 134 QMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGLARVAFSDTPMTVFWTDYVAT 192
Q+L A+++ H V HRD+K +NIL + N +LK+ DFG + +TD+ T
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-----VYTDFDGT 172
Query: 193 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252
R Y PE + + + +WS+G + +++ G F +
Sbjct: 173 RVYSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------------- 216
Query: 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
+R + V L++ +A P DRPT EE
Sbjct: 217 -----------------IRGQVFFR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
Query: 313 DPYFKGL 319
P+ + +
Sbjct: 255 HPWMQDV 261
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 1e-55
Identities = 68/304 (22%), Positives = 127/304 (41%), Gaps = 48/304 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
N + L+++GKG++G V + TG A+K + +V + + E ++L+ RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESD-LHQVIKANDDLTREHHQFFLYQMLRALK 140
P + +K + + V E L + T E +F+ +++ AL+
Sbjct: 65 PFLTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALE 119
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+H+ +V +RD+K +N++ + + +K+ DFGL + SD + T Y APE+
Sbjct: 120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF---CGTPEYLAPEV 176
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260
+ Y A+D W +G + E++ G+ F + +LI
Sbjct: 177 LED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI----------------- 217
Query: 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPY 315
+ ++ P + P A LL L+ DPK R A+E + +
Sbjct: 218 ---------LMEEIRFP-----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263
Query: 316 FKGL 319
F +
Sbjct: 264 FLSI 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 185 bits (470), Expect = 5e-54
Identities = 65/307 (21%), Positives = 116/307 (37%), Gaps = 49/307 (15%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH----DVFEHISDAIRILREVKLLRL 78
N + + +IG+G +G V TG+ A+K + + + + A+ + L+
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 79 LRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLR 137
P IV + P K + + +LM DLH + + + +F+ +++
Sbjct: 64 GDCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL 118
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
L++MH V +RDLKP NIL + + +++ D GLA P T Y A
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG-----THGYMA 173
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
PE+ Y + D +S+GC+ ++L G F +
Sbjct: 174 PEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----------------- 215
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALA 312
E+ + + + P LL+ L+ D R A+E
Sbjct: 216 -----------EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264
Query: 313 DPYFKGL 319
P+F+ L
Sbjct: 265 SPFFRSL 271
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 180 bits (457), Expect = 1e-52
Identities = 66/302 (21%), Positives = 118/302 (39%), Gaps = 51/302 (16%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRHPD 83
++IL +G GS+G V H G A+K + ++ + E +L ++ HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 84 IVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHH-QFFLYQMLRALKYM 142
I+ + ++ + I+++ + +E + +F+ ++ AL+Y+
Sbjct: 66 IIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 143 HTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCG 202
H+ ++ +RDLKP+NIL + N +K+ DFG A+ T Y APE+
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV------TYTLCGTPDYIAPEVVS 174
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262
+ Y +ID WS G + E+L G F + + + I
Sbjct: 175 T--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------------------- 213
Query: 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADPYFK 317
+ + P P + LL RLI D R E+ P+FK
Sbjct: 214 -------LNAELRFP-----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
Query: 318 GL 319
+
Sbjct: 262 EV 263
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 4e-51
Identities = 63/295 (21%), Positives = 112/295 (37%), Gaps = 52/295 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ K+L+ IGKG +G V + G KVA+K I + + A L E ++ LR
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND----ATAQAFLAEASVMTQLR 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD--LTREHHQFFLYQMLR 137
H ++V++ +++ E +Y+V E M L +++ L + F +
Sbjct: 59 HSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
A++Y+ N HRDL +N+L + + KV DFGL + A S + A
Sbjct: 115 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ------DTGKLPVKWTA 168
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE K++ D+WS G + E+ + G+ +P + + +
Sbjct: 169 PEAL--REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK----------- 215
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
K P P +++ D RP+ +
Sbjct: 216 --------------GYKMDAP-----DGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 176 bits (446), Expect = 9e-51
Identities = 55/302 (18%), Positives = 111/302 (36%), Gaps = 49/302 (16%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH-DVFEHISDAIRILREVKLLRLLRH 81
+++ ++ +G GS+G V +G A+K + + L E ++L+ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKY 141
P +V+++ K V+ + ++ ++ + H +F+ Q++ +Y
Sbjct: 101 PFLVKLEFSF----KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 142 MHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELC 201
+H+ ++ +RDLKP+N+L + ++V DFG A+ T APE+
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR------TWTLCGTPEALAPEII 210
Query: 202 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
S Y A+D W++G + E+ G P F + + I
Sbjct: 211 LS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------------------ 250
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDR-----PTAEEALADPYF 316
+ K P + LL+ L+ D R + +F
Sbjct: 251 --------VSGKVRFP-----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
Query: 317 KG 318
Sbjct: 298 AT 299
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (438), Expect = 3e-50
Identities = 56/307 (18%), Positives = 100/307 (32%), Gaps = 44/307 (14%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
NRY++ IG GS+G + D GE+VAIK +H ++ E K+ ++++
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQG 61
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALK 140
+ R E +V EL+ S + + + QM+ ++
Sbjct: 62 GVGIPTIRW----CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 141 YMHTANVYHRDLKPKNILAN---ANCKLKVCDFGLARVAFSDTPMTVFW----TDYVATR 193
Y+H+ N HRD+KP N L + + DFGLA+ + T
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 194 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253
Y + + + D+ S+G + G + G +
Sbjct: 178 RYASINTH--LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ------------ 223
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE---EA 310
KY KK P+ L + D+P +
Sbjct: 224 -----------KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 272
Query: 311 LADPYFK 317
+ + +
Sbjct: 273 FRNLFHR 279
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (438), Expect = 5e-50
Identities = 62/308 (20%), Positives = 126/308 (40%), Gaps = 44/308 (14%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTH---TGEKVAIKKIH--DVFEHISDAIRILREVKLLR 77
+++L+V+G G+YG V TG+ A+K + + + E ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQML 136
+R + + L + + ++++ + + +L + + T Q ++ +++
Sbjct: 84 HIRQSPFL----VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYR 196
AL+++H + +RD+K +NIL ++N + + DFGL++ F + +
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFVADETERAYDFCGTIEYMA 198
Query: 197 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
+ G S + A+D WS+G + E+LTG F + I
Sbjct: 199 PDIVRGG-DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI------------- 244
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEAL 311
++ +PP P + LA L+QRL+ DPK R A+E
Sbjct: 245 ---------SRRILKSEPPYP-----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290
Query: 312 ADPYFKGL 319
+F+ +
Sbjct: 291 EHLFFQKI 298
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 8e-50
Identities = 56/297 (18%), Positives = 111/297 (37%), Gaps = 45/297 (15%)
Query: 30 VIGKGSYGVVCAAI--DTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEI 87
+G G++G V + VA+K + + + +L E +++ L +P IV +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 88 KRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN 146
I E + +V E+ E L++ ++ N + ++ ++Q+ +KY+ +N
Sbjct: 74 IGIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 147 VYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFS 206
HRDL +N+L K+ DFGL++ +D T + APE
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--Y 185
Query: 207 KYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARK 265
K++ D+WS G + E + G+ + G ++
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---------------------- 223
Query: 266 YLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE---ALADPYFKGL 319
E ++ P L+ +D ++RP L + Y+ +
Sbjct: 224 ---EKGERMGCP-----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 1e-49
Identities = 71/316 (22%), Positives = 111/316 (35%), Gaps = 55/316 (17%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
++ +G+G +G V T VAIK + L+E ++++ LR
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEA---FLQEAQVMKKLR 70
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME---SDLHQVIKANDDLTREHHQFFLYQMLR 137
H +V++ ++ + IY+V E M + L Q+
Sbjct: 71 HEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ Y+ N HRDL+ NIL N KV DFGLAR+ + + A
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR--QGAKFPIKWTA 182
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE ++T D+WS G + E+ T G+ +PG LD + P P
Sbjct: 183 PEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP---- 236
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DP 314
P L+ + +P++RPT E A +
Sbjct: 237 --------------------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 270
Query: 315 YFKGLAKIEREPSCQP 330
YF EP QP
Sbjct: 271 YFTST-----EPQYQP 281
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-49
Identities = 68/322 (21%), Positives = 121/322 (37%), Gaps = 35/322 (10%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
A + E IGKG +G V GE+VA+K E + E+ +LRH
Sbjct: 2 ARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREE---RSWFREAEIYQTVMLRH 56
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALK 140
+I+ + + +++V + E L + +T E L
Sbjct: 57 ENILGFIAADNKDNGT-WTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTASGLA 114
Query: 141 YMHTA--------NVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT-PMTVFWTDYVA 191
++H + HRDLK KNIL N + D GLA S T + + V
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 192 TRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247
T+ Y APE+ + + DI+++G +F E+ + G +QL +
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYDLVP 233
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
PS E + RK + E + +P +P + + ++++ + R TA
Sbjct: 234 SDPSVEEM--------RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285
Query: 308 EEALADPYFKGLAKIEREPSCQ 329
L+++ ++ +
Sbjct: 286 LRIKKT-----LSQLSQQEGIK 302
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 169 bits (429), Expect = 5e-49
Identities = 51/298 (17%), Positives = 95/298 (31%), Gaps = 43/298 (14%)
Query: 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH 81
YK+ IG+GS+GV+ + ++VAIK SDA ++ E + +LL
Sbjct: 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP----RRSDAPQLRDEYRTYKLLAG 59
Query: 82 PDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD-LTREHHQFFLYQMLRALK 140
+ + +E +V +L+ L ++ + + QML ++
Sbjct: 60 CTGIPN----VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 141 YMHTANVYHRDLKPKNILANANC-----KLKVCDFGLARVAFSDTPMTVFW----TDYVA 191
+H ++ +RD+KP N L + V DFG+ + +
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 192 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPS 251
T Y + + + D+ ++G +F L G + G
Sbjct: 176 TARYMSINTH--LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ---------- 223
Query: 252 PETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE 309
KY KK PL + + + P +
Sbjct: 224 -------------KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDY 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (427), Expect = 1e-48
Identities = 71/321 (22%), Positives = 123/321 (38%), Gaps = 51/321 (15%)
Query: 16 FTEYGDANRYKILEVIGKGSYGVVCAAIDTHTGEK---VAIKKIHDVFEHISDAIRILRE 72
F + D + KI +VIG G +G VC+ G++ VAIK + + L E
Sbjct: 19 FAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE-KQRRDFLSE 77
Query: 73 VKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDD--LTREHHQF 130
++ HP+++ ++ ++ + + ++ E ME+ +D T
Sbjct: 78 ASIMGQFDHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSFLRQNDGQFTVIQLVG 132
Query: 131 FLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWT--D 188
L + +KY+ N HRDL +NIL N+N KV DFGL+R DT + +
Sbjct: 133 MLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLL 247
+ AP + K+T A D+WS G + EV++ G+ + + ++ I
Sbjct: 193 GKIPIRWTAP--EAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---- 246
Query: 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTA 307
E + P P + +L+ D RP
Sbjct: 247 ---------------------EQDYRLPPP-----MDCPSALHQLMLDCWQKDRNHRPKF 280
Query: 308 EEALADPYFKGLAKIEREPSC 328
+ + L K+ R P+
Sbjct: 281 GQIVNT-----LDKMIRNPNS 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (425), Expect = 1e-48
Identities = 62/310 (20%), Positives = 119/310 (38%), Gaps = 48/310 (15%)
Query: 23 NRYKILEV-IGKGSYGVVCAAIDTHTGEK--VAIKKIHDVFEHISDAIRILREVKLLRLL 79
+ I ++ +G G++G V + ++ VAIK + E +D ++RE +++ L
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQL 66
Query: 80 RHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLR 137
+P IV + + + + + +V E+ LH+ + +++ + L+Q+
Sbjct: 67 DNPYIVRLIGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+KY+ N HRDL +N+L K+ DFGL++ +D + + A
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE K++ D+WS G E L+ G+ + + I
Sbjct: 181 PECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI------------- 225
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE---ALAD 313
E K+ P P P L+ + +DRP +
Sbjct: 226 ------------EQGKRMECP-----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 268
Query: 314 PYFKGLAKIE 323
Y+ +K+E
Sbjct: 269 CYYSLASKVE 278
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-48
Identities = 61/302 (20%), Positives = 111/302 (36%), Gaps = 50/302 (16%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
K++E +G G +G V + KVA+K + + L E L++ L+
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLK---QGSMSPDAFLAEANLMKQLQ 66
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDL---HQVIKANDDLTREHHQFFLYQMLR 137
H +V + ++ + IY++ E ME+ + LT Q+
Sbjct: 67 HQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 138 ALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRA 197
+ ++ N HRDL+ NIL + K+ DFGLAR+ + + A
Sbjct: 121 GMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA--REGAKFPIKWTA 178
Query: 198 PELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256
PE + +T D+WS G + E++T G+ +PG + + + P+
Sbjct: 179 PEAI--NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--- 233
Query: 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DP 314
N +L++ P+DRPT + + +
Sbjct: 234 ---------------------------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLED 266
Query: 315 YF 316
+F
Sbjct: 267 FF 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-48
Identities = 61/303 (20%), Positives = 106/303 (34%), Gaps = 44/303 (14%)
Query: 16 FTEYGDANRYKILEVIGKGSYGVVCAAI---DTHTGEKVAIKKIH-DVFEHISDAIRILR 71
T ++LE +G GS+GVV + VA+K + DV +R
Sbjct: 1 LTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 60
Query: 72 EVKLLRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQ 129
EV + L H +++ + ++ + +V EL S L ++ K
Sbjct: 61 EVNAMHSLDHRNLIRLYGVV------LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS 114
Query: 130 FFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDY 189
+ Q+ + Y+ + HRDL +N+L +K+ DFGL R + V
Sbjct: 115 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 174
Query: 190 VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLG 248
+ APE + ++ A D W G E+ T G+ + G + L I
Sbjct: 175 KVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----- 227
Query: 249 TPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE 308
+ ++ P P + ++ + A P+DRPT
Sbjct: 228 -------------------DKEGERLPRP-----EDCPQDIYNVMVQCWAHKPEDRPTFV 263
Query: 309 EAL 311
Sbjct: 264 ALR 266
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 169 bits (427), Expect = 5e-48
Identities = 62/335 (18%), Positives = 114/335 (34%), Gaps = 37/335 (11%)
Query: 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHP 82
RY ++ +G G + V A D VA+K + + E+KLL+ +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDA 69
Query: 83 DIVEIKRIMLP------------PSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQF 130
D + + + + + + +
Sbjct: 70 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129
Query: 131 FLYQMLRALKYMHTA-NVYHRDLKPKNILANAN-CKLKVCDFGLARVAFSDTPMTVFWTD 188
Q+L L YMH + H D+KP+N+L + +A + + +T+
Sbjct: 130 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-HYTN 188
Query: 189 YVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSV------VHQLDL 242
+ TR YR+PE+ + + DIWS C+ E++TG LF +
Sbjct: 189 SIQTREYRSPEVL--LGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 243 ITDLLGTPSPETIAVVRNEK----ARKYLTEMRKKPPVPL-------FQKFPNVDPLALR 291
I +LLG + + + +R L + K PL ++ +
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 292 LLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREP 326
L ++ DP+ R A + P+ K +E
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIR 341
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 7e-48
Identities = 57/296 (19%), Positives = 102/296 (34%), Gaps = 46/296 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D L+ +G G +GVV VAIK I E + E K++ L
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIK---EGSMSEDEFIEEAKVMMNLS 57
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLRA 138
H +V++ + + + I+++ E M L+ + + + + A
Sbjct: 58 HEKLVQLYGVCT-----KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 112
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
++Y+ + HRDL +N L N +KV DFGL+R D + + P
Sbjct: 113 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS--VGSKFPVRWSPP 170
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
E+ SK++ DIW+ G + E+ + GK + + + I L P
Sbjct: 171 EVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH---- 224
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
++ +RPT + L++
Sbjct: 225 --------------------------LASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 1e-47
Identities = 68/323 (21%), Positives = 119/323 (36%), Gaps = 69/323 (21%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKL 75
+ +V+G G++G V A + +VA+K + + + S+ ++ E+K+
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKM 93
Query: 76 L-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD----------- 122
+ +L H +IV + IY++FE DL +++ +
Sbjct: 94 MTQLGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 123 ------------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDF 170
LT E F YQ+ + ++++ + HRDL +N+L +K+CDF
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208
Query: 171 GLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKP 229
GLAR SD+ V + APE F YT D+WS G + E+ + G
Sbjct: 209 GLARDIMSDSNYVVRGN-ARLPVKWMAPESL--FEGIYTIKSDVWSYGILLWEIFSLGVN 265
Query: 230 LFPGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLA 289
+PG V + + K P
Sbjct: 266 PYPGIPVDANFYKL------------------------IQNGFKMDQP-----FYATEEI 296
Query: 290 LRLLQRLIAFDPKDRPTAEEALA 312
++Q AFD + RP+ +
Sbjct: 297 YIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 9e-47
Identities = 66/294 (22%), Positives = 108/294 (36%), Gaps = 46/294 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
D + ++ IG G +G+V +KVAIK I + D + E +++ L
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEED---FIEEAEVMMKLS 58
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDDLTREHH-QFFLYQMLRA 138
HP +V++ + L + I +VFE ME L ++ L +
Sbjct: 59 HPKLVQLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 113
Query: 139 LKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAP 198
+ Y+ A V HRDL +N L N +KV DFG+ R D T + +P
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASP 171
Query: 199 ELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257
E+ FS+Y+ D+WS G + EV + GK + +S ++ I+ P
Sbjct: 172 EVF--SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPR---- 225
Query: 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
+++ P+DRP L
Sbjct: 226 --------------------------LASTHVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-45
Identities = 61/339 (17%), Positives = 123/339 (36%), Gaps = 52/339 (15%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+K ++V+G G++G V + GE VAIK++ + ++ IL E ++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAYVMASVD 69
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
+P + + I L + + + L V + D++ ++ + Q+ + +
Sbjct: 70 NPHVCRLLGICLTSTVQ----LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+ + HRDL +N+L +K+ DFGLA++ ++ + A E
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMALES 184
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
YT D+WS G E++T G + G ++
Sbjct: 185 ILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-------------- 228
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319
++ P P P ++ + D RP E + +
Sbjct: 229 -----------GERLPQP-----PICTIDVYMIMVKCWMIDADSRPKFRELIIE-----F 267
Query: 320 AKIEREPSCQPISKLEFEFERRRVTKDDIRELIYREILE 358
+K+ R+P L + + R YR +++
Sbjct: 268 SKMARDPQ----RYLVIQGDERMHLPSPTDSNFYRALMD 302
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (404), Expect = 2e-45
Identities = 55/292 (18%), Positives = 108/292 (36%), Gaps = 40/292 (13%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR 80
+ + +G G YG V + VA+K + + + L+E +++ ++
Sbjct: 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIK 71
Query: 81 HPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALK 140
HP++V++ + ++ + + L + +++ + Q+ A++
Sbjct: 72 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAME 129
Query: 141 YMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPEL 200
Y+ N HRDL +N L N +KV DFGL+R+ DT + APE
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA--HAGAKFPIKWTAPES 187
Query: 201 CGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259
+K++ D+W+ G + E+ T G +PG + +L+ PE
Sbjct: 188 LAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE------ 239
Query: 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311
L++ ++P DRP+ E
Sbjct: 240 ------------------------GCPEKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 6e-45
Identities = 67/299 (22%), Positives = 110/299 (36%), Gaps = 47/299 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHT---GEKVAIKKIHDVFEHISDAIRILREVKLLR 77
R ++ IG+G +G V I VAIK + S + L+E +R
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD-SVREKFLQEALTMR 63
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQM 135
HP IV++ ++ ++++ EL + L + YQ+
Sbjct: 64 QFDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 136 LRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWY 195
AL Y+ + HRD+ +N+L ++N +K+ DFGL+R T + +
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA--SKGKLPIKW 175
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPET 254
APE ++T A D+W G E+L G F G + I +
Sbjct: 176 MAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN--------- 224
Query: 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
++ P+P PN P L+ + A+DP RP E A
Sbjct: 225 ----------------GERLPMP-----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-44
Identities = 68/314 (21%), Positives = 120/314 (38%), Gaps = 50/314 (15%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK----VAIKKIHDVFEHISDAIRILREVKLL 76
+ +VIG G +G V + + K VAIK + + + L E ++
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE-KQRVDFLGEAGIM 63
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQ 134
H +I+ ++ ++ ++K + ++ E ME + + + + + + L
Sbjct: 64 GQFSHHNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 135 MLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRW 194
+ +KY+ N HRDL +NIL N+N KV DFGL+RV D T +
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 195 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPE 253
+ APE K+T A D+WS G + EV+T G+ + S + I D P+P
Sbjct: 179 WTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP- 235
Query: 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313
+ +L+ + + RP + ++
Sbjct: 236 -----------------------------MDCPSAIYQLMMQCWQQERARRPKFADIVSI 266
Query: 314 PYFKGLAKIEREPS 327
L K+ R P
Sbjct: 267 -----LDKLIRAPD 275
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (395), Expect = 5e-44
Identities = 57/320 (17%), Positives = 106/320 (33%), Gaps = 70/320 (21%)
Query: 23 NRYKILEVIGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLR 77
N + + IG+G++G V A + VA+K + + RE L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMA 71
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-------------- 122
+P+IV++ + + ++FE M DL++ +++
Sbjct: 72 EFDNPNIVKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 123 ----------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGL 172
L+ Q+ + Y+ HRDL +N L N +K+ DFGL
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLF 231
+R +S D + RW + + +YT D+W+ G + E+ + G +
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYN---RYTTESDVWAYGVVLWEIFSYGLQPY 243
Query: 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALR 291
G + + + D P N
Sbjct: 244 YGMAHEEVIYYVRD-------------------------GNILACP-----ENCPLELYN 273
Query: 292 LLQRLIAFDPKDRPTAEEAL 311
L++ + P DRP+
Sbjct: 274 LMRLCWSKLPADRPSFCSIH 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 8e-43
Identities = 65/317 (20%), Positives = 111/317 (35%), Gaps = 64/317 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAA-----IDTHTGEKVAIKKIHDVFEHISDAIRILREVKL 75
NR + +G G++G V A I + VA+K + H+++ ++ E+K+
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP-SAHLTEREALMSELKV 79
Query: 76 L-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD----------- 122
L L H +IV + V+ E DL ++ D
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 123 -------LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
L E F YQ+ + + ++ + N HRDL +NIL K+CDFGLAR
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234
+D+ V + +W + YT D+WS G E+ + G +PG
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNC---VYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
V + + + P + +++
Sbjct: 252 PVDSKFYKMIK------------------------EGFRMLSP-----EHAPAEMYDIMK 282
Query: 295 RLIAFDPKDRPTAEEAL 311
DP RPT ++ +
Sbjct: 283 TCWDADPLKRPTFKQIV 299
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 9e-43
Identities = 63/313 (20%), Positives = 110/313 (35%), Gaps = 63/313 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEK--VAIKKIHDVFEHISDAIRILREVKLL-R 77
D N K +VIG+G++G V A G + AIK++ + D E+++L +
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCK 66
Query: 78 LLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD-------------- 122
L HP+I+ + +Y+ E +L ++ +
Sbjct: 67 LGHHPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121
Query: 123 --LTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180
L+ + F + R + Y+ HRDL +NIL N K+ DFGL+R
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQ 239
T+ + A E S YT D+WS G + E+++ G + G +
Sbjct: 182 KKTMG----RLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235
Query: 240 LDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAF 299
+ + + P N D L+++
Sbjct: 236 YEKLPQ-------------------------GYRLEKP-----LNCDDEVYDLMRQCWRE 265
Query: 300 DPKDRPTAEEALA 312
P +RP+ + L
Sbjct: 266 KPYERPSFAQILV 278
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 3e-42
Identities = 55/291 (18%), Positives = 104/291 (35%), Gaps = 44/291 (15%)
Query: 29 EVIGKGSYGVVCAAID---THTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIV 85
EVIG+G +G V A+K ++ + I + + L E +++ HP+++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 86 EIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQ--FFLYQMLRALKYMH 143
+ I L VV M+ + N+ F Q+ + +K++
Sbjct: 92 SLLGICLRSEGS----PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 144 TANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFW-TDYVATRWYRAPELCG 202
+ HRDL +N + + +KV DFGLAR + +V T + A E
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 203 SFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261
+ K+T D+WS G + E++T G P +P + +
Sbjct: 208 T--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---------------- 249
Query: 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312
++ P ++ + + RP+ E ++
Sbjct: 250 ---------GRRLLQP-----EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 4e-42
Identities = 58/319 (18%), Positives = 114/319 (35%), Gaps = 65/319 (20%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE-------KVAIKKIHDVFEHISDAIRILREV 73
+R + + +G+G++G V A + KVA+K + D ++ E+
Sbjct: 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEM 69
Query: 74 KLL-RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIK------------- 118
+++ + +H +I+ + + +YV+ E +L + ++
Sbjct: 70 EMMKMIGKHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 119 ---ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175
+ L+ + YQ+ R ++Y+ + HRDL +N+L + +K+ DFGLAR
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGK 234
+ +W L YT D+WS G + E+ T G +PG
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFD---RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241
Query: 235 SVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQ 294
V L+ + + P N +++
Sbjct: 242 PVEELFKLLKE-------------------------GHRMDKP-----SNCTNELYMMMR 271
Query: 295 RLIAFDPKDRPTAEEALAD 313
P RPT ++ + D
Sbjct: 272 DCWHAVPSQRPTFKQLVED 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 2e-41
Identities = 53/320 (16%), Positives = 110/320 (34%), Gaps = 62/320 (19%)
Query: 21 DANRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKL 75
+ + +G+GS+G+V + +VAIK +++ + I L E +
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM-RERIEFLNEASV 76
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKANDD----------LT 124
++ +V + ++ V+ ELM DL +++ +
Sbjct: 77 MKEFNCHHVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131
Query: 125 REHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTV 184
++ + Y++ HRDL +N + + +K+ DFG+ R +T
Sbjct: 132 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD-IYETDYYR 190
Query: 185 FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLI 243
+ + +PE +T D+WS G + E+ T + + G S L +
Sbjct: 191 KGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248
Query: 244 TDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKD 303
+ P N + L++ ++PK
Sbjct: 249 ME-------------------------GGLLDKP-----DNCPDMLFELMRMCWQYNPKM 278
Query: 304 RPTAEEALA------DPYFK 317
RP+ E ++ +P F+
Sbjct: 279 RPSFLEIISSIKEEMEPGFR 298
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 2e-40
Identities = 59/314 (18%), Positives = 112/314 (35%), Gaps = 59/314 (18%)
Query: 21 DANRYKILEVIGKGSYGVVCAAID-----THTGEKVAIKKIHDVFEHISDAIRILREVKL 75
+R K+ + +G+G++G V A T T VA+K + + H + L
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70
Query: 76 LRLLRHPDIVEIKRIMLPPSKREFKDIYVVFELME-SDLHQVIKAN-------------- 120
+ + H ++V + P + V+ E + +L +++
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 121 --DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178
D LT EH + +Q+ + ++++ + HRDL +NIL + +K+CDFGLAR +
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVV 237
D + +W + YT D+WS G + E+ + +PG +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFD---RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 238 HQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLI 297
+ + + P P + +
Sbjct: 244 EEFCRR------------------------LKEGTRMRAP-----DYTTPEMYQTMLDCW 274
Query: 298 AFDPKDRPTAEEAL 311
+P RPT E +
Sbjct: 275 HGEPSQRPTFSELV 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.5 bits (234), Expect = 5e-23
Identities = 25/210 (11%), Positives = 62/210 (29%), Gaps = 30/210 (14%)
Query: 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIH--------DVFEHISDAIRILREVKLL 76
I +++G+G V + +K + +
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 77 RLLRHPDIVEIKRIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQML 136
+ +++ + +P ++ V+ EL+++ ++ E+ L +L
Sbjct: 61 ARNEFRALQKLQGLAVPK-VYAWEGNAVLMELIDAKELYRVR------VENPDEVLDMIL 113
Query: 137 RALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTD-YVATRWY 195
+ + + H DL N+L + + + DF + + + D ++
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVL-VSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 196 RAPELCGSFFSKYTPAIDIWSIGCIFAEVL 225
Y DI S +L
Sbjct: 173 S---------RTYRTEKDINS---AIDRIL 190
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 556 | |||
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.41 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.82 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.73 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.1 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.97 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.49 |
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-61 Score=496.52 Aligned_cols=332 Identities=40% Similarity=0.751 Sum_probs=278.5
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC-C
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-R 97 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~-~ 97 (556)
+...++|++++.||+|+||+||+|+++.+|+.||||+++...........+.+|+.+|+.++|||||+++++|..... .
T Consensus 14 ~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 14 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence 345679999999999999999999999999999999998766666677889999999999999999999999975432 3
Q ss_pred CCceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 98 EFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
...++|||||||+.+|..+++. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 94 ~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 94 DFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp TCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 4457899999998888887764 579999999999999999999999999999999999999999999999999998754
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.. .+..+||++|+|||++.+. ..++.++|||||||++|+|++|++||.+.+..+.+..+....+.++.+.+..
T Consensus 173 ~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (346)
T d1cm8a_ 173 SE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR 245 (346)
T ss_dssp SS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred Cc------cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence 32 2567799999999998752 4578999999999999999999999999999999999999999999999988
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhh
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFE 337 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~ 337 (556)
........+...........+...++.+++++.|||++||..||++|||++|+|+||||+.+...+.+|..+ +++..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~~~~~~---~~~~~ 322 (346)
T d1cm8a_ 246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQ---KYDDS 322 (346)
T ss_dssp CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC------CCC---CCCCC
T ss_pred hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccccccCC---CCCCc
Confidence 888877787777777777777778889999999999999999999999999999999999987776666544 33445
Q ss_pred HhhhcCCHHHHHHHHHHHHHhhCh
Q 008729 338 FERRRVTKDDIRELIYREILEYHP 361 (556)
Q Consensus 338 ~~~~~~~~~~~~~~~~~e~~~~~~ 361 (556)
++....+.+++++++++|+.+++|
T Consensus 323 ~~~~~~~~~e~k~~~~~e~~~~~~ 346 (346)
T d1cm8a_ 323 FDDVDRTLDEWKRVTYKEVLSFKP 346 (346)
T ss_dssp -----CCHHHHHHHHHHHHHTCCC
T ss_pred hhhhhcCHHHHHHHHHHHhhcCCC
Confidence 566667889999999999998765
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-60 Score=488.47 Aligned_cols=340 Identities=45% Similarity=0.812 Sum_probs=285.2
Q ss_pred cCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 19 YGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 19 ~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
+..+.||++++.||+|+||+||+|.++.+|+.||||++... .......++++|+.+|+.|+||||+++++++.......
T Consensus 4 ~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp CCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 45667999999999999999999999999999999999753 34456678899999999999999999999998766566
Q ss_pred CceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 99 FKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
...+|||+++++|+|++++..+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred cceEEEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 6778999988889999999765 699999999999999999999999999999999999999999999999999987544
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
...........+||+.|+|||++... ..|+.++||||+||++|+|++|++||.+.+..++...+...++.|..+.....
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 33333333567899999999998552 56889999999999999999999999999999999999999999999888777
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhH
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEF 338 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~ 338 (556)
.......+..........++...++.+++.+.+||.+||+.||++|||++|+|+||||+....+..++..... +.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~~~~~~~~~--~~~~~ 318 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAP--FKFDM 318 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGGGSCCCSSC--C----
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCccCccccCc--cCCCh
Confidence 7777777777777777777777788999999999999999999999999999999999987666555544332 33455
Q ss_pred hhhcCCHHHHHHHHHHHHHhhChhh
Q 008729 339 ERRRVTKDDIRELIYREILEYHPQL 363 (556)
Q Consensus 339 ~~~~~~~~~~~~~~~~e~~~~~~~~ 363 (556)
+......+++++++++|...++|+.
T Consensus 319 ~~~~~~~~~l~~l~~~e~~~~~~~~ 343 (345)
T d1pmea_ 319 ELDDLPKEKLKELIFEETARFQPGY 343 (345)
T ss_dssp ----CCHHHHHHHHHHHSGGGSTTT
T ss_pred hhhhCCHHHHHHHHHHHHHhcCCCC
Confidence 6677899999999999999988864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-60 Score=475.14 Aligned_cols=261 Identities=25% Similarity=0.414 Sum_probs=217.0
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
..++|++++.||+|+||+||+|+++.+|+.||||+++... .......+.+|+.+|+.++|||||++++++ .+.+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~-----~~~~ 76 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHR-----REGN 76 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEE-----EETT
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHhCCCCCEeeEeeee-----ccCc
Confidence 3468999999999999999999999999999999987432 222345688999999999999999999999 5557
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|||||||+ |+|.+++..++.+++.+++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 77 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 77 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 7999999998 699999988889999999999999999999999999999999999999999999999999999875433
Q ss_pred CCCcceecccccCcccCCcccccccCCCC-CCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y-~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.. ....+..+||+.|||||++.+ ..| +.++||||||||||+|++|++||.+.+.........
T Consensus 157 ~~-~~~~~~~~GT~~Y~APE~~~~--~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~-------------- 219 (271)
T d1nvra_ 157 NR-ERLLNKMCGTLPYVAPELLKR--REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-------------- 219 (271)
T ss_dssp TE-ECCBCCCCSCGGGSCTHHHHC--SSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH--------------
T ss_pred Cc-cccccceeeCcCccCHhHhcC--CCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH--------------
Confidence 22 122356789999999999877 454 678999999999999999999998765433222111
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
... ......+..+++++.+||++||+.||++|||++|+|+||||+.
T Consensus 220 ------------~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 220 ------------KEK--KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ------------HTT--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ------------hcC--CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 011 1122234568999999999999999999999999999999974
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-59 Score=468.97 Aligned_cols=253 Identities=26% Similarity=0.443 Sum_probs=220.5
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++|||||++++++ .+...
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-----HDATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEE-----EECCE
Confidence 47999999999999999999999999999999986421 1222345688999999999999999999999 55667
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|||||||+ |+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence 999999999 6999999988899999999999999999999999999999999999999999999999999997654322
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
....+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+..|..
T Consensus 161 -----~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~--------------- 218 (263)
T d2j4za1 161 -----RTTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--------------- 218 (263)
T ss_dssp -----CEETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT---------------
T ss_pred -----ccccCCCCcccCHHHHcC--CCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc---------------
Confidence 245679999999999988 7899999999999999999999999999887666555422
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
... .....+++++.+||.+||+.||++|||++|+|+||||.+
T Consensus 219 -----------~~~-----~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 219 -----------VEF-----TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -----------TCC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -----------CCC-----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 111 122458999999999999999999999999999999974
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-59 Score=482.10 Aligned_cols=330 Identities=42% Similarity=0.810 Sum_probs=282.4
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC-CCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REF 99 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~ 99 (556)
..+||+++++||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.|+|||||++++++..... ++.
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 3579999999999999999999999999999999998766666777889999999999999999999999975432 344
Q ss_pred ceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 100 KDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 100 ~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
..+|+++++++|+|.+++.. +.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+|++|||+|......
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc
Confidence 55677777766899998864 57999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.....||+.|+|||++.+. ..++.++|||||||++|+|++|++||.+.+.......|....+.+..+......
T Consensus 175 ------~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 175 ------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp ------GSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred ------cccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 2456799999999987662 456899999999999999999999999999999999999999999998888777
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCCCCCcchhhHh
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQPISKLEFEFE 339 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~~~~~~~~~~~ 339 (556)
......+...+.......+...+..++++++|||++||+.||.+|||++|+|+||||+++..+..++...+. ...++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~---~~~~~ 324 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY---DQSFE 324 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCC---CCGGG
T ss_pred chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCC---CCccc
Confidence 777777766666666666666677899999999999999999999999999999999998777777765544 45677
Q ss_pred hhcCCHHHHHHHHHHHHHhhCh
Q 008729 340 RRRVTKDDIRELIYREILEYHP 361 (556)
Q Consensus 340 ~~~~~~~~~~~~~~~e~~~~~~ 361 (556)
......+++++.+++|+.++.|
T Consensus 325 ~~~~~~~~~k~~~~~e~~~~~p 346 (348)
T d2gfsa1 325 SRDLLIDEWKSLTYDEVISFVP 346 (348)
T ss_dssp GCCCCHHHHHHHHHHHHHTCCC
T ss_pred chhcCHHHHHHHHHHHhhccCC
Confidence 7889999999999999988654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-59 Score=473.44 Aligned_cols=256 Identities=27% Similarity=0.472 Sum_probs=220.5
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+|+.+|+.++|||||++++++ .+.+.
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 91 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSY-----LVGDE 91 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EETTE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC--hHHHHHHHHHHHHHhCCCCCEeeEeEEE-----EECCE
Confidence 4589999999999999999999999999999999874322 2345788999999999999999999999 45567
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|||||||. |+|.+++.. +.+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp EEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999999 699988876 469999999999999999999999999999999999999999999999999998754332
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
. .....+||+.|+|||++.+ ..|+.++|||||||++|+|++|++||.+.+..+.+..+...
T Consensus 171 ~---~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~-------------- 231 (293)
T d1yhwa1 171 S---KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-------------- 231 (293)
T ss_dssp C---CBCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHH--------------
T ss_pred c---cccccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhC--------------
Confidence 2 2256689999999999987 68999999999999999999999999988876665544221
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
. .+....+..+++.+++||++||+.||++|||++|+|+||||+.
T Consensus 232 ------------~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 232 ------------G--TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp ------------C--SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ------------C--CCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 1 1111233568999999999999999999999999999999974
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-58 Score=459.32 Aligned_cols=257 Identities=25% Similarity=0.342 Sum_probs=216.6
Q ss_pred Ce-EEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 24 RY-KILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 24 ~Y-~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
|| ++.++||+|+||+||+|+++.+++.||+|++............+.+|+++|+.++|||||++++++.... .....+
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~ 87 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCI 87 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEE
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEE
Confidence 45 7888999999999999999999999999999765555666778999999999999999999999985432 334679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCCcEeec-CCCceEEeeeCccccccC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTAN--VYHRDLKPKNILAN-ANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~g--IvHrDLKP~NILl~-~~~~vKL~DFGla~~~~~ 178 (556)
|||||||+ |+|.+++..++.+++..++.|+.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|+....
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999998 699999999889999999999999999999999999 99999999999996 578999999999986432
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
. .....+||+.|+|||++.+ .|+.++||||||||||+|++|+.||.+......+...
T Consensus 168 ~-----~~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~--------------- 224 (270)
T d1t4ha_ 168 S-----FAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR--------------- 224 (270)
T ss_dssp T-----SBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH---------------
T ss_pred C-----ccCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHH---------------
Confidence 2 1246789999999999865 6999999999999999999999999876654433221
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
+..... ........++++.+||.+||+.||++|||++|+|+||||+
T Consensus 225 -----------i~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 225 -----------VTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp -----------HTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred -----------HHcCCC--CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 111111 0111235789999999999999999999999999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-58 Score=470.26 Aligned_cols=258 Identities=28% Similarity=0.459 Sum_probs=207.5
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||+||+|+++.+|+.||||++...... .....+.+|+.+|+.++|||||++++++ .+.+.+
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~ 82 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHL 82 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 4699999999999999999999999999999999753222 2335678999999999999999999999 556779
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec---CCCceEEeeeCccccccC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN---ANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~---~~~~vKL~DFGla~~~~~ 178 (556)
|||||||+ |+|.++|..++.+++..++.|+.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+....
T Consensus 83 ~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred EEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 99999998 69999999999999999999999999999999999999999999999994 578999999999986543
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.. .....+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+....|..
T Consensus 163 ~~----~~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~------------- 223 (307)
T d1a06a_ 163 GS----VLSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK------------- 223 (307)
T ss_dssp --------------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT-------------
T ss_pred CC----eeeeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc-------------
Confidence 22 2245789999999999988 7899999999999999999999999999887665555432
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.........++.+++++.+||++||+.||++|||++|+|+||||++.
T Consensus 224 --------------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 224 --------------AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp --------------TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred --------------cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 11222223456799999999999999999999999999999999863
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-59 Score=469.48 Aligned_cols=259 Identities=25% Similarity=0.445 Sum_probs=219.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+++|+.++||||+++++++ .+.+.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence 46999999999999999999999999999999986421 1223345788999999999999999999999 55677
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|||||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 999999999 6999999999999999999999999999999999999999999999999999999999999998754332
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
.. ......+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+....+..|..
T Consensus 163 ~~-~~~~~~~GT~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~--------------- 224 (288)
T d1uu3a_ 163 KQ-ARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK--------------- 224 (288)
T ss_dssp --------CCCCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT---------------
T ss_pred cc-cccccccCCccccCceeecc--CCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc---------------
Confidence 21 12356789999999999988 7899999999999999999999999999887666655422
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHH------HHhCccccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEE------ALADPYFKGLA 320 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~e------lL~hp~f~~~~ 320 (556)
... .....+++++++||++||+.||++|||++| +++||||+++.
T Consensus 225 -----------~~~-----~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 225 -----------LEY-----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp -----------TCC-----CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred -----------CCC-----CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 111 122468999999999999999999999987 68999999764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-59 Score=473.36 Aligned_cols=282 Identities=37% Similarity=0.570 Sum_probs=227.6
Q ss_pred EEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChh---HHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceEE
Q 008729 27 ILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHIS---DAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDIY 103 (556)
Q Consensus 27 i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~---~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ly 103 (556)
.+++||+|+||+||+|+++.+|+.||||++........ ....+.+|+.+|+.++|||||++++++ .+..++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence 57899999999999999999999999999864322211 234688999999999999999999999 5556799
Q ss_pred EEEecCcccHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCCC
Q 008729 104 VVFELMESDLHQ-VIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTPM 182 (556)
Q Consensus 104 lV~E~~~g~L~~-~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~~ 182 (556)
||||||.+++.. ++..+..+++..++.|++||+.||+|||++||+||||||+|||++.++.+||+|||+|+........
T Consensus 77 ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp EEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred ehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 999999965544 4444667999999999999999999999999999999999999999999999999999765433222
Q ss_pred cceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhHH
Q 008729 183 TVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNEK 262 (556)
Q Consensus 183 ~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~ 262 (556)
....+||++|+|||++.+. ..|+.++||||||||+|+|++|.+||.+.+..+++..|.+.+|+|..+.+.......
T Consensus 157 ---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 ---YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp ---CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSST
T ss_pred ---ccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccc
Confidence 2456899999999988652 468999999999999999999999999999999999999999999877553221100
Q ss_pred HHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 263 ARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 263 ~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.. .........++...++.+++++.+||++||+.||++|||++|+|+||||++..
T Consensus 233 ~~---~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 233 DY---VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp TC---CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hh---hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 00 00011112222334567899999999999999999999999999999998653
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-59 Score=481.32 Aligned_cols=282 Identities=23% Similarity=0.356 Sum_probs=218.9
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||+||+|+++.+|+.||+|+++... .......+.+|+.+|+.++|||||+++++| .+...+
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~ 79 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAF-----YSDGEI 79 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEE-----ECSSEE
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 47999999999999999999999999999999997542 334456789999999999999999999999 455679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
|||||||. |+|.+++.+++.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+......
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 99999999 6999999988899999999999999999999997 499999999999999999999999999998754322
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhhCCCChHHHHHhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVH-QLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~-~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.+..+||++|+|||++.+ ..|+.++||||||||+|||++|+.||.+.+... +...+....|.+.........
T Consensus 160 -----~~~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 160 -----ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp -----C---CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred -----cccccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence 246789999999999988 789999999999999999999999998876433 222233333332211100000
Q ss_pred --------------hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 260 --------------NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 260 --------------~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.....+.+..+....+.... ...+++++.|||++||+.||++|||++|+|+||||++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCC--BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccccccchhHHHHHhhhhccCCccCc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 00011112222222221111 12368999999999999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-58 Score=461.26 Aligned_cols=256 Identities=30% Similarity=0.462 Sum_probs=210.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||+||+|+++.+|+.||||++............+.+|+++|+.++|||||++++++.+. ....+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~~ 80 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTTL 80 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCEE
Confidence 479999999999999999999999999999999986655666677899999999999999999999998532 33568
Q ss_pred EEEEecCc-ccHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeccCCCCcEeecCCCceEEeeeCc
Q 008729 103 YVVFELME-SDLHQVIKA----NDDLTREHHQFFLYQMLRALKYMHTAN-----VYHRDLKPKNILANANCKLKVCDFGL 172 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~----~~~l~~~~~~~i~~QIl~aL~yLHs~g-----IvHrDLKP~NILl~~~~~vKL~DFGl 172 (556)
|||||||+ |+|.+++.+ ++.+++..++.|+.||+.||+|||+.| |+||||||+|||++.++.+||+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 99999998 699998864 467999999999999999999999976 99999999999999999999999999
Q ss_pred cccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
|+....... .....+||+.|+|||++.+ ..|+.++||||||||+|||++|++||.+.+..+....|..
T Consensus 161 a~~~~~~~~---~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~------- 228 (269)
T d2java1 161 ARILNHDTS---FAKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------- 228 (269)
T ss_dssp HHHC--------------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-------
T ss_pred eeecccCCC---ccccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc-------
Confidence 987643322 2356789999999999987 6899999999999999999999999998887665554422
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccc
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYF 316 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f 316 (556)
.. .......+++++.+||++||+.||++|||++|+|+|||+
T Consensus 229 --------------------~~---~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 229 --------------------GK---FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp --------------------TC---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --------------------CC---CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 11 112234689999999999999999999999999999996
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-58 Score=472.82 Aligned_cols=257 Identities=26% Similarity=0.459 Sum_probs=224.3
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++ .+...
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----ccccc
Confidence 47999999999999999999999999999999997431 1223456788999999999999999999999 56678
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|+|||||. |+|.+++..++.++++.++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred cccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 999999999 6999999999999999999999999999999999999999999999999999999999999998654332
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
. .....+||++|+|||++.+ ..|+.++||||||||||||++|++||.+.+..+.+..+..
T Consensus 160 ~---~~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~--------------- 219 (337)
T d1o6la_ 160 A---TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM--------------- 219 (337)
T ss_dssp C---CBCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------------
T ss_pred c---ccccceeCHHHhhhhhccC--CCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc---------------
Confidence 2 2356789999999999988 7899999999999999999999999999887665554422
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
... ..+..+++++++||++||++||.+|+ +++|+++||||+++.
T Consensus 220 -----------~~~-----~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~ 268 (337)
T d1o6la_ 220 -----------EEI-----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp -----------CCC-----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred -----------CCC-----CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence 111 12346899999999999999999999 499999999998753
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-58 Score=465.99 Aligned_cols=258 Identities=22% Similarity=0.345 Sum_probs=219.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
+.|++++.||+|+||+||+|+++.+|+.||||++... .......+.+|+++|+.|+|||||++++++ .+.+.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~~ 84 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAF-----YYENNL 84 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEE-----EETTEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----eeCCeE
Confidence 4699999999999999999999999999999999753 334456788999999999999999999999 455679
Q ss_pred EEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 103 YVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
|||||||. |+|.+++.. .+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 85 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp EEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence 99999998 699998765 5679999999999999999999999999999999999999999999999999997543211
Q ss_pred CCcceecccccCcccCCccccccc---CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSF---FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~---~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
......+||+.|+|||++... ...|+.++|||||||+||+|++|++||.+.+..+.+..+..
T Consensus 165 ---~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~------------ 229 (288)
T d2jfla1 165 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK------------ 229 (288)
T ss_dssp ---HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHH------------
T ss_pred ---ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHc------------
Confidence 112456799999999998431 25689999999999999999999999999887766655432
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
.. .+.......+++++.+||++||+.||++|||++|+|+||||+.
T Consensus 230 --------------~~--~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 230 --------------SE--PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp --------------SC--CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred --------------CC--CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 11 1122233568999999999999999999999999999999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=461.50 Aligned_cols=259 Identities=28% Similarity=0.453 Sum_probs=223.2
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCC----hhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH----ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~----~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
++|++++.||+|+||+||+|+++.+|+.||||++.+.... ......+.+|+.+|+.|+|||||++++++ .+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~ 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----EN 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EE
Confidence 5899999999999999999999999999999998643221 12356788999999999999999999999 56
Q ss_pred CceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC----ceEEeeeCcc
Q 008729 99 FKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC----KLKVCDFGLA 173 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~----~vKL~DFGla 173 (556)
...+|||||||+ |+|.++|..++.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 678999999999 69999999888999999999999999999999999999999999999998776 4999999999
Q ss_pred ccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChH
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e 253 (556)
+....... ....+||+.|+|||++.+ ..|+.++|||||||+||+|++|+.||.+.+..+.+..|......+.
T Consensus 165 ~~~~~~~~----~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~-- 236 (293)
T d1jksa_ 165 HKIDFGNE----FKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE-- 236 (293)
T ss_dssp EECTTSCB----CSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC--
T ss_pred hhcCCCcc----ccccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC--
Confidence 87543322 245679999999999987 6899999999999999999999999999887777666543221111
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
...++.+++.+++||++||+.||++|||++|+|+||||+..
T Consensus 237 -------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 237 -------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp -------------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred -------------------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 11235689999999999999999999999999999999864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9e-58 Score=473.05 Aligned_cols=258 Identities=25% Similarity=0.411 Sum_probs=224.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||+||+|+++.+|+.||||++... ...+...+.+|+.+|+.|+|||||++++++ .+.+.+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~~ 98 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEM 98 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----EETTEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 4899999999999999999999999999999999753 445567789999999999999999999999 556779
Q ss_pred EEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC--CCceEEeeeCccccccC
Q 008729 103 YVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA--NCKLKVCDFGLARVAFS 178 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~--~~~vKL~DFGla~~~~~ 178 (556)
|||||||+ |+|.+++.. .+.+++..++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+....
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 99999998 699999954 567999999999999999999999999999999999999964 57899999999987543
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.. .....+||++|||||++.+ ..|+.++||||||||+|+|++|++||.+.+..+.+..|......
T Consensus 179 ~~----~~~~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--------- 243 (350)
T d1koaa2 179 KQ----SVKVTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN--------- 243 (350)
T ss_dssp TS----CEEEECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------
T ss_pred cc----ccceecCcccccCHHHHcC--CCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 32 2356789999999999988 78999999999999999999999999999887777666432211
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.....++.+++++++||++||+.||++|||++|+|+||||+...
T Consensus 244 ------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 244 ------------------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp ------------------SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred ------------------CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 11223356899999999999999999999999999999998654
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-57 Score=470.95 Aligned_cols=325 Identities=37% Similarity=0.670 Sum_probs=254.1
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC-CCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK-REFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~-~~~~~ 101 (556)
++|+++++||+|+||+||+|+++.+|+.||||++...........++.+|+.+|+.++||||++++++|..... +...+
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 78999999999999999999999999999999998766666777889999999999999999999999975432 45678
Q ss_pred EEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 102 IYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 102 lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
+|+|||||.+++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+++......
T Consensus 97 ~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~- 173 (355)
T d2b1pa1 97 VYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF- 173 (355)
T ss_dssp EEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred eEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc-
Confidence 99999999998887774 569999999999999999999999999999999999999999999999999987654322
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
..+..+||+.|+|||++.+ ..|++++||||+||++|+|++|++||.+.+...++..+...++.+.++.+.....
T Consensus 174 ---~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~- 247 (355)
T d2b1pa1 174 ---MMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP- 247 (355)
T ss_dssp ----------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH-
T ss_pred ---ccccccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh-
Confidence 2356679999999999987 7899999999999999999999999999999999999999999998887765433
Q ss_pred HHHHHHHHhhcCCCCCcCCCC------------CCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccccCCCCCC
Q 008729 262 KARKYLTEMRKKPPVPLFQKF------------PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKIEREPSCQ 329 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~------------~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~e~~~~~~ 329 (556)
....+...............+ ...++++.|||++||.+||++||||+|+|+||||+....++.....+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~~~~~~~~~ 327 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPP 327 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCCHHHHTCCC
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCCcccccCCC
Confidence 333333332222211111111 12467899999999999999999999999999999764332222211
Q ss_pred CCCcchhhHhhhcCCHHHHHHHHHHHHH
Q 008729 330 PISKLEFEFERRRVTKDDIRELIYREIL 357 (556)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~e~~ 357 (556)
+ ...+.+.+.+..+.+++++++++|++
T Consensus 328 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 354 (355)
T d2b1pa1 328 P-QIYDKQLDEREHTIEEWKELIYKEVM 354 (355)
T ss_dssp C--------CCCCCCHHHHHHHHHHHHH
T ss_pred C-CCCCcchhhhhcCHHHHHHHHHHHhc
Confidence 1 23344667778889999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-58 Score=463.85 Aligned_cols=288 Identities=37% Similarity=0.621 Sum_probs=233.9
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||+||+|++..+|+.||||+++...........+.+|+++|++++|||||++++++ .+...+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~-----~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI-----HTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc-----ccccce
Confidence 489999999999999999999999999999999975433333356788999999999999999999999 556679
Q ss_pred EEEEecCcccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 103 YVVFELMESDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 103 ylV~E~~~g~L~~~i~~--~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
|+|||||++++.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99999999887776654 4579999999999999999999999999999999999999999999999999998764333
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
. .....+||+.|+|||++... ..++.++|||||||++|+|++|+.||.+.+..+++..+....+.|....+.....
T Consensus 157 ~---~~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 R---TYTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp B---CTTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred c---cceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence 2 23556899999999987662 3457899999999999999999999999999999999999888887665443221
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAK 321 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~ 321 (556)
.. .+...........+...++.+++++.+||++||+.||++|||++|+|+||||+++.+
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 233 MP--DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp ST--TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred cc--ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence 10 000001111111222234578999999999999999999999999999999997743
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.8e-57 Score=471.21 Aligned_cols=257 Identities=26% Similarity=0.450 Sum_probs=224.2
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||+||+|+++.+|+.||||+++.. ...+...+.+|+.+|+.|+|||||+++++| .+...+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~ 101 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEM 101 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEE
Confidence 4799999999999999999999999999999998753 334566788999999999999999999999 556779
Q ss_pred EEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec--CCCceEEeeeCccccccC
Q 008729 103 YVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN--ANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~--~~~~vKL~DFGla~~~~~ 178 (556)
|||||||+ |+|.+.+...+ .+++.+++.|+.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+....
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999999 69999887654 699999999999999999999999999999999999998 578999999999987644
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.. .....+||+.|+|||++.+ ..|+.++|||||||+||+|++|++||.+.+..+.+..|...
T Consensus 182 ~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~------------ 243 (352)
T d1koba_ 182 DE----IVKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC------------ 243 (352)
T ss_dssp TS----CEEEECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC------------
T ss_pred CC----ceeeccCcccccCHHHHcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------
Confidence 32 2345679999999999987 78999999999999999999999999998887776665432
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
........++.+++++.+||++||++||.+|||++|+|+||||++.
T Consensus 244 ---------------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 244 ---------------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp ---------------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred ---------------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 1112233456799999999999999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-58 Score=463.86 Aligned_cols=288 Identities=35% Similarity=0.599 Sum_probs=235.7
Q ss_pred CCeEEEeeeeecCceeEEEEEECCC-CcEEEEEEecCccCChhHHHHHHHHHHHHHhC---CCCCcceeeEEEcCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHT-GEKVAIKKIHDVFEHISDAIRILREVKLLRLL---RHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~t-g~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L---~HpnIv~l~~v~~~~~~~~ 98 (556)
++|++++.||+|+||+||+|++..+ ++.||||++............+.+|+.+|+.| +||||+++++++.......
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 5899999999999999999999766 56799999865433333334566788887766 7999999999986554455
Q ss_pred CceEEEEEecCcccHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELMESDLHQVIK--ANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~g~L~~~i~--~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
...+|+|||||++++..+.. ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 67899999999976555443 3457999999999999999999999999999999999999999999999999998764
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
.... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+++..|...+|.|..+.+.
T Consensus 167 ~~~~----~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 167 SFQM----ALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CGGG----GGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred cccc----cCCCcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 3222 2356789999999999987 789999999999999999999999999999999999999999998876653
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
...... ..........+.......+++.+.+||++||++||++|||++|+|+||||+++.
T Consensus 241 ~~~~~~----~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 241 RDVALP----RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp TTCSSC----GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccch----hhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 221100 001122233344445667899999999999999999999999999999999764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-57 Score=459.49 Aligned_cols=254 Identities=26% Similarity=0.383 Sum_probs=217.4
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCC-hhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-ISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
+|++++.||+|+||+||+|+++.+|+.||||++...... ......+.+|+.+|+.|+|||||++++++ .+...+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY-----LREHTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----EETTEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEE-----EECCEE
Confidence 699999999999999999999999999999999754332 34456789999999999999999999999 455679
Q ss_pred EEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|||||||. |+|..++..++.+++..++.|++||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 91 ~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp EEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred EEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 99999999 567767777888999999999999999999999999999999999999999999999999999864321
Q ss_pred CcceecccccCcccCCccccccc-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 182 MTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~-~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
...+||+.|+|||++.+. ...|+.++|||||||++|||++|+.||.+.+..+.+..+..
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~--------------- 228 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---------------
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh---------------
Confidence 346799999999998642 24689999999999999999999999998887665554422
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
...+.. ....+++.+.+||.+||+.||++|||++|+|+||||..
T Consensus 229 -----------~~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 229 -----------NESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (309)
T ss_dssp -----------SCCCCC---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred -----------CCCCCC---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcC
Confidence 111111 12458999999999999999999999999999999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.8e-57 Score=461.42 Aligned_cols=254 Identities=26% Similarity=0.466 Sum_probs=222.5
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++|||||++++++ .+...
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence 47999999999999999999999999999999996432 1223356788999999999999999999999 55677
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
+|+|||||. |+|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 999999999 699999999999999999999999999999999999999999999999999999999999999875432
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
....+||+.|+|||++.+ ..|+.++|||||||+||+|++|+.||.+.+..+.+..|..
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~--------------- 215 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN--------------- 215 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---------------
T ss_pred -----cccccCcccccCHHHHcC--CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc---------------
Confidence 245689999999999987 6899999999999999999999999999887666655532
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
... ...+.+++++.+||++||..||.+|+ |++++|+||||+++.
T Consensus 216 -----------~~~-----~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 216 -----------AEL-----RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp -----------CCC-----CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred -----------CCC-----CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 111 12346899999999999999999996 999999999999763
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-57 Score=467.62 Aligned_cols=255 Identities=22% Similarity=0.391 Sum_probs=222.9
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+++|+++|+.++|||||++++++ .+..
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~ 114 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----cccc
Confidence 368999999999999999999999999999999986421 2223345788999999999999999999999 5667
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|+||||+. |+|.+++..++.+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 115 ~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 7999999999 699999998889999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
....+||+.|||||++.+ ..|+.++||||||||||+|++|++||.+.+....+..|...
T Consensus 195 ------~~~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~------------- 253 (350)
T d1rdqe_ 195 ------TWTLCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG------------- 253 (350)
T ss_dssp ------BCCCEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-------------
T ss_pred ------cccccCccccCCHHHHcC--CCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC-------------
Confidence 245679999999999988 78999999999999999999999999998876666555321
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
.. .....+++++.+||++||..||.+|+ |++++|+||||+++.
T Consensus 254 -------------~~-----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 254 -------------KV-----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp -------------CC-----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred -------------CC-----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence 11 12346899999999999999999995 999999999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.7e-56 Score=447.49 Aligned_cols=261 Identities=28% Similarity=0.438 Sum_probs=223.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCC-------hhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH-------ISDAIRILREVKLLRLLR-HPDIVEIKRIMLPP 94 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~-------~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~ 94 (556)
++|++++.||+|+||+||+|+++.+|+.||||++...... ......+++|+.+|+.|+ ||||+++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--- 79 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY--- 79 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence 5899999999999999999999999999999998643221 112346889999999997 99999999999
Q ss_pred CCCCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcc
Q 008729 95 SKREFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (556)
Q Consensus 95 ~~~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla 173 (556)
.+.+.+|||||||+ |+|.++|+.++.++++.++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|
T Consensus 80 --~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 80 --ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp --ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred --ccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchhe
Confidence 56678999999998 699999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCcccCCcccccc----cCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCC
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGS----FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGT 249 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~----~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~ 249 (556)
+....... .+..+||+.|+|||++.+ ....|+.++||||+|||||+|++|+.||.+.+..+....|...
T Consensus 158 ~~~~~~~~----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~--- 230 (277)
T d1phka_ 158 CQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--- 230 (277)
T ss_dssp EECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT---
T ss_pred eEccCCCc----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC---
Confidence 87543322 255789999999998853 1245789999999999999999999999998877666555321
Q ss_pred CChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 250 PSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 250 p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
........++++|+++++||.+||+.||++|||++|+|+||||++.
T Consensus 231 ------------------------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 231 ------------------------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp ------------------------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred ------------------------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 1111222345799999999999999999999999999999999853
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=458.99 Aligned_cols=255 Identities=24% Similarity=0.451 Sum_probs=221.5
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||+||+|+++.+|+.||||+++.. ..+...+.+|+.+|+.++|||||++++++ ++.+.+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~ 76 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESF-----ESMEEL 76 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEE-----EETTEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEE
Confidence 4899999999999999999999999999999999742 23445688999999999999999999999 556779
Q ss_pred EEEEecCc-ccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC--CceEEeeeCccccccC
Q 008729 103 YVVFELME-SDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN--CKLKVCDFGLARVAFS 178 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~--~~vKL~DFGla~~~~~ 178 (556)
|||||||. |+|.++|..++ .+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++....
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred EEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99999999 59999998765 79999999999999999999999999999999999999854 4799999999987533
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.. .....+||+.|+|||++.+ ..|+.++||||||||+|+|++|.+||.+.+..+.+..|......+.
T Consensus 157 ~~----~~~~~~~t~~y~ape~~~~--~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~------- 223 (321)
T d1tkia_ 157 GD----NFRLLFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD------- 223 (321)
T ss_dssp TC----EEEEEESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC-------
T ss_pred CC----cccccccccccccchhccC--CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-------
Confidence 22 2345679999999999987 6899999999999999999999999999988777776654222221
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
...++.+++++++||++||..||++|||++|+|+||||++
T Consensus 224 --------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 224 --------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp --------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred --------------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 1223568999999999999999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7e-57 Score=453.61 Aligned_cols=284 Identities=38% Similarity=0.635 Sum_probs=232.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|+++++||+|+||+||+|+++ +|+.||||+++..........++.+|+.+|+.++||||+++++++ .+.+.+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-----HTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE-----ECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec-----ccCCce
Confidence 58999999999999999999986 789999999976443334456789999999999999999999999 555679
Q ss_pred EEEEecCcccHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELMESDLHQ-VIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~g~L~~-~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
|+||||+.+.+.. +....+.+++..++.|+.||+.||+|||+.||+||||||+|||++.++.+||+|||+|........
T Consensus 76 ~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred eEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9999999975544 445577899999999999999999999999999999999999999999999999999987543322
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhhhH
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVRNE 261 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~ 261 (556)
. ....+|++.|+|||++.+. ..++.++|||||||++|||++|++||.+.+..+++..+...+|.|....+......
T Consensus 156 ~---~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 K---YTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ---------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c---cceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 1 2455799999999998763 46789999999999999999999999999999999999999999877665432210
Q ss_pred HHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 262 KARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 262 ~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
..+..........+.....+.+++.+.|||++||++||++|||++|+|+||||++
T Consensus 232 --~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 232 --PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp --TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred --hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0111112222333444556788999999999999999999999999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=8.5e-56 Score=460.67 Aligned_cols=260 Identities=24% Similarity=0.352 Sum_probs=215.3
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc----CChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF----EHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~----~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
.++|+++++||+|+||.||+|+++.+|+.||||++.+.. .......+..+|+.+|+.++|||||++++++ .
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence 358999999999999999999999999999999986321 1112222334457777888899999999999 5
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
+...+|||||||. |+|.++|..+..+++..++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..
T Consensus 78 ~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 78 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred ECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 5567999999999 799999999999999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
.... ....+||+.|+|||++.+. ..|+.++||||||||||+|++|+.||.+.+..+....+..
T Consensus 158 ~~~~-----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~----------- 220 (364)
T d1omwa3 158 SKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----------- 220 (364)
T ss_dssp SSSC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH-----------
T ss_pred CCCc-----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----------
Confidence 4332 2456799999999998642 5689999999999999999999999987664433222111
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCC-----HHHHHhCccccccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPT-----AEEALADPYFKGLA 320 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpt-----a~elL~hp~f~~~~ 320 (556)
. .......+..+++++.+||.+||+.||++||| ++|+|+||||+++.
T Consensus 221 -------------~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 221 -------------T----LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp -------------S----SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred -------------c----ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 0 11111233568999999999999999999999 89999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-56 Score=459.57 Aligned_cols=285 Identities=35% Similarity=0.582 Sum_probs=232.8
Q ss_pred CeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC-CCCCceE
Q 008729 24 RYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS-KREFKDI 102 (556)
Q Consensus 24 ~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~-~~~~~~l 102 (556)
+|+.+++||+|+||+||+|+++.+|+.||||++..... ...+|+.+|+.|+||||++++++|.... ..+..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 69999999999999999999999999999999975321 2247999999999999999999986543 2455678
Q ss_pred EEEEecCcccHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC-ceEEeeeCcccccc
Q 008729 103 YVVFELMESDLHQVI----KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLARVAF 177 (556)
Q Consensus 103 ylV~E~~~g~L~~~i----~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~vKL~DFGla~~~~ 177 (556)
|||||||++++.+.+ .....+++.+++.|++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999999997665544 3466899999999999999999999999999999999999999775 89999999998654
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
... .....+||+.|+|||++.+. ..|+.++|||||||++|||++|++||.+.+..+++..|.+.+|.|..+.+..
T Consensus 175 ~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 175 RGE----PNVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp TTS----CCCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred CCc----ccccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 332 22456899999999987652 5789999999999999999999999999999999999999999999887764
Q ss_pred hhhHHHHHHHHHhhcCCCCCcC-CCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccccc
Q 008729 258 VRNEKARKYLTEMRKKPPVPLF-QKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLAKI 322 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~-~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~~~ 322 (556)
......... .......++. ...+.+++++.+||++||.+||++|||++|+|+||||+++...
T Consensus 250 ~~~~~~~~~---~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 250 MNPNYTEFK---FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp HCC---CCC---CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hccchhhcc---ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 432211100 0011111111 2235689999999999999999999999999999999987543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-56 Score=453.70 Aligned_cols=257 Identities=24% Similarity=0.400 Sum_probs=220.4
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCcc-CChhHHHHHHHHHHHHH-hCCCCCcceeeEEEcCCCCCCCc
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVF-EHISDAIRILREVKLLR-LLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~-~~~~~~~~~~rEi~iL~-~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
++|+++++||+|+||+||+|.++.+|+.||||++.+.. ........+.+|+.++. .++|||||++++++ .+..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence 47999999999999999999999999999999996421 11223456677887765 68999999999999 5567
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|||||||+ |+|.+++..++.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 7999999999 699999999999999999999999999999999999999999999999999999999999999865433
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
.. ..+..+||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||.+.+....+..|..
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-------------- 217 (320)
T d1xjda_ 157 DA---KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------------- 217 (320)
T ss_dssp TC---CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------------
T ss_pred cc---cccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc--------------
Confidence 22 2355789999999999988 7899999999999999999999999999887666655421
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHH-HHHhCccccccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE-EALADPYFKGLA 320 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~-elL~hp~f~~~~ 320 (556)
... .....+++.+.+||++||+.||++|||++ ++++||||+++.
T Consensus 218 ------------~~~-----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 218 ------------DNP-----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp ------------CCC-----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred ------------CCC-----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 111 12245899999999999999999999995 899999999763
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-56 Score=452.38 Aligned_cols=296 Identities=34% Similarity=0.557 Sum_probs=230.2
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC---C
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK---R 97 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~---~ 97 (556)
+.++|+++++||+|+||+||+|+++.+|+.||||++............+.+|+++|+.++||||+++++++..... .
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 4579999999999999999999999999999999987544444455678899999999999999999999865321 2
Q ss_pred CCceEEEEEecCcccHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 98 EFKDIYVVFELMESDLHQVI-KANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 98 ~~~~lylV~E~~~g~L~~~i-~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
....+|+|||||++.+...+ .....+++..++.|++||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 34579999999997665555 44568999999999999999999999999999999999999999999999999999764
Q ss_pred cCCCC-CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 177 FSDTP-MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 177 ~~~~~-~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
..... ........+||++|+|||++.+. ..|+.++|||||||++|+|++|++||.+.+..+.+..|...++.+.++..
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred ccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 32221 11223456899999999998762 46899999999999999999999999999999999999999999987765
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCC--CCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKF--PNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
...........+........ .....+ ...++++.|||.+||++||++|||++|+|+||||+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKR-KVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp TTCCCC-------CCSSCCB-CHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred cccchhhhhhhhcccccccc-cchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 54433322222211111100 000000 024788999999999999999999999999999984
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=454.64 Aligned_cols=259 Identities=28% Similarity=0.428 Sum_probs=208.8
Q ss_pred CCeEEEe-eeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHh-CCCCCcceeeEEEcCCCCCCCc
Q 008729 23 NRYKILE-VIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRL-LRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 23 ~~Y~i~~-~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~-L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
++|++++ +||+|+||+||+|++..+|+.||||++++ ...+.+|+.++.+ ++|||||+++++|.+.. ....
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~ 82 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRK 82 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCC
Confidence 4799875 69999999999999999999999999864 2356789998654 58999999999984321 2346
Q ss_pred eEEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC---CCceEEeeeCccc
Q 008729 101 DIYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA---NCKLKVCDFGLAR 174 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~---~~~vKL~DFGla~ 174 (556)
.+|||||||+ |+|.++|... ..+++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 7999999998 6999999875 36999999999999999999999999999999999999985 4679999999998
Q ss_pred cccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
....... ....+||+.|+|||++.+ ..|+.++||||||||||+|+||++||.+.+.......+....
T Consensus 163 ~~~~~~~----~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i------- 229 (335)
T d2ozaa1 163 ETTSHNS----LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI------- 229 (335)
T ss_dssp ECCCCCC----CCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CC-------
T ss_pred eccCCCc----cccccCCcccCCcHHHcC--CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHH-------
Confidence 7544332 245679999999999987 689999999999999999999999998876554443332111
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccc
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKG 318 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~ 318 (556)
...........+..+++++.+||++||+.||++|||++|+|+||||.+
T Consensus 230 ----------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 230 ----------------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp ----------------CSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred ----------------hcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 000000001122358999999999999999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=437.47 Aligned_cols=287 Identities=36% Similarity=0.576 Sum_probs=236.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||+||+|++..+|+.||||+++..........++.+|+.+|+.++||||+++++++ .+...+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence 589999999999999999999999999999999976555556778899999999999999999999999 556679
Q ss_pred EEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCCC
Q 008729 103 YVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDTP 181 (556)
Q Consensus 103 ylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~~ 181 (556)
++|+|++.+ +|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.|+.......
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred eEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999995 7788888888999999999999999999999999999999999999999999999999999987543332
Q ss_pred CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhhCCCChHHHHHhhh
Q 008729 182 MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQLDLITDLLGTPSPETIAVVRN 260 (556)
Q Consensus 182 ~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~p-F~~~~~~~~~~~i~~~~g~p~~e~i~~~~~ 260 (556)
. .....++++|+|||++.+. ..++.++|||||||++|+|++|+.| |.+.+..+++..+....+.+....+.....
T Consensus 157 ~---~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 157 C---YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp C---CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred c---ceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 2 2455688999999998762 3478999999999999999999866 677888888999999888887655432211
Q ss_pred HHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 261 EKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 261 ~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.. .+................+.+++.+.+||++||+.||++|||++|+|+||||+++.
T Consensus 233 ~~--~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 233 LP--DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp ST--TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred cc--cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 00 00000000111223344567899999999999999999999999999999998753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-55 Score=439.70 Aligned_cols=250 Identities=26% Similarity=0.442 Sum_probs=210.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCC----hhHHHHHHHHHHHHHhCC--CCCcceeeEEEcCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEH----ISDAIRILREVKLLRLLR--HPDIVEIKRIMLPPS 95 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~----~~~~~~~~rEi~iL~~L~--HpnIv~l~~v~~~~~ 95 (556)
.++|++++.||+|+||+||+|+++.+|+.||||++...... .....++.+|+.+|+.++ |||||++++++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~---- 78 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF---- 78 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE----
Confidence 46899999999999999999999999999999998643211 112334678999999997 89999999999
Q ss_pred CCCCceEEEEEecCc--ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC-CceEEeeeCc
Q 008729 96 KREFKDIYVVFELME--SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN-CKLKVCDFGL 172 (556)
Q Consensus 96 ~~~~~~lylV~E~~~--g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~-~~vKL~DFGl 172 (556)
.+.+.+|+||||+. +++.+++..+..+++++++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 79 -~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 79 -ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp -ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred -eeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccc
Confidence 55677999999997 4889999888899999999999999999999999999999999999999854 7899999999
Q ss_pred cccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 173 ARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 173 a~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
|+..... ..+..+||+.|+|||++.+. ..++.++|||||||+||+|++|+.||.+.+. +.
T Consensus 158 a~~~~~~-----~~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i~-------- 217 (273)
T d1xwsa_ 158 GALLKDT-----VYTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------II-------- 217 (273)
T ss_dssp CEECCSS-----CBCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------HH--------
T ss_pred ceecccc-----cccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCchH------Hh--------
Confidence 9864332 23567899999999998762 3346789999999999999999999976321 10
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccccc
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGL 319 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~ 319 (556)
.... .....+++++.+||++||+.||++|||++|+|+||||+++
T Consensus 218 ------------------~~~~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 218 ------------------RGQV-----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp ------------------HCCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred ------------------hccc-----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 1111 1224689999999999999999999999999999999864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-54 Score=434.11 Aligned_cols=266 Identities=25% Similarity=0.378 Sum_probs=214.8
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.++|++++.||+|+||+||+|++..+|+.||||+++.... +.....++.+|+.+|+.++||||+++++++.... ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 4689999999999999999999999999999999976433 3445667999999999999999999999986432 2334
Q ss_pred eEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 101 DIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
.+|||||||+ ++|.+++...+.+++.+++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||.+......
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred eEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 6899999999 699999999899999999999999999999999999999999999999999999999999998765444
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
..........+||+.|+|||++.+ ..|++++||||||||+|+|+||++||.+.+..+.+..+..
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~-------------- 228 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-------------- 228 (277)
T ss_dssp --------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH--------------
T ss_pred cccccccccccCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHh--------------
Confidence 333334466789999999999987 6899999999999999999999999998886655544321
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCcccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFK 317 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~ 317 (556)
..+.+.....+.+++.+.+||++||+.||++||+..+.|.|+|++
T Consensus 229 -------------~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 229 -------------EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp -------------CCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred -------------cCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 222333345567999999999999999999999544455566654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-54 Score=443.27 Aligned_cols=287 Identities=31% Similarity=0.558 Sum_probs=223.9
Q ss_pred ccCCCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCC
Q 008729 18 EYGDANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSK 96 (556)
Q Consensus 18 ~~~~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~ 96 (556)
+++..++|+++++||+|+||+||+|+++.+|+.||||+++.. ...++.+|+.+|+.++ ||||+++++++...
T Consensus 30 ~~~~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~-- 102 (328)
T d3bqca1 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDP-- 102 (328)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT--
T ss_pred CCCCCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEec--
Confidence 466778999999999999999999999999999999998742 2456889999999995 99999999998542
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCC-ceEEeeeCccc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANC-KLKVCDFGLAR 174 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~-~vKL~DFGla~ 174 (556)
....+|+|||||. ++|..+. +.+++..++.+++||+.||+|||++||+||||||+|||++.++ .+||+|||+|+
T Consensus 103 -~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 103 -VSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp -TTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred -CCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccce
Confidence 3456999999999 5776653 4699999999999999999999999999999999999998655 69999999998
Q ss_pred cccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCC-CChHHHHHHHHHhhCCCChH
Q 008729 175 VAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG-KSVVHQLDLITDLLGTPSPE 253 (556)
Q Consensus 175 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~-~~~~~~~~~i~~~~g~p~~e 253 (556)
....... ....+||+.|+|||++.+. ..|+.++|||||||++|+|++|+.||.. .+..++...+...+|.|...
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 179 FYHPGQE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp ECCTTCC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred eccCCCc----ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence 7543322 2566799999999998763 4689999999999999999999999864 45666777787777765433
Q ss_pred HHHHhhhHHHHHHHHHhhcCCCCC------cCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCccccccc
Q 008729 254 TIAVVRNEKARKYLTEMRKKPPVP------LFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADPYFKGLA 320 (556)
Q Consensus 254 ~i~~~~~~~~~~~l~~~~~~~~~~------~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp~f~~~~ 320 (556)
.............+.......... .......+++++.|||++||++||++|||++|+|+||||+.+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 222111000000000011111100 0112234789999999999999999999999999999998753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-53 Score=423.49 Aligned_cols=257 Identities=21% Similarity=0.266 Sum_probs=208.0
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||+|+||+||+|+. +..||||+++...........+.+|+.+|++++|||||++++++.. ..
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence 46899999999999999999964 3469999997655556677889999999999999999999998632 34
Q ss_pred EEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 799999999 7999999764 56999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcceecccccCcccCCccccccc-CCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSF-FSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
... ......+||+.|||||++.+. ...|+.++|||||||+||||+||+.||.+.+....+..+...
T Consensus 158 ~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~------------ 224 (276)
T d1uwha_ 158 SGS-HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR------------ 224 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH------------
T ss_pred CCc-ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhc------------
Confidence 221 223556799999999998642 135899999999999999999999999987765554333210
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
............++++.+.+||.+||..||++|||+++++++
T Consensus 225 -------------~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 225 -------------GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp -------------TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------CCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111112223445789999999999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-53 Score=423.15 Aligned_cols=255 Identities=21% Similarity=0.321 Sum_probs=207.8
Q ss_pred eEEE-eeeeecCceeEEEEEEC--CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 25 YKIL-EVIGKGSYGVVCAAIDT--HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 25 Y~i~-~~LG~G~~g~V~~a~~~--~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
+.+. ++||+|+||+||+|.+. .+++.||||+++...........+++|+.+|++++|||||++++++.. ..
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~------~~ 81 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ES 81 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES------SS
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc------CC
Confidence 4443 47999999999999864 456789999997654455556789999999999999999999999842 24
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCCC
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSDT 180 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~~ 180 (556)
.|||||||+ |+|.+++..+..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred EEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 799999999 6999999999999999999999999999999999999999999999999999999999999998765443
Q ss_pred CCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHHhh
Q 008729 181 PMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAVVR 259 (556)
Q Consensus 181 ~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~~ 259 (556)
..........||+.|+|||++.+ ..|+.++|||||||++|||++ |++||.+.+..+....|..
T Consensus 162 ~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-------------- 225 (277)
T d1xbba_ 162 NYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------------- 225 (277)
T ss_dssp SEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT--------------
T ss_pred cccccccccCCCceecCchhhcC--CCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc--------------
Confidence 33323345679999999999987 689999999999999999998 8999998876555444321
Q ss_pred hHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHH---HhCcccc
Q 008729 260 NEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA---LADPYFK 317 (556)
Q Consensus 260 ~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~el---L~hp~f~ 317 (556)
.... .....+++++.+||.+||+.||++|||++++ |+|+|++
T Consensus 226 -------------~~~~---~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 226 -------------GERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp -------------TCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------------CCCC---CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 1111 1234689999999999999999999999998 5666654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.9e-53 Score=424.86 Aligned_cols=249 Identities=22% Similarity=0.401 Sum_probs=208.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|++++.||+|+||+||+|+++.+|+.||||+++... .....+.+|+.+|+.++|||||++++++ .+...
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~ 87 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPP 87 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccE-----eeCCe
Confidence 458999999999999999999999999999999987532 2345788999999999999999999999 45566
Q ss_pred EEEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 102 IYVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
+|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 899999999 7999999764 5789999999999999999999999999999999999999999999999999987544
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCC-CCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL-FPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~p-F~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... ......|++.|+|||++.+ ..|+.++|||||||++|||++|..| |.+.+.....+.+.
T Consensus 168 ~~~~--~~~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~------------- 230 (287)
T d1opja_ 168 DTYT--AHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE------------- 230 (287)
T ss_dssp SSSE--EETTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-------------
T ss_pred CCce--eeccccccccccChHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHh-------------
Confidence 3222 2344568999999999887 7899999999999999999996654 55555433332221
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... ......+++.+.+||++||+.||++|||++++++
T Consensus 231 --------------~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 231 --------------KDYR---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp --------------TTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------cCCC---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 1111 1223568999999999999999999999999976
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=417.25 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=200.0
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
+.++|++++.||+|+||+||+|++. +++.||||++..... ....+.+|+++|+.++|||||++++++. ...
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~~ 73 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQA 73 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSS
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC---cHHHHHHHHHHHHhcCCCCcccccceec-----cCC
Confidence 3568999999999999999999986 567899999975322 2356889999999999999999999994 445
Q ss_pred eEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 101 DIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.+|+|||||. |+|.+++... ..++++.+..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred ceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccC
Confidence 6899999998 7999998765 5689999999999999999999999999999999999999999999999999987543
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
..... .....||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+.+..+....
T Consensus 154 ~~~~~--~~~~~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~---------- 219 (263)
T d1sm2a_ 154 DQYTS--STGTKFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF---------- 219 (263)
T ss_dssp -------------CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTC----------
T ss_pred CCcee--ecceecCcccCChHHhcC--CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcC----------
Confidence 33221 234679999999999987 789999999999999999999 578888777655555443210
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.. ......++.+.+||.+||+.||++|||++++|+|
T Consensus 220 ---------------~~-----~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 220 ---------------RL-----YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp ---------------CC-----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CC-----CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 00 1123578999999999999999999999999986
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-52 Score=423.93 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=200.8
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCc---EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGE---KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~---~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
+.++|++.++||+|+||+||+|.++.+++ .||||++... ........+.+|+.+|+.|+|||||++++++ .
T Consensus 24 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~-----~ 97 (299)
T d1jpaa_ 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVV-----T 97 (299)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred ChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEE-----e
Confidence 34689999999999999999999987765 5889988643 3345566799999999999999999999999 4
Q ss_pred CCceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
+...+|+|||||+ |+|.+++... +.+++.++..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 98 ~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 98 KSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred eCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceE
Confidence 4466999999999 6999988874 5799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcc--eecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 176 AFSDTPMTV--FWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 176 ~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
......... ......||+.|+|||++.+ ..|+.++|||||||+||||+| |++||.+.+..+.+..+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~------- 248 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ------- 248 (299)
T ss_dssp ------------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-------
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------
Confidence 543322211 1123568999999999987 689999999999999999998 8999999887665554422
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.... .....++..+.+||.+||+.||++|||+.|++++
T Consensus 249 --------------------~~~~---~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 249 --------------------DYRL---PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp --------------------TCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --------------------CCCC---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1111 1234688999999999999999999999999874
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=427.09 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=208.4
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCc-----EEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGE-----KVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~-----~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~ 96 (556)
++|+++++||+|+||+||+|++..+++ .||+|++... ........+.+|+.+|..+ +|||||++++++
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~----- 110 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSELKMMTQLGSHENIVNLLGAC----- 110 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccc-cCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE-----
Confidence 589999999999999999999876554 6999998643 2334456788999999998 899999999999
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 008729 97 REFKDIYVVFELME-SDLHQVIKAN-----------------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDL 152 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~-----------------------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDL 152 (556)
.+...+|||||||+ |+|.++|..+ +.+++..++.|+.||+.||+|||++||+||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 45567999999999 7999999764 24899999999999999999999999999999
Q ss_pred CCCcEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCC
Q 008729 153 KPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLF 231 (556)
Q Consensus 153 KP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF 231 (556)
||+|||++.++.+||+|||+|+........ ......+||+.|||||++.+ ..|+.++|||||||+||||+| |++||
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~Pf 267 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNY-VVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPY 267 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTS-EEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred chhccccccCCeEEEeeccccccccCCCce-eeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCCC
Confidence 999999999999999999999875443322 23345678999999999887 789999999999999999997 89999
Q ss_pred CCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 008729 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (556)
Q Consensus 232 ~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL 311 (556)
.+.+....+..+.. .... ......+++.+.+||.+||+.||++|||++||+
T Consensus 268 ~~~~~~~~~~~~~~--------------------------~~~~---~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~ 318 (325)
T d1rjba_ 268 PGIPVDANFYKLIQ--------------------------NGFK---MDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318 (325)
T ss_dssp TTCCCSHHHHHHHH--------------------------TTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHh--------------------------cCCC---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 98776554443321 1111 122346899999999999999999999999999
Q ss_pred hC
Q 008729 312 AD 313 (556)
Q Consensus 312 ~h 313 (556)
+|
T Consensus 319 ~~ 320 (325)
T d1rjba_ 319 SF 320 (325)
T ss_dssp HH
T ss_pred HH
Confidence 86
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-52 Score=418.61 Aligned_cols=256 Identities=22% Similarity=0.358 Sum_probs=213.4
Q ss_pred CCeEEEee-eeecCceeEEEEEECC--CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 23 NRYKILEV-IGKGSYGVVCAAIDTH--TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 23 ~~Y~i~~~-LG~G~~g~V~~a~~~~--tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
++|.+.+. ||+|+||+||+|.++. ++..||||+++.. ........+.+|+++|+.++|||||++++++..
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~------ 80 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------ 80 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc------
Confidence 47888885 9999999999998764 4457999999753 344566789999999999999999999999842
Q ss_pred ceEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
..+|||||||+ |+|.+++.. ++.+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 24899999999 699998865 4679999999999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
............+||+.|+|||++.+ ..|+.++|||||||++|||+| |++||.+.+..+.+..|.+
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~----------- 227 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ----------- 227 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-----------
T ss_pred ccccccccccccccCccccChHHHhC--CCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----------
Confidence 44333333345679999999999987 689999999999999999998 9999998876655544421
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHH---HhCcccc
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEA---LADPYFK 317 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~el---L~hp~f~ 317 (556)
... ....+.+++++.+||.+||..||++|||+.++ |+|+|+.
T Consensus 228 ----------------~~~---~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 228 ----------------GKR---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp ----------------TCC---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------------CCC---CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 111 12235689999999999999999999999887 6788875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=416.36 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=208.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||.||+|+++ +++.||||+++.... ....+.+|+.+|++++|||||++++++.. ..+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------~~~ 82 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQ------EPI 82 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC---CHHHHHHHHHHHHhCCCCCEeEEEeeecc------CCe
Confidence 58999999999999999999975 578899999975322 23568999999999999999999998732 347
Q ss_pred EEEEecCc-ccHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 103 YVVFELME-SDLHQVIKAN--DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~~--~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
|||||||+ |+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 83 ~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC
Confidence 99999999 7999877543 36999999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG-~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
.. .......||+.|+|||++.+ ..|+.++|||||||+||||+|| .+||.+.+..+.+..+..
T Consensus 163 ~~--~~~~~~~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~------------- 225 (272)
T d1qpca_ 163 EY--TAREGAKFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------- 225 (272)
T ss_dssp CE--ECCTTCCCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-------------
T ss_pred cc--ccccccCCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-------------
Confidence 21 12245679999999999987 6899999999999999999995 667777665554444321
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh--Ccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DPYFK 317 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~--hp~f~ 317 (556)
.... .....+++.+.+||++||+.||++|||++++++ |+||.
T Consensus 226 --------------~~~~---~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 226 --------------GYRM---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp --------------TCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------------cCCC---CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 1111 122468899999999999999999999999998 78885
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-52 Score=410.84 Aligned_cols=250 Identities=22% Similarity=0.314 Sum_probs=211.6
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
+.++|+++++||+|+||+||+|+++ +++.||||+++.... ....+++|+.+++.++||||+++++++ .+..
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~-----~~~~ 72 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQR 72 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEE-----CCSS
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEE-----eeCC
Confidence 3468999999999999999999985 788999999975322 234688999999999999999999999 4446
Q ss_pred eEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 101 DIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 101 ~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
.+|+|||||+ |+|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence 6999999998 789988765 45799999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.... ......||+.|+|||++.+ ..|+.++|||||||++|||+| |+.||.+.+..+....|.+.
T Consensus 153 ~~~~--~~~~~~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~----------- 217 (258)
T d1k2pa_ 153 DEYT--SSVGSKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG----------- 217 (258)
T ss_dssp SSCC--CCCCSCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-----------
T ss_pred CCce--eecccCCCCCcCCcHHhcC--CCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC-----------
Confidence 3222 1235679999999999987 689999999999999999998 89999998876665554321
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
... ......++.+.+||++||+.||++|||++++|+|
T Consensus 218 ----------------~~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 218 ----------------LRL---YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp ----------------CCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCC---CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 111 1223578899999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-52 Score=426.30 Aligned_cols=264 Identities=25% Similarity=0.416 Sum_probs=217.1
Q ss_pred CCeEEEeeeeecCceeEEEEEEC---CCCcEEEEEEecCcc--CChhHHHHHHHHHHHHHhCCC-CCcceeeEEEcCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDT---HTGEKVAIKKIHDVF--EHISDAIRILREVKLLRLLRH-PDIVEIKRIMLPPSK 96 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~---~tg~~vAiK~i~~~~--~~~~~~~~~~rEi~iL~~L~H-pnIv~l~~v~~~~~~ 96 (556)
++|++++.||+|+||+||+|++. .+|+.||||++++.. ........+.+|+++|++++| |||+++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~----- 98 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF----- 98 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE-----
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee-----
Confidence 67999999999999999999974 478999999987432 122334567899999999976 8999999999
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 97 REFKDIYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
.+...+|+|||||. |+|.+++...+.+.+..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 55667999999999 69999999999999999999999999999999999999999999999999999999999999976
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
....... ......|++.|+|||.+.+....++.++|||||||+||+|++|+.||.+.+..+....+....
T Consensus 179 ~~~~~~~--~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~-------- 248 (322)
T d1vzoa_ 179 FVADETE--RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI-------- 248 (322)
T ss_dssp CCGGGGG--GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--------
T ss_pred hcccccc--cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--------
Confidence 5332221 224567999999999987643467889999999999999999999998876555444432210
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCC-----CHHHHHhCccccccc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRP-----TAEEALADPYFKGLA 320 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rp-----ta~elL~hp~f~~~~ 320 (556)
..... .....+++++.+||++||+.||++|| |++|+|+||||+++.
T Consensus 249 --------------~~~~~-----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 249 --------------LKSEP-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp --------------HHCCC-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred --------------ccCCC-----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 11111 12346899999999999999999999 589999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=407.27 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=198.3
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCC----cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTG----EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg----~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
.++|++.++||+|+||.||+|.++.++ ..||||++... ........+++|+++|+.++|||||++++++ .
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~-----~ 79 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----S 79 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEE-----e
Confidence 357999999999999999999987665 47999999743 3344556789999999999999999999999 4
Q ss_pred CCceEEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
+...+|+|||||. ++|.+++... +.+++.++..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhc
Confidence 4566999999999 5788877654 6799999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhhCCCChHH
Q 008729 176 AFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLITDLLGTPSPET 254 (556)
Q Consensus 176 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG-~~pF~~~~~~~~~~~i~~~~g~p~~e~ 254 (556)
...............||+.|+|||++.+ ..|+.++|||||||+||||++| .+||.+.+..+.+..+.+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~--------- 228 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND--------- 228 (283)
T ss_dssp --------------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT---------
T ss_pred ccCCCccceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhc---------
Confidence 5443332222345678999999999987 7899999999999999999995 555655554444333321
Q ss_pred HHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 255 IAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 255 i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.... .....++..+.+||.+||..||++|||+.|+++
T Consensus 229 ------------------~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 229 ------------------GFRL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp ------------------TCCC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------cCCC---CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 1111 122458899999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-51 Score=407.45 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=200.0
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCC---cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~ 99 (556)
++|++++.||+|+||.||+|++..++ ..||||+++.. ........+.+|+.+|+.++|||||++++++..
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------ 79 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------ 79 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence 48999999999999999999987654 46899988643 344456678999999999999999999999832
Q ss_pred ceEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcccccc
Q 008729 100 KDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAF 177 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~ 177 (556)
..+|+|||||. |+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 35899999999 689888765 4579999999999999999999999999999999999999999999999999998653
Q ss_pred CCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHH
Q 008729 178 SDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIA 256 (556)
Q Consensus 178 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~ 256 (556)
..... ..+...||+.|+|||++.+ ..|+.++|||||||++|||++ |.+||.+.+..+.+..+..
T Consensus 160 ~~~~~--~~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~----------- 224 (273)
T d1mp8a_ 160 DSTYY--KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN----------- 224 (273)
T ss_dssp -------------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT-----------
T ss_pred CCcce--eccceecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHc-----------
Confidence 32221 1244568999999999987 789999999999999999998 8999998887666555422
Q ss_pred HhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 257 VVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 257 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
... ...++++++.+.+||.+||..||++|||++|+++|
T Consensus 225 ----------------~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 225 ----------------GER---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp ----------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------CCC---CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111 12346789999999999999999999999999876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-50 Score=404.63 Aligned_cols=253 Identities=26% Similarity=0.370 Sum_probs=204.5
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCceE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKDI 102 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~l 102 (556)
++|++++.||+|+||.||+|+++.+ +.||||+++.... ....+.+|+.+|++++|||||++++++.. +.+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~~~ 86 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPI 86 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEec------CCe
Confidence 5899999999999999999998765 5799999975432 23568899999999999999999999832 347
Q ss_pred EEEEecCc-ccHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 103 YVVFELME-SDLHQVIKA--NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 103 ylV~E~~~-g~L~~~i~~--~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
|+|||||. |+|..++.. .+.+++.++..|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 99999999 688887754 457999999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHhhCCCChHHHHHh
Q 008729 180 TPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLITDLLGTPSPETIAVV 258 (556)
Q Consensus 180 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG-~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~~ 258 (556)
... ......||+.|+|||++.+ ..++.++||||||||||||++| .++|.+....+.+..+..
T Consensus 167 ~~~--~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~------------- 229 (285)
T d1fmka3 167 EYT--ARQGAKFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER------------- 229 (285)
T ss_dssp -----------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-------------
T ss_pred Cce--eeccccccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHh-------------
Confidence 221 1244679999999999987 7899999999999999999995 566677666555544421
Q ss_pred hhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh--Ccccccc
Q 008729 259 RNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA--DPYFKGL 319 (556)
Q Consensus 259 ~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~--hp~f~~~ 319 (556)
.... ...+.+++.+.+||.+||+.||++|||++++++ ++||...
T Consensus 230 --------------~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 230 --------------GYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp --------------TCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred --------------cCCC---CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 1111 133568999999999999999999999999988 8898764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-50 Score=408.27 Aligned_cols=252 Identities=21% Similarity=0.344 Sum_probs=202.2
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCc----EEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGE----KVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKRE 98 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~ 98 (556)
.+|+++++||+|+||+||+|.+..+|+ +||+|+++.. ........+.+|+.+|+.++|||||++++++...
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence 469999999999999999999988886 5888887643 2223456789999999999999999999998532
Q ss_pred CceEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccc
Q 008729 99 FKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVA 176 (556)
Q Consensus 99 ~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~ 176 (556)
..++|+|||. ++|.+.+.. ...+++..+..|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 84 --~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 84 --TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp --SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred --CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 3677778777 789887776 457999999999999999999999999999999999999999999999999999875
Q ss_pred cCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHH
Q 008729 177 FSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETI 255 (556)
Q Consensus 177 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i 255 (556)
...... .......||+.|+|||++.+ ..|+.++|||||||+||||+| |.+||.+.+..+....+...
T Consensus 162 ~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~--------- 229 (317)
T d1xkka_ 162 GAEEKE-YHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--------- 229 (317)
T ss_dssp TTTCC---------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT---------
T ss_pred cccccc-ccccccccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------
Confidence 433222 12244568999999999887 689999999999999999998 89999988766554443221
Q ss_pred HHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhCc
Q 008729 256 AVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALADP 314 (556)
Q Consensus 256 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~hp 314 (556)
... ...+.+++.+.+||.+||..||.+|||+.|+++|.
T Consensus 230 ------------------~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 230 ------------------ERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp ------------------CCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ------------------CCC---CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 111 12346889999999999999999999999999883
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-50 Score=400.87 Aligned_cols=256 Identities=22% Similarity=0.314 Sum_probs=201.6
Q ss_pred CCCCCeEEEeeeeecCceeEEEEEECC-CC--cEEEEEEecCccC-ChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCC
Q 008729 20 GDANRYKILEVIGKGSYGVVCAAIDTH-TG--EKVAIKKIHDVFE-HISDAIRILREVKLLRLLRHPDIVEIKRIMLPPS 95 (556)
Q Consensus 20 ~~~~~Y~i~~~LG~G~~g~V~~a~~~~-tg--~~vAiK~i~~~~~-~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~ 95 (556)
-+.++|++++.||+|+||.||+|+... ++ ..||||++..... .......+.+|+.+|+.++||||+++++++..
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-- 82 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-- 82 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--
Confidence 345679999999999999999998643 33 3689999875433 33445678999999999999999999999943
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCcc
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLA 173 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla 173 (556)
..+|+|||||+ |+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 83 ----~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 83 ----PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp ----SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ----cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhh
Confidence 24799999999 788887755 457999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 174 RVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 174 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
+................|+.+|+|||++.+ ..|+.++|||||||++|||+| |++||.+.+..+.+..|..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~------- 229 (273)
T d1u46a_ 159 RALPQNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK------- 229 (273)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-------
T ss_pred hhcccCCCcceecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHh-------
Confidence 986554443333455678889999999988 789999999999999999998 8999999887766655422
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.. .. ....+.+++.+.+||.+||..||++|||++++++
T Consensus 230 -------------------~~-~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 230 -------------------EG-ER--LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp -------------------SC-CC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------CC-CC--CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 11 11 1233568999999999999999999999999964
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=403.34 Aligned_cols=254 Identities=24% Similarity=0.388 Sum_probs=199.1
Q ss_pred CCeEEEeeeeecCceeEEEEEECC-----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~ 96 (556)
++|++++.||+|+||.||+|.+.. +++.||||+++.. ........+.+|+.++.++ +|+||+.+++++.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~---- 87 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGACT---- 87 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec----
Confidence 479999999999999999999754 4578999998743 3334556778888888777 6899999999884
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEee
Q 008729 97 REFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILA 159 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl 159 (556)
.....+|+|||||+ |+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+|||+
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 33456899999999 7999999753 248999999999999999999999999999999999999
Q ss_pred cCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhC-CCCCCCCChHH
Q 008729 160 NANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVH 238 (556)
Q Consensus 160 ~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG-~~pF~~~~~~~ 238 (556)
+.++.+||+|||+|+........ ......+||+.|+|||++.+ ..|+.++|||||||++|||++| .+||.+.+...
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDY-VRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp CGGGCEEECC------CCSCTTS-CCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred CCCCcEEEccCcchhhccccccc-cccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999865433222 12345679999999999987 7899999999999999999986 57898776544
Q ss_pred HHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 239 QLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 239 ~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.+..+.. .... ......+++.+.+||.+||+.||++|||++|+++|
T Consensus 245 ~~~~~~~--------------------------~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 245 EFCRRLK--------------------------EGTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHH--------------------------HTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHh--------------------------cCCC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4322211 1111 12234688999999999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.5e-49 Score=401.42 Aligned_cols=251 Identities=22% Similarity=0.310 Sum_probs=208.8
Q ss_pred CCeEEEeeeeecCceeEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKR 97 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~ 97 (556)
++|++++.||+|+||+||+|+++ .+++.||||+++.. ........+.+|+.+|+.++||||+++++++ .
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~ 86 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVC-----A 86 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-cChHHHHHHHHHHHHHHhcCCCCcccceeee-----c
Confidence 47999999999999999999875 35678999998753 3344566799999999999999999999999 4
Q ss_pred CCceEEEEEecCc-ccHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 008729 98 EFKDIYVVFELME-SDLHQVIKAND------------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDL 152 (556)
Q Consensus 98 ~~~~lylV~E~~~-g~L~~~i~~~~------------------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDL 152 (556)
....+++|||||. |+|.+++.... .+++..+..|+.||+.||+|||++||+||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEE
Confidence 4567999999999 79999997532 3889999999999999999999999999999
Q ss_pred CCCcEeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCC-CCC
Q 008729 153 KPKNILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLF 231 (556)
Q Consensus 153 KP~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~-~pF 231 (556)
||+|||++.++.+||+|||+|+........ ...+...||+.|+|||++.+ ..|+.++|||||||++|||++|. +||
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYY-KADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCB-C----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred cccceEECCCCcEEEccchhheeccCCccc-cccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999999999999999865333221 12345679999999999987 78999999999999999999985 789
Q ss_pred CCCChHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHH
Q 008729 232 PGKSVVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEAL 311 (556)
Q Consensus 232 ~~~~~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL 311 (556)
.+.+..+.+..+.+ ... ......+++++.+||.+||+.||++|||+.|++
T Consensus 244 ~~~~~~e~~~~v~~---------------------------~~~---~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~ 293 (301)
T d1lufa_ 244 YGMAHEEVIYYVRD---------------------------GNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293 (301)
T ss_dssp TTSCHHHHHHHHHT---------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCHHHHHHHHHc---------------------------CCC---CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 88887665554422 111 122346899999999999999999999999996
Q ss_pred h
Q 008729 312 A 312 (556)
Q Consensus 312 ~ 312 (556)
+
T Consensus 294 ~ 294 (301)
T d1lufa_ 294 R 294 (301)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=394.97 Aligned_cols=244 Identities=25% Similarity=0.408 Sum_probs=198.9
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
.++|+++++||+|+||.||+|+++ |+.||||++++. .....+.+|+++|++++||||+++++++.. ....
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~ 75 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGG 75 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--C
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCc
Confidence 347999999999999999999874 789999999743 344678899999999999999999998853 2345
Q ss_pred EEEEEecCc-ccHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccC
Q 008729 102 IYVVFELME-SDLHQVIKAND--DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFS 178 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~--~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~ 178 (556)
+|||||||+ |+|.+++.... .+++..+..|+.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++....
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC
Confidence 899999998 79999996543 589999999999999999999999999999999999999999999999999986433
Q ss_pred CCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCChHHHHHHHHHhhCCCChHHHHH
Q 008729 179 DTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKSVVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 179 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.. ....+|..|+|||++.+ ..|++++|||||||++|||+| |++||.+.+..+.+..|..
T Consensus 156 ~~------~~~~~~~~y~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~------------ 215 (262)
T d1byga_ 156 TQ------DTGKLPVKWTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------ 215 (262)
T ss_dssp ------------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT------------
T ss_pred CC------ccccccccCCChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc------------
Confidence 22 34468999999999987 689999999999999999998 7899988776665544421
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
... ......+++.+.+||++||..||++|||+.+++++
T Consensus 216 ---------------~~~---~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 216 ---------------GYK---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ---------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------CCC---CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 111 12234688999999999999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=394.99 Aligned_cols=252 Identities=24% Similarity=0.400 Sum_probs=205.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCC-------cEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTG-------EKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLP 93 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg-------~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~ 93 (556)
.++|++++.||+|+||.||+|++..++ ..||||+++.. ........+.+|..++.++ +|||||++++++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~- 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT- 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc-cChHHHHHHHHHHHHHHHhcCCCeEEecccccc-
Confidence 358999999999999999999976654 47999999754 3345567788999999888 7999999999994
Q ss_pred CCCCCCceEEEEEecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 008729 94 PSKREFKDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (556)
Q Consensus 94 ~~~~~~~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (556)
+...+|+|||||+ |+|.++|... ..+++..++.|+.||+.||+|||+.||+||||||+|
T Consensus 90 ----~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~N 165 (299)
T d1fgka_ 90 ----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 165 (299)
T ss_dssp ----SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ----cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccc
Confidence 4566999999999 7999999754 358999999999999999999999999999999999
Q ss_pred EeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCC
Q 008729 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (556)
Q Consensus 157 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~ 235 (556)
||++.++.+||+|||+++......... .....+||+.|+|||.+.+ ..|+.++|||||||++|||++ |.+||.+.+
T Consensus 166 iLl~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 166 VLVTEDNVMKIADFGLARDIHHIDYYK-KTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp EEECTTCCEEECSTTCCCCGGGCCTTC-CCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eeecCCCCeEeccchhhcccccccccc-ccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 999999999999999998765433222 2345679999999999987 789999999999999999998 799998877
Q ss_pred hHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 236 ~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.......+. ..... .....+++.+.+||.+||+.||.+|||+.|+|+
T Consensus 243 ~~~~~~~i~---------------------------~~~~~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLK---------------------------EGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHH---------------------------TTCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHH---------------------------cCCCC---CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 654443331 11111 123468999999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=401.68 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=204.6
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcE--EEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCCCCCC
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEK--VAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~--vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~~~~~ 99 (556)
++|++.++||+|+||+||+|.++.+|.. ||||+++... .......+.+|+++|..+ +|||||++++++ .+.
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~ 83 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR 83 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEE-----EET
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEE-----ecC
Confidence 5899999999999999999999988874 6778775432 223456789999999999 799999999999 445
Q ss_pred ceEEEEEecCc-ccHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCC
Q 008729 100 KDIYVVFELME-SDLHQVIKAN----------------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANAN 162 (556)
Q Consensus 100 ~~lylV~E~~~-g~L~~~i~~~----------------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~ 162 (556)
..+|+|||||+ |+|.++|..+ ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~ 163 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 163 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGG
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCC
Confidence 67999999999 7999999754 578999999999999999999999999999999999999999
Q ss_pred CceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCC-CCCCCCChHHHHH
Q 008729 163 CKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKSVVHQLD 241 (556)
Q Consensus 163 ~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~-~pF~~~~~~~~~~ 241 (556)
+.+||+|||+|+........ ....||..|+|||.+.+ ..|+.++||||||||+|||++|. +||.+.+..+.+.
T Consensus 164 ~~~kl~DfG~a~~~~~~~~~----~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~ 237 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVKK----TMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237 (309)
T ss_dssp GCEEECCTTCEESSCEECCC--------CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred CceEEccccccccccccccc----cceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999764332221 34569999999999987 78999999999999999999965 6888877655544
Q ss_pred HHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 242 LITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 242 ~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
.|. .... ......+++.+.+||.+||+.||++|||++++|+|
T Consensus 238 ~i~---------------------------~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 238 KLP---------------------------QGYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HGG---------------------------GTCC---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHH---------------------------hcCC---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 431 1111 12335689999999999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-48 Score=395.09 Aligned_cols=265 Identities=20% Similarity=0.246 Sum_probs=204.9
Q ss_pred CCCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCc
Q 008729 21 DANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 21 ~~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~ 100 (556)
.+++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.++|+|++.++..+. .+..
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~----~~~~ 76 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCG----AEGD 76 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEE----EETT
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEE----ecCC
Confidence 457899999999999999999999999999999988643222 34678999999998877666555442 4456
Q ss_pred eEEEEEecCcccHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeec---CCCceEEeeeCccccc
Q 008729 101 DIYVVFELMESDLHQVIKA-NDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILAN---ANCKLKVCDFGLARVA 176 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~-~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~---~~~~vKL~DFGla~~~ 176 (556)
..|+|||||+++|.+.+.. ...+++..+..++.||+.||+|||++||+||||||+|||++ .+..+||+|||+|+..
T Consensus 77 ~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 77 YNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 7899999999988777765 55799999999999999999999999999999999999875 3457999999999876
Q ss_pred cCCCCCc----ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCCCh
Q 008729 177 FSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTPSP 252 (556)
Q Consensus 177 ~~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p~~ 252 (556)
....... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.........+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~---- 230 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE---- 230 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH----
T ss_pred cccccccceeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhc----
Confidence 4332211 12245679999999999988 6799999999999999999999999988765443332211100
Q ss_pred HHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHH---HHHhCccccc
Q 008729 253 ETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAE---EALADPYFKG 318 (556)
Q Consensus 253 e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~---elL~hp~f~~ 318 (556)
.....+.....+++++++.+||.+||..||++||+++ ++|+|+|.+.
T Consensus 231 -------------------~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 231 -------------------KKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp -------------------HHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -------------------ccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 0000111122356899999999999999999999987 4577877653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-48 Score=396.10 Aligned_cols=252 Identities=20% Similarity=0.363 Sum_probs=211.2
Q ss_pred CCCeEEEeeeeecCceeEEEEEECC-----CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTH-----TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSK 96 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~-----tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~ 96 (556)
.++|++++.||+|+||.||+|.+.. +++.||||+++.. ........+++|+++|++++||||+++++++
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~----- 92 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGVV----- 92 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE-----
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeEE-----
Confidence 4699999999999999999998753 4578999999753 3445666789999999999999999999999
Q ss_pred CCCceEEEEEecCc-ccHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCce
Q 008729 97 REFKDIYVVFELME-SDLHQVIKAN----------DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKL 165 (556)
Q Consensus 97 ~~~~~lylV~E~~~-g~L~~~i~~~----------~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~v 165 (556)
.....+|+|||||. |+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++++
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~ 172 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 172 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCE
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceE
Confidence 44556899999999 7999988642 247889999999999999999999999999999999999999999
Q ss_pred EEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHH
Q 008729 166 KVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKSVVHQLDLIT 244 (556)
Q Consensus 166 KL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG-~~pF~~~~~~~~~~~i~ 244 (556)
||+|||+|+....... ........||+.|+|||.+.+ ..|+.++|||||||+||||+|| .+||.+.+..+.+..+.
T Consensus 173 Kl~DFGla~~~~~~~~-~~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~ 249 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDY-YRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 249 (308)
T ss_dssp EECCTTCCCGGGGGGC-EEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred EEeecccceeccCCcc-eeeccceecccccCCHHHHcc--CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999986543322 112244578999999999987 7899999999999999999998 58898888766665543
Q ss_pred HhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 245 DLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 245 ~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
+ ... ....+.+++.+.+||.+||+.||++|||++++++
T Consensus 250 ~---------------------------~~~---~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 250 E---------------------------GGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp T---------------------------TCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred h---------------------------CCC---CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2 111 1123468899999999999999999999999998
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-48 Score=391.88 Aligned_cols=253 Identities=26% Similarity=0.372 Sum_probs=211.0
Q ss_pred CCCeEEEeeeeecCceeEEEEEEC-----CCCcEEEEEEecCccCChhHHHHHHHHHHHHHhC-CCCCcceeeEEEcCCC
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDT-----HTGEKVAIKKIHDVFEHISDAIRILREVKLLRLL-RHPDIVEIKRIMLPPS 95 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~-----~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L-~HpnIv~l~~v~~~~~ 95 (556)
.++|+++++||+|+||.||+|.+. .+++.||||+++.. ........+.+|+.+++.+ +|||||++++++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~---- 96 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGAC---- 96 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE----
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE----
Confidence 368999999999999999999863 56779999999753 3445666889999999999 699999999999
Q ss_pred CCCCceEEEEEecCc-ccHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 008729 96 KREFKDIYVVFELME-SDLHQVIKAND------------------DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKN 156 (556)
Q Consensus 96 ~~~~~~lylV~E~~~-g~L~~~i~~~~------------------~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~N 156 (556)
.+...+|||||||+ |+|.+++.... .+++..+..|+.||+.||+|||++||+||||||+|
T Consensus 97 -~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 97 -TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp -CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred -eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 44566899999998 69999997543 58999999999999999999999999999999999
Q ss_pred EeecCCCceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHh-CCCCCCCCC
Q 008729 157 ILANANCKLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT-GKPLFPGKS 235 (556)
Q Consensus 157 ILl~~~~~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyellt-G~~pF~~~~ 235 (556)
||++.++.+||+|||+++....... .......+||+.|+|||++.+ ..++.++|||||||++|||+| |.+||.+.+
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTT-SEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccCcccccccchheeccCCCc-ceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999987644332 223355789999999999987 689999999999999999998 778887777
Q ss_pred hHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 236 VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 236 ~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
....+..+.. . ... + .....+++.+.+||.+||+.||++|||++++|+
T Consensus 253 ~~~~~~~~i~-----------------------~---~~~-~--~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 253 VDSKFYKMIK-----------------------E---GFR-M--LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp SSHHHHHHHH-----------------------H---TCC-C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHh-----------------------c---CCC-C--CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6555444321 1 000 1 112457899999999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.7e-47 Score=386.48 Aligned_cols=257 Identities=18% Similarity=0.227 Sum_probs=206.4
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCC-CCcceeeEEEcCCCCCCCc
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH-PDIVEIKRIMLPPSKREFK 100 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H-pnIv~l~~v~~~~~~~~~~ 100 (556)
+++|++++.||+|+||+||+|++..+|+.||||++.... +...+.+|+++++.|+| +||+.+++++ ....
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~ 74 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFG-----QEGL 74 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEE-----EETT
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEe-----ecCC
Confidence 479999999999999999999999999999999886432 22346789999999975 8999999988 5566
Q ss_pred eEEEEEecCcccHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecC-----CCceEEeeeCccc
Q 008729 101 DIYVVFELMESDLHQVIKAND-DLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANA-----NCKLKVCDFGLAR 174 (556)
Q Consensus 101 ~lylV~E~~~g~L~~~i~~~~-~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~-----~~~vKL~DFGla~ 174 (556)
..|+|||||+++|.+++...+ .++...+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 75 ~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 75 HNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeE
Confidence 799999999999999997754 7999999999999999999999999999999999999974 5679999999998
Q ss_pred cccCCCCCc----ceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhhCCC
Q 008729 175 VAFSDTPMT----VFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLLGTP 250 (556)
Q Consensus 175 ~~~~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~g~p 250 (556)
......... ......+||+.|||||++.+ ..|++++|||||||++|+|++|+.||.+.........+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i---- 228 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI---- 228 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH----
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcC--CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHH----
Confidence 754332211 12345689999999999988 78999999999999999999999999876543332221110
Q ss_pred ChHHHHHhhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHh
Q 008729 251 SPETIAVVRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALA 312 (556)
Q Consensus 251 ~~e~i~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~ 312 (556)
.. .. ...+..+..+++++++.+++..|+..+|++||+.+.+.+
T Consensus 229 --------~~---------~~--~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 229 --------GE---------KK--QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp --------HH---------HH--HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred --------Hh---------cc--CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 00 00 001112233568899999999999999999999877654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-47 Score=384.76 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=200.6
Q ss_pred eEEEeeeeecCceeEEEEEECCCC---cEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTG---EKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg---~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
+.+.++||+|+||+||+|++..++ ..||||++++. .......++++|+++|++++||||+++++++.. ....
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~ 103 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGS 103 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTE
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCc
Confidence 445789999999999999987654 36999999743 455667889999999999999999999998742 3356
Q ss_pred EEEEEecCc-ccHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEeeeCccccccCC
Q 008729 102 IYVVFELME-SDLHQVIKAN-DDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVCDFGLARVAFSD 179 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~-~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~DFGla~~~~~~ 179 (556)
+|+|||||+ |+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+++++.+||+|||+++.....
T Consensus 104 ~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 104 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 899999999 6999988754 45778889999999999999999999999999999999999999999999999875433
Q ss_pred CC-CcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-hHHHHHHHHHhhCCCChHHHHH
Q 008729 180 TP-MTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS-VVHQLDLITDLLGTPSPETIAV 257 (556)
Q Consensus 180 ~~-~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~-~~~~~~~i~~~~g~p~~e~i~~ 257 (556)
.. .........||+.|+|||++.+ ..++.++|||||||+||||++|..||.... ..+....+
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i-------------- 247 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-------------- 247 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH--------------
T ss_pred ccccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH--------------
Confidence 22 1222345679999999999887 689999999999999999999776665433 22222211
Q ss_pred hhhHHHHHHHHHhhcCCCCCcCCCCCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 258 VRNEKARKYLTEMRKKPPVPLFQKFPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 258 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
...... ...+.+++.+.+||.+||..||++|||+.|+++|
T Consensus 248 -------------~~g~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 248 -------------LQGRRL---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp -------------HTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------HcCCCC---CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111111 1224678999999999999999999999999987
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.3e-47 Score=392.05 Aligned_cols=281 Identities=23% Similarity=0.346 Sum_probs=211.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-----------CCCcceeeEEE
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-----------HPDIVEIKRIM 91 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-----------HpnIv~l~~v~ 91 (556)
+||+++++||+|+||+||+|+++.+|+.||||+++. .......+.+|+++|+.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~---~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEec---cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 579999999999999999999999999999999974 2233456778999988875 47899999887
Q ss_pred cCCCCCCCceEEEEEecCc--ccHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEeecCCC---
Q 008729 92 LPPSKREFKDIYVVFELME--SDLHQVI--KANDDLTREHHQFFLYQMLRALKYMHT-ANVYHRDLKPKNILANANC--- 163 (556)
Q Consensus 92 ~~~~~~~~~~lylV~E~~~--g~L~~~i--~~~~~l~~~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP~NILl~~~~--- 163 (556)
... .....++|++++. ++..... .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 90 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 90 NHK---GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEE---ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred eec---cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 432 2344566666654 3443333 334679999999999999999999998 8999999999999998665
Q ss_pred ---ceEEeeeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHHHHHHHhCCCCCCCCC-----
Q 008729 164 ---KLKVCDFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKS----- 235 (556)
Q Consensus 164 ---~vKL~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~ilyelltG~~pF~~~~----- 235 (556)
.+||+|||.|....... ...+||+.|+|||++.+ ..|+.++||||+||++++|++|+.||....
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~ 238 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238 (362)
T ss_dssp TEEEEEECCCTTCEETTBCC------CSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeeEeeccccccccccc------ccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence 39999999997643222 45679999999999887 789999999999999999999999997543
Q ss_pred -hHHHHHHHHHhhCCCChHHHHHhhhHHHHHHHHHh---hcCCCCC----------cCCCCCCCCHHHHHHHHHhhhcCC
Q 008729 236 -VVHQLDLITDLLGTPSPETIAVVRNEKARKYLTEM---RKKPPVP----------LFQKFPNVDPLALRLLQRLIAFDP 301 (556)
Q Consensus 236 -~~~~~~~i~~~~g~p~~e~i~~~~~~~~~~~l~~~---~~~~~~~----------~~~~~~~~s~~~~dLl~~~L~~dP 301 (556)
..+.+..+...+|.++.+.+...... ..++... ....... ........++.+.|||.+||++||
T Consensus 239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP 316 (362)
T d1q8ya_ 239 KDDDHIAQIIELLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316 (362)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTH--HHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred chhHHHHHHHHHhCCCCHHHhhccccc--ccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCCh
Confidence 34567777888898877765432211 1111100 0000000 001122356789999999999999
Q ss_pred CCCCCHHHHHhCcccccc
Q 008729 302 KDRPTAEEALADPYFKGL 319 (556)
Q Consensus 302 ~~Rpta~elL~hp~f~~~ 319 (556)
.+|||++|+|+||||+..
T Consensus 317 ~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 317 RKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp TTCBCHHHHHTCGGGTTC
T ss_pred hHCcCHHHHhcCcccCCC
Confidence 999999999999999865
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-47 Score=384.59 Aligned_cols=273 Identities=22% Similarity=0.229 Sum_probs=195.1
Q ss_pred CCCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCCCCCCCce
Q 008729 22 ANRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 22 ~~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~~~~~~~~ 101 (556)
+.+|.+.+.||+|+||.||+|++ +|+.||||+++.. ........+|+..+..++||||+++++++.... .....
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceE
Confidence 35799999999999999999985 6899999998642 112222334566667789999999999986543 23356
Q ss_pred EEEEEecCc-ccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH--------CCceeccCCCCcEeecCCCceEEeeeCc
Q 008729 102 IYVVFELME-SDLHQVIKANDDLTREHHQFFLYQMLRALKYMHT--------ANVYHRDLKPKNILANANCKLKVCDFGL 172 (556)
Q Consensus 102 lylV~E~~~-g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs--------~gIvHrDLKP~NILl~~~~~vKL~DFGl 172 (556)
+|+|||||. |+|.++++++ .+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 899999998 7999999875 58999999999999999999997 5999999999999999999999999999
Q ss_pred cccccCCCCC-cceecccccCcccCCcccccccCC----CCCCcchhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHhh
Q 008729 173 ARVAFSDTPM-TVFWTDYVATRWYRAPELCGSFFS----KYTPAIDIWSIGCIFAEVLTGKPLFPGKSVVHQLDLITDLL 247 (556)
Q Consensus 173 a~~~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~----~y~~~~DIWSlG~ilyelltG~~pF~~~~~~~~~~~i~~~~ 247 (556)
++........ .......+||+.|+|||++.+... .++.++|||||||+||||+||.+||......... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~-~~~~~~ 233 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-YYDLVP 233 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-TTTTSC
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc-hhhccc
Confidence 9876443322 112345789999999999875211 2677899999999999999999887543211100 000000
Q ss_pred CCCChHHHHHhhhHHHHHHHHHhhcCCCCC-cCCC--CCCCCHHHHHHHHHhhhcCCCCCCCHHHHHhC
Q 008729 248 GTPSPETIAVVRNEKARKYLTEMRKKPPVP-LFQK--FPNVDPLALRLLQRLIAFDPKDRPTAEEALAD 313 (556)
Q Consensus 248 g~p~~e~i~~~~~~~~~~~l~~~~~~~~~~-~~~~--~~~~s~~~~dLl~~~L~~dP~~Rpta~elL~h 313 (556)
..+..+.+ .. ........+ .... .......+.+|+.+||+.||++|||+.|++++
T Consensus 234 ~~~~~~~~--------~~---~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 234 SDPSVEEM--------RK---VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHHH--------HH---HHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccchHHHH--------HH---HHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 01111111 11 111111111 1111 11223458899999999999999999999873
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=7.7e-26 Score=212.39 Aligned_cols=171 Identities=16% Similarity=0.105 Sum_probs=122.4
Q ss_pred eEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccC------C----------hhHHHHHHHHHHHHHhCCCCCcceee
Q 008729 25 YKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE------H----------ISDAIRILREVKLLRLLRHPDIVEIK 88 (556)
Q Consensus 25 Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~------~----------~~~~~~~~rEi~iL~~L~HpnIv~l~ 88 (556)
|.+.++||+|+||+||+|.+. +|+.||||+++.... . ......+.+|+.+|..+.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 578999999999999999985 689999998752110 0 01123456799999999999999988
Q ss_pred EEEcCCCCCCCceEEEEEecCcccHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEeecCCCceEEe
Q 008729 89 RIMLPPSKREFKDIYVVFELMESDLHQVIKANDDLTREHHQFFLYQMLRALKYMHTANVYHRDLKPKNILANANCKLKVC 168 (556)
Q Consensus 89 ~v~~~~~~~~~~~lylV~E~~~g~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs~gIvHrDLKP~NILl~~~~~vKL~ 168 (556)
+.. . -++||||+++... ..++...+..++.||+.+|.|||++||+||||||+|||++++ .++|+
T Consensus 81 ~~~-----~----~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 81 AWE-----G----NAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp EEE-----T----TEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEEC
T ss_pred Eec-----C----CEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEE
Confidence 764 1 2799999996422 125566678899999999999999999999999999999866 49999
Q ss_pred eeCccccccCCCCCcceecccccCcccCCcccccccCCCCCCcchhhhHHHH
Q 008729 169 DFGLARVAFSDTPMTVFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 220 (556)
Q Consensus 169 DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~y~~~~DIWSlG~i 220 (556)
|||+|..............+ +. .-.+.+. ..|+.++|+||+.--
T Consensus 145 DFG~a~~~~~~~~~~~l~rd-~~----~~~~~f~---r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 145 DFPQSVEVGEEGWREILERD-VR----NIITYFS---RTYRTEKDINSAIDR 188 (191)
T ss_dssp CCTTCEETTSTTHHHHHHHH-HH----HHHHHHH---HHHCCCCCHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHHHH-HH----HHHHHHc---CCCCCcccHHHHHHH
Confidence 99999764322111100000 00 0011221 468899999998643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.41 E-value=4.6e-07 Score=86.33 Aligned_cols=139 Identities=12% Similarity=0.141 Sum_probs=89.8
Q ss_pred CCeEEEeeeeecCceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCCce
Q 008729 23 NRYKILEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREFKD 101 (556)
Q Consensus 23 ~~Y~i~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~~~ 101 (556)
..|++++..+.++.+.||++. ..++.+++|+....... ....+.+|..+|+.|. +--+.+++... ++.+.
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~ 84 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGW 84 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCc
Confidence 368888876666667899884 56777889987643221 2334678999988875 43356666665 34466
Q ss_pred EEEEEecCcc-cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------
Q 008729 102 IYVVFELMES-DLHQVIKANDDLTREHHQFFLYQMLRALKYMHT------------------------------------ 144 (556)
Q Consensus 102 lylV~E~~~g-~L~~~i~~~~~l~~~~~~~i~~QIl~aL~yLHs------------------------------------ 144 (556)
.|+||++++| .+.+..... .....++.++...+..||+
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred eEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 8999999996 444332211 1112233344444444442
Q ss_pred -----------------C------CceeccCCCCcEeecCCCceEEeeeCcccc
Q 008729 145 -----------------A------NVYHRDLKPKNILANANCKLKVCDFGLARV 175 (556)
Q Consensus 145 -----------------~------gIvHrDLKP~NILl~~~~~vKL~DFGla~~ 175 (556)
. .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1 269999999999999776667999997753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.82 E-value=2.6e-05 Score=78.94 Aligned_cols=77 Identities=17% Similarity=0.055 Sum_probs=47.8
Q ss_pred EeeeeecCceeEEEEEECCCCcEEEEEEecCccC-----ChhHHHHHHHHHHHHHhCC-C--CCcceeeEEEcCCCCCCC
Q 008729 28 LEVIGKGSYGVVCAAIDTHTGEKVAIKKIHDVFE-----HISDAIRILREVKLLRLLR-H--PDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~tg~~vAiK~i~~~~~-----~~~~~~~~~rEi~iL~~L~-H--pnIv~l~~v~~~~~~~~~ 99 (556)
.+.||.|....||++.+..+++.|+||.-..... ......+..+|...|+.+. + ..+.+++.+- .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-----~-- 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-----T-- 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-----T--
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-----C--
Confidence 5678999999999998888888999996432111 1112345667888888773 2 3355555442 1
Q ss_pred ceEEEEEecCcc
Q 008729 100 KDIYVVFELMES 111 (556)
Q Consensus 100 ~~lylV~E~~~g 111 (556)
..-++|||++++
T Consensus 104 ~~~~lvmE~L~~ 115 (392)
T d2pula1 104 EMAVTVMEDLSH 115 (392)
T ss_dssp TTTEEEECCCTT
T ss_pred CCCEEEEeccCC
Confidence 124789999974
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.73 E-value=3.1e-05 Score=72.77 Aligned_cols=71 Identities=10% Similarity=0.010 Sum_probs=46.2
Q ss_pred eeeecCc-eeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCC--CCcceeeEEEcCCCCCCCceEEEEE
Q 008729 30 VIGKGSY-GVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRH--PDIVEIKRIMLPPSKREFKDIYVVF 106 (556)
Q Consensus 30 ~LG~G~~-g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~H--pnIv~l~~v~~~~~~~~~~~lylV~ 106 (556)
.+..|.. +.||++.. ..+..+++|..... ....+.+|...|+.|.. -.+.+++.+. .+.+..|+||
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~-----~~~~~~~~v~ 85 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVV-----TEAGRDWLLL 85 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEE-----ECSSCEEEEE
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCcc-----CHhHHHHHHHHHHHHHhcCCCCCceeeec-----ccccceEEEE
Confidence 4455554 67898863 45667889976532 12246678888887743 3356667665 3345689999
Q ss_pred ecCcc
Q 008729 107 ELMES 111 (556)
Q Consensus 107 E~~~g 111 (556)
++++|
T Consensus 86 ~~i~G 90 (255)
T d1nd4a_ 86 GEVPG 90 (255)
T ss_dssp ECCSS
T ss_pred Eeeec
Confidence 99975
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.10 E-value=0.00082 Score=65.61 Aligned_cols=72 Identities=14% Similarity=0.053 Sum_probs=42.5
Q ss_pred ceeEEEEEECCCCcEEEEEEecCccCChhHHHHHHHHHHHHHhCCCCCcceeeEEEcCC--CCCCCceEEEEEecCcc
Q 008729 36 YGVVCAAIDTHTGEKVAIKKIHDVFEHISDAIRILREVKLLRLLRHPDIVEIKRIMLPP--SKREFKDIYVVFELMES 111 (556)
Q Consensus 36 ~g~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~HpnIv~l~~v~~~~--~~~~~~~lylV~E~~~g 111 (556)
--.||++.. .+|+.|++|+.... ......+..|+..|..|..-+|.-..-+.... ........+.|+++++|
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~---~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPE---RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTT---TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cceeEEEEc-CCCCEEEEEEeCCC---CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 457999964 57889999987532 22345577899998888533322111111111 11233457889999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.97 E-value=0.0019 Score=64.60 Aligned_cols=71 Identities=14% Similarity=0.108 Sum_probs=49.0
Q ss_pred EeeeeecCceeEEEEEECC-------CCcEEEEEEecCccCChhHHHHHHHHHHHHHhCC-CCCcceeeEEEcCCCCCCC
Q 008729 28 LEVIGKGSYGVVCAAIDTH-------TGEKVAIKKIHDVFEHISDAIRILREVKLLRLLR-HPDIVEIKRIMLPPSKREF 99 (556)
Q Consensus 28 ~~~LG~G~~g~V~~a~~~~-------tg~~vAiK~i~~~~~~~~~~~~~~rEi~iL~~L~-HpnIv~l~~v~~~~~~~~~ 99 (556)
++.|+.|-.-.+|++.... ..+.|.+++.... .......+|..+++.+. +.-..++++++ .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIF-----SG- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT-
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC-
Confidence 5678889999999998653 3456777766421 12234568999999885 44445777776 22
Q ss_pred ceEEEEEecCcc
Q 008729 100 KDIYVVFELMES 111 (556)
Q Consensus 100 ~~lylV~E~~~g 111 (556)
.+|+||++|
T Consensus 117 ---g~I~efi~g 125 (395)
T d1nw1a_ 117 ---GRLEEYIPS 125 (395)
T ss_dssp ---EEEECCCCE
T ss_pred ---ceEEEEecc
Confidence 688999875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.49 E-value=0.002 Score=62.11 Aligned_cols=29 Identities=28% Similarity=0.264 Sum_probs=26.2
Q ss_pred CceeccCCCCcEeecCCCceEEeeeCccc
Q 008729 146 NVYHRDLKPKNILANANCKLKVCDFGLAR 174 (556)
Q Consensus 146 gIvHrDLKP~NILl~~~~~vKL~DFGla~ 174 (556)
|+||+|+.++||+++.+...-|+||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccccceeEecccccc
Confidence 79999999999999988777899999774
|